data_6yq5_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6yq5 _Structure_validation_residue.Date_analyzed 2020-10-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 HG11 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.454 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' O ' HG11 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG11 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' B' ' 115' ' ' SER . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.675 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 75' ' ' GLY . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.567 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 14' ' ' LEU . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 97' ' ' VAL . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG23 ' A' ' 151' ' ' VAL . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.422 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.421 HG11 ' O ' ' F' ' 32' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 65' ' ' VAL . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 112' ' ' TYR . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.842 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.487 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.501 HG23 ' OH ' ' A' ' 104' ' ' TYR . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.415 ' CG ' HD11 ' G' ' 143' ' ' ILE . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.448 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.518 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.464 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.499 HG21 ' OD1' ' B' ' 95' ' ' ASP . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' B' ' 25' ' ' ALA . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.452 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.429 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.422 ' O ' HG11 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.424 HG11 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . 0.412 ' HB2' ' HZ3' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.45 HG12 ' O ' ' B' ' 75' ' ' GLY . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.621 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.621 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.577 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.503 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 HD21 ' B' ' 14' ' ' LEU . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.499 ' OD1' HG21 ' B' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.407 ' O ' HG12 ' B' ' 97' ' ' VAL . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.835 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG23 ' B' ' 151' ' ' VAL . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . 0.423 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.536 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.675 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.453 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 32' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.421 HG12 ' HB ' ' B' ' 65' ' ' VAL . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' B' ' 112' ' ' TYR . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.536 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.448 HG12 ' HG ' ' A' ' 54' ' ' LEU . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.423 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.835 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.503 HG23 ' OH ' ' B' ' 104' ' ' TYR . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.455 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.455 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . 0.464 ' O ' HG21 ' H' ' 18' ' ' ILE . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' C' ' 95' ' ' ASP . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.504 HD21 HG11 ' C' ' 94' ' ' VAL . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' C' ' 25' ' ' ALA . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.442 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.455 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.522 ' O ' HG11 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.483 ' HA2' ' HG ' ' D' ' 115' ' ' SER . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.57 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.57 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.429 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HZ3' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.444 HG12 ' O ' ' C' ' 75' ' ' GLY . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.628 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.493 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.504 HG11 HD21 ' C' ' 14' ' ' LEU . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' C' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 97' ' ' VAL . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.835 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.499 ' OH ' HG23 ' C' ' 151' ' ' VAL . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . 0.423 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.623 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.455 ' HG ' ' HA2' ' B' ' 39' ' ' GLY . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . 0.422 HG11 ' O ' ' B' ' 32' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.429 HG12 ' HB ' ' C' ' 65' ' ' VAL . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' C' ' 112' ' ' TYR . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.535 ' HA ' HD21 ' B' ' 54' ' ' LEU . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.511 HG12 ' HG ' ' B' ' 54' ' ' LEU . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . 0.423 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.835 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' THR . . . . . 0.478 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' C' ' 104' ' ' TYR . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.44 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.44 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.439 ' O ' HG21 ' I' ' 18' ' ' ILE . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . 0.5 HG21 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.504 HD21 HG11 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' D' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' SER . . . . . 0.446 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.446 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . 0.456 ' O ' HG11 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.419 HG11 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' E' ' 115' ' ' SER . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.451 HG12 ' O ' ' D' ' 75' ' ' GLY . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.632 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . 0.402 ' CD2' ' C ' ' D' ' 83' ' ' TYR . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.632 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.588 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.504 HG11 HD21 ' D' ' 14' ' ' LEU . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . 0.5 ' OD1' HG21 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 97' ' ' VAL . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.841 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' D' ' 151' ' ' VAL . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . 0.425 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.529 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.63 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' SER . . . . . 0.483 ' HG ' ' HA2' ' C' ' 39' ' ' GLY . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . 0.522 HG11 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' D' ' 65' ' ' VAL . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' D' ' 112' ' ' TYR . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.529 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.461 HG12 ' HG ' ' C' ' 54' ' ' LEU . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . 0.416 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . 0.425 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.841 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' D' ' 104' ' ' TYR . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . 0.539 ' CG ' HD11 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.493 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.451 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . 0.592 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.489 HD21 HG11 ' E' ' 94' ' ' VAL . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' E' ' 25' ' ' ALA . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' SER . . . . . 0.469 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.441 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.469 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.56 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.587 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . 0.56 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' E' ' 75' ' ' GLY . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.624 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.486 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.489 HG11 HD21 ' E' ' 14' ' ' LEU . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . 0.484 ' OD1' HG21 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' E' ' 97' ' ' VAL . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.494 ' OH ' HG23 ' E' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . 0.426 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.536 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.659 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 115' ' ' SER . . . . . 0.43 ' HG ' ' HA2' ' D' ' 39' ' ' GLY . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . 0.456 HG11 ' O ' ' D' ' 32' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 129' ' ' SER . . . . . 0.508 ' O ' ' N ' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.412 HG12 ' HB ' ' E' ' 65' ' ' VAL . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' E' ' 112' ' ' TYR . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.536 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.465 HG12 ' HG ' ' D' ' 54' ' ' LEU . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 145' ' ' THR . . . . . 0.492 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.494 HG23 ' OH ' ' E' ' 104' ' ' TYR . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.452 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.452 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . 0.453 ' O ' HG21 ' K' ' 18' ' ' ILE . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.459 ' HB3' HG21 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . 0.489 HG21 ' OD1' ' F' ' 95' ' ' ASP . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.502 HD21 HG11 ' F' ' 94' ' ' VAL . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' F' ' 25' ' ' ALA . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' SER . . . . . 0.467 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.441 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.467 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . 0.421 ' O ' HG11 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . 0.407 ' HZ3' ' HB2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' F' ' 75' ' ' GLY . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.612 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.498 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.502 HG11 HD21 ' F' ' 14' ' ' LEU . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . 0.489 ' OD1' HG21 ' F' ' 11' ' ' VAL . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . 0.403 ' O ' HG12 ' F' ' 97' ' ' VAL . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.812 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.505 ' OH ' HG23 ' F' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.526 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . 0.429 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.524 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 129' ' ' SER . . . . . 0.494 ' O ' ' N ' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' F' ' 65' ' ' VAL . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' F' ' 112' ' ' TYR . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.56 ' HA ' HD21 ' E' ' 54' ' ' LEU . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.587 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . 0.421 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . 0.429 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.812 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 145' ' ' THR . . . . . 0.491 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.505 HG23 ' OH ' ' F' ' 104' ' ' TYR . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.945 ' CD2' HD11 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.522 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.528 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 3.9 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.597 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.452 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.478 ' O ' ' O ' ' L' ' 18' ' ' ILE . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . 0.86 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . 0.459 HE22 ' HA ' ' H' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' G' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . 0.491 HG21 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' G' ' 25' ' ' ALA . 6.3 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 17' ' ' SER . . . . . 0.464 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.518 HG21 ' O ' ' A' ' 168' ' ' GLY . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . 0.464 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . 0.404 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 38' ' ' SER . . . . . 0.448 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' G' ' 58' ' ' SER . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 58' ' ' SER . . . . . 0.425 ' O ' ' N ' ' G' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . 0.445 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . 0.402 ' HZ3' ' HB2' ' G' ' 77' ' ' LYS . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.445 HG12 ' O ' ' G' ' 75' ' ' GLY . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.622 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.622 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.567 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.512 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.501 HG11 HD21 ' G' ' 14' ' ' LEU . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . 0.491 ' OD1' HG21 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' G' ' 97' ' ' VAL . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.841 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.494 ' OH ' HG23 ' G' ' 151' ' ' VAL . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.526 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . 0.43 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.533 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . 0.422 ' HA ' HE22 ' L' ' 9' ' ' GLN . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . 0.548 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . 0.43 HG12 ' HB ' ' G' ' 65' ' ' VAL . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' G' ' 112' ' ' TYR . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.533 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . 0.427 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.841 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 145' ' ' THR . . . . . 0.486 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . 0.458 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.458 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 166' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . 0.501 HG21 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' H' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 168' ' ' GLY . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . 0.45 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 38' ' ' SER . . . . . 0.426 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . 0.554 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . 0.546 ' HB2' HG21 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . 0.554 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.449 HG12 ' O ' ' H' ' 75' ' ' GLY . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.617 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . 0.448 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.505 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.501 HG11 HD21 ' H' ' 14' ' ' LEU . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . 0.501 ' OD1' HG21 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . 0.406 ' O ' HG12 ' H' ' 97' ' ' VAL . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' H' ' 151' ' ' VAL . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . 0.422 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.534 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.444 ' HB2' HD22 ' G' ' 54' ' ' LEU . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . 0.459 ' HA ' HE22 ' G' ' 9' ' ' GLN . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 129' ' ' SER . . . . . 0.498 ' O ' ' N ' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.436 HG12 ' HB ' ' H' ' 65' ' ' VAL . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' H' ' 112' ' ' TYR . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.534 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.813 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 145' ' ' THR . . . . . 0.479 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' H' ' 104' ' ' TYR . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.443 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.443 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' I' ' 25' ' ' ALA . 6.3 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 17' ' ' SER . . . . . 0.458 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.439 HG21 ' O ' ' C' ' 168' ' ' GLY . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . 0.458 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 38' ' ' SER . . . . . 0.407 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . 0.563 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . 0.563 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HZ3' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' I' ' 75' ' ' GLY . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.566 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.492 HG11 HD21 ' I' ' 14' ' ' LEU . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . 0.42 ' O ' HG12 ' I' ' 97' ' ' VAL . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.499 ' OH ' HG23 ' I' ' 151' ' ' VAL . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . 0.421 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' I' ' 132' ' ' LEU . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . 0.545 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' I' ' 65' ' ' VAL . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' I' ' 112' ' ' TYR . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.535 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . 0.504 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.845 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.475 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' I' ' 104' ' ' TYR . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.455 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.455 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' K' ' 122' ' ' VAL . 3.3 mm-40 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.466 ' HB3' HG21 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . 0.486 HG21 ' OD1' ' J' ' 95' ' ' ASP . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.503 HD21 HG11 ' J' ' 94' ' ' VAL . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' J' ' 25' ' ' ALA . 6.3 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.592 HG21 ' O ' ' D' ' 168' ' ' GLY . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . 0.455 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . 0.574 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . 0.574 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.451 HG12 ' O ' ' J' ' 75' ' ' GLY . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.407 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.627 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.503 HG11 HD21 ' J' ' 14' ' ' LEU . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . 0.486 ' OD1' HG21 ' J' ' 11' ' ' VAL . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . 0.415 ' O ' HG12 ' J' ' 97' ' ' VAL . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG23 ' J' ' 151' ' ' VAL . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.53 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . 0.426 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.451 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.416 HG12 ' HB ' ' J' ' 65' ' ' VAL . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' J' ' 112' ' ' TYR . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.535 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . 0.418 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.826 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 145' ' ' THR . . . . . 0.474 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.5 HG23 ' OH ' ' J' ' 104' ' ' TYR . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.454 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.454 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.539 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . 0.427 HE22 ' HA ' ' L' ' 122' ' ' VAL . 3.2 mm-40 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.494 HG21 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.505 HD21 HG11 ' K' ' 94' ' ' VAL . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' K' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 17' ' ' SER . . . . . 0.46 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.453 HG21 ' O ' ' E' ' 168' ' ' GLY . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . 0.402 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' L' ' 115' ' ' SER . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' K' ' 58' ' ' SER . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . 0.448 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.448 HG12 ' O ' ' K' ' 75' ' ' GLY . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.62 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.504 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.505 HG11 HD21 ' K' ' 14' ' ' LEU . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . 0.494 ' OD1' HG21 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . 0.403 ' O ' HG12 ' K' ' 97' ' ' VAL . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.819 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' K' ' 151' ' ' VAL . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . 0.417 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.532 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.459 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . 0.414 ' HA ' HE22 ' J' ' 9' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' K' ' 65' ' ' VAL . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' K' ' 112' ' ' TYR . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.532 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 145' ' ' THR . . . . . 0.483 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' K' ' 104' ' ' TYR . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.444 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.444 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . 0.422 HE22 ' HA ' ' G' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.462 ' HB3' HG21 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . 0.487 HG21 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' L' ' 25' ' ' ALA . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 17' ' ' SER . . . . . 0.472 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.86 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . 0.472 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 22' ' ' THR . . . . . 0.448 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 38' ' ' SER . . . . . 0.41 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' L' ' 58' ' ' SER . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . 0.554 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . 0.555 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . 0.554 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . 0.44 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.44 HG12 ' O ' ' L' ' 75' ' ' GLY . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.609 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.609 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . 0.581 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.522 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.491 HG11 HD21 ' L' ' 14' ' ' LEU . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . 0.487 ' OD1' HG21 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . 0.406 ' O ' HG12 ' L' ' 97' ' ' VAL . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.831 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' L' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.523 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . 0.427 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.532 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.433 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 115' ' ' SER . . . . . 0.453 ' HG ' ' HA2' ' K' ' 39' ' ' GLY . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . 0.427 ' HA ' HE22 ' K' ' 9' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 129' ' ' SER . . . . . 0.493 ' O ' ' N ' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.421 HG12 ' HB ' ' L' ' 65' ' ' VAL . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' L' ' 112' ' ' TYR . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' K' ' 54' ' ' LEU . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . 0.446 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.945 HD11 ' CD2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' L' ' 104' ' ' TYR . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . 0.444 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.444 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 166' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.55 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' HG1' ' A' ' 66' ' ' THR . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.45 ' HG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.571 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.465 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.453 ' HB1' HG23 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.637 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.527 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.571 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.498 HG23 ' OH ' ' A' ' 104' ' ' TYR . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 6.2 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.564 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.465 ' HB3' HG21 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.5 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.545 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' B' ' 14' ' ' LEU . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.455 HG22 ' HG1' ' B' ' 66' ' ' THR . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' C' ' 134' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.455 ' HG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.681 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.681 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.525 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.566 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.408 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . 0.463 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.452 ' HB1' HG23 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.498 ' O ' ' N ' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.622 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.51 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.496 HG23 ' OH ' ' B' ' 104' ' ' TYR . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.422 ' HG2' ' OD2' ' H' ' 144' ' ' ASP . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.41 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.4 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.2 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . 0.493 ' O ' HG21 ' H' ' 18' ' ' ILE . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' C' ' 6' ' ' ILE . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.532 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' C' ' 14' ' ' LEU . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.468 ' O ' HG11 ' D' ' 122' ' ' VAL . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' THR . . . . . 0.462 HG22 ' HG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.413 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' D' ' 134' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' THR . . . . . 0.462 ' HG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.673 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.673 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.513 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.577 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.56 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.422 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.528 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . 0.446 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.536 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . 0.639 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.528 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.508 HG23 ' OH ' ' C' ' 104' ' ' TYR . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.402 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.402 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . 0.472 ' O ' HG21 ' I' ' 18' ' ' ILE . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . 0.451 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.451 ' HB3' HG21 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . 0.4 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' SER . . . . . 0.547 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.547 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.43 ' CB ' HD13 ' D' ' 14' ' ' LEU . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' THR . . . . . 0.453 HG22 ' HG1' ' D' ' 66' ' ' THR . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.408 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.44 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' THR . . . . . 0.453 ' HG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.684 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.684 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.592 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.564 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.41 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . 0.452 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . 0.468 HG11 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' SER . . . . . 0.505 ' O ' ' N ' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.465 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . 0.645 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.526 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . 0.564 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.495 HG23 ' OH ' ' D' ' 104' ' ' TYR . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.455 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 6.2 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.433 ' O ' ' O ' ' J' ' 18' ' ' ILE . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . 0.615 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.5 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' SER . . . . . 0.554 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.554 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' E' ' 14' ' ' LEU . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' THR . . . . . 0.44 HG22 ' HG1' ' E' ' 66' ' ' THR . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.41 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.582 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' THR . . . . . 0.44 ' HG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.53 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.569 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.414 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . 0.455 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 129' ' ' SER . . . . . 0.493 ' O ' ' N ' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.637 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.44 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . 0.637 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.523 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . 0.577 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.501 HG23 ' OH ' ' E' ' 104' ' ' TYR . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.431 ' HA ' HE22 ' K' ' 16' ' ' GLN . 4.4 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.402 ' C ' ' HA2' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . 0.495 ' O ' HG21 ' K' ' 18' ' ' ILE . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' F' ' 10' ' ' ASP . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' F' ' 6' ' ' ILE . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 126' ' ' VAL . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' SER . . . . . 0.539 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' F' ' 14' ' ' LEU . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 33' ' ' THR . . . . . 0.456 HG22 ' HG1' ' F' ' 66' ' ' THR . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 66' ' ' THR . . . . . 0.456 ' HG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.703 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.595 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.573 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.413 HG23 ' O ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.531 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . 0.464 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . 0.459 ' HB1' HG23 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 129' ' ' SER . . . . . 0.503 ' O ' ' N ' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.615 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.582 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . 0.615 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.531 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' F' ' 104' ' ' TYR . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD11 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.525 ' O ' ' CZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.682 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 4.4 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.416 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 6.3 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.587 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.691 ' O ' ' O ' ' L' ' 18' ' ' ILE . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . 0.903 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . 0.444 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . 0.434 HE22 ' HA ' ' H' ' 122' ' ' VAL . 2.5 mm-40 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.459 ' HB3' HG21 ' G' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.567 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 17' ' ' SER . . . . . 0.555 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.564 HG21 ' O ' ' A' ' 168' ' ' GLY . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . 0.555 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' G' ' 14' ' ' LEU . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 33' ' ' THR . . . . . 0.447 HG22 ' HG1' ' G' ' 66' ' ' THR . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . 0.41 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . 0.482 ' HB2' HG21 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 66' ' ' THR . . . . . 0.447 ' HG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.7 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.7 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.567 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.419 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.516 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . 0.456 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . 0.419 ' HA ' HE22 ' L' ' 9' ' ' GLN . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 129' ' ' SER . . . . . 0.499 ' O ' ' N ' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.632 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . 0.496 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.516 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' G' ' 104' ' ' TYR . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.415 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 6.2 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 166' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' G' ' 173' ' ' THR . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.443 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' H' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 17' ' ' SER . . . . . 0.546 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.493 HG21 ' O ' ' B' ' 168' ' ' GLY . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.41 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' H' ' 14' ' ' LEU . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 33' ' ' THR . . . . . 0.459 HG22 ' HG1' ' H' ' 66' ' ' THR . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 66' ' ' THR . . . . . 0.459 ' HG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.404 ' HA ' HD11 ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.496 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.598 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.571 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . 0.462 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.526 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . 0.434 ' HA ' HE22 ' G' ' 9' ' ' GLN . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 129' ' ' SER . . . . . 0.491 ' O ' ' N ' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.632 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.501 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.521 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . 0.422 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . 0.565 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' H' ' 104' ' ' TYR . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' H' ' 173' ' ' THR . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 167' ' ' THR . . . . . 0.412 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . 0.466 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.466 ' HB3' HG21 ' I' ' 6' ' ' ILE . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 17' ' ' SER . . . . . 0.542 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.472 HG21 ' O ' ' C' ' 168' ' ' GLY . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' I' ' 14' ' ' LEU . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 33' ' ' THR . . . . . 0.448 HG22 ' HG1' ' I' ' 66' ' ' THR . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.557 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 66' ' ' THR . . . . . 0.448 ' HG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.679 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.501 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.679 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.524 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.583 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.563 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.418 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 129' ' ' SER . . . . . 0.496 ' O ' ' N ' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.631 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.518 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.505 HG23 ' OH ' ' I' ' 104' ' ' TYR . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 6.2 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 167' ' ' THR . . . . . 0.414 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' J' ' 10' ' ' ASP . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.465 ' HB3' HG21 ' J' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . 0.412 HG22 HG11 ' K' ' 126' ' ' VAL . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 17' ' ' SER . . . . . 0.543 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.615 HG21 ' O ' ' D' ' 168' ' ' GLY . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' J' ' 14' ' ' LEU . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 33' ' ' THR . . . . . 0.452 HG22 ' HG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 66' ' ' THR . . . . . 0.452 ' HG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . 0.595 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.406 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . 0.451 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' I' ' 33' ' ' THR . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 129' ' ' SER . . . . . 0.5 ' O ' ' N ' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.557 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . 0.645 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . 0.407 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.524 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.493 HG23 ' OH ' ' J' ' 104' ' ' TYR . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.404 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.404 HE22 ' HD2' ' J' ' 163' ' ' PRO . 6.2 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' J' ' 173' ' ' THR . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 167' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' L' ' 122' ' ' VAL . 2.5 mm-40 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' K' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.415 HG22 HG11 ' L' ' 126' ' ' VAL . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 17' ' ' SER . . . . . 0.553 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.495 HG21 ' O ' ' E' ' 168' ' ' GLY . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' K' ' 14' ' ' LEU . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' K' ' 66' ' ' THR . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.53 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . 0.604 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.547 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.415 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . 0.452 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 129' ' ' SER . . . . . 0.506 ' O ' ' N ' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.643 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.609 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.537 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.475 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.503 HG23 ' OH ' ' K' ' 104' ' ' TYR . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.406 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.406 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.2 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 167' ' ' THR . . . . . 0.43 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' G' ' 122' ' ' VAL . 2.5 mm-40 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' L' ' 6' ' ' ILE . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 17' ' ' SER . . . . . 0.556 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.903 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . 0.556 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' L' ' 14' ' ' LEU . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' L' ' 66' ' ' THR . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.703 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.562 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.555 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.413 HG23 ' O ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.536 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.4 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . 0.466 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . 0.406 ' HA ' HE22 ' K' ' 9' ' ' GLN . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 129' ' ' SER . . . . . 0.508 ' O ' ' N ' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . 0.629 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . 0.428 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.682 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.6 HD11 ' CD2' ' F' ' 160' ' ' PHE . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.497 HG23 ' OH ' ' L' ' 104' ' ' TYR . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.407 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 6.3 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 166' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 167' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 96' ' ' THR . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 94' ' ' VAL . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.685 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.459 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.519 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' CE2' HD12 ' A' ' 128' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.435 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 14' ' ' LEU . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.54 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' A' ' 151' ' ' VAL . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 67' ' ' TYR . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.459 HG22 HD21 ' A' ' 14' ' ' LEU . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.578 HD12 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 146' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' A' ' 104' ' ' TYR . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.482 ' HA ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.755 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.755 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' B' ' 96' ' ' THR . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.421 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.546 HD12 HG21 ' B' ' 94' ' ' VAL . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.692 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' SER . . . . . 0.58 ' OG ' HD12 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.515 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.68 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' B' ' 128' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 79' ' ' ILE . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.474 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' B' ' 91' ' ' PHE . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.546 HG21 HD12 ' B' ' 14' ' ' LEU . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.495 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' B' ' 151' ' ' VAL . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB3' ' HG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' B' ' 67' ' ' TYR . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.42 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' SER . . . . . 0.632 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 54' ' ' LEU . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' B' ' 102' ' ' ASP . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' THR . . . . . 0.458 HG22 HD21 ' B' ' 14' ' ' LEU . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.58 HD12 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.401 HD12 HD23 ' B' ' 146' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' B' ' 104' ' ' TYR . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.614 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 15.5 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.499 ' HA ' ' NE2' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.743 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.536 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . 0.567 ' HG2' HD11 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.536 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . 0.743 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 96' ' ' THR . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . 0.423 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.535 HD12 HG21 ' C' ' 94' ' ' VAL . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.701 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' SER . . . . . 0.564 ' OG ' HD12 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.701 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.423 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.43 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.639 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.475 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 9.3 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.484 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' C' ' 91' ' ' PHE . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.535 HG21 HD12 ' C' ' 14' ' ' LEU . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . 0.55 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.528 ' CZ ' HG23 ' C' ' 151' ' ' VAL . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . 0.692 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . 0.46 ' HB3' ' HG ' ' B' ' 38' ' ' SER . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' C' ' 67' ' ' TYR . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.432 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.68 HD12 HD23 ' B' ' 54' ' ' LEU . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . 0.692 HD11 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.55 HG13 ' OD1' ' C' ' 102' ' ' ASP . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' THR . . . . . 0.467 HG22 HD21 ' C' ' 14' ' ' LEU . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . 0.564 HD12 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.497 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.528 HG23 ' CZ ' ' C' ' 104' ' ' TYR . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.61 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 15.6 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.749 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' THR . . . . . 0.547 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . 0.583 ' HG2' HD11 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.547 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . 0.749 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' D' ' 96' ' ' THR . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . 0.431 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.528 HD12 HG21 ' D' ' 94' ' ' VAL . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' SER . . . . . 0.567 ' OG ' HD12 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.431 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' SER . . . . . 0.487 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.502 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' D' ' 128' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 9.2 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . 0.43 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.492 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' D' ' 91' ' ' PHE . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.528 HG21 HD12 ' D' ' 14' ' ' LEU . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.496 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' D' ' 151' ' ' VAL . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . 0.402 ' HB3' ' HG ' ' C' ' 38' ' ' SER . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . 0.43 HD12 ' CE2' ' D' ' 67' ' ' TYR . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . 0.426 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.639 HD12 HD23 ' C' ' 54' ' ' LEU . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . 0.712 HD11 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.551 HG13 ' OD1' ' D' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 145' ' ' THR . . . . . 0.472 HG22 HD21 ' D' ' 14' ' ' LEU . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . 0.567 HD12 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . 0.4 HD12 HD23 ' D' ' 146' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' D' ' 104' ' ' TYR . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.597 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 15.5 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' NE2' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.753 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.553 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . 0.63 ' HG2' HD11 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.553 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . 0.753 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' E' ' 96' ' ' THR . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . 0.423 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.53 HD12 HG21 ' E' ' 94' ' ' VAL . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' SER . . . . . 0.573 ' OG ' HD12 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.685 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.423 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' SER . . . . . 0.468 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.629 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . 0.428 ' CE2' HD12 ' E' ' 128' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 9.3 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.488 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' E' ' 91' ' ' PHE . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.53 HG21 HD12 ' E' ' 14' ' ' LEU . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.495 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' E' ' 151' ' ' VAL . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . 0.701 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . 0.435 ' HB3' ' HG ' ' D' ' 38' ' ' SER . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . 0.428 HD12 ' CE2' ' E' ' 67' ' ' TYR . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.422 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 131' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . 0.674 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.502 HD12 HD23 ' D' ' 54' ' ' LEU . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . 0.701 HD11 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' E' ' 102' ' ' ASP . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 145' ' ' THR . . . . . 0.474 HG22 HD21 ' E' ' 14' ' ' LEU . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . 0.573 HD12 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . 0.406 HD12 HD23 ' E' ' 146' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' E' ' 104' ' ' TYR . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.62 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.753 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.547 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . 0.528 ' HG2' HD11 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.547 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . 0.753 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.484 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' F' ' 96' ' ' THR . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . 0.409 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.54 HD12 HG21 ' F' ' 94' ' ' VAL . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.682 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' SER . . . . . 0.578 ' OG ' HD12 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 38' ' ' SER . . . . . 0.435 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 62' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' F' ' 128' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . 0.468 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' F' ' 91' ' ' PHE . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.54 HG21 HD12 ' F' ' 14' ' ' LEU . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' F' ' 151' ' ' VAL . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 119' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . 0.43 HD12 ' CE2' ' F' ' 67' ' ' TYR . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.416 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 131' ' ' SER . . . . . 0.619 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.629 HD12 HD23 ' E' ' 54' ' ' LEU . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' F' ' 102' ' ' ASP . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 145' ' ' THR . . . . . 0.47 HG22 HD21 ' F' ' 14' ' ' LEU . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . 0.578 HD12 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' F' ' 104' ' ' TYR . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.555 ' CD1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.617 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 15.6 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.5 ' HA ' ' NE2' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.766 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.532 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.787 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.532 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . 0.766 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' G' ' 96' ' ' THR . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . 0.41 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.545 HD12 HG21 ' G' ' 94' ' ' VAL . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.69 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 24' ' ' SER . . . . . 0.58 ' OG ' HD12 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.69 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.41 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 62' ' ' SER . . . . . 0.654 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 9.3 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.479 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.479 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.523 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' G' ' 91' ' ' PHE . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.492 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.545 HG21 HD12 ' G' ' 14' ' ' LEU . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . 0.55 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' G' ' 151' ' ' VAL . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . 0.7 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' G' ' 67' ' ' TYR . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . 0.416 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 131' ' ' SER . . . . . 0.616 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . 0.654 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . 0.7 HD11 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.55 HG13 ' OD1' ' G' ' 102' ' ' ASP . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 145' ' ' THR . . . . . 0.465 HG22 HD21 ' G' ' 14' ' ' LEU . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . 0.58 HD12 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . 0.402 HD12 HD23 ' G' ' 146' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' G' ' 104' ' ' TYR . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . 0.617 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.496 ' HA ' ' NE2' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 166' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 167' ' ' THR . . . . . 0.537 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.537 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . 0.748 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' H' ' 96' ' ' THR . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.545 HD12 HG21 ' H' ' 94' ' ' VAL . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 24' ' ' SER . . . . . 0.573 ' OG ' HD12 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.702 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 38' ' ' SER . . . . . 0.401 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 62' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . 0.43 ' OH ' HG23 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.501 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' H' ' 91' ' ' PHE . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.545 HG21 HD12 ' H' ' 14' ' ' LEU . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . 0.546 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' H' ' 151' ' ' VAL . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . 0.426 HD12 ' CE2' ' H' ' 67' ' ' TYR . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.423 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 131' ' ' SER . . . . . 0.622 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . 0.697 HD11 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.546 HG13 ' OD1' ' H' ' 102' ' ' ASP . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 145' ' ' THR . . . . . 0.455 HG22 HD21 ' H' ' 14' ' ' LEU . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . 0.573 HD12 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' H' ' 104' ' ' TYR . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 167' ' ' THR . . . . . 0.531 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.531 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . 0.754 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . 0.413 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.442 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' I' ' 96' ' ' THR . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.544 HD12 HG21 ' I' ' 94' ' ' VAL . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.703 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 24' ' ' SER . . . . . 0.577 ' OG ' HD12 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.703 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 38' ' ' SER . . . . . 0.467 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.457 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 62' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG23 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' I' ' 79' ' ' ILE . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.489 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.544 HG21 HD12 ' I' ' 14' ' ' LEU . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . 0.543 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.533 ' CZ ' HG23 ' I' ' 151' ' ' VAL . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . 0.69 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' I' ' 67' ' ' TYR . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.431 ' O ' HG13 ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 131' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . 0.665 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . 0.69 HD11 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.543 HG13 ' OD1' ' I' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 145' ' ' THR . . . . . 0.458 HG22 HD21 ' I' ' 14' ' ' LEU . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' I' ' 104' ' ' TYR . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . 0.614 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.503 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.746 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 167' ' ' THR . . . . . 0.539 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.539 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . 0.746 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' J' ' 96' ' ' THR . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.532 HD12 HG21 ' J' ' 94' ' ' VAL . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.692 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 24' ' ' SER . . . . . 0.576 ' OG ' HD12 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 62' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . 0.429 ' CE2' HD12 ' J' ' 128' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.467 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 9.3 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.532 HG21 HD12 ' J' ' 14' ' ' LEU . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.521 ' CZ ' HG23 ' J' ' 151' ' ' VAL . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . 0.417 ' HB3' ' HG ' ' I' ' 38' ' ' SER . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . 0.429 HD12 ' CE2' ' J' ' 67' ' ' TYR . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.431 ' O ' HG13 ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 131' ' ' SER . . . . . 0.638 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . 0.676 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.457 HD12 HD23 ' I' ' 54' ' ' LEU . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . 0.699 HD11 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' J' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 145' ' ' THR . . . . . 0.472 HG22 HD21 ' J' ' 14' ' ' LEU . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . 0.576 HD12 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . 0.406 HD12 HD23 ' J' ' 146' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.521 HG23 ' CZ ' ' J' ' 104' ' ' TYR . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.493 ' HA ' ' NE2' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 167' ' ' THR . . . . . 0.55 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.55 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . 0.738 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.436 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' K' ' 96' ' ' THR . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . 0.429 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.526 HD12 HG21 ' K' ' 94' ' ' VAL . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.683 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.528 HD11 ' HG2' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 24' ' ' SER . . . . . 0.57 ' OG ' HD12 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 38' ' ' SER . . . . . 0.405 ' HG ' ' HB3' ' L' ' 116' ' ' ARG . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.513 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 62' ' ' SER . . . . . 0.654 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . 0.431 ' CE2' HD12 ' K' ' 128' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.458 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.486 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.486 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.449 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' K' ' 91' ' ' PHE . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.526 HG21 HD12 ' K' ' 14' ' ' LEU . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' K' ' 151' ' ' VAL . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . 0.713 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 119' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' K' ' 67' ' ' TYR . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.426 ' O ' HG13 ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 131' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . 0.654 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . 0.713 HD11 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' K' ' 102' ' ' ASP . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 145' ' ' THR . . . . . 0.476 HG22 HD21 ' K' ' 14' ' ' LEU . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . 0.57 HD12 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' K' ' 104' ' ' TYR . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 167' ' ' THR . . . . . 0.556 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.556 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . 0.751 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.442 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' L' ' 96' ' ' THR . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . 0.415 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.54 HD12 HG21 ' L' ' 94' ' ' VAL . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.682 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 24' ' ' SER . . . . . 0.572 ' OG ' HD12 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 62' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . 0.621 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . 0.428 ' CE2' HD12 ' L' ' 128' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 9.3 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.489 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.787 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' L' ' 91' ' ' PHE . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' F' ' 162' ' ' GLN . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.54 HG21 HD12 ' L' ' 14' ' ' LEU . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.5 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.528 ' CZ ' HG23 ' L' ' 151' ' ' VAL . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . 0.696 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . 0.405 ' HB3' ' HG ' ' K' ' 38' ' ' SER . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . 0.428 HD12 ' CE2' ' L' ' 67' ' ' TYR . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.41 ' O ' HG13 ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 131' ' ' SER . . . . . 0.621 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.513 HD12 HD23 ' K' ' 54' ' ' LEU . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.696 HD11 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 11.1 p-10 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' L' ' 102' ' ' ASP . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 145' ' ' THR . . . . . 0.47 HG22 HD21 ' L' ' 14' ' ' LEU . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . 0.572 HD12 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . 0.404 HD12 HD23 ' L' ' 146' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.528 HG23 ' CZ ' ' L' ' 104' ' ' TYR . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . 0.619 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 166' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 167' ' ' THR . . . . . 0.55 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.55 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . 0.768 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.412 ' O ' ' OG1' ' A' ' 96' ' ' THR . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.524 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' A' ' 94' ' ' VAL . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.418 ' OG ' HD12 ' A' ' 146' ' ' LEU . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.586 HH11 ' HA ' ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.57 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 10.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.417 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.417 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.512 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.712 HD11 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.407 HG21 ' CG2' ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 150' ' ' ILE . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 HD23 ' A' ' 146' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 17.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' B' ' 96' ' ' THR . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.522 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' B' ' 94' ' ' VAL . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.507 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' B' ' 146' ' ' LEU . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.522 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.557 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.598 HH11 ' HA ' ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.66 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.564 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 10.4 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' B' ' 78' ' ' ALA . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . 0.52 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.418 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.446 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.433 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' B' ' 14' ' ' LEU . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.557 ' CZ ' HG23 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.429 ' O ' HG12 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.509 HD12 HD23 ' A' ' 54' ' ' LEU . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.726 HD11 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' THR . . . . . 0.413 HG21 ' CG2' ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . 0.496 HD23 HD12 ' B' ' 150' ' ' ILE . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.496 HD12 HD23 ' B' ' 146' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.557 HG23 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.484 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 17.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' C' ' 96' ' ' THR . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . 0.503 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.464 ' CD1' HG21 ' C' ' 94' ' ' VAL . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.517 ' HA ' ' CE ' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' SER . . . . . 0.424 ' OG ' HD12 ' C' ' 146' ' ' LEU . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.433 HG23 ' OE1' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.605 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 41' ' ' ARG . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.653 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 10.5 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' C' ' 78' ' ' ALA . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' B' ' 54' ' ' LEU . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' C' ' 14' ' ' LEU . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.431 ' O ' HG12 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.425 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.539 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.494 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.66 HD12 HD23 ' B' ' 54' ' ' LEU . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . 0.726 HD11 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' THR . . . . . 0.416 HG21 ' CG2' ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . 0.499 HD23 HD12 ' C' ' 150' ' ' ILE . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . 0.499 HD12 HD23 ' C' ' 146' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.496 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 17.4 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.684 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . 0.684 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.404 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' D' ' 96' ' ' THR . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . 0.518 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' D' ' 94' ' ' VAL . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.523 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' D' ' 146' ' ' LEU . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' SER . . . . . 0.493 ' O ' ' N ' ' D' ' 41' ' ' ARG . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.555 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' D' ' 78' ' ' ALA . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.429 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 14' ' ' LEU . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.566 ' CZ ' HG23 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.429 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . 0.433 ' OE1' HG23 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . 0.553 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' SER . . . . . 0.494 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.605 HD12 HD23 ' C' ' 54' ' ' LEU . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . 0.732 HD11 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 145' ' ' THR . . . . . 0.414 HG21 ' CG2' ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . 0.49 HD23 HD12 ' D' ' 150' ' ' ILE . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . 0.49 HD12 HD23 ' D' ' 146' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.566 HG23 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 17.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . 0.682 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.403 ' O ' ' OG1' ' E' ' 96' ' ' THR . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . 0.526 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' E' ' 94' ' ' VAL . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' CE ' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' SER . . . . . 0.414 ' OG ' HD12 ' E' ' 146' ' ' LEU . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.596 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.599 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' SER . . . . . 0.477 ' O ' ' N ' ' E' ' 41' ' ' ARG . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.569 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' E' ' 78' ' ' ALA . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . 0.525 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' E' ' 14' ' ' LEU . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' E' ' 10' ' ' ASP . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.552 ' CZ ' HG23 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . 0.735 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.438 ' O ' HG12 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 119' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 131' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.478 HD12 HD23 ' D' ' 54' ' ' LEU . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . 0.735 HD11 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 145' ' ' THR . . . . . 0.404 HG21 ' CG2' ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 150' ' ' ILE . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . 0.478 HD12 HD23 ' E' ' 146' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.552 HG23 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 17.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . 0.697 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . 0.424 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.494 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.41 ' O ' ' OG1' ' F' ' 96' ' ' THR . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' F' ' 94' ' ' VAL . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . 0.524 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.521 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' SER . . . . . 0.423 ' OG ' HD12 ' F' ' 146' ' ' LEU . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . 0.585 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' F' ' 41' ' ' ARG . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 62' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.56 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 10.5 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' F' ' 78' ' ' ALA . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.451 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' F' ' 14' ' ' LEU . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' F' ' 10' ' ' ASP . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.565 ' CZ ' HG23 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 119' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 131' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.599 HD12 HD23 ' E' ' 54' ' ' LEU . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 145' ' ' THR . . . . . 0.408 HG22 HD21 ' F' ' 14' ' ' LEU . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' F' ' 150' ' ' ILE . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' F' ' 146' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.565 HG23 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.81 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.794 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.569 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.743 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 17.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.665 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' K' ' 54' ' ' LEU . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . 0.697 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.453 ' O ' HG23 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.413 ' O ' ' OG1' ' G' ' 96' ' ' THR . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' G' ' 94' ' ' VAL . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . 0.528 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' G' ' 146' ' ' LEU . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.506 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' G' ' 41' ' ' ARG . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . 0.569 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 10.5 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' G' ' 78' ' ' ALA . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.43 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.453 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' G' ' 14' ' ' LEU . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' G' ' 10' ' ' ASP . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.555 ' CZ ' HG23 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . 0.721 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.428 ' O ' HG12 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . 0.551 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 119' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . 0.407 HG23 HG13 ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . 0.551 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 131' ' ' SER . . . . . 0.513 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.428 HG12 ' O ' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . 0.721 HD11 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 145' ' ' THR . . . . . 0.407 HG22 HD21 ' G' ' 14' ' ' LEU . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . 0.475 HD23 HD12 ' G' ' 150' ' ' ILE . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . 0.475 HD12 HD23 ' G' ' 146' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.555 HG23 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . 0.503 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 166' ' ' THR . . . . . 0.69 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . 0.69 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.456 ' O ' HG23 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' H' ' 96' ' ' THR . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . 0.526 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' H' ' 94' ' ' VAL . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.515 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' H' ' 146' ' ' LEU . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . 0.596 HH11 ' HA ' ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 58' ' ' SER . . . . . 0.475 ' O ' ' N ' ' H' ' 41' ' ' ARG . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 62' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . 0.559 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' H' ' 78' ' ' ALA . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.413 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.443 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' H' ' 14' ' ' LEU . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.567 ' CZ ' HG23 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . 0.73 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.424 ' O ' HG12 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.413 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . 0.453 HG23 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.535 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.424 HG12 ' O ' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . 0.73 HD11 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' H' ' 150' ' ' ILE . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.429 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' H' ' 146' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.567 HG23 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . 0.483 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.691 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . 0.454 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.434 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' I' ' 96' ' ' THR . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . 0.521 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' I' ' 94' ' ' VAL . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . 0.522 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.519 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' I' ' 146' ' ' LEU . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . 0.597 HH11 ' HA ' ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.447 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 58' ' ' SER . . . . . 0.502 ' O ' ' N ' ' I' ' 41' ' ' ARG . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 62' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . 0.566 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.664 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' I' ' 78' ' ' ALA . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.418 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' I' ' 14' ' ' LEU . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.561 ' CZ ' HG23 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . 0.708 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.428 ' O ' HG12 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . 0.552 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 119' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . 0.456 HG23 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 131' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.428 HG12 ' O ' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . 0.708 HD11 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 145' ' ' THR . . . . . 0.41 HG21 ' CG2' ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . 0.496 HD23 HD12 ' I' ' 150' ' ' ILE . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . 0.496 HD12 HD23 ' I' ' 146' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.561 HG23 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . 0.42 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.445 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' J' ' 96' ' ' THR . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . 0.503 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.46 ' CD1' HG21 ' J' ' 94' ' ' VAL . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.517 ' HA ' ' CE ' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 24' ' ' SER . . . . . 0.416 ' OG ' HD12 ' J' ' 146' ' ' LEU . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . 0.595 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 58' ' ' SER . . . . . 0.488 ' O ' ' N ' ' J' ' 41' ' ' ARG . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 62' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.661 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' J' ' 78' ' ' ALA . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.432 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' J' ' 14' ' ' LEU . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.559 ' CZ ' HG23 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . 0.736 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.422 ' O ' HG12 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.432 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . 0.556 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 119' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 131' ' ' SER . . . . . 0.495 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.447 HD12 HD23 ' I' ' 54' ' ' LEU . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . 0.736 HD11 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' D' ' 160' ' ' PHE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . 0.494 HD23 HD12 ' J' ' 150' ' ' ILE . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . 0.494 HD12 HD23 ' J' ' 146' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.559 HG23 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . 0.49 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . 0.679 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.453 HG13 HG23 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.454 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' K' ' 96' ' ' THR . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . 0.52 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' K' ' 94' ' ' VAL . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.523 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' K' ' 146' ' ' LEU . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.507 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 58' ' ' SER . . . . . 0.465 ' O ' ' N ' ' K' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 62' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' K' ' 78' ' ' ALA . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' K' ' 14' ' ' LEU . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' K' ' 10' ' ' ASP . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.558 ' CZ ' HG23 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.431 ' O ' HG12 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 119' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 131' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.431 HG12 ' O ' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . 0.479 HD23 HD12 ' K' ' 150' ' ' ILE . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . 0.479 HD12 HD23 ' K' ' 146' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.558 HG23 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.676 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . 0.676 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.407 HG13 HG23 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.432 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' L' ' 96' ' ' THR . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' L' ' 94' ' ' VAL . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' L' ' 146' ' ' LEU . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . 0.593 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 58' ' ' SER . . . . . 0.482 ' O ' ' N ' ' L' ' 41' ' ' ARG . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . 0.561 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.653 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 10.5 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' L' ' 78' ' ' ALA . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.743 ' CZ2' ' HA ' ' F' ' 162' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.456 HG21 ' CD1' ' L' ' 14' ' ' LEU . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' L' ' 10' ' ' ASP . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' L' ' 138' ' ' LEU . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . 0.733 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.432 ' O ' HG12 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 119' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . 0.453 HG23 HG13 ' K' ' 6' ' ' ILE . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 131' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.507 HD12 HD23 ' K' ' 54' ' ' LEU . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.733 HD11 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.81 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.3 p-10 -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.784 HD13 ' CD1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 145' ' ' THR . . . . . 0.41 HG21 ' CG2' ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' L' ' 150' ' ' ILE . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' L' ' 146' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . 0.5 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 166' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 22' ' ' THR . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 20' ' ' ALA . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' A' ' 14' ' ' LEU . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 13' ' ' TYR . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.617 ' O ' HG11 ' B' ' 122' ' ' VAL . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.493 HG22 ' HG1' ' A' ' 66' ' ' THR . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG11 ' CG ' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' B' ' 115' ' ' SER . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.752 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.752 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.493 ' HG1' HG22 ' A' ' 33' ' ' THR . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HE1' HD22 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.411 ' OH ' HG23 ' A' ' 151' ' ' VAL . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.55 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.458 ' HG2' ' CG2' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' CG ' HG11 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.652 HG11 ' O ' ' F' ' 32' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 ' CG2' ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.415 HD22 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.518 HG11 ' HG3' ' A' ' 137' ' ' GLU . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.518 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.619 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.546 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.4 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.504 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.504 HE22 ' HD2' ' A' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . 0.487 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' B' ' 25' ' ' ALA . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.442 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' B' ' 22' ' ' THR . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' THR . . . . . 0.563 HG22 ' HB2' ' B' ' 20' ' ' ALA . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' B' ' 14' ' ' LEU . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' B' ' 13' ' ' TYR . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.626 ' O ' HG11 ' C' ' 122' ' ' VAL . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.507 HG22 ' HG1' ' B' ' 66' ' ' THR . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.424 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.747 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.773 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.747 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.507 ' HG1' HG22 ' B' ' 33' ' ' THR . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.8 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.8 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.422 ' HE1' HD22 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.547 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.596 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.402 ' OH ' HG23 ' B' ' 151' ' ' VAL . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.55 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.513 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.526 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.407 ' H ' HD12 ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.411 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.464 ' HG2' ' CG2' ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . 0.567 ' CG ' HG11 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 32' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.464 ' CG2' ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . 0.422 HD22 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' B' ' 137' ' ' GLU . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.699 HG12 ' HG ' ' A' ' 54' ' ' LEU . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.522 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.653 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.596 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . 0.478 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.426 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 4.4 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.508 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.508 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . 0.61 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.508 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.458 HD13 ' HB1' ' C' ' 25' ' ' ALA . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.549 ' HB2' HG22 ' C' ' 22' ' ' THR . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' THR . . . . . 0.549 HG22 ' HB2' ' C' ' 20' ' ' ALA . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' C' ' 14' ' ' LEU . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . 0.433 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' C' ' 13' ' ' TYR . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.726 ' O ' HG11 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' THR . . . . . 0.49 HG22 ' HG1' ' C' ' 66' ' ' THR . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' D' ' 115' ' ' SER . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.747 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.741 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.747 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' THR . . . . . 0.49 ' HG1' HG22 ' C' ' 33' ' ' THR . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.81 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.535 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . 0.415 ' HE1' HD22 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.508 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.62 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.546 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.502 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.535 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.424 ' HG ' ' HA2' ' B' ' 39' ' ' GLY . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . 0.462 ' HG2' ' CG2' ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . 0.626 HG11 ' O ' ' B' ' 32' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . 0.415 HD22 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' C' ' 137' ' ' GLU . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.773 HG12 ' HG ' ' B' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . 0.524 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.62 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . 0.402 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 4.4 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.505 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.505 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.517 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.507 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.452 HD13 ' HB1' ' D' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' SER . . . . . 0.447 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.549 ' HB2' HG22 ' D' ' 22' ' ' THR . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' THR . . . . . 0.549 HG22 ' HB2' ' D' ' 20' ' ' ALA . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.452 ' HB1' HD13 ' D' ' 14' ' ' LEU . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' D' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . 0.673 ' O ' HG11 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' D' ' 66' ' ' THR . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.576 HG11 ' CG ' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.407 ' HA2' ' HG ' ' E' ' 115' ' ' SER . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.727 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.682 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . 0.727 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' D' ' 33' ' ' THR . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . 0.61 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.801 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.801 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.532 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . 0.418 ' HE1' HD22 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.507 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.405 ' OH ' HG23 ' D' ' 151' ' ' VAL . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' D' ' 95' ' ' ASP . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.503 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' SER . . . . . 0.445 ' HG ' ' HA2' ' C' ' 39' ' ' GLY . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . 0.45 ' HG2' ' CG2' ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . 0.603 ' HG2' HG11 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . 0.726 HG11 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . 0.45 ' CG2' ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . 0.418 HD22 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.509 ' HA ' HD21 ' C' ' 54' ' ' LEU . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.741 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . 0.507 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.622 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.592 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.55 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.4 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.501 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.501 HE22 ' HD2' ' D' ' 163' ' ' PRO . 7.0 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . 0.424 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . 0.635 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.453 HD13 ' HB1' ' E' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.593 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' SER . . . . . 0.458 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.475 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' E' ' 22' ' ' THR . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' THR . . . . . 0.548 HG22 ' HB2' ' E' ' 20' ' ' ALA . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.453 ' HB1' HD13 ' E' ' 14' ' ' LEU . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' E' ' 13' ' ' TYR . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . 0.542 ' O ' HG11 ' F' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' THR . . . . . 0.508 HG22 ' HG1' ' E' ' 66' ' ' THR . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.458 HG11 ' CG ' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' SER . . . . . 0.431 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.405 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.739 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . 0.739 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' THR . . . . . 0.508 ' HG1' HG22 ' E' ' 33' ' ' THR . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.781 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.781 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.521 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . 0.533 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . 0.413 ' HE1' HD22 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.407 ' OH ' HG23 ' E' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' E' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.513 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . 0.446 ' HB1' HG23 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.521 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . 0.404 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 115' ' ' SER . . . . . 0.407 ' HG ' ' HA2' ' D' ' 39' ' ' GLY . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . 0.453 ' HG2' ' CG2' ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . 0.576 ' CG ' HG11 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . 0.673 HG11 ' O ' ' D' ' 32' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.453 ' CG2' ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.513 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.682 HG12 ' HG ' ' D' ' 54' ' ' LEU . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . 0.507 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.618 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.6 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.52 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.4 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.498 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.498 HE22 ' HD2' ' E' ' 163' ' ' PRO . 7.0 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.455 HD13 ' HB1' ' F' ' 25' ' ' ALA . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' SER . . . . . 0.468 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' F' ' 22' ' ' THR . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' THR . . . . . 0.547 HG22 ' HB2' ' F' ' 20' ' ' ALA . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' F' ' 14' ' ' LEU . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' F' ' 13' ' ' TYR . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . 0.652 ' O ' HG11 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 33' ' ' THR . . . . . 0.512 HG22 ' HG1' ' F' ' 66' ' ' THR . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.759 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . 0.759 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 66' ' ' THR . . . . . 0.512 ' HG1' HG22 ' F' ' 33' ' ' THR . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . 0.635 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.793 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . 0.431 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.497 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.793 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.525 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.532 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . 0.422 ' HE1' HD22 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . 0.53 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.626 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.406 ' OH ' HG23 ' F' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . 0.522 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.515 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . 0.4 ' H ' HD12 ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CG2' ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . 0.458 ' CG ' HG11 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . 0.542 HG11 ' O ' ' E' ' 32' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.461 ' CG2' ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . 0.422 HD22 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.523 HG11 ' HG3' ' F' ' 137' ' ' GLU . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.862 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' L' ' 143' ' ' ILE . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.789 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.722 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 4.4 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.504 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.504 HE22 ' HD2' ' F' ' 163' ' ' PRO . 7.0 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.649 HG21 ' CZ ' ' L' ' 110' ' ' PHE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . 0.61 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . 0.447 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' G' ' 10' ' ' ASP . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' H' ' 122' ' ' VAL . 1.6 mm-40 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB1' ' G' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.598 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.1 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 17' ' ' SER . . . . . 0.466 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.502 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . 0.56 ' HB2' HG22 ' G' ' 22' ' ' THR . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' G' ' 20' ' ' ALA . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' G' ' 14' ' ' LEU . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' G' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . 0.457 ' O ' HG11 ' H' ' 122' ' ' VAL . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 33' ' ' THR . . . . . 0.507 HG22 ' HG1' ' G' ' 66' ' ' THR . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 38' ' ' SER . . . . . 0.496 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . 0.752 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . 0.755 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . 0.752 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 66' ' ' THR . . . . . 0.507 ' HG1' HG22 ' G' ' 33' ' ' THR . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . 0.457 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.784 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . 0.42 ' HE1' HD22 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . 0.547 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.608 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' G' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' G' ' 95' ' ' ASP . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.518 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . 0.444 ' HB1' HG23 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . 0.404 ' CG ' HG11 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . 0.536 HG11 ' O ' ' L' ' 32' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . 0.409 HG21 ' O ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . 0.42 HD22 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' G' ' 137' ' ' GLU . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.773 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . 0.584 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.608 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . 0.502 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.502 HE22 ' HD2' ' G' ' 163' ' ' PRO . 7.0 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 167' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.449 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' H' ' 10' ' ' ASP . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' I' ' 122' ' ' VAL . 1.6 mm-40 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.504 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.455 HD13 ' HB1' ' H' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' H' ' 22' ' ' THR . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 22' ' ' THR . . . . . 0.554 HG22 ' HB2' ' H' ' 20' ' ' ALA . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' H' ' 14' ' ' LEU . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . 0.423 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' H' ' 13' ' ' TYR . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . 0.514 ' O ' HG11 ' I' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' H' ' 66' ' ' THR . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 38' ' ' SER . . . . . 0.475 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . 0.403 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . 0.749 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . 0.735 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . 0.749 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' H' ' 33' ' ' THR . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . 0.447 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.781 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.781 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.533 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . 0.553 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.504 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.612 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.404 ' OH ' HG23 ' H' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' H' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . 0.506 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.518 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . 0.409 ' H ' HD12 ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . 0.462 ' HG2' ' CG2' ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . 0.513 ' HA ' HE22 ' G' ' 9' ' ' GLN . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . 0.454 HG21 ' O ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.518 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.755 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . 0.516 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.597 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.612 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.512 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.512 HE22 ' HD2' ' H' ' 163' ' ' PRO . 7.0 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 167' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . 0.451 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.453 HD13 ' HB1' ' I' ' 25' ' ' ALA . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 17' ' ' SER . . . . . 0.456 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.492 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' I' ' 22' ' ' THR . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 22' ' ' THR . . . . . 0.563 HG22 ' HB2' ' I' ' 20' ' ' ALA . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.453 ' HB1' HD13 ' I' ' 14' ' ' LEU . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' I' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . 0.611 ' O ' HG11 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' I' ' 66' ' ' THR . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . 0.5 HG11 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 38' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . 0.401 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . 0.754 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.857 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . 0.754 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' I' ' 33' ' ' THR . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.798 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.597 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.798 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.536 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . 0.419 ' HE1' HD22 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 162' ' ' GLN . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.406 ' OH ' HG23 ' I' ' 151' ' ' VAL . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.507 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . 0.442 ' HB1' HG23 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . 0.514 HG11 ' O ' ' H' ' 32' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . 0.455 HG21 ' O ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . 0.419 HD22 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' I' ' 137' ' ' GLU . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.735 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . 0.515 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . 0.521 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.609 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.596 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.503 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.503 HE22 ' HD2' ' I' ' 163' ' ' PRO . 6.9 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 167' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' K' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.507 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' J' ' 25' ' ' ALA . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.1 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 17' ' ' SER . . . . . 0.448 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' J' ' 22' ' ' THR . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' J' ' 20' ' ' ALA . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' J' ' 14' ' ' LEU . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' J' ' 13' ' ' TYR . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . 0.587 ' O ' HG11 ' K' ' 122' ' ' VAL . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 33' ' ' THR . . . . . 0.511 HG22 ' HG1' ' J' ' 66' ' ' THR . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . 0.486 HG11 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . 0.74 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . 0.74 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 66' ' ' THR . . . . . 0.511 ' HG1' HG22 ' J' ' 33' ' ' THR . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . 0.488 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.802 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.453 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.51 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.802 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.536 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . 0.416 ' HE1' HD22 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . 0.534 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.507 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.4 ' OH ' HG23 ' J' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.506 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . 0.405 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . 0.5 ' CG ' HG11 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . 0.611 HG11 ' O ' ' I' ' 32' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . 0.416 HD22 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' J' ' 137' ' ' GLU . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.857 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . 0.511 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' J' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.617 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.497 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.497 HE22 ' HD2' ' J' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' L' ' 122' ' ' VAL . 1.6 mm-40 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.417 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.458 HD13 ' HB1' ' K' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.1 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 17' ' ' SER . . . . . 0.451 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' K' ' 22' ' ' THR . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 22' ' ' THR . . . . . 0.544 HG22 ' HB2' ' K' ' 20' ' ' ALA . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' K' ' 14' ' ' LEU . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' K' ' 13' ' ' TYR . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . 0.6 ' O ' HG11 ' L' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 33' ' ' THR . . . . . 0.502 HG22 ' HG1' ' K' ' 66' ' ' THR . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . 0.526 HG11 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' L' ' 115' ' ' SER . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . 0.731 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.827 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . 0.731 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 66' ' ' THR . . . . . 0.502 ' HG1' HG22 ' K' ' 33' ' ' THR . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . 0.472 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.789 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' HB2' ' J' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.789 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . 0.421 ' HE1' HD22 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . 0.542 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.542 ' OD1' ' HB2' ' K' ' 95' ' ' ASP . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . 0.503 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.51 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . 0.454 ' HG2' ' CG2' ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . 0.486 ' CG ' HG11 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . 0.587 HG11 ' O ' ' J' ' 32' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.51 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . 0.504 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.503 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.634 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.496 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.496 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.9 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 167' ' ' THR . . . . . 0.429 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . 0.418 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' L' ' 10' ' ' ASP . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . 0.465 HE22 ' HA ' ' G' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.513 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.441 HD13 ' HB1' ' L' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 17' ' ' SER . . . . . 0.459 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' L' ' 22' ' ' THR . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 22' ' ' THR . . . . . 0.542 HG22 ' HB2' ' L' ' 20' ' ' ALA . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' L' ' 14' ' ' LEU . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' L' ' 13' ' ' TYR . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . 0.536 ' O ' HG11 ' G' ' 122' ' ' VAL . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 33' ' ' THR . . . . . 0.508 HG22 ' HG1' ' L' ' 66' ' ' THR . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . 0.404 HG11 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 38' ' ' SER . . . . . 0.457 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . 0.403 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . 0.75 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . 0.773 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 66' ' ' THR . . . . . 0.508 ' HG1' HG22 ' L' ' 33' ' ' THR . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.782 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' K' ' 139' ' ' LYS . 2.9 mt-30 -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.647 ' HE2' ' HG1' ' F' ' 167' ' ' THR . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . 0.413 ' HE1' HD22 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.789 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.513 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.632 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' L' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' L' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . 0.436 ' HB1' HG23 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . 0.409 ' H ' HD12 ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 115' ' ' SER . . . . . 0.41 ' HG ' ' HA2' ' K' ' 39' ' ' GLY . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . 0.45 ' HG2' ' CG2' ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . 0.526 ' CG ' HG11 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . 0.6 HG11 ' O ' ' K' ' 32' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' K' ' 11' ' ' VAL . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.45 ' CG2' ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.518 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.827 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . 0.503 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . 0.556 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.633 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.632 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . 0.501 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.501 HE22 ' HD2' ' L' ' 163' ' ' PRO . 7.0 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 167' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.51 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.429 HG13 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.603 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.603 HD13 ' HG2' ' A' ' 12' ' ' LYS . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.691 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.638 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 76' ' ' GLN . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.484 HE21 ' HG3' ' F' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 17' ' ' SER . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HE ' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' A' ' 106' ' ' ALA . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG22 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.709 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB1' HG13 ' A' ' 94' ' ' VAL . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.477 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 61' ' ' ASP . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG2' HG12 ' A' ' 94' ' ' VAL . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.679 HG22 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.421 HG21 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.43 HG13 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.496 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.42 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.416 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' B' ' 12' ' ' LYS . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.436 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.79 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.631 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.498 ' O ' HG13 ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' B' ' 82' ' ' ALA . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' B' ' 76' ' ' GLN . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 78' ' ' ALA . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.638 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' B' ' 17' ' ' SER . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.43 ' HE ' HG13 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' B' ' 106' ' ' ALA . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG22 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.692 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' B' ' 94' ' ' VAL . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.545 ' HH ' ' HB3' ' A' ' 56' ' ' PRO . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 61' ' ' ASP . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 61' ' ' ASP . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' B' ' 94' ' ' VAL . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.673 HG22 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.412 ' OG1' HG21 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . 0.412 HG21 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.522 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . 0.425 HG13 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . 0.608 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.502 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.423 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . 0.417 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.608 HD13 ' HG2' ' C' ' 12' ' ' LYS . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . 0.438 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.619 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . 0.506 ' O ' HG13 ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 82' ' ' ALA . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' C' ' 76' ' ' GLN . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' C' ' 78' ' ' ALA . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' C' ' 17' ' ' SER . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.425 ' HE ' HG13 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' C' ' 106' ' ' ALA . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.676 ' CZ ' HG22 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.706 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' C' ' 94' ' ' VAL . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . 0.406 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.631 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . 0.79 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . 0.474 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.506 HG13 ' O ' ' C' ' 61' ' ' ASP . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' C' ' 61' ' ' ASP . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . 0.424 ' HG3' HE21 ' D' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' C' ' 94' ' ' VAL . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.414 ' OG1' HG21 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . 0.42 HG13 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . 0.611 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.498 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' SER . . . . . 0.426 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . 0.41 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.611 HD13 ' HG2' ' D' ' 12' ' ' LYS . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . 0.685 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . 0.401 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' D' ' 82' ' ' ALA . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' D' ' 76' ' ' GLN . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 78' ' ' ALA . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.424 HE21 ' HG3' ' C' ' 139' ' ' LYS . 0.1 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.619 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' D' ' 17' ' ' SER . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.42 ' HE ' HG13 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.497 HG13 ' HB1' ' D' ' 106' ' ' ALA . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.703 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' D' ' 94' ' ' VAL . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' C' ' 56' ' ' PRO . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . 0.401 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.496 HG13 ' O ' ' D' ' 61' ' ' ASP . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' D' ' 61' ' ' ASP . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.407 ' HG2' HG12 ' D' ' 94' ' ' VAL . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.686 HG22 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.419 ' OG1' HG21 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.523 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.523 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . 0.419 HG13 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . 0.605 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.508 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' SER . . . . . 0.426 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.504 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . 0.413 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.605 HD13 ' HG2' ' E' ' 12' ' ' LYS . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.486 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' E' ' 76' ' ' GLN . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' E' ' 78' ' ' ALA . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.589 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' E' ' 17' ' ' SER . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.419 ' HE ' HG13 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.507 HG13 ' HB1' ' E' ' 106' ' ' ALA . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.711 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.507 ' HB1' HG13 ' E' ' 94' ' ' VAL . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' D' ' 56' ' ' PRO . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . 0.685 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . 0.547 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 119' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . 0.486 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.496 HG13 ' O ' ' E' ' 61' ' ' ASP . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . 0.58 ' HG3' HE21 ' F' ' 84' ' ' GLN . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.403 ' HG2' HG12 ' E' ' 94' ' ' VAL . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.686 HG22 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.406 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.456 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.425 ' OG1' HG21 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . 0.425 HG21 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.51 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.51 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . 0.424 HG13 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . 0.605 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.503 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' SER . . . . . 0.434 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . 0.417 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.605 HD13 ' HG2' ' F' ' 12' ' ' LYS . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . 0.424 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . 0.499 ' O ' HG13 ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 82' ' ' ALA . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' F' ' 76' ' ' GLN . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 78' ' ' ALA . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.58 HE21 ' HG3' ' E' ' 139' ' ' LYS . 0.1 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.486 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' F' ' 17' ' ' SER . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.424 ' HE ' HG13 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' F' ' 106' ' ' ALA . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG22 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.711 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' F' ' 94' ' ' VAL . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.482 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.499 HG13 ' O ' ' F' ' 61' ' ' ASP . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . 0.484 ' HG3' HE21 ' A' ' 84' ' ' GLN . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.403 ' HG2' HG12 ' F' ' 94' ' ' VAL . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.679 HG22 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.685 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.79 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.422 ' OG1' HG21 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.543 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . 0.487 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . 0.422 HG21 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' H' ' 125' ' ' ALA . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 7' ' ' MET . . . . . 0.509 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.509 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . 0.43 HG13 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . 0.597 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 17' ' ' SER . . . . . 0.433 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . 0.418 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.597 HD13 ' HG2' ' G' ' 12' ' ' LYS . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . 0.49 ' O ' HG13 ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' G' ' 82' ' ' ALA . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' G' ' 76' ' ' GLN . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' G' ' 78' ' ' ALA . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.657 HE21 ' HG3' ' L' ' 139' ' ' LYS . 0.1 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.485 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.433 HD13 ' HA ' ' G' ' 17' ' ' SER . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.43 ' HE ' HG13 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' G' ' 106' ' ' ALA . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.683 ' CZ ' HG22 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.706 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' G' ' 94' ' ' VAL . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.485 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 119' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.49 HG13 ' O ' ' G' ' 61' ' ' ASP . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . 0.702 ' HG3' HE21 ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 1.1 p-10 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.407 ' HG2' HG12 ' G' ' 94' ' ' VAL . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.683 HG22 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' G' G ' 166' ' ' THR . . . . . 0.423 ' OG1' HG21 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . 0.423 HG21 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' I' ' 125' ' ' ALA . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 7' ' ' MET . . . . . 0.499 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . 0.428 HG13 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . 0.604 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 17' ' ' SER . . . . . 0.416 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . 0.414 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' H' ' 12' ' ' LYS . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 36' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' H' ' 82' ' ' ALA . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' H' ' 76' ' ' GLN . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' H' ' 78' ' ' ALA . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.702 HE21 ' HG3' ' G' ' 139' ' ' LYS . 0.1 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.473 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' H' ' 17' ' ' SER . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.428 ' HE ' HG13 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' H' ' 106' ' ' ALA . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG22 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.69 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.491 ' HB1' HG13 ' H' ' 94' ' ' VAL . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.473 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.497 HG13 ' O ' ' H' ' 61' ' ' ASP . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . 0.401 ' HA2' ' OD1' ' H' ' 61' ' ' ASP . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.669 ' HG3' HE21 ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . 0.443 ' HB3' ' OD2' ' B' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . 0.69 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' H' ' 94' ' ' VAL . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.682 HG22 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.3 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.42 ' OG1' HG21 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.5 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . 0.427 HG13 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . 0.614 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 17' ' ' SER . . . . . 0.419 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . 0.419 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.614 HD13 ' HG2' ' I' ' 12' ' ' LYS . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 36' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . 0.505 ' O ' HG13 ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' I' ' 82' ' ' ALA . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' I' ' 76' ' ' GLN . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' I' ' 78' ' ' ALA . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.669 HE21 ' HG3' ' H' ' 139' ' ' LYS . 0.1 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.462 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' I' ' 17' ' ' SER . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.427 ' HE ' HG13 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' I' ' 106' ' ' ALA . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.671 ' CZ ' HG22 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.69 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' I' ' 94' ' ' VAL . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.462 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.505 HG13 ' O ' ' I' ' 61' ' ' ASP . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' I' ' 61' ' ' ASP . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . 0.58 ' HG3' HE21 ' J' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . 0.69 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.41 ' HG2' HG12 ' I' ' 94' ' ' VAL . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.671 HG22 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.418 ' OG1' HG21 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . 0.418 HG21 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' K' ' 125' ' ' ALA . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . 0.427 HG13 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . 0.414 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' J' ' 12' ' ' LYS . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 36' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' J' ' 82' ' ' ALA . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' J' ' 76' ' ' GLN . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' J' ' 78' ' ' ALA . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.58 HE21 ' HG3' ' I' ' 139' ' ' LYS . 0.1 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.47 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' J' ' 17' ' ' SER . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.427 ' HE ' HG13 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' J' ' 106' ' ' ALA . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.675 ' CZ ' HG22 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.702 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' J' ' 94' ' ' VAL . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . 0.539 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 119' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.496 HG13 ' O ' ' J' ' 61' ' ' ASP . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . 0.402 ' HA2' ' OD1' ' J' ' 61' ' ' ASP . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . 0.677 ' HG3' HE21 ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . 0.525 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' J' ' 94' ' ' VAL . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.675 HG22 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.425 ' OG1' HG21 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . 0.425 HG21 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.522 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.429 HG13 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . 0.601 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 17' ' ' SER . . . . . 0.427 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . 0.419 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.601 HD13 ' HG2' ' K' ' 12' ' ' LYS . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 36' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' K' ' 82' ' ' ALA . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' K' ' 76' ' ' GLN . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' K' ' 78' ' ' ALA . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.677 HE21 ' HG3' ' J' ' 139' ' ' LYS . 0.1 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.48 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' K' ' 17' ' ' SER . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.429 ' HE ' HG13 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.509 HG13 ' HB1' ' K' ' 106' ' ' ALA . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.68 ' CZ ' HG22 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.721 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' K' ' 94' ' ' VAL . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.48 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.497 HG13 ' O ' ' K' ' 61' ' ' ASP . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.613 ' HG3' HE21 ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.405 ' HG2' HG12 ' K' ' 94' ' ' VAL . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.415 ' OG1' HG21 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . 0.415 HG21 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' G' ' 125' ' ' ALA . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . 0.431 HG13 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.504 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . 0.408 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' L' ' 12' ' ' LYS . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 36' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' L' ' 82' ' ' ALA . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' L' ' 76' ' ' GLN . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.42 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' L' ' 78' ' ' ALA . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.613 HE21 ' HG3' ' K' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.566 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' L' ' 17' ' ' SER . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.543 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.431 ' HE ' HG13 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB1' ' L' ' 106' ' ' ALA . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG22 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.722 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.51 ' HB1' HG13 ' L' ' 94' ' ' VAL . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' F' ' 171' ' ' PRO . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.486 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . 0.537 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.497 HG13 ' O ' ' L' ' 61' ' ' ASP . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . 0.401 ' HA2' ' OD1' ' L' ' 61' ' ' ASP . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.454 HD13 ' OD1' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . 0.657 ' HG3' HE21 ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.685 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.836 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.672 HG22 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' L' L ' 166' ' ' THR . . . . . 0.422 ' OG1' HG21 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . 0.422 HG21 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 90' ' ' LYS . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.645 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.633 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.458 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 HE22 ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.456 ' HB3' HE22 ' A' ' 88' ' ' GLN . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HB3' ' HG ' ' F' ' 38' ' ' SER . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.554 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.421 HD11 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.505 ' HG1' HG22 ' A' ' 151' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.491 HG22 HD22 ' A' ' 27' ' ' LEU . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.505 HG22 ' HG1' ' A' ' 145' ' ' THR . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 22.9 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HA ' ' NE2' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.474 HD22 HG22 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 62' ' ' SER . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' SER . . . . . 0.711 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.772 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . 0.421 ' H ' HE22 ' B' ' 76' ' ' GLN . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 7.0 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 75' ' ' GLY . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . 0.645 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . 0.416 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.588 ' HB3' ' HG ' ' A' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.45 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.633 HD12 HD23 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.416 HD11 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' THR . . . . . 0.51 ' HG1' HG22 ' B' ' 151' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG22 HD22 ' B' ' 27' ' ' LEU . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.51 HG22 ' HG1' ' B' ' 145' ' ' THR . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.41 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.439 ' HA ' ' NE2' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.631 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.631 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . 0.423 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.489 HD22 HG22 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.757 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.427 ' H ' HE22 ' C' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.491 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.427 HE22 ' H ' ' C' ' 70' ' ' LYS . 7.0 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 75' ' ' GLY . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . 0.711 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.449 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.587 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.449 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . 0.644 ' HB3' ' HG ' ' B' ' 38' ' ' SER . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . 0.526 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.523 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . 0.673 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.772 HD12 HD23 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . 0.421 HD11 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' THR . . . . . 0.51 ' HG1' HG22 ' C' ' 151' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . 0.489 HG22 HD22 ' C' ' 27' ' ' LEU . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.51 HG22 ' HG1' ' C' ' 145' ' ' THR . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.444 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' THR . . . . . 0.627 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.627 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.418 ' HA ' ' HB1' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.495 HD22 HG22 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' SER . . . . . 0.675 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.625 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.486 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.428 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' D' ' 75' ' ' GLY . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.453 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . 0.587 ' HB3' ' HG ' ' C' ' 38' ' ' SER . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . 0.513 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' SER . . . . . 0.556 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.757 HD12 HD23 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . 0.434 HD11 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 145' ' ' THR . . . . . 0.504 ' HG1' HG22 ' D' ' 151' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . 0.495 HG22 HD22 ' D' ' 27' ' ' LEU . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.504 HG22 ' HG1' ' D' ' 145' ' ' THR . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' J' ' 142' ' ' GLU . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.446 ' HA ' ' NE2' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.629 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.629 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.477 HD22 HG22 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' E' ' 62' ' ' SER . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' SER . . . . . 0.649 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.759 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.48 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 7.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.48 HG12 ' O ' ' E' ' 75' ' ' GLY . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.594 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.459 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . 0.621 ' HB3' ' HG ' ' D' ' 38' ' ' SER . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 119' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.528 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 131' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.625 HD12 HD23 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . 0.42 HD11 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 145' ' ' THR . . . . . 0.499 ' HG1' HG22 ' E' ' 151' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . 0.477 HG22 HD22 ' E' ' 27' ' ' LEU . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.499 HG22 ' HG1' ' E' ' 145' ' ' THR . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . 0.438 ' HA ' ' CH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.633 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.633 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . 0.417 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.571 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.494 HD22 HG22 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 38' ' ' SER . . . . . 0.618 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 62' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . 0.408 ' H ' HE22 ' F' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.479 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 7.0 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.479 HG12 ' O ' ' F' ' 75' ' ' GLY . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . 0.458 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.588 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.453 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . 0.543 ' HB3' ' HG ' ' E' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 119' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.526 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 131' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.759 HD12 HD23 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.498 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 145' ' ' THR . . . . . 0.498 ' HG1' HG22 ' F' ' 151' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . 0.494 HG22 HD22 ' F' ' 27' ' ' LEU . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.498 HG22 ' HG1' ' F' ' 145' ' ' THR . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.652 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.522 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.501 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 22.9 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.547 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.525 HG23 ' HB3' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.637 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.559 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.637 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 7' ' ' MET . . . . . 0.479 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.446 ' HB3' ' HZ1' ' G' ' 90' ' ' LYS . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.476 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.494 HD22 HG22 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' G' ' 62' ' ' SER . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 38' ' ' SER . . . . . 0.563 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . 0.518 HD23 HD12 ' H' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 62' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . 0.419 ' H ' HE22 ' G' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . 0.465 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . 0.484 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 7.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.484 HG12 ' O ' ' G' ' 75' ' ' GLY . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' G' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . 0.415 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.58 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' G' ' 88' ' ' GLN . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . 0.523 ' HB3' ' HG ' ' L' ' 38' ' ' SER . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . 0.526 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 131' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.574 HD12 HD23 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . 0.426 HD11 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.497 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 145' ' ' THR . . . . . 0.487 ' HG1' HG22 ' G' ' 151' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . 0.494 HG22 HD22 ' G' ' 27' ' ' LEU . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.487 HG22 ' HG1' ' G' ' 145' ' ' THR . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 167' ' ' THR . . . . . 0.633 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.633 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB1' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.488 HD22 HG22 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 38' ' ' SER . . . . . 0.563 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . 0.527 HD23 HD12 ' I' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 62' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . 0.429 ' H ' HE22 ' H' ' 76' ' ' GLN . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . 0.415 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . 0.47 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.429 HE22 ' H ' ' H' ' 70' ' ' LYS . 7.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.47 HG12 ' O ' ' H' ' 75' ' ' GLY . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' H' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . 0.484 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' H' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . 0.497 ' HB3' ' HG ' ' G' ' 38' ' ' SER . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 119' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.523 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 131' ' ' SER . . . . . 0.565 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . 0.659 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.518 HD12 HD23 ' G' ' 54' ' ' LEU . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . 0.415 HD11 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 145' ' ' THR . . . . . 0.486 ' HG1' HG22 ' H' ' 151' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . 0.488 HG22 HD22 ' H' ' 27' ' ' LEU . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.486 HG22 ' HG1' ' H' ' 145' ' ' THR . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . 0.407 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 167' ' ' THR . . . . . 0.624 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.624 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . 0.473 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.538 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.455 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.489 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.474 HD22 HG22 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' I' ' 62' ' ' SER . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 38' ' ' SER . . . . . 0.638 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.664 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 62' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . 0.428 ' H ' HE22 ' I' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . 0.484 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . 0.491 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.491 HG12 ' O ' ' I' ' 75' ' ' GLY . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' I' ' 110' ' ' PHE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . 0.508 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . 0.449 ' HB3' ' HG ' ' H' ' 38' ' ' SER . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.516 ' O ' HG13 ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 131' ' ' SER . . . . . 0.561 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . 0.684 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.527 HD12 HD23 ' H' ' 54' ' ' LEU . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . 0.413 HD11 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.491 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 145' ' ' THR . . . . . 0.498 ' HG1' HG22 ' I' ' 151' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . 0.474 HG22 HD22 ' I' ' 27' ' ' LEU . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.498 HG22 ' HG1' ' I' ' 145' ' ' THR . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . 0.413 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.446 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 167' ' ' THR . . . . . 0.614 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.614 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . 0.424 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.549 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.492 HD22 HG22 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 38' ' ' SER . . . . . 0.549 ' HG ' ' HB3' ' K' ' 116' ' ' ARG . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . 0.55 HD23 HD12 ' K' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 62' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . 0.508 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . 0.486 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.441 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 7.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' J' ' 75' ' ' GLY . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.456 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . 0.447 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.592 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.456 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . 0.637 ' HB3' ' HG ' ' I' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 119' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.518 ' O ' HG13 ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 131' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . 0.684 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.664 HD12 HD23 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.484 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 145' ' ' THR . . . . . 0.502 ' HG1' HG22 ' J' ' 151' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . 0.492 HG22 HD22 ' J' ' 27' ' ' LEU . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.502 HG22 ' HG1' ' J' ' 145' ' ' THR . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . 0.411 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 167' ' ' THR . . . . . 0.619 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.619 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.468 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.493 HD22 HG22 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 38' ' ' SER . . . . . 0.616 ' HG ' ' HB3' ' L' ' 116' ' ' ARG . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.705 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 62' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . 0.447 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . 0.483 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 7.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.483 HG12 ' O ' ' K' ' 75' ' ' GLY . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . 0.517 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.455 HE22 ' HB3' ' K' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.455 ' HB3' HE22 ' K' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . 0.549 ' HB3' ' HG ' ' J' ' 38' ' ' SER . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 119' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.522 ' O ' HG13 ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 131' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.55 HD12 HD23 ' J' ' 54' ' ' LEU . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . 0.434 HD11 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 145' ' ' THR . . . . . 0.492 ' HG1' HG22 ' K' ' 151' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . 0.493 HG22 HD22 ' K' ' 27' ' ' LEU . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.492 HG22 ' HG1' ' K' ' 145' ' ' THR . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . 0.409 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.442 ' HA ' ' NE2' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 167' ' ' THR . . . . . 0.615 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.615 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.529 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.448 ' HB3' ' HZ1' ' L' ' 90' ' ' LYS . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.478 HD22 HG22 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . 0.574 HD23 HD12 ' G' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . 0.414 ' H ' HE22 ' L' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . 0.482 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.437 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 7.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.482 HG12 ' O ' ' L' ' 75' ' ' GLY . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.406 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.559 ' HG3' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.547 ' HZ2' ' OE1' ' F' ' 165' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . 0.465 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.587 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . 0.418 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.461 ' HB3' HE22 ' L' ' 88' ' ' GLN . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . 0.616 ' HB3' ' HG ' ' K' ' 38' ' ' SER . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 119' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.521 ' O ' HG13 ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 131' ' ' SER . . . . . 0.569 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.705 HD12 HD23 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.418 HD11 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.652 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.0 p-10 -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' L' ' 103' ' ' LYS . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 145' ' ' THR . . . . . 0.493 ' HG1' HG22 ' L' ' 151' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . 0.478 HG22 HD22 ' L' ' 27' ' ' LEU . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.493 HG22 ' HG1' ' L' ' 145' ' ' THR . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 167' ' ' THR . . . . . 0.628 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.628 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.619 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.619 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.706 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HG2' ' A' ' 12' ' ' LYS . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.478 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' SER . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HZ3' ' HB2' ' A' ' 85' ' ' ASN . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.505 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG13 ' HB1' ' A' ' 106' ' ' ALA . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.464 ' OH ' HG22 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.588 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' A' ' 92' ' ' TRP . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.442 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.505 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.422 HG12 ' H ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.422 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.447 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.427 ' HB ' ' HZ3' ' G' ' 90' ' ' LYS . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.633 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.633 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.58 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.688 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' B' ' 12' ' ' LYS . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.434 ' O ' ' CE1' ' B' ' 31' ' ' TYR . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.466 ' HB3' ' OH ' ' B' ' 13' ' ' TYR . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.707 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.585 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 129' ' ' SER . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.421 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.519 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' B' ' 106' ' ' ALA . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.458 ' OH ' HG22 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' B' ' 140' ' ' ASN . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' B' ' 92' ' ' TRP . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.434 ' O ' HG21 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.501 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' B' ' 61' ' ' ASP . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.424 HG12 ' H ' ' B' ' 136' ' ' GLY . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . 0.424 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.535 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.436 ' O ' HG21 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . 0.436 HG21 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.641 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.641 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.718 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' C' ' 12' ' ' LYS . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CE1' ' C' ' 31' ' ' TYR . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' C' ' 13' ' ' TYR . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' SER . . . . . 0.46 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . 0.61 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.494 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . 0.43 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' C' ' 129' ' ' SER . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' HZ3' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' C' ' 85' ' ' ASN . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.564 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.422 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' C' ' 106' ' ' ALA . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.589 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' ND2' ' C' ' 140' ' ' ASN . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . 0.422 ' HE1' ' CE2' ' C' ' 92' ' ' TRP . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.456 ' O ' HG21 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.585 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.456 HG21 ' O ' ' C' ' 110' ' ' PHE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.431 HG12 ' H ' ' C' ' 136' ' ' GLY . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . 0.431 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . 0.434 ' OE1' ' OE2' ' I' ' 142' ' ' GLU . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.448 ' O ' HG21 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . 0.448 HG21 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.632 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.632 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . 0.592 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.718 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.592 HD13 ' HG2' ' D' ' 12' ' ' LYS . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . 0.43 ' O ' ' CE1' ' D' ' 31' ' ' TYR . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' D' ' 13' ' ' TYR . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' SER . . . . . 0.484 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . 0.631 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . 0.448 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' D' ' 129' ' ' SER . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.418 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.406 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.506 ' HG2' ' HD1' ' D' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.413 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' D' ' 106' ' ' ALA . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.6 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' D' ' 140' ' ' ASN . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' D' ' 92' ' ' TRP . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.454 ' O ' HG21 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.506 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.454 HG21 ' O ' ' D' ' 110' ' ' PHE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.429 HG12 ' H ' ' D' ' 136' ' ' GLY . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.542 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.542 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.442 ' O ' HG21 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.469 ' HB ' ' HZ3' ' J' ' 90' ' ' LYS . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . 0.442 HG21 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.629 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . 0.588 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.707 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.588 HD13 ' HG2' ' E' ' 12' ' ' LYS . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . 0.424 ' O ' ' CE1' ' E' ' 31' ' ' TYR . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' E' ' 13' ' ' TYR . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' E' ' 129' ' ' SER . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.412 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HZ3' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.508 ' HG2' ' HD1' ' E' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.424 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' E' ' 106' ' ' ALA . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' E' ' 140' ' ' ASN . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . 0.424 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.444 ' O ' HG21 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . 0.4 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 129' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' E' ' 61' ' ' ASP . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.429 HG12 ' H ' ' E' ' 136' ' ' GLY . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.428 ' O ' HG21 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.402 ' HB ' ' HZ3' ' K' ' 90' ' ' LYS . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . 0.428 HG21 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.63 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . 0.575 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.697 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' F' ' 12' ' ' LYS . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . 0.428 ' O ' ' CE1' ' F' ' 31' ' ' TYR . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' F' ' 13' ' ' TYR . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' HZ3' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' F' ' 85' ' ' ASN . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.507 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.697 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.428 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' F' ' 106' ' ' ALA . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.599 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' F' ' 140' ' ' ASN . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' F' ' 92' ' ' TRP . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.449 ' O ' HG21 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.507 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.449 HG21 ' O ' ' F' ' 110' ' ' PHE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.432 HG12 ' H ' ' F' ' 136' ' ' GLY . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . 0.432 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.692 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.763 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.74 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.435 ' O ' HG21 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.681 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . 0.57 ' O ' HG22 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . 0.435 HG21 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 7' ' ' MET . . . . . 0.639 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.639 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . 0.566 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.692 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' G' ' 12' ' ' LYS . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . 0.424 ' O ' ' CE1' ' G' ' 31' ' ' TYR . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' G' ' 13' ' ' TYR . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . 0.419 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' G' ' 129' ' ' SER . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' G' ' 87' ' ' LYS . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' HZ3' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' G' ' 85' ' ' ASN . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.503 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.692 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.425 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' G' ' 106' ' ' ALA . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.47 ' OH ' HG22 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.605 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.505 ' HB3' ' ND2' ' G' ' 140' ' ' ASN . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . 0.425 ' HE1' ' CE2' ' G' ' 92' ' ' TRP . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.448 ' O ' HG21 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.503 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . 0.402 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' G' ' 61' ' ' ASP . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.422 HG12 ' H ' ' G' ' 136' ' ' GLY . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . 0.422 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' G' ' 147' ' ' PRO . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.55 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.428 ' O ' HG21 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . 0.428 HG21 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 7' ' ' MET . . . . . 0.629 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.701 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.568 HD13 ' HG2' ' H' ' 12' ' ' LYS . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . 0.428 ' O ' ' CE1' ' H' ' 31' ' ' TYR . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . 0.466 ' HB3' ' OH ' ' H' ' 13' ' ' TYR . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' H' ' 129' ' ' SER . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.421 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . 0.405 ' HB2' ' HZ3' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.425 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.501 HG13 ' HB1' ' H' ' 106' ' ' ALA . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' H' ' 140' ' ' ASN . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . 0.425 ' HE1' ' CE2' ' H' ' 92' ' ' TRP . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.444 ' O ' HG21 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.495 ' CD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . 0.419 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 129' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' H' ' 61' ' ' ASP . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.42 HG12 ' H ' ' H' ' 136' ' ' GLY . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . 0.42 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' H' ' 147' ' ' PRO . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.627 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.457 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.71 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' I' ' 12' ' ' LYS . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . 0.433 ' O ' ' CE1' ' I' ' 31' ' ' TYR . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . 0.458 ' HB3' ' OH ' ' I' ' 13' ' ' TYR . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.493 ' HG2' ' CD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.71 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.423 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' I' ' 106' ' ' ALA . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.462 ' OH ' HG22 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' I' ' 140' ' ' ASN . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . 0.423 ' HE1' ' CE2' ' I' ' 92' ' ' TRP . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.449 ' O ' HG21 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.449 HG21 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.425 HG12 ' H ' ' I' ' 136' ' ' GLY . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . 0.425 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.548 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.633 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.633 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.694 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' J' ' 12' ' ' LYS . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . 0.433 ' O ' ' CE1' ' J' ' 31' ' ' TYR . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' J' ' 13' ' ' TYR . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' OE1' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' J' ' 129' ' ' SER . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . 0.408 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' HZ3' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' J' ' 85' ' ' ASN . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.491 ' HG2' ' CD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.694 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.411 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' J' ' 106' ' ' ALA . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.455 ' OH ' HG22 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.591 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' J' ' 140' ' ' ASN . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' J' ' 92' ' ' TRP . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.455 ' O ' HG21 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.455 HG21 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.43 HG12 ' H ' ' J' ' 136' ' ' GLY . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . 0.43 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.444 ' O ' HG21 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . 0.444 HG21 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.643 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.709 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' K' ' 12' ' ' LYS . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . 0.425 ' O ' ' CE1' ' K' ' 31' ' ' TYR . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' K' ' 13' ' ' TYR . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' K' ' 129' ' ' SER . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' HZ3' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.503 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.424 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' K' ' 106' ' ' ALA . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.603 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' ND2' ' K' ' 140' ' ' ASN . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . 0.424 ' HE1' ' CE2' ' K' ' 92' ' ' TRP . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.441 ' O ' HG21 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.503 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . 0.417 ' OE1' ' HB ' ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 129' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 61' ' ' ASP . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.429 HG12 ' H ' ' K' ' 136' ' ' GLY . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.475 ' HZ3' ' HB3' ' L' ' 80' ' ' GLU . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' K' ' 104' ' ' TYR . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.441 ' O ' HG21 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . 0.441 HG21 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . 0.446 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.646 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.646 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.716 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' L' ' 12' ' ' LYS . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CE1' ' L' ' 31' ' ' TYR . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' L' ' 13' ' ' TYR . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . 0.404 ' HB2' ' HZ3' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.492 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' L' ' 106' ' ' ALA . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.466 ' OH ' HG22 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.608 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' L' ' 140' ' ' ASN . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' L' ' 92' ' ' TRP . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.435 ' O ' HG21 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.492 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . 0.44 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' L' ' 61' ' ' ASP . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.433 HG12 ' H ' ' L' ' 136' ' ' GLY . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . 0.433 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.692 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.763 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . 0.74 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.544 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.437 ' O ' HG21 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . 0.437 HG21 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 10' ' ' ASP . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.526 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.554 HG21 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.543 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.769 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' O ' HG11 ' B' ' 122' ' ' VAL . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' HG1' ' A' ' 66' ' ' THR . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.559 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.449 ' HG1' HG22 ' A' ' 33' ' ' THR . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.539 ' HH ' HG13 ' A' ' 79' ' ' ILE . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' HD13 ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.572 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.539 HG13 ' HH ' ' A' ' 67' ' ' TYR . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.751 ' HD2' HD11 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.751 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.51 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.418 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HB2' HD22 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.443 HG11 ' O ' ' F' ' 32' ' ' GLN . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.636 HD13 ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.428 ' N ' HG12 ' A' ' 134' ' ' VAL . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.494 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.459 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.566 ' HG1' ' HG3' ' A' ' 147' ' ' PRO . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.566 ' HG3' ' HG1' ' A' ' 145' ' ' THR . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.511 HE22 ' HD2' ' A' ' 163' ' ' PRO . 5.8 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.663 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.471 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.663 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' B' ' 10' ' ' ASP . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.53 ' HB3' HG21 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.553 HG21 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' B' ' 25' ' ' ALA . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.546 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.758 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.585 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.441 ' O ' HG11 ' C' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.458 HG22 ' HG1' ' B' ' 66' ' ' THR . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.463 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.458 ' HG1' HG22 ' B' ' 33' ' ' THR . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.533 ' HH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.633 ' HA3' HD13 ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . 0.411 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . 0.579 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.533 HG13 ' HH ' ' B' ' 67' ' ' TYR . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.579 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.757 ' HD2' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.757 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.553 ' OD1' HG21 ' B' ' 11' ' ' VAL . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.423 ' OH ' HG23 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . 0.424 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.74 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 32' ' ' GLN . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.633 HD13 ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . 0.411 ' O ' HG13 ' B' ' 130' ' ' ILE . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.429 ' N ' HG12 ' B' ' 134' ' ' VAL . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.502 ' HB3' HE21 ' B' ' 107' ' ' GLN . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' B' ' 103' ' ' LYS . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' THR . . . . . 0.571 ' HG1' ' HG3' ' B' ' 147' ' ' PRO . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.571 ' HG3' ' HG1' ' B' ' 145' ' ' THR . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' B' ' 163' ' ' PRO . 5.8 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . 0.486 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.652 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' C' ' 10' ' ' ASP . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.543 ' HB3' HG21 ' C' ' 6' ' ' ILE . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . 0.545 HG21 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' C' ' 25' ' ' ALA . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' SER . . . . . 0.545 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . 0.583 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.583 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . 0.543 ' O ' HG11 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' C' ' 66' ' ' THR . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.561 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' C' ' 33' ' ' THR . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.53 ' HH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . 0.409 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.53 HG13 ' HH ' ' C' ' 67' ' ' TYR . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.677 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.752 ' HD2' HD11 ' C' ' 89' ' ' ILE . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.48 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.752 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . 0.545 ' OD1' HG21 ' C' ' 11' ' ' VAL . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.415 ' OH ' HG23 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . 0.524 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . 0.427 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.697 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.463 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . 0.441 HG11 ' O ' ' B' ' 32' ' ' GLN . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . 0.627 HD13 ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . 0.417 ' O ' HG13 ' C' ' 130' ' ' ILE . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' B' ' 54' ' ' LEU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.428 ' N ' HG12 ' C' ' 134' ' ' VAL . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . 0.506 ' HB3' HE21 ' C' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' C' ' 103' ' ' LYS . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' THR . . . . . 0.569 ' HG1' ' HG3' ' C' ' 147' ' ' PRO . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.569 ' HG3' ' HG1' ' C' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . 0.516 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' C' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' THR . . . . . 0.649 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . 0.449 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.649 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' D' ' 10' ' ' ASP . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' D' ' 6' ' ' ILE . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . 0.55 HG21 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' D' ' 25' ' ' ALA . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' SER . . . . . 0.54 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.768 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.54 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . 0.59 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.59 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . 0.454 ' O ' HG11 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' THR . . . . . 0.464 HG22 ' HG1' ' D' ' 66' ' ' THR . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' THR . . . . . 0.464 ' HG1' HG22 ' D' ' 33' ' ' THR . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.528 ' HH ' HG13 ' D' ' 79' ' ' ILE . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . 0.57 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.528 HG13 ' HH ' ' D' ' 67' ' ' TYR . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.678 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' D' ' 89' ' ' ILE . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.768 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . 0.55 ' OD1' HG21 ' D' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . 0.433 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.696 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . 0.543 HG11 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . 0.525 ' HA ' HD21 ' C' ' 54' ' ' LEU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' C' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . 0.491 ' HB3' HE21 ' D' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.469 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 145' ' ' THR . . . . . 0.56 ' HG1' ' HG3' ' D' ' 147' ' ' PRO . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.56 ' HG3' ' HG1' ' D' ' 145' ' ' THR . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' D' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 167' ' ' THR . . . . . 0.661 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . 0.478 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . 0.509 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 173' ' ' THR . . . . . 0.661 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . 0.4 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' E' ' 10' ' ' ASP . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.538 ' HB3' HG21 ' E' ' 6' ' ' ILE . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . 0.564 HG21 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' E' ' 25' ' ' ALA . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' SER . . . . . 0.536 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.771 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' THR . . . . . 0.464 HG22 ' HG1' ' E' ' 66' ' ' THR . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' SER . . . . . 0.52 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' THR . . . . . 0.464 ' HG1' HG22 ' E' ' 33' ' ' THR . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . 0.536 ' HH ' HG13 ' E' ' 79' ' ' ILE . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . 0.406 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.419 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . 0.576 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . 0.536 HG13 ' HH ' ' E' ' 67' ' ' TYR . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . 0.576 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.669 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' E' ' 89' ' ' ILE . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . 0.524 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . 0.564 ' OD1' HG21 ' E' ' 11' ' ' VAL . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . 0.524 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . 0.423 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.734 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . 0.41 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . 0.454 HG11 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . 0.402 ' O ' HG13 ' E' ' 130' ' ' ILE . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . 0.41 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.427 ' N ' HG12 ' E' ' 134' ' ' VAL . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . 0.504 ' HB3' HE21 ' E' ' 107' ' ' GLN . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.467 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 145' ' ' THR . . . . . 0.554 ' HG1' ' HG3' ' E' ' 147' ' ' PRO . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.554 ' HG3' ' HG1' ' E' ' 145' ' ' THR . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.463 0.218 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . 0.516 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' E' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 167' ' ' THR . . . . . 0.672 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 173' ' ' THR . . . . . 0.672 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' F' ' 10' ' ' ASP . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.52 ' HB3' HG21 ' F' ' 6' ' ' ILE . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' F' ' 25' ' ' ALA . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' SER . . . . . 0.537 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.767 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.537 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . 0.591 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . 0.443 ' O ' HG11 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 33' ' ' THR . . . . . 0.461 HG22 ' HG1' ' F' ' 66' ' ' THR . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 38' ' ' SER . . . . . 0.41 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 66' ' ' THR . . . . . 0.461 ' HG1' HG22 ' F' ' 33' ' ' THR . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . 0.528 ' HH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . 0.582 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.528 HG13 ' HH ' ' F' ' 67' ' ' TYR . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . 0.582 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.684 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' F' ' 89' ' ' ILE . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.48 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . 0.555 ' OD1' HG21 ' F' ' 11' ' ' VAL . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.418 ' OH ' HG23 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . 0.431 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.581 ' HB2' HD22 ' E' ' 54' ' ' LEU . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . 0.409 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' F' ' 130' ' ' ILE . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . 0.409 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' E' ' 54' ' ' LEU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' E' ' 54' ' ' LEU . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . 0.498 ' HB3' HE21 ' F' ' 107' ' ' GLN . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 145' ' ' THR . . . . . 0.558 ' HG1' ' HG3' ' F' ' 147' ' ' PRO . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HG1' ' F' ' 145' ' ' THR . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . 0.487 ' CG ' HD11 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.595 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.731 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 8.0 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.511 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.511 HE22 ' HD2' ' F' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.672 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . 0.745 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . 0.528 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 173' ' ' THR . . . . . 0.672 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' G' ' 6' ' ' ILE . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . 0.561 HG21 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' G' ' 25' ' ' ALA . 4.2 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 17' ' ' SER . . . . . 0.538 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.776 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . 0.538 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 24' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . 0.577 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 33' ' ' THR . . . . . 0.462 HG22 ' HG1' ' G' ' 66' ' ' THR . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 38' ' ' SER . . . . . 0.586 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 66' ' ' THR . . . . . 0.462 ' HG1' HG22 ' G' ' 33' ' ' THR . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . 0.526 ' HH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . 0.634 ' HA3' HD13 ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . 0.407 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . 0.423 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . 0.569 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . 0.526 HG13 ' HH ' ' G' ' 67' ' ' TYR . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . 0.569 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.693 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . 0.549 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.557 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' G' ' 89' ' ' ILE . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.485 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.776 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . 0.561 ' OD1' HG21 ' G' ' 11' ' ' VAL . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.415 ' OH ' HG23 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . 0.52 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.485 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . 0.634 HD13 ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' L' ' 54' ' ' LEU . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . 0.504 ' HB3' HE21 ' G' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . 0.572 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.463 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 145' ' ' THR . . . . . 0.556 ' HG1' ' HG3' ' G' ' 147' ' ' PRO . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.556 ' HG3' ' HG1' ' G' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . 0.509 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.509 HE22 ' HD2' ' G' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 167' ' ' THR . . . . . 0.67 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 173' ' ' THR . . . . . 0.67 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.411 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' H' ' 10' ' ' ASP . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.52 ' HB3' HG21 ' H' ' 6' ' ' ILE . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . 0.546 HG21 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.418 ' HB2' ' HB2' ' H' ' 25' ' ' ALA . 4.2 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 17' ' ' SER . . . . . 0.542 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 24' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . 0.581 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 33' ' ' THR . . . . . 0.463 HG22 ' HG1' ' H' ' 66' ' ' THR . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 66' ' ' THR . . . . . 0.463 ' HG1' HG22 ' H' ' 33' ' ' THR . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . 0.53 ' HH ' HG13 ' H' ' 79' ' ' ILE . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.636 ' HA3' HD13 ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . 0.416 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . 0.412 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . 0.568 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.53 HG13 ' HH ' ' H' ' 67' ' ' TYR . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . 0.568 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.572 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 3.5 mt-30 -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' H' ' 89' ' ' ILE . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . 0.546 ' OD1' HG21 ' H' ' 11' ' ' VAL . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.42 ' OH ' HG23 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . 0.522 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' G' ' 54' ' ' LEU . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . 0.529 HG23 ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . 0.636 HD13 ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . 0.405 ' O ' HG13 ' H' ' 130' ' ' ILE . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.472 HG21 ' HB2' ' G' ' 54' ' ' LEU . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . 0.499 ' HB3' HE21 ' H' ' 107' ' ' GLN . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.581 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' H' ' 103' ' ' LYS . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 145' ' ' THR . . . . . 0.549 ' HG1' ' HG3' ' H' ' 147' ' ' PRO . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.549 ' HG3' ' HG1' ' H' ' 145' ' ' THR . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' H' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 166' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 167' ' ' THR . . . . . 0.657 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 173' ' ' THR . . . . . 0.657 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' I' ' 10' ' ' ASP . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' I' ' 6' ' ' ILE . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . 0.545 HG21 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' I' ' 25' ' ' ALA . 4.3 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 17' ' ' SER . . . . . 0.549 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.755 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . 0.581 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 33' ' ' THR . . . . . 0.463 HG22 ' HG1' ' I' ' 66' ' ' THR . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 38' ' ' SER . . . . . 0.544 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . 0.563 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . 0.563 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 66' ' ' THR . . . . . 0.463 ' HG1' HG22 ' I' ' 33' ' ' THR . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . 0.526 ' HH ' HG13 ' I' ' 79' ' ' ILE . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . 0.415 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . 0.577 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.526 HG13 ' HH ' ' I' ' 67' ' ' TYR . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . 0.577 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.688 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.581 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HD2' HD11 ' I' ' 89' ' ' ILE . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . 0.747 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.755 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . 0.545 ' OD1' HG21 ' I' ' 11' ' ' VAL . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.419 ' OH ' HG23 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.428 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . 0.517 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . 0.628 HD13 ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' I' ' 130' ' ' ILE . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . 0.465 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.461 HG21 ' HB2' ' H' ' 54' ' ' LEU . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . 0.496 ' HB3' HE21 ' I' ' 107' ' ' GLN . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . 0.513 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.457 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 145' ' ' THR . . . . . 0.554 ' HG1' ' HG3' ' I' ' 147' ' ' PRO . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.554 ' HG3' ' HG1' ' I' ' 145' ' ' THR . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . 0.518 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.518 HE22 ' HD2' ' I' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 166' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 167' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 173' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.542 HG21 ' HB3' ' J' ' 10' ' ' ASP . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HB3' HG21 ' J' ' 6' ' ' ILE . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' J' ' 25' ' ' ALA . 4.2 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 17' ' ' SER . . . . . 0.548 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . 0.59 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . 0.59 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' J' ' 66' ' ' THR . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . 0.57 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . 0.5 HD22 ' HB2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . 0.57 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' J' ' 33' ' ' THR . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . 0.523 ' HH ' HG13 ' J' ' 79' ' ' ILE . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . 0.623 ' HA3' HD13 ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . 0.419 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . 0.585 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . 0.523 HG13 ' HH ' ' J' ' 67' ' ' TYR . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . 0.585 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.68 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' J' ' 89' ' ' ILE . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.485 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . 0.521 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . 0.555 ' OD1' HG21 ' J' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . 0.521 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.5 ' HB2' HD22 ' I' ' 54' ' ' LEU . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . 0.407 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . 0.623 HD13 ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . 0.401 ' O ' HG13 ' J' ' 130' ' ' ILE . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . 0.407 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' I' ' 54' ' ' LEU . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . 0.5 ' HB3' HE21 ' J' ' 107' ' ' GLN . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . 0.509 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' J' ' 103' ' ' LYS . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.459 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 145' ' ' THR . . . . . 0.545 ' HG1' ' HG3' ' J' ' 147' ' ' PRO . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.545 ' HG3' ' HG1' ' J' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . 0.519 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.519 HE22 ' HD2' ' J' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 166' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 167' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 173' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' K' ' 10' ' ' ASP . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.523 ' HB3' HG21 ' K' ' 6' ' ' ILE . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.554 HG21 ' OD1' ' K' ' 95' ' ' ASP . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' K' ' 25' ' ' ALA . 4.2 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 17' ' ' SER . . . . . 0.544 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.776 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . 0.544 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 24' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . 0.591 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 33' ' ' THR . . . . . 0.461 HG22 ' HG1' ' K' ' 66' ' ' THR . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 38' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' L' ' 116' ' ' ARG . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 66' ' ' THR . . . . . 0.461 ' HG1' HG22 ' K' ' 33' ' ' THR . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . 0.516 ' HH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . 0.586 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . 0.516 HG13 ' HH ' ' K' ' 67' ' ' TYR . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' OE1' ' K' ' 76' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' K' ' 89' ' ' ILE . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.483 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.776 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' K' ' 11' ' ' VAL . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . 0.525 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.5 ' HB2' HD22 ' J' ' 54' ' ' LEU . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . 0.412 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . 0.488 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . 0.405 ' O ' HG13 ' K' ' 130' ' ' ILE . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . 0.412 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . 0.456 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' J' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . 0.503 ' HB3' HE21 ' K' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.457 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 145' ' ' THR . . . . . 0.555 ' HG1' ' HG3' ' K' ' 147' ' ' PRO . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.555 ' HG3' ' HG1' ' K' ' 145' ' ' THR . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . 0.52 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.52 HE22 ' HD2' ' K' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 166' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 167' ' ' THR . . . . . 0.654 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 173' ' ' THR . . . . . 0.654 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.528 HG21 ' HB3' ' L' ' 10' ' ' ASP . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.528 ' HB3' HG21 ' L' ' 6' ' ' ILE . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . 0.561 HG21 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' L' ' 25' ' ' ALA . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 17' ' ' SER . . . . . 0.538 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.745 HG21 ' O ' ' F' ' 168' ' ' GLY . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . 0.538 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 22' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' L' ' 24' ' ' SER . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 24' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . 0.585 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 33' ' ' THR . . . . . 0.454 HG22 ' HG1' ' L' ' 66' ' ' THR . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 38' ' ' SER . . . . . 0.549 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . 0.499 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 66' ' ' THR . . . . . 0.454 ' HG1' HG22 ' L' ' 33' ' ' THR . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . 0.54 ' HH ' HG13 ' L' ' 79' ' ' ILE . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . 0.421 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . 0.576 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.54 HG13 ' HH ' ' L' ' 67' ' ' TYR . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.576 ' HG3' ' OE1' ' L' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.683 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' L' ' 89' ' ' ILE . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.546 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.742 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . 0.561 ' OD1' HG21 ' L' ' 11' ' ' VAL . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.417 ' OH ' HG23 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . 0.514 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.488 ' HB2' HD22 ' K' ' 54' ' ' LEU . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . 0.41 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . 0.455 ' O ' ' OG ' ' K' ' 38' ' ' SER . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . 0.627 HD13 ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . 0.412 ' O ' HG13 ' L' ' 130' ' ' ILE . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . 0.41 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' K' ' 54' ' ' LEU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' K' ' 54' ' ' LEU . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . 0.5 ' HB3' HE21 ' L' ' 107' ' ' GLN . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . 0.556 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.731 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' F' ' 160' ' ' PHE . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 145' ' ' THR . . . . . 0.546 ' HG1' ' HG3' ' L' ' 147' ' ' PRO . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.546 ' HG3' ' HG1' ' L' ' 145' ' ' THR . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . 0.51 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.51 HE22 ' HD2' ' L' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 167' ' ' THR . . . . . 0.668 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 173' ' ' THR . . . . . 0.668 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 7' ' ' MET . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.851 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.851 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.69 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 ' HG2' ' A' ' 12' ' ' LYS . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 HH22 ' HB1' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.663 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.679 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB1' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.69 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' HB1' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.661 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.652 ' HB3' HD12 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.476 HG12 ' H ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HZ3' ' HB3' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 104' ' ' TYR . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.44 ' H ' ' CD1' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.561 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' B' ' 7' ' ' MET . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' MET . . . . . 0.856 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LYS . . . . . 0.596 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' B' ' 12' ' ' LYS . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ARG . . . . . 0.436 HH22 ' HB1' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' PRO . . . . . 0.771 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.436 ' HB1' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.595 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLN . . . . . 0.663 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' PHE . . . . . 0.444 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.599 HG13 ' HB1' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ALA . . . . . 0.599 ' HB1' HG13 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PHE . . . . . 0.649 ' HB3' HD12 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' TYR . . . . . 0.679 ' HH ' ' HB3' ' A' ' 56' ' ' PRO . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.501 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.595 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.473 HG12 ' H ' ' B' ' 136' ' ' GLY . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLY . . . . . 0.473 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' LYS . . . . . 0.465 ' HZ3' ' HB3' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' B' ' 104' ' ' TYR . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' B' ' 174' ' ' VAL . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' THR . . . . . 0.545 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' C' ' 7' ' ' MET . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' MET . . . . . 0.861 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ASP . . . . . 0.861 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' LYS . . . . . 0.603 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' PHE . . . . . 0.438 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LEU . . . . . 0.603 HD13 ' HG2' ' C' ' 12' ' ' LYS . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' C' ' 67' ' ' TYR . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' ARG . . . . . 0.43 HH22 ' HB1' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' GLU . . . . . 0.632 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' LEU . . . . . 0.638 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' PRO . . . . . 0.634 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ALA . . . . . 0.43 ' HB1' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' THR . . . . . 0.607 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' C' ' 82' ' ' ALA . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.465 ' HB3' ' HZ3' ' B' ' 139' ' ' LYS . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLN . . . . . 0.702 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' PHE . . . . . 0.438 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.599 HG13 ' HB1' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' ALA . . . . . 0.599 ' HB1' HG13 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PHE . . . . . 0.638 ' HB3' HD12 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' TYR . . . . . 0.771 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' GLU . . . . . 0.686 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' ILE . . . . . 0.512 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' SER . . . . . 0.607 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' ILE . . . . . 0.474 HG12 ' H ' ' C' ' 136' ' ' GLY . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' GLY . . . . . 0.474 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' LEU . . . . . 0.638 HD12 ' HB3' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' C' ' 104' ' ' TYR . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' GLN . . . . . 0.436 ' O ' HG21 ' C' ' 174' ' ' VAL . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' THR . . . . . 0.513 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . 0.436 HG21 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 7' ' ' MET . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' MET . . . . . 0.872 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' ASP . . . . . 0.872 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' LYS . . . . . 0.602 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' LEU . . . . . 0.602 HD13 ' HG2' ' D' ' 12' ' ' LYS . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' ARG . . . . . 0.435 HH22 ' HB1' ' D' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' LEU . . . . . 0.633 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' PRO . . . . . 0.643 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ALA . . . . . 0.435 ' HB1' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' THR . . . . . 0.597 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' TYR . . . . . 0.52 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' D' ' 82' ' ' ALA . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLN . . . . . 0.638 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' PHE . . . . . 0.443 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.609 HG13 ' HB1' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' ALA . . . . . 0.609 ' HB1' HG13 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PHE . . . . . 0.635 ' HB3' HD12 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' TYR . . . . . 0.634 ' HH ' ' HB3' ' C' ' 56' ' ' PRO . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' ILE . . . . . 0.52 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' SER . . . . . 0.597 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 135' ' ' ILE . . . . . 0.477 HG12 ' H ' ' D' ' 136' ' ' GLY . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 136' ' ' GLY . . . . . 0.477 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 138' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 139' ' ' LYS . . . . . 0.427 ' HZ3' ' HB3' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' D' ' 104' ' ' TYR . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 143' ' ' ILE . . . . . 0.438 ' H ' ' CD1' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 147' ' ' PRO . . . . . 0.451 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 163' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 165' ' ' GLN . . . . . 0.445 ' O ' HG21 ' D' ' 174' ' ' VAL . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 166' ' ' THR . . . . . 0.452 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 174' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' E' ' 7' ' ' MET . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' MET . . . . . 0.855 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ASP . . . . . 0.855 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' LYS . . . . . 0.58 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' PHE . . . . . 0.432 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' E' ' 12' ' ' LYS . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' E' ' 67' ' ' TYR . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' ARG . . . . . 0.434 HH22 ' HB1' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' GLU . . . . . 0.583 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' LEU . . . . . 0.506 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' PRO . . . . . 0.512 ' HB3' ' HH ' ' F' ' 112' ' ' TYR . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' ALA . . . . . 0.434 ' HB1' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' THR . . . . . 0.601 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' TYR . . . . . 0.521 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' E' ' 82' ' ' ALA . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 80' ' ' GLU . . . . . 0.427 ' HB3' ' HZ3' ' D' ' 139' ' ' LYS . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 82' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 84' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 87' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 88' ' ' GLN . . . . . 0.633 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 91' ' ' PHE . . . . . 0.432 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 94' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 96' ' ' THR . . . . . 0.426 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 98' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 106' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 108' ' ' PHE . . . . . 0.637 ' HB3' HD12 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 112' ' ' TYR . . . . . 0.643 ' HH ' ' HB3' ' D' ' 56' ' ' PRO . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 114' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 115' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 118' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 127' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 128' ' ' ILE . . . . . 0.521 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 129' ' ' SER . . . . . 0.601 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 131' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 135' ' ' ILE . . . . . 0.475 HG12 ' H ' ' E' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 136' ' ' GLY . . . . . 0.475 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 138' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 142' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' E' ' 104' ' ' TYR . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 143' ' ' ILE . . . . . 0.433 ' H ' ' CD1' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 147' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 151' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 161' ' ' GLN . . . . . 0.422 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' E' ' 174' ' ' VAL . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 166' ' ' THR . . . . . 0.643 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' F' ' 7' ' ' MET . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' MET . . . . . 0.856 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' VAL . . . . . 0.436 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' LYS . . . . . 0.596 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' ILE . . . . . 0.688 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' F' ' 12' ' ' LYS . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' F' ' 67' ' ' TYR . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 41' ' ' ARG . . . . . 0.427 HH22 ' HB1' ' F' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 60' ' ' ALA . . . . . 0.427 ' HB1' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 66' ' ' THR . . . . . 0.605 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 67' ' ' TYR . . . . . 0.518 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 70' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' F' ' 82' ' ' ALA . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 79' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' F' ' 79' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 80' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 82' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 84' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 87' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 88' ' ' GLN . . . . . 0.506 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 90' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 94' ' ' VAL . . . . . 0.605 HG13 ' HB1' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 95' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 98' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.663 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 106' ' ' ALA . . . . . 0.605 ' HB1' HG13 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 108' ' ' PHE . . . . . 0.643 ' HB3' HD12 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 112' ' ' TYR . . . . . 0.512 ' HH ' ' HB3' ' E' ' 56' ' ' PRO . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 114' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 115' ' ' SER . . . . . 0.432 ' HB2' ' CB ' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 118' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 127' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 128' ' ' ILE . . . . . 0.518 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 129' ' ' SER . . . . . 0.605 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 131' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 135' ' ' ILE . . . . . 0.472 HG12 ' H ' ' F' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 136' ' ' GLY . . . . . 0.472 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 138' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 142' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' F' ' 104' ' ' TYR . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 143' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 147' ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 151' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 159' ' ' ASP . . . . . 0.623 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 161' ' ' GLN . . . . . 0.419 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 162' ' ' GLN . . . . . 0.876 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 163' ' ' PRO . . . . . 0.813 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 165' ' ' GLN . . . . . 0.442 ' O ' HG21 ' F' ' 174' ' ' VAL . 0.8 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 166' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 167' ' ' THR . . . . . 0.469 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 169' ' ' GLU . . . . . 0.656 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 174' ' ' VAL . . . . . 0.442 HG21 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' HA ' ' H' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 6' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' G' ' 7' ' ' MET . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 7' ' ' MET . . . . . 0.852 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 10' ' ' ASP . . . . . 0.852 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 14' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 15' ' ' PHE . . . . . 0.449 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 21' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' G' ' 12' ' ' LYS . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 41' ' ' ARG . . . . . 0.425 HH22 ' HB1' ' G' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 59' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 60' ' ' ALA . . . . . 0.425 ' HB1' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 65' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 66' ' ' THR . . . . . 0.604 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 67' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' G' ' 82' ' ' ALA . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 80' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 82' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' G' ' 87' ' ' LYS . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 84' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 87' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 88' ' ' GLN . . . . . 0.463 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 91' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 92' ' ' TRP . . . . . 0.542 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 94' ' ' VAL . . . . . 0.603 HG13 ' HB1' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 103' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 105' ' ' ASP . . . . . 0.652 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 106' ' ' ALA . . . . . 0.603 ' HB1' HG13 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 108' ' ' PHE . . . . . 0.651 ' HB3' HD12 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 112' ' ' TYR . . . . . 0.463 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 115' ' ' SER . . . . . 0.437 ' HB2' ' CB ' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 127' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 128' ' ' ILE . . . . . 0.51 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 129' ' ' SER . . . . . 0.604 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 131' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 135' ' ' ILE . . . . . 0.481 HG12 ' H ' ' G' ' 136' ' ' GLY . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 136' ' ' GLY . . . . . 0.481 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 138' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 141' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 142' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' G' ' 104' ' ' TYR . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 143' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 147' ' ' PRO . . . . . 0.444 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 165' ' ' GLN . . . . . 0.448 ' O ' HG21 ' G' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 174' ' ' VAL . . . . . 0.448 HG21 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' H' H ' 5' ' ' PRO . . . . . 0.464 ' CB ' ' HA ' ' I' ' 70' ' ' LYS . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' H' ' 7' ' ' MET . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 7' ' ' MET . . . . . 0.862 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 10' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 11' ' ' VAL . . . . . 0.426 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 12' ' ' LYS . . . . . 0.604 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 14' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 15' ' ' PHE . . . . . 0.439 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 18' ' ' ILE . . . . . 0.698 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 21' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 27' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' H' ' 12' ' ' LYS . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 30' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 39' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 41' ' ' ARG . . . . . 0.433 HH22 ' HB1' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 66' ' ' THR . . . . . 0.599 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 67' ' ' TYR . . . . . 0.514 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 70' ' ' LYS . . . . . 0.456 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' H' ' 82' ' ' ALA . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 79' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' H' ' 79' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 87' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 90' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 91' ' ' PHE . . . . . 0.439 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 92' ' ' TRP . . . . . 0.547 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 94' ' ' VAL . . . . . 0.598 HG13 ' HB1' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 95' ' ' ASP . . . . . 0.426 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 96' ' ' THR . . . . . 0.427 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 98' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 103' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 105' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 106' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 108' ' ' PHE . . . . . 0.656 ' HB3' HD12 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 112' ' ' TYR . . . . . 0.466 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 115' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 128' ' ' ILE . . . . . 0.514 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 129' ' ' SER . . . . . 0.599 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 131' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 135' ' ' ILE . . . . . 0.459 HG12 ' H ' ' H' ' 136' ' ' GLY . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 136' ' ' GLY . . . . . 0.459 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 138' ' ' LEU . . . . . 0.656 HD12 ' HB3' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 139' ' ' LYS . . . . . 0.404 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 141' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' H' ' 104' ' ' TYR . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 143' ' ' ILE . . . . . 0.438 ' H ' ' CD1' ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 147' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 161' ' ' GLN . . . . . 0.419 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' H' ' 174' ' ' VAL . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 6' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' I' ' 7' ' ' MET . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 7' ' ' MET . . . . . 0.859 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 10' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 11' ' ' VAL . . . . . 0.421 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 12' ' ' LYS . . . . . 0.594 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 14' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 18' ' ' ILE . . . . . 0.671 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 21' ' ' ALA . . . . . 0.513 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 27' ' ' LEU . . . . . 0.594 HD13 ' HG2' ' I' ' 12' ' ' LYS . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 30' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 41' ' ' ARG . . . . . 0.433 HH22 ' HB1' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 42' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 56' ' ' PRO . . . . . 0.453 ' HB3' ' HH ' ' J' ' 112' ' ' TYR . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 59' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 65' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 66' ' ' THR . . . . . 0.591 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 67' ' ' TYR . . . . . 0.509 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 70' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 78' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' I' ' 82' ' ' ALA . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 79' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' I' ' 79' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 82' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 87' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 90' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 91' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 92' ' ' TRP . . . . . 0.544 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 94' ' ' VAL . . . . . 0.602 HG13 ' HB1' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 95' ' ' ASP . . . . . 0.421 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 106' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 108' ' ' PHE . . . . . 0.65 ' HB3' HD12 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 112' ' ' TYR . . . . . 0.466 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 115' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 118' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 127' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 128' ' ' ILE . . . . . 0.509 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 129' ' ' SER . . . . . 0.591 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 131' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 135' ' ' ILE . . . . . 0.476 HG12 ' H ' ' I' ' 136' ' ' GLY . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 136' ' ' GLY . . . . . 0.476 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 138' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 142' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' I' ' 104' ' ' TYR . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 143' ' ' ILE . . . . . 0.431 ' H ' ' CD1' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 147' ' ' PRO . . . . . 0.446 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 151' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 165' ' ' GLN . . . . . 0.443 ' O ' HG21 ' I' ' 174' ' ' VAL . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 174' ' ' VAL . . . . . 0.443 HG21 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' J' J ' 6' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' J' ' 7' ' ' MET . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 7' ' ' MET . . . . . 0.837 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 10' ' ' ASP . . . . . 0.837 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 14' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 15' ' ' PHE . . . . . 0.441 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 21' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 23' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' J' ' 12' ' ' LYS . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 39' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 41' ' ' ARG . . . . . 0.433 HH22 ' HB1' ' J' ' 60' ' ' ALA . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 59' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 66' ' ' THR . . . . . 0.602 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 67' ' ' TYR . . . . . 0.519 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' J' ' 82' ' ' ALA . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 80' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 84' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 88' ' ' GLN . . . . . 0.467 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 91' ' ' PHE . . . . . 0.441 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 92' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 94' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 98' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 103' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 106' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 108' ' ' PHE . . . . . 0.636 ' HB3' HD12 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 112' ' ' TYR . . . . . 0.467 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 114' ' ' GLU . . . . . 0.482 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 115' ' ' SER . . . . . 0.445 ' HB2' ' CB ' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 118' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 127' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 128' ' ' ILE . . . . . 0.519 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 129' ' ' SER . . . . . 0.602 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 131' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 135' ' ' ILE . . . . . 0.479 HG12 ' H ' ' J' ' 136' ' ' GLY . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 136' ' ' GLY . . . . . 0.479 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 138' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 142' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' J' ' 104' ' ' TYR . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 147' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 165' ' ' GLN . . . . . 0.443 ' O ' HG21 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 174' ' ' VAL . . . . . 0.443 HG21 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 6' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' K' ' 7' ' ' MET . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 7' ' ' MET . . . . . 0.858 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 11' ' ' VAL . . . . . 0.436 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 12' ' ' LYS . . . . . 0.6 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 15' ' ' PHE . . . . . 0.439 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 21' ' ' ALA . . . . . 0.643 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 27' ' ' LEU . . . . . 0.6 HD13 ' HG2' ' K' ' 12' ' ' LYS . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 41' ' ' ARG . . . . . 0.434 HH22 ' HB1' ' K' ' 60' ' ' ALA . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 42' ' ' GLU . . . . . 0.463 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HH ' ' L' ' 112' ' ' TYR . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 60' ' ' ALA . . . . . 0.434 ' HB1' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 65' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 66' ' ' THR . . . . . 0.603 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 67' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 78' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' K' ' 82' ' ' ALA . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 82' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 87' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 88' ' ' GLN . . . . . 0.465 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 91' ' ' PHE . . . . . 0.439 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 94' ' ' VAL . . . . . 0.616 HG13 ' HB1' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 95' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 103' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 105' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 106' ' ' ALA . . . . . 0.616 ' HB1' HG13 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 108' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 112' ' ' TYR . . . . . 0.465 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 115' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 127' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 128' ' ' ILE . . . . . 0.513 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 129' ' ' SER . . . . . 0.603 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 131' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 135' ' ' ILE . . . . . 0.477 HG12 ' H ' ' K' ' 136' ' ' GLY . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 136' ' ' GLY . . . . . 0.477 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 138' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 139' ' ' LYS . . . . . 0.526 ' HZ3' ' HB3' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 141' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 142' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' K' ' 104' ' ' TYR . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 143' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 147' ' ' PRO . . . . . 0.451 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' K' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' L' L ' 6' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' L' ' 7' ' ' MET . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 7' ' ' MET . . . . . 0.849 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 10' ' ' ASP . . . . . 0.849 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 12' ' ' LYS . . . . . 0.592 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 14' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 18' ' ' ILE . . . . . 0.683 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 23' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 27' ' ' LEU . . . . . 0.592 HD13 ' HG2' ' L' ' 12' ' ' LYS . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 41' ' ' ARG . . . . . 0.419 HH22 ' HB1' ' L' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 60' ' ' ALA . . . . . 0.419 ' HB1' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 65' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 66' ' ' THR . . . . . 0.593 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 67' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 79' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' L' ' 79' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 80' ' ' GLU . . . . . 0.526 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 82' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 84' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 87' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 88' ' ' GLN . . . . . 0.656 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 90' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 92' ' ' TRP . . . . . 0.53 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 94' ' ' VAL . . . . . 0.613 HG13 ' HB1' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 98' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 105' ' ' ASP . . . . . 0.656 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 106' ' ' ALA . . . . . 0.613 ' HB1' HG13 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 108' ' ' PHE . . . . . 0.636 ' HB3' HD12 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 112' ' ' TYR . . . . . 0.468 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 114' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 115' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 128' ' ' ILE . . . . . 0.516 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 129' ' ' SER . . . . . 0.593 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 131' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 135' ' ' ILE . . . . . 0.468 HG12 ' H ' ' L' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 136' ' ' GLY . . . . . 0.468 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 138' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 140' ' ' ASN . . . . . 0.623 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 141' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 142' ' ' GLU . . . . . 0.876 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 144' ' ' ASP . . . . . 0.813 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 147' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 151' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 161' ' ' GLN . . . . . 0.423 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' L' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.404 ' HG3' ' HB ' ' L' ' 48' ' ' THR . 3.3 mm-40 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD21 HG11 ' A' ' 94' ' ' VAL . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.454 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.425 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' O ' HG11 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG11 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' B' ' 115' ' ' SER . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -65.46 139.57 58.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.54 35.33 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.265 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.62 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.78 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.13 22.54 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.569 1.548 . . . . 0.0 111.682 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.1 61.17 2.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 111.608 -164.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.63 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.499 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.07 13.85 30.19 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.92 1.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 mmp_? -110.2 23.58 14.12 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.597 HG13 HG22 ' B' ' 135' ' ' ILE . 0.9 OUTLIER -123.89 3.63 5.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.875 178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.675 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.8 22.58 14.91 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HZ3' ' HB2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 75' ' ' GLY . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.567 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG11 HD21 ' A' ' 14' ' ' LEU . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 97' ' ' VAL . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.842 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG23 ' A' ' 151' ' ' VAL . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.422 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.581 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.421 HG11 ' O ' ' F' ' 32' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' A' ' 65' ' ' VAL . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 112' ' ' TYR . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.842 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.487 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.501 HG23 ' OH ' ' A' ' 104' ' ' TYR . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.51 14.95 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.13 29.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.29 76.13 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.386 0.994 . . . . 0.0 113.037 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.91 23.49 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.15 46.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.28 1.032 . . . . 0.0 108.611 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.87 42.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.415 ' CG ' HD11 ' G' ' 143' ' ' ILE . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.448 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.448 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.518 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.464 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.415 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 3.3 mm-40 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.499 HG21 ' OD1' ' B' ' 95' ' ' ASP . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' B' ' 25' ' ' ALA . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.452 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.429 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.422 ' O ' HG11 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.424 HG11 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.56 58.51 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 128.61 35.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.267 171.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.54 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.82 -33.36 75.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.57 4.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.626 1.571 . . . . 0.0 111.649 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.06 61.2 2.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.576 -164.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.57 0.29 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.459 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.8 30.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.83 1.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.57 14.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.629 HG13 HG22 ' C' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.872 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -104.81 22.66 14.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . 0.412 ' HB2' ' HZ3' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.45 HG12 ' O ' ' B' ' 75' ' ' GLY . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.621 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.621 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.577 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.503 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.492 HG11 HD21 ' B' ' 14' ' ' LEU . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.499 ' OD1' HG21 ' B' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.407 ' O ' HG12 ' B' ' 97' ' ' VAL . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.835 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG23 ' B' ' 151' ' ' VAL . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.532 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . 0.423 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.536 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.675 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.453 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' L' ' 47' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.421 HG12 ' HB ' ' B' ' 65' ' ' VAL . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' B' ' 112' ' ' TYR . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.536 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.597 HG22 HG13 ' A' ' 53' ' ' ILE . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.419 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.423 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.835 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.503 HG23 ' OH ' ' B' ' 104' ' ' TYR . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.71 159.53 14.94 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.76 -0.14 29.2 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.24 76.12 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.421 1.01 . . . . 0.0 112.998 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.89 23.43 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.18 151.17 46.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.317 1.047 . . . . 0.0 108.626 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -58.36 -54.89 41.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -158.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.455 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.455 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . 0.464 ' O ' HG21 ' H' ' 18' ' ' ILE . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' C' ' 95' ' ' ASP . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.504 HD21 HG11 ' C' ' 94' ' ' VAL . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' C' ' 25' ' ' ALA . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.442 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.455 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.522 ' O ' HG11 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.483 ' HA2' ' HG ' ' D' ' 115' ' ' SER . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.57 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.53 58.5 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.75 128.61 35.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.238 171.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.57 109.95 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 155.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.77 -33.4 75.77 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.2 22.53 4.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.589 1.556 . . . . 0.0 111.656 -172.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.09 61.2 2.03 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.533 1.533 . . . . 0.0 111.554 -164.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.59 0.29 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.496 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.2 mmp_? -110.16 23.59 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.488 HG13 HG22 ' D' ' 135' ' ' ILE . 0.9 OUTLIER -123.83 3.65 5.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.915 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.63 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -104.84 22.6 14.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.57 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.429 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HZ3' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.444 HG12 ' O ' ' C' ' 75' ' ' GLY . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.628 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.493 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.504 HG11 HD21 ' C' ' 14' ' ' LEU . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' C' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . 0.419 ' O ' HG12 ' C' ' 97' ' ' VAL . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.835 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.499 ' OH ' HG23 ' C' ' 151' ' ' VAL . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . 0.423 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.623 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.455 ' HG ' ' HA2' ' B' ' 39' ' ' GLY . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' G' ' 47' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.429 HG12 ' HB ' ' C' ' 65' ' ' VAL . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' C' ' 112' ' ' TYR . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.535 ' HA ' HD21 ' B' ' 54' ' ' LEU . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.629 HG22 HG13 ' B' ' 53' ' ' ILE . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.423 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.835 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' THR . . . . . 0.478 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' C' ' 104' ' ' TYR . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.62 159.48 14.97 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.72 -0.15 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.58 -4.28 76.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.355 0.98 . . . . 0.0 113.049 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.78 139.92 23.5 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.23 151.1 46.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.35 1.06 . . . . 0.0 108.631 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.28 -54.9 41.74 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.44 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.44 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.439 ' O ' HG21 ' I' ' 18' ' ' ILE . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . 0.5 HG21 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.504 HD21 HG11 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' D' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' SER . . . . . 0.446 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.438 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.446 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . 0.456 ' O ' HG11 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.419 HG11 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.43 ' HA2' ' HG ' ' E' ' 115' ' ' SER . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.59 35.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.211 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.56 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 155.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.82 -33.34 75.62 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.18 22.49 4.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.627 1.571 . . . . 0.0 111.619 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.2 61.12 2.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 111.568 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.75 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.87 30.09 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.77 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.2 mmp_? -110.12 23.58 14.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.563 HG13 HG22 ' E' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.943 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -104.82 22.68 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 176.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.451 HG12 ' O ' ' D' ' 75' ' ' GLY . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.632 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . 0.402 ' CD2' ' C ' ' D' ' 83' ' ' TYR . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.632 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.588 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.482 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.504 HG11 HD21 ' D' ' 14' ' ' LEU . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.5 ' OD1' HG21 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . 0.416 ' O ' HG12 ' D' ' 97' ' ' VAL . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.841 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' D' ' 151' ' ' VAL . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . 0.425 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.529 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.63 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' SER . . . . . 0.483 ' HG ' ' HA2' ' C' ' 39' ' ' GLY . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . 0.522 HG11 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' D' ' 65' ' ' VAL . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' D' ' 112' ' ' TYR . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.529 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.488 HG22 HG13 ' C' ' 53' ' ' ILE . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . 0.416 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . 0.425 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.841 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' D' ' 104' ' ' TYR . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.58 159.5 14.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.8 -0.08 29.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.5 -4.23 76.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 113.056 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.86 139.86 23.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.13 151.2 46.46 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.321 1.048 . . . . 0.0 108.635 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.4 -54.83 42.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . 0.539 ' CG ' HD11 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.493 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.451 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . 0.592 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.474 ' HB3' HG21 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . 0.484 HG21 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.489 HD21 HG11 ' E' ' 94' ' ' VAL . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' E' ' 25' ' ' ALA . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' SER . . . . . 0.469 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.441 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.469 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.56 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER -65.41 139.51 58.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.79 128.6 35.33 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.235 171.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 109.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -33.39 75.76 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.52 4.41 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.59 1.556 . . . . 0.0 111.665 -172.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.16 61.18 2.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.521 1.529 . . . . 0.0 111.539 -164.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.58 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.49 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.85 30.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.2 mmp_? -110.15 23.58 14.14 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.543 HG13 HG22 ' F' ' 135' ' ' ILE . 0.9 OUTLIER -123.86 3.63 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.874 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.587 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -104.82 22.66 14.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . 0.56 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . 0.412 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' E' ' 75' ' ' GLY . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.624 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.624 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . 0.578 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.486 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.489 HG11 HD21 ' E' ' 14' ' ' LEU . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.484 ' OD1' HG21 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' E' ' 97' ' ' VAL . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.494 ' OH ' HG23 ' E' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . 0.426 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.536 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.659 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' SER . . . . . 0.43 ' HG ' ' HA2' ' D' ' 39' ' ' GLY . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . 0.456 HG11 ' O ' ' D' ' 32' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' SER . . . . . 0.508 ' O ' ' N ' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.412 HG12 ' HB ' ' E' ' 65' ' ' VAL . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' E' ' 112' ' ' TYR . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.536 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.563 HG22 HG13 ' D' ' 53' ' ' ILE . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.405 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' THR . . . . . 0.492 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.494 HG23 ' OH ' ' E' ' 104' ' ' TYR . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -78.67 -0.18 29.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.2 76.08 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 119.417 1.008 . . . . 0.0 113.036 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.87 23.41 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.16 151.16 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.379 1.072 . . . . 0.0 108.649 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.33 -54.89 41.92 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.452 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.452 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . 0.453 ' O ' HG21 ' K' ' 18' ' ' ILE . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.503 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.459 ' HB3' HG21 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . 0.489 HG21 ' OD1' ' F' ' 95' ' ' ASP . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.502 HD21 HG11 ' F' ' 94' ' ' VAL . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' F' ' 25' ' ' ALA . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' SER . . . . . 0.467 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.441 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.467 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . 0.421 ' O ' HG11 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER -65.48 139.56 58.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.64 35.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.201 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.53 109.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 155.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.86 -33.35 75.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.51 4.42 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.625 1.57 . . . . 0.0 111.66 -172.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.24 61.09 2.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.539 1.536 . . . . 0.0 111.533 -164.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.73 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.69 13.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.94 3.66 5.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.841 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -104.86 22.61 14.89 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . 0.407 ' HZ3' ' HB2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' F' ' 75' ' ' GLY . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.612 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.498 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.502 HG11 HD21 ' F' ' 14' ' ' LEU . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . 0.489 ' OD1' HG21 ' F' ' 11' ' ' VAL . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . 0.403 ' O ' HG12 ' F' ' 97' ' ' VAL . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.812 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.505 ' OH ' HG23 ' F' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.526 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . 0.429 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.524 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' J' ' 47' ' ' GLN . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' SER . . . . . 0.494 ' O ' ' N ' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.434 HG12 ' HB ' ' F' ' 65' ' ' VAL . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' F' ' 112' ' ' TYR . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.56 ' HA ' HD21 ' E' ' 54' ' ' LEU . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.587 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.421 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . 0.429 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.812 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' THR . . . . . 0.491 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.505 HG23 ' OH ' ' F' ' 104' ' ' TYR . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.61 159.5 14.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.14 29.19 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.27 76.09 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 119.347 0.976 . . . . 0.0 113.041 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . 0.417 ' CA ' HD11 ' L' ' 138' ' ' LEU . . . -77.84 139.91 23.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.17 151.19 46.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.294 1.037 . . . . 0.0 108.596 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.85 42.32 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.945 ' CD2' HD11 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.522 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.528 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 3.9 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.597 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.452 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.478 ' O ' ' O ' ' L' ' 18' ' ' ILE . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . 0.86 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . 0.459 HE22 ' HA ' ' H' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' G' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . 0.491 HG21 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' G' ' 25' ' ' ALA . 6.3 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' SER . . . . . 0.464 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.518 HG21 ' O ' ' A' ' 168' ' ' GLY . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . 0.464 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . 0.404 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 38' ' ' SER . . . . . 0.448 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' G' ' 58' ' ' SER . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.249 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.63 109.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.75 -33.38 75.74 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . 0.446 ' HB3' HG12 ' C' ' 122' ' ' VAL . 0.0 OUTLIER 71.17 22.47 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.574 1.55 . . . . 0.0 111.667 -172.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.415 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.6 OUTLIER 42.24 61.16 2.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.486 1.515 . . . . 0.0 111.526 -164.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.83 -127.54 0.29 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.498 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.05 13.83 30.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.9 1.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.52 14.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.83 3.59 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.857 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -104.77 22.63 14.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 176.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 58' ' ' SER . . . . . 0.425 ' O ' ' N ' ' G' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . 0.43 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . 0.445 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . 0.402 ' HZ3' ' HB2' ' G' ' 77' ' ' LYS . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.445 HG12 ' O ' ' G' ' 75' ' ' GLY . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.622 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.622 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.567 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.512 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.501 HG11 HD21 ' G' ' 14' ' ' LEU . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . 0.491 ' OD1' HG21 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' G' ' 97' ' ' VAL . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . 0.526 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.841 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.494 ' OH ' HG23 ' G' ' 151' ' ' VAL . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.526 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . 0.43 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.533 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . 0.422 ' HA ' HE22 ' L' ' 9' ' ' GLN . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . 0.548 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . 0.43 HG12 ' HB ' ' G' ' 65' ' ' VAL . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . 0.418 ' CB ' ' O ' ' G' ' 112' ' ' TYR . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.533 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . 0.427 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . 0.43 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.841 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 145' ' ' THR . . . . . 0.486 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.496 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.49 14.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.08 28.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.33 76.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.356 0.98 . . . . 0.0 113.044 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.76 139.88 23.46 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.21 151.16 46.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 108.601 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.9 41.79 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . 0.458 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.458 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 166' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.545 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . 0.501 HG21 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' H' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 168' ' ' GLY . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . 0.45 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 38' ' ' SER . . . . . 0.426 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.554 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER -65.55 139.59 58.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 128.58 35.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.202 171.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.57 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 155.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.8 -33.34 75.64 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . 0.44 ' HB3' HG12 ' D' ' 122' ' ' VAL . 0.0 OUTLIER 71.12 22.49 4.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.63 1.572 . . . . 0.0 111.69 -172.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.18 61.13 2.06 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.499 1.52 . . . . 0.0 111.609 -164.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.59 0.29 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.48 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.09 13.88 30.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.42 80.89 1.28 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.2 mmp_? -110.23 23.63 14.05 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.87 3.66 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.92 178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . 0.546 ' HB2' HG21 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.58 14.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . 0.554 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . 0.436 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.449 HG12 ' O ' ' H' ' 75' ' ' GLY . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.617 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . 0.448 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.617 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.505 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.501 HG11 HD21 ' H' ' 14' ' ' LEU . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . 0.501 ' OD1' HG21 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . 0.406 ' O ' HG12 ' H' ' 97' ' ' VAL . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.813 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.504 ' OH ' HG23 ' H' ' 151' ' ' VAL . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.605 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . 0.422 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.534 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.444 ' HB2' HD22 ' G' ' 54' ' ' LEU . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . 0.459 ' HA ' HE22 ' G' ' 9' ' ' GLN . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 129' ' ' SER . . . . . 0.498 ' O ' ' N ' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.436 HG12 ' HB ' ' H' ' 65' ' ' VAL . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' H' ' 112' ' ' TYR . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.534 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.813 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 145' ' ' THR . . . . . 0.479 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.504 HG23 ' OH ' ' H' ' 104' ' ' TYR . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.7 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.63 -0.25 29.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.23 76.02 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.385 0.993 . . . . 0.0 113.063 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.92 23.48 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.18 46.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.325 1.05 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.9 41.74 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.443 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.443 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.526 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . 0.469 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.469 ' HB3' HG21 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . 0.498 HG21 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' I' ' 25' ' ' ALA . 6.3 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' SER . . . . . 0.458 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.439 HG21 ' O ' ' C' ' 168' ' ' GLY . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . 0.458 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 38' ' ' SER . . . . . 0.407 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . 0.563 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER -65.53 139.54 58.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.61 35.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.234 171.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t0 73.51 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.77 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.17 22.51 4.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.639 1.576 . . . . 0.0 111.652 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.23 61.07 2.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 111.571 -164.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.495 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.03 13.82 30.3 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.54 80.86 1.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.2 mmp_? -110.19 23.6 14.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.414 HG13 HG22 ' J' ' 135' ' ' ILE . 0.9 OUTLIER -123.88 3.6 5.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.85 22.7 14.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . 0.563 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . 0.446 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HZ3' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.446 HG12 ' O ' ' I' ' 75' ' ' GLY . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.426 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.619 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.566 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.492 HG11 HD21 ' I' ' 14' ' ' LEU . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . 0.498 ' OD1' HG21 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . 0.42 ' O ' HG12 ' I' ' 97' ' ' VAL . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.499 ' OH ' HG23 ' I' ' 151' ' ' VAL . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.529 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . 0.421 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' I' ' 132' ' ' LEU . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . 0.545 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 129' ' ' SER . . . . . 0.495 ' O ' ' N ' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.432 HG12 ' HB ' ' I' ' 65' ' ' VAL . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' I' ' 112' ' ' TYR . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.535 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . 0.415 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . 0.504 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.63 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.845 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.475 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' I' ' 104' ' ' TYR . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.66 159.52 14.95 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.75 -0.19 29.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.62 -4.32 75.95 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.401 1.0 . . . . 0.0 113.02 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.92 23.51 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.22 151.17 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.26 1.024 . . . . 0.0 108.616 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.91 41.64 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.455 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.455 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.523 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' K' ' 122' ' ' VAL . 3.3 mm-40 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.466 ' HB3' HG21 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . 0.486 HG21 ' OD1' ' J' ' 95' ' ' ASP . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.503 HD21 HG11 ' J' ' 94' ' ' VAL . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' J' ' 25' ' ' ALA . 6.3 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.592 HG21 ' O ' ' D' ' 168' ' ' GLY . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . 0.455 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.493 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.572 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . 0.574 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.56 58.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.76 128.56 35.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.232 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.82 -33.36 75.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . 0.5 ' HB3' HG12 ' F' ' 122' ' ' VAL . 0.0 OUTLIER 71.15 22.54 4.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.605 1.562 . . . . 0.0 111.667 -172.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.17 61.07 2.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.468 1.507 . . . . 0.0 111.597 -164.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.72 -127.52 0.29 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.502 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.15 13.87 30.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.1 mmp_? -110.18 23.59 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.88 3.61 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.861 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -104.81 22.66 14.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . 0.574 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HZ3' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.451 HG12 ' O ' ' J' ' 75' ' ' GLY . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . 0.504 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.407 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.627 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . 0.571 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.497 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.503 HG11 HD21 ' J' ' 14' ' ' LEU . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . 0.486 ' OD1' HG21 ' J' ' 11' ' ' VAL . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . 0.415 ' O ' HG12 ' J' ' 97' ' ' VAL . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.826 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG23 ' J' ' 151' ' ' VAL . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.53 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . 0.426 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.535 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.451 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . 0.468 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.416 HG12 ' HB ' ' J' ' 65' ' ' VAL . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . 0.419 ' CB ' ' O ' ' J' ' 112' ' ' TYR . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.535 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . 0.418 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . 0.426 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.826 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 145' ' ' THR . . . . . 0.474 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.478 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.5 HG23 ' OH ' ' J' ' 104' ' ' TYR . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.6 159.49 14.97 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.68 -0.22 29.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.61 -4.3 75.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.332 0.969 . . . . 0.0 113.028 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.9 23.48 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -139.18 151.15 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.321 1.048 . . . . 0.0 108.63 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.97 41.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.454 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.454 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.539 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . 0.427 HE22 ' HA ' ' L' ' 122' ' ' VAL . 3.2 mm-40 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.472 ' HB3' HG21 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.494 HG21 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.505 HD21 HG11 ' K' ' 94' ' ' VAL . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' K' ' 25' ' ' ALA . 6.3 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' SER . . . . . 0.46 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.453 HG21 ' O ' ' E' ' 168' ' ' GLY . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . 0.402 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . 0.453 ' HA2' ' HG ' ' L' ' 115' ' ' SER . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' K' ' 58' ' ' SER . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.54 58.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.62 35.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 110.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -33.38 75.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.15 22.53 4.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.615 1.566 . . . . 0.0 111.686 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.15 61.16 2.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.476 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.06 13.86 30.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.49 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.1 mmp_? -110.17 23.6 14.1 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.87 3.58 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.873 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.73 22.57 14.88 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 176.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . 0.425 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . 0.448 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.448 HG12 ' O ' ' K' ' 75' ' ' GLY . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.62 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.504 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.505 HG11 HD21 ' K' ' 14' ' ' LEU . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . 0.494 ' OD1' HG21 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . 0.403 ' O ' HG12 ' K' ' 97' ' ' VAL . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.819 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' K' ' 151' ' ' VAL . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.61 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . 0.417 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.532 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.459 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . 0.414 ' HA ' HE22 ' J' ' 9' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 129' ' ' SER . . . . . 0.507 ' O ' ' N ' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' K' ' 65' ' ' VAL . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . 0.415 ' CB ' ' O ' ' K' ' 112' ' ' TYR . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.532 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . 0.41 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.61 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 145' ' ' THR . . . . . 0.483 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' K' ' 104' ' ' TYR . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.59 159.47 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.07 28.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.57 -4.3 76.1 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 119.329 0.968 . . . . 0.0 113.027 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.91 23.46 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.17 46.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 108.589 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.87 42.13 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -158.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.444 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.444 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . 0.422 HE22 ' HA ' ' G' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.462 ' HB3' HG21 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . 0.487 HG21 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' L' ' 25' ' ' ALA . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' SER . . . . . 0.472 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.86 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . 0.472 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' THR . . . . . 0.448 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.597 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 38' ' ' SER . . . . . 0.41 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' L' ' 58' ' ' SER . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . 0.554 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER -65.47 139.55 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.195 171.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.78 -33.39 75.75 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . 0.431 ' HB3' HG12 ' B' ' 122' ' ' VAL . 0.0 OUTLIER 71.18 22.52 4.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.59 1.556 . . . . 0.0 111.69 -172.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.404 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 42.16 61.15 2.06 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.502 1.521 . . . . 0.0 111.535 -164.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.465 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.83 30.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.47 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.58 14.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.86 3.6 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.874 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . 0.555 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.64 14.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . 0.554 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . 0.44 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . 0.405 ' HZ3' ' HB2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.44 HG12 ' O ' ' L' ' 75' ' ' GLY . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.609 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.609 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . 0.581 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.522 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.491 HG11 HD21 ' L' ' 14' ' ' LEU . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . 0.487 ' OD1' HG21 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . 0.406 ' O ' HG12 ' L' ' 97' ' ' VAL . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.831 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.506 ' OH ' HG23 ' L' ' 151' ' ' VAL . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.523 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.617 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . 0.427 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.532 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.433 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 115' ' ' SER . . . . . 0.453 ' HG ' ' HA2' ' K' ' 39' ' ' GLY . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . 0.427 ' HA ' HE22 ' K' ' 9' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 129' ' ' SER . . . . . 0.493 ' O ' ' N ' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.421 HG12 ' HB ' ' L' ' 65' ' ' VAL . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' L' ' 112' ' ' TYR . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.539 ' HA ' HD21 ' K' ' 54' ' ' LEU . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . 0.402 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.417 HD11 ' CA ' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . 0.446 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.617 ' HB2' ' HB3' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.945 HD11 ' CD2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 145' ' ' THR . . . . . 0.485 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' L' ' 104' ' ' TYR . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.47 14.97 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.78 -0.1 29.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.52 -4.26 76.2 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.393 0.997 . . . . 0.0 113.085 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.8 139.94 23.51 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.17 151.19 46.4 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.612 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.88 42.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -158.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . 0.444 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.444 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 166' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.501 ' CG ' ' HB ' ' L' ' 48' ' ' THR . 2.5 mm-40 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.448 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.55 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.45 HG22 ' HG1' ' A' ' 66' ' ' THR . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.02 58.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.83 36.59 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.266 171.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.36 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 155.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.3 -34.66 77.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.1 4.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 111.635 -172.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.579 1.552 . . . . 0.0 111.534 -164.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.48 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.14 10.13 39.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.22 81.65 1.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.6 27.62 8.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.26 4.19 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.877 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -103.09 23.44 12.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.45 ' HG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.571 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.465 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.453 ' HB1' HG23 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.637 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.527 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.571 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.498 HG23 ' OH ' ' A' ' 104' ' ' TYR . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.49 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.66 54.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.77 -1.27 61.42 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.386 0.994 . . . . 0.0 113.053 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 138.3 23.67 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.95 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.327 1.051 . . . . 0.0 108.614 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.62 58.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 6.2 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.564 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' G' ' 48' ' ' THR . 2.5 mm-40 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.465 ' HB3' HG21 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.5 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.545 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' B' ' 14' ' ' LEU . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.455 HG22 ' HG1' ' B' ' 66' ' ' THR . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' B' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.218 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.38 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.75 78.11 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.86 22.08 3.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.584 1.553 . . . . 0.0 111.701 -172.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.7 59.99 2.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.483 1.513 . . . . 0.0 111.578 -164.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.451 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.09 10.11 39.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.29 81.74 1.41 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -107.72 27.7 8.92 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -124.34 4.25 4.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.859 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' C' ' 134' ' ' VAL . 0.0 OUTLIER -103.1 23.41 12.38 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.455 ' HG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.681 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.681 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.525 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.566 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.47 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.408 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.625 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . 0.463 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.452 ' HB1' HG23 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' L' ' 47' ' ' GLN . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.498 ' O ' ' N ' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.622 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.51 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.496 HG23 ' OH ' ' B' ' 104' ' ' TYR . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.64 14.8 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.04 -5.58 54.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.3 61.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 119.447 1.022 . . . . 0.0 113.008 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.25 23.72 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.94 149.01 48.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.3 1.04 . . . . 0.0 108.603 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.95 -52.62 58.88 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -158.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.422 ' HG2' ' OD2' ' H' ' 144' ' ' ASP . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.41 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.4 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.2 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.416 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . 0.493 ' O ' HG21 ' H' ' 18' ' ' ILE . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.526 ' CG ' ' HB ' ' H' ' 48' ' ' THR . 2.5 mm-40 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' C' ' 6' ' ' ILE . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.532 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' C' ' 14' ' ' LEU . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.468 ' O ' HG11 ' D' ' 122' ' ' VAL . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' THR . . . . . 0.462 HG22 ' HG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.413 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' C' ' 53' ' ' ILE . 0.2 OUTLIER -64.67 141.99 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.192 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.41 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.83 22.1 4.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.591 1.557 . . . . 0.0 111.618 -172.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.77 59.92 2.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.49 1.516 . . . . 0.0 111.555 -164.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.15 10.07 39.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.68 1.4 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -107.68 27.67 8.94 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HB3' ' C' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.911 178.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' D' ' 134' ' ' VAL . 0.0 OUTLIER -103.07 23.46 12.29 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 176.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' THR . . . . . 0.462 ' HG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.673 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.673 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.513 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.577 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.56 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.422 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.528 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . 0.446 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.536 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . 0.639 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.528 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.508 HG23 ' OH ' ' C' ' 104' ' ' TYR . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.61 14.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.03 -5.6 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.28 61.3 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.343 0.974 . . . . 0.0 113.0 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.26 23.69 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.96 149.0 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.264 1.025 . . . . 0.0 108.603 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.61 58.88 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -158.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.402 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.402 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . 0.472 ' O ' HG21 ' I' ' 18' ' ' ILE . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . 0.427 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . 0.451 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.411 ' CG ' ' HB ' ' I' ' 48' ' ' THR . 2.5 mm-40 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.451 ' HB3' HG21 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . 0.4 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.564 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' SER . . . . . 0.547 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.547 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.43 ' CB ' HD13 ' D' ' 14' ' ' LEU . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' THR . . . . . 0.453 HG22 ' HG1' ' D' ' 66' ' ' THR . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.408 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' D' ' 53' ' ' ILE . 0.2 OUTLIER -64.64 142.0 58.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.35 131.79 36.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.224 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.42 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.32 -34.7 77.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.91 22.12 3.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.595 1.558 . . . . 0.0 111.658 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.66 59.98 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.495 1.518 . . . . 0.0 111.593 -164.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.08 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.469 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.09 10.03 39.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.61 1.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.62 27.66 8.93 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HB3' ' D' ' 43' ' ' LEU . 0.3 OUTLIER -124.32 4.21 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.88 178.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.44 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER -103.08 23.44 12.33 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' THR . . . . . 0.453 ' HG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.684 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.684 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.528 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.592 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.564 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.41 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . 0.452 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . 0.468 HG11 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' SER . . . . . 0.505 ' O ' ' N ' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.465 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . 0.645 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.526 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . 0.564 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.495 HG23 ' OH ' ' D' ' 104' ' ' TYR . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.59 14.83 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.62 54.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.33 61.41 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.336 0.971 . . . . 0.0 113.021 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.3 23.72 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.95 148.97 48.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.265 1.026 . . . . 0.0 108.578 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.0 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -158.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.455 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 6.2 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.433 ' O ' ' O ' ' J' ' 18' ' ' ILE . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . 0.615 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.468 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . 0.507 ' CG ' ' HB ' ' J' ' 48' ' ' THR . 2.5 mm-40 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.468 ' HB3' HG21 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.5 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' SER . . . . . 0.554 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.554 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.437 ' CB ' HD13 ' E' ' 14' ' ' LEU . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' THR . . . . . 0.44 HG22 ' HG1' ' E' ' 66' ' ' THR . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.41 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' E' ' 53' ' ' ILE . 0.2 OUTLIER -64.65 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.203 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.44 110.25 0.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.31 -34.66 77.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.82 22.1 4.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.623 1.569 . . . . 0.0 111.67 -172.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.68 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.503 1.521 . . . . 0.0 111.598 -164.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -114.99 -127.86 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.12 10.05 39.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.34 81.69 1.41 Allowed Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.409 ' HA ' ' HB3' ' E' ' 43' ' ' LEU . 0.3 OUTLIER -124.27 4.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.907 178.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.582 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -103.07 23.44 12.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 176.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' THR . . . . . 0.44 ' HG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.695 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.695 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.53 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . 0.601 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.569 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.414 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.523 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . 0.455 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 129' ' ' SER . . . . . 0.493 ' O ' ' N ' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.637 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.44 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.637 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.523 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . 0.577 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.501 HG23 ' OH ' ' E' ' 104' ' ' TYR . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.65 14.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.97 -5.68 54.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.26 61.36 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.36 0.982 . . . . 0.0 113.033 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 138.32 23.75 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.96 48.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 108.61 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.03 -52.57 58.82 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.431 ' HA ' HE22 ' K' ' 16' ' ' GLN . 4.4 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.402 ' C ' ' HA2' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.431 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . 0.495 ' O ' HG21 ' K' ' 18' ' ' ILE . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' F' ' 10' ' ' ASP . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.461 ' HB3' HG21 ' F' ' 6' ' ' ILE . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 126' ' ' VAL . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' SER . . . . . 0.539 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.443 ' CB ' HD13 ' F' ' 14' ' ' LEU . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 33' ' ' THR . . . . . 0.456 HG22 ' HG1' ' F' ' 66' ' ' THR . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' F' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 141.93 58.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.28 131.83 36.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.245 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.41 110.27 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 155.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.27 -34.71 77.98 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.2 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.657 1.583 . . . . 0.0 111.641 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.65 59.96 2.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.452 1.501 . . . . 0.0 111.616 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.47 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.11 10.13 39.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.68 27.66 8.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' F' ' 43' ' ' LEU . 0.3 OUTLIER -124.29 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.879 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.16 23.55 12.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 66' ' ' THR . . . . . 0.456 ' HG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.703 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.595 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.573 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.413 HG23 ' O ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.531 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.613 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . 0.464 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . 0.459 ' HB1' HG23 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' J' ' 47' ' ' GLN . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 129' ' ' SER . . . . . 0.503 ' O ' ' N ' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.615 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.582 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.615 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.531 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' F' ' 104' ' ' TYR . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.5 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.61 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.29 61.45 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 119.326 0.966 . . . . 0.0 113.06 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.63 138.29 23.74 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.478 ' N ' HD11 ' L' ' 138' ' ' LEU . 33.2 m-85 -135.92 149.0 48.78 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.323 1.049 . . . . 0.0 108.623 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.02 -52.6 58.74 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -158.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD11 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.525 ' O ' ' CZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.682 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 4.4 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.607 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.416 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 6.3 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.587 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.691 ' O ' ' O ' ' L' ' 18' ' ' ILE . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . 0.903 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . 0.444 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . 0.434 HE22 ' HA ' ' H' ' 122' ' ' VAL . 2.5 mm-40 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.459 ' HB3' HG21 ' G' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.567 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 17' ' ' SER . . . . . 0.555 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.564 HG21 ' O ' ' A' ' 168' ' ' GLY . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . 0.555 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' G' ' 14' ' ' LEU . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 33' ' ' THR . . . . . 0.447 HG22 ' HG1' ' G' ' 66' ' ' THR . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.41 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . 0.416 ' HB3' ' HA ' ' G' ' 53' ' ' ILE . 0.2 OUTLIER -64.66 141.97 58.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.191 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.43 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.33 -34.67 77.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.86 22.11 3.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 111.642 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' B' ' 9' ' ' GLN . 1.1 m 41.67 59.98 2.31 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.469 1.508 . . . . 0.0 111.593 -164.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.462 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.13 10.11 39.69 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.7 27.72 8.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.416 ' HA ' ' HB3' ' G' ' 43' ' ' LEU . 0.3 OUTLIER -124.31 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.913 178.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . 0.482 ' HB2' HG21 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -103.13 23.46 12.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 176.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 66' ' ' THR . . . . . 0.447 ' HG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.7 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.7 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.599 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.567 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.419 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.516 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . 0.456 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . 0.419 ' HA ' HE22 ' L' ' 9' ' ' GLN . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 129' ' ' SER . . . . . 0.499 ' O ' ' N ' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.632 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . 0.496 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.516 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.506 HG23 ' OH ' ' G' ' 104' ' ' TYR . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.66 14.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.99 -5.61 54.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 -1.22 61.45 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 119.368 0.985 . . . . 0.0 113.064 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.31 23.75 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -136.0 148.92 48.63 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.337 1.055 . . . . 0.0 108.617 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.85 -52.66 59.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -158.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.415 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 6.2 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 166' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' G' ' 173' ' ' THR . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.443 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' H' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 17' ' ' SER . . . . . 0.546 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.493 HG21 ' O ' ' B' ' 168' ' ' GLY . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.41 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' H' ' 14' ' ' LEU . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 33' ' ' THR . . . . . 0.459 HG22 ' HG1' ' H' ' 66' ' ' THR . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.411 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' H' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.04 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.78 36.62 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.213 171.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 155.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.3 -34.72 77.97 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . 0.435 ' HB3' HG12 ' D' ' 122' ' ' VAL . 0.0 OUTLIER 71.85 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.623 1.569 . . . . 0.0 111.677 -172.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' C' ' 9' ' ' GLN . 1.1 m 41.74 59.97 2.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.461 1.504 . . . . 0.0 111.558 -164.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.13 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.432 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.11 10.04 39.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.32 81.65 1.4 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.65 27.69 8.91 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.427 ' HA ' ' HB3' ' H' ' 43' ' ' LEU . 0.3 OUTLIER -124.36 4.22 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 178.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . 0.457 ' HB2' HG21 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -103.05 23.41 12.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 66' ' ' THR . . . . . 0.459 ' HG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.404 ' HA ' HD11 ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.687 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.496 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.687 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.598 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.571 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.41 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . 0.462 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.526 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . 0.434 ' HA ' HE22 ' G' ' 9' ' ' GLN . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . 0.466 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 129' ' ' SER . . . . . 0.491 ' O ' ' N ' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.632 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.501 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.623 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.521 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . 0.422 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . 0.565 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.499 HG23 ' OH ' ' H' ' 104' ' ' TYR . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.45 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.06 -5.53 54.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.27 61.47 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.415 1.007 . . . . 0.0 113.076 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.72 138.35 23.75 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.93 148.96 48.75 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.36 1.064 . . . . 0.0 108.627 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.99 -52.6 58.84 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -158.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' H' ' 173' ' ' THR . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 167' ' ' THR . . . . . 0.412 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . 0.466 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.466 ' HB3' HG21 ' I' ' 6' ' ' ILE . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 17' ' ' SER . . . . . 0.542 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.472 HG21 ' O ' ' C' ' 168' ' ' GLY . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' I' ' 14' ' ' LEU . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 33' ' ' THR . . . . . 0.448 HG22 ' HG1' ' I' ' 66' ' ' THR . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' I' ' 53' ' ' ILE . 0.2 OUTLIER -64.62 141.94 58.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.78 36.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.241 171.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.5 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 155.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.31 -34.69 77.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.14 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.645 1.578 . . . . 0.0 111.669 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 48' ' ' THR . . . . . 0.411 ' HB ' ' CG ' ' D' ' 9' ' ' GLN . 1.1 m 41.67 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.519 1.528 . . . . 0.0 111.584 -164.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.89 0.29 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.455 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.07 10.11 39.78 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.68 27.62 8.99 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' I' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.862 178.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.557 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -103.06 23.42 12.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 66' ' ' THR . . . . . 0.448 ' HG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.679 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.501 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.679 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.524 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.583 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.563 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.418 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.524 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 129' ' ' SER . . . . . 0.496 ' O ' ' N ' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.631 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.518 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . 0.576 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.505 HG23 ' OH ' ' I' ' 104' ' ' TYR . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.47 159.57 14.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.95 -5.58 54.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.33 61.5 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 119.345 0.975 . . . . 0.0 113.059 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.28 23.76 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.94 148.97 48.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.305 1.042 . . . . 0.0 108.604 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.01 -52.61 58.73 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -158.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 6.2 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 167' ' ' THR . . . . . 0.414 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.465 HG21 ' HB3' ' J' ' 10' ' ' ASP . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.465 ' HB3' HG21 ' J' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . 0.412 HG22 HG11 ' K' ' 126' ' ' VAL . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.551 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 17' ' ' SER . . . . . 0.543 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.615 HG21 ' O ' ' D' ' 168' ' ' GLY . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' J' ' 14' ' ' LEU . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.56 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 33' ' ' THR . . . . . 0.452 HG22 ' HG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' J' ' 53' ' ' ILE . 0.2 OUTLIER -64.66 142.01 58.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.31 131.81 36.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.223 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.4 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 155.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.28 -34.69 77.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . 0.46 ' HB3' HG12 ' F' ' 122' ' ' VAL . 0.0 OUTLIER 71.85 22.12 3.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.622 1.569 . . . . 0.0 111.659 -172.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 48' ' ' THR . . . . . 0.507 ' HB ' ' CG ' ' E' ' 9' ' ' GLN . 1.1 m 41.69 60.02 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 111.562 -164.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.82 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.487 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.15 10.12 39.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.31 81.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.66 27.68 8.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.415 ' HA ' ' HB3' ' J' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.17 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.922 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.49 12.26 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 66' ' ' THR . . . . . 0.452 ' HG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.686 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . 0.595 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.406 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . 0.451 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . 0.488 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . 0.42 ' O ' ' OG1' ' I' ' 33' ' ' THR . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 129' ' ' SER . . . . . 0.5 ' O ' ' N ' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.645 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.557 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . 0.645 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . 0.407 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.524 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . 0.56 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.493 HG23 ' OH ' ' J' ' 104' ' ' TYR . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.54 159.6 14.82 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.59 54.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.27 61.39 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.43 1.014 . . . . 0.0 113.041 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.31 23.75 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.95 148.98 48.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.31 1.044 . . . . 0.0 108.632 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.58 59.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -158.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.404 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.404 HE22 ' HD2' ' J' ' 163' ' ' PRO . 6.2 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.47 ' O ' ' HB ' ' J' ' 173' ' ' THR . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 167' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' L' ' 122' ' ' VAL . 2.5 mm-40 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' K' ' 6' ' ' ILE . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.415 HG22 HG11 ' L' ' 126' ' ' VAL . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 17' ' ' SER . . . . . 0.553 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.495 HG21 ' O ' ' E' ' 168' ' ' GLY . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' K' ' 14' ' ' LEU . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' K' ' 66' ' ' THR . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . 0.425 ' HB3' ' HA ' ' K' ' 53' ' ' ILE . 0.2 OUTLIER -64.59 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.81 36.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.211 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.29 -34.66 77.86 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.84 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 111.626 -172.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.74 59.95 2.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.485 1.514 . . . . 0.0 111.571 -164.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.06 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.441 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.17 10.18 39.58 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.62 1.4 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -107.61 27.71 8.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.425 ' HA ' ' HB3' ' K' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.921 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.536 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.46 12.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.696 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.53 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . 0.604 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.547 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.415 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . 0.452 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 129' ' ' SER . . . . . 0.506 ' O ' ' N ' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.643 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.609 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.537 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.475 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . 0.573 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.503 HG23 ' OH ' ' K' ' 104' ' ' TYR . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.53 159.62 14.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.64 54.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.27 61.34 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.385 0.993 . . . . 0.0 113.027 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.62 138.3 23.78 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.97 149.0 48.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.277 1.031 . . . . 0.0 108.588 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.01 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -158.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.406 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.406 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.2 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.48 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 167' ' ' THR . . . . . 0.43 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . 0.441 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' G' ' 122' ' ' VAL . 2.5 mm-40 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' L' ' 6' ' ' ILE . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 17' ' ' SER . . . . . 0.556 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.903 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . 0.556 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.441 ' CB ' HD13 ' L' ' 14' ' ' LEU . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.582 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' L' ' 66' ' ' THR . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' L' ' 53' ' ' ILE . 0.2 OUTLIER -64.56 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.3 131.84 36.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.2 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.34 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.68 77.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . 0.404 ' HB3' HG12 ' B' ' 122' ' ' VAL . 0.0 OUTLIER 71.83 22.08 4.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.598 1.559 . . . . 0.0 111.661 -172.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' A' ' 9' ' ' GLN . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.467 1.507 . . . . 0.0 111.575 -164.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.07 -127.86 0.29 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.46 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.11 10.07 39.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.3 81.69 1.41 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.419 ' HA ' ' HB3' ' L' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.2 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.89 178.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . 0.511 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.43 12.36 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.703 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . 0.591 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.562 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.555 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.413 HG23 ' O ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.536 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.4 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . 0.466 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . 0.406 ' HA ' HE22 ' K' ' 9' ' ' GLN . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 129' ' ' SER . . . . . 0.508 ' O ' ' N ' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . 0.629 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.478 HD11 ' N ' ' F' ' 158' ' ' TYR . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . 0.428 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.682 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.6 HD11 ' CD2' ' F' ' 160' ' ' PHE . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . 0.582 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.497 HG23 ' OH ' ' L' ' 104' ' ' TYR . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.51 159.68 14.77 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.05 -5.62 54.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.84 -1.32 61.29 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.354 0.979 . . . . 0.0 112.993 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.32 23.76 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.97 148.95 48.69 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.347 1.059 . . . . 0.0 108.629 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.65 58.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.407 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 6.3 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 166' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 167' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 96' ' ' THR . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD12 HG21 ' A' ' 94' ' ' VAL . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.685 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' O ' HG23 ' L' ' 48' ' ' THR . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.459 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.97 166.74 22.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' A' ' 53' ' ' ILE . 9.3 t80 -108.28 83.38 1.77 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.271 171.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.708 ' H ' HG23 ' A' ' 53' ' ' ILE . 34.1 t70 -106.44 92.09 3.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.51 -15.8 63.03 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.81 21.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.578 1.551 . . . . 0.0 111.66 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.5 53.71 1.38 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 111.577 -164.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.15 -92.06 0.52 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.427 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -150.62 29.99 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.85 34.72 14.55 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 122.68 44.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.708 HG23 ' H ' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -136.91 133.03 47.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.826 178.333 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.519 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER -108.12 22.18 16.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.45 ' HA ' ' OD1' ' F' ' 50' ' ' ASN . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.648 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' CE2' HD12 ' A' ' 128' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.473 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.435 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.547 HG21 HD12 ' A' ' 14' ' ' LEU . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.54 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' A' ' 151' ' ' VAL . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 67' ' ' TYR . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.624 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.648 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.54 HG13 ' OD1' ' A' ' 102' ' ' ASP . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.459 HG22 HD21 ' A' ' 14' ' ' LEU . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.578 HD12 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.491 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 146' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' A' ' 104' ' ' TYR . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.0 146.68 38.65 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.92 -38.94 57.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.7 65.5 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 119.353 0.979 . . . . 0.0 113.031 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.77 123.25 7.42 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.82 110.4 22.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 108.614 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -28.88 63.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.482 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.482 ' HA ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.755 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.55 ' HG2' HD11 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.755 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' B' ' 96' ' ' THR . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.421 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.546 HD12 HG21 ' B' ' 94' ' ' VAL . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.692 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.58 ' OG ' HD12 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.449 ' O ' HG23 ' G' ' 48' ' ' THR . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.515 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.93 166.74 22.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' B' ' 53' ' ' ILE . 9.3 t80 -108.31 83.46 1.78 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.195 171.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.703 ' H ' HG23 ' B' ' 53' ' ' ILE . 34.1 t70 -106.51 92.16 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.57 -15.77 63.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.07 35.8 21.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.596 1.558 . . . . 0.0 111.703 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.55 53.71 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.535 1.534 . . . . 0.0 111.57 -164.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.15 -92.07 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.443 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 7.8 m-20 -150.61 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.84 34.71 14.63 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 122.61 44.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.703 HG23 ' H ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -136.86 132.96 48.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.887 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.68 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -108.1 22.27 16.19 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.669 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' B' ' 128' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' B' ' 79' ' ' ILE . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.474 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' B' ' 91' ' ' PHE . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.546 HG21 HD12 ' B' ' 14' ' ' LEU . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.495 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' B' ' 151' ' ' VAL . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB3' ' HG ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' B' ' 67' ' ' TYR . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.42 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.632 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . 0.669 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.519 HD12 HD23 ' A' ' 54' ' ' LEU . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' B' ' 102' ' ' ASP . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' THR . . . . . 0.458 HG22 HD21 ' B' ' 14' ' ' LEU . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.58 HD12 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.401 HD12 HD23 ' B' ' 146' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' B' ' 104' ' ' TYR . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.68 38.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.87 57.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.6 65.59 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.36 0.982 . . . . 0.0 113.025 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 123.22 7.46 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.77 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.304 1.042 . . . . 0.0 108.629 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.94 63.56 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -158.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.614 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 15.5 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.499 ' HA ' ' NE2' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.743 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.536 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . 0.567 ' HG2' HD11 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.536 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.743 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 96' ' ' THR . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . 0.423 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.535 HD12 HG21 ' C' ' 94' ' ' VAL . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.701 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' SER . . . . . 0.564 ' OG ' HD12 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.701 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.423 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . 0.478 ' O ' HG23 ' H' ' 48' ' ' THR . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.43 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 166.71 22.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' C' ' 53' ' ' ILE . 9.3 t80 -108.26 83.41 1.78 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.256 171.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.701 ' H ' HG23 ' C' ' 53' ' ' ILE . 34.0 t70 -106.43 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.61 -15.7 63.0 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.604 1.562 . . . . 0.0 111.639 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.5 53.73 1.39 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.503 1.521 . . . . 0.0 111.587 -164.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.18 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . 0.567 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.76 34.79 14.65 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.29 122.62 44.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.701 HG23 ' H ' ' C' ' 45' ' ' ASP . 0.5 OUTLIER -136.83 133.01 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.857 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.639 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER -108.2 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' B' ' 50' ' ' ASN . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.475 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 9.3 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.475 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.484 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.515 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.484 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' C' ' 91' ' ' PHE . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.535 HG21 HD12 ' C' ' 14' ' ' LEU . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . 0.55 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.528 ' CZ ' HG23 ' C' ' 151' ' ' VAL . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . 0.692 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . 0.46 ' HB3' ' HG ' ' B' ' 38' ' ' SER . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . 0.444 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' C' ' 67' ' ' TYR . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.432 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . 0.67 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.68 HD12 HD23 ' B' ' 54' ' ' LEU . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . 0.692 HD11 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.55 HG13 ' OD1' ' C' ' 102' ' ' ASP . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' THR . . . . . 0.467 HG22 HD21 ' C' ' 14' ' ' LEU . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . 0.564 HD12 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.497 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.528 HG23 ' CZ ' ' C' ' 104' ' ' TYR . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.01 146.62 38.77 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.95 -38.9 57.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.61 8.59 65.53 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.423 1.01 . . . . 0.0 113.03 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.75 123.25 7.43 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.79 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.296 1.038 . . . . 0.0 108.623 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.85 63.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.61 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 15.6 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.749 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' THR . . . . . 0.547 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . 0.583 ' HG2' HD11 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.547 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . 0.749 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' D' ' 96' ' ' THR . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . 0.431 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.528 HD12 HG21 ' D' ' 94' ' ' VAL . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.691 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' SER . . . . . 0.567 ' OG ' HD12 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.431 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' SER . . . . . 0.487 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.95 166.8 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . 0.417 ' HA ' HG12 ' D' ' 53' ' ' ILE . 9.3 t80 -108.31 83.42 1.78 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.186 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.712 ' H ' HG23 ' D' ' 53' ' ' ILE . 34.0 t70 -106.47 92.13 3.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.58 -15.75 63.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.08 35.76 21.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.573 1.549 . . . . 0.0 111.717 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.59 53.71 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.477 1.511 . . . . 0.0 111.57 -164.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.16 -92.04 0.52 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.431 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -150.56 29.87 0.68 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.85 34.77 14.4 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.33 122.66 44.68 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.712 HG23 ' H ' ' D' ' 45' ' ' ASP . 0.5 OUTLIER -136.8 133.05 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.896 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.502 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER -108.2 22.32 16.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' SER . . . . . 0.567 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' D' ' 128' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 9.2 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . 0.43 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.492 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' D' ' 91' ' ' PHE . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.528 HG21 HD12 ' D' ' 14' ' ' LEU . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . 0.551 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.496 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' D' ' 151' ' ' VAL . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . 0.402 ' HB3' ' HG ' ' C' ' 38' ' ' SER . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . 0.43 HD12 ' CE2' ' D' ' 67' ' ' TYR . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . 0.426 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.667 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.639 HD12 HD23 ' C' ' 54' ' ' LEU . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . 0.712 HD11 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.551 HG13 ' OD1' ' D' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' THR . . . . . 0.472 HG22 HD21 ' D' ' 14' ' ' LEU . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . 0.567 HD12 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . 0.4 HD12 HD23 ' D' ' 146' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' D' ' 104' ' ' TYR . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.07 146.67 38.75 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.92 -38.85 57.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.62 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 119.367 0.985 . . . . 0.0 113.06 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.72 123.18 7.42 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.301 1.04 . . . . 0.0 108.593 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -28.83 63.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . 0.492 ' NE2' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.597 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 15.5 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' NE2' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.753 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.553 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . 0.63 ' HG2' HD11 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.553 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . 0.753 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' E' ' 96' ' ' THR . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . 0.423 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.53 HD12 HG21 ' E' ' 94' ' ' VAL . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' SER . . . . . 0.573 ' OG ' HD12 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.685 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.423 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' SER . . . . . 0.468 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.95 166.71 22.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . 0.406 ' HA ' HG12 ' E' ' 53' ' ' ILE . 9.3 t80 -108.25 83.35 1.77 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.254 171.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . 0.714 ' H ' HG23 ' E' ' 53' ' ' ILE . 34.1 t70 -106.44 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -65.55 -15.8 63.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.84 21.22 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.641 -172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.51 53.72 1.39 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 111.552 -164.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.15 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.464 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 7.8 m-20 -150.61 29.98 0.67 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.77 34.77 14.67 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.33 122.59 44.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.714 HG23 ' H ' ' E' ' 45' ' ' ASP . 0.5 OUTLIER -136.81 133.0 48.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.885 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.629 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER -108.11 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 176.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.428 ' CE2' HD12 ' E' ' 128' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 9.3 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.488 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' E' ' 91' ' ' PHE . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.53 HG21 HD12 ' E' ' 14' ' ' LEU . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . 0.553 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.495 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' E' ' 151' ' ' VAL . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . 0.701 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . 0.435 ' HB3' ' HG ' ' D' ' 38' ' ' SER . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . 0.428 HD12 ' CE2' ' E' ' 67' ' ' TYR . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.422 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 131' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . 0.674 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.502 HD12 HD23 ' D' ' 54' ' ' LEU . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . 0.701 HD11 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.553 HG13 ' OD1' ' E' ' 102' ' ' ASP . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 145' ' ' THR . . . . . 0.474 HG22 HD21 ' E' ' 14' ' ' LEU . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . 0.573 HD12 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . 0.406 HD12 HD23 ' E' ' 146' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' E' ' 104' ' ' TYR . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.65 38.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.94 -38.85 57.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.6 65.63 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.384 0.993 . . . . 0.0 113.048 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 123.26 7.48 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.34 22.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.343 1.057 . . . . 0.0 108.604 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.86 63.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.62 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.753 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.547 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . 0.528 ' HG2' HD11 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.547 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . 0.753 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.484 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' F' ' 96' ' ' THR . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . 0.409 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.54 HD12 HG21 ' F' ' 94' ' ' VAL . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.682 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' SER . . . . . 0.578 ' OG ' HD12 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 38' ' ' SER . . . . . 0.435 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.0 166.74 22.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . 0.428 ' HA ' HG12 ' F' ' 53' ' ' ILE . 9.2 t80 -108.25 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.235 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . 0.7 ' H ' HG23 ' F' ' 53' ' ' ILE . 34.1 t70 -106.49 92.05 3.95 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.54 -15.79 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.15 35.76 21.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.573 1.549 . . . . 0.0 111.66 -172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.59 53.7 1.43 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.505 1.522 . . . . 0.0 111.547 -164.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.23 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.419 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 7.8 m-20 -150.62 29.94 0.67 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.81 34.85 14.32 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.33 122.59 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.7 HG23 ' H ' ' F' ' 45' ' ' ASP . 0.5 OUTLIER -136.79 133.02 48.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.903 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.15 22.31 16.12 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 58' ' ' SER . . . . . 0.509 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 62' ' ' SER . . . . . 0.644 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . 0.619 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . 0.43 ' CE2' HD12 ' F' ' 128' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.472 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . 0.468 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' F' ' 91' ' ' PHE . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.54 HG21 HD12 ' F' ' 14' ' ' LEU . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' F' ' 151' ' ' VAL . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . 0.703 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 119' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . 0.43 HD12 ' CE2' ' F' ' 67' ' ' TYR . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.416 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 131' ' ' SER . . . . . 0.619 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . 0.644 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.629 HD12 HD23 ' E' ' 54' ' ' LEU . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . 0.703 HD11 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' F' ' 102' ' ' ASP . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 145' ' ' THR . . . . . 0.47 HG22 HD21 ' F' ' 14' ' ' LEU . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . 0.578 HD12 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.487 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.527 HG23 ' CZ ' ' F' ' 104' ' ' TYR . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.05 146.67 38.72 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.89 -38.93 57.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.56 65.53 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 119.399 1.0 . . . . 0.0 113.034 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . 0.543 ' HA3' ' CD2' ' L' ' 138' ' ' LEU . . . -74.63 123.16 7.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.427 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.6 t80 -101.76 110.33 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.299 1.04 . . . . 0.0 108.646 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.11 -28.87 63.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.555 ' CD1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.617 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 15.6 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.5 ' HA ' ' NE2' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.766 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.532 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.787 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.532 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . 0.766 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . 0.45 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' G' ' 96' ' ' THR . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . 0.41 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.545 HD12 HG21 ' G' ' 94' ' ' VAL . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.69 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.55 HD11 ' HG2' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 24' ' ' SER . . . . . 0.58 ' OG ' HD12 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.69 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.41 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.9 166.74 22.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' G' ' 53' ' ' ILE . 9.3 t80 -108.31 83.39 1.77 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.214 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . 0.704 ' H ' HG23 ' G' ' 53' ' ' ILE . 34.1 t70 -106.4 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.57 -15.78 63.05 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.16 35.77 21.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.593 1.557 . . . . 0.0 111.644 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.449 HG23 ' O ' ' B' ' 31' ' ' TYR . 0.0 OUTLIER 37.49 53.72 1.38 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.522 1.529 . . . . 0.0 111.598 -164.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.11 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.461 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 7.8 m-20 -150.65 30.02 0.67 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.84 34.71 14.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 122.66 44.64 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.704 HG23 ' H ' ' G' ' 45' ' ' ASP . 0.5 OUTLIER -136.89 132.96 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 58' ' ' SER . . . . . 0.554 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 62' ' ' SER . . . . . 0.654 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.469 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 9.3 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.479 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.479 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.523 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' G' ' 91' ' ' PHE . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.492 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.545 HG21 HD12 ' G' ' 14' ' ' LEU . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . 0.55 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' G' ' 151' ' ' VAL . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . 0.7 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' G' ' 67' ' ' TYR . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . 0.416 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 131' ' ' SER . . . . . 0.616 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . 0.654 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . 0.7 HD11 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.55 HG13 ' OD1' ' G' ' 102' ' ' ASP . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 145' ' ' THR . . . . . 0.465 HG22 HD21 ' G' ' 14' ' ' LEU . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . 0.58 HD12 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . 0.402 HD12 HD23 ' G' ' 146' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' G' ' 104' ' ' TYR . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.64 38.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.92 -38.89 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.61 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.386 0.994 . . . . 0.0 113.046 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 123.27 7.45 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.31 22.27 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.293 1.037 . . . . 0.0 108.639 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.9 63.57 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -158.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . 0.617 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.496 ' HA ' ' NE2' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 166' ' ' THR . . . . . 0.748 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 167' ' ' THR . . . . . 0.537 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.537 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . 0.748 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.464 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' H' ' 96' ' ' THR . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.545 HD12 HG21 ' H' ' 94' ' ' VAL . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.567 HD11 ' HG2' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 24' ' ' SER . . . . . 0.573 ' OG ' HD12 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.702 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 38' ' ' SER . . . . . 0.401 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER -73.92 166.78 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . 0.429 ' HA ' HG12 ' H' ' 53' ' ' ILE . 9.3 t80 -108.34 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.171 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . 0.705 ' H ' HG23 ' H' ' 53' ' ' ILE . 34.1 t70 -106.53 92.07 3.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.5 -15.79 63.01 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.13 35.74 21.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.573 1.549 . . . . 0.0 111.702 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.478 HG23 ' O ' ' C' ' 31' ' ' TYR . 0.0 OUTLIER 37.63 53.64 1.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.482 1.513 . . . . 0.0 111.568 -164.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.16 -91.98 0.52 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.464 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 7.8 m-20 -150.66 29.96 0.67 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 34.78 14.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.31 122.58 44.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.705 HG23 ' H ' ' H' ' 45' ' ' ASP . 0.5 OUTLIER -136.83 133.02 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.886 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 22.29 16.16 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 58' ' ' SER . . . . . 0.447 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 62' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . 0.43 ' OH ' HG23 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.477 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.477 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.501 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' H' ' 91' ' ' PHE . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.487 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.545 HG21 HD12 ' H' ' 14' ' ' LEU . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . 0.546 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' H' ' 151' ' ' VAL . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . 0.697 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . 0.426 HD12 ' CE2' ' H' ' 67' ' ' TYR . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.423 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 131' ' ' SER . . . . . 0.622 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . 0.697 HD11 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.546 HG13 ' OD1' ' H' ' 102' ' ' ASP . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 145' ' ' THR . . . . . 0.455 HG22 HD21 ' H' ' 14' ' ' LEU . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . 0.573 HD12 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.477 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.534 HG23 ' CZ ' ' H' ' 104' ' ' TYR . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.69 38.64 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.82 56.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.66 65.59 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 119.381 0.991 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.76 123.24 7.42 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.34 22.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.273 1.029 . . . . 0.0 108.622 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.79 63.48 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -158.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 167' ' ' THR . . . . . 0.531 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.531 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . 0.754 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . 0.413 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.442 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' I' ' 96' ' ' THR . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.544 HD12 HG21 ' I' ' 94' ' ' VAL . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.703 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.583 HD11 ' HG2' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 24' ' ' SER . . . . . 0.577 ' OG ' HD12 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.703 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 38' ' ' SER . . . . . 0.467 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.89 166.7 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' I' ' 53' ' ' ILE . 9.3 t80 -108.26 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.244 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . 0.688 ' H ' HG23 ' I' ' 53' ' ' ILE . 34.0 t70 -106.49 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.55 -15.83 63.09 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.18 35.77 21.04 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.582 1.553 . . . . 0.0 111.667 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.49 53.79 1.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 111.558 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -116.21 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 34.79 14.47 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.33 122.65 44.67 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.688 HG23 ' H ' ' I' ' 45' ' ' ASP . 0.5 OUTLIER -136.84 133.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.853 178.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.457 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -108.17 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 58' ' ' SER . . . . . 0.582 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 62' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG23 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' I' ' 79' ' ' ILE . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.476 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.489 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.544 HG21 HD12 ' I' ' 14' ' ' LEU . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . 0.543 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.493 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.533 ' CZ ' HG23 ' I' ' 151' ' ' VAL . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . 0.69 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' I' ' 67' ' ' TYR . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.431 ' O ' HG13 ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 131' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . 0.665 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . 0.69 HD11 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.543 HG13 ' OD1' ' I' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 145' ' ' THR . . . . . 0.458 HG22 HD21 ' I' ' 14' ' ' LEU . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.483 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' I' ' 104' ' ' TYR . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.67 38.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.94 -38.94 57.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 8.63 65.51 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.391 0.996 . . . . 0.0 113.04 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.71 123.21 7.44 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.289 1.036 . . . . 0.0 108.649 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -28.77 63.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . 0.614 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.503 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.746 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 167' ' ' THR . . . . . 0.539 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.539 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . 0.746 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.457 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' J' ' 96' ' ' THR . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . 0.422 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.532 HD12 HG21 ' J' ' 94' ' ' VAL . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.692 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.63 HD11 ' HG2' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 24' ' ' SER . . . . . 0.576 ' OG ' HD12 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.91 166.74 22.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . 0.406 ' HA ' HG12 ' J' ' 53' ' ' ILE . 9.2 t80 -108.27 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.252 171.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . 0.697 ' H ' HG23 ' J' ' 53' ' ' ILE . 34.1 t70 -106.45 92.11 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.63 -15.74 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.1 35.8 21.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.624 1.57 . . . . 0.0 111.653 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.54 53.71 1.4 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.452 1.501 . . . . 0.0 111.601 -164.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -116.18 -91.99 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.459 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . 0.533 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.81 34.74 14.64 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.26 122.69 44.7 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.697 HG23 ' H ' ' J' ' 45' ' ' ASP . 0.5 OUTLIER -136.86 133.01 48.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.87 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.21 22.3 16.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 58' ' ' SER . . . . . 0.504 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 62' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . 0.638 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . 0.429 ' CE2' HD12 ' J' ' 128' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.467 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 9.3 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.482 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.467 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.532 HG21 HD12 ' J' ' 14' ' ' LEU . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . 0.548 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.521 ' CZ ' HG23 ' J' ' 151' ' ' VAL . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . 0.699 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . 0.417 ' HB3' ' HG ' ' I' ' 38' ' ' SER . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . 0.429 HD12 ' CE2' ' J' ' 67' ' ' TYR . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.431 ' O ' HG13 ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 131' ' ' SER . . . . . 0.638 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . 0.676 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.457 HD12 HD23 ' I' ' 54' ' ' LEU . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . 0.699 HD11 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.548 HG13 ' OD1' ' J' ' 102' ' ' ASP . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 145' ' ' THR . . . . . 0.472 HG22 HD21 ' J' ' 14' ' ' LEU . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . 0.576 HD12 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . 0.406 HD12 HD23 ' J' ' 146' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.521 HG23 ' CZ ' ' J' ' 104' ' ' TYR . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.05 146.68 38.69 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.86 56.91 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.59 8.58 65.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.369 0.986 . . . . 0.0 113.037 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.23 7.5 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.33 22.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.346 1.058 . . . . 0.0 108.593 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.91 63.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -158.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . 0.493 ' NE2' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . 0.611 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.493 ' HA ' ' NE2' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 167' ' ' THR . . . . . 0.55 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.55 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . 0.738 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.436 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' K' ' 96' ' ' THR . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . 0.429 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.526 HD12 HG21 ' K' ' 94' ' ' VAL . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.683 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.528 HD11 ' HG2' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 24' ' ' SER . . . . . 0.57 ' OG ' HD12 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 38' ' ' SER . . . . . 0.405 ' HG ' ' HB3' ' L' ' 116' ' ' ARG . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 166.75 22.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' K' ' 53' ' ' ILE . 9.3 t80 -108.27 83.38 1.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.21 171.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . 0.697 ' H ' HG23 ' K' ' 53' ' ' ILE . 34.0 t70 -106.42 92.07 3.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 155.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.52 -15.79 63.04 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.58 1.552 . . . . 0.0 111.648 -172.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 37.49 53.73 1.38 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.528 1.531 . . . . 0.0 111.58 -164.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -116.11 -92.07 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.465 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . 0.649 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.82 34.74 14.59 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 122.61 44.56 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.697 HG23 ' H ' ' K' ' 45' ' ' ASP . 0.5 OUTLIER -136.84 132.96 48.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.88 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.513 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -108.08 22.24 16.22 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 58' ' ' SER . . . . . 0.533 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 62' ' ' SER . . . . . 0.654 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . 0.431 ' CE2' HD12 ' K' ' 128' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.458 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.486 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.486 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.449 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' K' ' 91' ' ' PHE . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.526 HG21 HD12 ' K' ' 14' ' ' LEU . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . 0.554 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.498 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.525 ' CZ ' HG23 ' K' ' 151' ' ' VAL . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . 0.713 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 119' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . 0.431 HD12 ' CE2' ' K' ' 67' ' ' TYR . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.426 ' O ' HG13 ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 131' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . 0.654 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . 0.713 HD11 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.554 HG13 ' OD1' ' K' ' 102' ' ' ASP . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 145' ' ' THR . . . . . 0.476 HG22 HD21 ' K' ' 14' ' ' LEU . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . 0.57 HD12 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.525 HG23 ' CZ ' ' K' ' 104' ' ' TYR . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.03 146.68 38.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.84 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.61 65.59 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.348 0.977 . . . . 0.0 113.052 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.7 123.26 7.47 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.85 110.38 22.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.311 1.044 . . . . 0.0 108.593 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.88 63.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . 0.495 ' NE2' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . 0.602 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.602 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.495 ' HA ' ' NE2' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.751 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 167' ' ' THR . . . . . 0.556 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.556 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . 0.751 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.442 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' L' ' 96' ' ' THR . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . 0.415 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.54 HD12 HG21 ' L' ' 94' ' ' VAL . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.682 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 24' ' ' SER . . . . . 0.572 ' OG ' HD12 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.415 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.95 166.77 22.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . 0.418 ' HA ' HG12 ' L' ' 53' ' ' ILE . 9.3 t80 -108.3 83.43 1.78 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.228 171.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . 0.687 ' H ' HG23 ' L' ' 53' ' ' ILE . 34.1 t70 -106.49 92.1 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -65.48 -15.84 63.06 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.12 35.84 21.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.639 1.575 . . . . 0.0 111.611 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER 37.48 53.82 1.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.53 1.532 . . . . 0.0 111.534 -164.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -116.2 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.452 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 7.9 m-20 -150.62 29.96 0.67 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.74 34.84 14.57 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.36 122.57 44.51 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.687 HG23 ' H ' ' L' ' 45' ' ' ASP . 0.5 OUTLIER -136.79 132.96 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.91 178.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 58' ' ' SER . . . . . 0.649 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 62' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . 0.621 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . 0.428 ' CE2' HD12 ' L' ' 128' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 9.3 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.489 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.787 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' L' ' 91' ' ' PHE . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' F' ' 162' ' ' GLN . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.54 HG21 HD12 ' L' ' 14' ' ' LEU . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . 0.556 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.5 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.528 ' CZ ' HG23 ' L' ' 151' ' ' VAL . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' F' ' 158' ' ' TYR . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . 0.696 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . 0.405 ' HB3' ' HG ' ' K' ' 38' ' ' SER . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 119' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . 0.428 HD12 ' CE2' ' L' ' 67' ' ' TYR . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.41 ' O ' HG13 ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 131' ' ' SER . . . . . 0.621 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . 0.662 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.513 HD12 HD23 ' K' ' 54' ' ' LEU . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.696 HD11 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 11.1 p-10 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.556 HG13 ' OD1' ' L' ' 102' ' ' ASP . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 145' ' ' THR . . . . . 0.47 HG22 HD21 ' L' ' 14' ' ' LEU . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . 0.572 HD12 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.494 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . 0.404 HD12 HD23 ' L' ' 146' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.528 HG23 ' CZ ' ' L' ' 104' ' ' TYR . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.04 146.67 38.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.9 57.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.6 65.49 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 119.378 0.99 . . . . 0.0 113.04 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.26 7.49 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.36 22.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.31 1.044 . . . . 0.0 108.634 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -28.86 63.51 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -158.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . 0.501 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . 0.619 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 166' ' ' THR . . . . . 0.768 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 167' ' ' THR . . . . . 0.55 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.55 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . 0.768 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.412 ' O ' ' OG1' ' A' ' 96' ' ' THR . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.434 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' A' ' 94' ' ' VAL . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.418 ' OG ' HD12 ' A' ' 146' ' ' LEU . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.524 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.586 HH11 ' HA ' ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.63 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.426 ' HA ' HG12 ' A' ' 53' ' ' ILE . 10.1 t80 -108.98 81.76 1.49 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 171.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.54 ' H ' HG23 ' A' ' 53' ' ' ILE . 34.1 t70 -106.24 96.49 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 155.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 12.4 pt-20 -67.56 -15.8 63.85 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.3 35.58 18.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 111.654 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.485 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.07 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.487 1.515 . . . . 0.0 111.571 -164.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.11 -89.87 0.57 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.484 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -151.32 28.17 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.82 35.02 17.11 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.13 123.61 46.29 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -136.09 133.42 50.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.849 178.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER -107.99 18.9 20.69 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.57 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 10.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.417 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.712 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.417 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.544 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.544 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.512 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.712 HD11 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.407 HG21 ' CG2' ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 150' ' ' ILE . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.484 HD12 HD23 ' A' ' 146' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.63 144.02 44.52 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HD3' ' HA3' ' G' ' 136' ' ' GLY . 11.7 mttt -80.14 -32.95 38.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.95 75.55 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.349 0.977 . . . . 0.0 113.053 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.59 114.81 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.327 1.051 . . . . 0.0 108.606 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.65 -31.71 65.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -158.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 17.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.701 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' B' ' 96' ' ' THR . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.522 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' B' ' 94' ' ' VAL . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.507 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' B' ' 146' ' ' LEU . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.522 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.431 ' O ' HG23 ' G' ' 48' ' ' THR . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.557 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.598 HH11 ' HA ' ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.65 164.23 26.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . 0.432 ' HA ' HG12 ' B' ' 53' ' ' ILE . 10.1 t80 -108.97 81.78 1.5 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.232 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.534 ' H ' HG23 ' B' ' 53' ' ' ILE . 34.1 t70 -106.3 96.45 6.47 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 12.4 pt-20 -67.47 -15.84 63.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.54 17.92 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.629 1.572 . . . . 0.0 111.617 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.482 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.05 1.95 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.499 1.52 . . . . 0.0 111.527 -164.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.424 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.75 35.06 17.22 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.18 123.68 46.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.534 HG23 ' H ' ' B' ' 45' ' ' ASP . 0.7 OUTLIER -136.16 133.35 50.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.85 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.66 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -107.95 18.89 20.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.564 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 10.4 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' B' ' 78' ' ' ALA . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . 0.52 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.418 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.446 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.433 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.458 HG21 ' CD1' ' B' ' 14' ' ' LEU . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.557 ' CZ ' HG23 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.429 ' O ' HG12 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.55 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.509 HD12 HD23 ' A' ' 54' ' ' LEU . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.726 HD11 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' THR . . . . . 0.413 HG21 ' CG2' ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . 0.496 HD23 HD12 ' B' ' 150' ' ' ILE . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.496 HD12 HD23 ' B' ' 146' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.557 HG23 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.58 144.03 44.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.488 ' HD3' ' HA3' ' H' ' 136' ' ' GLY . 11.7 mttt -80.19 -32.9 38.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.91 75.64 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.369 0.986 . . . . 0.0 113.063 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.35 123.35 9.2 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.79 28.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.337 1.055 . . . . 0.0 108.615 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.64 -31.69 65.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -158.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.484 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 17.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.68 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.68 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' C' ' 96' ' ' THR . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . 0.503 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.432 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.464 ' CD1' HG21 ' C' ' 94' ' ' VAL . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.517 ' HA ' ' CE ' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' SER . . . . . 0.424 ' OG ' HD12 ' C' ' 146' ' ' LEU . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . 0.47 ' O ' HG23 ' H' ' 48' ' ' THR . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.433 HG23 ' OE1' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . 0.547 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.73 164.27 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' C' ' 53' ' ' ILE . 10.1 t80 -109.01 81.8 1.5 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.229 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.544 ' H ' HG23 ' C' ' 53' ' ' ILE . 34.1 t70 -106.22 96.48 6.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 12.4 pt-20 -67.58 -15.86 63.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.36 35.51 17.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.591 1.556 . . . . 0.0 111.697 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.473 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 38.73 53.1 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.478 1.511 . . . . 0.0 111.594 -164.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.79 0.57 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . 0.562 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 6.9 m-20 -151.31 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.8 35.03 17.13 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.413 ' NE ' ' HB ' ' D' ' 135' ' ' ILE . 0.0 OUTLIER -102.08 123.61 46.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.544 HG23 ' H ' ' C' ' 45' ' ' ASP . 0.7 OUTLIER -136.14 133.38 50.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.903 178.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.605 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER -107.92 18.87 20.76 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 41' ' ' ARG . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.653 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 10.5 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' C' ' 78' ' ' ALA . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.428 ' HG3' ' HB2' ' B' ' 54' ' ' LEU . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.432 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' C' ' 14' ' ' LEU . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . 0.726 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.431 ' O ' HG12 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.425 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . 0.539 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.564 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.539 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.494 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.66 HD12 HD23 ' B' ' 54' ' ' LEU . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . 0.726 HD11 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' THR . . . . . 0.416 HG21 ' CG2' ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . 0.499 HD23 HD12 ' C' ' 150' ' ' ILE . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . 0.499 HD12 HD23 ' C' ' 146' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.59 144.07 44.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.41 ' HD3' ' HA3' ' I' ' 136' ' ' GLY . 11.7 mttt -80.23 -32.93 38.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.65 10.87 75.58 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 119.398 0.999 . . . . 0.0 113.036 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.3 9.19 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.54 114.81 28.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.669 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.67 65.24 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.496 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 17.4 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.684 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . 0.684 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.404 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' D' ' 96' ' ' THR . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . 0.518 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' D' ' 94' ' ' VAL . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.523 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' D' ' 146' ' ' LEU . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.518 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.412 HG23 ' OE1' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . 0.525 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.59 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.62 164.28 26.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . 0.431 ' HA ' HG12 ' D' ' 53' ' ' ILE . 10.1 t80 -109.0 81.8 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.228 171.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.545 ' H ' HG23 ' D' ' 53' ' ' ILE . 34.2 t70 -106.21 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 12.4 pt-20 -67.52 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.601 1.56 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.486 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 38.81 53.02 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.474 1.51 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.14 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.482 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -151.31 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.82 35.01 17.12 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.59 46.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.545 HG23 ' H ' ' D' ' 45' ' ' ASP . 0.7 OUTLIER -136.09 133.43 50.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.896 178.307 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER -108.01 18.91 20.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' SER . . . . . 0.562 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.555 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' D' ' 78' ' ' ALA . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.429 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.432 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' D' ' 14' ' ' LEU . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.566 ' CZ ' HG23 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . 0.732 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.429 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . 0.433 ' OE1' HG23 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . 0.553 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' SER . . . . . 0.494 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.605 HD12 HD23 ' C' ' 54' ' ' LEU . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . 0.732 HD11 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' THR . . . . . 0.414 HG21 ' CG2' ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . 0.49 HD23 HD12 ' D' ' 150' ' ' ILE . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . 0.49 HD12 HD23 ' D' ' 146' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.566 HG23 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.01 44.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.44 ' HD3' ' HA3' ' J' ' 136' ' ' GLY . 11.8 mttt -80.11 -33.0 39.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.82 75.51 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.31 123.32 9.23 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.85 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 108.64 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.63 65.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.492 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 17.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.506 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.682 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . 0.682 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.403 ' O ' ' OG1' ' E' ' 96' ' ' THR . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . 0.526 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . 0.423 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' E' ' 94' ' ' VAL . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' CE ' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' SER . . . . . 0.414 ' OG ' HD12 ' E' ' 146' ' ' LEU . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.596 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.68 164.23 26.09 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' E' ' 53' ' ' ILE . 10.2 t80 -108.99 81.78 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.236 171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . 0.534 ' H ' HG23 ' E' ' 53' ' ' ILE . 34.1 t70 -106.23 96.48 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 12.4 pt-20 -67.51 -15.81 63.86 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.31 35.54 18.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.573 1.549 . . . . 0.0 111.678 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.475 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 38.72 53.08 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.474 1.51 . . . . 0.0 111.559 -164.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.15 -89.79 0.57 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.533 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . 0.533 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 6.9 m-20 -151.32 28.16 0.66 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.76 35.05 17.22 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 123.64 46.32 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.534 HG23 ' H ' ' E' ' 45' ' ' ASP . 0.7 OUTLIER -136.1 133.39 50.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.845 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.599 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER -107.95 18.84 20.78 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 176.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' SER . . . . . 0.477 ' O ' ' N ' ' E' ' 41' ' ' ARG . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.569 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' E' ' 78' ' ' ALA . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . 0.525 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.438 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.423 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.452 HG21 ' CD1' ' E' ' 14' ' ' LEU . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' E' ' 10' ' ' ASP . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.552 ' CZ ' HG23 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . 0.735 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.438 ' O ' HG12 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . 0.557 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . 0.412 ' OE1' HG23 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 119' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 131' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.478 HD12 HD23 ' D' ' 54' ' ' LEU . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . 0.735 HD11 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 145' ' ' THR . . . . . 0.404 HG21 ' CG2' ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 150' ' ' ILE . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . 0.478 HD12 HD23 ' E' ' 146' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.552 HG23 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.05 44.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.444 ' HD3' ' HA3' ' K' ' 136' ' ' GLY . 11.8 mttt -80.23 -32.92 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.91 75.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 119.416 1.007 . . . . 0.0 113.014 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.37 9.13 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.6 114.83 28.83 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.305 1.042 . . . . 0.0 108.595 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -31.68 65.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -158.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.494 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 17.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . 0.697 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . 0.424 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.494 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.41 ' O ' ' OG1' ' F' ' 96' ' ' THR . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . 0.509 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' F' ' 94' ' ' VAL . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.524 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.521 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' SER . . . . . 0.423 ' OG ' HD12 ' F' ' 146' ' ' LEU . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.509 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.585 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.73 164.29 26.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' F' ' 53' ' ' ILE . 10.1 t80 -108.98 81.77 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.239 171.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . 0.533 ' H ' HG23 ' F' ' 53' ' ' ILE . 34.1 t70 -106.26 96.45 6.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . 0.477 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 12.4 pt-20 -67.49 -15.91 63.93 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.62 17.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.62 1.568 . . . . 0.0 111.634 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.477 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.498 1.519 . . . . 0.0 111.608 -164.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.81 0.57 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.5 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . 0.445 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 6.9 m-20 -151.3 28.19 0.66 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.79 35.05 17.12 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.09 123.63 46.29 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.533 HG23 ' H ' ' F' ' 45' ' ' ASP . 0.7 OUTLIER -136.07 133.42 50.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.98 18.86 20.74 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 58' ' ' SER . . . . . 0.533 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 62' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.56 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.652 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 10.5 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' F' ' 78' ' ' ALA . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.451 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' F' ' 14' ' ' LEU . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' F' ' 10' ' ' ASP . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.565 ' CZ ' HG23 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.436 ' O ' HG12 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 119' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.549 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 131' ' ' SER . . . . . 0.502 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.599 HD12 HD23 ' E' ' 54' ' ' LEU . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 145' ' ' THR . . . . . 0.408 HG22 HD21 ' F' ' 14' ' ' LEU . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' F' ' 150' ' ' ILE . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' F' ' 146' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.565 HG23 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.04 44.48 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.459 ' HD3' ' HA3' ' L' ' 136' ' ' GLY . 11.8 mttt -80.16 -32.97 38.77 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.83 75.49 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 119.365 0.984 . . . . 0.0 113.053 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' L' ' 138' ' ' LEU . . . -72.37 123.3 9.15 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.573 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.2 t80 -100.57 114.85 28.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.354 1.062 . . . . 0.0 108.6 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.81 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.62 65.09 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.794 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.569 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.743 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 17.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.533 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.665 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.697 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' K' ' 54' ' ' LEU . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . 0.697 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.453 ' O ' HG23 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.413 ' O ' ' OG1' ' G' ' 96' ' ' THR . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . 0.506 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' G' ' 94' ' ' VAL . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.528 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.508 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 24' ' ' SER . . . . . 0.419 ' OG ' HD12 ' G' ' 146' ' ' LEU . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.506 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.69 164.24 26.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' G' ' 53' ' ' ILE . 10.2 t80 -109.02 81.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.226 171.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . 0.537 ' H ' HG23 ' G' ' 53' ' ' ILE . 34.1 t70 -106.23 96.43 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . 0.477 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 12.4 pt-20 -67.54 -15.8 63.85 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.3 35.55 18.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.635 1.574 . . . . 0.0 111.654 -172.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.477 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.539 1.535 . . . . 0.0 111.554 -164.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.12 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.504 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 6.9 m-20 -151.31 28.14 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.74 35.04 17.29 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.67 46.38 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.537 HG23 ' H ' ' G' ' 45' ' ' ASP . 0.7 OUTLIER -136.12 133.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.877 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 18.88 20.71 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 58' ' ' SER . . . . . 0.584 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 62' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . 0.569 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 10.5 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' G' ' 78' ' ' ALA . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.43 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.453 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.437 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' G' ' 14' ' ' LEU . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' G' ' 10' ' ' ASP . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.555 ' CZ ' HG23 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . 0.721 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.428 ' O ' HG12 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . 0.551 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 119' ' ' SER . . . . . 0.571 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . 0.407 HG23 HG13 ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . 0.551 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 131' ' ' SER . . . . . 0.513 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.428 HG12 ' O ' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . 0.471 ' HA3' ' HD3' ' A' ' 155' ' ' LYS . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . 0.721 HD11 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 145' ' ' THR . . . . . 0.407 HG22 HD21 ' G' ' 14' ' ' LEU . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . 0.475 HD23 HD12 ' G' ' 150' ' ' ILE . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.417 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . 0.475 HD12 HD23 ' G' ' 146' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.555 HG23 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p -115.68 144.09 44.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.95 38.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.64 10.88 75.59 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.385 0.993 . . . . 0.0 113.034 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.36 9.19 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.64 114.87 28.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.291 1.037 . . . . 0.0 108.613 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.68 65.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . 0.503 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 166' ' ' THR . . . . . 0.69 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . 0.69 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.456 ' O ' HG23 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' H' ' 96' ' ' THR . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . 0.526 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.469 ' CD1' HG21 ' H' ' 94' ' ' VAL . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.515 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' H' ' 146' ' ' LEU . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.596 HH11 ' HA ' ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.67 164.29 26.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . 0.41 ' HA ' HG12 ' H' ' 53' ' ' ILE . 10.1 t80 -109.04 81.77 1.49 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.209 171.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . 0.538 ' H ' HG23 ' H' ' 53' ' ' ILE . 34.1 t70 -106.2 96.47 6.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . 0.486 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 12.4 pt-20 -67.58 -15.78 63.83 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.27 35.53 18.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.594 1.558 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.486 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.09 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.532 1.533 . . . . 0.0 111.517 -164.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.88 0.57 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.475 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . 0.589 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 6.9 m-20 -151.29 28.28 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.73 35.04 17.33 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.63 46.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.538 HG23 ' H ' ' H' ' 45' ' ' ASP . 0.7 OUTLIER -136.09 133.37 50.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.86 178.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.92 18.85 20.78 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 58' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 62' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . 0.559 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.663 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.663 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' H' ' 78' ' ' ALA . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.413 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.443 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.469 HG21 ' CD1' ' H' ' 14' ' ' LEU . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.567 ' CZ ' HG23 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . 0.73 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.424 ' O ' HG12 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.413 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 119' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . 0.453 HG23 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.535 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 131' ' ' SER . . . . . 0.497 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.424 HG12 ' O ' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' B' ' 155' ' ' LYS . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . 0.73 HD11 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' H' ' 150' ' ' ILE . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.429 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' H' ' 146' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.567 HG23 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.59 144.0 44.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.09 -32.99 39.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.9 75.46 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.338 0.972 . . . . 0.0 113.039 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.33 9.2 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.86 28.87 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.288 1.035 . . . . 0.0 108.611 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -31.61 65.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . 0.483 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.691 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . 0.691 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . 0.454 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.434 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' I' ' 96' ' ' THR . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . 0.521 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' I' ' 94' ' ' VAL . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . 0.522 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.519 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' I' ' 146' ' ' LEU . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.597 HH11 ' HA ' ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 164.3 26.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' I' ' 53' ' ' ILE . 10.2 t80 -109.04 81.81 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.193 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . 0.541 ' H ' HG23 ' I' ' 53' ' ' ILE . 34.1 t70 -106.28 96.41 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 12.4 pt-20 -67.5 -15.87 63.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.33 35.55 17.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.662 1.585 . . . . 0.0 111.638 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 48' ' ' THR . . . . . 0.48 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.0 1.96 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.474 1.509 . . . . 0.0 111.566 -164.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.12 -89.85 0.57 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.456 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 6.9 m-20 -151.29 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.77 35.07 17.13 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.56 46.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.541 HG23 ' H ' ' I' ' 45' ' ' ASP . 0.7 OUTLIER -136.12 133.36 50.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.447 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -107.95 18.92 20.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 58' ' ' SER . . . . . 0.589 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 62' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . 0.566 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.664 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.504 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' I' ' 78' ' ' ALA . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.418 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.438 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' I' ' 14' ' ' LEU . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.561 ' CZ ' HG23 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . 0.708 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.428 ' O ' HG12 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . 0.552 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 119' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . 0.456 HG23 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 131' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.428 HG12 ' O ' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' C' ' 155' ' ' LYS . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . 0.708 HD11 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 145' ' ' THR . . . . . 0.41 HG21 ' CG2' ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . 0.496 HD23 HD12 ' I' ' 150' ' ' ILE . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . 0.496 HD12 HD23 ' I' ' 146' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.561 HG23 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.06 44.45 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.23 -32.89 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.81 75.54 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 119.398 0.999 . . . . 0.0 113.066 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.31 9.21 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.56 114.87 28.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 108.619 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.63 65.16 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -158.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . 0.42 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.445 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' J' ' 96' ' ' THR . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . 0.503 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.46 ' CD1' HG21 ' J' ' 94' ' ' VAL . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.517 ' HA ' ' CE ' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 24' ' ' SER . . . . . 0.416 ' OG ' HD12 ' J' ' 146' ' ' LEU . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.503 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.595 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.65 164.3 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' J' ' 53' ' ' ILE . 10.1 t80 -109.06 81.82 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.228 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . 0.548 ' H ' HG23 ' J' ' 53' ' ' ILE . 34.1 t70 -106.26 96.46 6.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 12.4 pt-20 -67.5 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.28 35.54 18.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.637 1.575 . . . . 0.0 111.697 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 48' ' ' THR . . . . . 0.483 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.458 1.503 . . . . 0.0 111.577 -164.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.16 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.484 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 6.9 m-20 -151.27 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.77 35.08 17.1 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 123.6 46.28 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.548 HG23 ' H ' ' J' ' 45' ' ' ASP . 0.7 OUTLIER -136.06 133.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.91 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.96 18.93 20.67 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 58' ' ' SER . . . . . 0.54 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 62' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.661 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.661 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' J' ' 78' ' ' ALA . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.432 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' J' ' 14' ' ' LEU . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.559 ' CZ ' HG23 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . 0.736 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.422 ' O ' HG12 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.432 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . 0.556 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 119' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 131' ' ' SER . . . . . 0.495 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.447 HD12 HD23 ' I' ' 54' ' ' LEU . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' D' ' 155' ' ' LYS . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . 0.736 HD11 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . 0.432 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' D' ' 160' ' ' PHE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . 0.494 HD23 HD12 ' J' ' 150' ' ' ILE . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.433 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . 0.494 HD12 HD23 ' J' ' 146' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.559 HG23 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.03 44.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.16 -32.93 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.63 10.92 75.55 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.384 0.993 . . . . 0.0 113.064 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.32 9.1 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.55 114.84 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.302 1.041 . . . . 0.0 108.603 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -31.68 65.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . 0.49 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.679 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . 0.679 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.453 HG13 HG23 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.454 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.4 ' O ' ' OG1' ' K' ' 96' ' ' THR . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . 0.52 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' K' ' 94' ' ' VAL . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.523 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' K' ' 146' ' ' LEU . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.52 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.71 164.25 26.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . 0.424 ' HA ' HG12 ' K' ' 53' ' ' ILE . 10.1 t80 -108.97 81.79 1.5 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.197 171.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . 0.541 ' H ' HG23 ' K' ' 53' ' ' ILE . 34.1 t70 -106.24 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 155.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.472 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 12.4 pt-20 -67.46 -15.88 63.91 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.55 17.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.602 1.561 . . . . 0.0 111.625 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 48' ' ' THR . . . . . 0.472 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 38.7 53.05 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.449 1.5 . . . . 0.0 111.612 -164.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.14 -89.77 0.57 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.508 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . 0.659 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 6.9 m-20 -151.34 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.87 34.97 17.08 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.68 46.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.541 HG23 ' H ' ' K' ' 45' ' ' ASP . 0.7 OUTLIER -136.14 133.39 50.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.887 178.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.507 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -107.97 18.9 20.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 58' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 62' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . 0.568 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' K' ' 78' ' ' ALA . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.429 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.463 HG21 ' CD1' ' K' ' 14' ' ' LEU . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' K' ' 10' ' ' ASP . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.558 ' CZ ' HG23 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . 0.731 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.431 ' O ' HG12 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . 0.547 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 119' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 131' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.431 HG12 ' O ' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' E' ' 155' ' ' LYS . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . 0.731 HD11 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 145' ' ' THR . . . . . 0.409 HG21 ' CG2' ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . 0.479 HD23 HD12 ' K' ' 150' ' ' ILE . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . 0.479 HD12 HD23 ' K' ' 146' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.558 HG23 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.07 44.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.96 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.86 75.54 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 119.358 0.981 . . . . 0.0 113.051 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.53 114.78 28.7 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.341 1.056 . . . . 0.0 108.654 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 -31.77 65.38 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.676 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . 0.676 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.407 HG13 HG23 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.432 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.409 ' O ' ' OG1' ' L' ' 96' ' ' THR . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . 0.525 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . 0.427 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' L' ' 94' ' ' VAL . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . 0.518 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 24' ' ' SER . . . . . 0.421 ' OG ' HD12 ' L' ' 146' ' ' LEU . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.593 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.69 164.3 26.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' L' ' 53' ' ' ILE . 10.1 t80 -108.99 81.73 1.49 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.235 171.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . 0.531 ' H ' HG23 ' L' ' 53' ' ' ILE . 34.1 t70 -106.26 96.43 6.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . 0.481 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 12.4 pt-20 -67.5 -15.81 63.87 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.23 35.6 18.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.643 1.577 . . . . 0.0 111.669 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.481 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.02 1.93 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.452 1.501 . . . . 0.0 111.606 -164.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.82 0.57 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.488 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.65 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.71 35.09 17.25 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.64 46.33 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.531 HG23 ' H ' ' L' ' 45' ' ' ASP . 0.7 OUTLIER -136.17 133.43 50.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.827 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.01 18.92 20.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 58' ' ' SER . . . . . 0.659 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . 0.561 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.653 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 10.5 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.653 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' L' ' 78' ' ' ALA . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.431 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.743 ' CZ2' ' HA ' ' F' ' 162' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.427 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.456 HG21 ' CD1' ' L' ' 14' ' ' LEU . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' L' ' 10' ' ' ASP . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.564 ' CZ ' HG23 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' F' ' 158' ' ' TYR . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . 0.733 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.432 ' O ' HG12 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.431 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 119' ' ' SER . . . . . 0.574 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . 0.453 HG23 HG13 ' K' ' 6' ' ' ILE . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 131' ' ' SER . . . . . 0.508 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.507 HD12 HD23 ' K' ' 54' ' ' LEU . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . 0.459 ' HA3' ' HD3' ' F' ' 155' ' ' LYS . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.733 HD11 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.81 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.3 p-10 -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.784 HD13 ' CD1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 145' ' ' THR . . . . . 0.41 HG21 ' CG2' ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . 0.487 HD23 HD12 ' L' ' 150' ' ' ILE . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . 0.487 HD12 HD23 ' L' ' 146' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.564 HG23 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.63 143.99 44.55 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.18 -32.94 38.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.69 10.89 75.4 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.399 0.999 . . . . 0.0 113.013 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.35 9.16 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.8 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.335 1.054 . . . . 0.0 108.629 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.72 65.28 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . 0.5 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 166' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.492 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.445 ' HG3' ' HB ' ' L' ' 48' ' ' THR . 1.6 mm-40 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 22' ' ' THR . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.555 HG22 ' HB2' ' A' ' 20' ' ' ALA . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' A' ' 14' ' ' LEU . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 13' ' ' TYR . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.617 ' O ' HG11 ' B' ' 122' ' ' VAL . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.493 HG22 ' HG1' ' A' ' 66' ' ' THR . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG11 ' CG ' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HG ' ' B' ' 115' ' ' SER . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.752 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -66.04 134.76 53.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.51 34.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.238 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.5 113.93 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.091 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.0 23.08 1.34 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.648 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.02 61.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.52 0.29 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.433 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.01 9.87 36.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.27 83.28 1.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.493 HG13 HG22 ' B' ' 135' ' ' ILE . 0.6 OUTLIER -116.77 6.82 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.906 178.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.699 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.18 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.752 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.493 ' HG1' HG22 ' A' ' 33' ' ' THR . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.415 ' HE1' HD22 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.411 ' OH ' HG23 ' A' ' 151' ' ' VAL . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.55 ' OD1' ' HB2' ' A' ' 95' ' ' ASP . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 ' H ' HD12 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.458 ' HG2' ' CG2' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' CG ' HG11 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.652 HG11 ' O ' ' F' ' 32' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 ' CG2' ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.415 HD22 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.518 HG11 ' HG3' ' A' ' 137' ' ' GLU . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.518 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.619 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.73 163.8 12.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.39 54.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.2 64.61 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.37 0.986 . . . . 0.0 113.026 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.78 137.23 24.03 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.24 146.21 51.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.3 1.04 . . . . 0.0 108.576 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.57 -49.64 74.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.546 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.4 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.504 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.504 HE22 ' HD2' ' A' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.419 ' HB ' ' CG2' ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.487 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.46 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 1.6 mm-40 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' B' ' 25' ' ' ALA . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.442 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' B' ' 22' ' ' THR . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' THR . . . . . 0.563 HG22 ' HB2' ' B' ' 20' ' ' ALA . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' B' ' 14' ' ' LEU . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.422 ' OH ' ' O ' ' B' ' 13' ' ' TYR . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.626 ' O ' HG11 ' C' ' 122' ' ' VAL . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.507 HG22 ' HG1' ' B' ' 66' ' ' THR . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.565 HG11 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.424 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.747 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -66.03 134.77 53.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.53 130.49 34.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.231 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.46 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' B' ' 52' ' ' ARG . 0.3 OUTLIER -72.02 -39.47 69.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.98 23.1 1.35 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.599 1.56 . . . . 0.0 111.684 -172.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.67 1.67 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.477 1.511 . . . . 0.0 111.59 -164.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.496 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.06 9.88 36.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.31 83.31 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 5.8 mmp_? -108.65 18.43 20.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.541 HG13 HG22 ' C' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.82 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.892 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.773 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 176.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.747 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.507 ' HG1' HG22 ' B' ' 33' ' ' THR . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . 0.492 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.409 ' HA ' HD11 ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.8 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.8 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.526 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.422 ' HE1' HD22 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.547 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.55 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.596 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.402 ' OH ' HG23 ' B' ' 151' ' ' VAL . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.55 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.653 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.513 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.447 ' HB1' HG23 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.526 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.407 ' H ' HD12 ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.411 ' HG ' ' HA2' ' A' ' 39' ' ' GLY . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.464 ' HG2' ' CG2' ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . 0.567 ' CG ' HG11 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 32' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.464 ' CG2' ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . 0.422 HD22 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.522 HG11 ' HG3' ' B' ' 137' ' ' GLU . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.699 HG12 ' HG ' ' A' ' 54' ' ' LEU . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.522 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.653 ' HB2' ' HB3' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.596 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t -102.8 163.85 11.98 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.66 -4.42 54.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.19 64.58 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.372 0.987 . . . . 0.0 113.064 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.65 137.22 24.2 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.17 51.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.279 1.032 . . . . 0.0 108.617 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.54 -49.73 74.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . 0.478 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.426 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 4.4 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.508 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.508 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . 0.61 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.431 ' HG3' ' HB ' ' H' ' 48' ' ' THR . 1.6 mm-40 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.508 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.458 HD13 ' HB1' ' C' ' 25' ' ' ALA . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.549 ' HB2' HG22 ' C' ' 22' ' ' THR . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' THR . . . . . 0.549 HG22 ' HB2' ' C' ' 20' ' ' ALA . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' C' ' 14' ' ' LEU . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . 0.433 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . 0.427 ' OH ' ' O ' ' C' ' 13' ' ' TYR . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.726 ' O ' HG11 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' THR . . . . . 0.49 HG22 ' HG1' ' C' ' 66' ' ' THR . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.603 HG11 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.445 ' HA2' ' HG ' ' D' ' 115' ' ' SER . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.747 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -66.07 134.81 53.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.51 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.2 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.44 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' C' ' 52' ' ' ARG . 0.4 OUTLIER -71.97 -39.5 69.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.01 23.07 1.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.618 1.567 . . . . 0.0 111.667 -172.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.01 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.523 1.529 . . . . 0.0 111.573 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.464 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.87 36.32 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.33 1.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 5.8 mmp_? -108.7 18.47 20.78 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.442 HD13 HE22 ' D' ' 133' ' ' GLN . 0.6 OUTLIER -116.75 6.81 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.872 178.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.741 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.747 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' THR . . . . . 0.49 ' HG1' HG22 ' C' ' 33' ' ' THR . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.81 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.81 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.535 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . 0.415 ' HE1' HD22 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.508 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.62 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.546 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.502 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.535 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.424 ' HG ' ' HA2' ' B' ' 39' ' ' GLY . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . 0.462 ' HG2' ' CG2' ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . 0.565 ' HG2' HG11 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . 0.626 HG11 ' O ' ' B' ' 32' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . 0.415 HD22 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' C' ' 137' ' ' GLU . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.773 HG12 ' HG ' ' B' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.524 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB2' ' HB3' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.62 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.71 163.78 12.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -80.63 -4.37 53.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.06 2.16 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 113.021 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.66 137.22 24.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -133.25 146.2 51.21 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.309 1.043 . . . . 0.0 108.6 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.63 74.48 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . 0.402 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.432 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 4.4 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.505 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.505 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.517 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.507 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.452 HD13 ' HB1' ' D' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' SER . . . . . 0.447 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.549 ' HB2' HG22 ' D' ' 22' ' ' THR . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' THR . . . . . 0.549 HG22 ' HB2' ' D' ' 20' ' ' ALA . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.452 ' HB1' HD13 ' D' ' 14' ' ' LEU . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' D' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . 0.673 ' O ' HG11 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' D' ' 66' ' ' THR . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.576 HG11 ' CG ' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.407 ' HA2' ' HG ' ' E' ' 115' ' ' SER . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.727 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.78 53.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.52 130.57 34.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.42 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' D' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.52 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 176.089 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.02 23.08 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.641 1.577 . . . . 0.0 111.678 -172.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.11 61.65 1.69 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.564 -164.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.86 -128.54 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.473 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.05 9.95 36.24 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.25 1.27 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 5.8 mmp_? -108.67 18.52 20.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.466 HG13 HG22 ' E' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.899 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.682 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . 0.727 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' D' ' 33' ' ' THR . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . 0.61 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.801 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.801 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.532 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . 0.418 ' HE1' HD22 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.543 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.507 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.622 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.405 ' OH ' HG23 ' D' ' 151' ' ' VAL . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.543 ' OD1' ' HB2' ' D' ' 95' ' ' ASP . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.503 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.532 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' SER . . . . . 0.445 ' HG ' ' HA2' ' C' ' 39' ' ' GLY . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . 0.45 ' HG2' ' CG2' ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . 0.603 ' HG2' HG11 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . 0.726 HG11 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . 0.45 ' CG2' ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . 0.418 HD22 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.442 HE22 HD13 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.509 ' HA ' HD21 ' C' ' 54' ' ' LEU . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.741 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . 0.507 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . 0.505 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.652 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.622 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.592 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.78 12.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.64 -4.37 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.14 64.69 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.411 1.005 . . . . 0.0 113.074 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.21 24.15 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.17 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.304 1.042 . . . . 0.0 108.618 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.57 74.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -158.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.55 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.4 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.501 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.501 HE22 ' HD2' ' D' ' 163' ' ' PRO . 7.0 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . 0.424 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . 0.635 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . 0.454 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 1.6 mm-40 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.453 HD13 ' HB1' ' E' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.593 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' SER . . . . . 0.458 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.475 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' E' ' 22' ' ' THR . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' THR . . . . . 0.548 HG22 ' HB2' ' E' ' 20' ' ' ALA . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.453 ' HB1' HD13 ' E' ' 14' ' ' LEU . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' E' ' 13' ' ' TYR . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . 0.542 ' O ' HG11 ' F' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' THR . . . . . 0.508 HG22 ' HG1' ' E' ' 66' ' ' THR . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.458 HG11 ' CG ' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' SER . . . . . 0.431 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.405 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.739 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -66.08 134.81 53.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.52 34.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.205 171.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' E' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.49 69.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 176.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.98 23.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.646 1.579 . . . . 0.0 111.699 -172.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.495 1.518 . . . . 0.0 111.584 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.472 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.0 9.84 36.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.3 1.28 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 5.8 mmp_? -108.68 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.425 HG13 HG22 ' F' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.892 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER -105.32 22.14 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 176.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . 0.739 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' THR . . . . . 0.508 ' HG1' HG22 ' E' ' 33' ' ' THR . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.781 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.781 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.521 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . 0.533 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . 0.413 ' HE1' HD22 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.407 ' OH ' HG23 ' E' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' E' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.513 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . 0.446 ' HB1' HG23 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.521 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . 0.404 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 115' ' ' SER . . . . . 0.407 ' HG ' ' HA2' ' D' ' 39' ' ' GLY . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . 0.453 ' HG2' ' CG2' ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . 0.576 ' CG ' HG11 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . 0.673 HG11 ' O ' ' D' ' 32' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.453 ' CG2' ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.513 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.682 HG12 ' HG ' ' D' ' 54' ' ' LEU . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.507 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . 0.52 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.618 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.6 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.79 163.78 12.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.43 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.02 2.21 64.61 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 119.407 1.003 . . . . 0.0 113.029 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.72 137.22 24.1 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.21 146.21 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.317 1.047 . . . . 0.0 108.64 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.58 -49.65 74.41 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . 0.526 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.52 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.4 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.498 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.498 HE22 ' HD2' ' E' ' 163' ' ' PRO . 7.0 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.421 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . 0.402 HE22 ' HA ' ' A' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.455 HD13 ' HB1' ' F' ' 25' ' ' ALA . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' SER . . . . . 0.468 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' F' ' 22' ' ' THR . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' THR . . . . . 0.547 HG22 ' HB2' ' F' ' 20' ' ' ALA . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' F' ' 14' ' ' LEU . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' F' ' 13' ' ' TYR . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . 0.652 ' O ' HG11 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 33' ' ' THR . . . . . 0.512 HG22 ' HG1' ' F' ' 66' ' ' THR . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.404 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.759 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.72 53.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.5 34.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.272 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' F' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.48 69.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.07 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 111.65 -172.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.7 1.67 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.513 1.525 . . . . 0.0 111.522 -164.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.53 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.06 9.91 36.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 83.35 1.28 Allowed Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 5.8 mmp_? -108.7 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.75 6.79 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.864 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -105.3 22.09 16.0 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . 0.759 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . 0.41 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 66' ' ' THR . . . . . 0.512 ' HG1' HG22 ' F' ' 33' ' ' THR . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . 0.635 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.793 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . 0.431 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.497 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.793 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.525 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.532 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . 0.422 ' HE1' HD22 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . 0.53 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.626 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.406 ' OH ' HG23 ' F' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . 0.522 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.515 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . 0.439 ' HB1' HG23 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.525 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . 0.4 ' H ' HD12 ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CG2' ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . 0.458 ' CG ' HG11 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . 0.542 HG11 ' O ' ' E' ' 32' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.461 ' CG2' ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . 0.422 HD22 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.523 HG11 ' HG3' ' F' ' 137' ' ' GLU . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.862 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.626 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.73 163.79 12.01 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.22 64.75 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 119.385 0.993 . . . . 0.0 113.061 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.72 137.21 24.09 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.19 146.18 51.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.332 1.053 . . . . 0.0 108.649 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.65 -49.63 74.41 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -158.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' L' ' 143' ' ' ILE . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.789 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.722 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 4.4 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.504 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.504 HE22 ' HD2' ' F' ' 163' ' ' PRO . 7.0 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.649 HG21 ' CZ ' ' L' ' 110' ' ' PHE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . 0.61 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.501 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . 0.447 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.454 HG21 ' HB3' ' G' ' 10' ' ' ASP . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' H' ' 122' ' ' VAL . 1.6 mm-40 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.447 HD13 ' HB1' ' G' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.598 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.1 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 17' ' ' SER . . . . . 0.466 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.502 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . 0.56 ' HB2' HG22 ' G' ' 22' ' ' THR . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 22' ' ' THR . . . . . 0.56 HG22 ' HB2' ' G' ' 20' ' ' ALA . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' G' ' 14' ' ' LEU . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . 0.428 ' OH ' ' O ' ' G' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . 0.457 ' O ' HG11 ' H' ' 122' ' ' VAL . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 33' ' ' THR . . . . . 0.507 HG22 ' HG1' ' G' ' 66' ' ' THR . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 38' ' ' SER . . . . . 0.496 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . 0.752 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.77 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.44 130.49 34.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.29 171.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 155.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' G' ' 52' ' ' ARG . 0.4 OUTLIER -71.98 -39.5 69.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.01 1.34 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.611 1.564 . . . . 0.0 111.667 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.46 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.8 OUTLIER 41.15 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.459 1.504 . . . . 0.0 111.551 -164.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.53 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.95 9.84 36.49 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 5.8 mmp_? -108.68 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.71 6.84 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.887 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . 0.755 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.13 15.96 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 176.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . 0.752 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 66' ' ' THR . . . . . 0.507 ' HG1' HG22 ' G' ' 33' ' ' THR . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.784 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . 0.457 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.784 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.529 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.598 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . 0.42 ' HE1' HD22 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.546 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . 0.547 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.608 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.409 ' OH ' HG23 ' G' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' G' ' 95' ' ' ASP . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.518 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . 0.444 ' HB1' HG23 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.529 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . 0.404 ' CG ' HG11 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . 0.536 HG11 ' O ' ' L' ' 32' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . 0.409 HG21 ' O ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . 0.42 HD22 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' G' ' 137' ' ' GLU . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.773 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . 0.584 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.608 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.611 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.8 12.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.37 54.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.17 64.6 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.36 0.982 . . . . 0.0 113.077 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.64 137.2 24.19 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.18 51.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.369 1.068 . . . . 0.0 108.625 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.7 74.18 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . 0.502 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.502 HE22 ' HD2' ' G' ' 163' ' ' PRO . 7.0 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 167' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.449 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.461 HG21 ' HB3' ' H' ' 10' ' ' ASP . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' I' ' 122' ' ' VAL . 1.6 mm-40 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.504 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.455 HD13 ' HB1' ' H' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 17' ' ' SER . . . . . 0.45 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . 0.554 ' HB2' HG22 ' H' ' 22' ' ' THR . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 22' ' ' THR . . . . . 0.554 HG22 ' HB2' ' H' ' 20' ' ' ALA . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' H' ' 14' ' ' LEU . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . 0.423 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . 0.423 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' H' ' 13' ' ' TYR . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . 0.514 ' O ' HG11 ' I' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' H' ' 66' ' ' THR . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 38' ' ' SER . . . . . 0.475 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.403 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.749 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.79 53.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.47 34.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.264 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' H' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.48 69.02 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.97 23.11 1.35 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.59 1.556 . . . . 0.0 111.659 -172.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.431 ' HB ' ' HG3' ' C' ' 9' ' ' GLN . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 111.516 -164.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.88 -128.48 0.29 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.484 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.89 36.31 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.25 1.27 Allowed Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 5.8 mmp_? -108.64 18.49 20.8 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.838 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . 0.735 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.08 16.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . 0.749 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' H' ' 33' ' ' THR . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . 0.447 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.781 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.781 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.533 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.533 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.478 ' CH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . 0.553 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.504 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.612 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.404 ' OH ' HG23 ' H' ' 151' ' ' VAL . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' H' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . 0.506 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.518 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . 0.409 ' H ' HD12 ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . 0.462 ' HG2' ' CG2' ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . 0.513 ' HA ' HE22 ' G' ' 9' ' ' GLN . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . 0.454 HG21 ' O ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.462 ' CG2' ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.518 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.755 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . 0.516 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.597 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.612 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.8 163.8 12.01 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.58 -4.42 54.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.0 2.21 64.65 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 119.386 0.993 . . . . 0.0 113.047 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.22 24.17 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.2 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.31 1.044 . . . . 0.0 108.617 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.63 -49.6 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.512 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.512 HE22 ' HD2' ' H' ' 163' ' ' PRO . 7.0 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 167' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . 0.451 HG21 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.515 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.453 HD13 ' HB1' ' I' ' 25' ' ' ALA . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.591 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 17' ' ' SER . . . . . 0.456 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.492 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . 0.563 ' HB2' HG22 ' I' ' 22' ' ' THR . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 22' ' ' THR . . . . . 0.563 HG22 ' HB2' ' I' ' 20' ' ' ALA . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.453 ' HB1' HD13 ' I' ' 14' ' ' LEU . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . 0.431 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' I' ' 13' ' ' TYR . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . 0.611 ' O ' HG11 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 33' ' ' THR . . . . . 0.503 HG22 ' HG1' ' I' ' 66' ' ' THR . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . 0.5 HG11 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 38' ' ' SER . . . . . 0.453 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.401 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . 0.754 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.77 53.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.54 130.46 34.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.253 171.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.53 113.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' I' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.18 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.99 23.05 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.615 1.566 . . . . 0.0 111.653 -172.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.06 61.71 1.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.538 1.535 . . . . 0.0 111.567 -164.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.458 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.03 9.84 36.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.23 1.27 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . 0.509 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 5.8 mmp_? -108.61 18.48 20.82 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.73 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.9 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.857 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER -105.31 22.15 15.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . 0.754 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 66' ' ' THR . . . . . 0.503 ' HG1' HG22 ' I' ' 33' ' ' THR . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.798 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.475 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.597 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.798 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.536 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.591 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . 0.419 ' HE1' HD22 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' C' ' 162' ' ' GLN . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.515 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.406 ' OH ' HG23 ' I' ' 151' ' ' VAL . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . 0.521 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.507 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . 0.442 ' HB1' HG23 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . 0.514 HG11 ' O ' ' H' ' 32' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . 0.455 HG21 ' O ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . 0.419 HD22 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.515 HG11 ' HG3' ' I' ' 137' ' ' GLU . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.735 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . 0.515 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . 0.521 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.65 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.609 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.596 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.76 163.76 12.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.61 -4.34 53.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.99 2.23 64.67 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.396 0.998 . . . . 0.0 113.016 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.73 137.21 24.08 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.14 51.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.364 1.066 . . . . 0.0 108.66 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.6 74.57 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.503 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.503 HE22 ' HD2' ' I' ' 163' ' ' PRO . 6.9 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 167' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . 0.472 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' K' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.507 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.451 HD13 ' HB1' ' J' ' 25' ' ' ALA . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.605 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.1 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 17' ' ' SER . . . . . 0.448 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' J' ' 22' ' ' THR . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 22' ' ' THR . . . . . 0.55 HG22 ' HB2' ' J' ' 20' ' ' ALA . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.451 ' HB1' HD13 ' J' ' 14' ' ' LEU . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' J' ' 13' ' ' TYR . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . 0.587 ' O ' HG11 ' K' ' 122' ' ' VAL . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 33' ' ' THR . . . . . 0.511 HG22 ' HG1' ' J' ' 66' ' ' THR . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . 0.486 HG11 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . 0.74 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.77 53.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.49 34.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.241 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.49 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 155.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' J' ' 52' ' ' ARG . 0.4 OUTLIER -72.05 -39.44 69.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.96 23.08 1.36 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.645 1.578 . . . . 0.0 111.678 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 48' ' ' THR . . . . . 0.454 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 0.8 OUTLIER 41.1 61.69 1.67 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.543 1.537 . . . . 0.0 111.519 -164.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.473 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.04 9.96 36.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . 0.496 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 5.8 mmp_? -108.66 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.75 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.875 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.15 15.92 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . 0.74 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 66' ' ' THR . . . . . 0.511 ' HG1' HG22 ' J' ' 33' ' ' THR . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . 0.488 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.802 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.453 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.51 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.802 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.536 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . 0.416 ' HE1' HD22 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.55 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . 0.534 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.507 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.617 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.4 ' OH ' HG23 ' J' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.647 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.506 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . 0.445 ' HB1' HG23 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . 0.405 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . 0.46 ' HG2' ' CG2' ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . 0.5 ' CG ' HG11 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . 0.611 HG11 ' O ' ' I' ' 32' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . 0.416 HD22 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.511 HG11 ' HG3' ' J' ' 137' ' ' GLU . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.857 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . 0.511 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' J' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.647 ' HB2' ' HB3' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.617 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.593 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.77 12.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.62 -4.35 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.23 64.75 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 119.439 1.018 . . . . 0.0 113.071 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.23 24.18 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.16 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.375 1.07 . . . . 0.0 108.64 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.59 -49.65 74.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.497 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.497 HE22 ' HD2' ' J' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 167' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' L' ' 122' ' ' VAL . 1.6 mm-40 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.417 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.458 HD13 ' HB1' ' K' ' 25' ' ' ALA . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.1 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 17' ' ' SER . . . . . 0.451 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . 0.544 ' HB2' HG22 ' K' ' 22' ' ' THR . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 22' ' ' THR . . . . . 0.544 HG22 ' HB2' ' K' ' 20' ' ' ALA . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.458 ' HB1' HD13 ' K' ' 14' ' ' LEU . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . 0.425 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . 0.431 ' OH ' ' O ' ' K' ' 13' ' ' TYR . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . 0.6 ' O ' HG11 ' L' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 33' ' ' THR . . . . . 0.502 HG22 ' HG1' ' K' ' 66' ' ' THR . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . 0.526 HG11 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . 0.41 ' HA2' ' HG ' ' L' ' 115' ' ' SER . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . 0.731 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -66.06 134.75 53.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.5 130.49 34.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' K' ' 52' ' ' ARG . 0.4 OUTLIER -72.07 -39.43 69.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.01 23.09 1.34 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.624 1.569 . . . . 0.0 111.625 -172.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.02 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.541 1.536 . . . . 0.0 111.536 -164.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.93 -128.46 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.51 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.04 9.92 36.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.29 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . 0.506 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.74 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.873 178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.827 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER -105.37 22.12 15.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . 0.731 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 66' ' ' THR . . . . . 0.502 ' HG1' HG22 ' K' ' 33' ' ' THR . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . 0.472 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.789 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.517 ' OE1' ' HB2' ' J' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.789 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . 0.534 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . 0.421 ' HE1' HD22 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . 0.542 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.634 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.542 ' OD1' ' HB2' ' K' ' 95' ' ' ASP . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.635 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . 0.503 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.51 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . 0.441 ' HB1' HG23 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . 0.454 ' HG2' ' CG2' ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . 0.486 ' CG ' HG11 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . 0.587 HG11 ' O ' ' J' ' 32' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . 0.421 HD22 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.51 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . 0.504 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.503 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.634 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.84 11.98 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.44 54.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.18 64.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.378 0.99 . . . . 0.0 113.037 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.2 24.14 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.15 51.2 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.341 1.056 . . . . 0.0 108.605 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.55 -49.69 74.31 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.496 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.496 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.9 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 167' ' ' THR . . . . . 0.429 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . 0.418 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' L' ' 10' ' ' ASP . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . 0.465 HE22 ' HA ' ' G' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.513 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.441 HD13 ' HB1' ' L' ' 25' ' ' ALA . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 17' ' ' SER . . . . . 0.459 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' L' ' 22' ' ' THR . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 22' ' ' THR . . . . . 0.542 HG22 ' HB2' ' L' ' 20' ' ' ALA . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' L' ' 14' ' ' LEU . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . 0.43 ' OH ' ' O ' ' L' ' 13' ' ' TYR . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . 0.536 ' O ' HG11 ' G' ' 122' ' ' VAL . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 33' ' ' THR . . . . . 0.508 HG22 ' HG1' ' L' ' 66' ' ' THR . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . 0.404 HG11 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 38' ' ' SER . . . . . 0.457 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.403 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . 0.75 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.75 53.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.52 34.75 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.237 171.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' L' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.44 69.03 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.06 1.33 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.621 1.568 . . . . 0.0 111.626 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.8 OUTLIER 41.13 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.446 1.498 . . . . 0.0 111.573 -164.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.49 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.464 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.02 9.87 36.33 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 5.8 mmp_? -108.68 18.5 20.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.835 178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . 0.773 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER -105.35 22.14 15.94 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 66' ' ' THR . . . . . 0.508 ' HG1' HG22 ' L' ' 33' ' ' THR . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.782 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' K' ' 139' ' ' LYS . 2.9 mt-30 -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.782 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.52 ' HB3' ' CD1' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . 0.535 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.647 ' HE2' ' HG1' ' F' ' 167' ' ' THR . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . 0.413 ' HE1' HD22 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.789 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . 0.538 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.513 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.632 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.408 ' OH ' HG23 ' L' ' 151' ' ' VAL . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.538 ' OD1' ' HB2' ' L' ' 95' ' ' ASP . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . 0.436 ' HB1' HG23 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.52 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . 0.409 ' H ' HD12 ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 115' ' ' SER . . . . . 0.41 ' HG ' ' HA2' ' K' ' 39' ' ' GLY . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . 0.45 ' HG2' ' CG2' ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . 0.526 ' CG ' HG11 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . 0.6 HG11 ' O ' ' K' ' 32' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' K' ' 11' ' ' VAL . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.45 ' CG2' ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . 0.413 HD22 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.518 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.827 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . 0.503 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . 0.556 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.633 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.632 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.77 163.76 12.03 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.4 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.21 64.56 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.403 1.001 . . . . 0.0 113.053 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.18 24.12 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.22 146.21 51.27 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.319 1.048 . . . . 0.0 108.626 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.69 74.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -158.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . 0.501 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.501 HE22 ' HD2' ' L' ' 163' ' ' PRO . 7.0 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 167' ' ' THR . . . . . 0.424 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.51 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.429 HG13 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.603 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.603 HD13 ' HG2' ' A' ' 12' ' ' LYS . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.691 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.75 34.73 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.221 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.73 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.29 -51.93 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.1 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.596 1.558 . . . . 0.0 111.64 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.21 48.98 3.18 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 111.555 -164.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.52 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.468 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.36 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.72 48.31 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.21 125.38 49.05 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.658 HG12 HG23 ' B' ' 135' ' ' ILE . 1.3 pp -130.52 -31.94 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.638 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp -66.12 -18.93 65.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.545 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.495 ' O ' HG13 ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.48 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 76' ' ' GLN . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.484 HE21 ' HG3' ' F' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 17' ' ' SER . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.429 ' HE ' HG13 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' A' ' 106' ' ' ALA . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG22 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.709 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.494 ' HB1' HG13 ' A' ' 94' ' ' VAL . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.477 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 61' ' ' ASP . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.819 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.709 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG2' HG12 ' A' ' 94' ' ' VAL . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.679 HG22 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.53 -46.71 73.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' HA3' ' HH ' ' A' ' 158' ' ' TYR . . . 140.76 134.81 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 119.409 1.004 . . . . 0.0 113.048 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.03 78.38 0.38 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.7 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.294 1.038 . . . . 0.0 108.611 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 -77.38 -41.73 39.05 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.403 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.456 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.421 HG21 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.514 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.43 HG13 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.496 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.42 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.416 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' B' ' 12' ' ' LYS . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.436 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.79 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.72 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.67 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.264 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.77 13.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 155.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.4 mp0 -66.3 -51.9 52.69 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.14 36.14 18.3 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.646 1.578 . . . . 0.0 111.673 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.19 48.98 3.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.459 1.504 . . . . 0.0 111.594 -164.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.63 1.73 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.471 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.34 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.46 171.76 48.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.24 125.4 49.05 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.618 HG12 HG23 ' C' ' 135' ' ' ILE . 1.3 pp -130.49 -32.04 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp -66.13 -18.81 65.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.631 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.498 ' O ' HG13 ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.473 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' B' ' 82' ' ' ALA . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' B' ' 76' ' ' GLN . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 78' ' ' ALA . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.638 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' B' ' 17' ' ' SER . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.43 ' HE ' HG13 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' B' ' 106' ' ' ALA . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG22 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.692 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' B' ' 94' ' ' VAL . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.545 ' HH ' ' HB3' ' A' ' 56' ' ' PRO . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.691 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.498 HG13 ' O ' ' B' ' 61' ' ' ASP . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.658 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' B' ' 61' ' ' ASP . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.692 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' B' ' 94' ' ' VAL . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.673 HG22 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.24 29.47 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.56 -46.72 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.401 ' HA3' ' HH ' ' B' ' 158' ' ' TYR . . . 140.74 134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.361 0.982 . . . . 0.0 113.034 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.93 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.7 3.99 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.288 1.035 . . . . 0.0 108.607 177.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 -77.35 -41.77 39.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.404 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.404 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.412 ' OG1' HG21 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . 0.468 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . 0.412 HG21 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.522 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . 0.425 HG13 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . 0.608 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.502 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.423 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . 0.417 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.608 HD13 ' HG2' ' C' ' 12' ' ' LYS . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . 0.438 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.659 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.8 2.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.24 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.1 163.72 13.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.502 ' OE2' ' NE ' ' D' ' 41' ' ' ARG . 2.4 mp0 -66.28 -51.97 52.14 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.3 36.07 17.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.606 1.563 . . . . 0.0 111.665 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.23 49.0 3.21 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.508 1.523 . . . . 0.0 111.556 -164.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.58 -163.59 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.453 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 171.74 48.32 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.25 125.39 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.617 HG12 HG23 ' D' ' 135' ' ' ILE . 1.3 pp -130.51 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.874 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.619 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp -66.13 -18.87 65.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.46 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . 0.506 ' O ' HG13 ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' C' ' 82' ' ' ALA . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' C' ' 76' ' ' GLN . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' C' ' 78' ' ' ALA . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.695 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' C' ' 17' ' ' SER . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.425 ' HE ' HG13 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' C' ' 106' ' ' ALA . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.676 ' CZ ' HG22 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.706 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' C' ' 94' ' ' VAL . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . 0.406 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.631 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . 0.79 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . 0.541 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . 0.474 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . 0.457 ' HB3' HG22 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.506 HG13 ' O ' ' C' ' 61' ' ' ASP . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.618 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' C' ' 61' ' ' ASP . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.424 ' HG3' HE21 ' D' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.414 ' HG2' HG12 ' C' ' 94' ' ' VAL . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.676 HG22 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.3 29.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.63 -46.67 73.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' HH ' ' C' ' 158' ' ' TYR . . . 140.71 134.71 3.11 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.394 0.997 . . . . 0.0 113.058 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.39 0.38 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.296 1.038 . . . . 0.0 108.624 177.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.32 -41.7 39.59 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -158.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.414 ' OG1' HG21 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.462 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.526 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . 0.42 HG13 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . 0.611 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.498 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' SER . . . . . 0.426 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . 0.41 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.611 HD13 ' HG2' ' D' ' 12' ' ' LYS . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.502 ' NE ' ' OE2' ' C' ' 46' ' ' GLU . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . 0.685 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.05 120.8 34.8 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.75 88.85 2.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.264 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.15 163.8 13.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 155.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.33 -51.92 52.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.23 36.11 18.02 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.61 1.564 . . . . 0.0 111.66 -172.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.13 49.08 3.11 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.542 1.537 . . . . 0.0 111.556 -164.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.59 1.73 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.444 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.73 19.34 0.67 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 171.74 48.35 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.23 125.44 49.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.675 HG12 HG23 ' E' ' 135' ' ' ILE . 1.3 pp -130.51 -32.08 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.866 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp -66.07 -18.89 65.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . 0.507 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' SER . . . . . 0.439 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . 0.401 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' D' ' 82' ' ' ALA . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' D' ' 76' ' ' GLN . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' D' ' 78' ' ' ALA . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.424 HE21 ' HG3' ' C' ' 139' ' ' LYS . 0.1 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.619 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' D' ' 17' ' ' SER . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.42 ' HE ' HG13 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.497 HG13 ' HB1' ' D' ' 106' ' ' ALA . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.703 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.497 ' HB1' HG13 ' D' ' 94' ' ' VAL . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' C' ' 56' ' ' PRO . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.522 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . 0.401 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.535 ' HB3' HG22 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.496 ' HA ' ' CD1' ' C' ' 53' ' ' ILE . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.617 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' D' ' 61' ' ' ASP . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.407 ' HG2' HG12 ' D' ' 94' ' ' VAL . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.686 HG22 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.32 128.22 29.36 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.53 -46.66 73.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 140.73 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 119.38 0.991 . . . . 0.0 113.053 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.04 78.43 0.38 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -115.81 92.66 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 108.621 177.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . 0.525 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 -77.35 -41.7 39.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.403 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.419 ' OG1' HG21 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . 0.47 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . 0.419 HG21 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.523 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.523 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . 0.419 HG13 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . 0.605 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.508 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' SER . . . . . 0.426 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.504 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . 0.413 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.605 HD13 ' HG2' ' E' ' 12' ' ' LYS . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.03 120.76 34.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.76 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.222 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.12 163.77 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.547 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.4 mp0 -66.38 -51.92 52.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.33 36.0 17.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.617 1.567 . . . . 0.0 111.672 -172.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.24 48.96 3.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.531 1.532 . . . . 0.0 111.547 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.49 -163.57 1.72 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.478 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.75 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.71 48.29 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.13 125.47 49.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.757 HG12 HG23 ' F' ' 135' ' ' ILE . 1.3 pp -130.54 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.878 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.486 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp -66.08 -18.87 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.482 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' E' ' 76' ' ' GLN . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' E' ' 78' ' ' ALA . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.589 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' E' ' 17' ' ' SER . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.419 ' HE ' HG13 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.507 HG13 ' HB1' ' E' ' 106' ' ' ALA . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.711 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.507 ' HB1' HG13 ' E' ' 94' ' ' VAL . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.507 ' HH ' ' HB3' ' D' ' 56' ' ' PRO . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . 0.685 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . 0.547 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 119' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . 0.486 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . 0.406 ' HB3' HG22 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.496 HG13 ' O ' ' E' ' 61' ' ' ASP . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.675 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . 0.404 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . 0.58 ' HG3' HE21 ' F' ' 84' ' ' GLN . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.403 ' HG2' HG12 ' E' ' 94' ' ' VAL . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.686 HG22 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.3 128.25 29.44 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.59 -46.73 73.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' HH ' ' E' ' 158' ' ' TYR . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.409 1.004 . . . . 0.0 113.04 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.99 78.32 0.38 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.69 3.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 108.641 177.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.7 39.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.406 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.456 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.425 ' OG1' HG21 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . 0.47 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . 0.425 HG21 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.51 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.51 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . 0.424 HG13 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . 0.605 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.503 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' SER . . . . . 0.434 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . 0.417 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.605 HD13 ' HG2' ' F' ' 12' ' ' LYS . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . 0.424 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.538 ' NE ' ' OE2' ' E' ' 46' ' ' GLU . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.16 120.76 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.213 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.78 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.34 -51.92 52.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.09 17.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 111.669 -172.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 48.98 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.482 1.513 . . . . 0.0 111.597 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.51 -163.59 1.72 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.489 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.47 171.75 48.35 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.24 125.46 49.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.819 HG12 HG23 ' A' ' 135' ' ' ILE . 1.3 pp -130.49 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.897 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.11 -18.85 65.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 58' ' ' SER . . . . . 0.547 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . 0.499 ' O ' HG13 ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 82' ' ' ALA . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' F' ' 76' ' ' GLN . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 78' ' ' ALA . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.58 HE21 ' HG3' ' E' ' 139' ' ' LYS . 0.1 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.486 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' F' ' 17' ' ' SER . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.424 ' HE ' HG13 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' F' ' 106' ' ' ALA . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG22 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.711 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' F' ' 94' ' ' VAL . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.482 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 119' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . 0.401 ' HB3' HG22 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.505 ' HA ' ' CD1' ' E' ' 53' ' ' ILE . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.757 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . 0.484 ' HG3' HE21 ' A' ' 84' ' ' GLN . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.403 ' HG2' HG12 ' F' ' 94' ' ' VAL . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.679 HG22 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.26 29.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.52 ' HE3' ' HA3' ' L' ' 136' ' ' GLY . 1.1 pptp? -54.51 -46.74 73.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 140.75 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.333 0.97 . . . . 0.0 113.029 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.01 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -115.79 92.64 3.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.38 1.072 . . . . 0.0 108.622 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.685 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 -77.31 -41.75 39.46 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.79 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.422 ' OG1' HG21 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.543 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . 0.487 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . 0.422 HG21 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' H' ' 125' ' ' ALA . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 7' ' ' MET . . . . . 0.509 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.509 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . 0.43 HG13 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . 0.597 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 17' ' ' SER . . . . . 0.433 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.497 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . 0.418 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.597 HD13 ' HG2' ' G' ' 12' ' ' LYS . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . 0.434 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.66 88.81 2.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.288 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.16 163.81 13.25 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.4 -51.84 52.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.2 36.07 18.14 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 111.655 -172.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.18 49.04 3.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.529 1.532 . . . . 0.0 111.562 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.484 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.77 19.4 0.67 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.67 48.25 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.15 125.39 49.11 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.92 HG12 HG23 ' H' ' 135' ' ' ILE . 1.3 pp -130.47 -31.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.909 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.16 -18.79 65.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . 0.49 ' O ' HG13 ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' G' ' 82' ' ' ALA . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' G' ' 76' ' ' GLN . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' G' ' 78' ' ' ALA . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.657 HE21 ' HG3' ' L' ' 139' ' ' LYS . 0.1 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.485 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.433 HD13 ' HA ' ' G' ' 17' ' ' SER . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.43 ' HE ' HG13 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' G' ' 106' ' ' ALA . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.683 ' CZ ' HG22 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.706 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' G' ' 94' ' ' VAL . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.485 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 119' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.49 HG13 ' O ' ' G' ' 61' ' ' ASP . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.904 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . 0.702 ' HG3' HE21 ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 1.1 p-10 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.407 ' HG2' HG12 ' G' ' 94' ' ' VAL . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.683 HG22 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.52 -46.77 73.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 140.77 134.77 3.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 119.381 0.991 . . . . 0.0 113.046 -176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.36 0.38 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . 0.462 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -115.76 92.63 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.361 1.065 . . . . 0.0 108.616 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.69 39.44 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -158.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 166' ' ' THR . . . . . 0.423 ' OG1' HG21 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . 0.462 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . 0.423 HG21 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' I' ' 125' ' ' ALA . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 7' ' ' MET . . . . . 0.499 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . 0.428 HG13 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . 0.604 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 17' ' ' SER . . . . . 0.416 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . 0.414 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' H' ' 12' ' ' LYS . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 36' ' ' SER . . . . . 0.411 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.74 88.89 2.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.195 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.78 13.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 155.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.32 -51.91 52.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.28 36.03 17.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.609 1.564 . . . . 0.0 111.697 -172.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.2 49.05 3.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.457 1.503 . . . . 0.0 111.572 -164.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.61 -163.63 1.74 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.482 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.37 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.44 171.68 48.28 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.19 125.43 49.19 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.931 HG12 HG23 ' I' ' 135' ' ' ILE . 1.3 pp -130.51 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.14 -18.77 65.56 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' H' ' 82' ' ' ALA . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' H' ' 76' ' ' GLN . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' H' ' 78' ' ' ALA . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.702 HE21 ' HG3' ' G' ' 139' ' ' LYS . 0.1 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.473 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' H' ' 17' ' ' SER . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.428 ' HE ' HG13 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' H' ' 106' ' ' ALA . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG22 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.69 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.491 ' HB1' HG13 ' H' ' 94' ' ' VAL . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.473 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 119' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.497 HG13 ' O ' ' H' ' 61' ' ' ASP . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.92 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . 0.401 ' HA2' ' OD1' ' H' ' 61' ' ' ASP . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.669 ' HG3' HE21 ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . 0.443 ' HB3' ' OD2' ' B' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . 0.69 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' H' ' 94' ' ' VAL . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.682 HG22 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.18 128.27 29.72 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.51 -46.75 73.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 140.73 134.72 3.11 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 119.359 0.982 . . . . 0.0 113.089 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -115.82 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.359 1.064 . . . . 0.0 108.638 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.28 -41.79 39.53 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -158.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.3 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.42 ' OG1' HG21 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . 0.459 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.5 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . 0.427 HG13 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . 0.614 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.5 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 17' ' ' SER . . . . . 0.419 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . 0.419 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.614 HD13 ' HG2' ' I' ' 12' ' ' LYS . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . 0.43 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 36' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.74 34.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.9 2.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.255 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.19 163.74 13.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 155.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.29 -51.95 52.31 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.25 36.06 17.98 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.576 1.55 . . . . 0.0 111.674 -172.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.26 48.99 3.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.522 1.529 . . . . 0.0 111.566 -164.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.485 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.74 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.77 48.36 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.19 125.4 49.1 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.891 HG12 HG23 ' J' ' 135' ' ' ILE . 1.3 pp -130.51 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.864 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.11 -18.88 65.63 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . 0.505 ' O ' HG13 ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.484 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' I' ' 82' ' ' ALA . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.484 ' HB ' ' O ' ' I' ' 76' ' ' GLN . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' I' ' 78' ' ' ALA . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.669 HE21 ' HG3' ' H' ' 139' ' ' LYS . 0.1 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.462 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' I' ' 17' ' ' SER . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.427 ' HE ' HG13 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' I' ' 106' ' ' ALA . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.671 ' CZ ' HG22 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.69 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' I' ' 94' ' ' VAL . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.462 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.505 HG13 ' O ' ' I' ' 61' ' ' ASP . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.931 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . 0.406 ' HA2' ' OD1' ' I' ' 61' ' ' ASP . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . 0.58 ' HG3' HE21 ' J' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . 0.69 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.41 ' HG2' HG12 ' I' ' 94' ' ' VAL . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.671 HG22 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.29 128.24 29.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.54 -46.72 73.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . 0.401 ' HA3' ' HH ' ' I' ' 158' ' ' TYR . . . 140.73 134.76 3.11 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.392 0.996 . . . . 0.0 113.039 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.98 78.36 0.38 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.346 1.058 . . . . 0.0 108.597 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.72 39.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.418 ' OG1' HG21 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . 0.467 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . 0.418 HG21 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' K' ' 125' ' ' ALA . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . 0.427 HG13 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.492 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . 0.414 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.606 HD13 ' HG2' ' J' ' 12' ' ' LYS . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 36' ' ' SER . . . . . 0.437 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.88 2.52 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.242 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.2 163.79 13.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.32 -52.02 51.47 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.32 36.05 17.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.651 -172.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.16 49.05 3.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.533 1.533 . . . . 0.0 111.558 -164.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.443 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.76 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.39 171.69 48.26 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.13 125.43 49.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.897 HG12 HG23 ' K' ' 135' ' ' ILE . 1.3 pp -130.54 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.887 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.09 -18.9 65.64 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . 0.496 ' O ' HG13 ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' J' ' 82' ' ' ALA . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' J' ' 76' ' ' GLN . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' J' ' 78' ' ' ALA . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.58 HE21 ' HG3' ' I' ' 139' ' ' LYS . 0.1 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.47 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' J' ' 17' ' ' SER . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.427 ' HE ' HG13 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' J' ' 106' ' ' ALA . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.675 ' CZ ' HG22 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.702 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' J' ' 94' ' ' VAL . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . 0.539 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 119' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.496 HG13 ' O ' ' J' ' 61' ' ' ASP . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.891 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . 0.402 ' HA2' ' OD1' ' J' ' 61' ' ' ASP . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . 0.677 ' HG3' HE21 ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . 0.525 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.413 ' HG2' HG12 ' J' ' 94' ' ' VAL . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . 0.656 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.675 HG22 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.29 29.6 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.53 -46.7 73.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 140.74 134.73 3.11 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 119.34 0.973 . . . . 0.0 113.026 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.34 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.65 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.33 1.052 . . . . 0.0 108.646 177.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.76 39.15 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -158.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.425 ' OG1' HG21 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . 0.468 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . 0.425 HG21 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.522 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.429 HG13 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . 0.601 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 17' ' ' SER . . . . . 0.427 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . 0.419 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.601 HD13 ' HG2' ' K' ' 12' ' ' LYS . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 36' ' ' SER . . . . . 0.438 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . 0.451 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.71 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.209 171.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.82 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 155.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.468 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.4 mp0 -66.4 -51.89 52.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.0 OUTLIER 61.21 36.1 18.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.585 1.554 . . . . 0.0 111.662 -172.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.14 49.06 3.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.548 1.539 . . . . 0.0 111.534 -164.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.491 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.28 0.67 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.53 171.74 48.37 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.22 125.37 49.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.799 HG12 HG23 ' L' ' 135' ' ' ILE . 1.3 pp -130.49 -31.98 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.892 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.15 -18.84 65.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' K' ' 82' ' ' ALA . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' K' ' 76' ' ' GLN . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' K' ' 78' ' ' ALA . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.677 HE21 ' HG3' ' J' ' 139' ' ' LYS . 0.1 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.48 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' K' ' 17' ' ' SER . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.429 ' HE ' HG13 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.509 HG13 ' HB1' ' K' ' 106' ' ' ALA . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.68 ' CZ ' HG22 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.721 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' K' ' 94' ' ' VAL . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . 0.403 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.48 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 119' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.497 HG13 ' O ' ' K' ' 61' ' ' ASP . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.897 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.613 ' HG3' HE21 ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . 0.721 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.405 ' HG2' HG12 ' K' ' 94' ' ' VAL . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.24 128.27 29.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.53 -46.69 73.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . 0.401 ' HA3' ' HH ' ' K' ' 158' ' ' TYR . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 119.406 1.003 . . . . 0.0 113.014 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.37 0.38 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.67 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.338 1.055 . . . . 0.0 108.616 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.37 -41.74 39.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -158.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.415 ' OG1' HG21 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . 0.469 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . 0.415 HG21 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' G' ' 125' ' ' ALA . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.521 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . 0.431 HG13 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . 0.61 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.504 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . 0.408 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' L' ' 12' ' ' LYS . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 36' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.468 ' NE ' ' OE2' ' K' ' 46' ' ' GLU . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.76 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.254 171.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.74 13.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.29 -51.9 52.74 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 61.27 36.03 17.95 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.591 1.556 . . . . 0.0 111.694 -172.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 49.03 3.17 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.519 1.528 . . . . 0.0 111.574 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.55 -163.58 1.72 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.465 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.72 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.41 171.71 48.29 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -119.23 125.44 49.16 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.904 HG12 HG23 ' G' ' 135' ' ' ILE . 1.3 pp -130.54 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.14 -18.8 65.57 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . 0.497 ' O ' HG13 ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' L' ' 82' ' ' ALA . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' L' ' 76' ' ' GLN . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.42 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' L' ' 78' ' ' ALA . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.613 HE21 ' HG3' ' K' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.566 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' L' ' 17' ' ' SER . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.543 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.431 ' HE ' HG13 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.51 HG13 ' HB1' ' L' ' 106' ' ' ALA . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG22 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.722 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.51 ' HB1' HG13 ' L' ' 94' ' ' VAL . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.487 ' CD2' ' HB3' ' F' ' 171' ' ' PRO . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.486 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . 0.451 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 119' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . 0.537 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.531 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.799 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . 0.52 ' HA3' ' HE3' ' F' ' 155' ' ' LYS . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.454 HD13 ' OD1' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . 0.657 ' HG3' HE21 ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.685 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.836 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.672 HG22 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.27 128.27 29.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -54.56 -46.7 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . 0.402 ' HA3' ' HH ' ' L' ' 158' ' ' TYR . . . 140.75 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 119.422 1.01 . . . . 0.0 113.068 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.95 78.31 0.38 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.72 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.308 1.043 . . . . 0.0 108.572 177.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.77 39.2 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . 0.409 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' L' L ' 166' ' ' THR . . . . . 0.422 ' OG1' HG21 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . 0.467 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . 0.422 HG21 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.415 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 90' ' ' LYS . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.49 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD22 HG22 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.645 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -73.44 165.95 24.11 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.87 85.04 2.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.203 171.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.736 ' H ' HG23 ' A' ' 53' ' ' ILE . 26.4 t70 -110.68 100.09 8.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 10.2 pt-20 -68.69 -21.29 64.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 176.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.33 26.6 5.28 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.534 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.96 21.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.56 1.544 . . . . 0.0 111.537 -164.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -116.6 -92.19 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.3 33.93 0.52 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.2 36.16 25.03 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 116.27 32.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.736 HG23 ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.05 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.857 178.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.633 HD23 HD12 ' B' ' 135' ' ' ILE . 0.4 OUTLIER -109.07 25.12 12.17 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.458 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 78' ' ' ALA . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.438 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 74' ' ' ALA . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 75' ' ' GLY . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.618 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 HE22 ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.456 ' HB3' HE22 ' A' ' 88' ' ' GLN . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.484 ' HB3' ' HG ' ' F' ' 38' ' ' SER . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.554 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.421 HD11 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.505 ' HG1' HG22 ' A' ' 151' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.491 HG22 HD22 ' A' ' 27' ' ' LEU . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.505 HG22 ' HG1' ' A' ' 145' ' ' THR . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.5 144.68 37.42 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.63 -34.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.49 11.64 77.26 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.359 0.981 . . . . 0.0 113.057 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.72 4.79 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.19 24.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.282 1.033 . . . . 0.0 108.632 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -32.96 70.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.404 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 22.9 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' HA ' ' NE2' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.487 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.453 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.474 HD22 HG22 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' B' ' 62' ' ' SER . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' SER . . . . . 0.711 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.414 ' O ' HD11 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -73.43 166.01 24.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.188 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.724 ' H ' HG23 ' B' ' 53' ' ' ILE . 26.4 t70 -110.62 100.08 8.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.22 64.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.3 26.58 5.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.592 1.557 . . . . 0.0 111.667 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.53 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.93 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.516 1.526 . . . . 0.0 111.54 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -116.57 -92.22 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.444 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.495 ' CG ' HG21 ' C' ' 59' ' ' VAL . 17.8 m-20 -152.31 33.97 0.52 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.12 36.13 25.35 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.62 116.29 32.29 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.724 HG23 ' H ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -132.88 136.01 56.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.883 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.772 HD23 HD12 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -109.08 25.14 12.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.421 ' H ' HE22 ' B' ' 76' ' ' GLN . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' B' ' 78' ' ' ALA . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.48 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 7.0 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' B' ' 74' ' ' ALA . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.48 HG12 ' O ' ' B' ' 75' ' ' GLY . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . 0.645 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . 0.416 ' HA2' HD11 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.588 ' HB3' ' HG ' ' A' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.45 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.558 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.633 HD12 HD23 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.416 HD11 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' THR . . . . . 0.51 ' HG1' HG22 ' B' ' 151' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG22 HD22 ' B' ' 27' ' ' LEU . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.51 HG22 ' HG1' ' B' ' 145' ' ' THR . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.75 37.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.7 -34.01 62.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.52 11.66 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.397 0.999 . . . . 0.0 112.991 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.78 4.8 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.318 1.047 . . . . 0.0 108.631 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -33.01 70.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -158.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.41 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.439 ' HA ' ' NE2' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.631 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.631 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . 0.423 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.456 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.489 HD22 HG22 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.411 ' O ' HD11 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -73.46 166.01 24.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.85 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.239 171.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.734 ' H ' HG23 ' C' ' 53' ' ' ILE . 26.4 t70 -110.63 100.1 8.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.22 64.39 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.28 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.602 1.561 . . . . 0.0 111.664 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.518 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.97 21.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.514 1.526 . . . . 0.0 111.561 -164.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.62 -92.16 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.458 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . 0.574 ' CG ' HG21 ' D' ' 59' ' ' VAL . 17.9 m-20 -152.32 33.94 0.52 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.15 36.1 25.35 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.66 116.3 32.3 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.734 HG23 ' H ' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.03 56.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.915 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.757 HD23 HD12 ' D' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.18 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.495 HG21 ' CG ' ' B' ' 50' ' ' ASN . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.427 ' H ' HE22 ' C' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.576 ' O ' ' HB2' ' C' ' 78' ' ' ALA . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.491 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.427 HE22 ' H ' ' C' ' 70' ' ' LYS . 7.0 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' C' ' 74' ' ' ALA . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 75' ' ' GLY . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . 0.711 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.449 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.587 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.449 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . 0.644 ' HB3' ' HG ' ' B' ' 38' ' ' SER . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . 0.526 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.523 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . 0.673 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.772 HD12 HD23 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . 0.421 HD11 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' THR . . . . . 0.51 ' HG1' HG22 ' C' ' 151' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . 0.489 HG22 HD22 ' C' ' 27' ' ' LEU . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.51 HG22 ' HG1' ' C' ' 145' ' ' THR . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.51 144.67 37.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.62 -34.0 62.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.61 77.37 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 119.335 0.97 . . . . 0.0 113.059 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 117.79 4.82 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -94.03 112.25 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.274 1.03 . . . . 0.0 108.569 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -32.9 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -158.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.444 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' THR . . . . . 0.627 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.627 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . 0.464 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.418 ' HA ' ' HB1' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.495 HD22 HG22 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' SER . . . . . 0.675 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.406 ' O ' HD11 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -73.46 165.98 24.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.86 85.02 2.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.248 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.721 ' H ' HG23 ' D' ' 53' ' ' ILE . 26.4 t70 -110.63 100.09 8.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 155.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . 0.531 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.25 64.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.34 26.63 5.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.62 1.568 . . . . 0.0 111.64 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.531 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.9 21.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 111.587 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -116.56 -92.21 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.24 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.2 36.1 25.18 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.64 116.31 32.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.721 HG23 ' H ' ' D' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.0 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.84 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.625 HD23 HD12 ' E' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.13 12.17 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.574 HG21 ' CG ' ' C' ' 50' ' ' ASN . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' D' ' 78' ' ' ALA . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.486 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.428 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' D' ' 74' ' ' ALA . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' D' ' 75' ' ' GLY . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD11 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.453 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . 0.587 ' HB3' ' HG ' ' C' ' 38' ' ' SER . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . 0.513 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' SER . . . . . 0.556 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.687 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.757 HD12 HD23 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . 0.434 HD11 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' THR . . . . . 0.504 ' HG1' HG22 ' D' ' 151' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . 0.495 HG22 HD22 ' D' ' 27' ' ' LEU . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.504 HG22 ' HG1' ' D' ' 145' ' ' THR . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.79 37.32 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.69 -34.08 62.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.57 11.62 77.1 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.36 0.982 . . . . 0.0 113.038 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.91 112.15 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.331 1.052 . . . . 0.0 108.615 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.94 70.71 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' J' ' 142' ' ' GLU . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.414 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.446 ' HA ' ' NE2' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.629 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.629 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.477 HD22 HG22 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' E' ' 62' ' ' SER . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' SER . . . . . 0.649 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.414 ' O ' HD11 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -73.44 165.98 24.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -108.83 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.264 171.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . 0.728 ' H ' HG23 ' E' ' 53' ' ' ILE . 26.4 t70 -110.61 100.05 8.91 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 155.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.52 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.19 64.37 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.6 1.56 . . . . 0.0 111.685 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.52 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.89 21.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.527 1.531 . . . . 0.0 111.565 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.55 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.455 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . 0.554 ' CB ' HG21 ' F' ' 59' ' ' VAL . 17.9 m-20 -152.29 33.93 0.52 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.15 36.16 25.19 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.7 116.32 32.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.728 HG23 ' H ' ' E' ' 45' ' ' ASP . 0.3 OUTLIER -132.84 136.01 56.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.898 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.759 HD23 HD12 ' F' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.19 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . 0.464 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' E' ' 78' ' ' ALA . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.48 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 7.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' E' ' 74' ' ' ALA . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.48 HG12 ' O ' ' E' ' 75' ' ' GLY . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . 0.675 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.459 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.495 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.594 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . 0.42 ' HA2' HD11 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.459 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . 0.621 ' HB3' ' HG ' ' D' ' 38' ' ' SER . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 119' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.528 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 131' ' ' SER . . . . . 0.555 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.625 HD12 HD23 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . 0.42 HD11 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 145' ' ' THR . . . . . 0.499 ' HG1' HG22 ' E' ' 151' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . 0.477 HG22 HD22 ' E' ' 27' ' ' LEU . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.499 HG22 ' HG1' ' E' ' 145' ' ' THR . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.72 37.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.406 ' HD3' ' CA ' ' K' ' 136' ' ' GLY . 6.9 mttt -74.68 -34.02 62.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.64 77.31 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.389 0.995 . . . . 0.0 113.065 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.84 117.65 4.78 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.21 24.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.307 1.043 . . . . 0.0 108.622 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.93 70.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . 0.438 ' HA ' ' CH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.633 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.633 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . 0.417 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.571 ' HA ' ' HB1' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.478 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.441 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.494 HD22 HG22 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 38' ' ' SER . . . . . 0.618 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.418 ' O ' HD11 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -73.52 165.98 24.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.88 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.202 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . 0.727 ' H ' HG23 ' F' ' 53' ' ' ILE . 26.4 t70 -110.65 100.14 8.98 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . 0.521 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 10.1 pt-20 -68.8 -21.16 64.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.59 5.35 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.623 1.569 . . . . 0.0 111.702 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.521 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.87 21.73 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.492 1.517 . . . . 0.0 111.569 -164.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.51 -92.23 0.52 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.486 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -152.3 33.91 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.16 36.11 25.29 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.61 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.727 HG23 ' H ' ' F' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.0 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.849 178.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.05 25.13 12.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . 0.554 HG21 ' CB ' ' E' ' 50' ' ' ASN . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 62' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . 0.577 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . 0.408 ' H ' HE22 ' F' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' F' ' 78' ' ' ALA . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.479 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 7.0 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' F' ' 74' ' ' ALA . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.479 HG12 ' O ' ' F' ' 75' ' ' GLY . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . 0.458 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.588 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.453 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . 0.543 ' HB3' ' HG ' ' E' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 119' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.526 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 131' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . 0.66 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.759 HD12 HD23 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . 0.43 HD11 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.498 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 145' ' ' THR . . . . . 0.498 ' HG1' HG22 ' F' ' 151' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . 0.494 HG22 HD22 ' F' ' 27' ' ' LEU . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.498 HG22 ' HG1' ' F' ' 145' ' ' THR . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . 0.423 HG23 ' HD3' ' K' ' 49' ' ' LYS . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 154' ' ' SER . . . . . 0.411 ' C ' ' NZ ' ' K' ' 49' ' ' LYS . 5.4 p -109.54 144.72 37.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.64 -34.09 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.48 11.7 77.15 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 119.389 0.995 . . . . 0.0 113.001 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.86 117.77 4.81 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.59 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.652 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER -70.43 -32.95 70.75 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -158.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.522 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.501 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 22.9 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.547 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.525 HG23 ' HB3' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.637 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.559 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.637 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 7' ' ' MET . . . . . 0.479 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.446 ' HB3' ' HZ1' ' G' ' 90' ' ' LYS . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.476 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.494 HD22 HG22 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' G' ' 62' ' ' SER . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 38' ' ' SER . . . . . 0.563 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -73.45 165.94 24.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.83 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.265 171.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . 0.733 ' H ' HG23 ' G' ' 53' ' ' ILE . 26.4 t70 -110.62 100.06 8.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 10.2 pt-20 -68.68 -21.27 64.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.58 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.596 1.558 . . . . 0.0 111.667 -172.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.525 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 50.38 48.91 21.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 111.611 -164.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.55 -92.25 0.52 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.444 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.3 33.96 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 36.17 25.08 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.71 116.3 32.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.733 HG23 ' H ' ' G' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.01 56.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.888 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . 0.518 HD23 HD12 ' H' ' 135' ' ' ILE . 0.4 OUTLIER -109.07 25.15 12.14 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 62' ' ' SER . . . . . 0.666 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . 0.419 ' H ' HE22 ' G' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . 0.465 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' G' ' 78' ' ' ALA . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . 0.484 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.431 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 7.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' G' ' 74' ' ' ALA . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.484 HG12 ' O ' ' G' ' 75' ' ' GLY . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' G' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . 0.415 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.58 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' G' ' 88' ' ' GLN . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . 0.523 ' HB3' ' HG ' ' L' ' 38' ' ' SER . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 119' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . 0.526 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 131' ' ' SER . . . . . 0.572 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . 0.666 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.574 HD12 HD23 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . 0.426 HD11 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.497 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 145' ' ' THR . . . . . 0.487 ' HG1' HG22 ' G' ' 151' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . 0.494 HG22 HD22 ' G' ' 27' ' ' LEU . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.487 HG22 ' HG1' ' G' ' 145' ' ' THR . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.8 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.71 -34.09 62.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.54 11.68 77.03 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.386 0.994 . . . . 0.0 112.996 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.76 4.8 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.2 24.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.331 1.053 . . . . 0.0 108.638 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.94 70.66 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 167' ' ' THR . . . . . 0.633 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.633 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 7' ' ' MET . . . . . 0.47 ' HA ' ' HB1' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.485 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.488 HD22 HG22 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 38' ' ' SER . . . . . 0.563 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.526 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER -73.45 166.0 24.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -108.83 84.97 2.01 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.264 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . 0.726 ' H ' HG23 ' H' ' 53' ' ' ILE . 26.4 t70 -110.63 100.15 8.99 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 155.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.21 64.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.21 26.6 5.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.64 1.576 . . . . 0.0 111.715 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.534 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.92 21.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.495 1.518 . . . . 0.0 111.561 -164.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -116.56 -92.23 0.52 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.467 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.27 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.16 36.1 25.33 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.63 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.726 HG23 ' H ' ' H' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.02 56.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.86 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . 0.527 HD23 HD12 ' I' ' 135' ' ' ILE . 0.4 OUTLIER -109.12 25.22 12.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 62' ' ' SER . . . . . 0.659 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . 0.429 ' H ' HE22 ' H' ' 76' ' ' GLN . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . 0.415 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' H' ' 78' ' ' ALA . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . 0.47 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.429 HE22 ' H ' ' H' ' 70' ' ' LYS . 7.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' H' ' 74' ' ' ALA . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.47 HG12 ' O ' ' H' ' 75' ' ' GLY . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' H' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . 0.484 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.494 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . 0.415 ' HA2' HD11 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' H' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . 0.497 ' HB3' ' HG ' ' G' ' 38' ' ' SER . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 119' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.523 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 131' ' ' SER . . . . . 0.565 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . 0.659 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.518 HD12 HD23 ' G' ' 54' ' ' LEU . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . 0.415 HD11 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.494 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 145' ' ' THR . . . . . 0.486 ' HG1' HG22 ' H' ' 151' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . 0.488 HG22 HD22 ' H' ' 27' ' ' LEU . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.486 HG22 ' HG1' ' H' ' 145' ' ' THR . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.58 144.72 37.5 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.7 -33.99 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.68 77.29 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.402 1.001 . . . . 0.0 113.041 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.16 23.97 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.34 1.056 . . . . 0.0 108.646 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.96 70.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . 0.407 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.433 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 167' ' ' THR . . . . . 0.624 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.624 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . 0.473 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.538 ' HA ' ' HB1' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.455 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.489 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.474 HD22 HG22 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' I' ' 62' ' ' SER . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 38' ' ' SER . . . . . 0.638 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . 0.412 ' O ' HD11 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -73.51 166.0 24.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -108.85 85.02 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.247 171.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . 0.737 ' H ' HG23 ' I' ' 53' ' ' ILE . 26.4 t70 -110.62 100.07 8.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.2 64.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.24 26.61 5.37 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.603 1.561 . . . . 0.0 111.688 -172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 48' ' ' THR . . . . . 0.529 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 50.39 48.95 21.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.49 1.516 . . . . 0.0 111.554 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -116.58 -92.24 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.455 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.3 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 36.06 25.35 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.61 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.737 HG23 ' H ' ' I' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.03 56.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.899 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.664 HD23 HD12 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -109.13 25.2 12.08 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 176.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 62' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . 0.428 ' H ' HE22 ' I' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . 0.484 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' I' ' 78' ' ' ALA . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . 0.491 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.434 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' I' ' 74' ' ' ALA . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.491 HG12 ' O ' ' I' ' 75' ' ' GLY . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.563 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.462 HE22 ' HB3' ' I' ' 110' ' ' PHE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . 0.508 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.583 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.462 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . 0.449 ' HB3' ' HG ' ' H' ' 38' ' ' SER . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 119' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.516 ' O ' HG13 ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 131' ' ' SER . . . . . 0.561 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . 0.684 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.527 HD12 HD23 ' H' ' 54' ' ' LEU . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . 0.413 HD11 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.491 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 145' ' ' THR . . . . . 0.498 ' HG1' HG22 ' I' ' 151' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . 0.474 HG22 HD22 ' I' ' 27' ' ' LEU . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.498 HG22 ' HG1' ' I' ' 145' ' ' THR . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.76 37.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.67 -34.09 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.67 77.13 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 113.043 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.246 1.019 . . . . 0.0 108.633 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -32.97 70.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . 0.446 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . 0.413 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.446 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 167' ' ' THR . . . . . 0.614 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.614 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . 0.424 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.549 ' HA ' ' HB1' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.492 HD22 HG22 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 38' ' ' SER . . . . . 0.549 ' HG ' ' HB3' ' K' ' 116' ' ' ARG . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . 0.41 ' O ' HD11 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -73.49 165.95 24.13 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.84 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.228 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . 0.72 ' H ' HG23 ' J' ' 53' ' ' ILE . 26.4 t70 -110.58 100.06 8.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.526 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 10.2 pt-20 -68.73 -21.2 64.4 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.6 5.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.574 1.549 . . . . 0.0 111.693 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 48' ' ' THR . . . . . 0.526 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.94 21.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.498 1.519 . . . . 0.0 111.553 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.61 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.434 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.27 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 36.15 25.12 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 116.3 32.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.72 HG23 ' H ' ' J' ' 45' ' ' ASP . 0.3 OUTLIER -132.86 135.95 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.854 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . 0.55 HD23 HD12 ' K' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.14 12.15 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 62' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . 0.473 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . 0.508 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' J' ' 78' ' ' ALA . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . 0.486 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.441 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 7.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' J' ' 74' ' ' ALA . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.486 HG12 ' O ' ' J' ' 75' ' ' GLY . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.638 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.456 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . 0.447 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.592 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . 0.427 ' HA2' HD11 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.456 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . 0.637 ' HB3' ' HG ' ' I' ' 38' ' ' SER . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 119' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.518 ' O ' HG13 ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 131' ' ' SER . . . . . 0.562 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . 0.684 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.664 HD12 HD23 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . 0.427 HD11 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.484 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 145' ' ' THR . . . . . 0.502 ' HG1' HG22 ' J' ' 151' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . 0.492 HG22 HD22 ' J' ' 27' ' ' LEU . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.502 HG22 ' HG1' ' J' ' 145' ' ' THR . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.76 37.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.65 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.69 77.24 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.37 0.986 . . . . 0.0 113.079 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.97 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.29 1.036 . . . . 0.0 108.635 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.94 70.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . 0.411 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.448 ' HA ' ' NE2' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 167' ' ' THR . . . . . 0.619 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.619 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.524 ' HA ' ' HB1' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.468 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.493 HD22 HG22 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 38' ' ' SER . . . . . 0.616 ' HG ' ' HB3' ' L' ' 116' ' ' ARG . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . 0.417 ' O ' HD11 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -73.49 166.03 23.98 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.87 84.96 2.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.259 171.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . 0.731 ' H ' HG23 ' K' ' 53' ' ' ILE . 26.4 t70 -110.59 100.12 8.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.521 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 10.2 pt-20 -68.79 -21.22 64.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.62 5.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.636 1.575 . . . . 0.0 111.677 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 48' ' ' THR . . . . . 0.521 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.96 21.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.501 1.52 . . . . 0.0 111.57 -164.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . 0.423 ' HD3' HG23 ' F' ' 153' ' ' VAL . 6.3 tptt -116.57 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.31 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.16 36.12 25.24 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 116.25 32.22 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.731 HG23 ' H ' ' K' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 135.99 56.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.9 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.705 HD23 HD12 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.18 12.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 62' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . 0.447 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' K' ' 78' ' ' ALA . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . 0.483 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 7.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' K' ' 74' ' ' ALA . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.483 HG12 ' O ' ' K' ' 75' ' ' GLY . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . 0.517 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.455 HE22 ' HB3' ' K' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD11 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.455 ' HB3' HE22 ' K' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . 0.549 ' HB3' ' HG ' ' J' ' 38' ' ' SER . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 119' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.522 ' O ' HG13 ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 131' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.55 HD12 HD23 ' J' ' 54' ' ' LEU . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . 0.406 ' CA ' ' HD3' ' E' ' 155' ' ' LYS . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . 0.434 HD11 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.406 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.492 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 145' ' ' THR . . . . . 0.492 ' HG1' HG22 ' K' ' 151' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . 0.493 HG22 HD22 ' K' ' 27' ' ' LEU . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.492 HG22 ' HG1' ' K' ' 145' ' ' THR . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.59 144.71 37.52 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.46 11.69 77.23 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 119.389 0.995 . . . . 0.0 113.002 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 117.75 4.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.19 23.99 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.299 1.039 . . . . 0.0 108.595 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.92 70.64 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . 0.442 ' NE2' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . 0.409 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.442 ' HA ' ' NE2' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 167' ' ' THR . . . . . 0.615 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.615 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.529 ' HA ' ' HB1' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.448 ' HB3' ' HZ1' ' L' ' 90' ' ' LYS . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.478 HD22 HG22 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . 0.415 ' O ' HD11 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -73.48 166.05 23.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.207 171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . 0.733 ' H ' HG23 ' L' ' 53' ' ' ILE . 26.4 t70 -110.58 100.1 8.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . 0.524 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 10.1 pt-20 -68.76 -21.23 64.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.63 5.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.564 1.546 . . . . 0.0 111.641 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.524 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 50.35 48.92 21.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.496 1.518 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -116.58 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.457 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.3 33.85 0.52 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.24 36.15 24.93 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.65 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.733 HG23 ' H ' ' L' ' 45' ' ' ASP . 0.3 OUTLIER -132.9 135.98 56.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.861 178.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . 0.574 HD23 HD12 ' G' ' 135' ' ' ILE . 0.4 OUTLIER -109.03 25.14 12.16 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.164 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 62' ' ' SER . . . . . 0.683 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . 0.414 ' H ' HE22 ' L' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' L' ' 78' ' ' ALA . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . 0.482 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.437 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 7.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' L' ' 74' ' ' ALA . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.482 HG12 ' O ' ' L' ' 75' ' ' GLY . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . 0.506 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.406 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.559 ' HG3' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.547 ' HZ2' ' OE1' ' F' ' 165' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . 0.465 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.587 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . 0.418 ' HA2' HD11 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.461 ' HB3' HE22 ' L' ' 88' ' ' GLN . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . 0.616 ' HB3' ' HG ' ' K' ' 38' ' ' SER . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 119' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.521 ' O ' HG13 ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 131' ' ' SER . . . . . 0.569 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.705 HD12 HD23 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.418 HD11 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.652 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.0 p-10 -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.496 ' O ' ' HD2' ' L' ' 103' ' ' LYS . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 145' ' ' THR . . . . . 0.493 ' HG1' HG22 ' L' ' 151' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . 0.478 HG22 HD22 ' L' ' 27' ' ' LEU . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.493 HG22 ' HG1' ' L' ' 145' ' ' THR . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.54 144.73 37.43 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.68 -33.99 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.44 11.72 77.2 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 119.37 0.986 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.79 4.8 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.33 1.052 . . . . 0.0 108.613 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.97 70.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.438 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 167' ' ' THR . . . . . 0.628 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.628 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.619 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.619 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.706 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.574 HD13 ' HG2' ' A' ' 12' ' ' LYS . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.13 120.72 39.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.65 88.44 2.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.22 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.8 168.91 8.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 1.9 mp0 -71.8 -47.18 55.11 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.15 35.57 26.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.595 1.558 . . . . 0.0 111.672 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.91 48.95 5.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.51 1.524 . . . . 0.0 111.56 -164.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.502 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.99 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 174.09 49.85 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.26 122.36 42.74 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.599 HG12 HG23 ' B' ' 135' ' ' ILE . 1.2 pp -128.69 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.822 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER -65.25 -23.8 67.15 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.478 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 129' ' ' SER . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.408 ' HB2' ' HZ3' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HZ3' ' HB2' ' A' ' 85' ' ' ASN . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.505 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG13 ' HB1' ' A' ' 106' ' ' ALA . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' OH ' HG22 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.588 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' ND2' ' A' ' 140' ' ' ASN . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' A' ' 92' ' ' TRP . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.442 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.505 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' A' ' 61' ' ' ASP . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.771 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.422 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.469 HG21 ' HA ' ' L' ' 49' ' ' LYS . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.77 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 156' ' ' GLY . 0.2 OUTLIER -55.03 -44.53 74.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 155' ' ' LYS . . . 138.96 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.422 1.01 . . . . 0.0 113.073 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.83 -44.97 65.39 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.447 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.427 ' HB ' ' HZ3' ' G' ' 90' ' ' LYS . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.571 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 158' ' ' TYR . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.633 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.633 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.58 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.688 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' B' ' 12' ' ' LYS . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.434 ' O ' ' CE1' ' B' ' 31' ' ' TYR . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.466 ' HB3' ' OH ' ' B' ' 13' ' ' TYR . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.494 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.707 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 88.34 2.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.238 171.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.77 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 155.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.55 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.12 55.15 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.15 35.54 26.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.605 1.562 . . . . 0.0 111.691 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.4 p 42.89 48.97 5.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 111.551 -164.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.22 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.482 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.48 0.32 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.13 49.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.31 42.61 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.571 HG12 HG23 ' C' ' 135' ' ' ILE . 1.2 pp -128.66 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.564 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER -65.3 -23.75 67.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.585 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.443 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 129' ' ' SER . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.421 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.519 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.403 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' B' ' 106' ' ' ALA . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.458 ' OH ' HG22 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.584 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' B' ' 140' ' ' ASN . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' B' ' 92' ' ' TRP . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.434 ' O ' HG21 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.501 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' B' ' 61' ' ' ASP . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.424 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.535 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.452 HG21 ' HA ' ' G' ' 49' ' ' LYS . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.06 134.74 30.19 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' B' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.58 74.56 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' B' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.367 0.985 . . . . 0.0 113.053 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.17 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -111.53 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.24 1.016 . . . . 0.0 108.591 177.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.86 -44.98 65.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.436 ' O ' HG21 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . 0.572 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' B' ' 158' ' ' TYR . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . 0.436 HG21 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.641 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.641 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.458 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.718 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.585 HD13 ' HG2' ' C' ' 12' ' ' LYS . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CE1' ' C' ' 31' ' ' TYR . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' C' ' 13' ' ' TYR . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' SER . . . . . 0.46 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.61 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.07 120.73 38.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 88.38 2.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.198 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.78 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.524 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.16 54.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.12 35.64 26.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.627 1.571 . . . . 0.0 111.66 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.85 48.97 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.488 1.515 . . . . 0.0 111.581 -164.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.29 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.93 21.57 0.31 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.68 174.12 49.88 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 122.28 42.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.563 HG12 HG23 ' D' ' 135' ' ' ILE . 1.2 pp -128.64 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.879 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.494 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER -65.29 -23.78 67.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 176.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . 0.43 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.55 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' C' ' 129' ' ' SER . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' HZ3' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.406 ' HZ3' ' HB2' ' C' ' 85' ' ' ASN . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.564 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.422 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' C' ' 106' ' ' ALA . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.589 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' ND2' ' C' ' 140' ' ' ASN . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . 0.422 ' HE1' ' CE2' ' C' ' 92' ' ' TRP . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.456 ' O ' HG21 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.585 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . 0.707 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . 0.494 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.456 HG21 ' O ' ' C' ' 110' ' ' PHE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.571 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . 0.431 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.445 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' C' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . 0.424 ' O ' ' HD2' ' C' ' 155' ' ' LYS . . . 138.95 137.02 3.47 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.368 0.985 . . . . 0.0 113.032 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.13 80.62 0.36 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -111.59 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.298 1.039 . . . . 0.0 108.633 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.79 -44.99 65.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . 0.434 ' OE1' ' OE2' ' I' ' 142' ' ' GLU . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.448 ' O ' HG21 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.567 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' C' ' 158' ' ' TYR . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . 0.448 HG21 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.632 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.632 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . 0.592 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.465 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.718 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.592 HD13 ' HG2' ' D' ' 12' ' ' LYS . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . 0.43 ' O ' ' CE1' ' D' ' 31' ' ' TYR . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' D' ' 13' ' ' TYR . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' SER . . . . . 0.484 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.503 ' NE ' ' OE2' ' C' ' 46' ' ' GLU . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . 0.631 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.73 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -130.72 88.39 2.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.191 171.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.78 168.88 8.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 155.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.79 -47.14 55.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.07 35.66 26.64 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.645 1.578 . . . . 0.0 111.663 -172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.8 49.02 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 111.578 -164.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.32 -165.12 2.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.469 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.56 0.32 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.67 174.1 49.85 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 122.33 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.647 HG12 HG23 ' E' ' 135' ' ' ILE . 1.2 pp -128.73 -33.28 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.475 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER -65.35 -23.72 67.06 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . 0.448 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' SER . . . . . 0.524 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' D' ' 129' ' ' SER . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.418 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.406 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . 0.405 ' HB2' ' HZ3' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.506 ' HG2' ' HD1' ' D' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.718 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.413 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' D' ' 106' ' ' ALA . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.6 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' D' ' 140' ' ' ASN . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . 0.413 ' HE1' ' CE2' ' D' ' 92' ' ' TRP . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.454 ' O ' HG21 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.506 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.475 ' HA ' ' CD1' ' C' ' 53' ' ' ILE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.563 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.542 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.542 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' I' ' 49' ' ' LYS . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.02 134.73 30.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' D' ' 156' ' ' GLY . 0.2 OUTLIER -55.01 -44.53 74.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' D' ' 155' ' ' LYS . . . 138.96 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 119.367 0.985 . . . . 0.0 113.03 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.332 1.053 . . . . 0.0 108.633 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.88 -44.98 65.22 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -158.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.442 ' O ' HG21 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.469 ' HB ' ' HZ3' ' J' ' 90' ' ' LYS . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . 0.565 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' D' ' 158' ' ' TYR . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . 0.442 HG21 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.629 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . 0.588 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.707 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.588 HD13 ' HG2' ' E' ' 12' ' ' LYS . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . 0.424 ' O ' ' CE1' ' E' ' 31' ' ' TYR . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' E' ' 13' ' ' TYR . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.17 120.72 39.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -130.74 88.43 2.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.211 171.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.8 168.91 8.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 155.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.657 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 1.9 mp0 -71.91 -47.1 54.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.16 35.54 26.37 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.579 1.552 . . . . 0.0 111.629 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.9 48.98 5.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.519 1.527 . . . . 0.0 111.528 -164.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.457 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -78.06 21.62 0.32 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 174.09 49.86 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 122.32 42.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.704 HG12 HG23 ' F' ' 135' ' ' ILE . 1.2 pp -128.66 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.878 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.34 -23.72 67.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' E' ' 129' ' ' SER . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.412 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . 0.41 ' HB2' ' HZ3' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.508 ' HG2' ' HD1' ' E' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.424 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.493 HG13 ' HB1' ' E' ' 106' ' ' ALA . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' E' ' 140' ' ' ASN . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . 0.424 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.444 ' O ' HG21 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . 0.4 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 129' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' E' ' 61' ' ' ASP . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.647 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . 0.481 HG21 ' HA ' ' J' ' 49' ' ' LYS . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -140.99 134.75 30.33 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' E' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.56 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 175.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' E' ' 155' ' ' LYS . . . 139.02 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.382 0.992 . . . . 0.0 113.048 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -111.55 91.64 3.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.33 1.052 . . . . 0.0 108.575 177.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.88 -44.95 65.25 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.428 ' O ' HG21 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.402 ' HB ' ' HZ3' ' K' ' 90' ' ' LYS . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . 0.568 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . 0.419 ' HA3' ' CE1' ' E' ' 158' ' ' TYR . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . 0.428 HG21 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.63 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.63 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . 0.575 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.697 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' F' ' 12' ' ' LYS . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . 0.428 ' O ' ' CE1' ' F' ' 31' ' ' TYR . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' F' ' 13' ' ' TYR . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.521 ' NE ' ' OE2' ' E' ' 46' ' ' GLU . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.07 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.65 88.36 2.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.246 171.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.74 168.91 8.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.09 55.3 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.14 35.59 26.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 111.67 -172.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.88 48.97 5.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.454 1.501 . . . . 0.0 111.557 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.11 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.477 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.95 21.51 0.32 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.79 174.09 49.94 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.27 122.31 42.62 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.771 HG12 HG23 ' A' ' 135' ' ' ILE . 1.2 pp -128.67 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -23.76 67.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 58' ' ' SER . . . . . 0.657 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . 0.403 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.415 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.409 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' HZ3' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' F' ' 85' ' ' ASN . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.507 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.697 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.428 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' F' ' 106' ' ' ALA . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.599 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' F' ' 140' ' ' ASN . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . 0.428 ' HE1' ' CE2' ' F' ' 92' ' ' TRP . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.449 ' O ' HG21 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.507 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.467 ' HA ' ' CD1' ' E' ' 53' ' ' ILE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.704 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . 0.432 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.551 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' K' ' 49' ' ' LYS . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 154' ' ' SER . . . . . 0.464 ' HA ' ' ND2' ' K' ' 50' ' ' ASN . 1.6 p -141.04 134.7 30.19 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.452 ' CE ' ' O ' ' L' ' 136' ' ' GLY . 0.2 OUTLIER -54.95 -44.55 74.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' F' ' 155' ' ' LYS . . . 138.93 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.26 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.318 1.047 . . . . 0.0 108.636 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.692 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 -70.8 -45.06 65.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.763 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.74 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.435 ' O ' HG21 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.681 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . 0.57 ' O ' HG22 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . 0.563 ' HB2' ' CE2' ' F' ' 158' ' ' TYR . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' F' ' 158' ' ' TYR . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . 0.435 HG21 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . 0.494 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 7' ' ' MET . . . . . 0.639 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.639 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . 0.566 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . 0.46 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.459 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.692 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.566 HD13 ' HG2' ' G' ' 12' ' ' LYS . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . 0.424 ' O ' ' CE1' ' G' ' 31' ' ' TYR . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . 0.46 ' HB3' ' OH ' ' G' ' 13' ' ' TYR . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . 0.419 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.71 88.41 2.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.203 171.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.83 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 155.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.86 -47.15 54.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.17 35.58 26.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.631 1.573 . . . . 0.0 111.637 -172.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.86 48.96 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.477 1.511 . . . . 0.0 111.584 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . 0.452 ' HA ' HG21 ' B' ' 153' ' ' VAL . 12.9 mttm -147.26 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.459 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.95 21.48 0.32 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.77 174.09 49.93 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 122.38 42.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.888 HG12 HG23 ' H' ' 135' ' ' ILE . 1.2 pp -128.7 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.877 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.26 -23.8 67.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' G' ' 129' ' ' SER . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' G' ' 87' ' ' LYS . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' HZ3' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.414 ' HZ3' ' HB2' ' G' ' 85' ' ' ASN . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.503 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.692 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.425 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' G' ' 106' ' ' ALA . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.47 ' OH ' HG22 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.605 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.505 ' HB3' ' ND2' ' G' ' 140' ' ' ASN . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . 0.425 ' HE1' ' CE2' ' G' ' 92' ' ' TRP . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.448 ' O ' HG21 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.503 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . 0.402 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' G' ' 61' ' ' ASP . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.876 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . 0.422 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' G' ' 147' ' ' PRO . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.55 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.04 134.73 30.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' G' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' G' ' 155' ' ' LYS . . . 138.98 137.02 3.47 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.383 0.992 . . . . 0.0 113.043 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -111.48 91.65 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.315 1.046 . . . . 0.0 108.645 177.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.94 65.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -158.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.428 ' O ' HG21 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . 0.56 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' G' ' 158' ' ' TYR . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . 0.428 HG21 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 7' ' ' MET . . . . . 0.629 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.629 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.701 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.568 HD13 ' HG2' ' H' ' 12' ' ' LYS . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . 0.428 ' O ' ' CE1' ' H' ' 31' ' ' TYR . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . 0.466 ' HB3' ' OH ' ' H' ' 13' ' ' TYR . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.19 120.74 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.69 88.36 2.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.222 171.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.8 168.92 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 155.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.84 -47.14 55.16 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.15 35.56 26.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.62 -172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.94 48.91 5.16 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.501 1.52 . . . . 0.0 111.578 -164.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.482 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.73 174.11 49.91 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.26 122.34 42.69 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.919 HG12 HG23 ' I' ' 135' ' ' ILE . 1.2 pp -128.68 -33.29 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.36 -23.75 67.06 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' H' ' 129' ' ' SER . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.421 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . 0.405 ' HB2' ' HZ3' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.412 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.495 ' HG2' ' CD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.425 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.501 HG13 ' HB1' ' H' ' 106' ' ' ALA . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.468 ' OH ' HG22 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' H' ' 140' ' ' ASN . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . 0.425 ' HE1' ' CE2' ' H' ' 92' ' ' TRP . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.444 ' O ' HG21 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.495 ' CD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . 0.419 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 129' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.448 ' O ' ' HB2' ' H' ' 61' ' ' ASP . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.888 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . 0.42 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . 0.401 ' N ' ' HD3' ' H' ' 147' ' ' PRO . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.08 134.73 30.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' H' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' H' ' 155' ' ' LYS . . . 138.98 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 119.378 0.99 . . . . 0.0 113.039 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.2 80.61 0.36 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -111.54 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.32 1.048 . . . . 0.0 108.636 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.92 65.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -158.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . 0.567 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' H' ' 158' ' ' TYR . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.627 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.627 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.457 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.71 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' I' ' 12' ' ' LYS . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . 0.433 ' O ' ' CE1' ' I' ' 31' ' ' TYR . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . 0.458 ' HB3' ' OH ' ' I' ' 13' ' ' TYR . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.71 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.62 88.31 2.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.249 171.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.75 168.85 8.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 155.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.406 ' OE2' ' NE ' ' J' ' 41' ' ' ARG . 1.9 mp0 -71.82 -47.16 55.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.18 35.61 26.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.623 1.569 . . . . 0.0 111.644 -172.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 33.8 p 42.86 48.97 5.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.439 1.496 . . . . 0.0 111.609 -164.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . 0.462 ' HA ' HG21 ' D' ' 153' ' ' VAL . 12.9 mttm -147.3 -165.08 2.16 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.485 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.99 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.78 174.07 49.92 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -118.27 122.33 42.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.873 HG12 HG23 ' J' ' 135' ' ' ILE . 1.2 pp -128.65 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.875 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -23.72 67.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . 0.402 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.493 ' HG2' ' CD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.71 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.423 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' I' ' 106' ' ' ALA . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.462 ' OH ' HG22 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.586 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' I' ' 140' ' ' ASN . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . 0.423 ' HE1' ' CE2' ' I' ' 92' ' ' TRP . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.449 ' O ' HG21 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.449 HG21 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.919 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . 0.425 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.449 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . 0.4 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.548 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.76 30.25 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' I' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' I' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 113.046 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.21 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.61 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.329 1.052 . . . . 0.0 108.636 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.78 -45.05 65.41 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . 0.564 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' I' ' 158' ' ' TYR . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . . . . . . . . . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.633 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.633 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.464 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.694 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.586 HD13 ' HG2' ' J' ' 12' ' ' LYS . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . 0.433 ' O ' ' CE1' ' J' ' 31' ' ' TYR . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . 0.457 ' HB3' ' OH ' ' J' ' 13' ' ' TYR . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . 0.417 ' HB ' ' OE1' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.406 ' NE ' ' OE2' ' I' ' 46' ' ' GLU . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.71 88.38 2.61 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.222 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.79 168.93 8.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.401 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 1.9 mp0 -71.86 -47.12 55.17 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.17 35.56 26.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 111.653 -172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.84 49.0 5.06 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.538 1.535 . . . . 0.0 111.553 -164.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . 0.481 ' HA ' HG21 ' E' ' 153' ' ' VAL . 12.9 mttm -147.28 -165.08 2.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.96 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.75 174.11 49.93 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -118.32 122.33 42.62 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.863 HG12 HG23 ' K' ' 135' ' ' ILE . 1.2 pp -128.67 -33.34 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.852 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -23.73 67.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' J' ' 129' ' ' SER . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . 0.408 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . 0.408 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.42 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' HZ3' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' J' ' 85' ' ' ASN . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.491 ' HG2' ' CD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.694 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.411 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' J' ' 106' ' ' ALA . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.455 ' OH ' HG22 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.591 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' J' ' 140' ' ' ASN . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . 0.411 ' HE1' ' CE2' ' J' ' 92' ' ' TRP . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.455 ' O ' HG21 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 129' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.455 HG21 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.873 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . 0.43 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.539 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' J' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.55 74.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' J' ' 155' ' ' LYS . . . 138.98 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 119.407 1.003 . . . . 0.0 113.038 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.22 80.63 0.36 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -111.56 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.298 1.039 . . . . 0.0 108.618 177.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.85 -44.99 65.29 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -158.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.444 ' O ' HG21 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . 0.555 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' J' ' 158' ' ' TYR . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . 0.444 HG21 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . . . . . . . . . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.643 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.709 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' K' ' 12' ' ' LYS . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . 0.425 ' O ' ' CE1' ' K' ' 31' ' ' TYR . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . 0.41 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . 0.464 ' HB3' ' OH ' ' K' ' 13' ' ' TYR . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . 0.401 ' NE ' ' OE2' ' J' ' 46' ' ' GLU . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.18 120.73 39.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -130.64 88.44 2.62 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.222 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.82 168.9 8.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 1.9 mp0 -71.83 -47.16 55.04 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.5 mt-30 57.1 35.64 26.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.635 1.574 . . . . 0.0 111.655 -172.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.86 48.98 5.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.507 1.523 . . . . 0.0 111.541 -164.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . 0.49 ' HA ' HG21 ' F' ' 153' ' ' VAL . 12.9 mttm -147.25 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.463 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' F' ' 154' ' ' SER . 6.1 m-80 -77.91 21.51 0.31 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.73 174.16 49.96 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -118.34 122.28 42.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.802 HG12 HG23 ' L' ' 135' ' ' ILE . 1.2 pp -128.62 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -23.75 67.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' K' ' 129' ' ' SER . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . 0.405 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.422 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' HZ3' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.503 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.709 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.424 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.491 HG13 ' HB1' ' K' ' 106' ' ' ALA . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.457 ' OH ' HG22 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.603 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.509 ' HB3' ' ND2' ' K' ' 140' ' ' ASN . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . 0.424 ' HE1' ' CE2' ' K' ' 92' ' ' TRP . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.441 ' O ' HG21 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.503 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . 0.417 ' OE1' ' HB ' ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 129' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' K' ' 61' ' ' ASP . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.863 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . 0.429 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.475 ' HZ3' ' HB3' ' L' ' 80' ' ' GLU . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' K' ' 104' ' ' TYR . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.54 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.72 30.19 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' K' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.53 74.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 175.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' K' ' 155' ' ' LYS . . . 138.97 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.394 0.997 . . . . 0.0 112.995 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.28 80.64 0.36 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -111.51 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.319 1.048 . . . . 0.0 108.648 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.86 -44.92 65.37 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.441 ' O ' HG21 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . 0.567 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' K' ' 158' ' ' TYR . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . 0.441 HG21 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . 0.446 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.646 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.646 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.466 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.716 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.577 HD13 ' HG2' ' L' ' 12' ' ' LYS . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . 0.426 ' O ' ' CE1' ' L' ' 31' ' ' TYR . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . 0.456 ' HB3' ' OH ' ' L' ' 13' ' ' TYR . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . 0.402 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' K' ' 46' ' ' GLU . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -130.76 88.41 2.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.212 171.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -107.76 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.19 54.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.5 mt-30 57.17 35.51 26.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.602 1.561 . . . . 0.0 111.716 -172.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.94 48.94 5.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.491 1.516 . . . . 0.0 111.569 -164.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . 0.469 ' HA ' HG21 ' A' ' 153' ' ' VAL . 12.9 mttm -147.27 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.475 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.96 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.7 174.13 49.9 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 122.33 42.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.876 HG12 HG23 ' G' ' 135' ' ' ILE . 1.2 pp -128.65 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.901 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -23.74 67.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.423 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . 0.404 ' HB2' ' HZ3' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.492 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.427 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.494 HG13 ' HB1' ' L' ' 106' ' ' ALA . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.466 ' OH ' HG22 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.608 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.501 ' HB3' ' ND2' ' L' ' 140' ' ' ASN . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . 0.427 ' HE1' ' CE2' ' L' ' 92' ' ' TRP . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.435 ' O ' HG21 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.492 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . 0.44 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.512 ' HA ' ' CD1' ' K' ' 53' ' ' ILE . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.802 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . 0.452 ' O ' ' CE ' ' F' ' 155' ' ' LYS . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.692 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.763 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . 0.74 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.544 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.544 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.03 134.76 30.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' L' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.58 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . 0.424 ' O ' ' HD2' ' L' ' 155' ' ' LYS . . . 139.0 137.09 3.48 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.334 0.97 . . . . 0.0 112.994 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.304 1.042 . . . . 0.0 108.66 177.648 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.82 -45.02 65.31 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.437 ' O ' HG21 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . 0.565 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' L' ' 158' ' ' TYR . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . 0.437 HG21 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.526 HG21 ' HB3' ' A' ' 10' ' ' ASP . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.526 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.554 HG21 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.543 ' HG ' ' HB1' ' A' ' 20' ' ' ALA . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.769 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 17' ' ' SER . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.586 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.586 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' O ' HG11 ' B' ' 122' ' ' VAL . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.449 HG22 ' HG1' ' A' ' 66' ' ' THR . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.559 HD21 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.0 34.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.229 171.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.82 110.03 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 2.9 tt0 -67.43 -35.2 78.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.33 20.23 5.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.576 1.55 . . . . 0.0 111.657 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 5.8 m 42.35 55.38 4.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.468 1.507 . . . . 0.0 111.599 -164.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.74 -133.47 0.33 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.5 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.56 15.96 27.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.74 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG13 HG22 ' B' ' 135' ' ' ILE . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.878 178.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.559 ' HA3' HD21 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.449 ' HG1' HG22 ' A' ' 33' ' ' THR . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.539 ' HH ' HG13 ' A' ' 79' ' ' ILE . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.636 ' HA3' HD13 ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.572 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.539 HG13 ' HH ' ' A' ' 67' ' ' TYR . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.572 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.692 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.751 ' HD2' HD11 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.751 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.769 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.434 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.51 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.418 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.616 ' HB2' HD22 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.443 HG11 ' O ' ' F' ' 32' ' ' GLN . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.636 HD13 ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.401 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.428 ' N ' HG12 ' A' ' 134' ' ' VAL . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.494 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.459 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.566 ' HG1' ' HG3' ' A' ' 147' ' ' PRO . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.566 ' HG3' ' HG1' ' A' ' 145' ' ' THR . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.54 162.79 15.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.06 57.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.26 3.73 61.45 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 119.367 0.985 . . . . 0.0 113.044 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.25 136.39 28.39 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.33 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.323 1.049 . . . . 0.0 108.618 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.68 77.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.511 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.511 HE22 ' HD2' ' A' ' 163' ' ' PRO . 5.8 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.663 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.471 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.663 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' B' ' 10' ' ' ASP . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.53 ' HB3' HG21 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.553 HG21 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' B' ' 25' ' ' ALA . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.546 ' HG ' ' HB1' ' B' ' 20' ' ' ALA . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.758 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' B' ' 17' ' ' SER . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.585 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.441 ' O ' HG11 ' C' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.458 HG22 ' HG1' ' B' ' 66' ' ' THR . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.463 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -69.4 136.47 51.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.54 135.98 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.243 171.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.86 110.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 155.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 2.9 tt0 -67.51 -35.16 78.57 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.28 20.29 5.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.586 1.554 . . . . 0.0 111.637 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.449 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 5.8 m 42.26 55.42 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.511 1.525 . . . . 0.0 111.589 -164.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.464 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.32 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.72 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.482 HG13 HG22 ' C' ' 135' ' ' ILE . 0.7 OUTLIER -123.57 1.65 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.873 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -104.55 36.3 2.46 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.458 ' HG1' HG22 ' B' ' 33' ' ' THR . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.533 ' HH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.633 ' HA3' HD13 ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . 0.411 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . 0.579 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.533 HG13 ' HH ' ' B' ' 67' ' ' TYR . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.579 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.686 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.757 ' HD2' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.757 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' B' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.553 ' OD1' HG21 ' B' ' 11' ' ' VAL . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.451 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.423 ' OH ' HG23 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . 0.424 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.74 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.403 HG11 ' O ' ' A' ' 32' ' ' GLN . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . 0.401 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.633 HD13 ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . 0.411 ' O ' HG13 ' B' ' 130' ' ' ILE . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.429 ' N ' HG12 ' B' ' 134' ' ' VAL . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.502 ' HB3' HE21 ' B' ' 107' ' ' GLN . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' B' ' 103' ' ' LYS . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.451 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' THR . . . . . 0.571 ' HG1' ' HG3' ' B' ' 147' ' ' PRO . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.571 ' HG3' ' HG1' ' B' ' 145' ' ' THR . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.79 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.52 -5.07 57.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 3.77 61.48 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.395 0.998 . . . . 0.0 113.103 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.3 136.4 28.32 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.26 145.4 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.286 1.034 . . . . 0.0 108.603 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.83 -46.72 77.51 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' B' ' 163' ' ' PRO . 5.8 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.652 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . 0.486 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.652 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' C' ' 10' ' ' ASP . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.543 ' HB3' HG21 ' C' ' 6' ' ' ILE . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . 0.545 HG21 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' C' ' 25' ' ' ALA . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' SER . . . . . 0.545 ' HG ' ' HB1' ' C' ' 20' ' ' ALA . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' C' ' 17' ' ' SER . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . 0.583 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.583 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . 0.543 ' O ' HG11 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' C' ' 66' ' ' THR . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.561 HD21 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.48 51.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.97 34.96 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.263 171.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.84 110.06 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.14 78.58 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 20.31 5.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.601 1.56 . . . . 0.0 111.666 -172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.448 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 5.9 m 42.31 55.38 4.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.487 1.515 . . . . 0.0 111.537 -164.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.69 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.48 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.09 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.37 1.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.73 25.24 12.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.58 1.81 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.919 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.696 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -104.67 36.37 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . 0.561 ' HA3' HD21 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' C' ' 33' ' ' THR . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.53 ' HH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . 0.409 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . 0.573 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.53 HG13 ' HH ' ' C' ' 67' ' ' TYR . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.573 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.677 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.558 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.752 ' HD2' HD11 ' C' ' 89' ' ' ILE . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.48 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.752 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.545 ' OD1' HG21 ' C' ' 11' ' ' VAL . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.415 ' OH ' HG23 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . 0.524 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.427 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.697 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.463 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . 0.441 HG11 ' O ' ' B' ' 32' ' ' GLN . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.627 HD13 ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . 0.417 ' O ' HG13 ' C' ' 130' ' ' ILE . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' B' ' 54' ' ' LEU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.482 HG22 HG13 ' B' ' 53' ' ' ILE . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . 0.506 ' HB3' HE21 ' C' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' C' ' 103' ' ' LYS . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' THR . . . . . 0.569 ' HG1' ' HG3' ' C' ' 147' ' ' PRO . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.569 ' HG3' ' HG1' ' C' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.46 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.49 162.75 15.77 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.05 57.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.27 3.75 61.41 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.389 0.995 . . . . 0.0 113.063 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.26 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.16 145.4 47.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.327 1.051 . . . . 0.0 108.633 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.63 77.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . 0.516 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' C' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' THR . . . . . 0.649 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . 0.449 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.649 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . 0.525 HG21 ' HB3' ' D' ' 10' ' ' ASP . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.525 ' HB3' HG21 ' D' ' 6' ' ' ILE . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . 0.55 HG21 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' D' ' 25' ' ' ALA . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' SER . . . . . 0.54 ' HG ' ' HB1' ' D' ' 20' ' ' ALA . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.768 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.54 ' HB1' ' HG ' ' D' ' 17' ' ' SER . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . 0.59 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.59 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . 0.454 ' O ' HG11 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' THR . . . . . 0.464 HG22 ' HG1' ' D' ' 66' ' ' THR . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -69.5 136.55 51.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.59 136.0 34.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.232 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.81 110.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 155.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 2.9 tt0 -67.53 -35.09 78.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.22 20.26 5.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.602 1.561 . . . . 0.0 111.7 -172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 5.8 m 42.35 55.37 4.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.48 1.512 . . . . 0.0 111.592 -164.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.72 -133.44 0.33 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.56 15.95 27.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.81 81.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.84 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.403 HG13 HG22 ' E' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.66 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.854 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.734 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -104.56 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' THR . . . . . 0.464 ' HG1' HG22 ' D' ' 33' ' ' THR . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.528 ' HH ' HG13 ' D' ' 79' ' ' ILE . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . 0.57 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.528 HG13 ' HH ' ' D' ' 67' ' ' TYR . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.571 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.678 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.742 ' HD2' HD11 ' D' ' 89' ' ' ILE . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.768 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . 0.524 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.55 ' OD1' HG21 ' D' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.432 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . 0.433 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.696 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . 0.406 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . 0.543 HG11 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.525 ' HA ' HD21 ' C' ' 54' ' ' LEU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.433 HG21 ' HB2' ' C' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . 0.491 ' HB3' HE21 ' D' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.469 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' THR . . . . . 0.56 ' HG1' ' HG3' ' D' ' 147' ' ' PRO . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.56 ' HG3' ' HG1' ' D' ' 145' ' ' THR . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.57 162.72 15.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.425 ' CD ' ' OE2' ' I' ' 46' ' ' GLU . 4.7 mmtt -81.48 -5.04 57.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.23 3.79 61.46 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.357 0.98 . . . . 0.0 113.052 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.35 136.39 28.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.25 145.29 47.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.352 1.061 . . . . 0.0 108.642 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.75 -46.71 77.82 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -158.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' D' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 167' ' ' THR . . . . . 0.661 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . 0.478 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . 0.509 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 173' ' ' THR . . . . . 0.661 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . 0.4 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' E' ' 10' ' ' ASP . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.538 ' HB3' HG21 ' E' ' 6' ' ' ILE . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . 0.564 HG21 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' E' ' 25' ' ' ALA . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' SER . . . . . 0.536 ' HG ' ' HB1' ' E' ' 20' ' ' ALA . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.771 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.536 ' HB1' ' HG ' ' E' ' 17' ' ' SER . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . 0.594 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' THR . . . . . 0.464 HG22 ' HG1' ' E' ' 66' ' ' THR . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' SER . . . . . 0.52 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.572 HD21 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.57 135.98 34.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.245 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.85 110.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.18 78.65 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.21 20.28 5.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.588 1.555 . . . . 0.0 111.701 -172.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.449 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 5.8 m 42.26 55.47 3.96 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.539 1.536 . . . . 0.0 111.578 -164.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.75 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.463 -177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.55 15.91 27.4 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.78 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.6 1.8 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.873 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.581 HD22 ' HB2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -104.55 36.22 2.48 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . 0.572 ' HA3' HD21 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' THR . . . . . 0.464 ' HG1' HG22 ' E' ' 33' ' ' THR . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.536 ' HH ' HG13 ' E' ' 79' ' ' ILE . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . 0.625 ' HA3' HD13 ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . 0.406 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.419 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . 0.576 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . 0.536 HG13 ' HH ' ' E' ' 67' ' ' TYR . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . 0.576 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.669 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.564 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' E' ' 89' ' ' ILE . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.487 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . 0.524 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.564 ' OD1' HG21 ' E' ' 11' ' ' VAL . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . 0.524 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . 0.423 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.734 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . 0.41 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . 0.454 HG11 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . 0.625 HD13 ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.402 ' O ' HG13 ' E' ' 130' ' ' ILE . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . 0.41 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.427 ' N ' HG12 ' E' ' 134' ' ' VAL . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.504 ' HB3' HE21 ' E' ' 107' ' ' GLN . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . 0.483 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.467 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 145' ' ' THR . . . . . 0.554 ' HG1' ' HG3' ' E' ' 147' ' ' PRO . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.554 ' HG3' ' HG1' ' E' ' 145' ' ' THR . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.59 162.77 15.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.428 ' CD ' ' OE2' ' J' ' 46' ' ' GLU . 4.7 mmtt -81.49 -5.1 57.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.74 61.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.339 0.972 . . . . 0.0 113.048 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.34 28.36 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.36 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.333 1.053 . . . . 0.0 108.614 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.64 77.83 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -158.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . 0.516 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' E' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 167' ' ' THR . . . . . 0.672 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . 0.458 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 173' ' ' THR . . . . . 0.672 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' F' ' 10' ' ' ASP . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.52 ' HB3' HG21 ' F' ' 6' ' ' ILE . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' F' ' 25' ' ' ALA . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' SER . . . . . 0.537 ' HG ' ' HB1' ' F' ' 20' ' ' ALA . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.767 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.537 ' HB1' ' HG ' ' F' ' 17' ' ' SER . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . 0.591 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . 0.443 ' O ' HG11 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 33' ' ' THR . . . . . 0.461 HG22 ' HG1' ' F' ' 66' ' ' THR . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 38' ' ' SER . . . . . 0.41 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.56 51.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.65 135.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.24 171.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.88 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.19 78.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.62 1.568 . . . . 0.0 111.666 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.446 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 5.9 m 42.33 55.43 4.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 111.56 -164.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.75 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.457 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.51 15.93 27.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.78 25.32 11.93 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.885 178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -104.64 36.29 2.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 66' ' ' THR . . . . . 0.461 ' HG1' HG22 ' F' ' 33' ' ' THR . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . 0.528 ' HH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . 0.631 ' HA3' HD13 ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . 0.4 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . 0.582 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.528 HG13 ' HH ' ' F' ' 67' ' ' TYR . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . 0.582 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.684 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . 0.52 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' F' ' 89' ' ' ILE . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.48 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . 0.519 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . 0.555 ' OD1' HG21 ' F' ' 11' ' ' VAL . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.418 ' OH ' HG23 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . 0.519 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . 0.431 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.581 ' HB2' HD22 ' E' ' 54' ' ' LEU . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . 0.409 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . 0.631 HD13 ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' F' ' 130' ' ' ILE . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . 0.409 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.536 ' HA ' HD21 ' E' ' 54' ' ' LEU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' E' ' 54' ' ' LEU . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.498 ' HB3' HE21 ' F' ' 107' ' ' GLN . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.453 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 145' ' ' THR . . . . . 0.558 ' HG1' ' HG3' ' F' ' 147' ' ' PRO . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.558 ' HG3' ' HG1' ' F' ' 145' ' ' THR . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.56 162.75 15.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.54 -5.06 57.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.77 61.39 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.438 1.017 . . . . 0.0 113.047 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . 0.49 ' C ' HD11 ' L' ' 138' ' ' LEU . . . -69.3 136.39 28.3 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.2 145.36 47.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.342 1.057 . . . . 0.0 108.602 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.49 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 -65.86 -46.64 77.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -158.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . 0.487 ' CG ' HD11 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.595 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.731 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 8.0 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.511 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.511 HE22 ' HD2' ' F' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.672 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . 0.745 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.546 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . 0.528 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 173' ' ' THR . . . . . 0.672 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' G' ' 6' ' ' ILE . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . 0.561 HG21 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' G' ' 25' ' ' ALA . 4.2 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 17' ' ' SER . . . . . 0.538 ' HG ' ' HB1' ' G' ' 20' ' ' ALA . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.776 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . 0.538 ' HB1' ' HG ' ' G' ' 17' ' ' SER . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 24' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . 0.577 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . 0.577 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 33' ' ' THR . . . . . 0.462 HG22 ' HG1' ' G' ' 66' ' ' THR . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 38' ' ' SER . . . . . 0.586 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -69.46 136.53 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.99 34.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.244 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.8 110.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 155.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 2.9 tt0 -67.44 -35.17 78.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.23 20.31 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.617 1.567 . . . . 0.0 111.647 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 48' ' ' THR . . . . . 0.445 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 5.8 m 42.25 55.44 3.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.49 1.516 . . . . 0.0 111.609 -164.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.72 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.505 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.57 16.05 26.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.69 25.2 12.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.54 1.75 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.863 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.26 2.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 66' ' ' THR . . . . . 0.462 ' HG1' HG22 ' G' ' 33' ' ' THR . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . 0.526 ' HH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . 0.634 ' HA3' HD13 ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . 0.407 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . 0.423 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . 0.569 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . 0.526 HG13 ' HH ' ' G' ' 67' ' ' TYR . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . 0.569 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.693 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . 0.549 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.557 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' G' ' 89' ' ' ILE . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.485 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.776 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . 0.561 ' OD1' HG21 ' G' ' 11' ' ' VAL . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.415 ' OH ' HG23 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . 0.52 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.485 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . 0.634 HD13 ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . 0.459 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' L' ' 54' ' ' LEU . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . 0.504 ' HB3' HE21 ' G' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . 0.572 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.463 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 145' ' ' THR . . . . . 0.556 ' HG1' ' HG3' ' G' ' 147' ' ' PRO . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.556 ' HG3' ' HG1' ' G' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.74 15.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.45 -5.1 57.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.32 3.72 61.36 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.343 0.974 . . . . 0.0 113.019 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.27 136.36 28.32 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.22 145.35 47.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 108.62 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.83 -46.65 77.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -158.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . 0.509 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.509 HE22 ' HD2' ' G' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 167' ' ' THR . . . . . 0.67 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 173' ' ' THR . . . . . 0.67 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.411 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.52 HG21 ' HB3' ' H' ' 10' ' ' ASP . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.52 ' HB3' HG21 ' H' ' 6' ' ' ILE . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . 0.546 HG21 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.418 ' HB2' ' HB2' ' H' ' 25' ' ' ALA . 4.2 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 17' ' ' SER . . . . . 0.542 ' HG ' ' HB1' ' H' ' 20' ' ' ALA . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' H' ' 17' ' ' SER . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 24' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . 0.581 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 33' ' ' THR . . . . . 0.463 HG22 ' HG1' ' H' ' 66' ' ' THR . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . 0.551 HD21 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -69.54 136.55 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.6 135.95 34.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.85 110.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.15 78.57 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.24 20.34 5.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 111.627 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 48' ' ' THR . . . . . 0.446 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 5.9 m 42.28 55.46 3.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.519 1.527 . . . . 0.0 111.533 -164.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.78 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.489 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.51 15.9 27.39 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 81.44 1.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.75 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.58 1.75 5.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.902 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -104.58 36.27 2.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . 0.551 ' HA3' HD21 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 66' ' ' THR . . . . . 0.463 ' HG1' HG22 ' H' ' 33' ' ' THR . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . 0.53 ' HH ' HG13 ' H' ' 79' ' ' ILE . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.636 ' HA3' HD13 ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . 0.416 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . 0.412 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . 0.568 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.53 HG13 ' HH ' ' H' ' 67' ' ' TYR . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . 0.568 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.696 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . 0.586 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.572 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 3.5 mt-30 -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.736 ' HD2' HD11 ' H' ' 89' ' ' ILE . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . 0.736 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . 0.546 ' OD1' HG21 ' H' ' 11' ' ' VAL . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.42 ' OH ' HG23 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . 0.522 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . 0.486 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.502 ' HB2' HD22 ' G' ' 54' ' ' LEU . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . 0.529 HG23 ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . 0.636 HD13 ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . 0.405 ' O ' HG13 ' H' ' 130' ' ' ILE . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.472 HG21 ' HB2' ' G' ' 54' ' ' LEU . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . 0.499 ' HB3' HE21 ' H' ' 107' ' ' GLN . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.581 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' H' ' 103' ' ' LYS . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 145' ' ' THR . . . . . 0.549 ' HG1' ' HG3' ' H' ' 147' ' ' PRO . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.549 ' HG3' ' HG1' ' H' ' 145' ' ' THR . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.81 15.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.53 -5.07 57.63 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.78 61.39 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.405 1.002 . . . . 0.0 113.034 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.34 136.35 28.2 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.35 47.67 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.352 1.061 . . . . 0.0 108.66 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.6 77.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -158.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . 0.521 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.521 HE22 ' HD2' ' H' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 166' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 167' ' ' THR . . . . . 0.657 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 173' ' ' THR . . . . . 0.657 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . 0.535 HG21 ' HB3' ' I' ' 10' ' ' ASP . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' I' ' 6' ' ' ILE . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . 0.545 HG21 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' I' ' 25' ' ' ALA . 4.3 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 17' ' ' SER . . . . . 0.549 ' HG ' ' HB1' ' I' ' 20' ' ' ALA . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.755 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' I' ' 17' ' ' SER . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . 0.581 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . 0.581 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 33' ' ' THR . . . . . 0.463 HG22 ' HG1' ' I' ' 66' ' ' THR . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 38' ' ' SER . . . . . 0.544 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . 0.563 HD21 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.53 51.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.6 136.05 34.91 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.219 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.78 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 155.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 2.9 tt0 -67.46 -35.12 78.58 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.18 20.35 5.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.583 . . . . 0.0 111.678 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 48' ' ' THR . . . . . 0.446 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 5.8 m 42.29 55.46 3.99 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.474 1.509 . . . . 0.0 111.573 -164.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.77 -133.52 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.47 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.52 15.95 27.23 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.69 25.29 11.96 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.53 1.62 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.49 36.23 2.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . 0.563 ' HA3' HD21 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 66' ' ' THR . . . . . 0.463 ' HG1' HG22 ' I' ' 33' ' ' THR . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . 0.526 ' HH ' HG13 ' I' ' 79' ' ' ILE . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . 0.415 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . 0.577 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.526 HG13 ' HH ' ' I' ' 67' ' ' TYR . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . 0.577 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.688 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.581 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HD2' HD11 ' I' ' 89' ' ' ILE . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.492 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . 0.747 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.755 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' I' ' 93' ' ' ARG . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . 0.545 ' OD1' HG21 ' I' ' 11' ' ' VAL . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.419 ' OH ' HG23 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.428 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . 0.517 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . 0.449 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . 0.515 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . 0.628 HD13 ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . 0.414 ' O ' HG13 ' I' ' 130' ' ' ILE . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . 0.465 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.461 HG21 ' HB2' ' H' ' 54' ' ' LEU . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . 0.496 ' HB3' HE21 ' I' ' 107' ' ' GLN . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . 0.513 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.457 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 145' ' ' THR . . . . . 0.554 ' HG1' ' HG3' ' I' ' 147' ' ' PRO . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.554 ' HG3' ' HG1' ' I' ' 145' ' ' THR . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.78 15.76 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.01 57.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.3 3.66 61.42 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 119.388 0.994 . . . . 0.0 113.054 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.38 28.44 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.23 145.35 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.297 1.039 . . . . 0.0 108.57 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.85 -46.61 77.86 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . 0.518 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.518 HE22 ' HD2' ' I' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 166' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 167' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 173' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.542 HG21 ' HB3' ' J' ' 10' ' ' ASP . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HB3' HG21 ' J' ' 6' ' ' ILE . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . 0.555 HG21 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' J' ' 25' ' ' ALA . 4.2 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 17' ' ' SER . . . . . 0.548 ' HG ' ' HB1' ' J' ' 20' ' ' ALA . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.77 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' J' ' 17' ' ' SER . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 24' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . 0.59 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . 0.59 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 33' ' ' THR . . . . . 0.46 HG22 ' HG1' ' J' ' 66' ' ' THR . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . 0.57 HD21 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.01 34.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.267 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.83 110.07 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 2.9 tt0 -67.49 -35.14 78.57 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.564 1.546 . . . . 0.0 111.667 -172.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 48' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 5.8 m 42.31 55.41 4.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.477 1.511 . . . . 0.0 111.569 -164.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.78 -133.43 0.33 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.503 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.59 15.98 27.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.7 25.21 12.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.51 1.7 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.901 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . 0.5 HD22 ' HB2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -104.61 36.33 2.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 176.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . 0.57 ' HA3' HD21 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 66' ' ' THR . . . . . 0.46 ' HG1' HG22 ' J' ' 33' ' ' THR . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . 0.523 ' HH ' HG13 ' J' ' 79' ' ' ILE . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . 0.623 ' HA3' HD13 ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . 0.405 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . 0.419 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . 0.585 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . 0.523 HG13 ' HH ' ' J' ' 67' ' ' TYR . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . 0.585 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.68 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . 0.544 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.565 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' J' ' 89' ' ' ILE . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.485 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.77 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . 0.521 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . 0.555 ' OD1' HG21 ' J' ' 11' ' ' VAL . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.437 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . 0.521 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.5 ' HB2' HD22 ' I' ' 54' ' ' LEU . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . 0.407 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . 0.623 HD13 ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . 0.401 ' O ' HG13 ' J' ' 130' ' ' ILE . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . 0.407 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' I' ' 54' ' ' LEU . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . 0.5 ' HB3' HE21 ' J' ' 107' ' ' GLN . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . 0.509 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' J' ' 103' ' ' LYS . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.459 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 145' ' ' THR . . . . . 0.545 ' HG1' ' HG3' ' J' ' 147' ' ' PRO . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.545 ' HG3' ' HG1' ' J' ' 145' ' ' THR . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.57 162.79 15.77 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.08 57.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.24 3.74 61.47 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.365 0.984 . . . . 0.0 113.045 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.3 28.34 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.18 145.35 47.64 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 108.67 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.65 77.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . 0.519 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.519 HE22 ' HD2' ' J' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 166' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 167' ' ' THR . . . . . 0.643 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 173' ' ' THR . . . . . 0.643 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.523 HG21 ' HB3' ' K' ' 10' ' ' ASP . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.523 ' HB3' HG21 ' K' ' 6' ' ' ILE . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.554 HG21 ' OD1' ' K' ' 95' ' ' ASP . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' K' ' 25' ' ' ALA . 4.2 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 17' ' ' SER . . . . . 0.544 ' HG ' ' HB1' ' K' ' 20' ' ' ALA . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.776 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . 0.544 ' HB1' ' HG ' ' K' ' 17' ' ' SER . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 24' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . 0.591 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . 0.591 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 33' ' ' THR . . . . . 0.461 HG22 ' HG1' ' K' ' 66' ' ' THR . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 38' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' L' ' 116' ' ' ARG . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.55 136.0 34.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.245 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.82 110.15 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 155.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.452 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 2.9 tt0 -67.52 -35.14 78.53 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.24 20.26 5.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.618 1.567 . . . . 0.0 111.629 -172.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 48' ' ' THR . . . . . 0.452 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 5.9 m 42.31 55.47 4.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.519 1.527 . . . . 0.0 111.534 -164.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.522 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.57 15.91 27.4 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -109.74 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.64 1.76 5.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.858 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . 0.542 ' HB2' HG21 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.62 36.29 2.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 66' ' ' THR . . . . . 0.461 ' HG1' HG22 ' K' ' 33' ' ' THR . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . 0.516 ' HH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . 0.621 ' HA3' HD13 ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . 0.41 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . 0.586 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . 0.516 HG13 ' HH ' ' K' ' 67' ' ' TYR . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . 0.586 ' HG3' ' OE1' ' K' ' 76' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.675 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.569 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.722 ' HD2' HD11 ' K' ' 89' ' ' ILE . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.483 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . 0.722 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.776 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . 0.554 ' OD1' HG21 ' K' ' 11' ' ' VAL . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.424 ' OH ' HG23 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . 0.525 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . 0.458 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.5 ' HB2' HD22 ' J' ' 54' ' ' LEU . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . 0.412 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . 0.488 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . 0.621 HD13 ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . 0.405 ' O ' HG13 ' K' ' 130' ' ' ILE . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . 0.412 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . 0.456 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' J' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . 0.503 ' HB3' HE21 ' K' ' 107' ' ' GLN . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.437 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.457 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 145' ' ' THR . . . . . 0.555 ' HG1' ' HG3' ' K' ' 147' ' ' PRO . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.555 ' HG3' ' HG1' ' K' ' 145' ' ' THR . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.58 162.73 15.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.51 -5.1 57.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.75 61.37 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.393 0.997 . . . . 0.0 113.04 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.17 145.39 47.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.613 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.87 -46.64 77.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . 0.52 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.52 HE22 ' HD2' ' K' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 166' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 167' ' ' THR . . . . . 0.654 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 173' ' ' THR . . . . . 0.654 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.528 HG21 ' HB3' ' L' ' 10' ' ' ASP . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.528 ' HB3' HG21 ' L' ' 6' ' ' ILE . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . 0.561 HG21 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' L' ' 25' ' ' ALA . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 17' ' ' SER . . . . . 0.538 ' HG ' ' HB1' ' L' ' 20' ' ' ALA . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.745 HG21 ' O ' ' F' ' 168' ' ' GLY . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . 0.538 ' HB1' ' HG ' ' L' ' 17' ' ' SER . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 22' ' ' THR . . . . . 0.595 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' L' ' 24' ' ' SER . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 24' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.405 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . 0.585 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . 0.585 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 33' ' ' THR . . . . . 0.454 HG22 ' HG1' ' L' ' 66' ' ' THR . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 38' ' ' SER . . . . . 0.549 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . 0.558 HD21 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -69.52 136.47 51.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.49 135.99 34.99 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.25 171.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.8 110.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 155.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 2.9 tt0 -67.54 -35.11 78.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.21 20.38 5.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.642 1.577 . . . . 0.0 111.615 -172.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 48' ' ' THR . . . . . 0.453 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 5.8 m 42.31 55.39 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.583 -164.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -107.76 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.428 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.54 16.03 27.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.31 1.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -109.7 25.32 11.93 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.57 1.69 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.831 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . 0.499 ' HB2' HG21 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.55 36.27 2.46 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . 0.558 ' HA3' HD21 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 66' ' ' THR . . . . . 0.454 ' HG1' HG22 ' L' ' 33' ' ' THR . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . 0.54 ' HH ' HG13 ' L' ' 79' ' ' ILE . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . 0.421 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . 0.576 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.54 HG13 ' HH ' ' L' ' 67' ' ' TYR . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.576 ' HG3' ' OE1' ' L' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.683 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . 0.439 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.74 ' HD2' HD11 ' L' ' 89' ' ' ILE . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.546 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . 0.74 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.742 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' L' ' 93' ' ' ARG . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . . . . . . . . . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . 0.561 ' OD1' HG21 ' L' ' 11' ' ' VAL . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . 0.438 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.417 ' OH ' HG23 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.438 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . 0.514 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.488 ' HB2' HD22 ' K' ' 54' ' ' LEU . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . 0.41 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . 0.455 ' O ' ' OG ' ' K' ' 38' ' ' SER . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . 0.627 HD13 ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . 0.412 ' O ' HG13 ' L' ' 130' ' ' ILE . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . 0.41 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.488 ' HA ' HD21 ' K' ' 54' ' ' LEU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.542 HG21 ' HB2' ' K' ' 54' ' ' LEU . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . 0.5 ' HB3' HE21 ' L' ' 107' ' ' GLN . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.49 HD11 ' C ' ' F' ' 157' ' ' GLY . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . 0.556 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.49 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.731 ' OE2' ' OE1' ' F' ' 162' ' ' GLN . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' F' ' 160' ' ' PHE . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 145' ' ' THR . . . . . 0.546 ' HG1' ' HG3' ' L' ' 147' ' ' PRO . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.546 ' HG3' ' HG1' ' L' ' 145' ' ' THR . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.52 162.75 15.79 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.12 57.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.79 61.34 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 119.393 0.997 . . . . 0.0 113.038 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.33 136.35 28.22 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.38 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.325 1.05 . . . . 0.0 108.652 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.88 -46.59 77.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . 0.51 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.51 HE22 ' HD2' ' L' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 167' ' ' THR . . . . . 0.668 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 173' ' ' THR . . . . . 0.668 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 7' ' ' MET . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.851 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.851 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.449 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.69 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 ' HG2' ' A' ' 12' ' ' LYS . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 HH22 ' HB1' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.5 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.77 3.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.228 171.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 2.7 mp0 -71.25 -48.08 53.24 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.83 38.58 27.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.574 1.55 . . . . 0.0 111.658 -172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.25 3.29 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 111.542 -164.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.88 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.446 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.89 16.79 1.08 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.5 ' HA3' ' CE2' ' A' ' 44' ' ' PHE . . . 87.03 167.51 43.83 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.19 122.32 47.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.572 HG12 HG23 ' B' ' 135' ' ' ILE . 1.5 pp -127.16 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.923 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.663 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp -61.74 -16.91 53.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.679 ' HB3' ' HH ' ' B' ' 112' ' ' TYR . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB1' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.591 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.469 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.69 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.535 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.598 HG13 ' HB1' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.661 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.652 ' HB3' HD12 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.506 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.591 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.438 ' CB ' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.691 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.476 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.652 HD12 ' HB3' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.441 ' HZ3' ' HB3' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.661 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 104' ' ' TYR . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.44 ' H ' ' CD1' ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.448 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.73 137.76 31.88 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.36 -41.25 79.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' A' ' 158' ' ' TYR . . . 137.06 141.21 4.21 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.393 0.997 . . . . 0.0 113.062 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.26 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -108.81 89.32 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.353 1.061 . . . . 0.0 108.634 177.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.65 67.2 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -158.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' A' ' 174' ' ' VAL . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.561 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' B' ' 7' ' ' MET . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' MET . . . . . 0.856 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.596 ' HG2' HD13 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PHE . . . . . 0.444 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' B' ' 12' ' ' LYS . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' G' ' 47' ' ' GLN . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ARG . . . . . 0.436 HH22 ' HB1' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.686 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 121.6 42.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' B' ' 51' ' ' GLY . 0.3 OUTLIER -128.48 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.235 171.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.436 ' O ' ' HA2' ' B' ' 51' ' ' GLY . 3.2 t70 -111.78 170.22 8.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 155.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.7 mp0 -71.27 -48.16 52.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.91 38.6 27.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.618 1.567 . . . . 0.0 111.633 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.92 45.26 3.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -164.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.73 1.69 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.86 16.72 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' B' ' 44' ' ' PHE . . . 87.1 167.56 43.85 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.22 122.36 47.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.546 HG12 HG23 ' C' ' 135' ' ' ILE . 1.5 pp -127.22 -39.14 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.839 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.702 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp -61.83 -16.91 53.96 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' PRO . . . . . 0.771 ' HB3' ' HH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.429 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.436 ' HB1' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.595 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLN . . . . . 0.663 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' PHE . . . . . 0.444 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TRP . . . . . 0.537 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.599 HG13 ' HB1' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ALA . . . . . 0.599 ' HB1' HG13 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PHE . . . . . 0.649 ' HB3' HD12 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' TYR . . . . . 0.679 ' HH ' ' HB3' ' A' ' 56' ' ' PRO . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.501 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.595 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.572 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.473 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' LYS . . . . . 0.465 ' HZ3' ' HB3' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' B' ' 104' ' ' TYR . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.77 137.73 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.31 79.59 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' B' ' 158' ' ' TYR . . . 137.04 141.32 4.23 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.434 1.015 . . . . 0.0 113.043 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.468 ' CE2' ' HA3' ' B' ' 156' ' ' GLY . 0.0 OUTLIER -108.88 89.3 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.304 1.042 . . . . 0.0 108.587 177.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.65 67.1 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' B' ' 174' ' ' VAL . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' THR . . . . . 0.545 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' C' ' 7' ' ' MET . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' MET . . . . . 0.861 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ASP . . . . . 0.861 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' LYS . . . . . 0.603 ' HG2' HD13 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' LEU . . . . . 0.548 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' PHE . . . . . 0.438 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . 0.603 HD13 ' HG2' ' C' ' 12' ' ' LYS . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' H' ' 47' ' ' GLN . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' ARG . . . . . 0.43 HH22 ' HB1' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' GLU . . . . . 0.632 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' C' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.255 171.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' C' ' 51' ' ' GLY . 3.2 t70 -111.82 170.16 8.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 155.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' GLU . . . . . 0.564 ' OE2' ' NE ' ' D' ' 41' ' ' ARG . 2.7 mp0 -71.15 -48.12 53.76 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.561 1.544 . . . . 0.0 111.649 -172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.92 45.33 3.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.541 1.537 . . . . 0.0 111.521 -164.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.89 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.496 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.93 16.79 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' C' ' 44' ' ' PHE . . . 87.1 167.5 43.8 Favored Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -112.2 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . 0.527 HG12 HG23 ' D' ' 135' ' ' ILE . 1.5 pp -127.21 -39.18 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' LEU . . . . . 0.638 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp -61.75 -16.93 53.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' PRO . . . . . 0.634 ' HB3' ' HH ' ' D' ' 112' ' ' TYR . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.539 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ALA . . . . . 0.43 ' HB1' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' THR . . . . . 0.607 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' TYR . . . . . 0.512 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' C' ' 82' ' ' ALA . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.465 ' HB3' ' HZ3' ' B' ' 139' ' ' LYS . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLN . . . . . 0.702 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' PHE . . . . . 0.438 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.599 HG13 ' HB1' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ALA . . . . . 0.599 ' HB1' HG13 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PHE . . . . . 0.638 ' HB3' HD12 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' PHE . . . . . 0.412 ' O ' HD13 ' B' ' 53' ' ' ILE . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' TYR . . . . . 0.771 ' HH ' ' HB3' ' B' ' 56' ' ' PRO . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' GLU . . . . . 0.686 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.44 ' HB2' ' CB ' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' ILE . . . . . 0.512 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' SER . . . . . 0.607 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' SER . . . . . 0.44 ' CB ' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' B' ' 53' ' ' ILE . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ILE . . . . . 0.546 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' GLY . . . . . 0.474 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' LEU . . . . . 0.638 HD12 ' HB3' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' C' ' 104' ' ' TYR . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.72 137.72 31.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.35 79.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' C' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.353 0.979 . . . . 0.0 113.059 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.23 0.48 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.468 ' CE2' ' HA3' ' C' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.303 1.041 . . . . 0.0 108.641 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.27 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' GLN . . . . . 0.436 ' O ' HG21 ' C' ' 174' ' ' VAL . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' THR . . . . . 0.513 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' THR . . . . . . . . . . . . . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . 0.436 HG21 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' D' ' 7' ' ' MET . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' MET . . . . . 0.872 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' ASP . . . . . 0.872 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' LYS . . . . . 0.602 ' HG2' HD13 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' PHE . . . . . 0.443 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . 0.602 HD13 ' HG2' ' D' ' 12' ' ' LYS . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' I' ' 47' ' ' GLN . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' SER . . . . . 0.455 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' ARG . . . . . 0.564 ' NE ' ' OE2' ' C' ' 46' ' ' GLU . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' GLU . . . . . 0.604 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' PHE . . . . . 0.497 ' CE2' ' HA3' ' D' ' 51' ' ' GLY . 0.3 OUTLIER -128.46 90.83 3.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.205 171.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.441 ' O ' ' HA2' ' D' ' 51' ' ' GLY . 3.2 t70 -111.82 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.21 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.622 1.569 . . . . 0.0 111.673 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.26 3.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.466 1.506 . . . . 0.0 111.577 -164.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.75 1.69 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.483 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.92 16.83 1.07 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' GLY . . . . . 0.497 ' HA3' ' CE2' ' D' ' 44' ' ' PHE . . . 87.06 167.56 43.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.23 122.35 47.47 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . 0.617 HG12 HG23 ' E' ' 135' ' ' ILE . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' LEU . . . . . 0.633 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp -61.8 -16.87 53.44 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' PRO . . . . . 0.643 ' HB3' ' HH ' ' E' ' 112' ' ' TYR . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' SER . . . . . 0.511 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ALA . . . . . 0.435 ' HB1' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' THR . . . . . 0.597 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' TYR . . . . . 0.52 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' D' ' 82' ' ' ALA . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLN . . . . . 0.638 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' LYS . . . . . 0.687 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' PHE . . . . . 0.443 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.609 HG13 ' HB1' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.636 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' ALA . . . . . 0.609 ' HB1' HG13 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PHE . . . . . 0.635 ' HB3' HD12 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' TYR . . . . . 0.634 ' HH ' ' HB3' ' C' ' 56' ' ' PRO . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' SER . . . . . 0.449 ' HB2' ' CB ' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' ILE . . . . . 0.52 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' SER . . . . . 0.597 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' SER . . . . . 0.449 ' CB ' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' C' ' 53' ' ' ILE . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ILE . . . . . 0.527 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' GLY . . . . . 0.477 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' LYS . . . . . 0.427 ' HZ3' ' HB3' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.636 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' D' ' 104' ' ' TYR . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . 0.438 ' H ' ' CD1' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' PRO . . . . . 0.451 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' SER . . . . . 0.43 ' HA ' HD21 ' I' ' 50' ' ' ASN . 1.0 OUTLIER -141.79 137.76 31.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.31 79.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 156' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' D' ' 158' ' ' TYR . . . 137.07 141.28 4.22 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.339 0.972 . . . . 0.0 113.09 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.465 ' CE2' ' HA3' ' D' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.308 1.043 . . . . 0.0 108.595 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.03 -46.67 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -158.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 163' ' ' PRO . . . . . 0.434 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 165' ' ' GLN . . . . . 0.445 ' O ' HG21 ' D' ' 174' ' ' VAL . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 166' ' ' THR . . . . . 0.452 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 174' ' ' VAL . . . . . 0.445 HG21 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' E' ' 7' ' ' MET . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' MET . . . . . 0.855 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ASP . . . . . 0.855 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' LYS . . . . . 0.58 ' HG2' HD13 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' PHE . . . . . 0.432 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . 0.58 HD13 ' HG2' ' E' ' 12' ' ' LYS . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' J' ' 47' ' ' GLN . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' ARG . . . . . 0.434 HH22 ' HB1' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' GLU . . . . . 0.583 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' PHE . . . . . 0.503 ' CE2' ' HA3' ' E' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 171.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' ASP . . . . . 0.44 ' O ' ' HA2' ' E' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' GLU . . . . . 0.647 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.7 mp0 -71.2 -48.14 53.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.88 38.55 27.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.623 1.569 . . . . 0.0 111.663 -172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 41.98 45.28 3.27 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.482 1.513 . . . . 0.0 111.534 -164.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.81 1.71 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.83 16.77 1.07 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' GLY . . . . . 0.503 ' HA3' ' CE2' ' E' ' 44' ' ' PHE . . . 87.05 167.55 43.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.22 122.37 47.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . 0.664 HG12 HG23 ' F' ' 135' ' ' ILE . 1.5 pp -127.21 -39.19 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' LEU . . . . . 0.506 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp -61.78 -16.87 53.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' PRO . . . . . 0.512 ' HB3' ' HH ' ' F' ' 112' ' ' TYR . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' ALA . . . . . 0.434 ' HB1' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' THR . . . . . 0.601 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' TYR . . . . . 0.521 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' E' ' 82' ' ' ALA . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . 0.427 ' HB3' ' HZ3' ' D' ' 139' ' ' LYS . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 82' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 84' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 87' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 88' ' ' GLN . . . . . 0.633 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 91' ' ' PHE . . . . . 0.432 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 94' ' ' VAL . . . . . 0.615 HG13 ' HB1' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 96' ' ' THR . . . . . 0.426 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 98' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.644 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 106' ' ' ALA . . . . . 0.615 ' HB1' HG13 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 108' ' ' PHE . . . . . 0.637 ' HB3' HD12 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 112' ' ' TYR . . . . . 0.643 ' HH ' ' HB3' ' D' ' 56' ' ' PRO . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 114' ' ' GLU . . . . . 0.604 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 115' ' ' SER . . . . . 0.446 ' HB2' ' CB ' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 118' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 127' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 128' ' ' ILE . . . . . 0.521 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 129' ' ' SER . . . . . 0.601 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 131' ' ' SER . . . . . 0.446 ' CB ' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 135' ' ' ILE . . . . . 0.617 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 136' ' ' GLY . . . . . 0.475 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 138' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 142' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' E' ' 104' ' ' TYR . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . 0.433 ' H ' ' CD1' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 147' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 151' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.74 31.83 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -41.32 79.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 156' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' E' ' 158' ' ' TYR . . . 137.06 141.31 4.23 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.392 0.996 . . . . 0.0 113.047 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.34 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.465 ' CE2' ' HA3' ' E' ' 156' ' ' GLY . 0.0 OUTLIER -108.91 89.29 2.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.288 1.035 . . . . 0.0 108.651 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.3 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -158.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 161' ' ' GLN . . . . . 0.422 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' E' ' 174' ' ' VAL . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 166' ' ' THR . . . . . 0.643 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' F' ' 7' ' ' MET . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' MET . . . . . 0.856 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' ASP . . . . . 0.856 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' VAL . . . . . 0.436 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' LYS . . . . . 0.596 ' HG2' HD13 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' ILE . . . . . 0.688 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' F' ' 12' ' ' LYS . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' ALA . . . . . 0.607 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 41' ' ' ARG . . . . . 0.569 ' NE ' ' OE2' ' E' ' 46' ' ' GLU . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.57 42.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 44' ' ' PHE . . . . . 0.498 ' CE2' ' HA3' ' F' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.231 171.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 45' ' ' ASP . . . . . 0.431 ' O ' ' HA2' ' F' ' 51' ' ' GLY . 3.2 t70 -111.78 170.18 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 155.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.19 -48.19 53.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 57.86 38.61 27.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 111.642 -172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.97 45.27 3.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.442 1.497 . . . . 0.0 111.602 -164.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.92 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.461 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.87 16.77 1.08 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 51' ' ' GLY . . . . . 0.498 ' HA3' ' CE2' ' F' ' 44' ' ' PHE . . . 87.13 167.5 43.79 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.21 122.33 47.44 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . 0.691 HG12 HG23 ' A' ' 135' ' ' ILE . 1.5 pp -127.14 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.896 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.76 -16.92 53.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 58' ' ' SER . . . . . 0.647 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 60' ' ' ALA . . . . . 0.427 ' HB1' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 66' ' ' THR . . . . . 0.605 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 67' ' ' TYR . . . . . 0.518 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 70' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' F' ' 82' ' ' ALA . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' F' ' 79' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 82' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 84' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 87' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 88' ' ' GLN . . . . . 0.506 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 90' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 94' ' ' VAL . . . . . 0.605 HG13 ' HB1' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 95' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 98' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.663 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 106' ' ' ALA . . . . . 0.605 ' HB1' HG13 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 108' ' ' PHE . . . . . 0.643 ' HB3' HD12 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 112' ' ' TYR . . . . . 0.512 ' HH ' ' HB3' ' E' ' 56' ' ' PRO . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 114' ' ' GLU . . . . . 0.583 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 115' ' ' SER . . . . . 0.432 ' HB2' ' CB ' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 118' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 127' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 128' ' ' ILE . . . . . 0.518 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 129' ' ' SER . . . . . 0.605 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 131' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 134' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' E' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 135' ' ' ILE . . . . . 0.664 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 136' ' ' GLY . . . . . 0.472 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 138' ' ' LEU . . . . . 0.643 HD12 ' HB3' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 142' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' F' ' 104' ' ' TYR . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . 0.434 ' H ' ' CD1' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 147' ' ' PRO . . . . . 0.442 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 151' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 154' ' ' SER . . . . . 0.545 ' HA ' HD21 ' K' ' 50' ' ' ASN . 1.0 OUTLIER -141.72 137.71 31.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.25 79.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 156' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' F' ' 158' ' ' TYR . . . 137.03 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.393 0.997 . . . . 0.0 113.089 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.21 0.48 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.463 ' CE2' ' HA3' ' F' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.31 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.324 1.05 . . . . 0.0 108.613 177.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 159' ' ' ASP . . . . . 0.623 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 -69.07 -46.63 67.33 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -158.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 161' ' ' GLN . . . . . 0.419 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 162' ' ' GLN . . . . . 0.876 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 163' ' ' PRO . . . . . 0.813 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 165' ' ' GLN . . . . . 0.442 ' O ' HG21 ' F' ' 174' ' ' VAL . 0.8 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 166' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 167' ' ' THR . . . . . 0.469 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . 0.656 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 174' ' ' VAL . . . . . 0.442 HG21 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' HA ' ' H' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 6' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' G' ' 7' ' ' MET . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 7' ' ' MET . . . . . 0.852 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 10' ' ' ASP . . . . . 0.852 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 14' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 15' ' ' PHE . . . . . 0.449 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 21' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' G' ' 12' ' ' LYS . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 41' ' ' ARG . . . . . 0.432 ' NE ' ' OE2' ' L' ' 46' ' ' GLU . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.5 121.62 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 44' ' ' PHE . . . . . 0.493 ' CE2' ' HA3' ' G' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.83 3.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.224 171.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 45' ' ' ASP . . . . . 0.434 ' O ' ' HA2' ' G' ' 51' ' ' GLY . 3.2 t70 -111.81 170.14 8.35 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.12 -48.14 53.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 47' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 1.4 mt-30 57.86 38.6 27.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.611 1.564 . . . . 0.0 111.638 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p 41.95 45.3 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.478 1.511 . . . . 0.0 111.581 -164.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.94 16.83 1.08 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 51' ' ' GLY . . . . . 0.493 ' HA3' ' CE2' ' G' ' 44' ' ' PHE . . . 87.06 167.55 43.86 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.21 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . 0.816 HG12 HG23 ' H' ' 135' ' ' ILE . 1.5 pp -127.22 -39.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.844 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.73 -16.93 53.51 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 59' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 60' ' ' ALA . . . . . 0.425 ' HB1' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 65' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 66' ' ' THR . . . . . 0.604 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 67' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 78' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' G' ' 82' ' ' ALA . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 82' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' G' ' 87' ' ' LYS . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 84' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 87' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 88' ' ' GLN . . . . . 0.463 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 91' ' ' PHE . . . . . 0.449 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 92' ' ' TRP . . . . . 0.542 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 94' ' ' VAL . . . . . 0.603 HG13 ' HB1' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 98' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 103' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 105' ' ' ASP . . . . . 0.652 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 106' ' ' ALA . . . . . 0.603 ' HB1' HG13 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 108' ' ' PHE . . . . . 0.651 ' HB3' HD12 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 112' ' ' TYR . . . . . 0.463 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 115' ' ' SER . . . . . 0.437 ' HB2' ' CB ' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 127' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 128' ' ' ILE . . . . . 0.51 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 129' ' ' SER . . . . . 0.604 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 131' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 135' ' ' ILE . . . . . 0.797 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 136' ' ' GLY . . . . . 0.481 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 138' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 141' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 142' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' G' ' 104' ' ' TYR . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 147' ' ' PRO . . . . . 0.444 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.8 137.77 31.76 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -41.27 79.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 156' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' G' ' 158' ' ' TYR . . . 137.05 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.373 0.988 . . . . 0.0 113.085 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.31 71.26 0.47 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 158' ' ' TYR . . . . . 0.475 ' CE2' ' HA3' ' G' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.28 2.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.366 1.066 . . . . 0.0 108.604 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.12 -46.61 67.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 165' ' ' GLN . . . . . 0.448 ' O ' HG21 ' G' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 174' ' ' VAL . . . . . 0.448 HG21 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 5' ' ' PRO . . . . . 0.464 ' CB ' ' HA ' ' I' ' 70' ' ' LYS . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 6' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' H' ' 7' ' ' MET . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 7' ' ' MET . . . . . 0.862 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 10' ' ' ASP . . . . . 0.862 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 11' ' ' VAL . . . . . 0.426 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 12' ' ' LYS . . . . . 0.604 ' HG2' HD13 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 14' ' ' LEU . . . . . 0.547 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 15' ' ' PHE . . . . . 0.439 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 18' ' ' ILE . . . . . 0.698 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 21' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . 0.604 HD13 ' HG2' ' H' ' 12' ' ' LYS . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 30' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 39' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 41' ' ' ARG . . . . . 0.433 HH22 ' HB1' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.57 121.66 42.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 44' ' ' PHE . . . . . 0.496 ' CE2' ' HA3' ' H' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.81 3.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.179 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 45' ' ' ASP . . . . . 0.43 ' O ' ' HA2' ' H' ' 51' ' ' GLY . 3.2 t70 -111.85 170.18 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 46' ' ' GLU . . . . . 0.405 ' OE2' ' NE ' ' I' ' 41' ' ' ARG . 2.7 mp0 -71.19 -48.13 53.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 47' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 1.4 mt-30 57.89 38.56 27.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.583 1.553 . . . . 0.0 111.615 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 42.02 45.23 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.495 1.518 . . . . 0.0 111.581 -164.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.74 1.69 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.442 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.87 16.78 1.07 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 51' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' H' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.24 122.32 47.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . 0.81 HG12 HG23 ' I' ' 135' ' ' ILE . 1.5 pp -127.17 -39.18 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.844 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.75 -16.93 53.63 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 66' ' ' THR . . . . . 0.599 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 67' ' ' TYR . . . . . 0.514 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 70' ' ' LYS . . . . . 0.456 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' H' ' 82' ' ' ALA . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' H' ' 79' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 83' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 87' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 90' ' ' LYS . . . . . 0.698 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 91' ' ' PHE . . . . . 0.439 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 92' ' ' TRP . . . . . 0.547 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 94' ' ' VAL . . . . . 0.598 HG13 ' HB1' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 95' ' ' ASP . . . . . 0.426 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 96' ' ' THR . . . . . 0.427 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 98' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 103' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 105' ' ' ASP . . . . . 0.645 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 106' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 108' ' ' PHE . . . . . 0.656 ' HB3' HD12 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 112' ' ' TYR . . . . . 0.466 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 115' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 128' ' ' ILE . . . . . 0.514 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 129' ' ' SER . . . . . 0.599 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 131' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 135' ' ' ILE . . . . . 0.816 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 136' ' ' GLY . . . . . 0.459 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 138' ' ' LEU . . . . . 0.656 HD12 ' HB3' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 139' ' ' LYS . . . . . 0.404 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 141' ' ' GLY . . . . . 0.645 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 142' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' H' ' 104' ' ' TYR . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . 0.438 ' H ' ' CD1' ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 147' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.72 31.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.34 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 156' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' H' ' 158' ' ' TYR . . . 137.08 141.25 4.22 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.379 0.99 . . . . 0.0 113.034 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.3 71.3 0.47 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 158' ' ' TYR . . . . . 0.469 ' CE2' ' HA3' ' H' ' 156' ' ' GLY . 0.0 OUTLIER -108.89 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.277 1.031 . . . . 0.0 108.614 177.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.13 -46.62 67.21 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 161' ' ' GLN . . . . . 0.419 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' H' ' 174' ' ' VAL . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 167' ' ' THR . . . . . . . . . . . . . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' I' I ' 6' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' I' ' 7' ' ' MET . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 7' ' ' MET . . . . . 0.859 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 10' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 11' ' ' VAL . . . . . 0.421 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 12' ' ' LYS . . . . . 0.594 ' HG2' HD13 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 14' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 15' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 18' ' ' ILE . . . . . 0.671 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 21' ' ' ALA . . . . . 0.513 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . 0.594 HD13 ' HG2' ' I' ' 12' ' ' LYS . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 30' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 41' ' ' ARG . . . . . 0.433 HH22 ' HB1' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 42' ' ' GLU . . . . . 0.482 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.58 121.58 42.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 44' ' ' PHE . . . . . 0.498 ' CE2' ' HA3' ' I' ' 51' ' ' GLY . 0.3 OUTLIER -128.39 90.78 3.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.249 171.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 45' ' ' ASP . . . . . 0.431 ' O ' ' HA2' ' I' ' 51' ' ' GLY . 3.3 t70 -111.8 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 46' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' J' ' 41' ' ' ARG . 2.7 mp0 -71.16 -48.17 53.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 47' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 1.4 mt-30 57.87 38.6 27.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.6 1.56 . . . . 0.0 111.64 -172.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 42.0 45.28 3.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.501 1.521 . . . . 0.0 111.547 -164.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.442 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 50' ' ' ASN . . . . . 0.43 HD21 ' HA ' ' D' ' 154' ' ' SER . 7.6 m-80 -79.89 16.81 1.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 51' ' ' GLY . . . . . 0.498 ' HA3' ' CE2' ' I' ' 44' ' ' PHE . . . 87.09 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.33 47.43 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . 0.82 HG12 HG23 ' J' ' 135' ' ' ILE . 1.5 pp -127.17 -39.19 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.907 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.79 -16.86 53.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 56' ' ' PRO . . . . . 0.453 ' HB3' ' HH ' ' J' ' 112' ' ' TYR . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 59' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 65' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 66' ' ' THR . . . . . 0.591 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 67' ' ' TYR . . . . . 0.509 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 70' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 78' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' I' ' 82' ' ' ALA . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . 0.406 ' HA ' HD12 ' I' ' 79' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 82' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 84' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 87' ' ' LYS . . . . . 0.516 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 88' ' ' GLN . . . . . 0.466 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 90' ' ' LYS . . . . . 0.671 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 91' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 92' ' ' TRP . . . . . 0.544 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 94' ' ' VAL . . . . . 0.602 HG13 ' HB1' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 95' ' ' ASP . . . . . 0.421 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 98' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 106' ' ' ALA . . . . . 0.602 ' HB1' HG13 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 108' ' ' PHE . . . . . 0.65 ' HB3' HD12 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 112' ' ' TYR . . . . . 0.466 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 115' ' ' SER . . . . . 0.442 ' HB2' ' CB ' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 118' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 127' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 128' ' ' ILE . . . . . 0.509 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 129' ' ' SER . . . . . 0.591 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 131' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 135' ' ' ILE . . . . . 0.81 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 136' ' ' GLY . . . . . 0.476 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 138' ' ' LEU . . . . . 0.65 HD12 ' HB3' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 142' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' I' ' 104' ' ' TYR . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . 0.431 ' H ' ' CD1' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 147' ' ' PRO . . . . . 0.446 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 151' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.82 137.75 31.7 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -41.26 79.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 156' ' ' GLY . . . . . 0.465 ' HA3' ' CE2' ' I' ' 158' ' ' TYR . . . 137.04 141.28 4.22 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.353 0.979 . . . . 0.0 113.097 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.19 0.48 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 158' ' ' TYR . . . . . 0.465 ' CE2' ' HA3' ' I' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.33 2.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.311 1.044 . . . . 0.0 108.629 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.11 -46.63 67.22 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 161' ' ' GLN . . . . . 0.425 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 165' ' ' GLN . . . . . 0.443 ' O ' HG21 ' I' ' 174' ' ' VAL . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 174' ' ' VAL . . . . . 0.443 HG21 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' J' J ' 6' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' J' ' 7' ' ' MET . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 7' ' ' MET . . . . . 0.837 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 10' ' ' ASP . . . . . 0.837 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 11' ' ' VAL . . . . . 0.437 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 12' ' ' LYS . . . . . 0.587 ' HG2' HD13 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 14' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 15' ' ' PHE . . . . . 0.441 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 21' ' ' ALA . . . . . 0.452 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' J' ' 12' ' ' LYS . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 30' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 39' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 41' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' I' ' 46' ' ' GLU . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 121.59 42.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 44' ' ' PHE . . . . . 0.501 ' CE2' ' HA3' ' J' ' 51' ' ' GLY . 0.3 OUTLIER -128.4 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.287 171.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 45' ' ' ASP . . . . . 0.446 ' O ' ' HA2' ' J' ' 51' ' ' GLY . 3.2 t70 -111.81 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 155.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 46' ' ' GLU . . . . . 0.446 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 2.7 mp0 -71.2 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 47' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 1.4 mt-30 57.86 38.56 27.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.675 1.59 . . . . 0.0 111.656 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 42.01 45.24 3.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.51 1.524 . . . . 0.0 111.586 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.71 1.68 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.48 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -79.88 16.74 1.09 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 51' ' ' GLY . . . . . 0.501 ' HA3' ' CE2' ' J' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.19 122.41 47.66 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . 0.762 HG12 HG23 ' K' ' 135' ' ' ILE . 1.5 pp -127.24 -39.2 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.862 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 mp -61.75 -16.9 53.42 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 59' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 60' ' ' ALA . . . . . 0.433 ' HB1' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 65' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 66' ' ' THR . . . . . 0.602 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 67' ' ' TYR . . . . . 0.519 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 78' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' J' ' 82' ' ' ALA . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 84' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 88' ' ' GLN . . . . . 0.467 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 91' ' ' PHE . . . . . 0.441 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 92' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 94' ' ' VAL . . . . . 0.61 HG13 ' HB1' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 95' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 98' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 103' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 105' ' ' ASP . . . . . 0.642 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 106' ' ' ALA . . . . . 0.61 ' HB1' HG13 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 108' ' ' PHE . . . . . 0.636 ' HB3' HD12 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 112' ' ' TYR . . . . . 0.467 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 114' ' ' GLU . . . . . 0.482 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 115' ' ' SER . . . . . 0.445 ' HB2' ' CB ' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 118' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 127' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 128' ' ' ILE . . . . . 0.519 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 129' ' ' SER . . . . . 0.602 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 131' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 135' ' ' ILE . . . . . 0.82 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 136' ' ' GLY . . . . . 0.479 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 138' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 141' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 142' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' J' ' 104' ' ' TYR . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 147' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.7 137.75 31.93 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.34 79.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 156' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' J' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 119.365 0.984 . . . . 0.0 113.011 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 158' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' J' ' 156' ' ' GLY . 0.0 OUTLIER -108.85 89.33 2.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 108.63 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.63 67.12 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 165' ' ' GLN . . . . . 0.443 ' O ' HG21 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 167' ' ' THR . . . . . . . . . . . . . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 174' ' ' VAL . . . . . 0.443 HG21 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' K' K ' 6' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' K' ' 7' ' ' MET . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 7' ' ' MET . . . . . 0.858 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 10' ' ' ASP . . . . . 0.858 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 11' ' ' VAL . . . . . 0.436 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 12' ' ' LYS . . . . . 0.6 ' HG2' HD13 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 14' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 15' ' ' PHE . . . . . 0.439 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 18' ' ' ILE . . . . . 0.686 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 21' ' ' ALA . . . . . 0.643 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . 0.6 HD13 ' HG2' ' K' ' 12' ' ' LYS . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 41' ' ' ARG . . . . . 0.446 ' NE ' ' OE2' ' J' ' 46' ' ' GLU . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 42' ' ' GLU . . . . . 0.463 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.6 121.71 42.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 44' ' ' PHE . . . . . 0.498 ' CE2' ' HA3' ' K' ' 51' ' ' GLY . 0.3 OUTLIER -128.5 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.189 171.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 45' ' ' ASP . . . . . 0.443 ' O ' ' HA2' ' K' ' 51' ' ' GLY . 3.3 t70 -111.87 170.16 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 155.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 46' ' ' GLU . . . . . 0.542 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.7 mp0 -71.21 -48.13 53.28 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 47' ' ' GLN . . . . . 0.607 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.4 mt-30 57.81 38.58 27.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.609 1.563 . . . . 0.0 111.714 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p 41.98 45.31 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.5 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 50' ' ' ASN . . . . . 0.545 HD21 ' HA ' ' F' ' 154' ' ' SER . 7.7 m-80 -79.9 16.8 1.08 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 51' ' ' GLY . . . . . 0.498 ' HA3' ' CE2' ' K' ' 44' ' ' PHE . . . 87.04 167.47 43.78 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 52' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.36 47.53 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . 0.735 HG12 HG23 ' L' ' 135' ' ' ILE . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.87 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.77 -16.93 53.71 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HH ' ' L' ' 112' ' ' TYR . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 60' ' ' ALA . . . . . 0.434 ' HB1' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 65' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 66' ' ' THR . . . . . 0.603 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 67' ' ' TYR . . . . . 0.513 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 78' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' K' ' 82' ' ' ALA . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 82' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 84' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 87' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 88' ' ' GLN . . . . . 0.465 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 90' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 91' ' ' PHE . . . . . 0.439 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 92' ' ' TRP . . . . . 0.546 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 94' ' ' VAL . . . . . 0.616 HG13 ' HB1' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 95' ' ' ASP . . . . . 0.436 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 103' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 105' ' ' ASP . . . . . 0.659 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 106' ' ' ALA . . . . . 0.616 ' HB1' HG13 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 108' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 112' ' ' TYR . . . . . 0.465 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 115' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 127' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 128' ' ' ILE . . . . . 0.513 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 129' ' ' SER . . . . . 0.603 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 131' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 135' ' ' ILE . . . . . 0.762 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 136' ' ' GLY . . . . . 0.477 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 138' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 139' ' ' LYS . . . . . 0.526 ' HZ3' ' HB3' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 141' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 142' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' K' ' 104' ' ' TYR . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . 0.441 ' H ' ' CD1' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 147' ' ' PRO . . . . . 0.451 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.68 31.78 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.22 79.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 156' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' K' ' 158' ' ' TYR . . . 137.03 141.3 4.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 119.395 0.998 . . . . 0.0 113.03 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.29 71.24 0.47 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 158' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' K' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.26 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.347 1.059 . . . . 0.0 108.616 177.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.05 -46.64 67.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 -158.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 161' ' ' GLN . . . . . 0.417 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 165' ' ' GLN . . . . . 0.446 ' O ' HG21 ' K' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 174' ' ' VAL . . . . . 0.446 HG21 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' L' L ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' L' L ' 6' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' L' ' 7' ' ' MET . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 7' ' ' MET . . . . . 0.849 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 10' ' ' ASP . . . . . 0.849 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 12' ' ' LYS . . . . . 0.592 ' HG2' HD13 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 14' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 18' ' ' ILE . . . . . 0.683 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . 0.592 HD13 ' HG2' ' L' ' 12' ' ' LYS . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 39' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 41' ' ' ARG . . . . . 0.542 ' NE ' ' OE2' ' K' ' 46' ' ' GLU . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.59 121.63 42.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 44' ' ' PHE . . . . . 0.491 ' CE2' ' HA3' ' L' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.77 3.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 171.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 45' ' ' ASP . . . . . 0.436 ' O ' ' HA2' ' L' ' 51' ' ' GLY . 3.2 t70 -111.86 170.2 8.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 155.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 46' ' ' GLU . . . . . 0.432 ' OE2' ' NE ' ' G' ' 41' ' ' ARG . 2.7 mp0 -71.23 -48.13 53.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 47' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.4 mt-30 57.9 38.55 27.06 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.595 1.558 . . . . 0.0 111.665 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.94 45.32 3.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.479 1.512 . . . . 0.0 111.593 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.76 1.7 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.453 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.88 16.8 1.07 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 51' ' ' GLY . . . . . 0.491 ' HA3' ' CE2' ' L' ' 44' ' ' PHE . . . 87.07 167.49 43.8 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.28 47.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . 0.797 HG12 HG23 ' G' ' 135' ' ' ILE . 1.5 pp -127.18 -39.12 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.77 -16.92 53.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 60' ' ' ALA . . . . . 0.419 ' HB1' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 65' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 66' ' ' THR . . . . . 0.593 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 67' ' ' TYR . . . . . 0.516 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' L' ' 79' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . 0.526 ' HB3' ' HZ3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 82' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 83' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 84' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 87' ' ' LYS . . . . . 0.513 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 88' ' ' GLN . . . . . 0.656 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 90' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 92' ' ' TRP . . . . . 0.53 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 94' ' ' VAL . . . . . 0.613 HG13 ' HB1' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 98' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 105' ' ' ASP . . . . . 0.656 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 106' ' ' ALA . . . . . 0.613 ' HB1' HG13 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 108' ' ' PHE . . . . . 0.636 ' HB3' HD12 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 110' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 112' ' ' TYR . . . . . 0.468 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 114' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 115' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 118' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 127' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 128' ' ' ILE . . . . . 0.516 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 129' ' ' SER . . . . . 0.593 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 131' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 134' ' ' VAL . . . . . 0.433 ' HA ' ' CD1' ' K' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 135' ' ' ILE . . . . . 0.735 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 136' ' ' GLY . . . . . 0.468 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 138' ' ' LEU . . . . . 0.636 HD12 ' HB3' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 140' ' ' ASN . . . . . 0.623 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 141' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 142' ' ' GLU . . . . . 0.876 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . 0.432 ' H ' ' CD1' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 144' ' ' ASP . . . . . 0.813 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 147' ' ' PRO . . . . . 0.443 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 151' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.76 137.76 31.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -41.22 79.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 156' ' ' GLY . . . . . 0.47 ' HA3' ' CE2' ' L' ' 158' ' ' TYR . . . 137.05 141.25 4.22 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 119.425 1.012 . . . . 0.0 113.055 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 158' ' ' TYR . . . . . 0.47 ' CE2' ' HA3' ' L' ' 156' ' ' GLY . 0.0 OUTLIER -108.87 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.344 1.057 . . . . 0.0 108.603 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.68 67.13 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 161' ' ' GLN . . . . . 0.423 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 165' ' ' GLN . . . . . 0.447 ' O ' HG21 ' L' ' 174' ' ' VAL . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 167' ' ' THR . . . . . . . . . . . . . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 174' ' ' VAL . . . . . 0.447 HG21 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' HD13 ' A' ' 89' ' ' ILE . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.413 ' O ' HG13 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.754 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' A' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 40' ' ' GLU . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 133' ' ' GLN . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HA ' ' HZ1' ' A' ' 77' ' ' LYS . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB3' ' NH2' ' A' ' 116' ' ' ARG . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 17' ' ' SER . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.688 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 HG23 ' A' ' 150' ' ' ILE . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' A' ' 99' ' ' ASN . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 1.045 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.602 ' CE2' HG22 ' A' ' 145' ' ' THR . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.476 HG13 ' O ' ' F' ' 32' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.623 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.523 HG12 ' HG ' ' F' ' 54' ' ' LEU . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 1.045 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.602 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 96' ' ' THR . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 162' ' ' GLN . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' A' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.614 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.614 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.624 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.442 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.524 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' B' ' 89' ' ' ILE . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.605 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.432 ' O ' HG13 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' B' ' 59' ' ' VAL . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' B' ' 41' ' ' ARG . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.77 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.731 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.77 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' B' ' 40' ' ' GLU . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' B' ' 133' ' ' GLN . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.617 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.435 ' HA ' ' HZ1' ' B' ' 77' ' ' LYS . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.484 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' B' ' 116' ' ' ARG . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' B' ' 17' ' ' SER . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.61 HG22 HG23 ' B' ' 150' ' ' ILE . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' B' ' 104' ' ' TYR . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' B' ' 99' ' ' ASN . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 1.017 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' B' ' 145' ' ' THR . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.543 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.707 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' B' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 32' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' B' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' A' ' 54' ' ' LEU . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.481 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.543 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.876 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 1.017 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.61 HG23 HG22 ' B' ' 96' ' ' THR . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.548 ' HD2' ' HB2' ' B' ' 162' ' ' GLN . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' B' ' 165' ' ' GLN . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' B' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.631 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.631 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.621 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.419 ' O ' ' HB1' ' D' ' 125' ' ' ALA . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' C' ' 89' ' ' ILE . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.533 ' O ' HG13 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.638 HG13 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.759 ' HA ' HG22 ' C' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' C' ' 41' ' ' ARG . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.692 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' C' ' 41' ' ' ARG . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' C' ' 40' ' ' GLU . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' SER . . . . . 0.508 ' HB3' ' HG2' ' C' ' 133' ' ' GLN . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' C' ' 71' ' ' ARG . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.452 ' HB3' ' NH2' ' C' ' 116' ' ' ARG . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.498 ' O ' HG12 ' C' ' 18' ' ' ILE . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.702 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.594 HG22 HG23 ' C' ' 150' ' ' ILE . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' C' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' C' ' 99' ' ' ASN . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 1.042 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.592 ' CE2' HG22 ' C' ' 145' ' ' THR . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.542 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.404 ' CE1' ' HD2' ' C' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 32' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.508 ' HG2' ' HB3' ' C' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' C' ' 110' ' ' PHE . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.731 HG12 ' HG ' ' B' ' 54' ' ' LEU . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' D' ' 84' ' ' GLN . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.893 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 1.042 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 145' ' ' THR . . . . . 0.592 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.626 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.594 HG23 HG22 ' C' ' 96' ' ' THR . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 152' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' C' ' 162' ' ' GLN . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' C' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' C' ' 160' ' ' PHE . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.624 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.624 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.538 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' SER . . . . . 0.415 ' HA ' HD13 ' D' ' 89' ' ' ILE . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.626 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' D' ' 70' ' ' LYS . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.483 ' O ' HG13 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.75 ' HA ' HG22 ' D' ' 59' ' ' VAL . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.437 ' H ' ' CZ ' ' D' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.734 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.693 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.734 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' D' ' 40' ' ' GLU . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' D' ' 133' ' ' GLN . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' D' ' 71' ' ' ARG . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.519 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.444 ' HB3' ' NH2' ' D' ' 116' ' ' ARG . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' D' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.685 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' D' ' 150' ' ' ILE . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' D' ' 104' ' ' TYR . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' D' ' 99' ' ' ASN . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 1.024 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' D' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.621 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.544 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.656 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.412 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.533 HG13 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' C' ' 6' ' ' ILE . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 129' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' D' ' 62' ' ' SER . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.692 HG12 ' HG ' ' C' ' 54' ' ' LEU . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 137' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.544 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 1.024 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.601 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' D' ' 96' ' ' THR . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD13 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' D' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' D' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.616 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.5 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.491 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.404 HG22 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' E' ' 89' ' ' ILE . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.618 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' E' ' 70' ' ' LYS . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' F' ' 117' ' ' GLU . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 38' ' ' SER . . . . . 0.479 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 40' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' E' ' 59' ' ' VAL . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.435 ' H ' ' CZ ' ' E' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.743 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.819 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 55' ' ' GLY . . . . . 0.743 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 59' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' E' ' 40' ' ' GLU . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 62' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' E' ' 133' ' ' GLN . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.571 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.833 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.449 ' HB3' ' NH2' ' E' ' 116' ' ' ARG . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.833 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' E' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.433 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 95' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.616 HG22 HG23 ' E' ' 150' ' ' ILE . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' E' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 101' ' ' ASN . . . . . 0.464 ' H ' HD22 ' E' ' 99' ' ' ASN . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.974 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' E' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.689 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.414 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' E' ' 116' ' ' ARG . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.483 HG13 ' O ' ' D' ' 32' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.489 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' E' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.693 HG12 ' HG ' ' D' ' 54' ' ' LEU . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' E' ' 107' ' ' GLN . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.974 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.606 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.616 HG23 HG22 ' E' ' 96' ' ' THR . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.555 ' HD2' ' HB2' ' E' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' E' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.555 ' HB2' ' HD2' ' E' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.618 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.618 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.407 ' HB3' HG22 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 17' ' ' SER . . . . . 0.406 ' HA ' HD13 ' F' ' 89' ' ' ILE . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' F' ' 70' ' ' LYS . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 40' ' ' GLU . . . . . 0.749 ' HA ' HG22 ' F' ' 59' ' ' VAL . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' F' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.523 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 55' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 59' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' F' ' 40' ' ' GLU . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' F' ' 133' ' ' GLN . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.509 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.564 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 81' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.825 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.825 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' F' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.607 HG22 HG23 ' F' ' 150' ' ' ILE . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 98' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' F' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' F' ' 99' ' ' ASN . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.982 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.605 ' CE2' HG22 ' F' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.549 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.536 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.667 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' F' ' 116' ' ' ARG . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' E' ' 6' ' ' ILE . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 129' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' F' ' 62' ' ' SER . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' F' ' 110' ' ' PHE . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.819 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' F' ' 107' ' ' GLN . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.549 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.982 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.605 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.607 HG23 HG22 ' F' ' 96' ' ' THR . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.917 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.633 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 2.3 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.687 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.54 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.801 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.505 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 32.7 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' G' ' 89' ' ' ILE . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.607 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' G' ' 70' ' ' LYS . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 29' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 38' ' ' SER . . . . . 0.542 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' G' ' 59' ' ' VAL . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' G' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 42' ' ' GLU . . . . . 0.442 ' H ' ' CZ ' ' G' ' 41' ' ' ARG . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.769 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.707 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 55' ' ' GLY . . . . . 0.769 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' G' ' 40' ' ' GLU . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' G' ' 133' ' ' GLN . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HZ1' ' G' ' 77' ' ' LYS . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.529 ' HZ1' ' HA ' ' G' ' 74' ' ' ALA . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.57 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 81' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.5 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.618 HG22 HG23 ' G' ' 150' ' ' ILE . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' G' ' 104' ' ' TYR . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.633 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' G' ' 99' ' ' ASN . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 1.027 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.594 ' CE2' HG22 ' G' ' 145' ' ' THR . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.633 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.55 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.655 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.408 ' CE1' ' HD2' ' G' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.667 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.448 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' G' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.655 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.715 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 137' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' G' ' 107' ' ' GLN . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.909 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 1.027 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.594 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.618 HG23 HG22 ' G' ' 96' ' ' THR . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 152' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' G' G ' 160' ' ' PHE . . . . . 0.554 ' HD2' ' HB2' ' G' ' 162' ' ' GLN . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 162' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' G' ' 160' ' ' PHE . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 163' ' ' PRO . . . . . 0.627 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.627 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.524 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 32.8 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' H' ' 89' ' ' ILE . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.527 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 29' ' ' PRO . . . . . 0.513 ' HB2' ' HE3' ' H' ' 70' ' ' LYS . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 38' ' ' SER . . . . . 0.516 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' H' ' 59' ' ' VAL . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 42' ' ' GLU . . . . . 0.45 ' H ' ' CZ ' ' H' ' 41' ' ' ARG . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.766 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 55' ' ' GLY . . . . . 0.766 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' H' ' 40' ' ' GLU . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' H' ' 133' ' ' GLN . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.521 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.573 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.566 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 81' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.808 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.808 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' H' ' 17' ' ' SER . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' H' ' 150' ' ' ILE . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 98' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' H' ' 104' ' ' TYR . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 101' ' ' ASN . . . . . 0.455 ' H ' HD22 ' H' ' 99' ' ' ASN . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 1.008 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.591 ' CE2' HG22 ' H' ' 145' ' ' THR . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.632 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.664 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.454 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.672 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.647 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' H' ' 116' ' ' ARG . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 129' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.672 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.454 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' H' ' 62' ' ' SER . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.664 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.707 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' H' ' 107' ' ' GLN . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 1.008 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.591 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' H' ' 96' ' ' THR . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' H' H ' 160' ' ' PHE . . . . . 0.552 ' HD2' ' HB2' ' H' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' H' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 162' ' ' GLN . . . . . 0.552 ' HB2' ' HD2' ' H' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 171' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.4 HG22 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 32.8 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' I' ' 89' ' ' ILE . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.608 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.451 ' O ' HG13 ' J' ' 122' ' ' VAL . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.51 HG13 ' HG2' ' J' ' 117' ' ' GLU . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 38' ' ' SER . . . . . 0.5 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 40' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' I' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.448 ' H ' ' CZ ' ' I' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.801 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 55' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' I' ' 41' ' ' ARG . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 59' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' I' ' 40' ' ' GLU . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' I' ' 133' ' ' GLN . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.436 HH21 ' HD2' ' I' ' 71' ' ' ARG . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.575 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.816 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 95' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' I' ' 150' ' ' ILE . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' I' ' 104' ' ' TYR . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 101' ' ' ASN . . . . . 0.454 ' H ' HD22 ' I' ' 99' ' ' ASN . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 1.05 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' I' ' 145' ' ' THR . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' I' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' H' ' 6' ' ' ILE . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 129' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.459 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' I' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.662 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.477 ' HA ' HE22 ' J' ' 84' ' ' GLN . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.62 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 1.05 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' I' ' 96' ' ' THR . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' I' I ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' I' ' 162' ' ' GLN . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' I' ' 165' ' ' GLN . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' I' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 163' ' ' PRO . . . . . 0.632 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.62 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 170' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 171' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.62 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.642 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 32.7 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' J' ' 89' ' ' ILE . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.617 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.418 ' O ' HG13 ' K' ' 122' ' ' VAL . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' K' ' 117' ' ' GLU . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 38' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 40' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' J' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 42' ' ' GLU . . . . . 0.44 ' H ' ' CZ ' ' J' ' 41' ' ' ARG . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 59' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' J' ' 40' ' ' GLU . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' J' ' 133' ' ' GLN . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.51 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.525 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.828 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.5 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.828 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.489 ' O ' HG12 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.707 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' J' ' 150' ' ' ILE . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 98' ' ' LYS . . . . . 0.417 ' HA ' ' CE1' ' J' ' 104' ' ' TYR . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' J' ' 99' ' ' ASN . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.986 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.587 ' CE2' HG22 ' J' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.437 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.443 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.677 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.42 ' CE1' ' HD2' ' J' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 122' ' ' VAL . . . . . 0.451 HG13 ' O ' ' I' ' 32' ' ' GLN . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 129' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.677 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.443 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' J' ' 62' ' ' SER . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.675 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.801 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 137' ' ' GLU . . . . . 0.532 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.453 ' HA ' HE22 ' K' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.885 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.986 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.587 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' J' ' 96' ' ' THR . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' J' J ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' J' ' 162' ' ' GLN . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' J' ' 165' ' ' GLN . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' J' ' 160' ' ' PHE . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 163' ' ' PRO . . . . . 0.612 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.612 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 170' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 171' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.658 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.414 ' HB3' HG22 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 32.6 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 17' ' ' SER . . . . . 0.41 ' HA ' HD13 ' K' ' 89' ' ' ILE . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.63 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.52 ' HZ ' ' H ' ' K' ' 70' ' ' LYS . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 29' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.408 ' O ' HG13 ' L' ' 122' ' ' VAL . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' L' ' 117' ' ' GLU . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 40' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' K' ' 59' ' ' VAL . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' K' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 42' ' ' GLU . . . . . 0.434 ' H ' ' CZ ' ' K' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.742 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 55' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 59' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' K' ' 40' ' ' GLU . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' K' ' 133' ' ' GLN . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.52 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.45 ' HA ' ' HZ1' ' K' ' 77' ' ' LYS . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.524 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.45 ' HB3' ' NH2' ' K' ' 116' ' ' ARG . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.494 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.412 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 95' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.6 HG22 HG23 ' K' ' 150' ' ' ILE . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' K' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 101' ' ' ASN . . . . . 0.459 ' H ' HD22 ' K' ' 99' ' ' ASN . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 1.001 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' K' ' 145' ' ' THR . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.619 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.88 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.538 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.416 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' K' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 122' ' ' VAL . . . . . 0.418 HG13 ' O ' ' J' ' 32' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.642 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 129' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' K' ' 62' ' ' SER . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.717 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.551 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.585 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.88 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 1.001 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.6 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.6 HG23 HG22 ' K' ' 96' ' ' THR . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 152' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' K' K ' 160' ' ' PHE . . . . . 0.553 ' HD2' ' HB2' ' K' ' 162' ' ' GLN . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' K' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 162' ' ' GLN . . . . . 0.553 ' HB2' ' HD2' ' K' ' 160' ' ' PHE . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 163' ' ' PRO . . . . . 0.621 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.667 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 17' ' ' SER . . . . . 0.408 ' HA ' HD13 ' L' ' 89' ' ' ILE . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.801 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 22' ' ' THR . . . . . 0.516 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.521 ' HZ ' ' H ' ' L' ' 70' ' ' LYS . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 29' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' G' ' 117' ' ' GLU . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 38' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 40' ' ' GLU . . . . . 0.735 ' HA ' HG22 ' L' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' L' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' L' ' 41' ' ' ARG . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.745 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.715 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 55' ' ' GLY . . . . . 0.745 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 58' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 59' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' L' ' 40' ' ' GLU . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 62' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' L' ' 133' ' ' GLN . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.521 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HZ1' ' L' ' 77' ' ' LYS . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.51 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.473 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.577 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.824 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.445 ' HB3' ' NH2' ' L' ' 116' ' ' ARG . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.42 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.614 HG22 HG23 ' L' ' 150' ' ' ILE . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' L' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' L' ' 99' ' ' ASN . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 1.011 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.598 ' CE2' HG22 ' L' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.547 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.435 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.419 ' CE1' ' HD2' ' L' ' 116' ' ' ARG . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' K' ' 32' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.658 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.654 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' L' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' L' ' 110' ' ' PHE . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.75 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.437 ' HA ' HE22 ' G' ' 84' ' ' GLN . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.561 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 1.011 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.598 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.619 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.614 HG23 HG22 ' L' ' 96' ' ' THR . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' L' L ' 160' ' ' PHE . . . . . 0.542 ' HD2' ' HB2' ' L' ' 162' ' ' GLN . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' HB2' ' L' ' 165' ' ' GLN . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 162' ' ' GLN . . . . . 0.542 ' HB2' ' HD2' ' L' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 163' ' ' PRO . . . . . 0.622 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.622 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.513 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' B' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 29.3 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.445 ' HA ' HD13 ' A' ' 89' ' ' ILE . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 88' ' ' GLN . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 32' ' ' GLN . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' B' ' 118' ' ' TYR . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 43' ' ' LEU . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' F' ' 5' ' ' PRO . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HB2' HG21 ' A' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.743 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' A' ' 99' ' ' ASN . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 110' ' ' PHE . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.504 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.645 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD2' ' HB2' ' F' ' 36' ' ' SER . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.645 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' OE2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.469 HG12 ' HG ' ' F' ' 54' ' ' LEU . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.789 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.0 t30 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.443 ' HG2' ' OD2' ' G' ' 144' ' ' ASP . 2.6 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.502 ' C ' ' HA2' ' G' ' 23' ' ' GLY . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 2.8 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.605 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.486 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' B' ' 96' ' ' THR . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 29.4 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.437 ' HA ' HD13 ' B' ' 89' ' ' ILE . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 88' ' ' GLN . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' B' ' 70' ' ' LYS . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 32' ' ' GLN . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' C' ' 118' ' ' TYR . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' H ' ' B' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' B' ' 43' ' ' LEU . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 30' ' ' ALA . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' B' ' 76' ' ' GLN . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.455 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.561 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.884 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.53 ' HB2' HG21 ' B' ' 113' ' ' ILE . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.884 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.6 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.741 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ASN . . . . . 0.465 ' H ' HD22 ' B' ' 99' ' ' ASN . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' B' ' 110' ' ' PHE . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.469 ' CE2' ' HG2' ' B' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.673 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.845 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.861 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.706 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.614 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.0 t30 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.54 ' HG2' ' OD2' ' H' ' 144' ' ' ASP . 2.6 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.585 ' HB3' ' HD3' ' B' ' 175' ' ' PRO . 2.8 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.52 ' O ' HG23 ' C' ' 96' ' ' THR . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 29.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' SER . . . . . 0.444 ' HA ' HD13 ' C' ' 89' ' ' ILE . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 88' ' ' GLN . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' C' ' 70' ' ' LYS . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' C' ' 67' ' ' TYR . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.415 HG22 ' OG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' D' ' 118' ' ' TYR . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.558 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' C' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' C' ' 43' ' ' LEU . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' C' ' 30' ' ' ALA . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' C' ' 76' ' ' GLN . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.573 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.56 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.52 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' C' ' 99' ' ' ASN . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.621 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.56 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' C' ' 110' ' ' PHE . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.468 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.468 ' HD2' ' HB2' ' B' ' 36' ' ' SER . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.809 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.809 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 152' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.0 t30 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' I' ' 144' ' ' ASP . 2.6 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.442 ' C ' ' HA2' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' C' ' 175' ' ' PRO . 2.8 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.597 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 170' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' E' ' 126' ' ' VAL . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' D' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 29.4 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' SER . . . . . 0.455 ' HA ' HD13 ' D' ' 89' ' ' ILE . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.498 HG12 ' O ' ' D' ' 88' ' ' GLN . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' D' ' 70' ' ' LYS . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' D' ' 32' ' ' GLN . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' E' ' 118' ' ' TYR . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.612 ' HB2' ' H ' ' D' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' D' ' 43' ' ' LEU . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.416 ' OG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' D' ' 30' ' ' ALA . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' D' ' 76' ' ' GLN . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.453 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.51 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.845 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.608 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.499 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.456 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.565 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' D' ' 99' ' ' ASN . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.565 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.457 ' CZ ' ' HE2' ' D' ' 110' ' ' PHE . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.493 ' OE2' ' HG3' ' D' ' 133' ' ' GLN . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.641 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.432 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 129' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 149' ' ' GLU . . . . . 0.794 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 152' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.0 t30 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.422 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.448 ' HG2' ' OD2' ' J' ' 144' ' ' ASP . 2.6 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.569 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 2.8 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.585 ' O ' ' HB ' ' D' ' 173' ' ' THR . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.426 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 170' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' E' ' 96' ' ' THR . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.76 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 29.4 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' SER . . . . . 0.457 ' HA ' HD13 ' E' ' 89' ' ' ILE . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' E' ' 88' ' ' GLN . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 33' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' E' ' 32' ' ' GLN . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' F' ' 118' ' ' TYR . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 40' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' E' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.784 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 55' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' E' ' 43' ' ' LEU . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' E' ' 76' ' ' GLN . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.507 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' E' ' 113' ' ' ILE . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.462 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 101' ' ' ASN . . . . . 0.452 ' H ' HD22 ' E' ' 99' ' ' ASN . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.724 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' E' ' 110' ' ' PHE . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.544 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.48 ' HD2' ' HB2' ' D' ' 36' ' ' SER . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 129' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.479 ' HG3' ' OE2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.824 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.671 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 137' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.497 ' HD2' ' NE2' ' F' ' 84' ' ' GLN . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.724 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 149' ' ' GLU . . . . . 0.793 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.0 t30 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' OD2' ' K' ' 144' ' ' ASP . 2.6 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.514 ' C ' ' HA2' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' E' ' 175' ' ' PRO . 2.9 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.603 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 171' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' A' ' 126' ' ' VAL . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 17' ' ' SER . . . . . 0.452 ' HA ' HD13 ' F' ' 89' ' ' ILE . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.508 HG12 ' O ' ' F' ' 88' ' ' GLN . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.785 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' F' ' 70' ' ' LYS . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' F' ' 67' ' ' TYR . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' F' ' 32' ' ' GLN . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 118' ' ' TYR . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.618 ' HB2' ' H ' ' F' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 55' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' F' ' 43' ' ' LEU . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 63' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 66' ' ' THR . . . . . 0.4 ' OG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' CB ' ' E' ' 5' ' ' PRO . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' F' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.515 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' F' ' 113' ' ' ILE . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.599 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.458 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' F' ' 99' ' ' ASN . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.736 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' F' ' 110' ' ' PHE . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.493 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' E' ' 36' ' ' SER . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' E' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 129' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.632 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.493 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.784 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.736 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 149' ' ' GLU . . . . . 0.785 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.0 t30 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.6 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.832 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 2.6 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.699 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 2.8 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.735 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.742 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.553 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.512 ' O ' HG23 ' G' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 29.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 17' ' ' SER . . . . . 0.447 ' HA ' HD13 ' G' ' 89' ' ' ILE . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' G' ' 88' ' ' GLN . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 21' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' G' ' 70' ' ' LYS . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' G' ' 32' ' ' GLN . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 36' ' ' SER . . . . . 0.535 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' H' ' 113' ' ' ILE . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' G' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.668 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 55' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' G' ' 43' ' ' LEU . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 66' ' ' THR . . . . . 0.412 ' OG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.433 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' L' ' 5' ' ' PRO . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' G' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' G' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.866 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HB2' HG21 ' G' ' 113' ' ' ILE . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.866 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.752 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.564 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.512 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 101' ' ' ASN . . . . . 0.47 ' H ' HD22 ' G' ' 99' ' ' ASN . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.564 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' G' ' 110' ' ' PHE . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.548 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' G' ' 83' ' ' TYR . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.643 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.551 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.645 HG21 ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 129' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' OE2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.677 HG12 ' HG ' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 137' ' ' GLU . . . . . 0.848 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.608 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.848 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.722 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 144' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 162' ' ' GLN . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 149' ' ' GLU . . . . . 0.784 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.0 t30 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 2.8 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.607 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 171' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.654 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 29.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 17' ' ' SER . . . . . 0.449 ' HA ' HD13 ' H' ' 89' ' ' ILE . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' H' ' 88' ' ' GLN . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 21' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' H' ' 70' ' ' LYS . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 33' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' H' ' 32' ' ' GLN . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 36' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' I' ' 118' ' ' TYR . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' I' ' 113' ' ' ILE . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.597 ' HB2' ' H ' ' H' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.606 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 55' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' H' ' 43' ' ' LEU . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 66' ' ' THR . . . . . 0.402 ' OG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' G' ' 5' ' ' PRO . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' H' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.514 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.86 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG21 ' H' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.608 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.86 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.606 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.482 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.467 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' H' ' 99' ' ' ASN . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' H' ' 110' ' ' PHE . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' H' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.651 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.535 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.651 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.483 ' HG3' ' OE2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.831 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.668 HG12 ' HG ' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 137' ' ' GLU . . . . . 0.831 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.879 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 144' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 149' ' ' GLU . . . . . 0.782 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.0 t30 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' H' ' 175' ' ' PRO . 2.8 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.609 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' J' ' 126' ' ' VAL . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.519 ' O ' HG23 ' I' ' 96' ' ' THR . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.761 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 17' ' ' SER . . . . . 0.436 ' HA ' HD13 ' I' ' 89' ' ' ILE . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' I' ' 88' ' ' GLN . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' I' ' 32' ' ' GLN . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.595 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 40' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' I' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.771 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' I' ' 43' ' ' LEU . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 73' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' I' ' 76' ' ' GLN . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' I' ' 113' ' ' ILE . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.602 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.562 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.519 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' I' ' 99' ' ' ASN . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.611 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.562 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' I' ' 110' ' ' PHE . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.473 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' I' ' 83' ' ' TYR . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.49 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.657 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.498 ' HD2' ' HB2' ' H' ' 36' ' ' SER . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 129' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.49 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.606 HG12 ' HG ' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.498 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 144' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' C' ' 162' ' ' GLN . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 149' ' ' GLU . . . . . 0.779 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 152' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.0 t30 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 2.8 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 171' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' K' ' 126' ' ' VAL . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' J' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.757 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 29.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 17' ' ' SER . . . . . 0.446 ' HA ' HD13 ' J' ' 89' ' ' ILE . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' J' ' 88' ' ' GLN . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 21' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.569 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' J' ' 70' ' ' LYS . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 33' ' ' THR . . . . . 0.417 HG22 ' OG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 36' ' ' SER . . . . . 0.55 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 40' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' K' ' 113' ' ' ILE . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' J' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.647 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' J' ' 43' ' ' LEU . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 66' ' ' THR . . . . . 0.417 ' OG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' I' ' 5' ' ' PRO . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' J' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.854 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.538 ' HB2' HG21 ' J' ' 113' ' ' ILE . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.854 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.453 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.757 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.561 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' J' ' 99' ' ' ASN . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.561 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HE2' ' J' ' 110' ' ' PHE . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' J' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.647 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' I' ' 6' ' ' ILE . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 129' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.647 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.827 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.771 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 137' ' ' GLU . . . . . 0.827 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.726 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' D' ' 162' ' ' GLN . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 149' ' ' GLU . . . . . 0.795 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 152' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.0 t30 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.586 ' HB3' ' HD3' ' J' ' 175' ' ' PRO . 2.9 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.596 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' K' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.751 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 17' ' ' SER . . . . . 0.458 ' HA ' HD13 ' K' ' 89' ' ' ILE . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' K' ' 88' ' ' GLN . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 21' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' K' ' 70' ' ' LYS . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' K' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 33' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' K' ' 32' ' ' GLN . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 36' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' L' ' 118' ' ' TYR . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 40' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' K' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' K' ' 43' ' ' LEU . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' J' ' 5' ' ' PRO . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 73' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' K' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.513 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.857 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' K' ' 113' ' ' ILE . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.857 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.5 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.45 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.751 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' K' ' 99' ' ' ASN . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.556 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.448 ' CZ ' ' HE2' ' K' ' 110' ' ' PHE . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.549 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' K' ' 83' ' ' TYR . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.55 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.589 HG21 ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 129' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.477 ' HG3' ' OE2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.647 HG12 ' HG ' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.746 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 144' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' E' ' 162' ' ' GLN . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 149' ' ' GLU . . . . . 0.799 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 152' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.0 t30 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 2.8 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.6 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 170' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 171' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.749 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 29.4 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 17' ' ' SER . . . . . 0.459 ' HA ' HD13 ' L' ' 89' ' ' ILE . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.742 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 22' ' ' THR . . . . . 0.44 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' L' ' 32' ' ' GLN . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 36' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' G' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' L' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' L' ' 43' ' ' LEU . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 66' ' ' THR . . . . . 0.403 ' OG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.414 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' L' ' 76' ' ' GLN . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.516 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 81' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.534 ' HB2' HG21 ' L' ' 113' ' ' ILE . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.735 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.455 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.749 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' L' ' 99' ' ' ASN . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.618 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' L' ' 110' ' ' PHE . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.469 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' L' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.511 ' HD2' ' HB2' ' K' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.596 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 129' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.812 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 137' ' ' GLU . . . . . 0.812 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.542 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.745 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.595 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 149' ' ' GLU . . . . . 0.786 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.0 t30 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.585 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 2.8 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.584 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 170' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 171' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.442 HG22 ' OD1' ' A' ' 10' ' ' ASP . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' OD1' HG13 ' A' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' A' ' 93' ' ' ARG . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.569 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' A' ' 91' ' ' PHE . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.879 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' A' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' A' ' 33' ' ' THR . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' A' ' 32' ' ' GLN . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' H ' ' HA ' ' B' ' 115' ' ' SER . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' HH11 ' A' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.822 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' A' ' 34' ' ' ASP . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' A' ' 79' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.429 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.64 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 22.1 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.648 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 15' ' ' PHE . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' A' ' 11' ' ' VAL . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG13 ' OD1' ' A' ' 10' ' ' ASP . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 142' ' ' GLU . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 1.022 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' HB3' HE22 ' A' ' 88' ' ' GLN . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 89' ' ' ILE . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' A' ' 83' ' ' TYR . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.64 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' F' ' 33' ' ' THR . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.454 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' F' ' 8' ' ' GLY . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.822 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' GLY . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.022 HD12 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.95 HG21 HG21 ' A' ' 94' ' ' VAL . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.496 HD11 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 27' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' G' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.786 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 32.4 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.892 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.478 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.445 HG22 ' OD1' ' B' ' 10' ' ' ASP . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' B' ' 97' ' ' VAL . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.738 HG11 HH21 ' B' ' 93' ' ' ARG . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.473 ' HD2' ' HE1' ' B' ' 91' ' ' PHE . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' B' ' 89' ' ' ILE . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 87' ' ' LYS . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' SER . . . . . 0.495 ' OG ' HD11 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.436 ' HE1' ' HG ' ' B' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' B' ' 33' ' ' THR . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' B' ' 32' ' ' GLN . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.836 ' OD2' HG22 ' B' ' 65' ' ' VAL . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.629 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.449 ' HA ' HH11 ' B' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.43 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.836 HG22 ' OD2' ' B' ' 34' ' ' ASP . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.493 ' OH ' HG21 ' B' ' 79' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.572 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.2 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.653 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' B' ' 15' ' ' PHE . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.738 HH21 HG11 ' B' ' 11' ' ' VAL . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.936 HG21 HG21 ' B' ' 145' ' ' THR . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.502 HG13 ' OD1' ' B' ' 10' ' ' ASP . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' B' ' 142' ' ' GLU . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLY . . . . . 1.006 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.436 ' HB3' HE22 ' B' ' 88' ' ' GLN . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 89' ' ' ILE . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.433 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' B' ' 83' ' ' TYR . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 33' ' ' THR . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.533 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.512 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' B' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.872 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' B' ' 136' ' ' GLY . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 1.006 HD12 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.694 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' THR . . . . . 0.936 HG21 HG21 ' B' ' 94' ' ' VAL . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.495 HD11 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.648 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' B' ' 27' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.648 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.609 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 32.4 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.609 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.672 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' GLU . . . . . 0.741 ' HA ' HD13 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.672 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 5' ' ' PRO . . . . . 0.513 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' C' ' 10' ' ' ASP . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.494 ' OD1' HG13 ' C' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.745 HG11 HH21 ' C' ' 93' ' ' ARG . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' C' ' 91' ' ' PHE . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' C' ' 89' ' ' ILE . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' C' ' 87' ' ' LYS . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.898 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.771 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' TYR . . . . . 0.433 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' C' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' C' ' 32' ' ' GLN . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.536 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.518 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' C' ' 41' ' ' ARG . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' SER . . . . . 0.896 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' C' ' 34' ' ' ASP . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.559 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 22.2 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.443 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' C' ' 15' ' ' PHE . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.745 HH21 HG11 ' C' ' 11' ' ' VAL . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.928 HG21 HG21 ' C' ' 145' ' ' THR . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' C' ' 10' ' ' ASP . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' C' ' 99' ' ' ASN . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' C' ' 98' ' ' LYS . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.667 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' C' ' 142' ' ' GLU . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.567 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 109' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' C' ' 88' ' ' GLN . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' C' ' 89' ' ' ILE . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.443 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' C' ' 83' ' ' TYR . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' VAL . . . . . 0.428 HG23 HG22 ' B' ' 33' ' ' THR . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 124' ' ' GLY . . . . . 0.617 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 63' ' ' GLY . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.896 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.472 ' H ' HG12 ' C' ' 135' ' ' ILE . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 1.024 HD12 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.686 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 145' ' ' THR . . . . . 0.928 HG21 HG21 ' C' ' 94' ' ' VAL . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.631 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.771 HG23 HD22 ' C' ' 27' ' ' LEU . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 159' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' I' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.596 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.798 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 32.4 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.596 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.923 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.673 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 169' ' ' GLU . . . . . 0.726 ' HA ' HD13 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 170' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.673 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.923 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' D' ' 10' ' ' ASP . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.509 ' OD1' HG13 ' D' ' 97' ' ' VAL . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.744 HG11 HH21 ' D' ' 93' ' ' ARG . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.454 ' HD2' ' HE1' ' D' ' 91' ' ' PHE . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.525 ' HB3' HD11 ' D' ' 89' ' ' ILE . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.889 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' ASP . . . . . 0.439 ' OD2' ' HD3' ' D' ' 87' ' ' LYS . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' SER . . . . . 0.492 ' OG ' HD11 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.889 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.785 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' D' ' 33' ' ' THR . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' THR . . . . . 0.507 HG23 ' HG2' ' D' ' 32' ' ' GLN . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.833 ' OD2' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' SER . . . . . 0.595 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.449 ' H ' ' HA ' ' E' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' D' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.477 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.833 HG22 ' OD2' ' D' ' 34' ' ' ASP . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.489 ' OH ' HG21 ' D' ' 79' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 22.1 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.536 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 15' ' ' PHE . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.454 ' HE1' ' HD2' ' D' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.744 HH21 HG11 ' D' ' 11' ' ' VAL . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.939 HG21 HG21 ' D' ' 145' ' ' THR . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 97' ' ' VAL . . . . . 0.509 HG13 ' OD1' ' D' ' 10' ' ' ASP . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' D' ' 99' ' ' ASN . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' D' ' 98' ' ' LYS . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.669 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' D' ' 142' ' ' GLU . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.569 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 109' ' ' GLY . . . . . 0.968 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' D' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' D' ' 89' ' ' ILE . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.444 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' D' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 115' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' C' ' 33' ' ' THR . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.489 HG23 ' CG2' ' C' ' 33' ' ' THR . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.516 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' D' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.414 HG13 ' H ' ' D' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.414 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.968 HD12 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.692 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.939 HG21 HG21 ' D' ' 94' ' ' VAL . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 146' ' ' LEU . . . . . 0.492 HD11 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.785 HG23 HD22 ' D' ' 27' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 159' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' J' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.449 ' HZ ' ' OD1' ' J' ' 144' ' ' ASP . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.615 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 32.4 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 164' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.615 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.914 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.689 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 169' ' ' GLU . . . . . 0.745 ' HA ' HD13 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 170' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.689 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.914 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.419 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.44 HG22 ' OD1' ' E' ' 10' ' ' ASP . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.51 ' OD1' HG13 ' E' ' 97' ' ' VAL . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.736 HG11 HH21 ' E' ' 93' ' ' ARG . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 12' ' ' LYS . . . . . 0.573 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.45 ' HD2' ' HE1' ' E' ' 91' ' ' PHE . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' E' ' 89' ' ' ILE . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' E' ' 87' ' ' LYS . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.875 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.767 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' E' ' 33' ' ' THR . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' E' ' 32' ' ' GLN . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.826 ' OD2' HG22 ' E' ' 65' ' ' VAL . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' E' ' 41' ' ' ARG . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 62' ' ' SER . . . . . 0.891 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.811 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.826 HG22 ' OD2' ' E' ' 34' ' ' ASP . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' E' ' 79' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 22.2 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.417 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.447 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' E' ' 15' ' ' PHE . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.45 ' HE1' ' HD2' ' E' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.736 HH21 HG11 ' E' ' 11' ' ' VAL . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.952 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 97' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' E' ' 10' ' ' ASP . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 98' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' E' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' E' ' 98' ' ' LYS . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.668 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' E' ' 142' ' ' GLU . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 109' ' ' GLY . . . . . 0.989 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.426 ' HB3' HE22 ' E' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' E' ' 89' ' ' ILE . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.447 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' E' ' 83' ' ' TYR . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 115' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 120' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.431 HG23 HG22 ' D' ' 33' ' ' THR . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.402 ' HA ' ' N ' ' D' ' 8' ' ' GLY . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.811 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' E' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.891 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.42 HG12 ' H ' ' E' ' 135' ' ' ILE . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.41 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.989 HD12 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.7 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.952 HG21 HG21 ' E' ' 94' ' ' VAL . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.767 HG23 HD22 ' E' ' 27' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 159' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' K' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.622 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.807 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 32.4 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 164' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.622 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.698 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 169' ' ' GLU . . . . . 0.817 ' HA ' HD13 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 170' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 171' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.698 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.902 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.539 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' F' ' 10' ' ' ASP . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' F' ' 97' ' ' VAL . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.723 HG11 HH21 ' F' ' 93' ' ' ARG . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' F' ' 91' ' ' PHE . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.536 ' HB3' HD11 ' F' ' 89' ' ' ILE . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 19' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' F' ' 87' ' ' LYS . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 24' ' ' SER . . . . . 0.489 ' OG ' HD11 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.867 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.761 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 31' ' ' TYR . . . . . 0.435 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' F' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.495 HG23 ' HG2' ' F' ' 32' ' ' GLN . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 38' ' ' SER . . . . . 0.531 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' F' ' 41' ' ' ARG . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 63' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.821 HG22 ' OD2' ' F' ' 34' ' ' ASP . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' F' ' 79' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 74' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 22.1 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.66 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' F' ' 15' ' ' PHE . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' F' ' 13' ' ' TYR . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.719 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.723 HH21 HG11 ' F' ' 11' ' ' VAL . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.958 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' F' ' 10' ' ' ASP . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' F' ' 142' ' ' GLU . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 109' ' ' GLY . . . . . 1.007 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' F' ' 88' ' ' GLN . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' F' ' 89' ' ' ILE . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.45 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' F' ' 83' ' ' TYR . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 119' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 120' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' E' ' 33' ' ' THR . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.81 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' F' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' F' ' 136' ' ' GLY . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 1.007 HD12 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.701 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.958 HG21 HG21 ' F' ' 94' ' ' VAL . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 146' ' ' LEU . . . . . 0.489 HD11 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.628 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.761 HG23 HD22 ' F' ' 27' ' ' LEU . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.628 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.815 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.712 ' CE1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.7 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 32.4 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.69 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.855 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 170' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.69 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.915 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.434 HG22 ' OD1' ' G' ' 10' ' ' ASP . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 8' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' H' ' 125' ' ' ALA . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' G' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.734 HG11 HH21 ' G' ' 93' ' ' ARG . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.476 ' HD2' ' HE1' ' G' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 15' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' G' ' 89' ' ' ILE . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.887 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.754 HD13 ' HA ' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' G' ' 87' ' ' LYS . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 21' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 24' ' ' SER . . . . . 0.499 ' OG ' HD11 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.887 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.769 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' G' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' G' ' 32' ' ' GLN . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.837 ' OD2' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.45 ' HA ' HH11 ' G' ' 41' ' ' ARG . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.533 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 57' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 63' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.816 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.837 HG22 ' OD2' ' G' ' 34' ' ' ASP . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.476 ' OH ' HG21 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 22.2 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.662 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.495 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.422 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' G' ' 15' ' ' PHE . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' G' ' 13' ' ' TYR . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.723 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.734 HH21 HG11 ' G' ' 11' ' ' VAL . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.956 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 97' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' G' ' 10' ' ' ASP . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' G' ' 99' ' ' ASN . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' G' ' 98' ' ' LYS . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.606 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' G' ' 142' ' ' GLU . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 109' ' ' GLY . . . . . 0.996 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' G' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' G' ' 89' ' ' ILE . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' G' ' 83' ' ' TYR . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.503 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.816 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' G' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.44 ' H ' HG12 ' G' ' 135' ' ' ILE . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.404 ' H ' HG13 ' G' ' 135' ' ' ILE . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.996 HD12 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.694 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.956 HG21 HG21 ' G' ' 94' ' ' VAL . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 146' ' ' LEU . . . . . 0.499 HD11 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.641 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.769 HG23 HD22 ' G' ' 27' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.616 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' G' G ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.919 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.671 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 170' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.671 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.919 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.427 HG22 ' OD1' ' H' ' 10' ' ' ASP . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' H' ' 97' ' ' VAL . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' H' ' 93' ' ' ARG . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.472 ' HD2' ' HE1' ' H' ' 91' ' ' PHE . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' H' ' 89' ' ' ILE . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.896 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HD3' ' H' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 163' ' ' PRO . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 24' ' ' SER . . . . . 0.497 ' OG ' HD11 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.896 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.789 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' H' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' H' ' 32' ' ' GLN . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.834 ' OD2' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 38' ' ' SER . . . . . 0.49 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' H' ' 41' ' ' ARG . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 57' ' ' GLY . . . . . 0.483 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 63' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.829 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.834 HG22 ' OD2' ' H' ' 34' ' ' ASP . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.478 ' OH ' HG21 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.642 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 22.1 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.651 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.599 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' H' ' 15' ' ' PHE . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.472 ' HE1' ' HD2' ' H' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' H' ' 11' ' ' VAL . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 97' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' H' ' 10' ' ' ASP . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' H' ' 99' ' ' ASN . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' H' ' 98' ' ' LYS . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.659 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' H' ' 142' ' ' GLU . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 109' ' ' GLY . . . . . 1.043 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' H' ' 88' ' ' GLN . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' H' ' 89' ' ' ILE . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' H' ' 83' ' ' TYR . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 121' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.509 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.829 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.428 ' H ' HG12 ' H' ' 135' ' ' ILE . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.419 ' H ' HG13 ' H' ' 135' ' ' ILE . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 1.043 HD12 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.682 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 146' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.789 HG23 HD22 ' H' ' 27' ' ' LEU . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.607 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' H' H ' 162' ' ' GLN . . . . . 0.79 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 163' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.607 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.872 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.669 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 170' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.669 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.872 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.582 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' I' ' 10' ' ' ASP . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.506 ' OD1' HG13 ' I' ' 97' ' ' VAL . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.729 HG11 HH21 ' I' ' 93' ' ' ARG . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' I' ' 91' ' ' PHE . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' I' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' I' ' 87' ' ' LYS . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' C' ' 163' ' ' PRO . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 24' ' ' SER . . . . . 0.488 ' OG ' HD11 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.884 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.496 ' HG2' HG23 ' I' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.501 HG22 ' HA2' ' J' ' 121' ' ' GLY . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' I' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' I' ' 34' ' ' ASP . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.487 ' OH ' HG21 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.655 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 22.2 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.655 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' I' ' 15' ' ' PHE . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.463 ' HE1' ' HD2' ' I' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.729 HH21 HG11 ' I' ' 11' ' ' VAL . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.925 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 97' ' ' VAL . . . . . 0.506 HG13 ' OD1' ' I' ' 10' ' ' ASP . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.658 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.601 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' I' ' 142' ' ' GLU . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 109' ' ' GLY . . . . . 0.994 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.422 ' HB3' HE22 ' I' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.427 ' HB3' HG23 ' I' ' 89' ' ' ILE . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.435 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' I' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 120' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' H' ' 33' ' ' THR . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 121' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.52 HG13 ' O ' ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' I' ' 63' ' ' GLY . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.413 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.413 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.994 HD12 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.673 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 145' ' ' THR . . . . . 0.925 HG21 HG21 ' I' ' 94' ' ' VAL . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 146' ' ' LEU . . . . . 0.488 HD11 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' I' ' 27' ' ' LEU . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' I' I ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.609 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.684 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 170' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.684 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.532 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' J' ' 10' ' ' ASP . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.504 ' OD1' HG13 ' J' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.75 HG11 HH21 ' J' ' 93' ' ' ARG . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' J' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.515 ' HB3' HD11 ' J' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.87 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' J' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.87 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.77 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' J' ' 33' ' ' THR . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 33' ' ' THR . . . . . 0.502 HG23 ' HG2' ' J' ' 32' ' ' GLN . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.839 ' OD2' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 38' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' J' ' 41' ' ' ARG . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' E' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 62' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 63' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.839 HG22 ' OD2' ' J' ' 34' ' ' ASP . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' J' ' 79' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 69' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 71' ' ' ARG . . . . . 0.409 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 74' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 22.1 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.685 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' J' ' 15' ' ' PHE . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' J' ' 13' ' ' TYR . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.75 HH21 HG11 ' J' ' 11' ' ' VAL . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.938 HG21 HG21 ' J' ' 145' ' ' THR . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 97' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' J' ' 10' ' ' ASP . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' J' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' J' ' 98' ' ' LYS . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' J' ' 142' ' ' GLU . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' J' ' 88' ' ' GLN . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' J' ' 89' ' ' ILE . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.448 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.431 HG21 ' HD1' ' J' ' 83' ' ' TYR . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 120' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 121' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.48 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' J' ' 63' ' ' GLY . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.897 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.411 HG13 ' H ' ' J' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 140' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.68 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' HZ ' ' D' ' 160' ' ' PHE . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.938 HG21 HG21 ' J' ' 94' ' ' VAL . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.77 HG23 HD22 ' J' ' 27' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.617 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' J' J ' 162' ' ' GLN . . . . . 0.801 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 163' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 164' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.617 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.911 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.688 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 170' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.688 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.911 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.518 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' K' ' 10' ' ' ASP . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' K' ' 97' ' ' VAL . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.718 HG11 HH21 ' K' ' 93' ' ' ARG . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 12' ' ' LYS . . . . . 0.579 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.457 ' HD2' ' HE1' ' K' ' 91' ' ' PHE . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.523 ' HB3' HD11 ' K' ' 89' ' ' ILE . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.817 HD13 ' HA ' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' K' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 21' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.861 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.776 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' K' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 33' ' ' THR . . . . . 0.505 HG23 ' HG2' ' K' ' 32' ' ' GLN . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' K' ' 65' ' ' VAL . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 40' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' L' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.449 HH11 ' HA ' ' K' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 57' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 62' ' ' SER . . . . . 0.88 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 63' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.819 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' K' ' 34' ' ' ASP . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.491 ' OH ' HG21 ' K' ' 79' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.632 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 22.1 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.632 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' K' ' 15' ' ' PHE . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.457 ' HE1' ' HD2' ' K' ' 13' ' ' TYR . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.718 HH21 HG11 ' K' ' 11' ' ' VAL . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.955 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' K' ' 10' ' ' ASP . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' K' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' K' ' 98' ' ' LYS . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' K' ' 142' ' ' GLU . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 109' ' ' GLY . . . . . 0.975 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.437 ' HB3' HE22 ' K' ' 88' ' ' GLN . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' K' ' 89' ' ' ILE . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' K' ' 83' ' ' TYR . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 119' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' J' ' 8' ' ' GLY . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.507 HG13 ' O ' ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.819 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' K' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.88 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.412 ' H ' HG12 ' K' ' 135' ' ' ILE . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.975 HD12 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.955 HG21 HG21 ' K' ' 94' ' ' VAL . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.776 HG23 HD22 ' K' ' 27' ' ' LEU . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.611 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' K' K ' 162' ' ' GLN . . . . . 0.783 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 163' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 164' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.611 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.905 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.679 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 170' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 171' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.679 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.905 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.447 HG22 ' OD1' ' L' ' 10' ' ' ASP . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' L' ' 97' ' ' VAL . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.739 HG11 HH21 ' L' ' 93' ' ' ARG . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 12' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD2' ' HE1' ' L' ' 91' ' ' PHE . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' L' ' 89' ' ' ILE . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' L' ' 87' ' ' LYS . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 24' ' ' SER . . . . . 0.486 ' OG ' HD11 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.873 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.762 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' L' ' 33' ' ' THR . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' L' ' 32' ' ' GLN . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.828 ' OD2' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 38' ' ' SER . . . . . 0.495 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' L' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.828 HG22 ' OD2' ' L' ' 34' ' ' ASP . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.482 ' OH ' HG21 ' L' ' 79' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' L' ' 71' ' ' ARG . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.643 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 22.1 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.64 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.855 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' L' ' 15' ' ' PHE . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.469 ' HE1' ' HD2' ' L' ' 13' ' ' TYR . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.739 HH21 HG11 ' L' ' 11' ' ' VAL . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.947 HG21 HG21 ' L' ' 145' ' ' THR . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' L' ' 10' ' ' ASP . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 98' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' L' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' L' ' 98' ' ' LYS . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' L' ' 142' ' ' GLU . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' L' ' 138' ' ' LEU . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' L' ' 89' ' ' ILE . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.428 HG21 ' HD1' ' L' ' 83' ' ' TYR . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 115' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.418 HG23 HG22 ' K' ' 33' ' ' THR . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.505 HG13 ' O ' ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.812 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' L' ' 63' ' ' GLY . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.43 ' H ' HG12 ' L' ' 135' ' ' ILE . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.815 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 1.7 p30 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.712 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.491 ' OD1' ' HZ ' ' F' ' 160' ' ' PHE . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.947 HG21 HG21 ' L' ' 94' ' ' VAL . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 146' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.762 HG23 HD22 ' L' ' 27' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' L' L ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 164' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.606 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.889 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.686 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.686 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.889 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' A' ' 93' ' ' ARG . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.614 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.667 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.683 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HG2' HG23 ' A' ' 33' ' ' THR . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.585 HG22 HG23 ' B' ' 122' ' ' VAL . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.76 ' OD2' HG22 ' A' ' 65' ' ' VAL . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 117' ' ' GLU . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.794 ' HA ' HH11 ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.677 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' B' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.677 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.733 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.76 HG22 ' OD2' ' A' ' 34' ' ' ASP . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.419 ' OH ' HG21 ' A' ' 79' ' ' ILE . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 126' ' ' VAL . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.656 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.811 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 21.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 15' ' ' PHE . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.779 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.791 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.5 HG23 HG22 ' F' ' 33' ' ' THR . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.49 HG13 ' O ' ' F' ' 7' ' ' MET . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.699 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.733 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.009 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.948 HG21 HG21 ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.588 HG23 HD22 ' A' ' 27' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' G' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.508 ' HA ' ' CZ3' ' G' ' 92' ' ' TRP . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.525 ' H ' ' HH2' ' G' ' 92' ' ' TRP . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.67 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 33.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' G' ' 18' ' ' ILE . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.803 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' B' ' 6' ' ' ILE . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' B' ' 93' ' ' ARG . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.664 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.666 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.664 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' B' ' 33' ' ' THR . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.548 HG22 HG23 ' C' ' 122' ' ' VAL . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' B' ' 65' ' ' VAL . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' C' ' 117' ' ' GLU . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.67 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.791 ' HA ' HH11 ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.673 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.622 ' HB2' ' HG3' ' C' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' B' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' B' ' 79' ' ' ILE . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' B' ' 126' ' ' VAL . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' B' ' 77' ' ' LYS . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.569 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.825 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 21.5 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.825 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.635 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.41 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.609 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' B' ' 15' ' ' PHE . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 1.002 HG21 HG21 ' B' ' 145' ' ' THR . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' B' ' 94' ' ' VAL . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.611 ' HB2' HD11 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.609 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.791 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.485 ' HD2' ' NH2' ' B' ' 116' ' ' ARG . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.794 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.585 HG23 HG22 ' A' ' 33' ' ' THR . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.477 HG23 ' H ' ' B' ' 69' ' ' GLY . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.791 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' B' ' 110' ' ' PHE . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' THR . . . . . 1.002 HG21 HG21 ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.591 HG23 HD22 ' B' ' 27' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.456 ' HA ' ' CZ3' ' H' ' 92' ' ' TRP . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.668 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 33.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.479 ' HA ' HG22 ' B' ' 173' ' ' THR . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.479 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' C' ' 6' ' ' ILE . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.564 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' C' ' 93' ' ' ARG . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.633 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.66 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . 0.633 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' TYR . . . . . 0.405 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' C' ' 33' ' ' THR . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.634 HG22 HG23 ' D' ' 122' ' ' VAL . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' C' ' 65' ' ' VAL . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.791 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' D' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 41' ' ' ARG . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' C' ' 34' ' ' ASP . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.417 ' OH ' HG21 ' C' ' 79' ' ' ILE . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' C' ' 126' ' ' VAL . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' C' ' 77' ' ' LYS . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.815 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 21.7 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.815 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.67 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.633 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' C' ' 15' ' ' PHE . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.667 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 1.009 HG21 HG21 ' C' ' 145' ' ' THR . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' C' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.678 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' C' ' 94' ' ' VAL . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 109' ' ' GLY . . . . . 0.995 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.633 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.768 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.477 ' HD2' ' NH2' ' C' ' 116' ' ' ARG . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.773 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' VAL . . . . . 0.548 HG23 HG22 ' B' ' 33' ' ' THR . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' C' ' 69' ' ' GLY . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.773 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.768 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.726 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' C' ' 110' ' ' PHE . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.995 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 145' ' ' THR . . . . . 1.009 HG21 HG21 ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.604 HG23 HD22 ' C' ' 27' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.676 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 33.3 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.836 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.48 ' HA ' HG22 ' C' ' 173' ' ' THR . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.48 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.836 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.438 HG21 ' NH2' ' D' ' 93' ' ' ARG . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' LYS . . . . . 0.668 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.668 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' D' ' 33' ' ' THR . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' THR . . . . . 0.575 HG22 HG23 ' E' ' 122' ' ' VAL . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' D' ' 65' ' ' VAL . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.638 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.797 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.654 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.552 ' HB2' ' HG3' ' E' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLY . . . . . 0.654 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' SER . . . . . 0.493 ' O ' ' N ' ' D' ' 41' ' ' ARG . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' SER . . . . . 0.751 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' D' ' 34' ' ' ASP . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' D' ' 79' ' ' ILE . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.582 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.461 ' H ' HG23 ' D' ' 126' ' ' VAL . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' D' ' 77' ' ' LYS . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.648 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.816 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 21.6 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' D' ' 15' ' ' PHE . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.977 HG21 HG21 ' D' ' 145' ' ' THR . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.4 ' N ' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' D' ' 94' ' ' VAL . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 109' ' ' GLY . . . . . 0.981 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.785 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.478 ' HD2' ' NH2' ' D' ' 116' ' ' ARG . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.634 HG23 HG22 ' C' ' 33' ' ' THR . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 69' ' ' GLY . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.785 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.69 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.751 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' D' ' 110' ' ' PHE . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.981 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.615 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.977 HG21 HG21 ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' D' ' 27' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.681 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 159' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.583 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 33.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' J' ' 18' ' ' ILE . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' E' ' 93' ' ' ARG . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 12' ' ' LYS . . . . . 0.666 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.622 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 30' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' E' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' E' ' 32' ' ' GLN . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' E' ' 65' ' ' VAL . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.563 HG22 ' HG2' ' F' ' 117' ' ' GLU . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 40' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' F' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.658 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' F' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 57' ' ' GLY . . . . . 0.658 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 58' ' ' SER . . . . . 0.477 ' O ' ' N ' ' E' ' 41' ' ' ARG . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 62' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.754 HG22 ' OD2' ' E' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' E' ' 79' ' ' ILE . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 69' ' ' GLY . . . . . 0.453 ' H ' HG23 ' E' ' 126' ' ' VAL . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 77' ' ' LYS . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.813 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 21.6 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.638 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.62 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' E' ' 15' ' ' PHE . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.684 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.509 ' CB ' HG12 ' E' ' 94' ' ' VAL . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 109' ' ' GLY . . . . . 0.957 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.617 ' HB2' HD11 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.62 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 115' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.481 ' HD2' ' NH2' ' E' ' 116' ' ' ARG . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 119' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.575 HG23 HG22 ' D' ' 33' ' ' THR . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.453 HG23 ' H ' ' E' ' 69' ' ' GLY . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.801 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' E' ' 110' ' ' PHE . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.405 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.957 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.625 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.584 HG23 HD22 ' E' ' 27' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.486 ' HA ' ' CZ3' ' K' ' 92' ' ' TRP . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.484 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 33.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.81 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.478 ' HA ' HG22 ' E' ' 173' ' ' THR . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.478 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.81 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' F' ' 93' ' ' ARG . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 12' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.664 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.676 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' F' ' 33' ' ' THR . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.5 HG22 HG23 ' A' ' 122' ' ' VAL . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.75 ' OD2' HG22 ' F' ' 65' ' ' VAL . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 117' ' ' GLU . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 40' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' F' ' 41' ' ' ARG . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 62' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.713 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.75 HG22 ' OD2' ' F' ' 34' ' ' ASP . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' F' ' 79' ' ' ILE . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.59 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.471 ' H ' HG23 ' F' ' 126' ' ' VAL . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' F' ' 77' ' ' LYS . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 74' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.651 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 21.6 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' F' ' 15' ' ' PHE . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.666 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.966 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 97' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' F' ' 104' ' ' TYR . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' F' ' 142' ' ' GLU . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' F' ' 94' ' ' VAL . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 109' ' ' GLY . . . . . 0.974 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.788 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.489 ' HD2' ' NH2' ' F' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 122' ' ' VAL . . . . . 0.453 HG23 HG22 ' E' ' 33' ' ' THR . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.471 HG23 ' H ' ' F' ' 69' ' ' GLY . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.788 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.713 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' F' ' 110' ' ' PHE . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.4 ' N ' HG13 ' F' ' 135' ' ' ILE . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.974 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.626 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.966 HG21 HG21 ' F' ' 94' ' ' VAL . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.586 HG23 HD22 ' F' ' 27' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 1.003 ' CE1' HD13 ' L' ' 143' ' ' ILE . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.837 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.833 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 33.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.79 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.821 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.802 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.821 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.507 ' HB3' ' HE3' ' H' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.6 ' O ' HG22 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.44 HG21 ' NH2' ' G' ' 93' ' ' ARG . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 12' ' ' LYS . . . . . 0.679 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.679 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 31' ' ' TYR . . . . . 0.4 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' G' ' 33' ' ' THR . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' G' ' 32' ' ' GLN . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' G' ' 65' ' ' VAL . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.587 HG22 ' HG2' ' H' ' 117' ' ' GLU . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.8 ' HA ' HH11 ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' H' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' G' ' 41' ' ' ARG . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 62' ' ' SER . . . . . 0.713 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' G' ' 34' ' ' ASP . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.427 ' OH ' HG21 ' G' ' 79' ' ' ILE . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' G' ' 126' ' ' VAL . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 73' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' G' ' 77' ' ' LYS . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 21.6 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.549 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.631 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' G' ' 15' ' ' PHE . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' G' ' 104' ' ' TYR . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' G' ' 94' ' ' VAL . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.534 ' CE2' HD13 ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.631 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.588 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HB3' HH12 ' L' ' 93' ' ' ARG . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 119' ' ' SER . . . . . 0.772 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 122' ' ' VAL . . . . . 0.446 HG23 HG22 ' L' ' 33' ' ' THR . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.554 HG22 ' O ' ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.714 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.401 ' N ' HG13 ' G' ' 135' ' ' ILE . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 140' ' ' ASN . . . . . 0.43 ' CB ' ' HB3' ' A' ' 159' ' ' ASP . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.625 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' G' ' 94' ' ' VAL . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.59 HG23 HD22 ' G' ' 27' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.672 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.471 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' G' G ' 162' ' ' GLN . . . . . 0.687 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 163' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.467 ' HA ' HG22 ' G' ' 173' ' ' THR . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.467 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' HE3' ' I' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.607 ' O ' HG22 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' H' ' 93' ' ' ARG . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 12' ' ' LYS . . . . . 0.684 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.684 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' H' ' 33' ' ' THR . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 33' ' ' THR . . . . . 0.485 HG23 ' HG2' ' H' ' 32' ' ' GLN . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' H' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' I' ' 117' ' ' GLU . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.799 ' HA ' HH11 ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.676 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' I' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 57' ' ' GLY . . . . . 0.676 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 58' ' ' SER . . . . . 0.506 ' O ' ' N ' ' H' ' 41' ' ' ARG . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 62' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' H' ' 34' ' ' ASP . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.432 ' OH ' HG21 ' H' ' 79' ' ' ILE . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' H' ' 126' ' ' VAL . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' H' ' 77' ' ' LYS . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.645 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.808 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 21.6 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.808 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.4 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' H' ' 15' ' ' PHE . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.678 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.402 ' N ' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 97' ' ' VAL . . . . . 0.454 ' O ' ' HD1' ' H' ' 104' ' ' TYR . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' H' ' 142' ' ' GLU . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' H' ' 94' ' ' VAL . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 109' ' ' GLY . . . . . 1.0 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.771 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.587 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.512 ' HB3' HH12 ' G' ' 93' ' ' ARG . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 119' ' ' SER . . . . . 0.797 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.6 HG22 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.771 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.405 ' N ' HG13 ' H' ' 135' ' ' ILE . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 1.0 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.611 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.595 HG23 HD22 ' H' ' 27' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.67 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.483 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' H' H ' 162' ' ' GLN . . . . . 0.664 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 163' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 164' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.807 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.464 ' HA ' HG22 ' H' ' 173' ' ' THR . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.464 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.807 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.625 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.48 ' O ' HG22 ' J' ' 126' ' ' VAL . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' I' ' 93' ' ' ARG . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 12' ' ' LYS . . . . . 0.657 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' C' ' 163' ' ' PRO . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.657 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' I' ' 33' ' ' THR . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' I' ' 32' ' ' GLN . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' I' ' 65' ' ' VAL . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' J' ' 117' ' ' GLU . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 40' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' J' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.793 ' HA ' HH11 ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.666 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 57' ' ' GLY . . . . . 0.666 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 58' ' ' SER . . . . . 0.502 ' O ' ' N ' ' I' ' 41' ' ' ARG . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 62' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' I' ' 34' ' ' ASP . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' I' ' 79' ' ' ILE . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.476 ' H ' HG23 ' I' ' 126' ' ' VAL . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' I' ' 77' ' ' LYS . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.66 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 21.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.625 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' I' ' 15' ' ' PHE . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.531 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 1.011 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' I' ' 104' ' ' TYR . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' I' ' 142' ' ' GLU . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' I' ' 94' ' ' VAL . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 109' ' ' GLY . . . . . 0.999 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.625 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' I' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.607 HG22 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.686 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.745 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.407 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.999 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.605 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 145' ' ' THR . . . . . 1.011 HG21 HG21 ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' I' ' 27' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.673 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.487 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' I' I ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.826 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.473 ' HA ' HG22 ' I' ' 173' ' ' THR . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.826 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.616 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.507 ' O ' HG22 ' K' ' 126' ' ' VAL . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' J' ' 93' ' ' ARG . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 12' ' ' LYS . . . . . 0.665 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.665 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.402 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.498 ' HG2' HG23 ' J' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 33' ' ' THR . . . . . 0.498 HG23 ' HG2' ' J' ' 32' ' ' GLN . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' J' ' 65' ' ' VAL . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' K' ' 117' ' ' GLU . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' K' ' 83' ' ' TYR . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.653 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' K' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 57' ' ' GLY . . . . . 0.653 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 58' ' ' SER . . . . . 0.488 ' O ' ' N ' ' J' ' 41' ' ' ARG . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 62' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' J' ' 34' ' ' ASP . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG21 ' J' ' 79' ' ' ILE . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 69' ' ' GLY . . . . . 0.466 ' H ' HG23 ' J' ' 126' ' ' VAL . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.625 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 73' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' J' ' 77' ' ' LYS . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 74' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 21.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.637 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' J' ' 15' ' ' PHE . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.998 HG21 HG21 ' J' ' 145' ' ' THR . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HD1' ' J' ' 104' ' ' TYR . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' J' ' 94' ' ' VAL . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 109' ' ' GLY . . . . . 0.952 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.637 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.49 ' HD2' ' NH2' ' J' ' 116' ' ' ARG . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 119' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 122' ' ' VAL . . . . . 0.469 HG23 HG22 ' I' ' 33' ' ' THR . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.495 HG13 ' O ' ' I' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.789 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.737 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' J' ' 110' ' ' PHE . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.952 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 140' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.603 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.998 HG21 HG21 ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.603 HG23 HD22 ' J' ' 27' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.679 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.474 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' J' J ' 162' ' ' GLN . . . . . 0.669 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 164' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.474 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.485 ' HA ' HG22 ' J' ' 173' ' ' THR . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' J' J ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' J' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.445 ' O ' HG22 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.579 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.579 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' K' ' 93' ' ' ARG . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 12' ' ' LYS . . . . . 0.675 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.672 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.675 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' K' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 33' ' ' THR . . . . . 0.574 HG22 HG23 ' L' ' 122' ' ' VAL . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' K' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.595 HG22 ' HG2' ' L' ' 117' ' ' GLU . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 40' ' ' GLU . . . . . 0.498 ' HG3' ' CE1' ' L' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.794 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.651 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 57' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 58' ' ' SER . . . . . 0.465 ' O ' ' N ' ' K' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 62' ' ' SER . . . . . 0.744 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' K' ' 34' ' ' ASP . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' K' ' 79' ' ' ILE . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.468 ' H ' HG23 ' K' ' 126' ' ' VAL . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.616 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 73' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' K' ' 77' ' ' LYS . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.65 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.81 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 21.6 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.81 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' K' ' 15' ' ' PHE . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.663 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.959 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' K' ' 104' ' ' TYR . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' K' ' 142' ' ' GLU . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' K' ' 94' ' ' VAL . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.641 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.783 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HB3' HH12 ' J' ' 93' ' ' ARG . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 119' ' ' SER . . . . . 0.807 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 122' ' ' VAL . . . . . 0.495 HG23 HG22 ' J' ' 33' ' ' THR . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' J' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.807 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.707 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.744 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.406 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.604 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.959 HG21 HG21 ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.583 HG23 HD22 ' K' ' 27' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' K' K ' 162' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.818 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.49 ' HA ' HG22 ' K' ' 173' ' ' THR . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.49 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.818 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' K' K ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' K' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.554 ' O ' HG22 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.442 HG21 ' NH2' ' L' ' 93' ' ' ARG . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 12' ' ' LYS . . . . . 0.672 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.802 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 30' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 31' ' ' TYR . . . . . 0.401 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' L' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' L' ' 32' ' ' GLN . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' L' ' 65' ' ' VAL . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' G' ' 117' ' ' GLU . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.803 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' G' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 58' ' ' SER . . . . . 0.482 ' O ' ' N ' ' L' ' 41' ' ' ARG . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 62' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' L' ' 34' ' ' ASP . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' L' ' 79' ' ' ILE . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.594 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' L' ' 126' ' ' VAL . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' L' ' 77' ' ' LYS . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.658 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.827 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 21.6 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.827 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' L' ' 15' ' ' PHE . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.837 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.972 HG21 HG21 ' L' ' 145' ' ' THR . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' L' ' 104' ' ' TYR . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' L' ' 94' ' ' VAL . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' L' ' 138' ' ' LEU . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 115' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.774 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.486 ' HD2' ' NH2' ' L' ' 116' ' ' ARG . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 119' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.574 HG23 HG22 ' K' ' 33' ' ' THR . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' L' ' 69' ' ' GLY . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.795 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.74 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' L' ' 110' ' ' PHE . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.922 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 1.0 OUTLIER -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 1.003 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.972 HG21 HG21 ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.587 HG23 HD22 ' L' ' 27' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' L' L ' 162' ' ' GLN . . . . . 0.682 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.481 ' HA ' HG22 ' L' ' 173' ' ' THR . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.481 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 HG11 ' B' ' 126' ' ' VAL . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 26.8 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.681 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG13 ' HG2' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' B' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.963 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.887 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.963 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 29' ' ' PRO . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.621 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.584 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.815 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' A' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.665 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' HG13 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.525 HG13 ' O ' ' F' ' 32' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' F' ' 6' ' ' ILE . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 110' ' ' PHE . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.742 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.815 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.713 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.713 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 3.1 t30 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.587 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.631 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 3.2 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 2.3 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.788 ' HB ' HG22 ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.443 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.649 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.502 HG22 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.61 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 26.9 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.675 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.707 HG13 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' C' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.961 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.975 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.961 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.644 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 1.012 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 1.012 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.612 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.731 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.586 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.635 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.61 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.788 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.446 ' CB ' ' HB3' ' B' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.66 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.73 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.674 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.51 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.547 HD12 ' H ' ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.421 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.902 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.688 ' HG2' HG13 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 11' ' ' VAL . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.902 HG22 ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.674 HG13 ' O ' ' B' ' 110' ' ' PHE . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.887 HG12 ' HG ' ' A' ' 54' ' ' LEU . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.64 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.73 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.788 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.728 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.728 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 3.1 t30 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.604 ' HB2' ' HH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.51 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 3.2 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.642 ' HB3' ' HD3' ' B' ' 175' ' ' PRO . 2.3 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.64 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.64 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 5' ' ' PRO . . . . . 0.757 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.595 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 26.9 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.561 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.94 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 29' ' ' PRO . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ARG . . . . . 0.649 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 1.029 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 1.029 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' C' ' 82' ' ' ALA . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.736 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ASP . . . . . 0.634 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.595 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.817 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' C' ' 142' ' ' GLU . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.89 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.732 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.557 ' H ' HD12 ' C' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.419 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.899 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.707 ' HG2' HG13 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 32' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.899 HG22 ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.736 HD21 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' C' ' 110' ' ' PHE . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.975 HG12 ' HG ' ' B' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.732 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.817 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.735 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 3.1 t30 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.545 ' HB2' ' HH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.518 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 3.2 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 175' ' ' PRO . 2.3 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.632 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 5' ' ' PRO . . . . . 0.66 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.411 HG21 HG11 ' E' ' 126' ' ' VAL . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 26.8 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.67 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.529 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.698 HG13 ' HG2' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' E' ' 83' ' ' TYR . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.449 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.983 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.884 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.983 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' D' ' 29' ' ' PRO . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.757 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.474 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 1.025 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.624 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.581 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ASP . . . . . 0.647 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.601 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' D' ' 142' ' ' GLU . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.653 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.863 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.722 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.669 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.541 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.909 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.759 ' HG2' HG13 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.561 HG13 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.909 HG22 ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.669 HG13 ' O ' ' D' ' 110' ' ' PHE . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.94 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.418 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.863 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.825 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.732 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 3.1 t30 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.563 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.451 ' O ' ' HZ2' ' J' ' 92' ' ' TRP . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.633 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 3.3 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.454 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.64 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 2.3 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.784 ' HB ' HG22 ' J' ' 18' ' ' ILE . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.488 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 169' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' J' ' 88' ' ' GLN . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 170' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.798 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 26.8 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.663 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.581 HG13 ' HG2' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' SER . . . . . 0.53 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.988 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 55' ' ' GLY . . . . . 0.988 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 57' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.498 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' E' ' 29' ' ' PRO . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.66 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.487 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.745 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 95' ' ' ASP . . . . . 0.642 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.808 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.447 ' CB ' ' HB3' ' E' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.737 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.549 HD12 ' H ' ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.925 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.698 ' HG2' HG13 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.529 HG13 ' O ' ' D' ' 32' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.411 HG11 HG21 ' D' ' 11' ' ' VAL . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.925 HG22 ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.745 HD21 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.884 HG12 ' HG ' ' D' ' 54' ' ' LEU . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.808 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 152' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 3.1 t30 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.639 ' HB2' ' HH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.612 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 3.2 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.634 ' HB3' ' HD3' ' E' ' 175' ' ' PRO . 2.3 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.682 ' HB ' HG22 ' K' ' 18' ' ' ILE . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 168' ' ' GLY . . . . . 0.4 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.531 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.461 ' CG2' HG11 ' A' ' 126' ' ' VAL . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 26.8 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.54 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 29' ' ' PRO . . . . . 0.54 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.525 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.552 HG13 ' HG2' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 38' ' ' SER . . . . . 0.414 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.458 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.973 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.742 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 55' ' ' GLY . . . . . 0.973 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 57' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' F' ' 29' ' ' PRO . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 71' ' ' ARG . . . . . 0.798 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.492 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.976 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.976 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.732 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 95' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' F' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.723 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.555 HD12 ' H ' ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.9 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.581 ' HG2' HG13 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 122' ' ' VAL . . . . . 0.44 HG13 ' O ' ' E' ' 32' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 128' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' F' ' 69' ' ' GLY . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.9 HG22 ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.732 HD21 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' F' ' 110' ' ' PHE . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 1.037 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.709 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 3.1 t30 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' L' ' 92' ' ' TRP . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.913 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.804 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 3.2 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.605 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.651 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 2.3 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 167' ' ' THR . . . . . 1.122 ' HB ' HG22 ' L' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.759 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 170' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' H' ' 121' ' ' GLY . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 26.8 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB ' ' A' ' 167' ' ' THR . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.451 HG13 ' CG ' ' H' ' 117' ' ' GLU . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 38' ' ' SER . . . . . 0.592 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.919 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 55' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 57' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' G' ' 29' ' ' PRO . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 71' ' ' ARG . . . . . 0.553 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.963 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.675 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.963 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.631 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 95' ' ' ASP . . . . . 0.633 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' G' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.561 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.505 ' CG ' HG13 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 122' ' ' VAL . . . . . 0.439 HG13 ' O ' ' L' ' 32' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' G' ' 110' ' ' PHE . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.974 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 137' ' ' GLU . . . . . 0.624 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' G' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 3.1 t30 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.651 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 2.3 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.613 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 170' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 171' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.424 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.568 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.574 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 26.9 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.68 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.437 HG13 ' HG2' ' I' ' 117' ' ' GLU . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.945 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.909 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 55' ' ' GLY . . . . . 0.945 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 71' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 81' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.983 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.702 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.983 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.623 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.716 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.604 ' HH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 95' ' ' ASP . . . . . 0.641 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.811 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.455 ' CB ' ' HB3' ' H' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.712 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.551 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.412 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.907 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.451 ' CG ' HG13 ' G' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 121' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' G' ' 8' ' ' GLY . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.907 HG22 ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.716 HD21 ' HE1' ' H' ' 91' ' ' PHE . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.919 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.716 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.811 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.703 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 3.1 t30 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.633 ' HB3' ' HD3' ' H' ' 175' ' ' PRO . 2.3 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.628 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.623 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.608 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' J' ' 126' ' ' VAL . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 26.7 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.523 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.607 HG13 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.953 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 1.047 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 55' ' ' GLY . . . . . 0.953 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' I' ' 29' ' ' PRO . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.495 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 81' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 1.008 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 1.008 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.466 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.58 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 95' ' ' ASP . . . . . 0.629 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.608 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' I' ' 142' ' ' GLU . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.512 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.556 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.437 ' HG2' HG13 ' H' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 122' ' ' VAL . . . . . 0.427 HG13 ' O ' ' H' ' 32' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.574 HG21 ' HB ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' I' ' 110' ' ' PHE . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.909 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.733 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 3.1 t30 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.635 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 2.3 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.639 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 170' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 171' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.639 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.602 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.596 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.462 ' CG2' HG11 ' K' ' 126' ' ' VAL . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.575 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 26.8 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' D' ' 167' ' ' THR . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 38' ' ' SER . . . . . 0.493 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.969 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 55' ' ' GLY . . . . . 0.969 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 63' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' J' ' 29' ' ' PRO . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 71' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 81' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 1.021 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 1.021 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.625 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.459 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.733 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 95' ' ' ASP . . . . . 0.625 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.596 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.806 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.456 ' CB ' ' HB3' ' J' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.729 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.544 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.892 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.607 ' CG ' HG13 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 122' ' ' VAL . . . . . 0.523 HG13 ' O ' ' I' ' 32' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' I' ' 6' ' ' ILE . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.892 HG22 ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.733 HD21 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' J' ' 110' ' ' PHE . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 1.047 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.788 ' HB2' ' NE2' ' K' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.806 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.719 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 3.1 t30 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.625 ' HB3' ' HD3' ' J' ' 175' ' ' PRO . 2.3 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.635 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 171' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.635 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HE ' ' L' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.503 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 26.8 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' E' ' 167' ' ' THR . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.536 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' K' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.635 HG13 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 38' ' ' SER . . . . . 0.44 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.985 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 1.057 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 55' ' ' GLY . . . . . 0.985 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 57' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 63' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' K' ' 29' ' ' PRO . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 71' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.476 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.788 ' NE2' ' HB2' ' J' ' 139' ' ' LYS . 0.3 OUTLIER -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.617 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.456 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.718 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.639 ' HH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.836 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' K' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.658 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.726 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.551 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.593 ' CG ' HG13 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 122' ' ' VAL . . . . . 0.463 HG13 ' O ' ' J' ' 32' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' J' ' 6' ' ' ILE . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' K' ' 69' ' ' GLY . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.718 HD21 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.836 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.714 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.714 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 3.1 t30 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.624 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 2.3 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 170' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 171' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.553 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.611 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' G' ' 126' ' ' VAL . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.687 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 26.7 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 1.122 HG22 ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 22' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 38' ' ' SER . . . . . 0.553 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.982 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.974 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 55' ' ' GLY . . . . . 0.982 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 63' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 69' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' L' ' 128' ' ' ILE . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' L' ' 29' ' ' PRO . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.488 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.97 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.44 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.693 ' NE2' ' HB2' ' K' ' 139' ' ' LYS . 0.3 OUTLIER -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.913 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.611 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.837 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' L' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.648 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.738 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' F' ' 160' ' ' PHE . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.538 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.886 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.635 ' CG ' HG13 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.458 HG13 ' O ' ' K' ' 32' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' L' ' 69' ' ' GLY . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 1.057 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' L' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.837 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 3.1 t30 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.646 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 2.3 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.594 HG21 HG23 ' B' ' 126' ' ' VAL . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.713 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.47 HG11 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.669 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HG ' ' A' ' 14' ' ' LEU . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.574 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' B' ' 117' ' ' GLU . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.878 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HB3' ' OH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 34' ' ' ASP . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 113' ' ' ILE . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HD1' HG22 ' A' ' 113' ' ' ILE . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.687 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 82' ' ' ALA . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.47 ' HE ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.779 HG11 ' HG2' ' A' ' 142' ' ' GLU . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 10' ' ' ASP . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.854 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' A' ' 79' ' ' ILE . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' F' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' F' ' 8' ' ' GLY . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.663 HG23 HG21 ' F' ' 6' ' ' ILE . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.73 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.73 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.83 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 HD21 ' A' ' 14' ' ' LEU . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.7 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.676 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 172' ' ' GLY . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 167' ' ' THR . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HA ' HD13 ' G' ' 18' ' ' ILE . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 167' ' ' THR . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.588 HG21 HG23 ' C' ' 126' ' ' VAL . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.522 ' CG ' HD11 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.574 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.419 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.674 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.495 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.574 HD12 ' HG ' ' B' ' 14' ' ' LEU . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.538 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.439 ' HD1' ' HB3' ' B' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.648 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.924 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.912 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' B' ' 34' ' ' ASP . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 128' ' ' ILE . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.439 ' HB3' ' HD1' ' B' ' 31' ' ' TYR . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.61 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.791 HD12 HD11 ' B' ' 113' ' ' ILE . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.516 ' HD1' HG22 ' B' ' 113' ' ' ILE . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.43 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.878 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' B' ' 82' ' ' ALA . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.419 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.789 HG11 ' HG2' ' B' ' 142' ' ' GLU . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.417 HG13 ' OD1' ' B' ' 10' ' ' ASP . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.699 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' B' ' 138' ' ' LEU . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' B' ' 138' ' ' LEU . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.791 HD11 HD12 ' B' ' 79' ' ' ILE . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.846 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 37' ' ' VAL . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.754 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.746 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 8' ' ' GLY . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.594 HG23 HG21 ' A' ' 6' ' ' ILE . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.754 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' B' ' 66' ' ' THR . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 64' ' ' GLU . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' B' ' 111' ' ' ALA . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.714 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.535 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' B' ' 141' ' ' GLY . 2.1 p30 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' B' ' 14' ' ' LEU . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.699 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.75 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 172' ' ' GLY . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' GLY . . . . . 0.406 ' N ' HG22 ' B' ' 167' ' ' THR . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' GLU . . . . . 0.591 ' HA ' HD13 ' H' ' 18' ' ' ILE . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' B' ' 167' ' ' THR . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.546 HG21 HG23 ' D' ' 126' ' ' VAL . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.703 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.703 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' LYS . . . . . 0.525 ' CG ' HD11 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ASP . . . . . 0.491 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' C' ' 14' ' ' LEU . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' TYR . . . . . 0.45 ' HD1' ' HB3' ' C' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.568 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.708 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.812 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.836 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.708 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' C' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.568 HG13 ' OD1' ' C' ' 34' ' ' ASP . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 128' ' ' ILE . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.45 ' HB3' ' HD1' ' C' ' 31' ' ' TYR . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.771 HD12 HD11 ' C' ' 113' ' ' ILE . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' C' ' 113' ' ' ILE . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.607 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.912 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' C' ' 82' ' ' ALA . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' C' ' 142' ' ' GLU . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' VAL . . . . . 0.416 HG13 ' OD1' ' C' ' 10' ' ' ASP . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' C' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.677 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.707 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.771 HD11 HD12 ' C' ' 79' ' ' ILE . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.648 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.75 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' GLU . . . . . 0.681 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.588 HG23 HG21 ' B' ' 6' ' ' ILE . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 128' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 66' ' ' THR . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' C' ' 64' ' ' GLU . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.677 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.718 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 140' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' C' ' 141' ' ' GLY . 2.1 p30 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.693 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 146' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.536 HD12 HD21 ' C' ' 14' ' ' LEU . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.701 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 159' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' I' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.667 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.497 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.582 ' OG1' HG22 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.481 HG21 ' H ' ' C' ' 172' ' ' GLY . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 169' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' I' ' 18' ' ' ILE . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.481 ' H ' HG21 ' C' ' 167' ' ' THR . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.582 HG22 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.562 HG21 HG23 ' E' ' 126' ' ' VAL . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.723 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.723 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.461 HG11 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.423 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.659 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' D' ' 14' ' ' LEU . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' TYR . . . . . 0.444 ' HD1' ' HB3' ' D' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.575 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' SER . . . . . 0.645 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.717 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.853 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ALA . . . . . 0.717 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.575 HG13 ' OD1' ' D' ' 34' ' ' ASP . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' D' ' 128' ' ' ILE . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.444 ' HB3' ' HD1' ' D' ' 31' ' ' TYR . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.794 HD12 HD11 ' D' ' 113' ' ' ILE . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' D' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.836 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' D' ' 82' ' ' ALA . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.423 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.495 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.461 ' HE ' HG11 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.785 HG11 ' HG2' ' D' ' 142' ' ' GLU . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' D' ' 10' ' ' ASP . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.902 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' D' ' 138' ' ' LEU . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.683 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.794 HD11 HD12 ' D' ' 79' ' ' ILE . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' D' ' 116' ' ' ARG . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 123' ' ' GLU . . . . . 0.62 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.546 HG23 HG21 ' C' ' 6' ' ' ILE . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' D' ' 66' ' ' THR . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.734 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 140' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' D' ' 141' ' ' GLY . 2.1 p30 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.902 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.702 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 146' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.539 HD12 HD21 ' D' ' 14' ' ' LEU . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 159' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.711 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.763 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.53 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' D' ' 172' ' ' GLY . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.404 ' N ' HG22 ' D' ' 167' ' ' THR . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 169' ' ' GLU . . . . . 0.513 ' HA ' HD13 ' J' ' 18' ' ' ILE . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' J' ' 110' ' ' PHE . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' D' ' 167' ' ' THR . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.667 HG21 HG23 ' F' ' 126' ' ' VAL . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.728 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' F' ' 123' ' ' GLU . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.728 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.658 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.61 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' E' ' 14' ' ' LEU . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.523 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 30' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 31' ' ' TYR . . . . . 0.443 ' HD1' ' HB3' ' E' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.786 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.725 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' E' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' E' ' 34' ' ' ASP . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' E' ' 128' ' ' ILE . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.443 ' HB3' ' HD1' ' E' ' 31' ' ' TYR . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.618 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 78' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.782 HD12 HD11 ' E' ' 113' ' ' ILE . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.515 ' HD1' HG22 ' E' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' E' ' 82' ' ' ALA . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.494 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.463 ' HE ' HG11 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.771 HG11 ' HG2' ' E' ' 142' ' ' GLU . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' E' ' 10' ' ' ASP . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.883 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' E' ' 138' ' ' LEU . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.494 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.43 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.782 HD11 HD12 ' E' ' 79' ' ' ILE . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.853 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 119' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 123' ' ' GLU . . . . . 0.704 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 124' ' ' GLY . . . . . 0.431 ' H ' ' N ' ' D' ' 8' ' ' GLY . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.562 HG23 HG21 ' D' ' 6' ' ' ILE . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.765 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' E' ' 66' ' ' THR . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' E' ' 64' ' ' GLU . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.43 HD13 ' HB1' ' E' ' 111' ' ' ALA . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.718 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.52 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.835 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.697 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 146' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.537 HD12 HD21 ' E' ' 14' ' ' LEU . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 159' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' K' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.513 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.552 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' E' ' 172' ' ' GLY . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 167' ' ' THR . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 169' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' K' ' 18' ' ' ILE . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' E' ' 167' ' ' THR . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 126' ' ' VAL . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.712 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.712 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.464 HG11 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 12' ' ' LYS . . . . . 0.516 ' CG ' HD11 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 17' ' ' SER . . . . . 0.537 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.621 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' F' ' 14' ' ' LEU . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 29' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' F' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 121' ' ' GLY . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 36' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 117' ' ' GLU . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.72 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 60' ' ' ALA . . . . . 0.72 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' F' ' 130' ' ' ILE . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' F' ' 34' ' ' ASP . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' F' ' 128' ' ' ILE . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' F' ' 31' ' ' TYR . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.608 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 73' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.566 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.778 HD12 HD11 ' F' ' 113' ' ' ILE . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.525 ' HD1' HG22 ' F' ' 113' ' ' ILE . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.61 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.725 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' F' ' 82' ' ' ALA . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.477 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.464 ' HE ' HG11 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' F' ' 142' ' ' GLU . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 97' ' ' VAL . . . . . 0.408 HG13 ' OD1' ' F' ' 10' ' ' ASP . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.693 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' F' ' 138' ' ' LEU . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.68 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.703 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.778 HD11 HD12 ' F' ' 79' ' ' ILE . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 119' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 123' ' ' GLU . . . . . 0.452 ' HA ' ' HA3' ' E' ' 8' ' ' GLY . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.667 HG23 HG21 ' E' ' 6' ' ' ILE . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 128' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' F' ' 66' ' ' THR . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' F' ' 64' ' ' GLU . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.68 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.707 ' H ' HD13 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.536 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.834 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.69 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 146' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.53 HD12 HD21 ' F' ' 14' ' ' LEU . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.693 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.782 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.792 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.904 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.864 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.507 ' OE1' ' HZ ' ' L' ' 108' ' ' PHE . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.677 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.41 ' N ' HG22 ' F' ' 167' ' ' THR . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' F' ' 167' ' ' THR . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.765 HG21 HG23 ' H' ' 126' ' ' VAL . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.706 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.706 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.474 HG11 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 12' ' ' LYS . . . . . 0.513 ' CG ' HD11 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 17' ' ' SER . . . . . 0.54 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.568 HD12 ' HG ' ' G' ' 14' ' ' LEU . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.532 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 31' ' ' TYR . . . . . 0.449 ' HD1' ' HB3' ' G' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' H' ' 121' ' ' GLY . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 36' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' H' ' 118' ' ' TYR . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' H' ' 117' ' ' GLU . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 42' ' ' GLU . . . . . 0.572 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' H' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' G' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' G' ' 34' ' ' ASP . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' G' ' 128' ' ' ILE . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.449 ' HB3' ' HD1' ' G' ' 31' ' ' TYR . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.795 HD12 HD11 ' G' ' 113' ' ' ILE . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' G' ' 113' ' ' ILE . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' L' ' 139' ' ' LYS . 0.0 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.689 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' G' ' 82' ' ' ALA . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.559 ' HZ3' ' HA ' ' A' ' 160' ' ' PHE . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.474 ' HE ' HG11 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.77 HG11 ' HG2' ' G' ' 142' ' ' GLU . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' G' ' 10' ' ' ASP . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.69 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.886 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' G' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.689 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.795 HD11 HD12 ' G' ' 79' ' ' ILE . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' L' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 119' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 123' ' ' GLU . . . . . 0.591 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 124' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' L' ' 8' ' ' GLY . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.754 HG23 HG21 ' L' ' 6' ' ' ILE . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' G' ' 66' ' ' THR . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' G' ' 64' ' ' GLU . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' G' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.719 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 140' ' ' ASN . . . . . 0.556 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 2.1 p30 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.886 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.677 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 144' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 146' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.517 HD12 HD21 ' G' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.69 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.0 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.595 ' OG1' HG22 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' G' ' 172' ' ' GLY . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' G' ' 167' ' ' THR . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' G' ' 167' ' ' THR . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.595 HG22 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.761 HG21 HG23 ' I' ' 126' ' ' VAL . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.72 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.72 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.473 HG11 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.588 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.426 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 19' ' ' ASP . . . . . 0.487 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.606 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' H' ' 14' ' ' LEU . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' H' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 33' ' ' THR . . . . . 0.418 HG22 ' HA2' ' I' ' 121' ' ' GLY . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 36' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' I' ' 117' ' ' GLU . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.704 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 42' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.406 HD23 ' HG3' ' I' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 60' ' ' ALA . . . . . 0.704 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' H' ' 130' ' ' ILE . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' H' ' 34' ' ' ASP . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' H' ' 128' ' ' ILE . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' H' ' 31' ' ' TYR . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.775 HD12 HD11 ' H' ' 113' ' ' ILE . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' H' ' 113' ' ' ILE . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.47 ' OE1' ' HG3' ' G' ' 139' ' ' LYS . 0.0 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' H' ' 82' ' ' ALA . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.426 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.561 ' HZ3' ' HA ' ' B' ' 160' ' ' PHE . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.473 ' HE ' HG11 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.783 HG11 ' HG2' ' H' ' 142' ' ' GLU . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' H' ' 10' ' ' ASP . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 98' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.909 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.836 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' H' ' 138' ' ' LEU . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HG ' ' H' ' 138' ' ' LEU . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.686 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.775 HD11 HD12 ' H' ' 79' ' ' ILE . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.473 ' HB3' HG12 ' G' ' 37' ' ' VAL . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 119' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 124' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' G' ' 8' ' ' GLY . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.765 HG23 HG21 ' G' ' 6' ' ' ILE . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.738 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' H' ' 66' ' ' THR . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' H' ' 64' ' ' GLU . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' H' ' 111' ' ' ALA . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.667 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' OE1' ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 140' ' ' ASN . . . . . 0.532 ' HB3' ' OD2' ' B' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.909 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.75 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 144' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 146' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.523 HD12 HD21 ' H' ' 14' ' ' LEU . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.504 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.0 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.592 ' OG1' HG22 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.5 HG21 ' H ' ' H' ' 172' ' ' GLY . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' H' ' 167' ' ' THR . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 172' ' ' GLY . . . . . 0.5 ' H ' HG21 ' H' ' 167' ' ' THR . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.633 HG21 HG23 ' J' ' 126' ' ' VAL . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 8' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.71 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.468 HG11 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 12' ' ' LYS . . . . . 0.521 ' CG ' HD11 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 17' ' ' SER . . . . . 0.538 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' I' ' 14' ' ' LEU . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 31' ' ' TYR . . . . . 0.441 ' HD1' ' HB3' ' I' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.496 HG22 ' HA2' ' J' ' 121' ' ' GLY . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.557 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' J' ' 117' ' ' GLU . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.707 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.535 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 60' ' ' ALA . . . . . 0.707 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' I' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.557 HG13 ' OD1' ' I' ' 34' ' ' ASP . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 66' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' I' ' 128' ' ' ILE . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.441 ' HB3' ' HD1' ' I' ' 31' ' ' TYR . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.613 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.79 HD12 HD11 ' I' ' 113' ' ' ILE . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' I' ' 113' ' ' ILE . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.452 ' OE1' ' HG3' ' H' ' 139' ' ' LYS . 0.0 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.691 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' I' ' 82' ' ' ALA . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.429 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.496 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.468 ' HE ' HG11 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' I' ' 142' ' ' GLU . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' I' ' 10' ' ' ASP . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 98' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.696 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.91 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' I' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.691 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.79 HD11 HD12 ' I' ' 79' ' ' ILE . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' H' ' 37' ' ' VAL . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 119' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 121' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 123' ' ' GLU . . . . . 0.495 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 124' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' H' ' 8' ' ' GLY . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.761 HG23 HG21 ' H' ' 6' ' ' ILE . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 128' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' I' ' 66' ' ' THR . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' I' ' 64' ' ' GLU . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' I' ' 111' ' ' ALA . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.537 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.4 ' HG2' HE21 ' I' ' 107' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 140' ' ' ASN . . . . . 0.439 ' HB3' ' OD2' ' C' ' 159' ' ' ASP . 2.1 p30 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.825 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.703 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 144' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 146' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.521 HD12 HD21 ' I' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.0 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.59 ' OG1' HG22 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' I' ' 172' ' ' GLY . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' I' ' 167' ' ' THR . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' I' ' 167' ' ' THR . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.59 HG22 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.698 HG21 HG23 ' K' ' 126' ' ' VAL . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.694 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.584 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 17' ' ' SER . . . . . 0.541 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.668 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.604 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.584 HD12 ' HG ' ' J' ' 14' ' ' LEU . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.451 ' HD1' ' HB3' ' J' ' 67' ' ' TYR . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 33' ' ' THR . . . . . 0.472 HG22 ' HA2' ' K' ' 121' ' ' GLY . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 36' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' K' ' 117' ' ' GLU . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 42' ' ' GLU . . . . . 0.586 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' K' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' J' ' 34' ' ' ASP . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 66' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' J' ' 128' ' ' ILE . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.451 ' HB3' ' HD1' ' J' ' 31' ' ' TYR . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.597 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' J' ' 71' ' ' ARG . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.781 HD12 HD11 ' J' ' 113' ' ' ILE . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.51 ' HD1' HG22 ' J' ' 113' ' ' ILE . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.428 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.696 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' J' ' 82' ' ' ALA . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.556 ' HZ3' ' HA ' ' D' ' 160' ' ' PHE . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' J' ' 142' ' ' GLU . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' J' ' 10' ' ' ASP . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 98' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.892 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' J' ' 138' ' ' LEU . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.696 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.781 HD11 HD12 ' J' ' 79' ' ' ILE . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' I' ' 37' ' ' VAL . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 119' ' ' SER . . . . . 0.749 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 121' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' I' ' 6' ' ' ILE . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.633 HG23 HG21 ' I' ' 6' ' ' ILE . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.749 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 128' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' J' ' 66' ' ' THR . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' J' ' 111' ' ' ALA . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.734 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.468 ' HG3' ' OE1' ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 140' ' ' ASN . . . . . 0.61 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.892 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.826 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' D' ' 160' ' ' PHE . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 146' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.532 HD12 HD21 ' J' ' 14' ' ' LEU . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.498 ' HA ' ' HB3' ' J' ' 161' ' ' GLN . 0.0 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' J' ' 172' ' ' GLY . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 168' ' ' GLY . . . . . 0.4 ' N ' HG22 ' J' ' 167' ' ' THR . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' J' ' 167' ' ' THR . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.69 HG21 HG23 ' L' ' 126' ' ' VAL . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.705 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' K' ' 14' ' ' LEU . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' K' ' 67' ' ' TYR . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.572 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 36' ' ' SER . . . . . 0.537 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' L' ' 117' ' ' GLU . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.721 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 60' ' ' ALA . . . . . 0.721 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' K' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.572 HG13 ' OD1' ' K' ' 34' ' ' ASP . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' K' ' 128' ' ' ILE . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' K' ' 31' ' ' TYR . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.605 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 71' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' K' ' 71' ' ' ARG . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.789 HD12 HD11 ' K' ' 113' ' ' ILE . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' K' ' 113' ' ' ILE . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.468 ' OE1' ' HG3' ' J' ' 139' ' ' LYS . 0.0 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.596 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.685 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' K' ' 82' ' ' ALA . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.585 ' HZ3' ' HA ' ' E' ' 160' ' ' PHE . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.768 HG11 ' HG2' ' K' ' 142' ' ' GLU . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 97' ' ' VAL . . . . . 0.406 HG13 ' OD1' ' K' ' 10' ' ' ASP . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 98' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.87 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' K' ' 138' ' ' LEU . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.669 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.789 HD11 HD12 ' K' ' 79' ' ' ILE . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' J' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 119' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 121' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 123' ' ' GLU . . . . . 0.634 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 124' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' J' ' 8' ' ' GLY . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.698 HG23 HG21 ' J' ' 6' ' ' ILE . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' K' ' 66' ' ' THR . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' K' ' 64' ' ' GLU . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.446 HD13 ' HB1' ' K' ' 111' ' ' ALA . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.669 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.431 ' HG3' ' OE1' ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 140' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' E' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.87 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.676 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 144' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 146' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' K' ' 14' ' ' LEU . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' K' ' 161' ' ' GLN . 0.0 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.483 HG21 ' H ' ' K' ' 172' ' ' GLY . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 168' ' ' GLY . . . . . 0.401 ' N ' HG22 ' K' ' 167' ' ' THR . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 172' ' ' GLY . . . . . 0.483 ' H ' HG21 ' K' ' 167' ' ' THR . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.421 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.754 HG21 HG23 ' G' ' 126' ' ' VAL . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 12' ' ' LYS . . . . . 0.529 ' CG ' HD11 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 17' ' ' SER . . . . . 0.531 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.615 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.561 HD12 ' HG ' ' L' ' 14' ' ' LEU . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 30' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' L' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' G' ' 121' ' ' GLY . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 36' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 117' ' ' GLU . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.713 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' G' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 60' ' ' ALA . . . . . 0.713 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' L' ' 34' ' ' ASP . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' L' ' 128' ' ' ILE . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' L' ' 31' ' ' TYR . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD3' ' L' ' 71' ' ' ARG . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 73' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' L' ' 113' ' ' ILE . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' NZ ' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' L' ' 113' ' ' ILE . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.431 ' OE1' ' HG3' ' K' ' 139' ' ' LYS . 0.0 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.703 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' L' ' 82' ' ' ALA . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.677 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.501 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.762 HG11 ' HG2' ' L' ' 142' ' ' GLU . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' L' ' 10' ' ' ASP . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 98' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' L' ' 138' ' ' LEU . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.507 ' HZ ' ' OE1' ' F' ' 165' ' ' GLN . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' L' ' 79' ' ' ILE . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.525 ' HB3' HG12 ' K' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 119' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 123' ' ' GLU . . . . . 0.742 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 124' ' ' GLY . . . . . 0.512 ' H ' ' N ' ' K' ' 8' ' ' GLY . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' K' ' 6' ' ' ILE . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.69 HG23 HG21 ' K' ' 6' ' ' ILE . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.742 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 128' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' L' ' 66' ' ' THR . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' L' ' 111' ' ' ALA . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.72 HD13 ' H ' ' L' ' 135' ' ' ILE . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.782 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.904 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.88 ' O ' ' HG2' ' F' ' 162' ' ' GLN . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 146' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.421 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.527 HD12 HD21 ' L' ' 14' ' ' LEU . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.0 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.591 ' OG1' HG22 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.489 HG21 ' H ' ' L' ' 172' ' ' GLY . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' L' ' 167' ' ' THR . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 172' ' ' GLY . . . . . 0.489 ' H ' HG21 ' L' ' 167' ' ' THR . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.591 HG22 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 6' ' ' ILE . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 93' ' ' ARG . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 25' ' ' ALA . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 89' ' ' ILE . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' A' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.54 HG22 HG23 ' B' ' 122' ' ' VAL . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' OD1' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' B' ' 117' ' ' GLU . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.746 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' A' ' 42' ' ' GLU . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD22 HD13 ' B' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 43' ' ' LEU . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.847 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' OD1' ' A' ' 34' ' ' ASP . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.666 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 14.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HE2' ' OD1' ' A' ' 85' ' ' ASN . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 15' ' ' PHE . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' A' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.771 HG21 HG21 ' A' ' 145' ' ' THR . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 97' ' ' VAL . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.799 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 138' ' ' LEU . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.417 ' O ' HG13 ' A' ' 134' ' ' VAL . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' A' ' 83' ' ' TYR . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 132' ' ' LEU . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.529 ' HG3' HH11 ' A' ' 116' ' ' ARG . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' F' ' 33' ' ' THR . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' O ' ' F' ' 7' ' ' MET . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' A' ' 130' ' ' ILE . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.616 ' O ' HG13 ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.76 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.847 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 110' ' ' PHE . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 135' ' ' ILE . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' A' ' 94' ' ' VAL . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.578 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.771 HG21 HG21 ' A' ' 94' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 145' ' ' THR . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.527 ' HA ' ' HH2' ' G' ' 92' ' ' TRP . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 36.7 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.583 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.769 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.631 HG11 HH21 ' B' ' 93' ' ' ARG . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.497 ' HB3' HD11 ' B' ' 89' ' ' ILE . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.656 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' B' ' 18' ' ' ILE . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.434 ' HE1' ' HG ' ' B' ' 27' ' ' LEU . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.521 HG22 HG23 ' C' ' 122' ' ' VAL . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' B' ' 65' ' ' VAL . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' C' ' 117' ' ' GLU . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.812 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.401 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' B' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' B' ' 41' ' ' ARG . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.788 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.717 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.497 ' O ' HD22 ' B' ' 43' ' ' LEU . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLY . . . . . 0.788 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.732 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' B' ' 34' ' ' ASP . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' B' ' 70' ' ' LYS . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.615 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 13.9 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.471 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.471 ' HE2' ' OD1' ' B' ' 85' ' ' ASN . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' B' ' 15' ' ' PHE . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.656 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.631 HH21 HG11 ' B' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.769 HG21 HG21 ' B' ' 145' ' ' THR . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 11' ' ' VAL . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.495 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' B' ' 97' ' ' VAL . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 138' ' ' LEU . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.648 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' B' ' 83' ' ' TYR . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.534 ' HG3' ' HA ' ' B' ' 132' ' ' LEU . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.545 ' HG3' HH11 ' B' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.602 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.651 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 33' ' ' THR . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.626 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' B' ' 130' ' ' ILE . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.732 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.534 ' HA ' ' HG3' ' B' ' 114' ' ' GLU . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.861 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' B' ' 110' ' ' PHE . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.584 HD13 HD22 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' B' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' THR . . . . . 0.769 HG21 HG21 ' B' ' 94' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.672 HD12 ' O ' ' B' ' 145' ' ' THR . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.555 ' HA ' ' HH2' ' H' ' 92' ' ' TRP . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.591 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.636 HG11 HH21 ' C' ' 93' ' ' ARG . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' C' ' 12' ' ' LYS . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' C' ' 89' ' ' ILE . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.65 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ASP . . . . . 0.469 ' N ' HG13 ' C' ' 18' ' ' ILE . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.562 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' TYR . . . . . 0.439 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.595 ' CG2' HG23 ' D' ' 122' ' ' VAL . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.511 ' OD1' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.537 HG22 ' HG2' ' D' ' 117' ' ' GLU . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' C' ' 42' ' ' GLU . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.695 HD22 HD13 ' D' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' C' ' 43' ' ' LEU . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' SER . . . . . 0.884 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.511 HG22 ' OD1' ' C' ' 34' ' ' ASP . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' C' ' 70' ' ' LYS . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.58 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.616 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 13.9 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.475 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' C' ' 85' ' ' ASN . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.653 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' C' ' 15' ' ' PHE . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.636 HH21 HG11 ' C' ' 11' ' ' VAL . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.759 HG21 HG21 ' C' ' 145' ' ' THR . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' C' ' 11' ' ' VAL . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' C' ' 97' ' ' VAL . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.784 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' C' ' 138' ' ' LEU . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 109' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.653 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' C' ' 83' ' ' TYR . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' C' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' C' ' 116' ' ' ARG . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.576 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' VAL . . . . . 0.521 HG23 HG22 ' B' ' 33' ' ' THR . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' GLY . . . . . 0.714 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' ILE . . . . . 0.459 HG22 HG23 ' C' ' 130' ' ' ILE . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.598 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.739 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.532 ' HA ' ' HG3' ' C' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.884 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.415 HG13 ' O ' ' C' ' 110' ' ' PHE . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.717 HD13 HD22 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.443 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' C' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.572 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 145' ' ' THR . . . . . 0.759 HG21 HG21 ' C' ' 94' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' C' ' 145' ' ' THR . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.505 ' HA ' ' HH2' ' I' ' 92' ' ' TRP . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.793 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.793 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.626 HG11 HH21 ' D' ' 93' ' ' ARG . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' D' ' 12' ' ' LYS . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.628 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' D' ' 18' ' ' ILE . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' THR . . . . . 0.535 ' CG2' HG23 ' E' ' 122' ' ' VAL . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.601 HG22 ' HG2' ' E' ' 117' ' ' GLU . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' SER . . . . . 0.772 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' D' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' D' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.774 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.56 HD22 HD13 ' E' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' D' ' 43' ' ' LEU . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLY . . . . . 0.774 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' D' ' 34' ' ' ASP . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.448 HH11 ' HB ' ' C' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.478 ' OD2' ' HD3' ' D' ' 70' ' ' LYS . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.608 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 14.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' D' ' 85' ' ' ASN . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' D' ' 15' ' ' PHE . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.626 HH21 HG11 ' D' ' 11' ' ' VAL . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.765 HG21 HG21 ' D' ' 145' ' ' THR . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' D' ' 11' ' ' VAL . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' D' ' 97' ' ' VAL . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' D' ' 138' ' ' LEU . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 109' ' ' GLY . . . . . 0.791 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.652 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' D' ' 83' ' ' TYR . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' D' ' 132' ' ' LEU . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' D' ' 116' ' ' ARG . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.537 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' C' ' 33' ' ' THR . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' I' ' 43' ' ' LEU . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' C' ' 7' ' ' MET . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' D' ' 130' ' ' ILE . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.606 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' D' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 110' ' ' PHE . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.695 HD13 HD22 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.44 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.791 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.417 ' HG2' HG11 ' D' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.765 HG21 HG21 ' D' ' 94' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.685 HD12 ' O ' ' D' ' 145' ' ' THR . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' CH2' ' J' ' 92' ' ' TRP . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.595 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 36.7 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 169' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' I' ' 54' ' ' LEU . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.534 ' HB3' ' HG3' ' F' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' F' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' E' ' 93' ' ' ARG . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 12' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' E' ' 12' ' ' LYS . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' E' ' 25' ' ' ALA . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' E' ' 89' ' ' ILE . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.635 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.466 ' H ' HG13 ' E' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 26' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.576 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 31' ' ' TYR . . . . . 0.425 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.519 ' OD1' HG22 ' E' ' 65' ' ' VAL . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' F' ' 117' ' ' GLU . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 38' ' ' SER . . . . . 0.736 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' E' ' 42' ' ' GLU . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.801 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.652 HD22 HD13 ' F' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' E' ' 43' ' ' LEU . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' GLY . . . . . 0.801 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 62' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.519 HG22 ' OD1' ' E' ' 34' ' ' ASP . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.612 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.487 HH11 ' HB ' ' D' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' E' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 74' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 14.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.772 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' E' ' 85' ' ' ASN . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.649 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' E' ' 15' ' ' PHE . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' E' ' 11' ' ' VAL . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.784 HG21 HG21 ' E' ' 145' ' ' THR . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 95' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' E' ' 11' ' ' VAL . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 97' ' ' VAL . . . . . 0.499 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.499 ' HD1' ' O ' ' E' ' 97' ' ' VAL . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' E' ' 138' ' ' LEU . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 109' ' ' GLY . . . . . 0.779 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.649 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.416 HG21 ' HD1' ' E' ' 83' ' ' TYR . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' E' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.528 HH11 ' HG3' ' E' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.601 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 119' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' D' ' 33' ' ' THR . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 124' ' ' GLY . . . . . 0.559 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' E' ' 130' ' ' ILE . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.614 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.755 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' E' ' 114' ' ' GLU . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.882 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' E' ' 110' ' ' PHE . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.56 HD13 HD22 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.779 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.415 ' HG2' HG11 ' E' ' 94' ' ' VAL . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.573 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.784 HG21 HG21 ' E' ' 94' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' E' ' 145' ' ' THR . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.595 ' HA ' ' HH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.578 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.767 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.767 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.537 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 126' ' ' VAL . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' F' ' 93' ' ' ARG . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 12' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' F' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' F' ' 25' ' ' ALA . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' F' ' 89' ' ' ILE . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.633 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 19' ' ' ASP . . . . . 0.465 ' H ' HG13 ' F' ' 18' ' ' ILE . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.581 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 31' ' ' TYR . . . . . 0.424 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 33' ' ' THR . . . . . 0.472 ' CG2' HG23 ' A' ' 122' ' ' VAL . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 117' ' ' GLU . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 38' ' ' SER . . . . . 0.719 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' F' ' 42' ' ' GLU . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' F' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' F' ' 43' ' ' LEU . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.506 HG22 ' OD1' ' F' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' E' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 71' ' ' ARG . . . . . 0.498 HH11 ' HB ' ' E' ' 97' ' ' VAL . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 73' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' F' ' 70' ' ' LYS . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 74' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.576 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.601 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 13.9 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.474 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.474 ' HE2' ' OD1' ' F' ' 85' ' ' ASN . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.64 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' F' ' 15' ' ' PHE . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' F' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.776 HG21 HG21 ' F' ' 145' ' ' THR . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' F' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 97' ' ' VAL . . . . . 0.666 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.477 ' HD1' ' O ' ' F' ' 97' ' ' VAL . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.809 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.495 ' CE2' HD13 ' F' ' 138' ' ' LEU . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 109' ' ' GLY . . . . . 0.801 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.64 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.417 HG21 ' HD1' ' F' ' 83' ' ' TYR . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' F' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' F' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 124' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' K' ' 43' ' ' LEU . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 125' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' E' ' 7' ' ' MET . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' F' ' 130' ' ' ILE . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.763 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' HG3' ' F' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' F' ' 110' ' ' PHE . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.652 HD13 HD22 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.446 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.801 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' F' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.776 HG21 HG21 ' F' ' 94' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.683 HD12 ' O ' ' F' ' 145' ' ' THR . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.764 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.578 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 36.7 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' L' ' 23' ' ' GLY . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.685 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.577 HG23 ' HB2' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.781 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.653 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.781 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.537 ' O ' HG22 ' H' ' 126' ' ' VAL . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.634 HG11 HH21 ' G' ' 93' ' ' ARG . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 12' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' G' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 15' ' ' PHE . . . . . 0.5 ' HB3' HD11 ' G' ' 89' ' ' ILE . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 19' ' ' ASP . . . . . 0.475 ' H ' HG13 ' G' ' 18' ' ' ILE . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.638 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 31' ' ' TYR . . . . . 0.42 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.597 HG22 ' HG2' ' H' ' 117' ' ' GLU . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 38' ' ' SER . . . . . 0.648 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' G' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' G' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.799 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 56' ' ' PRO . . . . . 0.494 ' O ' HD22 ' G' ' 43' ' ' LEU . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 57' ' ' GLY . . . . . 0.799 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 62' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' G' ' 34' ' ' ASP . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 71' ' ' ARG . . . . . 0.705 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 73' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' G' ' 70' ' ' LYS . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.578 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.608 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 14.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.432 ' HG2' ' NZ ' ' L' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' G' ' 85' ' ' ASN . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.466 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' G' ' 15' ' ' PHE . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.527 ' HH2' ' HA ' ' A' ' 160' ' ' PHE . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.634 HH21 HG11 ' G' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.774 HG21 HG21 ' G' ' 145' ' ' THR . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' G' ' 11' ' ' VAL . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 97' ' ' VAL . . . . . 0.649 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.489 ' HD1' ' O ' ' G' ' 97' ' ' VAL . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.802 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' G' ' 138' ' ' LEU . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.412 ' O ' HG13 ' G' ' 134' ' ' VAL . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' G' ' 83' ' ' TYR . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' G' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.54 ' HG3' HH11 ' G' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 119' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.548 HG13 ' O ' ' L' ' 7' ' ' MET . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 128' ' ' ILE . . . . . 0.473 HG22 HG23 ' G' ' 130' ' ' ILE . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.624 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' G' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.854 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' G' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.456 HD13 HD22 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.447 ' H ' HG13 ' G' ' 135' ' ' ILE . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' G' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.576 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.774 HG21 HG21 ' G' ' 94' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' G' ' 145' ' ' THR . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.57 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' G' G ' 162' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 163' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.784 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.784 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.542 ' O ' HG22 ' I' ' 126' ' ' VAL . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.573 ' O ' HG13 ' I' ' 126' ' ' VAL . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.643 HG11 HH21 ' H' ' 93' ' ' ARG . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' H' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' H' ' 89' ' ' ILE . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 19' ' ' ASP . . . . . 0.471 ' H ' HG13 ' H' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.572 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.515 ' OD1' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' I' ' 117' ' ' GLU . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' H' ' 42' ' ' GLU . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' H' ' 41' ' ' ARG . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' H' ' 43' ' ' LEU . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 62' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' H' ' 34' ' ' ASP . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' OD2' ' H' ' 73' ' ' ASP . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 71' ' ' ARG . . . . . 0.649 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' H' ' 70' ' ' LYS . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.577 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 14.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.648 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' H' ' 85' ' ' ASN . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.451 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' H' ' 15' ' ' PHE . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.555 ' HH2' ' HA ' ' B' ' 160' ' ' PHE . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.643 HH21 HG11 ' H' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.762 HG21 HG21 ' H' ' 145' ' ' THR . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' H' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 97' ' ' VAL . . . . . 0.731 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' H' ' 97' ' ' VAL . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.788 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' H' ' 138' ' ' LEU . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.412 ' O ' HG13 ' H' ' 134' ' ' VAL . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' H' ' 83' ' ' TYR . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' H' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' H' ' 116' ' ' ARG . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.575 HG13 ' O ' ' G' ' 7' ' ' MET . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' H' ' 130' ' ' ILE . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.613 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.756 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' H' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.85 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' H' ' 110' ' ' PHE . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.442 HG13 ' H ' ' H' ' 136' ' ' GLY . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.442 ' H ' HG13 ' H' ' 135' ' ' ILE . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' H' ' 94' ' ' VAL . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.762 HG21 HG21 ' H' ' 94' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' H' ' 145' ' ' THR . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.588 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' H' H ' 162' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 163' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.588 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.788 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.788 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 8' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.633 HG11 HH21 ' I' ' 93' ' ' ARG . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 12' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' I' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' I' ' 89' ' ' ILE . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.643 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 19' ' ' ASP . . . . . 0.474 ' H ' HG13 ' I' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.57 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 31' ' ' TYR . . . . . 0.437 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.423 ' CG2' HG23 ' J' ' 122' ' ' VAL . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' J' ' 117' ' ' GLU . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 38' ' ' SER . . . . . 0.725 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' I' ' 42' ' ' GLU . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' I' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.522 HD22 HD13 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' I' ' 43' ' ' LEU . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 62' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' I' ' 34' ' ' ASP . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' OD2' ' I' ' 73' ' ' ASP . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.731 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' I' ' 70' ' ' LYS . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 74' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.602 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 13.9 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' I' ' 85' ' ' ASN . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.457 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' I' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.505 ' HH2' ' HA ' ' C' ' 160' ' ' PHE . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.633 HH21 HG11 ' I' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.763 HG21 HG21 ' I' ' 145' ' ' THR . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' I' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 97' ' ' VAL . . . . . 0.736 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.574 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' I' ' 97' ' ' VAL . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' I' ' 138' ' ' LEU . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 109' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' I' ' 83' ' ' TYR . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' I' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.533 ' HG3' HH11 ' I' ' 116' ' ' ARG . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.535 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 119' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.573 HG13 ' O ' ' H' ' 7' ' ' MET . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 128' ' ' ILE . . . . . 0.465 HG22 HG23 ' I' ' 130' ' ' ILE . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.602 HG13 ' O ' ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' I' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' I' ' 110' ' ' PHE . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.451 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.451 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.782 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.457 ' NZ ' ' HG2' ' J' ' 84' ' ' GLN . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.416 ' HG2' HG11 ' I' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.574 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 145' ' ' THR . . . . . 0.763 HG21 HG21 ' I' ' 94' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' I' ' 145' ' ' THR . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' I' I ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.796 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.796 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.555 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.441 ' O ' HG22 ' K' ' 126' ' ' VAL . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' J' ' 93' ' ' ARG . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' J' ' 12' ' ' LYS . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' J' ' 89' ' ' ILE . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.645 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' J' ' 18' ' ' ILE . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.652 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.561 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 33' ' ' THR . . . . . 0.446 ' CG2' HG23 ' K' ' 122' ' ' VAL . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' K' ' 117' ' ' GLU . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 38' ' ' SER . . . . . 0.615 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' J' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' J' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.785 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.441 HD22 HD13 ' K' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 56' ' ' PRO . . . . . 0.491 ' O ' HD22 ' J' ' 43' ' ' LEU . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 57' ' ' GLY . . . . . 0.785 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 62' ' ' SER . . . . . 0.885 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' J' ' 34' ' ' ASP . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 71' ' ' ARG . . . . . 0.736 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 73' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' J' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 74' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 14.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.457 ' HG2' ' NZ ' ' I' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' J' ' 85' ' ' ASN . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' J' ' 15' ' ' PHE . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' D' ' 160' ' ' PHE . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' J' ' 11' ' ' VAL . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.753 HG21 HG21 ' J' ' 145' ' ' THR . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 95' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' J' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 97' ' ' VAL . . . . . 0.682 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' J' ' 97' ' ' VAL . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.798 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' J' ' 138' ' ' LEU . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' J' ' 83' ' ' TYR . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' J' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.542 ' HG3' HH11 ' J' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 119' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 122' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' I' ' 33' ' ' THR . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.503 HG13 ' O ' ' I' ' 7' ' ' MET . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 128' ' ' ILE . . . . . 0.466 HG22 HG23 ' J' ' 130' ' ' ILE . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.735 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' J' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.885 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' J' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.522 HD13 HD22 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.456 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.439 ' NZ ' ' HG2' ' K' ' 84' ' ' GLN . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.753 HG21 HG21 ' J' ' 94' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.675 HD12 ' O ' ' J' ' 145' ' ' THR . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' J' J ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.798 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.798 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.436 ' O ' ' HB1' ' L' ' 125' ' ' ALA . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' K' ' 93' ' ' ARG . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 12' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' K' ' 12' ' ' LYS . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' K' ' 25' ' ' ALA . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 19' ' ' ASP . . . . . 0.476 ' H ' HG13 ' K' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.643 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.587 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 31' ' ' TYR . . . . . 0.427 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 33' ' ' THR . . . . . 0.494 HG22 HG23 ' L' ' 122' ' ' VAL . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' K' ' 65' ' ' VAL . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' L' ' 117' ' ' GLU . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 38' ' ' SER . . . . . 0.603 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' K' ' 42' ' ' GLU . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' K' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.803 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.613 HD22 HD13 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 56' ' ' PRO . . . . . 0.496 ' O ' HD22 ' K' ' 43' ' ' LEU . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 57' ' ' GLY . . . . . 0.803 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.743 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' K' ' 34' ' ' ASP . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 71' ' ' ARG . . . . . 0.682 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' K' ' 70' ' ' LYS . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.597 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 14.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.597 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.439 ' HG2' ' NZ ' ' J' ' 139' ' ' LYS . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' K' ' 85' ' ' ASN . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.461 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' K' ' 15' ' ' PHE . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' K' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.775 HG21 HG21 ' K' ' 145' ' ' THR . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 95' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' K' ' 11' ' ' VAL . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 97' ' ' VAL . . . . . 0.588 ' HB ' HH11 ' L' ' 71' ' ' ARG . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' K' ' 97' ' ' VAL . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' K' ' 138' ' ' LEU . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.418 ' O ' HG13 ' K' ' 134' ' ' VAL . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' K' ' 83' ' ' TYR . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' K' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.546 HH11 ' HG3' ' K' ' 116' ' ' ARG . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 119' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 122' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' J' ' 33' ' ' THR . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.52 HG13 ' O ' ' J' ' 7' ' ' MET . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' K' ' 130' ' ' ILE . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.604 HG13 ' O ' ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.743 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.524 ' HA ' ' HG3' ' K' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.418 HG13 ' O ' ' K' ' 110' ' ' PHE . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.455 HG13 ' H ' ' K' ' 136' ' ' GLY . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.455 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' K' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.775 HG21 HG21 ' K' ' 94' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' K' ' 145' ' ' THR . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.594 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' K' K ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.791 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.791 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' G' ' 126' ' ' VAL . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' L' ' 93' ' ' ARG . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 12' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' L' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' L' ' 25' ' ' ALA . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.493 ' HB3' HD11 ' L' ' 89' ' ' ILE . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.636 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' L' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' F' ' 164' ' ' GLY . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.591 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 31' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.596 HG22 ' HG2' ' G' ' 117' ' ' GLU . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 38' ' ' SER . . . . . 0.636 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' L' ' 42' ' ' GLU . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' L' ' 41' ' ' ARG . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.786 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.456 HD22 HD13 ' G' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 56' ' ' PRO . . . . . 0.498 ' O ' HD22 ' L' ' 43' ' ' LEU . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 57' ' ' GLY . . . . . 0.786 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' L' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.521 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.588 HH11 ' HB ' ' K' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 73' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' L' ' 70' ' ' LYS . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 74' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.594 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 14.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.594 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.512 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' L' ' 85' ' ' ASN . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.653 ' HG3' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' L' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.764 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' L' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.787 HG21 HG21 ' L' ' 145' ' ' THR . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' L' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 97' ' ' VAL . . . . . 0.705 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' L' ' 97' ' ' VAL . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' L' ' 138' ' ' LEU . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 109' ' ' GLY . . . . . 0.794 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.417 ' O ' HG13 ' L' ' 134' ' ' VAL . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' L' ' 83' ' ' TYR . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' L' ' 132' ' ' LEU . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.54 HH11 ' HG3' ' L' ' 116' ' ' ARG . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.608 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 119' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.494 HG23 HG22 ' K' ' 33' ' ' THR . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.449 HG13 ' O ' ' K' ' 7' ' ' MET . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' L' ' 130' ' ' ILE . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.615 HG13 ' O ' ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.769 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.529 ' HA ' ' HG3' ' L' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' L' ' 110' ' ' PHE . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.613 HD13 HD22 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.43 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.794 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.432 ' NZ ' ' HG2' ' G' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.75 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' F' ' 160' ' ' PHE . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.787 HG21 HG21 ' L' ' 94' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.684 HD12 ' O ' ' L' ' 145' ' ' THR . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' L' L ' 162' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.787 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.787 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' B' ' 126' ' ' VAL . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.851 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' B' ' 117' ' ' GLU . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.801 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' A' ' 34' ' ' ASP . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HD1' HG22 ' A' ' 113' ' ' ILE . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 82' ' ' ALA . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 142' ' ' GLU . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.78 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' A' ' 139' ' ' LYS . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' A' ' 138' ' ' LEU . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.668 HG22 ' HD1' ' A' ' 83' ' ' TYR . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.862 HG23 HG21 ' F' ' 6' ' ' ILE . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' A' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' A' ' 107' ' ' GLN . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 150' ' ' ILE . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.455 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.721 ' HB3' HG21 ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HB2' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.544 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' G' ' 21' ' ' ALA . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 172' ' ' GLY . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 167' ' ' THR . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.433 ' H ' HG21 ' A' ' 167' ' ' THR . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.789 HG21 HG23 ' C' ' 126' ' ' VAL . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.818 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.818 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.873 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.595 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' C' ' 117' ' ' GLU . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.574 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.872 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.574 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' B' ' 34' ' ' ASP . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.451 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.604 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.837 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' B' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.74 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.873 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 111' ' ' ALA . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.628 HG11 ' HG2' ' B' ' 142' ' ' GLU . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 104' ' ' TYR . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.553 ' HG2' ' HG2' ' B' ' 139' ' ' LYS . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' B' ' 138' ' ' LEU . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' B' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' B' ' 83' ' ' TYR . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.459 ' HB3' HG12 ' A' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 6' ' ' ILE . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.524 HG13 ' HB ' ' B' ' 65' ' ' VAL . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' B' ' 107' ' ' GLN . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' B' ' 150' ' ' ILE . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' B' ' 150' ' ' ILE . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' B' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.563 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' H' ' 21' ' ' ALA . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.426 HG21 ' H ' ' B' ' 172' ' ' GLY . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' GLY . . . . . 0.415 ' N ' HG22 ' B' ' 167' ' ' THR . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 167' ' ' THR . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' B' ' 176' ' ' ALA . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.743 HG21 HG23 ' D' ' 126' ' ' VAL . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.836 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.562 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' C' ' 76' ' ' GLN . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.722 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.775 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB3' ' HE ' ' C' ' 41' ' ' ARG . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' C' ' 34' ' ' ASP . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ARG . . . . . 0.41 HH21 ' HD3' ' C' ' 71' ' ' ARG . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.601 HD12 HD11 ' C' ' 113' ' ' ILE . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.672 ' HD1' HG22 ' C' ' 113' ' ' ILE . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 85' ' ' ASN . . . . . 0.417 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.781 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' C' ' 111' ' ' ALA . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.634 HG11 ' HG2' ' C' ' 142' ' ' GLU . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' C' ' 104' ' ' TYR . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.804 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.563 ' HG2' ' HG2' ' C' ' 139' ' ' LYS . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.669 ' HD2' HD11 ' C' ' 138' ' ' LEU . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.701 ' O ' HG23 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' C' ' 91' ' ' PHE . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.672 HG22 ' HD1' ' C' ' 83' ' ' TYR . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.872 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' B' ' 37' ' ' VAL . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' GLU . . . . . 0.605 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.789 HG23 HG21 ' B' ' 6' ' ' ILE . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB ' ' C' ' 65' ' ' VAL . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.701 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.665 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.617 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.669 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' C' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 140' ' ' ASN . . . . . 0.602 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.804 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.919 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.52 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' C' ' 150' ' ' ILE . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' C' ' 150' ' ' ILE . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' C' ' 145' ' ' THR . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.471 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 162' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.525 ' O ' HG22 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.427 HG22 ' HB1' ' I' ' 21' ' ' ALA . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' C' ' 172' ' ' GLY . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 168' ' ' GLY . . . . . 0.413 ' N ' HG22 ' C' ' 167' ' ' THR . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.428 ' H ' HG21 ' C' ' 167' ' ' THR . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' C' ' 176' ' ' ALA . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 176' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.8 HG21 HG23 ' E' ' 126' ' ' VAL . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.84 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.84 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.854 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' D' ' 76' ' ' GLN . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.713 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 117' ' ' GLU . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.809 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.681 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' D' ' 41' ' ' ARG . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ALA . . . . . 0.564 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.713 HG13 ' OD1' ' D' ' 34' ' ' ASP . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.493 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.598 HG23 HD13 ' D' ' 113' ' ' ILE . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.663 ' HD1' HG22 ' D' ' 113' ' ' ILE . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.704 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' D' ' 82' ' ' ALA . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' D' ' 142' ' ' GLU . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.546 ' OH ' HG21 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.794 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' D' ' 139' ' ' LYS . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' D' ' 138' ' ' LEU . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.709 ' O ' HG23 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.663 HG22 ' HD1' ' D' ' 83' ' ' TYR . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 123' ' ' GLU . . . . . 0.521 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.743 HG23 HG21 ' C' ' 6' ' ' ILE . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' D' ' 65' ' ' VAL . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.67 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' D' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.794 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.511 ' O ' HD12 ' D' ' 150' ' ' ILE . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.511 HD12 ' O ' ' D' ' 145' ' ' THR . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 159' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.584 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.526 ' O ' HG22 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' J' ' 21' ' ' ALA . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.442 HG21 ' H ' ' D' ' 172' ' ' GLY . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' D' ' 167' ' ' THR . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 172' ' ' GLY . . . . . 0.442 ' H ' HG21 ' D' ' 167' ' ' THR . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.526 HG22 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' D' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' D' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.848 HG21 HG23 ' F' ' 126' ' ' VAL . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.829 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.829 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.558 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' E' ' 76' ' ' GLN . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.476 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.704 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' F' ' 118' ' ' TYR . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' F' ' 117' ' ' GLU . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.737 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' F' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 59' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 61' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.704 HG13 ' OD1' ' E' ' 34' ' ' ASP . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.609 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' E' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.681 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' E' ' 82' ' ' ALA . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' E' ' 142' ' ' GLU . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' E' ' 104' ' ' TYR . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.779 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' E' ' 139' ' ' LYS . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.662 ' HD2' HD11 ' E' ' 138' ' ' LEU . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.668 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.677 HG22 ' HD1' ' E' ' 83' ' ' TYR . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.809 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.45 ' HB3' HG12 ' D' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 119' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 123' ' ' GLU . . . . . 0.611 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.8 HG23 HG21 ' D' ' 6' ' ' ILE . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 129' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' E' ' 65' ' ' VAL . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.665 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' E' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.535 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.51 ' O ' HD12 ' E' ' 150' ' ' ILE . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 146' ' ' LEU . . . . . 0.462 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.722 ' HB3' HG21 ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.51 HD12 ' O ' ' E' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 162' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.552 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.514 ' O ' HG22 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' K' ' 21' ' ' ALA . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' E' ' 172' ' ' GLY . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 168' ' ' GLY . . . . . 0.411 ' N ' HG22 ' E' ' 167' ' ' THR . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 172' ' ' GLY . . . . . 0.438 ' H ' HG21 ' E' ' 167' ' ' THR . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.514 HG22 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' E' ' 176' ' ' ALA . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' E' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.862 HG21 HG23 ' A' ' 126' ' ' VAL . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.802 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.802 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.603 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.603 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' F' ' 76' ' ' GLN . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.492 ' HA ' ' OE1' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 36' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 42' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 58' ' ' SER . . . . . 0.454 ' HB3' ' HE ' ' F' ' 41' ' ' ARG . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 59' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 61' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.716 HG13 ' OD1' ' F' ' 34' ' ' ASP . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 71' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' F' ' 113' ' ' ILE . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.653 ' HD1' HG22 ' F' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.613 HG11 ' HG2' ' F' ' 142' ' ' GLU . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' F' ' 104' ' ' TYR . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.543 ' OH ' HG21 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.768 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' F' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' F' ' 138' ' ' LEU . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.705 ' O ' HG23 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.653 HG22 ' HD1' ' F' ' 83' ' ' TYR . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.737 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' F' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.416 ' HB3' HG12 ' E' ' 37' ' ' VAL . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 119' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 125' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.848 HG23 HG21 ' E' ' 6' ' ' ILE . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' F' ' 65' ' ' VAL . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' F' ' 65' ' ' VAL . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.672 ' H ' HD13 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' F' ' 107' ' ' GLN . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.53 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.518 ' O ' HD12 ' F' ' 150' ' ' ILE . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' F' ' 150' ' ' ILE . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.716 ' HB3' HG21 ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.518 HD12 ' O ' ' F' ' 145' ' ' THR . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.799 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.504 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.835 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.812 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.562 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 172' ' ' GLY . . . . . 0.422 ' H ' HG21 ' F' ' 167' ' ' THR . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' F' ' 176' ' ' ALA . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' F' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.995 HG21 HG23 ' H' ' 126' ' ' VAL . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.795 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 8' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.795 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 21' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' THR . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' G' ' 76' ' ' GLN . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' G' ' 32' ' ' GLN . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.71 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.526 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 39' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 42' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 59' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 61' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.71 HG13 ' OD1' ' G' ' 34' ' ' ASP . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 71' ' ' ARG . . . . . 0.431 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.629 HD12 HD11 ' G' ' 113' ' ' ILE . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.673 ' HD1' HG22 ' G' ' 113' ' ' ILE . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.681 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' G' ' 142' ' ' GLU . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.542 ' OH ' HG21 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.762 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' G' ' 139' ' ' LYS . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.685 ' HD2' HD11 ' G' ' 138' ' ' LEU . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.681 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.673 HG22 ' HD1' ' G' ' 83' ' ' TYR . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.508 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 119' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 123' ' ' GLU . . . . . 0.507 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.93 HG23 HG21 ' L' ' 6' ' ' ILE . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 129' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' G' ' 65' ' ' VAL . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.61 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.685 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.557 ' HG2' ' HG2' ' G' ' 107' ' ' GLN . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 144' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.512 ' O ' HD12 ' G' ' 150' ' ' ILE . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' G' ' 150' ' ' ILE . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.512 HD12 ' O ' ' G' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' G' ' 172' ' ' GLY . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 168' ' ' GLY . . . . . 0.421 ' N ' HG22 ' G' ' 167' ' ' THR . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' G' G ' 172' ' ' GLY . . . . . 0.428 ' H ' HG21 ' G' ' 167' ' ' THR . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' G' ' 176' ' ' ALA . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' G' G ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' G' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.994 HG21 HG23 ' I' ' 126' ' ' VAL . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.811 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.571 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.855 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 21' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' B' ' 166' ' ' THR . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' H' ' 76' ' ' GLN . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' OE1' ' I' ' 117' ' ' GLU . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 60' ' ' ALA . . . . . 0.571 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' H' ' 34' ' ' ASP . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.429 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.617 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.83 ' HB2' HD11 ' H' ' 89' ' ' ILE . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.67 ' HD1' HG22 ' H' ' 113' ' ' ILE . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.68 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' H' ' 111' ' ' ALA . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' H' ' 142' ' ' GLU . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.777 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.915 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' H' ' 139' ' ' LYS . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' H' ' 138' ' ' LEU . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.717 ' O ' HG23 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' H' ' 91' ' ' PHE . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.67 HG22 ' HD1' ' H' ' 83' ' ' TYR . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.526 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 119' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 123' ' ' GLU . . . . . 0.475 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.995 HG23 HG21 ' G' ' 6' ' ' ILE . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' H' ' 65' ' ' VAL . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.717 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.68 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' H' ' 107' ' ' GLN . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 144' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' H' ' 150' ' ' ILE . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' H' ' 150' ' ' ILE . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' H' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.427 HG21 ' H ' ' H' ' 172' ' ' GLY . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 168' ' ' GLY . . . . . 0.419 ' N ' HG22 ' H' ' 167' ' ' THR . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' H' H ' 172' ' ' GLY . . . . . 0.427 ' H ' HG21 ' H' ' 167' ' ' THR . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' H' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' H' H ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' H' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.46 ' HB2' ' O ' ' J' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.867 HG21 HG23 ' J' ' 126' ' ' VAL . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.555 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.866 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 21' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 163' ' ' PRO . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' I' ' 76' ' ' GLN . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' J' ' 118' ' ' TYR . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' J' ' 117' ' ' GLU . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 39' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.624 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' I' ' 34' ' ' ASP . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.421 ' HD3' HH21 ' I' ' 71' ' ' ARG . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.608 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' I' ' 89' ' ' ILE . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.658 ' HD1' HG22 ' I' ' 113' ' ' ILE . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.673 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' I' ' 111' ' ' ALA . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.571 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' I' ' 142' ' ' GLU . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' I' ' 104' ' ' TYR . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.77 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.911 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' I' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.683 ' HD2' HD11 ' I' ' 138' ' ' LEU . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.708 ' O ' HG23 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' I' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.673 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' I' ' 83' ' ' TYR . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' H' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.994 HG23 HG21 ' H' ' 6' ' ' ILE . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 129' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' I' ' 65' ' ' VAL . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' I' ' 65' ' ' VAL . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.708 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' I' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.911 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.527 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 144' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 145' ' ' THR . . . . . 0.513 ' O ' HD12 ' I' ' 150' ' ' ILE . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 146' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.714 ' HB3' HG21 ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.513 HD12 ' O ' ' I' ' 145' ' ' THR . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.53 ' O ' HG22 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.43 HG21 ' H ' ' I' ' 172' ' ' GLY . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 168' ' ' GLY . . . . . 0.418 ' N ' HG22 ' I' ' 167' ' ' THR . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' I' I ' 172' ' ' GLY . . . . . 0.43 ' H ' HG21 ' I' ' 167' ' ' THR . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.53 HG22 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' I' ' 176' ' ' ALA . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' I' I ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' I' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.515 ' HB2' ' O ' ' K' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.914 HG21 HG23 ' K' ' 126' ' ' VAL . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.816 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 21' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' D' ' 166' ' ' THR . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' J' ' 76' ' ' GLN . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 36' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' K' ' 118' ' ' TYR . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 39' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.561 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 59' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 60' ' ' ALA . . . . . 0.561 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' J' ' 34' ' ' ASP . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 69' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 73' ' ' ASP . . . . . 0.504 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.42 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.614 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' J' ' 113' ' ' ILE . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.688 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' J' ' 82' ' ' ALA . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.627 HG11 ' HG2' ' J' ' 142' ' ' GLU . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' J' ' 139' ' ' LYS . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' J' ' 138' ' ' LEU . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.7 ' O ' HG23 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' J' ' 83' ' ' TYR . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' J' ' 116' ' ' ARG . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' I' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 119' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 123' ' ' GLU . . . . . 0.487 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.867 HG23 HG21 ' I' ' 6' ' ' ILE . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' J' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.7 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.68 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' J' ' 107' ' ' GLN . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.907 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' D' ' 160' ' ' PHE . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.515 ' O ' HD12 ' J' ' 150' ' ' ILE . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' J' ' 147' ' ' PRO . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.713 ' HB3' HG21 ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.515 HD12 ' O ' ' J' ' 145' ' ' THR . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.713 HG21 ' HB3' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.439 HG21 ' H ' ' J' ' 172' ' ' GLY . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 168' ' ' GLY . . . . . 0.416 ' N ' HG22 ' J' ' 167' ' ' THR . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' J' J ' 172' ' ' GLY . . . . . 0.439 ' H ' HG21 ' J' ' 167' ' ' THR . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' J' ' 176' ' ' ALA . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' J' J ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' J' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.434 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.945 HG21 HG23 ' L' ' 126' ' ' VAL . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.82 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.871 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 21' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' E' ' 166' ' ' THR . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' K' ' 76' ' ' GLN . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.707 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' L' ' 117' ' ' GLU . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 42' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.41 HD23 ' HG3' ' L' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 58' ' ' SER . . . . . 0.465 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 59' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.707 HG13 ' OD1' ' K' ' 34' ' ' ASP . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.428 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.665 ' HD1' HG22 ' K' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.678 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' K' ' 82' ' ' ALA . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' K' ' 142' ' ' GLU . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 98' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' K' ' 104' ' ' TYR . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.767 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.917 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' K' ' 139' ' ' LYS . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' K' ' 138' ' ' LEU . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.71 ' O ' HG23 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.678 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.665 HG22 ' HD1' ' K' ' 83' ' ' TYR . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.532 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' K' ' 116' ' ' ARG . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.537 ' HB3' HG12 ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 119' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.914 HG23 HG21 ' J' ' 6' ' ' ILE . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 129' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' K' ' 65' ' ' VAL . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.71 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.683 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.616 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' K' ' 107' ' ' GLN . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 140' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.917 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.522 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 144' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.497 ' O ' HD12 ' K' ' 150' ' ' ILE . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 146' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' K' ' 150' ' ' ILE . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.497 HD12 ' O ' ' K' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.517 ' O ' HG22 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.443 HG21 ' H ' ' K' ' 172' ' ' GLY . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' K' ' 167' ' ' THR . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' K' K ' 172' ' ' GLY . . . . . 0.443 ' H ' HG21 ' K' ' 167' ' ' THR . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' K' ' 176' ' ' ALA . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' K' K ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' K' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.559 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.93 HG21 HG23 ' G' ' 126' ' ' VAL . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.821 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 8' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.821 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.593 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.844 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.593 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' L' ' 76' ' ' GLN . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.48 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 36' ' ' SER . . . . . 0.41 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.508 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 39' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 42' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 59' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' L' ' 34' ' ' ASP . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 69' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.406 ' HD3' HH21 ' L' ' 71' ' ' ARG . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 73' ' ' ASP . . . . . 0.486 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.422 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.633 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.818 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' L' ' 113' ' ' ILE . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.684 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' L' ' 82' ' ' ALA . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.844 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.617 HG11 ' HG2' ' L' ' 142' ' ' GLU . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' L' ' 104' ' ' TYR . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.536 ' OH ' HG21 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' L' ' 139' ' ' LYS . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.674 ' HD2' HD11 ' L' ' 138' ' ' LEU . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.704 ' O ' HG23 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.684 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' L' ' 83' ' ' TYR . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' L' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' K' ' 37' ' ' VAL . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 119' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.945 HG23 HG21 ' K' ' 6' ' ' ILE . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 129' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' L' ' 65' ' ' VAL . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' L' ' 65' ' ' VAL . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.704 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.68 HD13 ' H ' ' L' ' 135' ' ' ILE . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.674 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' L' ' 107' ' ' GLN . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.799 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.835 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.514 ' O ' HD12 ' L' ' 150' ' ' ILE . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 146' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' L' ' 25' ' ' ALA . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.72 ' HB3' HG21 ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.514 HD12 ' O ' ' L' ' 145' ' ' THR . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.72 HG21 ' HB3' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' L' ' 172' ' ' GLY . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 168' ' ' GLY . . . . . 0.414 ' N ' HG22 ' L' ' 167' ' ' THR . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' L' L ' 172' ' ' GLY . . . . . 0.438 ' H ' HG21 ' L' ' 167' ' ' THR . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' L' ' 176' ' ' ALA . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' L' L ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' L' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.526 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 18' ' ' ILE . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' B' ' 117' ' ' GLU . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.84 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.84 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 40' ' ' GLU . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG12 ' HD1' ' A' ' 67' ' ' TYR . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD1' HG12 ' A' ' 65' ' ' VAL . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.691 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 75' ' ' GLY . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.672 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.873 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.873 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' A' ' 132' ' ' LEU . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.629 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 106' ' ' ALA . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.52 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' A' ' 137' ' ' GLU . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 91' ' ' PHE . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.695 ' HD1' HD13 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.464 HG11 ' O ' ' F' ' 31' ' ' TYR . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.608 ' CD1' ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' A' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.663 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.647 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 174' ' ' VAL . 1.7 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' G' ' 21' ' ' ALA . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.841 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.445 ' C ' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.841 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' B' ' 96' ' ' THR . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB3' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' B' ' 91' ' ' PHE . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' B' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' B' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.7 ' HZ ' ' H ' ' B' ' 70' ' ' LYS . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' C' ' 117' ' ' GLU . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.72 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' GLU . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.454 HG12 ' HD1' ' B' ' 67' ' ' TYR . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' B' ' 127' ' ' GLU . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' LYS . . . . . 0.7 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' B' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 75' ' ' GLY . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.67 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.573 ' HE1' HD21 ' B' ' 132' ' ' LEU . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.635 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' B' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.523 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG22 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.656 HE21 ' HB3' ' B' ' 137' ' ' GLU . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' B' ' 91' ' ' PHE . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.567 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.486 ' CD ' ' HG3' ' B' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.854 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.526 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' B' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.615 ' CD1' ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' B' ' 116' ' ' ARG . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.573 HD21 ' HE1' ' B' ' 91' ' ' PHE . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLN . . . . . 0.486 ' HG3' ' CD ' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.495 HG12 ' HG ' ' A' ' 54' ' ' LEU . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' B' ' 134' ' ' VAL . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' B' ' 107' ' ' GLN . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.579 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' B' ' 150' ' ' ILE . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' GLN . . . . . 0.439 ' CD ' ' HB2' ' H' ' 144' ' ' ASP . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' B' ' 174' ' ' VAL . 1.7 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.798 ' HA ' ' HB2' ' H' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.842 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.842 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 5' ' ' PRO . . . . . 0.479 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' D' ' 126' ' ' VAL . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' C' ' 96' ' ' THR . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.481 HG22 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' C' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.96 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ASP . . . . . 0.497 ' OD1' HD12 ' C' ' 18' ' ' ILE . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.692 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.488 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' SER . . . . . 0.404 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' C' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' D' ' 133' ' ' GLN . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.846 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' GLY . . . . . 0.846 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' C' ' 40' ' ' GLU . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.447 HG12 ' HD1' ' C' ' 67' ' ' TYR . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' C' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ARG . . . . . 0.417 ' HA ' HD11 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.49 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' GLN . . . . . 0.671 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' C' ' 80' ' ' GLU . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.503 HD13 ' N ' ' C' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.671 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.664 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.532 ' CD1' ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.579 ' HE1' HD21 ' C' ' 132' ' ' LEU . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' C' ' 106' ' ' ALA . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.638 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.491 ' OH ' HG22 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.811 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.657 HE21 ' HB3' ' C' ' 137' ' ' GLU . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' C' ' 91' ' ' PHE . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.555 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.72 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.487 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' ARG . . . . . 0.845 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' B' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' C' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' ILE . . . . . 0.845 HG22 ' HG2' ' C' ' 116' ' ' ARG . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.579 HD21 ' HE1' ' C' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.666 HG11 ' HG3' ' C' ' 137' ' ' GLU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' B' ' 54' ' ' LEU . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' GLU . . . . . 0.666 ' HG3' HG11 ' C' ' 134' ' ' VAL . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' C' ' 107' ' ' GLN . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.811 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.638 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.491 ' H ' HD12 ' C' ' 150' ' ' ILE . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.541 ' HB3' ' HA ' ' C' ' 174' ' ' VAL . 1.7 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' I' ' 21' ' ' ALA . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.853 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 171' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.853 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 175' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.496 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' D' ' 96' ' ' THR . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' D' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.931 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' D' ' 18' ' ' ILE . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' D' ' 14' ' ' LEU . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 28' ' ' PHE . . . . . 0.699 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.699 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' E' ' 117' ' ' GLU . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' GLU . . . . . 0.502 ' HA ' HG22 ' D' ' 59' ' ' VAL . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 40' ' ' GLU . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.461 HG12 ' HD1' ' D' ' 67' ' ' TYR . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' D' ' 32' ' ' GLN . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' D' ' 65' ' ' VAL . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' D' ' 127' ' ' GLU . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' CD1' ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' LYS . . . . . 0.68 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.479 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.502 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 77' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' D' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.502 HG12 ' O ' ' D' ' 75' ' ' GLY . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.895 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.895 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.529 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.931 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' D' ' 132' ' ' LEU . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.405 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.631 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' D' ' 106' ' ' ALA . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ASP . . . . . 0.517 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.666 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.496 ' OH ' HG22 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.64 HE21 ' HB3' ' D' ' 137' ' ' GLU . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.408 ' HD1' ' O ' ' D' ' 91' ' ' PHE . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.564 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.85 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.488 HG13 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.478 ' HG2' ' CE2' ' D' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 128' ' ' ILE . . . . . 0.619 ' CD1' ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' ILE . . . . . 0.85 HG22 ' HG2' ' D' ' 116' ' ' ARG . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' D' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' D' ' 137' ' ' GLU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.515 HG12 ' HG ' ' C' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 137' ' ' GLU . . . . . 0.68 ' HG3' HG11 ' D' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' D' ' 107' ' ' GLN . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.814 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.666 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.493 HD12 ' H ' ' D' ' 150' ' ' ILE . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.406 ' CD ' ' HB2' ' J' ' 144' ' ' ASP . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 164' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' J' ' 22' ' ' THR . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' D' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.886 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.864 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 168' ' ' GLY . . . . . 0.432 ' C ' HD13 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 171' ' ' PRO . . . . . 0.622 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 173' ' ' THR . . . . . 0.864 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 175' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' F' ' 126' ' ' VAL . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' E' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' HB3' ' E' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' E' ' 91' ' ' PHE . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.92 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' E' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 24' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' E' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 40' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.819 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 55' ' ' GLY . . . . . 0.819 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' E' ' 40' ' ' GLU . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.449 HG12 ' HD1' ' E' ' 67' ' ' TYR . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.449 ' HD1' HG12 ' E' ' 65' ' ' VAL . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' E' ' 127' ' ' GLU . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 70' ' ' LYS . . . . . 0.69 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.446 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 77' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' E' ' 80' ' ' GLU . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' E' ' 79' ' ' ILE . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.885 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.668 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.885 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.596 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.92 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' E' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.403 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.638 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' E' ' 106' ' ' ALA . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.652 HE21 ' HB3' ' E' ' 137' ' ' GLU . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' E' ' 91' ' ' PHE . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.561 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.859 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' D' ' 37' ' ' VAL . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 122' ' ' VAL . . . . . 0.42 HG13 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CD2' ' E' ' 68' ' ' TYR . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 128' ' ' ILE . . . . . 0.61 ' CD1' ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 130' ' ' ILE . . . . . 0.859 HG22 ' HG2' ' E' ' 116' ' ' ARG . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' E' ' 91' ' ' PHE . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 133' ' ' GLN . . . . . 0.495 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.685 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.49 HG12 ' HG ' ' D' ' 54' ' ' LEU . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 137' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' E' ' 134' ' ' VAL . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.602 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.668 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.486 HD12 ' H ' ' E' ' 150' ' ' ILE . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.463 0.218 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.566 ' HB3' ' HA ' ' E' ' 174' ' ' VAL . 1.7 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.826 ' HA ' ' HB2' ' K' ' 21' ' ' ALA . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.876 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 168' ' ' GLY . . . . . 0.462 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 171' ' ' PRO . . . . . 0.574 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 173' ' ' THR . . . . . 0.876 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 175' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.556 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.575 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 7' ' ' MET . . . . . 0.479 ' H ' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' F' ' 91' ' ' PHE . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.97 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 19' ' ' ASP . . . . . 0.488 ' OD1' HD12 ' F' ' 18' ' ' ILE . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 31' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 122' ' ' VAL . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 38' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 40' ' ' GLU . . . . . 0.489 ' HA ' HG22 ' F' ' 59' ' ' VAL . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.695 HD13 ' HD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' F' ' 40' ' ' GLU . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' F' ' 67' ' ' TYR . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.461 ' OH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.475 ' CD2' ' HG2' ' F' ' 127' ' ' GLU . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 71' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 77' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' F' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.501 HG12 ' O ' ' F' ' 75' ' ' GLY . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.567 ' HE1' HD21 ' F' ' 132' ' ' LEU . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' F' ' 106' ' ' ALA . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 95' ' ' ASP . . . . . 0.512 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' F' ' 137' ' ' GLU . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' F' ' 91' ' ' PHE . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.566 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' F' ' 88' ' ' GLN . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 116' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' E' ' 6' ' ' ILE . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' F' ' 68' ' ' TYR . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 128' ' ' ILE . . . . . 0.601 ' CD1' ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 130' ' ' ILE . . . . . 0.871 HG22 ' HG2' ' F' ' 116' ' ' ARG . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.567 HD21 ' HE1' ' F' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' F' ' 137' ' ' GLU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 137' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' F' ' 134' ' ' VAL . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.493 ' HB2' ' OE1' ' A' ' 84' ' ' GLN . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.652 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.472 HD12 ' H ' ' F' ' 150' ' ' ILE . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.601 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.717 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.881 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 5.3 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.491 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 164' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' F' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.863 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.857 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 168' ' ' GLY . . . . . 0.725 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.747 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 170' ' ' ALA . . . . . 0.435 ' O ' ' HE1' ' L' ' 110' ' ' PHE . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 171' ' ' PRO . . . . . 0.649 ' HA ' ' CD1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 173' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 175' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.573 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 7' ' ' MET . . . . . 0.474 ' H ' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 0.545 ' HA ' ' OG1' ' G' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 20.0 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.978 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 19' ' ' ASP . . . . . 0.49 ' OD1' HD12 ' G' ' 18' ' ' ILE . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 24' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 28' ' ' PHE . . . . . 0.693 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 36' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 38' ' ' SER . . . . . 0.677 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 40' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' G' ' 59' ' ' VAL . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 43' ' ' LEU . . . . . 0.841 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.528 HD13 ' HD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 55' ' ' GLY . . . . . 0.841 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 59' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' G' ' 40' ' ' GLU . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' G' ' 67' ' ' TYR . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.454 ' OH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' G' ' 127' ' ' GLU . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.611 ' HA3' ' CD1' ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD2' ' G' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 76' ' ' GLN . . . . . 0.674 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' G' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.502 HD13 ' N ' ' G' ' 79' ' ' ILE . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.674 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.872 HE22 ' HB2' ' L' ' 139' ' ' LYS . 0.4 OUTLIER -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.577 ' HE1' HD21 ' G' ' 132' ' ' LEU . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' G' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.659 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' G' ' 137' ' ' GLU . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' G' ' 91' ' ' PHE . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' L' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' G' ' 133' ' ' GLN . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.867 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.429 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.476 ' HG2' ' CE2' ' G' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 128' ' ' ILE . . . . . 0.611 ' CD1' ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 130' ' ' ILE . . . . . 0.867 HG22 ' HG2' ' G' ' 116' ' ' ARG . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.577 HD21 ' HE1' ' G' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.529 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' G' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.915 ' HB2' HE22 ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.659 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.481 HD12 ' H ' ' G' ' 150' ' ' ILE . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' G' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 166' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.87 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' G' G ' 173' ' ' THR . . . . . 0.87 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 175' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.584 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 7' ' ' MET . . . . . 0.48 ' H ' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.471 HG22 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' H' ' 27' ' ' LEU . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.404 ' HE2' ' CE1' ' H' ' 91' ' ' PHE . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 20.0 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' H' ' 18' ' ' ILE . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 21' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' H' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 28' ' ' PHE . . . . . 0.692 ' HZ ' ' H ' ' H' ' 70' ' ' LYS . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 29' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 40' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' H' ' 59' ' ' VAL . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' H' ' 40' ' ' GLU . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.453 HG12 ' HD1' ' H' ' 67' ' ' TYR . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.453 ' HD1' HG12 ' H' ' 65' ' ' VAL . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' H' ' 127' ' ' GLU . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 71' ' ' ARG . . . . . 0.419 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 77' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' H' ' 80' ' ' GLU . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.498 HG12 ' O ' ' H' ' 75' ' ' GLY . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.676 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.915 HE22 ' HB2' ' G' ' 139' ' ' LYS . 0.4 OUTLIER -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.54 ' CD1' ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' H' ' 132' ' ' LEU . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' H' ' 106' ' ' ALA . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 95' ' ' ASP . . . . . 0.513 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.646 HE21 ' HB3' ' H' ' 137' ' ' GLU . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.419 ' HD1' ' O ' ' H' ' 91' ' ' PHE . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' H' ' 88' ' ' GLN . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.438 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' H' ' 133' ' ' GLN . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 116' ' ' ARG . . . . . 0.853 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' H' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 128' ' ' ILE . . . . . 0.604 ' CD1' ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 130' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' H' ' 116' ' ' ARG . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' H' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 137' ' ' GLU . . . . . 0.668 ' HG3' HG11 ' H' ' 134' ' ' VAL . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.699 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.82 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.63 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' B' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.49 HD12 ' H ' ' H' ' 150' ' ' ILE . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' H' ' 174' ' ' VAL . 1.7 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 166' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' H' H ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 175' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' I' ' 96' ' ' THR . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' I' ' 27' ' ' LEU . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.412 ' HE2' ' CE1' ' I' ' 91' ' ' PHE . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 20.1 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 19' ' ' ASP . . . . . 0.494 ' OD1' HD12 ' I' ' 18' ' ' ILE . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 21' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 24' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' I' ' 14' ' ' LEU . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 28' ' ' PHE . . . . . 0.694 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 31' ' ' TYR . . . . . 0.458 ' O ' HG11 ' J' ' 122' ' ' VAL . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.4 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' J' ' 117' ' ' GLU . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 38' ' ' SER . . . . . 0.634 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 40' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 43' ' ' LEU . . . . . 0.852 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 55' ' ' GLY . . . . . 0.852 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' I' ' 40' ' ' GLU . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.455 HG12 ' HD1' ' I' ' 67' ' ' TYR . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.455 ' HD1' HG12 ' I' ' 65' ' ' VAL . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' I' ' 127' ' ' GLU . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' CD1' ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.694 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.404 ' HD2' HH21 ' I' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 76' ' ' GLN . . . . . 0.667 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' I' ' 80' ' ' GLU . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' I' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HE1' HD21 ' I' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' I' ' 106' ' ' ALA . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.635 HE21 ' HB3' ' I' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' I' ' 91' ' ' PHE . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.422 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' I' ' 133' ' ' GLN . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.843 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' I' ' 68' ' ' TYR . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 128' ' ' ILE . . . . . 0.618 ' CD1' ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 130' ' ' ILE . . . . . 0.843 HG22 ' HG2' ' I' ' 116' ' ' ARG . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.562 HD21 ' HE1' ' I' ' 91' ' ' PHE . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.476 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 137' ' ' GLU . . . . . 0.657 ' HG3' HG11 ' I' ' 134' ' ' VAL . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.632 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.489 HD12 ' H ' ' I' ' 150' ' ' ILE . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' I' ' 174' ' ' VAL . 1.7 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 166' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.844 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' I' I ' 173' ' ' THR . . . . . 0.844 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 175' ' ' PRO . . . . . 0.583 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.586 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.601 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 7' ' ' MET . . . . . 0.481 ' H ' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' J' ' 96' ' ' THR . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' J' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.414 ' HE2' ' CE1' ' J' ' 91' ' ' PHE . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 19.9 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.949 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' J' ' 18' ' ' ILE . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 21' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 22' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' D' ' 164' ' ' GLY . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 24' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' J' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 28' ' ' PHE . . . . . 0.701 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 29' ' ' PRO . . . . . 0.701 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 31' ' ' TYR . . . . . 0.492 ' O ' HG11 ' K' ' 122' ' ' VAL . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.4 ' HB3' ' OG1' ' J' ' 66' ' ' THR . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 36' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' K' ' 117' ' ' GLU . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 38' ' ' SER . . . . . 0.573 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 40' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' J' ' 59' ' ' VAL . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 43' ' ' LEU . . . . . 0.839 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 55' ' ' GLY . . . . . 0.839 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 59' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' J' ' 40' ' ' GLU . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' J' ' 67' ' ' TYR . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' J' ' 32' ' ' GLN . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' J' ' 65' ' ' VAL . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' J' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.679 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 76' ' ' GLN . . . . . 0.678 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' J' ' 80' ' ' GLU . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' J' ' 79' ' ' ILE . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.678 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.887 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.665 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.887 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.578 ' HE1' HD21 ' J' ' 132' ' ' LEU . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.634 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' J' ' 106' ' ' ALA . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.658 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' J' ' 137' ' ' GLU . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' J' ' 91' ' ' PHE . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' J' ' 88' ' ' GLN . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 116' ' ' ARG . . . . . 0.841 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' I' ' 37' ' ' VAL . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.492 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 122' ' ' VAL . . . . . 0.458 HG11 ' O ' ' I' ' 31' ' ' TYR . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' J' ' 68' ' ' TYR . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 130' ' ' ILE . . . . . 0.841 HG22 ' HG2' ' J' ' 116' ' ' ARG . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.578 HD21 ' HE1' ' J' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 137' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' J' ' 134' ' ' VAL . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.627 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.812 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' D' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.572 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.476 ' H ' HD12 ' J' ' 150' ' ' ILE . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.546 ' HB3' ' HA ' ' J' ' 174' ' ' VAL . 1.7 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 166' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' J' J ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' L' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' K' ' 96' ' ' THR . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.511 ' CG2' HG11 ' L' ' 126' ' ' VAL . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' K' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' K' ' 91' ' ' PHE . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 19.9 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.939 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' K' ' 18' ' ' ILE . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' K' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 31' ' ' TYR . . . . . 0.426 ' O ' HG11 ' L' ' 122' ' ' VAL . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 38' ' ' SER . . . . . 0.527 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 40' ' ' GLU . . . . . 0.492 ' HA ' HG22 ' K' ' 59' ' ' VAL . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.558 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 59' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' K' ' 40' ' ' GLU . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' K' ' 67' ' ' TYR . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' K' ' 127' ' ' GLU . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' CD1' ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' K' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 77' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' K' ' 80' ' ' GLU . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.499 HD13 ' N ' ' K' ' 79' ' ' ILE . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.88 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.588 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' K' ' 132' ' ' LEU . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' K' ' 106' ' ' ALA . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.489 ' OH ' HG22 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.641 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' K' ' 91' ' ' PHE . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' K' ' 88' ' ' GLN . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' J' ' 40' ' ' GLU . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.497 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 116' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' J' ' 37' ' ' VAL . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.428 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 122' ' ' VAL . . . . . 0.492 HG11 ' O ' ' J' ' 31' ' ' TYR . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.601 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' K' ' 68' ' ' TYR . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 128' ' ' ILE . . . . . 0.603 ' CD1' ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 130' ' ' ILE . . . . . 0.851 HG22 ' HG2' ' K' ' 116' ' ' ARG . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' K' ' 91' ' ' PHE . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 133' ' ' GLN . . . . . 0.497 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.527 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 137' ' ' GLU . . . . . 0.682 ' HG3' HG11 ' K' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.555 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.584 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.469 HD12 ' H ' ' K' ' 150' ' ' ILE . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' K' ' 174' ' ' VAL . 1.7 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 166' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.873 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' K' K ' 173' ' ' THR . . . . . 0.873 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 175' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 0.529 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.402 ' HE2' ' CE1' ' L' ' 91' ' ' PHE . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.928 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' L' ' 18' ' ' ILE . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 22' ' ' THR . . . . . 0.677 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 38' ' ' SER . . . . . 0.637 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 40' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' L' ' 59' ' ' VAL . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 43' ' ' LEU . . . . . 0.829 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.529 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 55' ' ' GLY . . . . . 0.829 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 59' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' L' ' 40' ' ' GLU . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' L' ' 67' ' ' TYR . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' L' ' 65' ' ' VAL . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' L' ' 127' ' ' GLU . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.442 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 75' ' ' GLY . . . . . 0.496 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 76' ' ' GLN . . . . . 0.663 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 77' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' L' ' 80' ' ' GLU . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.502 ' N ' HD13 ' L' ' 79' ' ' ILE . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.527 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.747 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.928 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' L' ' 132' ' ' LEU . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.717 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.628 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' L' ' 106' ' ' ALA . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' L' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' L' ' 91' ' ' PHE . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CD1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' L' ' 88' ' ' GLN . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.493 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 122' ' ' VAL . . . . . 0.426 HG11 ' O ' ' K' ' 31' ' ' TYR . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' L' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 128' ' ' ILE . . . . . 0.607 ' CD1' ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' L' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' L' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' L' ' 137' ' ' GLU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.558 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 137' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' L' ' 134' ' ' VAL . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.872 ' HB2' HE22 ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.601 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.881 ' OE2' ' NE2' ' F' ' 162' ' ' GLN . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.657 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.513 ' H ' ' NE2' ' F' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.473 HD12 ' H ' ' L' ' 150' ' ' ILE . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' L' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 166' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.88 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' L' L ' 173' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 175' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.812 HG21 HG23 ' B' ' 126' ' ' VAL . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 1.056 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 1.056 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HD1' ' CE1' ' A' ' 91' ' ' PHE . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.825 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 22' ' ' THR . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 65' ' ' VAL . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' B' ' 117' ' ' GLU . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.825 HH22 ' HB2' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 54' ' ' LEU . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.825 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' HA2' ' A' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.717 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' F' ' 5' ' ' PRO . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.737 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 113' ' ' ILE . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' A' ' 82' ' ' ALA . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.762 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 102' ' ' ASP . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.564 ' HB2' HD22 ' A' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 93' ' ' ARG . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.821 ' HD2' HD11 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.671 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 83' ' ' TYR . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.831 HG23 HG21 ' F' ' 6' ' ' ILE . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' A' ' 111' ' ' ALA . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.821 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.667 ' O ' HD12 ' A' ' 150' ' ' ILE . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 145' ' ' THR . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.488 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.516 ' CA ' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.778 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 172' ' ' GLY . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' G' ' 88' ' ' GLN . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' H ' HG21 ' A' ' 167' ' ' THR . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.739 HG21 HG23 ' C' ' 126' ' ' VAL . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' MET . . . . . 1.073 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASP . . . . . 1.073 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' B' ' 91' ' ' PHE . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.841 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 22' ' ' THR . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' B' ' 67' ' ' TYR . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' B' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' PRO . . . . . 0.532 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' B' ' 136' ' ' GLY . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' TYR . . . . . 0.714 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.412 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.748 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' B' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLN . . . . . 0.872 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' B' ' 82' ' ' ALA . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ARG . . . . . 0.507 ' HD2' ' HB2' ' B' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.406 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ASN . . . . . 0.577 HD22 ' HB2' ' B' ' 102' ' ' ASP . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASP . . . . . 0.577 ' HB2' HD22 ' B' ' 99' ' ' ASN . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' B' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.571 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' TYR . . . . . 0.663 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.553 HG22 ' HD1' ' B' ' 83' ' ' TYR . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . 0.789 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 116' ' ' ARG . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.563 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' VAL . . . . . 0.812 HG23 HG21 ' A' ' 6' ' ' ILE . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.714 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 132' ' ' LEU . . . . . 0.571 HD13 ' HB1' ' B' ' 111' ' ' ALA . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' VAL . . . . . 0.684 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.681 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLY . . . . . 0.663 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 139' ' ' LYS . . . . . 0.507 ' HD3' ' HG2' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.87 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' THR . . . . . 0.671 ' O ' HD12 ' B' ' 150' ' ' ILE . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 160' ' ' PHE . . . . . 0.567 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.429 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' B' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 166' ' ' THR . . . . . 0.735 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' B' ' 172' ' ' GLY . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' B' ' 167' ' ' THR . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.715 HG21 HG23 ' D' ' 126' ' ' VAL . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' MET . . . . . 1.07 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ASP . . . . . 1.07 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 13' ' ' TYR . . . . . 0.465 ' HD1' ' CE1' ' C' ' 91' ' ' PHE . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' LEU . . . . . 0.754 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' PHE . . . . . 0.563 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ILE . . . . . 0.857 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' THR . . . . . 0.439 HG22 ' H ' ' C' ' 23' ' ' GLY . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 23' ' ' GLY . . . . . 0.439 ' H ' HG22 ' C' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LEU . . . . . 0.614 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' C' ' 67' ' ' TYR . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' THR . . . . . 0.444 HG22 HG23 ' D' ' 122' ' ' VAL . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' C' ' 65' ' ' VAL . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' ARG . . . . . 0.798 HH22 ' HB2' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' GLU . . . . . 0.828 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' LEU . . . . . 0.847 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' C' ' 54' ' ' LEU . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' SER . . . . . 0.523 ' HB3' ' HE ' ' C' ' 41' ' ' ARG . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ALA . . . . . 0.798 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' C' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' C' ' 64' ' ' GLU . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.777 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 67' ' ' TYR . . . . . 0.718 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' C' ' 113' ' ' ILE . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' TYR . . . . . 0.552 ' CD1' HG22 ' C' ' 113' ' ' ILE . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLN . . . . . 0.886 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' C' ' 82' ' ' ALA . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 91' ' ' PHE . . . . . 0.563 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' TRP . . . . . 0.754 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 93' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' C' ' 107' ' ' GLN . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.748 HG12 ' HB2' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' C' ' 102' ' ' ASP . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ASP . . . . . 0.581 ' HB2' HD22 ' C' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 103' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.825 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' ALA . . . . . 0.748 ' HB2' HG12 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' GLN . . . . . 0.501 ' HB2' ' HD2' ' C' ' 93' ' ' ARG . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PHE . . . . . 0.834 ' HD2' HD11 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ALA . . . . . 0.581 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 112' ' ' TYR . . . . . 0.661 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' C' ' 83' ' ' TYR . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' VAL . . . . . 0.739 HG23 HG21 ' B' ' 6' ' ' ILE . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 128' ' ' ILE . . . . . 0.718 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' SER . . . . . 0.777 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 132' ' ' LEU . . . . . 0.581 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' VAL . . . . . 0.673 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 135' ' ' ILE . . . . . 0.671 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 136' ' ' GLY . . . . . 0.67 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 139' ' ' LYS . . . . . 0.457 ' HD3' ' HG2' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 142' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 143' ' ' ILE . . . . . 0.867 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' C' ' 150' ' ' ILE . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 146' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' C' ' 145' ' ' THR . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 160' ' ' PHE . . . . . 0.502 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 161' ' ' GLN . . . . . 0.506 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 165' ' ' GLN . . . . . 0.506 ' CA ' ' HB3' ' C' ' 161' ' ' GLN . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 166' ' ' THR . . . . . 0.721 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 167' ' ' THR . . . . . 0.553 HG21 ' H ' ' C' ' 172' ' ' GLY . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 172' ' ' GLY . . . . . 0.553 ' H ' HG21 ' C' ' 167' ' ' THR . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.776 HG21 HG23 ' E' ' 126' ' ' VAL . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' LYS . . . . . 0.571 ' HG2' HD11 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 13' ' ' TYR . . . . . 0.464 ' HD1' ' CE1' ' D' ' 91' ' ' PHE . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' LEU . . . . . 0.75 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' PHE . . . . . 0.554 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' D' ' 23' ' ' GLY . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 23' ' ' GLY . . . . . 0.444 ' H ' HG22 ' D' ' 22' ' ' THR . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.477 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' D' ' 65' ' ' VAL . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' SER . . . . . 0.556 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' ARG . . . . . 0.793 HH22 ' HB2' ' D' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' LEU . . . . . 0.814 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' D' ' 54' ' ' LEU . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' SER . . . . . 0.523 ' HB3' ' HE ' ' D' ' 41' ' ' ARG . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ALA . . . . . 0.793 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' D' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' D' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 66' ' ' THR . . . . . 0.79 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' TYR . . . . . 0.71 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' ARG . . . . . 0.417 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.4 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ILE . . . . . 0.526 HD12 HD11 ' D' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 81' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' TYR . . . . . 0.55 ' HD1' HG22 ' D' ' 113' ' ' ILE . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' LYS . . . . . 0.732 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLN . . . . . 0.847 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' D' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' PHE . . . . . 0.554 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 92' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 93' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' D' ' 107' ' ' GLN . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' ASN . . . . . 0.578 HD22 ' HB2' ' D' ' 102' ' ' ASP . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' ASP . . . . . 0.578 ' HB2' HD22 ' D' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.833 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 106' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HD2' ' D' ' 93' ' ' ARG . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PHE . . . . . 0.805 ' HD2' HD11 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 112' ' ' TYR . . . . . 0.672 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 113' ' ' ILE . . . . . 0.55 HG22 ' HD1' ' D' ' 83' ' ' TYR . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 114' ' ' GLU . . . . . 0.828 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 116' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' D' ' 116' ' ' ARG . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 117' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 33' ' ' THR . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 126' ' ' VAL . . . . . 0.715 HG23 HG21 ' C' ' 6' ' ' ILE . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 128' ' ' ILE . . . . . 0.71 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' SER . . . . . 0.79 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 131' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 134' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 135' ' ' ILE . . . . . 0.691 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 138' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.833 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 142' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 145' ' ' THR . . . . . 0.666 ' O ' HD12 ' D' ' 150' ' ' ILE . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 146' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 147' ' ' PRO . . . . . 0.568 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 150' ' ' ILE . . . . . 0.666 HD12 ' O ' ' D' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 160' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 163' ' ' PRO . . . . . 0.535 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' D' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 166' ' ' THR . . . . . 0.684 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 167' ' ' THR . . . . . 0.569 HG21 ' H ' ' D' ' 172' ' ' GLY . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 169' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' J' ' 88' ' ' GLN . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 172' ' ' GLY . . . . . 0.569 ' H ' HG21 ' D' ' 167' ' ' THR . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 5' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.823 HG21 HG23 ' F' ' 126' ' ' VAL . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 7' ' ' MET . . . . . 1.025 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ASP . . . . . 1.025 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 13' ' ' TYR . . . . . 0.456 ' HD1' ' CE1' ' E' ' 91' ' ' PHE . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 15' ' ' PHE . . . . . 0.559 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ILE . . . . . 0.84 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' E' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' E' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' LEU . . . . . 0.635 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 30' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' E' ' 67' ' ' TYR . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 32' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' E' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' SER . . . . . 0.415 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 42' ' ' GLU . . . . . 0.771 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 54' ' ' LEU . . . . . 0.697 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' E' ' 136' ' ' GLY . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 64' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' E' ' 64' ' ' GLU . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 66' ' ' THR . . . . . 0.775 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 67' ' ' TYR . . . . . 0.719 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 68' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 71' ' ' ARG . . . . . 0.427 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 79' ' ' ILE . . . . . 0.54 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 80' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 82' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 83' ' ' TYR . . . . . 0.554 ' CD1' HG22 ' E' ' 113' ' ' ILE . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 84' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 87' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 88' ' ' GLN . . . . . 0.814 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 89' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' E' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 90' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 91' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 93' ' ' ARG . . . . . 0.511 ' HD2' ' HB2' ' E' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 94' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 99' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 102' ' ' ASP . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 102' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' E' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.815 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 106' ' ' ALA . . . . . 0.761 ' HB2' HG12 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 107' ' ' GLN . . . . . 0.511 ' HB2' ' HD2' ' E' ' 93' ' ' ARG . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 111' ' ' ALA . . . . . 0.57 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 113' ' ' ILE . . . . . 0.554 HG22 ' CD1' ' E' ' 83' ' ' TYR . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 114' ' ' GLU . . . . . 0.784 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 115' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 116' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' E' ' 116' ' ' ARG . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 117' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 125' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 126' ' ' VAL . . . . . 0.776 HG23 HG21 ' D' ' 6' ' ' ILE . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 128' ' ' ILE . . . . . 0.719 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 129' ' ' SER . . . . . 0.775 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 131' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 132' ' ' LEU . . . . . 0.57 HD13 ' HB1' ' E' ' 111' ' ' ALA . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 134' ' ' VAL . . . . . 0.684 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 135' ' ' ILE . . . . . 0.68 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 136' ' ' GLY . . . . . 0.677 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 139' ' ' LYS . . . . . 0.422 ' HD3' HE21 ' F' ' 84' ' ' GLN . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 142' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 143' ' ' ILE . . . . . 0.844 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 145' ' ' THR . . . . . 0.652 ' O ' HD12 ' E' ' 150' ' ' ILE . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 147' ' ' PRO . . . . . 0.57 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 150' ' ' ILE . . . . . 0.652 HD12 ' O ' ' E' ' 145' ' ' THR . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 151' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 160' ' ' PHE . . . . . 0.461 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 163' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' E' ' 161' ' ' GLN . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 166' ' ' THR . . . . . 0.853 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 167' ' ' THR . . . . . 0.554 HG21 ' H ' ' E' ' 172' ' ' GLY . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 172' ' ' GLY . . . . . 0.554 ' H ' HG21 ' E' ' 167' ' ' THR . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 5' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.831 HG21 HG23 ' A' ' 126' ' ' VAL . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 7' ' ' MET . . . . . 1.033 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 10' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 13' ' ' TYR . . . . . 0.47 ' HD1' ' CE1' ' F' ' 91' ' ' PHE . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 14' ' ' LEU . . . . . 0.767 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 15' ' ' PHE . . . . . 0.56 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 16' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 18' ' ' ILE . . . . . 0.816 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' F' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' F' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.484 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 27' ' ' LEU . . . . . 0.633 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 30' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' F' ' 67' ' ' TYR . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 34' ' ' ASP . . . . . 0.43 ' OD1' HG22 ' F' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 41' ' ' ARG . . . . . 0.823 HH22 ' HB2' ' F' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 42' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 54' ' ' LEU . . . . . 0.516 HD23 ' HG3' ' A' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 56' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 58' ' ' SER . . . . . 0.517 ' HB3' ' HE ' ' F' ' 41' ' ' ARG . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 60' ' ' ALA . . . . . 0.823 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' F' ' 136' ' ' GLY . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' F' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 66' ' ' THR . . . . . 0.778 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 67' ' ' TYR . . . . . 0.723 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 68' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' F' ' 71' ' ' ARG . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' F' ' 113' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 80' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 82' ' ' ALA . . . . . 0.736 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 83' ' ' TYR . . . . . 0.556 ' HD1' HG22 ' F' ' 113' ' ' ILE . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 84' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 87' ' ' LYS . . . . . 0.736 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 88' ' ' GLN . . . . . 0.697 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 89' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' F' ' 82' ' ' ALA . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 90' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 91' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 92' ' ' TRP . . . . . 0.767 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' F' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 94' ' ' VAL . . . . . 0.758 HG12 ' HB2' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 96' ' ' THR . . . . . 0.428 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 98' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 99' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' F' ' 102' ' ' ASP . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 102' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' F' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 103' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.828 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 106' ' ' ALA . . . . . 0.758 ' HB2' HG12 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 107' ' ' GLN . . . . . 0.518 ' HB2' ' HD2' ' F' ' 93' ' ' ARG . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 110' ' ' PHE . . . . . 0.678 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 111' ' ' ALA . . . . . 0.576 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 112' ' ' TYR . . . . . 0.677 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 113' ' ' ILE . . . . . 0.556 HG22 ' HD1' ' F' ' 83' ' ' TYR . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 114' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 115' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 117' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 125' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 126' ' ' VAL . . . . . 0.823 HG23 HG21 ' E' ' 6' ' ' ILE . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 128' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 129' ' ' SER . . . . . 0.778 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 131' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 132' ' ' LEU . . . . . 0.576 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 134' ' ' VAL . . . . . 0.678 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 135' ' ' ILE . . . . . 0.672 HG12 ' H ' ' F' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 139' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 80' ' ' GLU . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 143' ' ' ILE . . . . . 0.869 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 145' ' ' THR . . . . . 0.673 ' O ' HD12 ' F' ' 150' ' ' ILE . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 146' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 147' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' F' ' 145' ' ' THR . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 151' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 159' ' ' ASP . . . . . 0.73 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 160' ' ' PHE . . . . . 0.606 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 162' ' ' GLN . . . . . 0.95 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 163' ' ' PRO . . . . . 0.903 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' F' ' 161' ' ' GLN . 0.0 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 166' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 167' ' ' THR . . . . . 0.61 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 169' ' ' GLU . . . . . 0.815 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 172' ' ' GLY . . . . . 0.561 ' H ' HG21 ' F' ' 167' ' ' THR . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 5' ' ' PRO . . . . . 0.566 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 6' ' ' ILE . . . . . 0.985 HG21 HG23 ' H' ' 126' ' ' VAL . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 7' ' ' MET . . . . . 1.055 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 10' ' ' ASP . . . . . 1.055 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 12' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 13' ' ' TYR . . . . . 0.468 ' HD1' ' CE1' ' G' ' 91' ' ' PHE . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 15' ' ' PHE . . . . . 0.556 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 18' ' ' ILE . . . . . 0.83 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 21' ' ' ALA . . . . . 0.778 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' G' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 23' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 25' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 27' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 32' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' G' ' 32' ' ' GLN . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 34' ' ' ASP . . . . . 0.425 ' OD1' HG22 ' G' ' 65' ' ' VAL . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 37' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' H' ' 117' ' ' GLU . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 39' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 41' ' ' ARG . . . . . 0.806 HH22 ' HB2' ' G' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 42' ' ' GLU . . . . . 0.517 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 54' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' H' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 56' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 58' ' ' SER . . . . . 0.521 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 60' ' ' ALA . . . . . 0.806 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' G' ' 136' ' ' GLY . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 64' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' G' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 67' ' ' TYR . . . . . 0.709 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 68' ' ' TYR . . . . . 0.653 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 70' ' ' LYS . . . . . 0.529 ' HG3' ' HA ' ' L' ' 5' ' ' PRO . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 79' ' ' ILE . . . . . 0.541 HD12 HD11 ' G' ' 113' ' ' ILE . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 82' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 83' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' G' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 87' ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 88' ' ' GLN . . . . . 0.658 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 89' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' G' ' 82' ' ' ALA . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 90' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 91' ' ' PHE . . . . . 0.556 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 93' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' G' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 94' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 99' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' G' ' 102' ' ' ASP . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 102' ' ' ASP . . . . . 0.563 ' HB2' HD22 ' G' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 105' ' ' ASP . . . . . 0.829 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 106' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' G' ' 93' ' ' ARG . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 108' ' ' PHE . . . . . 0.838 ' HD2' HD11 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 111' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 112' ' ' TYR . . . . . 0.658 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 113' ' ' ILE . . . . . 0.554 HG22 ' HD1' ' G' ' 83' ' ' TYR . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 114' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 115' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' G' ' 116' ' ' ARG . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 117' ' ' GLU . . . . . 0.477 ' HB3' HG12 ' L' ' 37' ' ' VAL . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 118' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 125' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 126' ' ' VAL . . . . . 0.917 HG23 HG21 ' L' ' 6' ' ' ILE . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 127' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 128' ' ' ILE . . . . . 0.709 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 131' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 132' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' G' ' 111' ' ' ALA . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 135' ' ' ILE . . . . . 0.672 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 138' ' ' LEU . . . . . 0.838 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HD3' HE21 ' H' ' 84' ' ' GLN . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 141' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 142' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 143' ' ' ILE . . . . . 0.861 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' G' ' 150' ' ' ILE . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 146' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' G' ' 145' ' ' THR . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 165' ' ' GLN . . . . . 0.505 ' CA ' ' HB3' ' G' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 167' ' ' THR . . . . . 0.543 HG21 ' H ' ' G' ' 172' ' ' GLY . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 172' ' ' GLY . . . . . 0.543 ' H ' HG21 ' G' ' 167' ' ' THR . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' H' H ' 5' ' ' PRO . . . . . 0.582 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 6' ' ' ILE . . . . . 0.938 HG21 HG23 ' I' ' 126' ' ' VAL . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 7' ' ' MET . . . . . 1.068 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 10' ' ' ASP . . . . . 1.068 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 11' ' ' VAL . . . . . 0.441 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HG2' HD11 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 13' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' H' ' 91' ' ' PHE . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 14' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 18' ' ' ILE . . . . . 0.827 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 21' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' H' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' H' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 25' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 27' ' ' LEU . . . . . 0.624 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 34' ' ' ASP . . . . . 0.428 ' OD1' HG22 ' H' ' 65' ' ' VAL . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' I' ' 117' ' ' GLU . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 41' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 42' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 54' ' ' LEU . . . . . 0.434 ' O ' ' HD3' ' H' ' 56' ' ' PRO . 1.4 mp . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 56' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 60' ' ' ALA . . . . . 0.802 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 61' ' ' ASP . . . . . 0.408 ' OD1' ' HA2' ' H' ' 136' ' ' GLY . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 64' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' H' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 65' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 67' ' ' TYR . . . . . 0.713 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 70' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 82' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 83' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' H' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 87' ' ' LYS . . . . . 0.738 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 88' ' ' GLN . . . . . 0.648 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' H' ' 82' ' ' ALA . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 90' ' ' LYS . . . . . 0.827 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' H' ' 107' ' ' GLN . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 95' ' ' ASP . . . . . 0.441 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 96' ' ' THR . . . . . 0.409 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 98' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 99' ' ' ASN . . . . . 0.555 HD22 ' HB2' ' H' ' 102' ' ' ASP . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 102' ' ' ASP . . . . . 0.555 ' HB2' HD22 ' H' ' 99' ' ' ASN . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 104' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 105' ' ' ASP . . . . . 0.847 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' H' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 108' ' ' PHE . . . . . 0.835 ' HD2' HD11 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 112' ' ' TYR . . . . . 0.648 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 113' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' H' ' 83' ' ' TYR . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 114' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 115' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 117' ' ' GLU . . . . . 0.469 ' HB3' HG12 ' G' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 118' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 120' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' G' ' 11' ' ' VAL . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 126' ' ' VAL . . . . . 0.985 HG23 HG21 ' G' ' 6' ' ' ILE . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 127' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 128' ' ' ILE . . . . . 0.713 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 131' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' H' ' 111' ' ' ALA . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 134' ' ' VAL . . . . . 0.683 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 135' ' ' ILE . . . . . 0.689 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 136' ' ' GLY . . . . . 0.66 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 138' ' ' LEU . . . . . 0.835 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 139' ' ' LYS . . . . . 0.534 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 141' ' ' GLY . . . . . 0.847 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 143' ' ' ILE . . . . . 0.859 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 145' ' ' THR . . . . . 0.669 ' O ' HD12 ' H' ' 150' ' ' ILE . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 146' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' H' ' 149' ' ' GLU . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' H' ' 148' ' ' GLU . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 150' ' ' ILE . . . . . 0.669 HD12 ' O ' ' H' ' 145' ' ' THR . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 165' ' ' GLN . . . . . 0.51 ' CA ' ' HB3' ' H' ' 161' ' ' GLN . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 167' ' ' THR . . . . . 0.551 HG21 ' H ' ' H' ' 172' ' ' GLY . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 172' ' ' GLY . . . . . 0.551 ' H ' HG21 ' H' ' 167' ' ' THR . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 174' ' ' VAL . . . . . 0.499 HG22 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' I' I ' 5' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' J' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' J' ' 126' ' ' VAL . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 7' ' ' MET . . . . . 1.078 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 10' ' ' ASP . . . . . 1.078 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 11' ' ' VAL . . . . . 0.439 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 12' ' ' LYS . . . . . 0.545 ' HG2' HD11 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' CE1' ' I' ' 91' ' ' PHE . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 14' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 15' ' ' PHE . . . . . 0.562 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 18' ' ' ILE . . . . . 0.849 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' I' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' I' ' 22' ' ' THR . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 25' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 27' ' ' LEU . . . . . 0.609 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 30' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 32' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 33' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' J' ' 120' ' ' ASP . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 34' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' I' ' 65' ' ' VAL . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 37' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' J' ' 117' ' ' GLU . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 39' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 41' ' ' ARG . . . . . 0.804 HH22 ' HB2' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 42' ' ' GLU . . . . . 0.662 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 54' ' ' LEU . . . . . 0.555 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 58' ' ' SER . . . . . 0.52 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 60' ' ' ALA . . . . . 0.804 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' I' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' I' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 66' ' ' THR . . . . . 0.764 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 67' ' ' TYR . . . . . 0.72 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' I' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' I' ' 71' ' ' ARG . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 79' ' ' ILE . . . . . 0.53 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 80' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 82' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 83' ' ' TYR . . . . . 0.555 ' HD1' HG22 ' I' ' 113' ' ' ILE . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 84' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' I' ' 82' ' ' ALA . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 90' ' ' LYS . . . . . 0.849 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 92' ' ' TRP . . . . . 0.764 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 93' ' ' ARG . . . . . 0.508 ' HD2' ' HB2' ' I' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 95' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 99' ' ' ASN . . . . . 0.579 HD22 ' HB2' ' I' ' 102' ' ' ASP . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 102' ' ' ASP . . . . . 0.579 ' HB2' HD22 ' I' ' 99' ' ' ASN . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 105' ' ' ASP . . . . . 0.857 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 107' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' I' ' 93' ' ' ARG . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 113' ' ' ILE . . . . . 0.555 HG22 ' HD1' ' I' ' 83' ' ' TYR . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 114' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 116' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' I' ' 116' ' ' ARG . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 117' ' ' GLU . . . . . 0.406 ' HB3' HG12 ' H' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 118' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 126' ' ' VAL . . . . . 0.938 HG23 HG21 ' H' ' 6' ' ' ILE . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 127' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 128' ' ' ILE . . . . . 0.72 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 129' ' ' SER . . . . . 0.764 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' I' ' 111' ' ' ALA . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 134' ' ' VAL . . . . . 0.674 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 135' ' ' ILE . . . . . 0.689 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 139' ' ' LYS . . . . . 0.572 ' HD3' ' HG2' ' J' ' 80' ' ' GLU . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 141' ' ' GLY . . . . . 0.857 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 142' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 143' ' ' ILE . . . . . 0.871 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 145' ' ' THR . . . . . 0.665 ' O ' HD12 ' I' ' 150' ' ' ILE . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 146' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 150' ' ' ILE . . . . . 0.665 HD12 ' O ' ' I' ' 145' ' ' THR . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' I' ' 161' ' ' GLN . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 167' ' ' THR . . . . . 0.558 HG21 ' H ' ' I' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 172' ' ' GLY . . . . . 0.558 ' H ' HG21 ' I' ' 167' ' ' THR . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 174' ' ' VAL . . . . . 0.501 HG22 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' J' J ' 5' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' K' ' 70' ' ' LYS . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' K' ' 126' ' ' VAL . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 7' ' ' MET . . . . . 1.059 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 10' ' ' ASP . . . . . 1.059 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 13' ' ' TYR . . . . . 0.454 ' HD1' ' CE1' ' J' ' 91' ' ' PHE . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 14' ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 15' ' ' PHE . . . . . 0.549 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 18' ' ' ILE . . . . . 0.858 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 21' ' ' ALA . . . . . 0.684 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 22' ' ' THR . . . . . 0.436 HG22 ' H ' ' J' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 27' ' ' LEU . . . . . 0.626 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 30' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' J' ' 32' ' ' GLN . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' J' ' 65' ' ' VAL . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 37' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' K' ' 117' ' ' GLU . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 41' ' ' ARG . . . . . 0.794 HH22 ' HB2' ' J' ' 60' ' ' ALA . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 54' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' K' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' J' ' 54' ' ' LEU . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 58' ' ' SER . . . . . 0.525 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 60' ' ' ALA . . . . . 0.794 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' J' ' 136' ' ' GLY . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' J' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 65' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 66' ' ' THR . . . . . 0.77 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 67' ' ' TYR . . . . . 0.722 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 68' ' ' TYR . . . . . 0.642 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 70' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' I' ' 5' ' ' PRO . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 71' ' ' ARG . . . . . 0.448 HH21 ' HD3' ' J' ' 71' ' ' ARG . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 79' ' ' ILE . . . . . 0.535 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 80' ' ' GLU . . . . . 0.572 ' HG2' ' HD3' ' I' ' 139' ' ' LYS . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 81' ' ' ASP . . . . . 0.41 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 82' ' ' ALA . . . . . 0.739 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 83' ' ' TYR . . . . . 0.553 ' CD1' HG22 ' J' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 87' ' ' LYS . . . . . 0.739 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 88' ' ' GLN . . . . . 0.651 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 89' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' J' ' 82' ' ' ALA . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 90' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 91' ' ' PHE . . . . . 0.549 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 92' ' ' TRP . . . . . 0.731 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 93' ' ' ARG . . . . . 0.509 ' HD2' ' HB2' ' J' ' 107' ' ' GLN . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 94' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 98' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 99' ' ' ASN . . . . . 0.58 HD22 ' HB2' ' J' ' 102' ' ' ASP . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 102' ' ' ASP . . . . . 0.58 ' HB2' HD22 ' J' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 105' ' ' ASP . . . . . 0.848 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 106' ' ' ALA . . . . . 0.757 ' HB2' HG12 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 107' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' J' ' 93' ' ' ARG . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 108' ' ' PHE . . . . . 0.827 ' HD2' HD11 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 111' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 112' ' ' TYR . . . . . 0.651 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 113' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' J' ' 83' ' ' TYR . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 114' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 117' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' I' ' 37' ' ' VAL . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 118' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 120' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 125' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' I' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 127' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 128' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 129' ' ' SER . . . . . 0.77 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 132' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' J' ' 111' ' ' ALA . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 134' ' ' VAL . . . . . 0.675 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 135' ' ' ILE . . . . . 0.69 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 138' ' ' LEU . . . . . 0.827 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 139' ' ' LYS . . . . . 0.527 ' HD3' ' HG2' ' K' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 141' ' ' GLY . . . . . 0.848 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 142' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 143' ' ' ILE . . . . . 0.868 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 144' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' J' ' 150' ' ' ILE . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' J' ' 145' ' ' THR . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 165' ' ' GLN . . . . . 0.503 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' J' ' 172' ' ' GLY . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' J' ' 167' ' ' THR . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' K' K ' 5' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' L' ' 126' ' ' VAL . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 7' ' ' MET . . . . . 1.035 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 8' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 10' ' ' ASP . . . . . 1.035 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 11' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 13' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' K' ' 91' ' ' PHE . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 18' ' ' ILE . . . . . 0.848 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 21' ' ' ALA . . . . . 0.853 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 22' ' ' THR . . . . . 0.431 HG22 ' H ' ' K' ' 23' ' ' GLY . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 27' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 30' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' K' ' 67' ' ' TYR . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 32' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 34' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' K' ' 65' ' ' VAL . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 36' ' ' SER . . . . . 0.402 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 37' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' L' ' 117' ' ' GLU . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 39' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 41' ' ' ARG . . . . . 0.818 HH22 ' HB2' ' K' ' 60' ' ' ALA . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 54' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 58' ' ' SER . . . . . 0.509 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 60' ' ' ALA . . . . . 0.818 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' K' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' K' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 66' ' ' THR . . . . . 0.793 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 67' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 68' ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 69' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' J' ' 5' ' ' PRO . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 75' ' ' GLY . . . . . 0.405 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 79' ' ' ILE . . . . . 0.548 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 80' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 82' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 83' ' ' TYR . . . . . 0.551 ' HD1' HG22 ' K' ' 113' ' ' ILE . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 87' ' ' LYS . . . . . 0.726 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 89' ' ' ILE . . . . . 0.719 HD11 ' HB2' ' K' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 90' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' K' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 94' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 95' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' K' ' 102' ' ' ASP . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' K' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 106' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' K' ' 93' ' ' ARG . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 108' ' ' PHE . . . . . 0.825 ' HD2' HD11 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 111' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 113' ' ' ILE . . . . . 0.551 HG22 ' HD1' ' K' ' 83' ' ' TYR . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 114' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 117' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' J' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 125' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' J' ' 6' ' ' ILE . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 128' ' ' ILE . . . . . 0.715 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 129' ' ' SER . . . . . 0.793 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 132' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' K' ' 111' ' ' ALA . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 135' ' ' ILE . . . . . 0.687 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 136' ' ' GLY . . . . . 0.676 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 138' ' ' LEU . . . . . 0.825 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 139' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 142' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 145' ' ' THR . . . . . 0.649 ' O ' HD12 ' K' ' 150' ' ' ILE . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' K' ' 149' ' ' GLU . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' K' ' 148' ' ' GLU . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 150' ' ' ILE . . . . . 0.649 HD12 ' O ' ' K' ' 145' ' ' THR . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' K' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 167' ' ' THR . . . . . 0.566 HG21 ' H ' ' K' ' 172' ' ' GLY . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 172' ' ' GLY . . . . . 0.566 ' H ' HG21 ' K' ' 167' ' ' THR . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 174' ' ' VAL . . . . . 0.49 HG22 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' L' L ' 5' ' ' PRO . . . . . 0.529 ' HA ' ' HG3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 6' ' ' ILE . . . . . 0.917 HG21 HG23 ' G' ' 126' ' ' VAL . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 12' ' ' LYS . . . . . 0.544 ' HG2' HD11 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD1' ' CE1' ' L' ' 91' ' ' PHE . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 14' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 15' ' ' PHE . . . . . 0.557 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 18' ' ' ILE . . . . . 0.833 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 21' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' L' ' 23' ' ' GLY . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 23' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 27' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 30' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' L' ' 67' ' ' TYR . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 34' ' ' ASP . . . . . 0.429 ' OD1' HG22 ' L' ' 65' ' ' VAL . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 37' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' G' ' 117' ' ' GLU . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 41' ' ' ARG . . . . . 0.816 HH22 ' HB2' ' L' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 42' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 54' ' ' LEU . . . . . 0.452 HD23 ' HG3' ' G' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' L' ' 54' ' ' LEU . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 60' ' ' ALA . . . . . 0.816 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 61' ' ' ASP . . . . . 0.409 ' OD1' ' HA2' ' L' ' 136' ' ' GLY . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' L' ' 64' ' ' GLU . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 65' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 66' ' ' THR . . . . . 0.768 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 67' ' ' TYR . . . . . 0.702 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 68' ' ' TYR . . . . . 0.625 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 69' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD3' ' L' ' 71' ' ' ARG . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 80' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 82' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 83' ' ' TYR . . . . . 0.547 ' HD1' HG22 ' L' ' 113' ' ' ILE . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 84' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 87' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 88' ' ' GLN . . . . . 0.815 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 89' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' L' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 90' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 91' ' ' PHE . . . . . 0.557 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 92' ' ' TRP . . . . . 0.756 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 93' ' ' ARG . . . . . 0.52 ' HD2' ' HB2' ' L' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 94' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 98' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' L' ' 102' ' ' ASP . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' L' ' 99' ' ' ASN . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 103' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 105' ' ' ASP . . . . . 0.819 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 106' ' ' ALA . . . . . 0.753 ' HB2' HG12 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HD2' ' L' ' 93' ' ' ARG . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 108' ' ' PHE . . . . . 0.837 ' HD2' HD11 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 111' ' ' ALA . . . . . 0.573 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 112' ' ' TYR . . . . . 0.655 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 113' ' ' ILE . . . . . 0.55 HD11 HD12 ' L' ' 79' ' ' ILE . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 115' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 116' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' L' ' 116' ' ' ARG . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 117' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' K' ' 37' ' ' VAL . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 123' ' ' GLU . . . . . 0.53 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 125' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' K' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 128' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 129' ' ' SER . . . . . 0.768 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 131' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 132' ' ' LEU . . . . . 0.573 HD13 ' HB1' ' L' ' 111' ' ' ALA . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 134' ' ' VAL . . . . . 0.674 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 135' ' ' ILE . . . . . 0.675 HG12 ' H ' ' L' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 136' ' ' GLY . . . . . 0.675 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 138' ' ' LEU . . . . . 0.837 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 139' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' G' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 140' ' ' ASN . . . . . 0.73 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 141' ' ' GLY . . . . . 0.819 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 142' ' ' GLU . . . . . 0.95 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 143' ' ' ILE . . . . . 0.864 HD12 ' H ' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 144' ' ' ASP . . . . . 0.903 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' L' ' 150' ' ' ILE . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 147' ' ' PRO . . . . . 0.556 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 148' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' L' ' 149' ' ' GLU . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' L' ' 148' ' ' GLU . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' L' ' 145' ' ' THR . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 151' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' L' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 167' ' ' THR . . . . . 0.559 HG21 ' H ' ' L' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 172' ' ' GLY . . . . . 0.559 ' H ' HG21 ' L' ' 167' ' ' THR . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 174' ' ' VAL . . . . . 0.486 HG22 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.533 ' HG3' ' HB ' ' L' ' 48' ' ' THR . 3.2 mm100 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' HD13 ' A' ' 89' ' ' ILE . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.413 ' O ' HG13 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.754 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' A' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -65.46 139.57 58.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.54 35.33 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.265 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.62 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 2.9 tt0 -65.78 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.13 22.54 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.569 1.548 . . . . 0.0 111.682 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.1 61.17 2.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 111.608 -164.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.63 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.499 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.07 13.85 30.19 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.92 1.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 mmp_? -110.2 23.58 14.12 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.862 HG13 HG22 ' B' ' 135' ' ' ILE . 0.9 OUTLIER -123.89 3.63 5.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.875 178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.8 22.58 14.91 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 40' ' ' GLU . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 133' ' ' GLN . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HA ' ' HZ1' ' A' ' 77' ' ' LYS . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB3' ' NH2' ' A' ' 116' ' ' ARG . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 17' ' ' SER . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.688 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 HG23 ' A' ' 150' ' ' ILE . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' A' ' 99' ' ' ASN . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 1.045 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.602 ' CE2' HG22 ' A' ' 145' ' ' THR . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.476 HG13 ' O ' ' F' ' 32' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.623 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.523 HG12 ' HG ' ' F' ' 54' ' ' LEU . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 1.045 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.602 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 96' ' ' THR . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.51 14.95 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.13 29.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.29 76.13 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.386 0.994 . . . . 0.0 113.037 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.91 23.49 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.15 46.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.28 1.032 . . . . 0.0 108.611 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.87 42.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 162' ' ' GLN . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' A' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.614 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.614 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.624 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.442 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.524 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 3.2 mm100 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' B' ' 89' ' ' ILE . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.605 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.432 ' O ' HG13 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' B' ' 59' ' ' VAL . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' B' ' 41' ' ' ARG . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.77 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.56 58.51 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 128.61 35.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.267 171.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.54 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 2.9 tt0 -65.82 -33.36 75.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.14 22.57 4.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.626 1.571 . . . . 0.0 111.649 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.06 61.2 2.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.576 -164.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.57 0.29 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.459 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.8 30.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.83 1.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.57 14.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.974 HG13 HG22 ' C' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.872 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.731 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -104.81 22.66 14.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.77 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' B' ' 40' ' ' GLU . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' B' ' 133' ' ' GLN . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.617 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.435 ' HA ' ' HZ1' ' B' ' 77' ' ' LYS . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.484 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' B' ' 116' ' ' ARG . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' B' ' 17' ' ' SER . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.61 HG22 HG23 ' B' ' 150' ' ' ILE . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' B' ' 104' ' ' TYR . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' B' ' 99' ' ' ASN . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 1.017 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' B' ' 145' ' ' THR . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.543 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.707 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' B' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 32' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' B' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 53' ' ' ILE . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.481 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.543 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.876 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 1.017 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.61 HG23 HG22 ' B' ' 96' ' ' THR . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.71 159.53 14.94 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.76 -0.14 29.2 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.24 76.12 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.421 1.01 . . . . 0.0 112.998 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.89 23.43 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.18 151.17 46.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.317 1.047 . . . . 0.0 108.626 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -58.36 -54.89 41.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -158.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.548 ' HD2' ' HB2' ' B' ' 162' ' ' GLN . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' B' ' 165' ' ' GLN . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' B' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.631 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.631 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.621 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.419 ' O ' ' HB1' ' D' ' 125' ' ' ALA . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.519 ' HG3' ' HB ' ' H' ' 48' ' ' THR . 3.2 mm100 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' C' ' 89' ' ' ILE . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.533 ' O ' HG13 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.638 HG13 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.759 ' HA ' HG22 ' C' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' C' ' 41' ' ' ARG . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.53 58.5 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.75 128.61 35.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.238 171.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.57 109.95 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 155.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' C' ' 52' ' ' ARG . 2.9 tt0 -65.77 -33.4 75.77 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.2 22.53 4.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.589 1.556 . . . . 0.0 111.656 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.09 61.2 2.03 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.533 1.533 . . . . 0.0 111.554 -164.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.59 0.29 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.496 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.2 mmp_? -110.16 23.59 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.803 HG13 HG22 ' D' ' 135' ' ' ILE . 0.9 OUTLIER -123.83 3.65 5.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.915 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.692 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -104.84 22.6 14.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' C' ' 41' ' ' ARG . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' C' ' 40' ' ' GLU . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' SER . . . . . 0.508 ' HB3' ' HG2' ' C' ' 133' ' ' GLN . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' C' ' 71' ' ' ARG . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.452 ' HB3' ' NH2' ' C' ' 116' ' ' ARG . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.498 ' O ' HG12 ' C' ' 18' ' ' ILE . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.702 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.594 HG22 HG23 ' C' ' 150' ' ' ILE . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' C' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' C' ' 99' ' ' ASN . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 1.042 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.592 ' CE2' HG22 ' C' ' 145' ' ' THR . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.542 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.404 ' CE1' ' HD2' ' C' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.432 HG13 ' O ' ' B' ' 32' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.508 ' HG2' ' HB3' ' C' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' C' ' 110' ' ' PHE . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.974 HG22 HG13 ' B' ' 53' ' ' ILE . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' D' ' 84' ' ' GLN . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.893 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 1.042 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' THR . . . . . 0.592 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.626 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.594 HG23 HG22 ' C' ' 96' ' ' THR . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.62 159.48 14.97 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.72 -0.15 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.58 -4.28 76.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.355 0.98 . . . . 0.0 113.049 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.78 139.92 23.5 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.23 151.1 46.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.35 1.06 . . . . 0.0 108.631 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.28 -54.9 41.74 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' C' ' 162' ' ' GLN . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' C' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' C' ' 160' ' ' PHE . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.624 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.624 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.538 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.477 ' HG3' ' HB ' ' I' ' 48' ' ' THR . 3.1 mm100 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' SER . . . . . 0.415 ' HA ' HD13 ' D' ' 89' ' ' ILE . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.626 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' D' ' 70' ' ' LYS . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.483 ' O ' HG13 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.75 ' HA ' HG22 ' D' ' 59' ' ' VAL . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.437 ' H ' ' CZ ' ' D' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.734 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.59 35.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.211 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.56 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 155.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.444 ' CG ' ' H ' ' D' ' 52' ' ' ARG . 2.9 tt0 -65.82 -33.34 75.62 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.18 22.49 4.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.627 1.571 . . . . 0.0 111.619 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.2 61.12 2.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 111.568 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.75 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.87 30.09 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.77 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.2 mmp_? -110.12 23.58 14.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.858 HG13 HG22 ' E' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.943 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.693 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER -104.82 22.68 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 176.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.734 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' D' ' 40' ' ' GLU . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' D' ' 133' ' ' GLN . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' D' ' 71' ' ' ARG . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.519 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.444 ' HB3' ' NH2' ' D' ' 116' ' ' ARG . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' D' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.685 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' D' ' 150' ' ' ILE . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' D' ' 104' ' ' TYR . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' D' ' 99' ' ' ASN . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 1.024 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' D' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.621 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.544 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.656 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.412 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.533 HG13 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' C' ' 6' ' ' ILE . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' D' ' 62' ' ' SER . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.803 HG22 HG13 ' C' ' 53' ' ' ILE . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.544 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 1.024 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.601 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' D' ' 96' ' ' THR . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.58 159.5 14.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.8 -0.08 29.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.5 -4.23 76.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 113.056 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.86 139.86 23.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.13 151.2 46.46 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.321 1.048 . . . . 0.0 108.635 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.4 -54.83 42.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD13 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' D' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' D' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.616 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.5 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.491 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 3.1 mm100 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.404 HG22 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' E' ' 89' ' ' ILE . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.618 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' E' ' 70' ' ' LYS . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' F' ' 117' ' ' GLU . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 38' ' ' SER . . . . . 0.479 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 40' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' E' ' 59' ' ' VAL . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.435 ' H ' ' CZ ' ' E' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.743 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER -65.41 139.51 58.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.79 128.6 35.33 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.235 171.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 109.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' E' ' 52' ' ' ARG . 2.9 tt0 -65.76 -33.39 75.76 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.14 22.52 4.41 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.59 1.556 . . . . 0.0 111.665 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.16 61.18 2.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.521 1.529 . . . . 0.0 111.539 -164.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.58 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.49 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.85 30.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.2 mmp_? -110.15 23.58 14.14 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.845 HG13 HG22 ' F' ' 135' ' ' ILE . 0.9 OUTLIER -123.86 3.63 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.874 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.819 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -104.82 22.66 14.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 55' ' ' GLY . . . . . 0.743 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' E' ' 40' ' ' GLU . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 62' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' E' ' 133' ' ' GLN . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.571 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.833 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.449 ' HB3' ' NH2' ' E' ' 116' ' ' ARG . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.833 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' E' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.433 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.616 HG22 HG23 ' E' ' 150' ' ' ILE . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' E' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 101' ' ' ASN . . . . . 0.464 ' H ' HD22 ' E' ' 99' ' ' ASN . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.974 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' E' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.689 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.414 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' E' ' 116' ' ' ARG . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.483 HG13 ' O ' ' D' ' 32' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.489 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' E' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.858 HG22 HG13 ' D' ' 53' ' ' ILE . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' E' ' 107' ' ' GLN . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.974 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.606 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.616 HG23 HG22 ' E' ' 96' ' ' THR . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -78.67 -0.18 29.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.2 76.08 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 119.417 1.008 . . . . 0.0 113.036 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.87 23.41 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.16 151.16 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.379 1.072 . . . . 0.0 108.649 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.33 -54.89 41.92 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.555 ' HD2' ' HB2' ' E' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' E' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.555 ' HB2' ' HD2' ' E' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.618 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.618 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.407 ' HB3' HG22 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 17' ' ' SER . . . . . 0.406 ' HA ' HD13 ' F' ' 89' ' ' ILE . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' F' ' 70' ' ' LYS . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 40' ' ' GLU . . . . . 0.749 ' HA ' HG22 ' F' ' 59' ' ' VAL . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' F' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER -65.48 139.56 58.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.64 35.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.201 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.53 109.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 155.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' F' ' 52' ' ' ARG . 2.9 tt0 -65.86 -33.35 75.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.14 22.51 4.42 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.625 1.57 . . . . 0.0 111.66 -172.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.24 61.09 2.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.539 1.536 . . . . 0.0 111.533 -164.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.73 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.69 13.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.94 3.66 5.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.841 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.523 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -104.86 22.61 14.89 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 55' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' F' ' 40' ' ' GLU . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' F' ' 133' ' ' GLN . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.509 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.564 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 81' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.825 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.825 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' F' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.607 HG22 HG23 ' F' ' 150' ' ' ILE . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 98' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' F' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' F' ' 99' ' ' ASN . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.982 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.605 ' CE2' HG22 ' F' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.549 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.536 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.667 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' F' ' 116' ' ' ARG . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' E' ' 6' ' ' ILE . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 129' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' F' ' 62' ' ' SER . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' F' ' 110' ' ' PHE . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.845 HG22 HG13 ' E' ' 53' ' ' ILE . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' F' ' 107' ' ' GLN . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.549 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.982 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.605 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.607 HG23 HG22 ' F' ' 96' ' ' THR . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.61 159.5 14.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.14 29.19 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.27 76.09 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 119.347 0.976 . . . . 0.0 113.041 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -77.84 139.91 23.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.17 151.19 46.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.294 1.037 . . . . 0.0 108.596 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.85 42.32 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.917 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.633 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 2.3 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.687 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.54 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.801 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.505 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 32.7 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' G' ' 89' ' ' ILE . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.607 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' G' ' 70' ' ' LYS . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 29' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 38' ' ' SER . . . . . 0.542 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' G' ' 59' ' ' VAL . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' G' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 42' ' ' GLU . . . . . 0.442 ' H ' ' CZ ' ' G' ' 41' ' ' ARG . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.769 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.249 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.63 109.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' G' ' 52' ' ' ARG . 2.9 tt0 -65.75 -33.38 75.74 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.17 22.47 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.574 1.55 . . . . 0.0 111.667 -172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.558 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.6 OUTLIER 42.24 61.16 2.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.486 1.515 . . . . 0.0 111.526 -164.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.83 -127.54 0.29 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.498 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.05 13.83 30.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.9 1.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.52 14.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.62 HG13 HG22 ' H' ' 135' ' ' ILE . 0.9 OUTLIER -123.83 3.59 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.857 178.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.707 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -104.77 22.63 14.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 176.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 55' ' ' GLY . . . . . 0.769 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' G' ' 40' ' ' GLU . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' G' ' 133' ' ' GLN . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HZ1' ' G' ' 77' ' ' LYS . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.529 ' HZ1' ' HA ' ' G' ' 74' ' ' ALA . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.57 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 81' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.5 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.618 HG22 HG23 ' G' ' 150' ' ' ILE . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' G' ' 104' ' ' TYR . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.633 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' G' ' 99' ' ' ASN . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 1.027 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.594 ' CE2' HG22 ' G' ' 145' ' ' THR . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.633 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.55 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.655 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.408 ' CE1' ' HD2' ' G' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.667 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.448 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' G' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.655 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.715 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 137' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' G' ' 107' ' ' GLN . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.909 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 1.027 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.594 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.618 HG23 HG22 ' G' ' 96' ' ' THR . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 152' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.49 14.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.08 28.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.33 76.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.356 0.98 . . . . 0.0 113.044 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.76 139.88 23.46 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.21 151.16 46.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 108.601 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.9 41.79 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 160' ' ' PHE . . . . . 0.554 ' HD2' ' HB2' ' G' ' 162' ' ' GLN . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 162' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' G' ' 160' ' ' PHE . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 163' ' ' PRO . . . . . 0.627 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.627 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.524 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 32.8 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' H' ' 89' ' ' ILE . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.527 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 29' ' ' PRO . . . . . 0.513 ' HB2' ' HE3' ' H' ' 70' ' ' LYS . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 38' ' ' SER . . . . . 0.516 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' H' ' 59' ' ' VAL . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 42' ' ' GLU . . . . . 0.45 ' H ' ' CZ ' ' H' ' 41' ' ' ARG . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.766 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER -65.55 139.59 58.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 128.58 35.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.202 171.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.57 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 155.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' H' ' 52' ' ' ARG . 2.9 tt0 -65.8 -33.34 75.64 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.12 22.49 4.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.63 1.572 . . . . 0.0 111.69 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.519 ' HB ' ' HG3' ' C' ' 9' ' ' GLN . 0.6 OUTLIER 42.18 61.13 2.06 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.499 1.52 . . . . 0.0 111.609 -164.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.59 0.29 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.48 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.09 13.88 30.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.42 80.89 1.28 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.2 mmp_? -110.23 23.63 14.05 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.489 HG13 HG22 ' I' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.66 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.92 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.58 14.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 55' ' ' GLY . . . . . 0.766 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' H' ' 40' ' ' GLU . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' H' ' 133' ' ' GLN . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.521 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.573 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.566 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 81' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.808 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.808 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' H' ' 17' ' ' SER . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' H' ' 150' ' ' ILE . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 98' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' H' ' 104' ' ' TYR . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 101' ' ' ASN . . . . . 0.455 ' H ' HD22 ' H' ' 99' ' ' ASN . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 1.008 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.591 ' CE2' HG22 ' H' ' 145' ' ' THR . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.632 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.664 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.454 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.672 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.647 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' H' ' 116' ' ' ARG . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 129' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.672 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.454 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' H' ' 62' ' ' SER . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.664 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.707 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' H' ' 107' ' ' GLN . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 1.008 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.591 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' H' ' 96' ' ' THR . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.7 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.63 -0.25 29.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.23 76.02 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.385 0.993 . . . . 0.0 113.063 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.92 23.48 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.18 46.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.325 1.05 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.9 41.74 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 160' ' ' PHE . . . . . 0.552 ' HD2' ' HB2' ' H' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' H' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 162' ' ' GLN . . . . . 0.552 ' HB2' ' HD2' ' H' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.4 HG22 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 32.8 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' I' ' 89' ' ' ILE . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.608 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.451 ' O ' HG13 ' J' ' 122' ' ' VAL . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.51 HG13 ' HG2' ' J' ' 117' ' ' GLU . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 38' ' ' SER . . . . . 0.5 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 40' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' I' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.448 ' H ' ' CZ ' ' I' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER -65.53 139.54 58.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.61 35.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.234 171.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t0 73.51 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' I' ' 52' ' ' ARG . 2.8 tt0 -65.77 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.17 22.51 4.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.639 1.576 . . . . 0.0 111.652 -172.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 0.6 OUTLIER 42.23 61.07 2.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 111.571 -164.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.495 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.03 13.82 30.3 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.54 80.86 1.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.2 mmp_? -110.19 23.6 14.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.702 HG13 HG22 ' J' ' 135' ' ' ILE . 0.9 OUTLIER -123.88 3.6 5.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.801 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.85 22.7 14.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 55' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' I' ' 41' ' ' ARG . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' I' ' 40' ' ' GLU . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' I' ' 133' ' ' GLN . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.436 HH21 ' HD2' ' I' ' 71' ' ' ARG . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.575 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.816 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 95' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' I' ' 150' ' ' ILE . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' I' ' 104' ' ' TYR . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 101' ' ' ASN . . . . . 0.454 ' H ' HD22 ' I' ' 99' ' ' ASN . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 1.05 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' I' ' 145' ' ' THR . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' I' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' H' ' 6' ' ' ILE . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 129' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.459 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' I' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.662 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.477 ' HA ' HE22 ' J' ' 84' ' ' GLN . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.62 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 1.05 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' I' ' 96' ' ' THR . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.66 159.52 14.95 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.75 -0.19 29.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.62 -4.32 75.95 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.401 1.0 . . . . 0.0 113.02 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.92 23.51 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.22 151.17 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.26 1.024 . . . . 0.0 108.616 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.91 41.64 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' I' ' 162' ' ' GLN . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' I' ' 165' ' ' GLN . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' I' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 163' ' ' PRO . . . . . 0.632 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.62 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 170' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.62 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.642 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 32.7 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' J' ' 89' ' ' ILE . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.617 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.418 ' O ' HG13 ' K' ' 122' ' ' VAL . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' K' ' 117' ' ' GLU . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 38' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 40' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' J' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 42' ' ' GLU . . . . . 0.44 ' H ' ' CZ ' ' J' ' 41' ' ' ARG . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.56 58.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.76 128.56 35.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.232 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' J' ' 52' ' ' ARG . 2.8 tt0 -65.82 -33.36 75.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.15 22.54 4.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.605 1.562 . . . . 0.0 111.667 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.547 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 0.6 OUTLIER 42.17 61.07 2.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.468 1.507 . . . . 0.0 111.597 -164.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.72 -127.52 0.29 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.502 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.15 13.87 30.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.1 mmp_? -110.18 23.59 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.605 HG13 HG22 ' K' ' 135' ' ' ILE . 0.9 OUTLIER -123.88 3.61 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.861 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -104.81 22.66 14.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' J' ' 40' ' ' GLU . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' J' ' 133' ' ' GLN . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.51 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.525 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.828 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.5 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.828 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.489 ' O ' HG12 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.707 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' J' ' 150' ' ' ILE . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 98' ' ' LYS . . . . . 0.417 ' HA ' ' CE1' ' J' ' 104' ' ' TYR . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' J' ' 99' ' ' ASN . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.986 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.587 ' CE2' HG22 ' J' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.437 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.443 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.677 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.42 ' CE1' ' HD2' ' J' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 122' ' ' VAL . . . . . 0.451 HG13 ' O ' ' I' ' 32' ' ' GLN . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 129' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.677 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.443 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' J' ' 62' ' ' SER . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.675 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.801 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 137' ' ' GLU . . . . . 0.532 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.453 ' HA ' HE22 ' K' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.885 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.986 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.587 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' J' ' 96' ' ' THR . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.6 159.49 14.97 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.68 -0.22 29.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.61 -4.3 75.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.332 0.969 . . . . 0.0 113.028 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.9 23.48 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -139.18 151.15 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.321 1.048 . . . . 0.0 108.63 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.97 41.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' J' ' 162' ' ' GLN . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' J' ' 165' ' ' GLN . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' J' ' 160' ' ' PHE . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 163' ' ' PRO . . . . . 0.612 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.612 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 170' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.658 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.414 ' HB3' HG22 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.556 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 32.6 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 17' ' ' SER . . . . . 0.41 ' HA ' HD13 ' K' ' 89' ' ' ILE . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.63 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.52 ' HZ ' ' H ' ' K' ' 70' ' ' LYS . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 29' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.408 ' O ' HG13 ' L' ' 122' ' ' VAL . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' L' ' 117' ' ' GLU . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 40' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' K' ' 59' ' ' VAL . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' K' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 42' ' ' GLU . . . . . 0.434 ' H ' ' CZ ' ' K' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.742 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.54 58.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.62 35.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 110.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.438 ' CG ' ' H ' ' K' ' 52' ' ' ARG . 2.9 tt0 -65.83 -33.38 75.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.15 22.53 4.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.615 1.566 . . . . 0.0 111.686 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.15 61.16 2.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.476 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.06 13.86 30.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.49 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.1 mmp_? -110.17 23.6 14.1 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.601 HG13 HG22 ' L' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.58 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.873 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.73 22.57 14.88 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 176.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 55' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' K' ' 40' ' ' GLU . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' K' ' 133' ' ' GLN . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.52 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.45 ' HA ' ' HZ1' ' K' ' 77' ' ' LYS . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.524 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.45 ' HB3' ' NH2' ' K' ' 116' ' ' ARG . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.494 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.412 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 95' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.6 HG22 HG23 ' K' ' 150' ' ' ILE . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' K' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 101' ' ' ASN . . . . . 0.459 ' H ' HD22 ' K' ' 99' ' ' ASN . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 1.001 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' K' ' 145' ' ' THR . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.619 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.88 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.538 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.416 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' K' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 122' ' ' VAL . . . . . 0.418 HG13 ' O ' ' J' ' 32' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.642 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 129' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' K' ' 62' ' ' SER . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.717 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.551 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.585 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.88 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 1.001 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.6 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.6 HG23 HG22 ' K' ' 96' ' ' THR . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 152' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.59 159.47 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.07 28.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.57 -4.3 76.1 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 119.329 0.968 . . . . 0.0 113.027 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.91 23.46 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.17 46.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 108.589 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.87 42.13 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -158.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 160' ' ' PHE . . . . . 0.553 ' HD2' ' HB2' ' K' ' 162' ' ' GLN . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' K' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 162' ' ' GLN . . . . . 0.553 ' HB2' ' HD2' ' K' ' 160' ' ' PHE . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 163' ' ' PRO . . . . . 0.621 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.667 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 17' ' ' SER . . . . . 0.408 ' HA ' HD13 ' L' ' 89' ' ' ILE . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.801 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 22' ' ' THR . . . . . 0.516 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.521 ' HZ ' ' H ' ' L' ' 70' ' ' LYS . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 29' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' G' ' 117' ' ' GLU . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 38' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 40' ' ' GLU . . . . . 0.735 ' HA ' HG22 ' L' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' L' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' L' ' 41' ' ' ARG . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.745 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER -65.47 139.55 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.195 171.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' L' ' 52' ' ' ARG . 2.9 tt0 -65.78 -33.39 75.75 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 71.18 22.52 4.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.59 1.556 . . . . 0.0 111.69 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.533 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 42.16 61.15 2.06 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.502 1.521 . . . . 0.0 111.535 -164.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.465 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.83 30.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.47 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.58 14.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.575 HG13 HG22 ' G' ' 135' ' ' ILE . 0.9 OUTLIER -123.86 3.6 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.874 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.715 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.64 14.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 55' ' ' GLY . . . . . 0.745 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 58' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' L' ' 40' ' ' GLU . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 62' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' L' ' 133' ' ' GLN . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.521 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HZ1' ' L' ' 77' ' ' LYS . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.51 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.473 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.577 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.824 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.445 ' HB3' ' NH2' ' L' ' 116' ' ' ARG . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.42 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.614 HG22 HG23 ' L' ' 150' ' ' ILE . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' L' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' L' ' 99' ' ' ASN . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 1.011 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.598 ' CE2' HG22 ' L' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.547 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.435 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.419 ' CE1' ' HD2' ' L' ' 116' ' ' ARG . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' K' ' 32' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.658 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.654 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' L' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' L' ' 110' ' ' PHE . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.75 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.561 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 1.011 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.598 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.619 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.614 HG23 HG22 ' L' ' 96' ' ' THR . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.47 14.97 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.78 -0.1 29.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.52 -4.26 76.2 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.393 0.997 . . . . 0.0 113.085 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.8 139.94 23.51 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.17 151.19 46.4 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.612 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.88 42.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -158.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 160' ' ' PHE . . . . . 0.542 ' HD2' ' HB2' ' L' ' 162' ' ' GLN . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' HB2' ' L' ' 165' ' ' GLN . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 162' ' ' GLN . . . . . 0.542 ' HB2' ' HD2' ' L' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 163' ' ' PRO . . . . . 0.622 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.622 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.513 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' B' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' CG ' ' HB ' ' L' ' 48' ' ' THR . 2.7 mm100 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 29.3 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.445 ' HA ' HD13 ' A' ' 89' ' ' ILE . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 88' ' ' GLN . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 32' ' ' GLN . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' B' ' 118' ' ' TYR . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.02 58.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.83 36.59 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.266 171.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.36 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 155.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 1.1 tt0 -67.3 -34.66 77.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.81 22.1 4.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 111.635 -172.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.579 1.552 . . . . 0.0 111.534 -164.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.48 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' A' ' 52' ' ' ARG . 2.1 t-20 -102.14 10.13 39.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.22 81.65 1.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.5 mmp_? -107.6 27.62 8.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.26 4.19 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.877 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -103.09 23.44 12.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 43' ' ' LEU . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' F' ' 5' ' ' PRO . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HB2' HG21 ' A' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.743 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' A' ' 99' ' ' ASN . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 110' ' ' PHE . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.504 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.645 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD2' ' HB2' ' F' ' 36' ' ' SER . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.645 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' OE2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.469 HG12 ' HG ' ' F' ' 54' ' ' LEU . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.789 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.0 t30 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.49 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.66 54.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.77 -1.27 61.42 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.386 0.994 . . . . 0.0 113.053 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 138.3 23.67 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.95 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.327 1.051 . . . . 0.0 108.614 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.62 58.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.443 ' HG2' ' OD2' ' G' ' 144' ' ' ASP . 2.6 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.502 ' C ' ' HA2' ' G' ' 23' ' ' GLY . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 2.8 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.605 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.486 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.611 ' CG ' ' HB ' ' G' ' 48' ' ' THR . 2.7 mm100 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' B' ' 96' ' ' THR . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 29.4 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.437 ' HA ' HD13 ' B' ' 89' ' ' ILE . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 88' ' ' GLN . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' B' ' 70' ' ' LYS . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 32' ' ' GLN . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' C' ' 118' ' ' TYR . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' H ' ' B' ' 55' ' ' GLY . 0.2 OUTLIER -64.61 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.218 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.38 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.75 78.11 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.86 22.08 3.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.584 1.553 . . . . 0.0 111.701 -172.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.7 59.99 2.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.483 1.513 . . . . 0.0 111.578 -164.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.451 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.44 ' HB3' HH12 ' B' ' 52' ' ' ARG . 2.1 t-20 -102.09 10.11 39.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.29 81.74 1.41 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.6 mmp_? -107.72 27.7 8.92 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.634 HG13 HG22 ' C' ' 135' ' ' ILE . 0.3 OUTLIER -124.34 4.25 4.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.859 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.41 12.38 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' B' ' 43' ' ' LEU . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 30' ' ' ALA . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' B' ' 76' ' ' GLN . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.455 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.561 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.884 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.53 ' HB2' HG21 ' B' ' 113' ' ' ILE . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.884 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.6 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.741 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ASN . . . . . 0.465 ' H ' HD22 ' B' ' 99' ' ' ASN . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' B' ' 110' ' ' PHE . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.469 ' CE2' ' HG2' ' B' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.673 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.845 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.861 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.706 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.614 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.0 t30 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.64 14.8 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.04 -5.58 54.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.3 61.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 119.447 1.022 . . . . 0.0 113.008 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.25 23.72 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.94 149.01 48.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.3 1.04 . . . . 0.0 108.603 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.95 -52.62 58.88 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -158.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.54 ' HG2' ' OD2' ' H' ' 144' ' ' ASP . 2.6 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.525 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.585 ' HB3' ' HD3' ' B' ' 175' ' ' PRO . 2.8 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.618 ' CG ' ' HB ' ' H' ' 48' ' ' THR . 2.7 mm100 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.52 ' O ' HG23 ' C' ' 96' ' ' THR . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 29.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' SER . . . . . 0.444 ' HA ' HD13 ' C' ' 89' ' ' ILE . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 88' ' ' GLN . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' C' ' 70' ' ' LYS . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' C' ' 67' ' ' TYR . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.415 HG22 ' OG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' D' ' 118' ' ' TYR . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.558 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' C' ' 55' ' ' GLY . 0.2 OUTLIER -64.67 141.99 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.192 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.41 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' C' ' 52' ' ' ARG . 1.1 tt0 -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.83 22.1 4.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.591 1.557 . . . . 0.0 111.618 -172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.77 59.92 2.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.49 1.516 . . . . 0.0 111.555 -164.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ASN . . . . . 0.438 ' HB3' HH12 ' C' ' 52' ' ' ARG . 2.1 t-20 -102.15 10.07 39.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.68 1.4 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.6 mmp_? -107.68 27.67 8.94 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.608 ' HA ' ' HB3' ' C' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.911 178.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -103.07 23.46 12.29 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 176.178 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' C' ' 43' ' ' LEU . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' C' ' 30' ' ' ALA . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' C' ' 76' ' ' GLN . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.573 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.56 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.52 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' C' ' 99' ' ' ASN . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.621 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.56 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' C' ' 110' ' ' PHE . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.468 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.468 ' HD2' ' HB2' ' B' ' 36' ' ' SER . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.809 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.809 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.0 t30 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.61 14.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.03 -5.6 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.28 61.3 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.343 0.974 . . . . 0.0 113.0 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.26 23.69 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.96 149.0 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.264 1.025 . . . . 0.0 108.603 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.61 58.88 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -158.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' I' ' 144' ' ' ASP . 2.6 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.442 ' C ' ' HA2' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' C' ' 175' ' ' PRO . 2.8 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.597 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 170' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' E' ' 126' ' ' VAL . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.545 ' HG3' ' HB ' ' I' ' 48' ' ' THR . 2.7 mm100 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' D' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 29.4 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' SER . . . . . 0.455 ' HA ' HD13 ' D' ' 89' ' ' ILE . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.498 HG12 ' O ' ' D' ' 88' ' ' GLN . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' D' ' 70' ' ' LYS . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' D' ' 32' ' ' GLN . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' E' ' 118' ' ' TYR . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' D' ' 53' ' ' ILE . 0.2 OUTLIER -64.64 142.0 58.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.35 131.79 36.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.224 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.42 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.32 -34.7 77.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.91 22.12 3.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.595 1.558 . . . . 0.0 111.658 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.66 59.98 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.495 1.518 . . . . 0.0 111.593 -164.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.08 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.469 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' ASN . . . . . 0.439 ' HB3' HH12 ' D' ' 52' ' ' ARG . 2.1 t-20 -102.09 10.03 39.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.61 1.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.5 mmp_? -107.62 27.66 8.93 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' D' ' 43' ' ' LEU . 0.3 OUTLIER -124.32 4.21 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.88 178.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER -103.08 23.44 12.33 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' D' ' 43' ' ' LEU . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.416 ' OG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' D' ' 30' ' ' ALA . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' D' ' 76' ' ' GLN . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.453 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.51 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.845 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.608 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.499 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.456 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.565 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' D' ' 99' ' ' ASN . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.565 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.457 ' CZ ' ' HE2' ' D' ' 110' ' ' PHE . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.493 ' OE2' ' HG3' ' D' ' 133' ' ' GLN . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.641 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.432 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 129' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 149' ' ' GLU . . . . . 0.794 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 152' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.0 t30 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.59 14.83 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.62 54.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.33 61.41 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.336 0.971 . . . . 0.0 113.021 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.3 23.72 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.95 148.97 48.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.265 1.026 . . . . 0.0 108.578 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.0 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -158.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.422 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.448 ' HG2' ' OD2' ' J' ' 144' ' ' ASP . 2.6 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.569 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 2.8 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.585 ' O ' ' HB ' ' D' ' 173' ' ' THR . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.426 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 170' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' GLN . . . . . 0.616 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 2.7 mm100 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' E' ' 96' ' ' THR . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.76 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 29.4 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' SER . . . . . 0.457 ' HA ' HD13 ' E' ' 89' ' ' ILE . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' E' ' 88' ' ' GLN . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 33' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' E' ' 32' ' ' GLN . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' F' ' 118' ' ' TYR . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 40' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' E' ' 55' ' ' GLY . 0.2 OUTLIER -64.65 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.203 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.44 110.25 0.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' E' ' 52' ' ' ARG . 1.1 tt0 -67.31 -34.66 77.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.82 22.1 4.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.623 1.569 . . . . 0.0 111.67 -172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.68 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.503 1.521 . . . . 0.0 111.598 -164.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -114.99 -127.86 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 50' ' ' ASN . . . . . 0.442 ' HB3' HH12 ' E' ' 52' ' ' ARG . 2.1 t-20 -102.12 10.05 39.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.34 81.69 1.41 Allowed Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' E' ' 43' ' ' LEU . 0.3 OUTLIER -124.27 4.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.907 178.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.784 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -103.07 23.44 12.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 176.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 55' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' E' ' 43' ' ' LEU . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' E' ' 76' ' ' GLN . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.507 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' E' ' 113' ' ' ILE . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.462 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 101' ' ' ASN . . . . . 0.452 ' H ' HD22 ' E' ' 99' ' ' ASN . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.724 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' E' ' 110' ' ' PHE . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.544 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.48 ' HD2' ' HB2' ' D' ' 36' ' ' SER . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 129' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.479 ' HG3' ' OE2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.824 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.671 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.497 ' HD2' ' NE2' ' F' ' 84' ' ' GLN . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.724 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 149' ' ' GLU . . . . . 0.793 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.0 t30 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.65 14.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.97 -5.68 54.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.26 61.36 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.36 0.982 . . . . 0.0 113.033 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 138.32 23.75 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.96 48.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 108.61 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.03 -52.57 58.82 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' OD2' ' K' ' 144' ' ' ASP . 2.6 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.514 ' C ' ' HA2' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' E' ' 175' ' ' PRO . 2.9 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.603 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' A' ' 126' ' ' VAL . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 9' ' ' GLN . . . . . 0.48 ' HG3' ' HB ' ' K' ' 48' ' ' THR . 2.7 mm100 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 17' ' ' SER . . . . . 0.452 ' HA ' HD13 ' F' ' 89' ' ' ILE . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.508 HG12 ' O ' ' F' ' 88' ' ' GLN . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.785 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' F' ' 70' ' ' LYS . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' F' ' 67' ' ' TYR . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' F' ' 32' ' ' GLN . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 118' ' ' TYR . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.618 ' HB2' ' H ' ' F' ' 55' ' ' GLY . 0.2 OUTLIER -64.61 141.93 58.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.28 131.83 36.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.245 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.41 110.27 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 155.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' F' ' 52' ' ' ARG . 1.1 tt0 -67.27 -34.71 77.98 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.81 22.2 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.657 1.583 . . . . 0.0 111.641 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.65 59.96 2.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.452 1.501 . . . . 0.0 111.616 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.47 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' F' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.13 39.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.5 mmp_? -107.68 27.66 8.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.61 ' HA ' ' HB3' ' F' ' 43' ' ' LEU . 0.3 OUTLIER -124.29 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.879 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.16 23.55 12.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 176.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 55' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' F' ' 43' ' ' LEU . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 63' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 66' ' ' THR . . . . . 0.4 ' OG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' CB ' ' E' ' 5' ' ' PRO . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' F' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.515 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' F' ' 113' ' ' ILE . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.599 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.458 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' F' ' 99' ' ' ASN . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.736 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' F' ' 110' ' ' PHE . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.493 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' E' ' 36' ' ' SER . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' E' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 129' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.632 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.493 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.784 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.736 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 149' ' ' GLU . . . . . 0.785 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.0 t30 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.5 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.61 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.29 61.45 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 119.326 0.966 . . . . 0.0 113.06 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.743 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -74.63 138.29 23.74 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.561 ' N ' HD11 ' L' ' 138' ' ' LEU . 33.2 m-85 -135.92 149.0 48.78 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.323 1.049 . . . . 0.0 108.623 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.02 -52.6 58.74 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -158.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.6 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.832 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 2.6 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.699 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 2.8 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.735 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.742 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.553 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.512 ' O ' HG23 ' G' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 29.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 17' ' ' SER . . . . . 0.447 ' HA ' HD13 ' G' ' 89' ' ' ILE . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' G' ' 88' ' ' GLN . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' G' ' 70' ' ' LYS . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' G' ' 32' ' ' GLN . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 36' ' ' SER . . . . . 0.535 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' H' ' 113' ' ' ILE . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' G' ' 55' ' ' GLY . 0.2 OUTLIER -64.66 141.97 58.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.191 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.43 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.33 -34.67 77.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.86 22.11 3.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 111.642 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.611 ' HB ' ' CG ' ' B' ' 9' ' ' GLN . 1.1 m 41.67 59.98 2.31 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.469 1.508 . . . . 0.0 111.593 -164.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.462 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 50' ' ' ASN . . . . . 0.441 ' HB3' HH12 ' G' ' 52' ' ' ARG . 2.1 t-20 -102.13 10.11 39.69 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.5 mmp_? -107.7 27.72 8.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.596 ' HA ' ' HB3' ' G' ' 43' ' ' LEU . 0.3 OUTLIER -124.31 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.913 178.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.668 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -103.13 23.46 12.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 176.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 55' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' G' ' 43' ' ' LEU . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 66' ' ' THR . . . . . 0.412 ' OG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.433 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' L' ' 5' ' ' PRO . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' G' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' G' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.866 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HB2' HG21 ' G' ' 113' ' ' ILE . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.866 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.752 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.564 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.512 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 101' ' ' ASN . . . . . 0.47 ' H ' HD22 ' G' ' 99' ' ' ASN . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.564 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' G' ' 110' ' ' PHE . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.548 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' G' ' 83' ' ' TYR . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.643 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.551 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.645 HG21 ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 129' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' OE2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.677 HG12 ' HG ' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 137' ' ' GLU . . . . . 0.848 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.608 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.848 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.722 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 144' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 162' ' ' GLN . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 149' ' ' GLU . . . . . 0.784 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.0 t30 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.66 14.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.99 -5.61 54.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 -1.22 61.45 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 119.368 0.985 . . . . 0.0 113.064 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.31 23.75 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -136.0 148.92 48.63 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.337 1.055 . . . . 0.0 108.617 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.85 -52.66 59.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -158.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 2.8 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.607 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.654 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 29.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 17' ' ' SER . . . . . 0.449 ' HA ' HD13 ' H' ' 89' ' ' ILE . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' H' ' 88' ' ' GLN . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' H' ' 70' ' ' LYS . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 33' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' H' ' 32' ' ' GLN . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 36' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' I' ' 118' ' ' TYR . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' I' ' 113' ' ' ILE . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' H' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.04 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.78 36.62 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.213 171.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 155.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' H' ' 52' ' ' ARG . 1.1 tt0 -67.3 -34.72 77.97 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.85 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.623 1.569 . . . . 0.0 111.677 -172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.618 ' HB ' ' CG ' ' C' ' 9' ' ' GLN . 1.1 m 41.74 59.97 2.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.461 1.504 . . . . 0.0 111.558 -164.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.13 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.432 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' H' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.04 39.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.32 81.65 1.4 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.5 mmp_? -107.65 27.69 8.91 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' H' ' 43' ' ' LEU . 0.3 OUTLIER -124.36 4.22 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 178.342 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.606 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -103.05 23.41 12.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 55' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' H' ' 43' ' ' LEU . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 66' ' ' THR . . . . . 0.402 ' OG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' G' ' 5' ' ' PRO . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' H' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.514 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.86 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG21 ' H' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.608 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.86 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.606 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.482 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.467 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' H' ' 99' ' ' ASN . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' H' ' 110' ' ' PHE . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' H' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.651 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.535 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.651 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.483 ' HG3' ' OE2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.831 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.668 HG12 ' HG ' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 137' ' ' GLU . . . . . 0.831 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.879 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 144' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 149' ' ' GLU . . . . . 0.782 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.0 t30 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.45 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.06 -5.53 54.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.27 61.47 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.415 1.007 . . . . 0.0 113.076 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.72 138.35 23.75 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.93 148.96 48.75 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.36 1.064 . . . . 0.0 108.627 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.99 -52.6 58.84 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -158.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.58 ' HB3' ' HD3' ' H' ' 175' ' ' PRO . 2.8 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.609 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' J' ' 126' ' ' VAL . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.519 ' O ' HG23 ' I' ' 96' ' ' THR . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.761 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 17' ' ' SER . . . . . 0.436 ' HA ' HD13 ' I' ' 89' ' ' ILE . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' I' ' 88' ' ' GLN . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' I' ' 32' ' ' GLN . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.595 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 40' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' I' ' 53' ' ' ILE . 0.2 OUTLIER -64.62 141.94 58.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.78 36.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.241 171.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.5 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 155.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.31 -34.69 77.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.81 22.14 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.645 1.578 . . . . 0.0 111.669 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.545 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 1.1 m 41.67 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.519 1.528 . . . . 0.0 111.584 -164.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.89 0.29 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.455 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 50' ' ' ASN . . . . . 0.437 ' HB3' HH12 ' I' ' 52' ' ' ARG . 2.1 t-20 -102.07 10.11 39.78 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.5 mmp_? -107.68 27.62 8.99 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' HB3' ' I' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.862 178.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.771 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -103.06 23.42 12.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' I' ' 43' ' ' LEU . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 73' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' I' ' 76' ' ' GLN . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' I' ' 113' ' ' ILE . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.602 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.562 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.519 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' I' ' 99' ' ' ASN . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.611 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.562 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' I' ' 110' ' ' PHE . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.473 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' I' ' 83' ' ' TYR . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.49 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.657 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.498 ' HD2' ' HB2' ' H' ' 36' ' ' SER . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 129' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.49 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.606 HG12 ' HG ' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.498 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 144' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' C' ' 162' ' ' GLN . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 149' ' ' GLU . . . . . 0.779 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 152' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.0 t30 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.47 159.57 14.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.95 -5.58 54.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.33 61.5 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 119.345 0.975 . . . . 0.0 113.059 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.28 23.76 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.94 148.97 48.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.305 1.042 . . . . 0.0 108.604 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.01 -52.61 58.73 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -158.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 2.8 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' K' ' 126' ' ' VAL . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' J' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.757 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 29.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 17' ' ' SER . . . . . 0.446 ' HA ' HD13 ' J' ' 89' ' ' ILE . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' J' ' 88' ' ' GLN . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 21' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.569 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' J' ' 70' ' ' LYS . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 33' ' ' THR . . . . . 0.417 HG22 ' OG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 36' ' ' SER . . . . . 0.55 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 40' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' K' ' 113' ' ' ILE . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' J' ' 55' ' ' GLY . 0.2 OUTLIER -64.66 142.01 58.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.31 131.81 36.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.223 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.4 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 155.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' J' ' 52' ' ' ARG . 1.1 tt0 -67.28 -34.69 77.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.85 22.12 3.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.622 1.569 . . . . 0.0 111.659 -172.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.616 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 1.1 m 41.69 60.02 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 111.562 -164.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.82 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.487 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 50' ' ' ASN . . . . . 0.434 ' HB3' HH12 ' J' ' 52' ' ' ARG . 2.1 t-20 -102.15 10.12 39.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.31 81.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.68 8.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.605 ' HA ' ' HB3' ' J' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.17 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.922 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.647 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.49 12.26 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' J' ' 43' ' ' LEU . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 66' ' ' THR . . . . . 0.417 ' OG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' I' ' 5' ' ' PRO . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' J' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.854 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.538 ' HB2' HG21 ' J' ' 113' ' ' ILE . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.854 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.453 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.757 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.561 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' J' ' 99' ' ' ASN . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.561 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HE2' ' J' ' 110' ' ' PHE . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' J' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.647 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' I' ' 6' ' ' ILE . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 129' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.647 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.827 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.771 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 137' ' ' GLU . . . . . 0.827 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.726 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' D' ' 162' ' ' GLN . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 149' ' ' GLU . . . . . 0.795 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 152' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.0 t30 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.54 159.6 14.82 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.59 54.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.27 61.39 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.43 1.014 . . . . 0.0 113.041 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.31 23.75 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.95 148.98 48.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.31 1.044 . . . . 0.0 108.632 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.58 59.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -158.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.586 ' HB3' ' HD3' ' J' ' 175' ' ' PRO . 2.9 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.596 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' K' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.751 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 29.4 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 17' ' ' SER . . . . . 0.458 ' HA ' HD13 ' K' ' 89' ' ' ILE . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' K' ' 88' ' ' GLN . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' K' ' 70' ' ' LYS . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' K' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 33' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' K' ' 32' ' ' GLN . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 36' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' L' ' 118' ' ' TYR . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 40' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' K' ' 55' ' ' GLY . 0.2 OUTLIER -64.59 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.81 36.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.211 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.29 -34.66 77.86 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.84 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 111.626 -172.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' F' ' 9' ' ' GLN . 1.1 m 41.74 59.95 2.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.485 1.514 . . . . 0.0 111.571 -164.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 49' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' F' ' 30' ' ' ALA . 7.1 mmtp -115.06 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.441 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 50' ' ' ASN . . . . . 0.433 ' HB3' HH12 ' K' ' 52' ' ' ARG . 2.1 t-20 -102.17 10.18 39.58 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.62 1.4 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.6 mmp_? -107.61 27.71 8.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.606 ' HA ' ' HB3' ' K' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.921 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.46 12.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' K' ' 43' ' ' LEU . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' J' ' 5' ' ' PRO . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 73' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' K' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.513 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.857 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' K' ' 113' ' ' ILE . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.857 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.5 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.45 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.751 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' K' ' 99' ' ' ASN . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.556 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.448 ' CZ ' ' HE2' ' K' ' 110' ' ' PHE . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.549 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' K' ' 83' ' ' TYR . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.55 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.589 HG21 ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 129' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.477 ' HG3' ' OE2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.647 HG12 ' HG ' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.746 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 144' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' E' ' 162' ' ' GLN . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 149' ' ' GLU . . . . . 0.799 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 152' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.0 t30 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.53 159.62 14.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.64 54.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.27 61.34 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.385 0.993 . . . . 0.0 113.027 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.62 138.3 23.78 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.97 149.0 48.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.277 1.031 . . . . 0.0 108.588 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.01 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -158.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 2.8 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.6 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 170' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.749 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 29.4 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 17' ' ' SER . . . . . 0.459 ' HA ' HD13 ' L' ' 89' ' ' ILE . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.742 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 22' ' ' THR . . . . . 0.44 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' L' ' 32' ' ' GLN . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 36' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' G' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' L' ' 53' ' ' ILE . 0.2 OUTLIER -64.56 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.3 131.84 36.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.2 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.34 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.68 77.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 71.83 22.08 4.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.598 1.559 . . . . 0.0 111.661 -172.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.591 ' HB ' ' CG ' ' A' ' 9' ' ' GLN . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.467 1.507 . . . . 0.0 111.575 -164.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.07 -127.86 0.29 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.46 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 50' ' ' ASN . . . . . 0.432 ' HB3' HH12 ' L' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.07 39.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.3 81.69 1.41 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' L' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.2 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.89 178.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.43 12.36 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' L' ' 43' ' ' LEU . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 66' ' ' THR . . . . . 0.403 ' OG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.414 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' L' ' 76' ' ' GLN . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.516 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 81' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.534 ' HB2' HG21 ' L' ' 113' ' ' ILE . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.735 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.455 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.749 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' L' ' 99' ' ' ASN . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.618 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' L' ' 110' ' ' PHE . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.469 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' L' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.511 ' HD2' ' HB2' ' K' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.596 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 129' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.812 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 137' ' ' GLU . . . . . 0.812 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.743 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.542 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.745 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.595 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 149' ' ' GLU . . . . . 0.786 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.0 t30 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.51 159.68 14.77 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.05 -5.62 54.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.84 -1.32 61.29 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.354 0.979 . . . . 0.0 112.993 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.32 23.76 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.97 148.95 48.69 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.347 1.059 . . . . 0.0 108.629 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.65 58.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.585 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 2.8 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.584 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 170' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.442 HG22 ' OD1' ' A' ' 10' ' ' ASP . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' OD1' HG13 ' A' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' A' ' 93' ' ' ARG . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.569 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' A' ' 91' ' ' PHE . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.879 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' O ' HG23 ' L' ' 48' ' ' THR . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' A' ' 33' ' ' THR . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' A' ' 32' ' ' GLN . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' H ' ' HA ' ' B' ' 115' ' ' SER . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' HH11 ' A' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -73.97 166.74 22.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' HG12 ' A' ' 53' ' ' ILE . 9.3 t80 -108.28 83.38 1.77 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.271 171.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' A' ' 53' ' ' ILE . 34.1 t70 -106.44 92.09 3.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 17.4 pt-20 -65.51 -15.8 63.03 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.81 21.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.578 1.551 . . . . 0.0 111.66 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.433 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 37.5 53.71 1.38 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 111.577 -164.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.06 0.52 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.427 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' B' ' 58' ' ' SER . 7.9 m-20 -150.62 29.99 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 84.85 34.72 14.55 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -102.27 122.68 44.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -136.91 133.03 47.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.826 178.333 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.12 22.18 16.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.556 ' HA ' ' OD1' ' F' ' 50' ' ' ASN . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.822 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' A' ' 34' ' ' ASP . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' A' ' 79' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.429 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.64 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 22.1 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.648 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 15' ' ' PHE . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' A' ' 11' ' ' VAL . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG13 ' OD1' ' A' ' 10' ' ' ASP . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 142' ' ' GLU . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 1.022 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' HB3' HE22 ' A' ' 88' ' ' GLN . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 89' ' ' ILE . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' A' ' 83' ' ' TYR . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.64 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' F' ' 33' ' ' THR . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.454 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' F' ' 8' ' ' GLY . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.822 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' GLY . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.022 HD12 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.95 HG21 HG21 ' A' ' 94' ' ' VAL . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.496 HD11 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 27' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.0 146.68 38.65 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HD3' ' HA3' ' G' ' 136' ' ' GLY . 12.3 mttt -75.92 -38.94 57.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.7 65.5 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 119.353 0.979 . . . . 0.0 113.031 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' G' ' 138' ' ' LEU . . . -74.77 123.25 7.42 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.82 110.4 22.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 108.614 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' G' ' 138' ' ' LEU . 0.5 OUTLIER -72.16 -28.88 63.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.786 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 32.4 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.892 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.478 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.445 HG22 ' OD1' ' B' ' 10' ' ' ASP . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' B' ' 97' ' ' VAL . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.738 HG11 HH21 ' B' ' 93' ' ' ARG . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.473 ' HD2' ' HE1' ' B' ' 91' ' ' PHE . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' B' ' 89' ' ' ILE . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 87' ' ' LYS . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.495 ' OG ' HD11 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.554 ' O ' HG23 ' G' ' 48' ' ' THR . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' B' ' 33' ' ' THR . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' B' ' 32' ' ' GLN . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.836 ' OD2' HG22 ' B' ' 65' ' ' VAL . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.629 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.449 ' HA ' HH11 ' B' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -73.93 166.74 22.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.609 ' HA ' HG12 ' B' ' 53' ' ' ILE . 9.3 t80 -108.31 83.46 1.78 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.195 171.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.453 ' H ' ' CG2' ' B' ' 53' ' ' ILE . 34.1 t70 -106.51 92.16 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' B' ' 51' ' ' GLY . 17.4 pt-20 -65.57 -15.77 63.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.07 35.8 21.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.596 1.558 . . . . 0.0 111.703 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.436 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 37.55 53.71 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.535 1.534 . . . . 0.0 111.57 -164.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' B' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.07 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.443 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 7.8 m-20 -150.61 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 84.84 34.71 14.63 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HG2' ' HG2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.61 44.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' B' ' 44' ' ' PHE . 0.5 OUTLIER -136.86 132.96 48.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.887 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.43 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -108.1 22.27 16.19 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.471 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.836 HG22 ' OD2' ' B' ' 34' ' ' ASP . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.493 ' OH ' HG21 ' B' ' 79' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.572 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 22.2 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.653 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' B' ' 15' ' ' PHE . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.738 HH21 HG11 ' B' ' 11' ' ' VAL . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.936 HG21 HG21 ' B' ' 145' ' ' THR . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.502 HG13 ' OD1' ' B' ' 10' ' ' ASP . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' B' ' 142' ' ' GLU . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLY . . . . . 1.006 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.436 ' HB3' HE22 ' B' ' 88' ' ' GLN . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 89' ' ' ILE . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.433 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' B' ' 83' ' ' TYR . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 33' ' ' THR . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.533 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.512 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' B' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.872 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' B' ' 136' ' ' GLY . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 1.006 HD12 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.694 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' THR . . . . . 0.936 HG21 HG21 ' B' ' 94' ' ' VAL . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.495 HD11 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.648 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' B' ' 27' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.648 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.68 38.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.473 ' HD3' ' HA3' ' H' ' 136' ' ' GLY . 12.3 mttt -75.96 -38.87 57.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.6 65.59 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.36 0.982 . . . . 0.0 113.025 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 123.22 7.46 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.77 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.304 1.042 . . . . 0.0 108.629 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.94 63.56 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -158.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.609 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 32.4 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.609 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.672 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLU . . . . . 0.741 ' HA ' HD13 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.672 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 5' ' ' PRO . . . . . 0.513 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' C' ' 10' ' ' ASP . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.494 ' OD1' HG13 ' C' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.745 HG11 HH21 ' C' ' 93' ' ' ARG . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' C' ' 91' ' ' PHE . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' C' ' 89' ' ' ILE . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' C' ' 87' ' ' LYS . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.898 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.771 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' TYR . . . . . 0.588 ' O ' HG23 ' H' ' 48' ' ' THR . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' C' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' C' ' 32' ' ' GLN . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.536 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.518 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' C' ' 41' ' ' ARG . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -73.89 166.71 22.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' C' ' 53' ' ' ILE . 9.3 t80 -108.26 83.41 1.78 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.256 171.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' C' ' 53' ' ' ILE . 34.0 t70 -106.43 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' H ' ' C' ' 51' ' ' GLY . 17.4 pt-20 -65.61 -15.7 63.0 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.604 1.562 . . . . 0.0 111.639 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.426 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 37.5 53.73 1.39 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.503 1.521 . . . . 0.0 111.587 -164.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HG2' ' C' ' 52' ' ' ARG . 17.6 tptt -116.18 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 84.76 34.79 14.65 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.437 ' HG2' ' HG2' ' C' ' 49' ' ' LYS . 0.0 OUTLIER -102.29 122.62 44.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' C' ' 44' ' ' PHE . 0.5 OUTLIER -136.83 133.01 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.857 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' B' ' 50' ' ' ASN . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' SER . . . . . 0.896 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' C' ' 34' ' ' ASP . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.559 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 22.2 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.443 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' C' ' 15' ' ' PHE . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.745 HH21 HG11 ' C' ' 11' ' ' VAL . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.928 HG21 HG21 ' C' ' 145' ' ' THR . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' C' ' 10' ' ' ASP . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' C' ' 99' ' ' ASN . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' C' ' 98' ' ' LYS . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.667 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' C' ' 142' ' ' GLU . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.567 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 109' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' C' ' 88' ' ' GLN . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' C' ' 89' ' ' ILE . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.443 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' C' ' 83' ' ' TYR . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.428 HG23 HG22 ' B' ' 33' ' ' THR . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 124' ' ' GLY . . . . . 0.617 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 63' ' ' GLY . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.896 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.472 ' H ' HG12 ' C' ' 135' ' ' ILE . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 1.024 HD12 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.686 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 145' ' ' THR . . . . . 0.928 HG21 HG21 ' C' ' 94' ' ' VAL . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.631 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.771 HG23 HD22 ' C' ' 27' ' ' LEU . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.01 146.62 38.77 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.433 ' HD3' ' HA3' ' I' ' 136' ' ' GLY . 12.4 mttt -75.95 -38.9 57.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.61 8.59 65.53 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.423 1.01 . . . . 0.0 113.03 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.75 123.25 7.43 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.79 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.296 1.038 . . . . 0.0 108.623 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 159' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' I' ' 138' ' ' LEU . 0.5 OUTLIER -72.14 -28.85 63.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.596 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.798 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 32.4 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.596 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.923 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.673 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 169' ' ' GLU . . . . . 0.726 ' HA ' HD13 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 170' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.673 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.923 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' D' ' 10' ' ' ASP . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.509 ' OD1' HG13 ' D' ' 97' ' ' VAL . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.744 HG11 HH21 ' D' ' 93' ' ' ARG . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.454 ' HD2' ' HE1' ' D' ' 91' ' ' PHE . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.525 ' HB3' HD11 ' D' ' 89' ' ' ILE . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.889 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' ASP . . . . . 0.439 ' OD2' ' HD3' ' D' ' 87' ' ' LYS . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' SER . . . . . 0.492 ' OG ' HD11 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.889 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.785 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' D' ' 33' ' ' THR . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' THR . . . . . 0.507 HG23 ' HG2' ' D' ' 32' ' ' GLN . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.833 ' OD2' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' SER . . . . . 0.595 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.449 ' H ' ' HA ' ' E' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' D' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.477 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.8 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 44' ' ' PHE . . . . . 0.622 ' HA ' HG12 ' D' ' 53' ' ' ILE . 9.3 t80 -108.31 83.42 1.78 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.186 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' D' ' 53' ' ' ILE . 34.0 t70 -106.47 92.13 3.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' D' ' 51' ' ' GLY . 17.4 pt-20 -65.58 -15.75 63.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.08 35.76 21.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.573 1.549 . . . . 0.0 111.717 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.435 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 37.59 53.71 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.477 1.511 . . . . 0.0 111.57 -164.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' HG2' ' D' ' 52' ' ' ARG . 17.6 tptt -116.16 -92.04 0.52 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.431 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' E' ' 58' ' ' SER . 7.8 m-20 -150.56 29.87 0.68 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 84.85 34.77 14.4 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.439 ' HG2' ' HG2' ' D' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.66 44.68 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.622 HG12 ' HA ' ' D' ' 44' ' ' PHE . 0.5 OUTLIER -136.8 133.05 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.896 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 22.32 16.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' SER . . . . . 0.679 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.437 ' H ' ' HB3' ' C' ' 50' ' ' ASN . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.833 HG22 ' OD2' ' D' ' 34' ' ' ASP . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.489 ' OH ' HG21 ' D' ' 79' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 22.1 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.536 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 15' ' ' PHE . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.454 ' HE1' ' HD2' ' D' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.744 HH21 HG11 ' D' ' 11' ' ' VAL . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.939 HG21 HG21 ' D' ' 145' ' ' THR . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 97' ' ' VAL . . . . . 0.509 HG13 ' OD1' ' D' ' 10' ' ' ASP . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' D' ' 99' ' ' ASN . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' D' ' 98' ' ' LYS . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.669 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' D' ' 142' ' ' GLU . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.569 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 109' ' ' GLY . . . . . 0.968 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' D' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' D' ' 89' ' ' ILE . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.444 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' D' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 115' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' C' ' 33' ' ' THR . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.489 HG23 ' CG2' ' C' ' 33' ' ' THR . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.516 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' D' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.414 HG13 ' H ' ' D' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.414 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.968 HD12 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.692 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.939 HG21 HG21 ' D' ' 94' ' ' VAL . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 146' ' ' LEU . . . . . 0.492 HD11 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.785 HG23 HD22 ' D' ' 27' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.07 146.67 38.75 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.422 ' HD3' ' HA3' ' J' ' 136' ' ' GLY . 12.3 mttt -75.92 -38.85 57.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.62 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 119.367 0.985 . . . . 0.0 113.06 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 157' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -74.72 123.18 7.42 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.301 1.04 . . . . 0.0 108.593 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 159' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' J' ' 138' ' ' LEU . 0.5 OUTLIER -72.16 -28.83 63.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.449 ' HZ ' ' OD1' ' J' ' 144' ' ' ASP . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.615 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 32.4 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 164' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.615 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.914 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.689 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 169' ' ' GLU . . . . . 0.745 ' HA ' HD13 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 170' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.689 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.914 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.419 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.44 HG22 ' OD1' ' E' ' 10' ' ' ASP . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.51 ' OD1' HG13 ' E' ' 97' ' ' VAL . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.736 HG11 HH21 ' E' ' 93' ' ' ARG . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 12' ' ' LYS . . . . . 0.573 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.45 ' HD2' ' HE1' ' E' ' 91' ' ' PHE . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' E' ' 89' ' ' ILE . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' E' ' 87' ' ' LYS . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.875 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.767 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' E' ' 33' ' ' THR . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' E' ' 32' ' ' GLN . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.826 ' OD2' HG22 ' E' ' 65' ' ' VAL . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' E' ' 41' ' ' ARG . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.71 22.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' E' ' 53' ' ' ILE . 9.3 t80 -108.25 83.35 1.77 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.254 171.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' E' ' 53' ' ' ILE . 34.1 t70 -106.44 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' E' ' 51' ' ' GLY . 17.3 pt-20 -65.55 -15.8 63.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.84 21.22 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.641 -172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.434 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 37.51 53.72 1.39 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 111.552 -164.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 49' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' E' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.464 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 50' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 7.8 m-20 -150.61 29.98 0.67 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 51' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 84.77 34.77 14.67 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' E' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.59 44.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.205 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' E' ' 44' ' ' PHE . 0.5 OUTLIER -136.81 133.0 48.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.885 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 58' ' ' SER . . . . . 0.498 ' HA ' ' OD1' ' D' ' 50' ' ' ASN . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 62' ' ' SER . . . . . 0.891 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.811 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.826 HG22 ' OD2' ' E' ' 34' ' ' ASP . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' E' ' 79' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 22.2 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.417 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.447 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' E' ' 15' ' ' PHE . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.45 ' HE1' ' HD2' ' E' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.736 HH21 HG11 ' E' ' 11' ' ' VAL . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.952 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 97' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' E' ' 10' ' ' ASP . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 98' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' E' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' E' ' 98' ' ' LYS . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.668 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' E' ' 142' ' ' GLU . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 109' ' ' GLY . . . . . 0.989 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.426 ' HB3' HE22 ' E' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' E' ' 89' ' ' ILE . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.447 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' E' ' 83' ' ' TYR . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 115' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 120' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.431 HG23 HG22 ' D' ' 33' ' ' THR . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.402 ' HA ' ' N ' ' D' ' 8' ' ' GLY . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.811 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' E' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.891 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.42 HG12 ' H ' ' E' ' 135' ' ' ILE . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.41 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.989 HD12 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.7 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.952 HG21 HG21 ' E' ' 94' ' ' VAL . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.767 HG23 HD22 ' E' ' 27' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.65 38.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.459 ' HD3' ' HA3' ' K' ' 136' ' ' GLY . 12.3 mttt -75.94 -38.85 57.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 175.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.6 65.63 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.384 0.993 . . . . 0.0 113.048 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 123.26 7.48 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.34 22.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.343 1.057 . . . . 0.0 108.604 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 159' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' K' ' 138' ' ' LEU . 0.5 OUTLIER -72.15 -28.86 63.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.622 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.807 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 32.4 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 164' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.622 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.698 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 169' ' ' GLU . . . . . 0.817 ' HA ' HD13 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 170' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.698 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.902 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.539 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' F' ' 10' ' ' ASP . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' F' ' 97' ' ' VAL . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.723 HG11 HH21 ' F' ' 93' ' ' ARG . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' F' ' 91' ' ' PHE . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.536 ' HB3' HD11 ' F' ' 89' ' ' ILE . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 19' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' F' ' 87' ' ' LYS . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 24' ' ' SER . . . . . 0.489 ' OG ' HD11 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.867 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.761 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.435 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' F' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.495 HG23 ' HG2' ' F' ' 32' ' ' GLN . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 38' ' ' SER . . . . . 0.531 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' F' ' 41' ' ' ARG . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -74.0 166.74 22.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 44' ' ' PHE . . . . . 0.614 ' HA ' HG12 ' F' ' 53' ' ' ILE . 9.2 t80 -108.25 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.235 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 45' ' ' ASP . . . . . 0.456 ' H ' ' CG2' ' F' ' 53' ' ' ILE . 34.1 t70 -106.49 92.05 3.95 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' F' ' 51' ' ' GLY . 17.4 pt-20 -65.54 -15.79 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.15 35.76 21.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.573 1.549 . . . . 0.0 111.66 -172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 37.59 53.7 1.43 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.505 1.522 . . . . 0.0 111.547 -164.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 49' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' F' ' 52' ' ' ARG . 17.6 tptt -116.23 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.419 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 50' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 7.8 m-20 -150.62 29.94 0.67 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 51' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 84.81 34.85 14.32 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' F' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.59 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' F' ' 44' ' ' PHE . 0.5 OUTLIER -136.79 133.02 48.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.903 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.15 22.31 16.12 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 58' ' ' SER . . . . . 0.627 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 63' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.821 HG22 ' OD2' ' F' ' 34' ' ' ASP . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' F' ' 79' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 74' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 22.1 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.66 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' F' ' 15' ' ' PHE . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' F' ' 13' ' ' TYR . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.719 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.723 HH21 HG11 ' F' ' 11' ' ' VAL . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.958 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' F' ' 10' ' ' ASP . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' F' ' 142' ' ' GLU . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 109' ' ' GLY . . . . . 1.007 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' F' ' 88' ' ' GLN . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' F' ' 89' ' ' ILE . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.45 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' F' ' 83' ' ' TYR . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 119' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 120' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' E' ' 33' ' ' THR . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.81 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' F' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' F' ' 136' ' ' GLY . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 1.007 HD12 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.701 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.958 HG21 HG21 ' F' ' 94' ' ' VAL . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 146' ' ' LEU . . . . . 0.489 HD11 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.628 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.761 HG23 HD22 ' F' ' 27' ' ' LEU . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.628 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.05 146.67 38.72 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.89 -38.93 57.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.56 65.53 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 119.399 1.0 . . . . 0.0 113.034 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.915 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -74.63 123.16 7.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.427 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.6 t80 -101.76 110.33 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.299 1.04 . . . . 0.0 108.646 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.815 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.11 -28.87 63.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.712 ' CE1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.7 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 32.4 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.69 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.855 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 170' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.69 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.915 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.434 HG22 ' OD1' ' G' ' 10' ' ' ASP . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 8' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' H' ' 125' ' ' ALA . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' G' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.734 HG11 HH21 ' G' ' 93' ' ' ARG . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.476 ' HD2' ' HE1' ' G' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' G' ' 89' ' ' ILE . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.887 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.754 HD13 ' HA ' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' G' ' 87' ' ' LYS . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 24' ' ' SER . . . . . 0.499 ' OG ' HD11 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.887 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.769 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' G' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' G' ' 32' ' ' GLN . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.837 ' OD2' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.45 ' HA ' HH11 ' G' ' 41' ' ' ARG . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.533 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -73.9 166.74 22.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 44' ' ' PHE . . . . . 0.595 ' HA ' HG12 ' G' ' 53' ' ' ILE . 9.3 t80 -108.31 83.39 1.77 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.214 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 45' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' G' ' 53' ' ' ILE . 34.1 t70 -106.4 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' G' ' 51' ' ' GLY . 17.4 pt-20 -65.57 -15.78 63.05 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.16 35.77 21.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.593 1.557 . . . . 0.0 111.644 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.554 HG23 ' O ' ' B' ' 31' ' ' TYR . 0.0 OUTLIER 37.49 53.72 1.38 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.522 1.529 . . . . 0.0 111.598 -164.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 49' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' G' ' 52' ' ' ARG . 17.6 tptt -116.11 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.461 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 50' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 7.8 m-20 -150.65 30.02 0.67 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 51' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 84.84 34.71 14.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' G' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.66 44.64 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' G' ' 44' ' ' PHE . 0.5 OUTLIER -136.89 132.96 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 57' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 58' ' ' SER . . . . . 0.668 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' L' ' 50' ' ' ASN . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 63' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.816 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.837 HG22 ' OD2' ' G' ' 34' ' ' ASP . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.476 ' OH ' HG21 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 22.2 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.662 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.495 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.422 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' G' ' 15' ' ' PHE . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' G' ' 13' ' ' TYR . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.723 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.734 HH21 HG11 ' G' ' 11' ' ' VAL . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.956 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 97' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' G' ' 10' ' ' ASP . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' G' ' 99' ' ' ASN . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' G' ' 98' ' ' LYS . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.606 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' G' ' 142' ' ' GLU . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 109' ' ' GLY . . . . . 0.996 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' G' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' G' ' 89' ' ' ILE . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' G' ' 83' ' ' TYR . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.503 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.816 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' G' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.44 ' H ' HG12 ' G' ' 135' ' ' ILE . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 155' ' ' LYS . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.996 HD12 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.694 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.956 HG21 HG21 ' G' ' 94' ' ' VAL . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 146' ' ' LEU . . . . . 0.499 HD11 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.641 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.769 HG23 HD22 ' G' ' 27' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.64 38.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.92 -38.89 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.61 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.386 0.994 . . . . 0.0 113.046 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 123.27 7.45 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.31 22.27 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.293 1.037 . . . . 0.0 108.639 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.9 63.57 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -158.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.616 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.919 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.671 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 170' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.671 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.919 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.427 HG22 ' OD1' ' H' ' 10' ' ' ASP . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' H' ' 97' ' ' VAL . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' H' ' 93' ' ' ARG . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.472 ' HD2' ' HE1' ' H' ' 91' ' ' PHE . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' H' ' 89' ' ' ILE . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.896 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HD3' ' H' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 163' ' ' PRO . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 24' ' ' SER . . . . . 0.497 ' OG ' HD11 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.896 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.789 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' H' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' H' ' 32' ' ' GLN . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.834 ' OD2' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 38' ' ' SER . . . . . 0.49 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' H' ' 41' ' ' ARG . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER -73.92 166.78 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' H' ' 53' ' ' ILE . 9.3 t80 -108.34 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.171 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' H' ' 53' ' ' ILE . 34.1 t70 -106.53 92.07 3.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' H' ' 51' ' ' GLY . 17.4 pt-20 -65.5 -15.79 63.01 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.13 35.74 21.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.573 1.549 . . . . 0.0 111.702 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.588 HG23 ' O ' ' C' ' 31' ' ' TYR . 0.0 OUTLIER 37.63 53.64 1.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.482 1.513 . . . . 0.0 111.568 -164.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 49' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' H' ' 52' ' ' ARG . 17.6 tptt -116.16 -91.98 0.52 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.464 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 50' ' ' ASN . . . . . 0.697 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 7.8 m-20 -150.66 29.96 0.67 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 51' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 84.82 34.78 14.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' H' ' 49' ' ' LYS . 0.0 OUTLIER -102.31 122.58 44.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' H' ' 44' ' ' PHE . 0.5 OUTLIER -136.83 133.02 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.886 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 22.29 16.16 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 57' ' ' GLY . . . . . 0.483 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 58' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 63' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.829 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.834 HG22 ' OD2' ' H' ' 34' ' ' ASP . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.478 ' OH ' HG21 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.642 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 22.1 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.651 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.599 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' H' ' 15' ' ' PHE . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.472 ' HE1' ' HD2' ' H' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' H' ' 11' ' ' VAL . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 97' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' H' ' 10' ' ' ASP . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' H' ' 99' ' ' ASN . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' H' ' 98' ' ' LYS . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.659 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' H' ' 142' ' ' GLU . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 109' ' ' GLY . . . . . 1.043 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' H' ' 88' ' ' GLN . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' H' ' 89' ' ' ILE . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' H' ' 83' ' ' TYR . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 121' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.509 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.829 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.428 ' H ' HG12 ' H' ' 135' ' ' ILE . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' B' ' 155' ' ' LYS . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 1.043 HD12 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.682 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 146' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.789 HG23 HD22 ' H' ' 27' ' ' LEU . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.69 38.64 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.82 56.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.66 65.59 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 119.381 0.991 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.76 123.24 7.42 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.34 22.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.273 1.029 . . . . 0.0 108.622 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.79 63.48 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -158.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.607 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 162' ' ' GLN . . . . . 0.79 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 163' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.607 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.872 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.669 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 170' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.669 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.872 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.582 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' I' ' 10' ' ' ASP . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.506 ' OD1' HG13 ' I' ' 97' ' ' VAL . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.729 HG11 HH21 ' I' ' 93' ' ' ARG . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' I' ' 91' ' ' PHE . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' I' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' I' ' 87' ' ' LYS . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' C' ' 163' ' ' PRO . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 24' ' ' SER . . . . . 0.488 ' OG ' HD11 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.884 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.496 ' HG2' HG23 ' I' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.501 HG22 ' HA2' ' J' ' 121' ' ' GLY . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' I' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -73.89 166.7 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 44' ' ' PHE . . . . . 0.62 ' HA ' HG12 ' I' ' 53' ' ' ILE . 9.3 t80 -108.26 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.244 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' I' ' 53' ' ' ILE . 34.0 t70 -106.49 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' I' ' 51' ' ' GLY . 17.4 pt-20 -65.55 -15.83 63.09 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.18 35.77 21.04 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.582 1.553 . . . . 0.0 111.667 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.424 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 37.49 53.79 1.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 111.558 -164.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 49' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' I' ' 52' ' ' ARG . 17.6 tptt -116.21 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 50' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 51' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 84.82 34.79 14.47 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' I' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.65 44.67 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' I' ' 44' ' ' PHE . 0.5 OUTLIER -136.84 133.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.853 178.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.17 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 58' ' ' SER . . . . . 0.697 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.445 ' H ' ' HB3' ' H' ' 50' ' ' ASN . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' I' ' 34' ' ' ASP . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.487 ' OH ' HG21 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.655 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 22.2 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.655 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' I' ' 15' ' ' PHE . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.463 ' HE1' ' HD2' ' I' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.729 HH21 HG11 ' I' ' 11' ' ' VAL . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.925 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 97' ' ' VAL . . . . . 0.506 HG13 ' OD1' ' I' ' 10' ' ' ASP . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.658 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.601 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' I' ' 142' ' ' GLU . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 109' ' ' GLY . . . . . 0.994 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.422 ' HB3' HE22 ' I' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.427 ' HB3' HG23 ' I' ' 89' ' ' ILE . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.435 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' I' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 120' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' H' ' 33' ' ' THR . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 121' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.52 HG13 ' O ' ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' I' ' 63' ' ' GLY . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.413 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' C' ' 155' ' ' LYS . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.994 HD12 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.673 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 145' ' ' THR . . . . . 0.925 HG21 HG21 ' I' ' 94' ' ' VAL . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 146' ' ' LEU . . . . . 0.488 HD11 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' I' ' 27' ' ' LEU . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.67 38.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.94 -38.94 57.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 8.63 65.51 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.391 0.996 . . . . 0.0 113.04 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.71 123.21 7.44 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.289 1.036 . . . . 0.0 108.649 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -28.77 63.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' I' I ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.609 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.684 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 170' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.684 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.532 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' J' ' 10' ' ' ASP . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.504 ' OD1' HG13 ' J' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.75 HG11 HH21 ' J' ' 93' ' ' ARG . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' J' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.515 ' HB3' HD11 ' J' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.87 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' J' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.87 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.77 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' J' ' 33' ' ' THR . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 33' ' ' THR . . . . . 0.502 HG23 ' HG2' ' J' ' 32' ' ' GLN . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.839 ' OD2' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 38' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' J' ' 41' ' ' ARG . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' E' ' 124' ' ' GLY . 0.0 OUTLIER -73.91 166.74 22.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 44' ' ' PHE . . . . . 0.61 ' HA ' HG12 ' J' ' 53' ' ' ILE . 9.2 t80 -108.27 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.252 171.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 45' ' ' ASP . . . . . 0.456 ' H ' ' CG2' ' J' ' 53' ' ' ILE . 34.1 t70 -106.45 92.11 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' J' ' 51' ' ' GLY . 17.4 pt-20 -65.63 -15.74 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.1 35.8 21.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.624 1.57 . . . . 0.0 111.653 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.433 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 37.54 53.71 1.4 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.452 1.501 . . . . 0.0 111.601 -164.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 49' ' ' LYS . . . . . 0.44 ' HG2' ' HG2' ' J' ' 52' ' ' ARG . 17.7 tptt -116.18 -91.99 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.459 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 50' ' ' ASN . . . . . 0.644 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 51' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 84.81 34.74 14.64 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HG2' ' J' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.69 44.7 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.61 HG12 ' HA ' ' J' ' 44' ' ' PHE . 0.5 OUTLIER -136.86 133.01 48.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.87 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.21 22.3 16.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 58' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' I' ' 50' ' ' ASN . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 62' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 63' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.839 HG22 ' OD2' ' J' ' 34' ' ' ASP . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' J' ' 79' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 71' ' ' ARG . . . . . 0.409 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 74' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 22.1 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.685 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' J' ' 15' ' ' PHE . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' J' ' 13' ' ' TYR . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.75 HH21 HG11 ' J' ' 11' ' ' VAL . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.938 HG21 HG21 ' J' ' 145' ' ' THR . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 97' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' J' ' 10' ' ' ASP . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' J' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' J' ' 98' ' ' LYS . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' J' ' 142' ' ' GLU . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' J' ' 88' ' ' GLN . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' J' ' 89' ' ' ILE . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.448 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.431 HG21 ' HD1' ' J' ' 83' ' ' TYR . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 120' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 121' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.48 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' J' ' 63' ' ' GLY . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.897 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.411 HG13 ' H ' ' J' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' D' ' 155' ' ' LYS . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 140' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.68 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' HZ ' ' D' ' 160' ' ' PHE . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.938 HG21 HG21 ' J' ' 94' ' ' VAL . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.77 HG23 HD22 ' J' ' 27' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.05 146.68 38.69 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.86 56.91 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.59 8.58 65.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.369 0.986 . . . . 0.0 113.037 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.23 7.5 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.33 22.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.346 1.058 . . . . 0.0 108.593 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.91 63.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -158.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.617 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' J' J ' 162' ' ' GLN . . . . . 0.801 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 163' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 164' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.617 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.911 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.688 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 170' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.688 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.911 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.518 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' K' ' 10' ' ' ASP . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' K' ' 97' ' ' VAL . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.718 HG11 HH21 ' K' ' 93' ' ' ARG . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 12' ' ' LYS . . . . . 0.579 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.457 ' HD2' ' HE1' ' K' ' 91' ' ' PHE . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.523 ' HB3' HD11 ' K' ' 89' ' ' ILE . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.817 HD13 ' HA ' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' K' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.861 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.776 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' K' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 33' ' ' THR . . . . . 0.505 HG23 ' HG2' ' K' ' 32' ' ' GLN . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' K' ' 65' ' ' VAL . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 40' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' L' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.449 HH11 ' HA ' ' K' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -73.99 166.75 22.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 44' ' ' PHE . . . . . 0.62 ' HA ' HG12 ' K' ' 53' ' ' ILE . 9.3 t80 -108.27 83.38 1.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.21 171.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' K' ' 53' ' ' ILE . 34.0 t70 -106.42 92.07 3.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 155.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' K' ' 51' ' ' GLY . 17.4 pt-20 -65.52 -15.79 63.04 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.58 1.552 . . . . 0.0 111.648 -172.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.435 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 37.49 53.73 1.38 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.528 1.531 . . . . 0.0 111.58 -164.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' HG2' ' K' ' 52' ' ' ARG . 17.7 tptt -116.11 -92.07 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.465 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 50' ' ' ASN . . . . . 0.765 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 51' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 84.82 34.74 14.59 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' K' ' 49' ' ' LYS . 0.0 OUTLIER -102.3 122.61 44.56 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' K' ' 44' ' ' PHE . 0.5 OUTLIER -136.84 132.96 48.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.88 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.08 22.24 16.22 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 57' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 58' ' ' SER . . . . . 0.644 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.421 ' H ' ' HB3' ' J' ' 50' ' ' ASN . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 62' ' ' SER . . . . . 0.88 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 63' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.819 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' K' ' 34' ' ' ASP . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.491 ' OH ' HG21 ' K' ' 79' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.632 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 22.1 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.632 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' K' ' 15' ' ' PHE . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.457 ' HE1' ' HD2' ' K' ' 13' ' ' TYR . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.718 HH21 HG11 ' K' ' 11' ' ' VAL . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.955 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' K' ' 10' ' ' ASP . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' K' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' K' ' 98' ' ' LYS . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' K' ' 142' ' ' GLU . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 109' ' ' GLY . . . . . 0.975 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.437 ' HB3' HE22 ' K' ' 88' ' ' GLN . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' K' ' 89' ' ' ILE . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' K' ' 83' ' ' TYR . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 119' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' J' ' 8' ' ' GLY . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.507 HG13 ' O ' ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.819 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' K' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.88 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.412 ' H ' HG12 ' K' ' 135' ' ' ILE . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.459 ' HA3' ' HD3' ' E' ' 155' ' ' LYS . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.975 HD12 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.955 HG21 HG21 ' K' ' 94' ' ' VAL . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.776 HG23 HD22 ' K' ' 27' ' ' LEU . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.03 146.68 38.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.84 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.61 65.59 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.348 0.977 . . . . 0.0 113.052 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.7 123.26 7.47 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.85 110.38 22.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.311 1.044 . . . . 0.0 108.593 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.88 63.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.611 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' K' K ' 162' ' ' GLN . . . . . 0.783 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 163' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 164' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.611 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.905 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.679 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 170' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.679 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.905 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.447 HG22 ' OD1' ' L' ' 10' ' ' ASP . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' L' ' 97' ' ' VAL . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.739 HG11 HH21 ' L' ' 93' ' ' ARG . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 12' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD2' ' HE1' ' L' ' 91' ' ' PHE . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' L' ' 89' ' ' ILE . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' L' ' 87' ' ' LYS . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 24' ' ' SER . . . . . 0.486 ' OG ' HD11 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.873 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.762 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' L' ' 33' ' ' THR . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' L' ' 32' ' ' GLN . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.828 ' OD2' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 38' ' ' SER . . . . . 0.495 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' L' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.77 22.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 44' ' ' PHE . . . . . 0.618 ' HA ' HG12 ' L' ' 53' ' ' ILE . 9.3 t80 -108.3 83.43 1.78 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.228 171.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' L' ' 53' ' ' ILE . 34.1 t70 -106.49 92.1 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' L' ' 51' ' ' GLY . 17.4 pt-20 -65.48 -15.84 63.06 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.12 35.84 21.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.639 1.575 . . . . 0.0 111.611 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER 37.48 53.82 1.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.53 1.532 . . . . 0.0 111.534 -164.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 49' ' ' LYS . . . . . 0.455 ' HG2' ' HG2' ' L' ' 52' ' ' ARG . 17.7 tptt -116.2 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.452 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 50' ' ' ASN . . . . . 0.668 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 7.9 m-20 -150.62 29.96 0.67 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 51' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 84.74 34.84 14.57 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' L' ' 49' ' ' LYS . 0.0 OUTLIER -102.36 122.57 44.51 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.618 HG12 ' HA ' ' L' ' 44' ' ' PHE . 0.5 OUTLIER -136.79 132.96 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.91 178.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 58' ' ' SER . . . . . 0.765 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.524 ' H ' ' HB3' ' K' ' 50' ' ' ASN . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.828 HG22 ' OD2' ' L' ' 34' ' ' ASP . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.482 ' OH ' HG21 ' L' ' 79' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' L' ' 71' ' ' ARG . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.643 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 22.1 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.64 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.855 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' L' ' 15' ' ' PHE . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.469 ' HE1' ' HD2' ' L' ' 13' ' ' TYR . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.739 HH21 HG11 ' L' ' 11' ' ' VAL . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.947 HG21 HG21 ' L' ' 145' ' ' THR . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' L' ' 10' ' ' ASP . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 98' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' L' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' L' ' 98' ' ' LYS . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' L' ' 142' ' ' GLU . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' L' ' 138' ' ' LEU . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' L' ' 89' ' ' ILE . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.428 HG21 ' HD1' ' L' ' 83' ' ' TYR . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 115' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.418 HG23 HG22 ' K' ' 33' ' ' THR . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.505 HG13 ' O ' ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.812 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' L' ' 63' ' ' GLY . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.43 ' H ' HG12 ' L' ' 135' ' ' ILE . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.815 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 1.7 p30 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.712 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.491 ' OD1' ' HZ ' ' F' ' 160' ' ' PHE . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.947 HG21 HG21 ' L' ' 94' ' ' VAL . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 146' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.762 HG23 HD22 ' L' ' 27' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.04 146.67 38.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.9 57.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.6 65.49 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 119.378 0.99 . . . . 0.0 113.04 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.26 7.49 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.36 22.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.31 1.044 . . . . 0.0 108.634 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -28.86 63.51 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -158.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' L' L ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 164' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.606 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.889 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.686 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.686 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.889 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' A' ' 93' ' ' ARG . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.614 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.667 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB2' HG21 ' L' ' 48' ' ' THR . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HG2' HG23 ' A' ' 33' ' ' THR . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.585 HG22 HG23 ' B' ' 122' ' ' VAL . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.76 ' OD2' HG22 ' A' ' 65' ' ' VAL . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 117' ' ' GLU . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.794 ' HA ' HH11 ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.677 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -76.63 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 53' ' ' ILE . 10.1 t80 -108.98 81.76 1.49 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 171.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.24 96.49 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 155.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 12.4 pt-20 -67.56 -15.8 63.85 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.3 35.58 18.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 111.654 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.604 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.07 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.487 1.515 . . . . 0.0 111.571 -164.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.11 -89.87 0.57 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.484 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' B' ' 58' ' ' SER . 6.9 m-20 -151.32 28.17 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.607 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 83.82 35.02 17.11 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NE ' ' HB ' ' B' ' 135' ' ' ILE . 0.0 OUTLIER -102.13 123.61 46.29 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.42 50.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.849 178.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' B' ' 88' ' ' GLN . 0.4 OUTLIER -107.99 18.9 20.69 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.677 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.551 ' HA ' ' OD1' ' F' ' 50' ' ' ASN . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.733 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.76 HG22 ' OD2' ' A' ' 34' ' ' ASP . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.419 ' OH ' HG21 ' A' ' 79' ' ' ILE . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 126' ' ' VAL . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.656 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.811 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 21.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 15' ' ' PHE . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.779 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.791 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.5 HG23 HG22 ' F' ' 33' ' ' THR . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.49 HG13 ' O ' ' F' ' 7' ' ' MET . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.699 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.733 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.009 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.948 HG21 HG21 ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.588 HG23 HD22 ' A' ' 27' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.63 144.02 44.52 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HD3' ' HA3' ' G' ' 136' ' ' GLY . 11.7 mttt -80.14 -32.95 38.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.95 75.55 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.349 0.977 . . . . 0.0 113.053 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.59 114.81 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.327 1.051 . . . . 0.0 108.606 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' G' ' 140' ' ' ASN . 0.5 OUTLIER -72.65 -31.71 65.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -158.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.508 ' HA ' ' CZ3' ' G' ' 92' ' ' TRP . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.525 ' H ' ' HH2' ' G' ' 92' ' ' TRP . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.67 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 33.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' G' ' 18' ' ' ILE . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.803 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' B' ' 6' ' ' ILE . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' B' ' 93' ' ' ARG . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.664 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.666 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.664 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.588 ' HB2' HG21 ' G' ' 48' ' ' THR . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' B' ' 33' ' ' THR . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.548 HG22 HG23 ' C' ' 122' ' ' VAL . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' B' ' 65' ' ' VAL . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' C' ' 117' ' ' GLU . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.67 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.791 ' HA ' HH11 ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.673 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -76.65 164.23 26.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' B' ' 53' ' ' ILE . 10.1 t80 -108.97 81.78 1.5 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.232 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.3 96.45 6.47 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.6 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 12.4 pt-20 -67.47 -15.84 63.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.54 17.92 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.629 1.572 . . . . 0.0 111.617 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.6 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.05 1.95 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.499 1.52 . . . . 0.0 111.527 -164.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 83.75 35.06 17.22 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.515 ' NE ' ' HB ' ' C' ' 135' ' ' ILE . 0.0 OUTLIER -102.18 123.68 46.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' B' ' 44' ' ' PHE . 0.7 OUTLIER -136.16 133.35 50.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.85 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.622 ' HB2' ' HG3' ' C' ' 88' ' ' GLN . 0.4 OUTLIER -107.95 18.89 20.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' B' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' B' ' 79' ' ' ILE . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' B' ' 126' ' ' VAL . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' B' ' 77' ' ' LYS . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.569 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.825 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 21.5 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.825 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.635 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.41 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.609 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' B' ' 15' ' ' PHE . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 1.002 HG21 HG21 ' B' ' 145' ' ' THR . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' B' ' 94' ' ' VAL . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.611 ' HB2' HD11 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.609 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.791 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.485 ' HD2' ' NH2' ' B' ' 116' ' ' ARG . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.794 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.585 HG23 HG22 ' A' ' 33' ' ' THR . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.477 HG23 ' H ' ' B' ' 69' ' ' GLY . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.791 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' B' ' 110' ' ' PHE . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' THR . . . . . 1.002 HG21 HG21 ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.591 HG23 HD22 ' B' ' 27' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.58 144.03 44.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.606 ' HD3' ' HA3' ' H' ' 136' ' ' GLY . 11.7 mttt -80.19 -32.9 38.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.91 75.64 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.369 0.986 . . . . 0.0 113.063 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.35 123.35 9.2 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.79 28.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.337 1.055 . . . . 0.0 108.615 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.64 -31.69 65.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -158.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.456 ' HA ' ' CZ3' ' H' ' 92' ' ' TRP . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.668 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 33.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.479 ' HA ' HG22 ' B' ' 173' ' ' THR . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.479 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' C' ' 6' ' ' ILE . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.564 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' C' ' 93' ' ' ARG . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.633 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.66 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . 0.633 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' TYR . . . . . 0.569 ' O ' HG23 ' H' ' 48' ' ' THR . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' C' ' 33' ' ' THR . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.634 HG22 HG23 ' D' ' 122' ' ' VAL . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' C' ' 65' ' ' VAL . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.791 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -76.73 164.27 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' C' ' 53' ' ' ILE . 10.1 t80 -109.01 81.8 1.5 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.229 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.22 96.48 6.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.601 ' HB2' ' H ' ' C' ' 51' ' ' GLY . 12.4 pt-20 -67.58 -15.86 63.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.36 35.51 17.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.591 1.556 . . . . 0.0 111.697 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 38.73 53.1 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.478 1.511 . . . . 0.0 111.594 -164.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.79 0.57 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ASN . . . . . 0.677 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 6.9 m-20 -151.31 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 83.8 35.03 17.13 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.529 ' NE ' ' HB ' ' D' ' 135' ' ' ILE . 0.0 OUTLIER -102.08 123.61 46.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' C' ' 44' ' ' PHE . 0.7 OUTLIER -136.14 133.38 50.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.903 178.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' D' ' 88' ' ' GLN . 0.4 OUTLIER -107.92 18.87 20.76 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' B' ' 50' ' ' ASN . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' C' ' 34' ' ' ASP . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.417 ' OH ' HG21 ' C' ' 79' ' ' ILE . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' C' ' 126' ' ' VAL . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' C' ' 77' ' ' LYS . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.815 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 21.7 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.815 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.67 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.633 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' C' ' 15' ' ' PHE . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.667 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 1.009 HG21 HG21 ' C' ' 145' ' ' THR . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' C' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.678 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' C' ' 94' ' ' VAL . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 109' ' ' GLY . . . . . 0.995 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.633 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.768 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.477 ' HD2' ' NH2' ' C' ' 116' ' ' ARG . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.773 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.548 HG23 HG22 ' B' ' 33' ' ' THR . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' C' ' 69' ' ' GLY . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.773 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.768 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.726 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' C' ' 110' ' ' PHE . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.995 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 145' ' ' THR . . . . . 1.009 HG21 HG21 ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.604 HG23 HD22 ' C' ' 27' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.59 144.07 44.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.543 ' HD3' ' HA3' ' I' ' 136' ' ' GLY . 11.7 mttt -80.23 -32.93 38.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.65 10.87 75.58 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 119.398 0.999 . . . . 0.0 113.036 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.3 9.19 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.54 114.81 28.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.669 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.67 65.24 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.676 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 33.3 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.836 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.48 ' HA ' HG22 ' C' ' 173' ' ' THR . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.48 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.836 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.438 HG21 ' NH2' ' D' ' 93' ' ' ARG . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' LYS . . . . . 0.668 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.668 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' TYR . . . . . 0.457 ' HB2' HG21 ' I' ' 48' ' ' THR . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' D' ' 33' ' ' THR . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' THR . . . . . 0.575 HG22 HG23 ' E' ' 122' ' ' VAL . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' D' ' 65' ' ' VAL . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.638 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.797 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.654 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -76.62 164.28 26.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 44' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' D' ' 53' ' ' ILE . 10.1 t80 -109.0 81.8 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.228 171.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.21 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' D' ' 51' ' ' GLY . 12.4 pt-20 -67.52 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.601 1.56 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.602 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 38.81 53.02 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.474 1.51 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.14 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.482 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' E' ' 58' ' ' SER . 6.9 m-20 -151.31 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 83.82 35.01 17.12 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.454 ' NE ' ' HB ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -102.12 123.59 46.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' D' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.43 50.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.896 178.307 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.552 ' HB2' ' HG3' ' E' ' 88' ' ' GLN . 0.4 OUTLIER -108.01 18.91 20.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLY . . . . . 0.654 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' SER . . . . . 0.677 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' SER . . . . . 0.751 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' D' ' 34' ' ' ASP . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' D' ' 79' ' ' ILE . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.582 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.461 ' H ' HG23 ' D' ' 126' ' ' VAL . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' D' ' 77' ' ' LYS . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.648 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.816 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 21.6 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' D' ' 15' ' ' PHE . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.977 HG21 HG21 ' D' ' 145' ' ' THR . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.4 ' N ' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' D' ' 94' ' ' VAL . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 109' ' ' GLY . . . . . 0.981 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.785 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.478 ' HD2' ' NH2' ' D' ' 116' ' ' ARG . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.634 HG23 HG22 ' C' ' 33' ' ' THR . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 69' ' ' GLY . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.785 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.69 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.751 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' D' ' 110' ' ' PHE . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.981 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.615 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.977 HG21 HG21 ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' D' ' 27' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.681 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.01 44.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.589 ' HD3' ' HA3' ' J' ' 136' ' ' GLY . 11.8 mttt -80.11 -33.0 39.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.82 75.51 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 157' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -72.31 123.32 9.23 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.85 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 108.64 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 159' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.63 65.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.583 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 33.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' J' ' 18' ' ' ILE . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' E' ' 93' ' ' ARG . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 12' ' ' LYS . . . . . 0.666 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.622 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 30' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 31' ' ' TYR . . . . . 0.407 ' HB2' HG21 ' J' ' 48' ' ' THR . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' E' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' E' ' 32' ' ' GLN . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' E' ' 65' ' ' VAL . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.563 HG22 ' HG2' ' F' ' 117' ' ' GLU . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 40' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' F' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.658 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -76.68 164.23 26.09 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 44' ' ' PHE . . . . . 0.602 ' HA ' HG12 ' E' ' 53' ' ' ILE . 10.2 t80 -108.99 81.78 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.236 171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.23 96.48 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' E' ' 51' ' ' GLY . 12.4 pt-20 -67.51 -15.81 63.86 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.31 35.54 18.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.573 1.549 . . . . 0.0 111.678 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.592 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 38.72 53.08 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.474 1.51 . . . . 0.0 111.559 -164.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.15 -89.79 0.57 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.533 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 50' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 6.9 m-20 -151.32 28.16 0.66 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 51' ' ' GLY . . . . . 0.609 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 83.76 35.05 17.22 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 123.64 46.32 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' E' ' 44' ' ' PHE . 0.7 OUTLIER -136.1 133.39 50.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.845 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' F' ' 88' ' ' GLN . 0.4 OUTLIER -107.95 18.84 20.78 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 176.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 57' ' ' GLY . . . . . 0.658 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 58' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' D' ' 50' ' ' ASN . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 62' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.754 HG22 ' OD2' ' E' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' E' ' 79' ' ' ILE . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 69' ' ' GLY . . . . . 0.453 ' H ' HG23 ' E' ' 126' ' ' VAL . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 77' ' ' LYS . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.813 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 21.6 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.638 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.62 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' E' ' 15' ' ' PHE . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.684 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.509 ' CB ' HG12 ' E' ' 94' ' ' VAL . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 109' ' ' GLY . . . . . 0.957 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.617 ' HB2' HD11 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.62 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 115' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.481 ' HD2' ' NH2' ' E' ' 116' ' ' ARG . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 119' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.575 HG23 HG22 ' D' ' 33' ' ' THR . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.453 HG23 ' H ' ' E' ' 69' ' ' GLY . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.801 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' E' ' 110' ' ' PHE . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.405 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.957 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.625 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.584 HG23 HD22 ' E' ' 27' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.05 44.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.564 ' HD3' ' HA3' ' K' ' 136' ' ' GLY . 11.8 mttt -80.23 -32.92 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.91 75.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 119.416 1.007 . . . . 0.0 113.014 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.37 9.13 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.6 114.83 28.83 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.305 1.042 . . . . 0.0 108.595 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -31.68 65.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -158.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.486 ' HA ' ' CZ3' ' K' ' 92' ' ' TRP . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.484 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 33.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.81 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.478 ' HA ' HG22 ' E' ' 173' ' ' THR . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.478 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.81 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' F' ' 93' ' ' ARG . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 12' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.664 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.676 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' K' ' 48' ' ' THR . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' F' ' 33' ' ' THR . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.5 HG22 HG23 ' A' ' 122' ' ' VAL . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.75 ' OD2' HG22 ' F' ' 65' ' ' VAL . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 117' ' ' GLU . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 40' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -76.73 164.29 26.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 44' ' ' PHE . . . . . 0.586 ' HA ' HG12 ' F' ' 53' ' ' ILE . 10.1 t80 -108.98 81.77 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.239 171.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.45 6.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' F' ' 51' ' ' GLY . 12.4 pt-20 -67.49 -15.91 63.93 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.62 17.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.62 1.568 . . . . 0.0 111.634 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.591 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.498 1.519 . . . . 0.0 111.608 -164.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.81 0.57 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.5 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 50' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 6.9 m-20 -151.3 28.19 0.66 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 51' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 83.79 35.05 17.12 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.09 123.63 46.29 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.586 HG12 ' HA ' ' F' ' 44' ' ' PHE . 0.7 OUTLIER -136.07 133.42 50.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.98 18.86 20.74 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 58' ' ' SER . . . . . 0.646 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 62' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.713 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.75 HG22 ' OD2' ' F' ' 34' ' ' ASP . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' F' ' 79' ' ' ILE . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.59 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.471 ' H ' HG23 ' F' ' 126' ' ' VAL . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' F' ' 77' ' ' LYS . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 74' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.651 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 21.6 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' F' ' 15' ' ' PHE . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.666 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.966 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 97' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' F' ' 104' ' ' TYR . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' F' ' 142' ' ' GLU . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' F' ' 94' ' ' VAL . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 109' ' ' GLY . . . . . 0.974 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.788 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.489 ' HD2' ' NH2' ' F' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 122' ' ' VAL . . . . . 0.453 HG23 HG22 ' E' ' 33' ' ' THR . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.471 HG23 ' H ' ' F' ' 69' ' ' GLY . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.788 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.713 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' F' ' 110' ' ' PHE . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.4 ' N ' HG13 ' F' ' 135' ' ' ILE . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.974 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.626 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.966 HG21 HG21 ' F' ' 94' ' ' VAL . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.586 HG23 HD22 ' F' ' 27' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 153' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' K' ' 49' ' ' LYS . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.04 44.48 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.541 ' HD3' ' HA3' ' L' ' 136' ' ' GLY . 11.8 mttt -80.16 -32.97 38.77 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.83 75.49 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 119.365 0.984 . . . . 0.0 113.053 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.778 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -72.37 123.3 9.15 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.573 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.2 t80 -100.57 114.85 28.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.354 1.062 . . . . 0.0 108.6 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.62 65.09 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 1.003 ' CE1' HD13 ' L' ' 143' ' ' ILE . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.837 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.833 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 33.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.79 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.821 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.802 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.821 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.507 ' HB3' ' HE3' ' H' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.6 ' O ' HG22 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.44 HG21 ' NH2' ' G' ' 93' ' ' ARG . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 12' ' ' LYS . . . . . 0.679 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.679 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 31' ' ' TYR . . . . . 0.4 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' G' ' 33' ' ' THR . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' G' ' 32' ' ' GLN . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' G' ' 65' ' ' VAL . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.587 HG22 ' HG2' ' H' ' 117' ' ' GLU . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.8 ' HA ' HH11 ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -76.69 164.24 26.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 44' ' ' PHE . . . . . 0.595 ' HA ' HG12 ' G' ' 53' ' ' ILE . 10.2 t80 -109.02 81.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.226 171.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.23 96.43 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' G' ' 51' ' ' GLY . 12.4 pt-20 -67.54 -15.8 63.85 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.3 35.55 18.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.635 1.574 . . . . 0.0 111.654 -172.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.594 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.539 1.535 . . . . 0.0 111.554 -164.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.12 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.504 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 50' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 6.9 m-20 -151.31 28.14 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 51' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 83.74 35.04 17.29 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.67 46.38 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' G' ' 44' ' ' PHE . 0.7 OUTLIER -136.12 133.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.877 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' H' ' 135' ' ' ILE . 0.4 OUTLIER -107.99 18.88 20.71 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 58' ' ' SER . . . . . 0.696 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 62' ' ' SER . . . . . 0.713 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' G' ' 34' ' ' ASP . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.427 ' OH ' HG21 ' G' ' 79' ' ' ILE . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' G' ' 126' ' ' VAL . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 73' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' G' ' 77' ' ' LYS . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 21.6 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.549 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.631 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' G' ' 15' ' ' PHE . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' G' ' 104' ' ' TYR . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' G' ' 94' ' ' VAL . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.534 ' CE2' HD13 ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.631 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.588 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HB3' HH12 ' L' ' 93' ' ' ARG . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 119' ' ' SER . . . . . 0.772 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 122' ' ' VAL . . . . . 0.446 HG23 HG22 ' L' ' 33' ' ' THR . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.554 HG22 ' O ' ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.714 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.598 ' HA3' ' HD3' ' A' ' 155' ' ' LYS . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 140' ' ' ASN . . . . . 0.43 ' CB ' ' HB3' ' A' ' 159' ' ' ASP . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.625 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' G' ' 94' ' ' VAL . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.59 HG23 HD22 ' G' ' 27' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.672 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p -115.68 144.09 44.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.95 38.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.64 10.88 75.59 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.385 0.993 . . . . 0.0 113.034 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.36 9.19 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.64 114.87 28.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.291 1.037 . . . . 0.0 108.613 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.68 65.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.471 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 162' ' ' GLN . . . . . 0.687 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 163' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.467 ' HA ' HG22 ' G' ' 173' ' ' THR . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.467 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' HE3' ' I' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.607 ' O ' HG22 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' H' ' 93' ' ' ARG . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 12' ' ' LYS . . . . . 0.684 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.684 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' H' ' 33' ' ' THR . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 33' ' ' THR . . . . . 0.485 HG23 ' HG2' ' H' ' 32' ' ' GLN . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' H' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' I' ' 117' ' ' GLU . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.799 ' HA ' HH11 ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.676 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -76.67 164.29 26.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 44' ' ' PHE . . . . . 0.604 ' HA ' HG12 ' H' ' 53' ' ' ILE . 10.1 t80 -109.04 81.77 1.49 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.209 171.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.2 96.47 6.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' H ' ' H' ' 51' ' ' GLY . 12.4 pt-20 -67.58 -15.78 63.83 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.27 35.53 18.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.594 1.558 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.604 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.09 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.532 1.533 . . . . 0.0 111.517 -164.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.88 0.57 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.475 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 50' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 6.9 m-20 -151.29 28.28 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 51' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 83.73 35.04 17.33 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.63 46.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.604 HG12 ' HA ' ' H' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.37 50.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.86 178.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' I' ' 135' ' ' ILE . 0.4 OUTLIER -107.92 18.85 20.78 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 57' ' ' GLY . . . . . 0.676 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 58' ' ' SER . . . . . 0.59 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 62' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' H' ' 34' ' ' ASP . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.432 ' OH ' HG21 ' H' ' 79' ' ' ILE . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' H' ' 126' ' ' VAL . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' H' ' 77' ' ' LYS . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.645 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.808 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 21.6 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.808 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.4 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' H' ' 15' ' ' PHE . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.678 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.402 ' N ' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 97' ' ' VAL . . . . . 0.454 ' O ' ' HD1' ' H' ' 104' ' ' TYR . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' H' ' 142' ' ' GLU . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' H' ' 94' ' ' VAL . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 109' ' ' GLY . . . . . 1.0 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.771 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.587 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.512 ' HB3' HH12 ' G' ' 93' ' ' ARG . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 119' ' ' SER . . . . . 0.797 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.6 HG22 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.771 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.606 ' HA3' ' HD3' ' B' ' 155' ' ' LYS . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 1.0 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.611 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.595 HG23 HD22 ' H' ' 27' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.67 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.59 144.0 44.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.09 -32.99 39.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.9 75.46 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.338 0.972 . . . . 0.0 113.039 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.33 9.2 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.86 28.87 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.288 1.035 . . . . 0.0 108.611 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -31.61 65.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.483 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 162' ' ' GLN . . . . . 0.664 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 163' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 164' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.807 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.464 ' HA ' HG22 ' H' ' 173' ' ' THR . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.464 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.807 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.625 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.48 ' O ' HG22 ' J' ' 126' ' ' VAL . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' I' ' 93' ' ' ARG . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 12' ' ' LYS . . . . . 0.657 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' C' ' 163' ' ' PRO . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.657 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' I' ' 33' ' ' THR . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' I' ' 32' ' ' GLN . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' I' ' 65' ' ' VAL . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' J' ' 117' ' ' GLU . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 40' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' J' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.793 ' HA ' HH11 ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.666 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -76.7 164.3 26.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 44' ' ' PHE . . . . . 0.579 ' HA ' HG12 ' I' ' 53' ' ' ILE . 10.2 t80 -109.04 81.81 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.193 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.28 96.41 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.613 ' HB2' ' H ' ' I' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.87 63.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.33 35.55 17.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.662 1.585 . . . . 0.0 111.638 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.599 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.0 1.96 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.474 1.509 . . . . 0.0 111.566 -164.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.12 -89.85 0.57 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.456 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 50' ' ' ASN . . . . . 0.656 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 6.9 m-20 -151.29 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 51' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 83.77 35.07 17.13 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.56 46.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' I' ' 44' ' ' PHE . 0.7 OUTLIER -136.12 133.36 50.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -107.95 18.92 20.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 57' ' ' GLY . . . . . 0.666 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 58' ' ' SER . . . . . 0.69 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 62' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' I' ' 34' ' ' ASP . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' I' ' 79' ' ' ILE . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.476 ' H ' HG23 ' I' ' 126' ' ' VAL . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' I' ' 77' ' ' LYS . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.66 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 21.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.625 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' I' ' 15' ' ' PHE . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.531 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 1.011 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' I' ' 104' ' ' TYR . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' I' ' 142' ' ' GLU . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' I' ' 94' ' ' VAL . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 109' ' ' GLY . . . . . 0.999 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.625 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' I' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.607 HG22 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.686 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.745 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.543 ' HA3' ' HD3' ' C' ' 155' ' ' LYS . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.999 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.605 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 145' ' ' THR . . . . . 1.011 HG21 HG21 ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' I' ' 27' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.673 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.06 44.45 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.23 -32.89 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.81 75.54 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 119.398 0.999 . . . . 0.0 113.066 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.31 9.21 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.56 114.87 28.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 108.619 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.63 65.16 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -158.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.487 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' I' I ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.826 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.473 ' HA ' HG22 ' I' ' 173' ' ' THR . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.826 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.616 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.507 ' O ' HG22 ' K' ' 126' ' ' VAL . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' J' ' 93' ' ' ARG . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 12' ' ' LYS . . . . . 0.665 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.665 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.402 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.498 ' HG2' HG23 ' J' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 33' ' ' THR . . . . . 0.498 HG23 ' HG2' ' J' ' 32' ' ' GLN . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' J' ' 65' ' ' VAL . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' K' ' 117' ' ' GLU . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' K' ' 83' ' ' TYR . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.653 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -76.65 164.3 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 44' ' ' PHE . . . . . 0.598 ' HA ' HG12 ' J' ' 53' ' ' ILE . 10.1 t80 -109.06 81.82 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.228 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.46 6.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' J' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.28 35.54 18.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.637 1.575 . . . . 0.0 111.697 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.458 1.503 . . . . 0.0 111.577 -164.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.16 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.484 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 50' ' ' ASN . . . . . 0.672 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 6.9 m-20 -151.27 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 51' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 83.77 35.08 17.1 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 123.6 46.28 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.598 HG12 ' HA ' ' J' ' 44' ' ' PHE . 0.7 OUTLIER -136.06 133.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.91 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' K' ' 135' ' ' ILE . 0.4 OUTLIER -107.96 18.93 20.67 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 57' ' ' GLY . . . . . 0.653 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 58' ' ' SER . . . . . 0.656 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 62' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' J' ' 34' ' ' ASP . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG21 ' J' ' 79' ' ' ILE . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.466 ' H ' HG23 ' J' ' 126' ' ' VAL . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.625 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 73' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' J' ' 77' ' ' LYS . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 74' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 21.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.637 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' J' ' 15' ' ' PHE . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.998 HG21 HG21 ' J' ' 145' ' ' THR . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HD1' ' J' ' 104' ' ' TYR . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' J' ' 94' ' ' VAL . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 109' ' ' GLY . . . . . 0.952 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.637 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.49 ' HD2' ' NH2' ' J' ' 116' ' ' ARG . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 119' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 122' ' ' VAL . . . . . 0.469 HG23 HG22 ' I' ' 33' ' ' THR . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.495 HG13 ' O ' ' I' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.789 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.737 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' J' ' 110' ' ' PHE . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' D' ' 155' ' ' LYS . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.952 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 140' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.603 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.998 HG21 HG21 ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.603 HG23 HD22 ' J' ' 27' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.679 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.03 44.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.16 -32.93 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.63 10.92 75.55 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.384 0.993 . . . . 0.0 113.064 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.32 9.1 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.55 114.84 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.302 1.041 . . . . 0.0 108.603 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -31.68 65.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.474 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' J' J ' 162' ' ' GLN . . . . . 0.669 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 164' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.474 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.485 ' HA ' HG22 ' J' ' 173' ' ' THR . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' J' J ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' J' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.445 ' O ' HG22 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.579 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.579 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' K' ' 93' ' ' ARG . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 12' ' ' LYS . . . . . 0.675 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.672 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.675 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' K' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 33' ' ' THR . . . . . 0.574 HG22 HG23 ' L' ' 122' ' ' VAL . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' K' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.595 HG22 ' HG2' ' L' ' 117' ' ' GLU . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 40' ' ' GLU . . . . . 0.498 ' HG3' ' CE1' ' L' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.794 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.651 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -76.71 164.25 26.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 44' ' ' PHE . . . . . 0.59 ' HA ' HG12 ' K' ' 53' ' ' ILE . 10.1 t80 -108.97 81.79 1.5 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.197 171.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.24 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 155.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.621 ' HB2' ' H ' ' K' ' 51' ' ' GLY . 12.4 pt-20 -67.46 -15.88 63.91 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.55 17.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.602 1.561 . . . . 0.0 111.625 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.589 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 38.7 53.05 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.449 1.5 . . . . 0.0 111.612 -164.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 49' ' ' LYS . . . . . 0.406 ' HD3' HG22 ' F' ' 153' ' ' VAL . 17.3 tptt -117.14 -89.77 0.57 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.508 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 50' ' ' ASN . . . . . 0.775 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 6.9 m-20 -151.34 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 51' ' ' GLY . . . . . 0.621 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 83.87 34.97 17.08 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.68 46.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' K' ' 44' ' ' PHE . 0.7 OUTLIER -136.14 133.39 50.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.887 178.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -107.97 18.9 20.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 57' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 58' ' ' SER . . . . . 0.672 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 62' ' ' SER . . . . . 0.744 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' K' ' 34' ' ' ASP . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' K' ' 79' ' ' ILE . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.468 ' H ' HG23 ' K' ' 126' ' ' VAL . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.616 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 73' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' K' ' 77' ' ' LYS . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.65 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.81 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 21.6 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.81 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' K' ' 15' ' ' PHE . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.663 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.959 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' K' ' 104' ' ' TYR . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' K' ' 142' ' ' GLU . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' K' ' 94' ' ' VAL . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.641 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.783 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HB3' HH12 ' J' ' 93' ' ' ARG . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 119' ' ' SER . . . . . 0.807 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 122' ' ' VAL . . . . . 0.495 HG23 HG22 ' J' ' 33' ' ' THR . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' J' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.807 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.707 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.744 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.564 ' HA3' ' HD3' ' E' ' 155' ' ' LYS . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.604 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.959 HG21 HG21 ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.583 HG23 HD22 ' K' ' 27' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.07 44.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.96 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.86 75.54 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 119.358 0.981 . . . . 0.0 113.051 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.53 114.78 28.7 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.341 1.056 . . . . 0.0 108.654 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 -31.77 65.38 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' K' K ' 162' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.818 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.49 ' HA ' HG22 ' K' ' 173' ' ' THR . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.49 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.818 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' K' K ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' K' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.554 ' O ' HG22 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.442 HG21 ' NH2' ' L' ' 93' ' ' ARG . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 12' ' ' LYS . . . . . 0.672 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.802 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 30' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.401 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' L' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' L' ' 32' ' ' GLN . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' L' ' 65' ' ' VAL . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' G' ' 117' ' ' GLU . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.803 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -76.69 164.3 26.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 44' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' L' ' 53' ' ' ILE . 10.1 t80 -108.99 81.73 1.49 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.235 171.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.43 6.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' L' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.81 63.87 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.23 35.6 18.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.643 1.577 . . . . 0.0 111.669 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.596 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.02 1.93 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.452 1.501 . . . . 0.0 111.606 -164.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.82 0.57 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.488 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 50' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.65 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 51' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 83.71 35.09 17.25 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.64 46.33 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' L' ' 44' ' ' PHE . 0.7 OUTLIER -136.17 133.43 50.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.827 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' G' ' 135' ' ' ILE . 0.4 OUTLIER -108.01 18.92 20.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 58' ' ' SER . . . . . 0.775 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' K' ' 50' ' ' ASN . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 62' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' L' ' 34' ' ' ASP . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' L' ' 79' ' ' ILE . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.594 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' L' ' 126' ' ' VAL . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' L' ' 77' ' ' LYS . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.658 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.827 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 21.6 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.827 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' L' ' 15' ' ' PHE . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.837 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.972 HG21 HG21 ' L' ' 145' ' ' THR . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' L' ' 104' ' ' TYR . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' L' ' 94' ' ' VAL . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' F' ' 158' ' ' TYR . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 115' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.774 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.486 ' HD2' ' NH2' ' L' ' 116' ' ' ARG . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 119' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.574 HG23 HG22 ' K' ' 33' ' ' THR . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' L' ' 69' ' ' GLY . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.795 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.74 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' L' ' 110' ' ' PHE . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.541 ' HA3' ' HD3' ' F' ' 155' ' ' LYS . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.922 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 1.0 OUTLIER -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 1.003 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.972 HG21 HG21 ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.587 HG23 HD22 ' L' ' 27' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.63 143.99 44.55 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.18 -32.94 38.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.69 10.89 75.4 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.399 0.999 . . . . 0.0 113.013 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.35 9.16 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.8 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.335 1.054 . . . . 0.0 108.629 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.72 65.28 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' L' L ' 162' ' ' GLN . . . . . 0.682 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.481 ' HA ' HG22 ' L' ' 173' ' ' THR . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.481 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.577 ' HG3' ' HB ' ' L' ' 48' ' ' THR . 2.0 mm100 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 HG11 ' B' ' 126' ' ' VAL . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 26.8 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.681 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG13 ' HG2' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' B' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.963 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -66.04 134.76 53.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.51 34.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.238 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.5 113.93 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.091 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.0 23.08 1.34 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.648 -172.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.02 61.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.52 0.29 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.433 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.01 9.87 36.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.27 83.28 1.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' H ' ' HG2' ' A' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.908 HG13 HG22 ' B' ' 135' ' ' ILE . 0.6 OUTLIER -116.77 6.82 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.906 178.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.887 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.18 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.963 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 29' ' ' PRO . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.621 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.584 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.815 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' A' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.665 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' HG13 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.525 HG13 ' O ' ' F' ' 32' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' F' ' 6' ' ' ILE . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 110' ' ' PHE . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.742 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.815 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.713 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.713 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 3.1 t30 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.73 163.8 12.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.39 54.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.2 64.61 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.37 0.986 . . . . 0.0 113.026 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.78 137.23 24.03 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.24 146.21 51.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.3 1.04 . . . . 0.0 108.576 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.57 -49.64 74.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.587 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.631 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 3.2 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.632 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . 2.3 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.788 ' HB ' HG22 ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.443 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.649 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.502 HG22 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 2.0 mm100 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.61 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 26.9 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.675 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.707 HG13 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' C' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.961 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -66.03 134.77 53.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.53 130.49 34.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.231 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.46 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.622 ' HG2' ' H ' ' B' ' 52' ' ' ARG . 0.3 OUTLIER -72.02 -39.47 69.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 75.98 23.1 1.35 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.599 1.56 . . . . 0.0 111.684 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.67 1.67 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.477 1.511 . . . . 0.0 111.59 -164.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.496 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.06 9.88 36.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.31 83.31 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.622 ' H ' ' HG2' ' B' ' 46' ' ' GLU . 5.8 mmp_? -108.65 18.43 20.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 1.018 HG13 HG22 ' C' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.82 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.892 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.975 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 176.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.961 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.644 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 1.012 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 1.012 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.612 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.731 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.586 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.635 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.61 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.788 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.446 ' CB ' ' HB3' ' B' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.66 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.73 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.674 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.51 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.547 HD12 ' H ' ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.421 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.902 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.688 ' HG2' HG13 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 11' ' ' VAL . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.902 HG22 ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.674 HG13 ' O ' ' B' ' 110' ' ' PHE . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 53' ' ' ILE . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.64 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.73 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.788 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.728 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.728 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 3.1 t30 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t -102.8 163.85 11.98 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.66 -4.42 54.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.19 64.58 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.372 0.987 . . . . 0.0 113.064 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.65 137.22 24.2 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.17 51.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.279 1.032 . . . . 0.0 108.617 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.54 -49.73 74.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.604 ' HB2' ' HH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.51 ' HB2' ' CH2' ' H' ' 92' ' ' TRP . 3.2 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.642 ' HB3' ' HD3' ' B' ' 175' ' ' PRO . 2.3 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.64 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.64 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 5' ' ' PRO . . . . . 0.757 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.578 ' HG3' ' HB ' ' H' ' 48' ' ' THR . 2.0 mm100 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.595 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 26.9 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.561 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -66.07 134.81 53.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.51 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.2 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.44 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' C' ' 52' ' ' ARG . 0.4 OUTLIER -71.97 -39.5 69.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.01 23.07 1.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.618 1.567 . . . . 0.0 111.667 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.01 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.523 1.529 . . . . 0.0 111.573 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.464 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.87 36.32 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.33 1.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.631 ' H ' ' HG2' ' C' ' 46' ' ' GLU . 5.8 mmp_? -108.7 18.47 20.78 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.858 HG13 HG22 ' D' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.81 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.872 178.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.94 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 29' ' ' PRO . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ARG . . . . . 0.649 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 1.029 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 1.029 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' C' ' 82' ' ' ALA . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.736 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.634 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.595 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.817 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' C' ' 142' ' ' GLU . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.89 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.732 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.557 ' H ' HD12 ' C' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.419 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.899 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.707 ' HG2' HG13 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.469 HG13 ' O ' ' B' ' 32' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.899 HG22 ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.736 HD21 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' C' ' 110' ' ' PHE . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 1.018 HG22 HG13 ' B' ' 53' ' ' ILE . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.732 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.817 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.735 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 3.1 t30 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.71 163.78 12.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -80.63 -4.37 53.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.06 2.16 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 113.021 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.66 137.22 24.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -133.25 146.2 51.21 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.309 1.043 . . . . 0.0 108.6 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.63 74.48 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.545 ' HB2' ' HH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.518 ' HB2' ' CH2' ' I' ' 92' ' ' TRP . 3.2 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.623 ' HB3' ' HD3' ' C' ' 175' ' ' PRO . 2.3 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.632 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 5' ' ' PRO . . . . . 0.66 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.527 ' HG3' ' HB ' ' I' ' 48' ' ' THR . 2.0 mm100 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.411 HG21 HG11 ' E' ' 126' ' ' VAL . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 26.8 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.67 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.529 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.698 HG13 ' HG2' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' E' ' 83' ' ' TYR . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.449 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.983 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.78 53.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.52 130.57 34.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.42 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' D' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.52 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 176.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.02 23.08 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.641 1.577 . . . . 0.0 111.678 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.11 61.65 1.69 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.564 -164.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.86 -128.54 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.473 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.05 9.95 36.24 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.25 1.27 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.631 ' H ' ' HG2' ' D' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.52 20.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.896 HG13 HG22 ' E' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.899 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.884 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.983 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' D' ' 29' ' ' PRO . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.757 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.474 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 1.025 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.624 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.581 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.647 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.601 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' D' ' 142' ' ' GLU . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.653 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.863 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.722 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.669 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.541 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.909 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.759 ' HG2' HG13 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.561 HG13 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.909 HG22 ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.669 HG13 ' O ' ' D' ' 110' ' ' PHE . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.94 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.418 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.863 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.825 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.732 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 3.1 t30 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.78 12.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.64 -4.37 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.14 64.69 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.411 1.005 . . . . 0.0 113.074 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 157' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -72.68 137.21 24.15 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.17 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.304 1.042 . . . . 0.0 108.618 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.57 74.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -158.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.563 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.451 ' O ' ' HZ2' ' J' ' 92' ' ' TRP . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.633 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 3.3 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.454 ' C ' ' HA2' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.64 ' HB3' ' HD3' ' D' ' 175' ' ' PRO . 2.3 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.784 ' HB ' HG22 ' J' ' 18' ' ' ILE . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.488 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 169' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' J' ' 88' ' ' GLN . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 170' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.798 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' GLN . . . . . 0.609 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 2.0 mm100 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 26.8 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.663 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.581 HG13 ' HG2' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' SER . . . . . 0.53 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.988 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -66.08 134.81 53.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.52 34.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.205 171.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' E' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.49 69.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 176.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 75.98 23.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.646 1.579 . . . . 0.0 111.699 -172.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.495 1.518 . . . . 0.0 111.584 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.472 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.0 9.84 36.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.3 1.28 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.628 ' H ' ' HG2' ' E' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.896 HG13 HG22 ' F' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.892 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER -105.32 22.14 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 176.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 55' ' ' GLY . . . . . 0.988 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 57' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.498 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' E' ' 29' ' ' PRO . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.66 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.487 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.745 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.642 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.808 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.447 ' CB ' ' HB3' ' E' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.737 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.549 HD12 ' H ' ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.925 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.698 ' HG2' HG13 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.529 HG13 ' O ' ' D' ' 32' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.411 HG11 HG21 ' D' ' 11' ' ' VAL . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.925 HG22 ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.745 HD21 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.896 HG22 HG13 ' D' ' 53' ' ' ILE . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.808 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 152' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 3.1 t30 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.79 163.78 12.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.43 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.02 2.21 64.61 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 119.407 1.003 . . . . 0.0 113.029 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.72 137.22 24.1 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.21 146.21 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.317 1.047 . . . . 0.0 108.64 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.58 -49.65 74.41 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.639 ' HB2' ' HH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.612 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 3.2 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.634 ' HB3' ' HD3' ' E' ' 175' ' ' PRO . 2.3 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.682 ' HB ' HG22 ' K' ' 18' ' ' ILE . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 168' ' ' GLY . . . . . 0.4 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.531 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 9' ' ' GLN . . . . . 0.443 ' HG3' ' HB ' ' K' ' 48' ' ' THR . 2.0 mm100 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.461 ' CG2' HG11 ' A' ' 126' ' ' VAL . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 26.8 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.54 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 29' ' ' PRO . . . . . 0.54 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.525 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.552 HG13 ' HG2' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 38' ' ' SER . . . . . 0.414 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.458 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.973 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.72 53.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.5 34.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.272 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' F' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.48 69.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.03 23.07 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 111.65 -172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.7 1.67 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.513 1.525 . . . . 0.0 111.522 -164.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.53 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.06 9.91 36.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 83.35 1.28 Allowed Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.616 ' H ' ' HG2' ' F' ' 46' ' ' GLU . 5.8 mmp_? -108.7 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.518 HG13 HG22 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.79 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.864 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.742 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -105.3 22.09 16.0 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 55' ' ' GLY . . . . . 0.973 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 57' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' F' ' 29' ' ' PRO . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 71' ' ' ARG . . . . . 0.798 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.492 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.976 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.976 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.732 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 95' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' F' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.723 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.555 HD12 ' H ' ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.9 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.581 ' HG2' HG13 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 122' ' ' VAL . . . . . 0.44 HG13 ' O ' ' E' ' 32' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 128' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' F' ' 69' ' ' GLY . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.9 HG22 ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.732 HD21 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' F' ' 110' ' ' PHE . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 1.037 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.709 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 3.1 t30 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.73 163.79 12.01 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.22 64.75 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 119.385 0.993 . . . . 0.0 113.061 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.773 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -72.72 137.21 24.09 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.19 146.18 51.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.332 1.053 . . . . 0.0 108.649 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.65 -49.63 74.41 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -158.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' L' ' 92' ' ' TRP . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.913 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.804 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 3.2 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.605 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.651 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 2.3 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 167' ' ' THR . . . . . 1.122 ' HB ' HG22 ' L' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.759 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 170' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' H' ' 121' ' ' GLY . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 26.8 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB ' ' A' ' 167' ' ' THR . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.451 HG13 ' CG ' ' H' ' 117' ' ' GLU . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 38' ' ' SER . . . . . 0.592 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.77 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.44 130.49 34.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.29 171.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 155.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.617 ' HG2' ' H ' ' G' ' 52' ' ' ARG . 0.4 OUTLIER -71.98 -39.5 69.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.03 23.01 1.34 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.611 1.564 . . . . 0.0 111.667 -172.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.614 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.8 OUTLIER 41.15 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.459 1.504 . . . . 0.0 111.551 -164.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.53 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.95 9.84 36.49 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.617 ' H ' ' HG2' ' G' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.655 HG13 HG22 ' H' ' 135' ' ' ILE . 0.6 OUTLIER -116.71 6.84 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.887 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.919 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.13 15.96 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 176.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 55' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 57' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' G' ' 29' ' ' PRO . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 71' ' ' ARG . . . . . 0.553 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.963 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.675 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.963 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.631 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 95' ' ' ASP . . . . . 0.633 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' G' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.561 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.505 ' CG ' HG13 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 122' ' ' VAL . . . . . 0.439 HG13 ' O ' ' L' ' 32' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' G' ' 110' ' ' PHE . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.974 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 137' ' ' GLU . . . . . 0.624 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' G' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 3.1 t30 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.8 12.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.37 54.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.17 64.6 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.36 0.982 . . . . 0.0 113.077 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.64 137.2 24.19 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.18 51.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.369 1.068 . . . . 0.0 108.625 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.7 74.18 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.651 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 2.3 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.613 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 170' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.424 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.568 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.574 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 26.9 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.68 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.437 HG13 ' HG2' ' I' ' 117' ' ' GLU . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.945 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.79 53.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.47 34.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.264 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' H' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.48 69.02 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 75.97 23.11 1.35 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.59 1.556 . . . . 0.0 111.659 -172.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HG3' ' C' ' 9' ' ' GLN . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 111.516 -164.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.88 -128.48 0.29 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.484 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.89 36.31 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.25 1.27 Allowed Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.628 ' H ' ' HG2' ' H' ' 46' ' ' GLU . 5.8 mmp_? -108.64 18.49 20.8 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.539 HG13 HG22 ' I' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.838 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.909 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.08 16.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 55' ' ' GLY . . . . . 0.945 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 71' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 81' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.983 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.702 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.983 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.623 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.716 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.604 ' HH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 95' ' ' ASP . . . . . 0.641 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.811 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.455 ' CB ' ' HB3' ' H' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.712 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.551 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.412 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.907 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.451 ' CG ' HG13 ' G' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 121' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' G' ' 8' ' ' GLY . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.907 HG22 ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.716 HD21 ' HE1' ' H' ' 91' ' ' PHE . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.919 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.716 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.811 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.703 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 3.1 t30 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.8 163.8 12.01 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.58 -4.42 54.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.0 2.21 64.65 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 119.386 0.993 . . . . 0.0 113.047 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.22 24.17 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.2 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.31 1.044 . . . . 0.0 108.617 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.63 -49.6 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.633 ' HB3' ' HD3' ' H' ' 175' ' ' PRO . 2.3 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.628 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.623 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.608 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' J' ' 126' ' ' VAL . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 26.7 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.523 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.607 HG13 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.953 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.77 53.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.54 130.46 34.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.253 171.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.53 113.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' I' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.18 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 75.99 23.05 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.615 1.566 . . . . 0.0 111.653 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.527 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 0.8 OUTLIER 41.06 61.71 1.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.538 1.535 . . . . 0.0 111.567 -164.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.458 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.03 9.84 36.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.23 1.27 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.63 ' H ' ' HG2' ' I' ' 46' ' ' GLU . 5.8 mmp_? -108.61 18.48 20.82 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.757 HG13 HG22 ' J' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.9 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 1.047 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER -105.31 22.15 15.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 55' ' ' GLY . . . . . 0.953 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' I' ' 29' ' ' PRO . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.495 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 81' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 1.008 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 1.008 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.466 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.58 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 95' ' ' ASP . . . . . 0.629 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.608 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' I' ' 142' ' ' GLU . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.512 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.556 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.437 ' HG2' HG13 ' H' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 122' ' ' VAL . . . . . 0.427 HG13 ' O ' ' H' ' 32' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.574 HG21 ' HB ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' I' ' 110' ' ' PHE . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.909 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.733 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 3.1 t30 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.76 163.76 12.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.61 -4.34 53.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.99 2.23 64.67 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.396 0.998 . . . . 0.0 113.016 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.73 137.21 24.08 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.14 51.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.364 1.066 . . . . 0.0 108.66 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.6 74.57 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.635 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 2.3 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.639 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 170' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.639 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.602 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.596 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.462 ' CG2' HG11 ' K' ' 126' ' ' VAL . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.575 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 26.8 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' D' ' 167' ' ' THR . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 38' ' ' SER . . . . . 0.493 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.969 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.77 53.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.49 34.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.241 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.49 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 155.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.629 ' HG2' ' H ' ' J' ' 52' ' ' ARG . 0.4 OUTLIER -72.05 -39.44 69.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 75.96 23.08 1.36 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.645 1.578 . . . . 0.0 111.678 -172.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.609 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 0.8 OUTLIER 41.1 61.69 1.67 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.543 1.537 . . . . 0.0 111.519 -164.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.473 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.04 9.96 36.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.629 ' H ' ' HG2' ' J' ' 46' ' ' GLU . 5.8 mmp_? -108.66 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.645 HG13 HG22 ' K' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.875 178.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.15 15.92 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 55' ' ' GLY . . . . . 0.969 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 63' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' J' ' 29' ' ' PRO . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 71' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 81' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 1.021 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 1.021 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.625 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.459 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.733 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 95' ' ' ASP . . . . . 0.625 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.596 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.806 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.456 ' CB ' ' HB3' ' J' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.729 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.544 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.892 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.607 ' CG ' HG13 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 122' ' ' VAL . . . . . 0.523 HG13 ' O ' ' I' ' 32' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' I' ' 6' ' ' ILE . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.892 HG22 ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.733 HD21 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' J' ' 110' ' ' PHE . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 1.047 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' D' ' 157' ' ' GLY . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.788 ' HB2' ' NE2' ' K' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.806 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.719 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 3.1 t30 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.77 12.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.62 -4.35 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.23 64.75 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 119.439 1.018 . . . . 0.0 113.071 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.23 24.18 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.16 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.375 1.07 . . . . 0.0 108.64 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.59 -49.65 74.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.625 ' HB3' ' HD3' ' J' ' 175' ' ' PRO . 2.3 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.635 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.635 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HE ' ' L' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.503 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 26.8 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' E' ' 167' ' ' THR . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.536 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' K' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.635 HG13 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 38' ' ' SER . . . . . 0.44 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.985 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -66.06 134.75 53.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.5 130.49 34.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.626 ' HG2' ' H ' ' K' ' 52' ' ' ARG . 0.4 OUTLIER -72.07 -39.43 69.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.01 23.09 1.34 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.624 1.569 . . . . 0.0 111.625 -172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.443 ' HB ' ' HG3' ' F' ' 9' ' ' GLN . 0.8 OUTLIER 41.02 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.541 1.536 . . . . 0.0 111.536 -164.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.93 -128.46 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.51 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.04 9.92 36.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.29 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.626 ' H ' ' HG2' ' K' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.64 HG13 HG22 ' L' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.873 178.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 1.057 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER -105.37 22.12 15.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 55' ' ' GLY . . . . . 0.985 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 57' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 63' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' K' ' 29' ' ' PRO . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 71' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.476 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.788 ' NE2' ' HB2' ' J' ' 139' ' ' LYS . 0.3 OUTLIER -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.617 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.456 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.718 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.639 ' HH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.836 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' K' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.658 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.726 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.551 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.593 ' CG ' HG13 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 122' ' ' VAL . . . . . 0.463 HG13 ' O ' ' J' ' 32' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' J' ' 6' ' ' ILE . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' K' ' 69' ' ' GLY . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.718 HD21 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.836 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.714 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.714 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 3.1 t30 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.84 11.98 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.44 54.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.18 64.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.378 0.99 . . . . 0.0 113.037 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.2 24.14 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.15 51.2 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.341 1.056 . . . . 0.0 108.605 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.55 -49.69 74.31 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.624 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 2.3 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 170' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.553 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.611 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' G' ' 126' ' ' VAL . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.687 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 26.7 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 1.122 HG22 ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 22' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 38' ' ' SER . . . . . 0.553 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.982 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.75 53.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.52 34.75 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.237 171.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.61 ' HG2' ' H ' ' L' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.44 69.03 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 76.03 23.06 1.33 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.621 1.568 . . . . 0.0 111.626 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.577 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.8 OUTLIER 41.13 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.446 1.498 . . . . 0.0 111.573 -164.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.49 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.464 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.02 9.87 36.33 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.61 ' H ' ' HG2' ' L' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.5 20.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.618 HG13 HG22 ' G' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.835 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.974 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER -105.35 22.14 15.94 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 55' ' ' GLY . . . . . 0.982 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 63' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 69' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' L' ' 128' ' ' ILE . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' L' ' 29' ' ' PRO . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.488 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.97 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.44 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.693 ' NE2' ' HB2' ' K' ' 139' ' ' LYS . 0.3 OUTLIER -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.913 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.611 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.837 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' L' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.648 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.738 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' F' ' 160' ' ' PHE . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.538 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.886 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.635 ' CG ' HG13 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.458 HG13 ' O ' ' K' ' 32' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' L' ' 69' ' ' GLY . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 1.057 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.773 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' L' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.837 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 3.1 t30 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.77 163.76 12.03 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.4 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.21 64.56 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.403 1.001 . . . . 0.0 113.053 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.18 24.12 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.22 146.21 51.27 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.319 1.048 . . . . 0.0 108.626 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.69 74.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -158.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.646 ' HB3' ' HD3' ' L' ' 175' ' ' PRO . 2.3 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.594 HG21 HG23 ' B' ' 126' ' ' VAL . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.713 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.47 HG11 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.669 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HG ' ' A' ' 14' ' ' LEU . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.574 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' B' ' 117' ' ' GLU . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.75 34.73 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.221 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.73 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 2.4 mp0 -66.29 -51.93 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.1 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.596 1.558 . . . . 0.0 111.64 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.21 48.98 3.18 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 111.555 -164.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.52 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.468 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.36 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.72 48.31 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -119.21 125.38 49.05 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.3 pp -130.52 -31.94 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.878 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp -66.12 -18.93 65.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HB3' ' OH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 34' ' ' ASP . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 113' ' ' ILE . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HD1' HG22 ' A' ' 113' ' ' ILE . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.687 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 82' ' ' ALA . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.47 ' HE ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.779 HG11 ' HG2' ' A' ' 142' ' ' GLU . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 10' ' ' ASP . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.854 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' A' ' 79' ' ' ILE . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' F' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' F' ' 8' ' ' GLY . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.663 HG23 HG21 ' F' ' 6' ' ' ILE . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.73 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.754 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.003 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.83 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 HD21 ' A' ' 14' ' ' LEU . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.7 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.71 73.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 155' ' ' LYS . . . 140.76 134.81 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 119.409 1.004 . . . . 0.0 113.048 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.03 78.38 0.38 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.7 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.294 1.038 . . . . 0.0 108.611 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 -77.38 -41.73 39.05 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.676 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 172' ' ' GLY . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 167' ' ' THR . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HA ' HD13 ' G' ' 18' ' ' ILE . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.554 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 167' ' ' THR . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.588 HG21 HG23 ' C' ' 126' ' ' VAL . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.522 ' CG ' HD11 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.574 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.419 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.674 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.495 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.574 HD12 ' HG ' ' B' ' 14' ' ' LEU . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.538 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.439 ' HD1' ' HB3' ' B' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.648 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.924 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.72 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.67 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.264 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.77 13.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 155.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.514 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.4 mp0 -66.3 -51.9 52.69 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.14 36.14 18.3 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.646 1.578 . . . . 0.0 111.673 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.19 48.98 3.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.459 1.504 . . . . 0.0 111.594 -164.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.63 1.73 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.471 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.34 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.46 171.76 48.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.504 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -119.24 125.4 49.05 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 1.026 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.3 pp -130.49 -32.04 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.912 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp -66.13 -18.81 65.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' B' ' 34' ' ' ASP . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 128' ' ' ILE . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.439 ' HB3' ' HD1' ' B' ' 31' ' ' TYR . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.61 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.791 HD12 HD11 ' B' ' 113' ' ' ILE . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.516 ' HD1' HG22 ' B' ' 113' ' ' ILE . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.43 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.878 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' B' ' 82' ' ' ALA . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.419 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.789 HG11 ' HG2' ' B' ' 142' ' ' GLU . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.417 HG13 ' OD1' ' B' ' 10' ' ' ASP . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.699 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' B' ' 138' ' ' LEU . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' B' ' 138' ' ' LEU . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.791 HD11 HD12 ' B' ' 79' ' ' ILE . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.846 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 37' ' ' VAL . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.754 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' L' ' 46' ' ' GLU . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.746 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 8' ' ' GLY . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.594 HG23 HG21 ' A' ' 6' ' ' ILE . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.754 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' B' ' 66' ' ' THR . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 64' ' ' GLU . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' B' ' 111' ' ' ALA . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.917 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.535 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' B' ' 141' ' ' GLY . 2.1 p30 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' B' ' 14' ' ' LEU . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.699 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.24 29.47 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' B' ' 156' ' ' GLY . 1.1 pptp? -54.56 -46.72 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' B' ' 155' ' ' LYS . . . 140.74 134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.361 0.982 . . . . 0.0 113.034 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.93 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.7 3.99 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.288 1.035 . . . . 0.0 108.607 177.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 -77.35 -41.77 39.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.75 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 172' ' ' GLY . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLY . . . . . 0.406 ' N ' HG22 ' B' ' 167' ' ' THR . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLU . . . . . 0.591 ' HA ' HD13 ' H' ' 18' ' ' ILE . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' B' ' 167' ' ' THR . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.546 HG21 HG23 ' D' ' 126' ' ' VAL . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.703 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.703 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' LYS . . . . . 0.525 ' CG ' HD11 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ASP . . . . . 0.491 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' C' ' 14' ' ' LEU . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' TYR . . . . . 0.45 ' HD1' ' HB3' ' C' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.568 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.708 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.812 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.8 2.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.24 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.1 163.72 13.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.505 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 2.4 mp0 -66.28 -51.97 52.14 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.3 36.07 17.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.606 1.563 . . . . 0.0 111.665 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.23 49.0 3.21 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.508 1.523 . . . . 0.0 111.556 -164.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.58 -163.59 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.453 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 171.74 48.32 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -119.25 125.39 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 1.04 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.3 pp -130.51 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.874 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.836 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp -66.13 -18.87 65.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.514 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.708 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' C' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.568 HG13 ' OD1' ' C' ' 34' ' ' ASP . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 128' ' ' ILE . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.45 ' HB3' ' HD1' ' C' ' 31' ' ' TYR . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.771 HD12 HD11 ' C' ' 113' ' ' ILE . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' C' ' 113' ' ' ILE . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.607 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.912 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' C' ' 82' ' ' ALA . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' C' ' 142' ' ' GLU . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' VAL . . . . . 0.416 HG13 ' OD1' ' C' ' 10' ' ' ASP . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' C' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.677 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.707 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.771 HD11 HD12 ' C' ' 79' ' ' ILE . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.648 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.75 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' G' ' 46' ' ' GLU . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' GLU . . . . . 0.681 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.588 HG23 HG21 ' B' ' 6' ' ' ILE . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 66' ' ' THR . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' C' ' 64' ' ' GLU . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 1.026 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.766 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' ASN . . . . . 0.409 ' HB2' ' H ' ' C' ' 141' ' ' GLY . 2.1 p30 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.693 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.536 HD12 HD21 ' C' ' 14' ' ' LEU . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.701 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.3 29.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' C' ' 156' ' ' GLY . 1.1 pptp? -54.63 -46.67 73.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 156' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' C' ' 155' ' ' LYS . . . 140.71 134.71 3.11 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.394 0.997 . . . . 0.0 113.058 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.39 0.38 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.296 1.038 . . . . 0.0 108.624 177.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 159' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' I' ' 140' ' ' ASN . 3.4 m-20 -77.32 -41.7 39.59 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -158.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.667 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.497 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.582 ' OG1' HG22 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.481 HG21 ' H ' ' C' ' 172' ' ' GLY . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 169' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' I' ' 18' ' ' ILE . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.558 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.481 ' H ' HG21 ' C' ' 167' ' ' THR . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.582 HG22 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.562 HG21 HG23 ' E' ' 126' ' ' VAL . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.723 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.723 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.461 HG11 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.423 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.659 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' D' ' 14' ' ' LEU . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' TYR . . . . . 0.444 ' HD1' ' HB3' ' D' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.575 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' SER . . . . . 0.645 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.717 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.853 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.05 120.8 34.8 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.75 88.85 2.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.264 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.15 163.8 13.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 155.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.33 -51.92 52.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.23 36.11 18.02 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.61 1.564 . . . . 0.0 111.66 -172.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.13 49.08 3.11 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.542 1.537 . . . . 0.0 111.556 -164.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.59 1.73 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.444 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.73 19.34 0.67 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 171.74 48.35 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -119.23 125.44 49.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.925 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.3 pp -130.51 -32.08 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.866 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp -66.07 -18.89 65.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' SER . . . . . 0.505 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.717 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.575 HG13 ' OD1' ' D' ' 34' ' ' ASP . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' D' ' 128' ' ' ILE . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.444 ' HB3' ' HD1' ' D' ' 31' ' ' TYR . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.794 HD12 HD11 ' D' ' 113' ' ' ILE . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' D' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.836 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' D' ' 82' ' ' ALA . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.423 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.495 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.461 ' HE ' HG11 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.785 HG11 ' HG2' ' D' ' 142' ' ' GLU . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' D' ' 10' ' ' ASP . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.902 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' D' ' 138' ' ' LEU . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.683 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.794 HD11 HD12 ' D' ' 79' ' ' ILE . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' D' ' 116' ' ' ARG . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' H' ' 46' ' ' GLU . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' GLU . . . . . 0.62 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.546 HG23 HG21 ' C' ' 6' ' ' ILE . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' D' ' 66' ' ' THR . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 1.04 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.771 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' D' ' 141' ' ' GLY . 2.1 p30 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.902 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.702 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.539 HD12 HD21 ' D' ' 14' ' ' LEU . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.32 128.22 29.36 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.66 73.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 156' ' ' GLY . . . . . 0.447 ' O ' ' HD2' ' D' ' 155' ' ' LYS . . . 140.73 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 119.38 0.991 . . . . 0.0 113.053 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.04 78.43 0.38 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -115.81 92.66 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 108.621 177.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 159' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 -77.35 -41.7 39.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.711 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.763 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.53 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' D' ' 172' ' ' GLY . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.404 ' N ' HG22 ' D' ' 167' ' ' THR . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 169' ' ' GLU . . . . . 0.513 ' HA ' HD13 ' J' ' 18' ' ' ILE . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.55 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' D' ' 167' ' ' THR . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.667 HG21 HG23 ' F' ' 126' ' ' VAL . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.728 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' F' ' 123' ' ' GLU . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.728 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.658 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.61 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' E' ' 14' ' ' LEU . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.523 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 30' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 31' ' ' TYR . . . . . 0.443 ' HD1' ' HB3' ' E' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.786 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.03 120.76 34.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.76 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.222 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.12 163.77 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.626 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.4 mp0 -66.38 -51.92 52.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.33 36.0 17.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.617 1.567 . . . . 0.0 111.672 -172.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.24 48.96 3.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.531 1.532 . . . . 0.0 111.547 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.49 -163.57 1.72 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.478 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.75 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.71 48.29 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -119.13 125.47 49.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 1.074 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.3 pp -130.54 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.878 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.725 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp -66.08 -18.87 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' E' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' E' ' 34' ' ' ASP . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' E' ' 128' ' ' ILE . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.443 ' HB3' ' HD1' ' E' ' 31' ' ' TYR . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.618 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 78' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.782 HD12 HD11 ' E' ' 113' ' ' ILE . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.515 ' HD1' HG22 ' E' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' E' ' 82' ' ' ALA . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.494 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.463 ' HE ' HG11 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.771 HG11 ' HG2' ' E' ' 142' ' ' GLU . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' E' ' 10' ' ' ASP . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.883 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' E' ' 138' ' ' LEU . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.494 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.43 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.782 HD11 HD12 ' E' ' 79' ' ' ILE . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.853 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 119' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 123' ' ' GLU . . . . . 0.704 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 124' ' ' GLY . . . . . 0.431 ' H ' ' N ' ' D' ' 8' ' ' GLY . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.562 HG23 HG21 ' D' ' 6' ' ' ILE . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.765 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' E' ' 66' ' ' THR . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' E' ' 64' ' ' GLU . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.43 HD13 ' HB1' ' E' ' 111' ' ' ALA . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.925 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.878 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.52 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.835 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.697 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 146' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.537 HD12 HD21 ' E' ' 14' ' ' LEU . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.3 128.25 29.44 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' E' ' 156' ' ' GLY . 1.1 pptp? -54.59 -46.73 73.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 156' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' E' ' 155' ' ' LYS . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.409 1.004 . . . . 0.0 113.04 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.99 78.32 0.38 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.69 3.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 108.641 177.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 159' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' K' ' 140' ' ' ASN . 3.5 m-20 -77.35 -41.7 39.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.513 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.552 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' E' ' 172' ' ' GLY . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 167' ' ' THR . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 169' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' K' ' 18' ' ' ILE . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.554 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' E' ' 167' ' ' THR . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 126' ' ' VAL . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.712 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.712 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.464 HG11 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 12' ' ' LYS . . . . . 0.516 ' CG ' HD11 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 17' ' ' SER . . . . . 0.537 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.621 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' F' ' 14' ' ' LEU . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 29' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' F' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 121' ' ' GLY . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 36' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 117' ' ' GLU . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.72 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.16 120.76 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.213 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.78 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.34 -51.92 52.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.09 17.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 111.669 -172.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 48.98 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.482 1.513 . . . . 0.0 111.597 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.51 -163.59 1.72 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.489 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.47 171.75 48.35 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' F' ' 52' ' ' ARG . 0.0 OUTLIER -119.24 125.46 49.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 1.003 HG12 HG23 ' A' ' 135' ' ' ILE . 1.3 pp -130.49 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.897 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.524 HD12 ' H ' ' F' ' 54' ' ' LEU . 1.6 mp -66.11 -18.85 65.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 58' ' ' SER . . . . . 0.626 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 60' ' ' ALA . . . . . 0.72 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' F' ' 130' ' ' ILE . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' F' ' 34' ' ' ASP . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' F' ' 128' ' ' ILE . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' F' ' 31' ' ' TYR . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.608 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 73' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.566 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.778 HD12 HD11 ' F' ' 113' ' ' ILE . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.525 ' HD1' HG22 ' F' ' 113' ' ' ILE . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.61 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.725 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' F' ' 82' ' ' ALA . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.477 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.464 ' HE ' HG11 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' F' ' 142' ' ' GLU . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 97' ' ' VAL . . . . . 0.408 HG13 ' OD1' ' F' ' 10' ' ' ASP . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.693 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' F' ' 138' ' ' LEU . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.68 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.703 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.778 HD11 HD12 ' F' ' 79' ' ' ILE . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 119' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 122' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' J' ' 46' ' ' GLU . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 123' ' ' GLU . . . . . 0.452 ' HA ' ' HA3' ' E' ' 8' ' ' GLY . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.667 HG23 HG21 ' E' ' 6' ' ' ILE . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 128' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' F' ' 66' ' ' THR . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' F' ' 64' ' ' GLU . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 1.074 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.863 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.536 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.834 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.69 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 146' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.53 HD12 HD21 ' F' ' 14' ' ' LEU . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.693 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.26 29.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HA3' ' L' ' 136' ' ' GLY . 1.1 pptp? -54.51 -46.74 73.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 156' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' F' ' 155' ' ' LYS . . . 140.75 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.333 0.97 . . . . 0.0 113.029 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.01 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -115.79 92.64 3.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.38 1.072 . . . . 0.0 108.622 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.782 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 -77.31 -41.75 39.46 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.792 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.904 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.864 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.507 ' OE1' ' HZ ' ' L' ' 108' ' ' PHE . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.677 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.41 ' N ' HG22 ' F' ' 167' ' ' THR . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' F' ' 167' ' ' THR . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.765 HG21 HG23 ' H' ' 126' ' ' VAL . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.706 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.706 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.474 HG11 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 12' ' ' LYS . . . . . 0.513 ' CG ' HD11 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 17' ' ' SER . . . . . 0.54 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.568 HD12 ' HG ' ' G' ' 14' ' ' LEU . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.532 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 31' ' ' TYR . . . . . 0.449 ' HD1' ' HB3' ' G' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' H' ' 121' ' ' GLY . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 36' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' H' ' 118' ' ' TYR . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' H' ' 117' ' ' GLU . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 42' ' ' GLU . . . . . 0.572 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.66 88.81 2.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.288 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.16 163.81 13.25 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' CG1' ' C' ' 122' ' ' VAL . 2.4 mp0 -66.4 -51.84 52.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 47' ' ' GLN . . . . . 0.61 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 1.0 OUTLIER 61.2 36.07 18.14 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 111.655 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.18 49.04 3.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.529 1.532 . . . . 0.0 111.562 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.484 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.77 19.4 0.67 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.67 48.25 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' G' ' 52' ' ' ARG . 0.0 OUTLIER -119.15 125.39 49.11 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 1.095 HG12 HG23 ' H' ' 135' ' ' ILE . 1.3 pp -130.47 -31.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.909 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.529 HD12 ' H ' ' G' ' 54' ' ' LEU . 1.6 mp -66.16 -18.79 65.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' G' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' G' ' 34' ' ' ASP . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' G' ' 128' ' ' ILE . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.449 ' HB3' ' HD1' ' G' ' 31' ' ' TYR . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.795 HD12 HD11 ' G' ' 113' ' ' ILE . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' G' ' 113' ' ' ILE . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' L' ' 139' ' ' LYS . 0.0 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.689 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' G' ' 82' ' ' ALA . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.559 ' HZ3' ' HA ' ' A' ' 160' ' ' PHE . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.474 ' HE ' HG11 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.77 HG11 ' HG2' ' G' ' 142' ' ' GLU . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' G' ' 10' ' ' ASP . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.69 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.886 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' G' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.689 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.795 HD11 HD12 ' G' ' 79' ' ' ILE . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' L' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 119' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 123' ' ' GLU . . . . . 0.591 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 124' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' L' ' 8' ' ' GLY . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.754 HG23 HG21 ' L' ' 6' ' ' ILE . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' G' ' 66' ' ' THR . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' G' ' 64' ' ' GLU . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' G' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.947 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 1.034 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.47 ' HG3' ' OE1' ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 140' ' ' ASN . . . . . 0.556 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 2.1 p30 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.886 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.677 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 144' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 146' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.517 HD12 HD21 ' G' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.69 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' G' ' 156' ' ' GLY . 1.1 pptp? -54.52 -46.77 73.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 156' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' G' ' 155' ' ' LYS . . . 140.77 134.77 3.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 119.381 0.991 . . . . 0.0 113.046 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.36 0.38 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -115.76 92.63 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.361 1.065 . . . . 0.0 108.616 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.69 39.44 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -158.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.0 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.595 ' OG1' HG22 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' G' ' 172' ' ' GLY . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' G' ' 167' ' ' THR . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.558 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' G' ' 167' ' ' THR . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.595 HG22 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.761 HG21 HG23 ' I' ' 126' ' ' VAL . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.72 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.72 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.473 HG11 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.588 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.426 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 19' ' ' ASP . . . . . 0.487 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.606 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' H' ' 14' ' ' LEU . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' H' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 33' ' ' THR . . . . . 0.418 HG22 ' HA2' ' I' ' 121' ' ' GLY . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 36' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' I' ' 117' ' ' GLU . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.704 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 42' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.74 88.89 2.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.195 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.78 13.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 155.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' D' ' 122' ' ' VAL . 2.4 mp0 -66.32 -51.91 52.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 47' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 0.9 OUTLIER 61.28 36.03 17.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.609 1.564 . . . . 0.0 111.697 -172.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.2 49.05 3.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.457 1.503 . . . . 0.0 111.572 -164.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.61 -163.63 1.74 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.482 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.37 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.44 171.68 48.28 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' H' ' 52' ' ' ARG . 0.0 OUTLIER -119.19 125.43 49.19 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 1.013 HG12 HG23 ' I' ' 135' ' ' ILE . 1.3 pp -130.51 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.527 HD12 ' H ' ' H' ' 54' ' ' LEU . 1.6 mp -66.14 -18.77 65.56 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 60' ' ' ALA . . . . . 0.704 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' H' ' 130' ' ' ILE . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' H' ' 34' ' ' ASP . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' H' ' 128' ' ' ILE . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' H' ' 31' ' ' TYR . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.775 HD12 HD11 ' H' ' 113' ' ' ILE . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' H' ' 113' ' ' ILE . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.47 ' OE1' ' HG3' ' G' ' 139' ' ' LYS . 0.0 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' H' ' 82' ' ' ALA . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.426 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.561 ' HZ3' ' HA ' ' B' ' 160' ' ' PHE . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.473 ' HE ' HG11 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.783 HG11 ' HG2' ' H' ' 142' ' ' GLU . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' H' ' 10' ' ' ASP . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 98' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.909 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.836 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' H' ' 138' ' ' LEU . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HG ' ' H' ' 138' ' ' LEU . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.686 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.775 HD11 HD12 ' H' ' 79' ' ' ILE . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.473 ' HB3' HG12 ' G' ' 37' ' ' VAL . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 119' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 124' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' G' ' 8' ' ' GLY . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.765 HG23 HG21 ' G' ' 6' ' ' ILE . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.738 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' H' ' 66' ' ' THR . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' H' ' 64' ' ' GLU . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' H' ' 111' ' ' ALA . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.923 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 1.095 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' OE1' ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 140' ' ' ASN . . . . . 0.532 ' HB3' ' OD2' ' B' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.909 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.75 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 144' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 146' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.523 HD12 HD21 ' H' ' 14' ' ' LEU . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.18 128.27 29.72 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 155' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' H' ' 156' ' ' GLY . 1.1 pptp? -54.51 -46.75 73.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 156' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' H' ' 155' ' ' LYS . . . 140.73 134.72 3.11 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 119.359 0.982 . . . . 0.0 113.089 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 158' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -115.82 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.359 1.064 . . . . 0.0 108.638 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.28 -41.79 39.53 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -158.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.504 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.0 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.592 ' OG1' HG22 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.5 HG21 ' H ' ' H' ' 172' ' ' GLY . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' H' ' 167' ' ' THR . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.549 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 172' ' ' GLY . . . . . 0.5 ' H ' HG21 ' H' ' 167' ' ' THR . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.633 HG21 HG23 ' J' ' 126' ' ' VAL . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 8' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.71 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.468 HG11 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 12' ' ' LYS . . . . . 0.521 ' CG ' HD11 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 17' ' ' SER . . . . . 0.538 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' I' ' 14' ' ' LEU . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 31' ' ' TYR . . . . . 0.441 ' HD1' ' HB3' ' I' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.496 HG22 ' HA2' ' J' ' 121' ' ' GLY . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.557 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' J' ' 117' ' ' GLU . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.707 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.74 34.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.9 2.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.255 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.19 163.74 13.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 155.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.29 -51.95 52.31 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 47' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 1.0 OUTLIER 61.25 36.06 17.98 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.576 1.55 . . . . 0.0 111.674 -172.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.26 48.99 3.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.522 1.529 . . . . 0.0 111.566 -164.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.485 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.74 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.77 48.36 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -119.19 125.4 49.1 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 1.041 HG12 HG23 ' J' ' 135' ' ' ILE . 1.3 pp -130.51 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.864 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.535 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.6 mp -66.11 -18.88 65.63 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 60' ' ' ALA . . . . . 0.707 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' I' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.557 HG13 ' OD1' ' I' ' 34' ' ' ASP . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 66' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' I' ' 128' ' ' ILE . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.441 ' HB3' ' HD1' ' I' ' 31' ' ' TYR . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.613 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.79 HD12 HD11 ' I' ' 113' ' ' ILE . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' I' ' 113' ' ' ILE . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.452 ' OE1' ' HG3' ' H' ' 139' ' ' LYS . 0.0 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.691 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' I' ' 82' ' ' ALA . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.429 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.496 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.468 ' HE ' HG11 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' I' ' 142' ' ' GLU . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' I' ' 10' ' ' ASP . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 98' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.696 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.91 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' I' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.691 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.79 HD11 HD12 ' I' ' 79' ' ' ILE . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' H' ' 37' ' ' VAL . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 119' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 121' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 123' ' ' GLU . . . . . 0.495 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 124' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' H' ' 8' ' ' GLY . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.761 HG23 HG21 ' H' ' 6' ' ' ILE . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 128' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' I' ' 66' ' ' THR . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' I' ' 64' ' ' GLU . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' I' ' 111' ' ' ALA . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.891 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 1.013 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.537 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.4 ' HG2' HE21 ' I' ' 107' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 140' ' ' ASN . . . . . 0.439 ' HB3' ' OD2' ' C' ' 159' ' ' ASP . 2.1 p30 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.825 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.703 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 144' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 146' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.521 HD12 HD21 ' I' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.29 128.24 29.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 155' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' I' ' 156' ' ' GLY . 1.1 pptp? -54.54 -46.72 73.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 156' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' I' ' 155' ' ' LYS . . . 140.73 134.76 3.11 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.392 0.996 . . . . 0.0 113.039 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.98 78.36 0.38 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.346 1.058 . . . . 0.0 108.597 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.72 39.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.0 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.59 ' OG1' HG22 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' I' ' 172' ' ' GLY . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' I' ' 167' ' ' THR . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' I' ' 167' ' ' THR . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.59 HG22 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.698 HG21 HG23 ' K' ' 126' ' ' VAL . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.694 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.584 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 17' ' ' SER . . . . . 0.541 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.668 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.604 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.584 HD12 ' HG ' ' J' ' 14' ' ' LEU . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.451 ' HD1' ' HB3' ' J' ' 67' ' ' TYR . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 33' ' ' THR . . . . . 0.472 HG22 ' HA2' ' K' ' 121' ' ' GLY . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 36' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' K' ' 117' ' ' GLU . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 42' ' ' GLU . . . . . 0.586 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.88 2.52 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.242 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.2 163.79 13.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.438 ' HB2' ' CG1' ' F' ' 122' ' ' VAL . 2.4 mp0 -66.32 -52.02 51.47 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 0.9 OUTLIER 61.32 36.05 17.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.651 -172.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.16 49.05 3.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.533 1.533 . . . . 0.0 111.558 -164.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.443 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.76 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.39 171.69 48.26 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -119.13 125.43 49.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 1.007 HG12 HG23 ' K' ' 135' ' ' ILE . 1.3 pp -130.54 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.887 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.531 HD12 ' H ' ' J' ' 54' ' ' LEU . 1.6 mp -66.09 -18.9 65.64 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' J' ' 34' ' ' ASP . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 66' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' J' ' 128' ' ' ILE . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.451 ' HB3' ' HD1' ' J' ' 31' ' ' TYR . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.597 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' J' ' 71' ' ' ARG . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.781 HD12 HD11 ' J' ' 113' ' ' ILE . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.51 ' HD1' HG22 ' J' ' 113' ' ' ILE . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.428 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.696 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' J' ' 82' ' ' ALA . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.556 ' HZ3' ' HA ' ' D' ' 160' ' ' PHE . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' J' ' 142' ' ' GLU . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' J' ' 10' ' ' ASP . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 98' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.892 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' J' ' 138' ' ' LEU . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.696 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.781 HD11 HD12 ' J' ' 79' ' ' ILE . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' I' ' 37' ' ' VAL . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 119' ' ' SER . . . . . 0.749 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 121' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' I' ' 6' ' ' ILE . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.633 HG23 HG21 ' I' ' 6' ' ' ILE . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.749 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 128' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' J' ' 66' ' ' THR . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' J' ' 111' ' ' ALA . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 1.019 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 1.041 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.468 ' HG3' ' OE1' ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 140' ' ' ASN . . . . . 0.61 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.892 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.826 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' D' ' 160' ' ' PHE . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 146' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.532 HD12 HD21 ' J' ' 14' ' ' LEU . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.29 29.6 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 155' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' J' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.7 73.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 156' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' J' ' 155' ' ' LYS . . . 140.74 134.73 3.11 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 119.34 0.973 . . . . 0.0 113.026 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.34 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.65 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.33 1.052 . . . . 0.0 108.646 177.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.76 39.15 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -158.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.498 ' HA ' ' HB3' ' J' ' 161' ' ' GLN . 0.0 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' J' ' 172' ' ' GLY . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 168' ' ' GLY . . . . . 0.4 ' N ' HG22 ' J' ' 167' ' ' THR . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' J' ' 167' ' ' THR . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.69 HG21 HG23 ' L' ' 126' ' ' VAL . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.705 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' K' ' 14' ' ' LEU . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' K' ' 67' ' ' TYR . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.572 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 36' ' ' SER . . . . . 0.537 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' L' ' 117' ' ' GLU . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.721 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.71 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.209 171.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.82 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 155.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.468 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.4 mp0 -66.4 -51.89 52.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 47' ' ' GLN . . . . . 0.726 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.0 OUTLIER 61.21 36.1 18.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.585 1.554 . . . . 0.0 111.662 -172.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.14 49.06 3.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.548 1.539 . . . . 0.0 111.534 -164.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.491 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.28 0.67 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.53 171.74 48.37 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.521 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -119.22 125.37 49.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 1.044 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.3 pp -130.49 -31.98 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.892 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.6 mp -66.15 -18.84 65.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 60' ' ' ALA . . . . . 0.721 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' K' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.572 HG13 ' OD1' ' K' ' 34' ' ' ASP . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' K' ' 128' ' ' ILE . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' K' ' 31' ' ' TYR . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.605 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 71' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' K' ' 71' ' ' ARG . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.789 HD12 HD11 ' K' ' 113' ' ' ILE . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' K' ' 113' ' ' ILE . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.468 ' OE1' ' HG3' ' J' ' 139' ' ' LYS . 0.0 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.596 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.685 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' K' ' 82' ' ' ALA . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.585 ' HZ3' ' HA ' ' E' ' 160' ' ' PHE . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.768 HG11 ' HG2' ' K' ' 142' ' ' GLU . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 97' ' ' VAL . . . . . 0.406 HG13 ' OD1' ' K' ' 10' ' ' ASP . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 98' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.87 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' K' ' 138' ' ' LEU . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.669 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.789 HD11 HD12 ' K' ' 79' ' ' ILE . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' J' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 119' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 121' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 123' ' ' GLU . . . . . 0.634 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 124' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' J' ' 8' ' ' GLY . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.698 HG23 HG21 ' J' ' 6' ' ' ILE . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' K' ' 66' ' ' THR . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' K' ' 64' ' ' GLU . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.446 HD13 ' HB1' ' K' ' 111' ' ' ALA . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.963 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 1.007 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.431 ' HG3' ' OE1' ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 140' ' ' ASN . . . . . 0.429 ' HB3' ' OD2' ' E' ' 159' ' ' ASP . 2.1 p30 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.87 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.676 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 144' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 146' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' K' ' 14' ' ' LEU . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.24 128.27 29.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 155' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' K' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.69 73.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 156' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' K' ' 155' ' ' LYS . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 119.406 1.003 . . . . 0.0 113.014 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.37 0.38 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.67 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.338 1.055 . . . . 0.0 108.616 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.37 -41.74 39.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -158.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' K' ' 161' ' ' GLN . 0.0 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.483 HG21 ' H ' ' K' ' 172' ' ' GLY . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 168' ' ' GLY . . . . . 0.401 ' N ' HG22 ' K' ' 167' ' ' THR . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 172' ' ' GLY . . . . . 0.483 ' H ' HG21 ' K' ' 167' ' ' THR . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.421 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.754 HG21 HG23 ' G' ' 126' ' ' VAL . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 12' ' ' LYS . . . . . 0.529 ' CG ' HD11 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 17' ' ' SER . . . . . 0.531 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.615 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.561 HD12 ' HG ' ' L' ' 14' ' ' LEU . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 30' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' L' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' G' ' 121' ' ' GLY . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 36' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 117' ' ' GLU . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.713 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.76 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.254 171.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.74 13.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' B' ' 122' ' ' VAL . 2.4 mp0 -66.29 -51.9 52.74 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 47' ' ' GLN . . . . . 0.633 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 61.27 36.03 17.95 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.591 1.556 . . . . 0.0 111.694 -172.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 49.03 3.17 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.519 1.528 . . . . 0.0 111.574 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.55 -163.58 1.72 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.465 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.72 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.41 171.71 48.29 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.515 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -119.23 125.44 49.16 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 1.034 HG12 HG23 ' G' ' 135' ' ' ILE . 1.3 pp -130.54 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.53 HD12 ' H ' ' L' ' 54' ' ' LEU . 1.6 mp -66.14 -18.8 65.57 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 60' ' ' ALA . . . . . 0.713 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' L' ' 34' ' ' ASP . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' L' ' 128' ' ' ILE . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' L' ' 31' ' ' TYR . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD3' ' L' ' 71' ' ' ARG . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 73' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' L' ' 113' ' ' ILE . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' NZ ' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' L' ' 113' ' ' ILE . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.431 ' OE1' ' HG3' ' K' ' 139' ' ' LYS . 0.0 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.703 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' L' ' 82' ' ' ALA . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.677 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.501 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.762 HG11 ' HG2' ' L' ' 142' ' ' GLU . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' L' ' 10' ' ' ASP . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 98' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' L' ' 138' ' ' LEU . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.507 ' HZ ' ' OE1' ' F' ' 165' ' ' GLN . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' L' ' 79' ' ' ILE . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.525 ' HB3' HG12 ' K' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 119' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 123' ' ' GLU . . . . . 0.742 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 124' ' ' GLY . . . . . 0.512 ' H ' ' N ' ' K' ' 8' ' ' GLY . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' K' ' 6' ' ' ILE . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.69 HG23 HG21 ' K' ' 6' ' ' ILE . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.742 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 128' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' L' ' 66' ' ' THR . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' L' ' 111' ' ' ALA . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 1.044 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.952 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.704 ' HA3' ' HE3' ' F' ' 155' ' ' LYS . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.782 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.904 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.88 ' O ' ' HG2' ' F' ' 162' ' ' GLN . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 146' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.421 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.527 HD12 HD21 ' L' ' 14' ' ' LEU . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.27 128.27 29.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 155' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' L' ' 156' ' ' GLY . 1.1 pptp? -54.56 -46.7 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 156' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' L' ' 155' ' ' LYS . . . 140.75 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 119.422 1.01 . . . . 0.0 113.068 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.95 78.31 0.38 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.72 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.308 1.043 . . . . 0.0 108.572 177.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.77 39.2 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.0 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.591 ' OG1' HG22 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.489 HG21 ' H ' ' L' ' 172' ' ' GLY . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' L' ' 167' ' ' THR . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 172' ' ' GLY . . . . . 0.489 ' H ' HG21 ' L' ' 167' ' ' THR . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.591 HG22 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 6' ' ' ILE . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 93' ' ' ARG . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 25' ' ' ALA . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 89' ' ' ILE . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' L' ' 48' ' ' THR . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.54 HG22 HG23 ' B' ' 122' ' ' VAL . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' OD1' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' B' ' 117' ' ' GLU . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.746 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' A' ' 42' ' ' GLU . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -73.44 165.95 24.11 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.477 ' HA ' HG12 ' A' ' 53' ' ' ILE . 5.4 t80 -108.87 85.04 2.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.203 171.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' H ' HG21 ' A' ' 53' ' ' ILE . 26.4 t70 -110.68 100.09 8.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 10.2 pt-20 -68.69 -21.29 64.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 176.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.33 26.6 5.28 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.649 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.96 21.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.56 1.544 . . . . 0.0 111.537 -164.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.3 tptt -116.6 -92.19 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.435 ' CG ' HG23 ' B' ' 59' ' ' VAL . 17.9 m-20 -152.3 33.93 0.52 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 80.2 36.16 25.03 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.27 32.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG21 ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.05 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.857 178.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD22 HD13 ' B' ' 135' ' ' ILE . 0.4 OUTLIER -109.07 25.12 12.17 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 43' ' ' LEU . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.847 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' OD1' ' A' ' 34' ' ' ASP . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.666 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 14.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HE2' ' OD1' ' A' ' 85' ' ' ASN . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.461 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 15' ' ' PHE . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' A' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.771 HG21 HG21 ' A' ' 145' ' ' THR . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 97' ' ' VAL . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.799 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 138' ' ' LEU . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.417 ' O ' HG13 ' A' ' 134' ' ' VAL . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' A' ' 83' ' ' TYR . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 132' ' ' LEU . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.529 ' HG3' HH11 ' A' ' 116' ' ' ARG . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' F' ' 33' ' ' THR . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' O ' ' F' ' 7' ' ' MET . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' A' ' 130' ' ' ILE . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.616 ' O ' HG13 ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.76 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.847 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 110' ' ' PHE . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 135' ' ' ILE . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' A' ' 94' ' ' VAL . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.578 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.771 HG21 HG21 ' A' ' 94' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 145' ' ' THR . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.524 HG22 ' HD3' ' L' ' 49' ' ' LYS . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.5 144.68 37.42 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HD3' ' CA ' ' G' ' 136' ' ' GLY . 6.8 mttt -74.63 -34.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.49 11.64 77.26 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.359 0.981 . . . . 0.0 113.057 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.72 4.79 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.19 24.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.282 1.033 . . . . 0.0 108.632 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -32.96 70.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.527 ' HA ' ' HH2' ' G' ' 92' ' ' TRP . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 36.7 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.583 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.769 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.631 HG11 HH21 ' B' ' 93' ' ' ARG . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.497 ' HB3' HD11 ' B' ' 89' ' ' ILE . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.656 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' B' ' 18' ' ' ILE . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.576 ' HB2' HG21 ' G' ' 48' ' ' THR . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.521 HG22 HG23 ' C' ' 122' ' ' VAL . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' B' ' 65' ' ' VAL . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' C' ' 117' ' ' GLU . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.812 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.401 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' B' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' B' ' 41' ' ' ARG . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.788 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -73.43 166.01 24.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.466 ' HA ' HG12 ' B' ' 53' ' ' ILE . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.188 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.545 ' H ' HG21 ' B' ' 53' ' ' ILE . 26.4 t70 -110.62 100.08 8.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.22 64.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.3 26.58 5.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.592 1.557 . . . . 0.0 111.667 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.646 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.93 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.516 1.526 . . . . 0.0 111.54 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HG2' ' HG2' ' B' ' 52' ' ' ARG . 6.3 tptt -116.57 -92.22 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.444 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.576 ' CG ' HG23 ' C' ' 59' ' ' VAL . 17.8 m-20 -152.31 33.97 0.52 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.56 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 80.12 36.13 25.35 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.55 ' HG2' ' HG2' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -102.62 116.29 32.29 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.545 HG21 ' H ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -132.88 136.01 56.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.883 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.717 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -109.08 25.14 12.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.497 ' O ' HD22 ' B' ' 43' ' ' LEU . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLY . . . . . 0.788 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.435 HG23 ' CG ' ' A' ' 50' ' ' ASN . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.732 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' B' ' 34' ' ' ASP . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.565 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' B' ' 70' ' ' LYS . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.615 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 13.9 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.471 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.471 ' HE2' ' OD1' ' B' ' 85' ' ' ASN . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' B' ' 15' ' ' PHE . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.656 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.631 HH21 HG11 ' B' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.769 HG21 HG21 ' B' ' 145' ' ' THR . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 11' ' ' VAL . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.495 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' B' ' 97' ' ' VAL . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 138' ' ' LEU . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.648 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' B' ' 83' ' ' TYR . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.534 ' HG3' ' HA ' ' B' ' 132' ' ' LEU . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.545 ' HG3' HH11 ' B' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.602 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.651 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 33' ' ' THR . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.626 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' B' ' 130' ' ' ILE . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.732 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.534 ' HA ' ' HG3' ' B' ' 114' ' ' GLU . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.861 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' B' ' 110' ' ' PHE . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.584 HD13 HD22 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' B' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' THR . . . . . 0.769 HG21 HG21 ' B' ' 94' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.672 HD12 ' O ' ' B' ' 145' ' ' THR . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.52 HG22 ' HD3' ' G' ' 49' ' ' LYS . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.75 37.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.491 ' HD3' ' CA ' ' H' ' 136' ' ' GLY . 6.8 mttt -74.7 -34.01 62.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.52 11.66 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.397 0.999 . . . . 0.0 112.991 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.78 4.8 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.318 1.047 . . . . 0.0 108.631 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -33.01 70.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -158.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.555 ' HA ' ' HH2' ' H' ' 92' ' ' TRP . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.591 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.636 HG11 HH21 ' C' ' 93' ' ' ARG . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' C' ' 12' ' ' LYS . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' C' ' 89' ' ' ILE . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.65 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ASP . . . . . 0.469 ' N ' HG13 ' C' ' 18' ' ' ILE . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.562 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' TYR . . . . . 0.519 ' HB2' HG21 ' H' ' 48' ' ' THR . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.595 ' CG2' HG23 ' D' ' 122' ' ' VAL . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.511 ' OD1' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.537 HG22 ' HG2' ' D' ' 117' ' ' GLU . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' C' ' 42' ' ' GLU . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -73.46 166.01 24.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.476 ' HA ' HG12 ' C' ' 53' ' ' ILE . 5.4 t80 -108.85 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.239 171.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.548 ' H ' HG21 ' C' ' 53' ' ' ILE . 26.4 t70 -110.63 100.1 8.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.632 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.22 64.39 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.28 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.602 1.561 . . . . 0.0 111.664 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.632 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.97 21.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.514 1.526 . . . . 0.0 111.561 -164.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.532 ' HG2' ' HG2' ' C' ' 52' ' ' ARG . 6.4 tptt -116.62 -92.16 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.458 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ASN . . . . . 0.662 ' CG ' HG23 ' D' ' 59' ' ' VAL . 17.9 m-20 -152.32 33.94 0.52 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 80.15 36.1 25.35 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' C' ' 49' ' ' LYS . 0.1 OUTLIER -102.66 116.3 32.3 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.548 HG21 ' H ' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.03 56.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.915 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.695 HD22 HD13 ' D' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.18 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' C' ' 43' ' ' LEU . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.576 HG23 ' CG ' ' B' ' 50' ' ' ASN . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' SER . . . . . 0.884 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.511 HG22 ' OD1' ' C' ' 34' ' ' ASP . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' C' ' 70' ' ' LYS . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.58 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.616 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 13.9 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.475 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' C' ' 85' ' ' ASN . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.653 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' C' ' 15' ' ' PHE . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.636 HH21 HG11 ' C' ' 11' ' ' VAL . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.759 HG21 HG21 ' C' ' 145' ' ' THR . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' C' ' 11' ' ' VAL . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' C' ' 97' ' ' VAL . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.784 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' C' ' 138' ' ' LEU . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.653 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' C' ' 83' ' ' TYR . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' C' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' C' ' 116' ' ' ARG . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.576 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' VAL . . . . . 0.521 HG23 HG22 ' B' ' 33' ' ' THR . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' GLY . . . . . 0.714 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.459 HG22 HG23 ' C' ' 130' ' ' ILE . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.598 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.739 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.532 ' HA ' ' HG3' ' C' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.884 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.415 HG13 ' O ' ' C' ' 110' ' ' PHE . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.717 HD13 HD22 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.443 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' C' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.572 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' THR . . . . . 0.759 HG21 HG21 ' C' ' 94' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' C' ' 145' ' ' THR . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.51 144.67 37.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.432 ' HD3' ' CA ' ' I' ' 136' ' ' GLY . 6.8 mttt -74.62 -34.0 62.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.61 77.37 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 119.335 0.97 . . . . 0.0 113.059 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 117.79 4.82 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -94.03 112.25 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.274 1.03 . . . . 0.0 108.569 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -32.9 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -158.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.505 ' HA ' ' HH2' ' I' ' 92' ' ' TRP . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.793 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.793 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.626 HG11 HH21 ' D' ' 93' ' ' ARG . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' D' ' 12' ' ' LYS . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.628 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' D' ' 18' ' ' ILE . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' THR . . . . . 0.535 ' CG2' HG23 ' E' ' 122' ' ' VAL . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.601 HG22 ' HG2' ' E' ' 117' ' ' GLU . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' SER . . . . . 0.772 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' D' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' D' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.774 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -73.46 165.98 24.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 44' ' ' PHE . . . . . 0.477 ' HA ' HG12 ' D' ' 53' ' ' ILE . 5.4 t80 -108.86 85.02 2.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.248 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.561 ' H ' HG21 ' D' ' 53' ' ' ILE . 26.4 t70 -110.63 100.09 8.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 155.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.641 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.25 64.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.34 26.63 5.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.62 1.568 . . . . 0.0 111.64 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.641 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.9 21.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 111.587 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' D' ' 52' ' ' ARG . 6.3 tptt -116.56 -92.21 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' ASN . . . . . 0.427 ' CG ' HG23 ' E' ' 59' ' ' VAL . 17.9 m-20 -152.24 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 80.2 36.1 25.18 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' D' ' 49' ' ' LYS . 0.1 OUTLIER -102.64 116.31 32.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.561 HG21 ' H ' ' D' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.0 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.84 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.56 HD22 HD13 ' E' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.13 12.17 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' D' ' 43' ' ' LEU . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLY . . . . . 0.774 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.662 HG23 ' CG ' ' C' ' 50' ' ' ASN . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' D' ' 34' ' ' ASP . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.591 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.448 HH11 ' HB ' ' C' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.478 ' OD2' ' HD3' ' D' ' 70' ' ' LYS . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.608 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 14.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' D' ' 85' ' ' ASN . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' D' ' 15' ' ' PHE . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.626 HH21 HG11 ' D' ' 11' ' ' VAL . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.765 HG21 HG21 ' D' ' 145' ' ' THR . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' D' ' 11' ' ' VAL . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' D' ' 97' ' ' VAL . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' D' ' 138' ' ' LEU . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 109' ' ' GLY . . . . . 0.791 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.652 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' D' ' 83' ' ' TYR . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' D' ' 132' ' ' LEU . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' D' ' 116' ' ' ARG . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.537 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' C' ' 33' ' ' THR . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' I' ' 43' ' ' LEU . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' C' ' 7' ' ' MET . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' D' ' 130' ' ' ILE . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.606 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' D' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 110' ' ' PHE . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.695 HD13 HD22 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.44 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.791 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.417 ' HG2' HG11 ' D' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.765 HG21 HG21 ' D' ' 94' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.685 HD12 ' O ' ' D' ' 145' ' ' THR . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' I' ' 49' ' ' LYS . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.79 37.32 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.44 ' HD3' ' CA ' ' J' ' 136' ' ' GLY . 6.8 mttt -74.69 -34.08 62.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.57 11.62 77.1 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.36 0.982 . . . . 0.0 113.038 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.91 112.15 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.331 1.052 . . . . 0.0 108.615 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.94 70.71 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' CH2' ' J' ' 92' ' ' TRP . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.595 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 36.7 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 169' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' I' ' 54' ' ' LEU . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.534 ' HB3' ' HG3' ' F' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' F' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' E' ' 93' ' ' ARG . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 12' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' E' ' 12' ' ' LYS . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' E' ' 25' ' ' ALA . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' E' ' 89' ' ' ILE . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.635 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.466 ' H ' HG13 ' E' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 26' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.576 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 31' ' ' TYR . . . . . 0.425 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.519 ' OD1' HG22 ' E' ' 65' ' ' VAL . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' F' ' 117' ' ' GLU . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 38' ' ' SER . . . . . 0.736 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' E' ' 42' ' ' GLU . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.801 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -73.44 165.98 24.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 44' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' E' ' 53' ' ' ILE . 5.3 t80 -108.83 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.264 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 45' ' ' ASP . . . . . 0.559 ' H ' HG21 ' E' ' 53' ' ' ILE . 26.4 t70 -110.61 100.05 8.91 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 155.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.634 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.19 64.37 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.6 1.56 . . . . 0.0 111.685 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.634 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.89 21.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.527 1.531 . . . . 0.0 111.565 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 49' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' E' ' 52' ' ' ARG . 6.4 tptt -116.55 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.455 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 50' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' F' ' 59' ' ' VAL . 17.9 m-20 -152.29 33.93 0.52 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 51' ' ' GLY . . . . . 0.556 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 80.15 36.16 25.19 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' E' ' 49' ' ' LYS . 0.1 OUTLIER -102.7 116.32 32.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.559 HG21 ' H ' ' E' ' 45' ' ' ASP . 0.3 OUTLIER -132.84 136.01 56.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.898 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.652 HD22 HD13 ' F' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.19 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' E' ' 43' ' ' LEU . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' GLY . . . . . 0.801 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.427 HG23 ' CG ' ' D' ' 50' ' ' ASN . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 62' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.519 HG22 ' OD1' ' E' ' 34' ' ' ASP . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.612 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.487 HH11 ' HB ' ' D' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' E' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 74' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.6 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 14.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.772 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' E' ' 85' ' ' ASN . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.649 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' E' ' 15' ' ' PHE . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' E' ' 11' ' ' VAL . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.784 HG21 HG21 ' E' ' 145' ' ' THR . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' E' ' 11' ' ' VAL . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 97' ' ' VAL . . . . . 0.499 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.499 ' HD1' ' O ' ' E' ' 97' ' ' VAL . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' E' ' 138' ' ' LEU . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 109' ' ' GLY . . . . . 0.779 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.649 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.416 HG21 ' HD1' ' E' ' 83' ' ' TYR . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' E' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.528 HH11 ' HG3' ' E' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.601 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 119' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' D' ' 33' ' ' THR . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 124' ' ' GLY . . . . . 0.559 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' E' ' 130' ' ' ILE . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.614 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.755 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' E' ' 114' ' ' GLU . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.882 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' E' ' 110' ' ' PHE . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.56 HD13 HD22 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.779 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.415 ' HG2' HG11 ' E' ' 94' ' ' VAL . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.573 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.784 HG21 HG21 ' E' ' 94' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' E' ' 145' ' ' THR . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 153' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' J' ' 49' ' ' LYS . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.72 37.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.501 ' HD3' ' CA ' ' K' ' 136' ' ' GLY . 6.9 mttt -74.68 -34.02 62.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.64 77.31 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.389 0.995 . . . . 0.0 113.065 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.84 117.65 4.78 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.21 24.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.307 1.043 . . . . 0.0 108.622 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.93 70.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.595 ' HA ' ' HH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.578 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 36.7 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.767 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.767 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.537 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 126' ' ' VAL . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' F' ' 93' ' ' ARG . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 12' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' F' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' F' ' 25' ' ' ALA . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' F' ' 89' ' ' ILE . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.633 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 19' ' ' ASP . . . . . 0.465 ' H ' HG13 ' F' ' 18' ' ' ILE . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.581 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' K' ' 48' ' ' THR . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 33' ' ' THR . . . . . 0.472 ' CG2' HG23 ' A' ' 122' ' ' VAL . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 117' ' ' GLU . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 38' ' ' SER . . . . . 0.719 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' F' ' 42' ' ' GLU . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' F' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -73.52 165.98 24.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 44' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' F' ' 53' ' ' ILE . 5.4 t80 -108.88 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.202 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 45' ' ' ASP . . . . . 0.559 ' H ' HG21 ' F' ' 53' ' ' ILE . 26.4 t70 -110.65 100.14 8.98 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.636 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 10.1 pt-20 -68.8 -21.16 64.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.59 5.35 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.623 1.569 . . . . 0.0 111.702 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.636 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.87 21.73 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.492 1.517 . . . . 0.0 111.569 -164.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 49' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' F' ' 52' ' ' ARG . 6.4 tptt -116.51 -92.23 0.52 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.486 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -152.3 33.91 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 51' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 80.16 36.11 25.29 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.556 ' HG2' ' HG2' ' F' ' 49' ' ' LYS . 0.1 OUTLIER -102.61 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.559 HG21 ' H ' ' F' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.0 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.849 178.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.05 25.13 12.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' F' ' 43' ' ' LEU . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' E' ' 50' ' ' ASN . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.506 HG22 ' OD1' ' F' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' E' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 71' ' ' ARG . . . . . 0.498 HH11 ' HB ' ' E' ' 97' ' ' VAL . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 73' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' F' ' 70' ' ' LYS . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 74' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.576 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.601 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 13.9 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.474 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.474 ' HE2' ' OD1' ' F' ' 85' ' ' ASN . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.64 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' F' ' 15' ' ' PHE . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' F' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.776 HG21 HG21 ' F' ' 145' ' ' THR . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' F' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 97' ' ' VAL . . . . . 0.666 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.477 ' HD1' ' O ' ' F' ' 97' ' ' VAL . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.809 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.495 ' CE2' HD13 ' F' ' 138' ' ' LEU . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 109' ' ' GLY . . . . . 0.801 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.64 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.417 HG21 ' HD1' ' F' ' 83' ' ' TYR . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' F' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' F' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 124' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' K' ' 43' ' ' LEU . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 125' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' E' ' 7' ' ' MET . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' F' ' 130' ' ' ILE . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.763 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' HG3' ' F' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' F' ' 110' ' ' PHE . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.652 HD13 HD22 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.446 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.801 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' F' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.776 HG21 HG21 ' F' ' 94' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.683 HD12 ' O ' ' F' ' 145' ' ' THR . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 153' ' ' VAL . . . . . 0.587 HG22 ' HD3' ' K' ' 49' ' ' LYS . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 154' ' ' SER . . . . . 0.411 ' C ' ' NZ ' ' K' ' 49' ' ' LYS . 5.4 p -109.54 144.72 37.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.467 ' HD3' ' HA2' ' L' ' 136' ' ' GLY . 6.8 mttt -74.64 -34.09 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.48 11.7 77.15 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 119.389 0.995 . . . . 0.0 113.001 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.658 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -77.86 117.77 4.81 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.59 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER -70.43 -32.95 70.75 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -158.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.764 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.578 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 36.7 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' L' ' 23' ' ' GLY . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.685 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.577 HG23 ' HB2' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.781 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.653 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.781 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.537 ' O ' HG22 ' H' ' 126' ' ' VAL . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.634 HG11 HH21 ' G' ' 93' ' ' ARG . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 12' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' G' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.5 ' HB3' HD11 ' G' ' 89' ' ' ILE . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 19' ' ' ASP . . . . . 0.475 ' H ' HG13 ' G' ' 18' ' ' ILE . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.638 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 31' ' ' TYR . . . . . 0.42 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.597 HG22 ' HG2' ' H' ' 117' ' ' GLU . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 38' ' ' SER . . . . . 0.648 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' G' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' G' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.799 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -73.45 165.94 24.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG12 ' G' ' 53' ' ' ILE . 5.4 t80 -108.83 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.265 171.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 45' ' ' ASP . . . . . 0.555 ' H ' HG21 ' G' ' 53' ' ' ILE . 26.4 t70 -110.62 100.06 8.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 10.2 pt-20 -68.68 -21.27 64.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.58 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.596 1.558 . . . . 0.0 111.667 -172.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.639 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 50.38 48.91 21.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 111.611 -164.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 49' ' ' LYS . . . . . 0.562 ' HG2' ' HG2' ' G' ' 52' ' ' ARG . 6.4 tptt -116.55 -92.25 0.52 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.444 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.3 33.96 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 51' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 80.18 36.17 25.08 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' G' ' 49' ' ' LYS . 0.1 OUTLIER -102.71 116.3 32.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.555 HG21 ' H ' ' G' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.01 56.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.888 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.07 25.15 12.14 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 56' ' ' PRO . . . . . 0.494 ' O ' HD22 ' G' ' 43' ' ' LEU . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 57' ' ' GLY . . . . . 0.799 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 62' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' G' ' 34' ' ' ASP . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 71' ' ' ARG . . . . . 0.705 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 73' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' G' ' 70' ' ' LYS . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.578 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.608 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 14.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.432 ' HG2' ' NZ ' ' L' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' G' ' 85' ' ' ASN . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.466 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' G' ' 15' ' ' PHE . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.527 ' HH2' ' HA ' ' A' ' 160' ' ' PHE . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.634 HH21 HG11 ' G' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.774 HG21 HG21 ' G' ' 145' ' ' THR . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' G' ' 11' ' ' VAL . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 97' ' ' VAL . . . . . 0.649 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.489 ' HD1' ' O ' ' G' ' 97' ' ' VAL . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.802 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' G' ' 138' ' ' LEU . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.412 ' O ' HG13 ' G' ' 134' ' ' VAL . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' G' ' 83' ' ' TYR . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' G' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.54 ' HG3' HH11 ' G' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 119' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.548 HG13 ' O ' ' L' ' 7' ' ' MET . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 128' ' ' ILE . . . . . 0.473 HG22 HG23 ' G' ' 130' ' ' ILE . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.624 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' G' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.854 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' G' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.456 HD13 HD22 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 155' ' ' LYS . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' G' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.576 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.774 HG21 HG21 ' G' ' 94' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' G' ' 145' ' ' THR . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.8 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.71 -34.09 62.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.54 11.68 77.03 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.386 0.994 . . . . 0.0 112.996 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.76 4.8 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.2 24.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.331 1.053 . . . . 0.0 108.638 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.94 70.66 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.57 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 162' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 163' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.784 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.784 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.542 ' O ' HG22 ' I' ' 126' ' ' VAL . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.573 ' O ' HG13 ' I' ' 126' ' ' VAL . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.643 HG11 HH21 ' H' ' 93' ' ' ARG . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' H' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' H' ' 89' ' ' ILE . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 19' ' ' ASP . . . . . 0.471 ' H ' HG13 ' H' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.572 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.515 ' OD1' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' I' ' 117' ' ' GLU . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' H' ' 42' ' ' GLU . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' H' ' 41' ' ' ARG . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -73.45 166.0 24.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 44' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' H' ' 53' ' ' ILE . 5.3 t80 -108.83 84.97 2.01 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.264 171.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 45' ' ' ASP . . . . . 0.549 ' H ' HG21 ' H' ' 53' ' ' ILE . 26.4 t70 -110.63 100.15 8.99 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 155.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.648 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.21 64.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.21 26.6 5.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.64 1.576 . . . . 0.0 111.715 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.648 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.92 21.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.495 1.518 . . . . 0.0 111.561 -164.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' H' ' 52' ' ' ARG . 6.3 tptt -116.56 -92.23 0.52 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.467 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.27 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 51' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 80.16 36.1 25.33 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.546 ' HG2' ' HG2' ' H' ' 49' ' ' LYS . 0.1 OUTLIER -102.63 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.549 HG21 ' H ' ' H' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.02 56.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.86 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.12 25.22 12.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' H' ' 43' ' ' LEU . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 62' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' H' ' 34' ' ' ASP . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' OD2' ' H' ' 73' ' ' ASP . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 71' ' ' ARG . . . . . 0.649 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' H' ' 70' ' ' LYS . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.577 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.612 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 14.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.648 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' H' ' 85' ' ' ASN . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.451 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' H' ' 15' ' ' PHE . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.555 ' HH2' ' HA ' ' B' ' 160' ' ' PHE . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.643 HH21 HG11 ' H' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.762 HG21 HG21 ' H' ' 145' ' ' THR . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' H' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 97' ' ' VAL . . . . . 0.731 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' H' ' 97' ' ' VAL . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.788 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' H' ' 138' ' ' LEU . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.412 ' O ' HG13 ' H' ' 134' ' ' VAL . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' H' ' 83' ' ' TYR . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' H' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' H' ' 116' ' ' ARG . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.575 HG13 ' O ' ' G' ' 7' ' ' MET . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' H' ' 130' ' ' ILE . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.613 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.756 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' H' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.85 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' H' ' 110' ' ' PHE . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.442 HG13 ' H ' ' H' ' 136' ' ' GLY . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.491 ' CA ' ' HD3' ' B' ' 155' ' ' LYS . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' H' ' 94' ' ' VAL . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.762 HG21 HG21 ' H' ' 94' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' H' ' 145' ' ' THR . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.58 144.72 37.5 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.7 -33.99 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.68 77.29 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.402 1.001 . . . . 0.0 113.041 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.16 23.97 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.34 1.056 . . . . 0.0 108.646 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.96 70.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.588 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 162' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 163' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.588 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.788 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.788 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 8' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.633 HG11 HH21 ' I' ' 93' ' ' ARG . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 12' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' I' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' I' ' 89' ' ' ILE . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.643 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 19' ' ' ASP . . . . . 0.474 ' H ' HG13 ' I' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.57 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 31' ' ' TYR . . . . . 0.437 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.423 ' CG2' HG23 ' J' ' 122' ' ' VAL . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' J' ' 117' ' ' GLU . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 38' ' ' SER . . . . . 0.725 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' I' ' 42' ' ' GLU . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' I' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -73.51 166.0 24.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 44' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' I' ' 53' ' ' ILE . 5.3 t80 -108.85 85.02 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.247 171.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 45' ' ' ASP . . . . . 0.549 ' H ' HG21 ' I' ' 53' ' ' ILE . 26.4 t70 -110.62 100.07 8.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.2 64.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.24 26.61 5.37 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.603 1.561 . . . . 0.0 111.688 -172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.646 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 50.39 48.95 21.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.49 1.516 . . . . 0.0 111.554 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 49' ' ' LYS . . . . . 0.539 ' HG2' ' HG2' ' I' ' 52' ' ' ARG . 6.3 tptt -116.58 -92.24 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.455 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 50' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' J' ' 59' ' ' VAL . 17.8 m-20 -152.3 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 51' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 80.18 36.06 25.35 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' I' ' 49' ' ' LYS . 0.1 OUTLIER -102.61 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.549 HG21 ' H ' ' I' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.03 56.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.899 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.522 HD22 HD13 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -109.13 25.2 12.08 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 176.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' I' ' 43' ' ' LEU . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 62' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' I' ' 34' ' ' ASP . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.49 ' HD3' ' OD2' ' I' ' 73' ' ' ASP . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.731 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' I' ' 70' ' ' LYS . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 74' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.602 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 13.9 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' I' ' 85' ' ' ASN . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.457 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' I' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.505 ' HH2' ' HA ' ' C' ' 160' ' ' PHE . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.633 HH21 HG11 ' I' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.763 HG21 HG21 ' I' ' 145' ' ' THR . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' I' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 97' ' ' VAL . . . . . 0.736 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.574 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' I' ' 97' ' ' VAL . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' I' ' 138' ' ' LEU . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 109' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.414 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' I' ' 83' ' ' TYR . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' I' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.533 ' HG3' HH11 ' I' ' 116' ' ' ARG . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.535 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 119' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.573 HG13 ' O ' ' H' ' 7' ' ' MET . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 128' ' ' ILE . . . . . 0.465 HG22 HG23 ' I' ' 130' ' ' ILE . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.602 HG13 ' O ' ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' I' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' I' ' 110' ' ' PHE . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.451 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.451 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.782 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.457 ' NZ ' ' HG2' ' J' ' 84' ' ' GLN . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.416 ' HG2' HG11 ' I' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.574 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 145' ' ' THR . . . . . 0.763 HG21 HG21 ' I' ' 94' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' I' ' 145' ' ' THR . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.76 37.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.67 -34.09 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.67 77.13 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 113.043 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.246 1.019 . . . . 0.0 108.633 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -32.97 70.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' I' I ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.796 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.796 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.555 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.441 ' O ' HG22 ' K' ' 126' ' ' VAL . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' J' ' 93' ' ' ARG . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' J' ' 12' ' ' LYS . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' J' ' 89' ' ' ILE . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.645 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' J' ' 18' ' ' ILE . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.652 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.561 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 33' ' ' THR . . . . . 0.446 ' CG2' HG23 ' K' ' 122' ' ' VAL . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' K' ' 117' ' ' GLU . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 38' ' ' SER . . . . . 0.615 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' J' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' J' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.785 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -73.49 165.95 24.13 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 44' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' J' ' 53' ' ' ILE . 5.4 t80 -108.84 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.228 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 45' ' ' ASP . . . . . 0.558 ' H ' HG21 ' J' ' 53' ' ' ILE . 26.4 t70 -110.58 100.06 8.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.635 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 10.2 pt-20 -68.73 -21.2 64.4 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.6 5.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.574 1.549 . . . . 0.0 111.693 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.635 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.94 21.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.498 1.519 . . . . 0.0 111.553 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 49' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' J' ' 52' ' ' ARG . 6.4 tptt -116.61 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.434 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.27 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 51' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 80.18 36.15 25.12 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.538 ' HG2' ' HG2' ' J' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.3 32.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.558 HG21 ' H ' ' J' ' 45' ' ' ASP . 0.3 OUTLIER -132.86 135.95 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.854 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.441 HD22 HD13 ' K' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.14 12.15 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 56' ' ' PRO . . . . . 0.491 ' O ' HD22 ' J' ' 43' ' ' LEU . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 57' ' ' GLY . . . . . 0.785 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' I' ' 50' ' ' ASN . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 62' ' ' SER . . . . . 0.885 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' J' ' 34' ' ' ASP . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.594 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 71' ' ' ARG . . . . . 0.736 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 73' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' J' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 74' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.599 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 14.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.457 ' HG2' ' NZ ' ' I' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' J' ' 85' ' ' ASN . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' J' ' 15' ' ' PHE . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' D' ' 160' ' ' PHE . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' J' ' 11' ' ' VAL . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.753 HG21 HG21 ' J' ' 145' ' ' THR . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 95' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' J' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 97' ' ' VAL . . . . . 0.682 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' J' ' 97' ' ' VAL . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.798 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' J' ' 138' ' ' LEU . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' J' ' 83' ' ' TYR . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' J' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.542 ' HG3' HH11 ' J' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 119' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 122' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' I' ' 33' ' ' THR . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.503 HG13 ' O ' ' I' ' 7' ' ' MET . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 128' ' ' ILE . . . . . 0.466 HG22 HG23 ' J' ' 130' ' ' ILE . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.735 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' J' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.885 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' J' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.522 HD13 HD22 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.456 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.439 ' NZ ' ' HG2' ' K' ' 84' ' ' GLN . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.753 HG21 HG21 ' J' ' 94' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.675 HD12 ' O ' ' J' ' 145' ' ' THR . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.76 37.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.65 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.69 77.24 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.37 0.986 . . . . 0.0 113.079 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.97 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.29 1.036 . . . . 0.0 108.635 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.94 70.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' J' J ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.798 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.798 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.436 ' O ' ' HB1' ' L' ' 125' ' ' ALA . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' K' ' 93' ' ' ARG . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 12' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' K' ' 12' ' ' LYS . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' K' ' 25' ' ' ALA . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 19' ' ' ASP . . . . . 0.476 ' H ' HG13 ' K' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.643 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.587 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 31' ' ' TYR . . . . . 0.427 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 33' ' ' THR . . . . . 0.494 HG22 HG23 ' L' ' 122' ' ' VAL . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' K' ' 65' ' ' VAL . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' L' ' 117' ' ' GLU . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 38' ' ' SER . . . . . 0.603 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' K' ' 42' ' ' GLU . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' K' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.803 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -73.49 166.03 23.98 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 44' ' ' PHE . . . . . 0.478 ' HA ' HG12 ' K' ' 53' ' ' ILE . 5.4 t80 -108.87 84.96 2.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.259 171.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 45' ' ' ASP . . . . . 0.56 ' H ' HG21 ' K' ' 53' ' ' ILE . 26.4 t70 -110.59 100.12 8.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 10.2 pt-20 -68.79 -21.22 64.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.62 5.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.636 1.575 . . . . 0.0 111.677 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.639 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.96 21.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.501 1.52 . . . . 0.0 111.57 -164.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 49' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' F' ' 153' ' ' VAL . 6.3 tptt -116.57 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 50' ' ' ASN . . . . . 0.476 ' CB ' HG23 ' L' ' 59' ' ' VAL . 17.8 m-20 -152.31 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 51' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 80.16 36.12 25.24 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' K' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.25 32.22 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.56 HG21 ' H ' ' K' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 135.99 56.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.9 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.613 HD22 HD13 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.18 12.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 56' ' ' PRO . . . . . 0.496 ' O ' HD22 ' K' ' 43' ' ' LEU . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 57' ' ' GLY . . . . . 0.803 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.743 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' K' ' 34' ' ' ASP . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.555 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 71' ' ' ARG . . . . . 0.682 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' K' ' 70' ' ' LYS . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.597 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 14.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.597 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.439 ' HG2' ' NZ ' ' J' ' 139' ' ' LYS . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' K' ' 85' ' ' ASN . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.461 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' K' ' 15' ' ' PHE . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' K' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.775 HG21 HG21 ' K' ' 145' ' ' THR . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 95' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' K' ' 11' ' ' VAL . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 97' ' ' VAL . . . . . 0.588 ' HB ' HH11 ' L' ' 71' ' ' ARG . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' K' ' 97' ' ' VAL . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' K' ' 138' ' ' LEU . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.418 ' O ' HG13 ' K' ' 134' ' ' VAL . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' K' ' 83' ' ' TYR . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' K' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.546 HH11 ' HG3' ' K' ' 116' ' ' ARG . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 119' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 122' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' J' ' 33' ' ' THR . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.52 HG13 ' O ' ' J' ' 7' ' ' MET . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' K' ' 130' ' ' ILE . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.604 HG13 ' O ' ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.743 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.524 ' HA ' ' HG3' ' K' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.418 HG13 ' O ' ' K' ' 110' ' ' PHE . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.455 HG13 ' H ' ' K' ' 136' ' ' GLY . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.501 ' CA ' ' HD3' ' E' ' 155' ' ' LYS . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' K' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.775 HG21 HG21 ' K' ' 94' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' K' ' 145' ' ' THR . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.59 144.71 37.52 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.46 11.69 77.23 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 119.389 0.995 . . . . 0.0 113.002 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 117.75 4.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.19 23.99 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.299 1.039 . . . . 0.0 108.595 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.92 70.64 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.594 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' K' K ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.791 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.791 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' G' ' 126' ' ' VAL . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' L' ' 93' ' ' ARG . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 12' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' L' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' L' ' 25' ' ' ALA . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.493 ' HB3' HD11 ' L' ' 89' ' ' ILE . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.636 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' L' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' F' ' 164' ' ' GLY . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.591 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.596 HG22 ' HG2' ' G' ' 117' ' ' GLU . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 38' ' ' SER . . . . . 0.636 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' L' ' 42' ' ' GLU . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' L' ' 41' ' ' ARG . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.786 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -73.48 166.05 23.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 44' ' ' PHE . . . . . 0.471 ' HA ' HG12 ' L' ' 53' ' ' ILE . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.207 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 45' ' ' ASP . . . . . 0.555 ' H ' HG21 ' L' ' 53' ' ' ILE . 26.4 t70 -110.58 100.1 8.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.638 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 10.1 pt-20 -68.76 -21.23 64.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.63 5.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.564 1.546 . . . . 0.0 111.641 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.638 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 50.35 48.92 21.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.496 1.518 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 49' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' L' ' 52' ' ' ARG . 6.4 tptt -116.58 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.457 -177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.3 33.85 0.52 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 51' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 80.24 36.15 24.93 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' L' ' 49' ' ' LYS . 0.1 OUTLIER -102.65 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.555 HG21 ' H ' ' L' ' 45' ' ' ASP . 0.3 OUTLIER -132.9 135.98 56.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.861 178.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.456 HD22 HD13 ' G' ' 135' ' ' ILE . 0.4 OUTLIER -109.03 25.14 12.16 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 56' ' ' PRO . . . . . 0.498 ' O ' HD22 ' L' ' 43' ' ' LEU . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 57' ' ' GLY . . . . . 0.786 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.476 HG23 ' CB ' ' K' ' 50' ' ' ASN . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' L' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.521 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.588 HH11 ' HB ' ' K' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 73' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' L' ' 70' ' ' LYS . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 74' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.594 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 14.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.594 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.512 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' L' ' 85' ' ' ASN . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.653 ' HG3' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' L' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.764 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' L' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.787 HG21 HG21 ' L' ' 145' ' ' THR . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' L' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 97' ' ' VAL . . . . . 0.705 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' L' ' 97' ' ' VAL . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' L' ' 138' ' ' LEU . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 109' ' ' GLY . . . . . 0.794 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.417 ' O ' HG13 ' L' ' 134' ' ' VAL . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' L' ' 83' ' ' TYR . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' L' ' 132' ' ' LEU . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.54 HH11 ' HG3' ' L' ' 116' ' ' ARG . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.608 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 119' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.494 HG23 HG22 ' K' ' 33' ' ' THR . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.449 HG13 ' O ' ' K' ' 7' ' ' MET . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' L' ' 130' ' ' ILE . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.615 HG13 ' O ' ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.769 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.529 ' HA ' ' HG3' ' L' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' L' ' 110' ' ' PHE . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.613 HD13 HD22 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' F' ' 155' ' ' LYS . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.794 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.432 ' NZ ' ' HG2' ' G' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.75 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' F' ' 160' ' ' PHE . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.787 HG21 HG21 ' L' ' 94' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.684 HD12 ' O ' ' L' ' 145' ' ' THR . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.54 144.73 37.43 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.68 -33.99 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.44 11.72 77.2 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 119.37 0.986 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.79 4.8 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.33 1.052 . . . . 0.0 108.613 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.97 70.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' L' L ' 162' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.787 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.787 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' B' ' 126' ' ' VAL . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.851 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' B' ' 117' ' ' GLU . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.801 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.13 120.72 39.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 0.6 OUTLIER -130.65 88.44 2.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.22 171.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 1.6 t70 -107.8 168.91 8.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 1.9 mp0 -71.8 -47.18 55.11 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.15 35.57 26.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.595 1.558 . . . . 0.0 111.672 -172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.91 48.95 5.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.51 1.524 . . . . 0.0 111.56 -164.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.502 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.99 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 44' ' ' PHE . . . 82.67 174.09 49.85 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HA ' HH11 ' A' ' 52' ' ' ARG . 0.0 OUTLIER -118.26 122.36 42.74 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.878 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.2 pp -128.69 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.822 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER -65.25 -23.8 67.15 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' A' ' 34' ' ' ASP . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HD1' HG22 ' A' ' 113' ' ' ILE . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 82' ' ' ALA . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 142' ' ' GLU . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.78 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' A' ' 139' ' ' LYS . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' A' ' 138' ' ' LEU . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.668 HG22 ' HD1' ' A' ' 83' ' ' TYR . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.862 HG23 HG21 ' F' ' 6' ' ' ILE . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' A' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.791 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.967 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' A' ' 107' ' ' GLN . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 150' ' ' ILE . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.721 ' HB3' HG21 ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.77 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 156' ' ' GLY . 0.2 OUTLIER -55.03 -44.53 74.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.551 ' O ' ' HD2' ' A' ' 155' ' ' LYS . . . 138.96 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.422 1.01 . . . . 0.0 113.073 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 2.2 m-20 -70.83 -44.97 65.39 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HB2' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.544 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' G' ' 21' ' ' ALA . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 172' ' ' GLY . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 167' ' ' THR . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.679 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 158' ' ' TYR . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.789 HG21 HG23 ' C' ' 126' ' ' VAL . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.818 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.818 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.873 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' G' ' 47' ' ' GLN . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.595 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' C' ' 117' ' ' GLU . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.574 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.872 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.459 ' CE2' ' HA3' ' B' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.34 2.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.238 171.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' B' ' 51' ' ' GLY . 1.6 t70 -107.77 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 155.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.633 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.12 55.15 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.15 35.54 26.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.605 1.562 . . . . 0.0 111.691 -172.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.4 p 42.89 48.97 5.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 111.551 -164.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.22 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.482 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.48 0.32 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' B' ' 45' ' ' ASP . . . 82.74 174.13 49.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.31 42.61 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.2 pp -128.66 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER -65.3 -23.75 67.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.199 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.516 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.574 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' B' ' 34' ' ' ASP . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.451 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.604 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.837 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' B' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.74 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.873 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 111' ' ' ALA . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.628 HG11 ' HG2' ' B' ' 142' ' ' GLU . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 104' ' ' TYR . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.553 ' HG2' ' HG2' ' B' ' 139' ' ' LYS . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' B' ' 138' ' ' LEU . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' B' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' B' ' 83' ' ' TYR . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.459 ' HB3' HG12 ' A' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 6' ' ' ILE . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.524 HG13 ' HB ' ' B' ' 65' ' ' VAL . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.878 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' B' ' 107' ' ' GLN . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' B' ' 150' ' ' ILE . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' B' ' 150' ' ' ILE . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' B' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.06 134.74 30.19 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.548 ' HD2' ' O ' ' B' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.58 74.56 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' B' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.367 0.985 . . . . 0.0 113.053 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.17 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -111.53 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.24 1.016 . . . . 0.0 108.591 177.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 2.2 m-20 -70.86 -44.98 65.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.563 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' H' ' 21' ' ' ALA . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.426 HG21 ' H ' ' B' ' 172' ' ' GLY . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLY . . . . . 0.415 ' N ' HG22 ' B' ' 167' ' ' THR . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' B' ' 158' ' ' TYR . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' B' ' 176' ' ' ALA . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.743 HG21 HG23 ' D' ' 126' ' ' VAL . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.836 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.562 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' C' ' 76' ' ' GLN . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' H' ' 47' ' ' GLN . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.722 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.775 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.07 120.73 38.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' C' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.38 2.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.198 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' C' ' 51' ' ' GLY . 1.6 t70 -107.78 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.608 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.16 54.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.12 35.64 26.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.627 1.571 . . . . 0.0 111.66 -172.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.85 48.97 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.488 1.515 . . . . 0.0 111.581 -164.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.29 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.93 21.57 0.31 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' C' ' 45' ' ' ASP . . . 82.68 174.12 49.88 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.28 42.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.952 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.2 pp -128.64 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.879 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER -65.29 -23.78 67.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 176.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.633 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' C' ' 34' ' ' ASP . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ARG . . . . . 0.41 HH21 ' HD3' ' C' ' 71' ' ' ARG . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.601 HD12 HD11 ' C' ' 113' ' ' ILE . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.672 ' HD1' HG22 ' C' ' 113' ' ' ILE . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 85' ' ' ASN . . . . . 0.417 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.781 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' C' ' 111' ' ' ALA . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.634 HG11 ' HG2' ' C' ' 142' ' ' GLU . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' C' ' 104' ' ' TYR . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.804 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.563 ' HG2' ' HG2' ' C' ' 139' ' ' LYS . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.669 ' HD2' HD11 ' C' ' 138' ' ' LEU . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.701 ' O ' HG23 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' C' ' 91' ' ' PHE . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.672 HG22 ' HD1' ' C' ' 83' ' ' TYR . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.872 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' B' ' 37' ' ' VAL . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' GLU . . . . . 0.605 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.789 HG23 HG21 ' B' ' 6' ' ' ILE . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB ' ' C' ' 65' ' ' VAL . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.967 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.777 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.617 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.669 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' C' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 140' ' ' ASN . . . . . 0.602 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.804 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.919 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.52 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' C' ' 150' ' ' ILE . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' C' ' 150' ' ' ILE . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' C' ' 145' ' ' THR . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' C' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 156' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' C' ' 155' ' ' LYS . . . 138.95 137.02 3.47 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.368 0.985 . . . . 0.0 113.032 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.13 80.62 0.36 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -111.59 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.298 1.039 . . . . 0.0 108.633 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.79 -44.99 65.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.471 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 162' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.525 ' O ' HG22 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.427 HG22 ' HB1' ' I' ' 21' ' ' ALA . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' C' ' 172' ' ' GLY . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 168' ' ' GLY . . . . . 0.413 ' N ' HG22 ' C' ' 167' ' ' THR . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.677 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' C' ' 158' ' ' TYR . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' C' ' 176' ' ' ALA . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 176' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.8 HG21 HG23 ' E' ' 126' ' ' VAL . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.84 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.84 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.854 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' D' ' 76' ' ' GLN . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' I' ' 47' ' ' GLN . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.713 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 117' ' ' GLU . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.809 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.73 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' PHE . . . . . 0.463 ' CE2' ' HA3' ' D' ' 51' ' ' GLY . 0.7 OUTLIER -130.72 88.39 2.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.191 171.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HA2' ' D' ' 51' ' ' GLY . 1.6 t70 -107.78 168.88 8.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 155.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.474 ' OE2' ' HB3' ' E' ' 58' ' ' SER . 1.9 mp0 -71.79 -47.14 55.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.07 35.66 26.64 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.645 1.578 . . . . 0.0 111.663 -172.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.8 49.02 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 111.578 -164.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.32 -165.12 2.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.469 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.56 0.32 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' D' ' 45' ' ' ASP . . . 82.67 174.1 49.85 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.33 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.87 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.2 pp -128.73 -33.28 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.681 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER -65.35 -23.72 67.06 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' SER . . . . . 0.608 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.564 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.713 HG13 ' OD1' ' D' ' 34' ' ' ASP . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.493 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.598 HG23 HD13 ' D' ' 113' ' ' ILE . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.663 ' HD1' HG22 ' D' ' 113' ' ' ILE . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.704 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' D' ' 82' ' ' ALA . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' D' ' 142' ' ' GLU . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.546 ' OH ' HG21 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.794 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' D' ' 139' ' ' LYS . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' D' ' 138' ' ' LEU . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.709 ' O ' HG23 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.663 HG22 ' HD1' ' D' ' 83' ' ' TYR . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' GLU . . . . . 0.521 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.743 HG23 HG21 ' C' ' 6' ' ' ILE . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' D' ' 65' ' ' VAL . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.952 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.759 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' D' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.794 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.511 ' O ' HD12 ' D' ' 150' ' ' ILE . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.511 HD12 ' O ' ' D' ' 145' ' ' THR . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' VAL . . . . . 0.461 HG21 ' O ' ' I' ' 48' ' ' THR . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.02 134.73 30.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' D' ' 156' ' ' GLY . 0.2 OUTLIER -55.01 -44.53 74.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 156' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' D' ' 155' ' ' LYS . . . 138.96 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 119.367 0.985 . . . . 0.0 113.03 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.666 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.332 1.053 . . . . 0.0 108.633 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 159' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 2.2 m-20 -70.88 -44.98 65.22 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -158.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.584 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.526 ' O ' HG22 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' J' ' 21' ' ' ALA . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.442 HG21 ' H ' ' D' ' 172' ' ' GLY . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' D' ' 167' ' ' THR . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.666 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 172' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' D' ' 158' ' ' TYR . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.526 HG22 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' D' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' D' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.848 HG21 HG23 ' F' ' 126' ' ' VAL . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.829 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.829 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.558 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' E' ' 76' ' ' GLN . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' J' ' 47' ' ' GLN . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.476 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.704 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' F' ' 118' ' ' TYR . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' F' ' 117' ' ' GLU . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.737 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.17 120.72 39.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' E' ' 51' ' ' GLY . 0.7 OUTLIER -130.74 88.43 2.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.211 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 45' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' E' ' 51' ' ' GLY . 1.6 t70 -107.8 168.91 8.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 155.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.737 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 1.9 mp0 -71.91 -47.1 54.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.16 35.54 26.37 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.579 1.552 . . . . 0.0 111.629 -172.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.9 48.98 5.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.519 1.527 . . . . 0.0 111.528 -164.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.457 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -78.06 21.62 0.32 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' E' ' 44' ' ' PHE . . . 82.69 174.09 49.86 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.488 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.32 42.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 1.006 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.2 pp -128.66 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.878 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' F' ' 88' ' ' GLN . 0.8 OUTLIER -65.34 -23.72 67.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 58' ' ' SER . . . . . 0.474 ' HB3' ' OE2' ' D' ' 46' ' ' GLU . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 61' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.704 HG13 ' OD1' ' E' ' 34' ' ' ASP . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.609 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' E' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.681 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' E' ' 82' ' ' ALA . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' E' ' 142' ' ' GLU . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' E' ' 104' ' ' TYR . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.779 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' E' ' 139' ' ' LYS . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.662 ' HD2' HD11 ' E' ' 138' ' ' LEU . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.668 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.677 HG22 ' HD1' ' E' ' 83' ' ' TYR . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.809 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.45 ' HB3' HG12 ' D' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 119' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 123' ' ' GLU . . . . . 0.611 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.8 HG23 HG21 ' D' ' 6' ' ' ILE . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 129' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' E' ' 65' ' ' VAL . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.87 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.825 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' E' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.535 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.51 ' O ' HD12 ' E' ' 150' ' ' ILE . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 146' ' ' LEU . . . . . 0.462 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.722 ' HB3' HG21 ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.51 HD12 ' O ' ' E' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 153' ' ' VAL . . . . . 0.43 HG21 ' O ' ' J' ' 48' ' ' THR . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -140.99 134.75 30.33 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.58 ' HE3' HG12 ' K' ' 135' ' ' ILE . 0.2 OUTLIER -55.0 -44.56 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 175.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 156' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' E' ' 155' ' ' LYS . . . 139.02 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.382 0.992 . . . . 0.0 113.048 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.67 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -111.55 91.64 3.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.33 1.052 . . . . 0.0 108.575 177.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.88 -44.95 65.25 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 162' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.552 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.514 ' O ' HG22 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' K' ' 21' ' ' ALA . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' E' ' 172' ' ' GLY . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 168' ' ' GLY . . . . . 0.411 ' N ' HG22 ' E' ' 167' ' ' THR . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.67 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 172' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' E' ' 158' ' ' TYR . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.514 HG22 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' E' ' 176' ' ' ALA . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' E' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.862 HG21 HG23 ' A' ' 126' ' ' VAL . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.802 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.802 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.603 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.603 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' F' ' 76' ' ' GLN . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.492 ' HA ' ' OE1' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 36' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 42' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.07 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' F' ' 51' ' ' GLY . 0.6 OUTLIER -130.65 88.36 2.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.246 171.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 45' ' ' ASP . . . . . 0.458 ' O ' ' HA2' ' F' ' 51' ' ' GLY . 1.6 t70 -107.74 168.91 8.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.09 55.3 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.14 35.59 26.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 111.67 -172.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.88 48.97 5.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.454 1.501 . . . . 0.0 111.557 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.11 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.477 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.95 21.51 0.32 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' F' ' 44' ' ' PHE . . . 82.79 174.09 49.94 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' F' ' 52' ' ' ARG . 0.0 OUTLIER -118.27 122.31 42.62 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.967 HG12 HG23 ' A' ' 135' ' ' ILE . 1.2 pp -128.67 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.451 HD12 ' H ' ' F' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.76 67.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 58' ' ' SER . . . . . 0.737 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 61' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.716 HG13 ' OD1' ' F' ' 34' ' ' ASP . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 71' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' F' ' 113' ' ' ILE . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.653 ' HD1' HG22 ' F' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.613 HG11 ' HG2' ' F' ' 142' ' ' GLU . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' F' ' 104' ' ' TYR . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.543 ' OH ' HG21 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.768 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' F' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' F' ' 138' ' ' LEU . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.705 ' O ' HG23 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.653 HG22 ' HD1' ' F' ' 83' ' ' TYR . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.737 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' F' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.416 ' HB3' HG12 ' E' ' 37' ' ' VAL . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 119' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 125' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.848 HG23 HG21 ' E' ' 6' ' ' ILE . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' F' ' 65' ' ' VAL . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' F' ' 65' ' ' VAL . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 1.006 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.893 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' F' ' 107' ' ' GLN . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.53 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.518 ' O ' HD12 ' F' ' 150' ' ' ILE . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' F' ' 150' ' ' ILE . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.716 ' HB3' HG21 ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.518 HD12 ' O ' ' F' ' 145' ' ' THR . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 153' ' ' VAL . . . . . 0.472 HG21 ' O ' ' K' ' 48' ' ' THR . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 154' ' ' SER . . . . . 0.423 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 1.6 p -141.04 134.7 30.19 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.534 ' HD2' ' O ' ' F' ' 156' ' ' GLY . 0.2 OUTLIER -54.95 -44.55 74.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 156' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' F' ' 155' ' ' LYS . . . 138.93 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.26 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.675 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.318 1.047 . . . . 0.0 108.636 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.799 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 -70.8 -45.06 65.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.504 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.835 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.812 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.562 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.675 ' HB2' ' CE2' ' F' ' 158' ' ' TYR . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 172' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' F' ' 158' ' ' TYR . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' F' ' 176' ' ' ALA . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' F' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.995 HG21 HG23 ' H' ' 126' ' ' VAL . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.795 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 8' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.795 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' THR . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' G' ' 76' ' ' GLN . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' G' ' 32' ' ' GLN . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.71 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.526 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 39' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 42' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 44' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' G' ' 51' ' ' GLY . 0.6 OUTLIER -130.71 88.41 2.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.203 171.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 45' ' ' ASP . . . . . 0.468 ' O ' ' HA2' ' G' ' 51' ' ' GLY . 1.6 t70 -107.83 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 155.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.86 -47.15 54.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 47' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 0.0 OUTLIER 57.17 35.58 26.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.631 1.573 . . . . 0.0 111.637 -172.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.86 48.96 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.477 1.511 . . . . 0.0 111.584 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.26 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.459 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -77.95 21.48 0.32 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 51' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' G' ' 45' ' ' ASP . . . 82.77 174.09 49.93 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' G' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.38 42.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 1.034 HG12 HG23 ' H' ' 135' ' ' ILE . 1.2 pp -128.7 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.877 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.453 HD12 ' H ' ' G' ' 54' ' ' LEU . 0.8 OUTLIER -65.26 -23.8 67.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 61' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.71 HG13 ' OD1' ' G' ' 34' ' ' ASP . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 71' ' ' ARG . . . . . 0.431 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.629 HD12 HD11 ' G' ' 113' ' ' ILE . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.673 ' HD1' HG22 ' G' ' 113' ' ' ILE . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.681 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' G' ' 142' ' ' GLU . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.542 ' OH ' HG21 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.762 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' G' ' 139' ' ' LYS . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.685 ' HD2' HD11 ' G' ' 138' ' ' LEU . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.681 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.673 HG22 ' HD1' ' G' ' 83' ' ' TYR . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.508 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 119' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 123' ' ' GLU . . . . . 0.507 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.93 HG23 HG21 ' L' ' 6' ' ' ILE . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 129' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' G' ' 65' ' ' VAL . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.972 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 1.028 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.61 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.685 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.557 ' HG2' ' HG2' ' G' ' 107' ' ' GLN . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 144' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.512 ' O ' HD12 ' G' ' 150' ' ' ILE . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' G' ' 150' ' ' ILE . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.512 HD12 ' O ' ' G' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.04 134.73 30.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 155' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' G' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 156' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' G' ' 155' ' ' LYS . . . 138.98 137.02 3.47 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.383 0.992 . . . . 0.0 113.043 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 158' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -111.48 91.65 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.315 1.046 . . . . 0.0 108.645 177.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.94 65.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -158.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' G' ' 172' ' ' GLY . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 168' ' ' GLY . . . . . 0.421 ' N ' HG22 ' G' ' 167' ' ' THR . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 171' ' ' PRO . . . . . 0.668 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 172' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' G' ' 158' ' ' TYR . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' G' ' 176' ' ' ALA . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' G' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.994 HG21 HG23 ' I' ' 126' ' ' VAL . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.811 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.571 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.855 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' B' ' 166' ' ' THR . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' H' ' 76' ' ' GLN . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' OE1' ' I' ' 117' ' ' GLU . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.19 120.74 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' H' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.36 2.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.222 171.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 45' ' ' ASP . . . . . 0.461 ' O ' ' HA2' ' H' ' 51' ' ' GLY . 1.6 t70 -107.8 168.92 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 155.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.84 -47.14 55.16 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 47' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 0.0 OUTLIER 57.15 35.56 26.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.62 -172.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.94 48.91 5.16 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.501 1.52 . . . . 0.0 111.578 -164.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.482 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' H' ' 44' ' ' PHE . . . 82.73 174.11 49.91 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.458 ' HA ' HH11 ' H' ' 52' ' ' ARG . 0.0 OUTLIER -118.26 122.34 42.69 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 1.023 HG12 HG23 ' I' ' 135' ' ' ILE . 1.2 pp -128.68 -33.29 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.443 HD12 ' H ' ' H' ' 54' ' ' LEU . 0.8 OUTLIER -65.36 -23.75 67.06 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 60' ' ' ALA . . . . . 0.571 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' H' ' 34' ' ' ASP . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.429 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.617 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.83 ' HB2' HD11 ' H' ' 89' ' ' ILE . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.67 ' HD1' HG22 ' H' ' 113' ' ' ILE . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.68 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' H' ' 111' ' ' ALA . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' H' ' 142' ' ' GLU . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.777 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.915 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' H' ' 139' ' ' LYS . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' H' ' 138' ' ' LEU . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.717 ' O ' HG23 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' H' ' 91' ' ' PHE . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.67 HG22 ' HD1' ' H' ' 83' ' ' TYR . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.526 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 119' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 123' ' ' GLU . . . . . 0.475 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.995 HG23 HG21 ' G' ' 6' ' ' ILE . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' H' ' 65' ' ' VAL . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.9 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 1.034 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' H' ' 107' ' ' GLN . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 144' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' H' ' 150' ' ' ILE . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' H' ' 150' ' ' ILE . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' H' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.08 134.73 30.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 155' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' H' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 156' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' H' ' 155' ' ' LYS . . . 138.98 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 119.378 0.99 . . . . 0.0 113.039 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.2 80.61 0.36 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 158' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -111.54 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.32 1.048 . . . . 0.0 108.636 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.92 65.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -158.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.427 HG21 ' H ' ' H' ' 172' ' ' GLY . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 168' ' ' GLY . . . . . 0.419 ' N ' HG22 ' H' ' 167' ' ' THR . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 171' ' ' PRO . . . . . 0.676 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 172' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' H' ' 158' ' ' TYR . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' H' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' H' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.46 ' HB2' ' O ' ' J' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.867 HG21 HG23 ' J' ' 126' ' ' VAL . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.555 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.866 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 163' ' ' PRO . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' I' ' 76' ' ' GLN . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' J' ' 118' ' ' TYR . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' J' ' 117' ' ' GLU . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 39' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.624 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.71 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 44' ' ' PHE . . . . . 0.461 ' CE2' ' HA3' ' I' ' 51' ' ' GLY . 0.6 OUTLIER -130.62 88.31 2.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.249 171.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' I' ' 51' ' ' GLY . 1.6 t70 -107.75 168.85 8.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 155.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' J' ' 58' ' ' SER . 1.9 mp0 -71.82 -47.16 55.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 47' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 0.0 OUTLIER 57.18 35.61 26.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.623 1.569 . . . . 0.0 111.644 -172.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.461 ' O ' HG21 ' D' ' 153' ' ' VAL . 33.8 p 42.86 48.97 5.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.439 1.496 . . . . 0.0 111.609 -164.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.3 -165.08 2.16 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.485 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -77.99 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 51' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' I' ' 45' ' ' ASP . . . 82.78 174.07 49.92 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.54 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -118.27 122.33 42.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 1.025 HG12 HG23 ' J' ' 135' ' ' ILE . 1.2 pp -128.65 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.875 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.449 ' H ' HD12 ' I' ' 54' ' ' LEU . 0.8 OUTLIER -65.32 -23.72 67.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' I' ' 34' ' ' ASP . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.421 ' HD3' HH21 ' I' ' 71' ' ' ARG . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.608 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' I' ' 89' ' ' ILE . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.658 ' HD1' HG22 ' I' ' 113' ' ' ILE . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.673 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' I' ' 111' ' ' ALA . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.571 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' I' ' 142' ' ' GLU . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' I' ' 104' ' ' TYR . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.77 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.911 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' I' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.683 ' HD2' HD11 ' I' ' 138' ' ' LEU . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.708 ' O ' HG23 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' I' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.673 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' I' ' 83' ' ' TYR . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' H' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.994 HG23 HG21 ' H' ' 6' ' ' ILE . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 129' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' I' ' 65' ' ' VAL . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' I' ' 65' ' ' VAL . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.955 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 1.023 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' I' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.911 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.527 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 144' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 145' ' ' THR . . . . . 0.513 ' O ' HD12 ' I' ' 150' ' ' ILE . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 146' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.714 ' HB3' HG21 ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.513 HD12 ' O ' ' I' ' 145' ' ' THR . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.76 30.25 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 155' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' I' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 156' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' I' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 113.046 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.21 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 158' ' ' TYR . . . . . 0.672 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.61 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.329 1.052 . . . . 0.0 108.636 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.78 -45.05 65.41 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.53 ' O ' HG22 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.43 HG21 ' H ' ' I' ' 172' ' ' GLY . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 168' ' ' GLY . . . . . 0.418 ' N ' HG22 ' I' ' 167' ' ' THR . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' I' I ' 171' ' ' PRO . . . . . 0.672 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 172' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' I' ' 158' ' ' TYR . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.53 HG22 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' I' ' 176' ' ' ALA . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' I' I ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' I' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.515 ' HB2' ' O ' ' K' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.914 HG21 HG23 ' K' ' 126' ' ' VAL . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.816 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 21' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' D' ' 166' ' ' THR . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' J' ' 76' ' ' GLN . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 36' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' K' ' 118' ' ' TYR . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 39' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.561 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 44' ' ' PHE . . . . . 0.463 ' CE2' ' HA3' ' J' ' 51' ' ' GLY . 0.6 OUTLIER -130.71 88.38 2.61 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.222 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 45' ' ' ASP . . . . . 0.472 ' O ' ' HA2' ' J' ' 51' ' ' GLY . 1.6 t70 -107.79 168.93 8.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.401 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 1.9 mp0 -71.86 -47.12 55.17 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 47' ' ' GLN . . . . . 0.519 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 0.0 OUTLIER 57.17 35.56 26.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 111.653 -172.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.43 ' O ' HG21 ' E' ' 153' ' ' VAL . 33.6 p 42.84 49.0 5.06 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.538 1.535 . . . . 0.0 111.553 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.08 2.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -77.96 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' J' ' 45' ' ' ASP . . . 82.75 174.11 49.93 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.532 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -118.32 122.33 42.62 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 1.067 HG12 HG23 ' K' ' 135' ' ' ILE . 1.2 pp -128.67 -33.34 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.852 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.438 HD12 ' H ' ' J' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.73 67.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 58' ' ' SER . . . . . 0.476 ' HB3' ' OE2' ' I' ' 46' ' ' GLU . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 60' ' ' ALA . . . . . 0.561 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' J' ' 34' ' ' ASP . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 73' ' ' ASP . . . . . 0.504 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.42 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.614 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' J' ' 113' ' ' ILE . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.688 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' J' ' 82' ' ' ALA . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.627 HG11 ' HG2' ' J' ' 142' ' ' GLU . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' J' ' 139' ' ' LYS . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' J' ' 138' ' ' LEU . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.7 ' O ' HG23 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' J' ' 83' ' ' TYR . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' J' ' 116' ' ' ARG . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' I' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 119' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 123' ' ' GLU . . . . . 0.487 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.867 HG23 HG21 ' I' ' 6' ' ' ILE . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' J' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.948 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 1.025 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' J' ' 107' ' ' GLN . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.907 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' D' ' 160' ' ' PHE . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.515 ' O ' HD12 ' J' ' 150' ' ' ILE . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' J' ' 147' ' ' PRO . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.713 ' HB3' HG21 ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.515 HD12 ' O ' ' J' ' 145' ' ' THR . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.713 HG21 ' HB3' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 155' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' J' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.55 74.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 156' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' J' ' 155' ' ' LYS . . . 138.98 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 119.407 1.003 . . . . 0.0 113.038 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.22 80.63 0.36 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 158' ' ' TYR . . . . . 0.661 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -111.56 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.298 1.039 . . . . 0.0 108.618 177.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.85 -44.99 65.29 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -158.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.439 HG21 ' H ' ' J' ' 172' ' ' GLY . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 168' ' ' GLY . . . . . 0.416 ' N ' HG22 ' J' ' 167' ' ' THR . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' J' J ' 171' ' ' PRO . . . . . 0.661 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 172' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' J' ' 158' ' ' TYR . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' J' ' 176' ' ' ALA . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' J' J ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' J' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.434 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.945 HG21 HG23 ' L' ' 126' ' ' VAL . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.82 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.871 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' E' ' 166' ' ' THR . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' K' ' 76' ' ' GLN . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.707 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' L' ' 117' ' ' GLU . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 42' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.18 120.73 39.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' K' ' 51' ' ' GLY . 0.6 OUTLIER -130.64 88.44 2.62 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.222 171.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 45' ' ' ASP . . . . . 0.475 ' O ' ' HA2' ' K' ' 51' ' ' GLY . 1.6 t70 -107.82 168.9 8.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 1.9 mp0 -71.83 -47.16 55.04 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 47' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 0.0 OUTLIER 57.1 35.64 26.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.635 1.574 . . . . 0.0 111.655 -172.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.472 ' O ' HG21 ' F' ' 153' ' ' VAL . 33.5 p 42.86 48.98 5.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.507 1.523 . . . . 0.0 111.541 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.25 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.463 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 50' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' F' ' 154' ' ' SER . 6.9 m120 -77.91 21.51 0.31 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 51' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' K' ' 45' ' ' ASP . . . 82.73 174.16 49.96 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -118.34 122.28 42.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 1.095 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.2 pp -128.62 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.448 HD12 ' H ' ' K' ' 54' ' ' LEU . 0.8 OUTLIER -65.33 -23.75 67.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 58' ' ' SER . . . . . 0.465 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.707 HG13 ' OD1' ' K' ' 34' ' ' ASP . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.428 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.665 ' HD1' HG22 ' K' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.678 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' K' ' 82' ' ' ALA . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' K' ' 142' ' ' GLU . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 98' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' K' ' 104' ' ' TYR . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.767 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.917 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' K' ' 139' ' ' LYS . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' K' ' 138' ' ' LEU . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.71 ' O ' HG23 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.678 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.665 HG22 ' HD1' ' K' ' 83' ' ' TYR . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.532 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' K' ' 116' ' ' ARG . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.537 ' HB3' HG12 ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 119' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.914 HG23 HG21 ' J' ' 6' ' ' ILE . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 129' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' K' ' 65' ' ' VAL . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.962 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 1.067 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.616 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' K' ' 107' ' ' GLN . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 140' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.917 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.522 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 144' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.497 ' O ' HD12 ' K' ' 150' ' ' ILE . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 146' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' K' ' 150' ' ' ILE . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.497 HD12 ' O ' ' K' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.72 30.19 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 155' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' K' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.53 74.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 175.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 156' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' K' ' 155' ' ' LYS . . . 138.97 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.394 0.997 . . . . 0.0 112.995 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.28 80.64 0.36 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 158' ' ' TYR . . . . . 0.667 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -111.51 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.319 1.048 . . . . 0.0 108.648 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.86 -44.92 65.37 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.517 ' O ' HG22 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.443 HG21 ' H ' ' K' ' 172' ' ' GLY . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' K' ' 167' ' ' THR . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' K' K ' 171' ' ' PRO . . . . . 0.667 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 172' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' K' ' 158' ' ' TYR . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' K' ' 176' ' ' ALA . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' K' K ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' K' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.559 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.93 HG21 HG23 ' G' ' 126' ' ' VAL . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.821 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 8' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.821 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.593 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.844 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.593 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' L' ' 76' ' ' GLN . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.48 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 36' ' ' SER . . . . . 0.41 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.508 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 39' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 42' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' L' ' 51' ' ' GLY . 0.7 OUTLIER -130.76 88.41 2.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.212 171.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HA2' ' L' ' 51' ' ' GLY . 1.6 t70 -107.76 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.19 54.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 47' ' ' GLN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 57.17 35.51 26.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.602 1.561 . . . . 0.0 111.716 -172.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.94 48.94 5.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.491 1.516 . . . . 0.0 111.569 -164.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.27 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.475 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -77.96 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' L' ' 44' ' ' PHE . . . 82.7 174.13 49.9 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -118.3 122.33 42.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 1.028 HG12 HG23 ' G' ' 135' ' ' ILE . 1.2 pp -128.65 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.901 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.45 HD12 ' H ' ' L' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.74 67.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' L' ' 34' ' ' ASP . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 69' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.406 ' HD3' HH21 ' L' ' 71' ' ' ARG . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 73' ' ' ASP . . . . . 0.486 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.422 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.633 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.818 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' L' ' 113' ' ' ILE . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.684 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' L' ' 82' ' ' ALA . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.844 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.617 HG11 ' HG2' ' L' ' 142' ' ' GLU . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' L' ' 104' ' ' TYR . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.536 ' OH ' HG21 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' L' ' 139' ' ' LYS . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.674 ' HD2' HD11 ' L' ' 138' ' ' LEU . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.704 ' O ' HG23 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.684 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' L' ' 83' ' ' TYR . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' L' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' K' ' 37' ' ' VAL . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 119' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.945 HG23 HG21 ' K' ' 6' ' ' ILE . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 129' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' L' ' 65' ' ' VAL . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' L' ' 65' ' ' VAL . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 1.095 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.949 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.674 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' L' ' 107' ' ' GLN . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.799 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.835 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.514 ' O ' HD12 ' L' ' 150' ' ' ILE . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 146' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' L' ' 25' ' ' ALA . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.72 ' HB3' HG21 ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.514 HD12 ' O ' ' L' ' 145' ' ' THR . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.72 HG21 ' HB3' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.03 134.76 30.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 155' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' L' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.58 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 156' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' L' ' 155' ' ' LYS . . . 139.0 137.09 3.48 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.334 0.97 . . . . 0.0 112.994 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 158' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.304 1.042 . . . . 0.0 108.66 177.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.82 -45.02 65.31 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' L' ' 172' ' ' GLY . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 168' ' ' GLY . . . . . 0.414 ' N ' HG22 ' L' ' 167' ' ' THR . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' L' L ' 171' ' ' PRO . . . . . 0.665 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 172' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' L' ' 158' ' ' TYR . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' L' ' 176' ' ' ALA . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' L' L ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' L' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.526 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 18' ' ' ILE . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' B' ' 117' ' ' GLU . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.84 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.0 34.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.229 171.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.82 110.03 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 2.9 tt0 -67.43 -35.2 78.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 2.0 mt-30 71.33 20.23 5.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.576 1.55 . . . . 0.0 111.657 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 5.8 m 42.35 55.38 4.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.468 1.507 . . . . 0.0 111.599 -164.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 8.8 mmtp -107.74 -133.47 0.33 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.5 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.56 15.96 27.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.1 mmp_? -109.74 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.839 HG13 HG22 ' B' ' 135' ' ' ILE . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.878 178.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.84 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 40' ' ' GLU . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG12 ' HD1' ' A' ' 67' ' ' TYR . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD1' HG12 ' A' ' 65' ' ' VAL . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.691 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 75' ' ' GLY . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.672 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.873 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.873 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' A' ' 132' ' ' LEU . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.629 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 106' ' ' ALA . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.52 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' A' ' 137' ' ' GLU . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 91' ' ' PHE . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.695 ' HD1' HD13 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.464 HG11 ' O ' ' F' ' 31' ' ' TYR . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.608 ' CD1' ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' A' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.428 HG22 HG13 ' F' ' 53' ' ' ILE . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.663 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.647 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.54 162.79 15.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.06 57.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.26 3.73 61.45 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 119.367 0.985 . . . . 0.0 113.044 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.25 136.39 28.39 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.33 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.323 1.049 . . . . 0.0 108.618 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.68 77.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.564 ' HB3' ' HA ' ' A' ' 174' ' ' VAL . 1.7 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' G' ' 21' ' ' ALA . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.841 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.445 ' C ' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.841 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' B' ' 96' ' ' THR . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB3' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' B' ' 91' ' ' PHE . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' B' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' B' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.7 ' HZ ' ' H ' ' B' ' 70' ' ' LYS . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' C' ' 117' ' ' GLU . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -69.4 136.47 51.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.54 135.98 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.243 171.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.86 110.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 155.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 2.9 tt0 -67.51 -35.16 78.57 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.427 ' HB2' ' HG2' ' B' ' 49' ' ' LYS . 2.0 mt-30 71.28 20.29 5.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.586 1.554 . . . . 0.0 111.637 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.558 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 5.8 m 42.26 55.42 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.511 1.525 . . . . 0.0 111.589 -164.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' B' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.464 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.32 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.0 mmp_? -109.72 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.922 HG13 HG22 ' C' ' 135' ' ' ILE . 0.7 OUTLIER -123.57 1.65 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.873 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.72 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -104.55 36.3 2.46 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' GLU . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.454 HG12 ' HD1' ' B' ' 67' ' ' TYR . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' B' ' 127' ' ' GLU . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' LYS . . . . . 0.7 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' B' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 75' ' ' GLY . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.67 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.573 ' HE1' HD21 ' B' ' 132' ' ' LEU . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.635 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' B' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.523 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG22 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.656 HE21 ' HB3' ' B' ' 137' ' ' GLU . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' B' ' 91' ' ' PHE . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.567 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.486 ' CD ' ' HG3' ' B' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.854 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.526 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' B' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.615 ' CD1' ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' B' ' 116' ' ' ARG . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.573 HD21 ' HE1' ' B' ' 91' ' ' PHE . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLN . . . . . 0.486 ' HG3' ' CD ' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.839 HG22 HG13 ' A' ' 53' ' ' ILE . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' B' ' 134' ' ' VAL . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' B' ' 107' ' ' GLN . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.579 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' B' ' 150' ' ' ILE . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.79 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.52 -5.07 57.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 3.77 61.48 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.395 0.998 . . . . 0.0 113.103 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' H' ' 138' ' ' LEU . . . -69.3 136.4 28.32 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.26 145.4 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.286 1.034 . . . . 0.0 108.603 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.83 -46.72 77.51 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLN . . . . . 0.439 ' CD ' ' HB2' ' H' ' 144' ' ' ASP . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' B' ' 174' ' ' VAL . 1.7 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.798 ' HA ' ' HB2' ' H' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.842 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.842 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 5' ' ' PRO . . . . . 0.479 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' D' ' 126' ' ' VAL . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' C' ' 96' ' ' THR . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.481 HG22 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' C' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.96 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ASP . . . . . 0.497 ' OD1' HD12 ' C' ' 18' ' ' ILE . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.692 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.488 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' SER . . . . . 0.404 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' C' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' D' ' 133' ' ' GLN . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.846 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.48 51.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.97 34.96 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.263 171.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.84 110.06 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.553 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.14 78.58 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLN . . . . . 0.428 ' HB2' ' HG2' ' C' ' 49' ' ' LYS . 2.0 mt-30 71.22 20.31 5.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.601 1.56 . . . . 0.0 111.666 -172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.553 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 5.9 m 42.31 55.38 4.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.487 1.515 . . . . 0.0 111.537 -164.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' C' ' 47' ' ' GLN . 8.8 mmtp -107.69 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.48 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.09 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.37 1.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.0 mmp_? -109.73 25.24 12.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.798 HG13 HG22 ' D' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.81 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.919 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -104.67 36.37 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 55' ' ' GLY . . . . . 0.846 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' C' ' 40' ' ' GLU . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.447 HG12 ' HD1' ' C' ' 67' ' ' TYR . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' C' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ARG . . . . . 0.417 ' HA ' HD11 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.49 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' GLN . . . . . 0.671 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' C' ' 80' ' ' GLU . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.503 HD13 ' N ' ' C' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.671 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.664 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.532 ' CD1' ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.579 ' HE1' HD21 ' C' ' 132' ' ' LEU . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' C' ' 106' ' ' ALA . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.638 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.491 ' OH ' HG22 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.811 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.657 HE21 ' HB3' ' C' ' 137' ' ' GLU . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' C' ' 91' ' ' PHE . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.555 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.72 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.487 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' ARG . . . . . 0.845 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' B' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' C' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' ILE . . . . . 0.845 HG22 ' HG2' ' C' ' 116' ' ' ARG . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.579 HD21 ' HE1' ' C' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.666 HG11 ' HG3' ' C' ' 137' ' ' GLU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.922 HG22 HG13 ' B' ' 53' ' ' ILE . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' GLU . . . . . 0.666 ' HG3' HG11 ' C' ' 134' ' ' VAL . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' C' ' 107' ' ' GLN . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.811 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.638 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.491 ' H ' HD12 ' C' ' 150' ' ' ILE . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.49 162.75 15.77 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.05 57.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.27 3.75 61.41 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.389 0.995 . . . . 0.0 113.063 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.26 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.16 145.4 47.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.327 1.051 . . . . 0.0 108.633 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.63 77.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.541 ' HB3' ' HA ' ' C' ' 174' ' ' VAL . 1.7 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' I' ' 21' ' ' ALA . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.853 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 171' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.853 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 175' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.496 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' D' ' 96' ' ' THR . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' D' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.931 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' D' ' 18' ' ' ILE . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' D' ' 14' ' ' LEU . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 28' ' ' PHE . . . . . 0.699 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.699 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' E' ' 117' ' ' GLU . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' GLU . . . . . 0.502 ' HA ' HG22 ' D' ' 59' ' ' VAL . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -69.5 136.55 51.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.59 136.0 34.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.232 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.81 110.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 155.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 2.9 tt0 -67.53 -35.09 78.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' D' ' 49' ' ' LYS . 2.0 mt-30 71.22 20.26 5.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.602 1.561 . . . . 0.0 111.7 -172.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.559 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 5.8 m 42.35 55.37 4.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.48 1.512 . . . . 0.0 111.592 -164.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' D' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.44 0.33 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.56 15.95 27.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.81 81.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.1 mmp_? -109.84 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.813 HG13 HG22 ' E' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.66 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.854 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -104.56 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 55' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 40' ' ' GLU . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.461 HG12 ' HD1' ' D' ' 67' ' ' TYR . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' D' ' 32' ' ' GLN . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' D' ' 65' ' ' VAL . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' D' ' 127' ' ' GLU . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' CD1' ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' LYS . . . . . 0.68 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.479 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.502 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 77' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' D' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.502 HG12 ' O ' ' D' ' 75' ' ' GLY . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.895 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.895 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.529 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.931 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' D' ' 132' ' ' LEU . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.405 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.631 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' D' ' 106' ' ' ALA . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.517 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.666 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.496 ' OH ' HG22 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.64 HE21 ' HB3' ' D' ' 137' ' ' GLU . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.408 ' HD1' ' O ' ' D' ' 91' ' ' PHE . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.564 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.85 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.488 HG13 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.478 ' HG2' ' CE2' ' D' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 128' ' ' ILE . . . . . 0.619 ' CD1' ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 130' ' ' ILE . . . . . 0.85 HG22 ' HG2' ' D' ' 116' ' ' ARG . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' D' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' D' ' 137' ' ' GLU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.798 HG22 HG13 ' C' ' 53' ' ' ILE . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' GLU . . . . . 0.68 ' HG3' HG11 ' D' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' D' ' 107' ' ' GLN . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.814 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.666 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.493 HD12 ' H ' ' D' ' 150' ' ' ILE . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.57 162.72 15.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.453 ' HD3' ' OE2' ' I' ' 46' ' ' GLU . 4.7 mmtt -81.48 -5.04 57.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.23 3.79 61.46 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.357 0.98 . . . . 0.0 113.052 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 157' ' ' GLY . . . . . 0.415 ' CA ' HD11 ' J' ' 138' ' ' LEU . . . -69.35 136.39 28.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.25 145.29 47.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.352 1.061 . . . . 0.0 108.642 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.75 -46.71 77.82 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -158.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.406 ' CD ' ' HB2' ' J' ' 144' ' ' ASP . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 164' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' J' ' 22' ' ' THR . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' D' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.886 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.864 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 168' ' ' GLY . . . . . 0.432 ' C ' HD13 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 171' ' ' PRO . . . . . 0.622 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 173' ' ' THR . . . . . 0.864 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 175' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' F' ' 126' ' ' VAL . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' E' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' HB3' ' E' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' E' ' 91' ' ' PHE . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.92 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' E' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 24' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' E' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 40' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.819 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.57 135.98 34.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.245 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.85 110.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.562 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.18 78.65 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' E' ' 49' ' ' LYS . 2.0 mt-30 71.21 20.28 5.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.588 1.555 . . . . 0.0 111.701 -172.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.562 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 5.8 m 42.26 55.47 3.96 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.539 1.536 . . . . 0.0 111.578 -164.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 49' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' E' ' 47' ' ' GLN . 8.8 mmtp -107.75 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.463 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.55 15.91 27.4 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.1 mmp_? -109.78 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.851 HG13 HG22 ' F' ' 135' ' ' ILE . 0.7 OUTLIER -123.6 1.8 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.873 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -104.55 36.22 2.48 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 55' ' ' GLY . . . . . 0.819 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' E' ' 40' ' ' GLU . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.449 HG12 ' HD1' ' E' ' 67' ' ' TYR . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.449 ' HD1' HG12 ' E' ' 65' ' ' VAL . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' E' ' 127' ' ' GLU . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 70' ' ' LYS . . . . . 0.69 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.446 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 77' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' E' ' 80' ' ' GLU . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' E' ' 79' ' ' ILE . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.885 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.668 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.885 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.596 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.92 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' E' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.403 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.638 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' E' ' 106' ' ' ALA . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.652 HE21 ' HB3' ' E' ' 137' ' ' GLU . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' E' ' 91' ' ' PHE . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.561 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.859 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' D' ' 37' ' ' VAL . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 122' ' ' VAL . . . . . 0.42 HG13 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CD2' ' E' ' 68' ' ' TYR . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 128' ' ' ILE . . . . . 0.61 ' CD1' ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.859 HG22 ' HG2' ' E' ' 116' ' ' ARG . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' E' ' 91' ' ' PHE . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 133' ' ' GLN . . . . . 0.495 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.685 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.813 HG22 HG13 ' D' ' 53' ' ' ILE . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' E' ' 134' ' ' VAL . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.602 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.668 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.486 HD12 ' H ' ' E' ' 150' ' ' ILE . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.59 162.77 15.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.458 ' HD3' ' OE2' ' J' ' 46' ' ' GLU . 4.7 mmtt -81.49 -5.1 57.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.74 61.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.339 0.972 . . . . 0.0 113.048 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.34 28.36 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.36 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.333 1.053 . . . . 0.0 108.614 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.64 77.83 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -158.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.566 ' HB3' ' HA ' ' E' ' 174' ' ' VAL . 1.7 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.826 ' HA ' ' HB2' ' K' ' 21' ' ' ALA . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.876 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 168' ' ' GLY . . . . . 0.462 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 171' ' ' PRO . . . . . 0.574 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 173' ' ' THR . . . . . 0.876 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 175' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.556 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.575 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 7' ' ' MET . . . . . 0.479 ' H ' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' F' ' 91' ' ' PHE . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.97 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 19' ' ' ASP . . . . . 0.488 ' OD1' HD12 ' F' ' 18' ' ' ILE . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.408 ' H ' ' HD2' ' K' ' 49' ' ' LYS . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 31' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 122' ' ' VAL . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 38' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 40' ' ' GLU . . . . . 0.489 ' HA ' HG22 ' F' ' 59' ' ' VAL . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.56 51.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.65 135.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.24 171.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.88 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 46' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.19 78.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' F' ' 49' ' ' LYS . 2.0 mt-30 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.62 1.568 . . . . 0.0 111.666 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.55 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 5.9 m 42.33 55.43 4.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 111.56 -164.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' F' ' 47' ' ' GLN . 8.8 mmtp -107.75 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.457 -177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.51 15.93 27.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.1 mmp_? -109.78 25.32 11.93 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.885 178.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.695 HD13 ' HD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -104.64 36.29 2.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' F' ' 40' ' ' GLU . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' F' ' 67' ' ' TYR . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.461 ' OH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.475 ' CD2' ' HG2' ' F' ' 127' ' ' GLU . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 71' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 77' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' F' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.501 HG12 ' O ' ' F' ' 75' ' ' GLY . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.567 ' HE1' HD21 ' F' ' 132' ' ' LEU . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' F' ' 106' ' ' ALA . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 95' ' ' ASP . . . . . 0.512 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' F' ' 137' ' ' GLU . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' F' ' 91' ' ' PHE . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.566 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' F' ' 88' ' ' GLN . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 116' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' E' ' 6' ' ' ILE . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' F' ' 68' ' ' TYR . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 128' ' ' ILE . . . . . 0.601 ' CD1' ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.871 HG22 ' HG2' ' F' ' 116' ' ' ARG . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.567 HD21 ' HE1' ' F' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' F' ' 137' ' ' GLU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.851 HG22 HG13 ' E' ' 53' ' ' ILE . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' F' ' 134' ' ' VAL . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.493 ' HB2' ' OE1' ' A' ' 84' ' ' GLN . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.652 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.472 HD12 ' H ' ' F' ' 150' ' ' ILE . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.56 162.75 15.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.54 -5.06 57.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.77 61.39 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.438 1.017 . . . . 0.0 113.047 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 157' ' ' GLY . . . . . 0.585 ' CA ' HD11 ' L' ' 138' ' ' LEU . . . -69.3 136.39 28.3 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.493 ' N ' HD11 ' L' ' 138' ' ' LEU . 46.5 m-85 -135.2 145.36 47.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.342 1.057 . . . . 0.0 108.602 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.601 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 -65.86 -46.64 77.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -158.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.717 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.881 ' NE2' ' OE2' ' L' ' 142' ' ' GLU . 5.3 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.491 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 164' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' F' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.863 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.857 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 168' ' ' GLY . . . . . 0.725 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.747 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 170' ' ' ALA . . . . . 0.435 ' O ' ' HE1' ' L' ' 110' ' ' PHE . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 171' ' ' PRO . . . . . 0.649 ' HA ' ' CD1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 173' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 175' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.573 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 7' ' ' MET . . . . . 0.474 ' H ' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 0.545 ' HA ' ' OG1' ' G' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 20.0 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.978 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 19' ' ' ASP . . . . . 0.49 ' OD1' HD12 ' G' ' 18' ' ' ILE . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 24' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 28' ' ' PHE . . . . . 0.693 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 36' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 38' ' ' SER . . . . . 0.677 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 40' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' G' ' 59' ' ' VAL . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 43' ' ' LEU . . . . . 0.841 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -69.46 136.53 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.99 34.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.244 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.8 110.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 155.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 2.9 tt0 -67.44 -35.17 78.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' G' ' 49' ' ' LYS . 2.0 mt-30 71.23 20.31 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.617 1.567 . . . . 0.0 111.647 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 48' ' ' THR . . . . . 0.551 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 5.8 m 42.25 55.44 3.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.49 1.516 . . . . 0.0 111.609 -164.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' G' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.505 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.57 16.05 26.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.0 mmp_? -109.69 25.2 12.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.582 HG13 HG22 ' H' ' 135' ' ' ILE . 0.7 OUTLIER -123.54 1.75 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.863 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.528 HD13 ' HD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.26 2.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 55' ' ' GLY . . . . . 0.841 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' G' ' 40' ' ' GLU . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' G' ' 67' ' ' TYR . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.454 ' OH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' G' ' 127' ' ' GLU . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.611 ' HA3' ' CD1' ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD2' ' G' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 76' ' ' GLN . . . . . 0.674 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' G' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.502 HD13 ' N ' ' G' ' 79' ' ' ILE . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.674 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.872 HE22 ' HB2' ' L' ' 139' ' ' LYS . 0.4 OUTLIER -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.577 ' HE1' HD21 ' G' ' 132' ' ' LEU . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' G' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.659 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' G' ' 137' ' ' GLU . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' G' ' 91' ' ' PHE . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' L' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' G' ' 133' ' ' GLN . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.867 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.429 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.476 ' HG2' ' CE2' ' G' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 128' ' ' ILE . . . . . 0.611 ' CD1' ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 130' ' ' ILE . . . . . 0.867 HG22 ' HG2' ' G' ' 116' ' ' ARG . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.577 HD21 ' HE1' ' G' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.546 HG22 HG13 ' L' ' 53' ' ' ILE . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' G' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.915 ' HB2' HE22 ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.659 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.481 HD12 ' H ' ' G' ' 150' ' ' ILE . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.74 15.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.45 -5.1 57.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.32 3.72 61.36 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.343 0.974 . . . . 0.0 113.019 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.27 136.36 28.32 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.22 145.35 47.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 108.62 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.83 -46.65 77.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -158.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' G' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 166' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.87 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 173' ' ' THR . . . . . 0.87 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 175' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.584 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 7' ' ' MET . . . . . 0.48 ' H ' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.471 HG22 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' H' ' 27' ' ' LEU . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.404 ' HE2' ' CE1' ' H' ' 91' ' ' PHE . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 20.0 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' H' ' 18' ' ' ILE . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' H' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 28' ' ' PHE . . . . . 0.692 ' HZ ' ' H ' ' H' ' 70' ' ' LYS . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 29' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 40' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' H' ' 59' ' ' VAL . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -69.54 136.55 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.6 135.95 34.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.85 110.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.15 78.57 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' H' ' 49' ' ' LYS . 2.0 mt-30 71.24 20.34 5.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 111.627 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 48' ' ' THR . . . . . 0.554 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 5.9 m 42.28 55.46 3.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.519 1.527 . . . . 0.0 111.533 -164.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' H' ' 47' ' ' GLN . 8.8 mmtp -107.78 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.489 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.51 15.9 27.39 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 81.44 1.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.1 mmp_? -109.75 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.481 HG13 HG22 ' I' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.75 5.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -104.58 36.27 2.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' H' ' 40' ' ' GLU . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.453 HG12 ' HD1' ' H' ' 67' ' ' TYR . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.453 ' HD1' HG12 ' H' ' 65' ' ' VAL . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' H' ' 127' ' ' GLU . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 71' ' ' ARG . . . . . 0.419 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 77' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' H' ' 80' ' ' GLU . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.498 HG12 ' O ' ' H' ' 75' ' ' GLY . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.676 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.915 HE22 ' HB2' ' G' ' 139' ' ' LYS . 0.4 OUTLIER -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.54 ' CD1' ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' H' ' 132' ' ' LEU . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' H' ' 106' ' ' ALA . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 95' ' ' ASP . . . . . 0.513 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.646 HE21 ' HB3' ' H' ' 137' ' ' GLU . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.419 ' HD1' ' O ' ' H' ' 91' ' ' PHE . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' H' ' 88' ' ' GLN . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.438 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' H' ' 133' ' ' GLN . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 116' ' ' ARG . . . . . 0.853 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' H' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 128' ' ' ILE . . . . . 0.604 ' CD1' ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 130' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' H' ' 116' ' ' ARG . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' H' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.582 HG22 HG13 ' G' ' 53' ' ' ILE . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 137' ' ' GLU . . . . . 0.668 ' HG3' HG11 ' H' ' 134' ' ' VAL . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.41 HD11 ' HA3' ' B' ' 157' ' ' GLY . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.699 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.82 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.63 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' B' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.49 HD12 ' H ' ' H' ' 150' ' ' ILE . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.81 15.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.53 -5.07 57.63 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.78 61.39 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.405 1.002 . . . . 0.0 113.034 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.34 136.35 28.2 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.35 47.67 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.352 1.061 . . . . 0.0 108.66 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.6 77.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -158.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' H' ' 174' ' ' VAL . 1.7 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 166' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 175' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' I' ' 96' ' ' THR . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' I' ' 27' ' ' LEU . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.412 ' HE2' ' CE1' ' I' ' 91' ' ' PHE . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 20.1 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 19' ' ' ASP . . . . . 0.494 ' OD1' HD12 ' I' ' 18' ' ' ILE . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 24' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' I' ' 14' ' ' LEU . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 28' ' ' PHE . . . . . 0.694 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 31' ' ' TYR . . . . . 0.458 ' O ' HG11 ' J' ' 122' ' ' VAL . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.4 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' J' ' 117' ' ' GLU . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 38' ' ' SER . . . . . 0.634 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 40' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 43' ' ' LEU . . . . . 0.852 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.53 51.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.6 136.05 34.91 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.219 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.78 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 155.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 2.9 tt0 -67.46 -35.12 78.58 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 47' ' ' GLN . . . . . 0.431 ' HB2' ' HG2' ' I' ' 49' ' ' LYS . 2.0 mt-30 71.18 20.35 5.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.583 . . . . 0.0 111.678 -172.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.552 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 5.8 m 42.29 55.46 3.99 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.474 1.509 . . . . 0.0 111.573 -164.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' I' ' 47' ' ' GLN . 8.8 mmtp -107.77 -133.52 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.47 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.52 15.95 27.23 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.0 mmp_? -109.69 25.29 11.96 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.708 HG13 HG22 ' J' ' 135' ' ' ILE . 0.7 OUTLIER -123.53 1.62 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 178.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.49 36.23 2.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 55' ' ' GLY . . . . . 0.852 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' I' ' 40' ' ' GLU . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.455 HG12 ' HD1' ' I' ' 67' ' ' TYR . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.455 ' HD1' HG12 ' I' ' 65' ' ' VAL . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' I' ' 127' ' ' GLU . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' CD1' ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.694 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.404 ' HD2' HH21 ' I' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 76' ' ' GLN . . . . . 0.667 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' I' ' 80' ' ' GLU . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' I' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HE1' HD21 ' I' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' I' ' 106' ' ' ALA . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.635 HE21 ' HB3' ' I' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' I' ' 91' ' ' PHE . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.422 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' I' ' 133' ' ' GLN . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.843 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' I' ' 68' ' ' TYR . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 128' ' ' ILE . . . . . 0.618 ' CD1' ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 130' ' ' ILE . . . . . 0.843 HG22 ' HG2' ' I' ' 116' ' ' ARG . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.562 HD21 ' HE1' ' I' ' 91' ' ' PHE . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.481 HG22 HG13 ' H' ' 53' ' ' ILE . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 137' ' ' GLU . . . . . 0.657 ' HG3' HG11 ' I' ' 134' ' ' VAL . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.632 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.489 HD12 ' H ' ' I' ' 150' ' ' ILE . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.78 15.76 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.01 57.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.3 3.66 61.42 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 119.388 0.994 . . . . 0.0 113.054 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.38 28.44 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.23 145.35 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.297 1.039 . . . . 0.0 108.57 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.85 -46.61 77.86 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' I' ' 174' ' ' VAL . 1.7 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 166' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.844 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' I' I ' 173' ' ' THR . . . . . 0.844 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 175' ' ' PRO . . . . . 0.583 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.586 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.601 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 7' ' ' MET . . . . . 0.481 ' H ' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' J' ' 96' ' ' THR . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' J' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.414 ' HE2' ' CE1' ' J' ' 91' ' ' PHE . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 19.9 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.949 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' J' ' 18' ' ' ILE . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 21' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 22' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' D' ' 164' ' ' GLY . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 24' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' J' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 28' ' ' PHE . . . . . 0.701 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 29' ' ' PRO . . . . . 0.701 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 31' ' ' TYR . . . . . 0.492 ' O ' HG11 ' K' ' 122' ' ' VAL . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.4 ' HB3' ' OG1' ' J' ' 66' ' ' THR . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 36' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' K' ' 117' ' ' GLU . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 38' ' ' SER . . . . . 0.573 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 40' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' J' ' 59' ' ' VAL . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 43' ' ' LEU . . . . . 0.839 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.01 34.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.267 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.83 110.07 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 2.9 tt0 -67.49 -35.14 78.57 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 47' ' ' GLN . . . . . 0.428 ' HB2' ' HG2' ' J' ' 49' ' ' LYS . 2.0 mt-30 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.564 1.546 . . . . 0.0 111.667 -172.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.559 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 5.8 m 42.31 55.41 4.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.477 1.511 . . . . 0.0 111.569 -164.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' J' ' 47' ' ' GLN . 8.8 mmtp -107.78 -133.43 0.33 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.503 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.59 15.98 27.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.0 mmp_? -109.7 25.21 12.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.566 HG13 HG22 ' K' ' 135' ' ' ILE . 0.7 OUTLIER -123.51 1.7 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.901 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -104.61 36.33 2.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 176.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 55' ' ' GLY . . . . . 0.839 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' J' ' 40' ' ' GLU . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' J' ' 67' ' ' TYR . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' J' ' 32' ' ' GLN . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' J' ' 65' ' ' VAL . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' J' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.679 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 76' ' ' GLN . . . . . 0.678 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' J' ' 80' ' ' GLU . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' J' ' 79' ' ' ILE . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.678 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.887 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.665 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.887 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.578 ' HE1' HD21 ' J' ' 132' ' ' LEU . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.634 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' J' ' 106' ' ' ALA . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.658 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' J' ' 137' ' ' GLU . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' J' ' 91' ' ' PHE . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' J' ' 88' ' ' GLN . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 116' ' ' ARG . . . . . 0.841 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' I' ' 37' ' ' VAL . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.492 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 122' ' ' VAL . . . . . 0.458 HG11 ' O ' ' I' ' 31' ' ' TYR . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' J' ' 68' ' ' TYR . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 130' ' ' ILE . . . . . 0.841 HG22 ' HG2' ' J' ' 116' ' ' ARG . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.578 HD21 ' HE1' ' J' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.708 HG22 HG13 ' I' ' 53' ' ' ILE . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 137' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' J' ' 134' ' ' VAL . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.415 HD11 ' CA ' ' D' ' 157' ' ' GLY . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.627 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.812 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' D' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.572 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.476 ' H ' HD12 ' J' ' 150' ' ' ILE . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.57 162.79 15.77 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.08 57.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.24 3.74 61.47 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.365 0.984 . . . . 0.0 113.045 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.3 28.34 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.18 145.35 47.64 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 108.67 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.65 77.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.546 ' HB3' ' HA ' ' J' ' 174' ' ' VAL . 1.7 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 166' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' J' J ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' L' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' K' ' 96' ' ' THR . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.511 ' CG2' HG11 ' L' ' 126' ' ' VAL . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' K' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' K' ' 91' ' ' PHE . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 19.9 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.939 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' K' ' 18' ' ' ILE . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' K' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 31' ' ' TYR . . . . . 0.426 ' O ' HG11 ' L' ' 122' ' ' VAL . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 38' ' ' SER . . . . . 0.527 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 40' ' ' GLU . . . . . 0.492 ' HA ' HG22 ' K' ' 59' ' ' VAL . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.55 136.0 34.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.245 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.82 110.15 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 155.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 2.9 tt0 -67.52 -35.14 78.53 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 47' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' K' ' 49' ' ' LYS . 2.0 mt-30 71.24 20.26 5.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.618 1.567 . . . . 0.0 111.629 -172.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.564 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 5.9 m 42.31 55.47 4.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.519 1.527 . . . . 0.0 111.534 -164.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' K' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.522 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.57 15.91 27.4 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.0 mmp_? -109.74 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.602 HG13 HG22 ' L' ' 135' ' ' ILE . 0.7 OUTLIER -123.64 1.76 5.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.858 178.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.558 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.62 36.29 2.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' K' ' 40' ' ' GLU . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' K' ' 67' ' ' TYR . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' K' ' 127' ' ' GLU . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' CD1' ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' K' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 77' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' K' ' 80' ' ' GLU . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.499 HD13 ' N ' ' K' ' 79' ' ' ILE . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.88 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.588 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' K' ' 132' ' ' LEU . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' K' ' 106' ' ' ALA . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.489 ' OH ' HG22 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.641 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' K' ' 91' ' ' PHE . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' K' ' 88' ' ' GLN . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' J' ' 40' ' ' GLU . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.497 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 116' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' J' ' 37' ' ' VAL . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.428 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 122' ' ' VAL . . . . . 0.492 HG11 ' O ' ' J' ' 31' ' ' TYR . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.601 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' K' ' 68' ' ' TYR . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 128' ' ' ILE . . . . . 0.603 ' CD1' ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 130' ' ' ILE . . . . . 0.851 HG22 ' HG2' ' K' ' 116' ' ' ARG . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' K' ' 91' ' ' PHE . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 133' ' ' GLN . . . . . 0.497 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.566 HG22 HG13 ' J' ' 53' ' ' ILE . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 137' ' ' GLU . . . . . 0.682 ' HG3' HG11 ' K' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.555 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.584 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.469 HD12 ' H ' ' K' ' 150' ' ' ILE . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.58 162.73 15.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.51 -5.1 57.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.75 61.37 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.393 0.997 . . . . 0.0 113.04 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.17 145.39 47.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.613 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.87 -46.64 77.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' K' ' 174' ' ' VAL . 1.7 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 166' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.873 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' K' K ' 173' ' ' THR . . . . . 0.873 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 175' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 0.529 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.402 ' HE2' ' CE1' ' L' ' 91' ' ' PHE . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.928 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' L' ' 18' ' ' ILE . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 22' ' ' THR . . . . . 0.677 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 38' ' ' SER . . . . . 0.637 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 40' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' L' ' 59' ' ' VAL . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 43' ' ' LEU . . . . . 0.829 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -69.52 136.47 51.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.49 135.99 34.99 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.25 171.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.8 110.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 155.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 2.9 tt0 -67.54 -35.11 78.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' HG2' ' L' ' 49' ' ' LYS . 2.0 mt-30 71.21 20.38 5.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.642 1.577 . . . . 0.0 111.615 -172.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 48' ' ' THR . . . . . 0.558 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 5.8 m 42.31 55.39 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.583 -164.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 49' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' L' ' 47' ' ' GLN . 8.8 mmtp -107.76 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.428 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.54 16.03 27.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.31 1.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.1 mmp_? -109.7 25.32 11.93 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.546 HG13 HG22 ' G' ' 135' ' ' ILE . 0.7 OUTLIER -123.57 1.69 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.831 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.529 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.55 36.27 2.46 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 55' ' ' GLY . . . . . 0.829 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' L' ' 40' ' ' GLU . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' L' ' 67' ' ' TYR . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' L' ' 65' ' ' VAL . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' L' ' 127' ' ' GLU . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.442 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 75' ' ' GLY . . . . . 0.496 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 76' ' ' GLN . . . . . 0.663 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 77' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' L' ' 80' ' ' GLU . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.502 ' N ' HD13 ' L' ' 79' ' ' ILE . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.527 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.747 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.928 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' L' ' 132' ' ' LEU . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.717 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.628 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' L' ' 106' ' ' ALA . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' L' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' L' ' 91' ' ' PHE . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CD1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' L' ' 88' ' ' GLN . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.493 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 122' ' ' VAL . . . . . 0.426 HG11 ' O ' ' K' ' 31' ' ' TYR . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' L' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 128' ' ' ILE . . . . . 0.607 ' CD1' ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' L' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' L' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' L' ' 137' ' ' GLU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.602 HG22 HG13 ' K' ' 53' ' ' ILE . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 137' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' L' ' 134' ' ' VAL . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.585 HD11 ' CA ' ' F' ' 157' ' ' GLY . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.872 ' HB2' HE22 ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.601 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.881 ' OE2' ' NE2' ' F' ' 162' ' ' GLN . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.657 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.513 ' H ' ' NE2' ' F' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.473 HD12 ' H ' ' L' ' 150' ' ' ILE . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.52 162.75 15.79 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.12 57.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.79 61.34 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 119.393 0.997 . . . . 0.0 113.038 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.33 136.35 28.22 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.38 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.325 1.05 . . . . 0.0 108.652 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.88 -46.59 77.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' L' ' 174' ' ' VAL . 1.7 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 166' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.88 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' L' L ' 173' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 175' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.812 HG21 HG23 ' B' ' 126' ' ' VAL . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 1.056 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.056 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HD1' ' CE1' ' A' ' 91' ' ' PHE . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.825 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 22' ' ' THR . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.752 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 65' ' ' VAL . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' B' ' 117' ' ' GLU . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.825 HH22 ' HB2' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.601 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.77 3.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.228 171.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.527 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 2.7 mp0 -71.25 -48.08 53.24 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.83 38.58 27.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.574 1.55 . . . . 0.0 111.658 -172.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.25 3.29 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 111.542 -164.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.88 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.446 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.89 16.79 1.08 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' ' 44' ' ' PHE . . . 87.03 167.51 43.83 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.19 122.32 47.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.5 pp -127.16 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.923 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp -61.74 -16.91 53.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 54' ' ' LEU . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.825 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' HA2' ' A' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.717 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' F' ' 5' ' ' PRO . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.737 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 113' ' ' ILE . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' A' ' 82' ' ' ALA . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.762 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 102' ' ' ASP . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.564 ' HB2' HD22 ' A' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 93' ' ' ARG . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.821 ' HD2' HD11 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.671 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 83' ' ' TYR . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.831 HG23 HG21 ' F' ' 6' ' ' ILE . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' A' ' 111' ' ' ALA . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.692 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.851 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.821 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.667 ' O ' HD12 ' A' ' 150' ' ' ILE . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 145' ' ' THR . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.73 137.76 31.88 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER -57.36 -41.25 79.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 158' ' ' TYR . . . 137.06 141.21 4.21 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.393 0.997 . . . . 0.0 113.062 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.26 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.561 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -108.81 89.32 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.353 1.061 . . . . 0.0 108.634 177.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.65 67.2 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -158.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.488 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.516 ' CA ' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.778 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 172' ' ' GLY . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' G' ' 88' ' ' GLN . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' H ' HG21 ' A' ' 167' ' ' THR . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.739 HG21 HG23 ' C' ' 126' ' ' VAL . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' MET . . . . . 1.073 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASP . . . . . 1.073 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' B' ' 91' ' ' PHE . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.841 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 22' ' ' THR . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . 0.707 ' HA ' ' HB3' ' G' ' 47' ' ' GLN . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' B' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 121.6 42.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PHE . . . . . 0.593 ' CE2' ' HA3' ' B' ' 51' ' ' GLY . 0.3 OUTLIER -128.48 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.235 171.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.53 ' O ' ' HA2' ' B' ' 51' ' ' GLY . 3.2 t70 -111.78 170.22 8.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 155.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLU . . . . . 0.617 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.7 mp0 -71.27 -48.16 52.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.91 38.6 27.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.618 1.567 . . . . 0.0 111.633 -172.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.92 45.26 3.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -164.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.73 1.69 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.86 16.72 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' B' ' 44' ' ' PHE . . . 87.1 167.56 43.85 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.54 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -112.22 122.36 47.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.5 pp -127.22 -39.14 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.839 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp -61.83 -16.91 53.96 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' PRO . . . . . 0.532 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' B' ' 136' ' ' GLY . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' TYR . . . . . 0.714 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.412 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.748 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' B' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLN . . . . . 0.872 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' B' ' 82' ' ' ALA . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.507 ' HD2' ' HB2' ' B' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.406 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASN . . . . . 0.577 HD22 ' HB2' ' B' ' 102' ' ' ASP . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASP . . . . . 0.577 ' HB2' HD22 ' B' ' 99' ' ' ASN . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' B' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.571 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' TYR . . . . . 0.663 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.553 HG22 ' HD1' ' B' ' 83' ' ' TYR . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . 0.789 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 116' ' ' ARG . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.563 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' VAL . . . . . 0.812 HG23 HG21 ' A' ' 6' ' ' ILE . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.714 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LEU . . . . . 0.571 HD13 ' HB1' ' B' ' 111' ' ' ALA . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' VAL . . . . . 0.816 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.758 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.663 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 139' ' ' LYS . . . . . 0.507 ' HD3' ' HG2' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.87 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' THR . . . . . 0.671 ' O ' HD12 ' B' ' 150' ' ' ILE . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.77 137.73 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.31 79.59 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' B' ' 158' ' ' TYR . . . 137.04 141.32 4.23 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.434 1.015 . . . . 0.0 113.043 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HA3' ' B' ' 156' ' ' GLY . 0.0 OUTLIER -108.88 89.3 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.304 1.042 . . . . 0.0 108.587 177.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.65 67.1 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' PHE . . . . . 0.567 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.429 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' B' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 166' ' ' THR . . . . . 0.735 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' B' ' 172' ' ' GLY . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' B' ' 167' ' ' THR . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.715 HG21 HG23 ' D' ' 126' ' ' VAL . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' MET . . . . . 1.07 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ASP . . . . . 1.07 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 13' ' ' TYR . . . . . 0.465 ' HD1' ' CE1' ' C' ' 91' ' ' PHE . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' LEU . . . . . 0.754 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' PHE . . . . . 0.563 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ILE . . . . . 0.857 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' THR . . . . . 0.439 HG22 ' H ' ' C' ' 23' ' ' GLY . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 23' ' ' GLY . . . . . 0.439 ' H ' HG22 ' C' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LEU . . . . . 0.614 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' H' ' 47' ' ' GLN . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' THR . . . . . 0.444 HG22 HG23 ' D' ' 122' ' ' VAL . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' C' ' 65' ' ' VAL . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' ARG . . . . . 0.798 HH22 ' HB2' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' GLU . . . . . 0.828 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' HA3' ' C' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.255 171.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.541 ' O ' ' HA2' ' C' ' 51' ' ' GLY . 3.2 t70 -111.82 170.16 8.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 155.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' GLU . . . . . 0.593 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 2.7 mp0 -71.15 -48.12 53.76 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.561 1.544 . . . . 0.0 111.649 -172.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.92 45.33 3.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.541 1.537 . . . . 0.0 111.521 -164.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.89 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.496 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.93 16.79 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.589 ' HA3' ' CE2' ' C' ' 44' ' ' PHE . . . 87.1 167.5 43.8 Favored Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -112.2 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.892 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.5 pp -127.21 -39.18 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' LEU . . . . . 0.847 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp -61.75 -16.93 53.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' C' ' 54' ' ' LEU . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.617 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ALA . . . . . 0.798 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' C' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' C' ' 64' ' ' GLU . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.777 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 67' ' ' TYR . . . . . 0.718 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' C' ' 113' ' ' ILE . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' TYR . . . . . 0.552 ' CD1' HG22 ' C' ' 113' ' ' ILE . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLN . . . . . 0.886 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' C' ' 82' ' ' ALA . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' PHE . . . . . 0.563 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' TRP . . . . . 0.754 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' C' ' 107' ' ' GLN . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.748 HG12 ' HB2' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' C' ' 102' ' ' ASP . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ASP . . . . . 0.581 ' HB2' HD22 ' C' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 103' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.825 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ALA . . . . . 0.748 ' HB2' HG12 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' GLN . . . . . 0.501 ' HB2' ' HD2' ' C' ' 93' ' ' ARG . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PHE . . . . . 0.834 ' HD2' HD11 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ALA . . . . . 0.581 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 112' ' ' TYR . . . . . 0.661 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' C' ' 83' ' ' TYR . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' VAL . . . . . 0.739 HG23 HG21 ' B' ' 6' ' ' ILE . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 128' ' ' ILE . . . . . 0.718 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' SER . . . . . 0.777 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 132' ' ' LEU . . . . . 0.581 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 134' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ILE . . . . . 0.728 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 136' ' ' GLY . . . . . 0.67 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 139' ' ' LYS . . . . . 0.457 ' HD3' ' HG2' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' ILE . . . . . 0.867 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' C' ' 150' ' ' ILE . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' C' ' 145' ' ' THR . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.72 137.72 31.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.414 ' HE3' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER -57.28 -41.35 79.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 175.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 156' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' C' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.353 0.979 . . . . 0.0 113.059 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.23 0.48 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' C' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.303 1.041 . . . . 0.0 108.641 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.27 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 160' ' ' PHE . . . . . 0.502 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 161' ' ' GLN . . . . . 0.506 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 165' ' ' GLN . . . . . 0.506 ' CA ' ' HB3' ' C' ' 161' ' ' GLN . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 166' ' ' THR . . . . . 0.721 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 167' ' ' THR . . . . . 0.553 HG21 ' H ' ' C' ' 172' ' ' GLY . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.553 ' H ' HG21 ' C' ' 167' ' ' THR . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.776 HG21 HG23 ' E' ' 126' ' ' VAL . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' LYS . . . . . 0.571 ' HG2' HD11 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 13' ' ' TYR . . . . . 0.464 ' HD1' ' CE1' ' D' ' 91' ' ' PHE . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' LEU . . . . . 0.75 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' PHE . . . . . 0.554 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' D' ' 23' ' ' GLY . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.444 ' H ' HG22 ' D' ' 22' ' ' THR . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.477 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' I' ' 47' ' ' GLN . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' D' ' 65' ' ' VAL . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' SER . . . . . 0.556 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' ARG . . . . . 0.793 HH22 ' HB2' ' D' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' PHE . . . . . 0.597 ' CE2' ' HA3' ' D' ' 51' ' ' GLY . 0.3 OUTLIER -128.46 90.83 3.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.205 171.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.544 ' O ' ' HA2' ' D' ' 51' ' ' GLY . 3.2 t70 -111.82 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' E' ' 58' ' ' SER . 2.7 mp0 -71.21 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.622 1.569 . . . . 0.0 111.673 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.26 3.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.466 1.506 . . . . 0.0 111.577 -164.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.75 1.69 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.483 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.92 16.83 1.07 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' D' ' 44' ' ' PHE . . . 87.06 167.56 43.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -112.23 122.35 47.47 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.83 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' LEU . . . . . 0.814 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp -61.8 -16.87 53.44 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' D' ' 54' ' ' LEU . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' SER . . . . . 0.593 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ALA . . . . . 0.793 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' D' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' D' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 66' ' ' THR . . . . . 0.79 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' TYR . . . . . 0.71 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' ARG . . . . . 0.417 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.4 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ILE . . . . . 0.526 HD12 HD11 ' D' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 81' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' TYR . . . . . 0.55 ' HD1' HG22 ' D' ' 113' ' ' ILE . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' LYS . . . . . 0.732 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLN . . . . . 0.847 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' D' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' PHE . . . . . 0.554 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 92' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 93' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' D' ' 107' ' ' GLN . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' ASN . . . . . 0.578 HD22 ' HB2' ' D' ' 102' ' ' ASP . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' ASP . . . . . 0.578 ' HB2' HD22 ' D' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.833 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 106' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HD2' ' D' ' 93' ' ' ARG . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PHE . . . . . 0.805 ' HD2' HD11 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 112' ' ' TYR . . . . . 0.672 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 113' ' ' ILE . . . . . 0.55 HG22 ' HD1' ' D' ' 83' ' ' TYR . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 114' ' ' GLU . . . . . 0.828 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 116' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' D' ' 116' ' ' ARG . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 117' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 33' ' ' THR . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 126' ' ' VAL . . . . . 0.715 HG23 HG21 ' C' ' 6' ' ' ILE . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 128' ' ' ILE . . . . . 0.71 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' SER . . . . . 0.79 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 131' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' VAL . . . . . 0.892 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ILE . . . . . 0.691 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.833 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 145' ' ' THR . . . . . 0.666 ' O ' HD12 ' D' ' 150' ' ' ILE . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 146' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 147' ' ' PRO . . . . . 0.568 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' ILE . . . . . 0.666 HD12 ' O ' ' D' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' VAL . . . . . 0.427 HG21 ' O ' ' I' ' 48' ' ' THR . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.79 137.76 31.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER -57.26 -41.31 79.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' D' ' 158' ' ' TYR . . . 137.07 141.28 4.22 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.339 0.972 . . . . 0.0 113.09 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' D' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.308 1.043 . . . . 0.0 108.595 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.03 -46.67 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -158.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 160' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 163' ' ' PRO . . . . . 0.535 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' D' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 166' ' ' THR . . . . . 0.684 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 167' ' ' THR . . . . . 0.569 HG21 ' H ' ' D' ' 172' ' ' GLY . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 169' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' J' ' 88' ' ' GLN . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 172' ' ' GLY . . . . . 0.569 ' H ' HG21 ' D' ' 167' ' ' THR . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 5' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.823 HG21 HG23 ' F' ' 126' ' ' VAL . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 7' ' ' MET . . . . . 1.025 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ASP . . . . . 1.025 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 13' ' ' TYR . . . . . 0.456 ' HD1' ' CE1' ' E' ' 91' ' ' PHE . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 15' ' ' PHE . . . . . 0.559 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ILE . . . . . 0.84 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' E' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' E' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 27' ' ' LEU . . . . . 0.635 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 30' ' ' ALA . . . . . 0.628 ' HA ' ' HB3' ' J' ' 47' ' ' GLN . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 32' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' E' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' SER . . . . . 0.415 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 42' ' ' GLU . . . . . 0.771 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 44' ' ' PHE . . . . . 0.603 ' CE2' ' HA3' ' E' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 171.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 45' ' ' ASP . . . . . 0.534 ' O ' ' HA2' ' E' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.7 mp0 -71.2 -48.14 53.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.88 38.55 27.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.623 1.569 . . . . 0.0 111.663 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 41.98 45.28 3.27 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.482 1.513 . . . . 0.0 111.534 -164.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.81 1.71 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.83 16.77 1.07 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' E' ' 44' ' ' PHE . . . 87.05 167.55 43.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -112.22 122.37 47.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.5 pp -127.21 -39.19 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 54' ' ' LEU . . . . . 0.697 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp -61.78 -16.87 53.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' E' ' 136' ' ' GLY . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 64' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' E' ' 64' ' ' GLU . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 66' ' ' THR . . . . . 0.775 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 67' ' ' TYR . . . . . 0.719 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 68' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 71' ' ' ARG . . . . . 0.427 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 79' ' ' ILE . . . . . 0.54 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 80' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 82' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 83' ' ' TYR . . . . . 0.554 ' CD1' HG22 ' E' ' 113' ' ' ILE . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 84' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 87' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 88' ' ' GLN . . . . . 0.814 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 89' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' E' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 90' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 91' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 93' ' ' ARG . . . . . 0.511 ' HD2' ' HB2' ' E' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 94' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 99' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 102' ' ' ASP . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 102' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' E' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.815 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 106' ' ' ALA . . . . . 0.761 ' HB2' HG12 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 107' ' ' GLN . . . . . 0.511 ' HB2' ' HD2' ' E' ' 93' ' ' ARG . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 111' ' ' ALA . . . . . 0.57 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 113' ' ' ILE . . . . . 0.554 HG22 ' CD1' ' E' ' 83' ' ' TYR . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 114' ' ' GLU . . . . . 0.784 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 115' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 116' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' E' ' 116' ' ' ARG . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 117' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 126' ' ' VAL . . . . . 0.776 HG23 HG21 ' D' ' 6' ' ' ILE . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 128' ' ' ILE . . . . . 0.719 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 129' ' ' SER . . . . . 0.775 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 131' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 132' ' ' LEU . . . . . 0.57 HD13 ' HB1' ' E' ' 111' ' ' ALA . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 134' ' ' VAL . . . . . 0.83 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 135' ' ' ILE . . . . . 0.789 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 136' ' ' GLY . . . . . 0.677 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 139' ' ' LYS . . . . . 0.422 ' HD3' HE21 ' F' ' 84' ' ' GLN . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 142' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 143' ' ' ILE . . . . . 0.844 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 145' ' ' THR . . . . . 0.652 ' O ' HD12 ' E' ' 150' ' ' ILE . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 147' ' ' PRO . . . . . 0.57 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 150' ' ' ILE . . . . . 0.652 HD12 ' O ' ' E' ' 145' ' ' THR . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 151' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 153' ' ' VAL . . . . . 0.402 HG21 ' O ' ' J' ' 48' ' ' THR . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.74 31.83 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.517 ' HE3' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER -57.26 -41.32 79.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 156' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' E' ' 158' ' ' TYR . . . 137.06 141.31 4.23 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.392 0.996 . . . . 0.0 113.047 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.34 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' E' ' 156' ' ' GLY . 0.0 OUTLIER -108.91 89.29 2.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.288 1.035 . . . . 0.0 108.651 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.3 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -158.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 160' ' ' PHE . . . . . 0.461 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 163' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' E' ' 161' ' ' GLN . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 166' ' ' THR . . . . . 0.853 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 167' ' ' THR . . . . . 0.554 HG21 ' H ' ' E' ' 172' ' ' GLY . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 172' ' ' GLY . . . . . 0.554 ' H ' HG21 ' E' ' 167' ' ' THR . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 5' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.831 HG21 HG23 ' A' ' 126' ' ' VAL . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 7' ' ' MET . . . . . 1.033 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 10' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 13' ' ' TYR . . . . . 0.47 ' HD1' ' CE1' ' F' ' 91' ' ' PHE . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 14' ' ' LEU . . . . . 0.767 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 15' ' ' PHE . . . . . 0.56 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 16' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 18' ' ' ILE . . . . . 0.816 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' F' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' F' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.484 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 27' ' ' LEU . . . . . 0.633 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 30' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 34' ' ' ASP . . . . . 0.43 ' OD1' HG22 ' F' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 41' ' ' ARG . . . . . 0.823 HH22 ' HB2' ' F' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 42' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.57 42.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 44' ' ' PHE . . . . . 0.599 ' CE2' ' HA3' ' F' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.231 171.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 45' ' ' ASP . . . . . 0.527 ' O ' ' HA2' ' F' ' 51' ' ' GLY . 3.2 t70 -111.78 170.18 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 155.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.19 -48.19 53.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 57.86 38.61 27.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 111.642 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.97 45.27 3.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.442 1.497 . . . . 0.0 111.602 -164.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.92 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.461 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.87 16.77 1.08 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 51' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' F' ' 44' ' ' PHE . . . 87.13 167.5 43.79 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 52' ' ' ARG . . . . . 0.471 ' HA ' HH11 ' F' ' 52' ' ' ARG . 0.0 OUTLIER -112.21 122.33 47.44 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.851 HG12 HG23 ' A' ' 135' ' ' ILE . 1.5 pp -127.14 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.896 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 54' ' ' LEU . . . . . 0.558 HD12 ' H ' ' F' ' 54' ' ' LEU . 1.3 mp -61.76 -16.92 53.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 56' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 58' ' ' SER . . . . . 0.721 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 60' ' ' ALA . . . . . 0.823 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' F' ' 136' ' ' GLY . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' F' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 66' ' ' THR . . . . . 0.778 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 67' ' ' TYR . . . . . 0.723 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 68' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' F' ' 71' ' ' ARG . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' F' ' 113' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 80' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 82' ' ' ALA . . . . . 0.736 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 83' ' ' TYR . . . . . 0.556 ' HD1' HG22 ' F' ' 113' ' ' ILE . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 84' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 87' ' ' LYS . . . . . 0.736 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 88' ' ' GLN . . . . . 0.697 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 89' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' F' ' 82' ' ' ALA . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 90' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 91' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 92' ' ' TRP . . . . . 0.767 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' F' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 94' ' ' VAL . . . . . 0.758 HG12 ' HB2' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 96' ' ' THR . . . . . 0.428 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 98' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 99' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' F' ' 102' ' ' ASP . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 102' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' F' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 103' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.828 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 106' ' ' ALA . . . . . 0.758 ' HB2' HG12 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 107' ' ' GLN . . . . . 0.518 ' HB2' ' HD2' ' F' ' 93' ' ' ARG . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 110' ' ' PHE . . . . . 0.678 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 111' ' ' ALA . . . . . 0.576 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 112' ' ' TYR . . . . . 0.677 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 113' ' ' ILE . . . . . 0.556 HG22 ' HD1' ' F' ' 83' ' ' TYR . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 114' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 115' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 117' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 125' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 126' ' ' VAL . . . . . 0.823 HG23 HG21 ' E' ' 6' ' ' ILE . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 128' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 129' ' ' SER . . . . . 0.778 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 131' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 132' ' ' LEU . . . . . 0.576 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 134' ' ' VAL . . . . . 0.914 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 135' ' ' ILE . . . . . 0.837 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 139' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 80' ' ' GLU . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 143' ' ' ILE . . . . . 0.869 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 145' ' ' THR . . . . . 0.673 ' O ' HD12 ' F' ' 150' ' ' ILE . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 146' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 147' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' F' ' 145' ' ' THR . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 151' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 153' ' ' VAL . . . . . 0.434 HG21 ' O ' ' K' ' 48' ' ' THR . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.72 137.71 31.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' L' ' 138' ' ' LEU . 0.1 OUTLIER -57.3 -41.25 79.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' F' ' 158' ' ' TYR . . . 137.03 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.393 0.997 . . . . 0.0 113.089 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.21 0.48 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' F' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.31 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.324 1.05 . . . . 0.0 108.613 177.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 159' ' ' ASP . . . . . 0.73 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 -69.07 -46.63 67.33 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -158.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 160' ' ' PHE . . . . . 0.606 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 162' ' ' GLN . . . . . 0.95 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 163' ' ' PRO . . . . . 0.903 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' F' ' 161' ' ' GLN . 0.0 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 166' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 167' ' ' THR . . . . . 0.61 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 169' ' ' GLU . . . . . 0.815 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 172' ' ' GLY . . . . . 0.561 ' H ' HG21 ' F' ' 167' ' ' THR . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 5' ' ' PRO . . . . . 0.566 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 6' ' ' ILE . . . . . 0.985 HG21 HG23 ' H' ' 126' ' ' VAL . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 7' ' ' MET . . . . . 1.055 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 10' ' ' ASP . . . . . 1.055 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 12' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 13' ' ' TYR . . . . . 0.468 ' HD1' ' CE1' ' G' ' 91' ' ' PHE . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 15' ' ' PHE . . . . . 0.556 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 18' ' ' ILE . . . . . 0.83 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 21' ' ' ALA . . . . . 0.778 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' G' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 23' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 25' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 27' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 32' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' G' ' 32' ' ' GLN . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 34' ' ' ASP . . . . . 0.425 ' OD1' HG22 ' G' ' 65' ' ' VAL . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 37' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' H' ' 117' ' ' GLU . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 39' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 41' ' ' ARG . . . . . 0.806 HH22 ' HB2' ' G' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 42' ' ' GLU . . . . . 0.517 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.5 121.62 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 44' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' G' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.83 3.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.224 171.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 45' ' ' ASP . . . . . 0.539 ' O ' ' HA2' ' G' ' 51' ' ' GLY . 3.2 t70 -111.81 170.14 8.35 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.12 -48.14 53.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 47' ' ' GLN . . . . . 0.707 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 0.1 OUTLIER 57.86 38.6 27.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.611 1.564 . . . . 0.0 111.638 -172.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p 41.95 45.3 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.478 1.511 . . . . 0.0 111.581 -164.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.94 16.83 1.08 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 51' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' G' ' 44' ' ' PHE . . . 87.06 167.55 43.86 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 52' ' ' ARG . . . . . 0.478 ' HA ' HH11 ' G' ' 52' ' ' ARG . 0.0 OUTLIER -112.21 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.99 HG12 HG23 ' H' ' 135' ' ' ILE . 1.5 pp -127.22 -39.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.844 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 54' ' ' LEU . . . . . 0.561 HD12 ' H ' ' G' ' 54' ' ' LEU . 1.3 mp -61.73 -16.93 53.51 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 56' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 58' ' ' SER . . . . . 0.521 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 60' ' ' ALA . . . . . 0.806 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' G' ' 136' ' ' GLY . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 64' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' G' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 67' ' ' TYR . . . . . 0.709 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 68' ' ' TYR . . . . . 0.653 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 70' ' ' LYS . . . . . 0.529 ' HG3' ' HA ' ' L' ' 5' ' ' PRO . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 79' ' ' ILE . . . . . 0.541 HD12 HD11 ' G' ' 113' ' ' ILE . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 82' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 83' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' G' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 87' ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 88' ' ' GLN . . . . . 0.658 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 89' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' G' ' 82' ' ' ALA . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 90' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 91' ' ' PHE . . . . . 0.556 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 93' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' G' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 94' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 99' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' G' ' 102' ' ' ASP . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 102' ' ' ASP . . . . . 0.563 ' HB2' HD22 ' G' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 105' ' ' ASP . . . . . 0.829 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 106' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' G' ' 93' ' ' ARG . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 108' ' ' PHE . . . . . 0.838 ' HD2' HD11 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 111' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 112' ' ' TYR . . . . . 0.658 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 113' ' ' ILE . . . . . 0.554 HG22 ' HD1' ' G' ' 83' ' ' TYR . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 114' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 115' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' G' ' 116' ' ' ARG . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 117' ' ' GLU . . . . . 0.477 ' HB3' HG12 ' L' ' 37' ' ' VAL . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 118' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 125' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 126' ' ' VAL . . . . . 0.917 HG23 HG21 ' L' ' 6' ' ' ILE . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 127' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 128' ' ' ILE . . . . . 0.709 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 131' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 132' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' G' ' 111' ' ' ALA . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 134' ' ' VAL . . . . . 0.871 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 135' ' ' ILE . . . . . 0.957 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 138' ' ' LEU . . . . . 0.838 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HD3' HE21 ' H' ' 84' ' ' GLN . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 141' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 142' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 143' ' ' ILE . . . . . 0.861 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' G' ' 150' ' ' ILE . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 146' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' G' ' 145' ' ' THR . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.8 137.77 31.76 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -41.27 79.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 156' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' G' ' 158' ' ' TYR . . . 137.05 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.373 0.988 . . . . 0.0 113.085 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.31 71.26 0.47 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 158' ' ' TYR . . . . . 0.565 ' CE2' ' HA3' ' G' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.28 2.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.366 1.066 . . . . 0.0 108.604 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.12 -46.61 67.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 165' ' ' GLN . . . . . 0.505 ' CA ' ' HB3' ' G' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 167' ' ' THR . . . . . 0.543 HG21 ' H ' ' G' ' 172' ' ' GLY . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 172' ' ' GLY . . . . . 0.543 ' H ' HG21 ' G' ' 167' ' ' THR . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 5' ' ' PRO . . . . . 0.582 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 6' ' ' ILE . . . . . 0.938 HG21 HG23 ' I' ' 126' ' ' VAL . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 7' ' ' MET . . . . . 1.068 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 10' ' ' ASP . . . . . 1.068 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 11' ' ' VAL . . . . . 0.441 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HG2' HD11 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 13' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' H' ' 91' ' ' PHE . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 14' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 18' ' ' ILE . . . . . 0.827 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 21' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' H' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' H' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 25' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 27' ' ' LEU . . . . . 0.624 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 34' ' ' ASP . . . . . 0.428 ' OD1' HG22 ' H' ' 65' ' ' VAL . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' I' ' 117' ' ' GLU . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 41' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 42' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.57 121.66 42.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 44' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' H' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.81 3.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.179 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 45' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' H' ' 51' ' ' GLY . 3.2 t70 -111.85 170.18 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 46' ' ' GLU . . . . . 0.405 ' OE2' ' NE ' ' I' ' 41' ' ' ARG . 2.7 mp0 -71.19 -48.13 53.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 47' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 0.1 OUTLIER 57.89 38.56 27.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.583 1.553 . . . . 0.0 111.615 -172.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 42.02 45.23 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.495 1.518 . . . . 0.0 111.581 -164.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.74 1.69 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.442 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.87 16.78 1.07 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 51' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' H' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' H' ' 52' ' ' ARG . 0.0 OUTLIER -112.24 122.32 47.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.946 HG12 HG23 ' I' ' 135' ' ' ILE . 1.5 pp -127.17 -39.18 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.844 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 54' ' ' LEU . . . . . 0.559 HD12 ' H ' ' H' ' 54' ' ' LEU . 1.4 mp -61.75 -16.93 53.63 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 56' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 60' ' ' ALA . . . . . 0.802 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 61' ' ' ASP . . . . . 0.408 ' OD1' ' HA2' ' H' ' 136' ' ' GLY . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 64' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' H' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 65' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 67' ' ' TYR . . . . . 0.713 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 70' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 82' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 83' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' H' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 87' ' ' LYS . . . . . 0.738 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 88' ' ' GLN . . . . . 0.648 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' H' ' 82' ' ' ALA . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 90' ' ' LYS . . . . . 0.827 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' H' ' 107' ' ' GLN . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 95' ' ' ASP . . . . . 0.441 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 96' ' ' THR . . . . . 0.409 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 98' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 99' ' ' ASN . . . . . 0.555 HD22 ' HB2' ' H' ' 102' ' ' ASP . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 102' ' ' ASP . . . . . 0.555 ' HB2' HD22 ' H' ' 99' ' ' ASN . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 104' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 105' ' ' ASP . . . . . 0.847 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' H' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 108' ' ' PHE . . . . . 0.835 ' HD2' HD11 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 112' ' ' TYR . . . . . 0.648 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 113' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' H' ' 83' ' ' TYR . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 114' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 115' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 117' ' ' GLU . . . . . 0.469 ' HB3' HG12 ' G' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 118' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 120' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' G' ' 11' ' ' VAL . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 126' ' ' VAL . . . . . 0.985 HG23 HG21 ' G' ' 6' ' ' ILE . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 127' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 128' ' ' ILE . . . . . 0.713 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 131' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' H' ' 111' ' ' ALA . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 134' ' ' VAL . . . . . 0.807 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 135' ' ' ILE . . . . . 0.99 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 136' ' ' GLY . . . . . 0.66 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 138' ' ' LEU . . . . . 0.835 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 139' ' ' LYS . . . . . 0.534 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 141' ' ' GLY . . . . . 0.847 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 143' ' ' ILE . . . . . 0.859 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 145' ' ' THR . . . . . 0.669 ' O ' HD12 ' H' ' 150' ' ' ILE . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 146' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' H' ' 149' ' ' GLU . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' H' ' 148' ' ' GLU . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 150' ' ' ILE . . . . . 0.669 HD12 ' O ' ' H' ' 145' ' ' THR . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.72 31.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.34 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 156' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' H' ' 158' ' ' TYR . . . 137.08 141.25 4.22 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.379 0.99 . . . . 0.0 113.034 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.3 71.3 0.47 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 158' ' ' TYR . . . . . 0.563 ' CE2' ' HA3' ' H' ' 156' ' ' GLY . 0.0 OUTLIER -108.89 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.277 1.031 . . . . 0.0 108.614 177.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.13 -46.62 67.21 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 165' ' ' GLN . . . . . 0.51 ' CA ' ' HB3' ' H' ' 161' ' ' GLN . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 167' ' ' THR . . . . . 0.551 HG21 ' H ' ' H' ' 172' ' ' GLY . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 172' ' ' GLY . . . . . 0.551 ' H ' HG21 ' H' ' 167' ' ' THR . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 174' ' ' VAL . . . . . 0.499 HG22 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' I' I ' 5' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' J' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' J' ' 126' ' ' VAL . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 7' ' ' MET . . . . . 1.078 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 10' ' ' ASP . . . . . 1.078 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 11' ' ' VAL . . . . . 0.439 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 12' ' ' LYS . . . . . 0.545 ' HG2' HD11 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' CE1' ' I' ' 91' ' ' PHE . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 14' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 15' ' ' PHE . . . . . 0.562 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 18' ' ' ILE . . . . . 0.849 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' I' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' I' ' 22' ' ' THR . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 25' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 27' ' ' LEU . . . . . 0.609 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 30' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 32' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 33' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' J' ' 120' ' ' ASP . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 34' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' I' ' 65' ' ' VAL . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 37' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' J' ' 117' ' ' GLU . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 39' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 41' ' ' ARG . . . . . 0.804 HH22 ' HB2' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 42' ' ' GLU . . . . . 0.662 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.58 121.58 42.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 44' ' ' PHE . . . . . 0.594 ' CE2' ' HA3' ' I' ' 51' ' ' GLY . 0.3 OUTLIER -128.39 90.78 3.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.249 171.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 45' ' ' ASP . . . . . 0.524 ' O ' ' HA2' ' I' ' 51' ' ' GLY . 3.3 t70 -111.8 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 46' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' J' ' 58' ' ' SER . 2.7 mp0 -71.16 -48.17 53.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 47' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 0.1 OUTLIER 57.87 38.6 27.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.6 1.56 . . . . 0.0 111.64 -172.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 48' ' ' THR . . . . . 0.427 ' O ' HG21 ' D' ' 153' ' ' VAL . 30.6 p 42.0 45.28 3.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.501 1.521 . . . . 0.0 111.547 -164.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.442 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.89 16.81 1.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 51' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' I' ' 44' ' ' PHE . . . 87.09 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.33 47.43 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.948 HG12 HG23 ' J' ' 135' ' ' ILE . 1.5 pp -127.17 -39.19 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.907 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 54' ' ' LEU . . . . . 0.565 ' H ' HD12 ' I' ' 54' ' ' LEU . 1.4 mp -61.79 -16.86 53.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 58' ' ' SER . . . . . 0.52 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 60' ' ' ALA . . . . . 0.804 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' I' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' I' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 66' ' ' THR . . . . . 0.764 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 67' ' ' TYR . . . . . 0.72 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' I' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' I' ' 71' ' ' ARG . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 79' ' ' ILE . . . . . 0.53 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 80' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 82' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 83' ' ' TYR . . . . . 0.555 ' HD1' HG22 ' I' ' 113' ' ' ILE . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 84' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' I' ' 82' ' ' ALA . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 90' ' ' LYS . . . . . 0.849 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 92' ' ' TRP . . . . . 0.764 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 93' ' ' ARG . . . . . 0.508 ' HD2' ' HB2' ' I' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 95' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 99' ' ' ASN . . . . . 0.579 HD22 ' HB2' ' I' ' 102' ' ' ASP . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 102' ' ' ASP . . . . . 0.579 ' HB2' HD22 ' I' ' 99' ' ' ASN . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 105' ' ' ASP . . . . . 0.857 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 107' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' I' ' 93' ' ' ARG . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 113' ' ' ILE . . . . . 0.555 HG22 ' HD1' ' I' ' 83' ' ' TYR . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 114' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 116' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' I' ' 116' ' ' ARG . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 117' ' ' GLU . . . . . 0.406 ' HB3' HG12 ' H' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 118' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 126' ' ' VAL . . . . . 0.938 HG23 HG21 ' H' ' 6' ' ' ILE . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 127' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 128' ' ' ILE . . . . . 0.72 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 129' ' ' SER . . . . . 0.764 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' I' ' 111' ' ' ALA . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 134' ' ' VAL . . . . . 0.857 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 135' ' ' ILE . . . . . 0.946 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 139' ' ' LYS . . . . . 0.572 ' HD3' ' HG2' ' J' ' 80' ' ' GLU . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 141' ' ' GLY . . . . . 0.857 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 142' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 143' ' ' ILE . . . . . 0.871 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 145' ' ' THR . . . . . 0.665 ' O ' HD12 ' I' ' 150' ' ' ILE . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 146' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 150' ' ' ILE . . . . . 0.665 HD12 ' O ' ' I' ' 145' ' ' THR . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.82 137.75 31.7 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -41.26 79.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 156' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' I' ' 158' ' ' TYR . . . 137.04 141.28 4.22 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.353 0.979 . . . . 0.0 113.097 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.19 0.48 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 158' ' ' TYR . . . . . 0.544 ' CE2' ' HA3' ' I' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.33 2.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.311 1.044 . . . . 0.0 108.629 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.11 -46.63 67.22 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' I' ' 161' ' ' GLN . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 167' ' ' THR . . . . . 0.558 HG21 ' H ' ' I' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 172' ' ' GLY . . . . . 0.558 ' H ' HG21 ' I' ' 167' ' ' THR . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 174' ' ' VAL . . . . . 0.501 HG22 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' J' J ' 5' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' K' ' 70' ' ' LYS . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' K' ' 126' ' ' VAL . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 7' ' ' MET . . . . . 1.059 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 10' ' ' ASP . . . . . 1.059 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 13' ' ' TYR . . . . . 0.454 ' HD1' ' CE1' ' J' ' 91' ' ' PHE . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 14' ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 15' ' ' PHE . . . . . 0.549 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 18' ' ' ILE . . . . . 0.858 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 21' ' ' ALA . . . . . 0.684 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 22' ' ' THR . . . . . 0.436 HG22 ' H ' ' J' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 27' ' ' LEU . . . . . 0.626 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 30' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' J' ' 32' ' ' GLN . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' J' ' 65' ' ' VAL . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 37' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' K' ' 117' ' ' GLU . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 41' ' ' ARG . . . . . 0.794 HH22 ' HB2' ' J' ' 60' ' ' ALA . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 121.59 42.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 44' ' ' PHE . . . . . 0.6 ' CE2' ' HA3' ' J' ' 51' ' ' GLY . 0.3 OUTLIER -128.4 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.287 171.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 45' ' ' ASP . . . . . 0.544 ' O ' ' HA2' ' J' ' 51' ' ' GLY . 3.2 t70 -111.81 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 155.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 46' ' ' GLU . . . . . 0.446 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 2.7 mp0 -71.2 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 47' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 0.1 OUTLIER 57.86 38.56 27.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.675 1.59 . . . . 0.0 111.656 -172.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 48' ' ' THR . . . . . 0.402 ' O ' HG21 ' E' ' 153' ' ' VAL . 30.4 p 42.01 45.24 3.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.51 1.524 . . . . 0.0 111.586 -164.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.71 1.68 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.48 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.88 16.74 1.09 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 51' ' ' GLY . . . . . 0.6 ' HA3' ' CE2' ' J' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 52' ' ' ARG . . . . . 0.534 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -112.19 122.41 47.66 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.92 HG12 HG23 ' K' ' 135' ' ' ILE . 1.5 pp -127.24 -39.2 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.862 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 54' ' ' LEU . . . . . 0.571 HD12 ' H ' ' J' ' 54' ' ' LEU . 1.3 mp -61.75 -16.9 53.42 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' J' ' 54' ' ' LEU . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 58' ' ' SER . . . . . 0.525 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 60' ' ' ALA . . . . . 0.794 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' J' ' 136' ' ' GLY . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' J' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 65' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 66' ' ' THR . . . . . 0.77 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 67' ' ' TYR . . . . . 0.722 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 68' ' ' TYR . . . . . 0.642 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 70' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' I' ' 5' ' ' PRO . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 71' ' ' ARG . . . . . 0.448 HH21 ' HD3' ' J' ' 71' ' ' ARG . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 79' ' ' ILE . . . . . 0.535 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 80' ' ' GLU . . . . . 0.572 ' HG2' ' HD3' ' I' ' 139' ' ' LYS . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 81' ' ' ASP . . . . . 0.41 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 82' ' ' ALA . . . . . 0.739 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 83' ' ' TYR . . . . . 0.553 ' CD1' HG22 ' J' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 87' ' ' LYS . . . . . 0.739 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 88' ' ' GLN . . . . . 0.651 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 89' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' J' ' 82' ' ' ALA . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 90' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 91' ' ' PHE . . . . . 0.549 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 92' ' ' TRP . . . . . 0.731 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 93' ' ' ARG . . . . . 0.509 ' HD2' ' HB2' ' J' ' 107' ' ' GLN . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 94' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 98' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 99' ' ' ASN . . . . . 0.58 HD22 ' HB2' ' J' ' 102' ' ' ASP . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 102' ' ' ASP . . . . . 0.58 ' HB2' HD22 ' J' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 105' ' ' ASP . . . . . 0.848 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 106' ' ' ALA . . . . . 0.757 ' HB2' HG12 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 107' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' J' ' 93' ' ' ARG . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 108' ' ' PHE . . . . . 0.827 ' HD2' HD11 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 111' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 112' ' ' TYR . . . . . 0.651 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 113' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' J' ' 83' ' ' TYR . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 114' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 117' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' I' ' 37' ' ' VAL . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 118' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 120' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 125' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' I' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 127' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 128' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 129' ' ' SER . . . . . 0.77 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 132' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' J' ' 111' ' ' ALA . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 134' ' ' VAL . . . . . 0.921 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 135' ' ' ILE . . . . . 0.948 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 138' ' ' LEU . . . . . 0.827 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 139' ' ' LYS . . . . . 0.527 ' HD3' ' HG2' ' K' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 141' ' ' GLY . . . . . 0.848 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 142' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 143' ' ' ILE . . . . . 0.868 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 144' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' J' ' 150' ' ' ILE . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' J' ' 145' ' ' THR . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.7 137.75 31.93 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.34 79.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 156' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' J' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 119.365 0.984 . . . . 0.0 113.011 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HA3' ' J' ' 156' ' ' GLY . 0.0 OUTLIER -108.85 89.33 2.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 108.63 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.63 67.12 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 165' ' ' GLN . . . . . 0.503 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' J' ' 172' ' ' GLY . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' J' ' 167' ' ' THR . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' K' K ' 5' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' L' ' 126' ' ' VAL . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 7' ' ' MET . . . . . 1.035 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 8' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 10' ' ' ASP . . . . . 1.035 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 11' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 13' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' K' ' 91' ' ' PHE . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 18' ' ' ILE . . . . . 0.848 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 21' ' ' ALA . . . . . 0.853 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 22' ' ' THR . . . . . 0.431 HG22 ' H ' ' K' ' 23' ' ' GLY . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 27' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 30' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' K' ' 67' ' ' TYR . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 32' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 34' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' K' ' 65' ' ' VAL . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 36' ' ' SER . . . . . 0.402 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 37' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' L' ' 117' ' ' GLU . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 39' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 41' ' ' ARG . . . . . 0.818 HH22 ' HB2' ' K' ' 60' ' ' ALA . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.6 121.71 42.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 44' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' K' ' 51' ' ' GLY . 0.3 OUTLIER -128.5 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.189 171.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 45' ' ' ASP . . . . . 0.541 ' O ' ' HA2' ' K' ' 51' ' ' GLY . 3.3 t70 -111.87 170.16 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 155.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 46' ' ' GLU . . . . . 0.542 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.7 mp0 -71.21 -48.13 53.28 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 47' ' ' GLN . . . . . 0.824 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 0.1 OUTLIER 57.81 38.58 27.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.609 1.563 . . . . 0.0 111.714 -172.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 48' ' ' THR . . . . . 0.434 ' O ' HG21 ' F' ' 153' ' ' VAL . 30.5 p 41.98 45.31 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.5 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.9 16.8 1.08 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' K' ' 44' ' ' PHE . . . 87.04 167.47 43.78 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 52' ' ' ARG . . . . . 0.532 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.36 47.53 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.973 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.87 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 54' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.4 mp -61.77 -16.93 53.71 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 58' ' ' SER . . . . . 0.509 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 60' ' ' ALA . . . . . 0.818 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' K' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' K' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 66' ' ' THR . . . . . 0.793 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 67' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 68' ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 69' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' J' ' 5' ' ' PRO . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 75' ' ' GLY . . . . . 0.405 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 79' ' ' ILE . . . . . 0.548 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 80' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 82' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 83' ' ' TYR . . . . . 0.551 ' HD1' HG22 ' K' ' 113' ' ' ILE . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 87' ' ' LYS . . . . . 0.726 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 89' ' ' ILE . . . . . 0.719 HD11 ' HB2' ' K' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 90' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' K' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 94' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 95' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' K' ' 102' ' ' ASP . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' K' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 106' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' K' ' 93' ' ' ARG . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 108' ' ' PHE . . . . . 0.825 ' HD2' HD11 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 111' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 113' ' ' ILE . . . . . 0.551 HG22 ' HD1' ' K' ' 83' ' ' TYR . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 114' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 117' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' J' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 125' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' J' ' 6' ' ' ILE . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 128' ' ' ILE . . . . . 0.715 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 129' ' ' SER . . . . . 0.793 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 132' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' K' ' 111' ' ' ALA . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 134' ' ' VAL . . . . . 0.857 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 135' ' ' ILE . . . . . 0.92 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 136' ' ' GLY . . . . . 0.676 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 138' ' ' LEU . . . . . 0.825 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 139' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 142' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 145' ' ' THR . . . . . 0.649 ' O ' HD12 ' K' ' 150' ' ' ILE . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' K' ' 149' ' ' GLU . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' K' ' 148' ' ' GLU . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 150' ' ' ILE . . . . . 0.649 HD12 ' O ' ' K' ' 145' ' ' THR . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.68 31.78 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.22 79.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' K' ' 158' ' ' TYR . . . 137.03 141.3 4.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 119.395 0.998 . . . . 0.0 113.03 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.29 71.24 0.47 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HA3' ' K' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.26 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.347 1.059 . . . . 0.0 108.616 177.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.05 -46.64 67.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 -158.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' K' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 167' ' ' THR . . . . . 0.566 HG21 ' H ' ' K' ' 172' ' ' GLY . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 172' ' ' GLY . . . . . 0.566 ' H ' HG21 ' K' ' 167' ' ' THR . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 174' ' ' VAL . . . . . 0.49 HG22 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' L' L ' 5' ' ' PRO . . . . . 0.529 ' HA ' ' HG3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 6' ' ' ILE . . . . . 0.917 HG21 HG23 ' G' ' 126' ' ' VAL . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 12' ' ' LYS . . . . . 0.544 ' HG2' HD11 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD1' ' CE1' ' L' ' 91' ' ' PHE . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 14' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 15' ' ' PHE . . . . . 0.557 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 18' ' ' ILE . . . . . 0.833 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 21' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' L' ' 23' ' ' GLY . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 27' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 30' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' L' ' 67' ' ' TYR . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 34' ' ' ASP . . . . . 0.429 ' OD1' HG22 ' L' ' 65' ' ' VAL . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 37' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' G' ' 117' ' ' GLU . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 41' ' ' ARG . . . . . 0.816 HH22 ' HB2' ' L' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 42' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.59 121.63 42.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 44' ' ' PHE . . . . . 0.594 ' CE2' ' HA3' ' L' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.77 3.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 171.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' L' ' 51' ' ' GLY . 3.2 t70 -111.86 170.2 8.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 155.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 46' ' ' GLU . . . . . 0.432 ' OE2' ' NE ' ' G' ' 41' ' ' ARG . 2.7 mp0 -71.23 -48.13 53.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 47' ' ' GLN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER 57.9 38.55 27.06 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.595 1.558 . . . . 0.0 111.665 -172.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.94 45.32 3.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.479 1.512 . . . . 0.0 111.593 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.76 1.7 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.453 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -79.88 16.8 1.07 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 51' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' L' ' 44' ' ' PHE . . . 87.07 167.49 43.8 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.28 47.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.957 HG12 HG23 ' G' ' 135' ' ' ILE . 1.5 pp -127.18 -39.12 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 54' ' ' LEU . . . . . 0.569 HD12 ' H ' ' L' ' 54' ' ' LEU . 1.4 mp -61.77 -16.92 53.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' L' ' 54' ' ' LEU . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 60' ' ' ALA . . . . . 0.816 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 61' ' ' ASP . . . . . 0.409 ' OD1' ' HA2' ' L' ' 136' ' ' GLY . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' L' ' 64' ' ' GLU . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 65' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 66' ' ' THR . . . . . 0.768 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 67' ' ' TYR . . . . . 0.702 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 68' ' ' TYR . . . . . 0.625 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 69' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD3' ' L' ' 71' ' ' ARG . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 80' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 82' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 83' ' ' TYR . . . . . 0.547 ' HD1' HG22 ' L' ' 113' ' ' ILE . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 84' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 87' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 88' ' ' GLN . . . . . 0.815 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 89' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' L' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 90' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 91' ' ' PHE . . . . . 0.557 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 92' ' ' TRP . . . . . 0.756 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 93' ' ' ARG . . . . . 0.52 ' HD2' ' HB2' ' L' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 94' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 98' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' L' ' 102' ' ' ASP . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' L' ' 99' ' ' ASN . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 103' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 105' ' ' ASP . . . . . 0.819 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 106' ' ' ALA . . . . . 0.753 ' HB2' HG12 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HD2' ' L' ' 93' ' ' ARG . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 108' ' ' PHE . . . . . 0.837 ' HD2' HD11 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 111' ' ' ALA . . . . . 0.573 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 112' ' ' TYR . . . . . 0.655 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 113' ' ' ILE . . . . . 0.55 HD11 HD12 ' L' ' 79' ' ' ILE . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 115' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 116' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' L' ' 116' ' ' ARG . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 117' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' K' ' 37' ' ' VAL . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 123' ' ' GLU . . . . . 0.53 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 125' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' K' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 128' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 129' ' ' SER . . . . . 0.768 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 131' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 132' ' ' LEU . . . . . 0.573 HD13 ' HB1' ' L' ' 111' ' ' ALA . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 134' ' ' VAL . . . . . 0.973 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 135' ' ' ILE . . . . . 0.873 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 136' ' ' GLY . . . . . 0.675 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 138' ' ' LEU . . . . . 0.837 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 139' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' G' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 140' ' ' ASN . . . . . 0.73 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 141' ' ' GLY . . . . . 0.819 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 142' ' ' GLU . . . . . 0.95 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 143' ' ' ILE . . . . . 0.864 HD12 ' H ' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 144' ' ' ASP . . . . . 0.903 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' L' ' 150' ' ' ILE . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 147' ' ' PRO . . . . . 0.556 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 148' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' L' ' 149' ' ' GLU . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' L' ' 148' ' ' GLU . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' L' ' 145' ' ' THR . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 151' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.76 137.76 31.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -41.22 79.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' L' ' 158' ' ' TYR . . . 137.05 141.25 4.22 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 119.425 1.012 . . . . 0.0 113.055 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' L' ' 156' ' ' GLY . 0.0 OUTLIER -108.87 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.344 1.057 . . . . 0.0 108.603 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.68 67.13 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' L' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 167' ' ' THR . . . . . 0.559 HG21 ' H ' ' L' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 172' ' ' GLY . . . . . 0.559 ' H ' HG21 ' L' ' 167' ' ' THR . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 174' ' ' VAL . . . . . 0.486 HG22 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' B' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' HD13 ' A' ' 89' ' ' ILE . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.413 ' O ' HG13 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.754 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' A' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 40' ' ' GLU . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 133' ' ' GLN . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HA ' ' HZ1' ' A' ' 77' ' ' LYS . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB3' ' NH2' ' A' ' 116' ' ' ARG . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 17' ' ' SER . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.688 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 HG23 ' A' ' 150' ' ' ILE . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' A' ' 99' ' ' ASN . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 1.045 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.602 ' CE2' HG22 ' A' ' 145' ' ' THR . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.587 ' HA ' HE22 ' F' ' 9' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.623 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.523 HG12 ' HG ' ' F' ' 54' ' ' LEU . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 1.045 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.602 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 96' ' ' THR . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 162' ' ' GLN . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' A' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.614 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.614 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.624 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.442 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.524 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' C' ' 122' ' ' VAL . 3.3 mm-40 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' B' ' 89' ' ' ILE . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.605 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.432 ' O ' HG13 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' B' ' 59' ' ' VAL . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' B' ' 41' ' ' ARG . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.77 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.731 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.77 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' B' ' 40' ' ' GLU . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' B' ' 133' ' ' GLN . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.617 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.435 ' HA ' ' HZ1' ' B' ' 77' ' ' LYS . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.484 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' B' ' 116' ' ' ARG . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' B' ' 17' ' ' SER . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.61 HG22 HG23 ' B' ' 150' ' ' ILE . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' B' ' 104' ' ' TYR . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' B' ' 99' ' ' ASN . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 1.017 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' B' ' 145' ' ' THR . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.543 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.707 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' B' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.562 ' HA ' HE22 ' A' ' 9' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' B' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' A' ' 54' ' ' LEU . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.481 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.543 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.876 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 1.017 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.61 HG23 HG22 ' B' ' 96' ' ' THR . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.548 ' HD2' ' HB2' ' B' ' 162' ' ' GLN . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' B' ' 165' ' ' GLN . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' B' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.631 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.631 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.621 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.419 ' O ' ' HB1' ' D' ' 125' ' ' ALA . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' C' ' 89' ' ' ILE . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.533 ' O ' HG13 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.638 HG13 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.759 ' HA ' HG22 ' C' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' C' ' 41' ' ' ARG . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.692 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' C' ' 41' ' ' ARG . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' C' ' 40' ' ' GLU . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . 0.508 ' HB3' ' HG2' ' C' ' 133' ' ' GLN . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' C' ' 71' ' ' ARG . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.452 ' HB3' ' NH2' ' C' ' 116' ' ' ARG . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.498 ' O ' HG12 ' C' ' 18' ' ' ILE . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.702 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.594 HG22 HG23 ' C' ' 150' ' ' ILE . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' C' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' C' ' 99' ' ' ASN . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 1.042 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.592 ' CE2' HG22 ' C' ' 145' ' ' THR . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.542 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.404 ' CE1' ' HD2' ' C' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.463 ' HA ' HE22 ' B' ' 9' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.508 ' HG2' ' HB3' ' C' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' C' ' 110' ' ' PHE . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.731 HG12 ' HG ' ' B' ' 54' ' ' LEU . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' D' ' 84' ' ' GLN . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.893 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 1.042 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 0.592 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.626 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.594 HG23 HG22 ' C' ' 96' ' ' THR . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' C' ' 162' ' ' GLN . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' C' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' C' ' 160' ' ' PHE . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.624 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.624 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.538 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.52 HE22 ' HA ' ' E' ' 122' ' ' VAL . 3.2 mm-40 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . 0.415 ' HA ' HD13 ' D' ' 89' ' ' ILE . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.626 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' D' ' 70' ' ' LYS . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.483 ' O ' HG13 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.75 ' HA ' HG22 ' D' ' 59' ' ' VAL . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.437 ' H ' ' CZ ' ' D' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.734 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.693 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.734 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' D' ' 40' ' ' GLU . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' D' ' 133' ' ' GLN . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' D' ' 71' ' ' ARG . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.519 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.444 ' HB3' ' NH2' ' D' ' 116' ' ' ARG . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' D' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.685 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' D' ' 150' ' ' ILE . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' D' ' 104' ' ' TYR . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' D' ' 99' ' ' ASN . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 1.024 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' D' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.621 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.544 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.656 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.412 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.533 HG13 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' C' ' 6' ' ' ILE . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.497 ' HG2' ' HB3' ' D' ' 62' ' ' SER . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.692 HG12 ' HG ' ' C' ' 54' ' ' LEU . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.544 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 1.024 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.601 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' D' ' 96' ' ' THR . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD13 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' D' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' D' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.616 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.5 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.491 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . 0.423 HE22 ' HA ' ' F' ' 122' ' ' VAL . 3.2 mm-40 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.404 HG22 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' E' ' 89' ' ' ILE . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.618 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' E' ' 70' ' ' LYS . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' F' ' 117' ' ' GLU . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . 0.479 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' E' ' 59' ' ' VAL . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.435 ' H ' ' CZ ' ' E' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.743 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.819 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . 0.743 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' E' ' 40' ' ' GLU . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' E' ' 133' ' ' GLN . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.571 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.833 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.449 ' HB3' ' NH2' ' E' ' 116' ' ' ARG . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.833 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' E' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.433 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.616 HG22 HG23 ' E' ' 150' ' ' ILE . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' E' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . 0.464 ' H ' HD22 ' E' ' 99' ' ' ASN . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.974 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' E' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.689 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.414 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' E' ' 116' ' ' ARG . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.52 ' HA ' HE22 ' D' ' 9' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.489 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' E' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.693 HG12 ' HG ' ' D' ' 54' ' ' LEU . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' E' ' 107' ' ' GLN . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.974 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.606 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.616 HG23 HG22 ' E' ' 96' ' ' THR . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.555 ' HD2' ' HB2' ' E' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' E' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.556 ' HA ' HE22 ' K' ' 16' ' ' GLN . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.618 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.618 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . 0.587 HE22 ' HA ' ' A' ' 122' ' ' VAL . 3.3 mm-40 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.407 ' HB3' HG22 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . 0.406 ' HA ' HD13 ' F' ' 89' ' ' ILE . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' F' ' 70' ' ' LYS . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . 0.749 ' HA ' HG22 ' F' ' 59' ' ' VAL . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' F' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.523 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' F' ' 40' ' ' GLU . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' F' ' 133' ' ' GLN . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.509 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.564 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.825 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.825 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' F' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.607 HG22 HG23 ' F' ' 150' ' ' ILE . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' F' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' F' ' 99' ' ' ASN . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.982 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.605 ' CE2' HG22 ' F' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.549 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.536 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.667 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' F' ' 116' ' ' ARG . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . 0.423 ' HA ' HE22 ' E' ' 9' ' ' GLN . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' E' ' 6' ' ' ILE . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' F' ' 62' ' ' SER . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' F' ' 110' ' ' PHE . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.819 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' F' ' 107' ' ' GLN . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.549 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.982 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.605 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.607 HG23 HG22 ' F' ' 96' ' ' THR . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.917 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.633 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' F' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.687 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.54 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.801 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.505 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' H' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 6.3 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' G' ' 89' ' ' ILE . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.607 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' G' ' 70' ' ' LYS . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . 0.542 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' G' ' 59' ' ' VAL . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' G' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . 0.442 ' H ' ' CZ ' ' G' ' 41' ' ' ARG . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.769 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.707 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . 0.769 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' G' ' 40' ' ' GLU . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' G' ' 133' ' ' GLN . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HZ1' ' G' ' 77' ' ' LYS . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.529 ' HZ1' ' HA ' ' G' ' 74' ' ' ALA . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.57 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.5 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.618 HG22 HG23 ' G' ' 150' ' ' ILE . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' G' ' 104' ' ' TYR . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.633 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' G' ' 99' ' ' ASN . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 1.027 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.594 ' CE2' HG22 ' G' ' 145' ' ' THR . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.633 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.55 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.655 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.408 ' CE1' ' HD2' ' G' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . 0.638 ' HA ' HE22 ' L' ' 9' ' ' GLN . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.667 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.448 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' G' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.655 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.715 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' G' ' 107' ' ' GLN . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.909 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 1.027 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.594 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.618 HG23 HG22 ' G' ' 96' ' ' THR . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . 0.554 ' HD2' ' HB2' ' G' ' 162' ' ' GLN . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' G' ' 160' ' ' PHE . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.627 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.627 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.524 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . 0.591 HE22 ' HA ' ' I' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' H' ' 89' ' ' ILE . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.527 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . 0.513 ' HB2' ' HE3' ' H' ' 70' ' ' LYS . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . 0.516 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' H' ' 59' ' ' VAL . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . 0.45 ' H ' ' CZ ' ' H' ' 41' ' ' ARG . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.766 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . 0.766 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' H' ' 40' ' ' GLU . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' H' ' 133' ' ' GLN . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.521 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.573 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.566 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.808 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.808 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' H' ' 17' ' ' SER . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' H' ' 150' ' ' ILE . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' H' ' 104' ' ' TYR . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . 0.455 ' H ' HD22 ' H' ' 99' ' ' ASN . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 1.008 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.591 ' CE2' HG22 ' H' ' 145' ' ' THR . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.632 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.664 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.454 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.672 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.647 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' H' ' 116' ' ' ARG . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . 0.649 ' HA ' HE22 ' G' ' 9' ' ' GLN . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.672 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.454 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' H' ' 62' ' ' SER . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.664 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.707 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' H' ' 107' ' ' GLN . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 1.008 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.591 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' H' ' 96' ' ' THR . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . 0.552 ' HD2' ' HB2' ' H' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' H' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . 0.552 ' HB2' ' HD2' ' H' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' J' ' 122' ' ' VAL . 3.3 mm-40 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.4 HG22 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' I' ' 89' ' ' ILE . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.608 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.451 ' O ' HG13 ' J' ' 122' ' ' VAL . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.51 HG13 ' HG2' ' J' ' 117' ' ' GLU . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . 0.5 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' I' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.448 ' H ' ' CZ ' ' I' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.801 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' I' ' 41' ' ' ARG . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' I' ' 40' ' ' GLU . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' I' ' 133' ' ' GLN . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.436 HH21 ' HD2' ' I' ' 71' ' ' ARG . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.575 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.816 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' I' ' 150' ' ' ILE . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' I' ' 104' ' ' TYR . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . 0.454 ' H ' HD22 ' I' ' 99' ' ' ASN . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 1.05 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' I' ' 145' ' ' THR . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' I' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . 0.591 ' HA ' HE22 ' H' ' 9' ' ' GLN . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' H' ' 6' ' ' ILE . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.459 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' I' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.662 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.477 ' HA ' HE22 ' J' ' 84' ' ' GLN . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.62 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 1.05 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' I' ' 96' ' ' THR . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' I' ' 162' ' ' GLN . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' I' ' 165' ' ' GLN . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' I' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.632 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.62 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.62 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.642 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . 0.613 HE22 ' HA ' ' K' ' 122' ' ' VAL . 3.3 mm-40 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 6.3 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' J' ' 89' ' ' ILE . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.617 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.418 ' O ' HG13 ' K' ' 122' ' ' VAL . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' K' ' 117' ' ' GLU . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' J' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . 0.44 ' H ' ' CZ ' ' J' ' 41' ' ' ARG . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' J' ' 40' ' ' GLU . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' J' ' 133' ' ' GLN . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.51 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.525 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.828 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.5 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.828 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.489 ' O ' HG12 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.707 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' J' ' 150' ' ' ILE . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . 0.417 ' HA ' ' CE1' ' J' ' 104' ' ' TYR . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' J' ' 99' ' ' ASN . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.986 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.587 ' CE2' HG22 ' J' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.437 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.443 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.677 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.42 ' CE1' ' HD2' ' J' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.568 ' HA ' HE22 ' I' ' 9' ' ' GLN . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.677 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.443 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' J' ' 62' ' ' SER . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.675 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.801 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . 0.532 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.453 ' HA ' HE22 ' K' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.885 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.986 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.587 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' J' ' 96' ' ' THR . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' J' ' 162' ' ' GLN . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' J' ' 165' ' ' GLN . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' J' ' 160' ' ' PHE . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.612 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.612 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.658 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . 0.62 HE22 ' HA ' ' L' ' 122' ' ' VAL . 3.2 mm-40 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.414 ' HB3' HG22 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.556 HE22 ' HA ' ' E' ' 162' ' ' GLN . 6.3 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . 0.41 ' HA ' HD13 ' K' ' 89' ' ' ILE . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.63 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.52 ' HZ ' ' H ' ' K' ' 70' ' ' LYS . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.408 ' O ' HG13 ' L' ' 122' ' ' VAL . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' L' ' 117' ' ' GLU . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' K' ' 59' ' ' VAL . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' K' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . 0.434 ' H ' ' CZ ' ' K' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.742 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' K' ' 40' ' ' GLU . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' K' ' 133' ' ' GLN . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.52 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.45 ' HA ' ' HZ1' ' K' ' 77' ' ' LYS . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.524 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.45 ' HB3' ' NH2' ' K' ' 116' ' ' ARG . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.494 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.412 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.6 HG22 HG23 ' K' ' 150' ' ' ILE . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' K' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . 0.459 ' H ' HD22 ' K' ' 99' ' ' ASN . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 1.001 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' K' ' 145' ' ' THR . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.619 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.88 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.538 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.416 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' K' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.613 ' HA ' HE22 ' J' ' 9' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.642 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' K' ' 62' ' ' SER . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.717 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.551 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.585 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.88 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 1.001 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.6 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.6 HG23 HG22 ' K' ' 96' ' ' THR . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . 0.553 ' HD2' ' HB2' ' K' ' 162' ' ' GLN . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' K' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . 0.553 ' HB2' ' HD2' ' K' ' 160' ' ' PHE . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.621 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.667 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . 0.638 HE22 ' HA ' ' G' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . 0.408 ' HA ' HD13 ' L' ' 89' ' ' ILE . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.801 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . 0.516 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.521 ' HZ ' ' H ' ' L' ' 70' ' ' LYS . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' G' ' 117' ' ' GLU . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . 0.735 ' HA ' HG22 ' L' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' L' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' L' ' 41' ' ' ARG . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.745 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.715 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . 0.745 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' L' ' 40' ' ' GLU . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' L' ' 133' ' ' GLN . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.521 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HZ1' ' L' ' 77' ' ' LYS . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.51 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.473 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.577 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.824 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.445 ' HB3' ' NH2' ' L' ' 116' ' ' ARG . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.42 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.614 HG22 HG23 ' L' ' 150' ' ' ILE . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' L' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' L' ' 99' ' ' ASN . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 1.011 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.598 ' CE2' HG22 ' L' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.547 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.435 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.419 ' CE1' ' HD2' ' L' ' 116' ' ' ARG . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.62 ' HA ' HE22 ' K' ' 9' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.658 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.654 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' L' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' L' ' 110' ' ' PHE . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.75 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.437 ' HA ' HE22 ' G' ' 84' ' ' GLN . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.561 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 1.011 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.598 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.619 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.614 HG23 HG22 ' L' ' 96' ' ' THR . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . 0.542 ' HD2' ' HB2' ' L' ' 162' ' ' GLN . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' HB2' ' L' ' 165' ' ' GLN . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . 0.542 ' HB2' ' HD2' ' L' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.622 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.622 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.513 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' B' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.54 HE22 ' HA ' ' B' ' 122' ' ' VAL . 2.5 mm-40 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.445 ' HA ' HD13 ' A' ' 89' ' ' ILE . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 88' ' ' GLN . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 32' ' ' GLN . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' B' ' 118' ' ' TYR . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 43' ' ' LEU . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' F' ' 5' ' ' PRO . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HB2' HG21 ' A' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.743 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' A' ' 99' ' ' ASN . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 110' ' ' PHE . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.504 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.645 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD2' ' HB2' ' F' ' 36' ' ' SER . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' HE22 ' F' ' 9' ' ' GLN . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.645 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' OE2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.469 HG12 ' HG ' ' F' ' 54' ' ' LEU . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.789 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 1.7 t-20 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.571 ' HA ' HE22 ' G' ' 16' ' ' GLN . 4.5 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.589 HE22 ' HD2' ' A' ' 163' ' ' PRO . 6.2 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.605 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.486 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . 0.444 HE22 ' HA ' ' C' ' 122' ' ' VAL . 2.5 mm-40 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' B' ' 96' ' ' THR . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.5 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.437 ' HA ' HD13 ' B' ' 89' ' ' ILE . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 88' ' ' GLN . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' B' ' 70' ' ' LYS . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 32' ' ' GLN . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' C' ' 118' ' ' TYR . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' H ' ' B' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' B' ' 43' ' ' LEU . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 30' ' ' ALA . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' B' ' 76' ' ' GLN . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.455 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.561 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.884 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.53 ' HB2' HG21 ' B' ' 113' ' ' ILE . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.884 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.6 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.741 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . 0.465 ' H ' HD22 ' B' ' 99' ' ' ASN . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' B' ' 110' ' ' PHE . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.469 ' CE2' ' HG2' ' B' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.54 ' HA ' HE22 ' A' ' 9' ' ' GLN . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.673 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.845 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.861 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.706 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.614 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 1.7 t-20 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.607 ' HA ' HE22 ' H' ' 16' ' ' GLN . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.59 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.59 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.2 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.52 ' O ' HG23 ' C' ' 96' ' ' THR . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . 0.444 ' HA ' HD13 ' C' ' 89' ' ' ILE . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 88' ' ' GLN . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' C' ' 70' ' ' LYS . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' C' ' 67' ' ' TYR . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.415 HG22 ' OG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' D' ' 118' ' ' TYR . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.558 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' C' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' C' ' 43' ' ' LEU . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' C' ' 30' ' ' ALA . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' C' ' 76' ' ' GLN . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.573 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.56 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.52 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' C' ' 99' ' ' ASN . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.621 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.56 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' C' ' 110' ' ' PHE . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.468 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.468 ' HD2' ' HB2' ' B' ' 36' ' ' SER . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.444 ' HA ' HE22 ' B' ' 9' ' ' GLN . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.809 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.809 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 1.7 t-20 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.578 ' HA ' HE22 ' I' ' 16' ' ' GLN . 4.5 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.583 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.583 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.597 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' E' ' 126' ' ' VAL . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.5 HE22 ' HA ' ' E' ' 122' ' ' VAL . 2.5 mm-40 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' D' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . 0.455 ' HA ' HD13 ' D' ' 89' ' ' ILE . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.498 HG12 ' O ' ' D' ' 88' ' ' GLN . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' D' ' 70' ' ' LYS . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' D' ' 32' ' ' GLN . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' E' ' 118' ' ' TYR . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.612 ' HB2' ' H ' ' D' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' D' ' 43' ' ' LEU . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.416 ' OG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' D' ' 30' ' ' ALA . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' D' ' 76' ' ' GLN . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.453 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.51 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.845 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.608 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.499 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.456 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.565 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' D' ' 99' ' ' ASN . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.565 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.457 ' CZ ' ' HE2' ' D' ' 110' ' ' PHE . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.493 ' OE2' ' HG3' ' D' ' 133' ' ' GLN . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.641 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.432 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . 0.794 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 1.6 t-20 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.422 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.479 ' HA ' HE22 ' J' ' 16' ' ' GLN . 4.4 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.585 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.585 HE22 ' HD2' ' D' ' 163' ' ' PRO . 6.2 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.585 ' O ' ' HB ' ' D' ' 173' ' ' THR . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.426 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' E' ' 96' ' ' THR . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.76 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.5 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . 0.457 ' HA ' HD13 ' E' ' 89' ' ' ILE . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' E' ' 88' ' ' GLN . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' E' ' 32' ' ' GLN . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' F' ' 118' ' ' TYR . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' E' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.784 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' E' ' 43' ' ' LEU . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' E' ' 76' ' ' GLN . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.507 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' E' ' 113' ' ' ILE . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.462 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . 0.452 ' H ' HD22 ' E' ' 99' ' ' ASN . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.724 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' E' ' 110' ' ' PHE . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.544 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.48 ' HD2' ' HB2' ' D' ' 36' ' ' SER . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.5 ' HA ' HE22 ' D' ' 9' ' ' GLN . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.479 ' HG3' ' OE2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.824 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.671 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.497 ' HD2' ' NE2' ' F' ' 84' ' ' GLN . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.724 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . 0.793 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 1.7 t-20 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.649 ' HA ' HE22 ' K' ' 16' ' ' GLN . 4.4 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.589 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.589 HE22 ' HD2' ' E' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.603 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' A' ' 126' ' ' VAL . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . 0.569 HE22 ' HA ' ' A' ' 122' ' ' VAL . 2.5 mm-40 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . 0.452 ' HA ' HD13 ' F' ' 89' ' ' ILE . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.508 HG12 ' O ' ' F' ' 88' ' ' GLN . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.785 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' F' ' 70' ' ' LYS . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' F' ' 67' ' ' TYR . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' F' ' 32' ' ' GLN . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 118' ' ' TYR . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.618 ' HB2' ' H ' ' F' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' F' ' 43' ' ' LEU . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . 0.4 ' OG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' CB ' ' E' ' 5' ' ' PRO . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' F' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.515 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' F' ' 113' ' ' ILE . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.599 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.458 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' F' ' 99' ' ' ASN . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.736 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' F' ' 110' ' ' PHE . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.493 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' E' ' 36' ' ' SER . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' E' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.632 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.493 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.784 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.736 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . 0.785 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.6 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.682 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 4.4 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.699 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 6.3 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.735 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.742 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.553 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . 0.648 HE22 ' HA ' ' H' ' 122' ' ' VAL . 2.5 mm-40 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.512 ' O ' HG23 ' G' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.571 HE22 ' HA ' ' A' ' 162' ' ' GLN . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . 0.447 ' HA ' HD13 ' G' ' 89' ' ' ILE . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' G' ' 88' ' ' GLN . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' G' ' 70' ' ' LYS . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' G' ' 32' ' ' GLN . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . 0.535 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' H' ' 113' ' ' ILE . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' G' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.668 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' G' ' 43' ' ' LEU . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . 0.412 ' OG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.433 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' L' ' 5' ' ' PRO . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' G' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' G' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.866 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HB2' HG21 ' G' ' 113' ' ' ILE . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.866 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.752 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.564 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.512 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . 0.47 ' H ' HD22 ' G' ' 99' ' ' ASN . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.564 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' G' ' 110' ' ' PHE . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.548 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' G' ' 83' ' ' TYR . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.643 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.551 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . 0.604 ' HA ' HE22 ' L' ' 9' ' ' GLN . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.645 HG21 ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' OE2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.677 HG12 ' HG ' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . 0.848 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.608 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.848 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.722 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 162' ' ' GLN . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . 0.784 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 1.7 t-20 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.586 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 6.2 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.607 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.654 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . 0.578 HE22 ' HA ' ' I' ' 122' ' ' VAL . 2.5 mm-40 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.607 HE22 ' HA ' ' B' ' 162' ' ' GLN . 5.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . 0.449 ' HA ' HD13 ' H' ' 89' ' ' ILE . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' H' ' 88' ' ' GLN . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' H' ' 70' ' ' LYS . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' H' ' 32' ' ' GLN . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' I' ' 118' ' ' TYR . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' I' ' 113' ' ' ILE . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.597 ' HB2' ' H ' ' H' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.606 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' H' ' 43' ' ' LEU . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . 0.402 ' OG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' G' ' 5' ' ' PRO . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' H' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.514 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.86 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG21 ' H' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.608 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.86 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.606 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.482 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.467 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' H' ' 99' ' ' ASN . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' H' ' 110' ' ' PHE . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' H' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.651 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.535 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . 0.648 ' HA ' HE22 ' G' ' 9' ' ' GLN . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.651 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.483 ' HG3' ' OE2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.831 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.668 HG12 ' HG ' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . 0.831 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.879 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . 0.782 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 1.7 t-20 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.592 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.592 HE22 ' HD2' ' H' ' 163' ' ' PRO . 6.2 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.609 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' J' ' 126' ' ' VAL . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . 0.549 HE22 ' HA ' ' J' ' 122' ' ' VAL . 2.5 mm-40 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.519 ' O ' HG23 ' I' ' 96' ' ' THR . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.761 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.578 HE22 ' HA ' ' C' ' 162' ' ' GLN . 5.5 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . 0.436 ' HA ' HD13 ' I' ' 89' ' ' ILE . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' I' ' 88' ' ' GLN . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' I' ' 32' ' ' GLN . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.595 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' I' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.771 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' I' ' 43' ' ' LEU . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' I' ' 76' ' ' GLN . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' I' ' 113' ' ' ILE . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.602 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.562 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.519 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' I' ' 99' ' ' ASN . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.611 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.562 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' I' ' 110' ' ' PHE . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.473 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' I' ' 83' ' ' TYR . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.49 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.657 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.498 ' HD2' ' HB2' ' H' ' 36' ' ' SER . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . 0.578 ' HA ' HE22 ' H' ' 9' ' ' GLN . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.49 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.606 HG12 ' HG ' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.498 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' C' ' 162' ' ' GLN . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . 0.779 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 1.7 t-20 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.578 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 6.2 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' K' ' 126' ' ' VAL . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . 0.612 HE22 ' HA ' ' K' ' 122' ' ' VAL . 2.5 mm-40 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' J' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.757 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . 0.446 ' HA ' HD13 ' J' ' 89' ' ' ILE . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' J' ' 88' ' ' GLN . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.569 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' J' ' 70' ' ' LYS . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . 0.417 HG22 ' OG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . 0.55 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' K' ' 113' ' ' ILE . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' J' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.647 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' J' ' 43' ' ' LEU . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . 0.417 ' OG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' I' ' 5' ' ' PRO . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' J' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.854 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.538 ' HB2' HG21 ' J' ' 113' ' ' ILE . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.854 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.453 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.757 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.561 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' J' ' 99' ' ' ASN . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.561 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HE2' ' J' ' 110' ' ' PHE . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' J' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.647 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.549 ' HA ' HE22 ' I' ' 9' ' ' GLN . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' I' ' 6' ' ' ILE . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.647 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.827 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.771 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . 0.827 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.726 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' D' ' 162' ' ' GLN . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . 0.795 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.591 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.591 HE22 ' HD2' ' J' ' 163' ' ' PRO . 6.2 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.596 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . 0.618 HE22 ' HA ' ' L' ' 122' ' ' VAL . 2.5 mm-40 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' K' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.751 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' E' ' 162' ' ' GLN . 5.5 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . 0.458 ' HA ' HD13 ' K' ' 89' ' ' ILE . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' K' ' 88' ' ' GLN . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' K' ' 70' ' ' LYS . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' K' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' K' ' 32' ' ' GLN . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' L' ' 118' ' ' TYR . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' K' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' K' ' 43' ' ' LEU . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' J' ' 5' ' ' PRO . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' K' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.513 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.857 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' K' ' 113' ' ' ILE . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.857 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.5 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.45 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.751 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' K' ' 99' ' ' ASN . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.556 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.448 ' CZ ' ' HE2' ' K' ' 110' ' ' PHE . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.549 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' K' ' 83' ' ' TYR . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.55 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.612 ' HA ' HE22 ' J' ' 9' ' ' GLN . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.589 HG21 ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.477 ' HG3' ' OE2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.647 HG12 ' HG ' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.746 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' E' ' 162' ' ' GLN . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . 0.799 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 1.7 t-20 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.233 0.211 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.573 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 6.2 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.6 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . 0.604 HE22 ' HA ' ' G' ' 122' ' ' VAL . 2.5 mm-40 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.749 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . 0.459 ' HA ' HD13 ' L' ' 89' ' ' ILE . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.742 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . 0.44 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' L' ' 32' ' ' GLN . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' G' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' L' ' 55' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' L' ' 43' ' ' LEU . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . 0.403 ' OG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.414 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' L' ' 76' ' ' GLN . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.516 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.534 ' HB2' HG21 ' L' ' 113' ' ' ILE . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.735 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.455 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.749 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' L' ' 99' ' ' ASN . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.618 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' L' ' 110' ' ' PHE . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.469 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' L' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.511 ' HD2' ' HB2' ' K' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.618 ' HA ' HE22 ' K' ' 9' ' ' GLN . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.596 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.812 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . 0.812 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.542 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.745 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.595 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . 0.786 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.594 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.594 HE22 ' HD2' ' L' ' 163' ' ' PRO . 6.3 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.584 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.442 HG22 ' OD1' ' A' ' 10' ' ' ASP . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' OD1' HG13 ' A' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' A' ' 93' ' ' ARG . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.569 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' A' ' 91' ' ' PHE . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.879 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' A' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' A' ' 33' ' ' THR . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' A' ' 32' ' ' GLN . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' H ' ' HA ' ' B' ' 115' ' ' SER . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' HH11 ' A' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.822 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' A' ' 34' ' ' ASP . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' A' ' 79' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.429 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.64 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.648 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.531 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 15' ' ' PHE . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' A' ' 11' ' ' VAL . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG13 ' OD1' ' A' ' 10' ' ' ASP . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 142' ' ' GLU . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 1.022 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' HB3' HE22 ' A' ' 88' ' ' GLN . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 89' ' ' ILE . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' A' ' 83' ' ' TYR . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.64 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' F' ' 33' ' ' THR . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.454 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' F' ' 8' ' ' GLY . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.822 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' GLY . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.022 HD12 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.95 HG21 HG21 ' A' ' 94' ' ' VAL . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.496 HD11 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 27' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' G' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.786 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.892 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.478 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.445 HG22 ' OD1' ' B' ' 10' ' ' ASP . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' B' ' 97' ' ' VAL . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.738 HG11 HH21 ' B' ' 93' ' ' ARG . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.473 ' HD2' ' HE1' ' B' ' 91' ' ' PHE . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' B' ' 89' ' ' ILE . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 87' ' ' LYS . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . 0.495 ' OG ' HD11 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.436 ' HE1' ' HG ' ' B' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' B' ' 33' ' ' THR . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' B' ' 32' ' ' GLN . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.836 ' OD2' HG22 ' B' ' 65' ' ' VAL . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.629 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.449 ' HA ' HH11 ' B' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.43 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.836 HG22 ' OD2' ' B' ' 34' ' ' ASP . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.493 ' OH ' HG21 ' B' ' 79' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.572 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.653 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' B' ' 15' ' ' PHE . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.738 HH21 HG11 ' B' ' 11' ' ' VAL . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.936 HG21 HG21 ' B' ' 145' ' ' THR . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.502 HG13 ' OD1' ' B' ' 10' ' ' ASP . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' B' ' 142' ' ' GLU . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . 1.006 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.436 ' HB3' HE22 ' B' ' 88' ' ' GLN . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 89' ' ' ILE . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.433 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' B' ' 83' ' ' TYR . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 33' ' ' THR . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.533 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.512 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' B' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.872 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' B' ' 136' ' ' GLY . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 1.006 HD12 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.694 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 0.936 HG21 HG21 ' B' ' 94' ' ' VAL . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.495 HD11 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.648 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' B' ' 27' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.648 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.609 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 15.5 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.609 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.672 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . 0.741 ' HA ' HD13 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.672 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . 0.513 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' C' ' 10' ' ' ASP . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.494 ' OD1' HG13 ' C' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.745 HG11 HH21 ' C' ' 93' ' ' ARG . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' C' ' 91' ' ' PHE . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' C' ' 89' ' ' ILE . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' C' ' 87' ' ' LYS . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.898 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.771 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . 0.433 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' C' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' C' ' 32' ' ' GLN . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.536 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.518 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' C' ' 41' ' ' ARG . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . 0.896 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' C' ' 34' ' ' ASP . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.559 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 9.3 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.443 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' C' ' 15' ' ' PHE . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.745 HH21 HG11 ' C' ' 11' ' ' VAL . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.928 HG21 HG21 ' C' ' 145' ' ' THR . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' C' ' 10' ' ' ASP . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' C' ' 99' ' ' ASN . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' C' ' 98' ' ' LYS . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.667 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' C' ' 142' ' ' GLU . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.567 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' C' ' 88' ' ' GLN . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' C' ' 89' ' ' ILE . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.443 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' C' ' 83' ' ' TYR . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.428 HG23 HG22 ' B' ' 33' ' ' THR . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . 0.617 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 63' ' ' GLY . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.896 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.472 ' H ' HG12 ' C' ' 135' ' ' ILE . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 1.024 HD12 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.686 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 0.928 HG21 HG21 ' C' ' 94' ' ' VAL . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.631 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.771 HG23 HD22 ' C' ' 27' ' ' LEU . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' I' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.61 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.798 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 15.6 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.61 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.923 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.673 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . 0.726 ' HA ' HD13 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.673 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.923 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' D' ' 10' ' ' ASP . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.509 ' OD1' HG13 ' D' ' 97' ' ' VAL . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.744 HG11 HH21 ' D' ' 93' ' ' ARG . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.454 ' HD2' ' HE1' ' D' ' 91' ' ' PHE . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.525 ' HB3' HD11 ' D' ' 89' ' ' ILE . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.889 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . 0.439 ' OD2' ' HD3' ' D' ' 87' ' ' LYS . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . 0.492 ' OG ' HD11 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.889 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.785 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' D' ' 33' ' ' THR . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . 0.507 HG23 ' HG2' ' D' ' 32' ' ' GLN . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.833 ' OD2' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . 0.595 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.449 ' H ' ' HA ' ' E' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' D' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.477 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.833 HG22 ' OD2' ' D' ' 34' ' ' ASP . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.489 ' OH ' HG21 ' D' ' 79' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 9.2 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.536 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 15' ' ' PHE . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.454 ' HE1' ' HD2' ' D' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.744 HH21 HG11 ' D' ' 11' ' ' VAL . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.939 HG21 HG21 ' D' ' 145' ' ' THR . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . 0.509 HG13 ' OD1' ' D' ' 10' ' ' ASP . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' D' ' 99' ' ' ASN . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' D' ' 98' ' ' LYS . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.669 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' D' ' 142' ' ' GLU . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.569 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . 0.968 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' D' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' D' ' 89' ' ' ILE . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.444 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' D' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' C' ' 33' ' ' THR . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.489 HG23 ' CG2' ' C' ' 33' ' ' THR . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.516 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' D' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.414 HG13 ' H ' ' D' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.414 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.968 HD12 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.692 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.939 HG21 HG21 ' D' ' 94' ' ' VAL . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . 0.492 HD11 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.785 HG23 HD22 ' D' ' 27' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' J' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.449 ' HZ ' ' OD1' ' J' ' 144' ' ' ASP . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.615 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 15.5 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.615 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.914 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.689 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . 0.745 ' HA ' HD13 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.689 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.914 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.419 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.44 HG22 ' OD1' ' E' ' 10' ' ' ASP . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.51 ' OD1' HG13 ' E' ' 97' ' ' VAL . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.736 HG11 HH21 ' E' ' 93' ' ' ARG . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . 0.573 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.45 ' HD2' ' HE1' ' E' ' 91' ' ' PHE . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' E' ' 89' ' ' ILE . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' E' ' 87' ' ' LYS . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.875 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.767 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' E' ' 33' ' ' THR . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' E' ' 32' ' ' GLN . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.826 ' OD2' HG22 ' E' ' 65' ' ' VAL . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' E' ' 41' ' ' ARG . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . 0.891 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.811 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.826 HG22 ' OD2' ' E' ' 34' ' ' ASP . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' E' ' 79' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 9.3 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.417 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.447 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' E' ' 15' ' ' PHE . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.45 ' HE1' ' HD2' ' E' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.736 HH21 HG11 ' E' ' 11' ' ' VAL . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.952 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' E' ' 10' ' ' ASP . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' E' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' E' ' 98' ' ' LYS . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.668 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' E' ' 142' ' ' GLU . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . 0.989 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.426 ' HB3' HE22 ' E' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' E' ' 89' ' ' ILE . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.447 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' E' ' 83' ' ' TYR . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.431 HG23 HG22 ' D' ' 33' ' ' THR . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.402 ' HA ' ' N ' ' D' ' 8' ' ' GLY . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.811 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' E' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.891 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.42 HG12 ' H ' ' E' ' 135' ' ' ILE . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.41 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.989 HD12 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.7 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.952 HG21 HG21 ' E' ' 94' ' ' VAL . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.767 HG23 HD22 ' E' ' 27' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' K' ' 138' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.622 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.807 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.622 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.698 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . 0.817 ' HA ' HD13 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.698 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.902 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.539 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' F' ' 10' ' ' ASP . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' F' ' 97' ' ' VAL . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.723 HG11 HH21 ' F' ' 93' ' ' ARG . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' F' ' 91' ' ' PHE . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.536 ' HB3' HD11 ' F' ' 89' ' ' ILE . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' F' ' 87' ' ' LYS . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . 0.489 ' OG ' HD11 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.867 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.761 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . 0.435 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' F' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.495 HG23 ' HG2' ' F' ' 32' ' ' GLN . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . 0.531 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' F' ' 41' ' ' ARG . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.821 HG22 ' OD2' ' F' ' 34' ' ' ASP . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' F' ' 79' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.66 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' F' ' 15' ' ' PHE . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' F' ' 13' ' ' TYR . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.719 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.723 HH21 HG11 ' F' ' 11' ' ' VAL . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.958 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' F' ' 10' ' ' ASP . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' F' ' 142' ' ' GLU . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . 1.007 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' F' ' 88' ' ' GLN . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' F' ' 89' ' ' ILE . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.45 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' F' ' 83' ' ' TYR . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' E' ' 33' ' ' THR . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.81 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' F' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' F' ' 136' ' ' GLY . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 1.007 HD12 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.701 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.958 HG21 HG21 ' F' ' 94' ' ' VAL . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . 0.489 HD11 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.628 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.761 HG23 HD22 ' F' ' 27' ' ' LEU . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.628 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.815 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.712 ' CE1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.7 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 15.6 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.69 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.855 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.69 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.915 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.434 HG22 ' OD1' ' G' ' 10' ' ' ASP . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' H' ' 125' ' ' ALA . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' G' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.734 HG11 HH21 ' G' ' 93' ' ' ARG . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.476 ' HD2' ' HE1' ' G' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' G' ' 89' ' ' ILE . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.887 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.754 HD13 ' HA ' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' G' ' 87' ' ' LYS . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . 0.499 ' OG ' HD11 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.887 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.769 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' G' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' G' ' 32' ' ' GLN . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.837 ' OD2' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.45 ' HA ' HH11 ' G' ' 41' ' ' ARG . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.533 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.816 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.837 HG22 ' OD2' ' G' ' 34' ' ' ASP . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.476 ' OH ' HG21 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 9.3 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.662 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.495 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.422 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' G' ' 15' ' ' PHE . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' G' ' 13' ' ' TYR . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.723 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.734 HH21 HG11 ' G' ' 11' ' ' VAL . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.956 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' G' ' 10' ' ' ASP . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' G' ' 99' ' ' ASN . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' G' ' 98' ' ' LYS . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.606 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' G' ' 142' ' ' GLU . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . 0.996 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' G' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' G' ' 89' ' ' ILE . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' G' ' 83' ' ' TYR . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.503 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.816 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' G' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.44 ' H ' HG12 ' G' ' 135' ' ' ILE . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.404 ' H ' HG13 ' G' ' 135' ' ' ILE . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.996 HD12 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.694 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.956 HG21 HG21 ' G' ' 94' ' ' VAL . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . 0.499 HD11 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.641 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.769 HG23 HD22 ' G' ' 27' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.616 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.919 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.671 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.671 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.919 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.427 HG22 ' OD1' ' H' ' 10' ' ' ASP . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' H' ' 97' ' ' VAL . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' H' ' 93' ' ' ARG . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.472 ' HD2' ' HE1' ' H' ' 91' ' ' PHE . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' H' ' 89' ' ' ILE . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.896 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HD3' ' H' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 163' ' ' PRO . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . 0.497 ' OG ' HD11 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.896 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.789 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' H' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' H' ' 32' ' ' GLN . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.834 ' OD2' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . 0.49 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' H' ' 41' ' ' ARG . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . 0.483 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.829 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.834 HG22 ' OD2' ' H' ' 34' ' ' ASP . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.478 ' OH ' HG21 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.642 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.651 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.599 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' H' ' 15' ' ' PHE . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.472 ' HE1' ' HD2' ' H' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' H' ' 11' ' ' VAL . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' H' ' 10' ' ' ASP . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' H' ' 99' ' ' ASN . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' H' ' 98' ' ' LYS . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.659 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' H' ' 142' ' ' GLU . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . 1.043 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' H' ' 88' ' ' GLN . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' H' ' 89' ' ' ILE . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' H' ' 83' ' ' TYR . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.509 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.829 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.428 ' H ' HG12 ' H' ' 135' ' ' ILE . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.419 ' H ' HG13 ' H' ' 135' ' ' ILE . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 1.043 HD12 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.682 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.789 HG23 HD22 ' H' ' 27' ' ' LEU . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.235 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.607 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . 0.79 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.607 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.872 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.669 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.669 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.872 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.582 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' I' ' 10' ' ' ASP . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.506 ' OD1' HG13 ' I' ' 97' ' ' VAL . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.729 HG11 HH21 ' I' ' 93' ' ' ARG . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' I' ' 91' ' ' PHE . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' I' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' I' ' 87' ' ' LYS . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' C' ' 163' ' ' PRO . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . 0.488 ' OG ' HD11 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.884 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.496 ' HG2' HG23 ' I' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.501 HG22 ' HA2' ' J' ' 121' ' ' GLY . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' I' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' I' ' 34' ' ' ASP . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.487 ' OH ' HG21 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.655 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.655 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' I' ' 15' ' ' PHE . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.463 ' HE1' ' HD2' ' I' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.729 HH21 HG11 ' I' ' 11' ' ' VAL . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.925 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . 0.506 HG13 ' OD1' ' I' ' 10' ' ' ASP . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.658 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.601 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' I' ' 142' ' ' GLU . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . 0.994 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.422 ' HB3' HE22 ' I' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.427 ' HB3' HG23 ' I' ' 89' ' ' ILE . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.435 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' I' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' H' ' 33' ' ' THR . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.52 HG13 ' O ' ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' I' ' 63' ' ' GLY . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.413 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.413 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.994 HD12 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.673 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 0.925 HG21 HG21 ' I' ' 94' ' ' VAL . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . 0.488 HD11 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' I' ' 27' ' ' LEU . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.609 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.684 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.684 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.532 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' J' ' 10' ' ' ASP . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.504 ' OD1' HG13 ' J' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.75 HG11 HH21 ' J' ' 93' ' ' ARG . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' J' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.515 ' HB3' HD11 ' J' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.87 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' J' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.87 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.77 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' J' ' 33' ' ' THR . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . 0.502 HG23 ' HG2' ' J' ' 32' ' ' GLN . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.839 ' OD2' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' J' ' 41' ' ' ARG . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' E' ' 124' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.839 HG22 ' OD2' ' J' ' 34' ' ' ASP . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' J' ' 79' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . 0.409 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 9.3 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.685 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' J' ' 15' ' ' PHE . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' J' ' 13' ' ' TYR . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.75 HH21 HG11 ' J' ' 11' ' ' VAL . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.938 HG21 HG21 ' J' ' 145' ' ' THR . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' J' ' 10' ' ' ASP . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' J' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' J' ' 98' ' ' LYS . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' J' ' 142' ' ' GLU . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' J' ' 88' ' ' GLN . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' J' ' 89' ' ' ILE . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.448 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.431 HG21 ' HD1' ' J' ' 83' ' ' TYR . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.48 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' J' ' 63' ' ' GLY . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.897 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.411 HG13 ' H ' ' J' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.68 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' HZ ' ' D' ' 160' ' ' PHE . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.938 HG21 HG21 ' J' ' 94' ' ' VAL . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.77 HG23 HD22 ' J' ' 27' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.617 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . 0.801 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.617 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.911 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.688 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.688 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.911 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.518 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' K' ' 10' ' ' ASP . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' K' ' 97' ' ' VAL . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.718 HG11 HH21 ' K' ' 93' ' ' ARG . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . 0.579 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.457 ' HD2' ' HE1' ' K' ' 91' ' ' PHE . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.523 ' HB3' HD11 ' K' ' 89' ' ' ILE . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.817 HD13 ' HA ' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' K' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.861 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.776 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' K' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . 0.505 HG23 ' HG2' ' K' ' 32' ' ' GLN . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' K' ' 65' ' ' VAL . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' L' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.449 HH11 ' HA ' ' K' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . 0.88 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.819 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' K' ' 34' ' ' ASP . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.491 ' OH ' HG21 ' K' ' 79' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.632 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.632 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' K' ' 15' ' ' PHE . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.457 ' HE1' ' HD2' ' K' ' 13' ' ' TYR . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.718 HH21 HG11 ' K' ' 11' ' ' VAL . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.955 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' K' ' 10' ' ' ASP . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' K' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' K' ' 98' ' ' LYS . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' K' ' 142' ' ' GLU . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . 0.975 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.437 ' HB3' HE22 ' K' ' 88' ' ' GLN . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' K' ' 89' ' ' ILE . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' K' ' 83' ' ' TYR . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' J' ' 8' ' ' GLY . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.507 HG13 ' O ' ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.819 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' K' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.88 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.412 ' H ' HG12 ' K' ' 135' ' ' ILE . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.975 HD12 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.955 HG21 HG21 ' K' ' 94' ' ' VAL . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.776 HG23 HD22 ' K' ' 27' ' ' LEU . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.611 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . 0.783 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.611 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.905 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.679 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.679 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.905 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.447 HG22 ' OD1' ' L' ' 10' ' ' ASP . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' L' ' 97' ' ' VAL . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.739 HG11 HH21 ' L' ' 93' ' ' ARG . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD2' ' HE1' ' L' ' 91' ' ' PHE . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' L' ' 89' ' ' ILE . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' L' ' 87' ' ' LYS . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . 0.486 ' OG ' HD11 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.873 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.762 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' L' ' 33' ' ' THR . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' L' ' 32' ' ' GLN . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.828 ' OD2' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . 0.495 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' L' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.828 HG22 ' OD2' ' L' ' 34' ' ' ASP . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.482 ' OH ' HG21 ' L' ' 79' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' L' ' 71' ' ' ARG . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.643 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 9.3 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.64 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.855 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' L' ' 15' ' ' PHE . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.469 ' HE1' ' HD2' ' L' ' 13' ' ' TYR . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.739 HH21 HG11 ' L' ' 11' ' ' VAL . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.947 HG21 HG21 ' L' ' 145' ' ' THR . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' L' ' 10' ' ' ASP . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' L' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' L' ' 98' ' ' LYS . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' L' ' 142' ' ' GLU . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' L' ' 138' ' ' LEU . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' L' ' 89' ' ' ILE . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.428 HG21 ' HD1' ' L' ' 83' ' ' TYR . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.418 HG23 HG22 ' K' ' 33' ' ' THR . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.505 HG13 ' O ' ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.812 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' L' ' 63' ' ' GLY . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.43 ' H ' HG12 ' L' ' 135' ' ' ILE . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.815 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 11.1 p-10 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.712 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.491 ' OD1' ' HZ ' ' F' ' 160' ' ' PHE . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.947 HG21 HG21 ' L' ' 94' ' ' VAL . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.762 HG23 HD22 ' L' ' 27' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.606 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.889 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.686 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.686 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.889 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' A' ' 93' ' ' ARG . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.614 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.667 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.683 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HG2' HG23 ' A' ' 33' ' ' THR . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.585 HG22 HG23 ' B' ' 122' ' ' VAL . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.76 ' OD2' HG22 ' A' ' 65' ' ' VAL . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 117' ' ' GLU . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.794 ' HA ' HH11 ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.677 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' B' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.677 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.733 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.76 HG22 ' OD2' ' A' ' 34' ' ' ASP . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.419 ' OH ' HG21 ' A' ' 79' ' ' ILE . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 126' ' ' VAL . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.656 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.811 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 10.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 15' ' ' PHE . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.779 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.791 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.5 HG23 HG22 ' F' ' 33' ' ' THR . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.49 HG13 ' O ' ' F' ' 7' ' ' MET . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.699 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.733 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.009 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.948 HG21 HG21 ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.588 HG23 HD22 ' A' ' 27' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' G' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.508 ' HA ' ' CZ3' ' G' ' 92' ' ' TRP . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.525 ' H ' ' HH2' ' G' ' 92' ' ' TRP . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.67 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 17.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' G' ' 18' ' ' ILE . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.803 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' B' ' 6' ' ' ILE . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' B' ' 93' ' ' ARG . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.664 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.666 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.664 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' B' ' 33' ' ' THR . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.548 HG22 HG23 ' C' ' 122' ' ' VAL . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' B' ' 65' ' ' VAL . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' C' ' 117' ' ' GLU . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.67 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.791 ' HA ' HH11 ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.673 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.622 ' HB2' ' HG3' ' C' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' B' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' B' ' 79' ' ' ILE . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' B' ' 126' ' ' VAL . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' B' ' 77' ' ' LYS . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.569 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.825 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 10.4 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.825 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.635 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.41 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.609 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' B' ' 15' ' ' PHE . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 1.002 HG21 HG21 ' B' ' 145' ' ' THR . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' B' ' 94' ' ' VAL . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.611 ' HB2' HD11 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.609 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.791 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.485 ' HD2' ' NH2' ' B' ' 116' ' ' ARG . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.794 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.585 HG23 HG22 ' A' ' 33' ' ' THR . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.477 HG23 ' H ' ' B' ' 69' ' ' GLY . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.791 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' B' ' 110' ' ' PHE . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 1.002 HG21 HG21 ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.591 HG23 HD22 ' B' ' 27' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.456 ' HA ' ' CZ3' ' H' ' 92' ' ' TRP . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.668 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 17.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.479 ' HA ' HG22 ' B' ' 173' ' ' THR . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.479 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' C' ' 6' ' ' ILE . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.564 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' C' ' 93' ' ' ARG . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.633 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.66 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . 0.633 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . 0.405 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' C' ' 33' ' ' THR . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.634 HG22 HG23 ' D' ' 122' ' ' VAL . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' C' ' 65' ' ' VAL . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.791 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' D' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.505 ' O ' ' N ' ' C' ' 41' ' ' ARG . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' C' ' 34' ' ' ASP . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.417 ' OH ' HG21 ' C' ' 79' ' ' ILE . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' C' ' 126' ' ' VAL . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' C' ' 77' ' ' LYS . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.815 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 10.5 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.815 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.67 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.633 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' C' ' 15' ' ' PHE . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.667 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 1.009 HG21 HG21 ' C' ' 145' ' ' THR . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' C' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.678 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' C' ' 94' ' ' VAL . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . 0.995 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.633 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.768 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.477 ' HD2' ' NH2' ' C' ' 116' ' ' ARG . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.773 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.548 HG23 HG22 ' B' ' 33' ' ' THR . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' C' ' 69' ' ' GLY . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.773 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.768 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.726 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' C' ' 110' ' ' PHE . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.995 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 1.009 HG21 HG21 ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.604 HG23 HD22 ' C' ' 27' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.676 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 17.4 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.836 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.48 ' HA ' HG22 ' C' ' 173' ' ' THR . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.48 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.836 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.438 HG21 ' NH2' ' D' ' 93' ' ' ARG . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . 0.668 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.668 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' D' ' 33' ' ' THR . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . 0.575 HG22 HG23 ' E' ' 122' ' ' VAL . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' D' ' 65' ' ' VAL . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.638 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.797 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.654 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.552 ' HB2' ' HG3' ' E' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . 0.654 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . 0.493 ' O ' ' N ' ' D' ' 41' ' ' ARG . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . 0.751 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' D' ' 34' ' ' ASP . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' D' ' 79' ' ' ILE . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.582 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.461 ' H ' HG23 ' D' ' 126' ' ' VAL . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' D' ' 77' ' ' LYS . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.648 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.816 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' D' ' 15' ' ' PHE . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.977 HG21 HG21 ' D' ' 145' ' ' THR . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.4 ' N ' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' D' ' 94' ' ' VAL . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . 0.981 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.785 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.478 ' HD2' ' NH2' ' D' ' 116' ' ' ARG . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.634 HG23 HG22 ' C' ' 33' ' ' THR . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 69' ' ' GLY . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.785 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.69 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.751 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' D' ' 110' ' ' PHE . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.981 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.615 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.977 HG21 HG21 ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' D' ' 27' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.681 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.583 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 17.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' J' ' 18' ' ' ILE . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' E' ' 93' ' ' ARG . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . 0.666 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.622 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' E' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' E' ' 32' ' ' GLN . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' E' ' 65' ' ' VAL . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.563 HG22 ' HG2' ' F' ' 117' ' ' GLU . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' F' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.658 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' F' ' 88' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . 0.658 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . 0.477 ' O ' ' N ' ' E' ' 41' ' ' ARG . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.754 HG22 ' OD2' ' E' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' E' ' 79' ' ' ILE . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . 0.453 ' H ' HG23 ' E' ' 126' ' ' VAL . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 77' ' ' LYS . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.813 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.638 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.62 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' E' ' 15' ' ' PHE . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.684 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.509 ' CB ' HG12 ' E' ' 94' ' ' VAL . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . 0.957 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.617 ' HB2' HD11 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.62 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.481 ' HD2' ' NH2' ' E' ' 116' ' ' ARG . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.575 HG23 HG22 ' D' ' 33' ' ' THR . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.453 HG23 ' H ' ' E' ' 69' ' ' GLY . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.801 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' E' ' 110' ' ' PHE . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.405 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.957 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.625 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.584 HG23 HD22 ' E' ' 27' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.486 ' HA ' ' CZ3' ' K' ' 92' ' ' TRP . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.484 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 17.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.81 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.478 ' HA ' HG22 ' E' ' 173' ' ' THR . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.478 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.81 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' F' ' 93' ' ' ARG . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.664 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.676 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' F' ' 33' ' ' THR . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.5 HG22 HG23 ' A' ' 122' ' ' VAL . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.75 ' OD2' HG22 ' F' ' 65' ' ' VAL . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 117' ' ' GLU . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' F' ' 41' ' ' ARG . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.713 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.75 HG22 ' OD2' ' F' ' 34' ' ' ASP . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' F' ' 79' ' ' ILE . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.59 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.471 ' H ' HG23 ' F' ' 126' ' ' VAL . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' F' ' 77' ' ' LYS . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.651 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 10.5 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' F' ' 15' ' ' PHE . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.666 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.966 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' F' ' 104' ' ' TYR . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' F' ' 142' ' ' GLU . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' F' ' 94' ' ' VAL . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . 0.974 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.788 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.489 ' HD2' ' NH2' ' F' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . 0.453 HG23 HG22 ' E' ' 33' ' ' THR . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.471 HG23 ' H ' ' F' ' 69' ' ' GLY . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.788 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.713 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' F' ' 110' ' ' PHE . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.4 ' N ' HG13 ' F' ' 135' ' ' ILE . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.974 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.626 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.966 HG21 HG21 ' F' ' 94' ' ' VAL . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.586 HG23 HD22 ' F' ' 27' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 1.003 ' CE1' HD13 ' L' ' 143' ' ' ILE . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.837 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.833 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 17.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.79 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.821 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.802 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.821 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.507 ' HB3' ' HE3' ' H' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.6 ' O ' HG22 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.44 HG21 ' NH2' ' G' ' 93' ' ' ARG . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . 0.679 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.679 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . 0.4 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' G' ' 33' ' ' THR . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' G' ' 32' ' ' GLN . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' G' ' 65' ' ' VAL . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.587 HG22 ' HG2' ' H' ' 117' ' ' GLU . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.8 ' HA ' HH11 ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' H' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' G' ' 41' ' ' ARG . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . 0.713 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' G' ' 34' ' ' ASP . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.427 ' OH ' HG21 ' G' ' 79' ' ' ILE . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' G' ' 126' ' ' VAL . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' G' ' 77' ' ' LYS . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 10.5 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.549 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.631 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' G' ' 15' ' ' PHE . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' G' ' 104' ' ' TYR . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' G' ' 94' ' ' VAL . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.534 ' CE2' HD13 ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.631 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.588 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HB3' HH12 ' L' ' 93' ' ' ARG . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . 0.772 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . 0.446 HG23 HG22 ' L' ' 33' ' ' THR . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.554 HG22 ' O ' ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.714 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.401 ' N ' HG13 ' G' ' 135' ' ' ILE . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . 0.43 ' CB ' ' HB3' ' A' ' 159' ' ' ASP . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.625 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' G' ' 94' ' ' VAL . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.59 HG23 HD22 ' G' ' 27' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.672 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.471 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . 0.687 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.467 ' HA ' HG22 ' G' ' 173' ' ' THR . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.467 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' HE3' ' I' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.607 ' O ' HG22 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' H' ' 93' ' ' ARG . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . 0.684 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.684 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' H' ' 33' ' ' THR . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . 0.485 HG23 ' HG2' ' H' ' 32' ' ' GLN . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' H' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' I' ' 117' ' ' GLU . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.799 ' HA ' HH11 ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.676 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' I' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . 0.676 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . 0.506 ' O ' ' N ' ' H' ' 41' ' ' ARG . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' H' ' 34' ' ' ASP . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.432 ' OH ' HG21 ' H' ' 79' ' ' ILE . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' H' ' 126' ' ' VAL . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' H' ' 77' ' ' LYS . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.645 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.808 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.808 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.4 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' H' ' 15' ' ' PHE . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.678 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.402 ' N ' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . 0.454 ' O ' ' HD1' ' H' ' 104' ' ' TYR . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' H' ' 142' ' ' GLU . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' H' ' 94' ' ' VAL . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . 1.0 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.771 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.587 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.512 ' HB3' HH12 ' G' ' 93' ' ' ARG . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . 0.797 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.6 HG22 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.771 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.405 ' N ' HG13 ' H' ' 135' ' ' ILE . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 1.0 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.611 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.595 HG23 HD22 ' H' ' 27' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.67 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.483 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . 0.664 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.807 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.464 ' HA ' HG22 ' H' ' 173' ' ' THR . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.464 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.807 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.625 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.48 ' O ' HG22 ' J' ' 126' ' ' VAL . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' I' ' 93' ' ' ARG . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . 0.657 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' C' ' 163' ' ' PRO . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.657 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' I' ' 33' ' ' THR . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' I' ' 32' ' ' GLN . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' I' ' 65' ' ' VAL . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' J' ' 117' ' ' GLU . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' J' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.793 ' HA ' HH11 ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.666 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . 0.666 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . 0.502 ' O ' ' N ' ' I' ' 41' ' ' ARG . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' I' ' 34' ' ' ASP . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' I' ' 79' ' ' ILE . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.476 ' H ' HG23 ' I' ' 126' ' ' VAL . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' I' ' 77' ' ' LYS . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.66 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.625 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' I' ' 15' ' ' PHE . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.531 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 1.011 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' I' ' 104' ' ' TYR . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' I' ' 142' ' ' GLU . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' I' ' 94' ' ' VAL . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . 0.999 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.625 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' I' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.607 HG22 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.686 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.745 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.407 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.999 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.605 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 1.011 HG21 HG21 ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' I' ' 27' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.673 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.487 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.826 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.473 ' HA ' HG22 ' I' ' 173' ' ' THR . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.826 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.616 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.507 ' O ' HG22 ' K' ' 126' ' ' VAL . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' J' ' 93' ' ' ARG . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . 0.665 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.665 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.402 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.498 ' HG2' HG23 ' J' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . 0.498 HG23 ' HG2' ' J' ' 32' ' ' GLN . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' J' ' 65' ' ' VAL . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' K' ' 117' ' ' GLU . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' K' ' 83' ' ' TYR . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.653 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' K' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . 0.653 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . 0.488 ' O ' ' N ' ' J' ' 41' ' ' ARG . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' J' ' 34' ' ' ASP . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG21 ' J' ' 79' ' ' ILE . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . 0.466 ' H ' HG23 ' J' ' 126' ' ' VAL . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.625 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' J' ' 77' ' ' LYS . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.637 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' J' ' 15' ' ' PHE . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.998 HG21 HG21 ' J' ' 145' ' ' THR . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HD1' ' J' ' 104' ' ' TYR . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' J' ' 94' ' ' VAL . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . 0.952 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.637 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.49 ' HD2' ' NH2' ' J' ' 116' ' ' ARG . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.469 HG23 HG22 ' I' ' 33' ' ' THR . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.495 HG13 ' O ' ' I' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.789 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.737 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' J' ' 110' ' ' PHE . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.952 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.603 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.998 HG21 HG21 ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.603 HG23 HD22 ' J' ' 27' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.679 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.233 0.21 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.474 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . 0.669 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.474 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.485 ' HA ' HG22 ' J' ' 173' ' ' THR . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' J' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.445 ' O ' HG22 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.579 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.579 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' K' ' 93' ' ' ARG . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . 0.675 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.672 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.675 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' K' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . 0.574 HG22 HG23 ' L' ' 122' ' ' VAL . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' K' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.595 HG22 ' HG2' ' L' ' 117' ' ' GLU . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . 0.498 ' HG3' ' CE1' ' L' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.794 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.651 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . 0.465 ' O ' ' N ' ' K' ' 41' ' ' ARG . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . 0.744 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' K' ' 34' ' ' ASP . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' K' ' 79' ' ' ILE . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.468 ' H ' HG23 ' K' ' 126' ' ' VAL . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.616 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' K' ' 77' ' ' LYS . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.65 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.81 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.81 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' K' ' 15' ' ' PHE . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.663 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.959 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' K' ' 104' ' ' TYR . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' K' ' 142' ' ' GLU . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' K' ' 94' ' ' VAL . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.641 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.783 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HB3' HH12 ' J' ' 93' ' ' ARG . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . 0.807 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.495 HG23 HG22 ' J' ' 33' ' ' THR . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' J' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.807 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.707 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.744 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.406 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.604 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.959 HG21 HG21 ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.583 HG23 HD22 ' K' ' 27' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.818 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.49 ' HA ' HG22 ' K' ' 173' ' ' THR . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.49 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.818 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' K' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.554 ' O ' HG22 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.442 HG21 ' NH2' ' L' ' 93' ' ' ARG . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . 0.672 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.802 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . 0.401 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' L' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' L' ' 32' ' ' GLN . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' L' ' 65' ' ' VAL . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' G' ' 117' ' ' GLU . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.803 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' G' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . 0.482 ' O ' ' N ' ' L' ' 41' ' ' ARG . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' L' ' 34' ' ' ASP . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' L' ' 79' ' ' ILE . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.594 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' L' ' 126' ' ' VAL . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' L' ' 77' ' ' LYS . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.658 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.827 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 10.5 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.827 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' L' ' 15' ' ' PHE . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.837 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.972 HG21 HG21 ' L' ' 145' ' ' THR . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' L' ' 104' ' ' TYR . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' L' ' 94' ' ' VAL . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' L' ' 138' ' ' LEU . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.774 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.486 ' HD2' ' NH2' ' L' ' 116' ' ' ARG . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.574 HG23 HG22 ' K' ' 33' ' ' THR . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' L' ' 69' ' ' GLY . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.795 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.74 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' L' ' 110' ' ' PHE . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.408 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.922 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.3 p-10 -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 1.003 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.972 HG21 HG21 ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.587 HG23 HD22 ' L' ' 27' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . 0.682 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.481 ' HA ' HG22 ' L' ' 173' ' ' THR . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.481 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.601 HE22 ' HA ' ' B' ' 122' ' ' VAL . 1.6 mm-40 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 HG11 ' B' ' 126' ' ' VAL . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.681 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG13 ' HG2' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' B' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.963 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.887 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.963 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 29' ' ' PRO . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.621 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.584 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.815 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' A' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.665 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' HG13 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' HE22 ' F' ' 9' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' F' ' 6' ' ' ILE . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 110' ' ' PHE . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.742 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.815 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.713 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.713 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.5 t-20 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.587 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.631 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.4 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.72 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.72 HE22 ' HD2' ' A' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.788 ' HB ' HG22 ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.443 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.649 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.502 HG22 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . 0.53 HE22 ' HA ' ' C' ' 122' ' ' VAL . 1.6 mm-40 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.61 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.675 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.707 HG13 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' C' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.961 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.975 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.961 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.644 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 1.012 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 1.012 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.612 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.731 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.586 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.635 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.61 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.788 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.446 ' CB ' ' HB3' ' B' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.66 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.73 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.674 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.51 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.547 HD12 ' H ' ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.421 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.902 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.688 ' HG2' HG13 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.601 ' HA ' HE22 ' A' ' 9' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 11' ' ' VAL . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.902 HG22 ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.674 HG13 ' O ' ' B' ' 110' ' ' PHE . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.887 HG12 ' HG ' ' A' ' 54' ' ' LEU . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.64 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.73 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.788 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.728 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.728 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.604 ' HB2' ' HH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.568 ' HA ' HE22 ' H' ' 16' ' ' GLN . 4.4 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.719 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.719 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.64 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.64 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . 0.757 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' D' ' 122' ' ' VAL . 1.6 mm-40 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.595 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.561 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.94 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 29' ' ' PRO . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . 0.649 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 1.029 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 1.029 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' C' ' 82' ' ' ALA . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.736 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . 0.634 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.595 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.817 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' C' ' 142' ' ' GLU . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.89 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.732 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.557 ' H ' HD12 ' C' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.419 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.899 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.707 ' HG2' HG13 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.53 ' HA ' HE22 ' B' ' 9' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.899 HG22 ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.736 HD21 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' C' ' 110' ' ' PHE . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.975 HG12 ' HG ' ' B' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.732 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.817 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.735 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.6 t-20 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.545 ' HB2' ' HH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.521 ' HA ' HE22 ' I' ' 16' ' ' GLN . 4.4 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.725 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.725 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.632 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . 0.66 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' E' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.411 HG21 HG11 ' E' ' 126' ' ' VAL . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.67 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.529 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.698 HG13 ' HG2' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' E' ' 83' ' ' TYR . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.449 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.983 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.884 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.983 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' D' ' 29' ' ' PRO . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.757 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.474 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 1.025 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.624 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.581 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . 0.647 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.601 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' D' ' 142' ' ' GLU . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.653 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.863 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.722 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.669 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.541 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.909 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.759 ' HG2' HG13 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.561 HG13 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.909 HG22 ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.669 HG13 ' O ' ' D' ' 110' ' ' PHE . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.94 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.418 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.863 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.825 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.732 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.5 t-20 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.563 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.451 ' O ' ' HZ2' ' J' ' 92' ' ' TRP . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.633 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.4 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.701 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.701 HE22 ' HD2' ' D' ' 163' ' ' PRO . 7.0 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.784 ' HB ' HG22 ' J' ' 18' ' ' ILE . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.488 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' J' ' 88' ' ' GLN . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.798 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . 0.5 HE22 ' HA ' ' F' ' 122' ' ' VAL . 1.6 mm-40 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.663 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.581 HG13 ' HG2' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . 0.53 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.988 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . 0.988 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.498 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' E' ' 29' ' ' PRO . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.66 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.487 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.745 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . 0.642 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.808 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.447 ' CB ' ' HB3' ' E' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.737 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.549 HD12 ' H ' ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.925 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.698 ' HG2' HG13 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.545 ' HA ' HE22 ' D' ' 9' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.411 HG11 HG21 ' D' ' 11' ' ' VAL . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.925 HG22 ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.745 HD21 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.884 HG12 ' HG ' ' D' ' 54' ' ' LEU . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.808 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.5 t-20 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.639 ' HB2' ' HH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.612 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.4 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.714 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.714 HE22 ' HD2' ' E' ' 163' ' ' PRO . 7.0 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.682 ' HB ' HG22 ' K' ' 18' ' ' ILE . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . 0.4 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.531 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . 0.62 HE22 ' HA ' ' A' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.461 ' CG2' HG11 ' A' ' 126' ' ' VAL . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.54 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . 0.54 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.525 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.552 HG13 ' HG2' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . 0.414 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.458 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.973 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.742 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . 0.973 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' F' ' 29' ' ' PRO . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . 0.798 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.492 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.976 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.976 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.732 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' F' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.723 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.555 HD12 ' H ' ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.9 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.581 ' HG2' HG13 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . 0.5 ' HA ' HE22 ' E' ' 9' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' F' ' 69' ' ' GLY . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.9 HG22 ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.732 HD21 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' F' ' 110' ' ' PHE . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 1.037 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.709 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.5 t-20 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' L' ' 92' ' ' TRP . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.913 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.804 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 4.4 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.723 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.723 HE22 ' HD2' ' F' ' 163' ' ' PRO . 7.0 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 1.122 ' HB ' HG22 ' L' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.759 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' H' ' 121' ' ' GLY . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . 0.731 HE22 ' HA ' ' H' ' 122' ' ' VAL . 1.6 mm-40 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.1 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB ' ' A' ' 167' ' ' THR . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.451 HG13 ' CG ' ' H' ' 117' ' ' GLU . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . 0.592 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.919 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' G' ' 29' ' ' PRO . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . 0.553 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.963 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.675 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.963 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.631 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . 0.633 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' G' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.561 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.505 ' CG ' HG13 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . 0.67 ' HA ' HE22 ' L' ' 9' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' G' ' 110' ' ' PHE . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.974 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . 0.624 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' G' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.711 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.711 HE22 ' HD2' ' G' ' 163' ' ' PRO . 7.0 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.613 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.424 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.568 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.574 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' I' ' 122' ' ' VAL . 1.6 mm-40 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.68 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.437 HG13 ' HG2' ' I' ' 117' ' ' GLU . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.945 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.909 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . 0.945 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.983 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.702 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.983 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.623 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.716 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.604 ' HH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . 0.641 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.811 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.455 ' CB ' ' HB3' ' H' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.712 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.551 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.412 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.907 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.451 ' CG ' HG13 ' G' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' G' ' 8' ' ' GLY . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . 0.731 ' HA ' HE22 ' G' ' 9' ' ' GLN . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.907 HG22 ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.716 HD21 ' HE1' ' H' ' 91' ' ' PHE . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.919 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.716 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.811 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.703 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.5 t-20 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.722 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.722 HE22 ' HD2' ' H' ' 163' ' ' PRO . 7.0 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.628 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.623 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . 0.615 HE22 ' HA ' ' J' ' 122' ' ' VAL . 1.6 mm-40 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.608 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' J' ' 126' ' ' VAL . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.523 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.607 HG13 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.953 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 1.047 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . 0.953 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' I' ' 29' ' ' PRO . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.495 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 1.008 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 1.008 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.466 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.58 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . 0.629 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.608 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' I' ' 142' ' ' GLU . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.512 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.556 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.437 ' HG2' HG13 ' H' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . 0.66 ' HA ' HE22 ' H' ' 9' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.574 HG21 ' HB ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' I' ' 110' ' ' PHE . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.909 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.733 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.6 t-20 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.693 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.693 HE22 ' HD2' ' I' ' 163' ' ' PRO . 6.9 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.639 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.639 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.602 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . 0.652 HE22 ' HA ' ' K' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.596 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.462 ' CG2' HG11 ' K' ' 126' ' ' VAL . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.575 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.1 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' D' ' 167' ' ' THR . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . 0.493 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.969 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . 0.969 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' J' ' 29' ' ' PRO . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 1.021 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 1.021 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.625 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.459 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.733 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . 0.625 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.596 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.806 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.456 ' CB ' ' HB3' ' J' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.729 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.544 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.892 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.607 ' CG ' HG13 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.615 ' HA ' HE22 ' I' ' 9' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' I' ' 6' ' ' ILE . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.892 HG22 ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.733 HD21 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' J' ' 110' ' ' PHE . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 1.047 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' J' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.806 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.719 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.6 t-20 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.727 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.727 HE22 ' HD2' ' J' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.635 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.635 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HE ' ' L' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . 0.653 HE22 ' HA ' ' L' ' 122' ' ' VAL . 1.6 mm-40 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.503 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.1 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' E' ' 167' ' ' THR . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.536 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' K' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.635 HG13 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . 0.44 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.985 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 1.057 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . 0.985 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' K' ' 29' ' ' PRO . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.476 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' J' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.617 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.456 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.718 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.639 ' HH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.836 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' K' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.658 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.726 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.551 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.593 ' CG ' HG13 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.652 ' HA ' HE22 ' J' ' 9' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' J' ' 6' ' ' ILE . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' K' ' 69' ' ' GLY . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.718 HD21 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.434 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.836 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.714 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.714 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.5 t-20 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.731 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.731 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.9 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.553 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . 0.67 HE22 ' HA ' ' G' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.611 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' G' ' 126' ' ' VAL . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.687 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 1.122 HG22 ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . 0.553 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.982 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.974 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . 0.982 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' L' ' 128' ' ' ILE . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' L' ' 29' ' ' PRO . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.488 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.97 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.44 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' K' ' 139' ' ' LYS . 2.9 mt-30 -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.913 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.611 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.837 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' L' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.648 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.738 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' F' ' 160' ' ' PHE . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.538 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.886 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.635 ' CG ' HG13 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.653 ' HA ' HE22 ' K' ' 9' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' L' ' 69' ' ' GLY . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 1.057 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' L' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.837 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.6 t-20 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.717 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.717 HE22 ' HD2' ' L' ' 163' ' ' PRO . 7.0 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.594 HG21 HG23 ' B' ' 126' ' ' VAL . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.713 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.47 HG11 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.669 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HG ' ' A' ' 14' ' ' LEU . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.574 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' B' ' 117' ' ' GLU . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.878 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HB3' ' OH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 34' ' ' ASP . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 113' ' ' ILE . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HD1' HG22 ' A' ' 113' ' ' ILE . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.685 HE21 ' HG3' ' F' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.687 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 82' ' ' ALA . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.47 ' HE ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.779 HG11 ' HG2' ' A' ' 142' ' ' GLU . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 10' ' ' ASP . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.854 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' A' ' 79' ' ' ILE . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' F' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' F' ' 8' ' ' GLY . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.663 HG23 HG21 ' F' ' 6' ' ' ILE . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.73 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.73 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.581 ' HG3' HE21 ' B' ' 84' ' ' GLN . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.83 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 HD21 ' A' ' 14' ' ' LEU . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.7 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.676 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 172' ' ' GLY . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 167' ' ' THR . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HA ' HD13 ' G' ' 18' ' ' ILE . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 167' ' ' THR . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.588 HG21 HG23 ' C' ' 126' ' ' VAL . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.522 ' CG ' HD11 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.574 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.419 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.674 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.495 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.574 HD12 ' HG ' ' B' ' 14' ' ' LEU . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.538 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.439 ' HD1' ' HB3' ' B' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.648 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.924 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.912 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' B' ' 34' ' ' ASP . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 128' ' ' ILE . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.439 ' HB3' ' HD1' ' B' ' 31' ' ' TYR . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.61 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.791 HD12 HD11 ' B' ' 113' ' ' ILE . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.516 ' HD1' HG22 ' B' ' 113' ' ' ILE . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.43 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.878 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' B' ' 82' ' ' ALA . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.419 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.789 HG11 ' HG2' ' B' ' 142' ' ' GLU . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.417 HG13 ' OD1' ' B' ' 10' ' ' ASP . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.699 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' B' ' 138' ' ' LEU . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' B' ' 138' ' ' LEU . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.791 HD11 HD12 ' B' ' 79' ' ' ILE . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.846 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 37' ' ' VAL . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.754 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.746 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 8' ' ' GLY . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.594 HG23 HG21 ' A' ' 6' ' ' ILE . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.754 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' B' ' 66' ' ' THR . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 64' ' ' GLU . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' B' ' 111' ' ' ALA . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.714 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.535 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HG3' HE21 ' C' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' B' ' 14' ' ' LEU . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.699 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.75 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 172' ' ' GLY . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . 0.406 ' N ' HG22 ' B' ' 167' ' ' THR . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . 0.591 ' HA ' HD13 ' H' ' 18' ' ' ILE . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' B' ' 167' ' ' THR . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.546 HG21 HG23 ' D' ' 126' ' ' VAL . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.703 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.703 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . 0.525 ' CG ' HD11 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . 0.491 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' C' ' 14' ' ' LEU . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . 0.45 ' HD1' ' HB3' ' C' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.568 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.708 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.812 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.836 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.708 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' C' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.568 HG13 ' OD1' ' C' ' 34' ' ' ASP . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 128' ' ' ILE . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.45 ' HB3' ' HD1' ' C' ' 31' ' ' TYR . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.771 HD12 HD11 ' C' ' 113' ' ' ILE . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' C' ' 113' ' ' ILE . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.523 HE21 ' HG3' ' B' ' 139' ' ' LYS . 0.1 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.607 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.912 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' C' ' 82' ' ' ALA . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' C' ' 142' ' ' GLU . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . 0.416 HG13 ' OD1' ' C' ' 10' ' ' ASP . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' C' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.677 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.707 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.771 HD11 HD12 ' C' ' 79' ' ' ILE . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.648 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.75 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . 0.681 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.588 HG23 HG21 ' B' ' 6' ' ' ILE . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 66' ' ' THR . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' C' ' 64' ' ' GLU . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.677 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.718 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.619 ' HG3' HE21 ' D' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . 0.55 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.693 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.536 HD12 HD21 ' C' ' 14' ' ' LEU . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.701 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' I' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.667 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.497 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.582 ' OG1' HG22 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.481 HG21 ' H ' ' C' ' 172' ' ' GLY . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' I' ' 18' ' ' ILE . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.481 ' H ' HG21 ' C' ' 167' ' ' THR . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.582 HG22 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.562 HG21 HG23 ' E' ' 126' ' ' VAL . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.723 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.723 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.461 HG11 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.423 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.659 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' D' ' 14' ' ' LEU . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . 0.444 ' HD1' ' HB3' ' D' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.575 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . 0.645 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.717 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.853 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . 0.717 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.575 HG13 ' OD1' ' D' ' 34' ' ' ASP . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' D' ' 128' ' ' ILE . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.444 ' HB3' ' HD1' ' D' ' 31' ' ' TYR . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.794 HD12 HD11 ' D' ' 113' ' ' ILE . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' D' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.619 HE21 ' HG3' ' C' ' 139' ' ' LYS . 0.1 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.836 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' D' ' 82' ' ' ALA . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.423 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.495 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.461 ' HE ' HG11 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.785 HG11 ' HG2' ' D' ' 142' ' ' GLU . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' D' ' 10' ' ' ASP . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.902 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' D' ' 138' ' ' LEU . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.683 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.794 HD11 HD12 ' D' ' 79' ' ' ILE . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' D' ' 116' ' ' ARG . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . 0.62 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.546 HG23 HG21 ' C' ' 6' ' ' ILE . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' D' ' 66' ' ' THR . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.734 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.559 ' HG3' HE21 ' E' ' 84' ' ' GLN . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.902 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.702 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.539 HD12 HD21 ' D' ' 14' ' ' LEU . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.711 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.763 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.53 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' D' ' 172' ' ' GLY . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.404 ' N ' HG22 ' D' ' 167' ' ' THR . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . 0.513 ' HA ' HD13 ' J' ' 18' ' ' ILE . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' J' ' 110' ' ' PHE . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' D' ' 167' ' ' THR . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.667 HG21 HG23 ' F' ' 126' ' ' VAL . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.728 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' F' ' 123' ' ' GLU . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.728 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.658 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.61 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' E' ' 14' ' ' LEU . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.523 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . 0.443 ' HD1' ' HB3' ' E' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.786 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.725 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' E' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' E' ' 34' ' ' ASP . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' E' ' 128' ' ' ILE . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.443 ' HB3' ' HD1' ' E' ' 31' ' ' TYR . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.618 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.782 HD12 HD11 ' E' ' 113' ' ' ILE . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.515 ' HD1' HG22 ' E' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' D' ' 139' ' ' LYS . 0.1 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' E' ' 82' ' ' ALA . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.494 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.463 ' HE ' HG11 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.771 HG11 ' HG2' ' E' ' 142' ' ' GLU . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' E' ' 10' ' ' ASP . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.883 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' E' ' 138' ' ' LEU . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.494 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.43 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.782 HD11 HD12 ' E' ' 79' ' ' ILE . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.853 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . 0.704 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . 0.431 ' H ' ' N ' ' D' ' 8' ' ' GLY . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.562 HG23 HG21 ' D' ' 6' ' ' ILE . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.765 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' E' ' 66' ' ' THR . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' E' ' 64' ' ' GLU . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.43 HD13 ' HB1' ' E' ' 111' ' ' ALA . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.718 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.52 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.773 ' HG3' HE21 ' F' ' 84' ' ' GLN . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.835 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.697 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.537 HD12 HD21 ' E' ' 14' ' ' LEU . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' K' ' 140' ' ' ASN . 3.5 m-20 . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.513 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.552 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' E' ' 172' ' ' GLY . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 167' ' ' THR . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' K' ' 18' ' ' ILE . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' E' ' 167' ' ' THR . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 126' ' ' VAL . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.712 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.712 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.464 HG11 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . 0.516 ' CG ' HD11 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . 0.537 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.621 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' F' ' 14' ' ' LEU . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' F' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 121' ' ' GLY . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 117' ' ' GLU . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.72 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . 0.72 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' F' ' 130' ' ' ILE . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' F' ' 34' ' ' ASP . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' F' ' 128' ' ' ILE . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' F' ' 31' ' ' TYR . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.608 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.566 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.778 HD12 HD11 ' F' ' 113' ' ' ILE . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.525 ' HD1' HG22 ' F' ' 113' ' ' ILE . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.773 HE21 ' HG3' ' E' ' 139' ' ' LYS . 0.1 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.61 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.725 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' F' ' 82' ' ' ALA . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.477 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.464 ' HE ' HG11 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' F' ' 142' ' ' GLU . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . 0.408 HG13 ' OD1' ' F' ' 10' ' ' ASP . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.693 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' F' ' 138' ' ' LEU . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.68 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.703 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.778 HD11 HD12 ' F' ' 79' ' ' ILE . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . 0.452 ' HA ' ' HA3' ' E' ' 8' ' ' GLY . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.667 HG23 HG21 ' E' ' 6' ' ' ILE . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' F' ' 66' ' ' THR . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' F' ' 64' ' ' GLU . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.68 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.707 ' H ' HD13 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.536 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.685 ' HG3' HE21 ' A' ' 84' ' ' GLN . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.834 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.69 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.53 HD12 HD21 ' F' ' 14' ' ' LEU . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.693 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.782 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.792 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.904 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.864 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.507 ' OE1' ' HZ ' ' L' ' 108' ' ' PHE . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.677 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.41 ' N ' HG22 ' F' ' 167' ' ' THR . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' F' ' 167' ' ' THR . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.765 HG21 HG23 ' H' ' 126' ' ' VAL . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.706 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.706 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.474 HG11 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . 0.513 ' CG ' HD11 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . 0.54 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.568 HD12 ' HG ' ' G' ' 14' ' ' LEU . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.532 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . 0.449 ' HD1' ' HB3' ' G' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' H' ' 121' ' ' GLY . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' H' ' 118' ' ' TYR . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' H' ' 117' ' ' GLU . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . 0.572 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.459 HD23 ' HG3' ' H' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' G' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' G' ' 34' ' ' ASP . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' G' ' 128' ' ' ILE . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.449 ' HB3' ' HD1' ' G' ' 31' ' ' TYR . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.795 HD12 HD11 ' G' ' 113' ' ' ILE . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' G' ' 113' ' ' ILE . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.846 HE21 ' HG3' ' L' ' 139' ' ' LYS . 0.1 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.689 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' G' ' 82' ' ' ALA . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.559 ' HZ3' ' HA ' ' A' ' 160' ' ' PHE . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.474 ' HE ' HG11 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.77 HG11 ' HG2' ' G' ' 142' ' ' GLU . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' G' ' 10' ' ' ASP . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.69 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.886 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' G' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.689 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.795 HD11 HD12 ' G' ' 79' ' ' ILE . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' L' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . 0.591 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' L' ' 8' ' ' GLY . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.754 HG23 HG21 ' L' ' 6' ' ' ILE . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' G' ' 66' ' ' THR . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' G' ' 64' ' ' GLU . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' G' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.719 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.893 ' HG3' HE21 ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . 0.556 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 1.1 p-10 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.886 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.677 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.517 HD12 HD21 ' G' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.69 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.595 ' OG1' HG22 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' G' ' 172' ' ' GLY . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' G' ' 167' ' ' THR . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' G' ' 167' ' ' THR . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.595 HG22 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.761 HG21 HG23 ' I' ' 126' ' ' VAL . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.72 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.72 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.473 HG11 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.588 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.426 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . 0.487 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.606 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' H' ' 14' ' ' LEU . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' H' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . 0.418 HG22 ' HA2' ' I' ' 121' ' ' GLY . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' I' ' 117' ' ' GLU . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.704 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.406 HD23 ' HG3' ' I' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . 0.704 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' H' ' 130' ' ' ILE . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' H' ' 34' ' ' ASP . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' H' ' 128' ' ' ILE . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' H' ' 31' ' ' TYR . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.775 HD12 HD11 ' H' ' 113' ' ' ILE . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' H' ' 113' ' ' ILE . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.893 HE21 ' HG3' ' G' ' 139' ' ' LYS . 0.1 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' H' ' 82' ' ' ALA . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.426 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.561 ' HZ3' ' HA ' ' B' ' 160' ' ' PHE . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.473 ' HE ' HG11 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.783 HG11 ' HG2' ' H' ' 142' ' ' GLU . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' H' ' 10' ' ' ASP . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.909 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.836 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' H' ' 138' ' ' LEU . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HG ' ' H' ' 138' ' ' LEU . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.686 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.775 HD11 HD12 ' H' ' 79' ' ' ILE . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.473 ' HB3' HG12 ' G' ' 37' ' ' VAL . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' G' ' 8' ' ' GLY . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.765 HG23 HG21 ' G' ' 6' ' ' ILE . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.738 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' H' ' 66' ' ' THR . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' H' ' 64' ' ' GLU . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' H' ' 111' ' ' ALA . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.667 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.868 ' HG3' HE21 ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.909 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.75 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.523 HD12 HD21 ' H' ' 14' ' ' LEU . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.504 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.3 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.592 ' OG1' HG22 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.5 HG21 ' H ' ' H' ' 172' ' ' GLY . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' H' ' 167' ' ' THR . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . 0.5 ' H ' HG21 ' H' ' 167' ' ' THR . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.633 HG21 HG23 ' J' ' 126' ' ' VAL . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.71 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.468 HG11 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . 0.521 ' CG ' HD11 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . 0.538 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' I' ' 14' ' ' LEU . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . 0.441 ' HD1' ' HB3' ' I' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.496 HG22 ' HA2' ' J' ' 121' ' ' GLY . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.557 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' J' ' 117' ' ' GLU . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.707 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.535 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . 0.707 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' I' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.557 HG13 ' OD1' ' I' ' 34' ' ' ASP . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' I' ' 128' ' ' ILE . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.441 ' HB3' ' HD1' ' I' ' 31' ' ' TYR . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.613 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.79 HD12 HD11 ' I' ' 113' ' ' ILE . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' I' ' 113' ' ' ILE . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.868 HE21 ' HG3' ' H' ' 139' ' ' LYS . 0.1 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.691 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' I' ' 82' ' ' ALA . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.429 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.496 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.468 ' HE ' HG11 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' I' ' 142' ' ' GLU . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' I' ' 10' ' ' ASP . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.696 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.91 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' I' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.691 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.79 HD11 HD12 ' I' ' 79' ' ' ILE . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' H' ' 37' ' ' VAL . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . 0.495 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' H' ' 8' ' ' GLY . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.761 HG23 HG21 ' H' ' 6' ' ' ILE . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' I' ' 66' ' ' THR . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' I' ' 64' ' ' GLU . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' I' ' 111' ' ' ALA . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.537 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.761 ' HG3' HE21 ' J' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.825 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.703 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.521 HD12 HD21 ' I' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.59 ' OG1' HG22 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' I' ' 172' ' ' GLY . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' I' ' 167' ' ' THR . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' I' ' 167' ' ' THR . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.59 HG22 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.698 HG21 HG23 ' K' ' 126' ' ' VAL . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.694 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.584 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . 0.541 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.668 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.604 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.584 HD12 ' HG ' ' J' ' 14' ' ' LEU . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.451 ' HD1' ' HB3' ' J' ' 67' ' ' TYR . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . 0.472 HG22 ' HA2' ' K' ' 121' ' ' GLY . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' K' ' 117' ' ' GLU . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . 0.586 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' K' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' J' ' 34' ' ' ASP . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' J' ' 128' ' ' ILE . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.451 ' HB3' ' HD1' ' J' ' 31' ' ' TYR . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.597 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' J' ' 71' ' ' ARG . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.781 HD12 HD11 ' J' ' 113' ' ' ILE . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.51 ' HD1' HG22 ' J' ' 113' ' ' ILE . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.761 HE21 ' HG3' ' I' ' 139' ' ' LYS . 0.1 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.428 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.696 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' J' ' 82' ' ' ALA . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.556 ' HZ3' ' HA ' ' D' ' 160' ' ' PHE . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' J' ' 142' ' ' GLU . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' J' ' 10' ' ' ASP . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.892 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' J' ' 138' ' ' LEU . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.696 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.781 HD11 HD12 ' J' ' 79' ' ' ILE . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' I' ' 37' ' ' VAL . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . 0.749 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' I' ' 6' ' ' ILE . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.633 HG23 HG21 ' I' ' 6' ' ' ILE . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.749 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' J' ' 66' ' ' THR . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' J' ' 111' ' ' ALA . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.734 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.853 ' HG3' HE21 ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . 0.61 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.892 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.826 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' D' ' 160' ' ' PHE . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.532 HD12 HD21 ' J' ' 14' ' ' LEU . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.498 ' HA ' ' HB3' ' J' ' 161' ' ' GLN . 0.3 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' J' ' 172' ' ' GLY . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . 0.4 ' N ' HG22 ' J' ' 167' ' ' THR . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' J' ' 167' ' ' THR . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.69 HG21 HG23 ' L' ' 126' ' ' VAL . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.705 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' K' ' 14' ' ' LEU . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' K' ' 67' ' ' TYR . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.572 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . 0.537 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' L' ' 117' ' ' GLU . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.721 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . 0.721 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' K' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.572 HG13 ' OD1' ' K' ' 34' ' ' ASP . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' K' ' 128' ' ' ILE . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' K' ' 31' ' ' TYR . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.605 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' K' ' 71' ' ' ARG . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.789 HD12 HD11 ' K' ' 113' ' ' ILE . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' K' ' 113' ' ' ILE . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.853 HE21 ' HG3' ' J' ' 139' ' ' LYS . 0.1 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.596 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.685 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' K' ' 82' ' ' ALA . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.585 ' HZ3' ' HA ' ' E' ' 160' ' ' PHE . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.768 HG11 ' HG2' ' K' ' 142' ' ' GLU . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . 0.406 HG13 ' OD1' ' K' ' 10' ' ' ASP . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.87 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' K' ' 138' ' ' LEU . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.669 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.789 HD11 HD12 ' K' ' 79' ' ' ILE . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' J' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . 0.634 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' J' ' 8' ' ' GLY . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.698 HG23 HG21 ' J' ' 6' ' ' ILE . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' K' ' 66' ' ' THR . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' K' ' 64' ' ' GLU . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.446 HD13 ' HB1' ' K' ' 111' ' ' ALA . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.669 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.733 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.796 ' HG3' HE21 ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.87 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.676 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' K' ' 14' ' ' LEU . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' K' ' 161' ' ' GLN . 0.3 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.483 HG21 ' H ' ' K' ' 172' ' ' GLY . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . 0.401 ' N ' HG22 ' K' ' 167' ' ' THR . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . 0.483 ' H ' HG21 ' K' ' 167' ' ' THR . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.421 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.754 HG21 HG23 ' G' ' 126' ' ' VAL . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . 0.529 ' CG ' HD11 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . 0.531 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.615 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.561 HD12 ' HG ' ' L' ' 14' ' ' LEU . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' L' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' G' ' 121' ' ' GLY . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 117' ' ' GLU . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.713 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' G' ' 88' ' ' GLN . 1.6 mp . . . . . 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . 0.713 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' L' ' 34' ' ' ASP . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' L' ' 128' ' ' ILE . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' L' ' 31' ' ' TYR . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD3' ' L' ' 71' ' ' ARG . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' L' ' 113' ' ' ILE . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' NZ ' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' L' ' 113' ' ' ILE . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.796 HE21 ' HG3' ' K' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.703 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' L' ' 82' ' ' ALA . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.677 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.501 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.762 HG11 ' HG2' ' L' ' 142' ' ' GLU . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' L' ' 10' ' ' ASP . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' L' ' 138' ' ' LEU . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.507 ' HZ ' ' OE1' ' F' ' 165' ' ' GLN . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' L' ' 79' ' ' ILE . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.525 ' HB3' HG12 ' K' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . 0.742 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . 0.512 ' H ' ' N ' ' K' ' 8' ' ' GLY . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' K' ' 6' ' ' ILE . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.69 HG23 HG21 ' K' ' 6' ' ' ILE . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.742 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' L' ' 66' ' ' THR . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' L' ' 111' ' ' ALA . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.679 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.72 HD13 ' H ' ' L' ' 135' ' ' ILE . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.846 ' HG3' HE21 ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.782 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.904 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.88 ' O ' ' HG2' ' F' ' 162' ' ' GLN . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.421 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.527 HD12 HD21 ' L' ' 14' ' ' LEU . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.591 ' OG1' HG22 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.489 HG21 ' H ' ' L' ' 172' ' ' GLY . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' L' ' 167' ' ' THR . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . 0.489 ' H ' HG21 ' L' ' 167' ' ' THR . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.591 HG22 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 6' ' ' ILE . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 93' ' ' ARG . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 25' ' ' ALA . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 89' ' ' ILE . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' A' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.54 HG22 HG23 ' B' ' 122' ' ' VAL . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.513 ' OD1' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' B' ' 117' ' ' GLU . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.746 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' A' ' 42' ' ' GLU . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD22 HD13 ' B' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 43' ' ' LEU . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.847 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' OD1' ' A' ' 34' ' ' ASP . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.598 ' H ' HE22 ' A' ' 76' ' ' GLN . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.666 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.478 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HE2' ' OD1' ' A' ' 85' ' ' ASN . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.641 HE22 ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 15' ' ' PHE . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' A' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.771 HG21 HG21 ' A' ' 145' ' ' THR . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 97' ' ' VAL . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.799 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 138' ' ' LEU . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' HE22 ' A' ' 88' ' ' GLN . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' A' ' 83' ' ' TYR . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 132' ' ' LEU . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.529 ' HG3' HH11 ' A' ' 116' ' ' ARG . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' F' ' 33' ' ' THR . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' O ' ' F' ' 7' ' ' MET . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' A' ' 130' ' ' ILE . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.616 ' O ' HG13 ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.76 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.847 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 110' ' ' PHE . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 135' ' ' ILE . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' A' ' 94' ' ' VAL . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.578 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.771 HG21 HG21 ' A' ' 94' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 145' ' ' THR . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.527 ' HA ' ' HH2' ' G' ' 92' ' ' TRP . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 22.9 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.583 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.769 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.631 HG11 HH21 ' B' ' 93' ' ' ARG . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.497 ' HB3' HD11 ' B' ' 89' ' ' ILE . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.656 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' B' ' 18' ' ' ILE . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.434 ' HE1' ' HG ' ' B' ' 27' ' ' LEU . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.521 HG22 HG23 ' C' ' 122' ' ' VAL . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' B' ' 65' ' ' VAL . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' C' ' 117' ' ' GLU . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.812 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.401 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' B' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' B' ' 41' ' ' ARG . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.788 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.717 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.497 ' O ' HD22 ' B' ' 43' ' ' LEU . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . 0.788 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.732 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' B' ' 34' ' ' ASP . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.594 ' H ' HE22 ' B' ' 76' ' ' GLN . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' B' ' 70' ' ' LYS . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.615 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 7.0 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.471 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.471 ' HE2' ' OD1' ' B' ' 85' ' ' ASN . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' B' ' 15' ' ' PHE . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.656 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.631 HH21 HG11 ' B' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.769 HG21 HG21 ' B' ' 145' ' ' THR . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 11' ' ' VAL . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.495 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' B' ' 97' ' ' VAL . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 138' ' ' LEU . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.648 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' B' ' 83' ' ' TYR . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.534 ' HG3' ' HA ' ' B' ' 132' ' ' LEU . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.545 ' HG3' HH11 ' B' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.602 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.651 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 33' ' ' THR . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.626 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' B' ' 130' ' ' ILE . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.732 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.534 ' HA ' ' HG3' ' B' ' 114' ' ' GLU . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.861 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' B' ' 110' ' ' PHE . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.584 HD13 HD22 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' B' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 0.769 HG21 HG21 ' B' ' 94' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.672 HD12 ' O ' ' B' ' 145' ' ' THR . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.555 ' HA ' ' HH2' ' H' ' 92' ' ' TRP . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.591 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.636 HG11 HH21 ' C' ' 93' ' ' ARG . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' C' ' 12' ' ' LYS . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' C' ' 89' ' ' ILE . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.65 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . 0.469 ' N ' HG13 ' C' ' 18' ' ' ILE . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.562 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . 0.439 ' HE1' ' HG ' ' C' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.595 ' CG2' HG23 ' D' ' 122' ' ' VAL . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.511 ' OD1' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.537 HG22 ' HG2' ' D' ' 117' ' ' GLU . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' C' ' 42' ' ' GLU . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.695 HD22 HD13 ' D' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' C' ' 43' ' ' LEU . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . 0.884 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.511 HG22 ' OD1' ' C' ' 34' ' ' ASP . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.608 ' H ' HE22 ' C' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' C' ' 70' ' ' LYS . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.58 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.616 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 7.0 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.475 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' C' ' 85' ' ' ASN . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.653 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' C' ' 15' ' ' PHE . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.636 HH21 HG11 ' C' ' 11' ' ' VAL . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.759 HG21 HG21 ' C' ' 145' ' ' THR . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' C' ' 11' ' ' VAL . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' C' ' 97' ' ' VAL . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.784 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' C' ' 138' ' ' LEU . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.653 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' C' ' 83' ' ' TYR . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' C' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' C' ' 116' ' ' ARG . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.576 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . 0.521 HG23 HG22 ' B' ' 33' ' ' THR . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . 0.714 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . 0.459 HG22 HG23 ' C' ' 130' ' ' ILE . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.598 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.739 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.532 ' HA ' ' HG3' ' C' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.884 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.415 HG13 ' O ' ' C' ' 110' ' ' PHE . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.717 HD13 HD22 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.443 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' C' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.572 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 0.759 HG21 HG21 ' C' ' 94' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' C' ' 145' ' ' THR . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.505 ' HA ' ' HH2' ' I' ' 92' ' ' TRP . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.793 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.793 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.626 HG11 HH21 ' D' ' 93' ' ' ARG . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' D' ' 12' ' ' LYS . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.628 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' D' ' 18' ' ' ILE . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . 0.535 ' CG2' HG23 ' E' ' 122' ' ' VAL . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.601 HG22 ' HG2' ' E' ' 117' ' ' GLU . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . 0.772 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' D' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' D' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.774 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.56 HD22 HD13 ' E' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' D' ' 43' ' ' LEU . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . 0.774 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' D' ' 34' ' ' ASP . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.621 ' H ' HE22 ' D' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.448 HH11 ' HB ' ' C' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.478 ' OD2' ' HD3' ' D' ' 70' ' ' LYS . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.621 HE22 ' H ' ' D' ' 70' ' ' LYS . 7.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' D' ' 85' ' ' ASN . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' D' ' 15' ' ' PHE . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.626 HH21 HG11 ' D' ' 11' ' ' VAL . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.765 HG21 HG21 ' D' ' 145' ' ' THR . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' D' ' 11' ' ' VAL . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' D' ' 97' ' ' VAL . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' D' ' 138' ' ' LEU . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . 0.791 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.652 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' D' ' 83' ' ' TYR . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' D' ' 132' ' ' LEU . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' D' ' 116' ' ' ARG . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.537 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' C' ' 33' ' ' THR . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' I' ' 43' ' ' LEU . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' C' ' 7' ' ' MET . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' D' ' 130' ' ' ILE . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.606 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' D' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 110' ' ' PHE . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.695 HD13 HD22 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.44 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.791 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.417 ' HG2' HG11 ' D' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.765 HG21 HG21 ' D' ' 94' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.685 HD12 ' O ' ' D' ' 145' ' ' THR . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' CH2' ' J' ' 92' ' ' TRP . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.595 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' I' ' 54' ' ' LEU . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.534 ' HB3' ' HG3' ' F' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' F' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' E' ' 93' ' ' ARG . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' E' ' 12' ' ' LYS . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' E' ' 25' ' ' ALA . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' E' ' 89' ' ' ILE . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.635 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.466 ' H ' HG13 ' E' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.576 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . 0.425 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.519 ' OD1' HG22 ' E' ' 65' ' ' VAL . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' F' ' 117' ' ' GLU . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . 0.736 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' E' ' 42' ' ' GLU . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.801 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.652 HD22 HD13 ' F' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' E' ' 43' ' ' LEU . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . 0.801 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.519 HG22 ' OD1' ' E' ' 34' ' ' ASP . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.615 ' H ' HE22 ' E' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.487 HH11 ' HB ' ' D' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' E' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.615 HE22 ' H ' ' E' ' 70' ' ' LYS . 7.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.772 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' E' ' 85' ' ' ASN . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.649 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' E' ' 15' ' ' PHE . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' E' ' 11' ' ' VAL . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.784 HG21 HG21 ' E' ' 145' ' ' THR . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' E' ' 11' ' ' VAL . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . 0.499 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.499 ' HD1' ' O ' ' E' ' 97' ' ' VAL . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' E' ' 138' ' ' LEU . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . 0.779 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.649 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.416 HG21 ' HD1' ' E' ' 83' ' ' TYR . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' E' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.528 HH11 ' HG3' ' E' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.601 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' D' ' 33' ' ' THR . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . 0.559 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' E' ' 130' ' ' ILE . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.614 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.755 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' E' ' 114' ' ' GLU . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.882 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' E' ' 110' ' ' PHE . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.56 HD13 HD22 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.779 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.415 ' HG2' HG11 ' E' ' 94' ' ' VAL . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.573 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.784 HG21 HG21 ' E' ' 94' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' E' ' 145' ' ' THR . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.595 ' HA ' ' HH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.578 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.767 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.767 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.537 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 126' ' ' VAL . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' F' ' 93' ' ' ARG . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' F' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' F' ' 25' ' ' ALA . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' F' ' 89' ' ' ILE . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.633 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . 0.465 ' H ' HG13 ' F' ' 18' ' ' ILE . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.581 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . 0.424 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . 0.472 ' CG2' HG23 ' A' ' 122' ' ' VAL . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 117' ' ' GLU . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . 0.719 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' F' ' 42' ' ' GLU . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' F' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' F' ' 43' ' ' LEU . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.506 HG22 ' OD1' ' F' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.616 ' H ' HE22 ' F' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . 0.498 HH11 ' HB ' ' E' ' 97' ' ' VAL . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' F' ' 70' ' ' LYS . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.576 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.616 HE22 ' H ' ' F' ' 70' ' ' LYS . 7.0 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.474 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.474 ' HE2' ' OD1' ' F' ' 85' ' ' ASN . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.64 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' F' ' 15' ' ' PHE . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' F' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.776 HG21 HG21 ' F' ' 145' ' ' THR . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' F' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . 0.666 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.477 ' HD1' ' O ' ' F' ' 97' ' ' VAL . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.809 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.495 ' CE2' HD13 ' F' ' 138' ' ' LEU . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . 0.801 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.64 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.417 HG21 ' HD1' ' F' ' 83' ' ' TYR . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' F' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' F' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' K' ' 43' ' ' LEU . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' E' ' 7' ' ' MET . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' F' ' 130' ' ' ILE . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.763 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' HG3' ' F' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' F' ' 110' ' ' PHE . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.652 HD13 HD22 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.446 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.801 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' F' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.776 HG21 HG21 ' F' ' 94' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.683 HD12 ' O ' ' F' ' 145' ' ' THR . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.764 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.578 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 22.9 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' L' ' 23' ' ' GLY . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.685 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.577 HG23 ' HB2' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.781 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.653 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.781 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.537 ' O ' HG22 ' H' ' 126' ' ' VAL . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.634 HG11 HH21 ' G' ' 93' ' ' ARG . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' G' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . 0.5 ' HB3' HD11 ' G' ' 89' ' ' ILE . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . 0.475 ' H ' HG13 ' G' ' 18' ' ' ILE . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.638 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . 0.42 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.597 HG22 ' HG2' ' H' ' 117' ' ' GLU . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . 0.648 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' G' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' G' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.799 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . 0.494 ' O ' HD22 ' G' ' 43' ' ' LEU . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . 0.799 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' G' ' 34' ' ' ASP . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.624 ' H ' HE22 ' G' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . 0.705 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' G' ' 70' ' ' LYS . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.578 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.624 HE22 ' H ' ' G' ' 70' ' ' LYS . 7.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.432 ' HG2' ' NZ ' ' L' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' G' ' 85' ' ' ASN . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.646 HE22 ' HB3' ' G' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' G' ' 15' ' ' PHE . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.527 ' HH2' ' HA ' ' A' ' 160' ' ' PHE . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.634 HH21 HG11 ' G' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.774 HG21 HG21 ' G' ' 145' ' ' THR . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' G' ' 11' ' ' VAL . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . 0.649 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.489 ' HD1' ' O ' ' G' ' 97' ' ' VAL . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.802 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' G' ' 138' ' ' LEU . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.646 ' HB3' HE22 ' G' ' 88' ' ' GLN . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' G' ' 83' ' ' TYR . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' G' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.54 ' HG3' HH11 ' G' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.548 HG13 ' O ' ' L' ' 7' ' ' MET . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . 0.473 HG22 HG23 ' G' ' 130' ' ' ILE . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.624 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' G' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.854 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' G' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.456 HD13 HD22 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.447 ' H ' HG13 ' G' ' 135' ' ' ILE . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' G' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.576 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.774 HG21 HG21 ' G' ' 94' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' G' ' 145' ' ' THR . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.57 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.784 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.784 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.542 ' O ' HG22 ' I' ' 126' ' ' VAL . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.573 ' O ' HG13 ' I' ' 126' ' ' VAL . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.643 HG11 HH21 ' H' ' 93' ' ' ARG . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' H' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' H' ' 89' ' ' ILE . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . 0.471 ' H ' HG13 ' H' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.572 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.515 ' OD1' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' I' ' 117' ' ' GLU . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' H' ' 42' ' ' GLU . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' H' ' 41' ' ' ARG . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' H' ' 43' ' ' LEU . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' H' ' 34' ' ' ASP . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.617 ' H ' HE22 ' H' ' 76' ' ' GLN . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . 0.649 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' H' ' 70' ' ' LYS . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.577 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.617 HE22 ' H ' ' H' ' 70' ' ' LYS . 7.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.648 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' H' ' 85' ' ' ASN . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.642 HE22 ' HB3' ' H' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' H' ' 15' ' ' PHE . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.555 ' HH2' ' HA ' ' B' ' 160' ' ' PHE . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.643 HH21 HG11 ' H' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.762 HG21 HG21 ' H' ' 145' ' ' THR . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' H' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . 0.731 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' H' ' 97' ' ' VAL . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.788 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' H' ' 138' ' ' LEU . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.642 ' HB3' HE22 ' H' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' H' ' 83' ' ' TYR . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' H' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' H' ' 116' ' ' ARG . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.575 HG13 ' O ' ' G' ' 7' ' ' MET . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' H' ' 130' ' ' ILE . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.613 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.756 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' H' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.85 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' H' ' 110' ' ' PHE . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.442 HG13 ' H ' ' H' ' 136' ' ' GLY . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.442 ' H ' HG13 ' H' ' 135' ' ' ILE . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' H' ' 94' ' ' VAL . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.762 HG21 HG21 ' H' ' 94' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' H' ' 145' ' ' THR . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.588 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.588 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.788 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.788 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.633 HG11 HH21 ' I' ' 93' ' ' ARG . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' I' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' I' ' 89' ' ' ILE . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.643 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . 0.474 ' H ' HG13 ' I' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.57 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . 0.437 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.423 ' CG2' HG23 ' J' ' 122' ' ' VAL . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' J' ' 117' ' ' GLU . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . 0.725 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' I' ' 42' ' ' GLU . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' I' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.522 HD22 HD13 ' J' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' I' ' 43' ' ' LEU . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' I' ' 34' ' ' ASP . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.625 ' H ' HE22 ' I' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.731 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' I' ' 70' ' ' LYS . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.625 HE22 ' H ' ' I' ' 70' ' ' LYS . 7.0 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' I' ' 85' ' ' ASN . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.65 HE22 ' HB3' ' I' ' 110' ' ' PHE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' I' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.505 ' HH2' ' HA ' ' C' ' 160' ' ' PHE . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.633 HH21 HG11 ' I' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.763 HG21 HG21 ' I' ' 145' ' ' THR . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' I' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . 0.736 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.574 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' I' ' 97' ' ' VAL . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' I' ' 138' ' ' LEU . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.65 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' I' ' 83' ' ' TYR . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' I' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.533 ' HG3' HH11 ' I' ' 116' ' ' ARG . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.535 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.573 HG13 ' O ' ' H' ' 7' ' ' MET . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . 0.465 HG22 HG23 ' I' ' 130' ' ' ILE . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.602 HG13 ' O ' ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' I' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' I' ' 110' ' ' PHE . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.451 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.451 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.782 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.457 ' NZ ' ' HG2' ' J' ' 84' ' ' GLN . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.416 ' HG2' HG11 ' I' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.574 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 0.763 HG21 HG21 ' I' ' 94' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' I' ' 145' ' ' THR . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.796 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.796 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.555 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.441 ' O ' HG22 ' K' ' 126' ' ' VAL . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' J' ' 93' ' ' ARG . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' J' ' 12' ' ' LYS . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' J' ' 89' ' ' ILE . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.645 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' J' ' 18' ' ' ILE . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.652 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.561 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . 0.446 ' CG2' HG23 ' K' ' 122' ' ' VAL . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' K' ' 117' ' ' GLU . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . 0.615 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' J' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' J' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.785 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.441 HD22 HD13 ' K' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . 0.491 ' O ' HD22 ' J' ' 43' ' ' LEU . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . 0.785 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . 0.885 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' J' ' 34' ' ' ASP . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.636 ' H ' HE22 ' J' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . 0.736 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' J' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.636 HE22 ' H ' ' J' ' 70' ' ' LYS . 7.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.457 ' HG2' ' NZ ' ' I' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' J' ' 85' ' ' ASN . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' J' ' 15' ' ' PHE . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' D' ' 160' ' ' PHE . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' J' ' 11' ' ' VAL . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.753 HG21 HG21 ' J' ' 145' ' ' THR . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' J' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . 0.682 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' J' ' 97' ' ' VAL . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.798 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' J' ' 138' ' ' LEU . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' J' ' 83' ' ' TYR . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' J' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.542 ' HG3' HH11 ' J' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' I' ' 33' ' ' THR . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.503 HG13 ' O ' ' I' ' 7' ' ' MET . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . 0.466 HG22 HG23 ' J' ' 130' ' ' ILE . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.735 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' J' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.885 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' J' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.522 HD13 HD22 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.456 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.439 ' NZ ' ' HG2' ' K' ' 84' ' ' GLN . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.753 HG21 HG21 ' J' ' 94' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.675 HD12 ' O ' ' J' ' 145' ' ' THR . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.798 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.798 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.436 ' O ' ' HB1' ' L' ' 125' ' ' ALA . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' K' ' 93' ' ' ARG . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' K' ' 12' ' ' LYS . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' K' ' 25' ' ' ALA . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . 0.476 ' H ' HG13 ' K' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.643 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.587 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . 0.427 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . 0.494 HG22 HG23 ' L' ' 122' ' ' VAL . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' K' ' 65' ' ' VAL . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' L' ' 117' ' ' GLU . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . 0.603 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' K' ' 42' ' ' GLU . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' K' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.803 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.613 HD22 HD13 ' L' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . 0.496 ' O ' HD22 ' K' ' 43' ' ' LEU . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . 0.803 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.743 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' K' ' 34' ' ' ASP . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.64 ' H ' HE22 ' K' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . 0.682 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' K' ' 70' ' ' LYS . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.64 HE22 ' H ' ' K' ' 70' ' ' LYS . 7.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.597 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.439 ' HG2' ' NZ ' ' J' ' 139' ' ' LYS . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' K' ' 85' ' ' ASN . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.657 HE22 ' HB3' ' K' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' K' ' 15' ' ' PHE . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' K' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.775 HG21 HG21 ' K' ' 145' ' ' THR . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' K' ' 11' ' ' VAL . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . 0.588 ' HB ' HH11 ' L' ' 71' ' ' ARG . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' K' ' 97' ' ' VAL . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' K' ' 138' ' ' LEU . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.657 ' HB3' HE22 ' K' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' K' ' 83' ' ' TYR . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' K' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.546 HH11 ' HG3' ' K' ' 116' ' ' ARG . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' J' ' 33' ' ' THR . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.52 HG13 ' O ' ' J' ' 7' ' ' MET . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' K' ' 130' ' ' ILE . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.604 HG13 ' O ' ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.743 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.524 ' HA ' ' HG3' ' K' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.418 HG13 ' O ' ' K' ' 110' ' ' PHE . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.455 HG13 ' H ' ' K' ' 136' ' ' GLY . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.455 ' H ' HG13 ' K' ' 135' ' ' ILE . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' K' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.775 HG21 HG21 ' K' ' 94' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' K' ' 145' ' ' THR . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.594 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.791 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.791 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' G' ' 126' ' ' VAL . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' L' ' 93' ' ' ARG . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' L' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' L' ' 25' ' ' ALA . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.493 ' HB3' HD11 ' L' ' 89' ' ' ILE . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.636 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' L' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' F' ' 164' ' ' GLY . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.591 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.596 HG22 ' HG2' ' G' ' 117' ' ' GLU . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . 0.636 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' L' ' 42' ' ' GLU . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' L' ' 41' ' ' ARG . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.786 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.456 HD22 HD13 ' G' ' 135' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . 0.498 ' O ' HD22 ' L' ' 43' ' ' LEU . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . 0.786 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' L' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.634 ' H ' HE22 ' L' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.588 HH11 ' HB ' ' K' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' L' ' 70' ' ' LYS . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.634 HE22 ' H ' ' L' ' 70' ' ' LYS . 7.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.594 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.512 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' L' ' 85' ' ' ASN . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' L' ' 110' ' ' PHE . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' L' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.764 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' L' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.787 HG21 HG21 ' L' ' 145' ' ' THR . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' L' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . 0.705 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' L' ' 97' ' ' VAL . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' L' ' 138' ' ' LEU . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . 0.794 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' L' ' 88' ' ' GLN . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' L' ' 83' ' ' TYR . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' L' ' 132' ' ' LEU . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.54 HH11 ' HG3' ' L' ' 116' ' ' ARG . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.608 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.494 HG23 HG22 ' K' ' 33' ' ' THR . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.449 HG13 ' O ' ' K' ' 7' ' ' MET . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' L' ' 130' ' ' ILE . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.615 HG13 ' O ' ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.769 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.529 ' HA ' ' HG3' ' L' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' L' ' 110' ' ' PHE . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.613 HD13 HD22 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.43 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.794 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.432 ' NZ ' ' HG2' ' G' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.75 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.0 p-10 -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' F' ' 160' ' ' PHE . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.787 HG21 HG21 ' L' ' 94' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.684 HD12 ' O ' ' L' ' 145' ' ' THR . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.787 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.787 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' B' ' 126' ' ' VAL . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.851 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' B' ' 117' ' ' GLU . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.801 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' A' ' 34' ' ' ASP . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HD1' HG22 ' A' ' 113' ' ' ILE . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 82' ' ' ALA . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 142' ' ' GLU . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.78 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' A' ' 139' ' ' LYS . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' A' ' 138' ' ' LEU . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.668 HG22 ' HD1' ' A' ' 83' ' ' TYR . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.862 HG23 HG21 ' F' ' 6' ' ' ILE . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' A' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' A' ' 107' ' ' GLN . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 150' ' ' ILE . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.455 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.721 ' HB3' HG21 ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HB2' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.544 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' G' ' 21' ' ' ALA . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 172' ' ' GLY . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 167' ' ' THR . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.433 ' H ' HG21 ' A' ' 167' ' ' THR . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.789 HG21 HG23 ' C' ' 126' ' ' VAL . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.818 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.818 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.873 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.595 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' C' ' 117' ' ' GLU . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.574 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.872 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.574 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' B' ' 34' ' ' ASP . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.451 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.604 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.837 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' B' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.74 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.873 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 111' ' ' ALA . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.628 HG11 ' HG2' ' B' ' 142' ' ' GLU . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 104' ' ' TYR . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.553 ' HG2' ' HG2' ' B' ' 139' ' ' LYS . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' B' ' 138' ' ' LEU . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' B' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' B' ' 83' ' ' TYR . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.459 ' HB3' HG12 ' A' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 6' ' ' ILE . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.524 HG13 ' HB ' ' B' ' 65' ' ' VAL . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' B' ' 107' ' ' GLN . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' B' ' 150' ' ' ILE . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' B' ' 150' ' ' ILE . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' B' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.563 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' H' ' 21' ' ' ALA . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.426 HG21 ' H ' ' B' ' 172' ' ' GLY . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . 0.415 ' N ' HG22 ' B' ' 167' ' ' THR . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . 0.426 ' H ' HG21 ' B' ' 167' ' ' THR . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' B' ' 176' ' ' ALA . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.743 HG21 HG23 ' D' ' 126' ' ' VAL . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.836 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.562 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' C' ' 76' ' ' GLN . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.722 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.775 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.458 ' HB3' ' HE ' ' C' ' 41' ' ' ARG . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' C' ' 34' ' ' ASP . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . 0.41 HH21 ' HD3' ' C' ' 71' ' ' ARG . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.601 HD12 HD11 ' C' ' 113' ' ' ILE . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.672 ' HD1' HG22 ' C' ' 113' ' ' ILE . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . 0.417 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.781 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' C' ' 111' ' ' ALA . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.634 HG11 ' HG2' ' C' ' 142' ' ' GLU . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' C' ' 104' ' ' TYR . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.804 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.563 ' HG2' ' HG2' ' C' ' 139' ' ' LYS . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.669 ' HD2' HD11 ' C' ' 138' ' ' LEU . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.701 ' O ' HG23 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' C' ' 91' ' ' PHE . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.672 HG22 ' HD1' ' C' ' 83' ' ' TYR . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.872 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' B' ' 37' ' ' VAL . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . 0.605 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.789 HG23 HG21 ' B' ' 6' ' ' ILE . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB ' ' C' ' 65' ' ' VAL . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.701 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.665 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.617 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.669 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' C' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . 0.602 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.804 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.919 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.52 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' C' ' 150' ' ' ILE . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' C' ' 150' ' ' ILE . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' C' ' 145' ' ' THR . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.471 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.525 ' O ' HG22 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.427 HG22 ' HB1' ' I' ' 21' ' ' ALA . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' C' ' 172' ' ' GLY . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . 0.413 ' N ' HG22 ' C' ' 167' ' ' THR . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.428 ' H ' HG21 ' C' ' 167' ' ' THR . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' C' ' 176' ' ' ALA . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.8 HG21 HG23 ' E' ' 126' ' ' VAL . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.84 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.84 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.854 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' D' ' 76' ' ' GLN . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.713 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 117' ' ' GLU . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.809 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.681 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' D' ' 41' ' ' ARG . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . 0.564 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.713 HG13 ' OD1' ' D' ' 34' ' ' ASP . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.493 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.598 HG23 HD13 ' D' ' 113' ' ' ILE . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.663 ' HD1' HG22 ' D' ' 113' ' ' ILE . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.704 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' D' ' 82' ' ' ALA . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' D' ' 142' ' ' GLU . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.546 ' OH ' HG21 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.794 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' D' ' 139' ' ' LYS . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' D' ' 138' ' ' LEU . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.709 ' O ' HG23 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.663 HG22 ' HD1' ' D' ' 83' ' ' TYR . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . 0.521 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.743 HG23 HG21 ' C' ' 6' ' ' ILE . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' D' ' 65' ' ' VAL . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.709 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.67 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' D' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.794 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.511 ' O ' HD12 ' D' ' 150' ' ' ILE . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.511 HD12 ' O ' ' D' ' 145' ' ' THR . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.584 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.526 ' O ' HG22 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' J' ' 21' ' ' ALA . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.442 HG21 ' H ' ' D' ' 172' ' ' GLY . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' D' ' 167' ' ' THR . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . 0.442 ' H ' HG21 ' D' ' 167' ' ' THR . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.526 HG22 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' D' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' D' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.848 HG21 HG23 ' F' ' 126' ' ' VAL . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.829 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.829 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.558 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' E' ' 76' ' ' GLN . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.476 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.704 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' F' ' 118' ' ' TYR . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' F' ' 117' ' ' GLU . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.737 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' F' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.704 HG13 ' OD1' ' E' ' 34' ' ' ASP . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.609 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' E' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.681 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' E' ' 82' ' ' ALA . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' E' ' 142' ' ' GLU . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' E' ' 104' ' ' TYR . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.779 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' E' ' 139' ' ' LYS . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.662 ' HD2' HD11 ' E' ' 138' ' ' LEU . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.668 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.677 HG22 ' HD1' ' E' ' 83' ' ' TYR . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.809 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.45 ' HB3' HG12 ' D' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . 0.611 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.8 HG23 HG21 ' D' ' 6' ' ' ILE . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' E' ' 65' ' ' VAL . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.665 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' E' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.535 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.51 ' O ' HD12 ' E' ' 150' ' ' ILE . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . 0.462 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.722 ' HB3' HG21 ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.51 HD12 ' O ' ' E' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.552 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.514 ' O ' HG22 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' K' ' 21' ' ' ALA . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' E' ' 172' ' ' GLY . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . 0.411 ' N ' HG22 ' E' ' 167' ' ' THR . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . 0.438 ' H ' HG21 ' E' ' 167' ' ' THR . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.514 HG22 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' E' ' 176' ' ' ALA . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' E' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.862 HG21 HG23 ' A' ' 126' ' ' VAL . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.802 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.802 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.603 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.603 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' F' ' 76' ' ' GLN . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.492 ' HA ' ' OE1' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . 0.454 ' HB3' ' HE ' ' F' ' 41' ' ' ARG . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.716 HG13 ' OD1' ' F' ' 34' ' ' ASP . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' F' ' 113' ' ' ILE . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.653 ' HD1' HG22 ' F' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.613 HG11 ' HG2' ' F' ' 142' ' ' GLU . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' F' ' 104' ' ' TYR . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.543 ' OH ' HG21 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.768 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' F' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' F' ' 138' ' ' LEU . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.705 ' O ' HG23 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.653 HG22 ' HD1' ' F' ' 83' ' ' TYR . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.737 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' F' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.416 ' HB3' HG12 ' E' ' 37' ' ' VAL . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.848 HG23 HG21 ' E' ' 6' ' ' ILE . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' F' ' 65' ' ' VAL . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' F' ' 65' ' ' VAL . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.705 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.672 ' H ' HD13 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' F' ' 107' ' ' GLN . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.53 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.518 ' O ' HD12 ' F' ' 150' ' ' ILE . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' F' ' 150' ' ' ILE . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.716 ' HB3' HG21 ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.518 HD12 ' O ' ' F' ' 145' ' ' THR . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.799 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 . . . . . 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.504 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.835 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.812 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.562 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . 0.422 ' H ' HG21 ' F' ' 167' ' ' THR . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' F' ' 176' ' ' ALA . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' F' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.995 HG21 HG23 ' H' ' 126' ' ' VAL . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.795 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.795 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' THR . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' G' ' 76' ' ' GLN . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' G' ' 32' ' ' GLN . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.71 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.526 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.71 HG13 ' OD1' ' G' ' 34' ' ' ASP . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . 0.431 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.629 HD12 HD11 ' G' ' 113' ' ' ILE . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.673 ' HD1' HG22 ' G' ' 113' ' ' ILE . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.681 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' G' ' 142' ' ' GLU . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.542 ' OH ' HG21 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.762 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' G' ' 139' ' ' LYS . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.685 ' HD2' HD11 ' G' ' 138' ' ' LEU . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.681 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.673 HG22 ' HD1' ' G' ' 83' ' ' TYR . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.508 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . 0.507 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.93 HG23 HG21 ' L' ' 6' ' ' ILE . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' G' ' 65' ' ' VAL . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.712 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.61 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.685 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.557 ' HG2' ' HG2' ' G' ' 107' ' ' GLN . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.512 ' O ' HD12 ' G' ' 150' ' ' ILE . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' G' ' 150' ' ' ILE . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.512 HD12 ' O ' ' G' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' G' ' 172' ' ' GLY . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . 0.421 ' N ' HG22 ' G' ' 167' ' ' THR . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . 0.428 ' H ' HG21 ' G' ' 167' ' ' THR . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' G' ' 176' ' ' ALA . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' G' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.994 HG21 HG23 ' I' ' 126' ' ' VAL . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.811 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.571 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.855 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' B' ' 166' ' ' THR . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' H' ' 76' ' ' GLN . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' OE1' ' I' ' 117' ' ' GLU . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . 0.571 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' H' ' 34' ' ' ASP . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.429 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.617 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.83 ' HB2' HD11 ' H' ' 89' ' ' ILE . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.67 ' HD1' HG22 ' H' ' 113' ' ' ILE . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.68 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' H' ' 111' ' ' ALA . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' H' ' 142' ' ' GLU . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.777 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.915 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' H' ' 139' ' ' LYS . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' H' ' 138' ' ' LEU . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.717 ' O ' HG23 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' H' ' 91' ' ' PHE . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.67 HG22 ' HD1' ' H' ' 83' ' ' TYR . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.526 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . 0.475 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.995 HG23 HG21 ' G' ' 6' ' ' ILE . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' H' ' 65' ' ' VAL . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.717 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.68 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' H' ' 107' ' ' GLN . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' H' ' 150' ' ' ILE . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' H' ' 150' ' ' ILE . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' H' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.427 HG21 ' H ' ' H' ' 172' ' ' GLY . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . 0.419 ' N ' HG22 ' H' ' 167' ' ' THR . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . 0.427 ' H ' HG21 ' H' ' 167' ' ' THR . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' H' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' H' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.46 ' HB2' ' O ' ' J' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.867 HG21 HG23 ' J' ' 126' ' ' VAL . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.555 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.866 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 163' ' ' PRO . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' I' ' 76' ' ' GLN . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' J' ' 118' ' ' TYR . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' J' ' 117' ' ' GLU . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.624 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' I' ' 34' ' ' ASP . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.421 ' HD3' HH21 ' I' ' 71' ' ' ARG . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.608 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' I' ' 89' ' ' ILE . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.658 ' HD1' HG22 ' I' ' 113' ' ' ILE . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.673 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' I' ' 111' ' ' ALA . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.571 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' I' ' 142' ' ' GLU . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' I' ' 104' ' ' TYR . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.77 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.911 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' I' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.683 ' HD2' HD11 ' I' ' 138' ' ' LEU . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.708 ' O ' HG23 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' I' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.673 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' I' ' 83' ' ' TYR . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' H' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.994 HG23 HG21 ' H' ' 6' ' ' ILE . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' I' ' 65' ' ' VAL . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' I' ' 65' ' ' VAL . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.708 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.679 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' I' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.911 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.527 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 0.513 ' O ' HD12 ' I' ' 150' ' ' ILE . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.714 ' HB3' HG21 ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.513 HD12 ' O ' ' I' ' 145' ' ' THR . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.53 ' O ' HG22 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.43 HG21 ' H ' ' I' ' 172' ' ' GLY . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . 0.418 ' N ' HG22 ' I' ' 167' ' ' THR . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . 0.43 ' H ' HG21 ' I' ' 167' ' ' THR . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.53 HG22 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' I' ' 176' ' ' ALA . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' I' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.515 ' HB2' ' O ' ' K' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.914 HG21 HG23 ' K' ' 126' ' ' VAL . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.816 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' D' ' 166' ' ' THR . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' J' ' 76' ' ' GLN . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' K' ' 118' ' ' TYR . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.561 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . 0.561 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' J' ' 34' ' ' ASP . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . 0.504 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.42 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.614 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' J' ' 113' ' ' ILE . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.688 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' J' ' 82' ' ' ALA . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.627 HG11 ' HG2' ' J' ' 142' ' ' GLU . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' J' ' 139' ' ' LYS . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' J' ' 138' ' ' LEU . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.7 ' O ' HG23 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' J' ' 83' ' ' TYR . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' J' ' 116' ' ' ARG . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' I' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . 0.487 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.867 HG23 HG21 ' I' ' 6' ' ' ILE . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' J' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.7 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.68 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' J' ' 107' ' ' GLN . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.907 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' D' ' 160' ' ' PHE . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.515 ' O ' HD12 ' J' ' 150' ' ' ILE . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' J' ' 147' ' ' PRO . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.713 ' HB3' HG21 ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.515 HD12 ' O ' ' J' ' 145' ' ' THR . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.713 HG21 ' HB3' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.439 HG21 ' H ' ' J' ' 172' ' ' GLY . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . 0.416 ' N ' HG22 ' J' ' 167' ' ' THR . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . 0.439 ' H ' HG21 ' J' ' 167' ' ' THR . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' J' ' 176' ' ' ALA . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' J' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.434 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.945 HG21 HG23 ' L' ' 126' ' ' VAL . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.82 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.871 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' E' ' 166' ' ' THR . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' K' ' 76' ' ' GLN . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.707 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' L' ' 117' ' ' GLU . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.41 HD23 ' HG3' ' L' ' 88' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . 0.465 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.707 HG13 ' OD1' ' K' ' 34' ' ' ASP . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.428 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.665 ' HD1' HG22 ' K' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.678 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' K' ' 82' ' ' ALA . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' K' ' 142' ' ' GLU . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' K' ' 104' ' ' TYR . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.767 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.917 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' K' ' 139' ' ' LYS . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' K' ' 138' ' ' LEU . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.71 ' O ' HG23 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.678 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.665 HG22 ' HD1' ' K' ' 83' ' ' TYR . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.532 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' K' ' 116' ' ' ARG . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.537 ' HB3' HG12 ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.914 HG23 HG21 ' J' ' 6' ' ' ILE . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' K' ' 65' ' ' VAL . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.71 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.683 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.616 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' K' ' 107' ' ' GLN . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.917 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.522 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.497 ' O ' HD12 ' K' ' 150' ' ' ILE . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' K' ' 150' ' ' ILE . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.497 HD12 ' O ' ' K' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.517 ' O ' HG22 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.443 HG21 ' H ' ' K' ' 172' ' ' GLY . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' K' ' 167' ' ' THR . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . 0.443 ' H ' HG21 ' K' ' 167' ' ' THR . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' K' ' 176' ' ' ALA . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' K' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.559 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.93 HG21 HG23 ' G' ' 126' ' ' VAL . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.821 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.821 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.593 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.844 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.593 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' L' ' 76' ' ' GLN . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.48 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . 0.41 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.508 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' L' ' 34' ' ' ASP . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.406 ' HD3' HH21 ' L' ' 71' ' ' ARG . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . 0.486 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.422 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.633 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.818 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' L' ' 113' ' ' ILE . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.684 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' L' ' 82' ' ' ALA . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.844 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.617 HG11 ' HG2' ' L' ' 142' ' ' GLU . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' L' ' 104' ' ' TYR . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.536 ' OH ' HG21 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' L' ' 139' ' ' LYS . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.674 ' HD2' HD11 ' L' ' 138' ' ' LEU . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.704 ' O ' HG23 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.684 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' L' ' 83' ' ' TYR . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' L' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' K' ' 37' ' ' VAL . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.945 HG23 HG21 ' K' ' 6' ' ' ILE . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' L' ' 65' ' ' VAL . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' L' ' 65' ' ' VAL . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.704 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.68 HD13 ' H ' ' L' ' 135' ' ' ILE . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.674 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' L' ' 107' ' ' GLN . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.799 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.835 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.514 ' O ' HD12 ' L' ' 150' ' ' ILE . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' L' ' 25' ' ' ALA . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.72 ' HB3' HG21 ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.514 HD12 ' O ' ' L' ' 145' ' ' THR . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.72 HG21 ' HB3' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' L' ' 172' ' ' GLY . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . 0.414 ' N ' HG22 ' L' ' 167' ' ' THR . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . 0.438 ' H ' HG21 ' L' ' 167' ' ' THR . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' L' ' 176' ' ' ALA . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' L' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.526 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 18' ' ' ILE . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' B' ' 117' ' ' GLU . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.84 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.84 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 40' ' ' GLU . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.451 HG12 ' HD1' ' A' ' 67' ' ' TYR . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD1' HG12 ' A' ' 65' ' ' VAL . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.691 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 75' ' ' GLY . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.672 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.873 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.873 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' A' ' 132' ' ' LEU . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.629 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 106' ' ' ALA . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.52 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' A' ' 137' ' ' GLU . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 91' ' ' PHE . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.695 ' HD1' HD13 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.464 HG11 ' O ' ' F' ' 31' ' ' TYR . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.608 ' CD1' ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' A' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.663 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.647 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.751 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.751 HE22 ' HD2' ' A' ' 163' ' ' PRO . 5.8 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' G' ' 21' ' ' ALA . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.841 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.445 ' C ' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.841 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' B' ' 96' ' ' THR . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB3' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' B' ' 91' ' ' PHE . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' B' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' B' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.7 ' HZ ' ' H ' ' B' ' 70' ' ' LYS . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' C' ' 117' ' ' GLU . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.72 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' GLU . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.454 HG12 ' HD1' ' B' ' 67' ' ' TYR . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' B' ' 127' ' ' GLU . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . 0.7 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' B' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 75' ' ' GLY . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.67 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.573 ' HE1' HD21 ' B' ' 132' ' ' LEU . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.635 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' B' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.523 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG22 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.656 HE21 ' HB3' ' B' ' 137' ' ' GLU . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' B' ' 91' ' ' PHE . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.567 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.486 ' CD ' ' HG3' ' B' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.854 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.526 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' B' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.615 ' CD1' ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' B' ' 116' ' ' ARG . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.573 HD21 ' HE1' ' B' ' 91' ' ' PHE . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . 0.486 ' HG3' ' CD ' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.495 HG12 ' HG ' ' A' ' 54' ' ' LEU . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' B' ' 134' ' ' VAL . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' B' ' 107' ' ' GLN . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.579 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' B' ' 150' ' ' ILE . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . 0.439 ' CD ' ' HB2' ' H' ' 144' ' ' ASP . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.752 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.752 HE22 ' HD2' ' B' ' 163' ' ' PRO . 5.8 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.798 ' HA ' ' HB2' ' H' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.842 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.842 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . 0.479 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' D' ' 126' ' ' VAL . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' C' ' 96' ' ' THR . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.481 HG22 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' C' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.96 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . 0.497 ' OD1' HD12 ' C' ' 18' ' ' ILE . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.692 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.488 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . 0.404 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' C' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' D' ' 133' ' ' GLN . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.846 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . 0.846 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' C' ' 40' ' ' GLU . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.447 HG12 ' HD1' ' C' ' 67' ' ' TYR . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' C' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . 0.417 ' HA ' HD11 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.49 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . 0.671 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' C' ' 80' ' ' GLU . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.503 HD13 ' N ' ' C' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.671 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.664 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.532 ' CD1' ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.579 ' HE1' HD21 ' C' ' 132' ' ' LEU . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' C' ' 106' ' ' ALA . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.638 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.491 ' OH ' HG22 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.811 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.657 HE21 ' HB3' ' C' ' 137' ' ' GLU . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' C' ' 91' ' ' PHE . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.555 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.72 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.487 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . 0.845 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' B' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' C' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . 0.845 HG22 ' HG2' ' C' ' 116' ' ' ARG . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.579 HD21 ' HE1' ' C' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.666 HG11 ' HG3' ' C' ' 137' ' ' GLU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' B' ' 54' ' ' LEU . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . 0.666 ' HG3' HG11 ' C' ' 134' ' ' VAL . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' C' ' 107' ' ' GLN . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.811 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.638 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.491 ' H ' HD12 ' C' ' 150' ' ' ILE . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . 0.752 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.752 HE22 ' HD2' ' C' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' I' ' 21' ' ' ALA . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.853 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.853 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.496 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' D' ' 96' ' ' THR . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' D' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.931 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' D' ' 18' ' ' ILE . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' D' ' 14' ' ' LEU . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . 0.699 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.699 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' E' ' 117' ' ' GLU . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . 0.502 ' HA ' HG22 ' D' ' 59' ' ' VAL . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 40' ' ' GLU . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.461 HG12 ' HD1' ' D' ' 67' ' ' TYR . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' D' ' 32' ' ' GLN . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' D' ' 65' ' ' VAL . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' D' ' 127' ' ' GLU . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' CD1' ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . 0.68 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.479 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.502 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' D' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.502 HG12 ' O ' ' D' ' 75' ' ' GLY . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.895 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.895 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.529 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.931 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' D' ' 132' ' ' LEU . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.405 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.631 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' D' ' 106' ' ' ALA . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . 0.517 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.666 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.496 ' OH ' HG22 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.64 HE21 ' HB3' ' D' ' 137' ' ' GLU . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.408 ' HD1' ' O ' ' D' ' 91' ' ' PHE . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.564 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.85 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.488 HG13 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.478 ' HG2' ' CE2' ' D' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . 0.619 ' CD1' ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . 0.85 HG22 ' HG2' ' D' ' 116' ' ' ARG . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' D' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' D' ' 137' ' ' GLU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.515 HG12 ' HG ' ' C' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . 0.68 ' HG3' HG11 ' D' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' D' ' 107' ' ' GLN . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.814 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.666 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.493 HD12 ' H ' ' D' ' 150' ' ' ILE . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.406 ' CD ' ' HB2' ' J' ' 144' ' ' ASP . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.75 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' J' ' 22' ' ' THR . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.75 HE22 ' HD2' ' D' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.886 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.864 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . 0.432 ' C ' HD13 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . 0.622 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . 0.864 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' F' ' 126' ' ' VAL . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' E' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' HB3' ' E' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' E' ' 91' ' ' PHE . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.92 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' E' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' E' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.819 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . 0.819 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' E' ' 40' ' ' GLU . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.449 HG12 ' HD1' ' E' ' 67' ' ' TYR . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.449 ' HD1' HG12 ' E' ' 65' ' ' VAL . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' E' ' 127' ' ' GLU . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . 0.69 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.446 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' E' ' 80' ' ' GLU . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' E' ' 79' ' ' ILE . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.885 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.668 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.885 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.596 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.92 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' E' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.403 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.638 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' E' ' 106' ' ' ALA . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.652 HE21 ' HB3' ' E' ' 137' ' ' GLU . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' E' ' 91' ' ' PHE . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.561 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.859 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' D' ' 37' ' ' VAL . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . 0.42 HG13 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CD2' ' E' ' 68' ' ' TYR . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . 0.61 ' CD1' ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . 0.859 HG22 ' HG2' ' E' ' 116' ' ' ARG . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' E' ' 91' ' ' PHE . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . 0.495 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.685 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.49 HG12 ' HG ' ' D' ' 54' ' ' LEU . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' E' ' 134' ' ' VAL . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.602 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.668 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.486 HD12 ' H ' ' E' ' 150' ' ' ILE . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.463 0.218 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' E' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.826 ' HA ' ' HB2' ' K' ' 21' ' ' ALA . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.876 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . 0.462 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . 0.574 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . 0.876 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.556 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.575 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 0.479 ' H ' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' F' ' 91' ' ' PHE . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.97 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . 0.488 ' OD1' HD12 ' F' ' 18' ' ' ILE . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 122' ' ' VAL . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . 0.489 ' HA ' HG22 ' F' ' 59' ' ' VAL . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.695 HD13 ' HD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' F' ' 40' ' ' GLU . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' F' ' 67' ' ' TYR . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.461 ' OH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.475 ' CD2' ' HG2' ' F' ' 127' ' ' GLU . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' F' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.501 HG12 ' O ' ' F' ' 75' ' ' GLY . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.567 ' HE1' HD21 ' F' ' 132' ' ' LEU . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' F' ' 106' ' ' ALA . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . 0.512 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' F' ' 137' ' ' GLU . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' F' ' 91' ' ' PHE . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.566 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' F' ' 88' ' ' GLN . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' E' ' 6' ' ' ILE . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' F' ' 68' ' ' TYR . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . 0.601 ' CD1' ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . 0.871 HG22 ' HG2' ' F' ' 116' ' ' ARG . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.567 HD21 ' HE1' ' F' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' F' ' 137' ' ' GLU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.636 HG12 ' HG ' ' E' ' 54' ' ' LEU . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' F' ' 134' ' ' VAL . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.493 ' HB2' ' OE1' ' A' ' 84' ' ' GLN . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.652 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.472 HD12 ' H ' ' F' ' 150' ' ' ILE . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.601 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.717 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.731 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 8.0 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.738 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.738 HE22 ' HD2' ' F' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.863 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.857 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . 0.725 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.747 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . 0.435 ' O ' ' HE1' ' L' ' 110' ' ' PHE . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . 0.649 ' HA ' ' CD1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.573 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 0.474 ' H ' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 0.545 ' HA ' ' OG1' ' G' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 4.2 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.978 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . 0.49 ' OD1' HD12 ' G' ' 18' ' ' ILE . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . 0.693 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . 0.677 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' G' ' 59' ' ' VAL . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . 0.841 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.528 HD13 ' HD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . 0.841 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' G' ' 40' ' ' GLU . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' G' ' 67' ' ' TYR . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.454 ' OH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' G' ' 127' ' ' GLU . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.611 ' HA3' ' CD1' ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD2' ' G' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . 0.674 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' G' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.502 HD13 ' N ' ' G' ' 79' ' ' ILE . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.674 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.676 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.577 ' HE1' HD21 ' G' ' 132' ' ' LEU . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' G' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.659 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' G' ' 137' ' ' GLU . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' G' ' 91' ' ' PHE . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' L' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' G' ' 133' ' ' GLN . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.867 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.429 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.476 ' HG2' ' CE2' ' G' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . 0.611 ' CD1' ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . 0.867 HG22 ' HG2' ' G' ' 116' ' ' ARG . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.577 HD21 ' HE1' ' G' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.529 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' G' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.691 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.659 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.481 HD12 ' H ' ' G' ' 150' ' ' ILE . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . 0.735 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.735 HE22 ' HD2' ' G' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.87 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . 0.87 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.584 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 0.48 ' H ' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.471 HG22 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' H' ' 27' ' ' LEU . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.404 ' HE2' ' CE1' ' H' ' 91' ' ' PHE . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 4.2 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' H' ' 18' ' ' ILE . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' H' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . 0.692 ' HZ ' ' H ' ' H' ' 70' ' ' LYS . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' H' ' 59' ' ' VAL . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' H' ' 40' ' ' GLU . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.453 HG12 ' HD1' ' H' ' 67' ' ' TYR . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.453 ' HD1' HG12 ' H' ' 65' ' ' VAL . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' H' ' 127' ' ' GLU . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . 0.419 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' H' ' 80' ' ' GLU . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.498 HG12 ' O ' ' H' ' 75' ' ' GLY . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.676 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.691 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 3.5 mt-30 -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.54 ' CD1' ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' H' ' 132' ' ' LEU . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' H' ' 106' ' ' ALA . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . 0.513 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.646 HE21 ' HB3' ' H' ' 137' ' ' GLU . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.419 ' HD1' ' O ' ' H' ' 91' ' ' PHE . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' H' ' 88' ' ' GLN . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.438 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' H' ' 133' ' ' GLN . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . 0.853 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' H' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . 0.604 ' CD1' ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' H' ' 116' ' ' ARG . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' H' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.521 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . 0.668 ' HG3' HG11 ' H' ' 134' ' ' VAL . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.699 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.82 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.63 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' B' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.49 HD12 ' H ' ' H' ' 150' ' ' ILE . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . 0.755 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.755 HE22 ' HD2' ' H' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' I' ' 96' ' ' THR . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' I' ' 27' ' ' LEU . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.412 ' HE2' ' CE1' ' I' ' 91' ' ' PHE . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 4.3 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . 0.494 ' OD1' HD12 ' I' ' 18' ' ' ILE . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' I' ' 14' ' ' LEU . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . 0.694 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . 0.458 ' O ' HG11 ' J' ' 122' ' ' VAL . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.4 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' J' ' 117' ' ' GLU . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . 0.634 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . 0.852 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . 0.852 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' I' ' 40' ' ' GLU . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.455 HG12 ' HD1' ' I' ' 67' ' ' TYR . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.455 ' HD1' HG12 ' I' ' 65' ' ' VAL . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' I' ' 127' ' ' GLU . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' CD1' ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.694 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.404 ' HD2' HH21 ' I' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . 0.667 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' I' ' 80' ' ' GLU . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' I' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HE1' HD21 ' I' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' I' ' 106' ' ' ALA . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.635 HE21 ' HB3' ' I' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' I' ' 91' ' ' PHE . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.422 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' I' ' 133' ' ' GLN . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.843 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' I' ' 68' ' ' TYR . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . 0.618 ' CD1' ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . 0.843 HG22 ' HG2' ' I' ' 116' ' ' ARG . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.562 HD21 ' HE1' ' I' ' 91' ' ' PHE . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.476 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . 0.657 ' HG3' HG11 ' I' ' 134' ' ' VAL . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.632 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.489 HD12 ' H ' ' I' ' 150' ' ' ILE . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . 0.749 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.749 HE22 ' HD2' ' I' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.844 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . 0.844 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . 0.583 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.586 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.601 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 0.481 ' H ' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' J' ' 96' ' ' THR . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' J' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.414 ' HE2' ' CE1' ' J' ' 91' ' ' PHE . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 4.2 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.949 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' J' ' 18' ' ' ILE . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' D' ' 164' ' ' GLY . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' J' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . 0.701 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . 0.701 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . 0.492 ' O ' HG11 ' K' ' 122' ' ' VAL . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.4 ' HB3' ' OG1' ' J' ' 66' ' ' THR . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' K' ' 117' ' ' GLU . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . 0.573 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' J' ' 59' ' ' VAL . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . 0.839 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . 0.839 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' J' ' 40' ' ' GLU . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' J' ' 67' ' ' TYR . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' J' ' 32' ' ' GLN . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' J' ' 65' ' ' VAL . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' J' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.679 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . 0.678 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' J' ' 80' ' ' GLU . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' J' ' 79' ' ' ILE . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.678 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.887 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.665 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.887 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.578 ' HE1' HD21 ' J' ' 132' ' ' LEU . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.634 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' J' ' 106' ' ' ALA . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.658 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' J' ' 137' ' ' GLU . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' J' ' 91' ' ' PHE . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' J' ' 88' ' ' GLN . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . 0.841 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' I' ' 37' ' ' VAL . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.492 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . 0.458 HG11 ' O ' ' I' ' 31' ' ' TYR . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' J' ' 68' ' ' TYR . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . 0.841 HG22 ' HG2' ' J' ' 116' ' ' ARG . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.578 HD21 ' HE1' ' J' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' J' ' 134' ' ' VAL . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.627 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.812 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' D' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.572 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.476 ' H ' HD12 ' J' ' 150' ' ' ILE . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' J' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' L' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' K' ' 96' ' ' THR . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.511 ' CG2' HG11 ' L' ' 126' ' ' VAL . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' K' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' K' ' 91' ' ' PHE . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 4.2 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.939 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' K' ' 18' ' ' ILE . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' K' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . 0.426 ' O ' HG11 ' L' ' 122' ' ' VAL . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . 0.527 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . 0.492 ' HA ' HG22 ' K' ' 59' ' ' VAL . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.558 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' K' ' 40' ' ' GLU . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' K' ' 67' ' ' TYR . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' K' ' 127' ' ' GLU . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' CD1' ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' K' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' K' ' 80' ' ' GLU . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.499 HD13 ' N ' ' K' ' 79' ' ' ILE . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.88 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.588 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' K' ' 132' ' ' LEU . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' K' ' 106' ' ' ALA . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.489 ' OH ' HG22 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.641 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' K' ' 91' ' ' PHE . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' K' ' 88' ' ' GLN . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' J' ' 40' ' ' GLU . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.497 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' J' ' 37' ' ' VAL . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.428 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . 0.492 HG11 ' O ' ' J' ' 31' ' ' TYR . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.601 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' K' ' 68' ' ' TYR . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . 0.603 ' CD1' ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . 0.851 HG22 ' HG2' ' K' ' 116' ' ' ARG . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' K' ' 91' ' ' PHE . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . 0.497 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.527 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . 0.682 ' HG3' HG11 ' K' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.555 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.584 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.469 HD12 ' H ' ' K' ' 150' ' ' ILE . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . 0.742 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.742 HE22 ' HD2' ' K' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.873 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . 0.873 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 0.529 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.402 ' HE2' ' CE1' ' L' ' 91' ' ' PHE . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.928 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' L' ' 18' ' ' ILE . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . 0.677 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . 0.637 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' L' ' 59' ' ' VAL . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . 0.829 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.529 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . 0.829 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' L' ' 40' ' ' GLU . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' L' ' 67' ' ' TYR . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' L' ' 65' ' ' VAL . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' L' ' 127' ' ' GLU . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.442 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . 0.496 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . 0.663 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' L' ' 80' ' ' GLU . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.502 ' N ' HD13 ' L' ' 79' ' ' ILE . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.527 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.747 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.928 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' L' ' 132' ' ' LEU . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.717 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.628 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' L' ' 106' ' ' ALA . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' L' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' L' ' 91' ' ' PHE . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CD1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' L' ' 88' ' ' GLN . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.493 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . 0.426 HG11 ' O ' ' K' ' 31' ' ' TYR . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' L' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . 0.607 ' CD1' ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' L' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' L' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' L' ' 137' ' ' GLU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.558 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' L' ' 134' ' ' VAL . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.676 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.601 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.657 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.473 HD12 ' H ' ' L' ' 150' ' ' ILE . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' L' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.88 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.812 HG21 HG23 ' B' ' 126' ' ' VAL . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 1.056 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 1.056 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HD1' ' CE1' ' A' ' 91' ' ' PHE . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.825 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 22' ' ' THR . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 67' ' ' TYR . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 65' ' ' VAL . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' B' ' 117' ' ' GLU . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.825 HH22 ' HB2' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 54' ' ' LEU . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.825 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' HA2' ' A' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.717 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' F' ' 5' ' ' PRO . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.737 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 113' ' ' ILE . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' A' ' 82' ' ' ALA . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.762 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 102' ' ' ASP . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.564 ' HB2' HD22 ' A' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 93' ' ' ARG . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.821 ' HD2' HD11 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.671 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 83' ' ' TYR . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.831 HG23 HG21 ' F' ' 6' ' ' ILE . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' A' ' 111' ' ' ALA . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 110' ' ' PHE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.685 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.821 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.667 ' O ' HD12 ' A' ' 150' ' ' ILE . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 145' ' ' THR . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.488 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.516 ' CA ' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.778 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 172' ' ' GLY . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' G' ' 88' ' ' GLN . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' H ' HG21 ' A' ' 167' ' ' THR . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.739 HG21 HG23 ' C' ' 126' ' ' VAL . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' MET . . . . . 1.073 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . 1.073 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' B' ' 91' ' ' PHE . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.841 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 22' ' ' THR . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' B' ' 67' ' ' TYR . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' B' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' PRO . . . . . 0.532 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' B' ' 136' ' ' GLY . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' TYR . . . . . 0.714 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.412 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.748 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' B' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLN . . . . . 0.872 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' B' ' 82' ' ' ALA . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ARG . . . . . 0.507 ' HD2' ' HB2' ' B' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.406 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ASN . . . . . 0.577 HD22 ' HB2' ' B' ' 102' ' ' ASP . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . 0.577 ' HB2' HD22 ' B' ' 99' ' ' ASN . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' B' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.571 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' TYR . . . . . 0.663 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.553 HG22 ' HD1' ' B' ' 83' ' ' TYR . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . 0.789 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 116' ' ' ARG . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.563 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' VAL . . . . . 0.812 HG23 HG21 ' A' ' 6' ' ' ILE . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.714 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' LEU . . . . . 0.571 HD13 ' HB1' ' B' ' 111' ' ' ALA . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' VAL . . . . . 0.684 HG23 ' O ' ' B' ' 110' ' ' PHE . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.681 ' H ' HD13 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLY . . . . . 0.663 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' LYS . . . . . 0.507 ' HD3' ' HG2' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.87 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' THR . . . . . 0.671 ' O ' HD12 ' B' ' 150' ' ' ILE . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' PHE . . . . . 0.567 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.429 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' B' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . 0.735 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' B' ' 172' ' ' GLY . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' B' ' 167' ' ' THR . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.715 HG21 HG23 ' D' ' 126' ' ' VAL . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' MET . . . . . 1.07 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ASP . . . . . 1.07 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' TYR . . . . . 0.465 ' HD1' ' CE1' ' C' ' 91' ' ' PHE . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' LEU . . . . . 0.754 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' PHE . . . . . 0.563 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ILE . . . . . 0.857 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . 0.439 HG22 ' H ' ' C' ' 23' ' ' GLY . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' GLY . . . . . 0.439 ' H ' HG22 ' C' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LEU . . . . . 0.614 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' C' ' 67' ' ' TYR . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' THR . . . . . 0.444 HG22 HG23 ' D' ' 122' ' ' VAL . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' C' ' 65' ' ' VAL . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' ARG . . . . . 0.798 HH22 ' HB2' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' GLU . . . . . 0.828 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' LEU . . . . . 0.847 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' C' ' 54' ' ' LEU . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' SER . . . . . 0.523 ' HB3' ' HE ' ' C' ' 41' ' ' ARG . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ALA . . . . . 0.798 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' C' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' C' ' 64' ' ' GLU . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.777 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' TYR . . . . . 0.718 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' C' ' 113' ' ' ILE . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' TYR . . . . . 0.552 ' CD1' HG22 ' C' ' 113' ' ' ILE . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLN . . . . . 0.886 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' C' ' 82' ' ' ALA . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' PHE . . . . . 0.563 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' TRP . . . . . 0.754 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' C' ' 107' ' ' GLN . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.748 HG12 ' HB2' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' C' ' 102' ' ' ASP . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ASP . . . . . 0.581 ' HB2' HD22 ' C' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.825 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' ALA . . . . . 0.748 ' HB2' HG12 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' GLN . . . . . 0.501 ' HB2' ' HD2' ' C' ' 93' ' ' ARG . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PHE . . . . . 0.834 ' HD2' HD11 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ALA . . . . . 0.581 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' TYR . . . . . 0.661 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' C' ' 83' ' ' TYR . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' VAL . . . . . 0.739 HG23 HG21 ' B' ' 6' ' ' ILE . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' ILE . . . . . 0.718 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' SER . . . . . 0.777 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' LEU . . . . . 0.581 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' VAL . . . . . 0.673 HG23 ' O ' ' C' ' 110' ' ' PHE . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' ILE . . . . . 0.671 ' H ' HD13 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' GLY . . . . . 0.67 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' LYS . . . . . 0.457 ' HD3' ' HG2' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' ILE . . . . . 0.867 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' C' ' 150' ' ' ILE . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' C' ' 145' ' ' THR . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 160' ' ' PHE . . . . . 0.502 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 161' ' ' GLN . . . . . 0.506 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' GLN . . . . . 0.506 ' CA ' ' HB3' ' C' ' 161' ' ' GLN . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' THR . . . . . 0.721 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' THR . . . . . 0.553 HG21 ' H ' ' C' ' 172' ' ' GLY . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' GLY . . . . . 0.553 ' H ' HG21 ' C' ' 167' ' ' THR . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.776 HG21 HG23 ' E' ' 126' ' ' VAL . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' LYS . . . . . 0.571 ' HG2' HD11 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' TYR . . . . . 0.464 ' HD1' ' CE1' ' D' ' 91' ' ' PHE . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' LEU . . . . . 0.75 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' PHE . . . . . 0.554 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' D' ' 23' ' ' GLY . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' GLY . . . . . 0.444 ' H ' HG22 ' D' ' 22' ' ' THR . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.477 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' D' ' 67' ' ' TYR . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' D' ' 65' ' ' VAL . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' SER . . . . . 0.556 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' ARG . . . . . 0.793 HH22 ' HB2' ' D' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' LEU . . . . . 0.814 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' D' ' 54' ' ' LEU . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' SER . . . . . 0.523 ' HB3' ' HE ' ' D' ' 41' ' ' ARG . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ALA . . . . . 0.793 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' D' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' D' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . 0.79 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' TYR . . . . . 0.71 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' ARG . . . . . 0.417 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.4 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . 0.526 HD12 HD11 ' D' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' TYR . . . . . 0.55 ' HD1' HG22 ' D' ' 113' ' ' ILE . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' LYS . . . . . 0.732 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLN . . . . . 0.847 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' D' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' PHE . . . . . 0.554 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' D' ' 107' ' ' GLN . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' ASN . . . . . 0.578 HD22 ' HB2' ' D' ' 102' ' ' ASP . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' ASP . . . . . 0.578 ' HB2' HD22 ' D' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.833 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HD2' ' D' ' 93' ' ' ARG . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PHE . . . . . 0.805 ' HD2' HD11 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' TYR . . . . . 0.672 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' ILE . . . . . 0.55 HG22 ' HD1' ' D' ' 83' ' ' TYR . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' GLU . . . . . 0.828 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' D' ' 116' ' ' ARG . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 33' ' ' THR . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' VAL . . . . . 0.715 HG23 HG21 ' C' ' 6' ' ' ILE . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' ILE . . . . . 0.71 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' SER . . . . . 0.79 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 134' ' ' VAL . . . . . 0.671 HG23 ' O ' ' D' ' 110' ' ' PHE . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 135' ' ' ILE . . . . . 0.691 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 138' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.833 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 142' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 145' ' ' THR . . . . . 0.666 ' O ' HD12 ' D' ' 150' ' ' ILE . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 146' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 147' ' ' PRO . . . . . 0.568 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 150' ' ' ILE . . . . . 0.666 HD12 ' O ' ' D' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 160' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 163' ' ' PRO . . . . . 0.535 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' D' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 166' ' ' THR . . . . . 0.684 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 167' ' ' THR . . . . . 0.569 HG21 ' H ' ' D' ' 172' ' ' GLY . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 169' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' J' ' 88' ' ' GLN . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 172' ' ' GLY . . . . . 0.569 ' H ' HG21 ' D' ' 167' ' ' THR . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.823 HG21 HG23 ' F' ' 126' ' ' VAL . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' MET . . . . . 1.025 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ASP . . . . . 1.025 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' TYR . . . . . 0.456 ' HD1' ' CE1' ' E' ' 91' ' ' PHE . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' PHE . . . . . 0.559 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ILE . . . . . 0.84 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' E' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' E' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' LEU . . . . . 0.635 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' E' ' 67' ' ' TYR . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' E' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' SER . . . . . 0.415 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' GLU . . . . . 0.771 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' LEU . . . . . 0.697 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' E' ' 136' ' ' GLY . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' E' ' 64' ' ' GLU . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' THR . . . . . 0.775 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' TYR . . . . . 0.719 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' ARG . . . . . 0.427 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 79' ' ' ILE . . . . . 0.54 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 80' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 82' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 83' ' ' TYR . . . . . 0.554 ' CD1' HG22 ' E' ' 113' ' ' ILE . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 84' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 87' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 88' ' ' GLN . . . . . 0.814 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 89' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' E' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 90' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 91' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 93' ' ' ARG . . . . . 0.511 ' HD2' ' HB2' ' E' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 94' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 99' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 102' ' ' ASP . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 102' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' E' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.815 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 106' ' ' ALA . . . . . 0.761 ' HB2' HG12 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 107' ' ' GLN . . . . . 0.511 ' HB2' ' HD2' ' E' ' 93' ' ' ARG . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 111' ' ' ALA . . . . . 0.57 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 113' ' ' ILE . . . . . 0.554 HG22 ' CD1' ' E' ' 83' ' ' TYR . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 114' ' ' GLU . . . . . 0.784 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 115' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 116' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' E' ' 116' ' ' ARG . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 117' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 125' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 126' ' ' VAL . . . . . 0.776 HG23 HG21 ' D' ' 6' ' ' ILE . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 128' ' ' ILE . . . . . 0.719 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 129' ' ' SER . . . . . 0.775 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 131' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 132' ' ' LEU . . . . . 0.57 HD13 ' HB1' ' E' ' 111' ' ' ALA . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 134' ' ' VAL . . . . . 0.684 HG23 ' O ' ' E' ' 110' ' ' PHE . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 135' ' ' ILE . . . . . 0.68 HD13 ' H ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 136' ' ' GLY . . . . . 0.677 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 139' ' ' LYS . . . . . 0.422 ' HD3' HE21 ' F' ' 84' ' ' GLN . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 142' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 143' ' ' ILE . . . . . 0.844 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 145' ' ' THR . . . . . 0.652 ' O ' HD12 ' E' ' 150' ' ' ILE . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 147' ' ' PRO . . . . . 0.57 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 150' ' ' ILE . . . . . 0.652 HD12 ' O ' ' E' ' 145' ' ' THR . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 151' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 160' ' ' PHE . . . . . 0.461 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 163' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' E' ' 161' ' ' GLN . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 166' ' ' THR . . . . . 0.853 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 167' ' ' THR . . . . . 0.554 HG21 ' H ' ' E' ' 172' ' ' GLY . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 172' ' ' GLY . . . . . 0.554 ' H ' HG21 ' E' ' 167' ' ' THR . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.831 HG21 HG23 ' A' ' 126' ' ' VAL . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' MET . . . . . 1.033 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' TYR . . . . . 0.47 ' HD1' ' CE1' ' F' ' 91' ' ' PHE . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' LEU . . . . . 0.767 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' PHE . . . . . 0.56 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' ILE . . . . . 0.816 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' F' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' F' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.484 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' LEU . . . . . 0.633 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' F' ' 67' ' ' TYR . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 34' ' ' ASP . . . . . 0.43 ' OD1' HG22 ' F' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 41' ' ' ARG . . . . . 0.823 HH22 ' HB2' ' F' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 42' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 54' ' ' LEU . . . . . 0.516 HD23 ' HG3' ' A' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 56' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 58' ' ' SER . . . . . 0.517 ' HB3' ' HE ' ' F' ' 41' ' ' ARG . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 60' ' ' ALA . . . . . 0.823 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' F' ' 136' ' ' GLY . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' F' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 66' ' ' THR . . . . . 0.778 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 67' ' ' TYR . . . . . 0.723 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 68' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' F' ' 71' ' ' ARG . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' F' ' 113' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 80' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 82' ' ' ALA . . . . . 0.736 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 83' ' ' TYR . . . . . 0.556 ' HD1' HG22 ' F' ' 113' ' ' ILE . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 84' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 87' ' ' LYS . . . . . 0.736 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 88' ' ' GLN . . . . . 0.697 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 89' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' F' ' 82' ' ' ALA . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 90' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 91' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 92' ' ' TRP . . . . . 0.767 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' F' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 94' ' ' VAL . . . . . 0.758 HG12 ' HB2' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 96' ' ' THR . . . . . 0.428 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 98' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 99' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' F' ' 102' ' ' ASP . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 102' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' F' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 103' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.828 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 106' ' ' ALA . . . . . 0.758 ' HB2' HG12 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 107' ' ' GLN . . . . . 0.518 ' HB2' ' HD2' ' F' ' 93' ' ' ARG . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 110' ' ' PHE . . . . . 0.678 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 111' ' ' ALA . . . . . 0.576 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 112' ' ' TYR . . . . . 0.677 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 113' ' ' ILE . . . . . 0.556 HG22 ' HD1' ' F' ' 83' ' ' TYR . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 114' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 115' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 117' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 125' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 126' ' ' VAL . . . . . 0.823 HG23 HG21 ' E' ' 6' ' ' ILE . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 128' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 129' ' ' SER . . . . . 0.778 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 131' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 132' ' ' LEU . . . . . 0.576 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 134' ' ' VAL . . . . . 0.678 HG23 ' O ' ' F' ' 110' ' ' PHE . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 135' ' ' ILE . . . . . 0.672 HG12 ' H ' ' F' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 139' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 80' ' ' GLU . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 143' ' ' ILE . . . . . 0.869 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 145' ' ' THR . . . . . 0.673 ' O ' HD12 ' F' ' 150' ' ' ILE . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 146' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 147' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' F' ' 145' ' ' THR . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 151' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 159' ' ' ASP . . . . . 0.73 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 160' ' ' PHE . . . . . 0.606 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 162' ' ' GLN . . . . . 0.95 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 163' ' ' PRO . . . . . 0.903 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' F' ' 161' ' ' GLN . 0.8 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 166' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 167' ' ' THR . . . . . 0.61 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 169' ' ' GLU . . . . . 0.815 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 172' ' ' GLY . . . . . 0.561 ' H ' HG21 ' F' ' 167' ' ' THR . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 5' ' ' PRO . . . . . 0.566 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 6' ' ' ILE . . . . . 0.985 HG21 HG23 ' H' ' 126' ' ' VAL . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 7' ' ' MET . . . . . 1.055 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 10' ' ' ASP . . . . . 1.055 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 12' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 13' ' ' TYR . . . . . 0.468 ' HD1' ' CE1' ' G' ' 91' ' ' PHE . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 15' ' ' PHE . . . . . 0.556 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 18' ' ' ILE . . . . . 0.83 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 21' ' ' ALA . . . . . 0.778 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' G' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 23' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 25' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 27' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 32' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' G' ' 32' ' ' GLN . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 34' ' ' ASP . . . . . 0.425 ' OD1' HG22 ' G' ' 65' ' ' VAL . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 37' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' H' ' 117' ' ' GLU . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 39' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 41' ' ' ARG . . . . . 0.806 HH22 ' HB2' ' G' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 42' ' ' GLU . . . . . 0.517 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 54' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' H' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 56' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 58' ' ' SER . . . . . 0.521 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 60' ' ' ALA . . . . . 0.806 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' G' ' 136' ' ' GLY . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 64' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' G' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 67' ' ' TYR . . . . . 0.709 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 68' ' ' TYR . . . . . 0.653 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 70' ' ' LYS . . . . . 0.529 ' HG3' ' HA ' ' L' ' 5' ' ' PRO . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 79' ' ' ILE . . . . . 0.541 HD12 HD11 ' G' ' 113' ' ' ILE . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 82' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 83' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' G' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 87' ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 88' ' ' GLN . . . . . 0.658 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 89' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' G' ' 82' ' ' ALA . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 90' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 91' ' ' PHE . . . . . 0.556 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 93' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' G' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 94' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 99' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' G' ' 102' ' ' ASP . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 102' ' ' ASP . . . . . 0.563 ' HB2' HD22 ' G' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 105' ' ' ASP . . . . . 0.829 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 106' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' G' ' 93' ' ' ARG . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 108' ' ' PHE . . . . . 0.838 ' HD2' HD11 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 111' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 112' ' ' TYR . . . . . 0.658 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 113' ' ' ILE . . . . . 0.554 HG22 ' HD1' ' G' ' 83' ' ' TYR . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 114' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 115' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' G' ' 116' ' ' ARG . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 117' ' ' GLU . . . . . 0.477 ' HB3' HG12 ' L' ' 37' ' ' VAL . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 118' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 125' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 126' ' ' VAL . . . . . 0.917 HG23 HG21 ' L' ' 6' ' ' ILE . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 127' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 128' ' ' ILE . . . . . 0.709 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 131' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 132' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' G' ' 111' ' ' ALA . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 134' ' ' VAL . . . . . 0.682 HG23 ' O ' ' G' ' 110' ' ' PHE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 135' ' ' ILE . . . . . 0.672 ' H ' HD13 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 138' ' ' LEU . . . . . 0.838 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HD3' HE21 ' H' ' 84' ' ' GLN . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 141' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 142' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 143' ' ' ILE . . . . . 0.861 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' G' ' 150' ' ' ILE . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 146' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' G' ' 145' ' ' THR . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 165' ' ' GLN . . . . . 0.505 ' CA ' ' HB3' ' G' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 167' ' ' THR . . . . . 0.543 HG21 ' H ' ' G' ' 172' ' ' GLY . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 172' ' ' GLY . . . . . 0.543 ' H ' HG21 ' G' ' 167' ' ' THR . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' H' H ' 5' ' ' PRO . . . . . 0.582 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 6' ' ' ILE . . . . . 0.938 HG21 HG23 ' I' ' 126' ' ' VAL . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 7' ' ' MET . . . . . 1.068 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 10' ' ' ASP . . . . . 1.068 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 11' ' ' VAL . . . . . 0.441 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HG2' HD11 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 13' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' H' ' 91' ' ' PHE . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 14' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 18' ' ' ILE . . . . . 0.827 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 21' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' H' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' H' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 25' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 27' ' ' LEU . . . . . 0.624 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 34' ' ' ASP . . . . . 0.428 ' OD1' HG22 ' H' ' 65' ' ' VAL . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' I' ' 117' ' ' GLU . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 41' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 42' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 54' ' ' LEU . . . . . 0.434 ' O ' ' HD3' ' H' ' 56' ' ' PRO . 1.4 mp . . . . . 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 56' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 60' ' ' ALA . . . . . 0.802 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 61' ' ' ASP . . . . . 0.408 ' OD1' ' HA2' ' H' ' 136' ' ' GLY . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 64' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' H' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 65' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 67' ' ' TYR . . . . . 0.713 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 70' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 82' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 83' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' H' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 87' ' ' LYS . . . . . 0.738 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 88' ' ' GLN . . . . . 0.648 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' H' ' 82' ' ' ALA . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 90' ' ' LYS . . . . . 0.827 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' H' ' 107' ' ' GLN . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 95' ' ' ASP . . . . . 0.441 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 96' ' ' THR . . . . . 0.409 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 98' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 99' ' ' ASN . . . . . 0.555 HD22 ' HB2' ' H' ' 102' ' ' ASP . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 102' ' ' ASP . . . . . 0.555 ' HB2' HD22 ' H' ' 99' ' ' ASN . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 104' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 105' ' ' ASP . . . . . 0.847 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' H' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 108' ' ' PHE . . . . . 0.835 ' HD2' HD11 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 112' ' ' TYR . . . . . 0.648 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 113' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' H' ' 83' ' ' TYR . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 114' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 115' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 117' ' ' GLU . . . . . 0.469 ' HB3' HG12 ' G' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 118' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 120' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' G' ' 11' ' ' VAL . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 126' ' ' VAL . . . . . 0.985 HG23 HG21 ' G' ' 6' ' ' ILE . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 127' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 128' ' ' ILE . . . . . 0.713 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 131' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' H' ' 111' ' ' ALA . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 134' ' ' VAL . . . . . 0.683 HG23 ' O ' ' H' ' 110' ' ' PHE . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 135' ' ' ILE . . . . . 0.689 ' H ' HD13 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 136' ' ' GLY . . . . . 0.66 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 138' ' ' LEU . . . . . 0.835 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 139' ' ' LYS . . . . . 0.534 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 141' ' ' GLY . . . . . 0.847 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 143' ' ' ILE . . . . . 0.859 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 145' ' ' THR . . . . . 0.669 ' O ' HD12 ' H' ' 150' ' ' ILE . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 146' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' H' ' 149' ' ' GLU . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' H' ' 148' ' ' GLU . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 150' ' ' ILE . . . . . 0.669 HD12 ' O ' ' H' ' 145' ' ' THR . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 165' ' ' GLN . . . . . 0.51 ' CA ' ' HB3' ' H' ' 161' ' ' GLN . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 167' ' ' THR . . . . . 0.551 HG21 ' H ' ' H' ' 172' ' ' GLY . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 172' ' ' GLY . . . . . 0.551 ' H ' HG21 ' H' ' 167' ' ' THR . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 174' ' ' VAL . . . . . 0.499 HG22 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' I' I ' 5' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' J' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' J' ' 126' ' ' VAL . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 7' ' ' MET . . . . . 1.078 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 10' ' ' ASP . . . . . 1.078 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 11' ' ' VAL . . . . . 0.439 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 12' ' ' LYS . . . . . 0.545 ' HG2' HD11 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' CE1' ' I' ' 91' ' ' PHE . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 14' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 15' ' ' PHE . . . . . 0.562 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 18' ' ' ILE . . . . . 0.849 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' I' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' I' ' 22' ' ' THR . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 25' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 27' ' ' LEU . . . . . 0.609 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 30' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 32' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 33' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' J' ' 120' ' ' ASP . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 34' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' I' ' 65' ' ' VAL . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 37' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' J' ' 117' ' ' GLU . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 39' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 41' ' ' ARG . . . . . 0.804 HH22 ' HB2' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 42' ' ' GLU . . . . . 0.662 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 54' ' ' LEU . . . . . 0.555 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 58' ' ' SER . . . . . 0.52 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 60' ' ' ALA . . . . . 0.804 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' I' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' I' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 66' ' ' THR . . . . . 0.764 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 67' ' ' TYR . . . . . 0.72 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' I' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' I' ' 71' ' ' ARG . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 79' ' ' ILE . . . . . 0.53 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 80' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 82' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 83' ' ' TYR . . . . . 0.555 ' HD1' HG22 ' I' ' 113' ' ' ILE . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 84' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' I' ' 82' ' ' ALA . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 90' ' ' LYS . . . . . 0.849 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 92' ' ' TRP . . . . . 0.764 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 93' ' ' ARG . . . . . 0.508 ' HD2' ' HB2' ' I' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 95' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 99' ' ' ASN . . . . . 0.579 HD22 ' HB2' ' I' ' 102' ' ' ASP . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 102' ' ' ASP . . . . . 0.579 ' HB2' HD22 ' I' ' 99' ' ' ASN . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 105' ' ' ASP . . . . . 0.857 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 107' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' I' ' 93' ' ' ARG . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 113' ' ' ILE . . . . . 0.555 HG22 ' HD1' ' I' ' 83' ' ' TYR . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 114' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 116' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' I' ' 116' ' ' ARG . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 117' ' ' GLU . . . . . 0.406 ' HB3' HG12 ' H' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 118' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 126' ' ' VAL . . . . . 0.938 HG23 HG21 ' H' ' 6' ' ' ILE . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 127' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 128' ' ' ILE . . . . . 0.72 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 129' ' ' SER . . . . . 0.764 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' I' ' 111' ' ' ALA . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 134' ' ' VAL . . . . . 0.674 HG23 ' O ' ' I' ' 110' ' ' PHE . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 135' ' ' ILE . . . . . 0.689 ' H ' HD13 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 139' ' ' LYS . . . . . 0.572 ' HD3' ' HG2' ' J' ' 80' ' ' GLU . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 141' ' ' GLY . . . . . 0.857 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 142' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 143' ' ' ILE . . . . . 0.871 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 145' ' ' THR . . . . . 0.665 ' O ' HD12 ' I' ' 150' ' ' ILE . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 146' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 150' ' ' ILE . . . . . 0.665 HD12 ' O ' ' I' ' 145' ' ' THR . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' I' ' 161' ' ' GLN . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 167' ' ' THR . . . . . 0.558 HG21 ' H ' ' I' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 172' ' ' GLY . . . . . 0.558 ' H ' HG21 ' I' ' 167' ' ' THR . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 174' ' ' VAL . . . . . 0.501 HG22 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' J' J ' 5' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' K' ' 70' ' ' LYS . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' K' ' 126' ' ' VAL . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 7' ' ' MET . . . . . 1.059 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 10' ' ' ASP . . . . . 1.059 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 13' ' ' TYR . . . . . 0.454 ' HD1' ' CE1' ' J' ' 91' ' ' PHE . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 14' ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 15' ' ' PHE . . . . . 0.549 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 18' ' ' ILE . . . . . 0.858 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 21' ' ' ALA . . . . . 0.684 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 22' ' ' THR . . . . . 0.436 HG22 ' H ' ' J' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 27' ' ' LEU . . . . . 0.626 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 30' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' J' ' 32' ' ' GLN . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' J' ' 65' ' ' VAL . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 37' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' K' ' 117' ' ' GLU . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 41' ' ' ARG . . . . . 0.794 HH22 ' HB2' ' J' ' 60' ' ' ALA . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 54' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' K' ' 88' ' ' GLN . 1.3 mp . . . . . 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' J' ' 54' ' ' LEU . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 58' ' ' SER . . . . . 0.525 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 60' ' ' ALA . . . . . 0.794 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' J' ' 136' ' ' GLY . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' J' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 65' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 66' ' ' THR . . . . . 0.77 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 67' ' ' TYR . . . . . 0.722 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 68' ' ' TYR . . . . . 0.642 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 70' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' I' ' 5' ' ' PRO . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 71' ' ' ARG . . . . . 0.448 HH21 ' HD3' ' J' ' 71' ' ' ARG . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 79' ' ' ILE . . . . . 0.535 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 80' ' ' GLU . . . . . 0.572 ' HG2' ' HD3' ' I' ' 139' ' ' LYS . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 81' ' ' ASP . . . . . 0.41 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 82' ' ' ALA . . . . . 0.739 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 83' ' ' TYR . . . . . 0.553 ' CD1' HG22 ' J' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 87' ' ' LYS . . . . . 0.739 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 88' ' ' GLN . . . . . 0.651 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 89' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' J' ' 82' ' ' ALA . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 90' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 91' ' ' PHE . . . . . 0.549 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 92' ' ' TRP . . . . . 0.731 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 93' ' ' ARG . . . . . 0.509 ' HD2' ' HB2' ' J' ' 107' ' ' GLN . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 94' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 98' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 99' ' ' ASN . . . . . 0.58 HD22 ' HB2' ' J' ' 102' ' ' ASP . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 102' ' ' ASP . . . . . 0.58 ' HB2' HD22 ' J' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 105' ' ' ASP . . . . . 0.848 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 106' ' ' ALA . . . . . 0.757 ' HB2' HG12 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 107' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' J' ' 93' ' ' ARG . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 108' ' ' PHE . . . . . 0.827 ' HD2' HD11 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 111' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 112' ' ' TYR . . . . . 0.651 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 113' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' J' ' 83' ' ' TYR . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 114' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 117' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' I' ' 37' ' ' VAL . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 118' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 120' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 125' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' I' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 127' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 128' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 129' ' ' SER . . . . . 0.77 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 132' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' J' ' 111' ' ' ALA . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 134' ' ' VAL . . . . . 0.675 HG23 ' O ' ' J' ' 110' ' ' PHE . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 135' ' ' ILE . . . . . 0.69 ' H ' HD13 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 138' ' ' LEU . . . . . 0.827 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 139' ' ' LYS . . . . . 0.527 ' HD3' ' HG2' ' K' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 141' ' ' GLY . . . . . 0.848 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 142' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 143' ' ' ILE . . . . . 0.868 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 144' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' J' ' 150' ' ' ILE . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' J' ' 145' ' ' THR . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.265 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 165' ' ' GLN . . . . . 0.503 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' J' ' 172' ' ' GLY . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' J' ' 167' ' ' THR . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' K' K ' 5' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' L' ' 126' ' ' VAL . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 7' ' ' MET . . . . . 1.035 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 8' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 10' ' ' ASP . . . . . 1.035 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 11' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 13' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' K' ' 91' ' ' PHE . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 18' ' ' ILE . . . . . 0.848 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 21' ' ' ALA . . . . . 0.853 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 22' ' ' THR . . . . . 0.431 HG22 ' H ' ' K' ' 23' ' ' GLY . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 27' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 30' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' K' ' 67' ' ' TYR . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 32' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 34' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' K' ' 65' ' ' VAL . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 36' ' ' SER . . . . . 0.402 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 37' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' L' ' 117' ' ' GLU . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 39' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 41' ' ' ARG . . . . . 0.818 HH22 ' HB2' ' K' ' 60' ' ' ALA . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 54' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 58' ' ' SER . . . . . 0.509 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 60' ' ' ALA . . . . . 0.818 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' K' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' K' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 66' ' ' THR . . . . . 0.793 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 67' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 68' ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 69' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' J' ' 5' ' ' PRO . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 75' ' ' GLY . . . . . 0.405 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 79' ' ' ILE . . . . . 0.548 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 80' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 82' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 83' ' ' TYR . . . . . 0.551 ' HD1' HG22 ' K' ' 113' ' ' ILE . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 87' ' ' LYS . . . . . 0.726 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 89' ' ' ILE . . . . . 0.719 HD11 ' HB2' ' K' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 90' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' K' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 94' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 95' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' K' ' 102' ' ' ASP . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' K' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 106' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' K' ' 93' ' ' ARG . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 108' ' ' PHE . . . . . 0.825 ' HD2' HD11 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 111' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 113' ' ' ILE . . . . . 0.551 HG22 ' HD1' ' K' ' 83' ' ' TYR . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 114' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 117' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' J' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 125' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' J' ' 6' ' ' ILE . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 128' ' ' ILE . . . . . 0.715 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 129' ' ' SER . . . . . 0.793 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 132' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' K' ' 111' ' ' ALA . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 134' ' ' VAL . . . . . 0.681 HG23 ' O ' ' K' ' 110' ' ' PHE . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 135' ' ' ILE . . . . . 0.687 ' H ' HD13 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 136' ' ' GLY . . . . . 0.676 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 138' ' ' LEU . . . . . 0.825 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 139' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 142' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 145' ' ' THR . . . . . 0.649 ' O ' HD12 ' K' ' 150' ' ' ILE . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' K' ' 149' ' ' GLU . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' K' ' 148' ' ' GLU . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 150' ' ' ILE . . . . . 0.649 HD12 ' O ' ' K' ' 145' ' ' THR . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' K' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 167' ' ' THR . . . . . 0.566 HG21 ' H ' ' K' ' 172' ' ' GLY . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 172' ' ' GLY . . . . . 0.566 ' H ' HG21 ' K' ' 167' ' ' THR . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 174' ' ' VAL . . . . . 0.49 HG22 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' L' L ' 5' ' ' PRO . . . . . 0.529 ' HA ' ' HG3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 6' ' ' ILE . . . . . 0.917 HG21 HG23 ' G' ' 126' ' ' VAL . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 12' ' ' LYS . . . . . 0.544 ' HG2' HD11 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD1' ' CE1' ' L' ' 91' ' ' PHE . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 14' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 15' ' ' PHE . . . . . 0.557 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 18' ' ' ILE . . . . . 0.833 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 21' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' L' ' 23' ' ' GLY . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 23' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 27' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 30' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' L' ' 67' ' ' TYR . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 34' ' ' ASP . . . . . 0.429 ' OD1' HG22 ' L' ' 65' ' ' VAL . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 37' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' G' ' 117' ' ' GLU . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 41' ' ' ARG . . . . . 0.816 HH22 ' HB2' ' L' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 42' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 54' ' ' LEU . . . . . 0.452 HD23 ' HG3' ' G' ' 88' ' ' GLN . 1.4 mp . . . . . 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' L' ' 54' ' ' LEU . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 60' ' ' ALA . . . . . 0.816 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 61' ' ' ASP . . . . . 0.409 ' OD1' ' HA2' ' L' ' 136' ' ' GLY . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' L' ' 64' ' ' GLU . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 65' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 66' ' ' THR . . . . . 0.768 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 67' ' ' TYR . . . . . 0.702 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 68' ' ' TYR . . . . . 0.625 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 69' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD3' ' L' ' 71' ' ' ARG . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 80' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 82' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 83' ' ' TYR . . . . . 0.547 ' HD1' HG22 ' L' ' 113' ' ' ILE . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 84' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 87' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 88' ' ' GLN . . . . . 0.815 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 89' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' L' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 90' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 91' ' ' PHE . . . . . 0.557 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 92' ' ' TRP . . . . . 0.756 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 93' ' ' ARG . . . . . 0.52 ' HD2' ' HB2' ' L' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 94' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 98' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' L' ' 102' ' ' ASP . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' L' ' 99' ' ' ASN . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 103' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 105' ' ' ASP . . . . . 0.819 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 106' ' ' ALA . . . . . 0.753 ' HB2' HG12 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HD2' ' L' ' 93' ' ' ARG . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 108' ' ' PHE . . . . . 0.837 ' HD2' HD11 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 111' ' ' ALA . . . . . 0.573 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 112' ' ' TYR . . . . . 0.655 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 113' ' ' ILE . . . . . 0.55 HD11 HD12 ' L' ' 79' ' ' ILE . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 115' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 116' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' L' ' 116' ' ' ARG . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 117' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' K' ' 37' ' ' VAL . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 123' ' ' GLU . . . . . 0.53 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 125' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' K' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 128' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 129' ' ' SER . . . . . 0.768 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 131' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 132' ' ' LEU . . . . . 0.573 HD13 ' HB1' ' L' ' 111' ' ' ALA . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 134' ' ' VAL . . . . . 0.674 HG23 ' O ' ' L' ' 110' ' ' PHE . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 135' ' ' ILE . . . . . 0.675 HG12 ' H ' ' L' ' 136' ' ' GLY . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 136' ' ' GLY . . . . . 0.675 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 138' ' ' LEU . . . . . 0.837 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 139' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' G' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 140' ' ' ASN . . . . . 0.73 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 141' ' ' GLY . . . . . 0.819 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 142' ' ' GLU . . . . . 0.95 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 143' ' ' ILE . . . . . 0.864 HD12 ' H ' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 144' ' ' ASP . . . . . 0.903 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' L' ' 150' ' ' ILE . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 147' ' ' PRO . . . . . 0.556 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 148' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' L' ' 149' ' ' GLU . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' L' ' 148' ' ' GLU . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' L' ' 145' ' ' THR . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 151' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' L' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 167' ' ' THR . . . . . 0.559 HG21 ' H ' ' L' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 172' ' ' GLY . . . . . 0.559 ' H ' HG21 ' L' ' 167' ' ' THR . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 174' ' ' VAL . . . . . 0.486 HG22 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.167 0 N-CA-C 102.083 -3.853 . . . . 0.0 102.083 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 4.6 mt -80.13 131.8 33.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.62 165.48 16.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.9 0.857 . . . . 0.0 110.757 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.33 86.96 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.537 175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' B' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.43 49.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.768 0.784 . . . . 0.0 112.394 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' A' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.29 81.03 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' A' ' 95' ' ' ASP . 44.4 t -92.43 116.31 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.54 156.58 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.66 0.743 . . . . 0.0 110.518 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.78 40.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.777 -164.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.688 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.45 42.19 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.58 143.68 48.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.49 0.662 . . . . 0.0 109.961 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 6.3 tt0 -123.69 126.69 47.01 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' HD13 ' A' ' 89' ' ' ILE . 56.7 p -71.42 147.77 47.56 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.552 0.691 . . . . 0.0 111.043 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -70.55 -44.25 77.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.004 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -74.64 -23.62 58.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.55 82.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.41 -175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.15 46.17 16.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.192 1.397 . . . . 0.0 111.78 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.05 161.31 16.02 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.29 3.65 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.726 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.54 143.55 4.11 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.965 0.383 . . . . 0.0 111.768 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 16' ' ' GLN . . . -106.13 115.11 61.69 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.966 2.106 . . . . 0.0 112.395 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.97 133.2 21.14 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.417 0.828 . . . . 0.0 112.479 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.78 155.07 28.49 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 26.3 t80 -106.68 141.97 23.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.812 -2.355 . . . . 0.0 110.574 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.5 Cg_endo -76.06 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.355 0 CA-C-N 119.036 0.692 . . . . 0.0 112.404 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.32 2.74 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.414 1.485 . . . . 0.0 111.491 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.02 144.8 42.89 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.551 1.167 . . . . 0.0 111.035 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.413 ' O ' HG13 ' B' ' 122' ' ' VAL . 8.9 tm0? -101.9 -63.5 1.14 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.25 159.3 2.02 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.773 1.273 . . . . 0.0 111.101 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.58 17.19 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.001 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.14 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.324 170.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.87 123.06 48.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' B' ' 117' ' ' GLU . 0.2 OUTLIER -125.65 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -173.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -105.97 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.21 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.754 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -71.24 144.31 50.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.733 0.778 . . . . 0.0 110.148 -174.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' A' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.54 7.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -65.46 139.57 58.52 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.502 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.54 35.33 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.265 171.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.62 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 52' ' ' ARG . 2.9 tt0 -65.78 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.13 22.54 4.42 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.569 1.548 . . . . 0.0 111.682 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.1 61.17 2.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.444 1.498 . . . . 0.0 111.608 -164.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.63 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.499 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.07 13.85 30.19 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.92 1.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.2 mmp_? -110.2 23.58 14.12 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.862 HG13 HG22 ' B' ' 135' ' ' ILE . 0.9 OUTLIER -123.89 3.63 5.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.875 178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.707 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.8 22.58 14.91 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -94.39 161.2 24.03 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.599 0.555 . . . . 0.0 113.997 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.4 155.88 50.61 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.77 172.35 13.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.499 0.666 . . . . 0.0 110.511 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.754 HG22 ' HA ' ' A' ' 40' ' ' GLU . 2.9 t -123.67 128.73 74.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.56 114.9 29.43 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.37 117.58 28.13 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 133' ' ' GLN . 60.2 p -143.08 146.48 33.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.946 0.898 . . . . 0.0 110.027 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.07 24.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.153 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.1 OUTLIER -121.84 151.17 40.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' A' ' 130' ' ' ILE . 46.0 t -132.93 123.59 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.97 140.7 47.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.2 169.2 24.66 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.27 119.82 38.53 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 175.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.76 21.45 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 114.939 0.736 . . . . 0.0 114.939 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.7 mttm -93.01 153.76 18.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.484 0.659 . . . . 0.0 109.268 174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.59 15.17 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -136.94 155.58 49.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.095 1.358 . . . . 0.0 111.003 169.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HA ' ' HZ1' ' A' ' 77' ' ' LYS . . . -74.6 -37.21 62.94 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -61.71 -40.26 98.54 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.855 168.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.52 84.15 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.84 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.51 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 9.6 mtmp? -63.43 -28.18 69.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.79 171.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.82 86.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.943 168.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.9 mm -59.61 -43.03 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.107 0.48 . . . . 0.0 110.457 172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.589 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.23 76.17 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.675 -0.641 . . . . 0.0 112.391 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 63.6 m-20 -64.39 -32.65 74.35 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.545 169.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -55.19 -59.53 4.64 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.564 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.448 ' HB3' ' NH2' ' A' ' 116' ' ' ARG . 11.3 t80 -78.46 -48.25 15.78 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.85 57.51 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.022 172.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.69 76.14 1.31 Allowed Glycine 0 N--CA 1.448 -0.525 0 O-C-N 122.281 -0.262 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.52 48.26 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.6 24.8 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 17' ' ' SER . 1.3 mm -121.12 142.56 36.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.371 0.605 . . . . 0.0 109.85 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.02 46.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 176.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.514 1.126 . . . . 0.0 110.028 -166.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.688 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 10.5 m95 -129.03 129.95 45.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -124.86 168.1 18.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.238 1.018 . . . . 0.0 109.397 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' A' ' 11' ' ' VAL . 1.0 OUTLIER -108.04 138.75 43.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.615 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.602 HG22 HG23 ' A' ' 150' ' ' ILE . 63.0 p -69.81 -29.78 67.16 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.631 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.81 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.661 0.743 . . . . 0.0 109.953 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.94 53.21 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.958 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -74.57 139.92 44.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.824 0.821 . . . . 0.0 109.963 171.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.91 35.3 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' A' ' 99' ' ' ASN . 11.6 m120 -126.83 24.72 6.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.762 0.71 . . . . 0.0 110.831 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 30.7 t0 -153.35 171.0 19.28 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 1.045 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.08 -62.35 1.76 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.907 -0.495 . . . . 0.0 110.572 171.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.602 ' CE2' HG22 ' A' ' 145' ' ' THR . 2.4 m-85 -143.4 -178.55 5.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.88 53.53 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.647 0.736 . . . . 0.0 109.47 177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -139.52 160.24 40.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.071 -163.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' A' ' 139' ' ' LYS . 38.9 tt0 -124.84 139.5 53.78 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.397 0.679 . . . . 0.0 110.404 -163.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.51 39.6 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.956 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -131.09 161.56 31.8 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.962 0.887 . . . . 0.0 111.128 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' F' ' 54' ' ' LEU . 2.1 t80 -128.2 162.66 26.44 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.019 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.413 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.69 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -42.9 97.52 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 177.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.81 158.69 37.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.944 0.793 . . . . 0.0 109.076 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.98 49.66 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 6.2 tm-20 -135.88 132.6 36.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.84 26.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 111.185 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.84 130.07 55.41 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.685 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.11 120.72 39.94 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.39 13.35 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-O 121.701 0.612 . . . . 0.0 111.594 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.587 ' HA ' HE22 ' F' ' 9' ' ' GLN . 17.3 m -71.19 -32.87 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.454 -0.439 . . . . 0.0 111.143 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -95.96 154.8 17.04 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.68 -151.73 34.48 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -138.11 162.65 33.64 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.624 0.726 . . . . 0.0 110.709 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.623 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 7.4 m -53.19 135.92 14.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.083 -171.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 127.99 45.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.114 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.5 mt -109.56 126.81 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 2.9 t -108.01 115.41 30.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 168.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.2 pt -117.15 128.64 74.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 2.2 m -115.64 140.6 49.04 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.337 0.655 . . . . 0.0 109.684 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.3 pp -144.17 147.26 33.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.15 -172.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 62' ' ' SER . 0.0 OUTLIER -102.77 161.07 14.04 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 167.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 110' ' ' PHE . 81.8 t -139.86 158.77 26.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.523 HG12 ' HG ' ' F' ' 54' ' ' LEU . 6.4 pt -101.21 26.29 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.357 0.599 . . . . 0.0 110.356 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.03 93.41 1.21 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.734 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' A' ' 134' ' ' VAL . 27.3 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.063 0.935 . . . . 0.0 110.663 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -118.77 154.93 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.24 34.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -100.89 141.93 15.57 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.378 169.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -83.97 128.23 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 1.045 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.813 -176.455 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.54 110.82 20.06 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.028 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.602 HG22 ' CE2' ' A' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.95 95.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.39 175.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.09 63.4 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.48 1.912 . . . . 0.0 109.37 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.67 -5.57 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 121.205 1.27 . . . . 0.0 115.317 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -37.8 85.73 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.568 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.84 -66.01 1.13 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 96' ' ' THR . 3.9 mp -59.96 -52.99 54.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 119.18 0.9 . . . . 0.0 111.264 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 52.0 t -68.91 -49.03 67.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.7 t-20 -106.15 107.19 18.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.415 -176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.67 3.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.51 14.95 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.13 29.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.29 76.13 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.386 0.994 . . . . 0.0 113.037 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.91 23.49 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.15 46.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.28 1.032 . . . . 0.0 108.611 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.87 42.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' A' ' 162' ' ' GLN . 1.4 p90 -146.51 162.3 38.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.658 2.383 . . . . 0.0 109.125 167.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.95 89.65 2.06 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' A' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.04 0.15 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.614 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.21 7.54 3.66 Favored 'Trans proline' 0 C--O 1.238 0.487 0 CA-C-N 122.056 1.77 . . . . 0.0 113.918 171.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.2 84.43 0.67 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.338 2.095 . . . . 0.0 118.338 -171.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.614 HE22 ' HD2' ' A' ' 163' ' ' PRO . 3.8 mp0 -100.71 68.33 1.31 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.925 1.362 . . . . 0.0 110.876 175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.624 ' O ' ' HB ' ' A' ' 173' ' ' THR . 94.6 m 26.7 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.827 1.651 . . . . 0.0 111.883 175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -96.8 161.63 13.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.323 -167.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.442 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -138.87 -154.2 6.35 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.426 172.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.41 64.63 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.695 0.283 . . . . 0.0 111.415 -177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.462 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -77.48 161.68 71.41 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.505 0.722 . . . . 0.0 109.262 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.462 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 121.345 1.363 . . . . 0.0 112.73 -156.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.44 0.2 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.64 13.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.993 0.896 . . . . 0.0 109.899 170.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.31 167.2 13.86 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.443 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.517 0.863 . . . . 0.0 111.741 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.446 1.498 . . . . 0.0 112.311 -171.731 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 102.069 -3.858 . . . . 0.0 102.069 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.524 ' O ' ' HB1' ' C' ' 125' ' ' ALA . 4.5 mt -80.13 131.82 33.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.51 16.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.87 0.843 . . . . 0.0 110.78 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.44 87.26 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.391 -0.822 . . . . 0.0 114.512 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 3.3 mm-40 -80.15 -18.42 49.79 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.758 0.779 . . . . 0.0 112.379 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' B' ' 6' ' ' ILE . 1.1 t70 -67.5 -43.29 81.26 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -171.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 44.4 t -92.49 116.29 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.55 156.63 38.77 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.685 0.755 . . . . 0.0 110.544 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.86 41.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.759 -164.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -117.97 148.41 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.53 143.71 48.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.482 0.658 . . . . 0.0 109.889 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 6.3 tt0 -123.73 126.68 46.96 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' B' ' 89' ' ' ILE . 56.7 p -71.37 147.81 47.62 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.062 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.605 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -70.55 -44.31 77.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.004 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.64 58.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.54 82.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.43 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.03 46.29 16.58 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.249 1.42 . . . . 0.0 111.825 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.32 16.01 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.756 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.57 4.11 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.934 0.367 . . . . 0.0 111.776 -177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' B' ' 16' ' ' GLN . . . -106.18 115.08 61.69 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.943 2.097 . . . . 0.0 112.365 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.91 133.19 21.24 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.413 0.826 . . . . 0.0 112.508 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 26.2 t80 -106.64 141.92 23.85 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.854 -2.338 . . . . 0.0 110.563 -167.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -76.04 175.55 11.17 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-N 119.021 0.686 . . . . 0.0 112.411 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.3 2.75 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.418 1.487 . . . . 0.0 111.53 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -75.03 144.81 42.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.509 1.147 . . . . 0.0 111.061 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.432 ' O ' HG13 ' C' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.29 159.25 2.0 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.792 1.282 . . . . 0.0 111.104 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.6 117.59 17.25 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.988 -164.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.1 121.08 5.42 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.346 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.05 48.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' C' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.7 66.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.48 109.18 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -166.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -105.95 121.1 6.61 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.275 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' B' ' 59' ' ' VAL . 10.5 tt0 -101.27 105.91 17.05 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' B' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.26 50.23 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.722 0.772 . . . . 0.0 110.187 -174.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' B' ' 41' ' ' ARG . 18.6 mt-10 -126.26 175.54 7.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.77 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.56 58.51 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.53 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.71 128.61 35.3 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.267 171.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.54 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' B' ' 52' ' ' ARG . 2.9 tt0 -65.82 -33.36 75.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.57 4.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.626 1.571 . . . . 0.0 111.649 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.06 61.2 2.02 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.576 -164.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.57 0.29 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.459 -177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.8 30.31 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.83 1.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.57 14.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.974 HG13 HG22 ' C' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.872 178.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.731 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -104.81 22.66 14.78 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.77 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -94.44 161.18 23.97 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-O 121.666 0.592 . . . . 0.0 113.953 -170.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.35 155.9 50.8 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.887 0.687 . . . . 0.0 113.887 -175.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.71 29.33 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.411 ' O ' ' N ' ' B' ' 41' ' ' ARG . 0.3 OUTLIER -76.73 172.31 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.56 0.695 . . . . 0.0 110.508 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.744 HG22 ' HA ' ' B' ' 40' ' ' GLU . 2.9 t -123.6 128.73 74.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.85 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.49 27.91 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' B' ' 133' ' ' GLN . 60.3 p -142.96 146.52 34.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.936 0.894 . . . . 0.0 110.074 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.16 24.29 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.16 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.22 40.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.617 ' HB ' HG12 ' B' ' 130' ' ' ILE . 46.0 t -132.98 123.58 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 73.5 p -112.96 140.7 47.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.17 169.21 24.66 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -99.3 119.77 38.46 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.31 130.74 21.68 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 9.8 mttm -93.01 153.74 18.55 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.09 -50.61 15.08 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.86 155.55 49.64 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.13 1.372 . . . . 0.0 111.032 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.435 ' HA ' ' HZ1' ' B' ' 77' ' ' LYS . . . -74.55 -37.24 63.05 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -61.72 -40.28 98.58 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.82 168.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -62.27 -47.43 84.36 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.846 171.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.484 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 9.6 mtmp? -63.44 -28.1 69.75 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.795 171.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.8 86.01 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.9 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.9 mm -59.55 -43.01 89.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.089 0.471 . . . . 0.0 110.535 172.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.16 76.41 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.78 -0.575 . . . . 0.0 112.474 -178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 63.6 m-20 -64.43 -32.59 74.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.605 169.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.534 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.438 ' HB3' ' NH2' ' B' ' 116' ' ' ARG . 11.3 t80 -78.51 -48.27 15.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.892 -174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -76.96 -34.89 57.57 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 34.5 t30 -83.22 -33.16 26.16 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.001 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.23 1.31 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.314 -0.242 . . . . 0.0 112.882 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.18 156.48 48.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' B' ' 17' ' ' SER . 1.3 mm -121.08 142.54 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.338 0.589 . . . . 0.0 109.885 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.8 mtmt -72.26 135.95 46.16 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.04 121.34 41.92 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.534 1.134 . . . . 0.0 110.015 -165.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 10.6 m95 -128.99 129.96 46.05 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.181 0.993 . . . . 0.0 108.36 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.52 16.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -124.83 168.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.29 1.043 . . . . 0.0 109.41 -173.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.628 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.61 HG22 HG23 ' B' ' 150' ' ' ILE . 62.8 p -69.74 -29.78 67.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.053 . . . . 0.0 112.646 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.88 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 121.7 0.762 . . . . 0.0 109.912 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' B' ' 104' ' ' TYR . 0.0 OUTLIER -63.43 133.0 53.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.903 -174.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -74.63 139.93 43.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.828 0.823 . . . . 0.0 109.96 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.53 -21.85 35.24 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' B' ' 99' ' ' ASN . 11.6 m120 -126.84 24.74 6.45 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.732 0.696 . . . . 0.0 110.908 169.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 30.7 t0 -153.35 170.94 19.43 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 1.017 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.877 -0.515 . . . . 0.0 110.647 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' B' ' 145' ' ' THR . 2.4 m-85 -143.41 -178.61 5.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.567 0.698 . . . . 0.0 109.453 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.876 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.52 160.25 40.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.05 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.543 ' CD ' ' HE3' ' B' ' 139' ' ' LYS . 39.0 tt0 -124.83 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.39 148.24 52.41 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.423 0.689 . . . . 0.0 110.41 -163.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.27 -178.54 39.62 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.941 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.5 m-30 -109.36 129.71 55.52 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.99 161.57 31.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.923 0.868 . . . . 0.0 111.218 -169.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.707 ' HB2' HD22 ' A' ' 54' ' ' LEU . 2.1 t80 -128.19 162.63 26.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.017 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.78 86.8 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.93 97.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.75 158.76 37.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.946 0.794 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.665 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.03 49.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.666 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 6.1 tm-20 -135.92 132.65 36.74 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' B' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.81 26.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.234 176.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.689 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.7 39.98 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.61 162.47 13.33 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.562 ' HA ' HE22 ' A' ' 9' ' ' GLN . 17.4 m -71.27 -32.83 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.488 -0.419 . . . . 0.0 111.104 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.86 17.01 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -138.13 162.6 33.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.543 0.687 . . . . 0.0 110.748 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.507 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 7.4 m -53.19 135.94 14.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.021 -171.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.18 128.02 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.124 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.86 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.666 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 2.9 t -108.05 115.42 30.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.2 pt -117.17 128.62 74.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 2.2 m -115.59 140.6 49.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.72 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.3 pp -144.17 147.32 33.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.139 -172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.537 HE22 HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -102.79 161.09 14.02 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' B' ' 110' ' ' PHE . 79.0 t -139.91 158.74 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.862 HG22 HG13 ' A' ' 53' ' ' ILE . 6.4 pt -101.18 26.25 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.323 0.583 . . . . 0.0 110.327 -173.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.02 93.43 1.21 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.712 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' B' ' 134' ' ' VAL . 27.2 mt-10 -81.92 137.16 35.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.011 0.91 . . . . 0.0 110.624 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.481 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.96 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -174.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.543 ' HE3' ' CD ' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.29 34.87 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.48 -169.88 3.36 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -100.93 141.93 15.56 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.145 -1.026 . . . . 0.0 111.329 170.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.876 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.23 34.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 1.017 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.91 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.756 -176.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.55 110.8 20.05 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.989 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' B' ' 104' ' ' TYR . 0.9 OUTLIER -63.63 -43.96 95.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.352 175.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.08 63.44 7.62 Favored Pre-proline 0 C--N 1.346 0.424 0 C-N-CA 126.423 1.889 . . . . 0.0 109.402 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.72 -5.52 15.63 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.212 1.275 . . . . 0.0 115.379 -159.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.84 85.88 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.572 171.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.81 -65.96 1.13 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.61 HG23 HG22 ' B' ' 96' ' ' THR . 3.9 mp -60.07 -52.89 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.126 0.875 . . . . 0.0 111.24 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 51.7 t -69.02 -49.0 66.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.16 18.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.443 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.47 97.61 3.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.71 159.53 14.94 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -172.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.76 -0.14 29.2 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.24 76.12 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.421 1.01 . . . . 0.0 112.998 -176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.89 23.43 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.18 151.17 46.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.317 1.047 . . . . 0.0 108.626 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -58.36 -54.89 41.89 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -158.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.548 ' HD2' ' HB2' ' B' ' 162' ' ' GLN . 1.5 p90 -146.47 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.71 2.404 . . . . 0.0 109.156 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' B' ' 165' ' ' GLN . 15.3 mt-30 -144.04 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' B' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.631 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -77.26 7.58 3.66 Favored 'Trans proline' 0 C--O 1.239 0.566 0 CA-C-N 122.061 1.772 . . . . 0.0 113.855 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.45 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.631 HE22 ' HD2' ' B' ' 163' ' ' PRO . 3.8 mp0 -100.68 68.32 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.851 1.326 . . . . 0.0 110.921 175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.621 ' O ' ' HB ' ' B' ' 173' ' ' THR . 94.5 m 26.7 73.2 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.85 1.66 . . . . 0.0 111.887 176.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.62 13.78 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.298 -167.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.87 -154.21 6.35 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.469 172.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.36 64.61 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.801 0.3 . . . . 0.0 111.42 -177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.456 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -77.43 161.68 71.56 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.473 0.709 . . . . 0.0 109.27 -178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.456 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -84.83 -9.58 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.324 1.35 . . . . 0.0 112.738 -156.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' B' ' 166' ' ' THR . 0.2 OUTLIER -94.45 163.71 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.964 0.882 . . . . 0.0 109.856 170.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.43 167.23 13.88 Favored Pre-proline 0 C--O 1.24 0.573 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.393 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.97 110.41 3.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.504 0.859 . . . . 0.0 111.751 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 125.475 1.51 . . . . 0.0 112.311 -171.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 102.103 -3.845 . . . . 0.0 102.103 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.419 ' O ' ' HB1' ' D' ' 125' ' ' ALA . 4.6 mt -80.1 131.84 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.59 165.51 16.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.889 0.852 . . . . 0.0 110.74 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.43 87.22 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.504 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.519 ' HG3' ' HB ' ' H' ' 48' ' ' THR . 3.2 mm-40 -80.19 -18.33 49.91 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.832 0.816 . . . . 0.0 112.405 172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' C' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.95 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.43 116.31 33.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.57 38.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.656 0.741 . . . . 0.0 110.522 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.5 m-85 -120.91 122.82 41.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.729 -164.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -117.93 148.44 42.17 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.66 48.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.472 0.653 . . . . 0.0 109.972 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.73 47.01 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' C' ' 89' ' ' ILE . 56.7 p -71.45 147.88 47.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.583 0.706 . . . . 0.0 110.995 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -70.61 -44.34 76.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.953 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.53 -23.63 58.84 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.23 -46.57 82.85 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.421 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.18 46.18 16.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.229 1.412 . . . . 0.0 111.798 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.98 161.35 15.94 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.89 36.27 3.66 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.319 -0.401 . . . . 0.0 113.746 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.5 4.11 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.922 0.361 . . . . 0.0 111.781 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 16' ' ' GLN . . . -106.12 115.08 61.75 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 126.957 2.103 . . . . 0.0 112.407 -174.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.92 133.21 21.25 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.382 0.815 . . . . 0.0 112.48 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.51 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 26.4 t80 -106.71 141.93 23.89 Favored Pre-proline 0 C--N 1.317 -0.829 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.512 -167.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.8 Cg_endo -75.98 175.59 11.12 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-O 121.897 0.707 . . . . 0.0 112.431 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.333 1.453 . . . . 0.0 111.56 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.597 1.189 . . . . 0.0 111.033 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.533 ' O ' HG13 ' D' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.31 2.03 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.738 1.256 . . . . 0.0 111.137 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.64 117.54 17.15 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.005 -164.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.08 121.1 5.43 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.377 170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.83 123.06 48.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.638 HG13 ' HG2' ' D' ' 117' ' ' GLU . 0.2 OUTLIER -125.69 134.7 66.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.47 109.15 7.03 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -105.95 121.13 6.62 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.245 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.759 ' HA ' HG22 ' C' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.91 17.04 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' C' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.29 50.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.709 0.766 . . . . 0.0 110.163 -174.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.445 ' H ' ' CZ ' ' C' ' 41' ' ' ARG . 18.7 mt-10 -126.26 175.54 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.741 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.2 OUTLIER -65.49 139.53 58.5 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.52 -179.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.75 128.61 35.31 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.238 171.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.57 109.95 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 155.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' C' ' 52' ' ' ARG . 2.9 tt0 -65.77 -33.4 75.77 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.2 22.53 4.37 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.589 1.556 . . . . 0.0 111.656 -172.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.09 61.2 2.03 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.533 1.533 . . . . 0.0 111.554 -164.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.59 0.29 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.496 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.2 mmp_? -110.16 23.59 14.12 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.803 HG13 HG22 ' D' ' 135' ' ' ILE . 0.9 OUTLIER -123.83 3.65 5.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.915 178.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.692 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -104.84 22.6 14.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 176.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.741 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -94.42 161.18 23.99 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.636 0.575 . . . . 0.0 113.94 -170.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.4 155.91 50.58 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.7 29.29 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' C' ' 41' ' ' ARG . 0.3 OUTLIER -76.76 172.35 13.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.599 0.714 . . . . 0.0 110.508 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' C' ' 40' ' ' GLU . 2.9 t -123.61 128.73 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.54 114.85 29.34 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.63 28.26 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -171.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . 0.508 ' HB3' ' HG2' ' C' ' 133' ' ' GLN . 60.3 p -143.06 146.51 33.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.971 0.909 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.16 156.14 24.3 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.145 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.13 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' C' ' 130' ' ' ILE . 45.8 t -132.91 123.58 48.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.95 140.74 47.51 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -159.22 169.21 24.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.77 38.48 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.33 130.8 21.69 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.506 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.8 mttm -93.09 153.77 18.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD2' ' C' ' 71' ' ' ARG . 0.0 OUTLIER -46.15 -50.54 15.44 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.31 0.18 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.55 49.66 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.127 1.371 . . . . 0.0 111.024 169.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.65 -37.21 62.79 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -61.67 -40.28 98.55 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.856 168.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.52 84.09 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.824 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.17 69.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.79 171.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.8 86.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.905 168.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.579 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.9 mm -59.56 -43.01 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.089 0.471 . . . . 0.0 110.496 172.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.2 76.28 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.736 -0.602 . . . . 0.0 112.435 -178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 63.5 m-20 -64.46 -32.51 74.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.588 169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.82 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -55.22 -59.54 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.555 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.452 ' HB3' ' NH2' ' C' ' 116' ' ' ARG . 11.4 t80 -78.48 -48.29 15.65 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.899 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.0 OUTLIER -76.97 -34.86 57.55 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -167.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 34.5 t30 -83.21 -33.18 26.18 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.053 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.25 1.32 Allowed Glycine 0 N--CA 1.449 -0.444 0 O-C-N 122.326 -0.233 . . . . 0.0 112.846 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.82 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.24 156.46 48.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.498 ' O ' HG12 ' C' ' 18' ' ' ILE . 0.0 OUTLIER -87.54 148.61 24.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.424 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -121.14 142.55 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.374 0.606 . . . . 0.0 109.846 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.99 46.03 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.54 1.136 . . . . 0.0 109.997 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.702 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 10.5 m95 -128.96 129.93 46.05 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.189 0.996 . . . . 0.0 108.342 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.548 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -124.88 168.04 18.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.267 1.032 . . . . 0.0 109.437 -173.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.0 138.77 43.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.633 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.594 HG22 HG23 ' C' ' 150' ' ' ILE . 62.8 p -69.79 -29.72 67.09 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.629 -176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.82 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.654 0.74 . . . . 0.0 109.888 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' C' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.95 53.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.007 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.94 44.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.829 0.823 . . . . 0.0 109.961 171.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.52 -21.92 35.22 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' C' ' 99' ' ' ASN . 11.7 m120 -126.85 24.82 6.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.874 169.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 30.7 t0 -153.42 170.95 19.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 1.042 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.38 1.75 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.885 -0.51 . . . . 0.0 110.583 171.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.592 ' CE2' HG22 ' C' ' 145' ' ' THR . 2.3 m-85 -143.35 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.638 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.89 53.52 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.601 0.715 . . . . 0.0 109.451 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.893 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.54 160.19 40.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -163.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.542 ' CD ' ' HE3' ' C' ' 139' ' ' LYS . 38.9 tt0 -124.88 139.47 53.81 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.26 52.42 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.384 0.674 . . . . 0.0 110.372 -163.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.46 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.946 170.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.5 m-30 -109.44 129.71 55.54 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 167.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -131.01 161.61 31.59 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.927 0.87 . . . . 0.0 111.167 -169.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.1 t80 -128.25 162.61 26.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.97 -174.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.74 86.73 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 0.9 OUTLIER -63.8 -42.99 97.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.95 0.795 . . . . 0.0 109.079 174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.02 49.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.673 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 6.1 tm-20 -135.94 132.66 36.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.404 ' CE1' ' HD2' ' C' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.79 26.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.048 0.451 . . . . 0.0 111.197 176.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.12 55.4 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.658 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.09 120.7 39.9 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.463 ' HA ' HE22 ' B' ' 9' ' ' GLN . 17.3 m -71.2 -32.82 48.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.475 -0.427 . . . . 0.0 111.137 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.77 17.06 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.62 -151.73 34.59 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 166.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -138.1 162.61 33.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.651 0.738 . . . . 0.0 110.718 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 7.3 m -53.18 135.98 14.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.044 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.21 128.05 45.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.071 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.66 126.8 66.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 2.9 t -107.97 115.43 30.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.2 pt -117.14 128.62 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 2.2 m -115.61 140.54 49.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.3 pp -144.1 147.28 33.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.163 -172.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.586 HE22 HD12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -102.78 161.08 14.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' C' ' 110' ' ' PHE . 80.3 t -139.88 158.81 26.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.974 HG22 HG13 ' B' ' 53' ' ' ILE . 6.4 pt -101.23 26.21 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.361 0.6 . . . . 0.0 110.328 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.688 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' C' ' 134' ' ' VAL . 27.3 mt-10 -81.95 137.12 35.22 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.997 0.903 . . . . 0.0 110.641 174.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' D' ' 84' ' ' GLN . 0.0 OUTLIER -118.72 154.94 31.96 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' CD ' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.21 34.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.84 3.35 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -100.86 141.88 15.55 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.384 169.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.893 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 1.042 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.89 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.753 -176.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.52 110.78 20.01 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.947 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 0.592 HG22 ' CE2' ' C' ' 104' ' ' TYR . 0.9 OUTLIER -63.61 -43.99 95.27 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.782 -0.628 . . . . 0.0 112.386 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.19 63.35 7.63 Favored Pre-proline 0 C--N 1.347 0.467 0 C-N-CA 126.439 1.896 . . . . 0.0 109.379 -173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.626 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -68.71 -5.53 15.64 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.245 1.297 . . . . 0.0 115.335 -159.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.73 85.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.637 171.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.594 HG23 HG22 ' C' ' 96' ' ' THR . 3.9 mp -60.08 -52.89 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.162 0.892 . . . . 0.0 111.249 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 51.4 t -69.01 -49.05 66.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.16 18.02 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.436 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.5 97.65 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.62 159.48 14.97 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.72 -0.15 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.58 -4.28 76.04 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.355 0.98 . . . . 0.0 113.049 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.78 139.92 23.5 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.23 151.1 46.26 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.35 1.06 . . . . 0.0 108.631 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.28 -54.9 41.74 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' C' ' 162' ' ' GLN . 1.4 p90 -146.45 162.37 38.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.684 2.394 . . . . 0.0 109.112 167.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' C' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.63 2.05 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 153.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' C' ' 160' ' ' PHE . 3.9 tt0 -110.03 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.624 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -77.19 7.47 3.69 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.06 1.772 . . . . 0.0 113.862 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.624 HE22 ' HD2' ' C' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.863 1.331 . . . . 0.0 110.918 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' C' ' 173' ' ' THR . 94.8 m 26.71 73.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.836 1.654 . . . . 0.0 111.88 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -96.86 161.57 13.79 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.304 -167.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.15 6.34 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.445 172.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.41 -23.44 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.755 0.277 . . . . 0.0 111.419 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -77.45 161.66 71.55 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.47 0.708 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.3 Cg_endo -84.87 -9.58 8.73 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.345 1.363 . . . . 0.0 112.697 -156.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.49 101.56 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.139 1.616 . . . . 0.0 117.139 165.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' C' ' 166' ' ' THR . 0.2 OUTLIER -94.56 163.72 13.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.891 . . . . 0.0 109.855 170.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.24 13.82 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.7 -1.137 . . . . 0.0 108.369 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -73.05 110.51 3.06 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.495 0.855 . . . . 0.0 111.715 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.281 0 C-N-CA 125.365 1.466 . . . . 0.0 112.337 -171.716 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 102.106 -3.844 . . . . 0.0 102.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.538 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 4.6 mt -80.08 131.9 33.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.69 165.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.906 0.86 . . . . 0.0 110.743 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.15 -33.51 87.45 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.488 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.52 HE22 ' HA ' ' E' ' 122' ' ' VAL . 3.2 mm-40 -80.17 -18.32 50.01 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 117.75 0.775 . . . . 0.0 112.429 172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' D' ' 6' ' ' ILE . 1.1 t70 -67.57 -43.27 81.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -172.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' D' ' 95' ' ' ASP . 44.3 t -92.4 116.28 33.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.62 38.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.499 176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.6 m-85 -120.95 122.85 41.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.741 -164.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.42 42.21 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.5 143.69 48.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 0.0 109.968 176.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.548 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.68 46.95 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . 0.415 ' HA ' HD13 ' D' ' 89' ' ' ILE . 56.6 p -71.45 147.78 47.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.565 0.698 . . . . 0.0 111.02 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.626 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -70.52 -44.32 77.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.965 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.21 -46.55 82.82 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.442 -175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.08 46.26 16.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.232 1.413 . . . . 0.0 111.82 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.98 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.81 36.18 3.68 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.367 0.417 . . . . 0.0 113.769 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.49 143.54 4.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 117.005 0.402 . . . . 0.0 111.8 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' D' ' 16' ' ' GLN . . . -106.14 115.09 61.71 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.958 2.103 . . . . 0.0 112.402 -174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.88 133.2 21.3 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.383 0.815 . . . . 0.0 112.439 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.14 28.42 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 168.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' D' ' 70' ' ' LYS . 26.3 t80 -106.78 141.96 23.97 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.478 -167.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 50.1 Cg_endo -75.99 175.53 11.2 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.458 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.05 62.25 2.77 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.384 1.474 . . . . 0.0 111.554 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.01 144.85 42.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.063 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.483 ' O ' HG13 ' E' ' 122' ' ' VAL . 8.9 tm0? -101.91 -63.53 1.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.26 159.27 2.01 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.773 1.273 . . . . 0.0 111.094 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.61 117.57 17.2 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.968 -164.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.13 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.373 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.85 123.05 48.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' E' ' 117' ' ' GLU . 0.2 OUTLIER -125.73 134.66 66.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 10.5 p -137.43 109.26 7.1 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -166.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -105.94 121.09 6.61 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.784 . . . . 0.0 113.241 -178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.75 ' HA ' HG22 ' D' ' 59' ' ' VAL . 10.6 tt0 -101.29 105.93 17.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' D' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.24 50.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.684 0.755 . . . . 0.0 110.158 -174.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.437 ' H ' ' CZ ' ' D' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.56 7.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.734 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.486 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.59 35.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.211 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.56 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 155.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.444 ' CG ' ' H ' ' D' ' 52' ' ' ARG . 2.9 tt0 -65.82 -33.34 75.62 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.18 22.49 4.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.627 1.571 . . . . 0.0 111.619 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.2 61.12 2.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.502 1.521 . . . . 0.0 111.568 -164.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.75 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.501 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.87 30.09 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.77 1.26 Allowed Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.2 mmp_? -110.12 23.58 14.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.858 HG13 HG22 ' E' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.65 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.943 178.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.693 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER -104.82 22.68 14.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 176.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.734 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -94.47 161.15 23.92 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.683 0.601 . . . . 0.0 113.957 -170.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.89 51.05 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.74 29.36 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.539 0.685 . . . . 0.0 110.537 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' D' ' 40' ' ' GLU . 2.9 t -123.63 128.69 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.34 117.5 27.93 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . 0.497 ' HB3' ' HG2' ' D' ' 133' ' ' GLN . 60.3 p -143.04 146.53 33.92 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.981 0.913 . . . . 0.0 110.063 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.12 156.11 24.26 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.161 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.1 OUTLIER -121.85 151.17 40.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 174.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.62 ' HB ' HG12 ' D' ' 130' ' ' ILE . 46.1 t -132.98 123.64 48.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 74.4 p -112.96 140.65 47.59 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.18 169.21 24.66 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.34 119.82 38.57 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.42 130.75 21.41 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.8 mttm -92.98 153.74 18.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.404 HH21 ' HD2' ' D' ' 71' ' ' ARG . 0.0 OUTLIER -46.14 -50.58 15.36 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -172.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.86 99.39 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.51 49.65 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.143 1.377 . . . . 0.0 111.009 169.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.57 -37.28 63.0 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.519 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -61.64 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.886 168.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -47.45 84.4 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.142 -0.622 . . . . 0.0 111.865 171.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.18 69.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.778 171.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.84 86.29 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.878 168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.569 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.082 0.468 . . . . 0.0 110.461 172.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 6.6 mm-40 -62.5 -49.18 76.39 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.741 -0.599 . . . . 0.0 112.439 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 63.7 m-20 -64.5 -32.52 74.19 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.571 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -55.21 -59.55 4.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.572 174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.444 ' HB3' ' NH2' ' D' ' 116' ' ' ARG . 11.4 t80 -78.44 -48.33 15.64 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.369 -0.533 . . . . 0.0 111.913 -174.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.0 OUTLIER -76.98 -34.82 57.51 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.2 26.18 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.01 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.24 1.32 Allowed Glycine 0 N--CA 1.449 -0.441 0 O-C-N 122.37 -0.206 . . . . 0.0 112.855 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.2 156.56 48.17 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' D' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.59 24.71 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -121.06 142.56 36.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.325 0.583 . . . . 0.0 109.857 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.626 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.8 mtmt -72.36 136.0 46.03 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.548 1.139 . . . . 0.0 109.984 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.685 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 10.6 m95 -129.02 129.93 45.97 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.202 1.001 . . . . 0.0 108.326 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.55 16.66 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -124.92 168.08 18.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.238 1.018 . . . . 0.0 109.379 -173.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' D' ' 11' ' ' VAL . 1.0 OUTLIER -107.98 138.81 43.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.663 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' D' ' 150' ' ' ILE . 63.2 p -69.81 -29.75 67.11 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.674 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.85 131.86 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.716 0.77 . . . . 0.0 109.883 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . 0.424 ' HA ' ' CE1' ' D' ' 104' ' ' TYR . 0.0 OUTLIER -63.4 132.95 53.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.949 -174.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.621 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -74.59 139.92 44.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.804 0.812 . . . . 0.0 109.992 171.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.49 -21.89 35.32 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' D' ' 99' ' ' ASN . 11.7 m120 -126.87 24.77 6.43 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.899 169.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 30.7 t0 -153.4 170.93 19.49 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 1.024 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -56.01 -62.38 1.74 Allowed 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.849 -0.532 . . . . 0.0 110.636 171.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.601 ' CE2' HG22 ' D' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.51 5.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.621 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.3 p-10 -123.88 139.92 53.49 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.582 0.706 . . . . 0.0 109.479 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.869 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.49 160.22 40.36 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.107 -163.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.544 ' CD ' ' HE3' ' D' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.45 53.82 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.34 148.26 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.421 0.688 . . . . 0.0 110.426 -163.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.28 -178.47 39.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.939 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.71 55.53 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.443 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -131.01 161.58 31.66 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.913 0.863 . . . . 0.0 111.196 -169.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.656 ' HB2' HD22 ' C' ' 54' ' ' LEU . 2.1 t80 -128.25 162.66 26.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.509 -1.223 . . . . 0.0 107.989 -174.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.412 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 0.9 OUTLIER -63.89 -42.95 97.35 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 177.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 11.6 t -156.71 158.73 37.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.934 0.788 . . . . 0.0 109.124 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.685 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 147.03 49.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 6.1 tm-20 -135.96 132.65 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -125.63 118.86 26.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.094 0.473 . . . . 0.0 111.193 176.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.88 130.06 55.42 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.655 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -116.07 120.75 40.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.6 162.45 13.33 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.533 HG13 ' O ' ' C' ' 32' ' ' GLN . 17.3 m -71.32 -32.75 48.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 122.5 -0.412 . . . . 0.0 111.12 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.8 17.05 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.7 34.52 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' C' ' 6' ' ' ILE . . . -138.11 162.62 33.73 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.567 0.698 . . . . 0.0 110.757 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 7.2 m -53.14 135.92 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.049 -171.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.17 128.01 45.45 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.111 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.82 66.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . 0.656 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 2.9 t -108.02 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.685 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.2 pt -117.12 128.58 74.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 2.2 m -115.54 140.54 49.07 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.764 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.2 pp -144.14 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.12 -172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.669 HE22 HD12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -102.88 161.09 14.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 167.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' D' ' 110' ' ' PHE . 80.3 t -139.92 158.79 26.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.803 HG22 HG13 ' C' ' 53' ' ' ILE . 6.4 pt -101.22 26.27 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.27 0.557 . . . . 0.0 110.294 -173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.725 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . 0.53 ' HG3' HG11 ' D' ' 134' ' ' VAL . 27.2 mt-10 -81.9 137.23 35.24 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 122.027 0.918 . . . . 0.0 110.64 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -118.83 154.89 32.14 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.544 ' HE3' ' CD ' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -100.31 140.24 34.84 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -177.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -100.88 141.86 15.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.418 169.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -83.9 128.24 34.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 1.024 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.764 -176.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.973 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.601 HG22 ' CE2' ' D' ' 104' ' ' TYR . 0.9 OUTLIER -63.7 -43.9 95.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.73 -0.653 . . . . 0.0 112.399 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.11 63.38 7.66 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.463 1.905 . . . . 0.0 109.361 -173.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.4 Cg_exo -68.59 -5.61 15.72 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.241 1.294 . . . . 0.0 115.364 -159.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.64 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.555 171.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.98 1.13 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' D' ' 96' ' ' THR . 3.9 mp -60.05 -52.86 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.128 0.876 . . . . 0.0 111.281 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 51.6 t -69.04 -49.01 66.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.8 t-20 -106.13 107.17 18.04 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.429 -176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.56 3.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.58 159.5 14.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.8 -0.08 29.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.5 -4.23 76.25 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 113.056 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.86 139.86 23.36 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.13 151.2 46.46 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.321 1.048 . . . . 0.0 108.635 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.4 -54.83 42.55 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.6 ' CD2' HD13 ' J' ' 143' ' ' ILE . 1.4 p90 -146.51 162.36 38.48 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.653 2.381 . . . . 0.0 109.133 167.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' D' ' 165' ' ' GLN . 15.3 mt-30 -144.03 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.548 ' HB2' ' HD2' ' D' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.08 0.15 Allowed Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -77.17 7.46 3.68 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.107 1.788 . . . . 0.0 113.858 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.23 84.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 118.372 2.109 . . . . 0.0 118.372 -171.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' D' ' 163' ' ' PRO . 3.8 mp0 -100.62 68.34 1.33 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.907 1.353 . . . . 0.0 110.91 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.616 ' O ' ' HB ' ' D' ' 173' ' ' THR . 94.5 m 26.71 73.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.825 1.65 . . . . 0.0 111.908 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.5 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -96.79 161.61 13.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.31 -167.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.491 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -138.82 -154.14 6.34 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.495 172.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -23.44 64.61 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.785 0.293 . . . . 0.0 111.405 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -77.45 161.71 71.4 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.458 0.703 . . . . 0.0 109.255 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 84.6 Cg_endo -84.91 -9.59 8.68 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.335 1.357 . . . . 0.0 112.689 -156.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.44 101.46 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 117.206 1.642 . . . . 0.0 117.206 165.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' D' ' 166' ' ' THR . 0.2 OUTLIER -94.43 163.7 13.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.027 0.913 . . . . 0.0 109.902 170.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.39 167.21 13.9 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.405 178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.513 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -72.99 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.51 0.861 . . . . 0.0 111.736 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.453 1.501 . . . . 0.0 112.284 -171.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.102 -3.845 . . . . 0.0 102.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -80.11 131.88 33.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.54 16.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.894 0.854 . . . . 0.0 110.748 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -33.41 87.18 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.494 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . 0.547 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 3.2 mm-40 -80.2 -18.37 49.77 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.774 0.787 . . . . 0.0 112.377 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' E' ' 6' ' ' ILE . 1.1 t70 -67.52 -43.33 81.05 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -172.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.404 HG22 ' OD1' ' E' ' 95' ' ' ASP . 44.4 t -92.4 116.32 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.57 156.6 38.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.727 0.775 . . . . 0.0 110.476 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.6 m-85 -120.96 122.78 40.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -117.85 148.43 42.13 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.64 48.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 109.944 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.558 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 6.3 tt0 -123.71 126.72 47.05 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' E' ' 89' ' ' ILE . 56.5 p -71.45 147.86 47.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.018 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.618 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -70.59 -44.3 76.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.981 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.56 -23.68 58.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.19 -46.51 82.79 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.438 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.02 46.26 16.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.219 1.408 . . . . 0.0 111.812 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.99 161.37 15.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.87 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.354 0.409 . . . . 0.0 113.747 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.57 4.13 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' E' ' 16' ' ' GLN . . . -106.14 115.03 61.82 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.009 2.123 . . . . 0.0 112.425 -174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.89 133.15 21.19 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.412 0.826 . . . . 0.0 112.493 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.12 28.42 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' E' ' 70' ' ' LYS . 26.4 t80 -106.68 141.93 23.87 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.567 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . 0.513 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -76.0 175.57 11.15 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 CA-C-O 121.824 0.677 . . . . 0.0 112.445 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.01 62.28 2.76 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.342 1.457 . . . . 0.0 111.543 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.81 42.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.51 1.147 . . . . 0.0 111.076 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.92 -63.45 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.32 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.755 1.265 . . . . 0.0 111.114 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.101 -1.408 . . . . 0.0 108.019 -164.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.08 5.42 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.361 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.82 123.09 48.31 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' F' ' 117' ' ' GLU . 0.2 OUTLIER -125.68 134.71 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . 0.479 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 10.6 p -137.52 109.19 7.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -105.95 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.222 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' E' ' 59' ' ' VAL . 10.5 tt0 -101.36 105.93 17.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' E' ' 41' ' ' ARG . 0.1 OUTLIER -71.16 144.24 50.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.651 0.738 . . . . 0.0 110.15 -174.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.435 ' H ' ' CZ ' ' E' ' 41' ' ' ARG . 18.7 mt-10 -126.27 175.53 7.75 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 -167.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.743 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.2 OUTLIER -65.41 139.51 58.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.556 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.79 128.6 35.33 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.235 171.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 109.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' E' ' 52' ' ' ARG . 2.9 tt0 -65.76 -33.39 75.76 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.52 4.41 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.59 1.556 . . . . 0.0 111.665 -172.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.16 61.18 2.05 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.521 1.529 . . . . 0.0 111.539 -164.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.58 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.49 -177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.11 13.85 30.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.55 80.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.2 mmp_? -110.15 23.58 14.14 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.845 HG13 HG22 ' F' ' 135' ' ' ILE . 0.9 OUTLIER -123.86 3.63 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.874 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.819 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -104.82 22.66 14.77 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . 0.743 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -94.43 161.14 23.96 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 121.691 0.606 . . . . 0.0 113.922 -170.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.37 155.93 50.73 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.97 -176.69 29.32 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.546 0.689 . . . . 0.0 110.523 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.743 HG22 ' HA ' ' E' ' 40' ' ' GLU . 2.9 t -123.54 128.78 74.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.59 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.43 117.5 27.88 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . 0.512 ' HB3' ' HG2' ' E' ' 133' ' ' GLN . 60.2 p -142.99 146.52 33.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.926 0.89 . . . . 0.0 110.015 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.14 24.29 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.168 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.19 40.93 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' E' ' 130' ' ' ILE . 45.7 t -132.98 123.59 48.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 73.9 p -112.94 140.66 47.56 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.18 169.2 24.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -99.31 119.82 38.56 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.34 130.76 21.62 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 114.946 0.739 . . . . 0.0 114.946 -175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.8 mttm -93.05 153.79 18.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -46.17 -50.5 15.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.38 0.18 Allowed Glycine 0 N--CA 1.453 -0.203 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.93 155.56 49.58 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.153 1.381 . . . . 0.0 111.029 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.64 -37.24 62.81 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -61.62 -40.31 98.56 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.876 168.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -47.55 83.99 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 122.144 -0.621 . . . . 0.0 111.832 171.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.18 69.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.19 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.874 168.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.571 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.9 mm -59.57 -43.03 90.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.072 0.463 . . . . 0.0 110.448 172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 6.6 mm-40 -62.54 -49.18 76.35 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.73 -0.606 . . . . 0.0 112.422 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 63.7 m-20 -64.47 -32.61 74.31 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.544 169.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.833 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -55.15 -59.58 4.57 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.566 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.449 ' HB3' ' NH2' ' E' ' 116' ' ' ARG . 11.3 t80 -78.48 -48.23 15.78 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.597 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.0 OUTLIER -77.02 -34.81 57.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 34.4 t30 -83.31 -33.09 26.01 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.004 172.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.21 1.31 Allowed Glycine 0 N--CA 1.449 -0.45 0 O-C-N 122.296 -0.252 . . . . 0.0 112.845 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.833 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.17 156.48 48.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.495 ' O ' HG12 ' E' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.58 24.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.433 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -121.03 142.53 36.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.328 0.585 . . . . 0.0 109.882 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.8 mtmt -72.32 135.98 46.08 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.35 41.98 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.503 1.121 . . . . 0.0 109.984 -165.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 10.6 m95 -129.01 129.97 46.03 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.54 16.61 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -124.87 168.03 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 122.277 1.036 . . . . 0.0 109.404 -173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.404 ' OD1' HG22 ' E' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.79 43.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.608 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.616 HG22 HG23 ' E' ' 150' ' ' ILE . 62.8 p -69.85 -29.7 67.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.619 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.9 131.77 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.89 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' CE1' ' E' ' 104' ' ' TYR . 0.0 OUTLIER -63.32 132.96 53.28 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.953 -174.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.99 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.851 0.834 . . . . 0.0 109.898 171.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.58 -21.88 35.06 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . 0.464 ' H ' HD22 ' E' ' 99' ' ' ASN . 11.6 m120 -126.82 24.67 6.47 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.839 169.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 30.7 t0 -153.33 171.0 19.28 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.974 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.4 1.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.906 -0.496 . . . . 0.0 110.577 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.606 ' CE2' HG22 ' E' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.3 p-10 -123.9 139.96 53.45 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.6 0.714 . . . . 0.0 109.412 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.52 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.104 -163.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' E' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.48 53.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 157.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.27 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.396 0.678 . . . . 0.0 110.404 -163.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.3 -178.52 39.62 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.467 -1.349 . . . . 0.0 111.982 170.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.5 m-30 -109.37 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.44 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -131.05 161.63 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.167 -169.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.689 ' HB2' HD22 ' D' ' 54' ' ' LEU . 2.1 t80 -128.25 162.62 26.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.977 -174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.414 ' H ' HD12 ' E' ' 113' ' ' ILE . 0.3 OUTLIER -96.78 86.76 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.447 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.97 97.43 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.76 37.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.921 0.782 . . . . 0.0 109.109 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.97 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 6.1 tm-20 -135.89 132.63 36.78 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' E' ' 116' ' ' ARG . 0.1 OUTLIER -125.66 118.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 111.194 176.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.85 130.1 55.41 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.643 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 167.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.46 13.33 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.52 ' HA ' HE22 ' D' ' 9' ' ' GLN . 17.3 m -71.32 -32.82 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 122.503 -0.41 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.81 17.03 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.65 -151.72 34.52 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -138.08 162.6 33.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.586 0.707 . . . . 0.0 110.755 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.489 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 7.3 m -53.16 135.9 14.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.055 -171.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.1 128.03 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.62 126.87 66.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 2.9 t -108.0 115.43 30.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.683 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.2 pt -117.17 128.63 74.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 2.2 m -115.6 140.62 49.01 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.356 0.662 . . . . 0.0 109.74 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.3 pp -144.2 147.35 33.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.084 -172.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.515 HE22 HD12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -102.86 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 167.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' E' ' 110' ' ' PHE . 82.3 t -139.84 158.77 26.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.858 HG22 HG13 ' D' ' 53' ' ' ILE . 6.4 pt -101.17 26.3 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.315 0.579 . . . . 0.0 110.382 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.97 93.33 1.21 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.743 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.525 ' HG3' HG11 ' E' ' 134' ' ' VAL . 27.2 mt-10 -81.87 137.17 35.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.033 0.921 . . . . 0.0 110.672 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' E' ' 107' ' ' GLN . 0.0 OUTLIER -118.78 154.88 32.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 -174.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' E' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.28 34.81 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.369 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.892 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.5 tp10 -83.91 128.21 34.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.974 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.2 OUTLIER -91.91 -44.88 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.806 -176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.59 110.88 20.12 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.946 -176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.606 HG22 ' CE2' ' E' ' 104' ' ' TYR . 0.9 OUTLIER -63.64 -43.98 95.22 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.18 63.28 7.72 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.441 1.897 . . . . 0.0 109.416 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.49 15.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.248 1.299 . . . . 0.0 115.326 -159.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.83 -37.78 85.75 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.576 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.87 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -173.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.616 HG23 HG22 ' E' ' 96' ' ' THR . 3.9 mp -60.04 -52.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.1 0.864 . . . . 0.0 111.271 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 51.4 t -68.99 -49.05 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.7 t-20 -106.14 107.19 18.07 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.465 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.62 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -78.67 -0.18 29.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.54 -4.2 76.08 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 119.417 1.008 . . . . 0.0 113.036 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.87 23.41 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -139.16 151.16 46.39 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.379 1.072 . . . . 0.0 108.649 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.33 -54.89 41.92 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.555 ' HD2' ' HB2' ' E' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.734 2.413 . . . . 0.0 109.157 167.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.401 ' OE1' ' HB2' ' E' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.67 2.06 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 153.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.556 ' HA ' HE22 ' K' ' 16' ' ' GLN . 3.9 tt0 -110.07 -25.14 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.618 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.62 3.62 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.018 1.756 . . . . 0.0 113.89 171.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.11 84.44 0.66 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.384 2.114 . . . . 0.0 118.384 -171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.618 HE22 ' HD2' ' E' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.3 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.889 1.344 . . . . 0.0 110.917 175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' E' ' 173' ' ' THR . 94.4 m 26.74 73.12 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.833 1.653 . . . . 0.0 111.934 176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.515 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -96.82 161.67 13.76 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.31 -167.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.89 -154.13 6.33 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.491 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.48 -23.42 64.57 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.83 0.315 . . . . 0.0 111.378 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -77.43 161.72 71.39 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.304 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.4 Cg_endo -84.82 -9.59 8.77 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.313 1.342 . . . . 0.0 112.771 -156.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.53 101.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' E' ' 166' ' ' THR . 0.2 OUTLIER -94.5 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.982 0.891 . . . . 0.0 109.898 170.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.36 167.19 13.92 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.406 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.41 3.04 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.489 0.853 . . . . 0.0 111.739 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.429 1.492 . . . . 0.0 112.355 -171.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.492 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 102.088 -3.851 . . . . 0.0 102.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.623 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 4.6 mt -80.08 131.85 33.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.51 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.875 0.845 . . . . 0.0 110.767 -177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.26 -33.36 87.03 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.531 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . 0.587 HE22 ' HA ' ' A' ' 122' ' ' VAL . 3.3 mm-40 -80.17 -18.42 49.74 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.775 0.788 . . . . 0.0 112.41 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.407 ' HB3' HG22 ' F' ' 6' ' ' ILE . 1.1 t70 -67.56 -43.3 81.0 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.4 116.3 33.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.52 156.57 38.81 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.686 0.755 . . . . 0.0 110.526 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.4 m-85 -120.92 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.761 -164.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -117.94 148.42 42.2 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.51 143.74 48.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.659 . . . . 0.0 109.914 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 6.3 tt0 -123.83 126.68 46.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . 0.406 ' HA ' HD13 ' F' ' 89' ' ' ILE . 56.6 p -71.45 147.83 47.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.046 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -70.6 -44.25 76.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.0 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -74.59 -23.61 58.76 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.58 82.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.409 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.13 46.23 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.228 1.411 . . . . 0.0 111.791 -173.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.07 161.32 16.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.82 36.2 3.67 Favored Glycine 0 N--CA 1.45 -0.394 0 O-C-N 123.363 0.415 . . . . 0.0 113.702 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.51 143.6 4.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.994 0.397 . . . . 0.0 111.802 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' F' ' 16' ' ' GLN . . . -106.17 115.03 61.78 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.983 2.113 . . . . 0.0 112.416 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.17 21.31 Favored 'Trans proline' 0 C--N 1.35 0.61 0 CA-C-N 119.41 0.825 . . . . 0.0 112.508 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.82 155.07 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.523 ' HZ ' ' H ' ' F' ' 70' ' ' LYS . 26.4 t80 -106.69 141.98 23.99 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.531 -167.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 49.5 Cg_endo -76.07 175.58 11.14 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.838 0.683 . . . . 0.0 112.423 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.99 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.329 1.451 . . . . 0.0 111.591 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.94 144.84 43.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.517 1.151 . . . . 0.0 111.081 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 122' ' ' VAL . 9.0 tm0? -101.92 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.24 159.32 2.03 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.55 17.14 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.982 -164.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.06 121.06 5.41 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.362 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.77 123.06 48.28 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -125.67 134.71 66.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.17 7.03 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -166.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -105.93 121.05 6.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.239 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . 0.749 ' HA ' HG22 ' F' ' 59' ' ' VAL . 10.5 tt0 -101.26 105.92 17.06 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' F' ' 41' ' ' ARG . 0.1 OUTLIER -71.13 144.31 50.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.778 0.799 . . . . 0.0 110.172 -174.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' F' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.53 7.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -167.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.767 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.2 OUTLIER -65.48 139.56 58.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.483 -179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.64 35.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.201 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 16.8 t0 73.53 109.96 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 155.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' F' ' 52' ' ' ARG . 2.9 tt0 -65.86 -33.35 75.63 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 176.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.14 22.51 4.42 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.625 1.57 . . . . 0.0 111.66 -172.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.24 61.09 2.09 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.539 1.536 . . . . 0.0 111.533 -164.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.73 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.0 13.78 30.39 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.91 1.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.69 13.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.487 HG13 HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -123.94 3.66 5.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.841 178.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.523 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -104.86 22.61 14.89 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 176.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . 0.767 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -94.43 161.21 24.0 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 121.7 0.611 . . . . 0.0 113.949 -170.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.38 155.95 50.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.03 -176.73 29.41 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.31 13.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.607 0.718 . . . . 0.0 110.503 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' F' ' 40' ' ' GLU . 2.9 t -123.55 128.68 74.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.082 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.9 29.42 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.56 28.05 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -171.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' F' ' 133' ' ' GLN . 60.2 p -143.05 146.47 33.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.949 0.9 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.08 156.13 24.25 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.166 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.1 OUTLIER -121.86 151.21 40.91 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' F' ' 130' ' ' ILE . 46.1 t -133.03 123.59 48.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 73.8 p -112.92 140.7 47.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.21 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.37 119.79 38.53 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.49 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.523 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.8 mttm -93.05 153.75 18.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.06 -50.57 15.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.93 99.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.84 155.59 49.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.117 1.367 . . . . 0.0 111.039 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.61 -37.17 62.91 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.509 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -61.67 -40.32 98.6 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.805 168.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.5 84.16 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.167 -0.607 . . . . 0.0 111.861 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 9.6 mtmp? -63.41 -28.16 69.79 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.788 171.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.82 86.2 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.917 168.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.564 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.9 mm -59.59 -43.01 90.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-O 121.073 0.464 . . . . 0.0 110.439 172.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 6.6 mm-40 -62.55 -49.13 76.51 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.711 -0.618 . . . . 0.0 112.426 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 63.8 m-20 -64.47 -32.62 74.32 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.539 169.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.825 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -55.15 -59.57 4.59 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.561 174.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 11.3 t80 -78.46 -48.27 15.73 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.894 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.88 57.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -167.008 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 34.4 t30 -83.21 -33.14 26.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.053 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.65 76.19 1.31 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.352 -0.217 . . . . 0.0 112.869 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.825 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.13 156.55 48.22 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' F' ' 18' ' ' ILE . 0.0 OUTLIER -87.68 148.54 24.74 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -121.06 142.53 36.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.314 0.578 . . . . 0.0 109.865 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.8 mtmt -72.32 136.0 46.08 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.39 42.09 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.489 1.116 . . . . 0.0 109.967 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 10.6 m95 -129.02 129.97 46.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -124.94 168.02 18.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.261 1.029 . . . . 0.0 109.396 -173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -108.02 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.664 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.607 HG22 HG23 ' F' ' 150' ' ' ILE . 63.6 p -69.69 -29.79 67.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.669 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.81 131.83 31.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.688 0.756 . . . . 0.0 109.896 176.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . 0.421 ' HA ' ' CE1' ' F' ' 104' ' ' TYR . 0.0 OUTLIER -63.37 132.93 53.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.99 -174.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -74.6 139.94 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.795 0.807 . . . . 0.0 109.975 171.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' F' ' 99' ' ' ASN . 11.7 m120 -126.79 24.71 6.48 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.765 0.711 . . . . 0.0 110.888 169.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 30.7 t0 -153.35 170.95 19.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.982 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -56.05 -62.37 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.899 -0.5 . . . . 0.0 110.586 171.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.605 ' CE2' HG22 ' F' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.55 5.92 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.626 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.89 53.52 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.603 0.716 . . . . 0.0 109.444 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.48 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.044 -163.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.549 ' CD ' ' HE3' ' F' ' 139' ' ' LYS . 39.1 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.36 148.3 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.679 . . . . 0.0 110.454 -163.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.31 -178.53 39.63 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.98 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.5 m-30 -109.35 129.72 55.52 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -131.06 161.61 31.64 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.898 0.856 . . . . 0.0 111.132 -169.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.536 ' HB2' HD22 ' E' ' 54' ' ' LEU . 2.1 t80 -128.22 162.66 26.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.999 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.76 86.78 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 0.9 OUTLIER -63.82 -42.97 97.54 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.72 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.946 0.794 . . . . 0.0 109.112 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.667 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.96 49.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.671 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 6.1 tm-20 -135.83 132.65 36.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' F' ' 116' ' ' ARG . 0.1 OUTLIER -125.6 118.8 26.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.011 0.434 . . . . 0.0 111.23 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.09 55.4 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.661 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.79 40.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.45 13.36 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . 0.423 ' HA ' HE22 ' E' ' 9' ' ' GLN . 17.2 m -71.3 -32.84 48.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.492 -0.417 . . . . 0.0 111.056 176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.9 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.72 34.64 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 166.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -138.09 162.65 33.63 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.635 0.731 . . . . 0.0 110.739 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' E' ' 6' ' ' ILE . 7.3 m -53.23 135.94 14.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.062 -171.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.14 128.0 45.47 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.124 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.58 126.87 66.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . 0.671 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 2.9 t -108.0 115.45 30.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.2 pt -117.16 128.66 74.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 2.2 m -115.66 140.61 49.03 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.339 0.655 . . . . 0.0 109.726 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.2 pp -144.22 147.3 33.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.075 -172.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.54 HE22 HD12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -102.75 161.07 14.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' F' ' 110' ' ' PHE . 80.9 t -139.88 158.8 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.845 HG22 HG13 ' E' ' 53' ' ' ILE . 6.4 pt -101.25 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.351 0.596 . . . . 0.0 110.345 -173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.04 93.32 1.21 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.737 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.535 ' HG3' HG11 ' F' ' 134' ' ' VAL . 27.3 mt-10 -81.87 137.14 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 122.018 0.913 . . . . 0.0 110.65 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' F' ' 107' ' ' GLN . 0.0 OUTLIER -118.74 154.93 31.98 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.549 ' HE3' ' CD ' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -100.33 140.26 34.83 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.42 -169.91 3.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -100.87 141.89 15.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.402 169.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.5 tp10 -83.88 128.21 34.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.982 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.2 OUTLIER -91.93 -44.93 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.727 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.56 110.81 20.05 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.979 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.605 HG22 ' CE2' ' F' ' 104' ' ' TYR . 0.9 OUTLIER -63.6 -43.97 95.34 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.716 -0.659 . . . . 0.0 112.377 175.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.4 7.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.482 1.913 . . . . 0.0 109.373 -173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.613 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.7 -5.51 15.58 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.191 1.261 . . . . 0.0 115.319 -159.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.76 85.63 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.592 171.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.93 1.14 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.607 HG23 HG22 ' F' ' 96' ' ' THR . 3.9 mp -60.13 -52.87 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.135 0.88 . . . . 0.0 111.251 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 51.5 t -68.93 -49.11 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.23 18.13 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.421 -176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.61 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 171.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.61 159.5 14.96 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.14 29.19 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.27 76.09 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 119.347 0.976 . . . . 0.0 113.041 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.596 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -77.84 139.91 23.44 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.17 151.19 46.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.294 1.037 . . . . 0.0 108.596 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.85 42.32 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -158.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.917 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -146.49 162.33 38.53 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.731 2.412 . . . . 0.0 109.179 167.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.633 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 15.4 mt-30 -143.96 89.61 2.06 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 154.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.561 ' HB2' ' HD2' ' F' ' 160' ' ' PHE . 3.9 tt0 -110.06 -25.07 0.15 Allowed Pre-proline 0 C--O 1.24 0.583 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.687 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.3 Cg_exo -77.22 7.59 3.64 Favored 'Trans proline' 0 C--O 1.238 0.519 0 CA-C-N 122.039 1.764 . . . . 0.0 113.857 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.19 84.45 0.67 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' F' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.3 1.32 Allowed 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.888 1.344 . . . . 0.0 110.92 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' F' ' 173' ' ' THR . 94.7 m 26.7 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.8 1.64 . . . . 0.0 111.902 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.54 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -96.79 161.64 13.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.342 -167.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.801 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -138.85 -154.18 6.34 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.474 172.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -68.39 -23.45 64.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.781 0.29 . . . . 0.0 111.445 -177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -77.43 161.7 71.47 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.482 0.713 . . . . 0.0 109.248 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 86.3 Cg_endo -84.86 -9.52 8.76 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.268 1.312 . . . . 0.0 112.779 -156.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.214 1.646 . . . . 0.0 117.214 165.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' F' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.68 13.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.997 0.898 . . . . 0.0 109.876 170.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.35 167.23 13.82 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.378 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.529 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.46 3.05 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.497 0.856 . . . . 0.0 111.729 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.411 1.484 . . . . 0.0 112.309 -171.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.505 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 102.09 -3.85 . . . . 0.0 102.09 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.679 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 4.5 mt -80.1 131.83 33.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 165.45 16.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.896 0.855 . . . . 0.0 110.766 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -33.45 87.29 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.516 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' H' ' 122' ' ' VAL . 3.3 mm-40 -80.18 -18.44 49.63 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 117.782 0.791 . . . . 0.0 112.367 172.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.56 -43.28 81.04 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' G' ' 95' ' ' ASP . 44.2 t -92.41 116.36 33.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.62 156.65 38.86 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.698 0.761 . . . . 0.0 110.489 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.74 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -164.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.704 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -117.91 148.46 42.14 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.73 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.517 0.675 . . . . 0.0 109.937 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 6.3 tt0 -123.75 126.66 46.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 170.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . 0.413 ' HA ' HD13 ' G' ' 89' ' ' ILE . 57.0 p -71.42 147.82 47.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.525 0.679 . . . . 0.0 111.056 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.607 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.009 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -74.54 -23.7 58.84 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.57 82.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.429 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.21 16.5 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.0 161.36 15.94 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -90.86 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.709 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.53 143.59 4.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.395 . . . . 0.0 111.802 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' G' ' 16' ' ' GLN . . . -106.16 115.09 61.7 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 126.976 2.11 . . . . 0.0 112.384 -174.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.95 133.18 21.14 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.409 0.825 . . . . 0.0 112.492 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.77 155.09 28.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.518 ' HZ ' ' H ' ' G' ' 70' ' ' LYS . 26.5 t80 -106.74 141.98 24.0 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.531 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.6 Cg_endo -76.03 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.877 0.699 . . . . 0.0 112.427 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.93 62.29 2.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.393 1.477 . . . . 0.0 111.575 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.99 144.9 42.92 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.576 1.179 . . . . 0.0 111.06 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.54 1.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.29 2.02 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.778 1.275 . . . . 0.0 111.08 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.54 17.13 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.987 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.07 121.05 5.41 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.366 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 44.2 m -114.84 123.01 48.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.67 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . 0.542 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 10.4 p -137.48 109.21 7.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -105.96 121.04 6.59 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.286 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' G' ' 59' ' ' VAL . 10.5 tt0 -101.23 105.89 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' G' ' 41' ' ' ARG . 0.1 OUTLIER -71.18 144.28 50.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.732 0.777 . . . . 0.0 110.162 -174.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . 0.442 ' H ' ' CZ ' ' G' ' 41' ' ' ARG . 18.7 mt-10 -126.25 175.55 7.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.769 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.2 OUTLIER -65.54 139.57 58.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.518 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.249 171.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.63 109.88 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' G' ' 52' ' ' ARG . 2.9 tt0 -65.75 -33.38 75.74 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.17 22.47 4.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.574 1.55 . . . . 0.0 111.667 -172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.558 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.6 OUTLIER 42.24 61.16 2.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.486 1.515 . . . . 0.0 111.526 -164.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.83 -127.54 0.29 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.498 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.05 13.83 30.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.51 80.9 1.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.1 mmp_? -110.19 23.52 14.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.62 HG13 HG22 ' H' ' 135' ' ' ILE . 0.9 OUTLIER -123.83 3.59 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.857 178.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.707 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -104.77 22.63 14.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 176.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . 0.769 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -94.46 161.17 23.95 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-O 121.628 0.571 . . . . 0.0 113.968 -170.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.31 155.89 51.03 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.96 -176.7 29.33 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.73 172.28 13.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.516 0.674 . . . . 0.0 110.536 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' G' ' 40' ' ' GLU . 2.9 t -123.57 128.72 74.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.048 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.53 114.92 29.47 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.55 28.01 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' G' ' 133' ' ' GLN . 60.2 p -143.05 146.51 33.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.912 0.885 . . . . 0.0 110.025 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.13 156.12 24.27 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.152 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.18 40.95 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' G' ' 130' ' ' ILE . 45.9 t -132.99 123.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.96 140.68 47.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.17 169.28 24.52 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.81 38.55 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.72 21.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.518 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.8 mttm -93.0 153.82 18.5 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.16 -50.58 15.42 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.37 0.18 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.94 155.6 49.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.079 1.352 . . . . 0.0 111.018 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HZ1' ' G' ' 77' ' ' LYS . . . -74.69 -37.15 62.73 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.523 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -61.68 -40.3 98.57 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.814 168.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -62.23 -47.42 84.48 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 122.172 -0.605 . . . . 0.0 111.843 171.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.529 ' HZ1' ' HA ' ' G' ' 74' ' ' ALA . 9.6 mtmp? -63.49 -28.1 69.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.79 85.88 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.886 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.57 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.9 mm -59.55 -43.07 90.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.093 0.473 . . . . 0.0 110.498 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.18 76.42 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.763 -0.585 . . . . 0.0 112.494 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 63.4 m-20 -64.36 -32.65 74.35 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.622 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.815 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -55.16 -59.54 4.63 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.504 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 11.2 t80 -78.49 -48.29 15.64 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.926 -174.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.81 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -167.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 34.4 t30 -83.25 -33.11 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.051 172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.59 76.18 1.31 Allowed Glycine 0 N--CA 1.449 -0.461 0 O-C-N 122.34 -0.225 . . . . 0.0 112.885 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.815 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.15 156.47 48.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.5 ' O ' HG12 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -87.6 148.6 24.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.426 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -121.09 142.52 36.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.347 0.594 . . . . 0.0 109.799 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.8 mtmt -72.31 135.96 46.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.98 121.33 41.95 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.52 1.128 . . . . 0.0 110.018 -165.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.704 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 10.8 m95 -129.01 129.91 45.96 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.547 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 15.8 ptm180 -130.88 115.54 16.69 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -124.89 168.06 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.277 1.037 . . . . 0.0 109.37 -173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' G' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.72 43.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.633 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.618 HG22 HG23 ' G' ' 150' ' ' ILE . 62.5 p -69.82 -29.71 67.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.627 -176.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.87 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.724 0.773 . . . . 0.0 109.882 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' CE1' ' G' ' 104' ' ' TYR . 0.0 OUTLIER -63.38 132.97 53.21 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.928 -174.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.633 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.5 OUTLIER -74.64 139.96 43.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.865 0.841 . . . . 0.0 109.972 171.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.5 -21.92 35.31 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' G' ' 99' ' ' ASN . 11.7 m120 -126.8 24.67 6.48 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.903 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 30.6 t0 -153.31 170.99 19.28 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 1.027 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -62.35 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.897 -0.502 . . . . 0.0 110.571 171.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.594 ' CE2' HG22 ' G' ' 145' ' ' THR . 2.4 m-85 -143.35 -178.56 5.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.633 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.3 p-10 -123.94 139.95 53.46 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.62 0.724 . . . . 0.0 109.383 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.909 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.56 160.22 40.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.004 -163.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.55 ' CD ' ' HE3' ' G' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.51 53.77 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -132.38 148.28 52.41 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.366 0.666 . . . . 0.0 110.392 -163.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.49 39.59 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.915 170.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.655 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.5 m-30 -109.38 129.76 55.52 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 167.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -131.07 161.62 31.64 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.418 ' O ' ' CB ' ' G' ' 132' ' ' LEU . 2.1 t80 -128.22 162.66 26.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.982 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.8 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 0.9 OUTLIER -63.88 -42.97 97.36 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.77 158.77 37.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.971 0.805 . . . . 0.0 109.072 174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.662 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -134.96 146.98 49.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.63 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.408 ' CE1' ' HD2' ' G' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.86 26.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.053 0.454 . . . . 0.0 111.188 176.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.04 55.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.716 177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.01 120.69 39.94 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.58 162.42 13.33 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 121.757 0.643 . . . . 0.0 111.56 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . 0.638 ' HA ' HE22 ' L' ' 9' ' ' GLN . 17.3 m -71.27 -32.82 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.454 -0.439 . . . . 0.0 111.131 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 169.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 -151.69 34.56 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -138.1 162.6 33.77 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.583 0.706 . . . . 0.0 110.789 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.667 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 7.7 m -53.23 135.92 14.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.043 -171.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.09 128.03 45.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.101 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 10.7 mt -109.61 126.84 66.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 2.9 t -108.02 115.37 30.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.2 pt -117.11 128.66 74.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 2.2 m -115.64 140.56 49.07 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.76 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.448 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.2 pp -144.13 147.35 33.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.073 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' G' ' 62' ' ' SER . 0.0 OUTLIER -102.86 161.04 14.07 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 167.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.655 HG13 ' O ' ' G' ' 110' ' ' PHE . 79.8 t -139.81 158.84 27.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.715 HG12 ' HG ' ' L' ' 54' ' ' LEU . 6.4 pt -101.27 26.33 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.354 0.597 . . . . 0.0 110.371 -173.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.01 93.37 1.21 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.721 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . 0.521 ' HG3' HG11 ' G' ' 134' ' ' VAL . 27.2 mt-10 -81.97 137.17 35.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 122.031 0.919 . . . . 0.0 110.636 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' G' ' 107' ' ' GLN . 0.0 OUTLIER -118.73 154.96 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HE3' ' CD ' ' G' ' 107' ' ' GLN . 0.1 OUTLIER -100.4 140.23 34.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -100.87 141.87 15.54 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.37 169.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.909 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.17 34.35 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 1.027 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.87 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.816 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.57 110.83 20.08 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.953 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.594 HG22 ' CE2' ' G' ' 104' ' ' TYR . 0.9 OUTLIER -63.66 -43.97 95.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.373 175.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.2 63.33 7.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.465 1.906 . . . . 0.0 109.362 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.52 15.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.257 1.305 . . . . 0.0 115.344 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.84 -37.71 85.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.622 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.93 -65.9 1.14 Allowed 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.618 HG23 HG22 ' G' ' 96' ' ' THR . 3.9 mp -60.12 -52.91 55.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.156 0.889 . . . . 0.0 111.255 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 52.0 t -68.9 -49.11 66.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.8 t-20 -106.09 107.14 18.0 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.445 -176.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.46 97.63 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.69 159.49 14.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.08 28.97 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.33 76.2 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.356 0.98 . . . . 0.0 113.044 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.76 139.88 23.46 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.21 151.16 46.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.289 1.036 . . . . 0.0 108.601 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.9 41.79 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . 0.554 ' HD2' ' HB2' ' G' ' 162' ' ' GLN . 1.4 p90 -146.47 162.33 38.51 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.679 2.392 . . . . 0.0 109.179 167.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.96 89.59 2.05 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . 0.554 ' HB2' ' HD2' ' G' ' 160' ' ' PHE . 3.9 tt0 -110.04 -25.05 0.15 Allowed Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -166.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.627 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -77.2 7.5 3.68 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.067 1.774 . . . . 0.0 113.882 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.26 84.38 0.67 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.627 HE22 ' HD2' ' G' ' 163' ' ' PRO . 3.8 mp0 -100.66 68.31 1.32 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.941 1.37 . . . . 0.0 110.913 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.615 ' O ' ' HB ' ' G' ' 173' ' ' THR . 94.5 m 26.79 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 111.879 175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.62 13.78 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.308 -167.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.82 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.487 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 -23.46 64.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.719 0.295 . . . . 0.0 111.444 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -77.38 161.7 71.62 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.486 0.714 . . . . 0.0 109.298 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.2 Cg_endo -84.85 -9.61 8.73 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.342 1.361 . . . . 0.0 112.742 -156.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.49 0.2 Allowed Glycine 0 C--N 1.334 0.442 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' G' ' 166' ' ' THR . 0.2 OUTLIER -94.49 163.74 13.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.87 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.496 0.856 . . . . 0.0 111.722 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.413 1.485 . . . . 0.0 112.294 -171.76 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.524 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.073 -3.857 . . . . 0.0 102.073 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 4.6 mt -80.06 131.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.65 165.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.945 0.878 . . . . 0.0 110.718 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.19 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.317 -0.856 . . . . 0.0 114.49 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . 0.591 HE22 ' HA ' ' I' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.4 49.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.806 0.803 . . . . 0.0 112.402 172.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.413 ' HB3' HG22 ' H' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.26 81.27 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.406 HG22 ' OD1' ' H' ' 95' ' ' ASP . 44.3 t -92.42 116.28 33.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.58 156.59 38.89 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.674 0.749 . . . . 0.0 110.522 176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.81 40.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.737 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.698 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.45 42.13 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.54 143.65 48.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.481 0.658 . . . . 0.0 109.999 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 6.3 tt0 -123.74 126.7 46.98 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 170.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . 0.429 ' HA ' HD13 ' H' ' 89' ' ' ILE . 56.3 p -71.45 147.84 47.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.582 0.706 . . . . 0.0 111.002 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.604 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pt -70.53 -44.32 77.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.017 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.53 -23.67 58.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.58 82.63 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.426 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.1 46.27 16.41 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.253 1.421 . . . . 0.0 111.797 -173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.04 161.3 16.03 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.527 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -90.82 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.745 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.55 143.56 4.11 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.942 0.371 . . . . 0.0 111.773 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' H' ' 16' ' ' GLN . . . -106.12 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.995 2.118 . . . . 0.0 112.44 -174.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.94 133.2 21.2 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.416 0.827 . . . . 0.0 112.496 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.09 28.52 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 26.3 t80 -106.7 141.94 23.9 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.524 -167.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . 0.513 ' HB2' ' HE3' ' H' ' 70' ' ' LYS . 50.1 Cg_endo -75.99 175.55 11.18 Favored 'Trans proline' 0 C--N 1.331 -0.354 0 CA-C-O 121.898 0.708 . . . . 0.0 112.404 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.98 62.31 2.75 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.386 1.474 . . . . 0.0 111.532 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.03 144.86 42.84 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.562 1.172 . . . . 0.0 111.028 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.95 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.29 159.33 2.01 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.795 1.283 . . . . 0.0 111.087 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.68 117.53 17.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.965 -164.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.11 121.17 5.44 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.329 170.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 43.7 m -114.88 123.04 48.15 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.72 134.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . 0.516 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 10.5 p -137.49 109.22 7.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -105.94 121.15 6.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.205 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' H' ' 59' ' ' VAL . 10.5 tt0 -101.32 105.9 17.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.481 ' NE ' ' HA ' ' H' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.3 50.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.722 0.772 . . . . 0.0 110.16 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . 0.45 ' H ' ' CZ ' ' H' ' 41' ' ' ARG . 18.7 mt-10 -126.28 175.54 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.766 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.2 OUTLIER -65.55 139.59 58.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.486 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 128.58 35.31 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.202 171.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.57 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 155.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' H' ' 52' ' ' ARG . 2.9 tt0 -65.8 -33.34 75.64 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.12 22.49 4.44 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.63 1.572 . . . . 0.0 111.69 -172.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.519 ' HB ' ' HG3' ' C' ' 9' ' ' GLN . 0.6 OUTLIER 42.18 61.13 2.06 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.499 1.52 . . . . 0.0 111.609 -164.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.59 0.29 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.48 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.09 13.88 30.11 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.42 80.89 1.28 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.2 mmp_? -110.23 23.63 14.05 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.489 HG13 HG22 ' I' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.66 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.92 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.58 14.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . 0.766 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -94.45 161.18 23.96 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.644 0.58 . . . . 0.0 113.948 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.34 155.91 50.88 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.99 -176.7 29.35 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . 0.408 ' O ' ' N ' ' H' ' 41' ' ' ARG . 0.3 OUTLIER -76.74 172.33 13.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.514 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' H' ' 40' ' ' GLU . 2.9 t -123.64 128.72 74.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.35 117.56 28.08 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' H' ' 133' ' ' GLN . 60.2 p -143.01 146.47 33.89 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.939 0.896 . . . . 0.0 110.051 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.1 156.18 24.29 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.197 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.1 OUTLIER -121.91 151.17 41.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 174.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.612 ' HB ' HG12 ' H' ' 130' ' ' ILE . 45.9 t -132.93 123.58 48.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.91 140.71 47.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -159.2 169.25 24.55 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.3 119.78 38.49 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -70.38 130.74 21.5 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 9.8 mttm -92.99 153.78 18.53 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.473 0.654 . . . . 0.0 109.277 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.17 -50.56 15.47 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.29 0.18 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.83 155.57 49.62 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.158 1.383 . . . . 0.0 111.063 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.25 62.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.467 2.395 . . . . 0.0 117.467 -156.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.521 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -61.61 -40.29 98.54 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.892 168.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -47.49 84.16 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.833 171.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.573 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 9.6 mtmp? -63.47 -28.07 69.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.794 171.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.86 86.03 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.889 168.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.566 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.9 mm -59.54 -43.04 89.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.495 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 6.6 mm-40 -62.52 -49.22 76.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 121.779 -0.576 . . . . 0.0 112.374 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 63.8 m-20 -64.46 -32.58 74.27 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.557 169.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.808 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -55.18 -59.56 4.6 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.573 174.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.542 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 11.3 t80 -78.47 -48.25 15.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.939 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.89 57.46 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 34.5 t30 -83.18 -33.14 26.26 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.042 172.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.14 1.31 Allowed Glycine 0 N--CA 1.449 -0.491 0 O-C-N 122.363 -0.211 . . . . 0.0 112.885 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.808 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.56 48.22 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.493 ' O ' HG12 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -87.64 148.56 24.76 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' H' ' 17' ' ' SER . 1.3 mm -121.06 142.59 36.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.348 0.594 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.8 mtmt -72.36 135.97 46.01 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.01 121.34 41.96 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.545 1.138 . . . . 0.0 110.004 -165.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.698 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 10.6 m95 -129.02 129.96 46.01 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.21 1.004 . . . . 0.0 108.351 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 15.8 ptm180 -130.97 115.57 16.68 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -124.95 168.04 18.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.229 1.014 . . . . 0.0 109.388 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . 0.406 ' OD1' HG22 ' H' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.73 43.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.638 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' H' ' 150' ' ' ILE . 62.6 p -69.78 -29.75 67.14 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.633 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.81 31.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.681 0.753 . . . . 0.0 109.921 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . 0.413 ' HA ' ' CE1' ' H' ' 104' ' ' TYR . 0.0 OUTLIER -63.28 132.98 53.38 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.961 -174.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.632 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.5 OUTLIER -74.62 139.98 44.0 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.853 0.835 . . . . 0.0 109.934 171.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.9 35.14 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . 0.455 ' H ' HD22 ' H' ' 99' ' ' ASN . 11.7 m120 -126.8 24.69 6.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.764 0.711 . . . . 0.0 110.897 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 30.7 t0 -153.33 171.01 19.25 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 1.008 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -56.1 -62.32 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.899 -0.501 . . . . 0.0 110.564 171.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.591 ' CE2' HG22 ' H' ' 145' ' ' THR . 2.4 m-85 -143.43 -178.55 5.93 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.632 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.3 p-10 -123.87 139.94 53.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.597 0.713 . . . . 0.0 109.472 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.5 160.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.031 -163.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' H' ' 139' ' ' LYS . 39.0 tt0 -124.86 139.45 53.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -132.35 148.28 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.392 0.677 . . . . 0.0 110.389 -163.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.52 39.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.984 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.664 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.77 55.51 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -131.06 161.61 31.65 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.98 0.895 . . . . 0.0 111.138 -169.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 2.1 t80 -128.22 162.65 26.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.452 -1.249 . . . . 0.0 107.997 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.81 86.82 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.454 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 0.9 OUTLIER -63.87 -42.96 97.39 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.77 37.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.904 0.774 . . . . 0.0 109.087 174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.672 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -134.92 147.01 49.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.647 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 6.1 tm-20 -135.86 132.68 36.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.407 ' CE1' ' HD2' ' H' ' 116' ' ' ARG . 0.1 OUTLIER -125.65 118.81 26.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 0.0 111.185 176.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.82 130.02 55.4 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.683 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.99 120.76 40.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.64 162.43 13.35 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-O 121.719 0.622 . . . . 0.0 111.566 175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . 0.649 ' HA ' HE22 ' G' ' 9' ' ' GLN . 17.3 m -71.29 -32.79 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.435 -0.45 . . . . 0.0 111.107 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -96.0 154.77 17.06 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.64 -151.69 34.51 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 166.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -138.07 162.61 33.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.61 0.719 . . . . 0.0 110.725 -177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.679 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 7.3 m -53.18 135.88 14.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.059 -171.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.11 128.02 45.55 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.083 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.81 66.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . 0.647 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 2.9 t -107.97 115.41 30.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 168.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.672 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.2 pt -117.14 128.66 74.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 2.2 m -115.59 140.61 49.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.697 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.454 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.3 pp -144.18 147.31 33.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.088 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' H' ' 62' ' ' SER . 0.0 OUTLIER -102.85 161.09 14.03 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 167.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.664 HG13 ' O ' ' H' ' 110' ' ' PHE . 79.6 t -139.88 158.75 26.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 175.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.707 HG12 ' HG ' ' G' ' 54' ' ' LEU . 6.3 pt -101.22 26.34 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.379 0.609 . . . . 0.0 110.366 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.98 93.43 1.22 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.722 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' H' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.14 35.22 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.055 0.931 . . . . 0.0 110.671 174.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.428 ' O ' ' HG3' ' H' ' 107' ' ' GLN . 0.0 OUTLIER -118.7 154.92 31.95 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.541 ' HE3' ' CD ' ' H' ' 107' ' ' GLN . 0.1 OUTLIER -100.39 140.27 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.44 -169.89 3.37 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -100.81 141.85 15.54 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.424 169.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.5 tp10 -83.89 128.22 34.39 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -174.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 1.008 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.2 OUTLIER -91.95 -44.89 14.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.735 -176.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -86.52 110.75 19.99 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.988 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.591 HG22 ' CE2' ' H' ' 104' ' ' TYR . 0.9 OUTLIER -63.55 -43.98 95.49 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.783 -0.627 . . . . 0.0 112.421 175.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.05 63.4 7.69 Favored Pre-proline 0 C--N 1.347 0.46 0 C-N-CA 126.469 1.908 . . . . 0.0 109.396 -173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.66 -5.51 15.55 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.189 1.259 . . . . 0.0 115.361 -159.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -37.72 85.47 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.595 171.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' H' ' 96' ' ' THR . 3.9 mp -60.03 -52.91 55.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.171 0.896 . . . . 0.0 111.287 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 51.5 t -68.95 -49.1 66.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.8 t-20 -106.07 107.21 18.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.485 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.55 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.7 159.44 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -172.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.63 -0.25 29.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.56 -4.23 76.02 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.385 0.993 . . . . 0.0 113.063 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.92 23.48 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.18 46.37 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.325 1.05 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.9 41.74 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . 0.552 ' HD2' ' HB2' ' H' ' 162' ' ' GLN . 1.4 p90 -146.47 162.34 38.5 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.685 2.394 . . . . 0.0 109.151 167.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.407 ' OE1' ' HB2' ' H' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.68 2.06 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 153.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . 0.552 ' HB2' ' HD2' ' H' ' 160' ' ' PHE . 3.9 tt0 -110.07 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.623 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.15 7.45 3.68 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.044 1.766 . . . . 0.0 113.861 171.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.17 84.41 0.67 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.623 HE22 ' HD2' ' H' ' 163' ' ' PRO . 3.8 mp0 -100.59 68.29 1.34 Allowed 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.847 1.324 . . . . 0.0 110.941 175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' H' ' 173' ' ' THR . 94.3 m 26.75 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.801 1.64 . . . . 0.0 111.894 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -96.83 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.334 -167.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.18 6.35 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.471 172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -23.46 64.65 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.776 0.288 . . . . 0.0 111.425 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -77.4 161.68 71.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.463 0.705 . . . . 0.0 109.289 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 84.9 Cg_endo -84.88 -9.54 8.74 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 C-N-CA 121.275 1.316 . . . . 0.0 112.706 -156.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.47 101.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.178 1.631 . . . . 0.0 117.178 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' H' ' 166' ' ' THR . 0.2 OUTLIER -94.47 163.67 13.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 118.002 0.901 . . . . 0.0 109.892 170.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.2 13.91 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.38 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -73.01 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.476 0.848 . . . . 0.0 111.736 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.243 0 C-N-CA 125.464 1.506 . . . . 0.0 112.283 -171.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.477 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.114 0 N-CA-C 102.079 -3.854 . . . . 0.0 102.079 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 4.6 mt -80.09 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.67 165.53 16.04 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.898 0.856 . . . . 0.0 110.726 -177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.47 87.32 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.481 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . 0.568 HE22 ' HA ' ' J' ' 122' ' ' VAL . 3.3 mm-40 -80.13 -18.45 49.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.77 0.785 . . . . 0.0 112.375 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' I' ' 6' ' ' ILE . 1.1 t70 -67.55 -43.23 81.19 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.4 HG22 ' OD1' ' I' ' 95' ' ' ASP . 44.3 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.61 156.59 38.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 110.485 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.81 41.0 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.748 -164.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -117.95 148.42 42.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.49 143.68 48.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.455 0.645 . . . . 0.0 109.983 176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 6.3 tt0 -123.77 126.68 46.92 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . 0.424 ' HA ' HD13 ' I' ' 89' ' ' ILE . 56.7 p -71.38 147.79 47.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.02 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.608 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pt -70.53 -44.35 77.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.966 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.56 -23.61 58.8 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.24 -46.51 82.92 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.427 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.07 46.28 16.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.211 1.404 . . . . 0.0 111.797 -173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.09 161.32 16.03 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -90.89 36.25 3.66 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.74 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.53 143.54 4.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.949 0.375 . . . . 0.0 111.805 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' I' ' 16' ' ' GLN . . . -106.12 115.01 61.87 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.009 2.124 . . . . 0.0 112.423 -174.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.87 133.15 21.2 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.454 0.841 . . . . 0.0 112.52 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 26.4 t80 -106.7 141.92 23.87 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.527 -167.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . 0.514 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.4 Cg_endo -75.96 175.56 11.16 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.85 0.687 . . . . 0.0 112.422 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.22 2.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.351 1.461 . . . . 0.0 111.568 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.92 144.79 43.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 122.498 1.142 . . . . 0.0 111.085 173.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.451 ' O ' HG13 ' J' ' 122' ' ' VAL . 9.0 tm0? -101.88 -63.52 1.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.22 159.29 2.04 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 122.81 1.291 . . . . 0.0 111.071 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.62 17.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.965 -164.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.08 5.41 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.306 170.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 43.9 m -114.85 123.09 48.29 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.51 HG13 ' HG2' ' J' ' 117' ' ' GLU . 0.2 OUTLIER -125.71 134.75 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . 0.5 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 10.4 p -137.55 109.19 7.01 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -166.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -105.96 121.1 6.61 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.207 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . 0.746 ' HA ' HG22 ' I' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.92 17.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' I' ' 41' ' ' ARG . 0.1 OUTLIER -71.17 144.33 50.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.139 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.448 ' H ' ' CZ ' ' I' ' 41' ' ' ARG . 18.7 mt-10 -126.29 175.57 7.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.756 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.2 OUTLIER -65.53 139.54 58.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.519 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.61 35.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.234 171.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t0 73.51 109.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' I' ' 52' ' ' ARG . 2.8 tt0 -65.77 -33.35 75.67 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.17 22.51 4.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.639 1.576 . . . . 0.0 111.652 -172.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 0.6 OUTLIER 42.23 61.07 2.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 111.571 -164.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.74 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.495 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.03 13.82 30.3 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.54 80.86 1.27 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.2 mmp_? -110.19 23.6 14.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.702 HG13 HG22 ' J' ' 135' ' ' ILE . 0.9 OUTLIER -123.88 3.6 5.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.801 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.85 22.7 14.73 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . 0.756 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -94.53 161.15 23.87 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-O 121.634 0.574 . . . . 0.0 113.934 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.3 155.86 51.09 Favored 'Trans proline' 0 CA--C 1.516 -0.424 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.71 29.3 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' I' ' 41' ' ' ARG . 0.3 OUTLIER -76.77 172.33 13.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.545 0.688 . . . . 0.0 110.538 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' I' ' 40' ' ' GLU . 2.9 t -123.6 128.74 74.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.61 114.9 29.42 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.33 117.53 28.03 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -171.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . 0.509 ' HB3' ' HG2' ' I' ' 133' ' ' GLN . 60.3 p -142.96 146.46 33.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.973 0.909 . . . . 0.0 110.11 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.15 24.29 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.165 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.1 OUTLIER -121.87 151.21 40.92 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.621 ' HB ' HG12 ' I' ' 130' ' ' ILE . 46.1 t -132.99 123.57 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 74.5 p -112.94 140.7 47.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -159.2 169.25 24.56 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -99.35 119.86 38.64 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -70.42 130.8 21.46 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.524 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 9.8 mttm -93.04 153.71 18.55 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.436 HH21 ' HD2' ' I' ' 71' ' ' ARG . 0.0 OUTLIER -46.09 -50.57 15.15 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -172.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.9 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.88 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.115 1.366 . . . . 0.0 111.002 169.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.62 -37.17 62.88 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.526 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -61.65 -40.34 98.62 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.859 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -47.51 84.23 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 122.154 -0.615 . . . . 0.0 111.842 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 9.6 mtmp? -63.45 -28.12 69.75 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.758 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.77 86.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.904 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.575 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.9 mm -59.51 -43.09 89.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.107 0.48 . . . . 0.0 110.497 172.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 6.6 mm-40 -62.49 -49.21 76.28 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.715 -0.616 . . . . 0.0 112.428 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 63.6 m-20 -64.4 -32.63 74.33 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.58 169.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.816 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -55.15 -59.52 4.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.558 174.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.516 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 11.3 t80 -78.52 -48.27 15.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.926 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 1.0 OUTLIER -76.99 -34.85 57.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 34.4 t30 -83.2 -33.18 26.21 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.043 172.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.67 76.2 1.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 O-C-N 122.354 -0.216 . . . . 0.0 112.854 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.816 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.48 48.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.501 ' O ' HG12 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -87.57 148.57 24.81 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 168.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -121.08 142.47 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.34 0.59 . . . . 0.0 109.883 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.8 mtmt -72.29 135.99 46.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.0 121.35 42.0 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.514 1.125 . . . . 0.0 109.996 -166.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 10.4 m95 -129.0 129.95 46.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.188 0.995 . . . . 0.0 108.321 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 15.8 ptm180 -130.96 115.55 16.65 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -124.9 168.02 18.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.29 1.043 . . . . 0.0 109.416 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . 0.4 ' OD1' HG22 ' I' ' 11' ' ' VAL . 1.0 OUTLIER -108.0 138.7 43.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.641 179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.604 HG22 HG23 ' I' ' 150' ' ' ILE . 62.9 p -69.72 -29.74 67.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.68 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.91 131.86 31.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.741 0.781 . . . . 0.0 109.879 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' I' ' 104' ' ' TYR . 0.0 OUTLIER -63.39 132.95 53.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.946 -174.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.795 0.807 . . . . 0.0 109.948 171.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.55 -21.91 35.14 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . 0.454 ' H ' HD22 ' I' ' 99' ' ' ASN . 11.7 m120 -126.84 24.75 6.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 118.738 0.699 . . . . 0.0 110.897 169.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 30.7 t0 -153.38 170.96 19.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 1.05 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -56.04 -62.35 1.76 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.866 -0.521 . . . . 0.0 110.594 171.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.599 ' CE2' HG22 ' I' ' 145' ' ' THR . 2.3 m-85 -143.39 -178.53 5.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.3 p-10 -123.91 139.91 53.5 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.615 0.722 . . . . 0.0 109.455 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.51 160.26 40.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.049 -163.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.541 ' CD ' ' HE3' ' I' ' 139' ' ' LYS . 38.9 tt0 -124.86 139.46 53.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 157.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.428 0.691 . . . . 0.0 110.436 -163.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.26 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.54 -1.314 . . . . 0.0 112.026 170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.7 55.53 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -131.02 161.61 31.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.939 0.876 . . . . 0.0 111.167 -169.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 2.1 t80 -128.23 162.68 26.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.989 -174.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.415 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.75 86.75 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 0.9 OUTLIER -63.81 -43.01 97.52 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 177.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.74 158.74 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.934 0.788 . . . . 0.0 109.108 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.664 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -134.97 146.96 49.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 6.1 tm-20 -135.87 132.61 36.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' I' ' 116' ' ' ARG . 0.1 OUTLIER -125.59 118.82 26.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.079 0.466 . . . . 0.0 111.219 176.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.83 130.07 55.4 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.654 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.06 120.68 39.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.65 162.42 13.36 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 121.702 0.612 . . . . 0.0 111.593 175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . 0.591 ' HA ' HE22 ' H' ' 9' ' ' GLN . 17.4 m -71.25 -32.78 48.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.47 -0.429 . . . . 0.0 111.156 176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.84 17.02 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.61 -151.73 34.59 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 166.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' H' ' 6' ' ' ILE . . . -138.07 162.63 33.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.58 0.705 . . . . 0.0 110.754 -177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.663 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 7.7 m -53.24 135.86 14.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.039 -171.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.04 127.99 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.173 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.53 126.85 66.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . 0.668 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 2.9 t -108.07 115.43 30.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 168.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.664 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.2 pt -117.17 128.57 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 2.2 m -115.6 140.58 49.04 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.331 0.652 . . . . 0.0 109.742 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.459 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.3 pp -144.17 147.33 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.083 -172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.509 ' HG2' ' HB3' ' I' ' 62' ' ' SER . 0.0 OUTLIER -102.79 161.01 14.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 167.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' I' ' 110' ' ' PHE . 80.2 t -139.8 158.86 27.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.662 HG12 ' HG ' ' H' ' 54' ' ' LEU . 6.3 pt -101.29 26.31 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.354 0.597 . . . . 0.0 110.341 -173.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.0 93.41 1.21 Allowed Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.717 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . 0.523 ' HG3' HG11 ' I' ' 134' ' ' VAL . 27.2 mt-10 -81.98 137.22 35.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.039 0.924 . . . . 0.0 110.655 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.477 ' HA ' HE22 ' J' ' 84' ' ' GLN . 0.0 OUTLIER -118.79 154.95 32.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.62 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -100.43 140.27 34.92 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.83 3.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -100.89 141.9 15.56 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.368 169.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -83.98 128.22 34.4 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 1.05 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.91 14.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.751 -176.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -86.54 110.76 20.01 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 0.599 HG22 ' CE2' ' I' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -44.01 95.37 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.396 175.1 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.15 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.468 1.907 . . . . 0.0 109.406 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.6 -5.63 15.75 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.26 1.307 . . . . 0.0 115.364 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -37.76 85.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.589 171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.91 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.604 HG23 HG22 ' I' ' 96' ' ' THR . 3.9 mp -60.0 -52.92 55.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 51.5 t -68.96 -49.06 66.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.7 t-20 -106.1 107.26 18.17 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.53 97.61 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.66 159.52 14.95 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.75 -0.19 29.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.62 -4.32 75.95 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.401 1.0 . . . . 0.0 113.02 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.92 23.51 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.22 151.17 46.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.26 1.024 . . . . 0.0 108.616 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.32 -54.91 41.64 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . 0.56 ' HD2' ' HB2' ' I' ' 162' ' ' GLN . 1.4 p90 -146.45 162.31 38.54 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.677 2.391 . . . . 0.0 109.163 167.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' I' ' 165' ' ' GLN . 15.3 mt-30 -143.97 89.62 2.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . 0.56 ' HB2' ' HD2' ' I' ' 160' ' ' PHE . 3.9 tt0 -110.08 -25.07 0.15 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.632 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -77.21 7.56 3.65 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.053 1.769 . . . . 0.0 113.887 171.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.18 84.43 0.67 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.632 HE22 ' HD2' ' I' ' 163' ' ' PRO . 3.8 mp0 -100.64 68.31 1.33 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.921 1.361 . . . . 0.0 110.934 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.62 ' O ' ' HB ' ' I' ' 173' ' ' THR . 94.3 m 26.77 73.16 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.791 1.636 . . . . 0.0 111.901 176.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -96.85 161.59 13.79 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.33 -167.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.84 -154.14 6.33 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.496 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 -23.47 64.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.813 0.306 . . . . 0.0 111.439 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -77.42 161.65 71.69 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.478 0.711 . . . . 0.0 109.268 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.5 Cg_endo -84.79 -9.63 8.78 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.369 1.379 . . . . 0.0 112.73 -156.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.5 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.62 ' HB ' ' O ' ' I' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.73 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.993 0.897 . . . . 0.0 109.877 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.38 167.22 13.88 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.374 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.503 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.4 Cg_exo -72.98 110.43 3.04 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.502 0.858 . . . . 0.0 111.761 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.376 1.471 . . . . 0.0 112.331 -171.714 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 102.037 -3.87 . . . . 0.0 102.037 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.642 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 4.5 mt -80.08 131.8 33.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.6 165.52 16.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.888 0.851 . . . . 0.0 110.731 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.25 -33.42 87.21 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.509 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . 0.613 HE22 ' HA ' ' K' ' 122' ' ' VAL . 3.3 mm-40 -80.14 -18.4 49.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.787 0.794 . . . . 0.0 112.414 172.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' J' ' 6' ' ' ILE . 1.1 t70 -67.6 -43.25 80.94 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.42 116.24 33.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.54 156.64 38.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.643 0.735 . . . . 0.0 110.548 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.5 m-85 -120.98 122.83 41.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -118.01 148.45 42.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.65 48.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.516 0.674 . . . . 0.0 109.953 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.551 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 6.3 tt0 -123.68 126.74 47.1 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . 0.412 ' HA ' HD13 ' J' ' 89' ' ' ILE . 56.7 p -71.49 147.87 47.35 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.596 0.712 . . . . 0.0 110.973 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.617 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pt -70.61 -44.26 76.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.01 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.57 -23.63 58.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.18 -46.59 82.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.418 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.19 46.13 16.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.165 1.386 . . . . 0.0 111.828 -173.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -110.95 161.33 15.96 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -90.87 36.21 3.67 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.709 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.51 143.62 4.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.995 0.397 . . . . 0.0 111.755 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' J' ' 16' ' ' GLN . . . -106.22 115.05 61.69 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.957 2.103 . . . . 0.0 112.411 -174.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.84 133.15 21.27 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.404 0.823 . . . . 0.0 112.519 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.79 155.13 28.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.516 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 26.6 t80 -106.7 141.93 23.88 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.568 -167.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . 0.516 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.4 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-N 119.046 0.695 . . . . 0.0 112.434 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 52.97 62.24 2.78 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.345 1.458 . . . . 0.0 111.596 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -74.98 144.88 42.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 122.55 1.166 . . . . 0.0 111.031 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.418 ' O ' HG13 ' K' ' 122' ' ' VAL . 8.9 tm0? -101.96 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 159.26 2.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.769 1.271 . . . . 0.0 111.081 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.62 117.6 17.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.008 -164.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.15 121.09 5.41 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.362 170.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.84 123.05 48.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.489 HG13 ' HG2' ' K' ' 117' ' ' GLU . 0.2 OUTLIER -125.7 134.72 65.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -173.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 10.4 p -137.51 109.29 7.09 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -105.99 121.05 6.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.251 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' J' ' 59' ' ' VAL . 10.5 tt0 -101.28 105.96 17.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' J' ' 41' ' ' ARG . 0.1 OUTLIER -71.23 144.35 50.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.742 0.782 . . . . 0.0 110.125 -174.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . 0.44 ' H ' ' CZ ' ' J' ' 41' ' ' ARG . 18.6 mt-10 -126.3 175.57 7.73 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -167.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.75 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.56 58.49 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.53 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.76 128.56 35.32 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.232 171.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' J' ' 52' ' ' ARG . 2.8 tt0 -65.82 -33.36 75.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.15 22.54 4.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.605 1.562 . . . . 0.0 111.667 -172.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.547 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 0.6 OUTLIER 42.17 61.07 2.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.468 1.507 . . . . 0.0 111.597 -164.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.72 -127.52 0.29 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.502 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.15 13.87 30.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.5 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.1 mmp_? -110.18 23.59 14.11 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.605 HG13 HG22 ' K' ' 135' ' ' ILE . 0.9 OUTLIER -123.88 3.61 5.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.861 178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.717 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -104.81 22.66 14.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . 0.75 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -94.46 161.13 23.93 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.588 0.549 . . . . 0.0 114.001 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.32 155.91 50.95 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 172.34 13.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.611 0.719 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.761 HG22 ' HA ' ' J' ' 40' ' ' GLU . 2.9 t -123.59 128.78 74.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.58 114.91 29.44 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.41 117.53 27.95 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' J' ' 133' ' ' GLN . 60.3 p -142.96 146.48 33.98 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.973 0.909 . . . . 0.0 110.065 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.09 156.15 24.26 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.155 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.1 OUTLIER -121.92 151.21 40.96 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 174.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.616 ' HB ' HG12 ' J' ' 130' ' ' ILE . 45.9 t -133.01 123.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 74.0 p -112.92 140.62 47.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.13 169.2 24.73 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -99.27 119.8 38.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.4 130.74 21.46 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.51 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.7 mttm -92.97 153.75 18.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.11 -50.56 15.25 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.91 99.33 0.18 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.9 155.61 49.54 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 111.015 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.7 -37.16 62.68 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.525 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -61.68 -40.26 98.53 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.879 168.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -47.48 84.25 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.14 -0.624 . . . . 0.0 111.867 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.526 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 9.6 mtmp? -63.39 -28.19 69.82 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.936 -0.705 . . . . 0.0 111.823 171.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -44.83 86.35 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.913 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.9 mm -59.59 -43.07 90.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.081 0.467 . . . . 0.0 110.44 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' I' ' 139' ' ' LYS . 6.6 mm-40 -62.52 -49.14 76.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.754 -0.591 . . . . 0.0 112.469 -178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 64.0 m-20 -64.46 -32.62 74.33 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.528 169.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.828 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -55.1 -59.52 4.64 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.62 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.5 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 11.3 t80 -78.56 -48.24 15.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.891 -174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.0 OUTLIER -77.05 -34.77 57.14 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 34.4 t30 -83.24 -33.15 26.13 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.035 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.64 76.17 1.31 Allowed Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.322 -0.236 . . . . 0.0 112.875 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.828 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.14 156.57 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.489 ' O ' HG12 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -87.65 148.56 24.75 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.427 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -121.07 142.51 36.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.393 0.616 . . . . 0.0 109.841 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.8 mtmt -72.33 136.0 46.08 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.07 121.33 41.87 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.541 1.136 . . . . 0.0 110.002 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.707 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 10.5 m95 -129.0 129.98 46.06 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.238 1.015 . . . . 0.0 108.372 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.538 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 15.8 ptm180 -131.0 115.49 16.55 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 172.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -124.86 168.04 18.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.258 1.028 . . . . 0.0 109.432 -173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.03 138.71 43.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.63 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.608 HG22 HG23 ' J' ' 150' ' ' ILE . 63.1 p -69.68 -29.8 67.32 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.643 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.89 131.82 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.675 0.75 . . . . 0.0 109.905 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . 0.417 ' HA ' ' CE1' ' J' ' 104' ' ' TYR . 0.0 OUTLIER -63.35 132.94 53.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.967 -174.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.5 OUTLIER -74.58 139.96 44.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.87 35.18 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' J' ' 99' ' ' ASN . 11.7 m120 -126.88 24.8 6.41 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.755 0.707 . . . . 0.0 110.88 169.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 30.7 t0 -153.38 170.93 19.46 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.986 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -55.98 -62.42 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.872 -0.518 . . . . 0.0 110.554 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.587 ' CE2' HG22 ' J' ' 145' ' ' THR . 2.4 m-85 -143.36 -178.55 5.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.636 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.3 p-10 -123.96 139.91 53.49 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.657 0.741 . . . . 0.0 109.423 177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.52 160.27 40.25 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.989 -163.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.545 ' CD ' ' HE3' ' J' ' 139' ' ' LYS . 39.0 tt0 -124.9 139.46 53.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.33 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.436 0.695 . . . . 0.0 110.431 -163.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.47 39.58 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.967 170.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.74 55.52 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.433 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -131.07 161.6 31.67 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.92 0.867 . . . . 0.0 111.18 -169.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.437 ' HB2' HD22 ' I' ' 54' ' ' LEU . 2.1 t80 -128.19 162.68 26.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.007 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.79 86.77 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.443 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -42.95 97.44 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.78 158.72 37.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.913 0.779 . . . . 0.0 109.089 174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.677 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 147.0 49.67 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.672 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 6.1 tm-20 -135.9 132.65 36.78 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.42 ' CE1' ' HD2' ' J' ' 116' ' ' ARG . 0.1 OUTLIER -125.67 118.85 26.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.086 0.47 . . . . 0.0 111.178 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.11 55.39 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.685 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.09 120.74 40.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.67 162.42 13.36 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.568 ' HA ' HE22 ' I' ' 9' ' ' GLN . 17.3 m -71.27 -32.84 48.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 O-C-N 122.479 -0.424 . . . . 0.0 111.088 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.92 154.84 17.02 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.58 -151.69 34.61 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 166.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -138.09 162.61 33.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.58 0.705 . . . . 0.0 110.783 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 7.3 m -53.16 135.96 14.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.064 -171.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.13 128.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.1 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.67 126.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . 0.672 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 2.9 t -108.07 115.46 30.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 168.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.677 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.2 pt -117.19 128.59 74.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 2.2 m -115.57 140.6 49.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.735 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.443 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.3 pp -144.15 147.33 33.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.072 -172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' J' ' 62' ' ' SER . 0.0 OUTLIER -102.9 161.06 14.06 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.675 HG13 ' O ' ' J' ' 110' ' ' PHE . 81.0 t -139.85 158.79 26.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 175.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.801 HG12 ' HG ' ' I' ' 54' ' ' LEU . 6.4 pt -101.23 26.26 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.343 0.592 . . . . 0.0 110.354 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 122.09 93.39 1.2 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.675 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . 0.532 ' HG3' HG11 ' J' ' 134' ' ' VAL . 27.2 mt-10 -81.94 137.17 35.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.079 0.943 . . . . 0.0 110.683 174.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.453 ' HA ' HE22 ' K' ' 84' ' ' GLN . 0.0 OUTLIER -118.78 154.97 31.97 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.545 ' HE3' ' CD ' ' J' ' 107' ' ' GLN . 0.1 OUTLIER -100.38 140.25 34.9 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.38 -169.79 3.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -100.91 141.92 15.56 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.325 169.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.885 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.5 tp10 -83.96 128.18 34.37 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.986 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.2 OUTLIER -91.92 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.748 -176.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 110.8 20.06 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.937 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.587 HG22 ' CE2' ' J' ' 104' ' ' TYR . 0.9 OUTLIER -63.56 -43.98 95.45 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.777 -0.63 . . . . 0.0 112.39 175.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.1 63.35 7.71 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.431 1.893 . . . . 0.0 109.408 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.57 -5.65 15.78 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.246 1.298 . . . . 0.0 115.337 -159.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.8 -37.76 85.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.566 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.89 -65.94 1.13 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.608 HG23 HG22 ' J' ' 96' ' ' THR . 3.9 mp -60.11 -52.86 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.152 0.887 . . . . 0.0 111.27 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 51.8 t -68.95 -49.08 66.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.8 t-20 -106.06 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.493 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.56 97.62 3.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.6 159.49 14.97 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.68 -0.22 29.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.61 -4.3 75.95 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.332 0.969 . . . . 0.0 113.028 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.77 139.9 23.48 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -139.18 151.15 46.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.321 1.048 . . . . 0.0 108.63 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.29 -54.97 41.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . 0.557 ' HD2' ' HB2' ' J' ' 162' ' ' GLN . 1.4 p90 -146.44 162.32 38.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.687 2.395 . . . . 0.0 109.162 167.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' J' ' 165' ' ' GLN . 15.3 mt-30 -144.0 89.67 2.06 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' HD2' ' J' ' 160' ' ' PHE . 3.9 tt0 -110.1 -25.03 0.15 Allowed Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.612 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.239 0.526 0 CA-C-N 122.08 1.779 . . . . 0.0 113.904 171.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.21 84.37 0.67 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.612 HE22 ' HD2' ' J' ' 163' ' ' PRO . 3.8 mp0 -100.6 68.32 1.34 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.913 1.356 . . . . 0.0 110.95 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.604 ' O ' ' HB ' ' J' ' 173' ' ' THR . 94.8 m 26.68 73.15 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.804 1.642 . . . . 0.0 111.903 176.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -96.72 161.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.344 -167.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.88 -154.17 6.34 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.524 172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -23.42 64.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.796 0.298 . . . . 0.0 111.464 -177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -77.37 161.67 71.72 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.474 0.709 . . . . 0.0 109.298 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.3 Cg_endo -84.85 -9.55 8.76 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.284 1.323 . . . . 0.0 112.738 -156.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.51 101.47 0.2 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.161 1.624 . . . . 0.0 117.161 165.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' J' ' 166' ' ' THR . 0.2 OUTLIER -94.48 163.72 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.983 0.892 . . . . 0.0 109.888 170.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.23 13.81 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.413 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.99 110.47 3.05 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.569 0.882 . . . . 0.0 111.701 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.443 1.497 . . . . 0.0 112.3 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.121 -3.838 . . . . 0.0 102.121 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.658 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -80.1 131.83 33.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.61 165.48 16.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.93 0.871 . . . . 0.0 110.755 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.46 87.32 Favored Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.497 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . 0.62 HE22 ' HA ' ' L' ' 122' ' ' VAL . 3.2 mm-40 -80.14 -18.47 49.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.414 ' HB3' HG22 ' K' ' 6' ' ' ILE . 1.1 t70 -67.51 -43.28 81.24 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.993 1.108 . . . . 0.0 113.993 -171.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' K' ' 95' ' ' ASP . 44.4 t -92.45 116.29 33.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.57 156.6 38.87 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.645 0.736 . . . . 0.0 110.556 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.477 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.5 m-85 -120.94 122.79 40.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -117.89 148.48 42.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.57 143.67 48.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.496 0.665 . . . . 0.0 109.944 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.556 HE22 ' HA ' ' E' ' 162' ' ' GLN . 6.3 tt0 -123.74 126.67 46.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . 0.41 ' HA ' HD13 ' K' ' 89' ' ' ILE . 56.5 p -71.41 147.83 47.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.009 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.63 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pt -70.58 -44.27 76.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.979 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -74.6 -23.64 58.76 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.17 -46.55 82.7 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.24 16.6 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.221 1.409 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -111.03 161.34 15.97 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.531 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -90.85 36.23 3.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 113.76 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 9.7 p -167.52 143.53 4.12 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.966 0.383 . . . . 0.0 111.81 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' K' ' 16' ' ' GLN . . . -106.1 115.04 61.85 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.95 2.1 . . . . 0.0 112.436 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.86 133.2 21.34 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.449 0.839 . . . . 0.0 112.462 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.83 155.11 28.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.52 ' HZ ' ' H ' ' K' ' 70' ' ' LYS . 26.4 t80 -106.71 142.0 24.03 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.54 -167.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . 0.512 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -76.06 175.6 11.11 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-O 121.865 0.694 . . . . 0.0 112.4 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.23 2.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.301 1.44 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.0 144.9 42.9 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.531 1.157 . . . . 0.0 111.071 173.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.408 ' O ' HG13 ' L' ' 122' ' ' VAL . 9.0 tm0? -101.97 -63.46 1.15 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -176.3 159.29 1.99 Allowed 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.778 1.275 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.67 117.57 17.14 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.95 -164.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.05 5.41 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.368 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.79 123.1 48.35 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' L' ' 117' ' ' GLU . 0.2 OUTLIER -125.66 134.72 65.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.6 p -137.48 109.19 7.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -166.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -105.93 121.13 6.63 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.246 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' K' ' 59' ' ' VAL . 10.5 tt0 -101.31 105.95 17.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' K' ' 41' ' ' ARG . 0.1 OUTLIER -71.21 144.3 50.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.718 0.77 . . . . 0.0 110.124 -174.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . 0.434 ' H ' ' CZ ' ' K' ' 41' ' ' ARG . 18.7 mt-10 -126.32 175.56 7.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.742 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.2 OUTLIER -65.52 139.54 58.49 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.49 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.77 128.62 35.32 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.227 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.53 110.02 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.438 ' CG ' ' H ' ' K' ' 52' ' ' ARG . 2.9 tt0 -65.83 -33.38 75.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.15 22.53 4.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.615 1.566 . . . . 0.0 111.686 -172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 42.15 61.16 2.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.79 -127.61 0.29 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.476 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.06 13.86 30.19 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.49 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.531 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.1 mmp_? -110.17 23.6 14.1 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.601 HG13 HG22 ' L' ' 135' ' ' ILE . 0.9 OUTLIER -123.87 3.58 5.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.873 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.73 22.57 14.88 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 176.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . 0.742 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -94.41 161.25 24.03 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.682 0.601 . . . . 0.0 113.942 -170.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.32 155.88 50.99 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.01 -176.75 29.43 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . 0.428 ' O ' ' N ' ' K' ' 41' ' ' ARG . 0.3 OUTLIER -76.66 172.35 13.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 0.0 110.497 179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.745 HG22 ' HA ' ' K' ' 40' ' ' GLU . 2.9 t -123.64 128.78 74.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.64 114.93 29.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.42 117.52 27.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . 0.515 ' HB3' ' HG2' ' K' ' 133' ' ' GLN . 60.2 p -142.98 146.44 33.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.96 0.904 . . . . 0.0 110.051 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.11 156.12 24.26 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.154 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.1 OUTLIER -121.88 151.17 40.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' K' ' 130' ' ' ILE . 46.0 t -132.93 123.61 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.95 140.65 47.57 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -159.16 169.26 24.56 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.33 119.75 38.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.32 130.74 21.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.52 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.8 mttm -93.02 153.78 18.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.441 0.638 . . . . 0.0 109.29 174.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.08 -50.62 15.05 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 99.34 0.18 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.87 155.54 49.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 111.073 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.45 ' HA ' ' HZ1' ' K' ' 77' ' ' LYS . . . -74.64 -37.2 62.84 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.524 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -61.59 -40.37 98.64 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.842 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.5 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.86 171.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.479 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 9.6 mtmp? -63.46 -28.2 69.81 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.761 171.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.44 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.942 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.573 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.9 mm -59.58 -43.02 90.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.051 0.453 . . . . 0.0 110.501 172.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 6.6 mm-40 -62.53 -49.15 76.47 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.739 -0.6 . . . . 0.0 112.441 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 63.7 m-20 -64.41 -32.64 74.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.582 169.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.831 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.568 175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.45 ' HB3' ' NH2' ' K' ' 116' ' ' ARG . 11.2 t80 -78.57 -48.22 15.63 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.877 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.0 OUTLIER -77.07 -34.76 57.02 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 34.4 t30 -83.28 -33.13 26.06 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.011 172.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.62 76.16 1.31 Allowed Glycine 0 N--CA 1.449 -0.492 0 O-C-N 122.305 -0.247 . . . . 0.0 112.913 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.831 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.12 156.52 48.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.494 ' O ' HG12 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -87.61 148.55 24.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.412 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -121.03 142.5 36.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.868 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.8 mtmt -72.29 136.0 46.13 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.02 121.36 42.01 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 10.6 m95 -129.03 129.92 45.93 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 108.342 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.51 16.62 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -124.87 168.08 18.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.288 1.042 . . . . 0.0 109.362 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' K' ' 11' ' ' VAL . 1.0 OUTLIER -107.99 138.76 43.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.623 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.6 HG22 HG23 ' K' ' 150' ' ' ILE . 62.9 p -69.8 -29.76 67.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.668 -176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.661 0.743 . . . . 0.0 109.939 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' K' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.92 53.12 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.994 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.619 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.96 44.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.863 0.84 . . . . 0.0 109.95 171.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.59 -21.8 35.06 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . 0.459 ' H ' HD22 ' K' ' 99' ' ' ASN . 11.6 m120 -126.89 24.76 6.41 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 30.8 t0 -153.38 170.99 19.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 1.001 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -56.06 -62.4 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.562 172.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' K' ' 145' ' ' THR . 2.4 m-85 -143.34 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.619 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.3 p-10 -123.89 139.92 53.49 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.596 0.712 . . . . 0.0 109.454 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.88 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.5 160.21 40.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.05 -163.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.538 ' CD ' ' HE3' ' K' ' 139' ' ' LYS . 38.9 tt0 -124.87 139.49 53.78 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -132.35 148.24 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.354 0.662 . . . . 0.0 110.427 -163.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.25 -178.47 39.56 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.5 m-30 -109.39 129.76 55.53 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.437 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -131.02 161.57 31.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.88 0.847 . . . . 0.0 111.198 -169.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.434 ' HB2' HD22 ' J' ' 54' ' ' LEU . 2.1 t80 -128.26 162.6 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.532 -1.213 . . . . 0.0 107.97 -174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.416 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 0.9 OUTLIER -63.86 -43.0 97.41 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 11.8 t -156.71 158.76 37.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.945 0.793 . . . . 0.0 109.095 174.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.671 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -134.98 147.02 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 6.2 tm-20 -135.89 132.7 36.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.418 ' CE1' ' HD2' ' K' ' 116' ' ' ARG . 0.1 OUTLIER -125.64 118.77 26.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.066 0.46 . . . . 0.0 111.185 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.81 130.04 55.39 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.689 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.02 120.79 40.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 167.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.71 162.42 13.38 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.613 ' HA ' HE22 ' J' ' 9' ' ' GLN . 17.3 m -71.23 -32.83 48.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.467 -0.431 . . . . 0.0 111.111 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.96 154.79 17.05 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 169.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.63 -151.77 34.61 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 166.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -138.07 162.63 33.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.642 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 7.6 m -53.24 135.96 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.98 -171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.15 128.01 45.48 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.119 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.61 126.87 66.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 2.9 t -108.02 115.32 29.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.671 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.2 pt -117.1 128.63 74.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 2.2 m -115.58 140.57 49.05 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.715 -178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.2 pp -144.15 147.36 33.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.094 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.515 ' HG2' ' HB3' ' K' ' 62' ' ' SER . 0.0 OUTLIER -102.83 161.04 14.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 167.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' K' ' 110' ' ' PHE . 79.7 t -139.81 158.79 27.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.717 HG12 ' HG ' ' J' ' 54' ' ' LEU . 6.4 pt -101.23 26.28 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.374 0.607 . . . . 0.0 110.337 -173.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.4 1.21 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.717 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' K' ' 134' ' ' VAL . 27.2 mt-10 -81.95 137.15 35.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.001 0.905 . . . . 0.0 110.691 174.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.551 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -118.74 154.91 32.02 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.585 ' HD3' ' OE1' ' L' ' 80' ' ' GLU . 0.1 OUTLIER -100.38 140.23 34.93 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.37 -169.85 3.36 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -100.87 141.91 15.56 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.385 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.88 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.5 tp10 -83.93 128.2 34.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 1.001 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.2 OUTLIER -91.9 -44.9 14.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.787 -176.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.53 110.81 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.005 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.6 HG22 ' CE2' ' K' ' 104' ' ' TYR . 0.9 OUTLIER -63.59 -44.0 95.32 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.375 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.7 mt 54.14 63.32 7.72 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.411 1.884 . . . . 0.0 109.435 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.62 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.4 Cg_exo -68.62 -5.56 15.61 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.258 1.305 . . . . 0.0 115.364 -159.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.611 171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.88 -65.99 1.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.6 HG23 HG22 ' K' ' 96' ' ' THR . 3.9 mp -60.01 -52.95 55.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 119.139 0.881 . . . . 0.0 111.3 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.62 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 51.6 t -68.91 -49.06 66.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.7 t-20 -106.13 107.21 18.09 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.436 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.51 97.58 3.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.59 159.47 14.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.77 -0.07 28.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.57 -4.3 76.1 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 119.329 0.968 . . . . 0.0 113.027 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 139.91 23.46 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.19 151.17 46.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.318 1.047 . . . . 0.0 108.589 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.31 -54.87 42.13 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -158.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . 0.553 ' HD2' ' HB2' ' K' ' 162' ' ' GLN . 1.4 p90 -146.48 162.3 38.58 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.713 2.405 . . . . 0.0 109.164 167.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' K' ' 165' ' ' GLN . 15.3 mt-30 -144.02 89.64 2.05 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 154.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . 0.553 ' HB2' ' HD2' ' K' ' 160' ' ' PHE . 3.9 tt0 -110.09 -25.06 0.15 Allowed Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -166.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.621 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -77.17 7.57 3.63 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.092 1.783 . . . . 0.0 113.9 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.16 84.43 0.66 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' K' ' 163' ' ' PRO . 3.8 mp0 -100.69 68.33 1.32 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 118.889 1.344 . . . . 0.0 110.913 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.613 ' O ' ' HB ' ' K' ' 173' ' ' THR . 94.2 m 26.75 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.814 1.646 . . . . 0.0 111.89 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.503 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -96.84 161.61 13.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.323 -167.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.86 -154.19 6.34 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.456 172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.705 0.288 . . . . 0.0 111.432 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . 0.465 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -77.41 161.62 71.8 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 123.52 0.728 . . . . 0.0 109.265 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.465 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -84.8 -9.59 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 121.341 1.361 . . . . 0.0 112.771 -156.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.52 101.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' K' ' 166' ' ' THR . 0.2 OUTLIER -94.52 163.71 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.921 0.86 . . . . 0.0 109.849 170.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.41 167.24 13.85 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.396 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.518 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.98 110.49 3.06 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.526 0.867 . . . . 0.0 111.676 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.25 0 C-N-CA 125.389 1.476 . . . . 0.0 112.373 -171.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.115 -3.84 . . . . 0.0 102.115 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.667 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 4.6 mt -80.06 131.87 33.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.71 165.47 16.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.924 0.868 . . . . 0.0 110.746 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.18 -33.41 87.18 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.382 -0.826 . . . . 0.0 114.527 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . 0.638 HE22 ' HA ' ' G' ' 122' ' ' VAL . 3.3 mm-40 -80.16 -18.43 49.75 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.781 0.79 . . . . 0.0 112.402 172.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.406 ' HB3' HG22 ' L' ' 6' ' ' ILE . 1.1 t70 -67.53 -43.29 81.11 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.409 HG22 ' OD1' ' L' ' 95' ' ' ASP . 44.2 t -92.34 116.29 33.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -125.59 156.64 38.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.486 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.5 m-85 -120.93 122.83 41.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.763 -164.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -117.96 148.47 42.17 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -120.55 143.67 48.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.455 0.645 . . . . 0.0 109.969 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.564 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 6.3 tt0 -123.76 126.69 46.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . 0.408 ' HA ' HD13 ' L' ' 89' ' ' ILE . 56.7 p -71.39 147.82 47.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.049 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.801 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.1 pt -70.6 -44.17 77.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.031 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -74.61 -23.66 58.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.22 -46.53 82.84 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.406 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.05 46.28 16.53 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.216 1.406 . . . . 0.0 111.778 -173.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . 0.516 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 8.8 t -111.06 161.34 15.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -90.87 36.24 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.693 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 9.8 p -167.56 143.52 4.09 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.991 0.396 . . . . 0.0 111.79 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' L' ' 16' ' ' GLN . . . -106.11 115.06 61.79 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.953 2.101 . . . . 0.0 112.429 -174.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.86 133.2 21.33 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.436 0.834 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.8 155.1 28.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.521 ' HZ ' ' H ' ' L' ' 70' ' ' LYS . 26.5 t80 -106.69 141.94 23.9 Favored Pre-proline 0 C--N 1.317 -0.824 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.54 -167.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.7 Cg_endo -75.99 175.54 11.19 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.851 0.688 . . . . 0.0 112.445 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.0 62.27 2.76 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.329 1.452 . . . . 0.0 111.596 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -75.06 144.84 42.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.524 1.154 . . . . 0.0 111.043 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -101.88 -63.49 1.14 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 4.1 t -176.26 159.31 2.02 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.769 1.271 . . . . 0.0 111.129 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.65 117.61 17.22 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.939 -164.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.09 121.07 5.41 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.353 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 44.1 m -114.81 123.11 48.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.421 HG13 ' HG2' ' G' ' 117' ' ' GLU . 0.2 OUTLIER -125.72 134.75 65.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -173.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . 0.504 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 10.4 p -137.46 109.23 7.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -105.96 121.09 6.6 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.261 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . 0.735 ' HA ' HG22 ' L' ' 59' ' ' VAL . 10.5 tt0 -101.29 105.9 17.03 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' L' ' 41' ' ' ARG . 0.1 OUTLIER -71.2 144.29 50.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.711 0.767 . . . . 0.0 110.174 -174.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CZ ' ' L' ' 41' ' ' ARG . 18.6 mt-10 -126.27 175.56 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.745 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.2 OUTLIER -65.47 139.55 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.513 -179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.8 128.58 35.33 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.195 171.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 t0 73.6 109.97 0.07 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.441 ' CG ' ' H ' ' L' ' 52' ' ' ARG . 2.9 tt0 -65.78 -33.39 75.75 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.18 22.52 4.39 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.59 1.556 . . . . 0.0 111.69 -172.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.533 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.6 OUTLIER 42.16 61.15 2.06 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.502 1.521 . . . . 0.0 111.535 -164.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -114.76 -127.56 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.465 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -105.04 13.83 30.26 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.47 80.88 1.27 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.2 mmp_? -110.21 23.58 14.11 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.575 HG13 HG22 ' G' ' 135' ' ' ILE . 0.9 OUTLIER -123.86 3.6 5.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.874 178.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.715 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.79 22.64 14.79 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . 0.745 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -94.43 161.16 23.98 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.637 0.576 . . . . 0.0 113.974 -170.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.39 155.88 50.63 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.93 -176.69 29.28 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' L' ' 41' ' ' ARG . 0.3 OUTLIER -76.71 172.33 13.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.576 0.703 . . . . 0.0 110.516 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' L' ' 40' ' ' GLU . 2.9 t -123.58 128.76 74.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.036 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.6 114.92 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.4 117.53 27.97 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' L' ' 133' ' ' GLN . 60.2 p -143.06 146.5 33.87 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.029 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.14 156.11 24.27 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.187 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.1 OUTLIER -121.82 151.2 40.88 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' L' ' 130' ' ' ILE . 45.8 t -132.98 123.57 48.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -112.9 140.68 47.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -159.18 169.22 24.64 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -99.26 119.79 38.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.38 130.73 21.47 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.972 0.749 . . . . 0.0 114.972 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.521 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.8 mttm -93.02 153.72 18.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.453 0.644 . . . . 0.0 109.287 174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -50.57 15.18 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.89 99.3 0.18 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -136.91 155.57 49.59 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.082 1.353 . . . . 0.0 111.028 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HZ1' ' L' ' 77' ' ' LYS . . . -74.63 -37.19 62.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.51 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -61.66 -40.32 98.6 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.858 168.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -47.43 84.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.896 171.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.473 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 9.6 mtmp? -63.53 -28.13 69.73 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.769 171.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.77 86.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.92 168.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.577 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.9 mm -59.62 -43.02 90.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.061 0.458 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 6.6 mm-40 -62.47 -49.2 76.37 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.747 -0.596 . . . . 0.0 112.453 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 63.7 m-20 -64.42 -32.64 74.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.554 169.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.824 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -55.18 -59.49 4.7 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.611 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.445 ' HB3' ' NH2' ' L' ' 116' ' ' ARG . 11.4 t80 -78.5 -48.28 15.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.915 -174.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.0 OUTLIER -77.0 -34.8 57.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.064 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 34.4 t30 -83.23 -33.21 26.13 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.028 172.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.68 76.13 1.31 Allowed Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.333 -0.229 . . . . 0.0 112.91 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.824 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.1 156.51 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.604 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -87.61 148.57 24.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 168.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.42 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -121.04 142.54 36.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.362 0.601 . . . . 0.0 109.9 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 7.8 mtmt -72.35 136.04 46.06 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -116.09 121.39 42.02 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.461 1.104 . . . . 0.0 109.952 -165.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.713 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 10.6 m95 -129.01 129.93 45.98 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.213 1.005 . . . . 0.0 108.348 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 15.8 ptm180 -130.95 115.56 16.67 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 172.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -124.91 168.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.312 1.053 . . . . 0.0 109.372 -173.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . 0.409 ' OD1' HG22 ' L' ' 11' ' ' VAL . 1.0 OUTLIER -108.01 138.76 43.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.646 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.614 HG22 HG23 ' L' ' 150' ' ' ILE . 63.2 p -69.78 -29.76 67.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.652 -176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.8 p -65.84 131.84 31.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 109.918 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' CE1' ' L' ' 104' ' ' TYR . 0.0 OUTLIER -63.34 132.9 53.04 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.015 -174.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.625 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.5 OUTLIER -74.55 139.92 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.814 0.816 . . . . 0.0 110.027 171.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.54 -21.86 35.19 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . 0.461 ' H ' HD22 ' L' ' 99' ' ' ASN . 11.6 m120 -126.84 24.76 6.44 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.768 0.713 . . . . 0.0 110.855 169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 30.7 t0 -153.4 170.98 19.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 1.011 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -56.11 -62.3 1.8 Allowed 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.897 -0.502 . . . . 0.0 110.565 172.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.598 ' CE2' HG22 ' L' ' 145' ' ' THR . 2.4 m-85 -143.37 -178.54 5.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.625 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.3 p-10 -123.93 139.89 53.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.63 0.728 . . . . 0.0 109.476 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -139.5 160.2 40.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.073 -163.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.547 ' CD ' ' HE3' ' L' ' 139' ' ' LYS . 38.9 tt0 -124.83 139.49 53.79 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 157.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -132.35 148.23 52.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.417 0.687 . . . . 0.0 110.41 -163.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.29 -178.53 39.62 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.49 -1.338 . . . . 0.0 111.942 170.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.5 m-30 -109.33 129.67 55.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.441 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.99 161.62 31.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.924 0.868 . . . . 0.0 111.174 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.435 ' HB2' HD22 ' K' ' 54' ' ' LEU . 2.1 t80 -128.24 162.59 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.0 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.406 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.3 OUTLIER -96.72 86.76 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.456 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 0.9 OUTLIER -63.83 -43.0 97.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 11.7 t -156.71 158.77 37.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.915 0.779 . . . . 0.0 109.113 174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -134.94 146.97 49.64 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.912 -2.255 . . . . 0.0 104.912 176.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 6.1 tm-20 -135.85 132.65 36.88 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.419 ' CE1' ' HD2' ' L' ' 116' ' ' ARG . 0.1 OUTLIER -125.62 118.82 26.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.075 0.464 . . . . 0.0 111.225 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.8 130.07 55.39 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.706 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -116.07 120.77 40.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -118.62 162.49 13.33 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.62 ' HA ' HE22 ' K' ' 9' ' ' GLN . 17.3 m -71.36 -32.82 48.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.501 -0.411 . . . . 0.0 111.085 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -95.94 154.82 17.03 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 -151.7 34.65 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.633 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -138.07 162.63 33.68 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.617 0.722 . . . . 0.0 110.739 -177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.658 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 7.5 m -53.21 135.85 14.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.027 -171.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -127.05 127.98 45.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.139 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.56 126.85 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . 0.667 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 2.9 t -108.01 115.35 29.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.654 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.2 pt -117.11 128.62 74.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 2.2 m -115.57 140.59 49.03 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.751 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.456 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.3 pp -144.18 147.29 33.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.15 -172.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' L' ' 62' ' ' SER . 0.0 OUTLIER -102.78 161.05 14.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 167.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' L' ' 110' ' ' PHE . 79.5 t -139.84 158.81 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.75 HG12 ' HG ' ' K' ' 54' ' ' LEU . 6.4 pt -101.26 26.3 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.381 0.61 . . . . 0.0 110.361 -173.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.99 93.34 1.21 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.725 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' L' ' 134' ' ' VAL . 27.3 mt-10 -81.83 137.17 35.32 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.019 0.914 . . . . 0.0 110.689 174.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.596 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -118.82 154.93 32.08 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.561 ' HD3' ' OE1' ' G' ' 80' ' ' GLU . 0.1 OUTLIER -100.39 140.25 34.91 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -177.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -154.4 -169.87 3.36 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -100.88 141.92 15.56 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.199 -1.001 . . . . 0.0 111.451 169.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.902 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -83.96 128.22 34.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 1.011 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.2 OUTLIER -91.94 -44.9 14.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.755 -176.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.5 110.79 20.01 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.987 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.598 HG22 ' CE2' ' L' ' 104' ' ' TYR . 0.9 OUTLIER -63.62 -43.95 95.35 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.385 175.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 11.8 mt 54.14 63.35 7.67 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.469 1.908 . . . . 0.0 109.365 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.619 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.65 -5.55 15.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.273 1.315 . . . . 0.0 115.36 -159.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.76 85.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.568 171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.94 -65.98 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.614 HG23 HG22 ' L' ' 96' ' ' THR . 3.8 mp -60.02 -52.91 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.157 0.889 . . . . 0.0 111.287 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 51.6 t -68.96 -49.06 66.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.8 t-20 -106.08 107.23 18.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.54 97.63 3.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.3 t -95.68 159.47 14.97 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -78.78 -0.1 29.09 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.52 -4.26 76.2 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 119.393 0.997 . . . . 0.0 113.085 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.8 139.94 23.51 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -139.17 151.19 46.4 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.612 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -58.37 -54.88 42.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -158.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . 0.542 ' HD2' ' HB2' ' L' ' 162' ' ' GLN . 1.4 p90 -146.5 162.3 38.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 109.16 167.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' HB2' ' L' ' 165' ' ' GLN . 15.4 mt-30 -143.97 89.64 2.06 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 153.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . 0.542 ' HB2' ' HD2' ' L' ' 160' ' ' PHE . 3.9 tt0 -110.05 -25.13 0.15 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.622 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -77.18 7.51 3.66 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.093 1.783 . . . . 0.0 113.911 171.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.22 84.42 0.67 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.622 HE22 ' HD2' ' L' ' 163' ' ' PRO . 3.8 mp0 -100.67 68.35 1.32 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.938 1.369 . . . . 0.0 110.904 175.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.622 ' O ' ' HB ' ' L' ' 173' ' ' THR . 94.4 m 26.66 73.17 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.834 1.654 . . . . 0.0 111.912 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.513 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -96.78 161.58 13.8 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.358 -167.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -138.81 -154.11 6.33 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.509 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -23.37 64.57 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.765 0.282 . . . . 0.0 111.432 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -77.42 161.63 71.77 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.511 0.724 . . . . 0.0 109.294 -178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -84.82 -9.54 8.79 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.359 1.373 . . . . 0.0 112.753 -156.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -158.55 101.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.184 1.634 . . . . 0.0 117.184 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' L' ' 166' ' ' THR . 0.2 OUTLIER -94.51 163.66 13.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.001 0.901 . . . . 0.0 109.875 170.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 3.5 m -121.34 167.28 13.7 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.713 -1.13 . . . . 0.0 108.441 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.517 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -73.02 110.45 3.05 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.481 0.85 . . . . 0.0 111.724 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.39 1.476 . . . . 0.0 112.345 -171.7 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 102.283 -3.776 . . . . 0.0 102.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.444 ' HB ' ' CG2' ' B' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.965 0.888 . . . . 0.0 110.72 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.59 90.31 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.448 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' CG ' ' HB ' ' L' ' 48' ' ' THR . 2.5 mm-40 -77.84 -19.31 55.11 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.818 0.809 . . . . 0.0 112.394 172.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -66.69 -38.84 87.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -171.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.5 116.92 32.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.86 48.89 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.506 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 93' ' ' ARG . 4.0 m-85 -119.01 118.49 31.63 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.78 -164.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.743 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.7 46.45 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.59 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.422 0.629 . . . . 0.0 109.953 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.72 53.74 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 170.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.445 ' HA ' HD13 ' A' ' 89' ' ' ILE . 52.2 p -70.66 147.51 49.06 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.04 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 88' ' ' GLN . 1.4 pt -70.5 -39.29 76.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.012 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.2 -20.4 41.23 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.5 83.1 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.473 -175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 55.98 45.7 23.32 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 111.818 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.19 15.84 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.66 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 113.702 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.42 145.7 1.29 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.994 0.397 . . . . 0.0 111.8 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.32 60.4 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.118 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.51 31.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.391 0.818 . . . . 0.0 112.515 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 28.5 t80 -104.57 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.895 -2.322 . . . . 0.0 110.514 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.95 174.32 13.04 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-O 121.89 0.704 . . . . 0.0 112.409 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . . . 51.73 63.97 2.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.382 1.473 . . . . 0.0 111.532 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.91 145.47 36.14 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.541 1.162 . . . . 0.0 111.072 173.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tm0? -99.07 -60.77 1.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 32' ' ' GLN . 3.7 t -178.64 163.0 1.44 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.789 1.281 . . . . 0.0 111.129 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.54 118.81 12.79 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.032 -164.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.33 5.17 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.37 170.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' B' ' 118' ' ' TYR . 13.7 m -109.22 126.93 53.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.82 70.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.46 107.49 7.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -166.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.243 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' B' ' 113' ' ' ILE . 5.5 tt0 -99.88 103.81 15.42 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.1 OUTLIER -69.87 146.07 51.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.747 0.784 . . . . 0.0 110.178 -174.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 13.7 mt-10 -126.93 173.57 9.51 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.02 58.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.492 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.83 36.59 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.266 171.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.36 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 155.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 1.1 tt0 -67.3 -34.66 77.83 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.1 4.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.629 1.572 . . . . 0.0 111.635 -172.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.579 1.552 . . . . 0.0 111.534 -164.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.48 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' A' ' 52' ' ' ARG . 2.1 t-20 -102.14 10.13 39.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.22 81.65 1.41 Allowed Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.5 mmp_? -107.6 27.62 8.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -124.26 4.19 4.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.877 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.0 OUTLIER -103.09 23.44 12.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' A' ' 43' ' ' LEU . . . -94.22 164.78 26.09 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.644 0.58 . . . . 0.0 113.963 -170.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.85 154.09 43.04 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -153.47 173.41 32.25 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.55 168.17 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 0.0 110.494 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.14 130.31 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.29 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.75 119.34 32.47 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.33 146.54 31.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.905 0.882 . . . . 0.0 110.064 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -139.48 152.52 22.52 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.161 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 144.31 51.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.36 37.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 33' ' ' THR . 72.3 p -108.03 143.01 37.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 44.6 p90 -159.73 167.59 27.94 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -94.43 121.8 36.35 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -71.7 129.41 16.28 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 -175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' F' ' 5' ' ' PRO . 8.3 mttm -95.11 152.06 18.67 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.53 13.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.77 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.7 51.03 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.122 1.369 . . . . 0.0 111.032 169.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -71.5 -42.95 67.38 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -57.62 -36.53 78.75 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.828 168.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -64.92 -51.04 64.04 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 122.148 -0.619 . . . . 0.0 111.833 171.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.575 ' HB2' ' HZ2' ' A' ' 77' ' ' LYS . 8.5 mtmp? -61.6 -26.38 67.94 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.795 171.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -66.33 -44.95 81.9 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.919 168.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -58.97 -39.95 79.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.069 0.461 . . . . 0.0 110.503 172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.56 62.82 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.753 -0.592 . . . . 0.0 112.412 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 56.0 m-20 -62.32 -36.64 82.81 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.613 169.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -49.9 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.548 174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.516 ' HB2' HG21 ' A' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.98 12.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.937 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.82 48.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.016 172.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.347 -0.22 . . . . 0.0 112.882 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.13 42.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -92.11 146.65 23.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.5 mm -119.26 146.39 23.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 0.0 109.876 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.09 38.58 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -117.76 123.32 45.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 109.99 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.743 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 21.0 m95 -127.82 127.32 43.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.19 0.996 . . . . 0.0 108.328 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.25 18.01 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.3 m -126.69 163.57 28.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.258 1.028 . . . . 0.0 109.41 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.13 36.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.636 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 10' ' ' ASP . 63.0 p -72.65 -28.49 62.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.649 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.18 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.688 0.756 . . . . 0.0 109.922 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 131.8 48.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.004 -174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.0 OUTLIER -76.91 138.31 39.64 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.836 0.827 . . . . 0.0 109.989 171.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.27 -21.94 33.15 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' H ' HD22 ' A' ' 99' ' ' ASN . 13.4 m120 -123.79 26.26 7.74 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.865 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 35.9 t0 -157.73 175.58 13.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.07 2.83 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.862 -0.524 . . . . 0.0 110.592 171.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' A' ' 142' ' ' GLU . 3.5 m-85 -143.93 175.58 9.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.616 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.8 p-10 -118.24 137.9 52.72 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.597 0.713 . . . . 0.0 109.449 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -137.89 161.6 36.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.027 -163.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.571 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 44.8 tt0 -125.81 143.51 51.03 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.454 ' CZ ' ' HE2' ' A' ' 110' ' ' PHE . 20.9 t80 -134.17 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.677 . . . . 0.0 110.432 -163.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.51 178.24 43.26 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.984 170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 90' ' ' LYS . 3.1 m-30 -109.75 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -133.37 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.906 0.86 . . . . 0.0 111.196 -169.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.021 -174.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 83' ' ' TYR . 0.2 OUTLIER -90.98 86.48 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.504 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 1.0 OUTLIER -65.04 -42.54 94.23 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 160.99 31.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.974 0.806 . . . . 0.0 109.115 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.645 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.02 45.14 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.44 40.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD2' ' HB2' ' F' ' 36' ' ' SER . 0.1 OUTLIER -123.74 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.111 0.481 . . . . 0.0 111.202 176.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.87 53.41 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.721 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.22 44.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.93 16.26 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.569 ' HA ' HE22 ' F' ' 9' ' ' GLN . 27.4 m -72.56 -32.33 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.49 -0.418 . . . . 0.0 111.107 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.48 153.27 18.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.26 34.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -136.96 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.596 0.713 . . . . 0.0 110.753 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' F' ' 6' ' ' ILE . 4.9 m -56.99 139.33 16.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.037 -171.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.39 52.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.118 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.73 123.9 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.645 HG22 ' HG2' ' A' ' 116' ' ' ARG . 1.1 pt -114.88 128.48 72.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.14 141.36 47.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.726 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HA ' ' H ' ' A' ' 114' ' ' GLU . 1.6 pp -141.72 147.83 38.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.087 -172.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' OE2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -100.32 159.27 15.26 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 137' ' ' GLU . 60.1 t -140.97 160.07 23.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.469 HG12 ' HG ' ' F' ' 54' ' ' LEU . 4.2 pt -106.22 23.26 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.32 0.581 . . . . 0.0 110.344 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.16 89.12 1.04 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.708 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.832 ' HG3' HG11 ' A' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.017 0.913 . . . . 0.0 110.69 174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.21 30.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.458 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.35 34.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.9 -165.45 1.85 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -102.65 146.1 16.62 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.229 -0.986 . . . . 0.0 111.362 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.881 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -92.76 -43.96 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.798 -176.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.6 104.7 11.31 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.929 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.57 77.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.392 175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.42 61.67 12.42 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.458 1.903 . . . . 0.0 109.456 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.7 17.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.226 1.284 . . . . 0.0 115.321 -159.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -42.61 89.32 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.527 171.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.789 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.15 1.54 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.33 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 119.1 0.864 . . . . 0.0 111.277 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 54.4 t -68.54 -44.54 82.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 1.7 t-20 -108.62 107.73 18.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.44 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.49 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -172.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.66 54.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.77 -1.27 61.42 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.386 0.994 . . . . 0.0 113.053 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 138.3 23.67 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.95 48.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.327 1.051 . . . . 0.0 108.614 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.62 58.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 115.435 1.643 . . . . 0.0 115.435 -158.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.61 161.05 38.88 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.688 2.395 . . . . 0.0 109.177 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.6 87.21 1.63 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 153.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.571 ' HA ' HE22 ' G' ' 16' ' ' GLN . 4.5 tt0 -112.86 -26.34 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -166.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -76.73 8.46 3.06 Favored 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.068 1.774 . . . . 0.0 113.882 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.45 0.72 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.369 2.107 . . . . 0.0 118.369 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.589 HE22 ' HD2' ' A' ' 163' ' ' PRO . 6.2 mp0 -101.75 65.17 1.0 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.93 1.365 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.579 ' O ' ' HB ' ' A' ' 173' ' ' THR . 29.8 m 29.46 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.819 1.648 . . . . 0.0 111.867 175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.605 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.2 OUTLIER -100.52 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.325 -167.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.53 -155.06 7.37 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.527 172.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.27 -24.14 63.93 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.799 0.3 . . . . 0.0 111.466 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -75.7 163.52 66.65 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 123.444 0.698 . . . . 0.0 109.247 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 84.6 Cg_endo -82.23 -12.88 10.3 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.252 1.301 . . . . 0.0 112.746 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.71 0.22 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 117.229 1.651 . . . . 0.0 117.229 165.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.35 12.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.957 0.878 . . . . 0.0 109.847 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.486 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 4.5 m -126.84 167.92 16.09 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.367 178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -69.28 116.84 4.7 Favored 'Trans proline' 0 C--N 1.349 0.558 0 CA-C-N 119.502 0.858 . . . . 0.0 111.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.376 1.471 . . . . 0.0 112.313 -171.762 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 4.6 mt -79.68 133.07 30.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.55 167.71 13.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.882 0.849 . . . . 0.0 110.748 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.79 -34.53 90.13 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.369 -0.832 . . . . 0.0 114.513 175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.611 ' CG ' ' HB ' ' G' ' 48' ' ' THR . 2.5 mm-40 -77.93 -19.18 55.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.742 0.771 . . . . 0.0 112.419 172.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.509 ' O ' HG23 ' B' ' 96' ' ' THR . 0.5 OUTLIER -66.72 -38.91 87.65 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -171.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.48 116.9 32.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.3 149.85 48.87 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.606 0.717 . . . . 0.0 110.565 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.48 31.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.781 -164.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.741 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -115.95 142.67 46.47 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.58 142.66 46.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.457 0.646 . . . . 0.0 109.968 176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.5 tt0 -118.99 127.77 53.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.437 ' HA ' HD13 ' B' ' 89' ' ' ILE . 51.7 p -70.74 147.52 48.92 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.002 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 88' ' ' GLN . 1.4 pt -70.5 -39.18 75.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.015 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.38 -20.31 40.78 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.59 82.55 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.413 -175.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.13 45.63 23.06 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.206 1.402 . . . . 0.0 111.761 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.71 159.19 15.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.7 38.67 3.15 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 116.328 -0.397 . . . . 0.0 113.748 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.69 1.27 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.967 0.383 . . . . 0.0 111.779 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.35 60.32 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.996 2.119 . . . . 0.0 112.367 -174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.32 137.46 31.04 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.388 0.817 . . . . 0.0 112.467 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 152.99 33.56 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 28.6 t80 -104.53 140.67 21.3 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.592 -167.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.876 0.698 . . . . 0.0 112.441 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' B' ' 70' ' ' LYS . . . 51.68 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.362 1.465 . . . . 0.0 111.58 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.49 36.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 122.507 1.146 . . . . 0.0 111.06 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 3.7 tm0? -99.09 -60.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' B' ' 32' ' ' GLN . 3.7 t -178.6 163.02 1.46 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.791 1.281 . . . . 0.0 111.103 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.83 12.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.0 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.3 121.35 5.18 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.388 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' C' ' 118' ' ' TYR . 13.7 m -109.19 126.91 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.75 130.89 70.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.0 p -135.53 107.47 7.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.66 6.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.642 -0.789 . . . . 0.0 113.226 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' C' ' 113' ' ' ILE . 5.5 tt0 -99.8 103.85 15.5 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.08 51.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.741 0.782 . . . . 0.0 110.118 -174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 13.7 mt-10 -126.92 173.6 9.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.601 ' HB2' ' H ' ' B' ' 55' ' ' GLY . 0.2 OUTLIER -64.61 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.526 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.218 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.38 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.75 78.11 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.86 22.08 3.98 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.584 1.553 . . . . 0.0 111.701 -172.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.7 59.99 2.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.483 1.513 . . . . 0.0 111.578 -164.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.451 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.44 ' HB3' HH12 ' B' ' 52' ' ' ARG . 2.1 t-20 -102.09 10.11 39.75 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.29 81.74 1.41 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.6 mmp_? -107.72 27.7 8.92 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.634 HG13 HG22 ' C' ' 135' ' ' ILE . 0.3 OUTLIER -124.34 4.25 4.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.859 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.762 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.41 12.38 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' B' ' 43' ' ' LEU . . . -94.17 164.82 26.17 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.667 0.593 . . . . 0.0 113.969 -170.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -74.91 154.03 42.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.874 0.682 . . . . 0.0 113.874 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -153.44 173.38 32.23 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.2 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.525 0.679 . . . . 0.0 110.527 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.11 120.25 40.13 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.68 119.34 32.53 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -171.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 81.3 p -145.29 146.53 31.69 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.964 0.906 . . . . 0.0 110.089 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -139.49 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.18 176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.29 51.09 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.408 ' OG1' HG22 ' B' ' 33' ' ' THR . 72.2 p -107.99 142.99 37.29 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 44.5 p90 -159.72 167.58 27.98 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.4 121.77 36.28 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 129.43 16.18 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' B' ' 30' ' ' ALA . 8.3 mttm -95.14 152.03 18.7 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.448 0.642 . . . . 0.0 109.274 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -45.99 -51.44 13.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' B' ' 76' ' ' GLN . 1.8 m-20 -136.28 152.65 50.94 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.143 1.377 . . . . 0.0 111.036 169.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -71.51 -42.96 67.35 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.455 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -57.62 -36.51 78.67 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.851 168.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.01 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 122.118 -0.636 . . . . 0.0 111.859 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.561 ' HB2' ' HZ2' ' B' ' 77' ' ' LYS . 8.5 mtmp? -61.71 -26.3 67.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.784 171.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -66.33 -44.99 81.81 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.879 168.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.521 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -58.98 -39.93 79.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.04 0.448 . . . . 0.0 110.49 172.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.6 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 5.7 mm-40 -62.77 -52.49 62.99 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.766 -0.584 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 56.2 m-20 -62.29 -36.74 83.02 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.972 -0.691 . . . . 0.0 111.589 169.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.884 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -49.91 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.104 -1.039 . . . . 0.0 111.562 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.53 ' HB2' HG21 ' B' ' 113' ' ' ILE . 10.6 t80 -81.16 -48.0 12.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.948 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.6 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 1.9 mt-30 -78.39 -34.76 47.95 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -167.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.94 31.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.072 172.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.289 -0.257 . . . . 0.0 112.793 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.884 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -138.62 159.12 42.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.6 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.66 23.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.5 mm -119.3 146.38 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.354 0.597 . . . . 0.0 109.851 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 6.7 mtmt -78.08 138.11 38.58 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.7 OUTLIER -117.74 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 110.004 -165.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.741 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 21.4 m95 -127.86 127.27 43.15 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 14.3 ptm180 -128.27 115.28 18.07 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.3 m -126.69 163.62 28.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.286 1.041 . . . . 0.0 109.361 -173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.15 36.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.677 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.509 HG23 ' O ' ' B' ' 10' ' ' ASP . 62.8 p -72.64 -28.47 62.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.687 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.24 135.42 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.709 0.766 . . . . 0.0 109.865 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.85 48.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.002 -174.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.507 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.0 OUTLIER -76.94 138.28 39.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.805 0.812 . . . . 0.0 110.003 171.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -21.88 33.06 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . 0.465 ' H ' HD22 ' B' ' 99' ' ' ASN . 13.4 m120 -123.75 26.2 7.78 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.76 0.709 . . . . 0.0 110.876 169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 35.9 t0 -157.66 175.61 13.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 167.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -61.13 -61.07 2.83 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.875 -0.516 . . . . 0.0 110.548 171.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' B' ' 142' ' ' GLU . 3.6 m-85 -143.98 175.54 9.95 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.625 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.96 52.63 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.602 0.715 . . . . 0.0 109.429 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.861 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -137.92 161.65 36.1 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.065 -163.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' B' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.61 50.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' B' ' 110' ' ' PHE . 20.9 t80 -134.23 150.3 51.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.386 0.674 . . . . 0.0 110.41 -163.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.29 43.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.914 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.469 ' CE2' ' HG2' ' B' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 167.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -133.39 162.95 30.47 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.139 -169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.6 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.0 OUTLIER -126.38 161.2 28.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.977 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -91.08 86.54 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.52 94.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 177.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.86 160.99 31.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.924 0.784 . . . . 0.0 109.081 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -136.83 146.05 45.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' B' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.4 40.8 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.44 38.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.075 0.464 . . . . 0.0 111.168 176.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.717 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.79 121.26 44.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.63 158.94 16.31 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-O 121.71 0.616 . . . . 0.0 111.575 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.54 ' HA ' HE22 ' A' ' 9' ' ' GLN . 27.3 m -72.55 -32.36 41.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 O-C-N 122.491 -0.417 . . . . 0.0 111.099 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.46 153.23 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.0 -149.29 34.22 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -136.96 165.3 26.3 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.612 0.72 . . . . 0.0 110.747 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.444 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 4.9 m -56.94 139.33 16.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.023 -171.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.49 52.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.108 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.8 123.95 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' B' ' 117' ' ' GLU . 3.2 t -107.85 117.26 33.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 168.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' B' ' 116' ' ' ARG . 1.1 pt -114.88 128.46 72.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.12 141.34 47.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.696 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' B' ' 114' ' ' GLU . 1.6 pp -141.72 147.85 38.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.129 -172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.845 HG11 ' HG3' ' B' ' 137' ' ' GLU . 59.7 t -140.99 160.02 23.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.673 HG12 ' HG ' ' A' ' 54' ' ' LEU . 4.2 pt -106.19 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.312 0.577 . . . . 0.0 110.325 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.703 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.845 ' HG3' HG11 ' B' ' 134' ' ' VAL . 25.5 mt-10 -78.07 136.82 37.97 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 122.054 0.93 . . . . 0.0 110.698 174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.26 30.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.446 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.4 34.33 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.01 -165.51 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -102.6 146.12 16.65 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.396 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.861 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.75 35.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.706 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.6 OUTLIER -92.85 -44.03 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.41 104.61 11.07 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.002 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.68 76.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.781 -0.628 . . . . 0.0 112.361 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.71 12.24 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.483 1.913 . . . . 0.0 109.337 -173.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.614 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -67.89 -6.78 17.81 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.271 1.314 . . . . 0.0 115.337 -159.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.6 171.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' B' ' 27' ' ' LEU . 1.2 mp0 -109.74 -62.06 1.55 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.34 -54.38 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 119.155 0.889 . . . . 0.0 111.282 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 54.7 t -68.51 -44.56 82.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 1.7 t-20 -108.54 107.65 18.25 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.479 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.96 95.62 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.64 14.8 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.04 -5.58 54.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.3 61.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 119.447 1.022 . . . . 0.0 113.008 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.25 23.72 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.94 149.01 48.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.3 1.04 . . . . 0.0 108.603 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.95 -52.62 58.88 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -158.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.53 161.11 38.71 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.689 2.396 . . . . 0.0 109.184 167.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.21 1.62 Allowed 'General case' 0 C--O 1.233 0.212 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.607 ' HA ' HE22 ' H' ' 16' ' ' GLN . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.59 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.2 Cg_exo -76.71 8.41 3.07 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.068 1.774 . . . . 0.0 113.887 171.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.5 0.71 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.59 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.2 mp0 -101.77 65.13 1.0 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.905 1.352 . . . . 0.0 110.907 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' B' ' 173' ' ' THR . 29.6 m 29.5 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.786 1.634 . . . . 0.0 111.877 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.0 15.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.318 -167.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.507 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -24.26 64.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.692 0.282 . . . . 0.0 111.473 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -75.67 163.46 67.08 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.501 0.72 . . . . 0.0 109.26 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.496 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.0 Cg_endo -82.17 -12.96 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.3 1.333 . . . . 0.0 112.725 -156.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.68 0.22 Allowed Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.217 1.647 . . . . 0.0 117.217 165.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -96.95 164.29 12.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.988 0.894 . . . . 0.0 109.913 170.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 4.5 m -126.7 168.0 15.79 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.429 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.5 Cg_exo -69.35 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.511 0.861 . . . . 0.0 111.736 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.409 1.484 . . . . 0.0 112.308 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 102.263 -3.783 . . . . 0.0 102.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.7 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.66 13.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.75 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.72 -34.55 90.21 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.376 -0.829 . . . . 0.0 114.477 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.618 ' CG ' ' HB ' ' H' ' 48' ' ' THR . 2.5 mm-40 -77.89 -19.29 55.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 117.788 0.794 . . . . 0.0 112.397 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.52 ' O ' HG23 ' C' ' 96' ' ' THR . 0.5 OUTLIER -66.65 -38.87 87.76 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.51 116.98 32.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.35 149.92 48.88 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.67 0.748 . . . . 0.0 110.453 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' C' ' 93' ' ' ARG . 4.1 m-85 -119.08 118.52 31.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.732 -164.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -115.98 142.67 46.48 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 174.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.472 0.653 . . . . 0.0 109.993 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.5 tt0 -118.94 127.76 53.78 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . 0.444 ' HA ' HD13 ' C' ' 89' ' ' ILE . 51.9 p -70.73 147.57 48.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.006 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.51 HG12 ' O ' ' C' ' 88' ' ' GLN . 1.4 pt -70.55 -39.21 75.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.0 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.57 82.82 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.453 -175.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.65 23.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.176 1.39 . . . . 0.0 111.826 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.79 159.2 15.84 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.73 38.72 3.14 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.382 0.426 . . . . 0.0 113.715 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.46 145.68 1.27 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.966 0.383 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.7 114.33 60.48 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.964 2.106 . . . . 0.0 112.452 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.31 137.54 31.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 CA-C-N 119.457 0.842 . . . . 0.0 112.455 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' C' ' 149' ' ' GLU . 0.5 OUTLIER -117.17 153.04 33.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.31 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.546 -167.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.85 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.348 0 CA-C-O 121.815 0.673 . . . . 0.0 112.471 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.401 ' HB3' ' HE2' ' C' ' 70' ' ' LYS . . . 51.76 63.84 2.08 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.328 1.451 . . . . 0.0 111.57 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.8 145.47 36.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 122.536 1.16 . . . . 0.0 111.071 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' C' ' 67' ' ' TYR . 3.7 tm0? -99.02 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.415 HG22 ' OG1' ' C' ' 66' ' ' THR . 3.7 t -178.61 163.01 1.46 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.766 1.27 . . . . 0.0 111.081 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.75 12.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.031 -164.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.41 5.2 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.353 170.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' D' ' 118' ' ' TYR . 13.8 m -109.24 126.97 53.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.84 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.56 107.44 7.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.47 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.247 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.558 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.5 tt0 -99.8 103.79 15.44 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.751 0.786 . . . . 0.0 110.189 -174.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 13.6 mt-10 -126.96 173.64 9.47 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -167.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' C' ' 55' ' ' GLY . 0.2 OUTLIER -64.67 141.99 58.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.499 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.192 171.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.41 110.3 0.07 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' C' ' 52' ' ' ARG . 1.1 tt0 -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.83 22.1 4.0 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.591 1.557 . . . . 0.0 111.618 -172.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.77 59.92 2.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.49 1.516 . . . . 0.0 111.555 -164.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.03 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . 0.438 ' HB3' HH12 ' C' ' 52' ' ' ARG . 2.1 t-20 -102.15 10.07 39.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.68 1.4 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.6 mmp_? -107.68 27.67 8.94 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.608 ' HA ' ' HB3' ' C' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.911 178.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -103.07 23.46 12.29 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 176.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' C' ' 43' ' ' LEU . . . -94.23 164.8 26.08 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.669 0.594 . . . . 0.0 113.931 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.8 154.04 43.24 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -153.49 173.41 32.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.51 168.15 18.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.537 0.684 . . . . 0.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.31 68.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.34 40.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -171.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 81.0 p -145.31 146.54 31.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.976 0.91 . . . . 0.0 110.087 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -139.53 152.44 22.49 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.163 176.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.83 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 49.5 t -133.55 120.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' C' ' 33' ' ' THR . 72.5 p -108.05 142.99 37.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 174.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 44.5 p90 -159.69 167.61 27.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.43 121.74 36.28 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 129.41 16.43 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' C' ' 30' ' ' ALA . 8.3 mttm -95.12 152.03 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.92 -51.55 13.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -172.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' C' ' 76' ' ' GLN . 1.8 m-20 -136.21 152.72 51.07 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.118 1.367 . . . . 0.0 111.051 169.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -71.54 -42.94 67.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -57.67 -36.47 78.81 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.826 168.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.462 ' HB2' ' CZ ' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -64.85 -51.05 64.17 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.904 171.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.573 ' HB2' ' HZ2' ' C' ' 77' ' ' LYS . 8.5 mtmp? -61.58 -26.38 67.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.785 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -66.37 -44.97 81.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.882 168.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -58.96 -40.0 79.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.023 0.44 . . . . 0.0 110.442 172.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.55 62.86 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 112.442 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 56.1 m-20 -62.34 -36.66 82.88 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.574 169.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -49.9 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 10.6 t80 -81.22 -47.97 12.68 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.88 -174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.69 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -167.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 28.1 t30 -83.16 -26.0 31.34 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.904 -0.719 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.31 1.12 Allowed Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.286 -0.259 . . . . 0.0 112.825 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.12 42.87 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' C' ' 87' ' ' LYS . 1.5 mm -119.31 146.47 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.382 0.61 . . . . 0.0 109.828 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 6.7 mtmt -78.13 138.09 38.54 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -117.71 123.33 45.81 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.123 . . . . 0.0 109.967 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 20.9 m95 -127.88 127.3 43.17 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.165 0.986 . . . . 0.0 108.356 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.56 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 14.3 ptm180 -128.29 115.21 17.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.3 m -126.66 163.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 122.255 1.026 . . . . 0.0 109.433 -173.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.11 36.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.52 HG23 ' O ' ' C' ' 10' ' ' ASP . 62.3 p -72.67 -28.48 62.73 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.604 -176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.21 135.51 28.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.698 0.761 . . . . 0.0 109.902 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.17 131.91 48.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 -174.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.25 39.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.795 0.807 . . . . 0.0 109.986 171.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 -21.98 33.29 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . 0.466 ' H ' HD22 ' C' ' 99' ' ' ASN . 13.4 m120 -123.79 26.23 7.75 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.743 0.701 . . . . 0.0 110.851 169.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 36.0 t0 -157.72 175.58 13.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -61.05 -61.08 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.93 -0.481 . . . . 0.0 110.59 171.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' C' ' 142' ' ' GLU . 3.6 m-85 -143.99 175.53 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.621 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.8 p-10 -118.16 137.88 52.67 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.62 0.724 . . . . 0.0 109.445 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -137.88 161.58 36.25 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.081 -163.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.56 ' OE1' ' HD3' ' C' ' 93' ' ' ARG . 44.7 tt0 -125.81 143.56 51.01 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' C' ' 110' ' ' PHE . 21.0 t80 -134.21 150.34 51.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.357 0.663 . . . . 0.0 110.417 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.953 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.468 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.1 m-30 -109.76 130.95 55.47 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 167.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -133.42 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.887 0.851 . . . . 0.0 111.177 -169.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.18 28.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.998 -174.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' B' ' 40' ' ' GLU . 0.2 OUTLIER -91.04 86.55 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.51 94.04 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.85 160.98 31.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.914 0.779 . . . . 0.0 109.078 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.653 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.08 45.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' C' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.47 40.82 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.468 ' HD2' ' HB2' ' B' ' 36' ' ' SER . 0.1 OUTLIER -123.81 122.47 38.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.13 0.491 . . . . 0.0 111.153 176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.35 124.86 53.42 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.702 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -108.78 121.24 44.65 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.444 ' HA ' HE22 ' B' ' 9' ' ' GLN . 27.2 m -72.57 -32.4 41.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 122.487 -0.42 . . . . 0.0 111.051 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.22 18.05 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.19 34.05 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.03 165.29 26.37 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.578 0.704 . . . . 0.0 110.753 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.044 -171.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.08 131.44 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.13 -176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.96 72.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' C' ' 117' ' ' GLU . 3.2 t -107.87 117.26 33.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.653 HG22 ' HG2' ' C' ' 116' ' ' ARG . 1.1 pt -114.92 128.49 72.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.08 141.34 47.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.733 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' C' ' 114' ' ' GLU . 1.6 pp -141.69 147.87 38.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.145 -172.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -100.28 159.29 15.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 167.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.809 HG11 ' HG3' ' C' ' 137' ' ' GLU . 59.7 t -140.98 160.06 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.762 HG12 ' HG ' ' B' ' 54' ' ' LEU . 4.2 pt -106.24 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 121.399 0.618 . . . . 0.0 110.372 -173.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.09 89.13 1.05 Allowed Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.741 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.809 ' HG3' HG11 ' C' ' 134' ' ' VAL . 25.5 mt-10 -78.08 136.85 37.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.036 0.922 . . . . 0.0 110.67 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.83 153.26 30.75 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.449 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.02 -165.45 1.84 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -102.72 146.12 16.6 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.327 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.6 OUTLIER -92.75 -44.0 13.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.803 -176.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.49 104.65 11.17 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.991 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.8 -49.68 76.78 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.362 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.57 61.66 12.29 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.447 1.899 . . . . 0.0 109.394 -173.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.617 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -67.91 -6.78 17.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.248 1.299 . . . . 0.0 115.297 -159.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.65 -42.65 88.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.614 171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' C' ' 27' ' ' LEU . 1.2 mp0 -109.79 -62.05 1.56 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.38 -54.31 35.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.186 0.903 . . . . 0.0 111.298 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 54.1 t -68.59 -44.56 82.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 1.7 t-20 -108.56 107.74 18.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.429 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.03 95.59 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.61 14.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.03 -5.6 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.83 -1.28 61.3 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.343 0.974 . . . . 0.0 113.0 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.26 23.69 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.96 149.0 48.72 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.264 1.025 . . . . 0.0 108.603 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.61 58.88 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -158.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.713 2.405 . . . . 0.0 109.152 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.19 1.62 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.578 ' HA ' HE22 ' I' ' 16' ' ' GLN . 4.5 tt0 -112.89 -26.36 0.12 Allowed Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.583 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.3 Cg_exo -76.69 8.45 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.059 1.771 . . . . 0.0 113.899 171.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.41 0.72 Allowed Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.583 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.14 1.01 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 118.925 1.363 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.582 ' O ' ' HB ' ' C' ' 173' ' ' THR . 29.3 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.804 1.641 . . . . 0.0 111.924 176.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.597 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -100.52 158.99 15.51 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.314 -167.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.46 -155.01 7.37 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.528 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.24 63.93 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.797 0.299 . . . . 0.0 111.429 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -75.72 163.47 66.93 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.461 0.704 . . . . 0.0 109.228 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.2 Cg_endo -82.18 -12.92 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.258 1.305 . . . . 0.0 112.71 -156.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.23 102.73 0.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -97.0 164.27 12.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.967 0.883 . . . . 0.0 109.862 170.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 4.5 m -126.76 167.97 15.89 Favored Pre-proline 0 C--O 1.241 0.656 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.427 178.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.83 4.7 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.548 0.874 . . . . 0.0 111.712 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.434 1.494 . . . . 0.0 112.331 -171.733 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 N-CA-C 102.268 -3.782 . . . . 0.0 102.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' CG2' ' E' ' 126' ' ' VAL . 4.6 mt -79.73 133.05 30.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.7 13.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.923 0.868 . . . . 0.0 110.756 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.82 -34.5 90.07 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.473 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.545 ' HG3' ' HB ' ' I' ' 48' ' ' THR . 2.5 mm-40 -77.95 -19.21 54.98 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.788 0.794 . . . . 0.0 112.403 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' D' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.9 87.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.49 116.99 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.87 48.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.676 0.751 . . . . 0.0 110.512 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' D' ' 93' ' ' ARG . 4.1 m-85 -118.98 118.51 31.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.759 -164.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.71 46.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.65 46.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.494 0.664 . . . . 0.0 109.958 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.565 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . 0.455 ' HA ' HD13 ' D' ' 89' ' ' ILE . 51.7 p -70.75 147.53 48.91 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.588 0.709 . . . . 0.0 111.004 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.498 HG12 ' O ' ' D' ' 88' ' ' GLN . 1.4 pt -70.53 -39.21 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.986 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.3 -20.34 41.0 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.6 82.64 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.439 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.69 23.07 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.239 1.416 . . . . 0.0 111.804 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.8 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.64 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.352 -0.386 . . . . 0.0 113.713 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.49 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.999 0.399 . . . . 0.0 111.782 -177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.79 114.36 60.29 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.931 2.093 . . . . 0.0 112.444 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.33 137.53 31.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.39 0.818 . . . . 0.0 112.486 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' D' ' 149' ' ' GLU . 0.5 OUTLIER -117.18 153.03 33.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 28.6 t80 -104.56 140.63 21.26 Favored Pre-proline 0 C--N 1.316 -0.879 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.558 -167.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.84 174.33 13.02 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.887 0.703 . . . . 0.0 112.445 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' D' ' 70' ' ' LYS . . . 51.74 63.89 2.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.404 1.481 . . . . 0.0 111.547 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.77 145.45 36.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.488 1.137 . . . . 0.0 111.1 173.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.717 -2.327 . . . . 0.0 104.717 178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' D' ' 32' ' ' GLN . 3.7 t -178.6 162.98 1.46 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.757 1.265 . . . . 0.0 111.074 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.4 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 1.1 t70 -139.57 118.78 12.74 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.085 -1.416 . . . . 0.0 107.995 -164.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.4 5.19 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.334 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' E' ' 118' ' ' TYR . 13.7 m -109.26 126.97 53.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.49 107.47 7.12 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.54 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.221 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.583 ' HB3' ' O ' ' E' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.8 15.44 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.06 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.711 0.767 . . . . 0.0 110.18 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 13.7 mt-10 -126.91 173.56 9.51 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' D' ' 53' ' ' ILE . 0.2 OUTLIER -64.64 142.0 58.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.513 -179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.35 131.79 36.6 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.224 171.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.42 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.32 -34.7 77.9 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.91 22.12 3.93 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.595 1.558 . . . . 0.0 111.658 -172.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.66 59.98 2.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.495 1.518 . . . . 0.0 111.593 -164.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.08 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.469 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . 0.439 ' HB3' HH12 ' D' ' 52' ' ' ARG . 2.1 t-20 -102.09 10.03 39.81 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 81.61 1.4 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.5 mmp_? -107.62 27.66 8.93 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' D' ' 43' ' ' LEU . 0.3 OUTLIER -124.32 4.21 4.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.88 178.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.671 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.0 OUTLIER -103.08 23.44 12.33 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.612 ' H ' ' HB2' ' D' ' 43' ' ' LEU . . . -94.13 164.8 26.21 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.663 0.59 . . . . 0.0 113.954 -170.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.85 154.08 43.03 Favored 'Trans proline' 0 CA--C 1.516 -0.423 0 N-CA-C 113.849 0.673 . . . . 0.0 113.849 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -153.49 173.37 32.27 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.47 168.16 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.548 0.69 . . . . 0.0 110.521 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.35 68.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.27 40.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.33 32.48 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -171.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.35 146.54 31.64 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.971 0.909 . . . . 0.0 110.032 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -139.49 152.47 22.49 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.116 176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.56 120.36 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.416 ' OG1' HG22 ' D' ' 33' ' ' THR . 72.1 p -108.06 143.01 37.38 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.418 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 44.7 p90 -159.71 167.59 27.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.83 36.46 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.72 129.43 16.28 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' D' ' 30' ' ' ALA . 8.3 mttm -95.14 152.01 18.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.478 0.656 . . . . 0.0 109.233 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.5 13.38 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.65 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' D' ' 76' ' ' GLN . 1.8 m-20 -136.25 152.72 51.04 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.159 1.384 . . . . 0.0 111.038 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -71.56 -42.95 67.21 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -156.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.453 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -57.68 -36.46 78.86 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.197 -1.001 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -64.95 -50.92 64.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.129 -0.629 . . . . 0.0 111.887 171.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' D' ' 77' ' ' LYS . 8.5 mtmp? -61.66 -26.44 68.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.75 171.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -66.28 -44.94 82.12 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.917 168.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.51 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -58.97 -40.0 79.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.48 63.13 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.754 -0.591 . . . . 0.0 112.451 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 56.2 m-20 -62.37 -36.71 83.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.559 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.845 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -49.86 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.547 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.558 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 10.6 t80 -81.13 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.898 -174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.81 48.04 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -167.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.88 31.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.033 172.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.493 0 O-C-N 122.29 -0.256 . . . . 0.0 112.873 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.845 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.1 42.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.608 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -92.02 146.62 23.59 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 168.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.499 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.5 mm -119.26 146.42 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.363 0.601 . . . . 0.0 109.869 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 6.6 mtmt -78.11 138.11 38.56 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.456 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.3 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 110.011 -165.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 21.0 m95 -127.85 127.24 43.1 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.211 1.004 . . . . 0.0 108.354 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.565 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 14.3 ptm180 -128.22 115.28 18.1 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.3 m -126.72 163.57 28.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.261 1.029 . . . . 0.0 109.374 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.65 140.15 36.33 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.663 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' D' ' 10' ' ' ASP . 62.8 p -72.65 -28.5 62.77 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.649 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.722 0.772 . . . . 0.0 109.899 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.84 48.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 -174.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.502 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.0 OUTLIER -76.93 138.3 39.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.818 0.818 . . . . 0.0 109.972 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . 0.458 ' H ' HD22 ' D' ' 99' ' ' ASN . 13.4 m120 -123.8 26.26 7.73 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.762 0.71 . . . . 0.0 110.895 169.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 36.0 t0 -157.77 175.59 13.68 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.1 2.82 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.883 -0.511 . . . . 0.0 110.55 172.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' D' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.5 9.98 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.607 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.596 0.713 . . . . 0.0 109.479 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -137.88 161.66 36.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.002 -163.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.565 ' OE1' ' HD3' ' D' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.457 ' CZ ' ' HE2' ' D' ' 110' ' ' PHE . 21.0 t80 -134.18 150.3 51.07 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.425 0.69 . . . . 0.0 110.457 -163.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.28 43.24 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.977 170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.1 m-30 -109.79 130.96 55.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.546 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -133.39 162.87 30.67 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.909 0.861 . . . . 0.0 111.194 -169.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.979 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.493 ' OE2' ' HG3' ' D' ' 133' ' ' GLN . 1.0 OUTLIER -65.07 -42.54 94.05 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.84 161.0 31.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.924 0.784 . . . . 0.0 109.09 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.641 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.03 45.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 176.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' D' ' 129' ' ' SER . 4.7 tm-20 -132.28 130.45 40.89 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.432 ' CE1' ' HD2' ' D' ' 116' ' ' ARG . 0.1 OUTLIER -123.76 122.46 38.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.112 0.482 . . . . 0.0 111.177 176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.97 53.64 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.665 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.25 44.69 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.95 16.29 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-O 121.739 0.633 . . . . 0.0 111.57 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.408 HG13 ' O ' ' C' ' 32' ' ' GLN . 27.7 m -72.55 -32.42 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.434 -0.451 . . . . 0.0 111.106 176.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.36 153.27 18.07 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.96 -149.25 34.22 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.29 26.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.613 0.72 . . . . 0.0 110.718 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 4.9 m -56.93 139.32 16.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.04 -171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.44 52.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.74 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . 0.592 ' HB3' ' HB3' ' D' ' 117' ' ' GLU . 3.2 t -107.88 117.24 33.59 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.641 HG22 ' HG2' ' D' ' 116' ' ' ARG . 1.1 pt -114.91 128.48 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.29 47.66 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.753 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.491 ' HA ' ' H ' ' D' ' 114' ' ' GLU . 1.6 pp -141.62 147.83 38.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.16 -172.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.524 HE22 HD12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -100.27 159.32 15.21 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' D' ' 137' ' ' GLU . 59.6 t -141.01 160.02 23.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.679 HG12 ' HG ' ' C' ' 54' ' ' LEU . 4.2 pt -106.2 23.19 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.374 0.607 . . . . 0.0 110.377 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.13 89.08 1.04 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.721 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' D' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.85 37.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.044 0.926 . . . . 0.0 110.651 174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.82 153.23 30.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.451 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.1 OUTLIER -98.49 139.37 34.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.607 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -102.7 146.17 16.63 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.7 35.34 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.734 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.6 OUTLIER -92.73 -44.02 13.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.796 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.55 104.68 11.25 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.97 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.82 -49.63 76.98 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.341 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.69 12.28 Favored Pre-proline 0 C--N 1.345 0.409 0 C-N-CA 126.464 1.906 . . . . 0.0 109.364 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.616 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.72 17.71 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.22 1.28 . . . . 0.0 115.31 -159.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -42.63 88.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.588 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . 0.794 ' HB3' HD11 ' D' ' 27' ' ' LEU . 1.2 mp0 -109.78 -62.13 1.55 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.35 -54.36 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.112 0.869 . . . . 0.0 111.279 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 54.4 t -68.52 -44.59 82.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 1.6 t-20 -108.58 107.69 18.28 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.446 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.61 2.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.46 159.59 14.83 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -172.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.98 -5.62 54.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.33 61.41 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.336 0.971 . . . . 0.0 113.021 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.3 23.72 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -135.95 148.97 48.73 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.265 1.026 . . . . 0.0 108.578 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.0 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -158.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -141.6 161.08 38.8 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.703 2.401 . . . . 0.0 109.138 167.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.422 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 11.0 mt-30 -147.72 87.18 1.62 Allowed 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.479 ' HA ' HE22 ' J' ' 16' ' ' GLN . 4.4 tt0 -112.87 -26.39 0.12 Allowed Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -166.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.585 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -76.77 8.5 3.05 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.097 1.785 . . . . 0.0 113.864 171.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.27 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.585 HE22 ' HD2' ' D' ' 163' ' ' PRO . 6.2 mp0 -101.76 65.19 1.0 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.909 1.354 . . . . 0.0 110.88 175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.585 ' O ' ' HB ' ' D' ' 173' ' ' THR . 29.4 m 29.35 79.0 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.784 1.634 . . . . 0.0 111.908 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.608 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.2 OUTLIER -100.51 159.02 15.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.305 -167.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.426 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.55 -155.0 7.35 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.503 172.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.809 0.304 . . . . 0.0 111.412 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -75.66 163.49 66.9 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.486 0.715 . . . . 0.0 109.286 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.6 Cg_endo -82.18 -12.98 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.352 1.368 . . . . 0.0 112.686 -156.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.72 0.22 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.608 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -96.96 164.22 12.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.469 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 4.5 m -126.73 167.98 15.85 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.387 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.4 Cg_exo -69.34 116.8 4.69 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.49 0.853 . . . . 0.0 111.754 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.391 1.477 . . . . 0.0 112.349 -171.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 N-CA-C 102.305 -3.767 . . . . 0.0 102.305 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.445 ' HB ' HG21 ' F' ' 126' ' ' VAL . 4.6 mt -79.7 133.07 30.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.52 167.63 13.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.879 0.847 . . . . 0.0 110.761 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.57 90.25 Favored Glycine 0 C--N 1.333 0.414 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.495 175.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . 0.616 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 2.5 mm-40 -77.87 -19.25 55.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.815 0.807 . . . . 0.0 112.439 172.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.514 ' O ' HG23 ' E' ' 96' ' ' THR . 0.5 OUTLIER -66.67 -38.89 87.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.44 116.95 32.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.37 149.89 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.644 0.735 . . . . 0.0 110.53 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' E' ' 93' ' ' ARG . 4.0 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.791 -164.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.76 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -115.99 142.69 46.46 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 174.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.62 142.67 46.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.462 0.649 . . . . 0.0 109.93 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.5 tt0 -118.97 127.74 53.75 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . 0.457 ' HA ' HD13 ' E' ' 89' ' ' ILE . 52.0 p -70.7 147.52 48.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.03 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.496 HG12 ' O ' ' E' ' 88' ' ' GLN . 1.4 pt -70.51 -39.22 75.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.004 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.3 -20.35 40.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.38 -46.54 82.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.459 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.05 45.67 23.18 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.266 1.426 . . . . 0.0 111.776 -173.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.74 159.14 15.88 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.67 38.7 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.75 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.45 145.72 1.28 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.965 0.383 . . . . 0.0 111.794 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.32 60.34 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.986 2.115 . . . . 0.0 112.423 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.32 137.47 31.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.402 0.822 . . . . 0.0 112.507 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' E' ' 149' ' ' GLU . 0.5 OUTLIER -117.12 153.04 33.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 28.8 t80 -104.6 140.7 21.33 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.86 -2.336 . . . . 0.0 110.489 -167.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.92 174.32 13.03 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.875 0.698 . . . . 0.0 112.449 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.79 63.93 2.05 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.412 1.485 . . . . 0.0 111.562 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.46 36.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.507 1.146 . . . . 0.0 111.042 173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.432 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 3.8 tm0? -99.08 -60.84 1.45 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' E' ' 32' ' ' GLN . 3.7 t -178.57 162.99 1.47 Allowed 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.762 1.267 . . . . 0.0 111.113 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.85 12.81 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.106 -1.406 . . . . 0.0 107.977 -164.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.37 5.18 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.329 170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' F' ' 118' ' ' TYR . 13.7 m -109.28 126.88 53.81 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.7 130.86 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.54 107.46 7.09 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.48 118.64 6.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.261 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . 0.598 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.5 tt0 -99.82 103.84 15.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.1 OUTLIER -69.88 146.05 51.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.705 0.764 . . . . 0.0 110.16 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 13.6 mt-10 -126.9 173.63 9.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' E' ' 55' ' ' GLY . 0.2 OUTLIER -64.65 142.0 58.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.501 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.203 171.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 75.44 110.25 0.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' E' ' 52' ' ' ARG . 1.1 tt0 -67.31 -34.66 77.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.82 22.1 4.01 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.623 1.569 . . . . 0.0 111.67 -172.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.68 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.503 1.521 . . . . 0.0 111.598 -164.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -114.99 -127.86 0.29 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . 0.442 ' HB3' HH12 ' E' ' 52' ' ' ARG . 2.1 t-20 -102.12 10.05 39.76 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.34 81.69 1.41 Allowed Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' E' ' 43' ' ' LEU . 0.3 OUTLIER -124.27 4.18 4.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.907 178.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.784 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -103.07 23.44 12.32 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 176.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' E' ' 43' ' ' LEU . . . -94.18 164.77 26.13 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.642 0.579 . . . . 0.0 113.996 -170.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.84 154.11 43.1 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -153.5 173.4 32.27 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.23 18.01 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.548 0.689 . . . . 0.0 110.558 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.28 68.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.15 120.3 40.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.72 119.38 32.61 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -171.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.38 146.46 31.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.97 0.908 . . . . 0.0 110.051 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -139.47 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.175 176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.86 144.33 51.09 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.5 120.31 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . 0.415 ' OG1' HG22 ' E' ' 33' ' ' THR . 72.3 p -108.03 142.97 37.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 44.8 p90 -159.7 167.56 28.06 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -94.39 121.76 36.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.7 129.41 16.29 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -95.14 152.02 18.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -51.57 12.97 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.69 98.78 0.18 Allowed Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' E' ' 76' ' ' GLN . 1.8 m-20 -136.29 152.67 50.95 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.012 169.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -71.47 -42.97 67.48 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -57.65 -36.53 78.98 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.184 -1.008 . . . . 0.0 112.814 168.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.03 64.3 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.157 -0.614 . . . . 0.0 111.866 171.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HZ2' ' E' ' 77' ' ' LYS . 8.4 mtmp? -61.67 -26.28 67.92 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.827 171.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -66.39 -44.93 81.73 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.889 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.507 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -58.94 -40.05 79.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.08 0.467 . . . . 0.0 110.526 172.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 5.7 mm-40 -62.68 -52.47 63.19 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.754 -0.591 . . . . 0.0 112.439 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 56.2 m-20 -62.38 -36.63 82.88 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.568 169.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -49.97 -60.33 3.02 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.572 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' E' ' 113' ' ' ILE . 10.6 t80 -81.19 -47.93 12.76 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.936 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 1.9 mt-30 -78.43 -34.81 47.61 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.9 31.43 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.072 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.57 77.28 1.12 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.336 -0.228 . . . . 0.0 112.823 178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -138.59 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.611 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -92.04 146.69 23.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.423 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.489 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.5 mm -119.31 146.39 24.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.307 0.575 . . . . 0.0 109.906 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 6.7 mtmt -78.11 138.09 38.55 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.462 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.29 45.69 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.535 1.134 . . . . 0.0 109.977 -165.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 21.1 m95 -127.81 127.29 43.27 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.186 0.994 . . . . 0.0 108.363 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.3 m -126.7 163.58 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.266 1.032 . . . . 0.0 109.369 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.13 36.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.649 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.514 HG23 ' O ' ' E' ' 10' ' ' ASP . 63.0 p -72.62 -28.48 62.79 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.679 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.22 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.639 0.733 . . . . 0.0 109.913 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.05 131.88 48.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.915 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.0 OUTLIER -76.98 138.32 39.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.963 171.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.87 33.0 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . 0.452 ' H ' HD22 ' E' ' 99' ' ' ASN . 13.4 m120 -123.77 26.24 7.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.774 0.715 . . . . 0.0 110.89 169.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 36.0 t0 -157.71 175.61 13.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.724 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -61.07 -61.07 2.84 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.857 -0.527 . . . . 0.0 110.615 171.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' E' ' 142' ' ' GLU . 3.6 m-85 -143.94 175.53 9.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.8 p-10 -118.19 137.85 52.72 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 109.466 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.874 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -137.83 161.64 36.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.043 -163.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.554 ' OE1' ' HD3' ' E' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.57 51.02 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 157.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' E' ' 110' ' ' PHE . 20.9 t80 -134.18 150.29 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.4 0.68 . . . . 0.0 110.437 -163.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 178.25 43.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.977 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 167.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.544 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -133.41 162.88 30.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.963 0.887 . . . . 0.0 111.175 -169.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.611 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.0 OUTLIER -126.34 161.15 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.04 -174.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.583 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.2 OUTLIER -90.98 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 1.0 OUTLIER -65.06 -42.53 94.12 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 177.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.88 160.98 31.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 118.898 0.772 . . . . 0.0 109.083 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.631 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.07 45.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' E' ' 129' ' ' SER . 4.7 tm-20 -132.36 130.46 40.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.48 ' HD2' ' HB2' ' D' ' 36' ' ' SER . 0.1 OUTLIER -123.77 122.44 38.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.074 0.464 . . . . 0.0 111.197 176.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.32 124.88 53.44 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.669 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.82 121.2 44.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.55 158.97 16.23 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-O 121.738 0.632 . . . . 0.0 111.6 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.5 ' HA ' HE22 ' D' ' 9' ' ' GLN . 27.5 m -72.57 -32.41 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.487 -0.42 . . . . 0.0 111.115 176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.38 153.22 18.08 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.34 34.21 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.93 165.34 26.21 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.613 0.721 . . . . 0.0 110.774 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.431 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 4.9 m -56.99 139.35 16.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.094 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.087 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.77 123.99 72.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' E' ' 117' ' ' GLU . 3.2 t -107.86 117.22 33.56 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' E' ' 116' ' ' ARG . 1.1 pt -114.92 128.46 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.06 141.32 47.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.731 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' E' ' 114' ' ' GLU . 1.6 pp -141.69 147.86 38.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.069 -172.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.479 ' HG3' ' OE2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.3 15.23 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.824 HG11 ' HG3' ' E' ' 137' ' ' GLU . 59.6 t -140.97 159.99 23.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.671 HG12 ' HG ' ' D' ' 54' ' ' LEU . 4.2 pt -106.14 23.17 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.339 0.59 . . . . 0.0 110.373 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.11 1.04 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.686 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' E' ' 134' ' ' VAL . 25.4 mt-10 -78.14 136.91 37.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.068 0.937 . . . . 0.0 110.636 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.497 ' HD2' ' NE2' ' F' ' 84' ' ' GLN . 0.1 OUTLIER -98.48 139.38 34.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.47 1.85 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -102.63 146.09 16.63 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.399 169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.874 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.73 35.33 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.724 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.99 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.777 -176.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -80.49 104.65 11.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.63 76.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.49 61.67 12.35 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.471 1.908 . . . . 0.0 109.436 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.7 17.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.251 1.301 . . . . 0.0 115.282 -159.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -42.57 89.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.585 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . 0.793 ' HB3' HD11 ' E' ' 27' ' ' LEU . 1.2 mp0 -109.77 -62.07 1.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.32 -54.4 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 119.149 0.886 . . . . 0.0 111.285 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 54.4 t -68.58 -44.52 82.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 1.7 t-20 -108.55 107.66 18.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.465 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.95 95.59 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.65 14.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -172.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.97 -5.68 54.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 -1.26 61.36 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.36 0.982 . . . . 0.0 113.033 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 138.32 23.75 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.98 148.96 48.68 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.297 1.039 . . . . 0.0 108.61 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.03 -52.57 58.82 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.19 167.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.64 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.649 ' HA ' HE22 ' K' ' 16' ' ' GLN . 4.4 tt0 -112.93 -26.32 0.12 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.589 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.3 Cg_exo -76.79 8.48 3.07 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.059 1.771 . . . . 0.0 113.892 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.35 83.4 0.72 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.589 HE22 ' HD2' ' E' ' 163' ' ' PRO . 6.2 mp0 -101.67 65.16 1.01 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.93 1.365 . . . . 0.0 110.939 175.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' E' ' 173' ' ' THR . 29.4 m 29.41 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.813 1.645 . . . . 0.0 111.897 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.603 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.2 OUTLIER -100.43 159.02 15.48 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.347 -167.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.55 -155.09 7.38 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.487 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -24.27 64.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.783 0.291 . . . . 0.0 111.463 -177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -75.66 163.47 67.01 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.71 . . . . 0.0 109.263 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -82.18 -12.9 10.36 Favored 'Trans proline' 0 C--N 1.323 -0.802 0 C-N-CA 121.283 1.322 . . . . 0.0 112.747 -156.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.29 102.76 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.603 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.27 12.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.93 0.865 . . . . 0.0 109.893 170.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 4.5 m -126.7 167.96 15.9 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.472 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.83 4.71 Favored 'Trans proline' 0 C--N 1.348 0.522 0 CA-C-N 119.521 0.865 . . . . 0.0 111.738 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 125.436 1.494 . . . . 0.0 112.312 -171.67 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 N-CA-C 102.286 -3.774 . . . . 0.0 102.286 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.56 ' HB ' HG21 ' A' ' 126' ' ' VAL . 4.6 mt -79.72 133.02 30.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.53 167.68 13.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.927 0.87 . . . . 0.0 110.737 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.54 90.16 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.355 -0.838 . . . . 0.0 114.514 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . 0.569 HE22 ' HA ' ' A' ' 122' ' ' VAL . 2.5 mm-40 -77.87 -19.3 55.06 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.772 0.786 . . . . 0.0 112.406 172.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.506 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.5 OUTLIER -66.63 -38.93 87.94 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -171.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.36 149.91 48.9 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.712 0.768 . . . . 0.0 110.482 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' F' ' 93' ' ' ARG . 4.1 m-85 -119.03 118.49 31.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.769 -164.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.746 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -116.01 142.72 46.42 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.61 142.65 46.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.464 0.649 . . . . 0.0 109.95 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.5 tt0 -118.98 127.77 53.77 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . 0.452 ' HA ' HD13 ' F' ' 89' ' ' ILE . 52.5 p -70.67 147.5 49.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.079 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.508 HG12 ' O ' ' F' ' 88' ' ' GLN . 1.4 pt -70.55 -39.23 75.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.954 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.27 -20.39 41.01 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.35 -46.6 82.75 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.425 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 56.09 45.61 23.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.22 1.408 . . . . 0.0 111.83 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.73 159.17 15.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.71 38.75 3.14 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 116.29 -0.413 . . . . 0.0 113.677 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.49 145.72 1.27 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.99 0.395 . . . . 0.0 111.745 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.37 60.31 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.978 2.111 . . . . 0.0 112.39 -174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 137.55 31.05 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.425 0.83 . . . . 0.0 112.451 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.785 HD11 ' HB3' ' F' ' 149' ' ' GLU . 0.5 OUTLIER -117.19 152.99 33.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 28.7 t80 -104.56 140.74 21.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.514 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.93 174.36 12.98 Favored 'Trans proline' 0 C--N 1.331 -0.366 0 CA-C-O 121.862 0.692 . . . . 0.0 112.395 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' F' ' 70' ' ' LYS . . . 51.71 63.93 2.05 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.379 1.472 . . . . 0.0 111.577 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.83 145.47 36.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.534 1.159 . . . . 0.0 111.025 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' F' ' 67' ' ' TYR . 3.7 tm0? -99.13 -60.86 1.45 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.415 ' HB ' ' O ' ' F' ' 32' ' ' GLN . 3.7 t -178.55 163.05 1.49 Allowed 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.768 1.27 . . . . 0.0 111.073 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.6 118.8 12.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.071 -1.422 . . . . 0.0 107.969 -164.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.26 121.4 5.2 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 118' ' ' TYR . 13.8 m -109.3 126.88 53.83 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.72 130.89 70.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.44 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.68 6.01 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.23 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -99.83 103.8 15.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.48 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.08 51.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.72 0.771 . . . . 0.0 110.16 -174.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.94 173.6 9.49 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.618 ' HB2' ' H ' ' F' ' 55' ' ' GLY . 0.2 OUTLIER -64.61 141.93 58.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.502 -179.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.28 131.83 36.54 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.245 171.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.41 110.27 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 155.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' F' ' 52' ' ' ARG . 1.1 tt0 -67.27 -34.71 77.98 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.2 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.657 1.583 . . . . 0.0 111.641 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m 41.65 59.96 2.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.452 1.501 . . . . 0.0 111.616 -164.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.85 0.29 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.47 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' F' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.13 39.71 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.5 mmp_? -107.68 27.66 8.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.61 ' HA ' ' HB3' ' F' ' 43' ' ' LEU . 0.3 OUTLIER -124.29 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.879 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.469 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -103.16 23.55 12.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 176.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' F' ' 43' ' ' LEU . . . -94.23 164.83 26.1 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.676 0.598 . . . . 0.0 113.983 -170.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.88 154.08 42.88 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 N-CA-C 113.825 0.663 . . . . 0.0 113.825 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -153.47 173.38 32.25 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.53 168.19 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 0.0 110.546 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.13 130.34 68.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.13 120.33 40.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.41 32.67 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.38 146.49 31.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.914 0.886 . . . . 0.0 110.052 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -139.47 152.48 22.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.134 176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.3 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 49.2 t -133.52 120.34 37.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . 0.4 ' OG1' HG22 ' F' ' 33' ' ' THR . 72.1 p -108.02 142.95 37.4 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.429 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 44.8 p90 -159.67 167.57 28.06 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.37 121.78 36.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -71.78 129.43 16.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 114.904 0.722 . . . . 0.0 114.904 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' CB ' ' E' ' 5' ' ' PRO . 8.3 mttm -95.11 152.03 18.69 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.99 -51.47 13.41 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.76 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' F' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.69 51.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.135 1.374 . . . . 0.0 111.007 169.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -71.53 -42.91 67.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.451 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -57.65 -36.48 78.73 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.829 168.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -64.93 -51.0 64.27 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.143 -0.622 . . . . 0.0 111.816 171.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.593 ' HB2' ' HZ2' ' F' ' 77' ' ' LYS . 8.5 mtmp? -61.7 -26.32 67.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.783 171.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -66.31 -44.94 82.04 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.971 168.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.515 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -58.95 -40.05 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.484 172.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 5.8 mm-40 -62.64 -52.57 62.83 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.737 -0.602 . . . . 0.0 112.429 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.9 m-20 -62.3 -36.68 82.87 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.62 169.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.871 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -49.89 -60.39 2.96 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.557 174.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' F' ' 113' ' ' ILE . 10.7 t80 -81.18 -47.92 12.79 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.306 -0.557 . . . . 0.0 111.964 -174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.82 47.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -167.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 28.1 t30 -83.16 -25.97 31.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.007 172.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.59 77.25 1.13 Allowed Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.318 -0.238 . . . . 0.0 112.836 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.871 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -138.57 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.599 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -92.07 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 168.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.5 mm -119.27 146.39 24.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.316 0.579 . . . . 0.0 109.906 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.57 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 6.7 mtmt -78.1 138.1 38.56 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.458 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.7 OUTLIER -117.71 123.33 45.8 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.506 1.123 . . . . 0.0 109.97 -165.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 21.1 m95 -127.85 127.25 43.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 14.3 ptm180 -128.23 115.29 18.11 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.3 m -126.71 163.6 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.253 1.025 . . . . 0.0 109.371 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.7 140.13 36.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.643 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 62.7 p -72.66 -28.48 62.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.635 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.44 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.713 0.768 . . . . 0.0 109.912 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.09 131.93 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.965 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.497 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.0 OUTLIER -77.05 138.32 39.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.845 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.91 33.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' F' ' 99' ' ' ASN . 13.4 m120 -123.8 26.31 7.72 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.766 0.712 . . . . 0.0 110.902 169.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 35.9 t0 -157.73 175.62 13.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.736 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -61.12 -61.03 2.86 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.895 -0.503 . . . . 0.0 110.583 171.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' F' ' 142' ' ' GLU . 3.6 m-85 -143.97 175.54 9.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.8 p-10 -118.21 137.87 52.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.462 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -137.84 161.6 36.18 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.126 -163.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' F' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.52 51.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' F' ' 110' ' ' PHE . 20.9 t80 -134.16 150.32 51.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.388 0.675 . . . . 0.0 110.449 -163.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.937 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.474 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.1 m-30 -109.72 130.97 55.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.55 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -133.46 162.89 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.985 0.898 . . . . 0.0 111.172 -169.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.16 28.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.96 -174.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.2 OUTLIER -90.97 86.54 2.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.493 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 1.0 OUTLIER -65.07 -42.6 93.99 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 160.97 31.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 118.91 0.777 . . . . 0.0 109.078 174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.632 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -136.72 146.06 45.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' F' ' 129' ' ' SER . 4.7 tm-20 -132.35 130.4 40.68 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.484 ' HD2' ' HB2' ' E' ' 36' ' ' SER . 0.1 OUTLIER -123.69 122.47 38.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.108 0.48 . . . . 0.0 111.235 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.34 124.9 53.49 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.689 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.61 158.93 16.29 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.57 -32.34 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.514 -0.403 . . . . 0.0 111.062 176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -94.39 153.23 18.08 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.98 -149.29 34.26 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 166.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.32 26.26 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.599 0.714 . . . . 0.0 110.704 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.445 HG21 ' HB ' ' E' ' 6' ' ' ILE . 4.9 m -57.01 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.062 -171.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.42 52.05 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.059 -176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' F' ' 117' ' ' GLU . 3.2 t -107.89 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 168.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.632 HG22 ' HG2' ' F' ' 116' ' ' ARG . 1.1 pt -114.91 128.53 72.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.33 47.61 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.697 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.493 ' HA ' ' H ' ' F' ' 114' ' ' GLU . 1.6 pp -141.69 147.89 38.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.097 -172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -100.33 159.31 15.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' F' ' 137' ' ' GLU . 59.4 t -140.97 160.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.784 HG12 ' HG ' ' E' ' 54' ' ' LEU . 4.2 pt -106.2 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.326 0.584 . . . . 0.0 110.369 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.19 89.07 1.04 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.703 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' F' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.88 38.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 122.064 0.935 . . . . 0.0 110.64 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.84 153.27 30.74 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.452 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.1 OUTLIER -98.54 139.38 34.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.95 -165.48 1.85 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -102.66 146.12 16.63 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.36 169.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 6.2 tp10 -87.84 127.75 35.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.736 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.785 -176.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -80.48 104.65 11.16 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.026 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.83 -49.52 77.39 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.401 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.43 61.68 12.4 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.42 1.888 . . . . 0.0 109.451 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.604 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.216 1.277 . . . . 0.0 115.315 -159.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.58 89.04 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.622 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . 0.785 ' HB3' HD11 ' F' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.12 1.55 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.3 -54.35 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.155 0.889 . . . . 0.0 111.277 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.604 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 54.4 t -68.59 -44.51 82.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.71 18.31 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.48 -176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.96 95.53 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.5 159.68 14.78 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.61 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.29 61.45 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 119.326 0.966 . . . . 0.0 113.06 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.743 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -74.63 138.29 23.74 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.561 ' N ' HD11 ' L' ' 138' ' ' LEU . 33.2 m-85 -135.92 149.0 48.78 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.323 1.049 . . . . 0.0 108.623 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.02 -52.6 58.74 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -158.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.706 ' CD2' HD13 ' L' ' 143' ' ' ILE . 1.4 p90 -141.55 161.09 38.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.648 2.379 . . . . 0.0 109.177 167.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.6 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 11.0 mt-30 -147.59 87.13 1.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.682 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 4.4 tt0 -112.87 -26.37 0.12 Allowed Pre-proline 0 C--O 1.241 0.615 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.699 ' O ' ' HA2' ' L' ' 23' ' ' GLY . 22.2 Cg_exo -76.68 8.41 3.06 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.03 1.761 . . . . 0.0 113.902 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 80.26 83.49 0.71 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 118.391 2.117 . . . . 0.0 118.391 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' F' ' 175' ' ' PRO . 6.3 mp0 -101.73 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.88 1.34 . . . . 0.0 110.911 175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 29.4 m 29.42 78.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.768 1.627 . . . . 0.0 111.909 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.735 HG21 ' HD3' ' L' ' 90' ' ' LYS . 0.2 OUTLIER -100.44 159.04 15.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.33 -167.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.742 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.59 -155.06 7.36 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.476 172.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.3 OUTLIER -69.21 -24.22 64.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.77 0.285 . . . . 0.0 111.455 -177.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -75.71 163.47 66.96 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.478 0.711 . . . . 0.0 109.259 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -82.12 -12.98 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.305 1.337 . . . . 0.0 112.711 -156.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.21 102.73 0.22 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -97.01 164.32 12.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.997 0.898 . . . . 0.0 109.849 170.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 4.5 m -126.8 167.92 16.07 Favored Pre-proline 0 C--O 1.241 0.633 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.4 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.77 4.68 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.515 0.862 . . . . 0.0 111.737 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.473 1.509 . . . . 0.0 112.323 -171.697 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.553 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 102.296 -3.771 . . . . 0.0 102.296 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.655 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.5 mt -79.69 133.07 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.58 167.72 13.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.915 0.864 . . . . 0.0 110.725 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.58 90.29 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.526 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . 0.648 HE22 ' HA ' ' H' ' 122' ' ' VAL . 2.5 mm-40 -77.85 -19.25 55.2 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.73 0.765 . . . . 0.0 112.429 172.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.512 ' O ' HG23 ' G' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.85 87.58 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.49 116.97 32.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.36 149.85 48.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.656 0.741 . . . . 0.0 110.541 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' G' ' 93' ' ' ARG . 4.1 m-85 -118.95 118.47 31.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.791 -164.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -115.93 142.68 46.46 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.56 142.67 46.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.444 0.64 . . . . 0.0 110.001 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.571 HE22 ' HA ' ' A' ' 162' ' ' GLN . 5.5 tt0 -118.93 127.79 53.81 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . 0.447 ' HA ' HD13 ' G' ' 89' ' ' ILE . 52.1 p -70.7 147.52 49.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 111.034 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.499 HG12 ' O ' ' G' ' 88' ' ' GLN . 1.4 pt -70.55 -39.2 75.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.971 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -81.3 -20.37 40.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.56 82.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.437 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 56.1 45.59 23.2 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.181 1.392 . . . . 0.0 111.793 -173.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.76 159.19 15.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.502 ' HA2' ' C ' ' A' ' 163' ' ' PRO . . . -87.68 38.67 3.15 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.43 145.68 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.977 0.388 . . . . 0.0 111.791 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.34 60.38 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.946 2.099 . . . . 0.0 112.432 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.27 137.46 31.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.405 0.823 . . . . 0.0 112.49 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' G' ' 149' ' ' GLU . 0.5 OUTLIER -117.13 153.01 33.53 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 28.6 t80 -104.56 140.72 21.35 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.871 -2.332 . . . . 0.0 110.523 -167.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.93 174.35 12.99 Favored 'Trans proline' 0 C--N 1.332 -0.304 0 CA-C-O 121.859 0.691 . . . . 0.0 112.438 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.403 ' HB3' ' HE2' ' G' ' 70' ' ' LYS . . . 51.75 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.374 1.47 . . . . 0.0 111.541 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.9 145.45 36.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.587 1.184 . . . . 0.0 111.03 173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 3.7 tm0? -99.04 -60.83 1.46 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' G' ' 32' ' ' GLN . 3.7 t -178.61 162.99 1.46 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 122.781 1.277 . . . . 0.0 111.076 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.52 118.83 12.82 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.07 -1.423 . . . . 0.0 108.003 -164.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.43 5.2 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.32 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . 0.535 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 13.8 m -109.31 126.93 53.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.76 130.82 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.44 7.1 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.44 118.67 6.01 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.24 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' H' ' 113' ' ' ILE . 5.5 tt0 -99.87 103.77 15.39 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.1 OUTLIER -69.84 146.12 51.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.725 0.774 . . . . 0.0 110.142 -174.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.98 173.64 9.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.613 ' HB2' ' H ' ' G' ' 55' ' ' GLY . 0.2 OUTLIER -64.66 141.97 58.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.508 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.85 36.58 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.191 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.43 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.33 -34.67 77.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.86 22.11 3.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.613 1.565 . . . . 0.0 111.642 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.611 ' HB ' ' CG ' ' B' ' 9' ' ' GLN . 1.1 m 41.67 59.98 2.31 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.469 1.508 . . . . 0.0 111.593 -164.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.83 0.29 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.462 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . 0.441 ' HB3' HH12 ' G' ' 52' ' ' ARG . 2.1 t-20 -102.13 10.11 39.69 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.5 mmp_? -107.7 27.72 8.9 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.596 ' HA ' ' HB3' ' G' ' 43' ' ' LEU . 0.3 OUTLIER -124.31 4.2 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.913 178.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.668 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.0 OUTLIER -103.13 23.46 12.33 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 176.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' G' ' 43' ' ' LEU . . . -94.18 164.78 26.14 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.655 0.586 . . . . 0.0 113.942 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.82 154.05 43.13 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -153.48 173.4 32.25 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.24 18.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.562 0.696 . . . . 0.0 110.545 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.19 130.35 68.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.12 120.34 40.27 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 174.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.77 119.4 32.63 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 81.1 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 110.065 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -139.52 152.49 22.51 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.138 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 144.36 51.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.25 37.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . 0.412 ' OG1' HG22 ' G' ' 33' ' ' THR . 72.3 p -108.02 142.98 37.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.433 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 44.7 p90 -159.68 167.62 27.95 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -94.42 121.79 36.32 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -71.72 129.42 16.25 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' L' ' 5' ' ' PRO . 8.3 mttm -95.09 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.01 -51.46 13.52 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.73 0.18 Allowed Glycine 0 N--CA 1.452 -0.267 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' G' ' 76' ' ' GLN . 1.8 m-20 -136.22 152.66 50.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.159 1.383 . . . . 0.0 111.032 169.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -71.46 -43.0 67.45 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.449 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -57.58 -36.54 78.49 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.858 168.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -64.89 -50.98 64.4 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.868 171.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' G' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.95 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.802 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -66.3 -44.98 81.94 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.882 168.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -59.03 -39.96 79.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.014 0.435 . . . . 0.0 110.436 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.591 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 5.8 mm-40 -62.63 -52.56 62.88 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.79 -0.568 . . . . 0.0 112.448 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 55.9 m-20 -62.32 -36.7 82.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.564 169.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.866 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -49.93 -60.36 3.0 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.043 -1.063 . . . . 0.0 111.582 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HB2' HG21 ' G' ' 113' ' ' ILE . 10.6 t80 -81.21 -47.99 12.66 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.891 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 1.9 mt-30 -78.37 -34.8 48.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 28.0 t30 -83.19 -25.9 31.36 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.056 172.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.341 -0.225 . . . . 0.0 112.891 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.866 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -138.56 159.16 42.79 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.607 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -92.05 146.64 23.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 168.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.5 mm -119.3 146.43 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.359 0.6 . . . . 0.0 109.86 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 6.6 mtmt -78.08 138.14 38.6 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.454 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -117.73 123.31 45.73 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.491 1.116 . . . . 0.0 110.028 -166.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.752 ' HB2' ' HG ' ' G' ' 14' ' ' LEU . 20.5 m95 -127.83 127.29 43.23 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.237 1.015 . . . . 0.0 108.363 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.564 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 14.3 ptm180 -128.25 115.25 18.03 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.3 m -126.75 163.58 28.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.241 1.019 . . . . 0.0 109.391 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.64 140.11 36.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.634 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.512 HG23 ' O ' ' G' ' 10' ' ' ASP . 62.7 p -72.67 -28.46 62.72 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.636 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.23 135.42 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.694 0.759 . . . . 0.0 109.912 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 131.9 48.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.93 -174.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.0 OUTLIER -76.96 138.3 39.57 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.8 0.809 . . . . 0.0 109.974 171.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.31 -21.87 33.1 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . 0.47 ' H ' HD22 ' G' ' 99' ' ' ASN . 13.4 m120 -123.78 26.22 7.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.734 0.697 . . . . 0.0 110.863 169.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 35.9 t0 -157.75 175.57 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.722 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.0 2.88 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.824 -0.547 . . . . 0.0 110.579 171.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' G' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.58 9.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.609 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.8 p-10 -118.26 137.84 52.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.594 0.711 . . . . 0.0 109.47 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.848 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -137.82 161.65 36.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.05 -163.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.564 ' OE1' ' HD3' ' G' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.56 51.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' G' ' 110' ' ' PHE . 21.1 t80 -134.2 150.29 51.06 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.4 0.68 . . . . 0.0 110.469 -163.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.26 43.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.919 170.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.96 55.47 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.548 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -133.4 162.97 30.4 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 111.18 -169.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.0 OUTLIER -126.42 161.15 28.55 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.49 -1.232 . . . . 0.0 107.995 -174.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' G' ' 83' ' ' TYR . 0.2 OUTLIER -90.97 86.46 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 1.0 OUTLIER -65.02 -42.55 94.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.85 161.0 31.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.943 0.792 . . . . 0.0 109.064 174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.643 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -136.79 146.07 45.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' G' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.41 40.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.551 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.39 37.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.069 0.462 . . . . 0.0 111.233 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.25 124.91 53.48 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.686 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.59 158.94 16.27 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . 0.604 ' HA ' HE22 ' L' ' 9' ' ' GLN . 27.6 m -72.53 -32.37 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.522 -0.399 . . . . 0.0 111.087 176.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.43 153.25 18.04 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.28 34.16 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.914 -1.675 . . . . 0.0 108.914 166.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.96 165.33 26.25 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.542 0.686 . . . . 0.0 110.736 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.645 HG21 ' HB ' ' L' ' 6' ' ' ILE . 4.9 m -57.0 139.34 16.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.072 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.14 131.46 52.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.057 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.76 124.06 72.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' G' ' 117' ' ' GLU . 3.2 t -107.95 117.23 33.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' G' ' 116' ' ' ARG . 1.1 pt -114.94 128.47 72.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.04 141.31 47.6 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.711 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' G' ' 114' ' ' GLU . 1.6 pp -141.68 147.89 38.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.139 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' OE2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -100.34 159.3 15.24 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' G' ' 137' ' ' GLU . 60.2 t -141.0 160.09 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.677 HG12 ' HG ' ' L' ' 54' ' ' LEU . 4.2 pt -106.25 23.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.326 -173.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.18 89.12 1.04 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.675 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . 0.848 ' HG3' HG11 ' G' ' 134' ' ' VAL . 25.4 mt-10 -78.11 136.86 37.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.095 0.95 . . . . 0.0 110.645 174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.22 30.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.608 ' HD2' ' NE2' ' H' ' 84' ' ' GLN . 0.1 OUTLIER -98.52 139.39 34.33 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -102.65 146.11 16.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.389 169.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.848 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 6.2 tp10 -87.81 127.68 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.722 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.6 OUTLIER -92.77 -44.0 13.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -176.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 162' ' ' GLN . 10.3 m-20 -80.56 104.65 11.23 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.999 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.81 -49.61 77.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 118.728 -0.654 . . . . 0.0 112.376 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.33 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.455 1.902 . . . . 0.0 109.398 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -67.93 -6.7 17.65 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 121.189 1.259 . . . . 0.0 115.338 -159.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.62 89.11 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.597 171.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . 0.784 ' HB3' HD11 ' G' ' 27' ' ' LEU . 1.2 mp0 -109.72 -62.2 1.53 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.28 -54.33 35.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.146 0.885 . . . . 0.0 111.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 54.1 t -68.63 -44.51 82.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 1.7 t-20 -108.57 107.68 18.28 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.448 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.95 95.58 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.52 159.66 14.79 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.99 -5.61 54.31 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 -1.22 61.45 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 119.368 0.985 . . . . 0.0 113.064 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 138.31 23.75 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -136.0 148.92 48.63 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.337 1.055 . . . . 0.0 108.617 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.85 -52.66 59.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -158.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.03 38.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.72 2.408 . . . . 0.0 109.157 167.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.6 87.25 1.63 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.006 -1.849 . . . . 0.0 106.006 154.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.91 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.586 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -76.7 8.46 3.05 Favored 'Trans proline' 0 C--O 1.238 0.506 0 CA-C-N 122.096 1.784 . . . . 0.0 113.917 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.44 0.71 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.368 2.107 . . . . 0.0 118.368 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.593 ' HB3' ' HD3' ' G' ' 175' ' ' PRO . 6.2 mp0 -101.7 65.16 1.0 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.869 1.335 . . . . 0.0 110.937 175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.575 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 29.5 m 29.44 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.808 1.643 . . . . 0.0 111.893 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.607 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -100.46 159.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.286 -167.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.01 7.35 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.518 172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 -24.21 63.93 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.792 0.296 . . . . 0.0 111.432 -177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -75.64 163.48 66.98 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 123.489 0.716 . . . . 0.0 109.258 -178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.8 Cg_endo -82.18 -12.93 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 121.309 1.339 . . . . 0.0 112.733 -156.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.26 102.66 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.607 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.01 0.905 . . . . 0.0 109.88 170.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 4.5 m -126.71 167.97 15.88 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.438 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -69.33 116.78 4.68 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.513 0.862 . . . . 0.0 111.743 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.406 1.482 . . . . 0.0 112.333 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.555 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 102.23 -3.796 . . . . 0.0 102.23 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.654 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.6 mt -79.67 133.05 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.5 167.68 13.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.905 0.86 . . . . 0.0 110.754 -177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.84 -34.52 90.1 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.456 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . 0.578 HE22 ' HA ' ' I' ' 122' ' ' VAL . 2.5 mm-40 -77.93 -19.23 55.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.782 0.791 . . . . 0.0 112.398 172.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.507 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.81 87.5 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.51 116.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.33 149.87 48.89 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.511 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' H' ' 93' ' ' ARG . 4.0 m-85 -119.0 118.46 31.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.769 -164.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -116.0 142.69 46.46 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 174.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.57 142.72 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.434 0.635 . . . . 0.0 109.944 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.607 HE22 ' HA ' ' B' ' 162' ' ' GLN . 5.5 tt0 -119.0 127.78 53.77 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . 0.449 ' HA ' HD13 ' H' ' 89' ' ' ILE . 51.8 p -70.77 147.56 48.85 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.582 0.705 . . . . 0.0 111.032 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' H' ' 88' ' ' GLN . 1.4 pt -70.57 -39.22 75.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.951 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -81.25 -20.42 41.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.4 -46.54 82.82 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.409 -175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.491 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 56.06 45.65 23.2 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.213 1.405 . . . . 0.0 111.79 -173.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.77 159.11 15.91 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.525 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -87.67 38.74 3.14 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.726 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -173.46 145.74 1.28 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.971 0.385 . . . . 0.0 111.787 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.78 114.34 60.34 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.968 2.107 . . . . 0.0 112.424 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.32 137.48 31.08 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.416 0.827 . . . . 0.0 112.46 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' H' ' 149' ' ' GLU . 0.5 OUTLIER -117.15 153.04 33.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 28.4 t80 -104.57 140.7 21.33 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.556 -167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.87 174.34 13.0 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.882 0.701 . . . . 0.0 112.453 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' H' ' 70' ' ' LYS . . . 51.8 63.86 2.07 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 111.542 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.81 145.49 36.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.56 1.171 . . . . 0.0 111.068 173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 3.7 tm0? -99.1 -60.85 1.45 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' H' ' 32' ' ' GLN . 3.7 t -178.56 163.02 1.48 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.839 1.304 . . . . 0.0 111.103 -179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.58 118.85 12.79 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.004 -164.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.32 121.37 5.18 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.37 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . 0.498 ' HB2' ' HD2' ' I' ' 118' ' ' TYR . 13.8 m -109.26 126.91 53.83 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.86 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.46 7.1 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.57 118.65 5.99 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' I' ' 113' ' ' ILE . 5.5 tt0 -99.84 103.81 15.44 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.1 OUTLIER -69.79 146.1 51.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.741 0.781 . . . . 0.0 110.165 -174.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.96 173.58 9.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -167.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.618 ' HB3' ' HA ' ' H' ' 53' ' ' ILE . 0.2 OUTLIER -64.61 142.04 58.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.523 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.36 131.78 36.62 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.213 171.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 155.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' H' ' 52' ' ' ARG . 1.1 tt0 -67.3 -34.72 77.97 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.85 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.623 1.569 . . . . 0.0 111.677 -172.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.618 ' HB ' ' CG ' ' C' ' 9' ' ' GLN . 1.1 m 41.74 59.97 2.33 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.461 1.504 . . . . 0.0 111.558 -164.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.13 -127.82 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.432 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . 0.443 ' HB3' HH12 ' H' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.04 39.77 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.32 81.65 1.4 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.5 mmp_? -107.65 27.69 8.91 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.618 ' HA ' ' HB3' ' H' ' 43' ' ' LEU . 0.3 OUTLIER -124.36 4.22 4.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.889 178.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.606 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.0 OUTLIER -103.05 23.41 12.35 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . 0.597 ' H ' ' HB2' ' H' ' 43' ' ' LEU . . . -94.21 164.85 26.14 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.689 0.605 . . . . 0.0 113.944 -170.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.89 154.08 42.8 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -153.5 173.32 32.28 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.54 168.18 18.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.617 0.722 . . . . 0.0 110.507 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 4.5 t -114.12 130.27 68.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.07 120.3 40.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.7 119.37 32.6 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 81.6 p -145.35 146.55 31.64 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.91 0.884 . . . . 0.0 110.005 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -139.51 152.49 22.51 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.169 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 144.34 51.1 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.54 120.31 37.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . 0.402 ' OG1' HG22 ' H' ' 33' ' ' THR . 72.3 p -108.07 143.03 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 44.6 p90 -159.69 167.61 27.94 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.43 121.74 36.27 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -71.65 129.4 16.42 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' G' ' 5' ' ' PRO . 8.3 mttm -95.11 151.99 18.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -45.95 -51.49 13.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -172.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' H' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.67 50.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.117 1.367 . . . . 0.0 111.037 169.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -71.52 -42.91 67.39 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -156.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -57.65 -36.55 79.09 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.796 168.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -64.83 -51.04 64.22 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.861 171.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.554 ' HZ2' ' HB2' ' H' ' 77' ' ' LYS . 8.5 mtmp? -61.61 -26.38 67.95 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.822 171.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -66.33 -44.92 81.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.923 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.514 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -58.99 -40.02 79.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.081 0.467 . . . . 0.0 110.448 172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 5.8 mm-40 -62.69 -52.53 62.92 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.764 -0.585 . . . . 0.0 112.441 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 56.1 m-20 -62.28 -36.74 83.02 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.569 169.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.86 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -49.84 -60.44 2.91 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.58 174.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.52 ' HB2' HG21 ' H' ' 113' ' ' ILE . 10.7 t80 -81.17 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.93 -174.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.608 ' NE2' ' HD2' ' G' ' 139' ' ' LYS . 1.9 mt-30 -78.41 -34.75 47.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 28.0 t30 -83.2 -25.91 31.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.026 172.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.53 77.3 1.12 Allowed Glycine 0 N--CA 1.448 -0.53 0 O-C-N 122.34 -0.225 . . . . 0.0 112.901 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.86 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -138.64 159.13 42.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.606 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.62 23.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.482 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.5 mm -119.29 146.45 23.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.35 0.595 . . . . 0.0 109.836 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 6.6 mtmt -78.13 138.13 38.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.467 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.7 OUTLIER -117.72 123.31 45.74 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.54 1.136 . . . . 0.0 109.992 -165.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.759 ' HB2' ' HG ' ' H' ' 14' ' ' LEU . 20.8 m95 -127.84 127.26 43.16 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.219 1.008 . . . . 0.0 108.362 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.566 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.3 18.1 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 172.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.3 m -126.69 163.56 28.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.226 1.012 . . . . 0.0 109.4 -173.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.13 36.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.64 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 62.2 p -72.62 -28.54 62.82 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.64 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.12 135.4 28.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.678 0.751 . . . . 0.0 109.91 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.9 48.93 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.013 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.33 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.823 0.821 . . . . 0.0 109.961 171.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -21.92 32.96 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' H' ' 99' ' ' ASN . 13.4 m120 -123.77 26.31 7.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.787 0.721 . . . . 0.0 110.874 169.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 36.0 t0 -157.77 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -61.11 -61.05 2.85 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.864 -0.522 . . . . 0.0 110.553 171.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' H' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.55 9.94 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.615 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.82 52.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.63 0.729 . . . . 0.0 109.458 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -137.82 161.63 36.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.077 -163.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.566 ' OE1' ' HD3' ' H' ' 93' ' ' ARG . 44.8 tt0 -125.78 143.55 51.01 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 157.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.459 ' CZ ' ' HE2' ' H' ' 110' ' ' PHE . 20.9 t80 -134.2 150.31 51.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.396 0.678 . . . . 0.0 110.424 -163.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.48 178.27 43.23 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.544 -1.312 . . . . 0.0 111.947 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.475 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.1 m-30 -109.74 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -133.4 162.88 30.64 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.86 0.838 . . . . 0.0 111.218 -169.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.606 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.16 28.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.0 -174.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' H' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 1.0 OUTLIER -64.99 -42.63 94.33 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.79 161.05 31.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.918 0.781 . . . . 0.0 109.113 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.651 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.01 45.16 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.572 ' HB3' ' HB3' ' H' ' 129' ' ' SER . 4.7 tm-20 -132.29 130.46 40.88 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.535 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.1 OUTLIER -123.76 122.46 38.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.212 176.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.92 53.55 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.645 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.91 121.25 44.72 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.57 158.96 16.25 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . 0.648 ' HA ' HE22 ' G' ' 9' ' ' GLN . 27.8 m -72.51 -32.44 41.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.523 -0.398 . . . . 0.0 111.122 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.34 153.22 18.1 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 169.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.04 -149.29 34.16 Favored Glycine 0 C--O 1.243 0.667 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.28 26.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.575 0.702 . . . . 0.0 110.755 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.655 HG21 ' HB ' ' G' ' 6' ' ' ILE . 4.9 m -56.96 139.29 16.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.09 -171.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.11 131.42 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.121 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.73 123.97 72.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' H' ' 117' ' ' GLU . 3.2 t -107.85 117.21 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 168.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.651 HG22 ' HG2' ' H' ' 116' ' ' ARG . 1.1 pt -114.87 128.39 72.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 141.31 47.59 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.373 0.669 . . . . 0.0 109.735 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' H' ' 114' ' ' GLU . 1.6 pp -141.7 147.88 38.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.091 -172.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.483 ' HG3' ' OE2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.28 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.831 HG11 ' HG3' ' H' ' 137' ' ' GLU . 59.4 t -141.0 160.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.668 HG12 ' HG ' ' G' ' 54' ' ' LEU . 4.2 pt -106.21 23.2 2.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.328 0.585 . . . . 0.0 110.337 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.13 1.04 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.712 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . 0.831 ' HG3' HG11 ' H' ' 134' ' ' VAL . 25.4 mt-10 -78.07 136.81 37.97 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.029 0.919 . . . . 0.0 110.659 174.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 153.25 30.7 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' I' ' 84' ' ' GLN . 0.1 OUTLIER -98.54 139.41 34.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -177.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.49 1.86 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -102.61 146.14 16.65 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.359 169.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.879 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.67 35.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.95 13.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.763 -176.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' B' ' 162' ' ' GLN . 10.2 m-20 -80.54 104.72 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.94 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.89 -49.6 77.17 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.35 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.52 61.73 12.23 Favored Pre-proline 0 C--N 1.346 0.431 0 C-N-CA 126.435 1.894 . . . . 0.0 109.357 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.599 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -67.95 -6.72 17.75 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 121.21 1.273 . . . . 0.0 115.335 -159.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -42.6 89.05 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.566 171.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . 0.782 ' HB3' HD11 ' H' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.11 1.55 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.36 -54.35 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 119.135 0.88 . . . . 0.0 111.246 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 54.4 t -68.58 -44.5 82.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 1.7 t-20 -108.61 107.66 18.23 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.434 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.0 95.56 2.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.45 159.65 14.79 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.06 -5.53 54.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.74 -1.27 61.47 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.415 1.007 . . . . 0.0 113.076 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.72 138.35 23.75 Favored Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -135.93 148.96 48.75 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.36 1.064 . . . . 0.0 108.627 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.99 -52.6 58.84 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -158.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.05 38.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.702 2.401 . . . . 0.0 109.127 167.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.86 -26.4 0.12 Allowed Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.592 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -76.67 8.43 3.05 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.06 1.771 . . . . 0.0 113.911 171.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.29 83.42 0.71 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.592 HE22 ' HD2' ' H' ' 163' ' ' PRO . 6.2 mp0 -101.68 65.13 1.01 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 118.905 1.353 . . . . 0.0 110.929 175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 29.5 m 29.46 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.791 1.637 . . . . 0.0 111.901 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.609 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -100.47 159.02 15.49 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.275 -167.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.56 -155.0 7.35 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.484 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.26 -24.26 63.96 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.807 0.304 . . . . 0.0 111.431 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -75.71 163.49 66.79 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.47 0.708 . . . . 0.0 109.235 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.0 Cg_endo -82.17 -12.94 10.36 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.305 1.336 . . . . 0.0 112.732 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.7 0.22 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.609 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -96.98 164.25 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.927 0.864 . . . . 0.0 109.891 170.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 4.5 m -126.71 167.95 15.92 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.433 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.506 0.859 . . . . 0.0 111.741 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.406 1.482 . . . . 0.0 112.294 -171.695 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 102.252 -3.788 . . . . 0.0 102.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.546 ' HB ' HG21 ' J' ' 126' ' ' VAL . 4.6 mt -79.72 133.07 30.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.51 167.69 13.74 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.903 0.859 . . . . 0.0 110.763 -177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.512 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . 0.549 HE22 ' HA ' ' J' ' 122' ' ' VAL . 2.5 mm-40 -77.86 -19.27 55.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.768 0.784 . . . . 0.0 112.416 172.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.519 ' O ' HG23 ' I' ' 96' ' ' THR . 0.5 OUTLIER -66.71 -38.83 87.51 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.47 116.98 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.37 149.92 48.9 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.692 0.758 . . . . 0.0 110.502 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' I' ' 93' ' ' ARG . 4.0 m-85 -118.99 118.52 31.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.771 -164.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.761 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -116.03 142.61 46.57 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.54 142.69 46.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.472 0.653 . . . . 0.0 109.965 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.578 HE22 ' HA ' ' C' ' 162' ' ' GLN . 5.5 tt0 -118.98 127.8 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . 0.436 ' HA ' HD13 ' I' ' 89' ' ' ILE . 51.8 p -70.77 147.54 48.87 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.578 0.704 . . . . 0.0 111.02 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.504 HG12 ' O ' ' I' ' 88' ' ' GLN . 1.4 pt -70.5 -39.2 75.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.009 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.35 -20.34 40.84 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.36 -46.63 82.55 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.428 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 56.08 45.7 23.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.224 1.41 . . . . 0.0 111.786 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' C' ' 163' ' ' PRO . . . -87.68 38.66 3.15 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 123.356 0.41 . . . . 0.0 113.773 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.44 145.73 1.28 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.902 0.351 . . . . 0.0 111.8 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 114.34 60.3 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.972 2.109 . . . . 0.0 112.423 -174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.29 137.52 31.26 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.396 0.82 . . . . 0.0 112.486 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' I' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.06 33.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 28.4 t80 -104.58 140.66 21.29 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.551 -167.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.87 174.3 13.07 Favored 'Trans proline' 0 C--N 1.331 -0.362 0 CA-C-N 119.047 0.695 . . . . 0.0 112.47 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.78 63.92 2.05 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.358 1.463 . . . . 0.0 111.545 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.87 145.51 36.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.086 173.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.7 tm0? -99.09 -60.86 1.45 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' I' ' 32' ' ' GLN . 3.7 t -178.62 163.02 1.45 Allowed 'General case' 0 C--O 1.242 0.704 0 CA-C-O 122.77 1.272 . . . . 0.0 111.106 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.81 12.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.991 -164.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.29 121.32 5.17 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.371 170.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.595 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 13.7 m -109.25 126.98 53.88 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.78 130.85 70.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.52 107.47 7.11 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.49 118.73 6.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.229 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.5 tt0 -99.91 103.87 15.47 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.482 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.1 OUTLIER -69.9 146.09 51.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.731 0.777 . . . . 0.0 110.181 -174.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 13.6 mt-10 -126.94 173.6 9.5 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.616 ' HB3' ' HA ' ' I' ' 53' ' ' ILE . 0.2 OUTLIER -64.62 141.94 58.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.498 -179.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.78 36.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.241 171.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.5 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 155.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.31 -34.69 77.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.81 22.14 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.645 1.578 . . . . 0.0 111.669 -172.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.545 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 1.1 m 41.67 59.96 2.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.519 1.528 . . . . 0.0 111.584 -164.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -115.05 -127.89 0.29 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.455 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.437 ' HB3' HH12 ' I' ' 52' ' ' ARG . 2.1 t-20 -102.07 10.11 39.78 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.7 1.41 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.5 mmp_? -107.68 27.62 8.99 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.616 ' HA ' ' HB3' ' I' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.24 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.862 178.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.771 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -103.06 23.42 12.34 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' I' ' 43' ' ' LEU . . . -94.19 164.8 26.13 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-O 121.727 0.626 . . . . 0.0 113.89 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.84 154.07 43.05 Favored 'Trans proline' 0 CA--C 1.516 -0.398 0 N-CA-C 113.893 0.69 . . . . 0.0 113.893 -175.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -153.48 173.37 32.26 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.56 168.2 18.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.578 0.704 . . . . 0.0 110.485 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.27 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.039 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.05 120.25 40.11 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.71 119.36 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.3 146.51 31.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.929 0.892 . . . . 0.0 110.059 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -139.53 152.42 22.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.159 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.3 51.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 49.3 t -133.49 120.33 37.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' I' ' 33' ' ' THR . 72.2 p -108.05 142.92 37.48 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 44.6 p90 -159.66 167.66 27.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -94.51 121.74 36.37 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.555 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -71.61 129.42 16.55 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' H' ' 5' ' ' PRO . 8.2 mttm -95.12 152.02 18.7 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.423 0.63 . . . . 0.0 109.319 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -51.47 13.3 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.78 98.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' I' ' 76' ' ' GLN . 1.8 m-20 -136.2 152.74 51.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.117 1.367 . . . . 0.0 111.031 169.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -71.57 -42.89 67.26 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -57.73 -36.42 79.03 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.855 168.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.06 64.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.854 171.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' I' ' 77' ' ' LYS . 8.5 mtmp? -61.59 -26.37 67.93 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.805 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -66.33 -44.96 81.86 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.876 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.52 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -58.98 -39.97 79.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-O 121.055 0.455 . . . . 0.0 110.461 172.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 5.7 mm-40 -62.71 -52.48 63.09 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.722 -0.611 . . . . 0.0 112.427 -178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 56.1 m-20 -62.36 -36.71 83.12 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.529 169.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.855 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -49.89 -60.38 2.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.572 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.526 ' HB2' HG21 ' I' ' 113' ' ' ILE . 10.6 t80 -81.15 -48.0 12.71 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.956 -174.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.609 ' NE2' ' HD2' ' H' ' 139' ' ' LYS . 1.9 mt-30 -78.42 -34.8 47.68 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -167.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 28.1 t30 -83.14 -25.97 31.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.03 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.58 77.24 1.13 Allowed Glycine 0 N--CA 1.449 -0.498 0 O-C-N 122.342 -0.224 . . . . 0.0 112.905 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.855 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.13 42.87 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.602 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -92.0 146.61 23.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.487 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.5 mm -119.27 146.49 23.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 109.89 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 6.6 mtmt -78.17 138.09 38.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.464 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -117.7 123.32 45.79 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.521 1.129 . . . . 0.0 109.978 -165.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 21.0 m95 -127.84 127.29 43.22 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.214 1.005 . . . . 0.0 108.36 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.562 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 14.3 ptm180 -128.28 115.26 18.03 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.3 m -126.71 163.58 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.269 1.033 . . . . 0.0 109.42 -173.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.68 140.19 36.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.626 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.519 HG23 ' O ' ' I' ' 10' ' ' ASP . 62.6 p -72.65 -28.48 62.76 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.673 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.26 135.45 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.701 0.762 . . . . 0.0 109.887 176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.1 131.9 48.9 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.986 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.0 OUTLIER -76.97 138.27 39.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.86 0.838 . . . . 0.0 109.952 171.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 -21.91 33.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . 0.469 ' H ' HD22 ' I' ' 99' ' ' ASN . 13.4 m120 -123.82 26.28 7.72 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.872 169.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 36.0 t0 -157.7 175.64 13.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.888 -0.508 . . . . 0.0 110.584 171.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' I' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.56 9.93 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.611 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.8 p-10 -118.18 137.89 52.68 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.671 0.748 . . . . 0.0 109.44 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -137.85 161.61 36.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.084 -163.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.562 ' OE1' ' HD3' ' I' ' 93' ' ' ARG . 44.7 tt0 -125.86 143.59 51.01 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 157.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.452 ' CZ ' ' HE2' ' I' ' 110' ' ' PHE . 20.8 t80 -134.22 150.34 51.04 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.349 0.659 . . . . 0.0 110.376 -163.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.52 178.25 43.25 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.929 170.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.473 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.1 m-30 -109.73 130.9 55.47 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.541 ' HB2' HG22 ' I' ' 134' ' ' VAL . . . -133.41 162.9 30.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.962 0.886 . . . . 0.0 111.15 -169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.602 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.24 28.3 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.978 -174.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' I' ' 83' ' ' TYR . 0.2 OUTLIER -91.06 86.56 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.49 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 1.0 OUTLIER -65.08 -42.54 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.84 161.0 31.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.969 0.804 . . . . 0.0 109.091 174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.657 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -136.77 146.04 45.29 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.574 ' HB3' ' HB3' ' I' ' 129' ' ' SER . 4.7 tm-20 -132.31 130.38 40.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.498 ' HD2' ' HB2' ' H' ' 36' ' ' SER . 0.1 OUTLIER -123.75 122.45 38.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.0 111.195 176.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.28 124.9 53.48 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.703 177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.84 121.19 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.52 158.96 16.2 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . 0.578 ' HA ' HE22 ' H' ' 9' ' ' GLN . 27.2 m -72.59 -32.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 O-C-N 122.488 -0.419 . . . . 0.0 111.107 176.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.39 153.22 18.08 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.05 -149.26 34.1 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 166.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.99 165.32 26.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 0.0 110.708 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.654 HG21 ' HB ' ' H' ' 6' ' ' ILE . 4.9 m -57.0 139.35 16.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.036 -171.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.16 131.44 52.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.084 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' I' ' 117' ' ' GLU . 3.2 t -107.84 117.23 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.657 HG22 ' HG2' ' I' ' 116' ' ' ARG . 1.1 pt -114.92 128.45 72.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.02 141.34 47.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.736 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.49 ' HA ' ' H ' ' I' ' 114' ' ' GLU . 1.6 pp -141.73 147.82 38.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.125 -172.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.49 ' HG3' ' OE2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -100.31 159.29 15.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.839 HG11 ' HG3' ' I' ' 137' ' ' GLU . 60.0 t -140.99 160.03 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.606 HG12 ' HG ' ' H' ' 54' ' ' LEU . 4.2 pt -106.18 23.25 2.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.323 0.582 . . . . 0.0 110.342 -173.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.17 89.1 1.04 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.648 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . 0.839 ' HG3' HG11 ' I' ' 134' ' ' VAL . 25.4 mt-10 -78.1 136.89 37.96 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.069 0.938 . . . . 0.0 110.642 174.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.87 153.26 30.8 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.498 ' HD3' ' OE1' ' J' ' 80' ' ' GLU . 0.1 OUTLIER -98.52 139.36 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.44 1.84 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -102.7 146.14 16.62 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.201 -0.999 . . . . 0.0 111.359 169.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 6.2 tp10 -87.85 127.71 35.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.723 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -44.0 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.756 -176.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' C' ' 162' ' ' GLN . 10.4 m-20 -80.51 104.61 11.16 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.01 -176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.75 -49.65 76.86 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.366 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.51 61.7 12.28 Favored Pre-proline 0 C--N 1.346 0.435 0 C-N-CA 126.423 1.889 . . . . 0.0 109.407 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.61 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -67.91 -6.75 17.76 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.236 1.291 . . . . 0.0 115.314 -159.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -42.64 89.15 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.54 171.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . 0.779 ' HB3' HD11 ' I' ' 27' ' ' LEU . 1.2 mp0 -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.35 35.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.164 0.893 . . . . 0.0 111.298 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 54.1 t -68.62 -44.51 82.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 1.7 t-20 -108.56 107.69 18.3 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.455 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.01 95.6 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.47 159.57 14.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -78.95 -5.58 54.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.75 -1.33 61.5 Favored Glycine 0 C--N 1.332 0.338 0 CA-C-N 119.345 0.975 . . . . 0.0 113.059 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 138.28 23.76 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.94 148.97 48.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.305 1.042 . . . . 0.0 108.604 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -64.01 -52.61 58.73 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 -158.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.58 161.06 38.84 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.683 2.393 . . . . 0.0 109.161 167.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.63 87.22 1.62 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.9 -26.35 0.12 Allowed Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -166.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.578 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -76.73 8.43 3.07 Favored 'Trans proline' 0 C--O 1.239 0.572 0 CA-C-N 122.061 1.772 . . . . 0.0 113.877 171.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' I' ' 175' ' ' PRO . 6.2 mp0 -101.68 65.17 1.01 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.902 1.351 . . . . 0.0 110.937 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.58 ' O ' ' HB ' ' I' ' 173' ' ' THR . 29.4 m 29.45 78.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.776 1.631 . . . . 0.0 111.923 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -100.48 159.05 15.46 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.28 -167.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.57 -155.09 7.37 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.503 172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -24.25 64.03 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.786 0.293 . . . . 0.0 111.471 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -75.65 163.51 66.79 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.479 0.712 . . . . 0.0 109.251 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.6 Cg_endo -82.19 -12.96 10.33 Favored 'Trans proline' 0 C--N 1.324 -0.736 0 C-N-CA 121.283 1.322 . . . . 0.0 112.754 -156.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.75 0.22 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -96.97 164.29 12.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.971 0.886 . . . . 0.0 109.895 170.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 4.5 m -126.71 167.93 15.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.44 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -69.33 116.81 4.69 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.506 0.859 . . . . 0.0 111.711 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.246 0 C-N-CA 125.402 1.481 . . . . 0.0 112.339 -171.726 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 102.294 -3.772 . . . . 0.0 102.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.589 ' HB ' HG21 ' K' ' 126' ' ' VAL . 4.6 mt -79.73 133.09 30.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.66 13.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.904 0.859 . . . . 0.0 110.747 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.73 -34.56 90.22 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.377 -0.829 . . . . 0.0 114.52 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . 0.612 HE22 ' HA ' ' K' ' 122' ' ' VAL . 2.5 mm-40 -77.82 -19.28 55.21 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.778 0.789 . . . . 0.0 112.42 172.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.506 ' O ' HG23 ' J' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.9 87.68 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -90.46 117.0 32.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -126.43 149.87 49.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.718 0.771 . . . . 0.0 110.47 176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' J' ' 93' ' ' ARG . 4.1 m-85 -119.04 118.51 31.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.733 -164.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.757 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -116.02 142.7 46.45 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.59 142.66 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.412 0.625 . . . . 0.0 109.957 176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.5 tt0 -119.01 127.8 53.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . 0.446 ' HA ' HD13 ' J' ' 89' ' ' ILE . 51.9 p -70.72 147.55 48.92 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.035 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.506 HG12 ' O ' ' J' ' 88' ' ' GLN . 1.4 pt -70.52 -39.2 75.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.031 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -81.34 -20.4 40.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.58 82.75 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.468 -175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 56.14 45.61 23.06 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.21 1.404 . . . . 0.0 111.785 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.22 15.82 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.569 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -87.72 38.69 3.15 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.725 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.47 145.71 1.27 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.986 0.393 . . . . 0.0 111.794 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.76 114.38 60.33 Favored Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.893 2.077 . . . . 0.0 112.411 -174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.3 137.54 31.26 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.395 0.82 . . . . 0.0 112.494 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' J' ' 149' ' ' GLU . 0.5 OUTLIER -117.16 153.04 33.51 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 28.5 t80 -104.58 140.71 21.34 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.835 -2.346 . . . . 0.0 110.479 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.91 174.36 12.97 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.849 0.687 . . . . 0.0 112.435 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.404 ' HB3' ' HE2' ' J' ' 70' ' ' LYS . . . 51.71 63.89 2.06 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 111.572 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.47 36.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.574 1.178 . . . . 0.0 111.071 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 3.7 tm0? -99.08 -60.82 1.46 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . 0.417 HG22 ' OG1' ' J' ' 66' ' ' THR . 3.7 t -178.57 163.04 1.47 Allowed 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.744 1.259 . . . . 0.0 111.093 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.59 118.8 12.74 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.1 -1.409 . . . . 0.0 107.996 -164.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.41 5.19 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.358 170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . 0.55 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 13.8 m -109.28 126.98 53.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.79 130.82 70.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.51 107.41 7.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.46 118.71 6.02 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.269 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' K' ' 113' ' ' ILE . 5.5 tt0 -99.83 103.77 15.41 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.477 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.09 51.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.7 0.762 . . . . 0.0 110.161 -174.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.59 9.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' H ' ' J' ' 55' ' ' GLY . 0.2 OUTLIER -64.66 142.01 58.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.512 -179.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.31 131.81 36.57 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.223 171.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.4 110.3 0.07 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 155.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' J' ' 52' ' ' ARG . 1.1 tt0 -67.28 -34.69 77.93 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.85 22.12 3.98 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.622 1.569 . . . . 0.0 111.659 -172.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.616 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 1.1 m 41.69 60.02 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 111.562 -164.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.1 -127.82 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.487 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . 0.434 ' HB3' HH12 ' J' ' 52' ' ' ARG . 2.1 t-20 -102.15 10.12 39.65 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.31 81.66 1.4 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.68 8.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.605 ' HA ' ' HB3' ' J' ' 43' ' ' LEU . 0.3 OUTLIER -124.3 4.17 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.922 178.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.647 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.49 12.26 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' J' ' 43' ' ' LEU . . . -94.24 164.78 26.06 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.926 -170.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.83 154.12 43.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 N-CA-C 113.875 0.683 . . . . 0.0 113.875 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -153.52 173.41 32.28 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.57 168.21 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 110.489 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.18 130.28 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.35 32.5 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -171.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 81.2 p -145.36 146.47 31.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.926 0.89 . . . . 0.0 110.052 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -139.46 152.49 22.49 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.145 176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.87 144.38 51.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.52 120.3 37.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . 0.417 ' OG1' HG22 ' J' ' 33' ' ' THR . 72.2 p -108.04 142.95 37.43 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 44.5 p90 -159.68 167.58 28.03 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.44 121.78 36.34 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.66 129.42 16.41 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.44 ' HG2' ' HB3' ' I' ' 5' ' ' PRO . 8.3 mttm -95.12 152.04 18.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.97 -51.49 13.34 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.73 98.76 0.18 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' J' ' 76' ' ' GLN . 1.8 m-20 -136.24 152.67 50.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.141 1.376 . . . . 0.0 111.049 169.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -71.47 -42.96 67.49 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.454 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -57.69 -36.46 78.92 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.849 168.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -64.88 -51.05 64.07 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.808 171.114 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.565 ' HB2' ' HZ2' ' J' ' 77' ' ' LYS . 8.5 mtmp? -61.65 -26.35 67.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.801 171.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -66.28 -44.98 82.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.909 168.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.519 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -58.91 -40.05 79.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.139 0.495 . . . . 0.0 110.512 172.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.598 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 5.8 mm-40 -62.67 -52.57 62.81 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 121.694 -0.629 . . . . 0.0 112.419 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.9 m-20 -62.24 -36.74 82.95 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.565 169.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.854 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -49.87 -60.37 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.596 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.538 ' HB2' HG21 ' J' ' 113' ' ' ILE . 10.7 t80 -81.22 -47.99 12.67 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.901 -174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 1.9 mt-30 -78.44 -34.78 47.57 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -167.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 28.1 t30 -83.18 -25.93 31.34 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.998 172.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.54 77.26 1.12 Allowed Glycine 0 N--CA 1.448 -0.516 0 O-C-N 122.359 -0.213 . . . . 0.0 112.877 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.854 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -138.63 159.07 43.0 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -91.98 146.7 23.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.5 mm -119.35 146.41 24.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 121.369 0.604 . . . . 0.0 109.86 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 6.6 mtmt -78.07 138.08 38.58 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.453 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.7 OUTLIER -117.73 123.32 45.74 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.5 1.12 . . . . 0.0 109.983 -165.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.757 ' HB2' ' HG ' ' J' ' 14' ' ' LEU . 21.1 m95 -127.82 127.33 43.3 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.561 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 14.3 ptm180 -128.3 115.27 18.04 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.3 m -126.7 163.59 28.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.239 1.018 . . . . 0.0 109.445 -173.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.72 140.14 36.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.604 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.506 HG23 ' O ' ' J' ' 10' ' ' ASP . 62.6 p -72.67 -28.45 62.71 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.63 -176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.25 135.47 28.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.723 0.773 . . . . 0.0 109.862 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 131.84 48.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.978 -174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.0 OUTLIER -76.92 138.3 39.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.791 0.805 . . . . 0.0 110.014 171.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.34 -21.85 33.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' J' ' 99' ' ' ASN . 13.5 m120 -123.79 26.21 7.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.723 0.692 . . . . 0.0 110.908 169.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 36.0 t0 -157.72 175.65 13.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 167.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -61.18 -61.02 2.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.915 -0.491 . . . . 0.0 110.546 172.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' J' ' 142' ' ' GLU . 3.6 m-85 -143.96 175.59 9.92 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.593 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.8 p-10 -118.2 137.9 52.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.573 0.701 . . . . 0.0 109.441 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -137.87 161.68 36.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.03 -163.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.561 ' OE1' ' HD3' ' J' ' 93' ' ' ARG . 44.7 tt0 -125.87 143.55 51.03 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 157.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HE2' ' J' ' 110' ' ' PHE . 20.9 t80 -134.21 150.3 51.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.404 0.681 . . . . 0.0 110.411 -163.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.5 178.31 43.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.466 -1.35 . . . . 0.0 111.923 170.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' J' ' 90' ' ' LYS . 3.1 m-30 -109.8 130.93 55.47 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 167.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -133.41 162.9 30.6 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.907 0.86 . . . . 0.0 111.18 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.0 OUTLIER -126.35 161.14 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.011 -174.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.2 OUTLIER -90.93 86.53 2.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 1.0 OUTLIER -65.05 -42.62 94.09 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.81 161.03 31.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.882 0.765 . . . . 0.0 109.088 174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.647 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -136.85 146.04 45.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 176.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.58 ' HB3' ' HB3' ' J' ' 129' ' ' SER . 4.7 tm-20 -132.27 130.53 41.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -123.82 122.39 37.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 111.148 176.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.29 124.92 53.53 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.703 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.83 121.25 44.68 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 167.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.97 16.26 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.549 ' HA ' HE22 ' I' ' 9' ' ' GLN . 27.5 m -72.54 -32.39 41.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.521 -0.399 . . . . 0.0 111.137 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.41 153.26 18.04 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.25 34.12 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.95 165.27 26.37 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.573 0.702 . . . . 0.0 110.745 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.546 HG21 ' HB ' ' I' ' 6' ' ' ILE . 4.8 m -56.93 139.29 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.045 -171.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.13 131.42 52.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.105 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.72 123.98 72.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . 0.58 ' HB3' ' HB3' ' J' ' 117' ' ' GLU . 3.2 t -107.91 117.21 33.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.647 HG22 ' HG2' ' J' ' 116' ' ' ARG . 1.1 pt -114.86 128.51 71.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.07 141.33 47.59 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.365 0.666 . . . . 0.0 109.736 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.503 ' HA ' ' H ' ' J' ' 114' ' ' GLU . 1.6 pp -141.72 147.81 38.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.098 -172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' OE2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.37 15.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.827 HG11 ' HG3' ' J' ' 137' ' ' GLU . 59.4 t -141.02 160.0 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.771 HG12 ' HG ' ' I' ' 54' ' ' LEU . 4.2 pt -106.2 23.24 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.39 0.614 . . . . 0.0 110.381 -173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.14 89.08 1.04 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.674 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . 0.827 ' HG3' HG11 ' J' ' 134' ' ' VAL . 25.5 mt-10 -78.05 136.83 37.99 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.035 0.922 . . . . 0.0 110.681 174.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.77 153.25 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.511 ' HD2' ' NE2' ' K' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.38 34.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.97 -165.47 1.85 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -102.67 146.14 16.63 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.381 169.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 6.2 tp10 -87.86 127.69 35.34 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.726 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.6 OUTLIER -92.81 -43.97 13.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.766 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' D' ' 162' ' ' GLN . 10.2 m-20 -80.52 104.61 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.947 -176.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.76 -49.64 76.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.382 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.54 61.66 12.32 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.412 1.885 . . . . 0.0 109.425 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.607 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -67.94 -6.67 17.61 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.234 1.289 . . . . 0.0 115.327 -159.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.8 -42.57 89.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.588 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . 0.795 ' HB3' HD11 ' J' ' 27' ' ' LEU . 1.2 mp0 -109.75 -62.09 1.55 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -173.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 3.6 mp -62.3 -54.39 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.146 0.884 . . . . 0.0 111.296 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.607 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 54.3 t -68.6 -44.52 82.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.451 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.93 95.64 2.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.54 159.6 14.82 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -172.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.59 54.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.78 -1.27 61.39 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.43 1.014 . . . . 0.0 113.041 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.31 23.75 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -177.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -135.95 148.98 48.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.31 1.044 . . . . 0.0 108.632 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.58 59.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -158.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.09 38.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.718 2.407 . . . . 0.0 109.171 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.61 87.16 1.62 Allowed 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 153.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.87 -26.32 0.12 Allowed Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.591 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -76.75 8.49 3.05 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.035 1.762 . . . . 0.0 113.891 171.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.33 83.48 0.71 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 118.316 2.086 . . . . 0.0 118.316 -171.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.591 HE22 ' HD2' ' J' ' 163' ' ' PRO . 6.2 mp0 -101.7 65.13 1.0 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.905 1.353 . . . . 0.0 110.927 175.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.574 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 29.3 m 29.43 78.92 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.817 1.647 . . . . 0.0 111.906 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.599 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -100.49 159.02 15.48 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.351 -167.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.52 -155.09 7.38 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.471 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.23 63.99 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.796 0.298 . . . . 0.0 111.432 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -75.7 163.49 66.85 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.52 0.728 . . . . 0.0 109.254 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.7 Cg_endo -82.17 -12.91 10.37 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.303 1.336 . . . . 0.0 112.769 -156.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.24 102.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -96.92 164.26 12.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.027 0.913 . . . . 0.0 109.907 170.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 4.5 m -126.76 167.94 16.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.415 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.6 Cg_exo -69.36 116.82 4.7 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.499 0.857 . . . . 0.0 111.657 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.434 1.494 . . . . 0.0 112.321 -171.741 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 102.273 -3.78 . . . . 0.0 102.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.596 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 4.6 mt -79.74 133.06 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.59 167.69 13.69 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.924 0.868 . . . . 0.0 110.703 -177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.5 90.06 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.48 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . 0.618 HE22 ' HA ' ' L' ' 122' ' ' VAL . 2.5 mm-40 -77.94 -19.25 54.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.791 0.796 . . . . 0.0 112.39 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.516 ' O ' HG23 ' K' ' 96' ' ' THR . 0.5 OUTLIER -66.7 -38.88 87.63 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 23.9 t -90.46 116.97 32.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.39 149.91 48.93 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.728 0.775 . . . . 0.0 110.499 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' K' ' 93' ' ' ARG . 4.1 m-85 -119.02 118.46 31.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.719 -164.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.751 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -115.96 142.71 46.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.6 142.73 46.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.46 0.648 . . . . 0.0 109.98 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.649 HE22 ' HA ' ' E' ' 162' ' ' GLN . 5.5 tt0 -118.98 127.75 53.76 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . 0.458 ' HA ' HD13 ' K' ' 89' ' ' ILE . 52.4 p -70.69 147.53 48.98 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.583 0.706 . . . . 0.0 111.017 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.495 HG12 ' O ' ' K' ' 88' ' ' GLN . 1.4 pt -70.54 -39.23 75.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.965 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.31 -20.35 40.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.43 -46.5 82.91 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.459 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 56.05 45.63 23.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.228 1.411 . . . . 0.0 111.829 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -103.78 159.17 15.86 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' C ' ' E' ' 163' ' ' PRO . . . -87.72 38.68 3.15 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 123.377 0.423 . . . . 0.0 113.731 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.4 145.74 1.3 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.918 0.359 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.77 114.29 60.41 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 127.003 2.121 . . . . 0.0 112.384 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.26 137.45 31.19 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.438 0.835 . . . . 0.0 112.503 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' K' ' 149' ' ' GLU . 0.5 OUTLIER -117.14 153.03 33.51 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 28.6 t80 -104.54 140.68 21.31 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.822 -2.351 . . . . 0.0 110.518 -167.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.9 174.37 12.96 Favored 'Trans proline' 0 C--N 1.332 -0.312 0 CA-C-O 121.873 0.697 . . . . 0.0 112.428 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' K' ' 70' ' ' LYS . . . 51.69 63.95 2.04 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.392 1.477 . . . . 0.0 111.556 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -77.84 145.46 36.3 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.508 1.147 . . . . 0.0 111.061 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' K' ' 33' ' ' THR . 3.7 tm0? -99.06 -60.75 1.47 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' K' ' 32' ' ' GLN . 3.7 t -178.66 162.96 1.43 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.802 1.287 . . . . 0.0 111.065 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.53 118.89 12.85 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.983 -164.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.35 121.42 5.19 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.337 170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' L' ' 118' ' ' TYR . 13.7 m -109.28 126.99 53.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.78 130.86 70.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 12.8 p -135.57 107.46 7.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.55 118.7 6.01 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.221 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' L' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.78 15.4 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.1 OUTLIER -69.8 146.05 51.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.674 0.749 . . . . 0.0 110.209 -174.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -126.94 173.63 9.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.611 ' HB2' ' H ' ' K' ' 55' ' ' GLY . 0.2 OUTLIER -64.59 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.505 -179.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.32 131.81 36.57 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.211 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.44 110.26 0.07 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 155.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.29 -34.66 77.86 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.84 22.1 3.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 111.626 -172.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.48 ' HB ' ' HG3' ' F' ' 9' ' ' GLN . 1.1 m 41.74 59.95 2.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.485 1.514 . . . . 0.0 111.571 -164.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . 0.403 ' HD2' ' H ' ' F' ' 30' ' ' ALA . 7.1 mmtp -115.06 -127.88 0.29 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.441 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.433 ' HB3' HH12 ' K' ' 52' ' ' ARG . 2.1 t-20 -102.17 10.18 39.58 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.28 81.62 1.4 Allowed Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.6 mmp_? -107.61 27.71 8.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.606 ' HA ' ' HB3' ' K' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.19 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.921 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.46 12.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . 0.611 ' H ' ' HB2' ' K' ' 43' ' ' LEU . . . -94.23 164.82 26.1 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.648 0.582 . . . . 0.0 113.923 -170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.86 154.09 42.99 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -153.5 173.39 32.27 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.22 17.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.576 0.703 . . . . 0.0 110.531 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.24 130.29 68.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.09 120.3 40.21 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.76 119.33 32.44 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 81.4 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -139.49 152.46 22.48 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.174 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.85 144.34 51.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 49.1 t -133.53 120.37 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . 0.407 ' OG1' HG22 ' K' ' 33' ' ' THR . 72.1 p -108.1 142.95 37.53 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 44.6 p90 -159.68 167.6 27.98 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.45 121.79 36.35 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -71.72 129.4 16.24 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.922 0.729 . . . . 0.0 114.922 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' J' ' 5' ' ' PRO . 8.3 mttm -95.1 152.02 18.69 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.0 -51.47 13.45 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.75 98.75 0.18 Allowed Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' K' ' 76' ' ' GLN . 1.8 m-20 -136.26 152.66 50.97 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.096 1.359 . . . . 0.0 111.041 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -71.49 -42.96 67.43 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.45 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -57.61 -36.47 78.41 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.885 168.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -64.91 -51.04 64.1 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.12 -0.635 . . . . 0.0 111.798 171.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HZ2' ' K' ' 77' ' ' LYS . 8.5 mtmp? -61.68 -26.28 67.93 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.787 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -66.38 -44.93 81.72 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.903 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.513 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -58.94 -40.04 79.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.077 0.465 . . . . 0.0 110.486 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 5.8 mm-40 -62.68 -52.47 63.17 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.764 -0.585 . . . . 0.0 112.454 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 56.3 m-20 -62.38 -36.65 82.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.566 169.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.857 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -49.88 -60.41 2.94 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.581 174.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.541 ' HB2' HG21 ' K' ' 113' ' ' ILE . 10.6 t80 -81.16 -47.99 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.879 -174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.606 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 1.9 mt-30 -78.42 -34.79 47.73 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -167.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 28.2 t30 -83.16 -25.95 31.37 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.069 172.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.29 1.12 Allowed Glycine 0 N--CA 1.449 -0.453 0 O-C-N 122.353 -0.217 . . . . 0.0 112.86 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.857 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -138.6 159.14 42.83 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -91.99 146.67 23.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 168.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.5 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.5 mm -119.31 146.45 23.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.378 0.609 . . . . 0.0 109.826 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 6.7 mtmt -78.19 138.06 38.48 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.45 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -117.68 123.31 45.79 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.516 1.126 . . . . 0.0 110.033 -165.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.751 ' HB2' ' HG ' ' K' ' 14' ' ' LEU . 21.0 m95 -127.78 127.29 43.3 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.195 0.998 . . . . 0.0 108.336 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.556 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 14.3 ptm180 -128.26 115.28 18.08 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.3 m -126.75 163.63 28.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 122.254 1.026 . . . . 0.0 109.329 -173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.74 140.13 36.45 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.634 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.516 HG23 ' O ' ' K' ' 10' ' ' ASP . 63.4 p -72.59 -28.52 62.84 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.696 -176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 p -67.19 135.43 28.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.675 0.75 . . . . 0.0 109.907 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.06 131.88 48.89 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.977 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.495 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.0 OUTLIER -77.02 138.3 39.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.872 0.844 . . . . 0.0 109.922 171.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.33 -21.91 33.03 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . 0.456 ' H ' HD22 ' K' ' 99' ' ' ASN . 13.4 m120 -123.78 26.3 7.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.741 0.7 . . . . 0.0 110.896 169.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 36.1 t0 -157.76 175.59 13.69 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 167.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.746 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -61.08 -61.08 2.83 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.884 -0.51 . . . . 0.0 110.552 172.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' K' ' 142' ' ' GLU . 3.6 m-85 -143.93 175.52 9.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.61 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.8 p-10 -118.17 137.89 52.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.644 0.735 . . . . 0.0 109.417 177.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.889 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -137.87 161.68 35.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.084 -163.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.556 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 44.7 tt0 -125.85 143.52 51.04 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.448 ' CZ ' ' HE2' ' K' ' 110' ' ' PHE . 21.0 t80 -134.18 150.32 51.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.378 0.671 . . . . 0.0 110.392 -163.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.29 43.2 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.976 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.467 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.1 m-30 -109.82 130.94 55.47 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 167.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.549 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -133.4 162.91 30.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.904 0.859 . . . . 0.0 111.176 -169.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.0 OUTLIER -126.36 161.13 28.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.032 -174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' K' ' 83' ' ' TYR . 0.2 OUTLIER -90.95 86.52 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 1.0 OUTLIER -65.13 -42.54 93.8 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 177.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 23.2 t -160.82 161.02 31.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.944 0.793 . . . . 0.0 109.088 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -136.82 146.05 45.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' K' ' 129' ' ' SER . 4.7 tm-20 -132.33 130.45 40.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.55 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.1 OUTLIER -123.68 122.45 38.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.024 0.44 . . . . 0.0 111.243 176.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.31 124.92 53.53 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.66 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -108.8 121.22 44.62 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.6 158.98 16.28 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.737 0.632 . . . . 0.0 111.555 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.612 ' HA ' HE22 ' J' ' 9' ' ' GLN . 27.3 m -72.59 -32.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.461 -0.434 . . . . 0.0 111.056 176.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.42 153.25 18.05 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 169.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.02 -149.33 34.25 Favored Glycine 0 C--O 1.243 0.672 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 166.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.91 165.35 26.17 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.609 0.719 . . . . 0.0 110.722 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.589 HG21 ' HB ' ' J' ' 6' ' ' ILE . 4.9 m -57.03 139.31 16.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.086 -171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.12 131.4 52.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.148 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.8 mt -117.75 123.94 72.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . 0.591 ' HB3' ' HB3' ' K' ' 117' ' ' GLU . 3.2 t -107.9 117.19 33.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' K' ' 116' ' ' ARG . 1.1 pt -114.88 128.53 71.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.1 141.31 47.64 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.724 -178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.496 ' HA ' ' H ' ' K' ' 114' ' ' GLU . 1.6 pp -141.68 147.84 38.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.136 -172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.477 ' HG3' ' OE2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -100.3 159.29 15.24 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 167.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.814 HG11 ' HG3' ' K' ' 137' ' ' GLU . 59.7 t -141.01 160.04 23.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.647 HG12 ' HG ' ' J' ' 54' ' ' LEU . 4.2 pt -106.24 23.24 2.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.374 0.607 . . . . 0.0 110.358 -173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.06 1.04 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.76 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . 0.814 ' HG3' HG11 ' K' ' 134' ' ' VAL . 25.5 mt-10 -78.02 136.87 38.02 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.073 0.94 . . . . 0.0 110.638 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.85 153.21 30.86 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.45 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.1 OUTLIER -98.52 139.4 34.31 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.96 -165.5 1.86 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -102.65 146.16 16.64 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.387 169.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.889 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 6.2 tp10 -87.83 127.71 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.746 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.6 OUTLIER -92.8 -43.98 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.787 -176.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' E' ' 162' ' ' GLN . 10.3 m-20 -80.51 104.67 11.2 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.973 -176.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.79 -49.61 77.04 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.4 175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 10.3 mt 51.56 61.64 12.34 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.397 1.879 . . . . 0.0 109.397 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.597 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -67.96 -6.64 17.55 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.269 1.313 . . . . 0.0 115.376 -159.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.82 -42.6 89.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.535 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . 0.799 ' HB3' HD11 ' K' ' 27' ' ' LEU . 1.2 mp0 -109.76 -62.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.39 -54.36 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.167 0.894 . . . . 0.0 111.225 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 54.5 t -68.56 -44.55 82.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -176.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 1.7 t-20 -108.62 107.66 18.23 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.446 -176.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.94 95.65 3.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.53 159.62 14.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.01 -5.64 54.39 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.8 -1.27 61.34 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.385 0.993 . . . . 0.0 113.027 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.62 138.3 23.78 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -135.97 149.0 48.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.277 1.031 . . . . 0.0 108.588 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.97 -52.58 59.01 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -158.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.59 161.11 38.74 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.622 2.369 . . . . 0.0 109.126 167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.62 87.21 1.63 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 154.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.91 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.65 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.573 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.2 Cg_exo -76.78 8.5 3.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.061 1.772 . . . . 0.0 113.843 171.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.28 83.52 0.71 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' K' ' 175' ' ' PRO . 6.2 mp0 -101.75 65.12 1.0 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 118.898 1.349 . . . . 0.0 110.916 175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.581 ' O ' ' HB ' ' K' ' 173' ' ' THR . 29.2 m 29.49 78.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.81 1.644 . . . . 0.0 111.889 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.6 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -100.53 159.03 15.49 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.304 -167.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.54 -155.04 7.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.5 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.25 64.0 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.781 0.291 . . . . 0.0 111.459 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -75.69 163.45 67.11 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.516 0.726 . . . . 0.0 109.256 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.6 Cg_endo -82.13 -12.94 10.4 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.305 1.337 . . . . 0.0 112.725 -156.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.27 102.68 0.22 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.145 1.618 . . . . 0.0 117.145 165.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -96.94 164.26 12.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 117.977 0.889 . . . . 0.0 109.896 170.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 4.5 m -126.74 167.9 16.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.449 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -69.32 116.84 4.71 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.523 0.865 . . . . 0.0 111.708 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.441 1.497 . . . . 0.0 112.336 -171.703 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 102.258 -3.785 . . . . 0.0 102.258 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.645 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.6 mt -79.71 133.06 30.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.54 167.68 13.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.888 0.851 . . . . 0.0 110.747 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.77 -34.56 90.23 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.467 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . 0.604 HE22 ' HA ' ' G' ' 122' ' ' VAL . 2.5 mm-40 -77.91 -19.22 55.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.79 0.795 . . . . 0.0 112.409 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.5 OUTLIER -66.68 -38.95 87.84 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.46 116.91 32.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -126.29 149.9 48.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.652 0.739 . . . . 0.0 110.535 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' L' ' 93' ' ' ARG . 4.1 m-85 -119.0 118.5 31.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.751 -164.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.749 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -115.97 142.7 46.44 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -117.62 142.72 46.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.448 0.642 . . . . 0.0 109.985 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.5 tt0 -119.0 127.75 53.74 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . 0.459 ' HA ' HD13 ' L' ' 89' ' ' ILE . 52.0 p -70.69 147.52 49.01 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.561 0.696 . . . . 0.0 111.016 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.742 HG21 ' O ' ' F' ' 168' ' ' GLY . 1.4 pt -70.52 -39.21 75.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.56 -0.746 . . . . 0.0 112.025 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -81.28 -20.34 41.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.51 82.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 56.03 45.68 23.21 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.212 1.405 . . . . 0.0 111.821 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . 0.44 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 6.6 t -103.76 159.18 15.85 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -87.66 38.68 3.15 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.72 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -173.48 145.74 1.27 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.998 0.399 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.83 114.33 60.27 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 126.944 2.098 . . . . 0.0 112.392 -174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.29 137.55 31.31 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.368 0.81 . . . . 0.0 112.503 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' L' ' 149' ' ' GLU . 0.5 OUTLIER -117.2 153.03 33.55 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 168.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 28.6 t80 -104.6 140.68 21.32 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.502 -167.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.91 174.31 13.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.836 0.682 . . . . 0.0 112.445 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 51.8 63.89 2.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 111.593 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -77.94 145.5 36.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 122.572 1.177 . . . . 0.0 111.024 173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 3.7 tm0? -99.05 -60.88 1.45 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' L' ' 32' ' ' GLN . 3.7 t -178.58 163.03 1.47 Allowed 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.821 1.296 . . . . 0.0 111.063 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -139.56 118.8 12.77 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.975 -164.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.31 121.36 5.18 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.38 170.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . 0.551 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 13.7 m -109.22 126.94 53.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.73 130.8 70.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -135.5 107.48 7.12 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -166.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.5 118.67 6.0 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.25 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' G' ' 113' ' ' ILE . 5.5 tt0 -99.86 103.82 15.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.478 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.1 OUTLIER -69.83 146.06 51.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.727 0.775 . . . . 0.0 110.142 -174.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -126.93 173.55 9.53 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' L' ' 53' ' ' ILE . 0.2 OUTLIER -64.56 141.95 58.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.494 -179.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.3 131.84 36.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.2 171.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t0 75.34 110.31 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.25 -34.68 77.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.83 22.08 4.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.598 1.559 . . . . 0.0 111.661 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.591 ' HB ' ' CG ' ' A' ' 9' ' ' GLN . 1.1 m 41.75 59.95 2.34 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.467 1.507 . . . . 0.0 111.575 -164.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -115.07 -127.86 0.29 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.46 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . 0.432 ' HB3' HH12 ' L' ' 52' ' ' ARG . 2.1 t-20 -102.11 10.07 39.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.3 81.69 1.41 Allowed Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.5 mmp_? -107.66 27.65 8.95 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.617 ' HA ' ' HB3' ' L' ' 43' ' ' LEU . 0.3 OUTLIER -124.28 4.2 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.89 178.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.677 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -103.1 23.43 12.36 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 176.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . 0.615 ' H ' ' HB2' ' L' ' 43' ' ' LEU . . . -94.14 164.84 26.22 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 121.668 0.593 . . . . 0.0 113.988 -170.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.88 154.09 42.87 Favored 'Trans proline' 0 CA--C 1.515 -0.438 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -153.52 173.37 32.29 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.48 168.24 17.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.589 0.709 . . . . 0.0 110.549 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -114.2 130.3 68.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.1 120.3 40.2 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -120.74 119.36 32.53 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -171.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 81.7 p -145.38 146.51 31.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -139.48 152.48 22.49 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.167 176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.84 144.35 51.09 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -133.5 120.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . 0.403 ' OG1' HG22 ' L' ' 33' ' ' THR . 72.2 p -108.07 142.97 37.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 44.6 p90 -159.71 167.58 27.98 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -94.41 121.8 36.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.73 129.42 16.22 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.914 0.725 . . . . 0.0 114.914 -175.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -95.1 152.02 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.414 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -45.94 -51.53 13.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -155.74 98.79 0.18 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' L' ' 76' ' ' GLN . 1.8 m-20 -136.23 152.71 51.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.12 1.368 . . . . 0.0 111.04 169.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -71.5 -42.96 67.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.444 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -57.6 -36.54 78.64 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.864 168.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -64.86 -51.02 64.31 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.852 171.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.579 ' HB2' ' HZ2' ' L' ' 77' ' ' LYS . 8.5 mtmp? -61.64 -26.35 67.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.793 171.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -66.32 -44.95 81.94 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.897 168.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.516 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -59.01 -39.95 79.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.113 0.482 . . . . 0.0 110.496 172.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 5.8 mm-40 -62.72 -52.5 63.01 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.701 -0.624 . . . . 0.0 112.431 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 56.1 m-20 -62.33 -36.71 83.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.542 169.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -49.88 -60.42 2.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.543 174.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.534 ' HB2' HG21 ' L' ' 113' ' ' ILE . 10.6 t80 -81.11 -48.07 12.64 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.91 -174.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.594 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 1.9 mt-30 -78.36 -34.8 48.14 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 28.2 t30 -83.2 -25.95 31.3 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.042 172.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.55 77.32 1.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.301 -0.25 . . . . 0.0 112.853 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -138.61 159.16 42.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -92.09 146.67 23.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 168.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.496 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.5 mm -119.31 146.35 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.338 0.589 . . . . 0.0 109.858 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.735 ' HD3' HG21 ' F' ' 167' ' ' THR . 6.7 mtmt -78.1 138.11 38.57 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.455 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.7 OUTLIER -117.7 123.34 45.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.538 1.135 . . . . 0.0 109.977 -165.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.749 ' HB2' ' HG ' ' L' ' 14' ' ' LEU . 21.3 m95 -127.85 127.32 43.23 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.174 0.99 . . . . 0.0 108.354 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 14.3 ptm180 -128.31 115.24 17.98 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.3 m -126.68 163.55 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.28 1.038 . . . . 0.0 109.367 -173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.66 140.1 36.41 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.647 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.502 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 62.9 p -72.51 -28.58 62.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.681 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.2 135.44 28.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.652 0.739 . . . . 0.0 109.872 176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 131.87 48.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.96 -174.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.0 OUTLIER -76.88 138.28 39.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 171.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.35 -21.91 32.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . 0.462 ' H ' HD22 ' L' ' 99' ' ' ASN . 13.5 m120 -123.75 26.26 7.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.762 0.71 . . . . 0.0 110.86 169.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 35.9 t0 -157.74 175.6 13.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.745 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -61.16 -61.05 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.915 -0.49 . . . . 0.0 110.57 171.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.56 ' O ' ' N ' ' L' ' 142' ' ' GLU . 3.6 m-85 -143.95 175.52 9.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.618 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.8 p-10 -118.13 137.87 52.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.585 0.707 . . . . 0.0 109.478 177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -137.85 161.66 36.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.047 -163.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.568 ' OE1' ' HD3' ' L' ' 93' ' ' ARG . 44.7 tt0 -125.84 143.55 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.453 ' CZ ' ' HE2' ' L' ' 110' ' ' PHE . 20.9 t80 -134.18 150.3 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.41 0.684 . . . . 0.0 110.45 -163.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.46 178.26 43.21 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.971 170.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.469 ' O ' HG13 ' L' ' 134' ' ' VAL . 3.1 m-30 -109.74 131.0 55.46 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' L' ' 134' ' ' VAL . . . -133.46 162.86 30.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.901 0.858 . . . . 0.0 111.213 -169.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.0 OUTLIER -126.33 161.19 28.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.964 -174.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' L' ' 83' ' ' TYR . 0.2 OUTLIER -91.0 86.49 2.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.502 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 1.0 OUTLIER -65.1 -42.51 93.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -160.87 160.98 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.972 0.805 . . . . 0.0 109.101 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.634 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -136.76 146.03 45.3 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' L' ' 129' ' ' SER . 4.7 tm-20 -132.26 130.42 40.87 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.511 ' HD2' ' HB2' ' K' ' 36' ' ' SER . 0.1 OUTLIER -123.73 122.47 38.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.103 0.478 . . . . 0.0 111.148 176.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.36 124.94 53.59 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.674 177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -108.85 121.2 44.59 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.58 158.95 16.26 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.618 ' HA ' HE22 ' K' ' 9' ' ' GLN . 27.2 m -72.56 -32.34 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.514 -0.403 . . . . 0.0 111.109 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -94.44 153.21 18.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 78.03 -149.29 34.17 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -136.94 165.31 26.28 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.599 0.714 . . . . 0.0 110.766 -177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.596 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 4.9 m -57.03 139.34 16.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.051 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -126.15 131.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.083 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.9 mt -117.73 123.96 72.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' L' ' 117' ' ' GLU . 3.2 t -107.87 117.18 33.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.634 HG22 ' HG2' ' L' ' 116' ' ' ARG . 1.1 pt -114.87 128.49 71.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 1.5 m -114.13 141.32 47.64 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.734 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.502 ' HA ' ' H ' ' L' ' 114' ' ' GLU . 1.6 pp -141.67 147.87 38.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.064 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' OE2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -100.27 159.32 15.22 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.812 HG11 ' HG3' ' L' ' 137' ' ' GLU . 59.3 t -141.0 160.0 23.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' K' ' 54' ' ' LEU . 4.2 pt -106.19 23.23 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.364 0.602 . . . . 0.0 110.394 -173.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.12 89.07 1.04 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.757 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . 0.812 ' HG3' HG11 ' L' ' 134' ' ' VAL . 25.4 mt-10 -78.08 136.87 37.98 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.03 0.919 . . . . 0.0 110.663 174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.743 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -114.85 153.26 30.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.542 ' HD2' ' NE2' ' G' ' 84' ' ' GLN . 0.1 OUTLIER -98.55 139.37 34.38 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.93 -165.47 1.86 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -102.68 146.15 16.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.39 169.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.865 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 6.2 tp10 -87.82 127.69 35.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.745 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.6 OUTLIER -92.79 -43.94 13.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.785 -176.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.44 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 10.2 m-20 -80.55 104.61 11.2 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.961 -176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 1.5 p -58.71 -49.63 76.88 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.41 175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.2 mt 51.47 61.67 12.37 Favored Pre-proline 0 C--N 1.346 0.443 0 C-N-CA 126.411 1.884 . . . . 0.0 109.447 -173.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.595 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -67.92 -6.67 17.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 121.182 1.254 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -42.59 89.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.597 171.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . 0.786 ' HB3' HD11 ' L' ' 27' ' ' LEU . 1.2 mp0 -109.8 -62.06 1.56 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.36 -54.36 35.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.147 0.885 . . . . 0.0 111.224 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 54.5 t -68.59 -44.5 82.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 1.7 t-20 -108.58 107.72 18.32 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.475 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.99 95.59 2.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 7.8 t -97.51 159.68 14.77 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -172.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.05 -5.62 54.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.84 -1.32 61.29 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.354 0.979 . . . . 0.0 112.993 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 138.32 23.76 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -135.97 148.95 48.69 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.347 1.059 . . . . 0.0 108.629 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -63.92 -52.65 58.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -141.56 161.09 38.76 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.665 2.386 . . . . 0.0 109.132 167.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -147.66 87.2 1.62 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 154.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -112.95 -26.38 0.12 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -166.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.594 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.3 Cg_exo -76.78 8.47 3.07 Favored 'Trans proline' 0 C--O 1.239 0.545 0 CA-C-N 122.09 1.782 . . . . 0.0 113.87 171.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 80.34 83.45 0.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.594 HE22 ' HD2' ' L' ' 163' ' ' PRO . 6.3 mp0 -101.7 65.14 1.0 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.959 1.379 . . . . 0.0 110.909 175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.584 ' O ' ' HB ' ' L' ' 173' ' ' THR . 29.7 m 29.47 78.93 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.841 1.657 . . . . 0.0 111.867 175.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.596 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -100.46 158.98 15.51 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.324 -167.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.5 -155.02 7.36 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.523 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -24.29 64.0 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.815 0.307 . . . . 0.0 111.455 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -75.67 163.47 67.0 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.494 0.718 . . . . 0.0 109.261 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.49 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 86.0 Cg_endo -82.11 -13.01 10.39 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.304 1.336 . . . . 0.0 112.723 -156.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.22 102.74 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 165.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -96.99 164.26 12.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.957 0.878 . . . . 0.0 109.9 170.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 4.5 m -126.71 167.92 16.02 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.412 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.4 Cg_exo -69.3 116.8 4.69 Favored 'Trans proline' 0 C--N 1.35 0.617 0 CA-C-N 119.484 0.851 . . . . 0.0 111.73 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.467 1.507 . . . . 0.0 112.281 -171.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 112.871 0.297 . . . . 0.0 112.871 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.442 HG22 ' OD1' ' A' ' 10' ' ' ASP . 6.2 pt -56.75 119.96 2.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -84.02 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.875 0.845 . . . . 0.0 110.742 -177.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.9 71.89 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.385 -0.825 . . . . 0.0 114.513 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.737 0.768 . . . . 0.0 112.444 172.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' OD1' HG13 ' A' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.82 82.83 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' A' ' 93' ' ' ARG . 35.3 m -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.569 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.4 43.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.693 0.759 . . . . 0.0 110.495 176.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' A' ' 91' ' ' PHE . 63.0 m-85 -111.75 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.774 -164.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.0 mp -77.59 144.76 37.26 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.539 ' HB3' HD11 ' A' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.24 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.445 0.641 . . . . 0.0 109.957 176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.879 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.3 43.58 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.02 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.576 0.703 . . . . 0.0 111.016 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pt -69.72 -49.23 59.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.011 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' A' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.73 78.09 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.474 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.85 4.12 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.198 1.399 . . . . 0.0 111.841 -173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.13 13.44 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.43 7.94 79.56 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.697 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.496 ' OG ' HD11 ' A' ' 146' ' ' LEU . 3.1 m -155.3 135.23 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.991 0.396 . . . . 0.0 111.838 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.879 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -94.46 122.85 60.15 Favored Pre-proline 0 C--O 1.238 0.468 0 C-N-CA 126.985 2.114 . . . . 0.0 112.443 -174.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.54 129.2 17.4 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.405 0.823 . . . . 0.0 112.503 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.787 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.05 54.24 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 76' ' ' GLN . 25.3 t80 -92.68 141.67 24.77 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.526 -167.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.36 178.88 6.96 Favored 'Trans proline' 0 CA--C 1.518 -0.287 0 CA-C-O 121.837 0.682 . . . . 0.0 112.491 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 54.76 46.28 24.93 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.339 1.455 . . . . 0.0 111.574 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' O ' HG23 ' L' ' 48' ' ' THR . 5.7 m-85 -72.21 134.29 45.57 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 122.562 1.173 . . . . 0.0 111.051 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' A' ' 33' ' ' THR . 35.7 tt0 -101.79 -110.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' A' ' 32' ' ' GLN . 12.2 p -119.2 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 122.771 1.272 . . . . 0.0 111.111 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -163.25 136.79 5.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.083 -1.417 . . . . 0.0 107.996 -164.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.76 7.62 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.362 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.24 97.78 7.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.67 51.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.9 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.29 7.12 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.247 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' H ' ' HA ' ' B' ' 115' ' ' SER . 0.0 OUTLIER -107.78 86.18 2.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HA ' HH11 ' A' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.82 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.698 0.761 . . . . 0.0 110.169 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.29 23.21 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -73.97 166.74 22.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.51 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.615 ' HA ' HG12 ' A' ' 53' ' ' ILE . 9.3 t80 -108.28 83.38 1.77 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.271 171.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' A' ' 53' ' ' ILE . 34.1 t70 -106.44 92.09 3.98 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.471 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 17.4 pt-20 -65.51 -15.8 63.03 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.81 21.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.578 1.551 . . . . 0.0 111.66 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.433 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 37.5 53.71 1.38 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.525 1.53 . . . . 0.0 111.577 -164.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.06 0.52 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.427 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' B' ' 58' ' ' SER . 7.9 m-20 -150.62 29.99 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 84.85 34.72 14.55 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.456 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -102.27 122.68 44.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.615 HG12 ' HA ' ' A' ' 44' ' ' PHE . 0.5 OUTLIER -136.91 133.03 47.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.826 178.333 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.12 22.18 16.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.51 13.73 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 121.657 0.587 . . . . 0.0 113.97 -170.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.67 159.39 28.32 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -121.38 -77.14 0.44 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.556 ' HA ' ' OD1' ' F' ' 50' ' ' ASN . 2.6 t -164.43 171.47 14.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.559 0.695 . . . . 0.0 110.523 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.36 112.42 40.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.38 3.07 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.08 102.18 12.19 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.4 p -135.52 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.927 0.891 . . . . 0.0 110.053 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -142.46 155.7 25.83 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.155 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.822 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.98 134.66 48.26 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 174.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' A' ' 34' ' ' ASP . 79.3 t -124.09 122.19 63.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.3 36.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' A' ' 79' ' ' ILE . 50.4 p90 -154.53 160.49 41.56 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -79.28 140.05 22.47 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -120.42 150.0 41.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.429 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.7 OUTLIER -54.83 -39.12 68.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -172.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.51 3.04 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.16 1.384 . . . . 0.0 111.046 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -90.72 -9.16 47.72 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -156.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 79' ' ' ILE . . . -74.2 -44.76 27.75 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.865 168.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.64 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.5 79.33 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.165 -0.609 . . . . 0.0 111.854 171.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.62 82.53 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.77 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.65 74.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.893 168.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.64 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.1 mm -62.67 -52.53 58.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.064 0.459 . . . . 0.0 110.449 172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.76 -39.1 73.44 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.762 -0.586 . . . . 0.0 112.476 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -58.99 -50.05 75.57 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.538 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.648 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -59.26 -43.52 92.45 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.539 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.531 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 7.1 t80 -64.97 -52.58 55.47 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.921 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.89 -36.74 59.39 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 14.3 m120 -86.18 -3.49 58.97 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.037 172.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.78 30.16 74.31 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.337 -0.227 . . . . 0.0 112.895 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.648 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 6.1 mttm -67.07 146.19 54.56 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.434 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -70.59 144.93 51.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 15' ' ' PHE . 4.8 tt -118.06 133.8 63.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.361 0.6 . . . . 0.0 109.837 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.4 mtmp? -88.64 121.39 30.96 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' A' ' 13' ' ' TYR . 0.1 OUTLIER -116.55 125.77 52.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.561 1.144 . . . . 0.0 110.0 -165.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m95 -123.35 116.55 23.49 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.166 0.987 . . . . 0.0 108.343 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' A' ' 11' ' ' VAL . 15.6 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.242 1.02 . . . . 0.0 109.391 -173.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.18 167.09 20.02 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.637 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 10' ' ' ASP . 13.4 m -107.16 -25.24 11.62 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG13 ' OD1' ' A' ' 10' ' ' ASP . 20.5 m -74.22 165.14 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.661 0.743 . . . . 0.0 109.922 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.82 19.62 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.973 -174.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.25 160.69 31.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.795 0.807 . . . . 0.0 109.997 171.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.68 26.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.94 -80.22 0.47 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.87 169.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.652 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -71.03 163.81 26.83 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.6 OUTLIER -56.12 -45.97 79.34 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 121.887 -0.508 . . . . 0.0 110.597 171.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 142' ' ' GLU . 55.8 m-85 -138.3 -170.86 2.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.7 t70 -139.59 141.2 37.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.62 0.724 . . . . 0.0 109.454 177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -131.66 145.89 51.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.065 -163.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.77 127.01 55.2 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 157.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 31.9 t80 -133.42 152.32 51.9 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.339 0.656 . . . . 0.0 110.373 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 1.022 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.923 170.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' HB3' HE22 ' A' ' 88' ' ' GLN . 6.1 m-85 -92.34 133.64 35.67 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 89' ' ' ILE . . . -132.49 158.28 42.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.926 0.869 . . . . 0.0 111.188 -169.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.434 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 6.9 t80 -134.82 130.73 36.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.025 -174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' A' ' 83' ' ' TYR . 1.4 mp -65.55 120.1 11.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.16 -27.2 13.64 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.48 9.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.932 0.787 . . . . 0.0 109.124 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.22 137.98 52.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.86 49.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 111.225 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.64 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.87 52.74 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.72 177.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' F' ' 33' ' ' THR . 3.9 t70 -122.46 115.41 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.69 -44.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.488 -0.419 . . . . 0.0 111.103 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.7 156.76 17.42 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 169.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.454 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 86.39 147.48 10.81 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.517 ' HA ' ' N ' ' F' ' 8' ' ' GLY . . . -71.8 165.51 23.94 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.621 0.724 . . . . 0.0 110.725 -177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.61 143.37 13.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.035 -171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 23.0 mp0 -118.51 134.0 55.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.119 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.62 117.12 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.73 50.09 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 130' ' ' ILE . 4.0 pt -123.75 126.67 73.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.822 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -107.98 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.753 -178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.66 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.103 -172.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.96 23.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 167.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.41 74.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.409 HG13 ' H ' ' A' ' 136' ' ' GLY . 6.5 pt -67.85 -51.86 45.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.373 0.606 . . . . 0.0 110.401 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.77 119.18 3.41 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.706 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.18 122.42 21.0 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.074 0.94 . . . . 0.0 110.633 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.022 HD12 ' HA2' ' A' ' 109' ' ' GLY . 1.7 mt -125.29 149.44 48.05 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 127.96 27.39 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.46 153.91 29.57 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -65.74 153.01 51.58 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.418 169.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 6.8 tp10 -111.88 137.47 49.8 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -104.17 -63.93 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.743 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.06 116.77 24.86 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.976 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.95 HG21 HG21 ' A' ' 94' ' ' VAL . 3.5 p -114.58 39.41 2.82 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.409 175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.496 HD11 ' OG ' ' A' ' 24' ' ' SER . 1.2 mm? 45.39 58.4 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.471 1.908 . . . . 0.0 109.388 -173.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.644 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.89 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 121.241 1.294 . . . . 0.0 115.323 -159.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -25.63 68.28 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.608 171.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.1 -43.59 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.787 HG23 HD22 ' A' ' 27' ' ' LEU . 46.8 mt -82.4 -44.94 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.132 0.878 . . . . 0.0 111.283 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.644 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 1.7 t -73.93 -39.52 51.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.43 113.71 25.93 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.451 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.32 117.83 43.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.0 146.68 38.65 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HD3' ' HA3' ' G' ' 136' ' ' GLY . 12.3 mttt -75.92 -38.94 57.15 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.7 65.5 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 119.353 0.979 . . . . 0.0 113.031 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' G' ' 138' ' ' LEU . . . -74.77 123.25 7.42 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.82 110.4 22.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 108.614 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' G' ' 138' ' ' LEU . 0.5 OUTLIER -72.16 -28.88 63.52 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.17 117.63 11.45 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.696 2.398 . . . . 0.0 109.158 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.597 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.75 0.94 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.786 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.97 4.51 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.3 Cg_exo -79.95 136.86 12.05 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.038 1.764 . . . . 0.0 113.874 171.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.38 34.42 87.82 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.597 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.0 tt0 -68.39 -40.54 81.3 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.86 1.33 . . . . 0.0 110.967 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.892 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.9 m 47.16 63.3 2.01 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.852 1.661 . . . . 0.0 111.897 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.677 ' HA ' HG22 ' A' ' 173' ' ' THR . 33.9 p -120.78 149.43 42.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.343 -167.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.82 -170.82 43.46 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.488 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' G' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.61 68.72 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.79 0.295 . . . . 0.0 111.48 -177.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -83.71 159.77 60.1 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.537 0.735 . . . . 0.0 109.254 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -78.95 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 121.256 1.304 . . . . 0.0 112.709 -156.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.88 1.13 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.173 1.629 . . . . 0.0 117.173 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -109.45 155.17 21.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.981 0.89 . . . . 0.0 109.866 170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.75 159.19 46.29 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.403 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.892 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -69.65 138.99 39.51 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.49 0.853 . . . . 0.0 111.73 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.436 1.494 . . . . 0.0 112.335 -171.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.478 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 N-CA-C 112.847 0.287 . . . . 0.0 112.847 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.445 HG22 ' OD1' ' B' ' 10' ' ' ASP . 6.3 pt -56.74 119.93 2.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.96 177.32 8.34 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.864 0.84 . . . . 0.0 110.79 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -29.92 71.79 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.416 -0.811 . . . . 0.0 114.48 175.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.85 -15.19 60.26 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.772 0.786 . . . . 0.0 112.372 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' B' ' 97' ' ' VAL . 6.1 t70 -67.14 -36.75 82.54 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.738 HG11 HH21 ' B' ' 93' ' ' ARG . 35.4 m -103.98 126.06 58.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -126.57 154.46 43.86 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.629 0.728 . . . . 0.0 110.52 176.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.473 ' HD2' ' HE1' ' B' ' 91' ' ' PHE . 63.5 m-85 -111.77 94.91 5.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.752 -164.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -77.63 144.74 37.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' B' ' 89' ' ' ILE . 88.1 m-85 -133.22 139.18 46.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.454 0.645 . . . . 0.0 109.976 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.893 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.35 43.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.99 38.96 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.035 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pt -69.75 -49.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.939 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 87' ' ' LYS . 0.9 OUTLIER -82.09 -8.96 59.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -171.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.66 77.89 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.474 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.36 46.86 4.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.176 1.39 . . . . 0.0 111.813 -173.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.09 163.13 13.43 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.46 8.05 79.38 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.688 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.495 ' OG ' HD11 ' B' ' 146' ' ' LEU . 3.1 m -155.4 135.26 12.8 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.98 0.39 . . . . 0.0 111.814 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.893 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -94.48 122.87 60.06 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.955 2.102 . . . . 0.0 112.361 -174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.55 129.23 17.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.827 . . . . 0.0 112.489 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.36 130.01 54.26 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 168.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 76' ' ' GLN . 25.5 t80 -92.62 141.7 24.88 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.568 -167.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.36 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.849 0.687 . . . . 0.0 112.424 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 54.76 46.32 24.84 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.332 1.453 . . . . 0.0 111.542 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.554 ' O ' HG23 ' G' ' 48' ' ' THR . 5.7 m-85 -72.17 134.35 45.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 122.527 1.156 . . . . 0.0 111.051 173.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' B' ' 33' ' ' THR . 35.8 tt0 -101.92 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' B' ' 32' ' ' GLN . 12.2 p -119.2 178.37 4.54 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 122.768 1.271 . . . . 0.0 111.127 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.836 ' OD2' HG22 ' B' ' 65' ' ' VAL . 5.3 t0 -163.33 136.7 5.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.107 -1.406 . . . . 0.0 107.97 -164.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.35 130.82 7.67 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.382 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.3 97.8 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 82.7 t -102.71 119.66 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.629 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 7.1 p -133.54 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.3 7.13 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.232 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.449 ' HA ' HH11 ' B' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.695 0.759 . . . . 0.0 110.156 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.22 23.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -73.93 166.74 22.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.505 -179.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.609 ' HA ' HG12 ' B' ' 53' ' ' ILE . 9.3 t80 -108.31 83.46 1.78 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.195 171.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.453 ' H ' ' CG2' ' B' ' 53' ' ' ILE . 34.1 t70 -106.51 92.16 4.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' B' ' 51' ' ' GLY . 17.4 pt-20 -65.57 -15.77 63.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.07 35.8 21.32 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.596 1.558 . . . . 0.0 111.703 -172.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.436 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 37.55 53.71 1.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.535 1.534 . . . . 0.0 111.57 -164.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' B' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.07 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.443 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 7.8 m-20 -150.61 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 84.84 34.71 14.63 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.452 ' HG2' ' HG2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.61 44.54 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.609 HG12 ' HA ' ' B' ' 44' ' ' PHE . 0.5 OUTLIER -136.86 132.96 48.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.887 178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.43 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -108.1 22.27 16.19 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.29 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.709 0.616 . . . . 0.0 113.959 -170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.64 159.38 28.41 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -121.37 -77.24 0.45 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.471 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 2.6 t -164.41 171.47 14.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 0.0 110.49 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.42 40.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.88 86.37 3.06 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.24 12.25 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.872 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 64.5 p -135.59 154.6 51.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.929 0.891 . . . . 0.0 110.055 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -142.39 155.7 25.8 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.143 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.64 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.836 HG22 ' OD2' ' B' ' 34' ' ' ASP . 79.4 t -124.09 122.2 63.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 174.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.493 ' OH ' HG21 ' B' ' 79' ' ' ILE . 50.3 p90 -154.56 160.46 41.52 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.572 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 27.2 m-85 -87.73 144.97 26.35 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.23 140.06 22.52 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -120.46 150.0 41.49 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.22 68.18 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.3 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.151 1.38 . . . . 0.0 111.035 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -90.71 -9.21 47.59 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.7 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.859 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.638 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.47 79.18 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.808 171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 2.8 mtmt -67.87 -41.63 82.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.761 171.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.72 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.901 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.1 mm -62.68 -52.4 60.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.083 0.468 . . . . 0.0 110.48 172.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.86 -39.09 73.1 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.721 -0.612 . . . . 0.0 112.44 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -49.98 75.84 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.58 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.653 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -59.28 -43.54 92.52 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.565 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 7.1 t80 -64.93 -52.62 55.43 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.901 -174.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.81 -36.79 59.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 14.2 m120 -86.18 -3.46 58.97 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.059 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.83 30.12 74.18 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.335 -0.228 . . . . 0.0 112.842 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.653 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 6.1 mttm -67.05 146.23 54.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -70.6 144.9 51.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' B' ' 15' ' ' PHE . 4.8 tt -118.04 133.75 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.318 0.58 . . . . 0.0 109.895 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.41 31.01 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.473 ' HE1' ' HD2' ' B' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.8 52.36 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.513 1.125 . . . . 0.0 110.009 -165.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 23.4 m95 -123.3 116.52 23.47 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.235 1.014 . . . . 0.0 108.353 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.738 HH21 HG11 ' B' ' 11' ' ' VAL . 15.5 ttt180 -102.05 106.29 17.16 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.936 HG21 HG21 ' B' ' 145' ' ' THR . 1.6 m -122.36 148.86 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.253 1.025 . . . . 0.0 109.402 -173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.12 19.98 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.589 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' B' ' 10' ' ' ASP . 13.5 m -107.23 -25.22 11.6 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.683 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.502 HG13 ' OD1' ' B' ' 10' ' ' ASP . 20.1 m -74.3 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.714 0.768 . . . . 0.0 109.872 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.52 107.75 19.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -72.16 160.69 32.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.835 0.826 . . . . 0.0 110.007 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.54 -8.63 26.23 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.88 -80.26 0.47 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.926 169.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 167.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.858 -0.526 . . . . 0.0 110.578 171.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.613 ' HB2' ' HB3' ' B' ' 142' ' ' GLU . 55.9 m-85 -138.34 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.571 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.7 t70 -139.58 141.24 37.19 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.614 0.721 . . . . 0.0 109.441 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -131.76 145.9 51.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.049 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.86 127.07 55.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' B' ' 138' ' ' LEU . 32.2 t80 -133.43 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.368 0.667 . . . . 0.0 110.395 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . 1.006 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -168.23 171.39 42.5 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.972 170.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.436 ' HB3' HE22 ' B' ' 88' ' ' GLN . 6.1 m-85 -92.45 133.69 35.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' B' ' 89' ' ' ILE . . . -132.52 158.29 42.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.909 0.862 . . . . 0.0 111.141 -169.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.433 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 6.9 t80 -134.82 130.8 36.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.96 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' B' ' 83' ' ' TYR . 1.4 mp -65.59 120.21 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.19 -27.3 13.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 27.6 t -164.36 147.51 9.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.936 0.789 . . . . 0.0 109.062 174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.23 137.95 52.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.38 119.96 21.38 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.84 49.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 0.0 111.181 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.644 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.689 177.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.44 115.37 22.13 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.15 -176.8 20.95 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.435 HG23 HG22 ' A' ' 33' ' ' THR . 4.5 t -80.68 -44.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 O-C-N 122.522 -0.399 . . . . 0.0 111.086 176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.64 156.82 17.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 169.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.533 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 86.32 147.42 10.64 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 166.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -71.72 165.54 23.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.554 0.693 . . . . 0.0 110.764 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.65 143.38 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.037 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 23.1 mp0 -118.59 133.93 55.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.085 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.57 117.09 53.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.78 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.512 ' O ' HG13 ' B' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.84 53.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.345 0.658 . . . . 0.0 109.703 -178.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' B' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.66 26.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.104 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.872 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -125.57 162.9 23.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.47 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' B' ' 136' ' ' GLY . 6.4 pt -67.97 -51.88 44.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.307 0.575 . . . . 0.0 110.332 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.72 119.17 3.41 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.741 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.35 20.82 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.033 0.92 . . . . 0.0 110.646 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 1.006 HD12 ' HA2' ' B' ' 109' ' ' GLY . 1.7 mt -125.28 149.42 48.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.95 27.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.49 153.91 29.52 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -65.77 153.06 51.59 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.396 169.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.47 49.85 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.694 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -104.11 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.805 -176.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.03 116.88 25.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.014 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 0.936 HG21 HG21 ' B' ' 94' ' ' VAL . 3.5 p -114.63 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.495 HD11 ' OG ' ' B' ' 24' ' ' SER . 1.2 mm? 45.38 58.41 15.17 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.451 1.9 . . . . 0.0 109.356 -173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.648 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.21 1.273 . . . . 0.0 115.351 -159.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.64 68.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.588 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' B' ' 27' ' ' LEU . 47.1 mt -82.44 -44.91 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 119.114 0.87 . . . . 0.0 111.263 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.648 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 1.7 t -73.95 -39.43 51.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.75 25.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.393 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.83 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.68 38.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.473 ' HD3' ' HA3' ' H' ' 136' ' ' GLY . 12.3 mttt -75.96 -38.87 57.08 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.58 8.6 65.59 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.36 0.982 . . . . 0.0 113.025 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.69 123.22 7.46 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.77 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.304 1.042 . . . . 0.0 108.629 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.94 63.56 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -158.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.15 117.62 11.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.675 2.39 . . . . 0.0 109.159 167.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.609 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -149.36 43.85 0.94 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 154.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 15.5 tt0 -53.97 -62.0 4.48 Favored Pre-proline 0 C--O 1.241 0.656 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.4 Cg_exo -79.99 136.89 12.02 Favored 'Trans proline' 0 C--O 1.238 0.5 0 CA-C-N 122.077 1.777 . . . . 0.0 113.86 171.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.44 34.33 87.47 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.609 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.0 tt0 -68.35 -40.58 81.48 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.891 1.346 . . . . 0.0 110.913 175.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.9 m 47.21 63.26 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.8 1.64 . . . . 0.0 111.882 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.672 ' HA ' HG22 ' B' ' 173' ' ' THR . 34.0 p -120.79 149.38 42.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.316 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.87 43.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.459 172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . 0.741 ' HA ' HD13 ' H' ' 18' ' ' ILE . 0.0 OUTLIER -61.47 -27.65 68.72 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.782 0.291 . . . . 0.0 111.442 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -83.71 159.74 60.16 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 109.28 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.5 Cg_endo -78.9 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.299 1.333 . . . . 0.0 112.739 -156.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.91 1.12 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.672 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -109.44 155.18 21.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.967 0.884 . . . . 0.0 109.864 170.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.8 159.25 46.31 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.383 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -69.63 138.98 39.53 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.525 0.866 . . . . 0.0 111.705 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 -171.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . 0.513 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.178 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' C' ' 10' ' ' ASP . 6.3 pt -56.73 119.95 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 177.35 8.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.936 0.874 . . . . 0.0 110.725 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -29.87 71.74 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.341 -0.845 . . . . 0.0 114.487 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.83 -15.24 60.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.818 0.809 . . . . 0.0 112.412 172.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.494 ' OD1' HG13 ' C' ' 97' ' ' VAL . 6.0 t70 -67.08 -36.85 82.87 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -171.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.745 HG11 HH21 ' C' ' 93' ' ' ARG . 35.3 m -103.88 126.04 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . 0.586 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.47 43.78 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.658 0.742 . . . . 0.0 110.527 176.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.468 ' HD2' ' HE1' ' C' ' 91' ' ' PHE . 63.2 m-85 -111.76 94.9 5.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.736 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -77.65 144.78 37.13 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.529 ' HB3' HD11 ' C' ' 89' ' ' ILE . 88.2 m-85 -133.25 139.25 46.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.491 0.662 . . . . 0.0 109.916 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.898 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.3 43.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 170.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.36 153.97 39.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.047 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.455 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pt -69.76 -49.2 59.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.999 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' C' ' 87' ' ' LYS . 0.9 OUTLIER -82.11 -8.96 59.68 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -171.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.31 -34.67 77.86 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.465 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.43 46.85 4.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.203 1.401 . . . . 0.0 111.759 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.08 163.09 13.45 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.39 7.98 79.62 Favored Glycine 0 N--CA 1.45 -0.405 0 O-C-N 123.342 0.401 . . . . 0.0 113.753 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' C' ' 146' ' ' LEU . 3.1 m -155.32 135.22 12.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.962 0.381 . . . . 0.0 111.81 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.898 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -94.46 122.94 59.93 Favored Pre-proline 0 C--O 1.237 0.444 0 C-N-CA 126.902 2.081 . . . . 0.0 112.367 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.56 129.19 17.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.409 0.824 . . . . 0.0 112.464 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.771 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.03 54.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' C' ' 76' ' ' GLN . 25.4 t80 -92.62 141.69 24.87 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.521 -167.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.36 178.81 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.325 0 CA-C-O 121.836 0.682 . . . . 0.0 112.451 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 54.81 46.26 24.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.342 1.457 . . . . 0.0 111.516 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . 0.588 ' O ' HG23 ' H' ' 48' ' ' THR . 5.7 m-85 -72.11 134.25 45.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.513 1.149 . . . . 0.0 111.1 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' C' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' C' ' 32' ' ' GLN . 12.2 p -119.21 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.729 1.252 . . . . 0.0 111.13 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -163.27 136.72 5.74 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.044 -164.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.42 130.78 7.64 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.318 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.28 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.536 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 7.0 p -133.5 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.25 7.11 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.253 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.518 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.0 OUTLIER -107.71 86.18 2.25 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.06 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' C' ' 41' ' ' ARG . 11.2 mmm180 -63.79 -178.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.732 0.777 . . . . 0.0 110.114 -174.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.16 142.22 23.09 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -73.89 166.71 22.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.537 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' C' ' 53' ' ' ILE . 9.3 t80 -108.26 83.41 1.78 Allowed 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.256 171.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' C' ' 53' ' ' ILE . 34.0 t70 -106.43 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' H ' ' C' ' 51' ' ' GLY . 17.4 pt-20 -65.61 -15.7 63.0 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 176.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.21 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.604 1.562 . . . . 0.0 111.639 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.426 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 37.5 53.73 1.39 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.503 1.521 . . . . 0.0 111.587 -164.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HG2' ' C' ' 52' ' ' ARG . 17.6 tptt -116.18 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . 0.679 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.462 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 84.76 34.79 14.65 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.437 ' HG2' ' HG2' ' C' ' 49' ' ' LYS . 0.0 OUTLIER -102.29 122.62 44.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' C' ' 44' ' ' PHE . 0.5 OUTLIER -136.83 133.01 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.857 178.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.26 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.662 0.59 . . . . 0.0 113.954 -170.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.72 159.42 28.15 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' B' ' 50' ' ' ASN . 2.6 t -164.39 171.53 14.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.527 0.68 . . . . 0.0 110.505 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.34 112.37 40.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.11 102.13 12.12 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -171.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . 0.896 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 64.3 p -135.49 154.65 51.34 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.955 0.902 . . . . 0.0 110.066 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -142.43 155.66 25.8 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.209 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.67 48.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 174.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' C' ' 34' ' ' ASP . 79.0 t -124.15 122.23 63.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.18 142.3 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' C' ' 79' ' ' ILE . 50.4 p90 -154.53 160.45 41.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.559 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 140.02 22.43 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.0 41.49 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.16 68.23 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.84 -124.52 3.04 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.3 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.169 1.388 . . . . 0.0 110.966 169.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -90.75 -9.16 47.68 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -44.75 27.57 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.855 168.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 9.3 tt0 -67.49 -35.48 79.23 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 122.161 -0.611 . . . . 0.0 111.818 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 2.8 mtmt -67.81 -41.72 82.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.771 171.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.76 74.68 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.856 168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.1 mm -62.63 -52.47 59.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.81 -39.09 73.29 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.708 -0.62 . . . . 0.0 112.474 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.03 -50.02 75.68 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.542 169.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -59.2 -43.56 92.24 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.631 174.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.629 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 7.1 t80 -64.92 -52.61 55.47 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.9 -174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -75.91 -36.69 59.34 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 14.5 m120 -86.27 -3.49 58.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.002 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.82 30.15 74.23 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.338 -0.226 . . . . 0.0 112.865 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 6.1 mttm -67.11 146.19 54.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.443 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -70.57 144.94 51.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' C' ' 15' ' ' PHE . 4.8 tt -118.09 133.78 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.384 0.611 . . . . 0.0 109.844 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.43 30.98 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.468 ' HE1' ' HD2' ' C' ' 13' ' ' TYR . 0.1 OUTLIER -116.56 125.76 52.33 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.51 1.124 . . . . 0.0 110.056 -165.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.696 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 23.2 m95 -123.27 116.53 23.51 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.198 0.999 . . . . 0.0 108.37 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.745 HH21 HG11 ' C' ' 11' ' ' VAL . 15.5 ttt180 -102.04 106.37 17.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.928 HG21 HG21 ' C' ' 145' ' ' THR . 1.6 m -122.45 148.92 25.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 CA-C-O 122.257 1.027 . . . . 0.0 109.354 -173.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.22 167.06 20.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.6 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.462 ' N ' ' O ' ' C' ' 10' ' ' ASP . 13.5 m -107.18 -25.28 11.6 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.64 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' C' ' 10' ' ' ASP . 20.2 m -74.23 165.08 3.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.702 0.763 . . . . 0.0 109.875 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' C' ' 99' ' ' ASN . 0.1 OUTLIER -93.5 107.8 19.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.981 -174.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' C' ' 98' ' ' LYS . 9.7 t30 -72.16 160.7 31.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.861 0.839 . . . . 0.0 109.959 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.7 26.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.85 -80.34 0.46 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.739 0.699 . . . . 0.0 110.895 169.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.667 ' OD1' HG13 ' C' ' 143' ' ' ILE . 0.4 OUTLIER -70.96 163.78 26.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.93 79.29 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.821 -0.549 . . . . 0.0 110.573 171.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.619 ' HB2' ' HB3' ' C' ' 142' ' ' GLU . 55.8 m-85 -138.37 -170.88 2.91 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.567 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.7 t70 -139.6 141.23 37.15 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.602 0.715 . . . . 0.0 109.421 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -131.67 145.91 51.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.063 -163.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.83 127.05 55.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' C' ' 138' ' ' LEU . 32.2 t80 -133.42 152.29 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.42 0.688 . . . . 0.0 110.426 -163.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -168.23 171.43 42.51 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.965 170.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' C' ' 88' ' ' GLN . 6.1 m-85 -92.47 133.65 35.71 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' C' ' 89' ' ' ILE . . . -132.49 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.891 0.853 . . . . 0.0 111.176 -169.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.443 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 6.9 t80 -134.84 130.76 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.987 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' C' ' 83' ' ' TYR . 1.4 mp -65.59 120.2 12.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.28 13.59 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 27.5 t -164.33 147.51 9.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.971 0.805 . . . . 0.0 109.082 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 138.02 51.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.41 119.93 21.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.072 0.463 . . . . 0.0 111.203 176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.633 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.86 52.74 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.677 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.41 115.45 22.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.78 20.9 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.678 0.599 . . . . 0.0 111.604 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.428 HG23 HG22 ' B' ' 33' ' ' THR . 4.5 t -80.73 -44.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.525 -0.397 . . . . 0.0 111.099 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.72 156.87 17.35 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . 0.617 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 86.23 147.47 10.6 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.81 165.57 23.82 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.599 0.714 . . . . 0.0 110.722 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 34.9 m -58.68 143.35 13.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.077 -171.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 23.1 mp0 -118.49 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.112 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.63 117.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.73 50.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 168.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' C' ' 130' ' ' ILE . 4.0 pt -123.76 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -108.03 126.89 53.26 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.703 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 63' ' ' GLY . 0.4 OUTLIER -138.51 165.64 26.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.121 -172.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.896 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.97 23.74 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.39 74.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.472 ' H ' HG12 ' C' ' 135' ' ' ILE . 6.5 pt -67.87 -51.9 45.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.329 0.585 . . . . 0.0 110.328 -173.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.76 119.17 3.4 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.69 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.1 122.37 20.83 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.999 0.904 . . . . 0.0 110.67 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 1.024 HD12 ' HA2' ' C' ' 109' ' ' GLY . 1.7 mt -125.27 149.42 48.04 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.9 27.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.49 153.89 29.49 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -65.73 153.01 51.57 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.423 169.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.619 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 6.8 tp10 -111.89 137.5 49.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.686 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.97 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.762 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.13 116.85 24.95 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.984 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 0.928 HG21 HG21 ' C' ' 94' ' ' VAL . 3.4 p -114.6 39.41 2.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.35 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' C' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.17 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.501 1.92 . . . . 0.0 109.386 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.631 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.85 -10.43 29.11 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.259 1.306 . . . . 0.0 115.263 -159.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.57 171.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.12 -43.6 1.8 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.771 HG23 HD22 ' C' ' 27' ' ' LEU . 46.7 mt -82.42 -44.95 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.128 0.876 . . . . 0.0 111.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 1.7 t -73.94 -39.4 51.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -176.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.63 25.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.465 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.26 117.89 43.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.01 146.62 38.77 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -172.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.433 ' HD3' ' HA3' ' I' ' 136' ' ' GLY . 12.4 mttt -75.95 -38.9 57.07 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.61 8.59 65.53 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.423 1.01 . . . . 0.0 113.03 -176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.75 123.25 7.43 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.79 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.296 1.038 . . . . 0.0 108.623 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' I' ' 138' ' ' LEU . 0.5 OUTLIER -72.14 -28.85 63.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.58 11.38 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.708 2.403 . . . . 0.0 109.155 167.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.61 ' NE2' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -149.31 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.798 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 15.6 tt0 -54.03 -61.93 4.61 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.2 Cg_exo -79.99 136.85 11.99 Favored 'Trans proline' 0 C--O 1.239 0.565 0 CA-C-N 122.071 1.775 . . . . 0.0 113.886 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.44 34.38 87.62 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.61 ' HA ' ' NE2' ' C' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.48 81.19 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.915 1.358 . . . . 0.0 110.931 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.923 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.9 m 47.14 63.25 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.761 1.624 . . . . 0.0 111.934 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.673 ' HA ' HG22 ' C' ' 173' ' ' THR . 33.8 p -120.75 149.44 42.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.313 -167.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.83 43.6 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.478 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . 0.726 ' HA ' HD13 ' I' ' 18' ' ' ILE . 0.0 OUTLIER -61.5 -27.6 68.71 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.795 0.297 . . . . 0.0 111.469 -177.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -83.7 159.72 60.24 Favored Pre-proline 0 C--O 1.235 0.34 0 C-N-CA 123.548 0.739 . . . . 0.0 109.276 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 85.1 Cg_endo -78.85 85.08 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.322 1.348 . . . . 0.0 112.722 -156.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.57 90.9 1.12 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.246 1.659 . . . . 0.0 117.246 165.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.673 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.2 t -109.47 155.17 21.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.993 0.896 . . . . 0.0 109.852 170.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.75 159.21 46.17 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.397 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.923 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.6 Cg_exo -69.63 138.99 39.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.5 0.857 . . . . 0.0 111.726 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.44 1.496 . . . . 0.0 112.332 -171.685 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.153 0 N-CA-C 112.859 0.292 . . . . 0.0 112.859 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' D' ' 10' ' ' ASP . 6.3 pt -56.67 119.96 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.01 177.37 8.3 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.948 0.88 . . . . 0.0 110.73 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -60.94 -29.91 71.91 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.467 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.18 60.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.802 0.801 . . . . 0.0 112.432 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.509 ' OD1' HG13 ' D' ' 97' ' ' VAL . 6.0 t70 -67.02 -36.85 83.01 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.744 HG11 HH21 ' D' ' 93' ' ' ARG . 35.2 m -103.94 126.0 58.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -126.52 154.49 43.73 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.643 0.735 . . . . 0.0 110.526 176.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.454 ' HD2' ' HE1' ' D' ' 91' ' ' PHE . 63.7 m-85 -111.81 94.84 5.15 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.765 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.7 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.0 mp -77.56 144.74 37.34 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 174.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.525 ' HB3' HD11 ' D' ' 89' ' ' ILE . 88.2 m-85 -133.21 139.2 46.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.501 0.667 . . . . 0.0 109.933 176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.889 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.59 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.38 153.98 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.596 0.713 . . . . 0.0 111.014 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.482 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pt -69.78 -49.25 59.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.96 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . 0.439 ' OD2' ' HD3' ' D' ' 87' ' ' LYS . 0.9 OUTLIER -82.03 -8.98 59.69 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.69 77.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.408 -175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.28 46.91 4.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 111.837 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.04 163.12 13.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.45 7.99 79.48 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.706 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . 0.492 ' OG ' HD11 ' D' ' 146' ' ' LEU . 3.1 m -155.35 135.2 12.79 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.952 0.376 . . . . 0.0 111.782 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.889 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -94.4 122.86 60.23 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.97 2.108 . . . . 0.0 112.435 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.55 129.16 17.32 Favored 'Trans proline' 0 C--N 1.348 0.535 0 CA-C-N 119.436 0.834 . . . . 0.0 112.471 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.785 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 129.94 54.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' D' ' 76' ' ' GLN . 25.5 t80 -92.55 141.7 24.96 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.851 -2.34 . . . . 0.0 110.564 -167.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.4 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-O 121.843 0.685 . . . . 0.0 112.43 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 54.77 46.29 24.89 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.367 1.467 . . . . 0.0 111.59 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.3 45.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.554 1.169 . . . . 0.0 111.033 173.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.507 ' HG2' HG23 ' D' ' 33' ' ' THR . 35.7 tt0 -101.91 -110.67 0.22 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . 0.507 HG23 ' HG2' ' D' ' 32' ' ' GLN . 12.2 p -119.2 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.813 1.292 . . . . 0.0 111.065 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.833 ' OD2' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -163.26 136.75 5.75 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.978 -164.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.38 130.81 7.66 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.343 170.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.32 97.82 7.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.64 119.66 51.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . 0.595 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 7.0 p -133.5 85.33 2.2 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.98 125.28 7.12 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.217 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.449 ' H ' ' HA ' ' E' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.447 HH11 ' HA ' ' D' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.695 0.76 . . . . 0.0 110.189 -174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 142.24 23.17 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -167.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.477 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.8 22.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.511 -179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . 0.622 ' HA ' HG12 ' D' ' 53' ' ' ILE . 9.3 t80 -108.31 83.42 1.78 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.186 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' D' ' 53' ' ' ILE . 34.0 t70 -106.47 92.13 3.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.454 ' HB2' ' H ' ' D' ' 51' ' ' GLY . 17.4 pt-20 -65.58 -15.75 63.02 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.08 35.76 21.29 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.573 1.549 . . . . 0.0 111.717 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.435 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 37.59 53.71 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.477 1.511 . . . . 0.0 111.57 -164.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' HG2' ' D' ' 52' ' ' ARG . 17.6 tptt -116.16 -92.04 0.52 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.431 -177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' E' ' 58' ' ' SER . 7.8 m-20 -150.56 29.87 0.68 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 84.85 34.77 14.4 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.439 ' HG2' ' HG2' ' D' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.66 44.68 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.622 HG12 ' HA ' ' D' ' 44' ' ' PHE . 0.5 OUTLIER -136.8 133.05 48.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.896 178.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 22.32 16.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.37 159.46 13.75 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.65 0.583 . . . . 0.0 113.943 -170.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.65 159.35 28.42 Favored 'Trans proline' 0 CA--C 1.516 -0.416 0 N-CA-C 113.854 0.675 . . . . 0.0 113.854 -175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -121.36 -77.24 0.45 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . 0.679 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 2.6 t -164.39 171.47 14.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.542 0.687 . . . . 0.0 110.532 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.437 ' H ' ' HB3' ' C' ' 50' ' ' ASN . 47.1 t -113.29 112.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.38 3.08 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.09 102.13 12.13 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 64.3 p -135.48 154.62 51.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.937 0.895 . . . . 0.0 110.067 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -142.42 155.65 25.79 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.207 176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.821 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.9 134.66 48.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.833 HG22 ' OD2' ' D' ' 34' ' ' ASP . 79.1 t -124.13 122.17 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.33 36.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.489 ' OH ' HG21 ' D' ' 79' ' ' ILE . 50.4 p90 -154.55 160.49 41.55 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 27.4 m-85 -87.72 144.98 26.35 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.28 139.97 22.38 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 114.978 0.751 . . . . 0.0 114.978 -175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -120.34 149.94 41.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.447 0.641 . . . . 0.0 109.287 174.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -39.18 67.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -172.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.79 -124.52 3.05 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 67.32 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.143 1.377 . . . . 0.0 110.998 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.549 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -90.75 -9.17 47.63 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.21 -44.76 27.72 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.819 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.656 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 9.2 tt0 -67.5 -35.48 79.21 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.139 -0.624 . . . . 0.0 111.856 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 2.8 mtmt -67.77 -41.68 82.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.815 171.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.64 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.88 168.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.656 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.1 mm -62.7 -52.41 59.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.038 0.447 . . . . 0.0 110.48 172.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.78 -39.17 73.35 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 121.759 -0.588 . . . . 0.0 112.447 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.95 -50.04 75.58 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.547 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.639 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -59.33 -43.47 92.74 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.561 175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.536 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 7.1 t80 -64.93 -52.59 55.55 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.906 -174.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.94 -36.68 59.27 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.036 172.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.09 74.14 Favored Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.32 -0.237 . . . . 0.0 112.882 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.639 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 6.1 mttm -67.12 146.19 54.52 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.444 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -70.6 144.92 51.03 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' D' ' 15' ' ' PHE . 4.8 tt -118.05 133.77 63.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.335 0.588 . . . . 0.0 109.897 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.4 mtmp? -88.61 121.43 30.98 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.454 ' HE1' ' HD2' ' D' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.85 52.45 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.483 1.113 . . . . 0.0 109.949 -165.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.7 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 23.3 m95 -123.34 116.49 23.39 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.223 1.009 . . . . 0.0 108.379 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.744 HH21 HG11 ' D' ' 11' ' ' VAL . 15.5 ttt180 -102.03 106.38 17.27 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.939 HG21 HG21 ' D' ' 145' ' ' THR . 1.6 m -122.41 148.87 25.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.291 1.043 . . . . 0.0 109.391 -173.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.15 167.12 20.02 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.615 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' D' ' 10' ' ' ASP . 13.5 m -107.19 -25.26 11.6 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.668 -176.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . 0.509 HG13 ' OD1' ' D' ' 10' ' ' ASP . 20.3 m -74.28 165.12 3.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.688 0.756 . . . . 0.0 109.931 176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' D' ' 99' ' ' ASN . 0.1 OUTLIER -93.52 107.78 19.58 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.968 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' D' ' 98' ' ' LYS . 9.7 t30 -72.17 160.69 32.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 109.988 171.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.67 26.35 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -98.86 -80.31 0.46 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.879 169.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.669 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.79 26.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.6 OUTLIER -56.14 -45.86 79.43 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.837 -0.539 . . . . 0.0 110.637 171.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' D' ' 142' ' ' GLU . 55.8 m-85 -138.38 -170.85 2.91 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.569 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.7 t70 -139.6 141.22 37.14 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.645 0.736 . . . . 0.0 109.436 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -131.68 145.91 51.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.074 -163.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -110.82 127.01 55.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' D' ' 138' ' ' LEU . 32.3 t80 -133.4 152.3 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.387 0.675 . . . . 0.0 110.403 -163.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . 0.968 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -168.23 171.44 42.51 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.961 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' D' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.62 35.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' D' ' 89' ' ' ILE . . . -132.52 158.25 42.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.932 0.873 . . . . 0.0 111.181 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.444 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 6.9 t80 -134.77 130.78 36.69 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.032 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' D' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 27.6 t -164.37 147.53 9.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.927 0.785 . . . . 0.0 109.124 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.96 52.04 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.94 21.38 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.2 123.89 49.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.053 0.454 . . . . 0.0 111.178 176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.691 177.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . 0.4 ' O ' ' HB ' ' C' ' 33' ' ' THR . 3.9 t70 -122.44 115.38 22.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.25 -176.82 20.9 Favored Glycine 0 N--CA 1.451 -0.349 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.489 HG23 ' CG2' ' C' ' 33' ' ' THR . 4.5 t -80.74 -44.82 21.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.539 -0.389 . . . . 0.0 111.091 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.82 17.38 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 169.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.45 10.69 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.77 165.49 23.95 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.596 0.712 . . . . 0.0 110.766 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.59 143.37 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.049 -171.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 23.0 mp0 -118.59 133.97 55.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.087 -176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.56 117.04 53.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.84 126.77 50.11 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 168.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.516 HG13 ' O ' ' D' ' 130' ' ' ILE . 4.0 pt -123.77 126.73 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -108.05 126.85 53.23 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.349 0.659 . . . . 0.0 109.715 -178.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' D' ' 63' ' ' GLY . 0.4 OUTLIER -138.44 165.68 26.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.077 -172.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.85 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.39 74.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 175.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.414 HG13 ' H ' ' D' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.325 0.584 . . . . 0.0 110.322 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.414 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.68 119.17 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.707 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.38 20.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.006 0.908 . . . . 0.0 110.686 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.968 HD12 ' HA2' ' D' ' 109' ' ' GLY . 1.7 mt -125.27 149.47 48.0 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.11 127.92 27.26 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.5 153.88 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -65.71 153.06 51.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.247 -0.977 . . . . 0.0 111.373 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 6.8 tp10 -111.96 137.52 49.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.692 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.785 -176.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.12 116.81 24.87 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.972 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.939 HG21 HG21 ' D' ' 94' ' ' VAL . 3.4 p -114.64 39.51 2.81 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.375 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . 0.492 HD11 ' OG ' ' D' ' 24' ' ' SER . 1.2 mm? 45.35 58.39 15.15 Favored Pre-proline 0 C--N 1.346 0.42 0 C-N-CA 126.46 1.904 . . . . 0.0 109.397 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.86 -10.4 29.02 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.19 1.26 . . . . 0.0 115.325 -159.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.623 171.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.785 HG23 HD22 ' D' ' 27' ' ' LEU . 46.4 mt -82.43 -44.93 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.156 0.889 . . . . 0.0 111.309 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 1.7 t -73.98 -39.43 51.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.44 113.73 25.96 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.472 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.07 146.67 38.75 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.422 ' HD3' ' HA3' ' J' ' 136' ' ' GLY . 12.3 mttt -75.92 -38.85 57.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.62 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 119.367 0.985 . . . . 0.0 113.06 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . 0.512 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -74.72 123.18 7.42 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.36 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.301 1.04 . . . . 0.0 108.593 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' J' ' 138' ' ' LEU . 0.5 OUTLIER -72.16 -28.83 63.49 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.449 ' HZ ' ' OD1' ' J' ' 144' ' ' ASP . 88.1 t80 -140.26 117.61 11.37 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.69 2.396 . . . . 0.0 109.13 167.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.615 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -149.32 43.78 0.95 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.777 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 15.5 tt0 -53.98 -61.93 4.58 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -79.94 136.85 12.06 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.053 1.769 . . . . 0.0 113.861 171.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.44 34.36 87.57 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.615 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.5 81.06 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.882 1.341 . . . . 0.0 110.893 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.914 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.9 m 47.19 63.23 2.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 111.896 176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.689 ' HA ' HG22 ' D' ' 173' ' ' THR . 34.0 p -120.74 149.43 42.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.339 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.85 43.59 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.525 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . 0.745 ' HA ' HD13 ' J' ' 18' ' ' ILE . 0.0 OUTLIER -61.45 -27.63 68.7 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.726 0.298 . . . . 0.0 111.5 -177.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . 0.417 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -83.76 159.79 59.92 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 123.473 0.709 . . . . 0.0 109.252 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.417 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.3 Cg_endo -78.94 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.28 1.32 . . . . 0.0 112.719 -156.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.84 1.13 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.171 1.628 . . . . 0.0 117.171 165.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.689 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -109.36 155.18 21.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.996 0.898 . . . . 0.0 109.883 170.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.73 159.18 46.2 Favored Pre-proline 0 C--O 1.24 0.58 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.43 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.914 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -69.59 139.04 39.79 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.515 0.862 . . . . 0.0 111.694 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.459 1.503 . . . . 0.0 112.289 -171.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.419 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.13 0 N-CA-C 112.836 0.283 . . . . 0.0 112.836 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.44 HG22 ' OD1' ' E' ' 10' ' ' ASP . 6.3 pt -56.7 119.95 2.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.0 177.37 8.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.875 0.845 . . . . 0.0 110.772 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.94 -29.87 71.8 Favored Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.378 -0.828 . . . . 0.0 114.492 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.84 -15.24 60.26 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.795 0.798 . . . . 0.0 112.398 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.51 ' OD1' HG13 ' E' ' 97' ' ' VAL . 6.0 t70 -67.06 -36.85 82.93 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.736 HG11 HH21 ' E' ' 93' ' ' ARG . 35.2 m -103.91 126.02 58.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . 0.573 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.46 43.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.557 176.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.45 ' HD2' ' HE1' ' E' ' 91' ' ' PHE . 63.0 m-85 -111.81 94.86 5.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.736 -164.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -77.62 144.81 37.17 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.518 ' HB3' HD11 ' E' ' 89' ' ' ILE . 88.2 m-85 -133.24 139.21 46.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.448 0.642 . . . . 0.0 109.998 176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.875 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.1 tm0? -136.48 142.28 43.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 153.97 39.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.547 0.689 . . . . 0.0 111.056 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.477 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pt -69.7 -49.29 59.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.992 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.427 ' OD2' ' HD3' ' E' ' 87' ' ' LYS . 0.9 OUTLIER -81.99 -9.06 59.68 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 -34.77 78.17 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.43 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.41 46.85 4.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.209 1.404 . . . . 0.0 111.802 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.1 13.45 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.41 7.97 79.58 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.38 0.425 . . . . 0.0 113.736 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' E' ' 146' ' ' LEU . 3.1 m -155.36 135.19 12.78 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.95 0.375 . . . . 0.0 111.777 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.875 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -94.4 122.87 60.21 Favored Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.936 2.094 . . . . 0.0 112.405 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.59 129.23 17.4 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.422 0.829 . . . . 0.0 112.459 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.767 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.05 54.24 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' E' ' 76' ' ' GLN . 25.4 t80 -92.67 141.68 24.8 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.526 -167.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.36 178.8 7.06 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 119.036 0.691 . . . . 0.0 112.454 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 54.83 46.24 24.92 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.333 1.453 . . . . 0.0 111.561 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 5.7 m-85 -72.12 134.32 45.69 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 122.539 1.161 . . . . 0.0 111.057 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.501 ' HG2' HG23 ' E' ' 33' ' ' THR . 35.7 tt0 -101.87 -110.61 0.22 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . 0.501 HG23 ' HG2' ' E' ' 32' ' ' GLN . 12.2 p -119.23 178.34 4.56 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.788 1.28 . . . . 0.0 111.102 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.826 ' OD2' HG22 ' E' ' 65' ' ' VAL . 5.3 t0 -163.26 136.78 5.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.985 -164.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.48 130.79 7.63 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.364 170.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.74 7.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.67 119.68 51.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 7.0 p -133.53 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -166.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.27 7.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.194 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.14 2.25 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' E' ' 41' ' ' ARG . 11.2 mmm180 -63.77 -178.77 0.33 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.677 0.751 . . . . 0.0 110.111 -174.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.28 23.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.71 22.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.507 -179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' E' ' 53' ' ' ILE . 9.3 t80 -108.25 83.35 1.77 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.254 171.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' E' ' 53' ' ' ILE . 34.1 t70 -106.44 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' E' ' 51' ' ' GLY . 17.3 pt-20 -65.55 -15.8 63.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.84 21.22 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.641 -172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.434 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 37.51 53.72 1.39 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 111.552 -164.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' E' ' 52' ' ' ARG . 17.6 tptt -116.15 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.464 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . 0.627 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 7.8 m-20 -150.61 29.98 0.67 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 84.77 34.77 14.67 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' E' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.59 44.55 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' E' ' 44' ' ' PHE . 0.5 OUTLIER -136.81 133.0 48.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.885 178.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.48 13.74 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-O 121.625 0.57 . . . . 0.0 113.958 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.66 159.38 28.35 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.876 0.683 . . . . 0.0 113.876 -175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -121.36 -77.19 0.45 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . 0.498 ' HA ' ' OD1' ' D' ' 50' ' ' ASN . 2.6 t -164.41 171.47 14.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.577 0.703 . . . . 0.0 110.506 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.31 112.34 39.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.8 86.39 3.08 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.12 12.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . 0.891 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 64.7 p -135.49 154.69 51.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.962 0.905 . . . . 0.0 110.063 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . 0.433 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -142.49 155.67 25.83 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.166 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.811 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.65 48.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.826 HG22 ' OD2' ' E' ' 34' ' ' ASP . 79.5 t -124.08 122.14 63.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 174.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.49 ' OH ' HG21 ' E' ' 79' ' ' ILE . 50.6 p90 -154.51 160.49 41.59 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 27.4 m-85 -87.77 144.94 26.35 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 139.97 22.4 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.921 0.728 . . . . 0.0 114.921 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.99 41.48 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.16 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.8 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.31 131.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.157 1.383 . . . . 0.0 111.016 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -90.68 -9.19 47.74 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 117.502 2.408 . . . . 0.0 117.502 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.82 27.72 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.845 168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.645 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 9.3 tt0 -67.48 -35.44 79.16 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.842 171.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 2.8 mtmt -67.85 -41.69 82.52 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.771 171.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.896 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.1 mm -62.67 -52.44 59.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 110.469 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.85 -39.06 73.14 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.726 -0.609 . . . . 0.0 112.418 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.03 -50.03 75.65 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.55 169.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.642 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -59.24 -43.54 92.39 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.548 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.595 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 7.0 t80 -64.96 -52.57 55.58 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.918 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.87 -36.79 59.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -167.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.417 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 14.3 m120 -86.2 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.017 172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.84 30.11 74.17 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.353 -0.217 . . . . 0.0 112.872 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.642 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 6.1 mttm -67.02 146.17 54.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.447 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -70.58 144.93 51.06 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' E' ' 15' ' ' PHE . 4.8 tt -118.07 133.8 63.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.33 0.586 . . . . 0.0 109.859 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.4 mtmp? -88.65 121.38 30.96 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.45 ' HE1' ' HD2' ' E' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.533 1.133 . . . . 0.0 110.01 -166.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 23.5 m95 -123.33 116.53 23.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.206 1.002 . . . . 0.0 108.321 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.736 HH21 HG11 ' E' ' 11' ' ' VAL . 15.5 ttt180 -101.99 106.34 17.24 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.952 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.41 148.84 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 122.266 1.031 . . . . 0.0 109.402 -173.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.08 167.09 20.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.668 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' E' ' 10' ' ' ASP . 13.8 m -107.26 -25.25 11.58 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 114.898 -1.046 . . . . 0.0 112.64 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' E' ' 10' ' ' ASP . 20.4 m -74.2 165.06 3.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.887 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' E' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.944 -174.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.409 ' O ' ' HD2' ' E' ' 98' ' ' LYS . 9.7 t30 -72.19 160.7 31.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.796 0.807 . . . . 0.0 109.994 171.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.69 26.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.89 -80.31 0.47 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.759 0.709 . . . . 0.0 110.883 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.668 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.4 OUTLIER -70.94 163.81 26.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.603 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.93 79.37 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.903 -0.498 . . . . 0.0 110.585 171.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' E' ' 142' ' ' GLU . 55.8 m-85 -138.34 -170.86 2.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.7 t70 -139.65 141.21 37.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.641 0.734 . . . . 0.0 109.43 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -131.67 145.93 51.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.069 -163.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.8 126.99 55.2 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 157.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' E' ' 138' ' ' LEU . 32.2 t80 -133.4 152.31 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.439 0.695 . . . . 0.0 110.41 -163.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . 0.989 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -168.23 171.42 42.51 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.483 -1.342 . . . . 0.0 111.924 170.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.426 ' HB3' HE22 ' E' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.63 35.72 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' E' ' 89' ' ' ILE . . . -132.44 158.29 42.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.941 0.877 . . . . 0.0 111.178 -169.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.447 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 6.9 t80 -134.81 130.76 36.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.958 -174.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' E' ' 83' ' ' TYR . 1.4 mp -65.63 120.2 12.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.37 13.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 27.6 t -164.3 147.49 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.944 0.793 . . . . 0.0 109.095 174.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.18 137.97 51.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 176.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.99 21.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.681 177.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' D' ' 33' ' ' THR . 3.9 t70 -122.46 115.35 22.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.24 -176.76 20.89 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 121.726 0.626 . . . . 0.0 111.551 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.431 HG23 HG22 ' D' ' 33' ' ' THR . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 122.448 -0.443 . . . . 0.0 111.103 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.78 17.4 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 169.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 86.35 147.43 10.69 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.402 ' HA ' ' N ' ' D' ' 8' ' ' GLY . . . -71.73 165.48 23.94 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.598 0.713 . . . . 0.0 110.774 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -58.58 143.37 13.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.082 -171.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 23.1 mp0 -118.52 133.95 55.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.096 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.55 117.1 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.82 126.75 50.07 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' E' ' 130' ' ' ILE . 4.0 pt -123.77 126.74 73.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.811 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -108.02 126.85 53.21 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.77 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' E' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.65 26.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.106 -172.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.891 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -125.6 162.94 23.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.31 129.42 74.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.42 HG12 ' H ' ' E' ' 135' ' ' ILE . 6.5 pt -67.89 -51.89 45.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.37 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.41 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.72 119.14 3.4 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.723 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.13 122.42 20.96 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.053 0.93 . . . . 0.0 110.665 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.989 HD12 ' HA2' ' E' ' 109' ' ' GLY . 1.7 mt -125.28 149.43 48.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.91 27.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.46 153.92 29.58 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -65.76 153.05 51.58 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.388 169.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.47 49.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.7 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -104.16 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.788 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.9 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.005 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.952 HG21 HG21 ' E' ' 94' ' ' VAL . 3.5 p -114.57 39.35 2.84 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.445 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' E' ' 24' ' ' SER . 1.2 mm? 45.46 58.37 15.29 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.475 1.91 . . . . 0.0 109.386 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.94 -10.37 28.96 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.227 1.285 . . . . 0.0 115.312 -159.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.73 -25.63 68.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.573 171.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.53 1.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.767 HG23 HD22 ' E' ' 27' ' ' LEU . 47.0 mt -82.44 -44.99 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 119.123 0.874 . . . . 0.0 111.248 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 1.7 t -73.89 -39.44 51.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.52 113.69 25.88 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.29 117.87 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.65 38.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.459 ' HD3' ' HA3' ' K' ' 136' ' ' GLY . 12.3 mttt -75.94 -38.85 57.17 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 175.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.6 65.63 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.384 0.993 . . . . 0.0 113.048 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.67 123.26 7.48 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.34 22.3 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.343 1.057 . . . . 0.0 108.604 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' K' ' 138' ' ' LEU . 0.5 OUTLIER -72.15 -28.86 63.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.21 117.62 11.42 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.666 2.386 . . . . 0.0 109.173 167.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.622 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -149.3 43.8 0.95 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 154.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.807 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.58 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -166.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.807 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -79.98 136.88 12.02 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.063 1.772 . . . . 0.0 113.889 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.4 34.4 87.73 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.622 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.0 tt0 -68.42 -40.52 81.21 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 118.909 1.354 . . . . 0.0 110.899 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.9 m 47.12 63.3 2.0 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.849 1.66 . . . . 0.0 111.895 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.698 ' HA ' HG22 ' E' ' 173' ' ' THR . 33.9 p -120.76 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.316 -167.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.88 -170.86 43.65 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.427 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . 0.817 ' HA ' HD13 ' K' ' 18' ' ' ILE . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.733 0.267 . . . . 0.0 111.471 -177.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -83.74 159.79 59.96 Favored Pre-proline 0 C--O 1.236 0.348 0 C-N-CA 123.461 0.704 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.425 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.1 Cg_endo -78.93 85.07 1.92 Allowed 'Trans proline' 0 C--N 1.323 -0.791 0 C-N-CA 121.28 1.32 . . . . 0.0 112.747 -156.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.67 90.82 1.13 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.698 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -109.41 155.11 21.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.027 0.913 . . . . 0.0 109.906 170.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.66 159.19 45.39 Favored Pre-proline 0 C--O 1.241 0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.425 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.902 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -69.6 139.0 39.69 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.554 0.876 . . . . 0.0 111.722 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.45 1.5 . . . . 0.0 112.345 -171.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.539 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 N-CA-C 112.842 0.285 . . . . 0.0 112.842 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' F' ' 10' ' ' ASP . 6.4 pt -56.63 119.89 2.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -84.03 177.37 8.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.886 0.85 . . . . 0.0 110.729 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.517 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -60.92 -29.88 71.76 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.404 -0.817 . . . . 0.0 114.508 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.91 -15.14 60.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.76 0.78 . . . . 0.0 112.407 172.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' F' ' 97' ' ' VAL . 6.0 t70 -67.13 -36.81 82.67 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.723 HG11 HH21 ' F' ' 93' ' ' ARG . 35.2 m -103.91 126.03 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.47 43.83 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.689 0.756 . . . . 0.0 110.521 176.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' F' ' 91' ' ' PHE . 63.3 m-85 -111.8 94.97 5.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.74 -164.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -77.67 144.81 37.07 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 174.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.536 ' HB3' HD11 ' F' ' 89' ' ' ILE . 88.3 m-85 -133.27 139.26 46.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.483 0.659 . . . . 0.0 109.96 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.867 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.52 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.43 153.97 38.97 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.007 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.466 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pt -69.74 -49.25 59.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.998 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' F' ' 87' ' ' LYS . 0.9 OUTLIER -82.04 -9.0 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.8 78.29 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.437 -175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.93 4.11 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.21 1.404 . . . . 0.0 111.788 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.14 13.43 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.44 7.97 79.51 Favored Glycine 0 N--CA 1.45 -0.375 0 O-C-N 123.378 0.424 . . . . 0.0 113.687 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . 0.489 ' OG ' HD11 ' F' ' 146' ' ' LEU . 3.1 m -155.33 135.25 12.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 117.027 0.413 . . . . 0.0 111.794 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.867 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -94.5 122.9 59.95 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.948 2.099 . . . . 0.0 112.377 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.59 129.26 17.46 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.381 0.815 . . . . 0.0 112.443 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.761 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.4 130.02 54.28 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' F' ' 76' ' ' GLN . 25.4 t80 -92.6 141.69 24.89 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.833 -2.347 . . . . 0.0 110.583 -167.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.44 178.78 7.11 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-O 121.887 0.703 . . . . 0.0 112.382 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 54.81 46.3 24.82 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.347 1.459 . . . . 0.0 111.543 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.435 ' HE1' ' HG ' ' F' ' 27' ' ' LEU . 5.7 m-85 -72.15 134.33 45.66 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 122.506 1.146 . . . . 0.0 111.105 173.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' F' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.64 0.22 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.495 HG23 ' HG2' ' F' ' 32' ' ' GLN . 12.2 p -119.22 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.717 1.246 . . . . 0.0 111.111 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.821 ' OD2' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -163.28 136.74 5.73 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.029 -164.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.44 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.34 170.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.19 97.81 7.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 173.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 81.5 t -102.68 119.64 51.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . 0.531 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 7.1 p -133.47 85.33 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.97 125.26 7.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.263 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 86.19 2.25 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' F' ' 41' ' ' ARG . 11.2 mmm180 -63.75 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.721 0.772 . . . . 0.0 110.146 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.1 142.27 23.19 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -74.0 166.74 22.84 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.484 -179.1 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . 0.614 ' HA ' HG12 ' F' ' 53' ' ' ILE . 9.2 t80 -108.25 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.235 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . 0.456 ' H ' ' CG2' ' F' ' 53' ' ' ILE . 34.1 t70 -106.49 92.05 3.95 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' F' ' 51' ' ' GLY . 17.4 pt-20 -65.54 -15.79 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.15 35.76 21.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.573 1.549 . . . . 0.0 111.66 -172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.425 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 37.59 53.7 1.43 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.505 1.522 . . . . 0.0 111.547 -164.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' F' ' 52' ' ' ARG . 17.6 tptt -116.23 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.419 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 7.8 m-20 -150.62 29.94 0.67 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 177.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 84.81 34.85 14.32 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' F' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.59 44.54 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.614 HG12 ' HA ' ' F' ' 44' ' ' PHE . 0.5 OUTLIER -136.79 133.02 48.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.903 178.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.15 22.31 16.12 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.3 159.46 13.75 Favored Glycine 0 N--CA 1.442 -0.9 0 CA-C-O 121.64 0.578 . . . . 0.0 113.955 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.68 159.45 28.29 Favored 'Trans proline' 0 CA--C 1.515 -0.427 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -121.46 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . 0.627 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 2.6 t -164.45 171.44 14.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 0.0 110.474 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 47.0 t -113.28 112.37 40.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.83 86.41 3.08 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.17 12.16 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.7 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.955 0.902 . . . . 0.0 110.05 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -142.45 155.69 25.82 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.183 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.81 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.93 134.7 48.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.821 HG22 ' OD2' ' F' ' 34' ' ' ASP . 79.3 t -124.12 122.14 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -106.12 142.32 36.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' F' ' 79' ' ' ILE . 50.5 p90 -154.54 160.47 41.54 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 27.4 m-85 -87.69 144.95 26.38 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 139.98 22.38 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -120.35 150.05 41.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 109.32 174.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -39.2 68.28 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.54 3.05 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.29 131.09 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.029 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -90.77 -9.18 47.53 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.23 -44.76 27.55 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.827 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.648 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 9.3 tt0 -67.45 -35.54 79.42 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 122.141 -0.623 . . . . 0.0 111.856 171.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 2.8 mtmt -67.79 -41.64 82.89 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.816 171.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -33.71 74.63 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.892 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.0 OUTLIER -62.72 -52.41 59.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.49 172.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -70.79 -39.18 73.31 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.752 -0.592 . . . . 0.0 112.426 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -59.01 -49.96 75.91 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.582 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.66 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -59.29 -43.53 92.57 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.57 174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 7.0 t80 -64.91 -52.67 55.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.859 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.9 -36.74 59.37 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.5 58.98 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.05 172.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.93 30.05 73.99 Favored Glycine 0 N--CA 1.448 -0.517 0 O-C-N 122.362 -0.211 . . . . 0.0 112.867 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.66 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 6.1 mttm -67.01 146.18 54.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.45 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -70.61 144.91 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 168.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' F' ' 15' ' ' PHE . 4.8 tt -118.05 133.76 63.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.351 0.596 . . . . 0.0 109.879 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.39 30.95 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' F' ' 13' ' ' TYR . 0.1 OUTLIER -116.54 125.83 52.45 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.512 1.125 . . . . 0.0 109.992 -166.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.719 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 23.8 m95 -123.4 116.59 23.52 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.723 HH21 HG11 ' F' ' 11' ' ' VAL . 15.4 ttt180 -102.06 106.36 17.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.958 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.37 148.89 25.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.249 1.023 . . . . 0.0 109.418 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.17 167.09 20.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.585 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.478 ' N ' ' O ' ' F' ' 10' ' ' ASP . 13.1 m -107.16 -25.32 11.59 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.694 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' F' ' 10' ' ' ASP . 20.4 m -74.2 165.15 3.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.685 0.755 . . . . 0.0 109.913 176.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.78 19.58 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.972 -174.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.19 160.68 32.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.801 0.81 . . . . 0.0 110.006 171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.44 -8.63 26.47 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.93 -80.35 0.47 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.821 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' F' ' 143' ' ' ILE . 0.4 OUTLIER -70.92 163.73 26.86 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.7 OUTLIER -56.03 -45.99 78.98 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.839 -0.538 . . . . 0.0 110.567 171.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.625 ' HB2' ' HB3' ' F' ' 142' ' ' GLU . 55.7 m-85 -138.33 -170.88 2.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.7 t70 -139.61 141.28 37.13 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 109.396 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -131.71 145.96 51.91 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.006 -163.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.87 126.99 55.27 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' F' ' 138' ' ' LEU . 32.4 t80 -133.4 152.28 51.9 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.423 0.689 . . . . 0.0 110.451 -163.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . 1.007 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -168.19 171.4 42.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.989 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' F' ' 88' ' ' GLN . 6.2 m-85 -92.39 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 167.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.429 ' HB3' HG23 ' F' ' 89' ' ' ILE . . . -132.48 158.32 42.38 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.926 0.87 . . . . 0.0 111.146 -169.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.45 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 6.8 t80 -134.81 130.76 36.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.026 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.437 HG21 ' HD1' ' F' ' 83' ' ' TYR . 1.4 mp -65.58 120.17 11.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.2 -27.26 13.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.39 147.52 9.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.915 0.78 . . . . 0.0 109.065 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.05 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.35 119.98 21.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.85 49.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.043 0.449 . . . . 0.0 111.202 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . 0.618 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 0.8 OUTLIER -106.18 126.92 52.8 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.72 177.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . 0.442 ' O ' ' HB ' ' E' ' 33' ' ' THR . 3.9 t70 -122.5 115.36 22.07 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.19 -176.79 20.93 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.586 -0.605 . . . . 0.0 111.586 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.74 -44.86 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.506 -0.408 . . . . 0.0 111.092 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.78 17.4 Favored 'General case' 0 CA--C 1.513 -0.442 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.47 10.75 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.79 165.54 23.86 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.604 0.716 . . . . 0.0 110.779 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.63 143.39 13.06 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.041 -171.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 22.9 mp0 -118.59 133.98 55.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.095 -176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.58 117.09 53.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.503 HG13 ' O ' ' F' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.81 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.85 53.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.744 -178.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' F' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.158 -172.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -125.59 162.97 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 167.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.35 129.46 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.416 HG13 ' H ' ' F' ' 136' ' ' GLY . 6.4 pt -67.94 -51.85 45.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.342 0.591 . . . . 0.0 110.342 -173.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.416 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.77 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.722 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.17 122.44 21.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 122.012 0.911 . . . . 0.0 110.67 174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 1.007 HD12 ' HA2' ' F' ' 109' ' ' GLY . 1.7 mt -125.34 149.44 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -174.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.04 127.92 27.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -156.51 153.94 29.54 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -65.71 153.06 51.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.397 169.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.625 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.54 49.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -174.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.701 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -104.22 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.713 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.08 116.9 25.08 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.93 -176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.958 HG21 HG21 ' F' ' 94' ' ' VAL . 3.4 p -114.68 39.45 2.83 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.368 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . 0.489 HD11 ' OG ' ' F' ' 24' ' ' SER . 1.2 mm? 45.32 58.39 15.11 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.504 1.922 . . . . 0.0 109.427 -173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.628 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.8 -10.45 29.14 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.255 1.304 . . . . 0.0 115.343 -159.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.51 68.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.571 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.18 -43.52 1.79 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.761 HG23 HD22 ' F' ' 27' ' ' LEU . 46.8 mt -82.48 -44.98 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.178 0.899 . . . . 0.0 111.269 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.628 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 1.7 t -73.9 -39.44 51.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.65 25.85 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.495 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.87 43.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.05 146.67 38.72 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.89 -38.93 57.33 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.56 65.53 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 119.399 1.0 . . . . 0.0 113.034 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.915 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -74.63 123.16 7.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.427 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.6 t80 -101.76 110.33 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.299 1.04 . . . . 0.0 108.646 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.815 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.11 -28.87 63.56 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.712 ' CE1' HD13 ' L' ' 143' ' ' ILE . 88.0 t80 -140.22 117.55 11.35 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.7 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -149.3 43.83 0.95 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 154.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.805 ' HB3' ' HD3' ' F' ' 163' ' ' PRO . 15.6 tt0 -53.99 -61.89 4.65 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.4 Cg_exo -80.06 136.88 11.91 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.05 1.768 . . . . 0.0 113.832 171.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.47 34.34 87.46 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 -171.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' F' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.55 81.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.933 1.366 . . . . 0.0 110.908 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.915 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.9 m 47.15 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.781 1.632 . . . . 0.0 111.904 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.69 ' HA ' HG22 ' F' ' 173' ' ' THR . 34.3 p -120.76 149.4 42.6 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.327 -167.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.87 43.6 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.491 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.855 ' OE1' ' HB2' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -61.47 -27.63 68.71 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.798 0.299 . . . . 0.0 111.416 -177.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -83.74 159.81 59.92 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.466 0.706 . . . . 0.0 109.268 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' L' ' 110' ' ' PHE . 85.7 Cg_endo -78.98 85.08 1.92 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.268 1.312 . . . . 0.0 112.746 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.69 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.69 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.1 t -109.48 155.17 21.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.984 0.892 . . . . 0.0 109.879 170.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.23 46.07 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.384 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.915 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -69.62 138.97 39.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.508 0.86 . . . . 0.0 111.71 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.406 1.483 . . . . 0.0 112.3 -171.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.556 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.23 0.103 0 N-CA-C 112.843 0.286 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.434 HG22 ' OD1' ' G' ' 10' ' ' ASP . 6.3 pt -56.61 119.88 2.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.36 8.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.903 0.859 . . . . 0.0 110.761 -177.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' H' ' 125' ' ' ALA . . . -60.97 -29.87 71.9 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.462 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.2 60.27 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 117.815 0.808 . . . . 0.0 112.41 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.499 ' OD1' HG13 ' G' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.79 82.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -172.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.734 HG11 HH21 ' G' ' 93' ' ' ARG . 35.3 m -103.93 126.01 58.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -126.56 154.44 43.88 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.677 0.751 . . . . 0.0 110.503 176.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.476 ' HD2' ' HE1' ' G' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.87 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.716 -164.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.0 mp -77.59 144.77 37.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' G' ' 89' ' ' ILE . 88.3 m-85 -133.24 139.28 46.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.517 0.675 . . . . 0.0 109.949 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.887 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.1 tm0? -136.51 142.33 43.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.41 153.96 38.99 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.571 0.701 . . . . 0.0 111.025 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.754 HD13 ' HA ' ' A' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.01 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' G' ' 87' ' ' LYS . 0.9 OUTLIER -82.07 -8.96 59.69 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.35 -34.68 77.83 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.408 -175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.416 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 42.36 46.9 4.12 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.245 1.418 . . . . 0.0 111.801 -173.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.13 163.07 13.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -91.42 8.05 79.46 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.748 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . 0.499 ' OG ' HD11 ' G' ' 146' ' ' LEU . 3.1 m -155.34 135.18 12.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.961 0.381 . . . . 0.0 111.795 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.887 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -94.4 122.82 60.32 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.968 2.107 . . . . 0.0 112.451 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.55 129.21 17.41 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.38 0.814 . . . . 0.0 112.507 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.769 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.04 54.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' G' ' 76' ' ' GLN . 25.4 t80 -92.7 141.72 24.81 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 115.768 -2.373 . . . . 0.0 110.558 -167.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.35 178.81 7.05 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.56 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 54.81 46.29 24.84 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.374 1.47 . . . . 0.0 111.545 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 5.7 m-85 -72.21 134.32 45.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.569 1.176 . . . . 0.0 111.044 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' G' ' 33' ' ' THR . 35.8 tt0 -101.89 -110.62 0.22 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' G' ' 32' ' ' GLN . 12.2 p -119.22 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.776 1.274 . . . . 0.0 111.075 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.837 ' OD2' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -163.32 136.77 5.71 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.97 -164.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.39 130.73 7.63 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.393 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.22 97.82 7.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.14 -2.171 . . . . 0.0 105.14 173.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.68 119.62 51.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.9 p -133.49 85.32 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.93 125.31 7.13 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.232 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.77 86.12 2.24 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.45 ' HA ' HH11 ' G' ' 41' ' ' ARG . 11.2 mmm180 -63.69 -178.77 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.731 0.777 . . . . 0.0 110.167 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 142.23 23.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.533 ' HG ' ' HA2' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -73.9 166.74 22.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.53 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . 0.595 ' HA ' HG12 ' G' ' 53' ' ' ILE . 9.3 t80 -108.31 83.39 1.77 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.214 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' G' ' 53' ' ' ILE . 34.1 t70 -106.4 92.1 3.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.456 ' HB2' ' H ' ' G' ' 51' ' ' GLY . 17.4 pt-20 -65.57 -15.78 63.05 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.16 35.77 21.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.593 1.557 . . . . 0.0 111.644 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.554 HG23 ' O ' ' B' ' 31' ' ' TYR . 0.0 OUTLIER 37.49 53.72 1.38 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.522 1.529 . . . . 0.0 111.598 -164.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . 0.459 ' HG2' ' HG2' ' G' ' 52' ' ' ARG . 17.6 tptt -116.11 -92.03 0.52 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.461 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 7.8 m-20 -150.65 30.02 0.67 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 84.84 34.71 14.65 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' G' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.66 44.64 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' G' ' 44' ' ' PHE . 0.5 OUTLIER -136.89 132.96 47.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.86 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.5 13.73 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-O 121.675 0.597 . . . . 0.0 113.931 -170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.71 159.37 28.19 Favored 'Trans proline' 0 CA--C 1.515 -0.45 0 N-CA-C 113.846 0.672 . . . . 0.0 113.846 -175.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -121.38 -77.2 0.44 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . 0.668 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 2.6 t -164.43 171.46 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.576 0.703 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' L' ' 50' ' ' ASN . 47.0 t -113.3 112.42 40.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.064 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.42 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . 0.86 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.2 p -135.52 154.65 51.32 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.934 0.894 . . . . 0.0 110.086 -178.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -142.43 155.69 25.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.179 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.816 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.99 134.67 48.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.837 HG22 ' OD2' ' G' ' 34' ' ' ASP . 79.4 t -124.1 122.18 63.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.12 142.31 36.02 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.476 ' OH ' HG21 ' G' ' 79' ' ' ILE . 50.5 p90 -154.54 160.52 41.56 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.56 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 27.3 m-85 -87.79 144.95 26.34 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -79.24 140.01 22.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 149.92 41.59 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.69 -39.25 67.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.77 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.25 131.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.149 1.38 . . . . 0.0 111.004 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -90.69 -9.19 47.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' G' ' 79' ' ' ILE . . . -74.15 -44.8 27.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.876 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.647 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 9.3 tt0 -67.53 -35.49 79.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.161 -0.615 . . . . 0.0 111.807 171.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 2.8 mtmt -67.82 -41.65 82.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.809 171.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -33.75 74.63 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.945 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.647 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.1 mm -62.62 -52.47 59.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.061 0.458 . . . . 0.0 110.48 172.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.11 73.2 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.771 -0.581 . . . . 0.0 112.421 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -58.96 -50.04 75.59 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.604 169.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.662 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -59.22 -43.58 92.31 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.079 -1.048 . . . . 0.0 111.603 174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.495 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 7.1 t80 -64.9 -52.61 55.54 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.931 -174.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.72 59.4 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -167.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.422 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 14.3 m120 -86.25 -3.5 58.99 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.013 172.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.88 30.09 74.09 Favored Glycine 0 N--CA 1.45 -0.425 0 O-C-N 122.393 -0.192 . . . . 0.0 112.81 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.662 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 6.0 mttm -67.04 146.15 54.64 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' OE1' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.92 51.15 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 168.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' G' ' 15' ' ' PHE . 4.8 tt -118.04 133.76 63.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-O 121.338 0.589 . . . . 0.0 109.857 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.48 31.1 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.476 ' HE1' ' HD2' ' G' ' 13' ' ' TYR . 0.1 OUTLIER -116.63 125.8 52.3 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.506 1.122 . . . . 0.0 109.987 -165.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.723 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 23.5 m95 -123.32 116.55 23.51 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.734 HH21 HG11 ' G' ' 11' ' ' VAL . 15.6 ttt180 -102.07 106.36 17.24 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.956 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.43 148.89 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.237 1.018 . . . . 0.0 109.416 -173.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.2 167.12 19.97 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.48 ' N ' ' O ' ' G' ' 10' ' ' ASP . 13.8 m -107.22 -25.29 11.58 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.638 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . 0.499 HG13 ' OD1' ' G' ' 10' ' ' ASP . 20.2 m -74.23 165.07 3.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.67 0.747 . . . . 0.0 109.898 176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' G' ' 99' ' ' ASN . 0.1 OUTLIER -93.48 107.79 19.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.999 -174.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' G' ' 98' ' ' LYS . 9.7 t30 -72.22 160.7 31.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.764 0.792 . . . . 0.0 110.003 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.48 -8.7 26.25 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.82 -80.29 0.46 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.8 0.727 . . . . 0.0 110.919 169.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.662 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -70.98 163.78 26.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.606 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.94 79.16 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.888 -0.508 . . . . 0.0 110.602 171.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' G' ' 142' ' ' GLU . 55.7 m-85 -138.35 -170.9 2.92 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.578 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.7 t70 -139.55 141.27 37.24 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 109.411 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -131.72 145.88 51.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.051 -163.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -110.79 127.05 55.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' G' ' 138' ' ' LEU . 32.3 t80 -133.38 152.33 51.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.408 0.683 . . . . 0.0 110.441 -163.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . 0.996 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -168.26 171.4 42.52 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.932 170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.43 ' HB3' HE22 ' G' ' 88' ' ' GLN . 6.1 m-85 -92.46 133.62 35.73 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.434 ' HB3' HG23 ' G' ' 89' ' ' ILE . . . -132.47 158.28 42.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.934 0.873 . . . . 0.0 111.187 -169.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 6.9 t80 -134.83 130.77 36.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.533 -1.212 . . . . 0.0 107.993 -174.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.438 HG21 ' HD1' ' G' ' 83' ' ' TYR . 1.4 mp -65.58 120.11 11.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.35 13.58 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.31 147.52 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.947 0.794 . . . . 0.0 109.108 174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.94 52.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.95 21.39 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.24 123.87 49.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 111.163 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.88 52.76 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.652 177.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.47 115.4 22.16 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -110.2 -176.77 20.92 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.72 -44.93 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 122.462 -0.434 . . . . 0.0 111.104 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.69 156.86 17.35 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.31 147.45 10.67 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -71.76 165.5 23.93 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.589 0.709 . . . . 0.0 110.769 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.62 143.37 13.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.051 -171.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 23.1 mp0 -118.54 133.96 55.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.105 -176.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 37.6 mt -117.55 117.06 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.71 50.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.503 ' O ' HG13 ' G' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.816 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -107.96 126.82 53.16 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.381 0.673 . . . . 0.0 109.77 -178.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' G' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.64 26.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -172.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.86 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -125.58 162.94 23.82 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.31 129.41 74.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.44 ' H ' HG12 ' G' ' 135' ' ' ILE . 6.5 pt -67.88 -51.89 45.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 110.373 -173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 155' ' ' LYS . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.716 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.21 122.37 20.94 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.068 0.937 . . . . 0.0 110.644 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.996 HD12 ' HA2' ' G' ' 109' ' ' GLY . 1.7 mt -125.29 149.43 48.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 127.87 27.21 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.41 153.94 29.68 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -65.81 153.07 51.63 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.379 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 6.8 tp10 -111.93 137.55 49.77 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.694 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -104.24 -63.91 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.739 -176.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.16 116.9 25.0 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.912 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.956 HG21 HG21 ' G' ' 94' ' ' VAL . 3.5 p -114.59 39.38 2.83 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.407 175.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . 0.499 HD11 ' OG ' ' G' ' 24' ' ' SER . 1.2 mm? 45.37 58.38 15.16 Favored Pre-proline 0 C--N 1.346 0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 109.412 -173.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.641 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.87 -10.39 28.99 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.175 1.25 . . . . 0.0 115.318 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -25.69 68.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.553 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.07 -43.54 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.769 HG23 HD22 ' G' ' 27' ' ' LEU . 47.0 mt -82.43 -44.99 19.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.138 0.881 . . . . 0.0 111.246 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.641 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 1.7 t -73.87 -39.49 51.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.69 25.89 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.462 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.24 117.85 43.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.64 38.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.92 -38.89 57.23 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.65 65.61 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.386 0.994 . . . . 0.0 113.046 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.73 123.27 7.45 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.78 110.31 22.27 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.293 1.037 . . . . 0.0 108.639 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.9 63.57 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -158.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.6 11.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.657 2.383 . . . . 0.0 109.12 167.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.616 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 153.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 15.5 tt0 -53.95 -61.98 4.49 Favored Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.92 12.03 Favored 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.072 1.776 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.41 34.36 87.6 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.616 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.58 81.35 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.907 1.354 . . . . 0.0 110.894 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.919 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 7.0 m 47.13 63.33 1.99 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.82 1.648 . . . . 0.0 111.891 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.671 ' HA ' HG22 ' G' ' 173' ' ' THR . 33.9 p -120.8 149.44 42.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.93 -170.83 43.72 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.442 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -27.59 68.71 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.752 0.276 . . . . 0.0 111.447 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -83.72 159.79 60.03 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.477 0.711 . . . . 0.0 109.265 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 85.1 Cg_endo -78.95 85.16 1.9 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.272 1.315 . . . . 0.0 112.681 -156.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 90.89 1.12 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.182 1.633 . . . . 0.0 117.182 165.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.671 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -109.41 155.18 21.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.95 0.875 . . . . 0.0 109.872 170.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.78 159.27 45.97 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.402 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.919 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.6 Cg_exo -69.68 139.0 39.41 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.428 1.491 . . . . 0.0 112.33 -171.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.571 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 N-CA-C 112.831 0.281 . . . . 0.0 112.831 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.427 HG22 ' OD1' ' H' ' 10' ' ' ASP . 6.4 pt -56.62 119.94 2.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' I' ' 125' ' ' ALA . 0.0 OUTLIER -83.99 177.39 8.3 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.856 0.836 . . . . 0.0 110.759 -177.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.91 -29.94 71.88 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.519 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.82 -15.19 60.28 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.743 0.771 . . . . 0.0 112.372 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' H' ' 97' ' ' VAL . 6.0 t70 -67.15 -36.83 82.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.749 HG11 HH21 ' H' ' 93' ' ' ARG . 35.3 m -103.87 125.98 58.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . 0.568 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.663 0.744 . . . . 0.0 110.545 176.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.472 ' HD2' ' HE1' ' H' ' 91' ' ' PHE . 63.3 m-85 -111.79 94.91 5.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.758 -164.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.714 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -77.66 144.74 37.15 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.543 ' HB3' HD11 ' H' ' 89' ' ' ILE . 88.3 m-85 -133.21 139.22 46.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.484 0.659 . . . . 0.0 109.99 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.896 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.1 tm0? -136.46 142.32 43.58 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.04 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.741 HD13 ' HA ' ' B' ' 169' ' ' GLU . 1.1 pt -69.77 -49.23 59.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.0 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . 0.423 ' OD2' ' HD3' ' H' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.0 59.69 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -171.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.79 78.25 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.461 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.217 1.407 . . . . 0.0 111.782 -173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.1 163.14 13.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' B' ' 163' ' ' PRO . . . -91.37 7.91 79.73 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 113.685 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . 0.497 ' OG ' HD11 ' H' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.998 0.399 . . . . 0.0 111.783 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.896 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -94.49 122.85 60.1 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.95 2.1 . . . . 0.0 112.425 -174.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -69.6 129.21 17.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.405 0.823 . . . . 0.0 112.446 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.789 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.32 130.01 54.23 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 168.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' H' ' 76' ' ' GLN . 25.3 t80 -92.67 141.73 24.86 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.801 -2.36 . . . . 0.0 110.571 -167.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -76.41 178.81 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.839 0.683 . . . . 0.0 112.391 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 54.77 46.3 24.86 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.325 1.45 . . . . 0.0 111.556 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 5.7 m-85 -72.18 134.33 45.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.541 1.163 . . . . 0.0 111.083 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' H' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.68 0.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' H' ' 32' ' ' GLN . 12.3 p -119.23 178.32 4.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.721 1.248 . . . . 0.0 111.114 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.834 ' OD2' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -163.23 136.77 5.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 114.097 -1.411 . . . . 0.0 108.008 -164.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.4 130.81 7.65 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.377 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.26 97.81 7.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 79.8 t -102.67 119.66 51.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . 0.49 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 7.0 p -133.53 85.34 2.2 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.3 7.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.236 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.7 86.13 2.25 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' H' ' 41' ' ' ARG . 11.2 mmm180 -63.7 -178.73 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.706 0.765 . . . . 0.0 110.165 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.17 142.24 23.1 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HA2' ' C' ' 124' ' ' GLY . 0.0 OUTLIER -73.92 166.78 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.504 -179.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . 0.608 ' HA ' HG12 ' H' ' 53' ' ' ILE . 9.3 t80 -108.34 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.171 171.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . 0.452 ' H ' ' CG2' ' H' ' 53' ' ' ILE . 34.1 t70 -106.53 92.07 3.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' H' ' 51' ' ' GLY . 17.4 pt-20 -65.5 -15.79 63.01 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.13 35.74 21.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.573 1.549 . . . . 0.0 111.702 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.588 HG23 ' O ' ' C' ' 31' ' ' TYR . 0.0 OUTLIER 37.63 53.64 1.44 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.482 1.513 . . . . 0.0 111.568 -164.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . 0.446 ' HG2' ' HG2' ' H' ' 52' ' ' ARG . 17.6 tptt -116.16 -91.98 0.52 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.464 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . 0.697 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 7.8 m-20 -150.66 29.96 0.67 Allowed 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . 0.457 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 84.82 34.78 14.48 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' H' ' 49' ' ' LYS . 0.0 OUTLIER -102.31 122.58 44.52 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.608 HG12 ' HA ' ' H' ' 44' ' ' PHE . 0.5 OUTLIER -136.83 133.02 48.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.886 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.14 22.29 16.16 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.682 0.601 . . . . 0.0 113.909 -170.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -78.72 159.43 28.13 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.811 0.658 . . . . 0.0 113.811 -175.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . 0.483 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -121.41 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 2.6 t -164.4 171.51 14.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.509 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -113.34 112.37 40.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.04 102.13 12.14 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -171.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 64.1 p -135.49 154.64 51.34 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.954 0.901 . . . . 0.0 110.074 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . 0.431 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -142.43 155.72 25.83 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.153 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.829 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -129.02 134.69 48.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 174.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.834 HG22 ' OD2' ' H' ' 34' ' ' ASP . 79.7 t -124.12 122.15 63.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.29 36.09 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.478 ' OH ' HG21 ' H' ' 79' ' ' ILE . 50.4 p90 -154.52 160.44 41.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 27.5 m-85 -87.69 144.91 26.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -79.18 139.99 22.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -120.38 150.01 41.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.419 0.628 . . . . 0.0 109.316 174.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.78 -39.24 68.21 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.47 3.04 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.23 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.13 1.372 . . . . 0.0 111.03 169.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -90.67 -9.17 47.83 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 -156.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' H' ' 79' ' ' ILE . . . -74.24 -44.79 27.41 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.834 168.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.642 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.44 79.2 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.893 171.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.61 82.49 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.785 171.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.69 74.62 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.913 168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.0 OUTLIER -62.7 -52.38 60.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.035 0.445 . . . . 0.0 110.472 172.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.79 -39.18 73.29 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.802 -0.561 . . . . 0.0 112.41 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.01 -49.99 75.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.651 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -59.3 -43.47 92.62 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.563 174.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 7.1 t80 -64.97 -52.57 55.52 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.91 -174.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.89 -36.74 59.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.428 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 14.5 m120 -86.25 -3.48 58.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.999 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.91 30.04 74.01 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 122.351 -0.218 . . . . 0.0 112.859 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.651 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 6.0 mttm -67.02 146.14 54.66 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.599 ' HB2' ' OE1' ' B' ' 169' ' ' GLU . 0.0 OUTLIER -70.57 144.92 51.09 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' H' ' 15' ' ' PHE . 4.8 tt -118.06 133.79 63.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.356 0.598 . . . . 0.0 109.906 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.4 mtmp? -88.68 121.42 31.03 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.472 ' HE1' ' HD2' ' H' ' 13' ' ' TYR . 0.1 OUTLIER -116.58 125.8 52.37 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.532 1.133 . . . . 0.0 109.97 -165.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.714 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 23.4 m95 -123.34 116.53 23.46 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.207 1.003 . . . . 0.0 108.334 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.749 HH21 HG11 ' H' ' 11' ' ' VAL . 15.5 ttt180 -102.07 106.39 17.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.39 148.85 25.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.255 1.026 . . . . 0.0 109.409 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.19 167.11 20.0 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.671 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.477 ' N ' ' O ' ' H' ' 10' ' ' ASP . 13.4 m -107.19 -25.27 11.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.672 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' H' ' 10' ' ' ASP . 20.4 m -74.19 165.12 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.736 0.779 . . . . 0.0 109.924 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' H' ' 99' ' ' ASN . 0.1 OUTLIER -93.57 107.81 19.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.964 -174.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.405 ' O ' ' HD2' ' H' ' 98' ' ' LYS . 9.7 t30 -72.27 160.74 31.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.833 0.825 . . . . 0.0 109.913 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.49 -8.7 26.23 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.87 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.762 0.71 . . . . 0.0 110.871 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.659 ' OD1' HG13 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -70.99 163.78 26.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.6 OUTLIER -56.1 -45.99 79.23 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.841 -0.537 . . . . 0.0 110.557 171.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' H' ' 142' ' ' GLU . 55.9 m-85 -138.3 -170.82 2.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.7 t70 -139.58 141.19 37.19 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.618 0.723 . . . . 0.0 109.454 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -131.7 145.97 51.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.055 -163.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.91 127.0 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' H' ' 138' ' ' LEU . 32.2 t80 -133.36 152.3 51.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.403 0.681 . . . . 0.0 110.413 -163.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . 1.043 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -168.26 171.41 42.52 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.948 170.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.439 ' HB3' HE22 ' H' ' 88' ' ' GLN . 6.1 m-85 -92.36 133.6 35.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 167.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' H' ' 89' ' ' ILE . . . -132.5 158.25 42.57 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.951 0.881 . . . . 0.0 111.163 -169.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.43 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 6.9 t80 -134.81 130.73 36.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' H' ' 83' ' ' TYR . 1.4 mp -65.57 120.13 11.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.14 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.5 9.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.904 0.775 . . . . 0.0 109.075 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.21 137.97 52.01 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.96 21.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.9 50.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.118 0.485 . . . . 0.0 111.152 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 0.8 OUTLIER -106.21 126.89 52.77 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.701 177.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.45 115.37 22.12 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -110.15 -176.8 20.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.703 0.613 . . . . 0.0 111.613 174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.68 -44.95 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.46 -0.435 . . . . 0.0 111.093 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.71 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 169.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.35 147.46 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -71.8 165.56 23.84 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.611 0.719 . . . . 0.0 110.727 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.67 143.34 13.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.004 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 23.1 mp0 -118.55 133.96 55.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.121 -176.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mt -117.55 117.1 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.85 126.75 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.509 ' O ' HG13 ' H' ' 130' ' ' ILE . 4.0 pt -123.72 126.74 73.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.829 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.87 53.24 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.737 -178.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' H' ' 63' ' ' GLY . 0.4 OUTLIER -138.46 165.67 26.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.091 -172.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.866 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.94 23.85 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.32 129.41 74.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.428 ' H ' HG12 ' H' ' 135' ' ' ILE . 6.5 pt -67.88 -51.93 44.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.35 0.595 . . . . 0.0 110.348 -173.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.473 ' HA3' ' HD3' ' B' ' 155' ' ' LYS . . . -125.72 119.27 3.44 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.723 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.19 122.41 20.98 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.03 0.919 . . . . 0.0 110.638 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 1.043 HD12 ' HA2' ' H' ' 109' ' ' GLY . 1.7 mt -125.33 149.43 48.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.09 127.92 27.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.48 153.89 29.5 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -65.72 153.0 51.56 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.384 169.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 6.8 tp10 -111.91 137.48 49.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.682 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -104.2 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.728 -176.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.86 25.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.959 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 3.4 p -114.63 39.38 2.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.374 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' H' ' 24' ' ' SER . 1.2 mm? 45.45 58.37 15.27 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.471 1.908 . . . . 0.0 109.375 -173.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.627 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.83 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.241 1.294 . . . . 0.0 115.34 -159.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -25.59 68.25 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.629 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.13 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.789 HG23 HD22 ' H' ' 27' ' ' LEU . 46.8 mt -82.4 -45.0 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.12 0.873 . . . . 0.0 111.259 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.627 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 1.7 t -73.91 -39.45 51.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.48 113.67 25.86 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.431 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.84 43.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.02 146.69 38.64 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.82 56.96 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.54 8.66 65.59 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 119.381 0.991 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.76 123.24 7.42 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.34 22.3 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.273 1.029 . . . . 0.0 108.622 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.14 -28.79 63.48 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -158.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.21 117.61 11.41 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.71 2.404 . . . . 0.0 109.149 167.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.607 ' NE2' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 153.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . 0.79 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.94 4.59 Favored Pre-proline 0 C--O 1.241 0.648 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.87 12.0 Favored 'Trans proline' 0 C--O 1.239 0.571 0 CA-C-N 122.088 1.782 . . . . 0.0 113.896 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.41 34.38 87.68 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 118.406 2.122 . . . . 0.0 118.406 -171.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.607 ' HA ' ' NE2' ' H' ' 161' ' ' GLN . 2.0 tt0 -68.49 -40.45 80.91 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 118.857 1.328 . . . . 0.0 110.902 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.872 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.9 m 47.17 63.24 2.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.84 1.656 . . . . 0.0 111.919 175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.669 ' HA ' HG22 ' H' ' 173' ' ' THR . 34.0 p -120.75 149.43 42.55 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.314 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.87 -170.85 43.62 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.498 172.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -27.62 68.7 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.788 0.294 . . . . 0.0 111.467 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -83.73 159.74 60.09 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.473 0.709 . . . . 0.0 109.281 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 86.4 Cg_endo -78.86 85.09 1.91 Allowed 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.321 1.348 . . . . 0.0 112.767 -156.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.62 90.85 1.13 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 117.211 1.645 . . . . 0.0 117.211 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.669 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.2 t -109.49 155.16 21.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.963 0.881 . . . . 0.0 109.847 170.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.7 159.18 45.86 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.419 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.872 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.4 Cg_exo -69.59 138.98 39.67 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.525 0.866 . . . . 0.0 111.738 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.273 0 C-N-CA 125.432 1.493 . . . . 0.0 112.267 -171.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.582 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 N-CA-C 112.809 0.273 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.444 HG22 ' OD1' ' I' ' 10' ' ' ASP . 6.4 pt -56.56 119.88 2.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.36 8.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 110.724 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -60.95 -29.86 71.8 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.527 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.86 -15.21 60.25 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 117.74 0.77 . . . . 0.0 112.419 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.506 ' OD1' HG13 ' I' ' 97' ' ' VAL . 6.0 t70 -67.05 -36.84 82.94 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.729 HG11 HH21 ' I' ' 93' ' ' ARG . 35.2 m -103.91 126.01 58.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . 0.578 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -126.55 154.47 43.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.686 0.755 . . . . 0.0 110.481 176.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.463 ' HD2' ' HE1' ' I' ' 91' ' ' PHE . 63.5 m-85 -111.83 94.94 5.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.715 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -77.67 144.78 37.08 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' I' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.22 46.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.411 0.624 . . . . 0.0 109.983 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.884 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.1 tm0? -136.49 142.31 43.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.45 153.97 38.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' C' ' 169' ' ' GLU . 1.1 pt -69.74 -49.2 59.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.006 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' I' ' 87' ' ' LYS . 0.9 OUTLIER -82.12 -8.89 59.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.33 -34.7 77.88 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.394 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 42.35 46.89 4.1 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.193 1.397 . . . . 0.0 111.813 -173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' C' ' 163' ' ' PRO . . . -91.4 7.98 79.58 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.268 -0.423 . . . . 0.0 113.669 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . 0.488 ' OG ' HD11 ' I' ' 146' ' ' LEU . 3.1 m -155.38 135.23 12.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.038 0.419 . . . . 0.0 111.786 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.884 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -94.4 122.82 60.31 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.956 2.102 . . . . 0.0 112.452 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.56 129.27 17.51 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.42 0.829 . . . . 0.0 112.491 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.779 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.35 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' I' ' 76' ' ' GLN . 25.4 t80 -92.64 141.69 24.86 Favored Pre-proline 0 C--N 1.316 -0.867 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.526 -167.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.39 178.77 7.11 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.87 0.696 . . . . 0.0 112.449 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 54.82 46.31 24.78 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.374 1.47 . . . . 0.0 111.529 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.28 45.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.496 ' HG2' HG23 ' I' ' 33' ' ' THR . 35.8 tt0 -101.82 -110.66 0.22 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.501 HG22 ' HA2' ' J' ' 121' ' ' GLY . 12.3 p -119.19 178.33 4.56 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.817 1.294 . . . . 0.0 111.092 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.84 ' OD2' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -163.27 136.73 5.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.998 -164.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.41 130.74 7.63 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.405 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.21 97.8 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . . . . . . . . . 81.4 t -102.67 119.64 51.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . 0.565 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 7.0 p -133.48 85.37 2.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.01 125.33 7.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.208 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 86.14 2.25 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.453 ' HA ' HH11 ' I' ' 41' ' ' ARG . 11.2 mmm180 -63.73 -178.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.758 0.789 . . . . 0.0 110.138 -174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.12 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.485 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -73.89 166.7 22.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.547 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . 0.62 ' HA ' HG12 ' I' ' 53' ' ' ILE . 9.3 t80 -108.26 83.44 1.78 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.244 171.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' I' ' 53' ' ' ILE . 34.0 t70 -106.49 92.12 3.99 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' I' ' 51' ' ' GLY . 17.4 pt-20 -65.55 -15.83 63.09 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.18 35.77 21.04 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.582 1.553 . . . . 0.0 111.667 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.424 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 37.49 53.79 1.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.528 1.531 . . . . 0.0 111.558 -164.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . 0.449 ' HG2' ' HG2' ' I' ' 52' ' ' ARG . 17.6 tptt -116.21 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.491 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . 0.458 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 84.82 34.79 14.47 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' I' ' 49' ' ' LYS . 0.0 OUTLIER -102.33 122.65 44.67 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' I' ' 44' ' ' PHE . 0.5 OUTLIER -136.84 133.01 48.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.853 178.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.17 22.28 16.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.52 13.72 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 121.671 0.595 . . . . 0.0 113.932 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.66 159.38 28.37 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.868 0.68 . . . . 0.0 113.868 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . 0.485 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -121.38 -77.21 0.45 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . 0.697 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 2.6 t -164.41 171.5 14.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.558 0.694 . . . . 0.0 110.509 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.445 ' H ' ' HB3' ' H' ' 50' ' ' ASN . 47.0 t -113.37 112.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.81 86.31 3.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 102.15 12.17 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -171.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.3 p -135.53 154.64 51.32 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.909 0.884 . . . . 0.0 110.072 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -142.41 155.7 25.81 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.184 176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.833 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -129.01 134.62 48.21 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.84 HG22 ' OD2' ' I' ' 34' ' ' ASP . 78.9 t -124.1 122.22 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -177.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.14 142.32 36.02 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.487 ' OH ' HG21 ' I' ' 79' ' ' ILE . 50.4 p90 -154.53 160.46 41.54 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 27.6 m-85 -87.68 144.87 26.43 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.571 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -79.28 140.03 22.46 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 149.96 41.53 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.75 -39.21 68.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.76 -124.49 3.05 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.141 1.376 . . . . 0.0 110.987 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -90.69 -9.19 47.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.78 27.73 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.834 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.655 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 9.3 tt0 -67.46 -35.46 79.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.897 171.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.68 82.39 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.747 171.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.76 74.6 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.933 168.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.655 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.1 mm -62.69 -52.45 59.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.049 0.452 . . . . 0.0 110.448 172.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.8 -39.09 73.31 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.793 -0.567 . . . . 0.0 112.472 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -59.04 -50.04 75.59 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.015 -0.674 . . . . 0.0 111.52 169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.641 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -59.18 -43.58 92.16 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.608 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.49 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 7.0 t80 -64.95 -52.58 55.55 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.902 -174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.92 -36.75 59.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -167.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.431 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 14.3 m120 -86.19 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.052 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.08 74.12 Favored Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.307 -0.245 . . . . 0.0 112.868 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.641 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 6.1 mttm -67.07 146.22 54.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.582 ' HB2' ' OE1' ' C' ' 169' ' ' GLU . 0.0 OUTLIER -70.65 144.91 50.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' I' ' 15' ' ' PHE . 4.8 tt -118.03 133.8 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.346 0.594 . . . . 0.0 109.914 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.4 mtmp? -88.66 121.4 31.0 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.463 ' HE1' ' HD2' ' I' ' 13' ' ' TYR . 0.1 OUTLIER -116.57 125.82 52.4 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.492 1.117 . . . . 0.0 110.02 -166.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.701 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 23.8 m95 -123.32 116.52 23.46 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.729 HH21 HG11 ' I' ' 11' ' ' VAL . 15.6 ttt180 -102.04 106.38 17.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.925 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.28 1.038 . . . . 0.0 109.401 -173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.12 20.03 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.711 -1.132 . . . . 0.0 110.646 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.471 ' N ' ' O ' ' I' ' 10' ' ' ASP . 13.5 m -107.2 -25.23 11.61 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.68 -176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . 0.506 HG13 ' OD1' ' I' ' 10' ' ' ASP . 20.2 m -74.24 165.1 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.698 0.761 . . . . 0.0 109.857 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 107.79 19.59 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.964 -174.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -72.18 160.68 32.03 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.828 0.823 . . . . 0.0 109.988 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.46 -8.74 26.23 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.84 -80.3 0.46 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.911 169.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.658 ' OD1' HG13 ' I' ' 143' ' ' ILE . 0.4 OUTLIER -71.0 163.75 26.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.601 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.6 OUTLIER -56.07 -45.98 79.13 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.887 -0.508 . . . . 0.0 110.601 171.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.611 ' HB2' ' HB3' ' I' ' 142' ' ' GLU . 56.1 m-85 -138.34 -170.87 2.91 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.572 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.7 t70 -139.56 141.18 37.22 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -131.65 145.89 51.91 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.059 -163.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.84 127.01 55.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' I' ' 138' ' ' LEU . 32.2 t80 -133.35 152.28 51.91 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 110.43 -163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . 0.994 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -168.18 171.43 42.48 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.967 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.422 ' HB3' HE22 ' I' ' 88' ' ' GLN . 6.2 m-85 -92.4 133.61 35.72 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 167.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.427 ' HB3' HG23 ' I' ' 89' ' ' ILE . . . -132.48 158.28 42.49 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.865 0.84 . . . . 0.0 111.198 -169.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.435 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 6.9 t80 -134.8 130.81 36.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.925 -174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.436 HG21 ' HD1' ' I' ' 83' ' ' TYR . 1.4 mp -65.61 120.15 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.2 -27.25 13.61 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 27.4 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.929 0.786 . . . . 0.0 109.078 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.94 52.04 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.36 119.93 21.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.18 123.85 49.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.058 0.456 . . . . 0.0 111.249 176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 0.8 OUTLIER -106.17 126.86 52.73 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.668 177.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . 0.418 ' O ' ' HB ' ' H' ' 33' ' ' THR . 3.9 t70 -122.47 115.35 22.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . 0.429 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -110.17 -176.76 20.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.702 0.612 . . . . 0.0 111.588 175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.77 -44.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.488 -0.419 . . . . 0.0 111.076 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.66 156.78 17.4 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.41 147.47 10.82 Favored Glycine 0 C--O 1.243 0.678 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -71.83 165.54 23.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 110.719 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 143.41 13.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.06 -171.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 23.1 mp0 -118.58 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.067 -176.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 37.1 mt -117.59 117.01 53.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.77 126.71 49.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 168.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.52 HG13 ' O ' ' I' ' 130' ' ' ILE . 4.0 pt -123.71 126.71 73.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.5 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.833 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -107.99 126.87 53.22 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.754 -178.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' I' ' 63' ' ' GLY . 0.4 OUTLIER -138.48 165.63 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.095 -172.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -125.53 162.98 23.71 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 t -123.36 129.37 74.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.413 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.5 pt -67.89 -51.87 45.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.282 0.563 . . . . 0.0 110.353 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' C' ' 155' ' ' LYS . . . -125.74 119.23 3.43 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.727 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.22 122.38 20.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.019 0.914 . . . . 0.0 110.628 174.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.994 HD12 ' HA2' ' I' ' 109' ' ' GLY . 1.7 mt -125.3 149.41 48.08 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 127.9 27.36 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.92 29.6 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -65.8 153.05 51.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.374 169.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 6.8 tp10 -111.9 137.49 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.673 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.92 1.7 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -176.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.09 116.83 24.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.968 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 0.925 HG21 HG21 ' I' ' 94' ' ' VAL . 3.4 p -114.59 39.43 2.82 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.402 175.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . 0.488 HD11 ' OG ' ' I' ' 24' ' ' SER . 1.2 mm? 45.38 58.37 15.18 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.472 1.909 . . . . 0.0 109.409 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.65 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -10.39 29.01 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.269 1.313 . . . . 0.0 115.291 -159.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -25.58 68.25 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.598 171.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.14 -43.55 1.8 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.779 HG23 HD22 ' I' ' 27' ' ' LEU . 47.0 mt -82.43 -44.95 19.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 119.139 0.881 . . . . 0.0 111.241 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.65 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 1.7 t -73.92 -39.5 51.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.42 113.67 25.89 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.505 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.25 117.82 43.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -112.98 146.67 38.63 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -172.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.94 -38.94 57.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 8.63 65.51 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 119.391 0.996 . . . . 0.0 113.04 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.71 123.21 7.44 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.8 110.37 22.33 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.289 1.036 . . . . 0.0 108.649 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.18 -28.77 63.42 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.26 117.57 11.35 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.684 2.394 . . . . 0.0 109.171 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -149.33 43.85 0.95 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . 0.8 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 15.5 tt0 -54.0 -61.96 4.55 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -166.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.8 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.1 Cg_exo -79.99 136.84 11.98 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.049 1.767 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.44 34.4 87.7 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.328 2.091 . . . . 0.0 118.328 -171.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.609 ' HA ' ' NE2' ' I' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.48 81.12 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.911 1.355 . . . . 0.0 110.933 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.904 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.9 m 47.1 63.34 1.99 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.831 1.653 . . . . 0.0 111.912 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.684 ' HA ' HG22 ' I' ' 173' ' ' THR . 34.2 p -120.78 149.37 42.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.319 -167.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.76 -170.86 43.4 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.53 172.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -27.56 68.7 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.806 0.303 . . . . 0.0 111.455 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -83.73 159.79 59.99 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.481 0.712 . . . . 0.0 109.252 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -78.9 85.1 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 121.309 1.339 . . . . 0.0 112.713 -156.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.174 1.63 . . . . 0.0 117.174 165.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.684 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.2 t -109.46 155.2 21.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.998 0.899 . . . . 0.0 109.856 170.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.76 159.26 45.88 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.397 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.904 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -69.66 138.96 39.41 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.517 0.863 . . . . 0.0 111.729 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.479 1.512 . . . . 0.0 112.306 -171.689 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.532 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 C--O 1.23 0.106 0 N-CA-C 112.835 0.283 . . . . 0.0 112.835 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.448 HG22 ' OD1' ' J' ' 10' ' ' ASP . 6.3 pt -56.69 119.97 2.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -84.01 177.38 8.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.953 0.882 . . . . 0.0 110.733 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.501 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -60.98 -29.88 71.97 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.475 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.79 -15.22 60.28 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.771 0.785 . . . . 0.0 112.42 172.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.504 ' OD1' HG13 ' J' ' 97' ' ' VAL . 6.0 t70 -67.14 -36.76 82.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.75 HG11 HH21 ' J' ' 93' ' ' ARG . 35.3 m -103.99 126.01 58.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . 0.585 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -126.53 154.49 43.75 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.646 0.736 . . . . 0.0 110.526 176.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.456 ' HD2' ' HE1' ' J' ' 91' ' ' PHE . 63.4 m-85 -111.79 94.88 5.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.768 -164.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -77.61 144.74 37.25 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.515 ' HB3' HD11 ' J' ' 89' ' ' ILE . 88.2 m-85 -133.23 139.29 46.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.528 0.68 . . . . 0.0 109.951 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.87 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 153.95 39.01 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.042 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.745 HD13 ' HA ' ' D' ' 169' ' ' GLU . 1.1 pt -69.73 -49.23 59.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . 0.438 ' OD2' ' HD3' ' J' ' 87' ' ' LYS . 0.9 OUTLIER -82.05 -9.04 59.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.74 78.12 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.489 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.34 46.88 4.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.191 1.397 . . . . 0.0 111.823 -173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.13 13.43 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -91.4 7.97 79.6 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.726 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . 0.494 ' OG ' HD11 ' J' ' 146' ' ' LEU . 3.1 m -155.35 135.16 12.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.97 0.385 . . . . 0.0 111.798 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.87 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -94.43 122.83 60.25 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 126.984 2.114 . . . . 0.0 112.402 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -69.52 129.18 17.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.412 0.826 . . . . 0.0 112.487 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.77 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.34 130.01 54.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' J' ' 76' ' ' GLN . 25.4 t80 -92.62 141.67 24.84 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.546 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.42 178.89 6.97 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.864 0.693 . . . . 0.0 112.412 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 54.71 46.32 24.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 111.561 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.443 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 5.7 m-85 -72.14 134.29 45.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 122.475 1.131 . . . . 0.0 111.111 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' J' ' 33' ' ' THR . 35.8 tt0 -101.87 -110.63 0.22 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . 0.502 HG23 ' HG2' ' J' ' 32' ' ' GLN . 12.1 p -119.24 178.32 4.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.753 1.263 . . . . 0.0 111.114 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.839 ' OD2' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -163.25 136.75 5.76 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.016 -164.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.372 170.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.2 97.79 7.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . . . . . . . . . 80.6 t -102.7 119.59 51.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . 0.441 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 7.1 p -133.46 85.36 2.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.0 125.28 7.13 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 86.19 2.26 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' J' ' 41' ' ' ARG . 11.2 mmm180 -63.83 -178.76 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.712 0.768 . . . . 0.0 110.132 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 142.21 23.11 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' HA2' ' E' ' 124' ' ' GLY . 0.0 OUTLIER -73.91 166.74 22.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.516 -179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . 0.61 ' HA ' HG12 ' J' ' 53' ' ' ILE . 9.2 t80 -108.27 83.46 1.78 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.252 171.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . 0.456 ' H ' ' CG2' ' J' ' 53' ' ' ILE . 34.1 t70 -106.45 92.11 3.98 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' J' ' 51' ' ' GLY . 17.4 pt-20 -65.63 -15.74 63.04 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.1 35.8 21.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.624 1.57 . . . . 0.0 111.653 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.433 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 37.54 53.71 1.4 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.452 1.501 . . . . 0.0 111.601 -164.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . 0.44 ' HG2' ' HG2' ' J' ' 52' ' ' ARG . 17.7 tptt -116.18 -91.99 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.459 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . 0.644 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 7.8 m-20 -150.65 30.0 0.67 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 84.81 34.74 14.64 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HG2' ' J' ' 49' ' ' LYS . 0.0 OUTLIER -102.26 122.69 44.7 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.61 HG12 ' HA ' ' J' ' 44' ' ' PHE . 0.5 OUTLIER -136.86 133.01 48.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.87 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.21 22.3 16.14 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.31 159.47 13.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.671 0.595 . . . . 0.0 113.946 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.63 159.39 28.46 Favored 'Trans proline' 0 CA--C 1.515 -0.434 0 N-CA-C 113.87 0.681 . . . . 0.0 113.87 -175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . 0.477 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -121.4 -77.15 0.44 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 2.6 t -164.4 171.53 14.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.565 0.698 . . . . 0.0 110.477 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.405 ' H ' ' HB3' ' I' ' 50' ' ' ASN . 47.1 t -113.36 112.35 39.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.79 86.34 3.07 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.06 102.15 12.16 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -171.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . 0.897 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 64.3 p -135.51 154.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.903 0.881 . . . . 0.0 110.016 -178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -142.48 155.69 25.83 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.163 176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.83 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.96 134.69 48.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.839 HG22 ' OD2' ' J' ' 34' ' ' ASP . 78.8 t -124.16 122.22 63.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -106.22 142.3 36.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.492 ' OH ' HG21 ' J' ' 79' ' ' ILE . 50.4 p90 -154.5 160.47 41.59 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.569 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 27.5 m-85 -87.7 144.96 26.37 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -79.21 139.96 22.43 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.961 0.745 . . . . 0.0 114.961 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -120.41 150.0 41.48 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . 0.409 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.7 OUTLIER -54.77 -39.19 68.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.81 -124.49 3.04 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 67.33 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.131 1.373 . . . . 0.0 111.052 169.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . 0.539 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -90.7 -9.25 47.46 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -156.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.17 -44.78 27.89 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.233 -0.985 . . . . 0.0 112.848 168.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.651 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 9.3 tt0 -67.55 -35.47 79.1 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.795 171.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 2.8 mtmt -67.78 -41.75 82.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.782 171.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -33.74 74.63 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.879 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.651 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.1 mm -62.63 -52.44 59.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.067 0.461 . . . . 0.0 110.49 172.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.82 -39.12 73.24 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.795 -0.566 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -59.01 -50.01 75.7 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.556 169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -59.21 -43.58 92.26 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.577 174.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.565 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 7.0 t80 -64.94 -52.62 55.33 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.894 -174.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.8 -36.82 59.63 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.427 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 14.4 m120 -86.2 -3.44 58.97 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.044 172.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 30.14 74.25 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 6.0 mttm -67.04 146.22 54.56 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.685 ' HB2' ' OE1' ' D' ' 169' ' ' GLU . 0.0 OUTLIER -70.66 144.91 50.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' J' ' 15' ' ' PHE . 4.8 tt -118.03 133.72 63.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.322 0.582 . . . . 0.0 109.876 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.4 mtmp? -88.63 121.4 30.97 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.456 ' HE1' ' HD2' ' J' ' 13' ' ' TYR . 0.1 OUTLIER -116.59 125.84 52.41 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.53 1.132 . . . . 0.0 109.974 -165.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.705 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 23.6 m95 -123.37 116.61 23.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.75 HH21 HG11 ' J' ' 11' ' ' VAL . 15.5 ttt180 -102.1 106.37 17.24 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.938 HG21 HG21 ' J' ' 145' ' ' THR . 1.6 m -122.42 148.87 25.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.256 1.027 . . . . 0.0 109.41 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.16 167.13 20.0 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.656 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.479 ' N ' ' O ' ' J' ' 10' ' ' ASP . 13.3 m -107.21 -25.27 11.59 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.661 -176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . 0.504 HG13 ' OD1' ' J' ' 10' ' ' ASP . 20.4 m -74.21 165.11 3.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.723 0.773 . . . . 0.0 109.906 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' J' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.79 19.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.963 -174.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.407 ' O ' ' HD2' ' J' ' 98' ' ' LYS . 9.7 t30 -72.23 160.73 31.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.789 0.804 . . . . 0.0 109.949 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.5 -8.68 26.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.83 -80.36 0.46 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.776 0.716 . . . . 0.0 110.863 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.665 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.607 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.7 OUTLIER -56.12 -45.97 79.32 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.617 ' HB2' ' HB3' ' J' ' 142' ' ' GLU . 55.9 m-85 -138.31 -170.83 2.9 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.7 t70 -139.6 141.2 37.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.612 0.72 . . . . 0.0 109.429 177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -131.65 145.88 51.9 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.103 -163.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -110.83 127.07 55.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 157.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' J' ' 138' ' ' LEU . 32.3 t80 -133.39 152.32 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.424 0.689 . . . . 0.0 110.46 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -168.23 171.4 42.5 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.438 ' HB3' HE22 ' J' ' 88' ' ' GLN . 6.1 m-85 -92.39 133.61 35.71 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.432 ' HB3' HG23 ' J' ' 89' ' ' ILE . . . -132.47 158.27 42.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.902 0.858 . . . . 0.0 111.199 -169.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.448 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 6.9 t80 -134.83 130.74 36.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.96 -174.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.431 HG21 ' HD1' ' J' ' 83' ' ' TYR . 1.4 mp -65.6 120.13 11.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -100.12 -27.29 13.61 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.34 147.58 9.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.918 0.781 . . . . 0.0 109.062 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.26 137.99 52.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.4 119.95 21.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.23 123.88 49.98 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.09 0.472 . . . . 0.0 111.192 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 0.8 OUTLIER -106.23 126.91 52.8 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.637 177.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . 0.467 ' O ' ' HB ' ' I' ' 33' ' ' THR . 3.9 t70 -122.51 115.4 22.13 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -110.22 -176.81 20.91 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.701 0.612 . . . . 0.0 111.586 175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.65 -44.96 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.467 -0.431 . . . . 0.0 111.095 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.67 156.84 17.36 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.37 147.46 10.76 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.48 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -71.76 165.55 23.82 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.627 0.727 . . . . 0.0 110.762 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.66 143.39 13.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.058 -171.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 23.0 mp0 -118.56 133.99 55.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.098 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.54 117.03 53.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 126.76 50.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.518 HG13 ' O ' ' J' ' 130' ' ' ILE . 4.0 pt -123.77 126.77 73.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.83 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -108.04 126.88 53.25 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.713 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' J' ' 63' ' ' GLY . 0.4 OUTLIER -138.49 165.68 26.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.101 -172.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.897 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -125.56 162.96 23.76 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 167.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 17.6 t -123.4 129.44 74.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.411 HG13 ' H ' ' J' ' 136' ' ' GLY . 6.5 pt -67.94 -51.87 45.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.306 0.574 . . . . 0.0 110.32 -173.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' D' ' 155' ' ' LYS . . . -125.76 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.723 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.15 122.43 20.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.042 0.925 . . . . 0.0 110.658 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' J' ' 109' ' ' GLY . 1.7 mt -125.31 149.42 48.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.06 127.92 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . 0.402 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 11.1 p-10 -156.51 153.9 29.49 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -65.71 153.04 51.53 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.419 169.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 6.8 tp10 -111.95 137.52 49.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.68 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -104.18 -63.96 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.743 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.449 ' OD1' ' HZ ' ' D' ' 160' ' ' PHE . 0.0 OUTLIER -122.08 116.83 24.95 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.978 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.938 HG21 HG21 ' J' ' 94' ' ' VAL . 3.5 p -114.61 39.42 2.82 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.376 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . 0.494 HD11 ' OG ' ' J' ' 24' ' ' SER . 1.2 mm? 45.39 58.39 15.19 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.463 1.905 . . . . 0.0 109.419 -173.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.651 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -10.36 28.91 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 121.195 1.263 . . . . 0.0 115.331 -159.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -25.59 68.24 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.538 171.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.16 -43.46 1.8 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.77 HG23 HD22 ' J' ' 27' ' ' LEU . 46.9 mt -82.48 -44.91 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.162 0.892 . . . . 0.0 111.273 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 1.7 t -73.93 -39.46 51.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.49 113.73 25.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.461 -176.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 10.7 p -98.31 117.87 43.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.05 146.68 38.69 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.99 -38.86 56.91 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.59 8.58 65.58 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.369 0.986 . . . . 0.0 113.037 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.23 7.5 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.33 22.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.346 1.058 . . . . 0.0 108.593 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.12 -28.91 63.59 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.435 1.642 . . . . 0.0 115.435 -158.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.15 117.61 11.45 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.676 2.39 . . . . 0.0 109.142 167.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.617 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -149.34 43.83 0.95 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 154.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . 0.801 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 15.6 tt0 -54.02 -61.9 4.66 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.801 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.3 Cg_exo -80.06 136.88 11.9 Favored 'Trans proline' 0 C--O 1.238 0.498 0 CA-C-N 122.054 1.769 . . . . 0.0 113.901 171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.42 34.36 87.59 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.381 2.113 . . . . 0.0 118.381 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.617 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 2.0 tt0 -68.38 -40.57 81.35 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.914 1.357 . . . . 0.0 110.917 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.911 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.812 1.645 . . . . 0.0 111.916 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.688 ' HA ' HG22 ' J' ' 173' ' ' THR . 34.1 p -120.77 149.41 42.59 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.338 -167.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.85 -170.83 43.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.483 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -27.59 68.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.777 0.288 . . . . 0.0 111.426 -177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . 0.423 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -83.73 159.82 59.92 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.431 0.692 . . . . 0.0 109.293 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.423 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 85.0 Cg_endo -78.93 85.13 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.271 1.314 . . . . 0.0 112.715 -156.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.63 90.87 1.13 Allowed Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.154 1.622 . . . . 0.0 117.154 165.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.688 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -109.39 155.2 21.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.015 0.908 . . . . 0.0 109.857 170.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.77 159.21 46.36 Favored Pre-proline 0 C--O 1.241 0.639 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.414 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.911 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.4 Cg_exo -69.58 138.98 39.69 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.534 0.869 . . . . 0.0 111.738 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.465 1.506 . . . . 0.0 112.307 -171.735 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.518 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.465 -0.152 0 N-CA-C 112.855 0.29 . . . . 0.0 112.855 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.446 HG22 ' OD1' ' K' ' 10' ' ' ASP . 6.4 pt -56.61 119.92 2.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -83.98 177.33 8.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.884 0.849 . . . . 0.0 110.768 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -60.89 -29.92 71.75 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.351 -0.841 . . . . 0.0 114.533 175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.26 60.27 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.768 0.784 . . . . 0.0 112.358 172.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' K' ' 97' ' ' VAL . 6.0 t70 -67.07 -36.86 82.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.718 HG11 HH21 ' K' ' 93' ' ' ARG . 35.3 m -103.92 126.0 58.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . 0.579 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -126.54 154.45 43.83 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.704 0.764 . . . . 0.0 110.499 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.457 ' HD2' ' HE1' ' K' ' 91' ' ' PHE . 63.2 m-85 -111.77 94.87 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.764 -164.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.699 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.0 mp -77.59 144.79 37.25 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.523 ' HB3' HD11 ' K' ' 89' ' ' ILE . 88.1 m-85 -133.23 139.26 46.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.457 0.646 . . . . 0.0 109.951 176.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.861 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.1 tm0? -136.53 142.3 43.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.39 153.97 39.01 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.014 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.817 HD13 ' HA ' ' E' ' 169' ' ' GLU . 1.1 pt -69.75 -49.21 59.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.009 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' K' ' 87' ' ' LYS . 0.9 OUTLIER -82.06 -9.01 59.69 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.26 -34.76 78.12 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.407 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 42.4 46.87 4.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.23 1.412 . . . . 0.0 111.779 -173.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.06 163.09 13.45 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -91.43 7.99 79.52 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 113.715 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . 0.484 ' OG ' HD11 ' K' ' 146' ' ' LEU . 3.1 m -155.37 135.2 12.78 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.99 0.395 . . . . 0.0 111.829 -177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.861 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -94.44 122.91 60.04 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.917 2.087 . . . . 0.0 112.369 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.24 17.45 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.409 0.825 . . . . 0.0 112.471 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.776 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.37 130.01 54.27 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' K' ' 76' ' ' GLN . 25.3 t80 -92.63 141.65 24.8 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.509 -167.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -76.33 178.82 7.04 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-N 118.993 0.676 . . . . 0.0 112.471 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 54.75 46.31 24.88 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.362 1.465 . . . . 0.0 111.575 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . 0.446 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 5.7 m-85 -72.17 134.33 45.64 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.491 1.139 . . . . 0.0 111.038 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' K' ' 33' ' ' THR . 35.8 tt0 -101.84 -110.69 0.22 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . 0.505 HG23 ' HG2' ' K' ' 32' ' ' GLN . 12.2 p -119.16 178.34 4.55 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.787 1.279 . . . . 0.0 111.134 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.831 ' OD2' HG22 ' K' ' 65' ' ' VAL . 5.3 t0 -163.27 136.79 5.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.012 -164.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.75 7.62 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.373 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.23 97.8 7.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 173.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.66 119.63 51.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 7.0 p -133.51 85.35 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.96 125.23 7.1 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.233 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . 0.435 ' H ' ' HA ' ' L' ' 115' ' ' SER . 0.0 OUTLIER -107.72 86.18 2.25 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.449 HH11 ' HA ' ' K' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.78 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.695 0.759 . . . . 0.0 110.138 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -167.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -73.99 166.75 22.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.512 -179.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . 0.62 ' HA ' HG12 ' K' ' 53' ' ' ILE . 9.3 t80 -108.27 83.38 1.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.21 171.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' K' ' 53' ' ' ILE . 34.0 t70 -106.42 92.07 3.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 155.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' K' ' 51' ' ' GLY . 17.4 pt-20 -65.52 -15.79 63.04 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.11 35.83 21.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.58 1.552 . . . . 0.0 111.648 -172.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.435 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 37.49 53.73 1.38 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.528 1.531 . . . . 0.0 111.58 -164.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' HG2' ' K' ' 52' ' ' ARG . 17.7 tptt -116.11 -92.07 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.465 -177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.765 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 7.8 m-20 -150.58 29.96 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . 0.47 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 84.82 34.74 14.59 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' K' ' 49' ' ' LYS . 0.0 OUTLIER -102.3 122.61 44.56 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' K' ' 44' ' ' PHE . 0.5 OUTLIER -136.84 132.96 48.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.88 178.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.08 22.24 16.22 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 159.49 13.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.703 0.613 . . . . 0.0 113.922 -170.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.67 159.37 28.34 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -121.39 -77.16 0.44 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . 0.644 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 2.5 t -164.42 171.43 14.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.549 0.69 . . . . 0.0 110.558 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.421 ' H ' ' HB3' ' J' ' 50' ' ' ASN . 47.0 t -113.3 112.4 40.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.86 86.37 3.07 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.05 102.14 12.15 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -171.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . 0.88 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.4 p -135.5 154.65 51.33 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.916 0.886 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -142.44 155.67 25.81 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.205 176.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.819 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.831 HG22 ' OD2' ' K' ' 34' ' ' ASP . 79.4 t -124.11 122.15 63.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 34.5 p -106.12 142.28 36.07 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.491 ' OH ' HG21 ' K' ' 79' ' ' ILE . 50.3 p90 -154.5 160.5 41.59 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 27.4 m-85 -87.75 144.93 26.36 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -79.25 139.98 22.42 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -120.39 149.98 41.48 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 174.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -54.79 -39.18 68.17 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.78 -124.56 3.05 Favored Glycine 0 N--CA 1.453 -0.205 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 67.37 131.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.12 1.368 . . . . 0.0 110.995 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -90.7 -9.21 47.63 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -156.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.22 -44.76 27.68 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.262 -0.97 . . . . 0.0 112.807 168.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.632 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 9.3 tt0 -67.51 -35.48 79.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.837 171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 2.8 mtmt -67.89 -41.64 82.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.747 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.82 -33.69 74.59 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.921 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.632 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.0 OUTLIER -62.69 -52.47 59.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.035 0.445 . . . . 0.0 110.469 172.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.73 -39.16 73.51 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.735 -0.603 . . . . 0.0 112.46 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -58.99 -50.03 75.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.569 169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.644 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -59.28 -43.49 92.54 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.575 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.441 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 7.0 t80 -64.97 -52.58 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.905 -174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.88 -36.73 59.42 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -167.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.419 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 14.3 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.018 172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.09 74.12 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 122.32 -0.238 . . . . 0.0 112.83 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.644 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 6.1 mttm -67.03 146.13 54.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.541 ' HB2' ' OE1' ' E' ' 169' ' ' GLU . 0.0 OUTLIER -70.54 144.94 51.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' K' ' 15' ' ' PHE . 4.8 tt -118.09 133.74 63.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.341 0.591 . . . . 0.0 109.908 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.4 mtmp? -88.62 121.37 30.92 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.457 ' HE1' ' HD2' ' K' ' 13' ' ' TYR . 0.1 OUTLIER -116.53 125.81 52.44 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.521 1.129 . . . . 0.0 110.0 -165.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 23.3 m95 -123.35 116.51 23.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.229 1.011 . . . . 0.0 108.356 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.718 HH21 HG11 ' K' ' 11' ' ' VAL . 15.6 ttt180 -102.02 106.36 17.26 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.955 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.44 148.83 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.258 1.027 . . . . 0.0 109.405 -173.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.1 20.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.624 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.476 ' N ' ' O ' ' K' ' 10' ' ' ASP . 13.5 m -107.2 -25.26 11.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.635 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' K' ' 10' ' ' ASP . 20.3 m -74.26 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.714 0.768 . . . . 0.0 109.858 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' K' ' 99' ' ' ASN . 0.1 OUTLIER -93.53 107.73 19.53 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.987 -174.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' K' ' 98' ' ' LYS . 9.6 t30 -72.17 160.71 31.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.798 0.808 . . . . 0.0 110.03 171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.47 -8.73 26.23 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -98.9 -80.3 0.47 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.786 0.721 . . . . 0.0 110.865 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' K' ' 143' ' ' ILE . 0.4 OUTLIER -70.95 163.78 26.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.598 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.7 OUTLIER -56.13 -45.96 79.36 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 121.894 -0.504 . . . . 0.0 110.552 171.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.616 ' HB2' ' HB3' ' K' ' 142' ' ' GLU . 55.6 m-85 -138.34 -170.89 2.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.7 t70 -139.56 141.19 37.24 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.596 0.712 . . . . 0.0 109.42 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -131.67 145.95 51.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.071 -163.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -110.85 127.01 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 157.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' K' ' 138' ' ' LEU . 31.9 t80 -133.42 152.31 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.364 0.666 . . . . 0.0 110.398 -163.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . 0.975 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -168.23 171.42 42.5 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.98 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.437 ' HB3' HE22 ' K' ' 88' ' ' GLN . 6.2 m-85 -92.46 133.6 35.76 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 167.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' K' ' 89' ' ' ILE . . . -132.45 158.29 42.42 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.937 0.875 . . . . 0.0 111.196 -169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 6.9 t80 -134.8 130.77 36.62 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.973 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' K' ' 83' ' ' TYR . 1.4 mp -65.62 120.14 11.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -100.15 -27.26 13.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 27.5 t -164.35 147.58 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 118.924 0.783 . . . . 0.0 109.091 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.24 137.97 52.02 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.43 119.94 21.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.22 123.87 49.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.124 0.488 . . . . 0.0 111.215 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . 0.609 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 0.8 OUTLIER -106.19 126.87 52.75 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.42 115.44 22.25 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 167.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -110.26 -176.81 20.89 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 t -80.67 -44.89 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.488 -0.419 . . . . 0.0 111.139 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.73 156.79 17.4 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 169.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.32 147.5 10.75 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 166.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.501 ' HA ' ' N ' ' J' ' 8' ' ' GLY . . . -71.82 165.58 23.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.603 0.715 . . . . 0.0 110.699 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.65 143.35 13.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.062 -171.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 23.2 mp0 -118.51 133.96 55.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.135 -176.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.59 117.04 53.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.79 126.73 50.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 168.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.507 HG13 ' O ' ' K' ' 130' ' ' ILE . 4.0 pt -123.75 126.71 73.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.819 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -108.01 126.86 53.22 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.705 -178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' K' ' 63' ' ' GLY . 0.4 OUTLIER -138.45 165.67 26.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.151 -172.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.88 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -125.61 162.91 23.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.32 129.44 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.412 ' H ' HG12 ' K' ' 135' ' ' ILE . 6.5 pt -67.91 -51.89 45.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.371 0.605 . . . . 0.0 110.342 -173.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.459 ' HA3' ' HD3' ' E' ' 155' ' ' LYS . . . -125.75 119.21 3.42 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.689 177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.11 122.37 20.84 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.008 0.909 . . . . 0.0 110.649 174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.975 HD12 ' HA2' ' K' ' 109' ' ' GLY . 1.7 mt -125.3 149.47 48.02 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 127.89 27.29 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -156.45 153.96 29.67 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -65.74 153.11 51.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.351 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 6.8 tp10 -111.99 137.45 49.98 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -104.1 -63.99 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.789 -176.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.07 116.8 24.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.988 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.955 HG21 HG21 ' K' ' 94' ' ' VAL . 3.4 p -114.61 39.49 2.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.75 -0.643 . . . . 0.0 112.395 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . 0.484 HD11 ' OG ' ' K' ' 24' ' ' SER . 1.2 mm? 45.32 58.41 15.1 Favored Pre-proline 0 C--N 1.346 0.44 0 C-N-CA 126.451 1.901 . . . . 0.0 109.402 -173.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.645 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -10.37 28.94 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 121.202 1.268 . . . . 0.0 115.335 -159.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -25.57 68.24 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.576 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.56 1.8 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.776 HG23 HD22 ' K' ' 27' ' ' LEU . 46.8 mt -82.4 -44.96 19.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.129 0.877 . . . . 0.0 111.293 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 1.7 t -73.92 -39.48 51.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.47 113.73 25.94 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.446 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.81 43.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.9 p -113.03 146.68 38.69 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.84 57.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.57 8.61 65.59 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.348 0.977 . . . . 0.0 113.052 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.7 123.26 7.47 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.85 110.38 22.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.311 1.044 . . . . 0.0 108.593 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -28.88 63.53 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -140.16 117.64 11.46 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.699 2.4 . . . . 0.0 109.13 167.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.611 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.79 0.94 Allowed 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . 0.783 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 15.6 tt0 -53.96 -61.99 4.49 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.3 Cg_exo -79.99 136.91 12.02 Favored 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.002 1.751 . . . . 0.0 113.905 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.37 34.42 87.86 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.611 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.0 tt0 -68.45 -40.53 81.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.879 1.34 . . . . 0.0 110.874 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.905 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.9 m 47.16 63.27 2.02 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.816 1.647 . . . . 0.0 111.898 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.679 ' HA ' HG22 ' K' ' 173' ' ' THR . 34.0 p -120.77 149.44 42.54 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.29 -167.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.83 -170.91 43.63 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.491 172.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -27.61 68.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.785 0.292 . . . . 0.0 111.468 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -83.77 159.77 59.91 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.491 0.717 . . . . 0.0 109.242 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.4 Cg_endo -78.9 85.07 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.311 1.341 . . . . 0.0 112.76 -156.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.68 90.8 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.679 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -109.42 155.19 21.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.994 0.897 . . . . 0.0 109.851 170.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.72 159.16 46.27 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.398 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.905 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.4 Cg_exo -69.55 138.97 39.77 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.508 0.86 . . . . 0.0 111.746 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.416 1.486 . . . . 0.0 112.284 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.19 0 N-CA-C 112.837 0.283 . . . . 0.0 112.837 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.447 HG22 ' OD1' ' L' ' 10' ' ' ASP . 6.4 pt -56.67 119.88 2.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -83.92 177.35 8.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.924 0.869 . . . . 0.0 110.76 -177.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -60.95 -29.89 71.89 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.494 175.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.8 -15.23 60.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.758 0.779 . . . . 0.0 112.417 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.511 ' OD1' HG13 ' L' ' 97' ' ' VAL . 6.0 t70 -67.09 -36.77 82.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.739 HG11 HH21 ' L' ' 93' ' ' ARG . 35.3 m -103.97 126.04 58.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -126.58 154.47 43.87 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.699 0.761 . . . . 0.0 110.481 176.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD2' ' HE1' ' L' ' 91' ' ' PHE . 63.4 m-85 -111.78 94.88 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.75 -164.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.0 mp -77.61 144.77 37.22 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' L' ' 89' ' ' ILE . 88.3 m-85 -133.25 139.2 46.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.498 0.666 . . . . 0.0 109.939 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.873 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.1 tm0? -136.47 142.32 43.57 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.4 154.0 38.99 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.015 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.709 HD13 ' HA ' ' F' ' 169' ' ' GLU . 1.1 pt -69.72 -49.28 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.018 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . 0.432 ' OD2' ' HD3' ' L' ' 87' ' ' LYS . 0.9 OUTLIER -82.01 -9.04 59.69 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -172.01 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.28 -34.71 77.99 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.421 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 42.37 46.88 4.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.207 1.403 . . . . 0.0 111.793 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.07 163.07 13.46 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -91.39 7.97 79.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.728 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . 0.486 ' OG ' HD11 ' L' ' 146' ' ' LEU . 3.1 m -155.34 135.25 12.85 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.966 0.383 . . . . 0.0 111.753 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.873 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -94.42 122.85 60.21 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.989 2.115 . . . . 0.0 112.393 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -69.57 129.18 17.34 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.443 0.837 . . . . 0.0 112.491 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.762 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.31 130.02 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' L' ' 76' ' ' GLN . 25.4 t80 -92.69 141.72 24.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.786 -2.366 . . . . 0.0 110.547 -167.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.38 178.8 7.07 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.855 0.69 . . . . 0.0 112.446 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 54.81 46.28 24.87 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.462 . . . . 0.0 111.565 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.442 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 5.7 m-85 -72.13 134.31 45.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 122.496 1.141 . . . . 0.0 111.073 173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' L' ' 33' ' ' THR . 35.8 tt0 -101.83 -110.62 0.22 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' L' ' 32' ' ' GLN . 12.1 p -119.24 178.28 4.58 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-O 122.717 1.246 . . . . 0.0 111.137 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.828 ' OD2' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -163.25 136.73 5.76 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.091 -1.413 . . . . 0.0 107.968 -164.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.45 130.78 7.63 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.345 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.18 97.77 7.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 80.9 t -102.69 119.69 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . 0.495 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 7.0 p -133.51 85.38 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.99 125.28 7.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.249 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 86.15 2.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' L' ' 41' ' ' ARG . 11.2 mmm180 -63.76 -178.77 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.708 0.766 . . . . 0.0 110.192 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.13 142.23 23.13 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -73.95 166.77 22.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.519 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . 0.618 ' HA ' HG12 ' L' ' 53' ' ' ILE . 9.3 t80 -108.3 83.43 1.78 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.228 171.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . 0.454 ' H ' ' CG2' ' L' ' 53' ' ' ILE . 34.1 t70 -106.49 92.1 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.465 ' HB2' ' H ' ' L' ' 51' ' ' GLY . 17.4 pt-20 -65.48 -15.84 63.06 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 60.12 35.84 21.18 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.639 1.575 . . . . 0.0 111.611 -172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER 37.48 53.82 1.38 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.53 1.532 . . . . 0.0 111.534 -164.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . 0.455 ' HG2' ' HG2' ' L' ' 52' ' ' ARG . 17.7 tptt -116.2 -92.02 0.52 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.452 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . 0.668 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 7.9 m-20 -150.62 29.96 0.67 Allowed 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 84.74 34.84 14.57 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.455 ' HG2' ' HG2' ' L' ' 49' ' ' LYS . 0.0 OUTLIER -102.36 122.57 44.51 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.618 HG12 ' HA ' ' L' ' 44' ' ' PHE . 0.5 OUTLIER -136.79 132.96 48.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.91 178.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.11 22.31 16.13 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.34 159.47 13.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.645 0.58 . . . . 0.0 113.926 -170.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -78.64 159.38 28.44 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -121.4 -77.22 0.44 Allowed Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . 0.765 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 2.6 t -164.35 171.47 14.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.61 0.719 . . . . 0.0 110.508 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.524 ' H ' ' HB3' ' K' ' 50' ' ' ASN . 47.0 t -113.32 112.44 40.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.89 86.45 3.08 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.12 102.18 12.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 64.3 p -135.51 154.63 51.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.918 0.887 . . . . 0.0 110.059 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -142.43 155.74 25.84 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.16 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.812 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -129.0 134.69 48.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.828 HG22 ' OD2' ' L' ' 34' ' ' ASP . 79.4 t -124.14 122.15 63.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 34.3 p -106.15 142.35 35.98 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.482 ' OH ' HG21 ' L' ' 79' ' ' ILE . 50.6 p90 -154.59 160.46 41.48 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 27.3 m-85 -87.75 144.99 26.33 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.26 140.01 22.44 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -120.43 150.03 41.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.468 0.652 . . . . 0.0 109.265 174.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.412 HH21 ' HD3' ' L' ' 71' ' ' ARG . 0.7 OUTLIER -54.79 -39.16 68.15 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.74 -124.5 3.05 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.156 -1.177 . . . . 0.0 110.156 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 67.27 131.04 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.143 1.377 . . . . 0.0 111.049 169.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -90.67 -9.28 47.42 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.19 -44.81 27.69 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.825 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.643 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 9.3 tt0 -67.47 -35.45 79.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.154 -0.615 . . . . 0.0 111.836 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 2.8 mtmt -67.8 -41.67 82.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.834 171.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.75 74.64 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.922 168.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.643 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.0 OUTLIER -62.66 -52.44 59.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.023 0.439 . . . . 0.0 110.469 172.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -70.83 -39.08 73.2 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.77 -0.581 . . . . 0.0 112.438 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -59.02 -50.02 75.69 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.567 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -59.25 -43.58 92.43 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.519 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 7.1 t80 -64.9 -52.63 55.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -75.85 -36.76 59.48 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.432 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 14.4 m120 -86.23 -3.49 58.98 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.831 -0.748 . . . . 0.0 111.023 172.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.85 30.13 74.16 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.355 -0.216 . . . . 0.0 112.856 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.64 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 6.1 mttm -67.08 146.16 54.59 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.855 ' HB2' ' OE1' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -70.61 144.93 51.0 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' L' ' 15' ' ' PHE . 4.8 tt -118.07 133.77 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-O 121.391 0.615 . . . . 0.0 109.839 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.4 mtmp? -88.58 121.39 30.91 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.469 ' HE1' ' HD2' ' L' ' 13' ' ' TYR . 0.1 OUTLIER -116.62 125.76 52.27 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.489 1.116 . . . . 0.0 110.003 -165.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.716 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 23.3 m95 -123.29 116.52 23.48 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 108.366 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.739 HH21 HG11 ' L' ' 11' ' ' VAL . 15.5 ttt180 -102.02 106.37 17.27 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.947 HG21 HG21 ' L' ' 145' ' ' THR . 1.6 m -122.45 148.86 25.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 CA-C-O 122.275 1.036 . . . . 0.0 109.428 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.14 167.03 20.13 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.621 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.473 ' N ' ' O ' ' L' ' 10' ' ' ASP . 13.5 m -107.12 -25.3 11.62 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.684 -176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . 0.511 HG13 ' OD1' ' L' ' 10' ' ' ASP . 20.2 m -74.22 165.13 3.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.663 0.744 . . . . 0.0 109.891 176.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . 0.4 ' HD2' ' O ' ' L' ' 99' ' ' ASN . 0.1 OUTLIER -93.55 107.82 19.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.961 -174.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.4 ' O ' ' HD2' ' L' ' 98' ' ' LYS . 9.7 t30 -72.28 160.69 31.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.875 0.845 . . . . 0.0 109.946 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 -8.74 26.3 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -98.81 -80.32 0.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.732 0.696 . . . . 0.0 110.883 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.67 ' OD1' HG13 ' L' ' 143' ' ' ILE . 0.4 OUTLIER -70.97 163.8 26.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.602 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.6 OUTLIER -56.11 -45.97 79.27 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.893 -0.504 . . . . 0.0 110.574 171.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' L' ' 142' ' ' GLU . 55.8 m-85 -138.32 -170.85 2.9 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.576 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.7 t70 -139.62 141.19 37.11 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.632 0.73 . . . . 0.0 109.476 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -131.66 145.97 51.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.019 -163.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -110.82 127.0 55.23 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' L' ' 138' ' ' LEU . 32.3 t80 -133.39 152.31 51.91 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.377 0.671 . . . . 0.0 110.428 -163.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -168.19 171.42 42.48 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.929 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' F' ' 171' ' ' PRO . 6.1 m-85 -92.47 133.69 35.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 167.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.439 ' HB3' HG23 ' L' ' 89' ' ' ILE . . . -132.54 158.26 42.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.943 0.878 . . . . 0.0 111.19 -169.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.446 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 6.9 t80 -134.75 130.75 36.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.482 -1.236 . . . . 0.0 107.992 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.428 HG21 ' HD1' ' L' ' 83' ' ' TYR . 1.4 mp -65.6 120.14 11.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -100.2 -27.24 13.61 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . 0.435 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 27.5 t -164.34 147.52 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.968 0.804 . . . . 0.0 109.09 174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -117.2 137.95 52.02 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.851 -2.277 . . . . 0.0 104.851 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.42 119.97 21.37 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.19 123.89 49.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.067 0.46 . . . . 0.0 111.17 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . 0.627 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 0.8 OUTLIER -106.24 126.93 52.83 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.618 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -122.51 115.36 22.07 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -110.18 -176.82 20.93 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-O 121.745 0.636 . . . . 0.0 111.545 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.418 HG23 HG22 ' K' ' 33' ' ' THR . 4.5 t -80.69 -44.88 21.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 O-C-N 122.467 -0.431 . . . . 0.0 111.125 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 156.8 17.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.34 147.47 10.74 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 166.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -71.79 165.58 23.78 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.603 0.716 . . . . 0.0 110.758 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -58.73 143.41 13.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.005 -171.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.627 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 23.0 mp0 -118.57 133.94 55.47 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.086 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 37.4 mt -117.55 117.05 53.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.83 126.75 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.505 HG13 ' O ' ' L' ' 130' ' ' ILE . 4.1 pt -123.74 126.73 73.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.812 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -108.0 126.86 53.21 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.764 -178.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' L' ' 63' ' ' GLY . 0.4 OUTLIER -138.47 165.63 26.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.102 -172.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -125.52 162.99 23.67 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 17.5 t -123.38 129.44 74.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.43 ' H ' HG12 ' L' ' 135' ' ' ILE . 6.5 pt -67.9 -51.85 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.325 0.583 . . . . 0.0 110.364 -173.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.415 ' H ' HG13 ' L' ' 135' ' ' ILE . . . -125.78 119.2 3.41 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.736 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.27 122.43 21.09 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 122.046 0.927 . . . . 0.0 110.627 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' L' ' 109' ' ' GLY . 1.7 mt -125.26 149.47 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.12 127.85 27.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.815 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 11.1 p-10 -156.47 153.95 29.62 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -65.72 153.04 51.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.37 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HB2' ' L' ' 104' ' ' TYR . 6.8 tp10 -111.97 137.47 49.93 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -174.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.712 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -104.13 -63.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.803 -176.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.491 ' OD1' ' HZ ' ' F' ' 160' ' ' PHE . 0.0 OUTLIER -122.11 116.88 25.0 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.955 -176.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.947 HG21 HG21 ' L' ' 94' ' ' VAL . 3.5 p -114.62 39.4 2.83 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.713 -0.66 . . . . 0.0 112.399 175.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' L' ' 24' ' ' SER . 1.2 mm? 45.43 58.4 15.23 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.422 1.889 . . . . 0.0 109.386 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.634 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -10.45 29.18 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.224 1.283 . . . . 0.0 115.295 -159.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -25.59 68.27 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.587 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.11 -43.54 1.8 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.762 HG23 HD22 ' L' ' 27' ' ' LEU . 47.2 mt -82.43 -44.96 19.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.159 0.89 . . . . 0.0 111.248 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 1.7 t -73.93 -39.44 51.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -93.45 113.64 25.83 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.441 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.6 p -98.26 117.85 43.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.0 p -113.04 146.67 38.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -75.96 -38.9 57.03 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.62 8.6 65.49 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 119.378 0.99 . . . . 0.0 113.04 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -74.66 123.26 7.49 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -101.83 110.36 22.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.31 1.044 . . . . 0.0 108.634 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.16 -28.86 63.51 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -158.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -140.19 117.67 11.47 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.694 2.398 . . . . 0.0 109.117 167.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.606 ' NE2' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -149.37 43.85 0.94 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . 0.806 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 15.6 tt0 -54.05 -61.89 4.67 Favored Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -166.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -80.02 136.89 11.97 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.103 1.787 . . . . 0.0 113.847 171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.43 34.39 87.66 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.606 ' HA ' ' NE2' ' L' ' 161' ' ' GLN . 2.0 tt0 -68.44 -40.55 81.11 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.938 1.369 . . . . 0.0 110.922 175.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.889 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 7.0 m 47.23 63.21 2.05 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.838 1.655 . . . . 0.0 111.885 175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.686 ' HA ' HG22 ' L' ' 173' ' ' THR . 33.8 p -120.76 149.45 42.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.299 -167.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.86 -170.81 43.54 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.517 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -27.69 68.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.799 0.3 . . . . 0.0 111.433 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . 0.418 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -83.69 159.8 60.08 Favored Pre-proline 0 C--O 1.235 0.32 0 C-N-CA 123.503 0.721 . . . . 0.0 109.258 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.418 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.6 Cg_endo -78.96 85.12 1.91 Allowed 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.279 1.319 . . . . 0.0 112.722 -156.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.65 90.85 1.13 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.686 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -109.42 155.17 21.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.991 0.896 . . . . 0.0 109.919 170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 15.4 m -62.73 159.2 46.03 Favored Pre-proline 0 C--O 1.241 0.612 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.402 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.889 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -69.61 138.96 39.55 Favored 'Trans proline' 0 C--N 1.348 0.542 0 CA-C-N 119.501 0.858 . . . . 0.0 111.726 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.195 0 C-N-CA 125.469 1.507 . . . . 0.0 112.348 -171.716 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 N-CA-C 114.1 0.769 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.2 pt -58.2 124.7 12.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.577 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.44 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.893 0.854 . . . . 0.0 110.767 -177.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.25 83.57 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.364 -0.834 . . . . 0.0 114.514 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.81 60.37 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.774 0.787 . . . . 0.0 112.421 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 8.0 t70 -68.28 -33.42 74.32 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' A' ' 93' ' ' ARG . 26.8 m -106.89 122.53 61.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.683 ' HG2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.685 0.755 . . . . 0.0 110.463 176.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' A' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.91 9.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.794 -164.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.676 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 5.1 mp -80.81 144.26 32.2 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.614 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 71.8 m-85 -131.49 137.11 48.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.474 0.654 . . . . 0.0 109.98 176.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.31 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.92 35.17 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.039 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.667 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.006 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.19 -6.51 59.28 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -171.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.41 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.72 6.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.207 1.403 . . . . 0.0 111.742 -173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.64 13.31 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 5.5 72.36 Favored Glycine 0 N--CA 1.451 -0.367 0 O-C-N 123.349 0.406 . . . . 0.0 113.729 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.71 136.1 20.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.982 0.391 . . . . 0.0 111.806 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.73 67.24 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.989 2.116 . . . . 0.0 112.402 -174.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.614 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.93 12.75 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.453 0.84 . . . . 0.0 112.502 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD21 ' HG2' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.0 56.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 168.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.37 143.12 27.75 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.531 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.37 173.88 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.997 0.678 . . . . 0.0 112.437 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 68' ' ' TYR . . . 57.38 45.8 19.35 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.342 1.457 . . . . 0.0 111.553 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' HB2' HG21 ' L' ' 48' ' ' THR . 2.9 m-85 -68.87 135.47 51.13 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.51 1.148 . . . . 0.0 111.061 173.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.484 ' HG2' HG23 ' A' ' 33' ' ' THR . 37.5 tt0 -100.25 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.585 HG22 HG23 ' B' ' 122' ' ' VAL . 11.1 p -120.82 174.93 6.29 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.762 1.268 . . . . 0.0 111.072 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.76 ' OD2' HG22 ' A' ' 65' ' ' VAL . 6.5 t0 -162.33 128.78 3.6 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.976 -164.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.4 10.37 Favored Glycine 0 N--CA 1.44 -1.039 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.375 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.22 100.97 9.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' B' ' 117' ' ' GLU . 88.1 t -105.37 120.12 55.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -173.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.0 85.46 2.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.79 125.83 7.26 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.23 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HG3' ' CE1' ' B' ' 83' ' ' TYR . 0.0 OUTLIER -105.96 88.48 2.82 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.794 ' HA ' HH11 ' A' ' 41' ' ' ARG . 8.9 mmm180 -62.62 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.698 0.761 . . . . 0.0 110.164 -174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 143.98 21.29 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.677 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -76.63 164.25 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.538 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 53' ' ' ILE . 10.1 t80 -108.98 81.76 1.49 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 171.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.24 96.49 6.51 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 155.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 12.4 pt-20 -67.56 -15.8 63.85 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.3 35.58 18.05 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 111.654 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.604 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.07 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.487 1.515 . . . . 0.0 111.571 -164.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.11 -89.87 0.57 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.484 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' B' ' 58' ' ' SER . 6.9 m-20 -151.32 28.17 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.607 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 83.82 35.02 17.11 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' NE ' ' HB ' ' B' ' 135' ' ' ILE . 0.0 OUTLIER -102.13 123.61 46.29 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.42 50.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.849 178.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' HB2' ' HG3' ' B' ' 88' ' ' GLN . 0.4 OUTLIER -107.99 18.9 20.69 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 121.672 0.595 . . . . 0.0 113.937 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.21 30.58 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.838 0.668 . . . . 0.0 113.838 -175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.677 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -125.56 -76.56 0.27 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.551 ' HA ' ' OD1' ' F' ' 50' ' ' ASN . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.478 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.21 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.014 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.1 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.76 106.42 16.91 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.733 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 64.0 p -136.63 159.29 42.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.961 0.904 . . . . 0.0 110.07 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.114 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.699 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.09 51.4 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.76 HG22 ' OD2' ' A' ' 34' ' ' ASP . 54.1 t -125.98 124.58 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.19 44.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.419 ' OH ' HG21 ' A' ' 79' ' ' ILE . 45.9 p90 -154.48 165.19 37.2 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 26.2 m-85 -87.73 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 126' ' ' VAL . . . -75.22 138.45 23.45 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.65 41.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -38.63 80.34 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.19 -124.71 2.95 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 88.6 m-20 65.82 133.06 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.146 1.378 . . . . 0.0 110.996 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -86.6 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.656 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -76.12 -45.65 15.09 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.865 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.811 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 10.5 tt0 -70.48 -35.05 73.04 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.865 171.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 3.5 mtmt -65.54 -41.51 92.95 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.824 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.0 71.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.915 168.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.811 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 mm -60.97 -51.25 75.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.097 0.475 . . . . 0.0 110.486 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.74 62.84 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.715 -0.615 . . . . 0.0 112.434 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.67 -45.33 85.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.591 169.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -61.84 -46.12 90.84 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.58 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.55 ' CE2' ' HG3' ' A' ' 84' ' ' GLN . 3.0 t80 -65.76 -52.45 50.86 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.946 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 83' ' ' TYR . 2.0 mt-30 -75.91 -32.87 59.82 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 22.9 m120 -86.32 -6.31 58.98 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.037 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.269 -0.27 . . . . 0.0 112.829 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.55 45.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 15' ' ' PHE . 6.5 tt -114.47 135.0 55.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.375 0.607 . . . . 0.0 109.816 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.667 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -84.9 126.31 33.38 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.41 52.13 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.511 1.124 . . . . 0.0 109.967 -165.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 20.1 m95 -124.45 116.33 22.35 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.181 0.992 . . . . 0.0 108.358 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' A' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.9 12.62 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 145' ' ' THR . 1.5 m -122.72 150.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.227 1.013 . . . . 0.0 109.424 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.647 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.8 m -108.92 -28.06 9.35 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.694 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 6.5 m -72.52 165.24 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.717 0.77 . . . . 0.0 109.863 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.6 104.69 16.79 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 15.6 t30 -68.11 162.13 25.38 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.848 0.833 . . . . 0.0 109.969 171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.39 -12.92 22.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.8 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.745 0.702 . . . . 0.0 110.859 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -71.74 158.82 35.43 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -52.1 -47.82 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.913 -0.492 . . . . 0.0 110.615 171.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.667 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 35.3 m-85 -136.72 -171.51 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.32 32.56 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.662 0.744 . . . . 0.0 109.433 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 94' ' ' VAL . . . -134.76 144.23 47.57 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.073 -163.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' A' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.36 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.412 0.685 . . . . 0.0 110.412 -163.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -172.24 169.68 42.76 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.989 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.625 ' HB2' HD11 ' A' ' 135' ' ' ILE . 5.4 m-85 -92.34 132.11 36.99 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.926 0.869 . . . . 0.0 111.179 -169.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' A' ' 88' ' ' GLN . 4.9 t80 -136.95 131.48 33.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.95 -174.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.08 12.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.2 147.29 16.1 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.954 0.797 . . . . 0.0 109.128 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.779 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.76 49.47 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 176.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.89 20.39 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.075 0.464 . . . . 0.0 111.176 176.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.791 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.3 m -100.93 126.11 47.55 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.673 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.48 17.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.56 21.82 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.5 HG23 HG22 ' F' ' 33' ' ' THR . 3.3 t -79.59 -44.68 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.46 -0.435 . . . . 0.0 111.076 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.27 16.49 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.57 144.38 11.0 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -72.22 164.96 25.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.558 0.694 . . . . 0.0 110.771 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.49 HG13 ' O ' ' F' ' 7' ' ' MET . 27.2 m -52.45 145.86 2.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.03 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.791 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 32.9 mp0 -124.34 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.094 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.88 116.48 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.779 HG22 ' HG2' ' A' ' 116' ' ' ARG . 3.9 pt -118.83 123.1 70.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.699 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.752 -178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.097 -172.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.733 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.14 19.53 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.62 72.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 110' ' ' PHE . 7.1 pt -69.26 -51.63 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 110.309 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.409 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -131.27 122.45 3.46 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.737 177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.92 122.14 22.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.036 0.922 . . . . 0.0 110.637 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.009 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.0 mt -122.53 150.35 42.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.36 33.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.85 35.19 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.37 51.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.384 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 104' ' ' TYR . 5.1 tp10 -112.07 138.44 48.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.618 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.94 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.805 -176.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.84 24.96 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.003 -176.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.948 HG21 HG21 ' A' ' 94' ' ' VAL . 1.8 p -111.78 40.14 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.703 -0.665 . . . . 0.0 112.346 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.74 57.21 14.57 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.892 . . . . 0.0 109.433 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.6 Cg_exo -68.95 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 121.226 1.284 . . . . 0.0 115.338 -159.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.12 67.93 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.609 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.28 1.59 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.588 HG23 HD22 ' A' ' 27' ' ' LEU . 42.2 mt -81.74 -42.63 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.126 0.875 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.667 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 1.5 t -76.26 -40.61 36.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.49 24.25 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.53 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.45 33.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.63 144.02 44.52 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HD3' ' HA3' ' G' ' 136' ' ' GLY . 11.7 mttt -80.14 -32.95 38.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.95 75.55 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.349 0.977 . . . . 0.0 113.053 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.59 114.81 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.327 1.051 . . . . 0.0 108.606 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' G' ' 140' ' ' ASN . 0.5 OUTLIER -72.65 -31.71 65.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -158.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.508 ' HA ' ' CZ3' ' G' ' 92' ' ' TRP . 92.3 t80 -141.66 114.65 8.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.684 2.393 . . . . 0.0 109.153 167.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.525 ' H ' ' HH2' ' G' ' 92' ' ' TRP . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.67 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 17.3 tt0 -55.7 -57.14 22.98 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -166.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.65 134.72 7.6 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.071 1.775 . . . . 0.0 113.887 171.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 175' ' ' PRO . . . 66.9 34.01 85.78 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 2.9 tt0 -63.34 -43.66 97.1 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.891 1.345 . . . . 0.0 110.872 175.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.803 ' HB ' ' HA ' ' A' ' 175' ' ' PRO . 6.2 m 48.68 66.11 1.17 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.853 1.661 . . . . 0.0 111.906 176.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' G' ' 18' ' ' ILE . 40.0 p -122.57 146.74 47.15 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.305 -167.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.34 49.63 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.496 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -28.14 67.46 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.771 0.285 . . . . 0.0 111.45 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.76 158.34 62.56 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.528 0.731 . . . . 0.0 109.272 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -79.24 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.299 1.333 . . . . 0.0 112.741 -156.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.53 92.43 1.08 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 167' ' ' THR . 10.1 t -114.76 158.73 21.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.977 0.888 . . . . 0.0 109.866 170.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.58 159.38 78.59 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.393 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.803 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.65 50.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 CA-C-N 119.501 0.857 . . . . 0.0 111.713 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.244 0 C-N-CA 125.405 1.482 . . . . 0.0 112.291 -171.749 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.49 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 50.2 Cg_endo . . . . . 0 C--O 1.231 0.138 0 N-CA-C 114.054 0.752 . . . . 0.0 114.054 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' B' ' 6' ' ' ILE . 3.2 pt -58.3 124.73 13.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -88.01 178.49 6.65 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.891 0.853 . . . . 0.0 110.787 -177.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.66 -32.21 83.46 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.468 175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.6 -13.78 60.35 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.8 0.8 . . . . 0.0 112.41 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 8.0 t70 -68.29 -33.39 74.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -171.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' B' ' 93' ' ' ARG . 26.8 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.664 ' HG2' HD21 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.94 39.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.552 176.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' B' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.88 9.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.766 -164.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 5.1 mp -80.8 144.26 32.22 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 174.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.619 ' O ' ' HD2' ' B' ' 26' ' ' PRO . 71.5 m-85 -131.52 137.06 48.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.519 0.676 . . . . 0.0 109.948 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 1.2 tm0? -139.38 140.36 37.43 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.021 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.666 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.987 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.23 -6.53 59.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.4 87.27 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.447 -175.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.9 45.66 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.173 1.389 . . . . 0.0 111.813 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.82 162.67 13.31 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.07 5.51 72.04 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 116.331 -0.395 . . . . 0.0 113.673 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.06 20.31 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.993 0.396 . . . . 0.0 111.766 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.17 122.8 67.18 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.951 2.101 . . . . 0.0 112.412 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.8 Cg_exo -74.14 128.96 12.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 CA-C-N 119.464 0.844 . . . . 0.0 112.468 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.664 HD21 ' HG2' ' B' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.05 56.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.39 143.04 27.61 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.906 -2.318 . . . . 0.0 110.531 -167.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.23 173.86 13.26 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.843 0.685 . . . . 0.0 112.424 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.57 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 57.35 45.8 19.41 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.334 1.454 . . . . 0.0 111.564 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.588 ' HB2' HG21 ' G' ' 48' ' ' THR . 2.9 m-85 -68.91 135.47 51.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 122.494 1.14 . . . . 0.0 111.063 173.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' B' ' 33' ' ' THR . 37.4 tt0 -100.24 -109.34 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.548 HG22 HG23 ' C' ' 122' ' ' VAL . 11.1 p -120.77 174.84 6.35 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 122.797 1.284 . . . . 0.0 111.103 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' B' ' 65' ' ' VAL . 6.4 t0 -162.28 128.87 3.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.0 -164.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.34 134.41 10.37 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.318 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.96 9.23 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 ' HG2' ' C' ' 117' ' ' GLU . 88.1 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.08 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.9 7.29 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.219 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.67 ' HG3' ' CE1' ' C' ' 83' ' ' TYR . 0.0 OUTLIER -106.0 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.791 ' HA ' HH11 ' B' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.683 0.754 . . . . 0.0 110.164 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.08 21.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -167.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.673 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -76.65 164.23 26.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' B' ' 53' ' ' ILE . 10.1 t80 -108.97 81.78 1.5 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.232 171.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.3 96.45 6.47 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 155.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.6 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 12.4 pt-20 -67.47 -15.84 63.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.54 17.92 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.629 1.572 . . . . 0.0 111.617 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.6 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.05 1.95 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.499 1.52 . . . . 0.0 111.527 -164.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 -177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' C' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.598 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 83.75 35.06 17.22 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.515 ' NE ' ' HB ' ' C' ' 135' ' ' ILE . 0.0 OUTLIER -102.18 123.68 46.44 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' B' ' 44' ' ' PHE . 0.7 OUTLIER -136.16 133.35 50.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.85 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.622 ' HB2' ' HG3' ' C' ' 88' ' ' GLN . 0.4 OUTLIER -107.95 18.89 20.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.48 162.18 12.65 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.642 0.579 . . . . 0.0 113.931 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.96 160.21 30.47 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.856 0.675 . . . . 0.0 113.856 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.673 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -125.57 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 41' ' ' ARG . 4.1 t -163.47 167.68 21.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 110.468 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.18 115.47 49.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 88.29 3.11 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.75 106.39 16.86 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.738 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 63.9 p -136.66 159.24 42.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.955 0.902 . . . . 0.0 110.049 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.01 155.55 26.56 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.149 176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -128.75 137.14 51.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' B' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.85 142.2 44.53 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' B' ' 79' ' ' ILE . 45.9 p90 -154.48 165.18 37.24 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.57 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 26.0 m-85 -87.76 140.4 29.55 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' B' ' 126' ' ' VAL . . . -75.19 138.44 23.47 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -119.0 149.65 41.29 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -38.57 80.28 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.2 -124.71 2.96 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' B' ' 77' ' ' LYS . 88.5 m-20 65.8 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.115 1.366 . . . . 0.0 111.012 169.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.569 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -86.51 -7.51 58.33 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 -156.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -76.19 -45.58 14.94 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.805 168.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.825 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 10.4 tt0 -70.57 -35.01 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.836 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.59 93.21 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.806 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.78 -30.98 71.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.884 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.825 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 1.3 mm -61.0 -51.22 75.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.023 0.44 . . . . 0.0 110.451 172.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.72 62.79 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.798 -0.564 . . . . 0.0 112.467 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -57.66 -45.27 85.76 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.626 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -61.95 -46.08 90.84 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.567 174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.635 ' CE1' ' HG3' ' A' ' 40' ' ' GLU . 3.0 t80 -65.77 -52.42 51.12 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.939 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' B' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.86 59.86 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.41 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 22.9 m120 -86.39 -6.3 58.96 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.029 172.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.13 26.99 73.53 Favored Glycine 0 N--CA 1.45 -0.417 0 O-C-N 122.366 -0.209 . . . . 0.0 112.83 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 5.1 mttm -67.84 146.07 54.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.609 ' HG2' ' HD2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.52 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' B' ' 15' ' ' PHE . 6.5 tt -114.45 134.98 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.318 0.58 . . . . 0.0 109.837 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.666 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -84.88 126.33 33.39 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.23 126.4 52.1 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.498 1.119 . . . . 0.0 109.995 -165.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.679 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 20.0 m95 -124.46 116.29 22.28 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.182 0.993 . . . . 0.0 108.363 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' B' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.96 12.68 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 1.002 HG21 HG21 ' B' ' 145' ' ' THR . 1.5 m -122.83 150.87 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.294 1.045 . . . . 0.0 109.368 -173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.28 20.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.667 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' B' ' 10' ' ' ASP . 6.8 m -108.99 -28.1 9.29 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.638 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 6.6 m -72.48 165.15 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.679 0.752 . . . . 0.0 109.909 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.53 104.74 16.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.936 -174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 15.5 t30 -68.07 162.13 25.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.843 0.83 . . . . 0.0 109.971 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.87 -81.78 0.38 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.892 169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' B' ' 143' ' ' ILE . 0.5 OUTLIER -71.73 158.86 35.38 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' B' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.78 65.51 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.912 -0.493 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 35.4 m-85 -136.67 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.27 32.51 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.561 0.696 . . . . 0.0 109.473 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' B' ' 94' ' ' VAL . . . -134.76 144.2 47.56 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.049 -163.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.13 129.52 54.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 157.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' B' ' 138' ' ' LEU . 15.7 t80 -132.77 155.16 49.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.34 0.656 . . . . 0.0 110.414 -163.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -172.29 169.61 42.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.947 170.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.611 ' HB2' HD11 ' B' ' 135' ' ' ILE . 5.4 m-85 -92.23 132.1 36.93 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.33 34.84 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.956 0.884 . . . . 0.0 111.187 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.609 ' HD2' ' HG2' ' B' ' 88' ' ' GLN . 4.9 t80 -136.99 131.44 32.92 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.027 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.04 12.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.83 13.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 40' ' ' GLU . 13.1 t -160.23 147.21 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.911 0.778 . . . . 0.0 109.091 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.791 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.7 OUTLIER -119.98 141.72 49.43 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.578 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.86 20.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 -177.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.485 ' HD2' ' NH2' ' B' ' 116' ' ' ARG . 0.3 OUTLIER -107.43 119.24 38.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.46 . . . . 0.0 111.182 176.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.794 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.3 m -100.94 126.07 47.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.713 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.5 17.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.49 -175.52 21.82 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.585 HG23 HG22 ' A' ' 33' ' ' THR . 3.4 t -79.72 -44.63 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.503 -0.41 . . . . 0.0 111.057 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.28 16.48 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 169.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.36 10.9 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -72.2 164.93 25.39 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.576 0.703 . . . . 0.0 110.756 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.477 HG23 ' H ' ' B' ' 69' ' ' GLY . 27.2 m -52.39 145.84 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.026 -171.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.794 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 33.0 mp0 -124.33 131.31 53.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.104 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.87 116.42 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.43 49.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.791 HG22 ' HG2' ' B' ' 116' ' ' ARG . 3.9 pt -118.8 123.06 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.13 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.736 -178.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.103 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.13 19.55 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.06 131.65 72.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' B' ' 110' ' ' PHE . 7.0 pt -69.18 -51.67 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.348 0.594 . . . . 0.0 110.346 -173.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.403 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -131.32 122.47 3.46 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.942 -0.646 . . . . 0.0 111.739 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.9 122.08 21.97 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.026 0.917 . . . . 0.0 110.674 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.0 mt -122.53 150.36 42.68 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.24 129.41 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.22 157.86 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.09 153.34 51.03 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.425 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 104' ' ' TYR . 5.2 tp10 -112.06 138.42 48.74 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -103.16 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -176.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.89 25.01 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.938 -176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 1.002 HG21 HG21 ' B' ' 94' ' ' VAL . 1.8 p -111.79 40.11 2.22 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.364 175.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.78 57.19 14.64 Favored Pre-proline 0 C--N 1.346 0.449 0 C-N-CA 126.431 1.892 . . . . 0.0 109.387 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.87 -9.35 26.04 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.235 1.29 . . . . 0.0 115.348 -159.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.25 -25.11 67.91 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.594 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.87 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.591 HG23 HD22 ' B' ' 27' ' ' LEU . 42.4 mt -81.73 -42.58 19.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 119.102 0.864 . . . . 0.0 111.299 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 1.5 t -76.33 -40.55 35.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -176.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.447 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.76 114.44 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.58 144.03 44.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.606 ' HD3' ' HA3' ' H' ' 136' ' ' GLY . 11.7 mttt -80.19 -32.9 38.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 175.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.91 75.64 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.369 0.986 . . . . 0.0 113.063 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.35 123.35 9.2 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.79 28.74 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.337 1.055 . . . . 0.0 108.615 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.64 -31.69 65.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -158.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.456 ' HA ' ' CZ3' ' H' ' 92' ' ' TRP . 92.4 t80 -141.62 114.67 8.66 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.65 2.38 . . . . 0.0 109.131 167.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.668 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 17.3 tt0 -55.72 -57.1 23.26 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.77 7.6 Favored 'Trans proline' 0 C--O 1.238 0.496 0 CA-C-N 122.067 1.774 . . . . 0.0 113.867 171.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' B' ' 175' ' ' PRO . . . 66.89 33.92 85.52 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.481 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 2.9 tt0 -63.23 -43.73 97.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.895 1.347 . . . . 0.0 110.901 175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' B' ' 175' ' ' PRO . 6.2 m 48.74 66.1 1.18 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.826 1.65 . . . . 0.0 111.886 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.479 ' HA ' HG22 ' B' ' 173' ' ' THR . 40.0 p -122.51 146.75 47.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.313 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.5 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.478 172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.16 67.46 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.805 0.303 . . . . 0.0 111.464 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.4 62.58 Favored Pre-proline 0 C--O 1.236 0.342 0 C-N-CA 123.487 0.715 . . . . 0.0 109.279 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.23 86.74 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.293 1.329 . . . . 0.0 112.755 -156.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.51 92.44 1.08 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 165.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.479 HG22 ' HA ' ' B' ' 167' ' ' THR . 10.1 t -114.77 158.73 21.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.958 0.879 . . . . 0.0 109.854 170.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -67.55 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.682 -1.144 . . . . 0.0 108.374 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.7 50.35 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.49 0.854 . . . . 0.0 111.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.269 0 C-N-CA 125.472 1.509 . . . . 0.0 112.256 -171.754 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . 0.533 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 N-CA-C 113.971 0.72 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' C' ' 6' ' ' ILE . 3.2 pt -58.21 124.71 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.564 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.43 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.889 0.852 . . . . 0.0 110.761 -177.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.6 -32.24 83.55 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.382 -0.827 . . . . 0.0 114.483 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.78 0.79 . . . . 0.0 112.403 172.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.564 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 8.0 t70 -68.22 -33.45 74.43 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' C' ' 93' ' ' ARG . 26.6 m -106.84 122.49 60.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.89 39.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.635 0.731 . . . . 0.0 110.544 176.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' C' ' 93' ' ' ARG . 50.6 m-85 -109.75 101.02 9.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.732 -164.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 5.1 mp -80.85 144.27 32.13 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.633 ' O ' ' HD2' ' C' ' 26' ' ' PRO . 71.7 m-85 -131.57 137.11 48.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.48 0.657 . . . . 0.0 109.936 176.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.1 154.99 35.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.995 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.66 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -66.31 -46.23 87.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.978 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.56 59.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.38 87.19 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.418 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.87 45.68 6.39 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.196 1.399 . . . . 0.0 111.798 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.61 13.33 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.0 5.49 72.29 Favored Glycine 0 N--CA 1.451 -0.35 0 O-C-N 123.372 0.42 . . . . 0.0 113.698 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.69 136.11 20.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.967 0.384 . . . . 0.0 111.722 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.23 122.78 67.13 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.937 2.095 . . . . 0.0 112.442 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . 0.633 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -74.11 128.96 12.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.481 178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' C' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.09 56.08 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 19.5 t80 -91.47 143.08 27.6 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.547 -167.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.9 Cg_endo -78.31 173.9 13.18 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.868 0.695 . . . . 0.0 112.437 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 57.31 45.88 19.42 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.412 1.485 . . . . 0.0 111.556 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . 0.569 ' O ' HG23 ' H' ' 48' ' ' THR . 2.9 m-85 -68.86 135.53 51.24 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 122.543 1.163 . . . . 0.0 111.05 173.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' C' ' 33' ' ' THR . 37.3 tt0 -100.3 -109.34 0.21 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.634 HG22 HG23 ' D' ' 122' ' ' VAL . 11.1 p -120.79 174.87 6.33 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 122.787 1.279 . . . . 0.0 111.112 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' C' ' 65' ' ' VAL . 6.5 t0 -162.31 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.963 -164.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.39 10.38 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.391 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.18 100.93 9.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 173.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.516 HG22 ' HG2' ' D' ' 117' ' ' GLU . 88.3 t -105.36 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -173.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.01 85.44 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -166.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.85 125.88 7.29 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.214 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' D' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.48 2.82 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.791 HH11 ' HA ' ' C' ' 41' ' ' ARG . 8.9 mmm180 -62.58 -176.01 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.724 0.773 . . . . 0.0 110.183 -174.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.62 144.03 21.32 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -167.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -76.73 164.27 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.532 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' C' ' 53' ' ' ILE . 10.1 t80 -109.01 81.8 1.5 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.229 171.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.22 96.48 6.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.601 ' HB2' ' H ' ' C' ' 51' ' ' GLY . 12.4 pt-20 -67.58 -15.86 63.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.36 35.51 17.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.591 1.556 . . . . 0.0 111.697 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.588 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 38.73 53.1 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.478 1.511 . . . . 0.0 111.594 -164.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.2 -89.79 0.57 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.496 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . 0.677 ' OD1' ' HA ' ' D' ' 58' ' ' SER . 6.9 m-20 -151.31 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 83.8 35.03 17.13 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.529 ' NE ' ' HB ' ' D' ' 135' ' ' ILE . 0.0 OUTLIER -102.08 123.61 46.25 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' C' ' 44' ' ' PHE . 0.7 OUTLIER -136.14 133.38 50.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.903 178.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' D' ' 88' ' ' GLN . 0.4 OUTLIER -107.92 18.87 20.76 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.45 162.2 12.65 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.651 0.584 . . . . 0.0 113.961 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.92 160.2 30.62 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -125.6 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' B' ' 50' ' ' ASN . 4.0 t -163.44 167.71 21.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.588 0.708 . . . . 0.0 110.487 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.23 115.44 49.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.13 88.31 3.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.42 16.9 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -171.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 63.6 p -136.67 159.27 42.32 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.899 0.879 . . . . 0.0 110.083 -178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.52 26.55 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.136 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.17 51.47 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' C' ' 34' ' ' ASP . 54.0 t -126.0 124.62 66.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.89 142.2 44.58 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.417 ' OH ' HG21 ' C' ' 79' ' ' ILE . 45.9 p90 -154.47 165.18 37.25 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 26.1 m-85 -87.71 140.35 29.6 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' C' ' 126' ' ' VAL . . . -75.26 138.43 23.4 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.68 41.22 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.26 -38.5 80.23 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.23 -124.75 2.96 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' C' ' 77' ' ' LYS . 88.6 m-20 65.77 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 111.041 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -86.54 -7.48 58.34 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -156.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -76.18 -45.57 15.0 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.226 -0.988 . . . . 0.0 112.864 168.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.815 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 10.5 tt0 -70.58 -34.99 72.8 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.147 -0.62 . . . . 0.0 111.851 171.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.827 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.8 -30.97 71.3 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.878 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.815 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 1.3 mm -61.01 -51.2 75.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.114 0.483 . . . . 0.0 110.472 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.67 62.82 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.728 -0.608 . . . . 0.0 112.459 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.8 -45.2 86.4 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.589 169.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -61.95 -46.09 90.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.589 174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.67 ' CE1' ' HG3' ' B' ' 40' ' ' GLU . 3.0 t80 -65.7 -52.45 51.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.96 -174.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HG3' ' CE2' ' C' ' 83' ' ' TYR . 2.0 mt-30 -75.94 -32.86 59.74 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.412 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 23.0 m120 -86.34 -6.28 58.98 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.816 -0.753 . . . . 0.0 111.044 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.06 73.48 Favored Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.28 -0.263 . . . . 0.0 112.882 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 5.1 mttm -67.88 146.12 53.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.633 ' HG2' ' HD2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -73.85 140.49 45.79 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 168.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' C' ' 15' ' ' PHE . 6.5 tt -114.38 135.01 55.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.331 0.586 . . . . 0.0 109.881 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.66 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -84.91 126.32 33.39 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 126.36 52.06 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.55 1.14 . . . . 0.0 110.047 -165.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.667 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 20.0 m95 -124.45 116.28 22.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.212 1.005 . . . . 0.0 108.34 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' C' ' 13' ' ' TYR . 19.9 ttt180 -104.12 102.88 12.62 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 1.009 HG21 HG21 ' C' ' 145' ' ' THR . 1.5 m -122.71 150.92 26.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.256 1.027 . . . . 0.0 109.422 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.2 20.12 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.626 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' C' ' 10' ' ' ASP . 6.7 m -108.92 -28.09 9.34 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.699 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 6.5 m -72.48 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.712 0.767 . . . . 0.0 109.89 176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.7 16.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.948 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 15.6 t30 -68.09 162.17 25.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.897 0.856 . . . . 0.0 109.932 171.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.98 22.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.79 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.761 0.709 . . . . 0.0 110.87 169.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' C' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.86 35.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' C' ' 104' ' ' TYR . 0.2 OUTLIER -52.23 -47.79 65.5 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.885 -0.509 . . . . 0.0 110.562 171.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.678 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 35.4 m-85 -136.69 -171.43 2.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.31 32.5 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.52 ' CB ' HG12 ' C' ' 94' ' ' VAL . . . -134.77 144.21 47.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.041 -163.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.11 129.49 54.82 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' C' ' 138' ' ' LEU . 15.9 t80 -132.71 155.2 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.378 0.671 . . . . 0.0 110.423 -163.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . 0.995 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -172.33 169.6 42.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.953 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' C' ' 135' ' ' ILE . 5.4 m-85 -92.2 132.12 36.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 167.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.967 0.889 . . . . 0.0 111.163 -169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.633 ' HD2' ' HG2' ' C' ' 88' ' ' GLN . 4.9 t80 -137.03 131.47 32.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 118.99 12.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.75 -31.8 13.03 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 13.1 t -160.21 147.28 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.885 0.766 . . . . 0.0 109.044 174.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.768 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.6 OUTLIER -120.02 141.78 49.41 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.554 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -134.43 120.92 20.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.477 ' HD2' ' NH2' ' C' ' 116' ' ' ARG . 0.3 OUTLIER -107.54 119.25 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.133 0.492 . . . . 0.0 111.166 176.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.773 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.3 m -101.0 126.08 47.65 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.626 177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.34 112.48 17.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 167.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.57 21.83 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.548 HG23 HG22 ' B' ' 33' ' ' THR . 3.3 t -79.62 -44.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.498 -0.413 . . . . 0.0 111.129 176.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.73 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 169.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.41 10.95 Favored Glycine 0 C--O 1.243 0.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 166.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -72.29 165.01 25.33 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.648 0.737 . . . . 0.0 110.716 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' C' ' 69' ' ' GLY . 27.2 m -52.42 145.88 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.06 -171.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.773 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 33.0 mp0 -124.36 131.26 53.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.128 -176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.84 116.45 49.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.81 124.41 49.53 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.768 HG22 ' HG2' ' C' ' 116' ' ' ARG . 4.0 pt -118.81 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.751 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 164.28 29.18 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.119 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.726 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.09 131.6 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' C' ' 110' ' ' PHE . 7.1 pt -69.19 -51.67 41.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.346 0.593 . . . . 0.0 110.358 -173.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -131.25 122.52 3.49 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.722 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.0 122.13 22.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.007 0.908 . . . . 0.0 110.648 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.995 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.0 mt -122.51 150.38 42.63 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -174.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.38 33.39 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.91 35.29 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.4 51.04 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.362 169.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.638 ' HB3' ' HB2' ' C' ' 104' ' ' TYR . 5.1 tp10 -112.1 138.42 48.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.617 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -103.18 -63.93 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.732 -176.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.79 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.972 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 1.009 HG21 HG21 ' C' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.375 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.24 14.6 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.453 1.901 . . . . 0.0 109.409 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.96 -9.25 25.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.28 -25.08 67.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.592 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.91 -42.25 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.604 HG23 HD22 ' C' ' 27' ' ' LEU . 42.2 mt -81.76 -42.58 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 119.156 0.889 . . . . 0.0 111.299 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.678 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 1.5 t -76.34 -40.57 35.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.63 114.57 24.36 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.461 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.43 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.59 144.07 44.42 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.543 ' HD3' ' HA3' ' I' ' 136' ' ' GLY . 11.7 mttt -80.23 -32.93 38.36 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.65 10.87 75.58 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 119.398 0.999 . . . . 0.0 113.036 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.3 9.19 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.54 114.81 28.76 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.338 1.055 . . . . 0.0 108.669 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.67 65.24 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.66 114.61 8.6 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.662 2.385 . . . . 0.0 109.137 167.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.65 1.53 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 154.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.676 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 17.4 tt0 -55.69 -57.08 23.27 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -166.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 134.79 7.56 Favored 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.07 1.775 . . . . 0.0 113.876 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' C' ' 175' ' ' PRO . . . 66.89 33.93 85.55 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.473 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 2.9 tt0 -63.28 -43.63 97.39 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.887 1.343 . . . . 0.0 110.966 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.836 ' HB ' ' HA ' ' C' ' 175' ' ' PRO . 6.1 m 48.74 66.05 1.19 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.793 1.637 . . . . 0.0 111.912 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.48 ' HA ' HG22 ' C' ' 173' ' ' THR . 39.9 p -122.54 146.75 47.12 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.272 -167.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.42 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.458 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -28.08 67.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.676 0.274 . . . . 0.0 111.492 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.84 158.42 62.19 Favored Pre-proline 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 109.261 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -79.26 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.291 1.328 . . . . 0.0 112.754 -156.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.55 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.167 1.627 . . . . 0.0 117.167 165.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.48 HG22 ' HA ' ' C' ' 167' ' ' THR . 10.1 t -114.78 158.66 21.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.045 0.923 . . . . 0.0 109.855 170.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.37 78.47 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.415 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.836 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.4 Cg_exo -68.1 140.73 50.46 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.568 0.881 . . . . 0.0 111.764 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.372 1.469 . . . . 0.0 112.338 -171.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 114.044 0.748 . . . . 0.0 114.044 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.26 124.69 12.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.57 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -88.05 178.48 6.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.908 0.861 . . . . 0.0 110.74 -177.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.67 -32.22 83.5 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.415 -0.811 . . . . 0.0 114.461 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.8 60.37 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.831 0.815 . . . . 0.0 112.391 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 8.0 t70 -68.24 -33.46 74.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.438 HG21 ' NH2' ' D' ' 93' ' ' ARG . 26.7 m -106.86 122.45 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . 0.668 ' HG2' HD21 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -122.21 153.0 39.4 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.678 0.752 . . . . 0.0 110.494 176.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.513 ' CE2' ' HG3' ' D' ' 93' ' ' ARG . 50.6 m-85 -109.84 100.97 9.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.743 -164.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 5.1 mp -80.84 144.25 32.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 71.6 m-85 -131.53 137.02 48.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.463 0.649 . . . . 0.0 109.964 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 1.2 tm0? -139.35 140.29 37.47 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.09 154.93 35.19 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.19 87.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.002 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.21 -6.53 59.27 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.85 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.81 45.74 6.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.232 1.413 . . . . 0.0 111.796 -173.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.68 13.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.04 5.42 72.12 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.672 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.62 136.05 20.4 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 117.008 0.404 . . . . 0.0 111.823 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.74 67.22 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.981 2.112 . . . . 0.0 112.44 -174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . 0.629 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.95 12.72 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.47 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.668 HD21 ' HG2' ' D' ' 12' ' ' LYS . 0.8 OUTLIER -112.31 130.07 56.07 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.405 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 19.5 t80 -91.45 143.08 27.62 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.542 -167.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.405 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -78.29 173.86 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.04 0.693 . . . . 0.0 112.405 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 57.36 45.84 19.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.36 1.464 . . . . 0.0 111.535 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . 0.457 ' HB2' HG21 ' I' ' 48' ' ' THR . 2.9 m-85 -68.91 135.57 51.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.538 1.161 . . . . 0.0 111.063 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.505 ' HG2' HG23 ' D' ' 33' ' ' THR . 37.5 tt0 -100.31 -109.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . 0.575 HG22 HG23 ' E' ' 122' ' ' VAL . 11.1 p -120.82 174.89 6.32 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.757 1.265 . . . . 0.0 111.07 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' D' ' 65' ' ' VAL . 6.5 t0 -162.31 128.78 3.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.016 -1.447 . . . . 0.0 107.988 -164.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.29 134.42 10.39 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.353 170.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 101.02 9.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' E' ' 117' ' ' GLU . 88.6 t -105.37 120.12 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 125.83 7.26 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.248 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.638 ' HG3' ' CE1' ' E' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.797 HH11 ' HA ' ' D' ' 41' ' ' ARG . 8.9 mmm180 -62.7 -175.99 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.738 0.78 . . . . 0.0 110.135 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 143.99 21.29 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.654 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -76.62 164.28 26.07 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.54 -179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . 0.583 ' HA ' HG12 ' D' ' 53' ' ' ILE . 10.1 t80 -109.0 81.8 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.228 171.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -106.21 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' D' ' 51' ' ' GLY . 12.4 pt-20 -67.52 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.47 17.96 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.601 1.56 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.602 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 38.81 53.02 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.474 1.51 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.14 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.482 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' E' ' 58' ' ' SER . 6.9 m-20 -151.31 28.23 0.66 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 83.82 35.01 17.12 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.454 ' NE ' ' HB ' ' E' ' 135' ' ' ILE . 0.0 OUTLIER -102.12 123.59 46.24 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.583 HG12 ' HA ' ' D' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.43 50.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.896 178.307 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.552 ' HB2' ' HG3' ' E' ' 88' ' ' GLN . 0.4 OUTLIER -108.01 18.91 20.66 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.56 162.19 12.64 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.586 . . . . 0.0 113.932 -170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -77.92 160.19 30.63 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . 0.654 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -125.57 -76.53 0.26 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . 0.677 ' HA ' ' OD1' ' C' ' 50' ' ' ASN . 4.1 t -163.47 167.66 21.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.581 0.705 . . . . 0.0 110.51 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.15 115.47 49.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.28 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.52 17.05 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . 0.751 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 63.9 p -136.72 159.23 42.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.966 0.906 . . . . 0.0 110.077 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.48 26.53 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.144 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.69 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.22 51.49 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' D' ' 34' ' ' ASP . 54.0 t -126.06 124.6 66.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.7 p -111.84 142.25 44.44 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' D' ' 79' ' ' ILE . 46.0 p90 -154.49 165.19 37.22 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.582 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.34 29.61 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.461 ' H ' HG23 ' D' ' 126' ' ' VAL . . . -75.21 138.46 23.48 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HB3' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.63 41.3 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.396 0.617 . . . . 0.0 109.336 174.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -38.55 80.18 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.3 -124.7 2.95 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' D' ' 77' ' ' LYS . 88.6 m-20 65.78 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.153 1.381 . . . . 0.0 111.019 169.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -86.55 -7.52 58.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 117.472 2.397 . . . . 0.0 117.472 -156.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.648 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -76.15 -45.62 15.01 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.819 168.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.816 ' HA ' ' HB ' ' D' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.09 72.97 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.159 -0.616 . . . . 0.0 111.813 171.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.586 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 3.5 mtmt -65.43 -41.56 93.37 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.793 171.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.0 71.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 1.3 mm -61.01 -51.19 76.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.127 0.489 . . . . 0.0 110.493 172.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.49 -41.7 62.79 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.688 -0.632 . . . . 0.0 112.452 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.74 -45.25 86.1 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.557 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -61.95 -46.09 90.82 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.537 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.654 ' CE1' ' HG3' ' C' ' 40' ' ' GLU . 3.0 t80 -65.8 -52.46 50.6 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.935 -174.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' D' ' 83' ' ' TYR . 2.0 mt-30 -75.92 -32.81 59.78 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 23.0 m120 -86.4 -6.29 58.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.004 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.07 27.02 73.53 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 122.321 -0.237 . . . . 0.0 112.888 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -73.82 140.5 45.84 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' D' ' 15' ' ' PHE . 6.5 tt -114.4 134.92 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.318 0.58 . . . . 0.0 109.885 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.36 33.41 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.27 126.48 52.24 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.525 1.13 . . . . 0.0 109.965 -165.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 20.3 m95 -124.53 116.29 22.24 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.19 0.996 . . . . 0.0 108.344 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' D' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.91 12.62 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.977 HG21 HG21 ' D' ' 145' ' ' THR . 1.5 m -122.71 150.87 26.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.214 1.007 . . . . 0.0 109.408 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.23 20.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.661 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.4 ' N ' ' O ' ' D' ' 10' ' ' ASP . 6.8 m -108.91 -28.09 9.34 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.672 -176.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 6.6 m -72.52 165.19 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.703 0.763 . . . . 0.0 109.932 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.72 16.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.972 -174.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 15.5 t30 -68.08 162.13 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.823 0.82 . . . . 0.0 109.967 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.41 -12.91 22.19 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.8 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.739 0.699 . . . . 0.0 110.919 169.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' D' ' 143' ' ' ILE . 0.5 OUTLIER -71.77 158.86 35.35 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' D' ' 104' ' ' TYR . 0.2 OUTLIER -52.2 -47.82 65.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.893 -0.504 . . . . 0.0 110.559 171.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.681 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 35.1 m-85 -136.65 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.31 32.47 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.605 0.717 . . . . 0.0 109.445 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' D' ' 94' ' ' VAL . . . -134.8 144.19 47.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.013 -163.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.03 129.5 54.79 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.531 ' CE2' HD13 ' D' ' 138' ' ' LEU . 15.8 t80 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 123.408 0.683 . . . . 0.0 110.43 -163.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . 0.981 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -172.28 169.63 42.73 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.554 -1.308 . . . . 0.0 111.989 170.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.602 ' HB2' HD11 ' D' ' 135' ' ' ILE . 5.4 m-85 -92.26 132.14 36.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.32 34.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.925 0.869 . . . . 0.0 111.189 -169.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' D' ' 88' ' ' GLN . 4.9 t80 -136.97 131.39 32.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.424 -1.262 . . . . 0.0 107.993 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.74 119.02 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' C' ' 40' ' ' GLU . 42.0 mt-10 -95.82 -31.76 13.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . 0.499 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 13.1 t -160.27 147.25 15.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.947 0.794 . . . . 0.0 109.039 174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.785 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.6 OUTLIER -119.99 141.71 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.478 ' HD2' ' NH2' ' D' ' 116' ' ' ARG . 0.3 OUTLIER -107.44 119.17 38.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 111.222 176.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.3 m -100.95 126.08 47.58 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.698 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.3 112.44 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.58 21.84 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-O 121.715 0.619 . . . . 0.0 111.564 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.634 HG23 HG22 ' C' ' 33' ' ' THR . 3.4 t -79.65 -44.58 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 O-C-N 122.473 -0.428 . . . . 0.0 111.117 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.35 10.87 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.24 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.595 0.712 . . . . 0.0 110.779 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 69' ' ' GLY . 27.2 m -52.43 145.85 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.995 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.771 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 33.0 mp0 -124.34 131.26 53.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.097 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.8 116.41 49.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.46 49.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.785 HG22 ' HG2' ' D' ' 116' ' ' ARG . 3.9 pt -118.86 123.08 70.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.69 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.07 51.17 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.712 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.57 164.28 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.137 -172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.751 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 0.0 OUTLIER -119.7 162.17 19.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 167.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.14 131.58 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.602 HD11 ' HB2' ' D' ' 110' ' ' PHE . 7.1 pt -69.15 -51.71 40.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.312 0.577 . . . . 0.0 110.353 -173.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.411 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -131.26 122.55 3.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.719 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.1 22.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.005 0.907 . . . . 0.0 110.689 174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.981 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.0 mt -122.51 150.42 42.57 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.31 129.42 33.47 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.2 157.88 35.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.11 153.42 51.07 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.233 -0.985 . . . . 0.0 111.372 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' D' ' 104' ' ' TYR . 5.2 tp10 -112.17 138.44 48.86 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.615 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.768 -176.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.999 -176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.977 HG21 HG21 ' D' ' 94' ' ' VAL . 1.8 p -111.72 40.02 2.23 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.418 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.86 57.19 14.77 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.457 1.903 . . . . 0.0 109.378 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.561 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -68.93 -9.32 26.0 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 121.205 1.27 . . . . 0.0 115.355 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.13 67.93 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.588 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -173.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' D' ' 27' ' ' LEU . 42.3 mt -81.75 -42.58 19.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 119.13 0.877 . . . . 0.0 111.263 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.681 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 1.5 t -76.38 -40.5 35.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.68 114.49 24.34 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.497 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.68 114.48 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.01 44.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.589 ' HD3' ' HA3' ' J' ' 136' ' ' GLY . 11.8 mttt -80.11 -33.0 39.07 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.82 75.51 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . 0.411 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -72.31 123.32 9.23 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.85 28.84 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.307 1.043 . . . . 0.0 108.64 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' J' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.63 65.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' J' ' 143' ' ' ILE . 92.4 t80 -141.69 114.64 8.61 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.641 2.376 . . . . 0.0 109.102 167.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.583 ' H ' ' HH2' ' J' ' 92' ' ' TRP . 0.0 OUTLIER -143.26 46.7 1.52 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 154.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 17.3 tt0 -55.74 -57.09 23.36 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -166.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.3 Cg_exo -82.67 134.72 7.58 Favored 'Trans proline' 0 C--O 1.239 0.562 0 CA-C-N 122.071 1.775 . . . . 0.0 113.868 171.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' D' ' 175' ' ' PRO . . . 66.9 34.03 85.85 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.334 2.094 . . . . 0.0 118.334 -171.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.478 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 2.9 tt0 -63.36 -43.64 97.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.885 1.342 . . . . 0.0 110.917 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' D' ' 175' ' ' PRO . 6.2 m 48.69 66.08 1.18 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.836 1.655 . . . . 0.0 111.921 176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' J' ' 18' ' ' ILE . 40.1 p -122.51 146.75 47.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.355 -167.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.46 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.866 -0.607 . . . . 0.0 112.471 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.12 67.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.82 0.31 . . . . 0.0 111.434 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.78 158.36 62.47 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.553 0.741 . . . . 0.0 109.265 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.27 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.29 1.326 . . . . 0.0 112.723 -156.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.52 1.07 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.155 1.622 . . . . 0.0 117.155 165.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' D' ' 167' ' ' THR . 10.1 t -114.77 158.71 21.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.953 0.877 . . . . 0.0 109.916 170.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.52 159.32 78.73 Favored Pre-proline 0 C--O 1.24 0.583 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.406 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.74 50.47 Favored 'Trans proline' 0 C--N 1.348 0.547 0 CA-C-N 119.499 0.857 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.404 1.481 . . . . 0.0 112.335 -171.68 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' HE3' ' F' ' 70' ' ' LYS . 50.4 Cg_endo . . . . . 0 N--CA 1.466 -0.126 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 pt -58.23 124.72 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -88.07 178.49 6.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.928 0.871 . . . . 0.0 110.712 -177.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.68 -32.2 83.41 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.342 -0.845 . . . . 0.0 114.477 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.51 -13.9 60.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.797 0.798 . . . . 0.0 112.427 172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 8.0 t70 -68.21 -33.44 74.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' E' ' 93' ' ' ARG . 26.7 m -106.87 122.48 60.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . 0.666 ' HG2' HD21 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.98 39.51 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.495 176.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' E' ' 93' ' ' ARG . 50.0 m-85 -109.79 100.93 9.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.786 -164.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 5.1 mp -80.84 144.22 32.19 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.622 ' O ' ' HD2' ' E' ' 26' ' ' PRO . 71.7 m-85 -131.5 137.1 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.97 176.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.18 154.96 34.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.561 0.696 . . . . 0.0 110.965 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -66.21 -46.26 87.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.983 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.26 -6.51 59.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -171.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.41 87.29 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.413 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.88 45.72 6.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.243 1.417 . . . . 0.0 111.763 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 162.6 13.32 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.51 72.46 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.741 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.68 136.08 20.35 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.922 0.361 . . . . 0.0 111.794 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.78 67.12 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.903 2.081 . . . . 0.0 112.394 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -74.07 128.97 12.72 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.412 0.826 . . . . 0.0 112.485 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.666 HD21 ' HG2' ' E' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 168.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.11 27.67 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.563 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.29 173.87 13.22 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.813 0.672 . . . . 0.0 112.421 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 57.36 45.85 19.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.381 1.472 . . . . 0.0 111.54 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . 0.407 ' HB2' HG21 ' J' ' 48' ' ' THR . 2.9 m-85 -68.93 135.56 51.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.51 1.148 . . . . 0.0 111.064 173.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.499 ' HG2' HG23 ' E' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . 0.499 HG23 ' HG2' ' E' ' 32' ' ' GLN . 11.0 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.75 1.262 . . . . 0.0 111.094 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.754 ' OD2' HG22 ' E' ' 65' ' ' VAL . 6.4 t0 -162.34 128.76 3.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.99 -164.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.368 170.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.97 9.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.563 HG22 ' HG2' ' F' ' 117' ' ' GLU . 87.8 t -105.46 120.16 55.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 13.6 p -134.02 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -166.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.77 125.86 7.27 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.201 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' F' ' 83' ' ' TYR . 0.0 OUTLIER -105.97 88.47 2.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' E' ' 41' ' ' ARG . 8.9 mmm180 -62.65 -176.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.711 0.767 . . . . 0.0 110.154 -174.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.53 144.0 21.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.658 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -76.68 164.23 26.09 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.504 -179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . 0.602 ' HA ' HG12 ' E' ' 53' ' ' ILE . 10.2 t80 -108.99 81.78 1.5 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.236 171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.23 96.48 6.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' E' ' 51' ' ' GLY . 12.4 pt-20 -67.51 -15.81 63.86 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.31 35.54 18.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.573 1.549 . . . . 0.0 111.678 -172.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.592 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 38.72 53.08 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.474 1.51 . . . . 0.0 111.559 -164.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.15 -89.79 0.57 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.533 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' F' ' 58' ' ' SER . 6.9 m-20 -151.32 28.16 0.66 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . 0.609 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 83.76 35.05 17.22 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.11 123.64 46.32 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' E' ' 44' ' ' PHE . 0.7 OUTLIER -136.1 133.39 50.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.845 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.417 ' HB2' ' HG3' ' F' ' 88' ' ' GLN . 0.4 OUTLIER -107.95 18.84 20.78 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 176.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 121.664 0.591 . . . . 0.0 113.947 -170.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 160.22 30.6 Favored 'Trans proline' 0 CA--C 1.516 -0.397 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . 0.658 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -125.56 -76.49 0.26 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' D' ' 50' ' ' ASN . 4.0 t -163.47 167.64 21.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.525 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.13 115.44 49.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.051 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.29 3.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.85 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 63.9 p -136.71 159.22 42.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.939 0.896 . . . . 0.0 110.034 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.52 26.55 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.155 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -128.71 137.17 51.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.754 HG22 ' OD2' ' E' ' 34' ' ' ASP . 54.0 t -126.03 124.59 66.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 35.3 p -111.9 142.24 44.54 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.421 ' OH ' HG21 ' E' ' 79' ' ' ILE . 46.0 p90 -154.44 165.23 37.07 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.586 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 26.1 m-85 -87.76 140.36 29.59 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . 0.453 ' H ' HG23 ' E' ' 126' ' ' VAL . . . -75.22 138.46 23.46 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 114.945 0.738 . . . . 0.0 114.945 -175.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.62 41.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.53 80.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.22 -124.7 2.95 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' E' ' 77' ' ' LYS . 88.6 m-20 65.76 133.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.146 1.379 . . . . 0.0 111.073 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -86.5 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -76.17 -45.6 15.0 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.801 168.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.813 ' HA ' ' HB ' ' E' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.0 72.9 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.867 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 3.5 mtmt -65.55 -41.53 92.9 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.792 171.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.72 -31.04 71.44 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.932 168.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.813 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 1.3 mm -61.01 -51.15 76.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.012 0.434 . . . . 0.0 110.495 172.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.8 62.74 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.783 -0.573 . . . . 0.0 112.393 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.71 -45.27 85.96 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.557 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.455 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.552 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.638 ' CE1' ' HG3' ' D' ' 40' ' ' GLU . 3.0 t80 -65.73 -52.49 50.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' E' ' 83' ' ' TYR . 2.0 mt-30 -75.95 -32.84 59.72 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.3 58.97 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.053 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.08 27.05 73.48 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.289 -0.257 . . . . 0.0 112.858 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 5.1 mttm -67.94 146.09 53.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.62 ' HG2' ' HD2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.58 45.88 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' E' ' 15' ' ' PHE . 6.5 tt -114.51 134.93 55.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.344 0.592 . . . . 0.0 109.857 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -84.81 126.24 33.28 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.42 52.19 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.534 1.134 . . . . 0.0 110.04 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.662 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 20.0 m95 -124.47 116.27 22.24 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.228 1.011 . . . . 0.0 108.36 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' E' ' 13' ' ' TYR . 20.0 ttt180 -104.17 102.89 12.61 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' E' ' 145' ' ' THR . 1.5 m -122.72 150.91 26.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.305 1.05 . . . . 0.0 109.389 -173.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.29 19.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.611 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -109.0 -28.12 9.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.635 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 6.6 m -72.49 165.16 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 109.901 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.47 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.957 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 15.6 t30 -68.13 162.14 25.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.808 0.813 . . . . 0.0 109.968 171.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.4 -12.94 22.16 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.8 0.38 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.901 169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.448 ' OD1' HG13 ' E' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.79 35.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' E' ' 104' ' ' TYR . 0.2 OUTLIER -52.13 -47.82 65.17 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.89 -0.506 . . . . 0.0 110.602 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.684 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.45 2.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.28 142.29 32.53 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.602 0.715 . . . . 0.0 109.469 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.509 ' CB ' HG12 ' E' ' 94' ' ' VAL . . . -134.83 144.19 47.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.057 -163.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.09 129.47 54.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' E' ' 138' ' ' LEU . 15.9 t80 -132.75 155.12 49.45 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.399 0.679 . . . . 0.0 110.446 -163.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . 0.957 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -172.28 169.67 42.76 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.977 170.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.617 ' HB2' HD11 ' E' ' 135' ' ' ILE . 5.4 m-85 -92.25 132.12 36.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.919 0.866 . . . . 0.0 111.163 -169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.62 ' HD2' ' HG2' ' E' ' 88' ' ' GLN . 4.9 t80 -136.99 131.5 33.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.461 -1.245 . . . . 0.0 107.966 -174.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.93 119.01 12.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.83 13.01 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' D' ' 40' ' ' GLU . 13.2 t -160.17 147.29 16.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.938 0.79 . . . . 0.0 109.134 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.7 OUTLIER -120.02 141.76 49.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.58 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.9 20.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.481 ' HD2' ' NH2' ' E' ' 116' ' ' ARG . 0.3 OUTLIER -107.45 119.23 38.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 111.22 176.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.3 m -100.95 126.03 47.57 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.661 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.44 17.6 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 167.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.43 -175.59 21.87 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.706 0.615 . . . . 0.0 111.611 175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.575 HG23 HG22 ' D' ' 33' ' ' THR . 3.3 t -79.55 -44.66 23.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 122.472 -0.428 . . . . 0.0 111.134 176.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.65 158.35 16.43 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 169.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.48 144.34 10.87 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -72.24 164.97 25.36 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.607 0.718 . . . . 0.0 110.705 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.453 HG23 ' H ' ' E' ' 69' ' ' GLY . 27.2 m -52.41 145.92 2.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.036 -171.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.801 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 33.0 mp0 -124.38 131.29 53.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.072 -176.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.47 49.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.47 49.62 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' E' ' 116' ' ' ARG . 4.0 pt -118.87 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.7 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.7 OUTLIER -104.36 126.09 51.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.725 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.28 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.106 -172.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 167.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.06 131.64 72.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' E' ' 110' ' ' PHE . 7.1 pt -69.24 -51.67 40.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.324 0.583 . . . . 0.0 110.296 -173.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.405 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -131.29 122.45 3.46 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.736 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.16 22.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.035 0.921 . . . . 0.0 110.657 174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.957 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.37 33.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.17 157.89 35.25 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.41 51.02 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.394 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' E' ' 104' ' ' TYR . 5.1 tp10 -112.09 138.44 48.75 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.625 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.738 -176.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.82 24.87 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.998 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' E' ' 94' ' ' VAL . 1.8 p -111.77 40.05 2.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.747 -0.644 . . . . 0.0 112.36 175.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.26 14.59 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.447 1.899 . . . . 0.0 109.39 -173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -68.92 -9.34 26.05 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.228 1.286 . . . . 0.0 115.327 -159.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.574 171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.584 HG23 HD22 ' E' ' 27' ' ' LEU . 42.3 mt -81.71 -42.6 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.109 0.868 . . . . 0.0 111.307 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 1.5 t -76.31 -40.56 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.67 114.59 24.43 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.426 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.47 33.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.05 44.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.564 ' HD3' ' HA3' ' K' ' 136' ' ' GLY . 11.8 mttt -80.23 -32.92 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.91 75.42 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 119.416 1.007 . . . . 0.0 113.014 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.37 9.13 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.6 114.83 28.83 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.305 1.042 . . . . 0.0 108.595 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -31.68 65.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -158.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.486 ' HA ' ' CZ3' ' K' ' 92' ' ' TRP . 92.3 t80 -141.64 114.63 8.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.693 2.397 . . . . 0.0 109.143 167.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.484 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.65 1.52 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 17.3 tt0 -55.73 -57.07 23.43 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.2 Cg_exo -82.67 134.71 7.58 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.035 1.763 . . . . 0.0 113.896 171.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' E' ' 175' ' ' PRO . . . 66.9 33.99 85.71 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.67 97.21 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.85 1.325 . . . . 0.0 110.935 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.81 ' HB ' ' HA ' ' E' ' 175' ' ' PRO . 6.1 m 48.76 66.01 1.2 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.769 1.627 . . . . 0.0 111.933 176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.478 ' HA ' HG22 ' E' ' 173' ' ' THR . 40.0 p -122.52 146.76 47.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.297 -167.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.31 49.62 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.442 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.13 67.5 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.737 0.268 . . . . 0.0 111.4 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.8 158.41 62.32 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.482 0.713 . . . . 0.0 109.286 -178.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.29 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.303 1.335 . . . . 0.0 112.71 -156.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.54 92.47 1.08 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.159 1.623 . . . . 0.0 117.159 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.478 HG22 ' HA ' ' E' ' 167' ' ' THR . 10.1 t -114.76 158.71 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.975 0.887 . . . . 0.0 109.881 170.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.33 78.67 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.412 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.81 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.5 Cg_exo -68.05 140.71 50.66 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.535 0.87 . . . . 0.0 111.746 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.429 1.492 . . . . 0.0 112.32 -171.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.605 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.136 0 N-CA-C 114.05 0.75 . . . . 0.0 114.05 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.2 pt -58.29 124.76 13.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.47 6.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.913 0.863 . . . . 0.0 110.751 -177.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.476 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -64.65 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.477 175.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.58 -13.82 60.36 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.771 0.786 . . . . 0.0 112.406 172.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 8.0 t70 -68.22 -33.46 74.45 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -172.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' F' ' 93' ' ' ARG . 26.5 m -106.86 122.51 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . 0.676 ' HG2' HD21 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.94 39.51 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.697 0.761 . . . . 0.0 110.532 176.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.523 ' CE2' ' HG3' ' F' ' 93' ' ' ARG . 50.9 m-85 -109.78 100.94 9.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.761 -164.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 5.1 mp -80.82 144.25 32.21 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' F' ' 26' ' ' PRO . 71.7 m-85 -131.47 137.07 48.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.463 0.649 . . . . 0.0 109.996 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 1.2 tm0? -139.39 140.31 37.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 155.0 35.07 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.031 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.664 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.31 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.972 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.2 -6.54 59.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.48 87.54 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.42 -175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.86 45.73 6.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.249 1.419 . . . . 0.0 111.773 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.85 162.66 13.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.03 5.49 72.19 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.691 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.12 20.4 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 117.01 0.405 . . . . 0.0 111.777 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.19 122.75 67.21 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.932 2.093 . . . . 0.0 112.444 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.8 Cg_exo -74.05 128.94 12.7 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.468 0.846 . . . . 0.0 112.485 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.676 HD21 ' HG2' ' F' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.07 56.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.14 27.72 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.781 -2.368 . . . . 0.0 110.518 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -78.34 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 CA-C-O 121.825 0.677 . . . . 0.0 112.421 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.59 ' HB1' ' HB2' ' F' ' 68' ' ' TYR . . . 57.32 45.87 19.41 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.393 1.477 . . . . 0.0 111.546 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.546 ' HB2' HG21 ' K' ' 48' ' ' THR . 2.9 m-85 -68.88 135.49 51.15 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.538 1.161 . . . . 0.0 111.066 173.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' F' ' 33' ' ' THR . 37.3 tt0 -100.2 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.5 HG22 HG23 ' A' ' 122' ' ' VAL . 11.1 p -120.84 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.746 1.26 . . . . 0.0 111.123 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.75 ' OD2' HG22 ' F' ' 65' ' ' VAL . 6.5 t0 -162.25 128.84 3.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.018 -164.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.33 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.068 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.342 170.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.21 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 117' ' ' GLU . 87.9 t -105.38 120.14 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.46 2.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.8 125.8 7.25 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.294 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -105.89 88.5 2.83 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.798 HH11 ' HA ' ' F' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.02 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.687 0.756 . . . . 0.0 110.172 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.05 21.37 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -167.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -76.73 164.29 26.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.493 -179.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . 0.586 ' HA ' HG12 ' F' ' 53' ' ' ILE . 10.1 t80 -108.98 81.77 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.239 171.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.45 6.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' F' ' 51' ' ' GLY . 12.4 pt-20 -67.49 -15.91 63.93 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.34 35.62 17.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.62 1.568 . . . . 0.0 111.634 -172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.591 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 38.69 53.02 1.9 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.498 1.519 . . . . 0.0 111.608 -164.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.81 0.57 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.5 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 58' ' ' SER . 6.9 m-20 -151.3 28.19 0.66 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . 0.602 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 83.79 35.05 17.12 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.09 123.63 46.29 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.586 HG12 ' HA ' ' F' ' 44' ' ' PHE . 0.7 OUTLIER -136.07 133.42 50.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.98 18.86 20.74 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.16 12.65 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-O 121.652 0.585 . . . . 0.0 113.972 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.94 160.2 30.56 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.84 0.669 . . . . 0.0 113.84 -175.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -125.55 -76.54 0.27 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . 0.646 ' HA ' ' OD1' ' E' ' 50' ' ' ASN . 4.1 t -163.44 167.7 21.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.582 0.706 . . . . 0.0 110.49 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.49 49.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.25 3.1 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.49 17.0 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . 0.724 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 64.3 p -136.7 159.24 42.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.943 0.897 . . . . 0.0 110.084 -178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.99 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.213 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.713 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.17 51.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.75 HG22 ' OD2' ' F' ' 34' ' ' ASP . 53.8 t -126.04 124.59 66.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.93 142.21 44.61 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.42 ' OH ' HG21 ' F' ' 79' ' ' ILE . 46.1 p90 -154.44 165.25 37.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.59 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 26.3 m-85 -87.79 140.31 29.64 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.471 ' H ' HG23 ' F' ' 126' ' ' VAL . . . -75.2 138.45 23.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.448 ' HE3' ' HB3' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -118.97 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.29 -38.49 80.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' F' ' 77' ' ' LYS . 88.6 m-20 65.87 133.02 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 110.978 169.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -86.49 -7.56 58.3 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.651 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -76.17 -45.61 14.95 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.811 168.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' F' ' 79' ' ' ILE . 10.5 tt0 -70.55 -35.03 72.89 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.134 -0.627 . . . . 0.0 111.87 171.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.577 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.55 93.28 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.824 171.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.01 71.37 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.949 168.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 1.3 mm -61.0 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.069 0.461 . . . . 0.0 110.501 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.53 -41.71 62.67 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 121.74 -0.6 . . . . 0.0 112.438 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.73 -45.28 86.01 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.557 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -61.91 -46.06 91.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.565 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.548 ' CE2' ' HG3' ' F' ' 84' ' ' GLN . 3.0 t80 -65.79 -52.42 50.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.945 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' F' ' 83' ' ' TYR . 2.0 mt-30 -75.99 -32.81 59.62 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -167.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -86.38 -6.33 58.96 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.013 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.12 27.03 73.48 Favored Glycine 0 N--CA 1.449 -0.486 0 O-C-N 122.348 -0.22 . . . . 0.0 112.846 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 5.0 mttm -67.87 146.08 54.0 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.632 ' HG2' ' HD2' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.49 45.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' F' ' 15' ' ' PHE . 6.5 tt -114.39 134.96 55.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.314 0.578 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.37 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.22 126.38 52.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.551 1.141 . . . . 0.0 109.994 -165.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.666 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 19.9 m95 -124.45 116.31 22.32 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.233 1.013 . . . . 0.0 108.383 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' F' ' 13' ' ' TYR . 20.0 ttt180 -104.16 102.92 12.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.966 HG21 HG21 ' F' ' 145' ' ' THR . 1.5 m -122.77 150.88 26.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 122.248 1.023 . . . . 0.0 109.42 -173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.61 168.26 20.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.99 -28.06 9.32 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.624 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . 0.446 ' O ' ' HD1' ' F' ' 104' ' ' TYR . 6.6 m -72.51 165.18 3.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.926 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.998 -174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 15.5 t30 -68.02 162.15 25.13 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.792 0.806 . . . . 0.0 109.973 171.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.49 -12.79 22.22 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.87 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.777 0.717 . . . . 0.0 110.844 169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' F' ' 142' ' ' GLU . 0.5 OUTLIER -71.71 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 167.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' F' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.85 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 121.869 -0.52 . . . . 0.0 110.575 171.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 35.2 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.29 142.29 32.53 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.626 0.727 . . . . 0.0 109.414 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' F' ' 94' ' ' VAL . . . -134.79 144.19 47.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.048 -163.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.07 129.5 54.81 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.529 ' CE2' HD13 ' F' ' 138' ' ' LEU . 16.0 t80 -132.71 155.11 49.42 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.436 0.694 . . . . 0.0 110.471 -163.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . 0.974 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -172.27 169.66 42.75 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.485 -1.34 . . . . 0.0 111.94 170.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' F' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.07 36.99 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.4 161.28 34.97 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.925 0.869 . . . . 0.0 111.17 -169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.632 ' HD2' ' HG2' ' F' ' 88' ' ' GLN . 4.9 t80 -136.95 131.44 33.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.46 -1.245 . . . . 0.0 107.982 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.86 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.85 -31.77 12.99 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 13.2 t -160.25 147.3 16.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.982 0.81 . . . . 0.0 109.097 174.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.788 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.7 OUTLIER -120.06 141.77 49.46 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -134.4 120.91 20.41 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.489 ' HD2' ' NH2' ' F' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.21 38.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.031 0.444 . . . . 0.0 111.179 176.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.3 m -100.88 126.07 47.47 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.679 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.47 17.64 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -175.52 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . 0.453 HG23 HG22 ' E' ' 33' ' ' THR . 3.3 t -79.67 -44.63 23.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.495 -0.415 . . . . 0.0 111.093 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.47 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 166.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -72.17 165.04 25.18 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 0.0 110.725 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.471 HG23 ' H ' ' F' ' 69' ' ' GLY . 27.2 m -52.48 145.92 2.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.043 -171.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 33.0 mp0 -124.4 131.25 53.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.13 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.82 116.43 49.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.76 124.42 49.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.788 HG22 ' HG2' ' F' ' 116' ' ' ARG . 4.0 pt -118.85 123.08 70.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.713 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.7 OUTLIER -104.38 126.06 51.14 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.713 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.61 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.112 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' F' ' 110' ' ' PHE . 7.1 pt -69.15 -51.67 41.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.357 0.598 . . . . 0.0 110.354 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.4 ' N ' HG13 ' F' ' 135' ' ' ILE . . . -131.3 122.54 3.48 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.688 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.99 122.12 22.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.98 0.895 . . . . 0.0 110.654 174.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.974 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.0 mt -122.5 150.42 42.56 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.37 129.38 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.14 157.9 35.32 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.392 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.47 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.626 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -103.17 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.721 -176.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.98 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.938 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.966 HG21 HG21 ' F' ' 94' ' ' VAL . 1.8 p -111.77 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.381 175.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.72 57.3 14.52 Favored Pre-proline 0 C--N 1.345 0.411 0 C-N-CA 126.496 1.919 . . . . 0.0 109.398 -173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -68.95 -9.32 26.01 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.206 1.271 . . . . 0.0 115.364 -159.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.2 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.612 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.9 -42.23 1.59 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.586 HG23 HD22 ' F' ' 27' ' ' LEU . 42.0 mt -81.7 -42.65 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 119.19 0.905 . . . . 0.0 111.302 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 1.5 t -76.3 -40.55 35.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -176.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.66 114.55 24.38 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' K' ' 49' ' ' LYS . 14.6 p -96.7 114.47 33.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 171.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.64 144.04 44.48 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.541 ' HD3' ' HA3' ' L' ' 136' ' ' GLY . 11.8 mttt -80.16 -32.97 38.77 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.83 75.49 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 119.365 0.984 . . . . 0.0 113.053 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.778 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -72.37 123.3 9.15 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 -177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.573 ' O ' ' CE2' ' L' ' 108' ' ' PHE . 2.2 t80 -100.57 114.85 28.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.354 1.062 . . . . 0.0 108.6 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.922 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.5 OUTLIER -72.73 -31.62 65.09 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 1.003 ' CE1' HD13 ' L' ' 143' ' ' ILE . 92.3 t80 -141.71 114.64 8.6 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.633 2.373 . . . . 0.0 109.11 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.837 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.833 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 17.3 tt0 -55.68 -57.13 22.95 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -166.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.64 134.7 7.6 Favored 'Trans proline' 0 C--O 1.24 0.578 0 CA-C-N 122.114 1.791 . . . . 0.0 113.876 171.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' F' ' 175' ' ' PRO . . . 66.89 34.0 85.76 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.396 2.118 . . . . 0.0 118.396 -171.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.79 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 3.0 tt0 -63.34 -43.68 97.04 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.881 1.341 . . . . 0.0 110.92 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.821 ' HB ' ' HA ' ' F' ' 175' ' ' PRO . 6.2 m 48.74 66.06 1.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.802 1.641 . . . . 0.0 111.918 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.802 ' O ' ' HB ' ' L' ' 18' ' ' ILE . 40.1 p -122.49 146.73 47.12 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.373 -167.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 -173.36 49.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.447 172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.494 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -60.01 -28.11 67.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.791 0.295 . . . . 0.0 111.446 -177.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.37 62.29 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.468 0.707 . . . . 0.0 109.281 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.23 86.75 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.287 1.325 . . . . 0.0 112.776 -156.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.59 92.42 1.09 Allowed Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' F' ' 167' ' ' THR . 10.2 t -114.72 158.65 21.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 118.024 0.912 . . . . 0.0 109.912 170.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.49 159.34 78.53 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.422 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.821 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -68.12 140.74 50.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.488 0.853 . . . . 0.0 111.744 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.474 1.51 . . . . 0.0 112.297 -171.677 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.507 ' HB3' ' HE3' ' H' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 114.067 0.756 . . . . 0.0 114.067 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.6 ' O ' HG22 ' H' ' 126' ' ' VAL . 3.2 pt -58.19 124.7 12.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.58 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -88.04 178.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.95 0.881 . . . . 0.0 110.758 -177.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.63 -32.22 83.49 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.395 -0.82 . . . . 0.0 114.488 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.59 -13.85 60.36 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.762 0.781 . . . . 0.0 112.384 172.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 8.0 t70 -68.27 -33.44 74.37 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.44 HG21 ' NH2' ' G' ' 93' ' ' ARG . 26.7 m -106.84 122.44 60.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . 0.679 ' HG2' HD21 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.99 39.45 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.718 0.77 . . . . 0.0 110.468 176.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.524 ' CE2' ' HG3' ' G' ' 93' ' ' ARG . 51.1 m-85 -109.82 100.97 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.748 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.15 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' G' ' 26' ' ' PRO . 71.6 m-85 -131.47 137.1 48.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.651 . . . . 0.0 109.952 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 1.2 tm0? -139.43 140.31 37.32 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 170.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.92 35.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.038 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -66.24 -46.18 87.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.013 -179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.27 -6.51 59.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.39 87.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.469 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.82 45.74 6.32 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.213 1.405 . . . . 0.0 111.808 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 163' ' ' PRO . . . -94.01 5.51 72.26 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.709 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.7 136.04 20.29 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.955 0.378 . . . . 0.0 111.814 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.402 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -90.21 122.73 67.21 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.968 2.107 . . . . 0.0 112.385 -174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.6 Cg_exo -73.99 128.92 12.74 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.374 0.812 . . . . 0.0 112.483 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.679 HD21 ' HG2' ' G' ' 12' ' ' LYS . 0.8 OUTLIER -112.36 130.04 56.1 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.4 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 19.5 t80 -91.4 143.11 27.71 Favored Pre-proline 0 C--N 1.316 -0.864 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.507 -167.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.5 Cg_endo -78.32 173.94 13.12 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.864 0.693 . . . . 0.0 112.404 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 57.26 45.91 19.54 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.346 1.458 . . . . 0.0 111.549 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . 0.4 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -68.89 135.49 51.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.542 1.163 . . . . 0.0 111.054 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.49 ' HG2' HG23 ' G' ' 33' ' ' THR . 37.4 tt0 -100.28 -109.32 0.2 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . 0.49 HG23 ' HG2' ' G' ' 32' ' ' GLN . 11.1 p -120.81 174.88 6.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.789 1.281 . . . . 0.0 111.081 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' G' ' 65' ' ' VAL . 6.5 t0 -162.31 128.77 3.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.018 -164.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.27 134.44 10.41 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.322 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.23 100.93 9.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.587 HG22 ' HG2' ' H' ' 117' ' ' GLU . 88.4 t -105.29 120.12 55.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -173.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.07 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.78 7.25 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.264 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.86 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.8 ' HA ' HH11 ' G' ' 41' ' ' ARG . 8.9 mmm180 -62.66 -176.0 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.726 0.774 . . . . 0.0 110.149 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.58 143.99 21.34 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.671 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -76.69 164.24 26.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.52 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . 0.595 ' HA ' HG12 ' G' ' 53' ' ' ILE . 10.2 t80 -109.02 81.81 1.5 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.226 171.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.23 96.43 6.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.61 ' HB2' ' H ' ' G' ' 51' ' ' GLY . 12.4 pt-20 -67.54 -15.8 63.85 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.3 35.55 18.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.635 1.574 . . . . 0.0 111.654 -172.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.594 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.539 1.535 . . . . 0.0 111.554 -164.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -117.12 -89.81 0.57 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.504 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' H' ' 58' ' ' SER . 6.9 m-20 -151.31 28.14 0.66 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 83.74 35.04 17.29 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.67 46.38 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' G' ' 44' ' ' PHE . 0.7 OUTLIER -136.12 133.39 50.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.877 178.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.407 ' HB3' HG21 ' H' ' 135' ' ' ILE . 0.4 OUTLIER -107.99 18.88 20.71 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.55 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-O 121.627 0.571 . . . . 0.0 113.917 -170.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.88 160.23 30.73 Favored 'Trans proline' 0 CA--C 1.516 -0.399 0 N-CA-C 113.88 0.685 . . . . 0.0 113.88 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . 0.671 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -125.61 -76.5 0.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . 0.696 ' HA ' ' OD1' ' L' ' 50' ' ' ASN . 4.1 t -163.51 167.64 21.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.49 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.11 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.041 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.26 3.11 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 174.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.8 106.48 16.99 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . 0.713 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 64.0 p -136.68 159.23 42.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.974 0.909 . . . . 0.0 110.058 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.02 155.54 26.56 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.146 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.13 51.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' G' ' 34' ' ' ASP . 54.1 t -126.03 124.62 66.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.88 142.23 44.53 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.427 ' OH ' HG21 ' G' ' 79' ' ' ILE . 46.0 p90 -154.51 165.18 37.24 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.566 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 26.1 m-85 -87.7 140.3 29.66 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' G' ' 126' ' ' VAL . . . -75.17 138.41 23.44 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.944 0.738 . . . . 0.0 114.944 -175.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -118.95 149.64 41.26 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -38.55 80.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.71 2.95 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.186 -1.165 . . . . 0.0 110.186 176.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' G' ' 77' ' ' LYS . 88.6 m-20 65.77 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.128 1.371 . . . . 0.0 111.024 169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -86.55 -7.49 58.33 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 -156.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.659 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -76.18 -45.58 15.01 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.83 168.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' G' ' 79' ' ' ILE . 10.5 tt0 -70.58 -35.08 72.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.169 -0.613 . . . . 0.0 111.774 171.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 3.5 mtmt -65.48 -41.57 93.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.778 171.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.71 -31.04 71.44 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.927 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 1.3 mm -60.98 -51.2 75.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.492 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.48 -41.74 62.75 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.735 -0.603 . . . . 0.0 112.451 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -57.71 -45.27 85.97 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.572 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.462 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -61.91 -46.12 90.76 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.555 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' G' ' 84' ' ' GLN . 3.0 t80 -65.67 -52.51 50.97 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.945 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.549 ' HG3' ' CE2' ' G' ' 83' ' ' TYR . 2.1 mt-30 -75.91 -32.83 59.79 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -167.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.402 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 23.0 m120 -86.36 -6.32 58.97 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.018 172.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.02 27.04 73.54 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 122.324 -0.235 . . . . 0.0 112.916 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 5.1 mttm -67.87 146.09 53.99 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.631 ' HG2' ' HD2' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -73.79 140.51 45.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 168.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' G' ' 15' ' ' PHE . 6.5 tt -114.44 134.95 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.365 0.603 . . . . 0.0 109.876 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.37 33.41 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.26 126.45 52.19 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.483 1.113 . . . . 0.0 109.967 -165.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 20.3 m95 -124.49 116.3 22.28 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.249 1.02 . . . . 0.0 108.325 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' G' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.978 HG21 HG21 ' G' ' 145' ' ' THR . 1.5 m -122.78 150.92 26.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-O 122.273 1.035 . . . . 0.0 109.382 -173.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.62 168.2 20.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.644 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -27.99 9.36 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.648 -176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . 0.453 ' O ' ' HD1' ' G' ' 104' ' ' TYR . 6.6 m -72.5 165.23 3.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 121.711 0.767 . . . . 0.0 109.916 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.52 104.67 16.78 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.941 -174.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 15.5 t30 -68.09 162.13 25.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.844 0.83 . . . . 0.0 110.005 171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.87 22.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.85 -81.77 0.38 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.75 0.705 . . . . 0.0 110.878 169.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' G' ' 143' ' ' ILE . 0.5 OUTLIER -71.69 158.79 35.51 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 167.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' G' ' 104' ' ' TYR . 0.2 OUTLIER -52.15 -47.83 65.22 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.842 -0.536 . . . . 0.0 110.601 171.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.672 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 35.3 m-85 -136.66 -171.44 2.92 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.32 142.32 32.49 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.625 0.726 . . . . 0.0 109.442 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.515 ' CB ' HG12 ' G' ' 94' ' ' VAL . . . -134.83 144.19 47.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.078 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.12 129.51 54.82 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 157.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.534 ' CE2' HD13 ' G' ' 138' ' ' LEU . 15.8 t80 -132.74 155.17 49.35 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.357 0.663 . . . . 0.0 110.442 -163.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . 0.976 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -172.24 169.65 42.74 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.976 170.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.632 ' HB2' HD11 ' G' ' 135' ' ' ILE . 5.4 m-85 -92.28 132.11 36.96 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 167.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.24 35.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.866 0.841 . . . . 0.0 111.201 -169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.631 ' HD2' ' HG2' ' G' ' 88' ' ' GLN . 4.9 t80 -136.96 131.48 33.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.522 -1.217 . . . . 0.0 107.999 -174.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.81 119.04 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.84 -31.83 12.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.26 16.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.943 0.792 . . . . 0.0 109.091 174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.6 OUTLIER -119.97 141.77 49.37 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.588 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -134.41 120.85 20.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.492 ' HB3' HH12 ' L' ' 93' ' ' ARG . 0.3 OUTLIER -107.46 119.21 38.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.035 0.445 . . . . 0.0 111.248 176.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . 0.772 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.3 m -100.91 126.09 47.52 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.675 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.38 112.43 17.56 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 167.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.45 -175.52 21.85 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-O 121.744 0.636 . . . . 0.0 111.537 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . 0.446 HG23 HG22 ' L' ' 33' ' ' THR . 3.3 t -79.68 -44.63 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.469 -0.43 . . . . 0.0 111.089 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.33 16.45 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.49 144.37 10.9 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 166.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.615 0.721 . . . . 0.0 110.734 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.554 HG22 ' O ' ' L' ' 6' ' ' ILE . 27.2 m -52.45 145.87 2.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.035 -171.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.772 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 33.0 mp0 -124.32 131.32 53.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.05 -176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.93 116.44 49.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.83 124.44 49.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' G' ' 116' ' ' ARG . 4.0 pt -118.82 123.1 70.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.714 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.07 51.15 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.363 0.665 . . . . 0.0 109.724 -178.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.65 164.29 29.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.117 -172.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.713 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 0.0 OUTLIER -119.74 162.18 19.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.58 72.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' G' ' 110' ' ' PHE . 7.1 pt -69.18 -51.66 41.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.305 0.574 . . . . 0.0 110.322 -173.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.598 ' HA3' ' HD3' ' A' ' 155' ' ' LYS . . . -131.28 122.52 3.48 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.711 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.02 122.13 22.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.105 0.955 . . . . 0.0 110.647 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.976 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.0 mt -122.51 150.37 42.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.44 33.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . 0.43 ' CB ' ' HB3' ' A' ' 159' ' ' ASP . 13.3 p-10 -157.21 157.89 35.19 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.345 169.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' G' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.44 48.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.625 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -64.02 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.778 -176.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.96 117.84 24.94 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.231 -0.587 . . . . 0.0 110.96 -176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.978 HG21 HG21 ' G' ' 94' ' ' VAL . 1.8 p -111.72 40.08 2.21 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.396 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.76 57.2 14.61 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.482 1.913 . . . . 0.0 109.428 -173.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -68.88 -9.39 26.16 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.255 1.303 . . . . 0.0 115.324 -159.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.11 67.92 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.607 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.84 -42.24 1.6 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.59 HG23 HD22 ' G' ' 27' ' ' LEU . 42.6 mt -81.8 -42.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.138 0.881 . . . . 0.0 111.261 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.672 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 1.5 t -76.27 -40.63 36.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.61 114.51 24.29 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.428 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.71 114.48 33.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 6.9 p -115.68 144.09 44.43 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.95 38.7 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.64 10.88 75.59 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.385 0.993 . . . . 0.0 113.034 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.37 123.36 9.19 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.64 114.87 28.93 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.291 1.037 . . . . 0.0 108.613 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.68 65.2 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -141.62 114.62 8.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.693 2.397 . . . . 0.0 109.153 167.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.471 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.72 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 153.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . 0.687 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 17.4 tt0 -55.7 -57.11 23.17 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -166.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.7 134.69 7.53 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.043 1.765 . . . . 0.0 113.919 171.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' G' ' 175' ' ' PRO . . . 66.96 33.94 85.49 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 2.9 tt0 -63.29 -43.62 97.37 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.935 1.367 . . . . 0.0 110.928 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.823 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 6.1 m 48.62 66.12 1.16 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.802 1.641 . . . . 0.0 111.942 176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.467 ' HA ' HG22 ' G' ' 173' ' ' THR . 40.0 p -122.58 146.75 47.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.287 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.44 -173.32 49.62 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.5 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -28.07 67.51 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.849 0.325 . . . . 0.0 111.422 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.85 158.39 62.2 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.509 0.724 . . . . 0.0 109.211 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -79.25 86.77 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.334 1.356 . . . . 0.0 112.715 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.52 92.4 1.08 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.467 HG22 ' HA ' ' G' ' 167' ' ' THR . 10.1 t -114.78 158.71 21.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.95 0.875 . . . . 0.0 109.908 170.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.53 159.33 78.73 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.392 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.823 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -68.11 140.69 50.32 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.531 0.868 . . . . 0.0 111.714 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.462 1.505 . . . . 0.0 112.306 -171.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' HE3' ' I' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 N-CA-C 114.029 0.742 . . . . 0.0 114.029 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.607 ' O ' HG22 ' I' ' 126' ' ' VAL . 3.2 pt -58.24 124.73 12.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.576 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -88.1 178.47 6.63 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.905 0.86 . . . . 0.0 110.73 -177.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.22 83.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.494 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.57 -13.84 60.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 0.0 112.398 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 8.0 t70 -68.24 -33.43 74.38 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -171.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' H' ' 93' ' ' ARG . 26.7 m -106.88 122.47 60.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . 0.684 ' HG2' HD21 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -122.24 152.91 39.52 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 110.537 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.53 ' CE2' ' HG3' ' H' ' 93' ' ' ARG . 51.1 m-85 -109.78 100.92 9.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.744 -164.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 5.1 mp -80.84 144.29 32.15 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' H' ' 26' ' ' PRO . 71.6 m-85 -131.54 137.14 48.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.501 0.667 . . . . 0.0 109.922 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 1.2 tm0? -139.45 140.26 37.26 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 170.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.537 0.684 . . . . 0.0 111.037 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.18 87.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.044 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.22 -6.55 59.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.42 87.33 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.442 -175.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.85 45.73 6.37 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.211 1.404 . . . . 0.0 111.804 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 162.62 13.33 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' B' ' 163' ' ' PRO . . . -94.04 5.5 72.14 Favored Glycine 0 N--CA 1.45 -0.422 0 O-C-N 123.37 0.419 . . . . 0.0 113.7 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.64 136.02 20.35 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.019 0.41 . . . . 0.0 111.796 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.2 122.82 67.13 Favored Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.954 2.102 . . . . 0.0 112.416 -174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.9 Cg_exo -74.12 128.92 12.63 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.394 0.819 . . . . 0.0 112.499 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.684 HD21 ' HG2' ' H' ' 12' ' ' LYS . 0.8 OUTLIER -112.32 130.06 56.08 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.499 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.41 143.1 27.68 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.57 -167.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.25 173.92 13.17 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.862 0.692 . . . . 0.0 112.419 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 57.29 45.89 19.47 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.376 1.471 . . . . 0.0 111.536 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.51 51.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.488 1.137 . . . . 0.0 111.093 173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.485 ' HG2' HG23 ' H' ' 33' ' ' THR . 37.3 tt0 -100.24 -109.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . 0.485 HG23 ' HG2' ' H' ' 32' ' ' GLN . 11.1 p -120.79 174.88 6.32 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.758 1.266 . . . . 0.0 111.092 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' H' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.05 -164.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.31 134.4 10.37 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.361 170.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.17 100.91 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' I' ' 117' ' ' GLU . 88.4 t -105.35 120.13 55.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -173.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.04 85.48 2.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.88 125.84 7.28 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.799 ' HA ' HH11 ' H' ' 41' ' ' ARG . 8.9 mmm180 -62.75 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.75 0.786 . . . . 0.0 110.113 -173.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.55 144.08 21.44 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -167.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.676 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -76.67 164.29 26.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.487 -179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . 0.604 ' HA ' HG12 ' H' ' 53' ' ' ILE . 10.1 t80 -109.04 81.77 1.49 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.209 171.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.2 96.47 6.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 155.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.605 ' HB2' ' H ' ' H' ' 51' ' ' GLY . 12.4 pt-20 -67.58 -15.78 63.83 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.27 35.53 18.14 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.594 1.558 . . . . 0.0 111.678 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.604 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.09 1.93 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.532 1.533 . . . . 0.0 111.517 -164.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.88 0.57 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.475 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . 0.69 ' OD1' ' HA ' ' I' ' 58' ' ' SER . 6.9 m-20 -151.29 28.28 0.66 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . 0.605 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 83.73 35.04 17.33 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.63 46.31 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.604 HG12 ' HA ' ' H' ' 44' ' ' PHE . 0.7 OUTLIER -136.09 133.37 50.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.86 178.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' I' ' 135' ' ' ILE . 0.4 OUTLIER -107.92 18.85 20.78 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.53 162.17 12.65 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-O 121.628 0.571 . . . . 0.0 113.927 -170.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.91 160.19 30.67 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.835 0.667 . . . . 0.0 113.835 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . 0.676 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -125.56 -76.52 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . 0.59 ' HA ' ' OD1' ' G' ' 50' ' ' ASN . 4.1 t -163.5 167.67 21.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.573 0.701 . . . . 0.0 110.502 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.16 115.44 49.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.27 3.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.78 106.41 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -171.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 63.6 p -136.68 159.29 42.27 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.914 0.886 . . . . 0.0 110.04 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.98 155.51 26.54 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.147 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.698 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -128.76 137.16 51.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' H' ' 34' ' ' ASP . 53.9 t -126.0 124.64 66.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 35.4 p -111.92 142.21 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.432 ' OH ' HG21 ' H' ' 79' ' ' ILE . 45.9 p90 -154.49 165.15 37.33 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 26.2 m-85 -87.74 140.41 29.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 175.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.477 ' H ' HG23 ' H' ' 126' ' ' VAL . . . -75.24 138.42 23.39 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.61 41.33 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.441 0.639 . . . . 0.0 109.29 174.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.6 80.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.74 2.96 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' H' ' 77' ' ' LYS . 88.6 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.162 1.385 . . . . 0.0 111.012 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -86.56 -7.44 58.36 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.645 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -76.13 -45.62 15.09 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.851 168.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.808 ' HA ' ' HB ' ' H' ' 79' ' ' ILE . 10.5 tt0 -70.53 -35.04 72.93 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.12 -0.636 . . . . 0.0 111.82 171.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.56 93.01 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.765 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -30.96 71.29 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.897 168.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.808 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 1.3 mm -61.02 -51.21 75.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.47 -41.74 62.79 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 121.712 -0.618 . . . . 0.0 112.399 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -57.69 -45.36 85.76 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.014 -0.675 . . . . 0.0 111.529 169.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -61.91 -46.07 90.94 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.575 175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' H' ' 84' ' ' GLN . 3.0 t80 -65.77 -52.46 50.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.887 -174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' H' ' 83' ' ' TYR . 2.0 mt-30 -75.88 -32.89 59.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -167.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.4 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 22.9 m120 -86.37 -6.27 58.98 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.029 172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.07 73.49 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.323 -0.236 . . . . 0.0 112.845 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 5.1 mttm -67.84 146.09 54.01 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.626 ' HG2' ' HD2' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -73.81 140.58 45.92 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' H' ' 15' ' ' PHE . 6.5 tt -114.48 134.94 55.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.368 0.604 . . . . 0.0 109.857 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -84.86 126.33 33.38 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.19 126.39 52.1 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.541 1.137 . . . . 0.0 110.044 -166.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.678 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 20.1 m95 -124.43 116.27 22.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.344 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.53 ' HG3' ' CE2' ' H' ' 13' ' ' TYR . 20.0 ttt180 -104.12 102.87 12.6 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 172.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.949 HG21 HG21 ' H' ' 145' ' ' THR . 1.5 m -122.72 150.93 26.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.222 1.011 . . . . 0.0 109.384 -173.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.68 168.25 20.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.625 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.402 ' N ' ' O ' ' H' ' 10' ' ' ASP . 6.8 m -108.94 -28.05 9.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.616 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . 0.454 ' O ' ' HD1' ' H' ' 104' ' ' TYR . 6.6 m -72.53 165.22 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 121.657 0.741 . . . . 0.0 109.904 176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 104.66 16.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 15.5 t30 -68.03 162.17 25.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.806 0.812 . . . . 0.0 109.986 171.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.48 -12.91 22.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.81 0.38 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.757 0.708 . . . . 0.0 110.882 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' H' ' 142' ' ' GLU . 0.5 OUTLIER -71.72 158.82 35.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' H' ' 104' ' ' TYR . 0.2 OUTLIER -52.12 -47.88 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.882 -0.511 . . . . 0.0 110.636 171.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 35.5 m-85 -136.63 -171.38 2.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.31 142.26 32.49 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.625 0.726 . . . . 0.0 109.465 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' H' ' 94' ' ' VAL . . . -134.78 144.2 47.52 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.066 -163.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.81 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' H' ' 138' ' ' LEU . 16.0 t80 -132.77 155.07 49.58 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.37 0.668 . . . . 0.0 110.414 -163.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . 1.0 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -172.22 169.63 42.71 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.964 170.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' H' ' 135' ' ' ILE . 5.4 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.35 161.26 34.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.906 0.86 . . . . 0.0 111.185 -169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.626 ' HD2' ' HG2' ' H' ' 88' ' ' GLN . 4.9 t80 -136.94 131.46 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.493 -1.231 . . . . 0.0 107.984 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.01 12.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.76 -31.85 13.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.22 147.3 16.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 118.903 0.774 . . . . 0.0 109.079 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.771 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.7 OUTLIER -120.05 141.77 49.45 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.587 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -134.37 120.88 20.4 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.512 ' HB3' HH12 ' G' ' 93' ' ' ARG . 0.3 OUTLIER -107.47 119.22 38.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.192 176.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . 0.797 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.708 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.35 112.47 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.5 -175.57 21.81 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -79.62 -44.66 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.67 158.34 16.44 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -72.26 164.96 25.4 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.542 0.687 . . . . 0.0 110.756 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.6 HG22 ' O ' ' G' ' 6' ' ' ILE . 27.2 m -52.42 145.89 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.039 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.797 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 32.9 mp0 -124.4 131.31 53.5 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.088 -176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 19.3 mt -121.83 116.41 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.86 124.46 49.61 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.771 HG22 ' HG2' ' H' ' 116' ' ' ARG . 3.9 pt -118.8 123.11 70.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.698 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.7 OUTLIER -104.4 126.04 51.15 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.355 0.662 . . . . 0.0 109.701 -178.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.3 29.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.122 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.723 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 0.0 OUTLIER -119.72 162.12 19.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 167.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.61 72.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' H' ' 110' ' ' PHE . 7.1 pt -69.17 -51.69 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.34 0.591 . . . . 0.0 110.323 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.606 ' HA3' ' HD3' ' B' ' 155' ' ' LYS . . . -131.28 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.692 177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -74.03 122.17 22.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.023 0.916 . . . . 0.0 110.63 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 1.0 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.0 mt -122.59 150.35 42.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.23 129.43 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.24 157.88 35.12 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.14 153.39 51.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.351 169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.64 ' HB3' ' HB2' ' H' ' 104' ' ' TYR . 5.1 tp10 -112.08 138.38 48.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.611 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.4 OUTLIER -103.12 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.761 -176.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.94 117.86 24.99 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.993 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.949 HG21 HG21 ' H' ' 94' ' ' VAL . 1.8 p -111.74 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.39 175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.77 57.22 14.63 Favored Pre-proline 0 C--O 1.238 0.458 0 C-N-CA 126.42 1.888 . . . . 0.0 109.423 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.32 26.02 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.231 1.287 . . . . 0.0 115.327 -159.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.21 -25.14 67.94 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.615 171.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.86 -42.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.595 HG23 HD22 ' H' ' 27' ' ' LEU . 42.3 mt -81.73 -42.58 19.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 119.098 0.863 . . . . 0.0 111.31 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.67 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 1.5 t -76.29 -40.61 35.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.59 114.54 24.29 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.472 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.48 33.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.59 144.0 44.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -80.09 -32.99 39.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.9 75.46 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.338 0.972 . . . . 0.0 113.039 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.34 123.33 9.2 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.57 114.86 28.87 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.288 1.035 . . . . 0.0 108.611 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -31.61 65.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -158.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.7 114.62 8.59 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.67 2.388 . . . . 0.0 109.13 167.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.483 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.69 1.52 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 154.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . 0.664 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 17.4 tt0 -55.74 -57.13 23.15 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -166.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 134.7 7.53 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.055 1.77 . . . . 0.0 113.878 171.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' H' ' 175' ' ' PRO . . . 66.92 33.94 85.53 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.371 2.109 . . . . 0.0 118.371 -171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.483 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 2.9 tt0 -63.25 -43.66 97.4 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.907 1.353 . . . . 0.0 110.963 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.807 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 6.2 m 48.76 66.05 1.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.829 1.652 . . . . 0.0 111.889 175.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.464 ' HA ' HG22 ' H' ' 173' ' ' THR . 40.1 p -122.54 146.75 47.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.304 -167.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.3 49.61 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.509 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -28.12 67.49 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.783 0.292 . . . . 0.0 111.455 -177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.72 158.36 62.64 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 123.475 0.71 . . . . 0.0 109.327 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 86.73 1.64 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 C-N-CA 121.34 1.36 . . . . 0.0 112.765 -156.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 165.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.464 HG22 ' HA ' ' H' ' 167' ' ' THR . 10.1 t -114.75 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.996 0.898 . . . . 0.0 109.872 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.56 159.37 78.57 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.42 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.807 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.6 Cg_exo -68.15 140.7 50.13 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.515 0.862 . . . . 0.0 111.705 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.436 1.494 . . . . 0.0 112.31 -171.727 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.625 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.141 0 N-CA-C 114.028 0.742 . . . . 0.0 114.028 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.48 ' O ' HG22 ' J' ' 126' ' ' VAL . 3.2 pt -58.27 124.76 13.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.572 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -88.09 178.45 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.909 0.862 . . . . 0.0 110.736 -177.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . 0.446 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -64.68 -32.14 83.24 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.524 175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.78 60.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.792 0.796 . . . . 0.0 112.371 172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.572 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -172.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.441 HG21 ' NH2' ' I' ' 93' ' ' ARG . 27.0 m -106.87 122.5 61.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . 0.657 ' HG2' HD21 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -122.27 152.9 39.58 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.683 0.754 . . . . 0.0 110.505 176.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.531 ' CE2' ' HG3' ' I' ' 93' ' ' ARG . 50.5 m-85 -109.76 100.93 9.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.768 -164.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 5.1 mp -80.86 144.29 32.11 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.63 ' O ' ' HD2' ' I' ' 26' ' ' PRO . 71.4 m-85 -131.57 137.13 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.519 0.676 . . . . 0.0 109.929 176.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 1.2 tm0? -139.42 140.35 37.34 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.11 154.96 35.11 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.997 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -66.34 -46.14 87.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.985 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.28 -6.52 59.25 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.77 -37.52 87.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.415 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.89 45.72 6.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.246 1.419 . . . . 0.0 111.789 -173.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.91 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' C' ' 163' ' ' PRO . . . -93.96 5.47 72.42 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.754 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -148.65 136.08 20.38 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.934 0.367 . . . . 0.0 111.809 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.72 67.18 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.96 2.104 . . . . 0.0 112.407 -174.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.7 Cg_exo -74.09 128.95 12.68 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.448 0.839 . . . . 0.0 112.481 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.657 HD21 ' HG2' ' I' ' 12' ' ' LYS . 0.8 OUTLIER -112.34 130.08 56.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -91.44 143.09 27.64 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.535 -167.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -78.32 173.91 13.15 Favored 'Trans proline' 0 C--N 1.332 -0.322 0 CA-C-O 121.843 0.684 . . . . 0.0 112.417 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 57.31 45.81 19.54 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.319 1.447 . . . . 0.0 111.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -68.92 135.53 51.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.534 1.159 . . . . 0.0 111.044 173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.494 ' HG2' HG23 ' I' ' 33' ' ' THR . 37.4 tt0 -100.26 -109.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.494 HG23 ' HG2' ' I' ' 32' ' ' GLN . 11.1 p -120.82 174.91 6.31 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.736 1.255 . . . . 0.0 111.124 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' I' ' 65' ' ' VAL . 6.4 t0 -162.3 128.81 3.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.004 -164.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.37 134.44 10.37 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.301 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.26 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' J' ' 117' ' ' GLU . 88.2 t -105.36 120.12 55.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.03 85.55 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -166.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.91 125.85 7.28 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' J' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.54 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.793 ' HA ' HH11 ' I' ' 41' ' ' ARG . 8.9 mmm180 -62.69 -176.04 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.672 0.748 . . . . 0.0 110.185 -174.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.02 21.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -167.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.666 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -76.7 164.3 26.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.487 -179.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . 0.579 ' HA ' HG12 ' I' ' 53' ' ' ILE . 10.2 t80 -109.04 81.81 1.5 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.193 171.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.28 96.41 6.45 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.613 ' HB2' ' H ' ' I' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.87 63.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 61.33 35.55 17.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.662 1.585 . . . . 0.0 111.638 -172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.599 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 38.8 53.0 1.96 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.474 1.509 . . . . 0.0 111.566 -164.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.12 -89.85 0.57 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.456 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.656 ' OD1' ' HA ' ' J' ' 58' ' ' SER . 6.9 m-20 -151.29 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . 0.613 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 83.77 35.07 17.13 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.56 46.17 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' I' ' 44' ' ' PHE . 0.7 OUTLIER -136.12 133.36 50.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.861 178.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -107.95 18.92 20.69 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 176.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.5 162.21 12.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.653 0.585 . . . . 0.0 113.951 -170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.96 160.24 30.47 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 N-CA-C 113.864 0.678 . . . . 0.0 113.864 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . 0.666 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -125.59 -76.53 0.26 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . 0.69 ' HA ' ' OD1' ' H' ' 50' ' ' ASN . 4.1 t -163.46 167.72 21.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.582 0.706 . . . . 0.0 110.525 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.2 115.46 49.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.3 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.82 106.44 16.94 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -171.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . 0.745 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 64.1 p -136.65 159.27 42.32 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.004 0.921 . . . . 0.0 110.056 -178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.07 155.49 26.54 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -128.72 137.18 51.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' I' ' 34' ' ' ASP . 53.9 t -126.05 124.58 66.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.87 142.23 44.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.433 ' OH ' HG21 ' I' ' 79' ' ' ILE . 46.1 p90 -154.52 165.19 37.24 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.58 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 26.0 m-85 -87.74 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.476 ' H ' HG23 ' I' ' 126' ' ' VAL . . . -75.22 138.44 23.44 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -118.93 149.65 41.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.43 0.633 . . . . 0.0 109.307 174.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.19 -38.59 80.22 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.26 -124.74 2.95 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' I' ' 77' ' ' LYS . 88.6 m-20 65.76 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.102 1.361 . . . . 0.0 111.042 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -86.59 -7.51 58.29 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.444 2.387 . . . . 0.0 117.444 -156.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.66 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -76.19 -45.57 14.97 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.823 168.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB ' ' I' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.06 73.02 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.152 -0.617 . . . . 0.0 111.882 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.57 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.49 93.07 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.796 171.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.93 71.25 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.002 -0.679 . . . . 0.0 110.914 168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.819 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 1.3 mm -61.05 -51.16 76.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 172.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.82 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.79 -0.569 . . . . 0.0 112.442 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.71 -45.29 85.92 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.572 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -61.93 -46.04 91.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.56 174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' I' ' 84' ' ' GLN . 3.0 t80 -65.82 -52.45 50.52 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.883 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 2.1 mt-30 -75.92 -32.86 59.79 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.408 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 22.9 m120 -86.33 -6.29 58.98 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.009 172.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.99 73.57 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.335 -0.228 . . . . 0.0 112.891 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.464 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 5.1 mttm -67.81 146.11 54.02 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.625 ' HG2' ' HD2' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.55 45.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 168.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' I' ' 15' ' ' PHE . 6.4 tt -114.51 134.96 55.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.366 0.603 . . . . 0.0 109.829 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.38 33.42 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.25 126.48 52.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.532 1.133 . . . . 0.0 109.996 -166.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.671 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 20.3 m95 -124.54 116.35 22.33 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.531 ' HG3' ' CE2' ' I' ' 13' ' ' TYR . 19.9 ttt180 -104.16 102.87 12.59 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 1.011 HG21 HG21 ' I' ' 145' ' ' THR . 1.5 m -122.77 150.89 26.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-O 122.222 1.01 . . . . 0.0 109.383 -173.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.63 168.25 20.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.619 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' I' ' 10' ' ' ASP . 6.7 m -108.95 -28.13 9.3 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.655 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . 0.45 ' O ' ' HD1' ' I' ' 104' ' ' TYR . 6.6 m -72.46 165.19 3.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.683 0.754 . . . . 0.0 109.885 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.49 104.62 16.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.96 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 15.5 t30 -68.06 162.15 25.2 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.819 0.819 . . . . 0.0 109.984 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.44 -12.88 22.18 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.83 -81.82 0.38 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.798 0.726 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' I' ' 142' ' ' GLU . 0.5 OUTLIER -71.77 158.81 35.43 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' I' ' 104' ' ' TYR . 0.2 OUTLIER -52.14 -47.8 65.19 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.891 -0.506 . . . . 0.0 110.621 171.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.673 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 35.2 m-85 -136.67 -171.43 2.91 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.3 142.32 32.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.585 0.707 . . . . 0.0 109.479 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' I' ' 94' ' ' VAL . . . -134.85 144.16 47.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.029 -163.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -107.05 129.53 54.8 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 157.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.527 ' CE2' HD13 ' I' ' 138' ' ' LEU . 15.7 t80 -132.8 155.14 49.48 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.372 0.669 . . . . 0.0 110.397 -163.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . 0.999 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -172.27 169.63 42.72 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.486 -1.34 . . . . 0.0 111.937 170.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.616 ' HB2' HD11 ' I' ' 135' ' ' ILE . 5.4 m-85 -92.22 132.12 36.91 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.39 161.33 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.97 0.89 . . . . 0.0 111.132 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.625 ' HD2' ' HG2' ' I' ' 88' ' ' GLN . 4.9 t80 -137.04 131.44 32.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.977 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.88 119.03 12.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -95.78 -31.84 13.0 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.15 147.26 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.95 0.796 . . . . 0.0 109.097 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.79 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.7 OUTLIER -120.04 141.72 49.49 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 176.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.524 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -134.33 120.91 20.49 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 -177.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.488 ' HD2' ' NH2' ' I' ' 116' ' ' ARG . 0.3 OUTLIER -107.52 119.26 38.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.104 0.478 . . . . 0.0 111.177 176.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.3 m -101.0 126.09 47.65 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.669 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.33 112.46 17.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.53 21.83 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-O 121.73 0.628 . . . . 0.0 111.554 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.62 -44.7 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.483 -0.422 . . . . 0.0 111.092 176.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.33 16.44 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.35 10.94 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -72.28 164.97 25.39 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 110.741 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.607 HG22 ' O ' ' H' ' 6' ' ' ILE . 27.2 m -52.37 145.82 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.039 -171.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.8 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 32.8 mp0 -124.35 131.34 53.51 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.088 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.42 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.82 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.79 HG22 ' HG2' ' I' ' 116' ' ' ARG . 3.9 pt -118.79 123.11 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.686 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.7 OUTLIER -104.45 126.08 51.22 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.683 -178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.63 164.31 29.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.137 -172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.745 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.14 19.51 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 167.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.1 131.59 72.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' I' ' 110' ' ' PHE . 7.1 pt -69.17 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.307 0.575 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.543 ' HA3' ' HD3' ' C' ' 155' ' ' LYS . . . -131.34 122.46 3.46 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.693 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.93 122.12 22.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.09 0.948 . . . . 0.0 110.679 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.999 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.0 mt -122.53 150.39 42.63 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -174.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.3 129.4 33.47 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.21 157.9 35.2 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.12 153.36 51.0 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.398 169.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.634 ' HB3' ' HB2' ' I' ' 104' ' ' TYR . 5.1 tp10 -112.13 138.4 48.85 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -174.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.605 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -103.13 -63.98 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.731 -176.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.82 24.86 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.004 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 1.011 HG21 HG21 ' I' ' 94' ' ' VAL . 1.8 p -111.73 40.07 2.22 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.727 -0.654 . . . . 0.0 112.392 175.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.79 57.24 14.64 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 126.428 1.891 . . . . 0.0 109.384 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.33 26.04 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.226 1.284 . . . . 0.0 115.349 -159.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.22 -25.12 67.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.592 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.93 -42.21 1.59 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.594 HG23 HD22 ' I' ' 27' ' ' LEU . 41.7 mt -81.66 -42.69 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.173 0.897 . . . . 0.0 111.345 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.673 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 1.5 t -76.28 -40.56 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.64 114.58 24.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.469 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.74 114.46 33.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.06 44.45 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.23 -32.89 38.4 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.81 75.54 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 119.398 0.999 . . . . 0.0 113.066 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.32 123.31 9.21 Favored Glycine 0 CA--C 1.52 0.375 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.56 114.87 28.88 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.315 1.046 . . . . 0.0 108.619 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.7 -31.63 65.16 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -158.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.67 114.65 8.62 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.693 2.397 . . . . 0.0 109.142 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.487 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -143.27 46.67 1.52 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . 0.673 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 17.3 tt0 -55.64 -57.17 22.67 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.673 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.69 134.75 7.57 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.094 1.784 . . . . 0.0 113.862 171.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' I' ' 175' ' ' PRO . . . 66.83 34.02 85.93 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 118.386 2.114 . . . . 0.0 118.386 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.75 97.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.857 1.328 . . . . 0.0 110.942 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.826 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 6.2 m 48.75 66.12 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.775 1.63 . . . . 0.0 111.895 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.473 ' HA ' HG22 ' I' ' 173' ' ' THR . 40.0 p -122.58 146.78 47.12 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.252 -167.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.28 49.6 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.503 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.07 -28.1 67.52 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.846 0.323 . . . . 0.0 111.432 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.82 158.33 62.39 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.515 0.726 . . . . 0.0 109.285 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.2 86.76 1.64 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.331 1.354 . . . . 0.0 112.764 -156.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.42 1.08 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.473 HG22 ' HA ' ' I' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.94 0.87 . . . . 0.0 109.871 170.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -67.44 159.36 78.24 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.408 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.826 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.5 Cg_exo -68.14 140.69 50.18 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.497 0.856 . . . . 0.0 111.7 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.463 1.505 . . . . 0.0 112.308 -171.725 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.616 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.185 0 N-CA-C 114.076 0.76 . . . . 0.0 114.076 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.507 ' O ' HG22 ' K' ' 126' ' ' VAL . 3.2 pt -58.25 124.77 13.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.574 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -88.11 178.48 6.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.946 0.879 . . . . 0.0 110.72 -177.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.46 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -64.61 -32.32 83.82 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.386 -0.824 . . . . 0.0 114.472 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.55 -13.79 60.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.764 0.782 . . . . 0.0 112.41 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.574 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 8.0 t70 -68.26 -33.43 74.36 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -172.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' J' ' 93' ' ' ARG . 26.6 m -106.91 122.49 61.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . 0.665 ' HG2' HD21 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -122.26 152.94 39.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.652 0.739 . . . . 0.0 110.537 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' J' ' 93' ' ' ARG . 50.7 m-85 -109.73 100.94 9.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.795 -164.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 5.1 mp -80.9 144.25 32.08 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' J' ' 26' ' ' PRO . 71.4 m-85 -131.48 137.07 48.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 1.2 tm0? -139.4 140.34 37.38 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.16 154.98 35.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.049 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -66.26 -46.22 87.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.991 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.29 -6.5 59.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -37.4 87.23 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.406 -175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.83 45.72 6.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.219 1.408 . . . . 0.0 111.811 -173.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.89 162.67 13.3 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' D' ' 163' ' ' PRO . . . -93.98 5.43 72.33 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.0 113.674 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.67 136.04 20.32 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.043 0.421 . . . . 0.0 111.793 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.21 122.75 67.18 Favored Pre-proline 0 C--O 1.238 0.487 0 C-N-CA 126.916 2.087 . . . . 0.0 112.451 -174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -73.99 128.96 12.78 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.413 0.826 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.665 HD21 ' HG2' ' J' ' 12' ' ' LYS . 0.8 OUTLIER -112.42 130.07 56.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -91.42 143.11 27.68 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.821 -2.352 . . . . 0.0 110.535 -167.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -78.23 173.87 13.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.852 0.688 . . . . 0.0 112.438 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 57.35 45.84 19.37 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.37 1.468 . . . . 0.0 111.547 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.402 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -68.93 135.48 51.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.547 1.165 . . . . 0.0 111.095 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.498 ' HG2' HG23 ' J' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . 0.498 HG23 ' HG2' ' J' ' 32' ' ' GLN . 11.1 p -120.78 174.9 6.31 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.787 1.279 . . . . 0.0 111.099 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.761 ' OD2' HG22 ' J' ' 65' ' ' VAL . 6.5 t0 -162.32 128.8 3.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.068 -1.423 . . . . 0.0 107.992 -164.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.32 134.39 10.36 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.376 170.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 101.0 9.28 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 173.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' K' ' 117' ' ' GLU . 87.8 t -105.41 120.15 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.06 85.43 2.19 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -166.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.8 7.25 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.241 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . 0.408 ' HG3' ' CE1' ' K' ' 83' ' ' TYR . 0.0 OUTLIER -105.91 88.54 2.84 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' J' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.745 0.783 . . . . 0.0 110.127 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.57 144.03 21.38 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.653 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -76.65 164.3 26.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.507 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . 0.598 ' HA ' HG12 ' J' ' 53' ' ' ILE . 10.1 t80 -109.06 81.82 1.5 Allowed 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.228 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.46 6.49 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' J' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.86 63.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.28 35.54 18.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.637 1.575 . . . . 0.0 111.697 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.598 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 38.77 53.04 1.94 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.458 1.503 . . . . 0.0 111.577 -164.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.16 -89.86 0.57 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.484 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . 0.672 ' OD1' ' HA ' ' K' ' 58' ' ' SER . 6.9 m-20 -151.27 28.15 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . 0.62 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 83.77 35.08 17.1 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.14 123.6 46.28 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.598 HG12 ' HA ' ' J' ' 44' ' ' PHE . 0.7 OUTLIER -136.06 133.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.91 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.418 ' HB3' HG21 ' K' ' 135' ' ' ILE . 0.4 OUTLIER -107.96 18.93 20.67 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.14 12.66 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.618 0.566 . . . . 0.0 113.95 -170.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -77.9 160.19 30.69 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.866 0.679 . . . . 0.0 113.866 -175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . 0.653 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -125.57 -76.54 0.26 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . 0.656 ' HA ' ' OD1' ' I' ' 50' ' ' ASN . 4.1 t -163.45 167.71 21.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.559 0.695 . . . . 0.0 110.49 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 15.2 t -112.18 115.46 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.09 88.28 3.11 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.81 106.44 16.94 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . 0.737 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 63.8 p -136.64 159.3 42.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.933 0.893 . . . . 0.0 110.054 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.48 26.53 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.185 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -128.7 137.2 51.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 174.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.761 HG22 ' OD2' ' J' ' 34' ' ' ASP . 54.0 t -126.04 124.62 66.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.89 142.2 44.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.429 ' OH ' HG21 ' J' ' 79' ' ' ILE . 46.0 p90 -154.48 165.18 37.23 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.581 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 26.2 m-85 -87.77 140.35 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.466 ' H ' HG23 ' J' ' 126' ' ' VAL . . . -75.19 138.41 23.42 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.625 ' HE3' ' HB3' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -119.01 149.63 41.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.454 0.645 . . . . 0.0 109.286 174.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.23 -38.54 80.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.21 -124.69 2.95 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' J' ' 77' ' ' LYS . 88.4 m-20 65.73 133.12 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.175 1.39 . . . . 0.0 111.002 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -86.59 -7.5 58.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 117.462 2.393 . . . . 0.0 117.462 -156.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.652 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -76.16 -45.61 15.0 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.854 168.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.828 ' HA ' ' HB ' ' J' ' 79' ' ' ILE . 10.5 tt0 -70.54 -35.02 72.9 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.863 171.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.58 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 3.5 mtmt -65.46 -41.56 93.26 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.817 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.898 168.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.828 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 1.3 mm -61.02 -51.22 75.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.052 0.454 . . . . 0.0 110.465 172.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.44 -41.76 62.85 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.747 -0.596 . . . . 0.0 112.434 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.72 -45.28 85.99 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.547 169.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.46 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -61.93 -46.1 90.81 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.557 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' J' ' 84' ' ' GLN . 3.0 t80 -65.73 -52.47 50.93 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.884 -174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.546 ' HG3' ' CE2' ' J' ' 83' ' ' TYR . 2.1 mt-30 -75.88 -32.93 59.91 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -167.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.409 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 23.0 m120 -86.32 -6.27 58.99 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.047 172.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.09 27.01 73.53 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.373 -0.204 . . . . 0.0 112.858 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 5.1 mttm -67.86 146.07 54.01 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.637 ' HG2' ' HD2' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -73.77 140.47 45.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' J' ' 15' ' ' PHE . 6.5 tt -114.47 134.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.388 0.613 . . . . 0.0 109.818 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -84.84 126.28 33.32 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.16 126.45 52.24 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.511 1.124 . . . . 0.0 109.976 -165.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.658 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 20.2 m95 -124.53 116.31 22.27 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.179 0.992 . . . . 0.0 108.331 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' J' ' 13' ' ' TYR . 20.0 ttt180 -104.13 102.84 12.57 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.998 HG21 HG21 ' J' ' 145' ' ' THR . 1.5 m -122.7 150.91 26.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.247 1.022 . . . . 0.0 109.417 -173.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.6 168.3 19.97 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.613 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.405 ' N ' ' O ' ' J' ' 10' ' ' ASP . 6.8 m -109.0 -28.11 9.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.637 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . 0.447 ' O ' ' HD1' ' J' ' 104' ' ' TYR . 6.5 m -72.51 165.17 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.666 0.746 . . . . 0.0 109.914 176.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 104.69 16.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.97 -174.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 15.5 t30 -68.09 162.16 25.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.812 0.815 . . . . 0.0 109.975 171.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.47 -12.9 22.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -94.81 -81.78 0.38 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.773 0.715 . . . . 0.0 110.902 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.44 ' OD1' HG13 ' J' ' 143' ' ' ILE . 0.5 OUTLIER -71.71 158.82 35.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' J' ' 104' ' ' TYR . 0.2 OUTLIER -52.21 -47.78 65.44 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.853 -0.529 . . . . 0.0 110.579 171.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.679 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 35.2 m-85 -136.68 -171.43 2.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.33 142.25 32.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.617 0.722 . . . . 0.0 109.441 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' J' ' 94' ' ' VAL . . . -134.74 144.16 47.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.079 -163.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 157.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' J' ' 138' ' ' LEU . 15.9 t80 -132.8 155.15 49.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.404 0.681 . . . . 0.0 110.408 -163.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . 0.952 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -172.3 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.499 -1.334 . . . . 0.0 111.971 170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' J' ' 135' ' ' ILE . 5.4 m-85 -92.33 132.12 36.97 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.38 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.888 0.851 . . . . 0.0 111.168 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.637 ' HD2' ' HG2' ' J' ' 88' ' ' GLN . 4.9 t80 -137.02 131.4 32.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.965 -174.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.77 119.0 12.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.8 12.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.2 147.25 16.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.921 0.782 . . . . 0.0 109.097 174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.793 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.6 OUTLIER -120.01 141.74 49.44 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 176.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.667 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.89 20.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.49 ' HD2' ' NH2' ' J' ' 116' ' ' ARG . 0.3 OUTLIER -107.48 119.24 38.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.101 0.477 . . . . 0.0 111.203 176.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.3 m -100.93 126.08 47.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.669 177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.37 112.48 17.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.56 21.83 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-O 121.733 0.629 . . . . 0.0 111.578 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.469 HG23 HG22 ' I' ' 33' ' ' THR . 3.3 t -79.61 -44.7 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.47 -0.429 . . . . 0.0 111.08 176.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.62 158.36 16.43 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.44 144.36 10.84 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 166.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HA ' ' N ' ' I' ' 8' ' ' GLY . . . -72.21 164.96 25.35 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.557 0.694 . . . . 0.0 110.78 -177.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.495 HG13 ' O ' ' I' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.069 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.789 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 32.9 mp0 -124.32 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.135 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.9 116.46 49.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.8 124.48 49.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.793 HG22 ' HG2' ' J' ' 116' ' ' ARG . 4.0 pt -118.86 123.13 70.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.692 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.7 OUTLIER -104.44 126.02 51.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.701 -178.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.27 29.21 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.141 -172.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.737 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 0.0 OUTLIER -119.65 162.13 19.51 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.12 131.64 72.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' J' ' 110' ' ' PHE . 7.2 pt -69.16 -51.68 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.303 0.573 . . . . 0.0 110.367 -173.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' D' ' 155' ' ' LYS . . . -131.3 122.48 3.47 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.696 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.15 22.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.018 0.913 . . . . 0.0 110.658 174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.952 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.0 mt -122.6 150.35 42.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 129.36 33.49 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . 0.514 ' CB ' ' HB3' ' D' ' 159' ' ' ASP . 13.4 p-10 -157.15 157.9 35.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.17 153.41 50.97 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.385 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' J' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.4 48.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.603 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -103.09 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.77 -176.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.95 117.83 24.91 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.956 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.998 HG21 HG21 ' J' ' 94' ' ' VAL . 1.8 p -111.79 40.15 2.21 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.36 175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.71 57.24 14.52 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.438 1.895 . . . . 0.0 109.422 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.9 -9.32 25.99 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.207 1.272 . . . . 0.0 115.375 -159.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.17 -25.15 67.95 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.634 171.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.89 -42.25 1.59 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.603 HG23 HD22 ' J' ' 27' ' ' LEU . 42.1 mt -81.74 -42.65 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.175 0.898 . . . . 0.0 111.26 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.679 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 1.5 t -76.31 -40.58 35.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.47 24.24 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.451 -176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.68 114.42 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 171.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.6 144.03 44.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.16 -32.93 38.77 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.63 10.92 75.55 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.384 0.993 . . . . 0.0 113.064 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.43 123.32 9.1 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.55 114.84 28.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.302 1.041 . . . . 0.0 108.603 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -31.68 65.21 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.62 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.678 2.391 . . . . 0.0 109.17 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.474 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -143.23 46.64 1.52 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 154.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . 0.669 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 17.3 tt0 -55.68 -57.1 23.16 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -166.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.669 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.76 7.58 Favored 'Trans proline' 0 C--O 1.239 0.547 0 CA-C-N 122.041 1.764 . . . . 0.0 113.908 171.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' J' ' 175' ' ' PRO . . . 66.81 34.02 85.97 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.474 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 3.0 tt0 -63.34 -43.61 97.23 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.874 1.337 . . . . 0.0 110.893 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.831 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 6.2 m 48.7 66.07 1.18 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.795 1.638 . . . . 0.0 111.931 176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.485 ' HA ' HG22 ' J' ' 173' ' ' THR . 40.0 p -122.54 146.76 47.12 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.299 -167.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.48 -173.3 49.62 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.474 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.01 -28.17 67.5 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.742 0.271 . . . . 0.0 111.424 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.7 158.41 62.62 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.499 0.72 . . . . 0.0 109.26 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.78 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.259 1.306 . . . . 0.0 112.787 -156.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.49 92.44 1.08 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.485 HG22 ' HA ' ' J' ' 167' ' ' THR . 10.1 t -114.74 158.66 21.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.948 0.874 . . . . 0.0 109.881 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.46 159.34 78.45 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.46 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.831 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.73 50.48 Favored 'Trans proline' 0 C--N 1.348 0.548 0 CA-C-N 119.558 0.878 . . . . 0.0 111.729 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' J' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.465 0.283 0 C-N-CA 125.478 1.511 . . . . 0.0 112.296 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 C--O 1.231 0.141 0 N-CA-C 114.084 0.763 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.445 ' O ' HG22 ' L' ' 126' ' ' VAL . 3.2 pt -58.25 124.76 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.579 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -88.12 178.46 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -177.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.458 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -64.64 -32.18 83.36 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.351 -0.84 . . . . 0.0 114.497 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.63 -13.8 60.35 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.808 0.804 . . . . 0.0 112.385 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.579 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 8.0 t70 -68.2 -33.48 74.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.439 HG21 ' NH2' ' K' ' 93' ' ' ARG . 26.6 m -106.9 122.49 61.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . 0.675 ' HG2' HD21 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -122.28 152.94 39.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.712 0.767 . . . . 0.0 110.48 176.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' K' ' 93' ' ' ARG . 50.3 m-85 -109.76 100.92 9.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.755 -164.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.663 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 5.1 mp -80.81 144.2 32.25 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.626 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 71.5 m-85 -131.46 137.12 48.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.466 0.65 . . . . 0.0 109.982 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 1.2 tm0? -139.46 140.27 37.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.12 154.94 35.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.56 0.695 . . . . 0.0 111.027 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.672 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -66.3 -46.17 87.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.973 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.24 -6.59 59.25 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.46 87.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.385 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 43.92 45.73 6.52 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.198 1.399 . . . . 0.0 111.772 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.62 13.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' E' ' 163' ' ' PRO . . . -93.98 5.47 72.33 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.699 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.65 136.07 20.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.011 0.406 . . . . 0.0 111.769 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.22 122.77 67.14 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.951 2.1 . . . . 0.0 112.394 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . 0.626 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.7 Cg_exo -74.01 128.92 12.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.392 0.819 . . . . 0.0 112.461 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.675 HD21 ' HG2' ' K' ' 12' ' ' LYS . 0.8 OUTLIER -112.35 130.03 56.1 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 168.387 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -91.4 143.05 27.61 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.886 -2.325 . . . . 0.0 110.539 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.22 173.89 13.24 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-O 121.846 0.686 . . . . 0.0 112.467 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 57.32 45.86 19.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.334 1.454 . . . . 0.0 111.554 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.94 135.53 51.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.535 1.159 . . . . 0.0 111.015 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.502 ' HG2' HG23 ' K' ' 33' ' ' THR . 37.4 tt0 -100.27 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . 0.574 HG22 HG23 ' L' ' 122' ' ' VAL . 11.0 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.751 1.262 . . . . 0.0 111.114 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.758 ' OD2' HG22 ' K' ' 65' ' ' VAL . 6.4 t0 -162.26 128.79 3.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.047 -1.433 . . . . 0.0 107.991 -164.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.25 134.38 10.38 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.399 170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.19 100.98 9.25 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.595 HG22 ' HG2' ' L' ' 117' ' ' GLU . 87.5 t -105.38 120.17 55.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -134.03 85.45 2.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 -166.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.84 125.86 7.28 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.252 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . 0.498 ' HG3' ' CE1' ' L' ' 83' ' ' TYR . 0.0 OUTLIER -105.93 88.52 2.83 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.794 HH11 ' HA ' ' K' ' 41' ' ' ARG . 8.9 mmm180 -62.67 -176.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.722 0.772 . . . . 0.0 110.196 -174.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.56 144.04 21.4 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -167.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.651 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -76.71 164.25 26.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.506 -179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . 0.59 ' HA ' HG12 ' K' ' 53' ' ' ILE . 10.1 t80 -108.97 81.79 1.5 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.197 171.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.24 96.41 6.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 155.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.621 ' HB2' ' H ' ' K' ' 51' ' ' GLY . 12.4 pt-20 -67.46 -15.88 63.91 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.35 35.55 17.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.602 1.561 . . . . 0.0 111.625 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.589 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 38.7 53.05 1.91 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.449 1.5 . . . . 0.0 111.612 -164.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . 0.406 ' HD3' HG22 ' F' ' 153' ' ' VAL . 17.3 tptt -117.14 -89.77 0.57 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.508 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.775 ' OD1' ' HA ' ' L' ' 58' ' ' SER . 6.9 m-20 -151.34 28.11 0.66 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . 0.621 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 83.87 34.97 17.08 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.08 123.68 46.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.59 HG12 ' HA ' ' K' ' 44' ' ' PHE . 0.7 OUTLIER -136.14 133.39 50.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.887 178.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -107.97 18.9 20.7 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.22 12.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 121.7 0.611 . . . . 0.0 113.941 -170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -77.95 160.24 30.51 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -125.64 -76.55 0.26 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . 0.672 ' HA ' ' OD1' ' J' ' 50' ' ' ASN . 4.1 t -163.43 167.71 21.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.593 0.711 . . . . 0.0 110.493 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.21 115.47 49.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.08 88.25 3.11 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.74 106.43 16.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -171.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . 0.744 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 64.0 p -136.66 159.27 42.31 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.958 0.903 . . . . 0.0 110.075 -178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.05 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.148 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.707 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -128.74 137.19 51.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.758 HG22 ' OD2' ' K' ' 34' ' ' ASP . 54.0 t -126.06 124.62 66.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 35.5 p -111.9 142.22 44.56 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 174.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.425 ' OH ' HG21 ' K' ' 79' ' ' ILE . 46.3 p90 -154.48 165.16 37.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 25.9 m-85 -87.75 140.32 29.63 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.468 ' H ' HG23 ' K' ' 126' ' ' VAL . . . -75.16 138.44 23.49 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.616 ' HE3' ' HB3' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -118.98 149.66 41.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.419 0.628 . . . . 0.0 109.306 174.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -38.54 80.27 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -172.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.17 -124.71 2.96 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' K' ' 77' ' ' LYS . 88.5 m-20 65.83 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.074 1.35 . . . . 0.0 111.023 169.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -86.53 -7.52 58.31 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.511 2.411 . . . . 0.0 117.511 -156.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.65 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -76.16 -45.61 14.98 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.86 168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.81 ' HA ' ' HB ' ' K' ' 79' ' ' ILE . 10.5 tt0 -70.5 -35.07 73.03 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.867 171.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.588 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 3.5 mtmt -65.49 -41.54 93.15 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.773 171.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.79 -30.98 71.32 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.924 168.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.81 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 1.3 mm -61.07 -51.13 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.034 0.445 . . . . 0.0 110.478 172.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.51 -41.67 62.76 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.748 -0.595 . . . . 0.0 112.444 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -57.75 -45.28 86.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.559 169.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -61.93 -46.1 90.82 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.557 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.544 ' CE2' ' HG3' ' K' ' 84' ' ' GLN . 3.0 t80 -65.74 -52.46 50.98 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.955 -174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' K' ' 83' ' ' TYR . 2.0 mt-30 -75.89 -32.87 59.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 22.9 m120 -86.3 -6.3 58.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.051 172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.04 27.04 73.52 Favored Glycine 0 N--CA 1.449 -0.462 0 O-C-N 122.351 -0.218 . . . . 0.0 112.893 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 5.1 mttm -67.81 146.07 54.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.641 ' HG2' ' HD2' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -73.84 140.53 45.82 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 168.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' K' ' 15' ' ' PHE . 6.5 tt -114.45 135.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.349 0.595 . . . . 0.0 109.829 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.672 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -84.93 126.34 33.42 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.43 52.19 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.492 1.117 . . . . 0.0 110.007 -165.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.663 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 20.0 m95 -124.49 116.3 22.29 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.183 0.993 . . . . 0.0 108.35 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' K' ' 13' ' ' TYR . 20.0 ttt180 -104.15 102.89 12.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.959 HG21 HG21 ' K' ' 145' ' ' THR . 1.5 m -122.72 150.92 26.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.308 1.052 . . . . 0.0 109.368 -173.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.22 20.08 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.66 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.91 -28.1 9.33 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.652 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . 0.455 ' O ' ' HD1' ' K' ' 104' ' ' TYR . 6.5 m -72.53 165.18 3.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.671 0.748 . . . . 0.0 109.914 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.43 104.65 16.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.002 -174.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 15.6 t30 -68.08 162.12 25.34 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.737 0.779 . . . . 0.0 110.015 171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.42 -12.88 22.2 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.86 -81.82 0.38 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.748 0.703 . . . . 0.0 110.857 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' K' ' 142' ' ' GLU . 0.5 OUTLIER -71.69 158.84 35.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' K' ' 104' ' ' TYR . 0.2 OUTLIER -52.16 -47.83 65.27 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.85 -0.531 . . . . 0.0 110.574 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.674 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 35.1 m-85 -136.73 -171.49 2.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.26 142.34 32.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.656 0.741 . . . . 0.0 109.444 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' K' ' 94' ' ' VAL . . . -134.85 144.18 47.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.038 -163.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.53 54.8 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.526 ' CE2' HD13 ' K' ' 138' ' ' LEU . 15.8 t80 -132.78 155.12 49.5 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.362 0.665 . . . . 0.0 110.418 -163.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . 0.972 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -172.26 169.66 42.75 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.965 170.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' K' ' 135' ' ' ILE . 5.4 m-85 -92.3 132.09 36.98 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.36 161.32 34.84 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.941 0.877 . . . . 0.0 111.155 -169.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.641 ' HD2' ' HG2' ' K' ' 88' ' ' GLN . 4.9 t80 -137.04 131.48 32.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.422 -1.263 . . . . 0.0 107.976 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.87 119.03 12.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.83 -31.74 13.01 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 13.1 t -160.26 147.22 15.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.955 0.798 . . . . 0.0 109.085 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.783 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.79 49.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.624 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -134.39 120.9 20.41 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.504 ' HB3' HH12 ' J' ' 93' ' ' ARG . 0.3 OUTLIER -107.51 119.23 38.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.02 0.438 . . . . 0.0 111.183 176.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . 0.807 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.3 m -100.9 126.06 47.49 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.695 177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.39 112.48 17.6 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 167.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.47 -175.55 21.84 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.495 HG23 HG22 ' J' ' 33' ' ' THR . 3.4 t -79.65 -44.64 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.47 -0.43 . . . . 0.0 111.135 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.7 158.32 16.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.54 144.37 10.97 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 166.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -72.25 165.0 25.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.767 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.518 HG13 ' O ' ' J' ' 7' ' ' MET . 27.2 m -52.41 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.021 -171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.807 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 33.0 mp0 -124.36 131.29 53.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.09 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt -121.85 116.43 49.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.79 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 168.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' K' ' 116' ' ' ARG . 3.9 pt -118.86 123.07 70.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.707 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.7 OUTLIER -104.37 126.05 51.12 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.729 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.3 29.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.744 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 0.0 OUTLIER -119.69 162.15 19.5 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . . . . . . . . . 11.8 t -123.12 131.57 72.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' K' ' 110' ' ' PHE . 7.1 pt -69.13 -51.74 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.301 0.572 . . . . 0.0 110.29 -173.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.564 ' HA3' ' HD3' ' E' ' 155' ' ' LYS . . . -131.27 122.52 3.48 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.74 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.95 122.12 22.07 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 122.01 0.91 . . . . 0.0 110.675 174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.972 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.0 mt -122.57 150.34 42.73 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 129.45 33.58 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -157.19 157.93 35.3 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.16 153.35 50.94 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.406 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.608 ' HB3' ' HB2' ' K' ' 104' ' ' TYR . 5.2 tp10 -112.09 138.45 48.73 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.604 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -103.15 -63.95 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.783 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.97 117.83 24.91 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.968 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.959 HG21 HG21 ' K' ' 94' ' ' VAL . 1.8 p -111.81 40.09 2.22 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.375 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 44.75 57.24 14.59 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.405 1.882 . . . . 0.0 109.414 -173.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -68.96 -9.31 25.99 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.201 1.267 . . . . 0.0 115.358 -159.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.24 -25.15 67.93 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.553 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.18 1.6 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.583 HG23 HD22 ' K' ' 27' ' ' LEU . 42.4 mt -81.8 -42.55 19.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.156 0.889 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.674 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 1.5 t -76.3 -40.61 35.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.6 114.6 24.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.451 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.77 114.44 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 6.8 p -115.61 144.07 44.43 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.17 -32.96 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.67 10.86 75.54 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 119.358 0.981 . . . . 0.0 113.051 -176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.32 9.15 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.53 114.78 28.7 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.341 1.056 . . . . 0.0 108.654 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 -31.77 65.38 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.64 8.64 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.665 2.386 . . . . 0.0 109.181 167.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.494 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -143.25 46.62 1.52 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 154.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . 0.657 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 17.4 tt0 -55.64 -57.14 22.77 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -166.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 134.7 7.55 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 122.055 1.77 . . . . 0.0 113.862 171.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' K' ' 175' ' ' PRO . . . 66.93 33.96 85.59 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 2.9 tt0 -63.32 -43.61 97.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.9 1.35 . . . . 0.0 110.916 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.818 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 6.2 m 48.75 66.01 1.2 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.788 1.635 . . . . 0.0 111.91 175.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.49 ' HA ' HG22 ' K' ' 173' ' ' THR . 40.0 p -122.52 146.72 47.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.32 -167.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.38 -173.3 49.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.477 172.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -28.15 67.53 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.701 0.286 . . . . 0.0 111.459 -177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.73 158.4 62.56 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.472 0.709 . . . . 0.0 109.272 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.29 86.8 1.63 Allowed 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.3 1.333 . . . . 0.0 112.726 -156.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.56 92.4 1.08 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.49 HG22 ' HA ' ' K' ' 167' ' ' THR . 10.1 t -114.76 158.68 21.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.001 0.9 . . . . 0.0 109.895 170.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 m -67.46 159.32 78.56 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.437 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.818 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -68.1 140.69 50.33 Favored 'Trans proline' 0 C--N 1.348 0.537 0 CA-C-N 119.525 0.866 . . . . 0.0 111.688 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . 0.402 ' H ' HG21 ' K' ' 166' ' ' THR . . . . . . . . 0 N--CA 1.464 0.256 0 C-N-CA 125.42 1.488 . . . . 0.0 112.285 -171.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.55 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 114.066 0.756 . . . . 0.0 114.066 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.554 ' O ' HG22 ' G' ' 126' ' ' VAL . 3.2 pt -58.23 124.71 12.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.581 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -88.08 178.51 6.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.903 0.858 . . . . 0.0 110.698 -177.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.417 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -64.65 -32.23 83.53 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.348 -0.842 . . . . 0.0 114.52 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.56 -13.83 60.37 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 117.718 0.759 . . . . 0.0 112.403 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 8.0 t70 -68.25 -33.45 74.4 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.442 HG21 ' NH2' ' L' ' 93' ' ' ARG . 26.8 m -106.84 122.47 60.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . 0.672 ' HG2' HD21 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -122.22 152.92 39.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.672 0.749 . . . . 0.0 110.502 176.293 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' L' ' 93' ' ' ARG . 51.0 m-85 -109.76 100.97 9.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.735 -164.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.673 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 5.1 mp -80.86 144.24 32.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.613 ' O ' ' HD2' ' L' ' 26' ' ' PRO . 71.5 m-85 -131.48 137.07 48.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.648 . . . . 0.0 109.93 176.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 1.2 tm0? -139.44 140.32 37.3 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.13 154.96 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.802 ' HB ' ' O ' ' F' ' 167' ' ' THR . 1.0 OUTLIER -66.3 -46.15 87.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.997 -179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -85.25 -6.54 59.26 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.81 -37.45 87.42 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.446 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.635 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 43.85 45.76 6.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.237 1.415 . . . . 0.0 111.789 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.95 162.62 13.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' F' ' 163' ' ' PRO . . . -93.95 5.44 72.44 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.399 0.437 . . . . 0.0 113.701 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -148.66 136.09 20.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.0 0.4 . . . . 0.0 111.796 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.4 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -90.19 122.71 67.25 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 126.94 2.096 . . . . 0.0 112.437 -174.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . 0.613 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.6 Cg_exo -74.02 128.98 12.77 Favored 'Trans proline' 0 C--N 1.349 0.555 0 CA-C-N 119.444 0.837 . . . . 0.0 112.472 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.672 HD21 ' HG2' ' L' ' 12' ' ' LYS . 0.8 OUTLIER -112.37 130.06 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.403 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 19.5 t80 -91.42 143.09 27.66 Favored Pre-proline 0 C--N 1.316 -0.862 0 C-N-CA 115.842 -2.343 . . . . 0.0 110.537 -167.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.1 Cg_endo -78.27 173.9 13.19 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.851 0.688 . . . . 0.0 112.453 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 57.31 45.82 19.52 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.338 1.455 . . . . 0.0 111.575 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.401 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -68.92 135.5 51.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.526 1.155 . . . . 0.0 111.064 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.493 ' HG2' HG23 ' L' ' 33' ' ' THR . 37.3 tt0 -100.19 -109.28 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . 0.493 HG23 ' HG2' ' L' ' 32' ' ' GLN . 11.1 p -120.82 174.86 6.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.792 1.282 . . . . 0.0 111.111 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.756 ' OD2' HG22 ' L' ' 65' ' ' VAL . 6.4 t0 -162.26 128.81 3.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.007 -164.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.3 134.43 10.39 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.371 170.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.25 100.97 9.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' G' ' 117' ' ' GLU . 88.0 t -105.36 120.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -134.05 85.53 2.2 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -166.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.87 125.87 7.29 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.234 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.97 88.55 2.83 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.803 HH11 ' HA ' ' L' ' 41' ' ' ARG . 8.9 mmm180 -62.73 -176.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.722 0.772 . . . . 0.0 110.178 -174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 144.03 21.36 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.66 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -76.69 164.3 26.02 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.527 -179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' L' ' 53' ' ' ILE . 10.1 t80 -108.99 81.73 1.49 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.235 171.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.26 96.43 6.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 155.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.618 ' HB2' ' H ' ' L' ' 51' ' ' GLY . 12.4 pt-20 -67.5 -15.81 63.87 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 61.23 35.6 18.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.643 1.577 . . . . 0.0 111.669 -172.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.596 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 38.74 53.02 1.93 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.452 1.501 . . . . 0.0 111.606 -164.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -117.13 -89.82 0.57 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.488 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . 0.696 ' OD1' ' HA ' ' G' ' 58' ' ' SER . 6.9 m-20 -151.33 28.23 0.65 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . 0.618 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 83.71 35.09 17.25 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.12 123.64 46.33 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' L' ' 44' ' ' PHE . 0.7 OUTLIER -136.17 133.43 50.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.827 178.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' G' ' 135' ' ' ILE . 0.4 OUTLIER -108.01 18.92 20.66 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 176.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.54 162.16 12.65 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.656 0.587 . . . . 0.0 113.956 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.86 160.19 30.82 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.904 0.694 . . . . 0.0 113.904 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . 0.66 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -125.59 -76.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . 0.775 ' HA ' ' OD1' ' K' ' 50' ' ' ASN . 4.1 t -163.46 167.7 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 110.516 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' K' ' 50' ' ' ASN . 15.0 t -112.18 115.45 49.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.12 88.31 3.12 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.86 106.43 16.92 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 63.8 p -136.66 159.29 42.28 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.918 0.887 . . . . 0.0 110.073 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.04 155.5 26.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.158 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -128.68 137.16 51.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 174.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.756 HG22 ' OD2' ' L' ' 34' ' ' ASP . 53.8 t -125.99 124.61 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 35.6 p -111.91 142.2 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' L' ' 79' ' ' ILE . 46.1 p90 -154.45 165.16 37.28 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.594 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 26.1 m-85 -87.73 140.33 29.62 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . 0.474 ' H ' HG23 ' L' ' 126' ' ' VAL . . . -75.17 138.49 23.56 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.965 0.746 . . . . 0.0 114.965 -175.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -118.99 149.64 41.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.28 -38.51 80.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -123.27 -124.72 2.95 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' L' ' 77' ' ' LYS . 88.7 m-20 65.81 133.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.088 1.355 . . . . 0.0 111.051 169.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -86.64 -7.47 58.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.658 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -76.2 -45.58 14.9 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.832 168.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.827 ' HA ' ' HB ' ' L' ' 79' ' ' ILE . 10.5 tt0 -70.52 -35.02 72.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.817 171.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 3.5 mtmt -65.52 -41.52 93.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.798 171.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.01 71.35 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.881 168.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.827 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 1.3 mm -60.96 -51.21 75.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.044 0.45 . . . . 0.0 110.49 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -73.46 -41.75 62.78 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.77 -0.581 . . . . 0.0 112.433 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -57.73 -45.26 86.03 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.587 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -61.9 -46.17 90.56 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.532 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' L' ' 84' ' ' GLN . 3.0 t80 -65.72 -52.45 51.16 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.965 -174.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' L' ' 83' ' ' TYR . 2.0 mt-30 -75.85 -32.9 59.96 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.406 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 22.9 m120 -86.34 -6.24 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.085 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.98 73.58 Favored Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.301 -0.25 . . . . 0.0 112.884 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 5.0 mttm -67.83 146.09 54.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.64 ' HG2' ' HD2' ' L' ' 112' ' ' TYR . 0.0 OUTLIER -73.83 140.51 45.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' L' ' 15' ' ' PHE . 6.5 tt -114.46 134.98 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-O 121.38 0.609 . . . . 0.0 109.892 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -84.87 126.28 33.34 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.17 126.5 52.34 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.486 1.114 . . . . 0.0 109.985 -165.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.837 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 20.0 m95 -124.55 116.28 22.21 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.205 1.002 . . . . 0.0 108.356 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.521 ' HG3' ' CE2' ' L' ' 13' ' ' TYR . 19.9 ttt180 -104.13 102.95 12.68 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 172.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.972 HG21 HG21 ' L' ' 145' ' ' THR . 1.5 m -122.79 150.94 26.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.291 1.043 . . . . 0.0 109.355 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.64 168.24 20.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.605 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 6.8 m -108.97 -28.13 9.29 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.63 -176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' L' ' 104' ' ' TYR . 6.5 m -72.47 165.17 3.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.669 0.747 . . . . 0.0 109.891 176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 104.71 16.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.962 -174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 15.6 t30 -68.09 162.14 25.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.842 0.829 . . . . 0.0 109.944 171.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -97.46 -12.92 22.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -94.83 -81.87 0.38 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.763 0.71 . . . . 0.0 110.847 169.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -71.7 158.88 35.36 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' L' ' 104' ' ' TYR . 0.2 OUTLIER -52.22 -47.78 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.582 171.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.682 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 35.1 m-85 -136.72 -171.46 2.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -142.27 142.27 32.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.64 0.734 . . . . 0.0 109.406 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' L' ' 94' ' ' VAL . . . -134.79 144.18 47.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.04 -163.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -107.08 129.51 54.81 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 157.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.573 ' CE2' ' O ' ' F' ' 158' ' ' TYR . 15.8 t80 -132.79 155.17 49.41 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.351 0.66 . . . . 0.0 110.383 -163.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . 0.993 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -172.26 169.64 42.73 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.983 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' L' ' 135' ' ' ILE . 5.5 m-85 -92.27 132.09 36.96 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.37 161.32 34.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.894 0.854 . . . . 0.0 111.208 -169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.64 ' HD2' ' HG2' ' L' ' 88' ' ' GLN . 4.9 t80 -136.97 131.42 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.502 -1.226 . . . . 0.0 107.991 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.84 119.06 12.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -95.83 -31.8 12.99 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' K' ' 40' ' ' GLU . 13.2 t -160.2 147.24 16.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.922 0.783 . . . . 0.0 109.106 174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.774 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.7 OUTLIER -120.0 141.74 49.43 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.595 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -134.36 120.93 20.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.486 ' HD2' ' NH2' ' L' ' 116' ' ' ARG . 0.3 OUTLIER -107.5 119.22 38.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.186 176.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . 0.795 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.3 m -100.89 126.05 47.48 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.725 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -123.32 112.42 17.58 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 167.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.39 -175.54 21.89 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.689 0.605 . . . . 0.0 111.614 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.574 HG23 HG22 ' K' ' 33' ' ' THR . 3.4 t -79.68 -44.61 23.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 122.474 -0.427 . . . . 0.0 111.093 176.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.68 158.34 16.44 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.5 144.36 10.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 166.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -72.21 165.01 25.27 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.593 0.711 . . . . 0.0 110.765 -177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.474 HG23 ' H ' ' L' ' 69' ' ' GLY . 27.2 m -52.42 145.86 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.997 -171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.795 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 33.0 mp0 -124.35 131.31 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.131 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 mt -121.89 116.45 49.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.78 124.45 49.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.774 HG22 ' HG2' ' L' ' 116' ' ' ARG . 3.9 pt -118.85 123.15 71.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.696 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.7 OUTLIER -104.48 126.08 51.25 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.704 -178.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.62 164.23 29.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.091 -172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.74 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 0.0 OUTLIER -119.67 162.17 19.45 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 167.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . . . . . . . . . 11.9 t -123.11 131.63 72.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' L' ' 110' ' ' PHE . 7.1 pt -69.18 -51.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.322 0.582 . . . . 0.0 110.33 -173.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.541 ' HA3' ' HD3' ' F' ' 155' ' ' LYS . . . -131.3 122.51 3.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.707 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -73.97 122.13 22.11 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.049 0.928 . . . . 0.0 110.682 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.993 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.0 mt -122.58 150.37 42.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.29 129.4 33.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.922 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.3 p-10 -157.17 157.86 35.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . . . . . . . . . . . -71.13 153.37 51.0 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.42 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.794 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 5.2 tp10 -112.12 138.43 48.8 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 1.003 HD13 ' CE1' ' F' ' 160' ' ' PHE . 0.4 OUTLIER -103.14 -63.99 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.768 -176.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.99 117.86 24.94 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.981 -176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.972 HG21 HG21 ' L' ' 94' ' ' VAL . 1.8 p -111.77 40.08 2.22 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.354 175.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 44.85 57.17 14.75 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.423 1.889 . . . . 0.0 109.38 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -68.89 -9.38 26.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.249 1.3 . . . . 0.0 115.309 -159.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.18 -25.16 67.95 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.599 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -127.88 -42.22 1.59 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.587 HG23 HD22 ' L' ' 27' ' ' LEU . 41.9 mt -81.7 -42.68 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.183 0.901 . . . . 0.0 111.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 1.5 t -76.26 -40.59 36.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -87.65 114.6 24.42 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.445 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.75 114.5 33.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 171.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 6.7 p -115.63 143.99 44.55 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -80.18 -32.94 38.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.69 10.89 75.4 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.399 0.999 . . . . 0.0 113.013 -176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.39 123.35 9.16 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.58 114.8 28.77 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.335 1.054 . . . . 0.0 108.629 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.72 65.28 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -141.61 114.66 8.66 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.623 2.369 . . . . 0.0 109.12 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -143.21 46.63 1.52 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 153.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . 0.682 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 17.3 tt0 -55.67 -57.08 23.22 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -166.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.682 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.3 Cg_exo -82.75 134.77 7.51 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.022 1.758 . . . . 0.0 113.826 171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' L' ' 175' ' ' PRO . . . 66.92 33.93 85.51 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.379 2.112 . . . . 0.0 118.379 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 2.9 tt0 -63.26 -43.67 97.32 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.928 1.364 . . . . 0.0 110.917 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.801 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 6.2 m 48.67 66.14 1.16 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.831 1.652 . . . . 0.0 111.905 176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.481 ' HA ' HG22 ' L' ' 173' ' ' THR . 39.9 p -122.6 146.8 47.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.284 -167.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.45 -173.29 49.6 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.462 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.09 -28.09 67.54 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.795 0.297 . . . . 0.0 111.416 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -83.83 158.39 62.25 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.443 0.697 . . . . 0.0 109.286 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.25 86.82 1.62 Allowed 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 121.321 1.347 . . . . 0.0 112.714 -156.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 88.45 92.44 1.07 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.481 HG22 ' HA ' ' L' ' 167' ' ' THR . 10.1 t -114.76 158.67 21.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.957 0.879 . . . . 0.0 109.873 170.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 m -67.51 159.31 78.75 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.404 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.801 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -68.04 140.7 50.67 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.471 0.847 . . . . 0.0 111.732 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.424 1.49 . . . . 0.0 112.264 -171.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.644 ' HA ' ' HE ' ' B' ' 71' ' ' ARG . 49.3 Cg_endo . . . . . 0 N--CA 1.465 -0.162 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 10' ' ' ASP . 4.4 mt -87.26 130.63 36.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.54 166.06 16.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.923 0.868 . . . . 0.0 110.739 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.72 93.11 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.517 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.601 HE22 ' HA ' ' B' ' 122' ' ' VAL . 1.6 mm-40 -72.85 -25.98 61.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.784 0.792 . . . . 0.0 112.389 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.64 89.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -172.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.402 HG21 HG11 ' B' ' 126' ' ' VAL . 23.4 t -86.61 118.77 33.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.41 155.41 42.21 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.721 0.772 . . . . 0.0 110.469 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.436 ' CE1' ' OD1' ' A' ' 34' ' ' ASP . 14.3 m-85 -120.64 121.44 38.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.845 -1.071 . . . . 0.0 108.762 -164.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -120.62 151.59 39.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.512 0.672 . . . . 0.0 109.967 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 5.1 tt0 -121.87 129.36 52.52 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.44 141.23 45.03 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.552 0.692 . . . . 0.0 111.036 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.681 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.8 OUTLIER -66.67 -36.63 77.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.001 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.29 -13.17 58.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -47.97 69.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.447 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.56 18.52 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.213 1.405 . . . . 0.0 111.793 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.17 16.46 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.55 2.75 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.305 -0.407 . . . . 0.0 113.707 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.18 149.75 2.35 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 117.004 0.402 . . . . 0.0 111.837 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.78 110.25 49.54 Favored Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.955 2.102 . . . . 0.0 112.396 -174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.4 145.06 33.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.431 0.833 . . . . 0.0 112.496 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.82 40.07 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 168.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 31.4 t80 -104.27 144.09 27.99 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.836 -2.346 . . . . 0.0 110.535 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 49.8 Cg_endo -78.02 174.52 12.38 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.885 0.702 . . . . 0.0 112.41 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.375 1.47 . . . . 0.0 111.549 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.76 139.45 40.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.556 1.169 . . . . 0.0 111.055 173.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' A' ' 67' ' ' TYR . 2.7 tm0? -98.62 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.63 3.24 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 122.804 1.288 . . . . 0.0 111.082 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.436 ' OD1' ' CE1' ' A' ' 13' ' ' TYR . 0.9 OUTLIER -134.9 115.1 13.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.973 -164.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 121.97 5.4 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.366 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.95 125.37 53.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG13 ' HG2' ' B' ' 117' ' ' GLU . 1.3 t -123.5 133.36 69.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.04 105.07 5.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -166.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.3 7.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.263 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' B' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.06 11.47 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -68.2 147.04 52.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.734 0.778 . . . . 0.0 110.142 -174.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' B' ' 112' ' ' TYR . 21.1 mt-10 -128.63 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.963 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -66.04 134.76 53.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.49 -179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.51 34.74 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.238 171.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.5 113.93 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' HG2' ' H ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 176.091 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.0 23.08 1.34 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.648 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.02 61.71 1.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.513 1.525 . . . . 0.0 111.595 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.52 0.29 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.433 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.01 9.87 36.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.27 83.28 1.28 Allowed Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' H ' ' HG2' ' A' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.908 HG13 HG22 ' B' ' 135' ' ' ILE . 0.6 OUTLIER -116.77 6.82 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.906 178.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.887 ' HG ' HG12 ' B' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.18 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.963 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -93.53 160.83 24.72 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.673 0.596 . . . . 0.0 113.94 -170.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.08 151.4 34.77 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.851 0.674 . . . . 0.0 113.851 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 41' ' ' ARG . . . -148.96 176.68 27.63 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.48 170.13 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.552 0.692 . . . . 0.0 110.488 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.73 129.91 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.07 48.7 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.83 14.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.1 p -140.88 144.22 35.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.904 0.882 . . . . 0.0 110.032 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -133.89 149.32 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.18 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.07 142.83 49.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.55 118.24 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.61 146.96 28.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 174.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 32' ' ' GLN . 37.8 p90 -164.23 170.49 16.2 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -98.73 123.76 43.15 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 29' ' ' PRO . 7.5 mttm -93.51 159.56 15.18 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HE ' ' HA ' ' F' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.83 78.7 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -172.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.56 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.78 43.39 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.132 1.373 . . . . 0.0 111.003 169.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 78' ' ' ALA . . . -74.21 -38.19 63.65 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.86 95.69 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.264 -0.97 . . . . 0.0 112.826 168.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.66 95.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.854 171.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.91 -29.29 69.13 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.793 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . -64.37 -41.07 96.91 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.906 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.4 mm -63.07 -44.28 99.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.051 0.453 . . . . 0.0 110.458 172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.05 85.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.728 -0.608 . . . . 0.0 112.428 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 55.2 m-20 -62.76 -39.49 94.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.582 169.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.992 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -51.5 -57.62 8.55 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.554 174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 36.2 t80 -79.37 -53.86 6.5 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.98 -174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 2.9 mt-30 -75.04 -34.82 61.91 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 29.2 t30 -84.14 -27.76 27.9 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.889 -0.725 . . . . 0.0 111.056 172.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.19 1.16 Allowed Glycine 0 N--CA 1.448 -0.508 0 O-C-N 122.316 -0.24 . . . . 0.0 112.896 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.992 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -139.3 152.56 47.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.621 ' HB3' ' CD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.44 28.91 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.89 143.01 29.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.329 0.585 . . . . 0.0 109.889 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.12 39.87 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.22 42.28 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 109.957 -165.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.584 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 14.9 m95 -127.36 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' HG3' ' A' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.07 30.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' ALA . 1.1 m -134.04 157.46 41.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 122.229 1.014 . . . . 0.0 109.423 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 138.05 31.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.618 179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 10' ' ' ASP . 66.9 p -72.1 -21.91 61.42 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.646 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.59 137.25 23.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 121.722 0.772 . . . . 0.0 109.88 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 129.87 41.3 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.968 -174.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 0.7 OUTLIER -76.48 141.15 41.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.791 0.805 . . . . 0.0 109.982 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.21 -23.21 35.53 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.87 34.6 5.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.77 0.714 . . . . 0.0 110.882 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.35 176.55 6.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.815 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.881 -0.512 . . . . 0.0 110.568 171.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' A' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.75 6.11 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 4.0 p-10 -119.07 134.42 55.21 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.584 0.707 . . . . 0.0 109.419 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -136.63 162.53 32.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.073 -163.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' A' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.27 48.1 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.19 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.394 0.678 . . . . 0.0 110.406 -163.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.29 169.11 41.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.976 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.665 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.84 44.7 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' A' ' 134' ' ' VAL . . . -130.49 160.91 32.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.948 0.88 . . . . 0.0 111.173 -169.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 88' ' ' GLN . 1.7 t80 -125.17 165.22 18.64 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.981 -174.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.2 OUTLIER -95.81 92.72 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 132' ' ' LEU . 4.0 tt0 -70.9 -42.91 69.35 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.4 157.72 20.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.926 0.785 . . . . 0.0 109.074 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.98 40.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' HG13 ' F' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.6 32.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.17 52.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.077 0.465 . . . . 0.0 111.191 176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.52 49.01 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.26 15.99 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-O 121.712 0.618 . . . . 0.0 111.577 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.62 ' HA ' HE22 ' F' ' 9' ' ' GLN . 21.2 m -69.71 -29.9 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.485 -0.421 . . . . 0.0 111.077 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.04 155.24 17.54 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.73 -142.51 26.79 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 166.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -143.5 162.59 35.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.587 0.708 . . . . 0.0 110.737 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' F' ' 6' ' ' ILE . 27.1 m -53.57 138.54 12.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.997 -171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.03 49.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.093 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.46 123.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.19 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' A' ' 116' ' ' ARG . 2.8 pt -114.55 121.17 66.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 3.1 m -107.14 143.19 35.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.348 0.659 . . . . 0.0 109.713 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' A' ' 91' ' ' PHE . 2.6 pp -140.26 141.61 35.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.106 -172.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 110' ' ' PHE . 61.5 t -142.37 155.91 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.742 HG12 ' HG ' ' F' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.358 0.599 . . . . 0.0 110.361 -173.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.79 89.81 1.03 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.724 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HG3' HG11 ' A' ' 134' ' ' VAL . 23.6 mt-10 -80.31 133.1 35.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.063 0.935 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HA ' HE22 ' B' ' 84' ' ' GLN . 0.0 OUTLIER -116.52 150.63 37.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.18 30.53 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.67 -163.7 1.31 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -104.34 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.423 169.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.87 34.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -174.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.815 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -97.99 -42.23 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.809 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.46 109.09 17.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.957 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.92 -46.18 89.01 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.732 -0.651 . . . . 0.0 112.388 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.65 61.29 13.52 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.486 1.914 . . . . 0.0 109.4 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.713 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.34 8.86 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.235 1.29 . . . . 0.0 115.342 -159.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.29 86.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.563 171.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.92 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.172 0.896 . . . . 0.0 111.251 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.713 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 41.7 t -70.62 -43.71 77.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' PRO . 2.5 t-20 -110.71 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.447 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.3 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.73 163.8 12.01 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.39 54.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.03 2.2 64.61 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.37 0.986 . . . . 0.0 113.026 -176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.78 137.23 24.03 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.24 146.21 51.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.3 1.04 . . . . 0.0 108.576 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.57 -49.64 74.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.587 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.5 p90 -143.85 155.23 44.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.674 2.389 . . . . 0.0 109.151 167.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.98 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.631 ' HB2' ' CH2' ' G' ' 92' ' ' TRP . 4.4 tt0 -115.8 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.72 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.043 1.765 . . . . 0.0 113.916 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.04 90.62 0.34 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 -171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.72 HE22 ' HD2' ' A' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.23 0.62 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.884 1.342 . . . . 0.0 110.902 175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.97 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.773 1.629 . . . . 0.0 111.899 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.788 ' HB ' HG22 ' G' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.66 11.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.286 -167.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.443 ' O ' HG21 ' G' ' 18' ' ' ILE . . . -134.98 -158.29 8.3 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.49 172.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -27.03 64.0 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.812 0.306 . . . . 0.0 111.467 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 171' ' ' PRO . . . -72.25 162.28 74.55 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.477 0.711 . . . . 0.0 109.264 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 170' ' ' ALA . 85.6 Cg_endo -81.01 -9.07 13.05 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.237 1.291 . . . . 0.0 112.75 -156.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.85 97.71 0.16 Allowed Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 117.17 1.628 . . . . 0.0 117.17 165.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.633 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.27 18.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.959 0.88 . . . . 0.0 109.877 170.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 24.6 m -129.33 168.24 17.01 Favored Pre-proline 0 C--O 1.24 0.602 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.458 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.521 0.865 . . . . 0.0 111.708 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.39 1.476 . . . . 0.0 112.338 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.649 ' HA ' ' HE ' ' C' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.174 1 N-CA-C 100.755 -4.363 . . . . 0.0 100.755 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.502 HG22 ' HB3' ' B' ' 10' ' ' ASP . 4.3 mt -87.21 130.62 36.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.05 16.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.894 0.854 . . . . 0.0 110.709 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.03 -37.71 93.16 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.482 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.614 ' HG3' ' HB ' ' G' ' 48' ' ' THR . 1.6 mm-40 -72.92 -25.88 61.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 117.78 0.79 . . . . 0.0 112.394 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.61 ' O ' HG23 ' B' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.54 90.13 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -172.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.68 118.74 33.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.4 155.38 42.23 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.655 0.74 . . . . 0.0 110.502 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' B' ' 34' ' ' ASP . 14.3 m-85 -120.61 121.45 38.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.758 -164.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.586 ' HG ' ' HB2' ' B' ' 92' ' ' TRP . 0.3 OUTLIER -120.63 151.56 39.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.78 145.45 50.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.4 52.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.48 141.21 44.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.988 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.675 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.67 77.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.963 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.26 -13.14 58.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.17 -48.03 69.2 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.427 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.8 43.51 18.3 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.21 1.404 . . . . 0.0 111.77 -173.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.15 16.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.339 -0.392 . . . . 0.0 113.664 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.8 2.34 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 117.011 0.406 . . . . 0.0 111.791 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.26 49.33 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.956 2.102 . . . . 0.0 112.372 -174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.42 145.06 33.37 Favored 'Trans proline' 0 C--N 1.349 0.592 0 CA-C-N 119.43 0.832 . . . . 0.0 112.457 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 168.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.544 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 31.3 t80 -104.27 144.13 28.06 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.514 -167.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.544 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.1 Cg_endo -78.04 174.5 12.41 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 CA-C-O 121.837 0.682 . . . . 0.0 112.428 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.42 66.72 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.379 1.471 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.49 40.45 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.583 1.182 . . . . 0.0 111.084 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.501 ' HB2' ' HA ' ' B' ' 67' ' ' TYR . 2.7 tm0? -98.6 -66.1 0.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.79 155.61 3.24 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.811 1.291 . . . . 0.0 111.06 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' B' ' 13' ' ' TYR . 0.8 OUTLIER -134.93 115.08 13.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.943 -164.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.368 170.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.95 125.39 54.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.707 HG13 ' HG2' ' C' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.15 5.43 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.268 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' CE1' ' C' ' 83' ' ' TYR . 5.7 tt0 -101.81 101.1 11.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -68.18 147.0 52.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.767 0.794 . . . . 0.0 110.127 -174.045 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.55 ' OE1' ' HB3' ' C' ' 112' ' ' TYR . 21.0 mt-10 -128.55 173.89 9.86 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.961 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -66.03 134.77 53.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.494 -179.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.53 130.49 34.74 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.231 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.46 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.622 ' HG2' ' H ' ' B' ' 52' ' ' ARG . 0.3 OUTLIER -72.02 -39.47 69.14 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.98 23.1 1.35 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.599 1.56 . . . . 0.0 111.684 -172.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.67 1.67 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.477 1.511 . . . . 0.0 111.59 -164.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.496 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.06 9.88 36.26 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.31 83.31 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.622 ' H ' ' HG2' ' B' ' 46' ' ' GLU . 5.8 mmp_? -108.65 18.43 20.86 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 1.018 HG13 HG22 ' C' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.82 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.892 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.975 ' HG ' HG12 ' C' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 176.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.961 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -93.53 160.84 24.72 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 121.677 0.598 . . . . 0.0 113.942 -170.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.05 151.36 34.87 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' B' ' 41' ' ' ARG . . . -148.95 176.65 27.64 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.11 14.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.545 0.688 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.73 127.1 48.65 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.81 14.13 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -171.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.9 144.23 35.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.942 0.897 . . . . 0.0 110.039 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.523 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -133.95 149.21 19.69 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.145 176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.03 142.84 49.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.22 34.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.67 146.88 29.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.501 ' HA ' ' HB2' ' B' ' 32' ' ' GLN . 38.1 p90 -164.14 170.47 16.36 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.67 123.76 43.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.15 129.72 26.49 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' B' ' 29' ' ' PRO . 7.5 mttm -93.51 159.52 15.2 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.644 ' HE ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.8 78.56 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.1 0.17 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.72 158.83 43.33 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.153 1.381 . . . . 0.0 111.054 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -74.23 -38.19 63.59 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.9 95.61 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.877 168.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.22 -44.66 94.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.895 171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.37 69.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.759 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.48 -40.98 96.7 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.884 168.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' B' ' 79' ' ' ILE . 1.4 mm -63.06 -44.21 99.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.078 0.466 . . . . 0.0 110.47 172.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.537 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 10.6 mm-40 -62.64 -47.04 85.46 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.743 -0.598 . . . . 0.0 112.434 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 85' ' ' ASN . 55.0 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.578 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 1.012 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -51.5 -57.56 8.71 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.574 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 40' ' ' GLU . 36.3 t80 -79.44 -53.92 6.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.908 -174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 2.9 mt-30 -74.98 -34.87 62.05 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -167.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' B' ' 81' ' ' ASP . 29.1 t30 -84.18 -27.7 27.87 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.062 172.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.519 0 O-C-N 122.253 -0.28 . . . . 0.0 112.86 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 1.012 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.54 47.26 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.612 ' HB3' ' CD1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -84.25 144.42 28.93 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 168.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.82 143.09 29.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.312 0.577 . . . . 0.0 109.868 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.689 ' HB2' ' O ' ' B' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.76 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.731 ' HE1' HD21 ' B' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.23 42.29 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.521 1.128 . . . . 0.0 110.03 -166.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.586 ' HB2' ' HG ' ' B' ' 14' ' ' LEU . 14.9 m95 -127.39 129.89 48.38 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.219 1.007 . . . . 0.0 108.364 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 93' ' ' ARG . 13.4 ptm180 -125.28 120.11 30.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 106' ' ' ALA . 1.1 m -134.13 157.43 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 122.257 1.027 . . . . 0.0 109.405 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.635 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.633 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.61 HG23 ' O ' ' B' ' 10' ' ' ASP . 67.7 p -72.07 -21.9 61.45 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.648 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.58 137.17 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.691 0.758 . . . . 0.0 109.923 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 129.91 41.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.979 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.791 0.805 . . . . 0.0 109.938 171.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -23.14 35.35 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.754 0.706 . . . . 0.0 110.879 169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.3 176.59 6.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.788 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 0.0 110.594 171.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.446 ' CB ' ' HB3' ' B' ' 142' ' ' GLU . 2.1 m-85 -139.72 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.66 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 4.0 p-10 -119.05 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.61 0.719 . . . . 0.0 109.454 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.852 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -136.69 162.52 32.94 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.037 -163.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.73 ' HB2' ' HG3' ' B' ' 139' ' ' LYS . 43.9 tt0 -132.34 139.26 48.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.16 51.05 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.397 0.679 . . . . 0.0 110.399 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.11 41.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.964 170.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.674 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.78 44.64 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.51 ' CB ' HG22 ' B' ' 134' ' ' VAL . . . -130.5 160.94 32.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.912 0.863 . . . . 0.0 111.196 -169.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.612 ' CD1' ' HB3' ' B' ' 88' ' ' GLN . 1.7 t80 -125.2 165.16 18.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.957 -174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.547 HD12 ' H ' ' B' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.73 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.421 ' H ' ' HA ' ' B' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.95 69.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.75 20.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.953 0.797 . . . . 0.0 109.063 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.902 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -138.02 142.97 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.688 ' HG2' HG13 ' A' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.63 33.04 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.14 51.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 111.2 176.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.47 48.89 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.655 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.06 50.98 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.22 15.98 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.601 ' HA ' HE22 ' A' ' 9' ' ' GLN . 21.5 m -69.68 -29.84 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 122.537 -0.39 . . . . 0.0 111.128 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.25 17.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.75 -142.51 26.78 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 166.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -143.48 162.6 35.39 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.581 0.705 . . . . 0.0 110.764 -177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.402 HG11 HG21 ' A' ' 11' ' ' VAL . 27.1 m -53.59 138.48 13.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.043 -171.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.38 128.07 49.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.14 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.5 123.05 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.04 27.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.902 HG22 ' HG2' ' B' ' 116' ' ' ARG . 2.8 pt -114.63 121.23 66.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' B' ' 64' ' ' GLU . 3.1 m -107.16 143.23 35.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.729 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' B' ' 91' ' ' PHE . 2.6 pp -140.25 141.56 35.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.113 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.459 HE22 HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -96.3 158.77 15.28 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 167.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.674 HG13 ' O ' ' B' ' 110' ' ' PHE . 61.4 t -142.36 155.9 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.908 HG22 HG13 ' A' ' 53' ' ' ILE . 2.1 pt -104.3 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.83 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.74 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.64 ' HG3' HG11 ' B' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.037 0.923 . . . . 0.0 110.632 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.467 ' HA ' HE22 ' C' ' 84' ' ' GLN . 0.0 OUTLIER -116.48 150.56 37.7 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.73 ' HG3' ' HB2' ' B' ' 107' ' ' GLN . 0.4 OUTLIER -98.56 142.2 30.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.75 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.345 169.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.852 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.92 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.788 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.26 11.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.791 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.45 109.06 17.03 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.976 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.91 -46.14 89.19 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.392 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.63 61.26 13.55 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.442 1.897 . . . . 0.0 109.408 -173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.728 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -68.28 -2.37 8.89 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 121.236 1.29 . . . . 0.0 115.326 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.25 86.64 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.586 171.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.37 1.61 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.91 77.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.122 0.874 . . . . 0.0 111.288 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.728 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 41.7 t -70.65 -43.61 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -176.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' B' ' 147' ' ' PRO . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.455 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.33 96.41 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 10.0 t -102.8 163.85 11.98 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.66 -4.42 54.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.19 64.58 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.372 0.987 . . . . 0.0 113.064 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.65 137.22 24.2 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.17 51.2 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.279 1.032 . . . . 0.0 108.617 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.54 -49.73 74.13 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.604 ' HB2' ' HH2' ' H' ' 92' ' ' TRP . 4.5 p90 -143.76 155.35 44.14 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.64 2.376 . . . . 0.0 109.136 167.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.05 88.48 2.28 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 154.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.568 ' HA ' HE22 ' H' ' 16' ' ' GLN . 4.4 tt0 -115.86 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -166.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.719 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.1 Cg_exo -77.94 13.05 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.556 0 CA-C-N 122.038 1.763 . . . . 0.0 113.877 171.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.95 90.66 0.33 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.719 HE22 ' HD2' ' B' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.902 1.351 . . . . 0.0 110.955 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 19.0 m 31.98 73.06 0.06 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.835 1.654 . . . . 0.0 111.884 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.64 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.68 11.01 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 119.869 -0.732 . . . . 0.0 109.342 -167.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.99 -158.26 8.29 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.422 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -27.07 64.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.803 0.301 . . . . 0.0 111.395 -177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' B' ' 171' ' ' PRO . . . -72.24 162.23 74.82 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.515 0.726 . . . . 0.0 109.264 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' B' ' 170' ' ' ALA . 85.6 Cg_endo -81.03 -9.06 13.03 Favored 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 121.261 1.308 . . . . 0.0 112.722 -156.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.74 0.16 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.169 1.627 . . . . 0.0 117.169 165.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.64 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.935 0.867 . . . . 0.0 109.863 170.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 25.0 m -129.33 168.23 17.03 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.449 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' B' ' 165' ' ' GLN . 31.4 Cg_exo -70.54 113.56 3.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.529 0.868 . . . . 0.0 111.751 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.454 1.502 . . . . 0.0 112.309 -171.756 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . 0.757 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.758 -4.362 . . . . 0.0 100.758 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' C' ' 10' ' ' ASP . 4.4 mt -87.28 130.59 36.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.882 0.849 . . . . 0.0 110.749 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.72 93.1 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.521 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.578 ' HG3' ' HB ' ' H' ' 48' ' ' THR . 1.6 mm-40 -72.91 -25.9 61.22 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 117.812 0.806 . . . . 0.0 112.387 172.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.595 ' O ' HG23 ' C' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.57 89.94 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -172.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.68 118.79 33.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.45 155.39 42.31 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.672 0.749 . . . . 0.0 110.482 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.433 ' CE1' ' OD1' ' C' ' 34' ' ' ASP . 14.2 m-85 -120.63 121.47 38.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.753 -164.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' C' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.59 39.3 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.35 50.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.44 0.638 . . . . 0.0 109.966 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.1 p -74.39 141.14 45.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.063 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.685 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.033 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.3 -13.21 58.68 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -47.96 69.49 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.414 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.69 43.57 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.244 1.417 . . . . 0.0 111.811 -173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.58 161.13 16.53 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.77 47.6 2.76 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.707 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 6.2 p -172.23 149.76 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.986 0.393 . . . . 0.0 111.792 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.75 110.23 49.63 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.952 2.101 . . . . 0.0 112.444 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.37 145.09 33.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.436 0.834 . . . . 0.0 112.468 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.48 157.84 40.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 31.3 t80 -104.33 144.11 28.04 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.823 -2.351 . . . . 0.0 110.568 -167.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 49.2 Cg_endo -78.04 174.54 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.305 0 CA-C-O 121.863 0.693 . . . . 0.0 112.407 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.78 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.368 1.467 . . . . 0.0 111.507 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.83 139.47 40.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 122.516 1.15 . . . . 0.0 111.09 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.561 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -98.56 -66.16 0.92 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.76 155.64 3.27 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.785 1.279 . . . . 0.0 111.081 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' C' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.03 13.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.995 -164.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.95 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.388 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.39 53.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' D' ' 117' ' ' GLU . 1.2 t -123.53 133.39 69.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.09 105.1 5.41 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.45 123.27 7.81 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.624 -0.798 . . . . 0.0 113.248 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' D' ' 83' ' ' TYR . 5.7 tt0 -101.82 101.07 11.48 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.462 ' O ' ' HA3' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -68.09 147.09 52.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.672 0.749 . . . . 0.0 110.192 -174.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' D' ' 112' ' ' TYR . 21.1 mt-10 -128.66 173.89 9.9 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.967 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -66.07 134.81 53.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.455 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.51 34.72 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.2 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.44 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' C' ' 52' ' ' ARG . 0.4 OUTLIER -71.97 -39.5 69.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.01 23.07 1.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.618 1.567 . . . . 0.0 111.667 -172.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.01 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.523 1.529 . . . . 0.0 111.573 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.464 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.87 36.32 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.33 1.28 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.631 ' H ' ' HG2' ' C' ' 46' ' ' GLU . 5.8 mmp_? -108.7 18.47 20.78 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.858 HG13 HG22 ' D' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.81 7.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.872 178.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.94 ' HG ' HG12 ' D' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.967 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -93.48 160.84 24.78 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-O 121.689 0.605 . . . . 0.0 113.974 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.04 151.36 34.9 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.841 0.67 . . . . 0.0 113.841 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' C' ' 41' ' ' ARG . . . -148.94 176.71 27.6 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.13 14.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.522 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.77 129.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.14 48.58 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.74 111.81 14.09 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 87.9 p -140.85 144.23 35.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.916 0.886 . . . . 0.0 110.068 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -133.91 149.25 19.69 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.171 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.05 142.8 49.97 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.21 34.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.63 146.93 29.04 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.51 ' HA ' ' HB2' ' C' ' 32' ' ' GLN . 37.8 p90 -164.2 170.48 16.27 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 175.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -98.71 123.79 43.15 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.2 129.71 26.36 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 29' ' ' PRO . 7.5 mttm -93.5 159.56 15.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.469 0.652 . . . . 0.0 109.292 174.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . 0.649 ' HE ' ' HA ' ' B' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.8 78.78 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.59 100.12 0.17 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.74 158.87 43.28 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.11 1.364 . . . . 0.0 111.021 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -74.21 -38.23 63.63 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.466 2.395 . . . . 0.0 117.466 -156.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.84 95.65 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.862 168.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.3 -44.65 95.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.812 171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.86 -29.38 69.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.795 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.39 -40.98 96.86 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.964 168.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' C' ' 79' ' ' ILE . 1.4 mm -63.07 -44.25 99.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.033 0.444 . . . . 0.0 110.503 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.07 85.44 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.796 -0.565 . . . . 0.0 112.464 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' C' ' 85' ' ' ASN . 55.3 m-20 -62.74 -39.49 94.28 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.589 169.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 1.029 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -51.48 -57.63 8.49 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.546 174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.48 ' CE1' ' HB2' ' B' ' 40' ' ' GLU . 36.2 t80 -79.37 -53.94 6.43 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.931 -174.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 2.9 mt-30 -74.95 -34.89 62.12 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -167.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' C' ' 81' ' ' ASP . 29.0 t30 -84.19 -27.63 27.89 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.026 172.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.16 1.16 Allowed Glycine 0 N--CA 1.448 -0.56 0 O-C-N 122.304 -0.247 . . . . 0.0 112.876 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 1.029 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.39 28.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 168.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.453 HG13 ' HB2' ' C' ' 82' ' ' ALA . 1.3 mm -117.83 143.06 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.343 0.592 . . . . 0.0 109.844 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' C' ' 16' ' ' GLN . 10.7 mtmt -76.23 137.12 39.77 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.736 ' HE1' HD21 ' C' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.19 42.19 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.489 1.115 . . . . 0.0 110.028 -166.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HG ' ' C' ' 14' ' ' LEU . 14.9 m95 -127.33 129.93 48.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.194 0.997 . . . . 0.0 108.358 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' C' ' 93' ' ' ARG . 13.4 ptm180 -125.33 120.1 30.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' C' ' 106' ' ' ALA . 1.1 m -134.1 157.49 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.245 1.021 . . . . 0.0 109.38 -173.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.634 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.4 OUTLIER -92.6 137.98 31.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.637 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.595 HG23 ' O ' ' C' ' 10' ' ' ASP . 67.0 p -72.03 -21.91 61.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.665 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.65 137.25 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.757 0.789 . . . . 0.0 109.852 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.61 129.96 41.6 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.931 -174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 0.7 OUTLIER -76.57 141.16 41.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.821 0.819 . . . . 0.0 109.974 171.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.17 35.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.755 0.707 . . . . 0.0 110.901 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.29 176.63 6.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 167.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.817 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.866 -0.521 . . . . 0.0 110.599 171.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' C' ' 142' ' ' GLU . 2.1 m-85 -139.75 -179.83 6.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.606 0.717 . . . . 0.0 109.467 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.89 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -136.59 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.051 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.732 ' HB2' ' HG3' ' C' ' 139' ' ' LYS . 43.8 tt0 -132.34 139.32 48.1 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.25 151.21 51.01 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.343 0.657 . . . . 0.0 110.414 -163.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.26 169.13 41.32 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.945 170.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.2 m-85 -97.83 128.85 44.73 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' C' ' 134' ' ' VAL . . . -130.56 160.91 32.77 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.915 0.864 . . . . 0.0 111.188 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' C' ' 88' ' ' GLN . 1.7 t80 -125.16 165.17 18.73 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.027 -174.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.557 ' H ' HD12 ' C' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.75 3.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.419 ' H ' ' HA ' ' C' ' 132' ' ' LEU . 4.0 tt0 -70.89 -42.94 69.34 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.36 157.77 20.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.928 0.786 . . . . 0.0 109.078 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.899 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.94 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.707 ' HG2' HG13 ' B' ' 37' ' ' VAL . 4.5 tm-20 -133.85 127.66 33.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.09 124.15 51.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.061 0.458 . . . . 0.0 111.222 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.47 48.9 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -107.79 125.05 50.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 167.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -121.0 157.23 16.01 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 121.688 0.605 . . . . 0.0 111.598 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.53 ' HA ' HE22 ' B' ' 9' ' ' GLN . 21.4 m -69.67 -29.82 42.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.445 -0.444 . . . . 0.0 111.149 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.41 26.66 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.555 0.693 . . . . 0.0 110.767 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.53 138.52 12.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.028 -171.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.1 49.34 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.08 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 12.2 mt -116.5 123.04 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.16 114.02 27.9 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.899 HG22 ' HG2' ' C' ' 116' ' ' ARG . 2.8 pt -114.56 121.22 66.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' C' ' 64' ' ' GLU . 3.1 m -107.13 143.18 35.67 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.371 0.668 . . . . 0.0 109.744 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.736 HD21 ' HE1' ' C' ' 91' ' ' PHE . 2.6 pp -140.25 141.58 35.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.127 -172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.507 HE22 HD12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -96.31 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' C' ' 110' ' ' PHE . 61.4 t -142.39 155.9 18.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 1.018 HG22 HG13 ' B' ' 53' ' ' ILE . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.348 0.594 . . . . 0.0 110.318 -173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.79 1.03 Allowed Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.751 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' C' ' 134' ' ' VAL . 23.5 mt-10 -80.31 133.08 35.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.061 0.934 . . . . 0.0 110.624 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.43 150.66 37.45 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.732 ' HG3' ' HB2' ' C' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.21 30.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -104.34 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.359 169.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 5.4 tp10 -89.4 132.99 34.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.817 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 0.5 OUTLIER -98.05 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -176.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.45 109.04 17.01 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.95 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.93 -46.13 89.23 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.372 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.33 13.43 Favored Pre-proline 0 C--N 1.346 0.43 0 C-N-CA 126.501 1.921 . . . . 0.0 109.353 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.735 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -68.28 -2.41 8.96 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.255 1.304 . . . . 0.0 115.293 -159.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.16 86.32 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.591 171.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.42 -62.36 1.61 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 119.155 0.889 . . . . 0.0 111.288 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.735 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 41.7 t -70.63 -43.72 77.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' C' ' 147' ' ' PRO . 2.6 t-20 -110.66 113.26 25.73 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.516 -176.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.35 96.35 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -102.71 163.78 12.02 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -80.63 -4.37 53.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.06 2.16 64.57 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 113.021 -176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.66 137.22 24.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -133.25 146.2 51.21 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.309 1.043 . . . . 0.0 108.6 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.63 74.48 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -158.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.545 ' HB2' ' HH2' ' I' ' 92' ' ' TRP . 4.6 p90 -143.86 155.28 44.05 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.657 2.383 . . . . 0.0 109.109 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.03 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 154.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.521 ' HA ' HE22 ' I' ' 16' ' ' GLN . 4.4 tt0 -115.79 -29.87 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -166.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.725 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.4 Cg_exo -77.97 13.05 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 CA-C-N 122.017 1.756 . . . . 0.0 113.901 171.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.725 HE22 ' HD2' ' C' ' 163' ' ' PRO . 6.9 mp0 -108.68 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.918 1.359 . . . . 0.0 110.907 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.88 73.07 0.06 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.82 1.648 . . . . 0.0 111.912 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.632 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.2 OUTLIER -92.88 168.62 11.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.284 -167.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.92 -158.22 8.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.489 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -27.04 63.97 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.804 0.302 . . . . 0.0 111.435 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' C' ' 171' ' ' PRO . . . -72.3 162.2 75.05 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.442 0.697 . . . . 0.0 109.295 -178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' C' ' 170' ' ' ALA . 86.1 Cg_endo -80.93 -9.09 13.15 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.297 1.331 . . . . 0.0 112.737 -156.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 117.196 1.639 . . . . 0.0 117.196 165.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.632 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -101.56 154.28 18.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.979 0.89 . . . . 0.0 109.848 170.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 25.1 m -129.36 168.29 16.83 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' C' ' 165' ' ' GLN . 31.5 Cg_exo -70.6 113.56 3.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.519 0.864 . . . . 0.0 111.714 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.451 1.5 . . . . 0.0 112.307 -171.753 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . 0.66 ' HA ' ' HE ' ' E' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.132 1 N-CA-C 100.75 -4.366 . . . . 0.0 100.75 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.516 HG22 ' HB3' ' D' ' 10' ' ' ASP . 4.4 mt -87.15 130.63 36.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.46 166.02 16.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.912 0.863 . . . . 0.0 110.752 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.76 93.15 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.345 -0.843 . . . . 0.0 114.501 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' E' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.85 61.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.795 0.797 . . . . 0.0 112.432 172.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.601 ' O ' HG23 ' D' ' 96' ' ' THR . 0.4 OUTLIER -60.84 -46.55 90.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -172.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.411 HG21 HG11 ' E' ' 126' ' ' VAL . 23.4 t -86.64 118.78 33.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.39 42.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.676 0.75 . . . . 0.0 110.485 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' D' ' 34' ' ' ASP . 14.3 m-85 -120.65 121.36 38.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.771 -164.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.581 ' HG ' ' HB2' ' D' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.61 39.22 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.41 50.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 109.96 176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.5 141.21 44.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.996 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.67 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.64 77.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.009 -179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.32 -13.16 58.69 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.96 69.44 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.438 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.58 18.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.275 1.43 . . . . 0.0 111.791 -173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.54 161.14 16.5 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.8 47.62 2.75 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.694 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.943 0.372 . . . . 0.0 111.762 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.25 49.49 Favored Pre-proline 0 C--O 1.238 0.494 0 C-N-CA 126.961 2.104 . . . . 0.0 112.411 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.41 145.07 33.41 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.46 0.843 . . . . 0.0 112.5 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.81 40.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.539 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 31.3 t80 -104.28 144.11 28.03 Favored Pre-proline 0 C--N 1.316 -0.882 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.523 -167.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.9 Cg_endo -78.06 174.56 12.31 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.83 0.679 . . . . 0.0 112.427 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.77 1.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.395 1.478 . . . . 0.0 111.562 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.47 40.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.52 1.152 . . . . 0.0 111.068 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.529 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -98.63 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.82 155.57 3.22 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.8 1.286 . . . . 0.0 111.07 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' D' ' 13' ' ' TYR . 0.8 OUTLIER -134.86 115.11 13.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.991 -164.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.342 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -111.98 125.38 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.698 HG13 ' HG2' ' E' ' 117' ' ' GLU . 1.2 t -123.45 133.34 69.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -173.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.5 p -138.08 105.11 5.42 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.41 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.22 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.435 ' HB2' ' CE1' ' E' ' 83' ' ' TYR . 5.7 tt0 -101.88 101.08 11.47 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.449 ' O ' ' HA3' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.05 52.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.76 0.79 . . . . 0.0 110.156 -174.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.496 ' OE1' ' HB3' ' E' ' 112' ' ' TYR . 21.1 mt-10 -128.64 173.87 9.91 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.983 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.78 53.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.52 130.57 34.73 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.42 113.92 0.07 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 155.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' D' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.52 69.17 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 176.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.02 23.08 1.33 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.641 1.577 . . . . 0.0 111.678 -172.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.11 61.65 1.69 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.564 -164.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.86 -128.54 0.29 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.473 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.05 9.95 36.24 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.25 1.27 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.631 ' H ' ' HG2' ' D' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.52 20.75 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.896 HG13 HG22 ' E' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.899 178.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.884 ' HG ' HG12 ' E' ' 135' ' ' ILE . 0.1 OUTLIER -105.33 22.11 15.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.983 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -93.46 160.84 24.8 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-O 121.639 0.577 . . . . 0.0 113.956 -170.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.05 151.39 34.88 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 N-CA-C 113.823 0.663 . . . . 0.0 113.823 -175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' D' ' 41' ' ' ARG . . . -149.01 176.71 27.66 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.43 170.1 14.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.589 0.709 . . . . 0.0 110.486 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.69 129.86 74.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.7 127.12 48.6 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.69 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.23 35.24 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 123.934 0.894 . . . . 0.0 110.02 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -133.96 149.22 19.69 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.139 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.86 49.89 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.54 118.22 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 49.9 p -105.71 146.92 29.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' D' ' 32' ' ' GLN . 37.9 p90 -164.15 170.46 16.36 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.69 123.77 43.1 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.07 129.7 26.71 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 114.956 0.742 . . . . 0.0 114.956 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' D' ' 29' ' ' PRO . 7.5 mttm -93.53 159.57 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.757 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -56.05 -46.79 78.78 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.21 0.17 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.81 158.8 43.36 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.166 1.386 . . . . 0.0 111.047 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' D' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.473 2.397 . . . . 0.0 117.473 -156.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.46 -43.88 95.64 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.828 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.61 95.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.874 171.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.9 -29.29 69.13 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.828 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 74' ' ' ALA . . . -64.5 -40.93 96.57 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.939 168.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.474 HD13 ' N ' ' D' ' 79' ' ' ILE . 1.4 mm -63.11 -44.23 99.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -62.59 -47.09 85.35 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.758 -0.589 . . . . 0.0 112.436 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' D' ' 85' ' ' ASN . 55.2 m-20 -62.73 -39.55 94.43 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.572 169.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 1.025 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -51.42 -57.65 8.4 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.576 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' C' ' 40' ' ' GLU . 36.3 t80 -79.38 -53.91 6.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.921 -174.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.87 61.99 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' D' ' 81' ' ' ASP . 29.0 t30 -84.22 -27.67 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.014 172.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.308 -0.245 . . . . 0.0 112.826 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 1.025 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.57 47.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.624 ' HB3' ' CD1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -84.26 144.42 28.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.354 0.597 . . . . 0.0 109.83 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.684 ' HB2' ' O ' ' D' ' 16' ' ' GLN . 10.7 mtmt -76.25 137.19 39.79 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' D' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.488 1.115 . . . . 0.0 109.986 -165.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.581 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 14.9 m95 -127.32 129.89 48.49 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 108.375 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' D' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.12 30.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 172.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' D' ' 106' ' ' ALA . 1.1 m -134.12 157.51 41.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.26 1.029 . . . . 0.0 109.421 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.647 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.02 31.87 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.617 179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.601 HG23 ' O ' ' D' ' 10' ' ' ASP . 67.8 p -72.1 -21.9 61.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.646 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.62 137.23 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.673 0.749 . . . . 0.0 109.884 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.92 41.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.947 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 0.7 OUTLIER -76.56 141.19 41.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.798 0.809 . . . . 0.0 109.987 171.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.38 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.92 34.62 5.15 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.734 0.697 . . . . 0.0 110.874 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.31 176.58 6.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.825 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.883 -0.511 . . . . 0.0 110.6 171.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.453 ' CB ' ' HB3' ' D' ' 142' ' ' GLU . 2.1 m-85 -139.68 -179.82 6.14 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.653 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.43 55.2 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.579 0.704 . . . . 0.0 109.492 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.863 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -136.64 162.47 33.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.068 -163.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.722 ' HB2' ' HG3' ' D' ' 139' ' ' LYS . 43.8 tt0 -132.27 139.31 48.2 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.24 50.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.35 0.66 . . . . 0.0 110.378 -163.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.34 169.07 41.33 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.918 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.669 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.2 m-85 -97.72 128.86 44.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 167.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' D' ' 134' ' ' VAL . . . -130.56 160.87 32.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.973 0.892 . . . . 0.0 111.163 -169.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' D' ' 88' ' ' GLN . 1.7 t80 -125.14 165.16 18.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.477 -1.238 . . . . 0.0 107.967 -174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.541 ' H ' HD12 ' D' ' 113' ' ' ILE . 0.2 OUTLIER -95.75 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' D' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.92 69.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.38 157.77 20.4 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.943 0.792 . . . . 0.0 109.066 174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.909 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -137.99 142.97 40.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.759 ' HG2' HG13 ' C' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.65 33.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.16 51.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.068 0.461 . . . . 0.0 111.146 176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.29 123.45 48.8 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.702 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.82 125.02 50.93 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.88 157.23 15.97 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.561 HG13 ' O ' ' C' ' 32' ' ' GLN . 21.7 m -69.68 -29.87 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.503 -0.41 . . . . 0.0 111.147 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -98.99 155.22 17.54 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 169.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.74 -142.46 26.72 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 166.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.61 35.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.589 0.709 . . . . 0.0 110.746 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.54 138.51 12.93 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.046 -171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.37 128.04 49.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.108 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.47 123.02 71.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.03 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.909 HG22 ' HG2' ' D' ' 116' ' ' ARG . 2.8 pt -114.6 121.2 66.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' D' ' 64' ' ' GLU . 3.1 m -107.1 143.26 35.51 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.71 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' D' ' 91' ' ' PHE . 2.6 pp -140.33 141.57 35.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.098 -172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.59 HE22 HD12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -96.32 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.513 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.669 HG13 ' O ' ' D' ' 110' ' ' PHE . 61.6 t -142.32 155.95 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.94 HG12 ' HG ' ' C' ' 54' ' ' LEU . 2.1 pt -104.31 31.58 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.375 0.607 . . . . 0.0 110.35 -173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.82 89.74 1.03 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.709 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' D' ' 134' ' ' VAL . 23.5 mt-10 -80.27 133.07 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.032 0.92 . . . . 0.0 110.648 174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.418 ' HA ' HE22 ' E' ' 84' ' ' GLN . 0.0 OUTLIER -116.42 150.67 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -174.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.722 ' HG3' ' HB2' ' D' ' 107' ' ' GLN . 0.4 OUTLIER -98.65 142.2 30.52 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.73 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -104.38 150.32 17.25 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.372 169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.863 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 5.4 tp10 -89.34 132.92 34.72 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -174.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.825 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 0.5 OUTLIER -97.97 -42.38 11.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.766 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.34 109.06 16.96 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.019 -176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 18.8 p -62.96 -46.14 89.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.386 175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.27 13.54 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.423 1.889 . . . . 0.0 109.442 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.732 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.6 Cg_exo -68.31 -2.32 8.83 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.203 1.268 . . . . 0.0 115.33 -159.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 -37.25 86.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.576 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.45 -62.25 1.63 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.85 -49.94 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.154 0.888 . . . . 0.0 111.298 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.732 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 41.5 t -70.66 -43.59 77.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' D' ' 147' ' ' PRO . 2.5 t-20 -110.79 113.28 25.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.435 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.44 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.78 12.01 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.64 -4.37 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.01 2.14 64.69 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.411 1.005 . . . . 0.0 113.074 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' J' ' 138' ' ' LEU . . . -72.68 137.21 24.15 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.17 51.22 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.304 1.042 . . . . 0.0 108.618 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.57 74.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -158.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.563 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.6 p90 -143.83 155.24 44.05 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.69 2.396 . . . . 0.0 109.143 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.451 ' O ' ' HZ2' ' J' ' 92' ' ' TRP . 6.0 mt-30 -138.94 88.44 2.28 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 153.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.633 ' HB2' ' CH2' ' J' ' 92' ' ' TRP . 4.4 tt0 -115.76 -29.86 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.701 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.2 Cg_exo -77.94 12.99 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.095 1.784 . . . . 0.0 113.903 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.06 90.65 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.333 2.093 . . . . 0.0 118.333 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.701 HE22 ' HD2' ' D' ' 163' ' ' PRO . 7.0 mp0 -108.71 56.3 0.62 Allowed 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.879 1.339 . . . . 0.0 110.87 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.91 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.822 1.649 . . . . 0.0 111.925 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.784 ' HB ' HG22 ' J' ' 18' ' ' ILE . 0.2 OUTLIER -92.91 168.61 11.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.317 -167.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.488 ' O ' HG21 ' J' ' 18' ' ' ILE . . . -134.92 -158.2 8.29 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.507 172.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' J' ' 88' ' ' GLN . 0.2 OUTLIER -70.44 -27.01 63.92 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.806 0.303 . . . . 0.0 111.463 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' D' ' 171' ' ' PRO . . . -72.27 162.27 74.66 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.49 0.716 . . . . 0.0 109.246 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' D' ' 170' ' ' ALA . 85.7 Cg_endo -81.0 -9.1 13.06 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.3 1.334 . . . . 0.0 112.72 -156.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.88 97.7 0.16 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 165.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.23 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.984 0.892 . . . . 0.0 109.942 170.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.425 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 24.9 m -129.34 168.25 16.96 Favored Pre-proline 0 C--O 1.241 0.613 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.429 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' D' ' 165' ' ' GLN . 31.5 Cg_exo -70.52 113.63 3.56 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.497 0.856 . . . . 0.0 111.742 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.289 0 C-N-CA 125.398 1.479 . . . . 0.0 112.318 -171.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.798 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.15 1 N-CA-C 100.785 -4.352 . . . . 0.0 100.785 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' E' ' 10' ' ' ASP . 4.3 mt -87.21 130.64 36.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.49 166.08 16.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.895 0.855 . . . . 0.0 110.728 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.04 -37.68 93.13 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.495 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . 0.609 ' HG3' ' HB ' ' J' ' 48' ' ' THR . 1.6 mm-40 -72.91 -26.0 61.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.766 0.783 . . . . 0.0 112.344 172.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' E' ' 96' ' ' THR . 0.4 OUTLIER -60.72 -46.6 89.78 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 23.3 t -86.63 118.78 33.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.43 155.36 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.678 0.751 . . . . 0.0 110.507 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' E' ' 34' ' ' ASP . 14.5 m-85 -120.66 121.38 38.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.727 -164.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' E' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.66 39.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.83 145.43 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.526 0.679 . . . . 0.0 109.92 176.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.48 141.18 44.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.961 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.663 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.8 OUTLIER -66.6 -36.72 77.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.973 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -81.24 -13.18 58.79 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.95 69.47 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.432 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.72 43.53 18.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.195 1.398 . . . . 0.0 111.793 -173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.19 16.44 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.57 2.75 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.716 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.2 149.83 2.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.979 0.39 . . . . 0.0 111.756 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.83 110.26 49.38 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.902 2.081 . . . . 0.0 112.428 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.07 33.64 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.422 0.829 . . . . 0.0 112.52 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.83 40.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 168.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 31.3 t80 -104.31 144.09 28.0 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.552 -167.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.2 Cg_endo -78.03 174.5 12.41 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.837 0.682 . . . . 0.0 112.455 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.76 1.14 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.373 1.469 . . . . 0.0 111.555 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.76 139.47 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.502 1.144 . . . . 0.0 111.075 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.498 ' HB2' ' HA ' ' E' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.8 155.55 3.22 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 122.77 1.271 . . . . 0.0 111.082 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' E' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.11 13.25 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.967 -164.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.01 122.02 5.41 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.31 170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.93 125.37 53.97 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.581 HG13 ' HG2' ' F' ' 117' ' ' GLU . 1.2 t -123.44 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . 0.53 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 4.5 p -138.13 105.09 5.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -166.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.29 7.81 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.235 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.7 tt0 -101.84 101.08 11.48 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -68.16 147.06 52.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.701 0.762 . . . . 0.0 110.171 -174.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.488 ' OE1' ' HB3' ' F' ' 112' ' ' TYR . 21.0 mt-10 -128.69 173.87 9.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.988 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -66.08 134.81 53.6 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.45 -179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.58 130.52 34.72 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.205 171.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 155.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' E' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.49 69.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 176.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.98 23.07 1.35 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.646 1.579 . . . . 0.0 111.699 -172.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.495 1.518 . . . . 0.0 111.584 -164.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.472 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.0 9.84 36.39 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.3 1.28 Allowed Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.628 ' H ' ' HG2' ' E' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.896 HG13 HG22 ' F' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.892 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.1 OUTLIER -105.32 22.14 15.93 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 176.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . 0.988 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -93.59 160.9 24.7 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.708 0.615 . . . . 0.0 113.907 -170.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.08 151.37 34.73 Favored 'Trans proline' 0 CA--C 1.516 -0.385 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' E' ' 41' ' ' ARG . . . -148.98 176.74 27.63 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.12 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.695 . . . . 0.0 110.452 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.79 129.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.15 48.67 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.72 111.79 14.08 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.85 144.17 35.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.979 0.911 . . . . 0.0 110.072 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.132 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.88 49.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.19 34.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.64 146.89 29.11 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.498 ' HA ' ' HB2' ' E' ' 32' ' ' GLN . 37.9 p90 -164.16 170.48 16.32 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.74 123.74 43.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.14 129.7 26.51 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' E' ' 29' ' ' PRO . 7.5 mttm -93.55 159.55 15.18 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.457 0.646 . . . . 0.0 109.287 174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.66 ' HE ' ' HA ' ' D' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.79 78.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.75 158.88 43.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.072 1.349 . . . . 0.0 111.002 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' E' ' 78' ' ' ALA . . . -74.24 -38.16 63.59 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 117.494 2.405 . . . . 0.0 117.494 -156.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.55 -43.74 95.88 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.876 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.63 95.27 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.134 -0.627 . . . . 0.0 111.837 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.29 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.787 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' E' ' 74' ' ' ALA . . . -64.44 -40.98 96.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.935 168.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.487 HD13 ' N ' ' E' ' 79' ' ' ILE . 1.4 mm -63.07 -44.26 99.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.055 0.455 . . . . 0.0 110.472 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 10.6 mm-40 -62.6 -47.08 85.35 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.761 -0.587 . . . . 0.0 112.406 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' E' ' 85' ' ' ASN . 55.0 m-20 -62.69 -39.58 94.42 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.569 169.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -51.45 -57.65 8.42 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.526 174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' D' ' 40' ' ' GLU . 36.1 t80 -79.38 -53.92 6.44 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.916 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 2.9 mt-30 -75.01 -34.79 61.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -167.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' E' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.79 27.88 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.042 172.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.17 1.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 O-C-N 122.354 -0.216 . . . . 0.0 112.862 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -139.26 152.58 47.4 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.42 28.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.461 HD11 ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.87 143.06 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.415 0.626 . . . . 0.0 109.859 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' E' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.18 39.86 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.745 ' HE1' HD21 ' E' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.16 42.14 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 110.015 -165.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 14.9 m95 -127.37 129.91 48.45 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.192 0.997 . . . . 0.0 108.354 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' E' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.05 30.19 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' E' ' 106' ' ' ALA . 1.1 m -134.1 157.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 122.265 1.031 . . . . 0.0 109.417 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.642 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.4 OUTLIER -92.52 137.99 31.89 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.638 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' E' ' 10' ' ' ASP . 67.5 p -72.03 -21.95 61.47 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.675 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.15 23.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.676 0.75 . . . . 0.0 109.958 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.9 41.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.983 -174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.655 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.19 41.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.819 0.819 . . . . 0.0 110.01 171.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.25 -23.13 35.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.92 34.59 5.16 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.766 0.712 . . . . 0.0 110.866 169.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.63 6.55 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.808 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.76 0.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.86 -0.525 . . . . 0.0 110.542 172.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.447 ' CB ' ' HB3' ' E' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.655 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.39 55.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.584 0.706 . . . . 0.0 109.428 177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.857 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -136.59 162.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.1 -163.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.737 ' HB2' ' HG3' ' E' ' 139' ' ' LYS . 43.8 tt0 -132.39 139.25 48.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.598 -1.631 . . . . 0.0 106.598 157.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.22 151.14 51.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.385 0.674 . . . . 0.0 110.422 -163.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.23 169.13 41.31 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.5 -1.333 . . . . 0.0 111.961 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.673 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.81 44.67 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' E' ' 134' ' ' VAL . . . -130.5 160.84 32.9 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.926 0.869 . . . . 0.0 111.222 -169.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' E' ' 88' ' ' GLN . 1.7 t80 -125.13 165.12 18.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.985 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.549 HD12 ' H ' ' E' ' 113' ' ' ILE . 0.2 OUTLIER -95.72 92.67 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' E' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.97 69.56 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.39 157.74 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.945 0.793 . . . . 0.0 109.093 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.925 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.95 40.42 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 176.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.698 ' HG2' HG13 ' D' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.1 124.14 51.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.103 0.478 . . . . 0.0 111.129 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.5 49.0 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.665 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.04 50.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.94 157.23 15.99 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 121.726 0.626 . . . . 0.0 111.589 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.545 ' HA ' HE22 ' D' ' 9' ' ' GLN . 21.5 m -69.62 -29.94 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.428 -0.454 . . . . 0.0 111.103 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.05 155.22 17.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.81 -142.51 26.72 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 166.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -143.51 162.6 35.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.573 0.701 . . . . 0.0 110.786 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.411 HG11 HG21 ' D' ' 11' ' ' VAL . 27.1 m -53.56 138.57 12.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.0 -171.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.45 128.04 49.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.1 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.48 123.06 71.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.2 114.05 27.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 168.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.925 HG22 ' HG2' ' E' ' 116' ' ' ARG . 2.8 pt -114.57 121.15 66.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' E' ' 64' ' ' GLU . 3.1 m -107.12 143.24 35.57 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.74 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.745 HD21 ' HE1' ' E' ' 91' ' ' PHE . 2.6 pp -140.29 141.54 35.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.146 -172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.46 HE22 HD12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -96.3 158.8 15.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 167.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.673 HG13 ' O ' ' E' ' 110' ' ' PHE . 61.6 t -142.39 155.93 18.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.896 HG22 HG13 ' D' ' 53' ' ' ILE . 2.1 pt -104.33 31.6 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.393 0.616 . . . . 0.0 110.326 -173.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.85 89.8 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.68 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.632 ' HG3' HG11 ' E' ' 134' ' ' VAL . 23.6 mt-10 -80.32 133.02 35.9 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 122.066 0.936 . . . . 0.0 110.657 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.42 150.6 37.55 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -174.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.737 ' HG3' ' HB2' ' E' ' 107' ' ' GLN . 0.4 OUTLIER -98.6 142.2 30.48 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -104.34 150.36 17.27 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.399 169.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.857 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 5.4 tp10 -89.42 132.96 34.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.808 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 0.5 OUTLIER -98.04 -42.31 11.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.746 -176.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.35 109.06 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.975 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.1 89.28 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.378 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.6 61.28 13.5 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.422 1.889 . . . . 0.0 109.404 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -68.27 -2.36 8.85 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.249 1.299 . . . . 0.0 115.353 -159.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.82 -37.17 86.39 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.556 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.4 -62.35 1.61 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.86 -49.88 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.145 0.884 . . . . 0.0 111.296 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 41.5 t -70.73 -43.55 77.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' E' ' 147' ' ' PRO . 2.5 t-20 -110.79 113.32 25.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.402 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.39 96.46 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.79 163.78 12.02 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.43 54.09 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.02 2.21 64.61 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 119.407 1.003 . . . . 0.0 113.029 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.72 137.22 24.1 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.21 146.21 51.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.317 1.047 . . . . 0.0 108.64 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.58 -49.65 74.41 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.639 ' HB2' ' HH2' ' K' ' 92' ' ' TRP . 4.6 p90 -143.82 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.631 2.372 . . . . 0.0 109.141 167.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.99 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 153.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.612 ' HB2' ' CH2' ' K' ' 92' ' ' TRP . 4.4 tt0 -115.75 -29.84 0.1 OUTLIER Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.714 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -77.98 13.04 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.042 1.765 . . . . 0.0 113.888 171.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.09 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.714 HE22 ' HD2' ' E' ' 163' ' ' PRO . 7.0 mp0 -108.67 56.19 0.63 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.944 1.372 . . . . 0.0 110.914 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.96 73.11 0.06 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.813 1.645 . . . . 0.0 111.905 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.682 ' HB ' HG22 ' K' ' 18' ' ' ILE . 0.2 OUTLIER -92.95 168.62 11.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.274 -167.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . 0.4 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -134.91 -158.26 8.31 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.478 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -26.93 63.85 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.77 0.285 . . . . 0.0 111.413 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' E' ' 171' ' ' PRO . . . -72.31 162.2 75.06 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.556 0.742 . . . . 0.0 109.216 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' E' ' 170' ' ' ALA . 85.9 Cg_endo -80.96 -9.11 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 121.288 1.325 . . . . 0.0 112.761 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.75 0.16 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.204 1.641 . . . . 0.0 117.204 165.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -101.49 154.24 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.944 0.872 . . . . 0.0 109.869 170.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 24.9 m -129.34 168.26 16.92 Favored Pre-proline 0 C--O 1.24 0.592 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.44 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' E' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.61 3.56 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 119.493 0.855 . . . . 0.0 111.758 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 125.42 1.488 . . . . 0.0 112.339 -171.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.531 ' HA ' ' HE ' ' A' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.181 1 N-CA-C 100.764 -4.36 . . . . 0.0 100.764 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.525 HG22 ' HB3' ' F' ' 10' ' ' ASP . 4.4 mt -87.28 130.67 36.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.44 166.05 16.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.882 0.849 . . . . 0.0 110.771 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.72 93.14 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.499 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . 0.62 HE22 ' HA ' ' A' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.99 61.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.768 0.784 . . . . 0.0 112.401 172.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' F' ' 96' ' ' THR . 0.4 OUTLIER -60.7 -46.63 89.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -172.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.461 ' CG2' HG11 ' A' ' 126' ' ' VAL . 23.5 t -86.69 118.81 33.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.47 155.34 42.42 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.667 0.746 . . . . 0.0 110.473 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.445 ' CE1' ' OD1' ' F' ' 34' ' ' ASP . 14.5 m-85 -120.6 121.41 38.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.761 -164.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.579 ' HG ' ' HB2' ' F' ' 92' ' ' TRP . 0.3 OUTLIER -120.57 151.57 39.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.73 145.47 50.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.472 0.653 . . . . 0.0 109.968 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.692 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.35 52.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.0 p -74.44 141.23 45.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.549 0.69 . . . . 0.0 111.005 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.687 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.8 OUTLIER -66.66 -36.68 77.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.984 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -81.24 -13.14 58.83 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.93 69.41 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.443 -175.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.67 43.57 18.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.249 1.42 . . . . 0.0 111.792 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.53 161.13 16.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.72 47.57 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 113.73 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.8 2.33 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.007 0.403 . . . . 0.0 111.791 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.41 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.926 2.091 . . . . 0.0 112.402 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.41 145.12 33.49 Favored 'Trans proline' 0 C--N 1.348 0.544 0 CA-C-N 119.431 0.832 . . . . 0.0 112.441 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.53 157.78 40.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 168.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.54 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 31.1 t80 -104.27 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.869 0 C-N-CA 115.866 -2.334 . . . . 0.0 110.549 -167.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . 0.54 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -77.98 174.5 12.43 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-O 121.863 0.693 . . . . 0.0 112.45 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.73 1.15 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.426 1.491 . . . . 0.0 111.524 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.76 139.39 40.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.541 1.163 . . . . 0.0 111.086 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.525 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -98.48 -66.15 0.92 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.78 155.63 3.26 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 122.803 1.287 . . . . 0.0 111.076 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' CE1' ' F' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.14 13.24 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.965 -164.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.02 121.98 5.4 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.368 170.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.91 125.36 53.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.552 HG13 ' HG2' ' A' ' 117' ' ' GLU . 1.3 t -123.46 133.43 69.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . 0.414 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 4.5 p -138.16 105.1 5.4 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.37 123.23 7.8 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.258 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.77 101.08 11.5 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.458 ' O ' ' HA3' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -68.11 147.04 52.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.704 0.764 . . . . 0.0 110.137 -174.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.64 173.88 9.9 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.973 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.72 53.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.525 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.5 34.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.272 171.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.616 ' HG2' ' H ' ' F' ' 52' ' ' ARG . 0.4 OUTLIER -72.0 -39.48 69.19 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.07 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 111.65 -172.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 41.07 61.7 1.67 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.513 1.525 . . . . 0.0 111.522 -164.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.45 0.29 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.53 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.06 9.91 36.24 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 83.35 1.28 Allowed Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 111.101 -0.799 . . . . 0.0 111.101 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.616 ' H ' ' HG2' ' F' ' 46' ' ' GLU . 5.8 mmp_? -108.7 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.518 HG13 HG22 ' A' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.79 7.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.864 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.742 ' HG ' HG12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -105.3 22.09 16.0 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . 0.973 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -93.53 160.85 24.73 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.68 0.6 . . . . 0.0 113.935 -170.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.06 151.36 34.79 Favored 'Trans proline' 0 CA--C 1.516 -0.413 0 N-CA-C 113.854 0.674 . . . . 0.0 113.854 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' F' ' 41' ' ' ARG . . . -148.95 176.68 27.62 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.45 170.1 14.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.531 0.682 . . . . 0.0 110.536 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.73 129.91 74.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.75 127.12 48.67 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.68 111.74 14.05 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -171.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.85 144.21 35.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.934 0.894 . . . . 0.0 110.071 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -133.91 149.23 19.69 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.151 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.06 142.85 49.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 49.6 p -105.72 146.92 29.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' F' ' 32' ' ' GLN . 37.7 p90 -164.16 170.47 16.34 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -98.71 123.77 43.13 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -68.22 129.73 26.31 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.899 0.72 . . . . 0.0 114.899 -175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' F' ' 29' ' ' PRO . 7.5 mttm -93.52 159.59 15.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . 0.798 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -56.03 -46.8 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -172.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.11 0.17 Allowed Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.84 43.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.109 1.364 . . . . 0.0 111.033 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' F' ' 78' ' ' ALA . . . -74.21 -38.2 63.64 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.49 -43.83 95.73 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.844 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.63 95.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.862 171.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.35 69.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.748 171.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' F' ' 74' ' ' ALA . . . -64.37 -41.06 96.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.917 168.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.492 ' N ' HD13 ' F' ' 79' ' ' ILE . 1.4 mm -62.99 -44.31 99.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.094 0.473 . . . . 0.0 110.486 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 10.6 mm-40 -62.58 -47.06 85.45 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.726 -0.609 . . . . 0.0 112.422 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' F' ' 85' ' ' ASN . 55.1 m-20 -62.7 -39.59 94.49 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.591 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.976 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -51.44 -57.57 8.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.62 174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.53 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 36.2 t80 -79.38 -54.0 6.36 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.925 -174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.615 ' OE1' ' HB2' ' E' ' 139' ' ' LYS . 2.9 mt-30 -74.87 -34.82 62.29 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -167.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' F' ' 81' ' ' ASP . 29.1 t30 -84.26 -27.68 27.74 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.022 172.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.29 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.291 -0.256 . . . . 0.0 112.873 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.976 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.57 47.36 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.46 28.89 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.471 HD11 ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.88 143.03 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.372 0.606 . . . . 0.0 109.852 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.692 ' HB2' ' O ' ' F' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.18 39.82 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.732 ' HE1' HD21 ' F' ' 132' ' ' LEU . 0.8 OUTLIER -123.67 124.16 42.14 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.544 1.138 . . . . 0.0 110.008 -165.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.579 ' HB2' ' HG ' ' F' ' 14' ' ' LEU . 14.8 m95 -127.34 129.9 48.47 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.199 1.0 . . . . 0.0 108.314 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' F' ' 93' ' ' ARG . 13.4 ptm180 -125.23 120.12 30.39 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 172.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' F' ' 106' ' ' ALA . 1.1 m -134.14 157.45 41.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.263 1.03 . . . . 0.0 109.381 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.4 OUTLIER -92.55 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.629 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' F' ' 10' ' ' ASP . 67.2 p -72.04 -22.0 61.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.649 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.23 23.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.687 0.756 . . . . 0.0 109.901 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 129.91 41.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.95 -174.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.64 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.22 41.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.82 0.819 . . . . 0.0 109.949 171.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.23 -23.2 35.49 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.9 34.67 5.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 118.76 0.709 . . . . 0.0 110.852 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.821 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -59.59 -65.76 0.62 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.838 -0.538 . . . . 0.0 110.568 171.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.452 ' CB ' ' HB3' ' F' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.77 6.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.64 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 4.0 p-10 -119.08 134.43 55.2 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.604 0.716 . . . . 0.0 109.425 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.87 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -136.61 162.51 32.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.053 -163.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.723 ' HB2' ' HG3' ' F' ' 139' ' ' LYS . 43.9 tt0 -132.29 139.28 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.26 151.16 51.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.399 0.68 . . . . 0.0 110.439 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.1 41.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.492 -1.337 . . . . 0.0 111.943 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.658 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.87 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' F' ' 134' ' ' VAL . . . -130.58 160.94 32.67 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.936 0.874 . . . . 0.0 111.154 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' F' ' 88' ' ' GLN . 1.7 t80 -125.18 165.2 18.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.449 -1.25 . . . . 0.0 107.979 -174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.555 HD12 ' H ' ' F' ' 113' ' ' ILE . 0.2 OUTLIER -95.79 92.79 3.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' F' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.28 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.39 157.76 20.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.032 174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.9 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -138.04 142.96 40.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.581 ' HG2' HG13 ' E' ' 37' ' ' VAL . 4.5 tm-20 -133.79 127.65 33.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.05 124.11 51.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.056 0.455 . . . . 0.0 111.187 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.699 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.88 125.08 51.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.21 16.0 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 175.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . 0.5 ' HA ' HE22 ' E' ' 9' ' ' GLN . 21.4 m -69.69 -29.8 42.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.532 -0.393 . . . . 0.0 111.113 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.09 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.72 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.64 35.34 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.64 0.733 . . . . 0.0 110.723 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -53.57 138.55 12.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.026 -171.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.06 49.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.068 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . 0.4 HD11 ' HA3' ' F' ' 69' ' ' GLY . 12.1 mt -116.45 123.04 71.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.13 114.04 27.94 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.9 HG22 ' HG2' ' F' ' 116' ' ' ARG . 2.8 pt -114.61 121.24 66.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' F' ' 64' ' ' GLU . 3.1 m -107.14 143.24 35.59 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.712 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.732 HD21 ' HE1' ' F' ' 91' ' ' PHE . 2.6 pp -140.36 141.57 35.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.139 -172.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.444 HE22 HD12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -96.3 158.71 15.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 167.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.658 HG13 ' O ' ' F' ' 110' ' ' PHE . 61.4 t -142.32 155.93 18.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 1.037 HG12 ' HG ' ' E' ' 54' ' ' LEU . 2.1 pt -104.33 31.69 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-O 121.32 0.581 . . . . 0.0 110.348 -173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.77 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.752 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' F' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.07 35.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 122.008 0.909 . . . . 0.0 110.679 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.47 150.67 37.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.723 ' HG3' ' HB2' ' F' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.78 -163.74 1.31 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -104.33 150.37 17.28 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.391 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.87 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 5.4 tp10 -89.43 132.93 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.821 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 0.5 OUTLIER -98.01 -42.29 11.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.77 -176.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.37 109.04 16.96 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.94 -46.16 89.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.394 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.34 13.43 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.479 1.912 . . . . 0.0 109.355 -173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.709 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.6 Cg_exo -68.32 -2.36 8.9 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.232 1.288 . . . . 0.0 115.324 -159.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.7 -37.29 86.78 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.593 171.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.36 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.88 -49.91 77.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.118 0.872 . . . . 0.0 111.305 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 41.8 t -70.6 -43.68 77.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' F' ' 147' ' ' PRO . 2.5 t-20 -110.72 113.31 25.8 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.473 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.34 96.4 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.73 163.79 12.01 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.31 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.22 64.75 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 119.385 0.993 . . . . 0.0 113.061 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.773 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -72.72 137.21 24.09 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.19 146.18 51.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.332 1.053 . . . . 0.0 108.649 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.65 -49.63 74.41 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -158.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' L' ' 92' ' ' TRP . 4.5 p90 -143.85 155.21 44.04 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.722 2.409 . . . . 0.0 109.191 167.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.913 ' O ' ' HZ2' ' L' ' 92' ' ' TRP . 6.0 mt-30 -138.99 88.53 2.29 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 154.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.804 ' HB2' ' CH2' ' L' ' 92' ' ' TRP . 4.4 tt0 -115.85 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.646 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -166.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.723 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -77.96 13.09 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.072 1.776 . . . . 0.0 113.919 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.0 90.63 0.33 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.35 2.1 . . . . 0.0 118.35 -171.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.723 HE22 ' HD2' ' F' ' 163' ' ' PRO . 7.0 mp0 -108.66 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.922 1.361 . . . . 0.0 110.926 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.823 1.649 . . . . 0.0 111.909 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 1.122 ' HB ' HG22 ' L' ' 18' ' ' ILE . 0.2 OUTLIER -92.93 168.63 11.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.316 -167.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.759 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -134.91 -158.24 8.31 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.475 172.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.2 OUTLIER -70.45 -27.01 63.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.792 0.296 . . . . 0.0 111.414 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . 0.474 ' HB1' ' HD2' ' F' ' 171' ' ' PRO . . . -72.32 162.21 75.01 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.518 0.727 . . . . 0.0 109.229 -178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.474 ' HD2' ' HB1' ' F' ' 170' ' ' ALA . 85.5 Cg_endo -80.98 -9.08 13.09 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.34 1.36 . . . . 0.0 112.728 -156.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.87 97.72 0.16 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 117.231 1.652 . . . . 0.0 117.231 165.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.627 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -101.55 154.25 19.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 117.985 0.892 . . . . 0.0 109.861 170.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 25.2 m -129.38 168.27 16.9 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.432 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' F' ' 165' ' ' GLN . 31.5 Cg_exo -70.59 113.61 3.57 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.516 0.863 . . . . 0.0 111.687 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.376 1.471 . . . . 0.0 112.318 -171.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.57 ' HA ' ' HE ' ' H' ' 71' ' ' ARG . 49.4 Cg_endo . . . . . 0 N--CA 1.465 -0.151 1 N-CA-C 100.743 -4.368 . . . . 0.0 100.743 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' H' ' 126' ' ' VAL . 4.3 mt -87.19 130.64 36.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.51 166.05 16.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.912 0.863 . . . . 0.0 110.772 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' H' ' 121' ' ' GLY . . . -60.01 -37.68 93.08 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.495 175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . 0.731 HE22 ' HA ' ' H' ' 122' ' ' VAL . 1.6 mm-40 -72.9 -25.94 61.25 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 117.77 0.785 . . . . 0.0 112.437 172.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.609 ' O ' HG23 ' G' ' 96' ' ' THR . 0.4 OUTLIER -60.78 -46.56 90.0 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -172.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.66 118.8 33.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.47 155.33 42.44 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.66 0.743 . . . . 0.0 110.515 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' G' ' 34' ' ' ASP . 14.4 m-85 -120.61 121.41 38.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.777 -164.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' G' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.63 39.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.44 50.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.434 0.635 . . . . 0.0 109.947 176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 5.1 tt0 -121.9 129.38 52.51 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 59.8 p -74.5 141.19 44.91 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.529 0.681 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.788 HG22 ' HB ' ' A' ' 167' ' ' THR . 0.8 OUTLIER -66.66 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.026 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -81.34 -13.08 58.76 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.97 69.36 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.413 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.68 43.52 18.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.199 1.399 . . . . 0.0 111.813 -173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.08 16.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.73 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 116.318 -0.401 . . . . 0.0 113.742 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.978 0.389 . . . . 0.0 111.787 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.27 49.42 Favored Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.929 2.092 . . . . 0.0 112.376 -174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -74.43 145.09 33.36 Favored 'Trans proline' 0 C--N 1.349 0.599 0 CA-C-N 119.449 0.839 . . . . 0.0 112.442 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.84 40.05 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 168.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 31.3 t80 -104.3 144.11 28.04 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.865 -2.334 . . . . 0.0 110.52 -167.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.4 Cg_endo -78.1 174.49 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-N 119.024 0.687 . . . . 0.0 112.403 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.45 66.76 1.15 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.358 1.463 . . . . 0.0 111.561 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.42 40.42 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.524 1.154 . . . . 0.0 111.064 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' G' ' 67' ' ' TYR . 2.7 tm0? -98.54 -66.09 0.92 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 122.806 1.289 . . . . 0.0 111.061 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' G' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.07 13.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.018 -164.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.99 122.0 5.41 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.367 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 25.0 m -111.91 125.42 54.02 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.451 HG13 ' CG ' ' H' ' 117' ' ' GLU . 1.2 t -123.54 133.37 69.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . 0.592 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 4.5 p -138.1 105.1 5.41 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.39 123.33 7.83 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.238 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.08 11.49 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.02 52.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.709 0.766 . . . . 0.0 110.12 -174.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -128.61 173.87 9.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -167.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.959 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.77 53.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.46 -179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.44 130.49 34.76 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.29 171.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.86 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 155.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.617 ' HG2' ' H ' ' G' ' 52' ' ' ARG . 0.4 OUTLIER -71.98 -39.5 69.26 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.01 1.34 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.611 1.564 . . . . 0.0 111.667 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.614 ' HB ' ' HG3' ' B' ' 9' ' ' GLN . 0.8 OUTLIER 41.15 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.459 1.504 . . . . 0.0 111.551 -164.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.53 0.29 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -103.95 9.84 36.49 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.617 ' H ' ' HG2' ' G' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.47 20.79 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.655 HG13 HG22 ' H' ' 135' ' ' ILE . 0.6 OUTLIER -116.71 6.84 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.887 178.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.919 ' HG ' HG12 ' H' ' 135' ' ' ILE . 0.1 OUTLIER -105.36 22.13 15.96 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 176.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . 0.959 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -93.56 160.85 24.7 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 121.731 0.628 . . . . 0.0 113.929 -170.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.03 151.34 34.92 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' G' ' 41' ' ' ARG . . . -148.92 176.74 27.56 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.44 170.12 14.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.587 0.708 . . . . 0.0 110.466 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.8 129.84 74.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.65 127.1 48.55 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.67 111.76 14.08 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 88.0 p -140.82 144.23 35.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.938 0.895 . . . . 0.0 110.039 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -133.88 149.27 19.69 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.181 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.84 49.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 174.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.55 118.16 33.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 49.3 p -105.59 146.92 29.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' G' ' 32' ' ' GLN . 37.8 p90 -164.19 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.74 123.76 43.16 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -68.15 129.7 26.48 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 114.891 0.717 . . . . 0.0 114.891 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' G' ' 29' ' ' PRO . 7.5 mttm -93.55 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.476 0.655 . . . . 0.0 109.272 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . 0.553 ' HE ' ' HA ' ' L' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.86 78.57 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.19 0.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.83 158.85 43.29 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.072 1.349 . . . . 0.0 110.99 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -74.23 -38.16 63.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -156.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.86 95.63 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.853 168.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -44.68 95.08 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.163 -0.61 . . . . 0.0 111.856 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.92 -29.28 69.11 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.804 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.39 -41.02 96.89 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.947 168.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.493 HD13 ' N ' ' G' ' 79' ' ' ILE . 1.4 mm -63.02 -44.27 99.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 172.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 10.6 mm-40 -62.67 -47.06 85.31 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.732 -0.605 . . . . 0.0 112.387 -177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' G' ' 85' ' ' ASN . 54.9 m-20 -62.71 -39.52 94.28 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.609 169.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.963 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -51.48 -57.6 8.57 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.554 174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.553 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 36.0 t80 -79.34 -53.95 6.42 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.952 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.675 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 2.9 mt-30 -75.03 -34.81 61.93 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' G' ' 81' ' ' ASP . 29.2 t30 -84.19 -27.64 27.89 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.108 172.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.28 77.22 1.15 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.296 -0.253 . . . . 0.0 112.836 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.963 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -139.36 152.57 47.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.622 ' HB3' ' CD1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -84.29 144.39 28.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.469 HD11 ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.83 143.07 29.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' G' ' 16' ' ' GLN . 10.7 mtmt -76.22 137.17 39.81 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' G' ' 132' ' ' LEU . 0.8 OUTLIER -123.72 124.21 42.23 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.512 1.125 . . . . 0.0 110.023 -165.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.631 ' CH2' ' HB2' ' A' ' 162' ' ' GLN . 14.9 m95 -127.38 129.91 48.43 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.202 1.001 . . . . 0.0 108.363 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' G' ' 93' ' ' ARG . 13.4 ptm180 -125.3 120.06 30.13 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' G' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.268 1.032 . . . . 0.0 109.413 -173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . 0.633 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 137.95 31.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.648 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.609 HG23 ' O ' ' G' ' 10' ' ' ASP . 66.9 p -71.99 -21.94 61.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.694 -176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.2 23.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 121.725 0.774 . . . . 0.0 109.911 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.57 129.86 41.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.981 -174.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.654 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 0.7 OUTLIER -76.52 141.26 41.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.79 0.805 . . . . 0.0 109.964 171.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -23.14 35.23 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.85 34.57 5.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.727 0.694 . . . . 0.0 110.922 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.28 176.58 6.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 167.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -59.58 -65.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 121.915 -0.491 . . . . 0.0 110.616 171.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.449 ' CB ' ' HB3' ' G' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.81 6.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.654 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 4.0 p-10 -119.04 134.49 55.16 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.599 0.714 . . . . 0.0 109.426 177.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -136.66 162.49 33.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.077 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.717 ' HB2' ' HG3' ' G' ' 139' ' ' LYS . 43.9 tt0 -132.32 139.34 48.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.13 51.13 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.386 0.674 . . . . 0.0 110.419 -163.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.24 169.14 41.32 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.532 -1.318 . . . . 0.0 111.971 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.668 ' O ' HG13 ' G' ' 134' ' ' VAL . 3.2 m-85 -97.74 128.87 44.7 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 167.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' G' ' 134' ' ' VAL . . . -130.58 160.92 32.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.888 0.851 . . . . 0.0 111.164 -169.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' G' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.024 -174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.561 HD12 ' H ' ' G' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.73 3.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' G' ' 132' ' ' LEU . 4.0 tt0 -70.88 -42.89 69.44 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 20.0 t -163.4 157.73 20.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.984 0.811 . . . . 0.0 109.062 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -137.95 142.97 40.53 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 176.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.505 ' CG ' HG13 ' L' ' 37' ' ' VAL . 4.5 tm-20 -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.06 124.15 51.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.087 0.47 . . . . 0.0 111.191 176.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.23 123.49 48.96 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.693 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.86 125.06 51.01 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.96 157.2 16.0 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.693 0.607 . . . . 0.0 111.604 174.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . 0.67 ' HA ' HE22 ' L' ' 9' ' ' GLN . 21.4 m -69.63 -29.89 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 122.474 -0.427 . . . . 0.0 111.103 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.54 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.77 -142.48 26.73 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.52 162.58 35.48 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.566 0.698 . . . . 0.0 110.733 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.536 HG21 ' HB ' ' L' ' 6' ' ' ILE . 27.0 m -53.57 138.57 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.017 -171.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.49 128.06 49.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.41 122.98 70.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' G' ' 116' ' ' ARG . 2.8 pt -114.56 121.19 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' G' ' 64' ' ' GLU . 3.1 m -107.15 143.26 35.59 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.72 -178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' G' ' 91' ' ' PHE . 2.6 pp -140.28 141.57 35.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.063 -172.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.3 158.76 15.29 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.668 HG13 ' O ' ' G' ' 110' ' ' PHE . 61.4 t -142.37 155.95 18.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.974 HG12 ' HG ' ' L' ' 54' ' ' LEU . 2.1 pt -104.35 31.66 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.352 0.596 . . . . 0.0 110.313 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.75 89.76 1.03 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.767 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . 0.624 ' HG3' HG11 ' G' ' 134' ' ' VAL . 23.6 mt-10 -80.26 133.03 35.94 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.029 0.919 . . . . 0.0 110.674 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.41 150.66 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.717 ' HG3' ' HB2' ' G' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.16 30.58 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.75 1.31 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -104.32 150.34 17.28 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.374 169.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 5.4 tp10 -89.37 133.0 34.7 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 0.5 OUTLIER -98.07 -42.31 11.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.772 -176.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.12 17.05 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.946 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.15 89.02 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.336 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.64 61.24 13.59 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.438 1.895 . . . . 0.0 109.41 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.701 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.6 Cg_exo -68.22 -2.45 8.97 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.274 1.316 . . . . 0.0 115.318 -159.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -37.18 86.41 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.607 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.39 -62.36 1.61 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.82 -49.9 77.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.187 0.903 . . . . 0.0 111.298 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.701 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 41.7 t -70.66 -43.64 77.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' G' ' 147' ' ' PRO . 2.6 t-20 -110.76 113.28 25.75 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.453 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.32 96.39 2.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.8 12.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.37 54.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.17 64.6 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.36 0.982 . . . . 0.0 113.077 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.64 137.2 24.19 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.18 51.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.369 1.068 . . . . 0.0 108.625 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.7 74.18 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.711 2.404 . . . . 0.0 109.166 167.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.52 2.29 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 154.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.84 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.711 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.2 Cg_exo -77.92 12.98 1.82 Allowed 'Trans proline' 0 C--O 1.239 0.568 0 CA-C-N 122.076 1.777 . . . . 0.0 113.873 171.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.58 0.34 Allowed Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.711 HE22 ' HD2' ' G' ' 163' ' ' PRO . 7.0 mp0 -108.61 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.94 1.37 . . . . 0.0 110.943 175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.98 73.1 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.844 1.657 . . . . 0.0 111.853 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.613 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.65 11.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 119.889 -0.725 . . . . 0.0 109.302 -167.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.95 -158.27 8.3 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.488 172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.39 -27.0 63.96 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.808 0.304 . . . . 0.0 111.429 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' G' ' 171' ' ' PRO . . . -72.33 162.17 75.2 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.502 0.721 . . . . 0.0 109.236 -178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' G' ' 170' ' ' ALA . 86.6 Cg_endo -80.88 -9.15 13.19 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.313 1.342 . . . . 0.0 112.768 -156.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.613 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -101.52 154.26 18.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.958 0.879 . . . . 0.0 109.873 170.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.424 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 25.0 m -129.39 168.22 17.1 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.392 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.651 ' HD3' ' HB3' ' G' ' 165' ' ' GLN . 31.4 Cg_exo -70.51 113.57 3.54 Favored 'Trans proline' 0 C--N 1.348 0.55 0 CA-C-N 119.54 0.871 . . . . 0.0 111.742 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.426 1.49 . . . . 0.0 112.321 -171.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.568 ' HA ' ' HE ' ' I' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 1 N-CA-C 100.744 -4.368 . . . . 0.0 100.744 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.574 ' HB ' HG21 ' I' ' 126' ' ' VAL . 4.4 mt -87.22 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.45 166.06 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.909 0.862 . . . . 0.0 110.726 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.72 93.16 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.513 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' I' ' 122' ' ' VAL . 1.6 mm-40 -72.83 -25.99 61.32 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.772 0.786 . . . . 0.0 112.395 172.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.605 ' O ' HG23 ' H' ' 96' ' ' THR . 0.4 OUTLIER -60.75 -46.61 89.78 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -171.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 t -86.67 118.81 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.46 155.4 42.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.66 0.743 . . . . 0.0 110.51 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' H' ' 34' ' ' ASP . 14.4 m-85 -120.66 121.43 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 -164.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.571 ' HG ' ' HB2' ' H' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.54 39.31 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.42 50.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.497 0.665 . . . . 0.0 109.977 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.38 52.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.47 141.21 44.97 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.574 0.702 . . . . 0.0 110.98 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.68 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.8 OUTLIER -66.68 -36.62 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.004 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.27 -13.14 58.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -172.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 -47.92 69.42 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.445 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.71 43.48 18.63 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.199 1.4 . . . . 0.0 111.837 -173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.5 161.09 16.52 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' B' ' 163' ' ' PRO . . . -91.75 47.65 2.76 Favored Glycine 0 N--CA 1.45 -0.37 0 O-C-N 123.379 0.424 . . . . 0.0 113.667 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.26 149.76 2.31 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.01 0.405 . . . . 0.0 111.754 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.28 49.47 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.912 2.085 . . . . 0.0 112.4 -174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -74.37 145.08 33.6 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.431 0.833 . . . . 0.0 112.508 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.47 157.84 40.02 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 168.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.537 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 31.2 t80 -104.31 144.13 28.07 Favored Pre-proline 0 C--N 1.317 -0.831 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.551 -167.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . 0.537 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.0 Cg_endo -78.06 174.53 12.35 Favored 'Trans proline' 0 C--N 1.332 -0.336 0 CA-C-O 121.865 0.694 . . . . 0.0 112.432 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.43 66.75 1.15 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.394 1.477 . . . . 0.0 111.567 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -76.75 139.4 40.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.476 1.131 . . . . 0.0 111.07 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.505 ' HB2' ' HA ' ' H' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.03 0.93 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.55 3.19 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 122.78 1.276 . . . . 0.0 111.121 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' H' ' 13' ' ' TYR . 0.8 OUTLIER -134.88 115.06 13.18 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.025 -164.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.99 5.41 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.368 170.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 24.7 m -111.96 125.39 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.437 HG13 ' HG2' ' I' ' 117' ' ' GLU . 1.2 t -123.53 133.41 69.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . 0.567 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 4.5 p -138.13 105.14 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.214 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.84 101.06 11.46 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -68.15 147.01 52.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.737 0.78 . . . . 0.0 110.141 -174.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.59 173.9 9.87 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -167.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.945 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -66.11 134.79 53.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.505 -179.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.47 34.75 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.264 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.98 0.07 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' H' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.48 69.02 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.97 23.11 1.35 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.59 1.556 . . . . 0.0 111.659 -172.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HG3' ' C' ' 9' ' ' GLN . 0.8 OUTLIER 41.07 61.68 1.67 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.535 1.534 . . . . 0.0 111.516 -164.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.88 -128.48 0.29 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.484 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.03 9.89 36.31 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.25 1.27 Allowed Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.628 ' H ' ' HG2' ' H' ' 46' ' ' GLU . 5.8 mmp_? -108.64 18.49 20.8 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.539 HG13 HG22 ' I' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.79 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.838 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.909 ' HG ' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.08 16.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . 0.945 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -93.49 160.93 24.81 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-O 121.681 0.601 . . . . 0.0 113.936 -170.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.14 151.35 34.43 Favored 'Trans proline' 0 CA--C 1.515 -0.442 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' H' ' 41' ' ' ARG . . . -148.95 176.73 27.6 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.47 170.14 14.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.709 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.77 129.96 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.76 127.05 48.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.63 111.82 14.17 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.87 144.19 35.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.969 0.907 . . . . 0.0 110.048 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -133.93 149.24 19.69 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.191 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.04 142.85 49.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.52 118.19 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 49.8 p -105.6 146.95 28.99 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.505 ' HA ' ' HB2' ' H' ' 32' ' ' GLN . 38.0 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.72 123.81 43.17 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -68.16 129.7 26.47 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' H' ' 29' ' ' PRO . 7.5 mttm -93.49 159.59 15.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.48 0.657 . . . . 0.0 109.256 174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' G' ' 5' ' ' PRO . 0.0 OUTLIER -56.11 -46.8 79.01 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.15 0.17 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.73 158.8 43.37 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.142 1.377 . . . . 0.0 111.04 169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -74.22 -38.2 63.62 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -156.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.85 95.64 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.89 168.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.71 94.98 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.142 -0.623 . . . . 0.0 111.851 171.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.35 69.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.822 171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.42 -41.0 96.85 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.917 168.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.492 HD13 ' N ' ' H' ' 79' ' ' ILE . 1.4 mm -63.08 -44.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.112 0.482 . . . . 0.0 110.506 172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 10.5 mm-40 -62.7 -46.95 85.74 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.737 -0.602 . . . . 0.0 112.443 -178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' H' ' 85' ' ' ASN . 55.3 m-20 -62.77 -39.55 94.54 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.563 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.983 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -51.45 -57.61 8.53 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.575 174.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 36.1 t80 -79.4 -53.95 6.41 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.903 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.702 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 2.9 mt-30 -74.96 -34.88 62.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -167.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' H' ' 81' ' ' ASP . 29.1 t30 -84.16 -27.71 27.91 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.037 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.23 77.2 1.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 O-C-N 122.378 -0.201 . . . . 0.0 112.883 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.983 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -139.29 152.56 47.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.623 ' HB3' ' CD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -84.31 144.4 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.84 143.08 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 121.394 0.616 . . . . 0.0 109.83 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.69 ' HB2' ' O ' ' H' ' 16' ' ' GLN . 10.7 mtmt -76.2 137.16 39.83 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.716 ' HE1' HD21 ' H' ' 132' ' ' LEU . 0.8 OUTLIER -123.73 124.19 42.17 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.539 1.136 . . . . 0.0 110.031 -166.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.604 ' HH2' ' HB2' ' B' ' 160' ' ' PHE . 15.0 m95 -127.39 129.88 48.37 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' H' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.05 30.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' H' ' 106' ' ' ALA . 1.1 m -134.07 157.41 41.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.235 1.017 . . . . 0.0 109.41 -173.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . 0.641 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.4 OUTLIER -92.51 138.0 31.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.635 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.605 HG23 ' O ' ' H' ' 10' ' ' ASP . 67.6 p -72.05 -21.96 61.45 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.885 -1.052 . . . . 0.0 112.65 -176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.49 137.24 23.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 121.668 0.746 . . . . 0.0 109.929 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 129.96 41.59 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.942 -174.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.821 0.819 . . . . 0.0 109.952 171.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.21 35.34 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.84 34.63 5.14 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.749 0.704 . . . . 0.0 110.9 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.34 176.62 6.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.811 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -59.57 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.839 -0.538 . . . . 0.0 110.571 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.455 ' CB ' ' HB3' ' H' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.36 55.24 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.636 0.731 . . . . 0.0 109.453 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.862 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -136.61 162.53 32.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.07 -163.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.712 ' HB2' ' HG3' ' H' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.28 48.1 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 157.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.2 151.18 51.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.42 0.688 . . . . 0.0 110.455 -163.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.13 41.35 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.529 -1.32 . . . . 0.0 111.968 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG13 ' H' ' 134' ' ' VAL . 3.2 m-85 -97.77 128.82 44.69 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' H' ' 134' ' ' VAL . . . -130.51 160.89 32.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.932 0.872 . . . . 0.0 111.179 -169.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.623 ' CD1' ' HB3' ' H' ' 88' ' ' GLN . 1.7 t80 -125.16 165.15 18.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.986 -174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.551 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.75 3.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.412 ' H ' ' HA ' ' H' ' 132' ' ' LEU . 4.0 tt0 -70.91 -42.94 69.27 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 19.9 t -163.35 157.75 20.45 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.943 0.792 . . . . 0.0 109.117 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.907 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -138.01 142.98 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.451 ' CG ' HG13 ' G' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.69 33.21 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.08 124.07 51.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.019 0.437 . . . . 0.0 111.224 176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.18 123.47 48.96 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.687 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.85 125.0 50.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' G' ' 8' ' ' GLY . . . -120.89 157.24 15.97 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . 0.731 ' HA ' HE22 ' G' ' 9' ' ' GLN . 21.6 m -69.67 -29.93 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.544 -0.386 . . . . 0.0 111.112 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.0 155.23 17.53 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.76 -142.44 26.68 Favored Glycine 0 C--O 1.243 0.703 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.51 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.534 0.683 . . . . 0.0 110.758 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' G' ' 6' ' ' ILE . 27.1 m -53.53 138.52 12.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.013 -171.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.46 128.08 49.31 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.095 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.44 123.03 71.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.15 114.0 27.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.907 HG22 ' HG2' ' H' ' 116' ' ' ARG . 2.8 pt -114.57 121.19 66.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' H' ' 64' ' ' GLU . 3.1 m -107.12 143.19 35.63 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.716 HD21 ' HE1' ' H' ' 91' ' ' PHE . 2.6 pp -140.3 141.58 35.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.153 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.667 HG13 ' O ' ' H' ' 110' ' ' PHE . 61.5 t -142.34 155.9 18.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.919 HG12 ' HG ' ' G' ' 54' ' ' LEU . 2.1 pt -104.29 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.325 0.583 . . . . 0.0 110.352 -173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.78 89.86 1.04 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.713 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . 0.641 ' HG3' HG11 ' H' ' 134' ' ' VAL . 23.6 mt-10 -80.33 133.07 35.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.038 0.923 . . . . 0.0 110.644 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.46 150.67 37.48 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.716 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 0.4 OUTLIER -98.63 142.19 30.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.71 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -104.33 150.36 17.28 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.37 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.862 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 5.4 tp10 -89.48 132.94 34.79 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.811 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.31 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.771 -176.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.08 17.0 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.96 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -63.0 -46.09 89.28 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.391 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.61 61.29 13.48 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.445 1.898 . . . . 0.0 109.376 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.703 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -68.25 -2.42 8.95 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.218 1.279 . . . . 0.0 115.318 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -37.21 86.5 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.589 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.38 -62.34 1.61 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 119.175 0.898 . . . . 0.0 111.246 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.703 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 41.6 t -70.69 -43.58 77.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' H' ' 147' ' ' PRO . 2.5 t-20 -110.75 113.37 25.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.43 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.4 96.4 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.8 163.8 12.01 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.58 -4.42 54.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.0 2.21 64.65 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 119.386 0.993 . . . . 0.0 113.047 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.22 24.17 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.2 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.31 1.044 . . . . 0.0 108.617 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.63 -49.6 74.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.84 155.27 44.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.673 2.389 . . . . 0.0 109.154 167.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.01 88.51 2.29 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 153.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.78 0.1 OUTLIER Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.722 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.3 Cg_exo -77.96 13.01 1.82 Allowed 'Trans proline' 0 C--O 1.238 0.477 0 CA-C-N 122.074 1.776 . . . . 0.0 113.882 171.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.01 90.62 0.33 Allowed Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.722 HE22 ' HD2' ' H' ' 163' ' ' PRO . 7.0 mp0 -108.63 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.869 1.335 . . . . 0.0 110.953 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 19.2 m 31.99 73.08 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.836 1.654 . . . . 0.0 111.877 176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.628 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.2 OUTLIER -92.86 168.67 11.02 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.298 -167.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.508 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -27.0 63.93 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.775 0.287 . . . . 0.0 111.447 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . 0.48 ' HB1' ' HD2' ' H' ' 171' ' ' PRO . . . -72.29 162.2 75.0 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 123.454 0.701 . . . . 0.0 109.292 -178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' H' ' 170' ' ' ALA . 87.1 Cg_endo -80.93 -9.1 13.14 Favored 'Trans proline' 0 C--N 1.323 -0.78 0 C-N-CA 121.313 1.342 . . . . 0.0 112.798 -156.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.82 97.73 0.16 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.21 1.644 . . . . 0.0 117.21 165.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.628 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -101.51 154.23 19.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.025 0.913 . . . . 0.0 109.858 170.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.418 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 24.8 m -129.32 168.26 16.89 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.451 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' H' ' 165' ' ' GLN . 31.5 Cg_exo -70.57 113.55 3.54 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.501 0.857 . . . . 0.0 111.745 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.43 1.492 . . . . 0.0 112.275 -171.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.623 ' HA ' ' HE ' ' J' ' 71' ' ' ARG . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.114 1 N-CA-C 100.766 -4.359 . . . . 0.0 100.766 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.505 HG22 ' HB3' ' I' ' 10' ' ' ASP . 4.4 mt -87.27 130.69 36.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.07 16.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.959 0.885 . . . . 0.0 110.749 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.71 93.11 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.502 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . 0.615 HE22 ' HA ' ' J' ' 122' ' ' VAL . 1.6 mm-40 -72.89 -25.96 61.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.734 0.767 . . . . 0.0 112.436 172.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.608 ' O ' HG23 ' I' ' 96' ' ' THR . 0.4 OUTLIER -60.77 -46.6 89.85 Favored 'General case' 0 CA--C 1.521 -0.173 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.438 ' CG2' HG11 ' J' ' 126' ' ' VAL . 23.2 t -86.58 118.76 33.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.42 155.38 42.28 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.668 0.747 . . . . 0.0 110.518 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.43 ' CE1' ' OD1' ' I' ' 34' ' ' ASP . 14.2 m-85 -120.62 121.34 38.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.78 -164.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' I' ' 92' ' ' TRP . 0.3 OUTLIER -120.53 151.61 39.16 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.42 50.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.46 0.648 . . . . 0.0 109.944 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.681 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 5.1 tt0 -121.91 129.36 52.48 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.49 141.19 44.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.026 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.8 OUTLIER -66.63 -36.61 77.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.006 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -81.31 -13.17 58.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.11 -48.06 69.29 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.101 -0.639 . . . . 0.0 111.438 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.51 18.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 111.798 -173.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.5 161.16 16.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.78 47.56 2.75 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.306 -0.407 . . . . 0.0 113.717 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.24 149.77 2.32 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.986 0.393 . . . . 0.0 111.82 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.79 110.19 49.55 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 127.012 2.125 . . . . 0.0 112.409 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -74.37 145.13 33.68 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.435 0.834 . . . . 0.0 112.485 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.49 157.83 40.05 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 168.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 31.2 t80 -104.33 144.07 27.95 Favored Pre-proline 0 C--N 1.316 -0.888 0 C-N-CA 115.859 -2.336 . . . . 0.0 110.53 -167.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 49.7 Cg_endo -78.03 174.53 12.37 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.851 0.688 . . . . 0.0 112.472 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.72 1.16 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.384 1.474 . . . . 0.0 111.57 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.75 139.41 40.42 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.545 1.164 . . . . 0.0 111.069 173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.523 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -98.5 -66.08 0.92 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.83 155.61 3.22 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.793 1.283 . . . . 0.0 111.076 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' CE1' ' I' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.05 13.16 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.031 -1.441 . . . . 0.0 107.998 -164.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.96 122.01 5.42 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.353 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 24.9 m -111.98 125.39 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.133 -2.173 . . . . 0.0 105.133 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.607 HG13 ' CG ' ' J' ' 117' ' ' GLU . 1.2 t -123.5 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -173.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . 0.547 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 4.5 p -138.09 105.07 5.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.38 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.261 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.6 tt0 -101.84 101.1 11.5 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.466 ' O ' ' HA3' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.04 52.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -174.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' J' ' 112' ' ' TYR . 21.1 mt-10 -128.67 173.85 9.94 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -167.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.953 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.77 53.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.518 -179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.54 130.46 34.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.253 171.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.53 113.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.63 ' HG2' ' H ' ' I' ' 52' ' ' ARG . 0.4 OUTLIER -72.01 -39.46 69.18 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.99 23.05 1.35 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.615 1.566 . . . . 0.0 111.653 -172.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.527 ' HB ' ' HG3' ' D' ' 9' ' ' GLN . 0.8 OUTLIER 41.06 61.71 1.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.538 1.535 . . . . 0.0 111.567 -164.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.89 -128.49 0.29 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.458 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.03 9.84 36.32 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.29 83.23 1.27 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.63 ' H ' ' HG2' ' I' ' 46' ' ' GLU . 5.8 mmp_? -108.61 18.48 20.82 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.757 HG13 HG22 ' J' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.9 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 1.047 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER -105.31 22.15 15.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 176.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . 0.953 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -93.48 160.86 24.78 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-O 121.658 0.588 . . . . 0.0 113.943 -170.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.06 151.35 34.79 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.861 0.677 . . . . 0.0 113.861 -175.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' I' ' 41' ' ' ARG . . . -148.96 176.7 27.63 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.45 170.12 14.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 0.0 110.504 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.75 129.95 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.78 127.08 48.73 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.76 14.09 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -171.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 87.8 p -140.83 144.22 35.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.922 0.889 . . . . 0.0 110.068 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -133.9 149.19 19.67 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.185 176.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.89 49.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.56 118.21 34.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 49.5 p -105.64 146.92 29.07 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' I' ' 32' ' ' GLN . 37.8 p90 -164.18 170.48 16.29 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.75 123.78 43.19 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -68.14 129.68 26.5 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -175.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' I' ' 29' ' ' PRO . 7.5 mttm -93.47 159.54 15.2 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.423 0.63 . . . . 0.0 109.33 174.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.568 ' HE ' ' HA ' ' H' ' 5' ' ' PRO . 0.0 OUTLIER -55.98 -46.86 78.52 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -172.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.16 0.17 Allowed Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.76 158.82 43.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.137 1.375 . . . . 0.0 111.03 169.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.502 ' O ' ' N ' ' I' ' 78' ' ' ALA . . . -74.24 -38.21 63.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -156.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.45 -43.83 95.65 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.885 168.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -44.62 95.26 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.838 171.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.757 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' I' ' 74' ' ' ALA . . . -64.46 -40.97 96.73 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.925 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.495 HD13 ' N ' ' I' ' 79' ' ' ILE . 1.4 mm -63.03 -44.3 99.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.036 0.446 . . . . 0.0 110.465 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.07 85.39 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.73 -0.606 . . . . 0.0 112.408 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' I' ' 85' ' ' ASN . 55.1 m-20 -62.71 -39.55 94.38 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.582 169.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 1.008 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -51.47 -57.62 8.52 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.567 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 36.1 t80 -79.32 -54.02 6.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.954 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 2.9 mt-30 -74.9 -34.89 62.24 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -167.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' I' ' 81' ' ' ASP . 29.1 t30 -84.12 -27.78 27.93 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.024 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.31 77.15 1.16 Allowed Glycine 0 N--CA 1.449 -0.483 0 O-C-N 122.321 -0.237 . . . . 0.0 112.882 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 1.008 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -139.28 152.57 47.37 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.619 ' HB3' ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -84.27 144.4 28.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 168.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.466 HD11 ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.83 143.05 29.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.32 0.581 . . . . 0.0 109.857 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' I' ' 16' ' ' GLN . 10.7 mtmt -76.19 137.11 39.81 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.737 ' HE1' HD21 ' I' ' 132' ' ' LEU . 0.8 OUTLIER -123.64 124.19 42.23 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.486 1.115 . . . . 0.0 110.005 -165.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.58 ' HB2' ' HG ' ' I' ' 14' ' ' LEU . 15.0 m95 -127.37 129.91 48.44 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.185 0.994 . . . . 0.0 108.323 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' I' ' 93' ' ' ARG . 13.4 ptm180 -125.26 120.07 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' I' ' 106' ' ' ALA . 1.1 m -134.07 157.44 41.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.221 1.01 . . . . 0.0 109.421 -173.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . 0.629 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.4 OUTLIER -92.57 138.04 31.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.63 179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.608 HG23 ' O ' ' I' ' 10' ' ' ASP . 67.1 p -72.07 -21.92 61.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.67 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.53 137.24 23.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.692 0.758 . . . . 0.0 109.869 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 129.95 41.55 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.949 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.65 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 0.7 OUTLIER -76.54 141.21 41.28 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.805 0.812 . . . . 0.0 110.001 171.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.14 35.35 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -120.88 34.56 5.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.782 0.719 . . . . 0.0 110.872 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.62 6.56 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.805 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.75 0.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.896 -0.502 . . . . 0.0 110.6 171.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' I' ' 142' ' ' GLU . 2.1 m-85 -139.66 -179.74 6.09 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.65 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 4.0 p-10 -119.15 134.46 55.19 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.673 0.749 . . . . 0.0 109.406 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -136.67 162.52 32.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.079 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.733 ' HB2' ' HG3' ' I' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.29 48.1 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 157.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.28 151.15 51.11 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.415 0.686 . . . . 0.0 110.363 -163.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.3 169.14 41.35 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.473 -1.346 . . . . 0.0 111.975 170.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' I' ' 134' ' ' VAL . 3.2 m-85 -97.73 128.81 44.66 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.512 ' CB ' HG22 ' I' ' 134' ' ' VAL . . . -130.5 160.92 32.66 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.941 0.877 . . . . 0.0 111.136 -169.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' I' ' 88' ' ' GLN . 1.7 t80 -125.2 165.17 18.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.498 -1.228 . . . . 0.0 107.972 -174.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.556 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.2 OUTLIER -95.77 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' I' ' 132' ' ' LEU . 4.0 tt0 -70.83 -42.99 69.48 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.37 157.71 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.914 0.779 . . . . 0.0 109.102 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.901 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.92 40.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.894 -2.261 . . . . 0.0 104.894 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.437 ' HG2' HG13 ' H' ' 37' ' ' VAL . 4.5 tm-20 -133.83 127.66 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.01 124.16 51.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.26 123.45 48.83 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.68 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.81 125.02 50.93 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.91 157.25 15.98 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-O 121.726 0.626 . . . . 0.0 111.6 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . 0.66 ' HA ' HE22 ' H' ' 9' ' ' GLN . 21.1 m -69.74 -29.8 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 122.467 -0.431 . . . . 0.0 111.078 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.12 155.22 17.57 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.48 26.69 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.59 35.48 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.592 0.711 . . . . 0.0 110.743 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.574 HG21 ' HB ' ' H' ' 6' ' ' ILE . 27.1 m -53.55 138.54 12.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.994 -171.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.44 128.02 49.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.114 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 12.1 mt -116.49 123.08 71.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.901 HG22 ' HG2' ' I' ' 116' ' ' ARG . 2.8 pt -114.57 121.23 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' I' ' 64' ' ' GLU . 3.1 m -107.15 143.22 35.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.755 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.737 HD21 ' HE1' ' I' ' 91' ' ' PHE . 2.7 pp -140.29 141.6 35.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.092 -172.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 158.77 15.29 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' I' ' 110' ' ' PHE . 61.7 t -142.35 155.88 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.909 HG12 ' HG ' ' H' ' 54' ' ' LEU . 2.1 pt -104.28 31.63 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.363 0.602 . . . . 0.0 110.377 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.84 89.76 1.03 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.724 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' I' ' 134' ' ' VAL . 23.6 mt-10 -80.29 133.07 35.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.09 0.948 . . . . 0.0 110.63 174.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.44 150.63 37.52 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.733 ' HG3' ' HB2' ' I' ' 107' ' ' GLN . 0.4 OUTLIER -98.62 142.19 30.51 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.72 -163.74 1.31 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -104.35 150.35 17.27 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.205 -0.997 . . . . 0.0 111.352 169.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 5.4 tp10 -89.44 132.92 34.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -174.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.805 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.32 11.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.749 -176.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.42 109.03 16.99 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.959 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.89 -46.13 89.28 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.422 175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.3 13.49 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 109.39 -173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.721 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -68.32 -2.33 8.85 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.224 1.283 . . . . 0.0 115.344 -159.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -37.13 86.23 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.564 171.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.43 -62.32 1.62 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.87 -49.89 77.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.165 0.893 . . . . 0.0 111.282 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.721 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 41.7 t -70.7 -43.61 77.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' I' ' 147' ' ' PRO . 2.6 t-20 -110.74 113.26 25.71 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.466 -176.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.3 96.41 2.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.76 163.76 12.03 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.61 -4.34 53.78 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.99 2.23 64.67 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 119.396 0.998 . . . . 0.0 113.016 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.73 137.21 24.08 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.24 146.14 51.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.364 1.066 . . . . 0.0 108.66 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.61 -49.6 74.57 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -158.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.81 155.27 44.08 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.696 2.398 . . . . 0.0 109.171 167.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.46 2.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.76 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.631 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 -166.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.693 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.2 Cg_exo -77.95 13.06 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.54 0 CA-C-N 122.055 1.769 . . . . 0.0 113.875 171.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.57 0.34 Allowed Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.693 HE22 ' HD2' ' I' ' 163' ' ' PRO . 6.9 mp0 -108.69 56.32 0.62 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.892 1.346 . . . . 0.0 110.9 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.88 73.13 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.8 1.64 . . . . 0.0 111.91 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.639 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.316 -167.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.96 -158.21 8.28 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.43 172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.52 -27.0 63.84 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.787 0.293 . . . . 0.0 111.378 -177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' I' ' 171' ' ' PRO . . . -72.3 162.23 74.85 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 123.449 0.7 . . . . 0.0 109.302 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' I' ' 170' ' ' ALA . 85.1 Cg_endo -81.03 -9.01 13.04 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.289 1.326 . . . . 0.0 112.722 -156.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.9 97.78 0.16 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.639 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.28 18.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.962 0.881 . . . . 0.0 109.879 170.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 25.0 m -129.37 168.32 16.73 Favored Pre-proline 0 C--O 1.24 0.604 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.431 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' I' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.53 3.54 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.502 0.858 . . . . 0.0 111.736 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 125.423 1.489 . . . . 0.0 112.307 -171.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.602 ' HA ' ' HE ' ' K' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 1 N-CA-C 100.777 -4.355 . . . . 0.0 100.777 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' J' ' 10' ' ' ASP . 4.4 mt -87.24 130.67 36.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.5 166.08 16.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.906 0.86 . . . . 0.0 110.722 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.02 -37.7 93.14 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.495 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . 0.652 HE22 ' HA ' ' K' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.98 61.28 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.786 0.793 . . . . 0.0 112.387 172.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.596 ' O ' HG23 ' J' ' 96' ' ' THR . 0.4 OUTLIER -60.76 -46.62 89.74 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -172.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.462 ' CG2' HG11 ' K' ' 126' ' ' VAL . 23.5 t -86.68 118.88 33.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.48 155.31 42.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 110.537 176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.438 ' CE1' ' OD1' ' J' ' 34' ' ' ASP . 14.1 m-85 -120.57 121.46 38.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.795 -164.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.575 ' HG ' ' HB2' ' J' ' 92' ' ' TRP . 0.3 OUTLIER -120.67 151.58 39.31 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 174.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.77 145.4 50.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.523 0.677 . . . . 0.0 109.93 176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.693 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 5.1 tt0 -121.92 129.35 52.46 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p -74.41 141.2 45.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.04 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.784 HG22 ' HB ' ' D' ' 167' ' ' THR . 0.8 OUTLIER -66.62 -36.63 77.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.002 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -81.35 -13.15 58.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.08 -48.08 69.31 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.458 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.76 43.58 18.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 111.782 -173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -111.55 161.07 16.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' D' ' 163' ' ' PRO . . . -91.7 47.62 2.77 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 116.322 -0.399 . . . . 0.0 113.77 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.22 149.77 2.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.983 0.391 . . . . 0.0 111.817 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 110.25 49.43 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 127.003 2.121 . . . . 0.0 112.438 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.39 145.08 33.53 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.451 0.84 . . . . 0.0 112.484 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.54 157.87 40.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 168.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.542 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 31.4 t80 -104.34 144.12 28.05 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.509 -167.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . 0.542 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 49.7 Cg_endo -78.05 174.5 12.4 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.853 0.689 . . . . 0.0 112.405 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 66.8 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.379 1.472 . . . . 0.0 111.552 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -76.8 139.43 40.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.543 1.163 . . . . 0.0 111.073 173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' J' ' 67' ' ' TYR . 2.7 tm0? -98.57 -66.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.61 3.26 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.789 1.28 . . . . 0.0 111.087 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.438 ' OD1' ' CE1' ' J' ' 13' ' ' TYR . 0.8 OUTLIER -134.87 115.06 13.2 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.035 -1.439 . . . . 0.0 107.998 -164.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.0 122.03 5.42 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.337 170.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -112.0 125.37 54.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' K' ' 117' ' ' GLU . 1.3 t -123.49 133.4 69.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . 0.493 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 4.5 p -138.1 105.17 5.43 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.24 7.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.245 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -101.83 101.07 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.06 52.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.719 0.771 . . . . 0.0 110.125 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.7 173.89 9.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -167.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.969 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -66.02 134.77 53.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.515 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.51 130.49 34.74 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.241 171.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.49 113.92 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 155.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.629 ' HG2' ' H ' ' J' ' 52' ' ' ARG . 0.4 OUTLIER -72.05 -39.44 69.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.96 23.08 1.36 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.645 1.578 . . . . 0.0 111.678 -172.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.609 ' HB ' ' HG3' ' E' ' 9' ' ' GLN . 0.8 OUTLIER 41.1 61.69 1.67 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.543 1.537 . . . . 0.0 111.519 -164.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.9 -128.5 0.29 Allowed 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.473 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.04 9.96 36.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.26 1.28 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.629 ' H ' ' HG2' ' J' ' 46' ' ' GLU . 5.8 mmp_? -108.66 18.49 20.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.645 HG13 HG22 ' K' ' 135' ' ' ILE . 0.6 OUTLIER -116.75 6.77 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.875 178.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.931 ' HG ' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER -105.34 22.15 15.92 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 176.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . 0.969 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -93.5 160.84 24.75 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-O 121.666 0.592 . . . . 0.0 113.922 -170.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.04 151.33 34.84 Favored 'Trans proline' 0 CA--C 1.515 -0.44 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' J' ' 41' ' ' ARG . . . -148.94 176.63 27.63 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.14 14.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.554 0.692 . . . . 0.0 110.501 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 t -119.78 129.92 74.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.79 127.09 48.73 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.64 111.79 14.13 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -171.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -140.81 144.24 35.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.924 0.889 . . . . 0.0 110.074 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -133.94 149.19 19.68 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.163 176.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -121.98 142.84 49.9 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 174.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.49 118.27 34.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 49.7 p -105.68 146.93 29.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.5 ' HA ' ' HB2' ' J' ' 32' ' ' GLN . 37.7 p90 -164.2 170.45 16.31 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -98.73 123.79 43.17 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.17 129.73 26.46 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 114.915 0.726 . . . . 0.0 114.915 -175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' J' ' 29' ' ' PRO . 7.5 mttm -93.58 159.53 15.18 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . 0.623 ' HE ' ' HA ' ' I' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.81 78.58 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.55 100.16 0.17 Allowed Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.83 43.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.106 1.362 . . . . 0.0 110.982 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' J' ' 78' ' ' ALA . . . -74.21 -38.18 63.65 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.84 95.75 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.851 168.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -44.64 95.06 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.109 -0.642 . . . . 0.0 111.901 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.87 -29.33 69.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.811 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' J' ' 74' ' ' ALA . . . -64.48 -40.95 96.64 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.902 168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.488 HD13 ' N ' ' J' ' 79' ' ' ILE . 1.4 mm -63.13 -44.19 99.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.033 0.444 . . . . 0.0 110.47 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 10.6 mm-40 -62.63 -47.08 85.31 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.763 -0.585 . . . . 0.0 112.428 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' J' ' 85' ' ' ASN . 55.0 m-20 -62.72 -39.52 94.31 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.603 169.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 1.021 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -51.46 -57.64 8.44 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.551 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.547 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 36.1 t80 -79.33 -54.0 6.38 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.938 -174.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.626 ' OE1' ' HB2' ' I' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.9 62.19 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' J' ' 81' ' ' ASP . 29.0 t30 -84.15 -27.74 27.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.012 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.2 1.16 Allowed Glycine 0 N--CA 1.448 -0.529 0 O-C-N 122.238 -0.289 . . . . 0.0 112.835 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 1.021 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -139.31 152.58 47.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.625 ' HB3' ' CD1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.43 28.89 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.459 HD11 ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.86 143.05 29.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.366 0.603 . . . . 0.0 109.83 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' J' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.09 39.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.733 ' HE1' HD21 ' J' ' 132' ' ' LEU . 0.8 OUTLIER -123.69 124.22 42.26 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.535 1.134 . . . . 0.0 110.014 -166.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB2' ' D' ' 162' ' ' GLN . 15.0 m95 -127.37 129.9 48.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.205 1.002 . . . . 0.0 108.311 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.536 ' O ' ' HG3' ' J' ' 93' ' ' ARG . 13.4 ptm180 -125.27 120.09 30.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' J' ' 106' ' ' ALA . 1.1 m -134.09 157.4 41.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.254 1.026 . . . . 0.0 109.416 -173.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . 0.625 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.4 OUTLIER -92.53 138.04 31.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.639 179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.596 HG23 ' O ' ' J' ' 10' ' ' ASP . 67.0 p -72.06 -21.97 61.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.649 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.55 137.2 23.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.724 0.773 . . . . 0.0 109.907 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 129.94 41.54 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.93 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.649 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 0.7 OUTLIER -76.58 141.23 41.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.845 0.831 . . . . 0.0 109.944 171.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.23 35.41 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.87 34.66 5.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.772 0.715 . . . . 0.0 110.886 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.33 176.6 6.57 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.806 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -59.56 -65.77 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.89 -0.506 . . . . 0.0 110.575 171.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.456 ' CB ' ' HB3' ' J' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.76 6.11 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.649 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 4.0 p-10 -119.13 134.44 55.2 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.677 0.751 . . . . 0.0 109.423 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.871 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -136.6 162.54 32.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.034 -163.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.729 ' HB2' ' HG3' ' J' ' 139' ' ' LYS . 43.9 tt0 -132.33 139.23 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 157.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -130.18 151.21 50.95 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.421 0.688 . . . . 0.0 110.436 -163.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.1 41.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.953 170.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.67 ' O ' HG13 ' J' ' 134' ' ' VAL . 3.2 m-85 -97.76 128.83 44.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.508 ' CB ' HG22 ' J' ' 134' ' ' VAL . . . -130.54 160.95 32.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.94 0.876 . . . . 0.0 111.175 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' J' ' 88' ' ' GLN . 1.7 t80 -125.15 165.16 18.74 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.008 -174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.544 ' H ' HD12 ' J' ' 113' ' ' ILE . 0.2 OUTLIER -95.8 92.71 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' J' ' 132' ' ' LEU . 4.0 tt0 -70.86 -42.93 69.45 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.4 157.71 20.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.961 0.801 . . . . 0.0 109.082 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.892 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -137.98 142.97 40.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.607 ' CG ' HG13 ' I' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.68 33.15 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.414 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.1 OUTLIER -113.08 124.08 51.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.047 0.451 . . . . 0.0 111.215 176.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.19 123.51 49.07 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.66 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.02 50.95 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.26 15.99 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.615 ' HA ' HE22 ' I' ' 9' ' ' GLN . 21.0 m -69.74 -29.85 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 122.53 -0.394 . . . . 0.0 111.064 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.06 155.21 17.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.85 -142.49 26.65 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . . . . . . . . . . . -143.57 162.58 35.5 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.591 0.71 . . . . 0.0 110.71 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' I' ' 6' ' ' ILE . 27.1 m -53.52 138.49 12.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.0 -171.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.41 128.04 49.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.141 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 12.0 mt -116.44 123.02 71.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.12 114.03 27.92 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.892 HG22 ' HG2' ' J' ' 116' ' ' ARG . 2.8 pt -114.61 121.18 66.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' J' ' 64' ' ' GLU . 3.1 m -107.1 143.25 35.52 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.727 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.733 HD21 ' HE1' ' J' ' 91' ' ' PHE . 2.6 pp -140.33 141.59 35.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.108 -172.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.27 158.69 15.32 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' J' ' 110' ' ' PHE . 61.6 t -142.29 155.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 1.047 HG12 ' HG ' ' I' ' 54' ' ' LEU . 2.1 pt -104.25 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.301 0.572 . . . . 0.0 110.351 -173.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.81 89.77 1.03 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' J' ' 134' ' ' VAL . 23.6 mt-10 -80.28 133.06 35.94 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.999 0.904 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.403 HD21 ' HA3' ' D' ' 157' ' ' GLY . 0.0 OUTLIER -116.46 150.66 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -174.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' J' ' 107' ' ' GLN . 0.4 OUTLIER -98.63 142.23 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.74 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -104.31 150.32 17.27 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.408 169.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.871 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 5.4 tp10 -89.38 132.98 34.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.806 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 0.5 OUTLIER -98.06 -42.29 11.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.755 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.4 109.05 16.99 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.98 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.99 -46.07 89.43 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 118.717 -0.658 . . . . 0.0 112.394 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.57 61.33 13.38 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.445 1.898 . . . . 0.0 109.397 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.719 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -68.33 -2.37 8.93 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.242 1.294 . . . . 0.0 115.332 -159.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -37.19 86.44 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.618 171.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.3 1.62 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.9 -49.93 77.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 119.118 0.872 . . . . 0.0 111.26 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.719 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 41.6 t -70.64 -43.6 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' J' ' 147' ' ' PRO . 2.6 t-20 -110.79 113.3 25.79 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.485 -176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 11.0 p -131.37 96.46 2.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 171.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.81 163.77 12.02 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.62 -4.35 53.84 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.95 2.23 64.75 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 119.439 1.018 . . . . 0.0 113.071 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.23 24.18 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.16 51.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.375 1.07 . . . . 0.0 108.64 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.59 -49.65 74.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.82 155.29 44.08 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.654 2.382 . . . . 0.0 109.114 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.93 88.43 2.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.039 -1.837 . . . . 0.0 106.039 154.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.8 -29.77 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -166.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.727 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.2 Cg_exo -77.97 13.0 1.83 Allowed 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.073 1.776 . . . . 0.0 113.838 171.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.07 90.57 0.34 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 118.388 2.115 . . . . 0.0 118.388 -171.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.727 HE22 ' HD2' ' J' ' 163' ' ' PRO . 7.0 mp0 -108.7 56.21 0.63 Allowed 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.925 1.362 . . . . 0.0 110.916 175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 32.01 73.09 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.766 1.626 . . . . 0.0 111.888 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.635 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.2 OUTLIER -92.9 168.67 11.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.304 -167.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.97 -158.24 8.29 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.462 172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -27.0 63.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.771 0.285 . . . . 0.0 111.419 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' J' ' 171' ' ' PRO . . . -72.35 162.23 74.91 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.424 0.69 . . . . 0.0 109.264 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' J' ' 170' ' ' ALA . 86.3 Cg_endo -80.94 -9.1 13.13 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.294 1.329 . . . . 0.0 112.749 -156.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.77 0.16 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 165.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.635 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -101.53 154.27 18.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.954 0.877 . . . . 0.0 109.904 170.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 25.3 m -129.4 168.29 16.85 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.416 178.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' J' ' 165' ' ' GLN . 31.5 Cg_exo -70.58 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.564 0.88 . . . . 0.0 111.709 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.404 1.482 . . . . 0.0 112.332 -171.717 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.504 ' HA ' ' HE ' ' L' ' 71' ' ' ARG . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.163 1 N-CA-C 100.754 -4.364 . . . . 0.0 100.754 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' K' ' 10' ' ' ASP . 4.4 mt -87.22 130.6 36.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.42 166.02 16.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.927 0.87 . . . . 0.0 110.777 -177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.97 -37.71 93.08 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.372 -0.831 . . . . 0.0 114.489 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . 0.653 HE22 ' HA ' ' L' ' 122' ' ' VAL . 1.6 mm-40 -72.93 -25.92 61.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 117.801 0.801 . . . . 0.0 112.391 172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.604 ' O ' HG23 ' K' ' 96' ' ' THR . 0.4 OUTLIER -60.81 -46.55 90.09 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -172.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.503 ' CG2' HG11 ' L' ' 126' ' ' VAL . 23.5 t -86.7 118.8 33.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -126.44 155.34 42.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.72 0.772 . . . . 0.0 110.481 176.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' K' ' 34' ' ' ASP . 14.3 m-85 -120.62 121.44 38.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.743 -164.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' K' ' 92' ' ' TRP . 0.3 OUTLIER -120.61 151.6 39.23 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.75 145.39 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.442 0.639 . . . . 0.0 109.96 176.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.685 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 5.1 tt0 -121.88 129.33 52.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.44 141.18 45.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.561 0.696 . . . . 0.0 110.995 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' E' ' 167' ' ' THR . 0.8 OUTLIER -66.63 -36.59 77.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.991 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.37 -13.12 58.67 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.14 -48.03 69.3 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.422 -175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.75 43.52 18.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.19 1.396 . . . . 0.0 111.837 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 2.6 t -111.55 161.11 16.53 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.74 47.61 2.76 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 113.743 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.19 149.76 2.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.981 0.391 . . . . 0.0 111.81 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.76 110.25 49.59 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.976 2.11 . . . . 0.0 112.414 -174.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.36 145.08 33.64 Favored 'Trans proline' 0 C--N 1.349 0.554 0 CA-C-N 119.44 0.836 . . . . 0.0 112.488 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.5 157.82 40.11 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.536 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 31.2 t80 -104.33 144.06 27.94 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.856 -2.337 . . . . 0.0 110.549 -167.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 49.9 Cg_endo -78.0 174.51 12.4 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.904 0.71 . . . . 0.0 112.414 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.4 66.76 1.15 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.414 1.486 . . . . 0.0 111.561 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -76.79 139.49 40.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.588 1.185 . . . . 0.0 111.028 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' K' ' 67' ' ' TYR . 2.7 tm0? -98.56 -66.11 0.92 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.77 155.6 3.26 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.776 1.274 . . . . 0.0 111.102 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.447 ' OD1' ' CE1' ' K' ' 13' ' ' TYR . 0.8 OUTLIER -134.9 115.02 13.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.038 -164.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 122.01 5.42 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.385 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 24.8 m -111.89 125.4 53.99 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.635 HG13 ' CG ' ' L' ' 117' ' ' GLU . 1.2 t -123.48 133.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . 0.44 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 4.5 p -138.07 105.13 5.43 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.43 123.25 7.8 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.22 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.79 101.07 11.49 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -68.13 147.0 52.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.721 0.772 . . . . 0.0 110.17 -174.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -128.65 173.86 9.92 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.985 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -66.06 134.75 53.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.53 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.5 130.49 34.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.245 171.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.51 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.626 ' HG2' ' H ' ' K' ' 52' ' ' ARG . 0.4 OUTLIER -72.07 -39.43 69.01 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.01 23.09 1.34 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.624 1.569 . . . . 0.0 111.625 -172.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.443 ' HB ' ' HG3' ' F' ' 9' ' ' GLN . 0.8 OUTLIER 41.02 61.72 1.65 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.541 1.536 . . . . 0.0 111.536 -164.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.93 -128.46 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.51 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -104.04 9.92 36.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.25 83.29 1.28 Allowed Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.626 ' H ' ' HG2' ' K' ' 46' ' ' GLU . 5.8 mmp_? -108.67 18.51 20.76 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.64 HG13 HG22 ' L' ' 135' ' ' ILE . 0.6 OUTLIER -116.74 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.873 178.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 1.057 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.1 OUTLIER -105.37 22.12 15.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . 0.985 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -93.52 160.88 24.76 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-O 121.729 0.627 . . . . 0.0 113.898 -170.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.07 151.37 34.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.828 0.665 . . . . 0.0 113.828 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' K' ' 41' ' ' ARG . . . -149.0 176.65 27.68 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.41 170.12 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.545 0.688 . . . . 0.0 110.55 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.72 129.86 74.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.71 127.08 48.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.66 111.77 14.1 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -140.81 144.27 35.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.92 0.888 . . . . 0.0 110.054 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -133.92 149.28 19.7 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.154 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.02 142.84 49.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . . . . . . . . . 46.0 t -132.56 118.25 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 49.4 p -105.68 146.92 29.1 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.507 ' HA ' ' HB2' ' K' ' 32' ' ' GLN . 37.7 p90 -164.16 170.51 16.28 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -98.78 123.84 43.26 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -68.13 129.71 26.54 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' K' ' 29' ' ' PRO . 7.5 mttm -93.54 159.57 15.17 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' J' ' 5' ' ' PRO . 0.0 OUTLIER -56.0 -46.83 78.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.61 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.144 -1.183 . . . . 0.0 110.144 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.83 158.78 43.38 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.124 1.37 . . . . 0.0 111.01 169.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' K' ' 78' ' ' ALA . . . -74.21 -38.15 63.66 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.52 -43.84 95.77 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.827 168.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -44.64 95.17 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.164 -0.609 . . . . 0.0 111.846 171.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.93 -29.3 69.13 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.742 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' K' ' 74' ' ' ALA . . . -64.49 -40.92 96.57 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.947 168.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.476 HD13 ' N ' ' K' ' 79' ' ' ILE . 1.4 mm -63.1 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.071 0.462 . . . . 0.0 110.476 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.6 mm-40 -62.61 -47.13 85.13 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.7 -0.625 . . . . 0.0 112.403 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' K' ' 85' ' ' ASN . 55.2 m-20 -62.68 -39.58 94.4 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.998 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -51.48 -57.6 8.59 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.553 174.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 36.2 t80 -79.35 -53.96 6.42 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.943 -174.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.638 ' OE1' ' HB2' ' J' ' 139' ' ' LYS . 2.9 mt-30 -74.92 -34.93 62.19 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -167.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' K' ' 81' ' ' ASP . 29.1 t30 -84.13 -27.71 27.97 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.085 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.26 77.26 1.15 Allowed Glycine 0 N--CA 1.449 -0.436 0 O-C-N 122.348 -0.22 . . . . 0.0 112.827 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.998 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -139.37 152.55 47.23 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.617 ' HB3' ' CD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -84.28 144.46 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.456 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.86 143.07 29.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.377 0.608 . . . . 0.0 109.869 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' K' ' 16' ' ' GLN . 10.7 mtmt -76.18 137.16 39.85 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.718 ' HE1' HD21 ' K' ' 132' ' ' LEU . 0.8 OUTLIER -123.71 124.18 42.16 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.543 1.137 . . . . 0.0 110.034 -165.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.639 ' HH2' ' HB2' ' E' ' 160' ' ' PHE . 14.9 m95 -127.38 129.88 48.37 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.223 1.009 . . . . 0.0 108.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' K' ' 93' ' ' ARG . 13.4 ptm180 -125.29 120.09 30.24 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 172.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' K' ' 106' ' ' ALA . 1.1 m -134.09 157.44 41.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 122.268 1.032 . . . . 0.0 109.386 -173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.4 OUTLIER -92.56 138.02 31.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.615 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.604 HG23 ' O ' ' K' ' 10' ' ' ASP . 67.1 p -72.06 -21.98 61.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.632 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.52 137.21 23.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.69 0.757 . . . . 0.0 109.87 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 129.85 41.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.007 -174.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 0.7 OUTLIER -76.45 141.18 41.44 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.802 0.811 . . . . 0.0 110.021 171.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.29 -23.13 35.36 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.86 34.57 5.17 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.855 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -167.32 176.58 6.59 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.836 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -59.51 -65.79 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.859 -0.526 . . . . 0.0 110.581 171.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.458 ' CB ' ' HB3' ' K' ' 142' ' ' GLU . 2.1 m-85 -139.71 -179.8 6.13 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.658 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 4.0 p-10 -119.1 134.43 55.21 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.642 0.734 . . . . 0.0 109.43 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.868 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -136.61 162.55 32.83 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.079 -163.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.726 ' HB2' ' HG3' ' K' ' 139' ' ' LYS . 43.8 tt0 -132.31 139.28 48.13 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 157.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -130.23 151.23 50.97 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.411 0.684 . . . . 0.0 110.405 -163.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.31 169.08 41.32 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.942 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.671 ' O ' HG13 ' K' ' 134' ' ' VAL . 3.2 m-85 -97.75 128.8 44.66 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' K' ' 134' ' ' VAL . . . -130.52 160.9 32.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.925 0.869 . . . . 0.0 111.16 -169.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' K' ' 88' ' ' GLN . 1.7 t80 -125.16 165.14 18.78 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.468 -1.242 . . . . 0.0 107.966 -174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.551 ' H ' HD12 ' K' ' 113' ' ' ILE . 0.2 OUTLIER -95.78 92.68 3.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' K' ' 132' ' ' LEU . 4.0 tt0 -70.81 -42.94 69.6 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.74 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.962 0.801 . . . . 0.0 109.078 174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.908 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -138.0 142.97 40.42 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.593 ' CG ' HG13 ' J' ' 37' ' ' VAL . 4.5 tm-20 -133.82 127.65 33.08 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.03 124.13 51.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.446 . . . . 0.0 111.222 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.22 123.5 49.01 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.678 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.01 50.94 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.27 15.98 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-O 121.739 0.633 . . . . 0.0 111.552 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.652 ' HA ' HE22 ' J' ' 9' ' ' GLN . 21.4 m -69.71 -29.82 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.445 -0.444 . . . . 0.0 111.133 176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.07 155.27 17.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 169.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.68 -142.45 26.78 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 166.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -143.52 162.54 35.59 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.601 0.715 . . . . 0.0 110.765 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' J' ' 6' ' ' ILE . 27.0 m -53.5 138.49 12.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.036 -171.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.43 128.05 49.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.085 -176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' K' ' 69' ' ' GLY . 12.1 mt -116.49 123.05 71.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.07 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.908 HG22 ' HG2' ' K' ' 116' ' ' ARG . 2.8 pt -114.61 121.17 66.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' K' ' 64' ' ' GLU . 3.1 m -107.14 143.3 35.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.688 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.718 HD21 ' HE1' ' K' ' 91' ' ' PHE . 2.6 pp -140.35 141.54 35.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.099 -172.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.31 158.75 15.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.671 HG13 ' O ' ' K' ' 110' ' ' PHE . 61.4 t -142.37 155.88 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.931 HG12 ' HG ' ' J' ' 54' ' ' LEU . 2.1 pt -104.24 31.62 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.335 0.588 . . . . 0.0 110.389 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.8 89.75 1.03 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.717 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . 0.651 ' HG3' HG11 ' K' ' 134' ' ' VAL . 23.5 mt-10 -80.28 133.08 35.94 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.039 0.923 . . . . 0.0 110.63 174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.434 ' HA ' HE22 ' L' ' 84' ' ' GLN . 0.0 OUTLIER -116.46 150.72 37.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.726 ' HG3' ' HB2' ' K' ' 107' ' ' GLN . 0.4 OUTLIER -98.71 142.24 30.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -177.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.77 -163.78 1.31 Allowed 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -104.34 150.38 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.399 169.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.868 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.97 34.73 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.836 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 0.5 OUTLIER -98.03 -42.37 11.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.745 -176.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.38 109.1 17.01 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.004 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 18.6 p -63.0 -46.13 89.11 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.34 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 11.0 mt 46.63 61.35 13.41 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.477 1.911 . . . . 0.0 109.359 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.714 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -68.35 -2.35 8.91 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.242 1.295 . . . . 0.0 115.297 -159.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -37.19 86.47 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.555 171.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.84 -49.97 77.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.146 0.885 . . . . 0.0 111.296 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.714 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 41.7 t -70.63 -43.62 77.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' K' ' 147' ' ' PRO . 2.5 t-20 -110.74 113.3 25.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.438 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.36 96.43 2.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 171.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.83 163.84 11.98 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.65 -4.44 54.24 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.07 2.18 64.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.378 0.99 . . . . 0.0 113.037 -176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.2 24.14 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -133.23 146.15 51.2 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.341 1.056 . . . . 0.0 108.605 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -62.55 -49.69 74.31 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -143.78 155.25 44.1 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.721 2.408 . . . . 0.0 109.143 167.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -139.02 88.49 2.28 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 154.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.82 -29.81 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.731 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -77.95 13.04 1.81 Allowed 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.048 1.767 . . . . 0.0 113.855 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.03 90.58 0.34 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 118.384 2.113 . . . . 0.0 118.384 -171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.731 HE22 ' HD2' ' K' ' 163' ' ' PRO . 6.9 mp0 -108.66 56.22 0.63 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.927 1.364 . . . . 0.0 110.935 175.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 19.1 m 31.95 73.08 0.06 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.857 1.663 . . . . 0.0 111.878 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.624 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.2 OUTLIER -92.91 168.66 11.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.324 -167.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.93 -158.24 8.3 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.48 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -27.01 63.98 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.802 0.301 . . . . 0.0 111.469 -177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' K' ' 171' ' ' PRO . . . -72.36 162.24 74.86 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 123.507 0.723 . . . . 0.0 109.244 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' K' ' 170' ' ' ALA . 85.7 Cg_endo -80.96 -9.15 13.1 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.32 1.347 . . . . 0.0 112.741 -156.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.84 97.73 0.16 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.624 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -101.45 154.28 18.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.963 0.881 . . . . 0.0 109.939 170.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 25.2 m -129.41 168.26 16.98 Favored Pre-proline 0 C--O 1.24 0.598 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.377 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' K' ' 165' ' ' GLN . 31.5 Cg_exo -70.55 113.58 3.55 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.729 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.421 1.488 . . . . 0.0 112.319 -171.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.553 ' HA ' ' HE ' ' G' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.158 1 N-CA-C 100.731 -4.373 . . . . 0.0 100.731 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.536 ' HB ' HG21 ' G' ' 126' ' ' VAL . 4.4 mt -87.24 130.64 36.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.52 166.09 16.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.862 0.839 . . . . 0.0 110.76 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.72 93.15 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.492 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . 0.67 HE22 ' HA ' ' G' ' 122' ' ' VAL . 1.6 mm-40 -72.88 -25.92 61.25 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 117.773 0.786 . . . . 0.0 112.416 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.611 ' O ' HG23 ' L' ' 96' ' ' THR . 0.4 OUTLIER -60.82 -46.56 90.07 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -171.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' G' ' 126' ' ' VAL . 23.5 t -86.72 118.78 33.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -126.41 155.4 42.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.701 0.762 . . . . 0.0 110.45 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.44 ' CE1' ' OD1' ' L' ' 34' ' ' ASP . 14.5 m-85 -120.62 121.45 38.36 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.758 -164.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' L' ' 92' ' ' TRP . 0.3 OUTLIER -120.6 151.63 39.18 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 174.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -125.81 145.42 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.503 0.668 . . . . 0.0 109.92 176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.687 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 5.1 tt0 -121.89 129.34 52.49 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -74.43 141.17 45.04 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.083 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 1.122 HG22 ' HB ' ' F' ' 167' ' ' THR . 0.8 OUTLIER -66.68 -36.57 77.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -81.36 -13.08 58.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.13 -47.98 69.45 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.454 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 58.7 43.51 18.64 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.182 1.393 . . . . 0.0 111.823 -173.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 2.6 t -111.53 161.14 16.48 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -91.76 47.59 2.76 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.693 -178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 6.3 p -172.23 149.78 2.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.024 0.412 . . . . 0.0 111.792 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.8 110.3 49.42 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.908 2.083 . . . . 0.0 112.398 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -74.35 145.1 33.68 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.434 0.834 . . . . 0.0 112.47 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.55 157.84 40.09 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 168.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 31.3 t80 -104.28 144.04 27.89 Favored Pre-proline 0 C--N 1.316 -0.88 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.541 -167.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 50.0 Cg_endo -78.0 174.47 12.46 Favored 'Trans proline' 0 C--N 1.332 -0.339 0 CA-C-O 121.841 0.684 . . . . 0.0 112.463 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.44 66.79 1.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.358 1.463 . . . . 0.0 111.562 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -76.82 139.46 40.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 122.534 1.159 . . . . 0.0 111.032 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.509 ' HB2' ' HA ' ' L' ' 67' ' ' TYR . 2.7 tm0? -98.53 -66.07 0.92 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -172.84 155.61 3.21 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.79 1.281 . . . . 0.0 111.062 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.44 ' OD1' ' CE1' ' L' ' 13' ' ' TYR . 0.8 OUTLIER -134.94 115.06 13.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.025 -164.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.94 121.96 5.4 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.386 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 24.9 m -111.93 125.38 53.99 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.505 HG13 ' CG ' ' G' ' 117' ' ' GLU . 1.3 t -123.52 133.4 69.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . 0.553 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 4.5 p -138.12 105.08 5.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -102.4 123.3 7.82 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.216 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -101.82 101.03 11.43 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.468 ' O ' ' HA3' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -68.1 147.04 52.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.71 0.767 . . . . 0.0 110.139 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -128.63 173.89 9.89 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -167.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.982 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -66.05 134.75 53.52 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.512 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.49 130.52 34.75 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.237 171.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 77.47 113.89 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 155.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.61 ' HG2' ' H ' ' L' ' 52' ' ' ARG . 0.4 OUTLIER -72.06 -39.44 69.03 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 176.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.03 23.06 1.33 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.621 1.568 . . . . 0.0 111.626 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.577 ' HB ' ' HG3' ' A' ' 9' ' ' GLN . 0.8 OUTLIER 41.13 61.67 1.69 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.446 1.498 . . . . 0.0 111.573 -164.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -113.94 -128.49 0.29 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.464 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -104.02 9.87 36.33 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.28 83.32 1.28 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.61 ' H ' ' HG2' ' L' ' 46' ' ' GLU . 5.8 mmp_? -108.68 18.5 20.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.618 HG13 HG22 ' G' ' 135' ' ' ILE . 0.6 OUTLIER -116.73 6.78 7.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.835 178.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.974 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER -105.35 22.14 15.94 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . 0.982 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -93.49 160.84 24.77 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.624 0.569 . . . . 0.0 113.984 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -76.06 151.35 34.81 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 N-CA-C 113.842 0.67 . . . . 0.0 113.842 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' L' ' 41' ' ' ARG . . . -148.93 176.69 27.59 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.42 170.09 15.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 0.0 110.491 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 t -119.74 129.93 74.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.69 127.1 48.6 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.71 111.75 14.05 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 87.4 p -140.84 144.16 35.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.982 0.913 . . . . 0.0 110.078 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -133.89 149.2 19.68 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.16 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -121.99 142.89 49.86 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . . . . . . . . . 45.7 t -132.51 118.18 34.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -105.61 146.88 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.509 ' HA ' ' HB2' ' L' ' 32' ' ' GLN . 37.8 p90 -164.16 170.49 16.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -98.75 123.77 43.18 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' L' ' 128' ' ' ILE . . . -68.14 129.71 26.53 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.964 0.745 . . . . 0.0 114.964 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' L' ' 29' ' ' PRO . 7.5 mttm -93.52 159.56 15.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.504 ' HE ' ' HA ' ' K' ' 5' ' ' PRO . 0.0 OUTLIER -55.99 -46.83 78.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -172.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -164.63 100.2 0.17 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.8 158.83 43.32 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.101 1.361 . . . . 0.0 111.015 169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' L' ' 78' ' ' ALA . . . -74.24 -38.17 63.59 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 -156.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.5 -43.83 95.74 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.191 -1.005 . . . . 0.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.23 -44.72 94.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.804 171.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -66.85 -29.36 69.25 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.785 171.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' L' ' 74' ' ' ALA . . . -64.47 -40.95 96.67 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.92 168.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.488 ' N ' HD13 ' L' ' 79' ' ' ILE . 1.4 mm -63.05 -44.29 99.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.086 0.469 . . . . 0.0 110.476 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.6 mm-40 -62.56 -47.13 85.23 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.71 -0.619 . . . . 0.0 112.425 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' L' ' 85' ' ' ASN . 55.2 m-20 -62.67 -39.57 94.36 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.558 169.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.97 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -51.46 -57.61 8.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.558 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.44 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 36.2 t80 -79.43 -53.91 6.44 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.894 -174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.549 ' OE1' ' HB2' ' K' ' 139' ' ' LYS . 2.9 mt-30 -74.98 -34.89 62.05 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -167.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' L' ' 81' ' ' ASP . 29.1 t30 -84.2 -27.68 27.85 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.044 172.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 77.19 1.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 O-C-N 122.319 -0.238 . . . . 0.0 112.821 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.97 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -139.34 152.55 47.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -84.22 144.4 28.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 168.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.462 HD11 ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.88 143.05 29.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.38 0.61 . . . . 0.0 109.892 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.687 ' HB2' ' O ' ' L' ' 16' ' ' GLN . 10.7 mtmt -76.16 137.16 39.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.723 ' HE1' HD21 ' L' ' 132' ' ' LEU . 0.8 OUTLIER -123.68 124.17 42.16 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.512 1.125 . . . . 0.0 110.035 -165.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.913 ' HZ2' ' O ' ' F' ' 161' ' ' GLN . 14.9 m95 -127.35 129.89 48.45 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.177 0.991 . . . . 0.0 108.338 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' L' ' 93' ' ' ARG . 13.4 ptm180 -125.22 120.13 30.42 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 172.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' L' ' 106' ' ' ALA . 1.1 m -134.14 157.43 41.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-O 122.231 1.015 . . . . 0.0 109.369 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . 0.643 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.4 OUTLIER -92.58 138.06 31.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.643 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.611 HG23 ' O ' ' L' ' 10' ' ' ASP . 67.1 p -72.02 -22.0 61.47 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.666 -176.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.47 137.17 23.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.702 0.763 . . . . 0.0 109.921 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.6 129.87 41.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.97 -174.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.648 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 0.7 OUTLIER -76.5 141.25 41.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -23.25 35.4 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -120.85 34.64 5.14 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.742 0.701 . . . . 0.0 110.886 169.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -167.33 176.62 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 167.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.837 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -59.63 -65.77 0.62 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 171.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.45 ' CB ' ' HB3' ' L' ' 142' ' ' GLU . 2.1 m-85 -139.7 -179.78 6.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.648 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 4.0 p-10 -119.06 134.44 55.2 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.593 0.711 . . . . 0.0 109.413 177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.872 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -136.66 162.51 32.94 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.057 -163.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.738 ' HB2' ' HG3' ' L' ' 139' ' ' LYS . 43.9 tt0 -132.35 139.3 48.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 157.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' F' ' 160' ' ' PHE . 16.2 t80 -130.25 151.18 51.05 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.43 0.692 . . . . 0.0 110.432 -163.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.27 169.07 41.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.987 170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.827 ' CZ ' HG21 ' F' ' 167' ' ' THR . 3.2 m-85 -97.8 128.86 44.72 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.5 ' CB ' HG22 ' L' ' 134' ' ' VAL . . . -130.52 160.85 32.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.897 0.856 . . . . 0.0 111.202 -169.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' L' ' 88' ' ' GLN . 1.7 t80 -125.15 165.17 18.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.017 -174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.538 HD12 ' H ' ' L' ' 113' ' ' ILE . 0.2 OUTLIER -95.74 92.7 3.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HA ' ' L' ' 132' ' ' LEU . 4.0 tt0 -70.87 -42.97 69.37 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 19.8 t -163.39 157.75 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.966 0.803 . . . . 0.0 109.095 174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.886 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -137.96 142.95 40.5 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 176.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.635 ' CG ' HG13 ' K' ' 37' ' ' VAL . 4.5 tm-20 -133.8 127.63 33.07 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.04 124.14 51.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.24 123.47 48.91 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.668 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -107.84 125.07 51.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 167.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -120.95 157.23 15.99 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-O 121.686 0.603 . . . . 0.0 111.606 174.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.653 ' HA ' HE22 ' K' ' 9' ' ' GLN . 21.5 m -69.62 -29.89 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.465 -0.433 . . . . 0.0 111.124 176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.08 155.22 17.56 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.8 -142.45 26.65 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 166.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -143.56 162.55 35.57 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.602 0.715 . . . . 0.0 110.743 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 27.0 m -53.51 138.5 12.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.017 -171.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -123.42 128.08 49.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.089 -176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' L' ' 69' ' ' GLY . 12.1 mt -116.51 123.03 71.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -106.18 114.05 27.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.886 HG22 ' HG2' ' L' ' 116' ' ' ARG . 2.8 pt -114.59 121.22 66.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' L' ' 64' ' ' GLU . 3.1 m -107.14 143.27 35.56 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.723 HD21 ' HE1' ' L' ' 91' ' ' PHE . 2.6 pp -140.27 141.57 35.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.154 -172.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.444 HE22 HD12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -96.33 158.72 15.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.67 HG13 ' O ' ' L' ' 110' ' ' PHE . 61.6 t -142.33 155.92 18.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 1.057 HG12 ' HG ' ' K' ' 54' ' ' LEU . 2.1 pt -104.27 31.61 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.327 0.584 . . . . 0.0 110.346 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 121.86 89.74 1.02 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.721 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . 0.643 ' HG3' HG11 ' L' ' 134' ' ' VAL . 23.6 mt-10 -80.27 133.08 35.94 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.014 0.911 . . . . 0.0 110.669 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.773 HD21 ' HA3' ' F' ' 157' ' ' GLY . 0.0 OUTLIER -116.49 150.63 37.59 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.738 ' HG3' ' HB2' ' L' ' 107' ' ' GLN . 0.4 OUTLIER -98.66 142.17 30.56 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -177.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.7 -163.72 1.31 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -104.34 150.35 17.27 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.404 169.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.872 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 5.4 tp10 -89.41 132.92 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.837 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 0.5 OUTLIER -98.02 -42.25 11.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.787 -176.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.43 109.07 17.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.278 0.561 . . . . 0.0 110.946 -176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 18.7 p -62.95 -46.14 89.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.379 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 10.9 mt 46.62 61.32 13.45 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.51 1.924 . . . . 0.0 109.382 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.6 Cg_exo -68.29 -2.38 8.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.227 1.285 . . . . 0.0 115.279 -159.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -37.22 86.55 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.56 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -114.41 -62.31 1.62 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . . . . . . . . . 2.8 mp -64.89 -49.89 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.146 0.884 . . . . 0.0 111.276 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.706 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 41.6 t -70.69 -43.61 77.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' L' ' 147' ' ' PRO . 2.6 t-20 -110.74 113.31 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.452 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 10.9 p -131.31 96.38 2.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 9.9 t -102.77 163.76 12.03 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.6 -4.4 53.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.21 64.56 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 119.403 1.001 . . . . 0.0 113.053 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.67 137.18 24.12 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -133.22 146.21 51.27 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.319 1.048 . . . . 0.0 108.626 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.59 -49.69 74.24 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 -158.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.8 155.25 44.08 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.657 2.383 . . . . 0.0 109.127 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -138.97 88.49 2.29 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -115.77 -29.9 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.717 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.2 Cg_exo -77.93 13.02 1.81 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.078 1.778 . . . . 0.0 113.896 171.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.99 90.68 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.337 2.095 . . . . 0.0 118.337 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.717 HE22 ' HD2' ' L' ' 163' ' ' PRO . 7.0 mp0 -108.69 56.2 0.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.894 1.347 . . . . 0.0 110.895 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 18.9 m 31.99 73.07 0.06 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.792 1.637 . . . . 0.0 111.889 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.614 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.2 OUTLIER -92.85 168.64 11.04 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.335 -167.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -134.94 -158.29 8.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.487 172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -26.89 63.83 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.791 0.296 . . . . 0.0 111.429 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . 0.472 ' HB1' ' HD2' ' L' ' 171' ' ' PRO . . . -72.36 162.27 74.72 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.463 0.705 . . . . 0.0 109.232 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' L' ' 170' ' ' ALA . 85.7 Cg_endo -80.94 -9.15 13.11 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 121.286 1.324 . . . . 0.0 112.746 -156.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -159.83 97.75 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 165.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -101.47 154.26 18.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.007 0.903 . . . . 0.0 109.884 170.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 24.9 m -129.37 168.24 17.0 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.444 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' L' ' 165' ' ' GLN . 31.5 Cg_exo -70.54 113.65 3.57 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 125.445 1.498 . . . . 0.0 112.312 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 115.051 1.135 . . . . 0.0 115.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.594 HG21 HG23 ' B' ' 126' ' ' VAL . 58.0 mt -134.62 155.71 39.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.713 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.14 26.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.924 0.868 . . . . 0.0 110.748 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -64.7 -16.69 61.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.34 -0.846 . . . . 0.0 114.535 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.75 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.744 0.772 . . . . 0.0 112.366 172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.713 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 20.3 t0 -71.28 -53.26 14.9 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -172.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.47 HG11 ' HE ' ' A' ' 93' ' ' ARG . 62.8 t -87.76 112.3 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.63 43.86 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.667 0.746 . . . . 0.0 110.553 176.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.73 -164.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -95.24 138.19 33.28 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 174.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 14.4 m-85 -125.65 113.85 17.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.492 0.663 . . . . 0.0 109.956 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.49 129.63 55.28 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HA ' HD13 ' A' ' 89' ' ' ILE . 88.0 p -76.06 146.88 39.07 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.549 0.69 . . . . 0.0 110.98 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.669 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.3 pt -64.8 -41.77 93.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.009 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' N ' HG13 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -20.98 66.56 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.98 74.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.427 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.15 56.36 7.59 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.27 1.428 . . . . 0.0 111.769 -173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.2 176.84 8.43 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.58 7.96 Favored Glycine 0 N--CA 1.45 -0.413 0 O-C-N 123.366 0.417 . . . . 0.0 113.701 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.83 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.971 0.386 . . . . 0.0 111.816 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.613 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 57.0 77.63 0.41 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 127.0 2.12 . . . . 0.0 112.413 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -72.31 145.48 43.43 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.384 0.816 . . . . 0.0 112.487 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HG ' ' A' ' 14' ' ' LEU . 6.3 tt -132.33 144.69 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 47.2 t80 -103.2 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.872 -2.331 . . . . 0.0 110.497 -167.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.22 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.316 0 CA-C-O 121.841 0.684 . . . . 0.0 112.423 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.633 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 58.17 39.92 25.47 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.403 1.481 . . . . 0.0 111.56 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.448 ' HD1' ' HB3' ' A' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.05 48.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.561 1.172 . . . . 0.0 111.101 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.697 -2.334 . . . . 0.0 104.697 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.02 169.78 16.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 122.749 1.261 . . . . 0.0 111.091 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.574 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.3 t0 -158.4 102.27 1.74 Allowed 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.981 -164.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.34 133.84 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.339 170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' B' ' 118' ' ' TYR . 43.4 t -127.5 124.15 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG12 ' HB3' ' B' ' 117' ' ' GLU . 24.1 m -128.05 145.69 34.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.28 121.63 27.94 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -166.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -116.47 114.83 3.15 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.201 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.73 125.81 48.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.168 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.65 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -167.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.75 34.73 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.522 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.221 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.21 163.73 13.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 2.4 mp0 -66.29 -51.93 52.41 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.1 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.596 1.558 . . . . 0.0 111.64 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.21 48.98 3.18 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.51 1.524 . . . . 0.0 111.555 -164.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.52 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.468 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.36 0.68 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.72 48.31 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.487 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -119.21 125.38 49.05 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.917 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.3 pp -130.52 -31.94 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.878 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.6 mp -66.12 -18.93 65.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.38 105.39 0.63 Allowed Glycine 0 N--CA 1.442 -0.924 0 CA-C-O 121.63 0.572 . . . . 0.0 113.995 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HB3' ' OH ' ' B' ' 112' ' ' TYR . 67.9 Cg_endo -74.11 167.19 27.79 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.67 20.36 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 0.0 110.537 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 7.2 p -103.21 129.02 55.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -108.87 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 11.9 m-20 -104.05 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.12 143.13 26.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.934 0.894 . . . . 0.0 110.057 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.18 151.24 22.75 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.18 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.95 13.98 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 34' ' ' ASP . 35.1 t -109.81 120.76 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 128' ' ' ILE . 26.8 p -109.14 139.73 43.65 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 3.1 p90 -157.68 158.54 35.61 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' HB2' ' HB1' ' A' ' 30' ' ' ALA . 18.1 m-30 -79.06 140.63 37.85 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 114.946 0.738 . . . . 0.0 114.946 -175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.457 0.646 . . . . 0.0 109.259 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -51.0 21.62 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.31 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.125 1.37 . . . . 0.0 111.01 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -87.83 -29.05 21.23 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.18 -53.77 41.98 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.831 168.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -60.66 -42.39 96.95 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.837 171.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -56.77 -37.25 70.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.804 171.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.55 99.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.922 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 113' ' ' ILE . 7.9 mm -52.64 -49.13 46.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.127 0.489 . . . . 0.0 110.501 172.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.25 -44.93 78.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.723 -0.61 . . . . 0.0 112.477 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.8 -33.3 73.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.573 169.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 87' ' ' LYS . . . -64.25 -48.06 77.22 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.55 174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.521 ' HD1' HG22 ' A' ' 113' ' ' ILE . 47.7 t80 -71.55 -47.1 57.3 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.929 -174.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.685 HE21 ' HG3' ' F' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.42 46.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.13 20.93 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.053 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.85 97.46 2.42 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 112.885 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.4 mptt -130.48 147.75 52.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.687 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 82' ' ' ALA . 23.4 mm -116.37 130.09 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.328 0.585 . . . . 0.0 109.834 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.3 20.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 41.0 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.485 1.114 . . . . 0.0 110.012 -165.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.48 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.11 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.179 0.992 . . . . 0.0 108.323 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.47 ' HE ' HG11 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -102.28 102.79 13.22 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 172.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.779 HG11 ' HG2' ' A' ' 142' ' ' GLU . 22.4 m -120.7 152.92 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-O 122.289 1.042 . . . . 0.0 109.393 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.25 154.8 17.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.627 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.05 -0.08 57.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.628 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' A' ' 10' ' ' ASP . 30.0 m -93.87 131.52 40.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.719 0.771 . . . . 0.0 109.858 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.1 tttp -66.39 119.74 12.13 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.965 -174.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.17 164.22 26.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.835 0.826 . . . . 0.0 109.982 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.82 1.44 56.44 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.48 -42.89 1.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.716 0.689 . . . . 0.0 110.886 169.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.6 11.35 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -66.87 -40.0 87.69 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.804 -0.56 . . . . 0.0 110.577 171.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.7 ' CZ ' HG21 ' A' ' 151' ' ' VAL . 98.0 m-85 -143.88 -176.85 5.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.854 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.21 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.629 0.728 . . . . 0.0 109.423 177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.83 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.03 -163.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.35 53.69 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 88.4 t80 -126.83 147.22 50.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.396 0.678 . . . . 0.0 110.426 -163.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.15 36.91 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.984 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.664 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.4 m-85 -84.7 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -129.86 146.85 51.58 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.908 0.861 . . . . 0.0 111.21 -169.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 2.6 t80 -128.33 122.16 30.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.954 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' A' ' 79' ' ' ILE . 73.6 mt -80.87 101.29 5.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 2.7 mt-10 -94.09 -11.78 29.88 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.98 42.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.908 0.776 . . . . 0.0 109.093 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.9 5.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' F' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.97 28.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 15.3 p90 -118.29 134.9 54.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 111.19 176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 24.3 t -106.35 147.76 28.85 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.661 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.42 115.42 22.22 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' F' ' 33' ' ' THR . . . -96.44 178.08 33.85 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.13 -42.33 89.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.508 -0.407 . . . . 0.0 111.104 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.44 47.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' F' ' 8' ' ' GLY . . . 125.09 164.09 11.79 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 166.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' F' ' 6' ' ' ILE . . . -71.75 155.07 40.87 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.641 0.734 . . . . 0.0 110.737 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.663 HG23 HG21 ' F' ' 6' ' ' ILE . 91.7 t -59.42 125.89 16.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.001 -171.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.73 ' HB2' ' HB3' ' A' ' 119' ' ' SER . 0.5 OUTLIER -79.22 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.086 -176.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 1.9 mt -99.83 113.24 34.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.35 40.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.9 pp -118.9 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.61 140.05 48.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.711 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HB1' ' A' ' 111' ' ' ALA . 1.5 pp -142.24 150.87 41.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.125 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.88 150.12 28.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.754 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.5 p -142.9 132.23 21.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.003 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -54.02 -46.64 65.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.364 0.602 . . . . 0.0 110.316 -173.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.531 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -162.14 145.73 11.13 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.73 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.39 48.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 122.022 0.915 . . . . 0.0 110.621 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.89 40.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -174.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.581 ' HG3' HE21 ' B' ' 84' ' ' GLN . 11.4 mtmt -89.82 137.41 32.36 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -166.91 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.854 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -128.12 154.34 19.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.388 169.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.83 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 20.5 tp10 -103.6 151.0 23.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.691 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -107.46 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.762 -176.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.66 99.87 11.25 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.015 -176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.21 24.01 10.83 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.743 -0.646 . . . . 0.0 112.379 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.61 16.77 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.431 1.892 . . . . 0.0 109.366 -173.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.417 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.03 34.42 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.251 1.3 . . . . 0.0 115.357 -159.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.86 26.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.606 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.73 6.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 HD21 ' A' ' 14' ' ' LEU . 1.5 mt -77.23 -49.89 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.132 0.878 . . . . 0.0 111.244 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.7 HG21 ' CZ ' ' A' ' 104' ' ' TYR . 5.1 t -71.21 -33.39 50.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.58 26.08 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.398 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.1 124.74 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.71 73.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 155' ' ' LYS . . . 140.76 134.81 3.11 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 119.409 1.004 . . . . 0.0 113.048 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.03 78.38 0.38 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.7 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.294 1.038 . . . . 0.0 108.611 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.556 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 3.5 m-20 -77.38 -41.73 39.05 Favored 'General case' 0 C--N 1.342 0.273 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -158.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.676 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -131.45 117.85 19.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.667 2.387 . . . . 0.0 109.134 167.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.2 2.02 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.5 OUTLIER -70.87 -33.47 2.98 Favored Pre-proline 0 C--O 1.241 0.63 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.4 Cg_exo -82.81 -1.0 10.33 Favored 'Trans proline' 0 C--O 1.239 0.559 0 CA-C-N 122.056 1.77 . . . . 0.0 113.827 171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 118.348 2.099 . . . . 0.0 118.348 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.45 86.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.885 1.343 . . . . 0.0 110.936 175.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' A' ' 174' ' ' VAL . 1.7 p 52.43 39.25 27.27 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.82 1.648 . . . . 0.0 111.886 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 172' ' ' GLY . 48.2 m -116.93 156.7 26.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.298 -167.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 167' ' ' THR . . . -84.34 -149.16 9.85 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.432 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HA ' HD13 ' G' ' 18' ' ' ILE . 1.2 tt0 -65.89 -40.37 91.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.786 0.293 . . . . 0.0 111.443 -177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.53 33.9 Favored Pre-proline 0 C--O 1.235 0.319 0 C-N-CA 123.48 0.712 . . . . 0.0 109.314 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.554 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.2 Cg_endo -80.06 147.3 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.288 1.325 . . . . 0.0 112.746 -156.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 167' ' ' THR . . . 81.31 12.11 82.55 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.22 124.16 47.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.981 0.891 . . . . 0.0 109.873 170.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' A' ' 166' ' ' THR . 16.0 t -102.97 120.46 52.31 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.357 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.72 170.6 19.15 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.479 0.85 . . . . 0.0 111.705 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 112.364 -171.67 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 115.096 1.152 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.588 HG21 HG23 ' C' ' 126' ' ' VAL . 58.3 mt -134.64 155.68 39.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.925 0.869 . . . . 0.0 110.76 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -64.72 -16.64 61.58 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.46 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.65 -3.97 41.82 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.798 0.799 . . . . 0.0 112.414 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 20.5 t0 -71.37 -53.16 15.04 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -171.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' B' ' 93' ' ' ARG . 62.9 t -87.78 112.28 23.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.522 ' CG ' HD11 ' B' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.59 43.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.677 0.751 . . . . 0.0 110.509 176.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -111.81 108.71 18.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.76 -164.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.574 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.15 33.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.419 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.454 0.645 . . . . 0.0 109.953 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.62 55.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 89' ' ' ILE . 88.1 p -76.06 146.86 39.09 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.674 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.3 pt -64.79 -41.73 93.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.015 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.495 ' N ' HG13 ' B' ' 18' ' ' ILE . 0.5 OUTLIER -65.52 -21.02 66.57 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.95 74.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.409 -175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.14 56.34 7.62 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.235 1.414 . . . . 0.0 111.808 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.22 176.85 8.43 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.69 25.62 7.96 Favored Glycine 0 N--CA 1.45 -0.393 0 O-C-N 123.4 0.437 . . . . 0.0 113.71 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.3 93.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.005 0.402 . . . . 0.0 111.774 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.602 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 57.01 77.54 0.41 Allowed Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 126.937 2.095 . . . . 0.0 112.468 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.32 145.49 43.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 119.399 0.821 . . . . 0.0 112.483 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.574 HD12 ' HG ' ' B' ' 14' ' ' LEU . 6.3 tt -132.36 144.68 50.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 29' ' ' PRO . 46.9 t80 -103.22 136.42 19.23 Favored Pre-proline 0 C--N 1.316 -0.855 0 C-N-CA 115.847 -2.341 . . . . 0.0 110.52 -167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.538 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 49.7 Cg_endo -76.0 -178.22 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.302 0 CA-C-O 121.84 0.683 . . . . 0.0 112.459 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' B' ' 68' ' ' TYR . . . 58.18 39.97 25.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.374 1.47 . . . . 0.0 111.519 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.439 ' HD1' ' HB3' ' B' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.01 48.06 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 122.502 1.144 . . . . 0.0 111.068 173.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.04 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -133.04 169.84 16.25 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 122.783 1.278 . . . . 0.0 111.103 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.3 t0 -158.38 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.008 -164.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.25 133.85 11.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.322 170.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.648 ' HB3' ' CE1' ' C' ' 118' ' ' TYR . 43.5 t -127.5 124.19 37.72 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 23.6 m -128.0 145.68 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.6 27.8 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -116.48 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.219 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.78 48.41 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.63 51.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.716 0.77 . . . . 0.0 110.163 -174.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.924 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -131.98 123.65 27.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.72 34.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.491 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.67 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.264 171.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.77 13.3 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 155.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.514 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.4 mp0 -66.3 -51.9 52.69 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.14 36.14 18.3 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.646 1.578 . . . . 0.0 111.673 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.19 48.98 3.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.459 1.504 . . . . 0.0 111.594 -164.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.63 1.73 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.471 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.34 0.66 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.46 171.76 48.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.504 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -119.24 125.4 49.05 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 1.026 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.3 pp -130.49 -32.04 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.912 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.6 mp -66.13 -18.81 65.58 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.5 105.45 0.65 Allowed Glycine 0 N--CA 1.443 -0.869 0 CA-C-O 121.617 0.565 . . . . 0.0 113.957 -170.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.546 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.4 Cg_endo -74.12 167.19 27.78 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 N-CA-C 113.844 0.671 . . . . 0.0 113.844 -175.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.6 -168.65 20.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 1.0 OUTLIER -86.11 154.37 21.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.587 0.708 . . . . 0.0 110.476 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 7.2 p -103.15 129.03 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.016 -177.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -108.86 114.4 28.14 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 11.8 m-20 -104.03 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.13 143.11 26.83 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.908 0.883 . . . . 0.0 110.037 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.163 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' B' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.93 13.98 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' B' ' 34' ' ' ASP . 35.0 t -109.85 120.8 61.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' B' ' 128' ' ' ILE . 26.9 p -109.17 139.7 43.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.439 ' HB3' ' HD1' ' B' ' 31' ' ' TYR . 3.2 p90 -157.62 158.58 35.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.61 ' HB2' ' HB1' ' B' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.66 37.7 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.42 36.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 9.4 tttp -119.75 148.83 42.94 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.48 -50.93 21.95 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.42 -111.71 2.6 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 0.9 OUTLIER 74.03 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.105 1.362 . . . . 0.0 111.043 169.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -87.77 -29.07 21.3 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -156.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.75 42.04 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.827 168.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' B' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.855 171.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 0.0 OUTLIER -56.74 -37.34 70.88 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.773 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.56 99.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.936 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.791 HD12 HD11 ' B' ' 113' ' ' ILE . 7.9 mm -52.79 -49.02 48.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.081 0.467 . . . . 0.0 110.467 172.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.27 -44.93 78.11 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.684 -0.635 . . . . 0.0 112.43 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.84 -33.27 73.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.591 169.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -64.23 -48.08 77.17 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.58 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.516 ' HD1' HG22 ' B' ' 113' ' ' ILE . 47.7 t80 -71.49 -47.11 57.6 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.955 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.581 HE21 ' HG3' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.49 -52.44 45.99 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -167.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.43 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 33.1 m120 -81.31 -42.17 20.99 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.041 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.86 97.48 2.42 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.339 -0.226 . . . . 0.0 112.848 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.878 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.7 tm0? -72.79 141.91 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.607 HD11 ' HB2' ' B' ' 82' ' ' ALA . 23.4 mm -116.42 130.09 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.366 0.603 . . . . 0.0 109.844 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.674 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 7.3 mtmt -84.67 112.34 20.37 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.419 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 40.9 t80 -107.21 126.63 52.65 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.523 1.129 . . . . 0.0 109.997 -165.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 1.9 m95 -123.47 115.76 22.09 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' B' ' 11' ' ' VAL . 0.6 OUTLIER -102.22 102.82 13.27 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.789 HG11 ' HG2' ' B' ' 142' ' ' GLU . 22.4 m -120.75 152.92 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.267 1.032 . . . . 0.0 109.373 -173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.25 154.78 17.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.607 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -89.98 -0.13 57.41 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.691 -176.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.417 HG13 ' OD1' ' B' ' 10' ' ' ASP . 30.0 m -93.82 131.49 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.681 0.753 . . . . 0.0 109.927 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.1 tttp -66.39 119.69 12.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.959 -174.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.13 164.19 26.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.751 0.786 . . . . 0.0 110.011 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.73 1.35 56.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.52 -42.74 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.866 169.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.27 170.62 11.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 167.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.0 OUTLIER -66.94 -39.92 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.868 -0.52 . . . . 0.0 110.596 171.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.699 ' CZ ' HG21 ' B' ' 151' ' ' VAL . 97.9 m-85 -143.95 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.871 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 3.1 p-10 -120.78 148.25 44.24 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.635 0.731 . . . . 0.0 109.427 177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -140.46 151.08 44.56 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.062 -163.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' B' ' 138' ' ' LEU . 61.7 mt-30 -122.91 131.32 53.68 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 157.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.498 ' O ' ' HG ' ' B' ' 138' ' ' LEU . 88.4 t80 -126.9 147.16 50.08 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.371 0.668 . . . . 0.0 110.419 -163.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.14 36.9 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.962 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.4 33.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -129.92 146.8 51.63 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.874 0.845 . . . . 0.0 111.182 -169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 2.6 t80 -128.29 122.12 30.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.961 -174.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.791 HD11 HD12 ' B' ' 79' ' ' ILE . 73.4 mt -80.79 101.3 5.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.846 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 2.7 mt-10 -94.14 -11.73 29.86 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 142.02 42.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 118.952 0.796 . . . . 0.0 109.062 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.96 5.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.508 ' HB3' HG12 ' A' ' 37' ' ' VAL . 11.4 mt-10 -120.84 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.599 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 15.1 p90 -118.14 134.89 54.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.088 0.471 . . . . 0.0 111.202 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.754 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 24.2 t -106.4 147.78 28.88 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.654 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.39 22.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.39 178.05 33.9 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' L' ' 46' ' ' GLU . 61.1 t -60.17 -42.24 89.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.516 -0.402 . . . . 0.0 111.088 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.746 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.0 tp10 -133.04 140.46 47.73 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 169.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 8' ' ' GLY . . . 125.07 164.04 11.78 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 166.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.69 154.98 40.99 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.554 0.692 . . . . 0.0 110.759 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.594 HG23 HG21 ' A' ' 6' ' ' ILE . 91.4 t -59.41 125.81 16.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.045 -171.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.754 ' HB2' ' HB3' ' B' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.21 12.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.105 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' B' ' 66' ' ' THR . 1.9 mt -99.85 113.27 34.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.46 121.36 40.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' B' ' 64' ' ' GLU . 1.9 pp -118.88 134.54 62.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 140.03 48.53 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 -178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' B' ' 111' ' ' ALA . 1.5 pp -142.22 150.83 41.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.151 -172.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.08 28.18 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 167.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.917 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.5 p -142.9 132.18 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.63 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.371 0.605 . . . . 0.0 110.338 -173.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.535 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -162.09 145.74 11.15 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.724 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.02 0.914 . . . . 0.0 110.665 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -174.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.523 ' HG3' HE21 ' C' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -166.93 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.871 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -128.19 154.35 19.86 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.369 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 20.6 tp10 -103.57 150.95 23.46 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.681 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.2 OUTLIER -107.49 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.766 -176.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.87 11.24 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.944 -176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.19 23.99 10.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.369 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.7 OUTLIER 46.75 58.62 16.78 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.449 1.899 . . . . 0.0 109.378 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.88 -12.01 34.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.219 1.279 . . . . 0.0 115.337 -159.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.31 -53.95 24.95 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.588 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.51 -34.75 6.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' B' ' 14' ' ' LEU . 1.5 mt -77.23 -49.87 21.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 119.128 0.876 . . . . 0.0 111.254 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.699 HG21 ' CZ ' ' B' ' 104' ' ' TYR . 5.0 t -71.27 -33.34 50.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.59 113.57 26.06 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.422 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.08 124.79 69.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.24 29.47 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' B' ' 156' ' ' GLY . 1.1 pptp? -54.56 -46.72 73.73 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 175.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' B' ' 155' ' ' LYS . . . 140.74 134.74 3.11 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 119.361 0.982 . . . . 0.0 113.034 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.93 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -177.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.7 3.99 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.288 1.035 . . . . 0.0 108.607 177.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . 0.532 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 3.4 m-20 -77.35 -41.77 39.11 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.75 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.85 19.4 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.72 2.408 . . . . 0.0 109.15 167.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.5 OUTLIER -70.96 -33.45 2.91 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -166.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.455 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -82.77 -0.94 10.32 Favored 'Trans proline' 0 C--O 1.238 0.513 0 CA-C-N 122.057 1.77 . . . . 0.0 113.907 171.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.02 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.501 ' HA ' ' HB3' ' B' ' 161' ' ' GLN . 0.3 OUTLIER -67.08 -40.55 87.0 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.946 1.373 . . . . 0.0 110.894 175.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' B' ' 174' ' ' VAL . 1.7 p 52.52 39.22 27.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.832 1.653 . . . . 0.0 111.865 176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.482 HG21 ' H ' ' B' ' 172' ' ' GLY . 49.3 m -116.93 156.74 26.88 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.268 -167.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . 0.406 ' N ' HG22 ' B' ' 167' ' ' THR . . . -84.32 -149.15 9.8 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.451 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . 0.591 ' HA ' HD13 ' H' ' 18' ' ' ILE . 1.2 tt0 -65.91 -40.39 91.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.418 -177.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.58 33.8 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.506 0.722 . . . . 0.0 109.271 -178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.31 18.59 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.275 1.316 . . . . 0.0 112.729 -156.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' B' ' 167' ' ' THR . . . 81.33 12.08 82.56 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 165.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.15 47.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.95 0.875 . . . . 0.0 109.871 170.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' B' ' 166' ' ' THR . 16.2 t -102.96 120.44 52.39 Favored Pre-proline 0 C--O 1.241 0.611 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.397 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.71 170.58 19.18 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.494 0.855 . . . . 0.0 111.722 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.216 0 C-N-CA 125.469 1.508 . . . . 0.0 112.303 -171.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 115.109 1.157 . . . . 0.0 115.109 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.546 HG21 HG23 ' D' ' 126' ' ' VAL . 58.2 mt -134.67 155.68 38.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.703 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.1 27.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.954 0.883 . . . . 0.0 110.731 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -64.65 -16.7 61.5 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.352 -0.84 . . . . 0.0 114.514 175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.67 -3.96 41.76 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 117.795 0.797 . . . . 0.0 112.383 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.703 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 20.5 t0 -71.32 -53.23 14.93 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' C' ' 93' ' ' ARG . 63.3 t -87.67 112.29 23.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . 0.525 ' CG ' HD11 ' C' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.57 43.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.516 176.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.84 108.7 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.763 -164.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.2 33.23 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 14.4 m-85 -125.63 113.89 17.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.495 0.664 . . . . 0.0 110.001 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.53 129.64 55.29 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' C' ' 89' ' ' ILE . 88.0 p -76.07 146.92 39.03 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.564 0.697 . . . . 0.0 111.02 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.676 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.3 pt -64.86 -41.7 92.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.972 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . 0.491 ' N ' HG13 ' C' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.01 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.01 74.46 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.456 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.25 7.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.204 1.402 . . . . 0.0 111.823 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.71 25.64 7.95 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.264 -0.426 . . . . 0.0 113.75 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.79 -39.38 93.51 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.958 0.379 . . . . 0.0 111.811 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.612 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 57.11 77.61 0.41 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.994 2.117 . . . . 0.0 112.378 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.37 145.6 43.36 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.379 0.814 . . . . 0.0 112.479 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' C' ' 14' ' ' LEU . 6.3 tt -132.44 144.66 50.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.535 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 47.3 t80 -103.21 136.48 19.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.527 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.535 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.2 Cg_endo -76.04 -178.26 4.25 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.857 0.691 . . . . 0.0 112.409 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' C' ' 68' ' ' TYR . . . 58.24 39.91 25.26 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.381 1.473 . . . . 0.0 111.543 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . 0.45 ' HD1' ' HB3' ' C' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.05 48.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.511 1.148 . . . . 0.0 111.051 173.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.12 -94.37 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.3 p -133.0 169.82 16.27 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.783 1.277 . . . . 0.0 111.118 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.568 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.3 t0 -158.41 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.121 -1.4 . . . . 0.0 107.993 -164.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.31 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.343 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' D' ' 118' ' ' TYR . 43.5 t -127.47 124.22 37.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 23.6 m -128.03 145.68 34.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.29 121.64 27.96 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -116.5 114.8 3.14 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.218 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.76 48.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.708 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.2 mtm-85 -63.72 132.63 51.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.697 0.76 . . . . 0.0 110.201 -174.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.812 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -132.02 123.63 27.66 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -167.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.538 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.8 2.51 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.24 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.1 163.72 13.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.505 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 2.4 mp0 -66.28 -51.97 52.14 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.3 36.07 17.84 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.606 1.563 . . . . 0.0 111.665 -172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.23 49.0 3.21 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.508 1.523 . . . . 0.0 111.556 -164.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.58 -163.59 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.453 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.79 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.4 171.74 48.32 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.469 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -119.25 125.39 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 1.04 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.3 pp -130.51 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.874 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.836 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.6 mp -66.13 -18.87 65.62 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.4 105.38 0.63 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-O 121.672 0.595 . . . . 0.0 113.962 -170.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.2 27.76 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.68 20.36 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.514 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.4 21.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.524 0.678 . . . . 0.0 110.498 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 7.2 p -103.21 129.03 55.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.708 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -108.84 114.36 28.06 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 11.9 m-20 -104.04 100.3 10.06 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.1 143.08 26.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.925 0.89 . . . . 0.0 110.064 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.29 22.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.16 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' C' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.94 13.96 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.568 HG13 ' OD1' ' C' ' 34' ' ' ASP . 35.5 t -109.84 120.77 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 128' ' ' ILE . 27.0 p -109.12 139.7 43.67 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.45 ' HB3' ' HD1' ' C' ' 31' ' ' TYR . 3.1 p90 -157.64 158.52 35.64 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.609 ' HB2' ' HB1' ' C' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.72 37.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.17 145.44 36.23 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 9.3 tttp -119.79 148.85 42.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 109.242 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.95 21.56 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 0.9 OUTLIER 74.13 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.09 1.356 . . . . 0.0 110.989 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.82 -29.12 21.2 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -156.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.73 42.27 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.848 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' C' ' 79' ' ' ILE . 0.0 OUTLIER -60.67 -42.38 96.95 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.83 171.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -37.25 70.81 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.819 171.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.887 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.771 HD12 HD11 ' C' ' 113' ' ' ILE . 7.8 mm -52.74 -49.04 48.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 110.436 172.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.26 -44.94 78.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.779 -0.576 . . . . 0.0 112.461 -178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.85 -33.26 73.86 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.564 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -64.23 -48.04 77.37 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.617 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' C' ' 113' ' ' ILE . 47.9 t80 -71.56 -47.09 57.23 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.889 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.523 HE21 ' HG3' ' B' ' 139' ' ' LYS . 0.1 OUTLIER -66.49 -52.45 45.9 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -167.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 33.0 m120 -81.35 -42.16 20.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.032 172.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.9 97.48 2.42 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.334 -0.229 . . . . 0.0 112.868 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.607 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.4 mptt -130.5 147.77 52.23 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.912 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.7 tm0? -72.77 141.91 48.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 168.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' C' ' 82' ' ' ALA . 23.4 mm -116.41 130.11 71.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.343 0.592 . . . . 0.0 109.876 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.676 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.35 20.37 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 41.0 t80 -107.27 126.67 52.73 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.509 1.124 . . . . 0.0 109.992 -165.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.492 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 1.9 m95 -123.51 115.79 22.11 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' C' ' 11' ' ' VAL . 0.7 OUTLIER -102.32 102.82 13.22 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 172.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' C' ' 142' ' ' GLU . 22.3 m -120.72 152.85 23.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 122.235 1.017 . . . . 0.0 109.434 -173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.17 154.85 17.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.663 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.07 -0.1 57.42 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.604 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . 0.416 HG13 ' OD1' ' C' ' 10' ' ' ASP . 30.0 m -93.85 131.55 40.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.703 0.763 . . . . 0.0 109.915 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.2 tttp -66.4 119.69 12.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.978 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.18 164.24 26.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.844 0.83 . . . . 0.0 109.977 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.83 1.47 56.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.729 0.695 . . . . 0.0 110.865 169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.15 170.63 11.33 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.94 87.55 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.825 -0.547 . . . . 0.0 110.61 171.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' C' ' 151' ' ' VAL . 97.9 m-85 -143.96 -176.91 5.18 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.894 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.29 44.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.612 0.72 . . . . 0.0 109.415 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.831 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -140.45 151.02 44.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.076 -163.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' C' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.36 53.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' C' ' 138' ' ' LEU . 88.3 t80 -126.85 147.22 50.06 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.337 0.655 . . . . 0.0 110.383 -163.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.66 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 119.497 -1.335 . . . . 0.0 111.95 170.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.677 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.4 m-85 -84.72 126.39 33.35 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -129.9 146.85 51.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.949 0.881 . . . . 0.0 111.148 -169.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.707 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 2.6 t80 -128.34 122.13 30.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.97 -174.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.771 HD11 HD12 ' C' ' 79' ' ' ILE . 73.4 mt -80.82 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.86 142.0 42.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.923 0.783 . . . . 0.0 109.071 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.06 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 11.4 mt-10 -120.81 117.94 28.71 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.648 ' CE1' ' HB3' ' B' ' 36' ' ' SER . 15.3 p90 -118.19 134.88 54.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.13 0.491 . . . . 0.0 111.202 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.75 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 24.6 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.678 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.38 115.42 22.24 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 167.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.47 178.09 33.82 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' G' ' 46' ' ' GLU . 61.2 t -60.17 -42.3 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.456 -0.438 . . . . 0.0 111.096 176.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . 0.681 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.44 47.81 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.06 164.02 11.77 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 166.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.71 155.02 40.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.573 0.701 . . . . 0.0 110.752 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.588 HG23 HG21 ' B' ' 6' ' ' ILE . 91.4 t -59.38 125.81 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.059 -171.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' C' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.2 12.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 -176.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 66' ' ' THR . 1.9 mt -99.84 113.23 34.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.39 121.36 40.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' C' ' 64' ' ' GLU . 1.9 pp -118.96 134.53 62.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.59 139.99 48.55 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.752 -178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.5 pp -142.18 150.92 41.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.098 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.91 150.12 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 1.026 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.5 p -142.9 132.18 21.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.766 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.58 65.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 -173.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -162.15 145.72 11.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.706 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.84 124.43 48.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.055 0.931 . . . . 0.0 110.63 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -174.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.619 ' HG3' HE21 ' D' ' 84' ' ' GLN . 11.4 mtmt -89.84 137.43 32.35 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . 0.55 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -166.89 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.894 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -128.21 154.33 19.86 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.371 169.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.831 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 20.5 tp10 -103.54 151.02 23.36 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.693 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.56 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.748 -176.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.7 99.89 11.27 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.977 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.21 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 118.745 -0.645 . . . . 0.0 112.388 175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER 46.79 58.6 16.84 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 126.455 1.902 . . . . 0.0 109.355 -173.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.85 -12.02 34.37 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.265 1.31 . . . . 0.0 115.306 -159.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.8 26.92 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.597 171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.8 6.64 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.536 HD12 HD21 ' C' ' 14' ' ' LEU . 1.5 mt -77.21 -49.82 21.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 119.155 0.888 . . . . 0.0 111.289 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.701 HG21 ' CZ ' ' C' ' 104' ' ' TYR . 5.1 t -71.27 -33.32 50.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.49 25.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.464 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.02 124.8 69.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.3 29.65 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' C' ' 156' ' ' GLY . 1.1 pptp? -54.63 -46.67 73.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' C' ' 155' ' ' LYS . . . 140.71 134.71 3.11 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 119.394 0.997 . . . . 0.0 113.058 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.39 0.38 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.296 1.038 . . . . 0.0 108.624 177.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' I' ' 140' ' ' ASN . 3.4 m-20 -77.32 -41.7 39.59 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 -158.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.667 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.86 19.36 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.671 2.388 . . . . 0.0 109.132 167.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.497 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.2 2.02 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 154.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.86 -0.95 10.29 Favored 'Trans proline' 0 C--O 1.238 0.505 0 CA-C-N 122.025 1.759 . . . . 0.0 113.825 171.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' C' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 118.895 1.348 . . . . 0.0 110.889 175.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.582 ' OG1' HG22 ' C' ' 174' ' ' VAL . 1.7 p 52.53 39.13 27.37 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.805 1.642 . . . . 0.0 111.89 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.481 HG21 ' H ' ' C' ' 172' ' ' GLY . 48.3 m -116.89 156.67 26.95 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.315 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.29 -149.14 9.76 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.512 172.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . 0.559 ' HA ' HD13 ' I' ' 18' ' ' ILE . 1.2 tt0 -65.84 -40.4 91.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.837 0.318 . . . . 0.0 111.435 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.57 33.77 Favored Pre-proline 0 C--O 1.235 0.331 0 C-N-CA 123.473 0.709 . . . . 0.0 109.235 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.558 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 85.1 Cg_endo -80.07 147.3 18.63 Favored 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.291 1.327 . . . . 0.0 112.709 -156.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.481 ' H ' HG21 ' C' ' 167' ' ' THR . . . 81.33 12.13 82.49 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.175 1.63 . . . . 0.0 117.175 165.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.12 124.16 47.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.972 0.886 . . . . 0.0 109.884 170.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.582 HG22 ' OG1' ' C' ' 166' ' ' THR . 16.2 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.609 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.395 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.71 170.63 19.07 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.541 0.872 . . . . 0.0 111.713 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.229 0 C-N-CA 125.429 1.491 . . . . 0.0 112.306 -171.755 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 115.086 1.149 . . . . 0.0 115.086 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.562 HG21 HG23 ' E' ' 126' ' ' VAL . 58.1 mt -134.59 155.74 39.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.723 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -123.01 160.1 27.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.863 0.839 . . . . 0.0 110.76 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -64.67 -16.66 61.49 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.529 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.62 -3.97 41.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.83 0.815 . . . . 0.0 112.423 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.723 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 20.5 t0 -71.36 -53.21 14.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -171.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.461 HG11 ' HE ' ' D' ' 93' ' ' ARG . 62.2 t -87.74 112.27 23.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' D' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.53 43.9 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.691 0.757 . . . . 0.0 110.527 176.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.74 108.67 18.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.753 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.17 33.25 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 174.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.423 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 14.5 m-85 -125.67 113.82 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.478 0.656 . . . . 0.0 109.971 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.52 129.62 55.29 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' D' ' 89' ' ' ILE . 88.1 p -76.02 146.85 39.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.063 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.659 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.3 pt -64.77 -41.77 93.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.983 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' D' ' 18' ' ' ILE . 0.5 OUTLIER -65.47 -21.13 66.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.33 -42.99 74.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.445 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.217 1.407 . . . . 0.0 111.791 -173.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 176.9 8.38 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.56 7.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.715 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.76 -39.37 93.5 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.987 0.394 . . . . 0.0 111.832 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.594 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 57.03 77.62 0.41 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.947 2.099 . . . . 0.0 112.416 -174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -72.4 145.57 43.17 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.39 0.818 . . . . 0.0 112.436 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' D' ' 14' ' ' LEU . 6.3 tt -132.4 144.63 50.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 168.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 46.9 t80 -103.13 136.48 19.22 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 115.858 -2.337 . . . . 0.0 110.531 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.8 Cg_endo -76.09 -178.18 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.294 0 CA-C-N 119.023 0.687 . . . . 0.0 112.427 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' D' ' 68' ' ' TYR . . . 58.14 39.94 25.54 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.368 1.467 . . . . 0.0 111.56 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . 0.444 ' HD1' ' HB3' ' D' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.03 48.07 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.52 1.152 . . . . 0.0 111.033 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.09 -94.39 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.4 p -133.01 169.79 16.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.819 1.295 . . . . 0.0 111.097 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.575 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.3 t0 -158.41 102.24 1.73 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.992 -164.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.21 133.8 11.59 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.353 170.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . 0.645 ' HB3' ' CE1' ' E' ' 118' ' ' TYR . 43.5 t -127.51 124.12 37.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 24.0 m -128.0 145.75 34.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.38 121.61 27.77 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -166.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -116.4 114.82 3.16 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.23 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.7 125.84 48.43 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.717 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.2 mtm-85 -63.88 132.63 51.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.708 0.766 . . . . 0.0 110.165 -174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.853 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -131.97 123.65 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -167.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.05 120.8 34.8 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.502 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.75 88.85 2.52 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.264 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.15 163.8 13.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 155.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.33 -51.92 52.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.23 36.11 18.02 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.61 1.564 . . . . 0.0 111.66 -172.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.13 49.08 3.11 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.542 1.537 . . . . 0.0 111.556 -164.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.59 1.73 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.444 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.73 19.34 0.67 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 171.74 48.35 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.51 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -119.23 125.44 49.17 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.925 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.3 pp -130.51 -32.08 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.866 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.833 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.6 mp -66.07 -18.89 65.64 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.46 0.65 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.658 0.588 . . . . 0.0 113.937 -170.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 N-CA-C 113.824 0.663 . . . . 0.0 113.824 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.61 -168.72 20.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . 0.505 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.0 OUTLIER -86.1 154.37 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.606 0.717 . . . . 0.0 110.512 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 7.3 p -103.12 129.03 55.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.072 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.717 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -108.85 114.36 28.07 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.751 -1.204 . . . . 0.0 107.751 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 11.9 m-20 -104.08 100.32 10.07 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.03 143.11 26.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.944 0.898 . . . . 0.0 110.081 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.2 22.71 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.177 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.41 123.97 14.03 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.575 HG13 ' OD1' ' D' ' 34' ' ' ASP . 35.2 t -109.82 120.81 61.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' D' ' 128' ' ' ILE . 27.1 p -109.18 139.69 43.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.444 ' HB3' ' HD1' ' D' ' 31' ' ' TYR . 3.1 p90 -157.63 158.55 35.72 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' D' ' 30' ' ' ALA . 18.1 m-30 -79.13 140.66 37.75 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.06 145.4 36.31 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 9.3 tttp -119.81 148.86 42.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 174.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.68 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.158 1.383 . . . . 0.0 110.989 169.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -87.73 -29.19 21.26 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.2 -53.74 42.2 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.83 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' D' ' 79' ' ' ILE . 0.0 OUTLIER -60.65 -42.4 96.91 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.181 -0.607 . . . . 0.0 111.839 171.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.31 70.78 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.793 171.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.64 99.75 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.93 168.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.794 HD12 HD11 ' D' ' 113' ' ' ILE . 7.8 mm -52.65 -49.06 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.084 0.469 . . . . 0.0 110.523 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.29 -44.95 78.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.717 -0.614 . . . . 0.0 112.431 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.989 -0.685 . . . . 0.0 111.578 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -64.23 -48.08 77.22 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.566 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' D' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.06 57.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.929 -174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.619 HE21 ' HG3' ' C' ' 139' ' ' LYS . 0.1 OUTLIER -66.55 -52.44 45.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 33.2 m120 -81.37 -42.11 20.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.001 172.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.92 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.475 0 O-C-N 122.34 -0.225 . . . . 0.0 112.879 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.609 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.4 mptt -130.51 147.83 52.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.836 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.7 tm0? -72.86 141.87 47.96 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' D' ' 82' ' ' ALA . 23.4 mm -116.37 130.08 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.301 0.572 . . . . 0.0 109.874 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.39 20.41 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.423 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 41.1 t80 -107.29 126.65 52.71 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.506 1.122 . . . . 0.0 109.953 -165.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.495 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 1.9 m95 -123.46 115.75 22.1 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.179 0.992 . . . . 0.0 108.339 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.461 ' HE ' HG11 ' D' ' 11' ' ' VAL . 0.6 OUTLIER -102.28 102.82 13.25 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.785 HG11 ' HG2' ' D' ' 142' ' ' GLU . 22.3 m -120.78 152.91 24.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.275 1.036 . . . . 0.0 109.363 -173.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.27 154.75 17.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.624 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 15.7 m -90.0 -0.07 57.38 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.649 -176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' D' ' 10' ' ' ASP . 30.1 m -93.86 131.5 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.705 0.764 . . . . 0.0 109.855 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.2 tttp -66.31 119.72 12.03 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.963 -174.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.2 164.18 26.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.87 0.843 . . . . 0.0 109.955 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.74 1.32 56.56 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.47 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.761 0.709 . . . . 0.0 110.897 169.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.29 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 167.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.883 -0.51 . . . . 0.0 110.632 171.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' D' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.87 5.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.902 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 3.1 p-10 -120.75 148.28 44.19 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.607 0.718 . . . . 0.0 109.444 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.81 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -140.44 151.05 44.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.021 -163.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' D' ' 138' ' ' LEU . 61.5 mt-30 -122.88 131.34 53.7 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 157.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' D' ' 138' ' ' LEU . 88.4 t80 -126.88 147.22 50.07 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.348 0.659 . . . . 0.0 110.417 -163.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.13 36.89 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 119.535 -1.317 . . . . 0.0 111.97 170.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.4 m-85 -84.67 126.39 33.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 167.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -129.94 146.78 51.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.966 0.889 . . . . 0.0 111.16 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.683 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 2.6 t80 -128.24 122.14 31.04 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.997 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.794 HD11 HD12 ' D' ' 79' ' ' ILE . 73.5 mt -80.87 101.32 5.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.812 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.75 29.96 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.88 141.97 42.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.887 0.767 . . . . 0.0 109.114 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' D' ' 116' ' ' ARG . 2.4 ttt180 -142.07 108.94 5.42 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 176.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 11.4 mt-10 -120.83 117.98 28.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 15.4 p90 -118.25 134.91 54.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.057 0.456 . . . . 0.0 111.169 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.739 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 24.5 t -106.35 147.79 28.81 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.646 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.45 115.36 22.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.38 178.07 33.92 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' H' ' 46' ' ' GLU . 61.4 t -60.13 -42.29 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 122.491 -0.417 . . . . 0.0 111.149 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . 0.62 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.0 tp10 -133.03 140.42 47.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.06 11.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.602 0.715 . . . . 0.0 110.738 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.546 HG23 HG21 ' C' ' 6' ' ' ILE . 90.9 t -59.36 125.82 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.097 -171.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.739 ' HB2' ' HB3' ' D' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.2 12.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.073 -176.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' D' ' 66' ' ' THR . 1.9 mt -99.86 113.22 34.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.3 40.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 168.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.86 134.58 62.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.99 48.57 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.734 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.5 pp -142.23 150.92 41.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.078 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.09 28.23 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 167.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 1.04 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.5 p -142.91 132.11 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.771 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -53.87 -46.7 64.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.359 0.599 . . . . 0.0 110.382 -173.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -162.08 145.75 11.17 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.735 177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.83 124.37 48.8 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.03 0.919 . . . . 0.0 110.68 174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -99.55 135.87 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.559 ' HG3' HE21 ' E' ' 84' ' ' GLN . 11.5 mtmt -89.82 137.39 32.37 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -166.88 -156.28 0.22 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.902 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -128.21 154.31 19.85 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.218 -0.992 . . . . 0.0 111.369 169.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.81 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 20.5 tp10 -103.53 150.97 23.41 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.702 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.779 -176.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.69 99.82 11.19 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.991 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.13 23.95 10.86 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.386 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.68 16.68 Favored Pre-proline 0 C--N 1.346 0.421 0 C-N-CA 126.497 1.919 . . . . 0.0 109.392 -173.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.429 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.87 -11.98 34.23 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.233 1.289 . . . . 0.0 115.326 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.43 -53.87 26.23 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.565 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.76 6.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.539 HD12 HD21 ' D' ' 14' ' ' LEU . 1.5 mt -77.21 -49.81 21.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.124 0.874 . . . . 0.0 111.308 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' D' ' 104' ' ' TYR . 5.0 t -71.28 -33.33 50.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.51 25.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.471 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.01 124.82 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.32 128.22 29.36 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' D' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.66 73.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . 0.447 ' O ' ' HD2' ' D' ' 155' ' ' LYS . . . 140.73 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 119.38 0.991 . . . . 0.0 113.053 -176.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.04 78.43 0.38 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -115.81 92.66 3.97 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.293 1.037 . . . . 0.0 108.621 177.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . 0.61 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 3.5 m-20 -77.35 -41.7 39.43 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.711 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.2 OUTLIER -131.52 117.84 19.34 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.654 2.381 . . . . 0.0 109.132 167.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.29 2.01 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.763 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.5 OUTLIER -70.97 -33.44 2.9 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.53 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.2 Cg_exo -82.74 -1.03 10.37 Favored 'Trans proline' 0 C--O 1.238 0.521 0 CA-C-N 122.066 1.773 . . . . 0.0 113.86 171.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.87 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 118.312 2.085 . . . . 0.0 118.312 -171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' D' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.53 86.96 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.896 1.348 . . . . 0.0 110.899 175.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.593 ' OG1' HG22 ' D' ' 174' ' ' VAL . 1.7 p 52.51 39.19 27.41 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.874 1.669 . . . . 0.0 111.877 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.487 HG21 ' H ' ' D' ' 172' ' ' GLY . 48.5 m -116.87 156.7 26.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.297 -167.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.404 ' N ' HG22 ' D' ' 167' ' ' THR . . . -84.27 -149.15 9.75 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.498 172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . 0.513 ' HA ' HD13 ' J' ' 18' ' ' ILE . 1.2 tt0 -65.86 -40.48 91.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.777 0.288 . . . . 0.0 111.412 -177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.6 33.74 Favored Pre-proline 0 C--O 1.236 0.346 0 C-N-CA 123.43 0.692 . . . . 0.0 109.266 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.55 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 85.2 Cg_endo -80.09 147.32 18.62 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.305 1.337 . . . . 0.0 112.736 -156.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . 0.487 ' H ' HG21 ' D' ' 167' ' ' THR . . . 81.31 12.08 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 117.186 1.635 . . . . 0.0 117.186 165.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.16 47.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.007 0.903 . . . . 0.0 109.904 170.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.593 HG22 ' OG1' ' D' ' 166' ' ' THR . 16.3 t -102.94 120.43 52.47 Favored Pre-proline 0 C--O 1.24 0.593 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.418 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -72.68 170.69 18.9 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.511 0.861 . . . . 0.0 111.686 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.428 1.491 . . . . 0.0 112.327 -171.728 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.154 0 N-CA-C 115.066 1.141 . . . . 0.0 115.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.667 HG21 HG23 ' F' ' 126' ' ' VAL . 58.1 mt -134.61 155.74 39.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.728 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -123.07 160.12 27.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.882 0.848 . . . . 0.0 110.775 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' F' ' 123' ' ' GLU . . . -64.75 -16.65 61.66 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.467 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.94 42.0 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 117.801 0.8 . . . . 0.0 112.42 172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.728 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 20.5 t0 -71.37 -53.22 14.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -172.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.463 HG11 ' HE ' ' E' ' 93' ' ' ARG . 61.9 t -87.78 112.32 23.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' E' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.58 43.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.646 0.736 . . . . 0.0 110.512 176.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.75 108.63 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.765 -164.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.18 33.23 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.435 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 14.2 m-85 -125.66 113.88 17.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.459 0.647 . . . . 0.0 109.94 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.64 55.3 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' E' ' 89' ' ' ILE . 87.9 p -76.08 146.87 39.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.003 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.658 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.3 pt -64.85 -41.68 92.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.977 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' E' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.03 66.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.94 74.32 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.33 7.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.238 1.415 . . . . 0.0 111.793 -173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.19 176.87 8.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.72 25.64 7.94 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.728 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.81 -39.43 93.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.987 0.394 . . . . 0.0 111.771 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.61 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 57.11 77.56 0.41 Allowed Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.923 2.089 . . . . 0.0 112.441 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.53 43.44 Favored 'Trans proline' 0 C--N 1.349 0.603 0 CA-C-N 119.417 0.828 . . . . 0.0 112.465 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' E' ' 14' ' ' LEU . 6.3 tt -132.39 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 168.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.523 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 47.2 t80 -103.15 136.49 19.22 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 115.806 -2.358 . . . . 0.0 110.547 -167.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . 0.523 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 49.8 Cg_endo -76.06 -178.27 4.26 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-N 119.015 0.684 . . . . 0.0 112.452 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' E' ' 68' ' ' TYR . . . 58.18 40.01 25.36 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.413 1.485 . . . . 0.0 111.504 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . 0.443 ' HD1' ' HB3' ' E' ' 67' ' ' TYR . 8.4 m-30 -70.65 135.06 48.1 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.541 1.162 . . . . 0.0 111.046 173.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.15 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.664 -2.346 . . . . 0.0 104.664 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -133.01 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.766 1.269 . . . . 0.0 111.084 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.3 t0 -158.43 102.27 1.73 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.984 -164.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.27 133.82 11.59 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.396 170.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 43.5 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 24.1 m -128.06 145.7 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.36 121.59 27.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -116.43 114.82 3.15 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.216 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.83 48.42 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.714 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.2 mtm-85 -63.84 132.6 51.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.678 0.751 . . . . 0.0 110.191 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.786 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -131.95 123.64 27.78 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.03 120.76 34.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.51 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.76 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.278 -0.873 . . . . 0.0 111.222 171.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.12 163.77 13.28 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.626 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.4 mp0 -66.38 -51.92 52.12 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.33 36.0 17.79 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.617 1.567 . . . . 0.0 111.672 -172.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.24 48.96 3.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.531 1.532 . . . . 0.0 111.547 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.49 -163.57 1.72 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.478 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.75 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.71 48.29 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -119.13 125.47 49.34 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 1.074 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.3 pp -130.54 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.878 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.725 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.6 mp -66.08 -18.87 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.41 105.42 0.64 Allowed Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.605 0.558 . . . . 0.0 113.946 -170.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -74.08 167.21 27.74 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.65 20.32 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.15 154.36 21.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.579 0.705 . . . . 0.0 110.515 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 7.3 p -103.15 129.04 55.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . 0.714 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -108.85 114.35 28.04 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 12.0 m-20 -104.09 100.32 10.07 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 143.09 26.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.936 0.894 . . . . 0.0 110.101 -178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 151.28 22.76 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.18 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' E' ' 130' ' ' ILE . 0.9 OUTLIER -143.47 123.92 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' E' ' 34' ' ' ASP . 35.4 t -109.86 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' E' ' 128' ' ' ILE . 27.0 p -109.1 139.73 43.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.443 ' HB3' ' HD1' ' E' ' 31' ' ' TYR . 3.1 p90 -157.69 158.6 35.72 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.618 ' HB2' ' HB1' ' E' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.64 37.69 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.13 145.43 36.27 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 9.3 tttp -119.78 148.86 42.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.43 -50.97 21.54 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.75 2.6 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.15 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.097 1.359 . . . . 0.0 111.027 169.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -87.75 -29.12 21.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.25 -53.65 42.81 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.879 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' E' ' 79' ' ' ILE . 0.0 OUTLIER -60.68 -42.39 97.03 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 122.144 -0.621 . . . . 0.0 111.827 171.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 0.0 OUTLIER -56.73 -37.27 70.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.806 171.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' E' ' 82' ' ' ALA . . . -62.76 -42.58 99.75 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.957 168.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.782 HD12 HD11 ' E' ' 113' ' ' ILE . 7.8 mm -52.7 -49.06 47.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.079 0.466 . . . . 0.0 110.473 172.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.93 78.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.779 -0.576 . . . . 0.0 112.432 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.83 -33.28 73.86 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.984 -0.687 . . . . 0.0 111.589 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.618 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -64.24 -48.1 77.11 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 119.094 -1.043 . . . . 0.0 111.566 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.515 ' HD1' HG22 ' E' ' 113' ' ' ILE . 47.8 t80 -71.51 -47.08 57.66 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.94 -174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.559 HE21 ' HG3' ' D' ' 139' ' ' LYS . 0.1 OUTLIER -66.5 -52.41 46.32 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -167.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 33.1 m120 -81.42 -42.11 20.88 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.019 172.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 122.308 -0.245 . . . . 0.0 112.863 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.4 mptt -130.46 147.8 52.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.833 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.7 tm0? -72.81 141.87 48.04 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.618 HD11 ' HB2' ' E' ' 82' ' ' ALA . 23.4 mm -116.43 130.1 71.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.349 0.595 . . . . 0.0 109.831 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.658 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 7.3 mtmt -84.68 112.37 20.41 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.435 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 41.0 t80 -107.23 126.67 52.71 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.499 1.12 . . . . 0.0 110.03 -166.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.494 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 1.9 m95 -123.44 115.67 21.98 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.272 1.029 . . . . 0.0 108.383 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.463 ' HE ' HG11 ' E' ' 11' ' ' VAL . 0.6 OUTLIER -102.23 102.77 13.22 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.771 HG11 ' HG2' ' E' ' 142' ' ' GLU . 22.2 m -120.69 152.9 23.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 122.246 1.022 . . . . 0.0 109.407 -173.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.24 154.83 17.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.657 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.05 -0.06 57.39 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.641 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' E' ' 10' ' ' ASP . 30.2 m -93.87 131.5 40.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.656 0.741 . . . . 0.0 109.896 176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.1 tttp -66.37 119.72 12.06 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.974 -174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.15 164.22 26.57 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.845 0.831 . . . . 0.0 109.977 171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.4 56.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.55 -42.81 1.15 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.872 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.67 11.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.0 OUTLIER -66.97 -39.93 87.32 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.804 -0.56 . . . . 0.0 110.573 171.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' E' ' 151' ' ' VAL . 98.0 m-85 -143.95 -176.85 5.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.883 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.26 44.22 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.63 0.729 . . . . 0.0 109.443 177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.835 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -140.44 151.07 44.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.074 -163.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' E' ' 138' ' ' LEU . 61.6 mt-30 -122.94 131.32 53.67 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.494 ' HE1' ' CE2' ' E' ' 92' ' ' TRP . 88.4 t80 -126.82 147.2 50.04 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.385 0.674 . . . . 0.0 110.453 -163.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.13 36.9 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.34 33.31 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 167.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.43 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -129.88 146.84 51.6 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.942 0.877 . . . . 0.0 111.185 -169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 2.6 t80 -128.3 122.13 30.87 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.002 -174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.782 HD11 HD12 ' E' ' 79' ' ' ILE . 73.3 mt -80.8 101.31 5.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.853 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.8 29.81 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.0 42.85 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.95 0.796 . . . . 0.0 109.077 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.97 5.42 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 11.4 mt-10 -120.9 117.98 28.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.645 ' CE1' ' HB3' ' D' ' 36' ' ' SER . 15.3 p90 -118.25 134.87 54.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 111.175 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . 0.765 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 24.6 t -106.33 147.79 28.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.698 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.43 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.45 178.07 33.84 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.14 -42.29 89.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.473 -0.427 . . . . 0.0 111.099 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . 0.704 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.42 47.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . 0.431 ' H ' ' N ' ' D' ' 8' ' ' GLY . . . 125.07 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 166.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.73 155.03 40.92 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.6 0.715 . . . . 0.0 110.74 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.562 HG23 HG21 ' D' ' 6' ' ' ILE . 92.0 t -59.41 125.86 16.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.02 -171.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.765 ' HB2' ' HB3' ' E' ' 119' ' ' SER . 0.5 OUTLIER -79.19 108.19 12.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.103 -176.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' E' ' 66' ' ' THR . 1.9 mt -99.84 113.21 34.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.43 121.38 40.89 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' E' ' 64' ' ' GLU . 1.9 pp -118.94 134.56 62.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.98 48.59 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.739 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.43 HD13 ' HB1' ' E' ' 111' ' ' ALA . 1.5 pp -142.19 150.86 41.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.16 -172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 150.14 28.09 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.925 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.5 p -142.95 132.16 21.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.878 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -53.99 -46.61 65.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.31 0.576 . . . . 0.0 110.355 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.52 ' HA2' ' OD1' ' E' ' 61' ' ' ASP . . . -162.12 145.68 11.07 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.732 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.997 0.904 . . . . 0.0 110.652 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -99.61 135.91 40.32 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.773 ' HG3' HE21 ' F' ' 84' ' ' GLN . 11.5 mtmt -89.87 137.42 32.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -166.94 -156.33 0.22 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.883 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.407 169.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.835 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 20.6 tp10 -103.62 151.0 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.697 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.762 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.71 99.9 11.27 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.968 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.0 10.83 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 118.723 -0.656 . . . . 0.0 112.388 175.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER 46.76 58.63 16.79 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.409 1.884 . . . . 0.0 109.379 -173.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.6 Cg_exo -66.92 -11.98 34.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.235 1.29 . . . . 0.0 115.313 -159.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.82 26.38 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.634 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.83 6.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.537 HD12 HD21 ' E' ' 14' ' ' LEU . 1.5 mt -77.13 -49.88 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.138 0.881 . . . . 0.0 111.271 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' E' ' 104' ' ' TYR . 5.1 t -71.25 -33.39 50.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.57 26.08 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.422 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.06 124.83 69.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.3 128.25 29.44 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' E' ' 156' ' ' GLY . 1.1 pptp? -54.59 -46.73 73.82 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' E' ' 155' ' ' LYS . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.409 1.004 . . . . 0.0 113.04 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.99 78.32 0.38 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.554 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.69 3.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.315 1.046 . . . . 0.0 108.641 177.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' K' ' 140' ' ' ASN . 3.5 m-20 -77.35 -41.7 39.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.647 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.2 OUTLIER -131.44 117.86 19.42 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.69 2.396 . . . . 0.0 109.191 167.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -123.2 47.31 2.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 154.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.5 OUTLIER -70.99 -33.45 2.89 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -166.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.513 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.81 -0.92 10.3 Favored 'Trans proline' 0 C--O 1.238 0.515 0 CA-C-N 122.032 1.761 . . . . 0.0 113.884 171.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.79 69.01 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.552 ' OE1' ' HD2' ' K' ' 90' ' ' LYS . 0.3 OUTLIER -67.03 -40.59 87.24 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.898 1.349 . . . . 0.0 110.904 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' E' ' 174' ' ' VAL . 1.7 p 52.57 39.18 27.61 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.854 1.662 . . . . 0.0 111.856 176.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' E' ' 172' ' ' GLY . 48.4 m -116.92 156.68 26.96 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.28 -167.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' E' ' 167' ' ' THR . . . -84.29 -149.11 9.72 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.442 172.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' K' ' 18' ' ' ILE . 1.2 tt0 -65.92 -40.38 91.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.761 0.281 . . . . 0.0 111.402 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.85 Favored Pre-proline 0 C--O 1.235 0.31 0 C-N-CA 123.494 0.718 . . . . 0.0 109.25 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.554 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.3 Cg_endo -80.07 147.33 18.66 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.301 1.334 . . . . 0.0 112.728 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' E' ' 167' ' ' THR . . . 81.29 12.16 82.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.13 47.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.044 0.922 . . . . 0.0 109.916 170.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' E' ' 166' ' ' THR . 16.4 t -102.9 120.42 52.52 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.411 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.63 170.6 19.09 Favored 'Trans proline' 0 C--N 1.348 0.541 0 CA-C-N 119.507 0.86 . . . . 0.0 111.738 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.394 1.478 . . . . 0.0 112.359 -171.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 115.102 1.155 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 126' ' ' VAL . 58.2 mt -134.67 155.72 39.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.712 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.15 26.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.898 0.856 . . . . 0.0 110.699 -177.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -64.74 -16.66 61.63 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.357 -0.838 . . . . 0.0 114.499 175.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.66 -3.94 41.82 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 117.797 0.798 . . . . 0.0 112.418 172.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.712 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 20.4 t0 -71.32 -53.26 14.81 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.464 HG11 ' HE ' ' F' ' 93' ' ' ARG . 62.3 t -87.72 112.32 23.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . 0.516 ' CG ' HD11 ' F' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.57 43.97 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.679 0.752 . . . . 0.0 110.483 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.76 108.66 18.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.747 -164.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.573 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -95.26 138.18 33.31 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 14.2 m-85 -125.62 113.85 17.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.485 0.66 . . . . 0.0 110.003 176.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.65 55.31 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 170.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . 0.537 ' HA ' HD13 ' F' ' 89' ' ' ILE . 88.0 p -76.07 146.87 39.06 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.541 0.686 . . . . 0.0 110.988 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.3 pt -64.77 -41.78 93.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.971 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' F' ' 18' ' ' ILE . 0.5 OUTLIER -65.5 -21.09 66.59 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -171.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.4 -42.94 74.44 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.432 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.3 7.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.21 1.404 . . . . 0.0 111.747 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.87 8.4 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.73 25.65 7.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.3 -0.409 . . . . 0.0 113.7 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.86 -39.33 93.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.008 0.404 . . . . 0.0 111.785 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.621 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.927 2.091 . . . . 0.0 112.406 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.39 145.5 43.06 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.429 0.832 . . . . 0.0 112.452 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.573 HD12 ' HG ' ' F' ' 14' ' ' LEU . 6.3 tt -132.35 144.67 50.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 47.1 t80 -103.19 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.567 -167.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -76.07 -178.19 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.298 0 CA-C-O 121.877 0.699 . . . . 0.0 112.428 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.726 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 58.13 39.97 25.55 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.384 1.474 . . . . 0.0 111.568 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' F' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 122.525 1.155 . . . . 0.0 111.077 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.11 -94.32 0.33 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.426 HG22 ' HA2' ' A' ' 121' ' ' GLY . 25.5 p -133.04 169.83 16.26 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.803 1.287 . . . . 0.0 111.089 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.3 t0 -158.41 102.18 1.73 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.83 11.6 Favored Glycine 0 N--CA 1.441 -1.03 0 C-N-CA 120.741 -0.743 . . . . 0.0 111.385 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 118' ' ' TYR . 43.7 t -127.45 124.2 37.84 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 117' ' ' GLU . 23.7 m -128.07 145.69 34.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.67 27.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -166.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -116.42 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.209 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.65 125.78 48.37 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.72 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.2 mtm-85 -63.79 132.62 51.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.722 0.773 . . . . 0.0 110.125 -174.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -132.04 123.73 27.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -167.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.16 120.76 34.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.492 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.7 88.86 2.52 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.213 171.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.78 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.34 -51.92 52.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 61.26 36.09 17.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 111.669 -172.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 48.98 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.482 1.513 . . . . 0.0 111.597 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.51 -163.59 1.72 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.489 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.47 171.75 48.35 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HD3' ' F' ' 52' ' ' ARG . 0.0 OUTLIER -119.24 125.46 49.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 1.003 HG12 HG23 ' A' ' 135' ' ' ILE . 1.3 pp -130.49 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.897 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.524 HD12 ' H ' ' F' ' 54' ' ' LEU . 1.6 mp -66.11 -18.85 65.61 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.43 105.47 0.65 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.622 0.568 . . . . 0.0 113.986 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -74.09 167.16 27.87 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.68 20.36 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . 0.626 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.0 OUTLIER -86.06 154.34 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.558 0.694 . . . . 0.0 110.529 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 7.2 p -103.16 129.0 55.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . 0.72 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -108.75 114.3 27.98 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 12.0 m-20 -104.03 100.34 10.1 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.962 0.905 . . . . 0.0 110.055 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.06 151.33 22.78 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.179 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' F' ' 130' ' ' ILE . 0.9 OUTLIER -143.48 123.92 13.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' F' ' 34' ' ' ASP . 35.3 t -109.82 120.78 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' F' ' 128' ' ' ILE . 26.9 p -109.11 139.76 43.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' F' ' 31' ' ' TYR . 3.1 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.608 ' HB2' ' HB1' ' F' ' 30' ' ' ALA . 18.1 m-30 -79.08 140.63 37.82 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.41 36.29 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 9.3 tttp -119.73 148.84 42.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 109.282 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.38 -51.08 20.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.71 2.61 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . 0.506 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.22 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.172 1.389 . . . . 0.0 111.052 169.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.79 -29.1 21.25 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.74 42.14 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 120.27 -0.967 . . . . 0.0 112.833 168.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.566 ' O ' ' HB ' ' F' ' 79' ' ' ILE . 0.0 OUTLIER -60.62 -42.36 96.72 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.886 171.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -37.27 70.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.748 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.6 99.77 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.913 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.778 HD12 HD11 ' F' ' 113' ' ' ILE . 7.9 mm -52.7 -49.03 47.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.092 0.472 . . . . 0.0 110.484 172.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.98 77.93 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.714 -0.616 . . . . 0.0 112.431 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.79 -33.25 73.77 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.956 -0.697 . . . . 0.0 111.589 169.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -64.27 -48.11 77.0 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.557 174.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.525 ' HD1' HG22 ' F' ' 113' ' ' ILE . 47.6 t80 -71.45 -47.12 57.74 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.773 HE21 ' HG3' ' E' ' 139' ' ' LYS . 0.1 OUTLIER -66.52 -52.46 45.61 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -167.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 33.1 m120 -81.37 -42.09 21.0 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.044 172.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.4 2.41 Favored Glycine 0 N--CA 1.449 -0.452 0 O-C-N 122.358 -0.214 . . . . 0.0 112.857 178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.61 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.4 mptt -130.45 147.8 52.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.725 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.7 tm0? -72.85 141.91 47.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 168.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' F' ' 82' ' ' ALA . 23.5 mm -116.4 130.04 71.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.356 0.598 . . . . 0.0 109.865 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 7.3 mtmt -84.64 112.35 20.37 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 40.9 t80 -107.2 126.66 52.69 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.526 1.13 . . . . 0.0 110.018 -166.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.477 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 1.9 m95 -123.51 115.74 22.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.178 0.991 . . . . 0.0 108.368 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.464 ' HE ' HG11 ' F' ' 11' ' ' VAL . 0.7 OUTLIER -102.26 102.79 13.23 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' F' ' 142' ' ' GLU . 22.2 m -120.72 152.88 23.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-O 122.27 1.033 . . . . 0.0 109.439 -173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.85 17.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.665 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -90.04 -0.14 57.43 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.617 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . 0.408 HG13 ' OD1' ' F' ' 10' ' ' ASP . 30.1 m -93.85 131.52 40.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.68 0.752 . . . . 0.0 109.891 176.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.1 tttp -66.37 119.66 11.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.986 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.23 26.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.808 0.813 . . . . 0.0 109.969 171.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.76 1.37 56.52 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.51 -42.76 1.16 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.744 0.702 . . . . 0.0 110.907 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.58 11.34 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 167.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.95 87.49 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.854 -0.529 . . . . 0.0 110.588 171.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.693 ' CZ ' HG21 ' F' ' 151' ' ' VAL . 97.8 m-85 -143.92 -176.86 5.16 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 3.1 p-10 -120.76 148.29 44.18 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.62 0.724 . . . . 0.0 109.426 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.834 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -140.47 151.04 44.52 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.099 -163.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' F' ' 138' ' ' LEU . 61.5 mt-30 -122.94 131.33 53.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 157.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' F' ' 138' ' ' LEU . 88.3 t80 -126.85 147.19 50.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.37 0.668 . . . . 0.0 110.383 -163.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.63 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 119.529 -1.32 . . . . 0.0 112.007 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.68 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.4 m-85 -84.62 126.33 33.25 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 167.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -129.94 146.79 51.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.937 0.875 . . . . 0.0 111.152 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.703 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 2.6 t80 -128.25 122.18 31.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.963 -174.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.778 HD11 HD12 ' F' ' 79' ' ' ILE . 73.5 mt -80.9 101.29 5.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 2.7 mt-10 -94.07 -11.81 29.85 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.79 141.99 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.976 0.807 . . . . 0.0 109.14 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.09 108.92 5.41 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 11.4 mt-10 -120.78 117.93 28.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 15.3 p90 -118.2 134.89 54.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.066 0.46 . . . . 0.0 111.214 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . 0.764 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 24.5 t -106.31 147.75 28.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.655 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.41 22.21 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.04 33.83 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-O 121.681 0.6 . . . . 0.0 111.602 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' J' ' 46' ' ' GLU . 61.1 t -60.1 -42.29 89.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 122.468 -0.431 . . . . 0.0 111.127 176.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . 0.452 ' HA ' ' HA3' ' E' ' 8' ' ' GLY . 3.0 tp10 -132.99 140.39 47.75 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.11 164.03 11.77 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.72 155.02 40.94 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.564 0.697 . . . . 0.0 110.789 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.667 HG23 HG21 ' E' ' 6' ' ' ILE . 91.5 t -59.39 125.79 16.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.041 -171.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' F' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.18 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.109 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' F' ' 66' ' ' THR . 1.9 mt -99.85 113.3 34.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.48 121.26 40.52 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' F' ' 64' ' ' GLU . 1.9 pp -118.86 134.56 62.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.53 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.726 -178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.098 -172.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.1 28.21 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 1.074 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.5 p -142.89 132.19 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.863 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -54.03 -46.68 66.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 121.361 0.601 . . . . 0.0 110.298 -173.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.536 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -162.07 145.68 11.08 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.747 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.42 48.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.029 0.918 . . . . 0.0 110.658 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.89 40.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.685 ' HG3' HE21 ' A' ' 84' ' ' GLN . 11.4 mtmt -89.89 137.44 32.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -166.9 -156.3 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -128.2 154.33 19.85 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.382 169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.834 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 20.5 tp10 -103.56 151.0 23.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.69 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.2 OUTLIER -107.45 -78.54 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.748 -176.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -97.68 99.88 11.25 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.97 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 77.7 p -102.22 24.06 10.76 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.366 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER 46.7 58.62 16.72 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.403 1.881 . . . . 0.0 109.439 -173.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.9 -12.02 34.42 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.282 1.321 . . . . 0.0 115.278 -159.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -53.84 26.18 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.625 171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.55 -34.78 6.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.53 HD12 HD21 ' F' ' 14' ' ' LEU . 1.5 mt -77.15 -49.87 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 119.157 0.889 . . . . 0.0 111.302 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.693 HG21 ' CZ ' ' F' ' 104' ' ' TYR . 5.1 t -71.22 -33.35 50.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.55 113.51 25.97 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.48 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.06 124.8 69.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.28 128.26 29.5 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HA3' ' L' ' 136' ' ' GLY . 1.1 pptp? -54.51 -46.74 73.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . 0.443 ' O ' ' HD2' ' F' ' 155' ' ' LYS . . . 140.75 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.333 0.97 . . . . 0.0 113.029 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.01 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -115.79 92.64 3.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.38 1.072 . . . . 0.0 108.622 177.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.782 ' HB3' ' CG ' ' L' ' 140' ' ' ASN . 3.4 m-20 -77.31 -41.75 39.46 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -158.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.792 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.2 OUTLIER -131.51 117.88 19.38 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.656 2.382 . . . . 0.0 109.115 167.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -123.18 47.28 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 153.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.904 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.5 OUTLIER -70.91 -33.44 2.94 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.864 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.8 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.501 0 CA-C-N 122.073 1.776 . . . . 0.0 113.846 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.81 69.11 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.507 ' OE1' ' HZ ' ' L' ' 108' ' ' PHE . 0.3 OUTLIER -67.1 -40.53 86.92 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.88 1.34 . . . . 0.0 110.909 175.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' F' ' 174' ' ' VAL . 1.7 p 52.5 39.15 27.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.791 1.636 . . . . 0.0 111.947 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.677 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 48.1 m -116.9 156.69 26.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.41 ' N ' HG22 ' F' ' 167' ' ' THR . . . -84.33 -149.15 9.82 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.457 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.703 ' HG3' ' HB2' ' L' ' 88' ' ' GLN . 1.2 tt0 -65.9 -40.37 91.46 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 111.458 -177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.11 132.6 33.74 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 123.48 0.712 . . . . 0.0 109.243 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' L' ' 110' ' ' PHE . 85.2 Cg_endo -80.11 147.26 18.52 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.29 1.327 . . . . 0.0 112.72 -156.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . 0.482 ' H ' HG21 ' F' ' 167' ' ' THR . . . 81.36 12.13 82.45 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.14 47.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.998 0.899 . . . . 0.0 109.848 170.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' F' ' 166' ' ' THR . 16.2 t -102.97 120.47 52.29 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.39 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.7 170.62 19.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.5 0.857 . . . . 0.0 111.706 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.402 1.481 . . . . 0.0 112.273 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.765 HG21 HG23 ' H' ' 126' ' ' VAL . 58.2 mt -134.64 155.71 39.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.706 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -123.03 160.11 27.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.896 0.855 . . . . 0.0 110.72 -177.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -64.69 -16.65 61.52 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.336 -0.847 . . . . 0.0 114.511 175.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.94 41.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.804 0.802 . . . . 0.0 112.448 172.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.706 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 20.5 t0 -71.38 -53.22 14.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.474 HG11 ' HE ' ' G' ' 93' ' ' ARG . 62.5 t -87.75 112.27 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . 0.513 ' CG ' HD11 ' G' ' 27' ' ' LEU . 0.1 OUTLIER -117.29 145.64 43.85 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.673 0.749 . . . . 0.0 110.48 176.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -111.85 108.68 18.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.703 -164.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.568 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.14 33.32 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.425 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 14.3 m-85 -125.6 113.84 17.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.471 0.653 . . . . 0.0 109.981 176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.55 129.61 55.3 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . 0.54 ' HA ' HD13 ' G' ' 89' ' ' ILE . 87.9 p -76.08 146.91 39.02 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.571 0.7 . . . . 0.0 110.978 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.3 pt -64.76 -41.77 93.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . 0.498 ' N ' HG13 ' G' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.06 66.56 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.34 -43.01 74.52 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.463 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.16 56.28 7.69 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 111.805 -173.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.13 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.75 25.68 7.91 Favored Glycine 0 N--CA 1.45 -0.378 0 O-C-N 123.384 0.427 . . . . 0.0 113.745 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.81 -39.37 93.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.932 0.366 . . . . 0.0 111.823 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.616 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 57.03 77.59 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 112.413 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.33 145.52 43.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 CA-C-N 119.426 0.831 . . . . 0.0 112.435 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.568 HD12 ' HG ' ' G' ' 14' ' ' LEU . 6.3 tt -132.35 144.69 50.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.532 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 47.1 t80 -103.23 136.44 19.23 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.554 -167.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 49.9 Cg_endo -76.02 -178.24 4.23 Favored 'Trans proline' 0 C--N 1.332 -0.342 0 CA-C-O 121.868 0.695 . . . . 0.0 112.4 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 58.14 39.95 25.53 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.363 1.465 . . . . 0.0 111.551 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . 0.449 ' HD1' ' HB3' ' G' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.0 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.541 1.163 . . . . 0.0 111.091 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.05 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' H' ' 121' ' ' GLY . 25.3 p -132.96 169.81 16.26 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 122.769 1.271 . . . . 0.0 111.09 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.576 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.3 t0 -158.41 102.2 1.73 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.032 -164.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.403 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' H' ' 118' ' ' TYR . 43.5 t -127.45 124.18 37.8 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.132 -2.174 . . . . 0.0 105.132 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.473 HG12 ' HB3' ' H' ' 117' ' ' GLU . 23.8 m -128.11 145.66 34.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.31 121.59 27.81 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -166.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -116.41 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.248 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.36 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.67 51.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.704 0.764 . . . . 0.0 110.158 -174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . 0.572 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -132.06 123.6 27.55 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.522 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.66 88.81 2.52 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.288 171.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.16 163.81 13.25 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 155.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.478 ' HB2' ' CG1' ' C' ' 122' ' ' VAL . 2.4 mp0 -66.4 -51.84 52.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . 0.61 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 1.0 OUTLIER 61.2 36.07 18.14 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.618 1.567 . . . . 0.0 111.655 -172.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.18 49.04 3.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.529 1.532 . . . . 0.0 111.562 -164.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.54 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.484 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.77 19.4 0.67 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.42 171.67 48.25 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' G' ' 52' ' ' ARG . 0.0 OUTLIER -119.15 125.39 49.11 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 1.095 HG12 HG23 ' H' ' 135' ' ' ILE . 1.3 pp -130.47 -31.99 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.909 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.529 HD12 ' H ' ' G' ' 54' ' ' LEU . 1.6 mp -66.16 -18.79 65.57 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.52 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.85 0 CA-C-O 121.673 0.596 . . . . 0.0 113.904 -170.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -74.05 167.18 27.82 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.885 0.687 . . . . 0.0 113.885 -175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.58 -168.66 20.33 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.13 154.38 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.567 0.699 . . . . 0.0 110.497 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 7.2 p -103.16 128.98 55.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -108.81 114.4 28.15 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.05 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.06 143.12 26.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.941 0.896 . . . . 0.0 110.069 -178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.17 151.23 22.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.137 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' G' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.96 14.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 174.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.576 HG13 ' OD1' ' G' ' 34' ' ' ASP . 35.2 t -109.83 120.8 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' G' ' 128' ' ' ILE . 27.0 p -109.21 139.75 43.73 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 174.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.449 ' HB3' ' HD1' ' G' ' 31' ' ' TYR . 3.2 p90 -157.66 158.6 35.75 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.6 ' HB2' ' HB1' ' G' ' 30' ' ' ALA . 18.1 m-30 -79.17 140.67 37.69 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -73.12 145.41 36.24 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 114.916 0.726 . . . . 0.0 114.916 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 9.3 tttp -119.69 148.87 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.45 -50.96 21.63 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.35 -111.76 2.61 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 0.9 OUTLIER 74.04 121.24 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.133 1.373 . . . . 0.0 111.046 169.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.77 -29.14 21.25 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -156.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -53.73 42.22 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.821 168.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.577 ' O ' ' HB ' ' G' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.4 96.82 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 122.162 -0.61 . . . . 0.0 111.88 171.086 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -37.24 70.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.62 99.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.872 168.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.795 HD12 HD11 ' G' ' 113' ' ' ILE . 7.8 mm -52.7 -49.0 48.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 0.0 110.476 172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.31 -44.92 78.0 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.769 -0.582 . . . . 0.0 112.433 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.88 -33.24 73.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.577 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.61 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -64.26 -48.08 77.1 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.561 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' G' ' 113' ' ' ILE . 47.8 t80 -71.5 -47.13 57.39 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.896 -174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.846 HE21 ' HG3' ' L' ' 139' ' ' LYS . 0.1 OUTLIER -66.45 -52.47 45.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.12 20.94 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.048 172.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.39 2.41 Favored Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.346 -0.221 . . . . 0.0 112.882 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.599 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.4 mptt -130.48 147.78 52.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.689 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.87 48.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 168.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.61 HD11 ' HB2' ' G' ' 82' ' ' ALA . 23.4 mm -116.38 130.05 71.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-O 121.347 0.594 . . . . 0.0 109.857 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 7.3 mtmt -84.65 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.425 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 41.0 t80 -107.22 126.61 52.63 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.54 1.136 . . . . 0.0 110.004 -165.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.559 ' HZ3' ' HA ' ' A' ' 160' ' ' PHE . 1.8 m95 -123.4 115.75 22.14 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.21 1.004 . . . . 0.0 108.364 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.474 ' HE ' HG11 ' G' ' 11' ' ' VAL . 0.6 OUTLIER -102.26 102.82 13.26 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.77 HG11 ' HG2' ' G' ' 142' ' ' GLU . 22.4 m -120.74 152.93 23.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 122.29 1.043 . . . . 0.0 109.383 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.83 17.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.641 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -89.99 -0.18 57.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.671 -176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' G' ' 10' ' ' ASP . 30.1 m -93.82 131.58 40.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-O 121.727 0.775 . . . . 0.0 109.881 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.1 tttp -66.47 119.71 12.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.921 -174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.06 164.23 26.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.775 0.797 . . . . 0.0 110.026 171.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.37 56.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.5 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.745 0.702 . . . . 0.0 110.873 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.21 170.61 11.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.0 OUTLIER -66.91 -39.95 87.53 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.9 -0.5 . . . . 0.0 110.597 171.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.69 ' CZ ' HG21 ' G' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.886 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 3.1 p-10 -120.73 148.25 44.22 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.613 0.72 . . . . 0.0 109.442 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -140.49 151.04 44.5 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.09 -163.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' G' ' 138' ' ' LEU . 61.5 mt-30 -122.92 131.29 53.66 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' G' ' 138' ' ' LEU . 88.3 t80 -126.81 147.18 50.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.459 0.704 . . . . 0.0 110.403 -163.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 119.495 -1.335 . . . . 0.0 111.96 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.4 33.35 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -129.97 146.8 51.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.946 0.879 . . . . 0.0 111.159 -169.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.689 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 2.6 t80 -128.26 122.14 31.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.973 -174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.795 HD11 HD12 ' G' ' 79' ' ' ILE . 73.5 mt -80.88 101.3 5.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.76 29.93 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.87 141.98 42.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.924 0.783 . . . . 0.0 109.102 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.4 ttt180 -142.09 108.92 5.4 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' L' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 15.3 p90 -118.22 134.93 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.082 0.468 . . . . 0.0 111.189 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . 0.751 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 24.6 t -106.39 147.74 28.91 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.653 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.41 115.38 22.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' L' ' 33' ' ' THR . . . -96.44 178.07 33.84 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.17 -42.24 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.53 -0.394 . . . . 0.0 111.128 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . 0.591 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.4 47.78 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . 0.427 ' H ' ' H ' ' L' ' 8' ' ' GLY . . . 125.1 164.07 11.78 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 166.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' L' ' 6' ' ' ILE . . . -71.76 155.02 40.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.564 0.697 . . . . 0.0 110.761 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.754 HG23 HG21 ' L' ' 6' ' ' ILE . 91.4 t -59.36 125.78 15.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.092 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' G' ' 119' ' ' SER . 0.5 OUTLIER -79.12 108.17 12.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.083 -176.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' G' ' 66' ' ' THR . 1.9 mt -99.82 113.2 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.4 121.35 40.84 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 168.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' G' ' 64' ' ' GLU . 1.9 pp -118.94 134.54 62.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.02 48.52 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.748 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.422 HD13 ' HB1' ' G' ' 111' ' ' ALA . 1.5 pp -142.19 150.93 41.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.075 -172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.97 150.11 28.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.947 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.5 p -142.93 132.19 21.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 1.034 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -54.04 -46.6 66.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.339 0.59 . . . . 0.0 110.321 -173.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -162.12 145.71 11.11 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.675 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.79 124.4 48.83 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.091 0.948 . . . . 0.0 110.692 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -99.6 135.85 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.893 ' HG3' HE21 ' H' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.39 32.38 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . 0.556 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . 1.1 p-10 -166.87 -156.27 0.22 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.886 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -128.17 154.34 19.84 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.413 169.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 20.5 tp10 -103.54 150.98 23.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.677 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.2 OUTLIER -107.47 -78.55 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.784 -176.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . 0.666 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.83 11.21 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.291 -0.563 . . . . 0.0 111.014 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.18 23.93 10.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.344 175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.67 16.74 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 126.526 1.93 . . . . 0.0 109.35 -173.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.425 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.4 Cg_exo -66.89 -11.97 34.23 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.242 1.295 . . . . 0.0 115.359 -159.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.84 26.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.602 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.57 -34.72 6.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.517 HD12 HD21 ' G' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 119.16 0.891 . . . . 0.0 111.263 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.69 HG21 ' CZ ' ' G' ' 104' ' ' TYR . 5.0 t -71.26 -33.4 50.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.51 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.477 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.05 124.77 69.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 171.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.26 128.27 29.54 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' G' ' 156' ' ' GLY . 1.1 pptp? -54.52 -46.77 73.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . 0.449 ' O ' ' HD2' ' G' ' 155' ' ' LYS . . . 140.77 134.77 3.11 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 119.381 0.991 . . . . 0.0 113.046 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.36 0.38 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -115.76 92.63 3.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.361 1.065 . . . . 0.0 108.616 177.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.69 39.44 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -158.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.52 117.84 19.33 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.702 2.401 . . . . 0.0 109.126 167.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -123.17 47.24 2.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.39 2.87 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.85 -0.89 10.27 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.061 1.772 . . . . 0.0 113.851 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.8 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.362 2.105 . . . . 0.0 118.362 -171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' G' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.5 86.91 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.912 1.356 . . . . 0.0 110.926 175.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.595 ' OG1' HG22 ' G' ' 174' ' ' VAL . 1.7 p 52.48 39.16 27.25 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.823 1.649 . . . . 0.0 111.923 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' G' ' 172' ' ' GLY . 48.5 m -116.86 156.72 26.83 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.336 -167.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' G' ' 167' ' ' THR . . . -84.3 -149.13 9.76 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.473 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.773 0.287 . . . . 0.0 111.459 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.54 33.86 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 123.539 0.736 . . . . 0.0 109.262 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.558 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.5 Cg_endo -80.09 147.24 18.57 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.293 1.328 . . . . 0.0 112.769 -156.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' G' ' 167' ' ' THR . . . 81.32 12.21 82.41 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.17 47.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.001 0.901 . . . . 0.0 109.907 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.595 HG22 ' OG1' ' G' ' 166' ' ' THR . 16.3 t -102.91 120.42 52.52 Favored Pre-proline 0 C--O 1.241 0.643 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.439 178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.61 19.07 Favored 'Trans proline' 0 C--N 1.349 0.559 0 CA-C-N 119.541 0.872 . . . . 0.0 111.703 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 125.444 1.498 . . . . 0.0 112.349 -171.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 C--O 1.231 0.134 0 N-CA-C 115.092 1.151 . . . . 0.0 115.092 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.761 HG21 HG23 ' I' ' 126' ' ' VAL . 58.1 mt -134.6 155.78 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.72 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -123.08 160.07 27.16 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.915 0.864 . . . . 0.0 110.743 -177.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -64.6 -16.76 61.48 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.353 -0.84 . . . . 0.0 114.526 175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.64 -3.93 41.89 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 117.727 0.763 . . . . 0.0 112.4 172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.72 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 20.5 t0 -71.35 -53.22 14.91 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.473 HG11 ' HE ' ' H' ' 93' ' ' ARG . 62.6 t -87.77 112.31 23.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . 0.528 ' CG ' HD11 ' H' ' 27' ' ' LEU . 0.1 OUTLIER -117.34 145.6 43.93 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.475 176.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -111.77 108.69 18.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.764 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.588 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -95.25 138.18 33.3 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.426 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 14.2 m-85 -125.61 113.86 17.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.412 0.625 . . . . 0.0 109.979 176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.54 129.63 55.3 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . 0.539 ' HA ' HD13 ' H' ' 89' ' ' ILE . 87.9 p -76.09 146.9 39.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.557 0.694 . . . . 0.0 111.005 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.679 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.3 pt -64.75 -41.8 93.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.992 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . 0.487 ' N ' HG13 ' H' ' 18' ' ' ILE . 0.5 OUTLIER -65.54 -21.01 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.38 -43.0 74.41 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.11 -0.636 . . . . 0.0 111.408 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.18 56.28 7.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.202 1.401 . . . . 0.0 111.806 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.87 8.4 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.73 25.66 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 113.733 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.82 -39.37 93.48 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 117.012 0.406 . . . . 0.0 111.793 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.606 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 57.1 77.61 0.41 Allowed Pre-proline 0 C--O 1.239 0.503 0 C-N-CA 126.993 2.117 . . . . 0.0 112.362 -174.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -72.35 145.53 43.35 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.474 0.848 . . . . 0.0 112.459 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.588 HD12 ' HG ' ' H' ' 14' ' ' LEU . 6.3 tt -132.4 144.62 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 168.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.534 ' CD1' ' HD2' ' H' ' 29' ' ' PRO . 47.2 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 115.857 -2.337 . . . . 0.0 110.5 -167.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.21 4.21 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.911 0.713 . . . . 0.0 112.392 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 58.14 39.92 25.57 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.374 1.47 . . . . 0.0 111.576 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' H' ' 67' ' ' TYR . 8.4 m-30 -70.62 135.02 48.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.544 1.164 . . . . 0.0 111.015 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -104.08 -94.34 0.33 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . 0.418 HG22 ' HA2' ' I' ' 121' ' ' GLY . 25.5 p -133.06 169.78 16.35 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 122.721 1.248 . . . . 0.0 111.146 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.3 t0 -158.36 102.25 1.74 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.941 -164.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.22 133.81 11.59 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.399 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' I' ' 118' ' ' TYR . 43.6 t -127.45 124.17 37.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' I' ' 117' ' ' GLU . 23.9 m -128.04 145.71 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -166.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -116.43 114.77 3.14 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.225 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.82 48.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.704 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.2 mtm-85 -63.81 132.59 51.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.701 0.762 . . . . 0.0 110.196 -174.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.65 27.74 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -167.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.04 120.76 34.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.517 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.74 88.89 2.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.195 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.78 13.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 155.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' D' ' 122' ' ' VAL . 2.4 mp0 -66.32 -51.91 52.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 0.9 OUTLIER 61.28 36.03 17.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.609 1.564 . . . . 0.0 111.697 -172.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.2 49.05 3.19 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.457 1.503 . . . . 0.0 111.572 -164.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.61 -163.63 1.74 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.482 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.71 19.37 0.67 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.44 171.68 48.28 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' H' ' 52' ' ' ARG . 0.0 OUTLIER -119.19 125.43 49.19 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 1.013 HG12 HG23 ' I' ' 135' ' ' ILE . 1.3 pp -130.51 -32.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.527 HD12 ' H ' ' H' ' 54' ' ' LEU . 1.6 mp -66.14 -18.77 65.56 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.37 0.64 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 121.683 0.602 . . . . 0.0 113.986 -170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -74.05 167.17 27.84 Favored 'Trans proline' 0 CA--C 1.515 -0.437 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.59 -168.73 20.43 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.06 154.36 21.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.547 0.689 . . . . 0.0 110.542 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 7.2 p -103.15 129.0 55.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . 0.704 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -108.81 114.39 28.13 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.32 10.08 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.08 26.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.954 0.901 . . . . 0.0 110.06 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.12 151.23 22.72 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.152 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' H' ' 130' ' ' ILE . 0.9 OUTLIER -143.42 123.99 14.04 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' H' ' 34' ' ' ASP . 35.5 t -109.86 120.79 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' H' ' 128' ' ' ILE . 26.8 p -109.16 139.76 43.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 174.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' H' ' 31' ' ' TYR . 3.2 p90 -157.68 158.51 35.56 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.612 ' HB2' ' HB1' ' H' ' 30' ' ' ALA . 18.1 m-30 -79.04 140.66 37.87 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 9.3 tttp -119.77 148.86 42.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.44 -50.98 21.52 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.33 -111.67 2.61 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 0.9 OUTLIER 74.0 121.18 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.14 1.376 . . . . 0.0 111.069 169.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -87.76 -29.07 21.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -156.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.66 42.74 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.86 168.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.572 ' O ' ' HB ' ' H' ' 79' ' ' ILE . 0.0 OUTLIER -60.74 -42.35 97.21 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.841 171.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.28 70.73 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.814 171.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.59 99.77 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.888 168.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.775 HD12 HD11 ' H' ' 113' ' ' ILE . 7.8 mm -52.69 -49.11 47.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.065 0.459 . . . . 0.0 110.426 172.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.24 -44.99 78.08 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.764 -0.585 . . . . 0.0 112.405 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.77 -33.29 73.83 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.555 169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -64.28 -48.03 77.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.084 -1.047 . . . . 0.0 111.553 175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.529 ' HD1' HG22 ' H' ' 113' ' ' ILE . 47.8 t80 -71.53 -47.13 57.21 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.882 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.893 HE21 ' HG3' ' G' ' 139' ' ' LYS . 0.1 OUTLIER -66.47 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.423 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 33.1 m120 -81.38 -42.17 20.86 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.007 172.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.95 97.5 2.42 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.303 -0.248 . . . . 0.0 112.825 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.686 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.7 tm0? -72.77 141.89 48.1 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' H' ' 82' ' ' ALA . 23.4 mm -116.4 130.1 71.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.332 0.587 . . . . 0.0 109.844 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.679 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 7.3 mtmt -84.66 112.32 20.36 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.426 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 40.8 t80 -107.19 126.61 52.62 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.525 1.13 . . . . 0.0 110.052 -166.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.561 ' HZ3' ' HA ' ' B' ' 160' ' ' PHE . 1.9 m95 -123.44 115.76 22.12 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.186 0.995 . . . . 0.0 108.367 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.473 ' HE ' HG11 ' H' ' 11' ' ' VAL . 0.7 OUTLIER -102.25 102.77 13.21 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 172.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.783 HG11 ' HG2' ' H' ' 142' ' ' GLU . 22.4 m -120.7 152.88 23.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-O 122.204 1.002 . . . . 0.0 109.424 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.26 154.81 17.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.619 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 15.3 m -89.99 -0.1 57.4 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.66 -176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . 0.413 HG13 ' OD1' ' H' ' 10' ' ' ASP . 30.2 m -93.85 131.56 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.687 0.756 . . . . 0.0 109.859 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.1 tttp -66.39 119.66 11.98 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.976 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.15 164.21 26.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.814 0.816 . . . . 0.0 109.985 171.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 1.41 56.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.52 -42.77 1.16 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.922 169.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.61 11.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 167.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.0 OUTLIER -66.9 -39.89 87.56 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.883 -0.511 . . . . 0.0 110.634 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' H' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.86 5.16 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.909 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.3 44.16 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.636 0.731 . . . . 0.0 109.461 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.836 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -140.52 151.05 44.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.047 -163.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' H' ' 138' ' ' LEU . 61.8 mt-30 -122.87 131.32 53.69 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 157.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HG ' ' H' ' 138' ' ' LEU . 88.3 t80 -126.83 147.21 50.05 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.4 0.68 . . . . 0.0 110.414 -163.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.67 163.14 36.9 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.512 -1.327 . . . . 0.0 111.967 170.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.667 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.31 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -129.95 146.8 51.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 111.209 -169.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.686 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 2.6 t80 -128.26 122.1 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.016 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.775 HD11 HD12 ' H' ' 79' ' ' ILE . 73.5 mt -80.83 101.33 5.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.8 29.79 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 142.01 42.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.984 0.811 . . . . 0.0 109.099 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.4 ttt180 -142.02 108.94 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.473 ' HB3' HG12 ' G' ' 37' ' ' VAL . 11.4 mt-10 -120.85 117.92 28.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 15.4 p90 -118.16 134.88 54.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.06 0.457 . . . . 0.0 111.209 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 24.6 t -106.36 147.75 28.87 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.4 115.37 22.15 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 167.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . 0.435 ' HA2' HG22 ' G' ' 33' ' ' THR . . . -96.4 178.06 33.9 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 121.72 0.622 . . . . 0.0 111.548 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.27 89.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.501 -0.411 . . . . 0.0 111.13 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.46 47.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 169.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . 0.441 ' H ' ' H ' ' G' ' 8' ' ' GLY . . . 125.04 164.07 11.79 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' G' ' 6' ' ' ILE . . . -71.74 155.08 40.86 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.624 0.726 . . . . 0.0 110.727 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.765 HG23 HG21 ' G' ' 6' ' ' ILE . 91.5 t -59.43 125.87 16.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.006 -171.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.738 ' HB2' ' HB3' ' H' ' 119' ' ' SER . 0.5 OUTLIER -79.23 108.2 12.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.091 -176.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' H' ' 66' ' ' THR . 1.9 mt -99.85 113.24 34.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.33 40.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' H' ' 64' ' ' GLU . 1.9 pp -118.92 134.6 62.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 139.96 48.61 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.718 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.443 HD13 ' HB1' ' H' ' 111' ' ' ALA . 1.5 pp -142.14 150.88 41.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.136 -172.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.89 150.15 28.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.923 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.5 p -142.96 132.18 21.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 1.095 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -54.06 -46.6 66.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 121.283 0.563 . . . . 0.0 110.329 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.532 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -162.11 145.72 11.13 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.949 -0.644 . . . . 0.0 111.718 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.78 124.45 48.92 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.007 0.908 . . . . 0.0 110.641 174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -99.59 135.88 40.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -174.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.868 ' HG3' HE21 ' I' ' 84' ' ' GLN . 11.4 mtmt -89.91 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.909 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -128.25 154.31 19.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.373 169.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.96 23.43 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.75 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.2 OUTLIER -107.43 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -176.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . 0.662 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 8.9 p-10 -97.66 99.84 11.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.975 -176.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 77.9 p -102.2 24.03 10.78 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 118.708 -0.663 . . . . 0.0 112.38 175.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.7 OUTLIER 46.67 58.69 16.66 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.462 1.905 . . . . 0.0 109.377 -173.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.43 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -66.88 -12.04 34.5 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.228 1.286 . . . . 0.0 115.29 -159.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.35 -53.91 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.573 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.523 HD12 HD21 ' H' ' 14' ' ' LEU . 1.5 mt -77.15 -49.84 21.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.169 0.895 . . . . 0.0 111.264 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' H' ' 104' ' ' TYR . 5.0 t -71.32 -33.36 50.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.53 113.57 26.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.458 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 17.2 m -112.09 124.7 69.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 171.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.18 128.27 29.72 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' H' ' 156' ' ' GLY . 1.1 pptp? -54.51 -46.75 73.55 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' H' ' 155' ' ' LYS . . . 140.73 134.72 3.11 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 119.359 0.982 . . . . 0.0 113.089 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.4 0.38 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -115.82 92.63 3.96 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.359 1.064 . . . . 0.0 108.638 177.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.28 -41.79 39.53 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -158.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.41 117.86 19.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.703 2.401 . . . . 0.0 109.168 167.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -123.16 47.27 2.01 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 153.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -166.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.94 10.3 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.045 1.766 . . . . 0.0 113.861 171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.504 ' HA ' ' HB3' ' H' ' 161' ' ' GLN . 0.3 OUTLIER -67.07 -40.56 87.08 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.942 1.371 . . . . 0.0 110.907 175.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.592 ' OG1' HG22 ' H' ' 174' ' ' VAL . 1.7 p 52.58 39.12 27.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.812 1.645 . . . . 0.0 111.876 176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.5 HG21 ' H ' ' H' ' 172' ' ' GLY . 48.9 m -116.91 156.69 26.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.316 -167.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . 0.409 ' N ' HG22 ' H' ' 167' ' ' THR . . . -84.31 -149.08 9.71 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.508 172.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.94 -40.35 91.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.834 0.317 . . . . 0.0 111.435 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.16 132.59 33.69 Favored Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 123.463 0.705 . . . . 0.0 109.278 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.549 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -80.05 147.29 18.68 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.315 1.343 . . . . 0.0 112.702 -156.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . 0.5 ' H ' HG21 ' H' ' 167' ' ' THR . . . 81.36 12.07 82.53 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.156 1.622 . . . . 0.0 117.156 165.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 124.15 47.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.018 0.909 . . . . 0.0 109.889 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.592 HG22 ' OG1' ' H' ' 166' ' ' THR . 16.4 t -102.96 120.42 52.45 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.413 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.65 170.65 18.99 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.522 0.865 . . . . 0.0 111.759 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.399 1.48 . . . . 0.0 112.303 -171.75 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.466 -0.134 0 N-CA-C 115.059 1.138 . . . . 0.0 115.059 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.633 HG21 HG23 ' J' ' 126' ' ' VAL . 58.2 mt -134.56 155.75 39.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.71 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -123.04 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.879 0.847 . . . . 0.0 110.774 -177.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -64.72 -16.7 61.65 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.517 175.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.93 41.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 117.757 0.779 . . . . 0.0 112.413 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.71 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 20.4 t0 -71.35 -53.24 14.84 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -172.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.468 HG11 ' HE ' ' I' ' 93' ' ' ARG . 63.3 t -87.71 112.26 23.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . 0.521 ' CG ' HD11 ' I' ' 27' ' ' LEU . 0.1 OUTLIER -117.28 145.6 43.86 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.664 0.745 . . . . 0.0 110.538 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.82 108.68 18.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.725 -164.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.22 33.19 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 14.2 m-85 -125.68 113.84 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.943 176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.57 129.68 55.31 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . 0.538 ' HA ' HD13 ' I' ' 89' ' ' ILE . 88.0 p -76.05 146.85 39.12 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.01 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.661 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.3 pt -64.81 -41.79 93.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.929 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' I' ' 18' ' ' ILE . 0.5 OUTLIER -65.48 -21.1 66.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -171.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.39 -42.98 74.4 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.436 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.17 56.28 7.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.172 1.389 . . . . 0.0 111.815 -173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.17 176.86 8.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.7 25.61 7.97 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.735 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 3.1 p -64.84 -39.35 93.42 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.988 0.394 . . . . 0.0 111.755 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.603 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 57.06 77.61 0.41 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.98 2.112 . . . . 0.0 112.383 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.31 145.56 43.59 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 119.421 0.829 . . . . 0.0 112.467 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' I' ' 14' ' ' LEU . 6.3 tt -132.39 144.66 50.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 168.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 47.0 t80 -103.17 136.45 19.23 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.855 -2.338 . . . . 0.0 110.567 -167.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.2 Cg_endo -76.05 -178.18 4.2 Favored 'Trans proline' 0 CA--C 1.518 -0.292 0 CA-C-O 121.889 0.704 . . . . 0.0 112.436 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 58.11 39.97 25.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.371 1.468 . . . . 0.0 111.579 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . 0.441 ' HD1' ' HB3' ' I' ' 67' ' ' TYR . 8.4 m-30 -70.7 135.07 48.04 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 122.557 1.17 . . . . 0.0 111.047 173.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -104.1 -94.34 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.496 HG22 ' HA2' ' J' ' 121' ' ' GLY . 25.4 p -133.03 169.76 16.37 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.765 1.269 . . . . 0.0 111.087 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.557 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.3 t0 -158.36 102.27 1.74 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.042 -1.436 . . . . 0.0 107.977 -164.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.75 11.57 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.395 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.635 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 43.5 t -127.46 124.16 37.72 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.565 HG12 ' HB3' ' J' ' 117' ' ' GLU . 23.8 m -128.02 145.7 34.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -173.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.32 121.59 27.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -166.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -116.42 114.76 3.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.27 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.64 125.82 48.37 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.707 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.2 mtm-85 -63.85 132.65 51.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.77 0.795 . . . . 0.0 110.122 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.697 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.65 27.66 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -167.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.74 34.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.498 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.9 2.52 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.255 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.19 163.74 13.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 155.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.29 -51.95 52.31 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 1.0 OUTLIER 61.25 36.06 17.98 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.576 1.55 . . . . 0.0 111.674 -172.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . . . . . . . . . 41.3 p 41.26 48.99 3.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.522 1.529 . . . . 0.0 111.566 -164.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.6 -163.6 1.73 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.485 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.74 19.33 0.67 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.43 171.77 48.36 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -119.19 125.4 49.1 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 1.041 HG12 HG23 ' J' ' 135' ' ' ILE . 1.3 pp -130.51 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.864 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.535 HD23 ' HG3' ' J' ' 88' ' ' GLN . 1.6 mp -66.11 -18.88 65.63 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.49 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.712 0.618 . . . . 0.0 113.935 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 68.9 Cg_endo -74.08 167.15 27.88 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 N-CA-C 113.857 0.676 . . . . 0.0 113.857 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.68 20.34 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.1 154.39 21.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.541 0.686 . . . . 0.0 110.547 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 7.3 p -103.17 128.97 55.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . 0.707 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -108.82 114.39 28.13 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 12.0 m-20 -104.07 100.35 10.1 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -171.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.12 26.84 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.927 0.891 . . . . 0.0 110.004 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.14 151.27 22.76 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.156 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' I' ' 130' ' ' ILE . 0.9 OUTLIER -143.46 123.96 13.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 174.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.557 HG13 ' OD1' ' I' ' 34' ' ' ASP . 35.7 t -109.85 120.78 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' I' ' 128' ' ' ILE . 27.1 p -109.19 139.77 43.67 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.441 ' HB3' ' HD1' ' I' ' 31' ' ' TYR . 3.1 p90 -157.66 158.56 35.69 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.613 ' HB2' ' HB1' ' I' ' 30' ' ' ALA . 18.1 m-30 -79.11 140.64 37.78 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -73.08 145.38 36.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 9.3 tttp -119.73 148.88 42.88 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -47.46 -50.99 21.71 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.38 -111.72 2.6 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 0.9 OUTLIER 74.09 121.13 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.109 1.364 . . . . 0.0 111.042 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -87.71 -29.15 21.31 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 -156.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.24 -53.62 43.11 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.875 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' I' ' 79' ' ' ILE . 0.0 OUTLIER -60.71 -42.41 97.19 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.803 171.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 0.0 OUTLIER -56.71 -37.28 70.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.792 171.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.59 99.78 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.865 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.79 HD12 HD11 ' I' ' 113' ' ' ILE . 7.8 mm -52.72 -49.1 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.06 0.457 . . . . 0.0 110.426 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.22 -44.94 78.27 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.74 -0.6 . . . . 0.0 112.466 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.31 73.9 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.533 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -64.26 -48.04 77.29 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.554 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' I' ' 113' ' ' ILE . 47.8 t80 -71.56 -47.06 57.48 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.921 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.868 HE21 ' HG3' ' H' ' 139' ' ' LYS . 0.1 OUTLIER -66.53 -52.45 45.65 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -167.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.427 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 33.2 m120 -81.38 -42.08 20.99 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.035 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.43 2.41 Favored Glycine 0 N--CA 1.449 -0.48 0 O-C-N 122.31 -0.244 . . . . 0.0 112.846 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.4 mptt -130.46 147.76 52.19 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.691 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.7 tm0? -72.75 141.89 48.14 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 168.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' I' ' 82' ' ' ALA . 23.5 mm -116.39 130.09 71.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.33 0.585 . . . . 0.0 109.918 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 7.3 mtmt -84.7 112.33 20.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.429 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 40.9 t80 -107.22 126.65 52.68 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 0.0 109.995 -165.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.496 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 1.9 m95 -123.47 115.79 22.15 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.468 ' HE ' HG11 ' I' ' 11' ' ' VAL . 0.7 OUTLIER -102.3 102.85 13.27 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' I' ' 142' ' ' GLU . 22.0 m -120.74 152.88 23.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.207 1.003 . . . . 0.0 109.429 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.29 154.84 17.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.613 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 15.5 m -90.01 -0.12 57.41 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.661 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' I' ' 10' ' ' ASP . 30.1 m -93.82 131.52 40.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.714 0.769 . . . . 0.0 109.859 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.1 tttp -66.39 119.71 12.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.984 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.12 164.26 26.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.841 0.829 . . . . 0.0 109.958 171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 1.38 56.43 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.49 -42.86 1.16 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.729 0.695 . . . . 0.0 110.864 169.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 170.59 11.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.0 OUTLIER -66.96 -39.89 87.36 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.865 -0.522 . . . . 0.0 110.572 171.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.696 ' CZ ' HG21 ' I' ' 151' ' ' VAL . 98.0 m-85 -143.96 -176.88 5.17 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.91 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 3.1 p-10 -120.74 148.28 44.18 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.642 0.734 . . . . 0.0 109.414 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.825 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -140.49 151.07 44.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -163.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' I' ' 138' ' ' LEU . 61.6 mt-30 -122.88 131.3 53.68 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 157.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.509 ' O ' ' HG ' ' I' ' 138' ' ' LEU . 88.3 t80 -126.84 147.2 50.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.375 0.67 . . . . 0.0 110.454 -163.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.6 163.18 36.94 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.964 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.4 m-85 -84.71 126.35 33.32 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.444 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -129.93 146.8 51.64 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.955 0.883 . . . . 0.0 111.13 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.691 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 2.6 t80 -128.25 122.14 31.03 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.432 -1.258 . . . . 0.0 107.975 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.79 HD11 HD12 ' I' ' 79' ' ' ILE . 73.4 mt -80.85 101.35 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 2.7 mt-10 -94.15 -11.75 29.8 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.979 0.809 . . . . 0.0 109.11 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.4 ttt180 -142.08 108.91 5.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' H' ' 37' ' ' VAL . 11.4 mt-10 -120.8 117.96 28.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 15.2 p90 -118.18 134.87 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.071 0.462 . . . . 0.0 111.218 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . 0.746 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 24.5 t -106.34 147.82 28.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.4 22.18 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . 0.418 ' HA2' HG22 ' H' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.732 0.629 . . . . 0.0 111.572 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.14 -42.3 89.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 122.476 -0.426 . . . . 0.0 111.113 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . 0.495 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.0 tp10 -132.96 140.37 47.77 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 169.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' H' ' 8' ' ' GLY . . . 125.13 164.05 11.77 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' H' ' 6' ' ' ILE . . . -71.7 155.02 40.96 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.612 0.72 . . . . 0.0 110.758 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.761 HG23 HG21 ' H' ' 6' ' ' ILE . 91.9 t -59.42 125.85 16.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.052 -171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.746 ' HB2' ' HB3' ' I' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.14 12.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.062 -176.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' I' ' 66' ' ' THR . 1.9 mt -99.8 113.23 34.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.42 121.31 40.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' I' ' 64' ' ' GLU . 1.9 pp -118.89 134.56 62.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.58 140.08 48.47 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.716 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.444 HD13 ' HB1' ' I' ' 111' ' ' ALA . 1.5 pp -142.24 150.95 41.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.117 -172.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.96 150.14 28.17 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.891 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.5 p -142.89 132.17 21.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 1.013 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -54.0 -46.63 65.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.401 0.619 . . . . 0.0 110.367 -173.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.537 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -162.1 145.75 11.16 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.72 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.43 48.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.07 0.938 . . . . 0.0 110.639 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -99.58 135.89 40.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.761 ' HG3' HE21 ' J' ' 84' ' ' GLN . 11.4 mtmt -89.83 137.38 32.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -166.88 -156.31 0.22 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.91 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -128.15 154.36 19.85 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.374 169.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.825 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 20.5 tp10 -103.58 151.0 23.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.703 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.2 OUTLIER -107.44 -78.53 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.821 -176.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.81 11.17 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.973 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 77.6 p -102.13 24.02 10.75 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.385 175.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 126.463 1.905 . . . . 0.0 109.414 -173.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -66.82 -12.0 34.27 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.243 1.295 . . . . 0.0 115.382 -159.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.32 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.612 171.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.53 -34.78 6.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.521 HD12 HD21 ' I' ' 14' ' ' LEU . 1.5 mt -77.25 -49.82 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.149 0.886 . . . . 0.0 111.265 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.696 HG21 ' CZ ' ' I' ' 104' ' ' TYR . 5.1 t -71.23 -33.38 50.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.52 113.52 25.99 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.488 -176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.29 128.24 29.44 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -172.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' I' ' 156' ' ' GLY . 1.1 pptp? -54.54 -46.72 73.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 175.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' I' ' 155' ' ' LYS . . . 140.73 134.76 3.11 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.392 0.996 . . . . 0.0 113.039 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.98 78.36 0.38 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -115.78 92.66 3.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.346 1.058 . . . . 0.0 108.597 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.72 39.38 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 117.85 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.659 2.384 . . . . 0.0 109.139 167.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -123.13 47.25 2.01 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -33.44 2.91 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -166.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.78 -0.98 10.33 Favored 'Trans proline' 0 C--O 1.238 0.508 0 CA-C-N 122.073 1.776 . . . . 0.0 113.88 171.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.85 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 118.351 2.101 . . . . 0.0 118.351 -171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' I' ' 161' ' ' GLN . 0.3 OUTLIER -67.1 -40.47 86.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.894 1.347 . . . . 0.0 110.969 175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.59 ' OG1' HG22 ' I' ' 174' ' ' VAL . 1.7 p 52.54 39.13 27.4 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 111.911 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.499 HG21 ' H ' ' I' ' 172' ' ' GLY . 48.3 m -116.91 156.74 26.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.322 -167.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' I' ' 167' ' ' THR . . . -84.33 -149.18 9.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.447 172.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.8 -40.42 91.89 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.76 0.28 . . . . 0.0 111.463 -177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.17 132.61 33.63 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 123.481 0.712 . . . . 0.0 109.206 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.4 Cg_endo -80.09 147.29 18.59 Favored 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.269 1.313 . . . . 0.0 112.731 -156.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . 0.499 ' H ' HG21 ' I' ' 167' ' ' THR . . . 81.29 12.16 82.52 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.2 124.19 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.983 0.892 . . . . 0.0 109.882 170.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.59 HG22 ' OG1' ' I' ' 166' ' ' THR . 16.3 t -102.95 120.41 52.5 Favored Pre-proline 0 C--O 1.241 0.63 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.413 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.68 170.59 19.13 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.536 0.87 . . . . 0.0 111.707 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.447 1.499 . . . . 0.0 112.285 -171.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.198 0 N-CA-C 115.11 1.158 . . . . 0.0 115.11 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.698 HG21 HG23 ' K' ' 126' ' ' VAL . 58.0 mt -134.63 155.71 39.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.694 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -123.06 160.18 26.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.942 0.877 . . . . 0.0 110.731 -177.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -64.76 -16.63 61.66 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.466 175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.61 -4.03 41.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 117.808 0.804 . . . . 0.0 112.389 172.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.694 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 20.4 t0 -71.28 -53.29 14.77 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.466 HG11 ' HE ' ' J' ' 93' ' ' ARG . 62.8 t -87.64 112.24 23.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' J' ' 27' ' ' LEU . 0.1 OUTLIER -117.3 145.67 43.84 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.699 0.761 . . . . 0.0 110.483 176.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -111.9 108.7 18.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.719 -164.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.584 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -95.2 138.18 33.25 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 174.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 14.4 m-85 -125.67 113.9 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.492 0.663 . . . . 0.0 109.952 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.7 55.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . 0.541 ' HA ' HD13 ' J' ' 89' ' ' ILE . 88.0 p -76.14 146.92 38.89 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.022 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.668 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.3 pt -64.81 -41.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.981 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' J' ' 18' ' ' ILE . 0.5 OUTLIER -65.58 -21.02 66.55 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 -171.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.36 -42.99 74.49 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.441 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.26 7.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.22 1.408 . . . . 0.0 111.843 -173.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.11 176.83 8.43 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.67 25.62 7.97 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.702 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.85 -39.32 93.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 117.001 0.4 . . . . 0.0 111.767 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.604 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 57.07 77.6 0.41 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.932 2.093 . . . . 0.0 112.416 -174.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.37 145.51 43.15 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.443 0.837 . . . . 0.0 112.509 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.584 HD12 ' HG ' ' J' ' 14' ' ' LEU . 6.3 tt -132.34 144.68 50.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 46.9 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.516 -167.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.1 Cg_endo -76.05 -178.2 4.21 Favored 'Trans proline' 0 C--N 1.333 -0.281 0 CA-C-O 121.876 0.698 . . . . 0.0 112.421 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 58.15 39.94 25.5 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.356 1.463 . . . . 0.0 111.57 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.451 ' HD1' ' HB3' ' J' ' 67' ' ' TYR . 8.4 m-30 -70.66 135.06 48.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.537 1.16 . . . . 0.0 111.092 173.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.12 -94.38 0.33 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . 0.472 HG22 ' HA2' ' K' ' 121' ' ' GLY . 25.6 p -133.04 169.83 16.27 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 122.757 1.265 . . . . 0.0 111.1 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.567 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.06 -1.427 . . . . 0.0 107.975 -164.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.23 133.79 11.58 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.385 170.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' K' ' 118' ' ' TYR . 43.6 t -127.46 124.2 37.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 173.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.551 HG12 ' HB3' ' K' ' 117' ' ' GLU . 23.9 m -128.09 145.72 34.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.4 121.61 27.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -116.4 114.78 3.15 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.288 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.69 125.8 48.42 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.709 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.61 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.708 0.766 . . . . 0.0 110.193 -174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . 0.586 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -132.03 123.61 27.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -167.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 120.76 34.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.479 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.88 2.52 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.242 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.2 163.79 13.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 155.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.438 ' HB2' ' CG1' ' F' ' 122' ' ' VAL . 2.4 mp0 -66.32 -52.02 51.47 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 0.9 OUTLIER 61.32 36.05 17.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.592 1.557 . . . . 0.0 111.651 -172.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.16 49.05 3.14 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.533 1.533 . . . . 0.0 111.558 -164.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.443 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.76 19.42 0.67 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.39 171.69 48.26 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -119.13 125.43 49.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 1.007 HG12 HG23 ' K' ' 135' ' ' ILE . 1.3 pp -130.54 -31.97 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.887 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.531 HD12 ' H ' ' J' ' 54' ' ' LEU . 1.6 mp -66.09 -18.9 65.64 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.44 0.65 Allowed Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 121.688 0.605 . . . . 0.0 113.932 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.04 167.14 27.91 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.55 -168.71 20.38 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.07 154.39 21.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.535 0.683 . . . . 0.0 110.503 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 7.3 p -103.23 128.99 55.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . 0.709 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -108.81 114.38 28.12 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 11.9 m-20 -104.07 100.29 10.04 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.09 143.07 26.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.968 0.907 . . . . 0.0 110.082 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.08 151.31 22.77 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.156 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.51 123.87 13.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.567 HG13 ' OD1' ' J' ' 34' ' ' ASP . 34.8 t -109.76 120.78 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' J' ' 128' ' ' ILE . 26.8 p -109.15 139.72 43.68 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.451 ' HB3' ' HD1' ' J' ' 31' ' ' TYR . 3.1 p90 -157.62 158.61 35.83 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.597 ' HB2' ' HB1' ' J' ' 30' ' ' ALA . 18.1 m-30 -79.18 140.67 37.67 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.09 145.37 36.24 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.499 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 9.4 tttp -119.74 148.9 42.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' J' ' 71' ' ' ARG . 8.6 ptp180 -47.44 -51.01 21.48 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.36 -111.69 2.6 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 0.9 OUTLIER 74.02 121.16 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.115 1.366 . . . . 0.0 111.016 169.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.74 -29.05 21.35 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.28 -53.7 42.38 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.81 168.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.569 ' O ' ' HB ' ' J' ' 79' ' ' ILE . 0.0 OUTLIER -60.69 -42.34 96.96 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.143 -0.622 . . . . 0.0 111.834 171.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -37.28 70.81 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.78 171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.84 -42.55 99.78 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.9 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.781 HD12 HD11 ' J' ' 113' ' ' ILE . 7.9 mm -52.73 -49.05 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.04 0.447 . . . . 0.0 110.479 172.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.28 -44.92 78.12 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.769 -0.582 . . . . 0.0 112.463 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.81 -33.28 73.85 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.59 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -64.25 -48.02 77.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.62 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.51 ' HD1' HG22 ' J' ' 113' ' ' ILE . 47.9 t80 -71.47 -47.2 57.17 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.888 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.761 HE21 ' HG3' ' I' ' 139' ' ' LYS . 0.1 OUTLIER -66.46 -52.44 46.25 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -167.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.428 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.12 20.88 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.004 172.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.93 97.42 2.41 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 122.32 -0.237 . . . . 0.0 112.863 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.602 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.4 mptt -130.49 147.8 52.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.696 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.7 tm0? -72.76 141.89 48.11 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 168.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' J' ' 82' ' ' ALA . 23.4 mm -116.4 130.07 71.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.344 0.592 . . . . 0.0 109.842 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 7.3 mtmt -84.72 112.37 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 41.0 t80 -107.23 126.66 52.7 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.521 1.128 . . . . 0.0 110.013 -166.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.556 ' HZ3' ' HA ' ' D' ' 160' ' ' PHE . 1.9 m95 -123.48 115.76 22.1 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 108.319 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.466 ' HE ' HG11 ' J' ' 11' ' ' VAL . 0.7 OUTLIER -102.29 102.79 13.21 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.786 HG11 ' HG2' ' J' ' 142' ' ' GLU . 22.4 m -120.7 152.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.287 1.041 . . . . 0.0 109.393 -173.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.31 154.83 17.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.658 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 15.2 m -90.02 -0.06 57.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.696 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . 0.418 HG13 ' OD1' ' J' ' 10' ' ' ASP . 30.1 m -93.86 131.53 40.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-O 121.676 0.75 . . . . 0.0 109.844 176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.1 tttp -66.36 119.69 12.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.962 -174.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.18 26.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.809 0.814 . . . . 0.0 109.993 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.81 1.42 56.46 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -130.48 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.853 169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.62 11.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.9 87.45 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.931 -0.481 . . . . 0.0 110.605 171.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' J' ' 151' ' ' VAL . 97.9 m-85 -143.97 -176.93 5.19 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.892 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 3.1 p-10 -120.72 148.3 44.13 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.626 0.727 . . . . 0.0 109.432 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.826 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -140.47 151.0 44.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.074 -163.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' J' ' 138' ' ' LEU . 61.7 mt-30 -122.86 131.31 53.69 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HG ' ' J' ' 138' ' ' LEU . 88.4 t80 -126.87 147.24 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.421 0.688 . . . . 0.0 110.401 -163.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.65 163.11 36.88 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 119.507 -1.33 . . . . 0.0 111.941 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.4 m-85 -84.68 126.38 33.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -129.91 146.83 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.902 0.858 . . . . 0.0 111.149 -169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.696 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 2.6 t80 -128.3 122.18 31.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.955 -174.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.781 HD11 HD12 ' J' ' 79' ' ' ILE . 73.6 mt -80.89 101.31 5.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.697 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 2.7 mt-10 -94.1 -11.78 29.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.83 141.96 42.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.922 0.783 . . . . 0.0 109.09 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.04 108.93 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.565 ' HB3' HG12 ' I' ' 37' ' ' VAL . 11.3 mt-10 -120.81 117.96 28.76 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' I' ' 36' ' ' SER . 15.4 p90 -118.21 134.85 54.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.076 0.465 . . . . 0.0 111.186 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . 0.749 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 24.4 t -106.33 147.83 28.74 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.691 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . 0.434 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.2 OUTLIER -122.47 115.37 22.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 167.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' I' ' 33' ' ' THR . . . -96.38 178.05 33.91 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.2 -42.27 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 O-C-N 122.534 -0.392 . . . . 0.0 111.086 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . 0.576 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.0 tp10 -132.97 140.41 47.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 169.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.09 164.05 11.78 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 166.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.419 ' HB1' ' HB ' ' I' ' 6' ' ' ILE . . . -71.7 154.99 40.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.593 0.711 . . . . 0.0 110.735 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.633 HG23 HG21 ' I' ' 6' ' ' ILE . 90.9 t -59.39 125.79 16.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.088 -171.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.749 ' HB2' ' HB3' ' J' ' 119' ' ' SER . 0.5 OUTLIER -79.14 108.11 12.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.136 -176.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' J' ' 66' ' ' THR . 1.9 mt -99.8 113.25 34.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.33 40.75 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 168.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.91 134.53 62.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.6 140.04 48.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.707 -178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' J' ' 111' ' ' ALA . 1.5 pp -142.23 150.89 41.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 -172.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.94 150.13 28.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 167.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 1.019 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.5 p -142.94 132.16 21.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 1.041 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -54.01 -46.62 65.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.317 0.58 . . . . 0.0 110.338 -173.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.534 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -162.14 145.7 11.09 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.718 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -103.78 124.36 48.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.063 0.935 . . . . 0.0 110.694 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -99.54 135.91 40.26 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -174.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.853 ' HG3' HE21 ' K' ' 84' ' ' GLN . 11.5 mtmt -89.93 137.41 32.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . 0.61 ' HB3' ' OD2' ' D' ' 159' ' ' ASP . 1.1 p-10 -166.92 -156.27 0.22 Allowed 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.892 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -128.17 154.33 19.84 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.382 169.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.826 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 20.5 tp10 -103.59 150.97 23.45 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.711 HD11 ' CB ' ' D' ' 160' ' ' PHE . 0.2 OUTLIER -107.48 -78.48 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.751 -176.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.763 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 8.9 p-10 -97.68 99.83 11.2 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.994 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 77.5 p -102.15 23.93 10.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.369 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.7 OUTLIER 46.74 58.6 16.77 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 126.451 1.9 . . . . 0.0 109.408 -173.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.89 -11.95 34.14 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.221 1.281 . . . . 0.0 115.321 -159.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -53.88 26.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.558 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.44 -34.84 6.66 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.532 HD12 HD21 ' J' ' 14' ' ' LEU . 1.5 mt -77.16 -49.89 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 119.16 0.891 . . . . 0.0 111.287 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' J' ' 104' ' ' TYR . 5.0 t -71.24 -33.35 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -176.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.54 113.5 25.96 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.507 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 17.3 m -112.04 124.8 69.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.25 128.29 29.6 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' J' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.7 73.62 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' J' ' 155' ' ' LYS . . . 140.74 134.73 3.11 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 119.34 0.973 . . . . 0.0 113.026 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.94 78.34 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.65 3.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.33 1.052 . . . . 0.0 108.646 177.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.35 -41.76 39.15 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -158.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 117.87 19.46 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.684 2.393 . . . . 0.0 109.176 167.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -123.15 47.3 2.01 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 154.005 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.93 -33.54 2.98 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -166.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.047 1.767 . . . . 0.0 113.867 171.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 69.01 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.498 ' HA ' ' HB3' ' J' ' 161' ' ' GLN . 0.3 OUTLIER -67.11 -40.52 86.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.898 1.349 . . . . 0.0 110.898 175.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.594 ' OG1' HG22 ' J' ' 174' ' ' VAL . 1.7 p 52.54 39.11 27.37 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.781 1.632 . . . . 0.0 111.961 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.491 HG21 ' H ' ' J' ' 172' ' ' GLY . 48.1 m -116.9 156.7 26.92 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.331 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . 0.4 ' N ' HG22 ' J' ' 167' ' ' THR . . . -84.3 -149.14 9.77 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.433 172.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.9 -40.35 91.45 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.74 0.27 . . . . 0.0 111.437 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.15 132.55 33.84 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.5 0.72 . . . . 0.0 109.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.9 Cg_endo -80.06 147.26 18.64 Favored 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 121.343 1.362 . . . . 0.0 112.739 -156.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . 0.491 ' H ' HG21 ' J' ' 167' ' ' THR . . . 81.32 12.11 82.53 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.18 124.12 47.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.008 0.904 . . . . 0.0 109.895 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.594 HG22 ' OG1' ' J' ' 166' ' ' THR . 16.4 t -102.94 120.45 52.41 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.422 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -72.73 170.63 19.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.501 0.858 . . . . 0.0 111.717 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.265 0 C-N-CA 125.414 1.486 . . . . 0.0 112.271 -171.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 N-CA-C 115.083 1.147 . . . . 0.0 115.083 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.69 HG21 HG23 ' L' ' 126' ' ' VAL . 58.3 mt -134.64 155.73 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.705 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -123.05 160.13 26.98 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.937 0.875 . . . . 0.0 110.735 -177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -64.71 -16.65 61.57 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.368 -0.833 . . . . 0.0 114.533 175.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.63 -3.94 41.92 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.758 0.779 . . . . 0.0 112.441 172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.705 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 20.6 t0 -71.43 -53.21 14.78 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.467 HG11 ' HE ' ' K' ' 93' ' ' ARG . 62.6 t -87.67 112.3 23.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . 0.526 ' CG ' HD11 ' K' ' 27' ' ' LEU . 0.1 OUTLIER -117.36 145.6 43.95 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.703 0.763 . . . . 0.0 110.485 176.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -111.78 108.64 18.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.775 -164.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.578 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -95.18 138.16 33.26 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.43 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 14.3 m-85 -125.61 113.88 17.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.451 0.643 . . . . 0.0 109.956 176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.58 129.68 55.31 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . 0.534 ' HA ' HD13 ' K' ' 89' ' ' ILE . 87.9 p -76.14 146.88 38.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.595 0.712 . . . . 0.0 110.972 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.673 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.3 pt -64.78 -41.75 93.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.027 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . 0.494 ' N ' HG13 ' K' ' 18' ' ' ILE . 0.5 OUTLIER -65.45 -21.15 66.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.01 74.63 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.425 -175.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.13 56.33 7.64 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.223 1.409 . . . . 0.0 111.784 -173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.95 8.33 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.8 25.67 7.89 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 116.306 -0.406 . . . . 0.0 113.658 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.89 -39.32 93.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.029 0.415 . . . . 0.0 111.758 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.601 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 57.01 77.66 0.41 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.978 2.111 . . . . 0.0 112.412 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.38 145.56 43.22 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.419 0.828 . . . . 0.0 112.485 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.578 HD12 ' HG ' ' K' ' 14' ' ' LEU . 6.3 tt -132.43 144.64 50.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.526 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 47.2 t80 -103.13 136.45 19.23 Favored Pre-proline 0 C--N 1.318 -0.799 0 C-N-CA 115.838 -2.345 . . . . 0.0 110.534 -167.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.4 Cg_endo -76.0 -178.25 4.24 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-N 119.01 0.682 . . . . 0.0 112.478 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 58.2 39.92 25.37 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.364 1.466 . . . . 0.0 111.589 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' K' ' 67' ' ' TYR . 8.3 m-30 -70.7 134.99 47.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.534 1.159 . . . . 0.0 111.059 173.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -104.0 -94.41 0.33 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 25.5 p -132.99 169.83 16.25 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 122.776 1.274 . . . . 0.0 111.082 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.572 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.3 t0 -158.42 102.23 1.73 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.07 -1.423 . . . . 0.0 107.988 -164.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.26 133.76 11.57 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.376 170.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . 0.537 ' HB3' ' CE1' ' L' ' 118' ' ' TYR . 43.5 t -127.44 124.23 37.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 173.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' L' ' 117' ' ' GLU . 24.0 m -128.08 145.73 34.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -173.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 4.4 m -129.34 121.61 27.81 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -166.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -116.43 114.79 3.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.699 -0.763 . . . . 0.0 113.262 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.68 125.77 48.4 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.721 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.2 mtm-85 -63.75 132.66 51.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.736 0.779 . . . . 0.0 110.154 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -132.05 123.67 27.71 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -167.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.09 120.71 34.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.511 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.68 88.91 2.52 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.209 171.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.22 163.82 13.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 155.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.468 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.4 mp0 -66.4 -51.89 52.36 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . 0.726 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.0 OUTLIER 61.21 36.1 18.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.585 1.554 . . . . 0.0 111.662 -172.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.14 49.06 3.12 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.548 1.539 . . . . 0.0 111.534 -164.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.56 -163.61 1.73 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.491 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.7 19.28 0.67 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.53 171.74 48.37 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.521 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -119.22 125.37 49.0 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 1.044 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.3 pp -130.49 -31.98 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.892 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.6 mp -66.15 -18.84 65.6 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.53 105.48 0.66 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-O 121.666 0.592 . . . . 0.0 113.912 -170.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.3 Cg_endo -74.13 167.21 27.73 Favored 'Trans proline' 0 CA--C 1.516 -0.405 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.57 -168.66 20.33 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.05 154.4 21.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.536 0.684 . . . . 0.0 110.529 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 7.3 p -103.2 128.98 55.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.049 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . 0.721 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -108.86 114.45 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 174.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 12.0 m-20 -104.06 100.26 10.02 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.14 143.09 26.86 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.951 0.9 . . . . 0.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.07 151.23 22.71 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' K' ' 130' ' ' ILE . 0.9 OUTLIER -143.44 123.98 14.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.572 HG13 ' OD1' ' K' ' 34' ' ' ASP . 35.4 t -109.8 120.77 61.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' K' ' 128' ' ' ILE . 26.9 p -109.12 139.75 43.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' K' ' 31' ' ' TYR . 3.2 p90 -157.66 158.54 35.65 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 175.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.605 ' HB2' ' HB1' ' K' ' 30' ' ' ALA . 18.1 m-30 -79.1 140.64 37.79 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.1 145.38 36.24 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.495 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 9.3 tttp -119.75 148.89 42.87 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . 0.434 HH21 ' HD3' ' K' ' 71' ' ' ARG . 8.6 ptp180 -47.45 -50.95 21.69 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.39 -111.7 2.6 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . 0.495 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 0.9 OUTLIER 74.01 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.1 1.36 . . . . 0.0 111.067 169.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -87.72 -29.09 21.35 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -156.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.22 -53.77 41.9 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.818 168.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.578 ' O ' ' HB ' ' K' ' 79' ' ' ILE . 0.0 OUTLIER -60.63 -42.42 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 122.161 -0.611 . . . . 0.0 111.842 171.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 0.0 OUTLIER -56.72 -37.3 70.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.803 171.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.59 99.76 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.89 168.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.789 HD12 HD11 ' K' ' 113' ' ' ILE . 7.9 mm -52.68 -49.07 47.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.05 0.453 . . . . 0.0 110.456 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -67.34 -44.87 78.0 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.725 -0.61 . . . . 0.0 112.414 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.88 -33.27 73.89 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.54 169.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -64.24 -48.09 77.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.57 174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.52 ' HD1' HG22 ' K' ' 113' ' ' ILE . 47.8 t80 -71.54 -47.04 57.69 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.905 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.853 HE21 ' HG3' ' J' ' 139' ' ' LYS . 0.1 OUTLIER -66.54 -52.44 45.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.429 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 33.1 m120 -81.36 -42.12 20.98 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.055 172.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.88 97.47 2.42 Favored Glycine 0 N--CA 1.448 -0.513 0 O-C-N 122.262 -0.274 . . . . 0.0 112.883 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.596 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.4 mptt -130.52 147.76 52.25 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.685 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.7 tm0? -72.81 141.91 48.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 168.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' K' ' 82' ' ' ALA . 23.4 mm -116.37 130.03 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.321 0.581 . . . . 0.0 109.896 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 7.3 mtmt -84.63 112.38 20.4 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.43 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 41.0 t80 -107.22 126.68 52.72 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.539 1.135 . . . . 0.0 109.976 -166.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.585 ' HZ3' ' HA ' ' E' ' 160' ' ' PHE . 1.8 m95 -123.54 115.7 21.96 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.221 1.008 . . . . 0.0 108.328 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.467 ' HE ' HG11 ' K' ' 11' ' ' VAL . 0.7 OUTLIER -102.24 102.84 13.29 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.768 HG11 ' HG2' ' K' ' 142' ' ' GLU . 22.2 m -120.76 152.88 23.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.288 1.042 . . . . 0.0 109.405 -173.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -99.21 154.79 17.87 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.632 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 15.4 m -90.04 -0.04 57.38 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . 0.406 HG13 ' OD1' ' K' ' 10' ' ' ASP . 30.2 m -93.88 131.62 40.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.695 0.76 . . . . 0.0 109.89 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.1 tttp -66.46 119.72 12.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.965 -174.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.17 164.24 26.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.832 0.825 . . . . 0.0 109.984 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.78 1.37 56.5 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.85 1.16 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.736 0.698 . . . . 0.0 110.872 169.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.24 170.62 11.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.0 OUTLIER -66.93 -39.93 87.49 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.87 -0.519 . . . . 0.0 110.612 171.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.704 ' CZ ' HG21 ' K' ' 151' ' ' VAL . 97.8 m-85 -143.91 -176.89 5.17 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.87 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 3.1 p-10 -120.7 148.29 44.15 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.612 0.72 . . . . 0.0 109.494 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.837 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -140.49 150.99 44.45 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.061 -163.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' K' ' 138' ' ' LEU . 61.6 mt-30 -122.85 131.36 53.72 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 157.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.506 ' O ' ' HG ' ' K' ' 138' ' ' LEU . 88.4 t80 -126.91 147.19 50.09 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.436 -163.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.59 163.12 36.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.955 170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.669 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.4 m-85 -84.65 126.39 33.32 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -129.95 146.87 51.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.926 0.87 . . . . 0.0 111.159 -169.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 2.6 t80 -128.35 122.15 30.83 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.947 -174.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.789 HD11 HD12 ' K' ' 79' ' ' ILE . 73.5 mt -80.82 101.26 5.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 2.7 mt-10 -94.08 -11.8 29.85 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.85 141.98 42.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.967 0.803 . . . . 0.0 109.099 174.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.1 108.91 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.551 ' HB3' HG12 ' J' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.97 28.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 15.1 p90 -118.17 134.9 54.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.049 0.452 . . . . 0.0 111.185 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 24.4 t -106.38 147.79 28.83 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.666 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.33 22.06 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' J' ' 33' ' ' THR . . . -96.4 178.06 33.89 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.1 -42.34 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.513 -0.404 . . . . 0.0 111.069 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . 0.634 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.38 47.75 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 169.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' J' ' 8' ' ' GLY . . . 125.11 164.05 11.78 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' J' ' 6' ' ' ILE . . . -71.71 154.99 40.98 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.611 0.719 . . . . 0.0 110.75 -177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.698 HG23 HG21 ' J' ' 6' ' ' ILE . 91.5 t -59.4 125.84 16.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.065 -171.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' K' ' 119' ' ' SER . 0.5 OUTLIER -79.17 108.21 12.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.068 -176.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' K' ' 66' ' ' THR . 1.9 mt -99.89 113.26 34.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.41 121.3 40.69 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' K' ' 64' ' ' GLU . 1.9 pp -118.88 134.51 62.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.62 139.98 48.57 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.725 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.446 HD13 ' HB1' ' K' ' 111' ' ' ALA . 1.5 pp -142.16 150.91 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.116 -172.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.93 150.15 28.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.963 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.5 p -142.93 132.16 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 1.007 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -53.98 -46.63 65.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.326 0.584 . . . . 0.0 110.376 -173.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.528 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -162.08 145.71 11.12 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.729 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.81 124.4 48.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 122.05 0.929 . . . . 0.0 110.705 174.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -99.56 135.94 40.23 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.796 ' HG3' HE21 ' L' ' 84' ' ' GLN . 11.4 mtmt -89.92 137.42 32.35 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -166.92 -156.25 0.22 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.87 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -128.24 154.32 19.87 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.23 -0.986 . . . . 0.0 111.368 169.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.837 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 20.5 tp10 -103.55 150.98 23.41 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.676 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.2 OUTLIER -107.48 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.801 -176.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 8.9 p-10 -97.73 99.91 11.27 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.981 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 77.8 p -102.22 23.99 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.753 -0.642 . . . . 0.0 112.389 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.7 OUTLIER 46.69 58.71 16.67 Favored Pre-proline 0 C--N 1.346 0.441 0 C-N-CA 126.498 1.919 . . . . 0.0 109.364 -173.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.91 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.177 1.251 . . . . 0.0 115.308 -159.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -53.83 26.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.6 -34.7 6.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.535 HD12 HD21 ' K' ' 14' ' ' LEU . 1.5 mt -77.23 -49.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.167 0.894 . . . . 0.0 111.304 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.704 HG21 ' CZ ' ' K' ' 104' ' ' TYR . 5.1 t -71.26 -33.36 50.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.56 113.6 26.12 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.44 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.13 124.77 69.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.24 128.27 29.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' K' ' 156' ' ' GLY . 1.1 pptp? -54.53 -46.69 73.6 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . 0.453 ' O ' ' HD2' ' K' ' 155' ' ' LYS . . . 140.77 134.8 3.11 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 119.406 1.003 . . . . 0.0 113.014 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -128.0 78.37 0.38 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -115.8 92.67 3.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.338 1.055 . . . . 0.0 108.616 177.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.37 -41.74 39.09 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -158.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.46 117.83 19.38 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.673 2.389 . . . . 0.0 109.167 167.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.492 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -123.14 47.26 2.01 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 153.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -33.36 2.85 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -166.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.83 -0.95 10.31 Favored 'Trans proline' 0 C--O 1.239 0.557 0 CA-C-N 122.049 1.767 . . . . 0.0 113.87 171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.82 69.04 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 -171.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.492 ' HA ' ' HB3' ' K' ' 161' ' ' GLN . 0.3 OUTLIER -67.06 -40.53 87.09 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.886 1.343 . . . . 0.0 110.883 175.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.586 ' OG1' HG22 ' K' ' 174' ' ' VAL . 1.7 p 52.48 39.15 27.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.815 1.646 . . . . 0.0 111.899 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.483 HG21 ' H ' ' K' ' 172' ' ' GLY . 48.3 m -116.88 156.69 26.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.344 -167.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . 0.401 ' N ' HG22 ' K' ' 167' ' ' THR . . . -84.28 -149.12 9.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.471 172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.88 -40.4 91.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.801 0.301 . . . . 0.0 111.408 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.19 132.56 33.72 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 123.468 0.707 . . . . 0.0 109.224 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.559 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 86.6 Cg_endo -80.02 147.22 18.69 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.356 1.371 . . . . 0.0 112.766 -156.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . 0.483 ' H ' HG21 ' K' ' 167' ' ' THR . . . 81.37 12.06 82.53 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.14 124.19 47.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.999 0.9 . . . . 0.0 109.916 170.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.586 HG22 ' OG1' ' K' ' 166' ' ' THR . 16.4 t -102.98 120.39 52.51 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.41 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.61 170.57 19.13 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.502 0.858 . . . . 0.0 111.75 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.451 1.5 . . . . 0.0 112.301 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.421 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.182 0 N-CA-C 115.067 1.141 . . . . 0.0 115.067 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.754 HG21 HG23 ' G' ' 126' ' ' VAL . 58.3 mt -134.59 155.69 39.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.707 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -123.02 160.18 26.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.914 0.864 . . . . 0.0 110.732 -177.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -64.76 -16.7 61.75 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.322 -0.854 . . . . 0.0 114.453 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -96.6 -3.96 41.98 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.826 0.813 . . . . 0.0 112.445 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.707 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 20.4 t0 -71.32 -53.22 14.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -172.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.472 HG11 ' HE ' ' L' ' 93' ' ' ARG . 62.1 t -87.77 112.29 23.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . 0.529 ' CG ' HD11 ' L' ' 27' ' ' LEU . 0.1 OUTLIER -117.32 145.61 43.9 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.702 0.763 . . . . 0.0 110.487 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -111.83 108.74 18.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.766 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.561 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -95.22 138.15 33.32 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.433 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 14.4 m-85 -125.62 113.88 17.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.466 0.65 . . . . 0.0 109.919 176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -108.6 129.66 55.32 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . 0.531 ' HA ' HD13 ' L' ' 89' ' ' ILE . 87.9 p -76.05 146.85 39.12 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.017 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.677 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.3 pt -64.74 -41.74 93.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.031 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . 0.492 ' N ' HG13 ' L' ' 18' ' ' ILE . 0.5 OUTLIER -65.57 -21.05 66.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.0 74.53 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.441 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . . . . . . . . . . . 53.24 56.25 7.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.149 1.38 . . . . 0.0 111.788 -173.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.14 176.91 8.37 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.76 25.62 7.93 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.719 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 3.2 p -64.84 -39.28 93.32 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.973 0.386 . . . . 0.0 111.789 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.615 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 57.01 77.56 0.41 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.914 2.086 . . . . 0.0 112.462 -174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -72.34 145.52 43.34 Favored 'Trans proline' 0 C--N 1.349 0.573 0 CA-C-N 119.408 0.824 . . . . 0.0 112.494 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.561 HD12 ' HG ' ' L' ' 14' ' ' LEU . 6.3 tt -132.36 144.66 50.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 168.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 47.2 t80 -103.22 136.47 19.22 Favored Pre-proline 0 C--N 1.317 -0.816 0 C-N-CA 115.781 -2.367 . . . . 0.0 110.51 -167.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.5 Cg_endo -76.04 -178.17 4.19 Favored 'Trans proline' 0 C--N 1.332 -0.299 0 CA-C-O 121.871 0.696 . . . . 0.0 112.439 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 58.1 39.96 25.64 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.371 1.468 . . . . 0.0 111.555 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.447 ' HD1' ' HB3' ' L' ' 67' ' ' TYR . 8.4 m-30 -70.64 135.02 48.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 122.539 1.161 . . . . 0.0 111.119 173.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -104.07 -94.31 0.33 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . 0.435 HG22 ' HA2' ' G' ' 121' ' ' GLY . 25.5 p -133.07 169.81 16.3 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.81 1.291 . . . . 0.0 111.066 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.573 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.3 t0 -158.36 102.2 1.74 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.0 -164.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -96.2 133.8 11.59 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.375 170.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . 0.534 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 43.6 t -127.44 124.17 37.8 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' G' ' 117' ' ' GLU . 24.0 m -128.06 145.73 34.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -129.35 121.62 27.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -166.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -116.42 114.81 3.15 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.249 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -101.67 125.81 48.4 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.713 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.2 mtm-85 -63.78 132.6 51.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.646 0.736 . . . . 0.0 110.187 -174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . 0.562 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -132.01 123.63 27.67 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.07 120.76 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.528 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.72 88.82 2.51 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.254 171.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.18 163.74 13.32 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 155.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' B' ' 122' ' ' VAL . 2.4 mp0 -66.29 -51.9 52.74 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . 0.633 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.0 OUTLIER 61.27 36.03 17.95 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.591 1.556 . . . . 0.0 111.694 -172.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 41.2 p 41.2 49.03 3.17 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.519 1.528 . . . . 0.0 111.574 -164.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -144.55 -163.58 1.72 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.465 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -79.72 19.34 0.67 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.41 171.71 48.29 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.515 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -119.23 125.44 49.16 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 1.034 HG12 HG23 ' G' ' 135' ' ' ILE . 1.3 pp -130.54 -32.01 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.853 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.53 HD12 ' H ' ' L' ' 54' ' ' LEU . 1.6 mp -66.14 -18.8 65.57 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.51 105.43 0.65 Allowed Glycine 0 N--CA 1.443 -0.871 0 CA-C-O 121.643 0.58 . . . . 0.0 113.93 -170.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.07 167.19 27.8 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.56 -168.69 20.37 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.09 154.39 21.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.564 0.697 . . . . 0.0 110.493 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 7.3 p -103.23 129.02 55.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . 0.713 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -108.81 114.45 28.23 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 11.9 m-20 -104.13 100.3 10.04 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.08 143.05 26.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.991 0.916 . . . . 0.0 110.072 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.05 151.28 22.74 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.168 176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.45 123.95 13.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.573 HG13 ' OD1' ' L' ' 34' ' ' ASP . 35.5 t -109.85 120.83 61.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' L' ' 128' ' ' ILE . 27.1 p -109.2 139.74 43.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.447 ' HB3' ' HD1' ' L' ' 31' ' ' TYR . 3.2 p90 -157.65 158.6 35.78 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' HB1' ' L' ' 30' ' ' ALA . 18.1 m-30 -79.16 140.65 37.7 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.41 36.23 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.508 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 9.3 tttp -119.77 148.89 42.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD3' ' L' ' 71' ' ' ARG . 8.6 ptp180 -47.51 -50.92 22.2 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -117.4 -111.77 2.6 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . 0.508 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 0.9 OUTLIER 74.06 121.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.001 169.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -87.74 -29.07 21.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.27 -53.7 42.4 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.846 168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' L' ' 79' ' ' ILE . 0.0 OUTLIER -60.64 -42.44 96.96 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.838 171.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 0.0 OUTLIER -56.69 -37.35 70.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.774 171.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.59 99.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.89 168.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.798 HD12 HD11 ' L' ' 113' ' ' ILE . 7.8 mm -52.72 -49.05 47.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.057 0.456 . . . . 0.0 110.469 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.415 ' HB3' ' NZ ' ' K' ' 139' ' ' LYS . 1.2 mt-10 -67.22 -45.01 78.08 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.734 -0.603 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.82 -33.24 73.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.626 169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -64.21 -48.12 77.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.581 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.522 ' HD1' HG22 ' L' ' 113' ' ' ILE . 47.8 t80 -71.48 -47.14 57.41 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.923 -174.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.796 HE21 ' HG3' ' K' ' 139' ' ' LYS . 0.1 OUTLIER -66.48 -52.45 46.04 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.424 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 33.2 m120 -81.41 -42.08 20.96 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.009 172.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 110.89 97.45 2.41 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.3 -0.25 . . . . 0.0 112.826 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.604 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.4 mptt -130.52 147.78 52.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.703 ' HB2' ' HG3' ' F' ' 169' ' ' GLU . 1.7 tm0? -72.77 141.85 48.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 168.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' L' ' 82' ' ' ALA . 23.4 mm -116.37 130.13 71.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 109.86 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.677 ' NZ ' ' H ' ' F' ' 167' ' ' THR . 7.3 mtmt -84.71 112.34 20.39 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.433 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 40.7 t80 -107.18 126.65 52.67 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.002 -165.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.501 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 1.8 m95 -123.49 115.68 21.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.197 0.999 . . . . 0.0 108.382 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.472 ' HE ' HG11 ' L' ' 11' ' ' VAL . 0.7 OUTLIER -102.21 102.84 13.31 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.762 HG11 ' HG2' ' L' ' 142' ' ' GLU . 22.3 m -120.76 152.88 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.256 1.027 . . . . 0.0 109.376 -173.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -99.22 154.8 17.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.659 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 15.6 m -90.03 -0.1 57.41 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.616 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . 0.415 HG13 ' OD1' ' L' ' 10' ' ' ASP . 30.1 m -93.83 131.55 40.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.655 0.74 . . . . 0.0 109.913 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.1 tttp -66.42 119.63 11.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.967 -174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -72.09 164.27 26.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.808 . . . . 0.0 109.993 171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.77 1.31 56.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -177.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -130.47 -42.84 1.16 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.77 0.714 . . . . 0.0 110.886 169.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.2 170.58 11.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 167.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.0 OUTLIER -66.88 -39.95 87.64 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.881 -0.512 . . . . 0.0 110.6 171.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.703 ' CZ ' HG21 ' L' ' 151' ' ' VAL . 98.0 m-85 -143.93 -176.9 5.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.869 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 3.1 p-10 -120.68 148.27 44.16 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.543 0.687 . . . . 0.0 109.492 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.45 151.08 44.58 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.06 -163.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' L' ' 138' ' ' LEU . 61.6 mt-30 -122.93 131.38 53.7 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 157.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.507 ' HZ ' ' OE1' ' F' ' 165' ' ' GLN . 88.3 t80 -126.93 147.17 50.1 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.369 0.668 . . . . 0.0 110.434 -163.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.55 163.12 36.88 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.986 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.679 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.4 m-85 -84.66 126.38 33.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 167.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -129.91 146.82 51.62 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.903 0.859 . . . . 0.0 111.162 -169.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.694 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 2.6 t80 -128.31 122.11 30.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.027 -174.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.798 HD11 HD12 ' L' ' 79' ' ' ILE . 73.4 mt -80.82 101.31 5.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 2.7 mt-10 -94.11 -11.76 29.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.3 m -136.84 142.02 42.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.944 0.793 . . . . 0.0 109.127 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -142.07 108.92 5.41 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.525 ' HB3' HG12 ' K' ' 37' ' ' VAL . 11.4 mt-10 -120.82 117.99 28.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.594 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 15.0 p90 -118.17 134.89 54.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.106 0.479 . . . . 0.0 111.206 176.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . 0.742 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 24.3 t -106.4 147.77 28.88 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.668 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.44 115.48 22.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 167.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.43 178.06 33.85 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 121.723 0.624 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.16 -42.28 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.444 -0.445 . . . . 0.0 111.116 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . 0.742 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.0 tp10 -132.98 140.41 47.77 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . 0.512 ' H ' ' N ' ' K' ' 8' ' ' GLY . . . 125.13 164.08 11.78 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 166.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' K' ' 6' ' ' ILE . . . -71.72 155.0 40.96 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.599 0.714 . . . . 0.0 110.731 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.69 HG23 HG21 ' K' ' 6' ' ' ILE . 91.4 t -59.38 125.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.029 -171.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.742 ' HB2' ' HB3' ' L' ' 119' ' ' SER . 0.5 OUTLIER -79.18 108.17 12.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.053 -176.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' L' ' 66' ' ' THR . 1.9 mt -99.88 113.31 34.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 2.0 t -117.44 121.32 40.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 168.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.9 pp -118.89 134.59 62.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.64 140.04 48.54 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.733 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' L' ' 111' ' ' ALA . 1.5 pp -142.24 150.9 41.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.089 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.92 150.12 28.18 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 1.044 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.5 p -142.93 132.17 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.952 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -53.96 -46.67 65.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-O 121.311 0.577 . . . . 0.0 110.346 -173.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.704 ' HA3' ' HE3' ' F' ' 155' ' ' LYS . . . -162.1 145.76 11.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.701 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -103.85 124.44 48.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.016 0.912 . . . . 0.0 110.642 174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.55 ' CD1' ' HA ' ' F' ' 159' ' ' ASP . 0.1 OUTLIER -99.64 135.94 40.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.846 ' HG3' HE21 ' G' ' 84' ' ' GLN . 11.4 mtmt -89.85 137.4 32.36 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.782 ' CG ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -166.9 -156.28 0.22 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.869 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -128.2 154.39 19.88 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.35 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.904 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 20.6 tp10 -103.61 150.97 23.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.2 OUTLIER -107.44 -78.49 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.824 -176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.88 ' O ' ' HG2' ' F' ' 162' ' ' GLN . 8.9 p-10 -97.75 99.87 11.23 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.966 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 77.2 p -102.18 24.0 10.81 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 118.738 -0.648 . . . . 0.0 112.391 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . 0.615 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.7 OUTLIER 46.68 58.64 16.69 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.419 1.888 . . . . 0.0 109.416 -173.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.421 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.84 -12.04 34.44 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.261 1.308 . . . . 0.0 115.301 -159.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.41 -53.85 26.24 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.598 171.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -108.52 -34.77 6.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.527 HD12 HD21 ' L' ' 14' ' ' LEU . 1.5 mt -77.19 -49.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 119.13 0.877 . . . . 0.0 111.286 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.703 HG21 ' CZ ' ' L' ' 104' ' ' TYR . 5.1 t -71.24 -33.37 50.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -111.58 113.57 26.06 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.428 -176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.09 124.8 69.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 3.5 p -136.27 128.27 29.53 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' L' ' 156' ' ' GLY . 1.1 pptp? -54.56 -46.7 73.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' L' ' 155' ' ' LYS . . . 140.75 134.75 3.11 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 119.422 1.01 . . . . 0.0 113.068 -176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.95 78.31 0.38 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -115.83 92.72 3.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.308 1.043 . . . . 0.0 108.572 177.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -77.34 -41.77 39.2 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.43 117.89 19.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.711 2.404 . . . . 0.0 109.201 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -123.22 47.25 2.02 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 154.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.41 2.89 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -82.77 -0.99 10.34 Favored 'Trans proline' 0 C--O 1.238 0.512 0 CA-C-N 122.089 1.782 . . . . 0.0 113.867 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.83 68.97 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.491 ' HA ' ' HB3' ' L' ' 161' ' ' GLN . 0.3 OUTLIER -67.09 -40.51 86.98 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.902 1.351 . . . . 0.0 110.93 175.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.591 ' OG1' HG22 ' L' ' 174' ' ' VAL . 1.7 p 52.5 39.17 27.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.824 1.65 . . . . 0.0 111.881 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.489 HG21 ' H ' ' L' ' 172' ' ' GLY . 48.9 m -116.89 156.71 26.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.866 -0.733 . . . . 0.0 109.311 -167.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' L' ' 167' ' ' THR . . . -84.26 -149.1 9.67 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.474 172.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.96 -40.38 91.23 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.759 0.279 . . . . 0.0 111.407 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.14 132.55 33.84 Favored Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 123.507 0.723 . . . . 0.0 109.251 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 85.4 Cg_endo -80.07 147.31 18.65 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.289 1.326 . . . . 0.0 112.741 -156.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . 0.489 ' H ' HG21 ' L' ' 167' ' ' THR . . . 81.35 12.05 82.56 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.17 124.19 47.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.988 0.894 . . . . 0.0 109.897 170.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.591 HG22 ' OG1' ' L' ' 166' ' ' THR . 16.4 t -102.92 120.44 52.45 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.418 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -72.7 170.61 19.11 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.51 0.861 . . . . 0.0 111.7 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.412 1.485 . . . . 0.0 112.34 -171.707 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HB3' ' HE3' ' B' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.171 -1.127 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.406 ' H ' HG12 ' A' ' 6' ' ' ILE . 6.0 pt -61.5 127.87 21.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' B' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.92 5.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.917 0.865 . . . . 0.0 110.726 -177.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.94 -31.6 78.57 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.383 -0.826 . . . . 0.0 114.505 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -18.37 62.11 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.795 0.797 . . . . 0.0 112.4 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 96' ' ' THR . 4.8 t70 -66.21 -37.68 86.15 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -172.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' A' ' 93' ' ' ARG . 28.0 m -101.61 117.79 47.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.43 26.57 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.659 0.742 . . . . 0.0 110.513 176.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -114.15 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.832 -164.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' A' ' 25' ' ' ALA . 5.5 mp -86.95 141.23 28.86 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HB3' HD11 ' A' ' 89' ' ' ILE . 19.0 m-85 -126.04 137.68 53.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' A' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.24 47.17 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.31 47.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.048 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.984 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.91 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -171.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.55 82.54 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.407 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.06 20.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.221 1.408 . . . . 0.0 111.78 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.63 13.58 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.87 4.88 68.74 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.759 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.48 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.954 0.377 . . . . 0.0 111.797 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . . . -100.18 122.57 49.84 Favored Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 126.96 2.104 . . . . 0.0 112.384 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 15' ' ' PHE . 27.8 Cg_exo -70.4 127.21 13.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.378 0.813 . . . . 0.0 112.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 168.466 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.316 -0.868 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.537 -167.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.93 169.95 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.864 0.693 . . . . 0.0 112.429 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.11 48.53 12.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.355 1.462 . . . . 0.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' HB2' HG21 ' L' ' 48' ' ' THR . 2.9 m-85 -71.84 133.14 45.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 122.577 1.18 . . . . 0.0 111.065 173.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.25 -111.05 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.54 HG22 HG23 ' B' ' 122' ' ' VAL . 18.3 p -121.4 174.15 6.92 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.754 1.264 . . . . 0.0 111.103 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.513 ' OD1' HG22 ' A' ' 65' ' ' VAL . 5.2 t0 -159.06 129.5 5.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.004 -164.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.92 131.65 7.6 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.367 170.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.53 108.98 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG22 ' HG2' ' B' ' 117' ' ' GLU . 57.3 t -107.22 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.746 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 6.1 p -130.78 80.44 1.95 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -166.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.71 118.51 4.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.275 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.05 90.7 3.52 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' A' ' 42' ' ' GLU . 10.5 mmm180 -65.45 -179.52 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.734 0.778 . . . . 0.0 110.173 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.45 27.3 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -167.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -73.44 165.95 24.11 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.498 -179.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.477 ' HA ' HG12 ' A' ' 53' ' ' ILE . 5.4 t80 -108.87 85.04 2.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.203 171.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.558 ' H ' HG21 ' A' ' 53' ' ' ILE . 26.4 t70 -110.68 100.09 8.92 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.649 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 10.2 pt-20 -68.69 -21.29 64.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 176.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.33 26.6 5.28 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.578 1.551 . . . . 0.0 111.628 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.649 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.96 21.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.56 1.544 . . . . 0.0 111.537 -164.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' A' ' 52' ' ' ARG . 6.3 tptt -116.6 -92.19 0.52 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.462 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.435 ' CG ' HG23 ' B' ' 59' ' ' VAL . 17.9 m-20 -152.3 33.93 0.52 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 46' ' ' GLU . . . 80.2 36.16 25.03 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.27 32.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.558 HG21 ' H ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.05 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.857 178.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD22 HD13 ' B' ' 135' ' ' ILE . 0.4 OUTLIER -109.07 25.12 12.17 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 176.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-O 121.634 0.574 . . . . 0.0 113.971 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 43' ' ' LEU . 68.7 Cg_endo -80.13 160.09 23.56 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.822 0.662 . . . . 0.0 113.822 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -124.8 -70.96 0.21 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.522 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.17 2.65 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.79 104.6 14.13 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.847 ' HA ' ' HA ' ' A' ' 133' ' ' GLN . 92.3 p -142.76 163.41 32.88 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.039 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -147.02 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.152 176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.61 51.55 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' OD1' ' A' ' 34' ' ' ASP . 85.2 t -129.28 125.16 61.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.04 137.61 51.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.41 167.86 24.16 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.4 143.1 26.96 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.69 141.7 22.95 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.902 0.721 . . . . 0.0 114.902 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.598 ' H ' HE22 ' A' ' 76' ' ' GLN . 0.4 OUTLIER -123.04 151.07 42.29 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.666 HH11 ' HB ' ' F' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.15 -123.05 2.88 Favored Glycine 0 N--CA 1.452 -0.265 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 70' ' ' LYS . 87.7 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 110.992 169.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 77' ' ' LYS . . . -85.27 -12.11 53.21 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 -156.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -74.23 -46.97 19.14 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.814 168.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 79' ' ' ILE . 7.0 tt0 -66.99 -37.06 83.54 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.145 -0.621 . . . . 0.0 111.888 171.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 74' ' ' ALA . 1.6 mtmt -66.49 -38.47 87.35 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.808 171.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.84 79.36 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.89 168.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' HB ' ' HA ' ' A' ' 76' ' ' GLN . 4.4 mm -59.5 -48.69 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.497 172.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.42 64.59 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.724 -0.61 . . . . 0.0 112.428 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.61 -46.16 87.62 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.58 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.69 86.26 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.589 174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 5.3 t80 -62.23 -50.37 72.02 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.921 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.46 -25.63 35.92 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.478 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.3 53.93 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.038 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.67 30.05 75.71 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.302 -0.249 . . . . 0.0 112.846 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.478 ' HE2' ' OD1' ' A' ' 85' ' ' ASN . 15.1 mttm -70.65 142.95 51.57 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.641 HE22 ' HB3' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -73.63 142.21 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 15' ' ' PHE . 7.7 tt -118.75 139.49 45.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.363 0.601 . . . . 0.0 109.82 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 4.9 mtmp? -85.83 131.14 34.37 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.11 122.89 42.03 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.514 1.126 . . . . 0.0 109.971 -165.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.23 115.11 20.53 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.199 0.999 . . . . 0.0 108.378 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' A' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.82 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.771 HG21 HG21 ' A' ' 145' ' ' THR . 2.5 m -122.35 152.4 26.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.274 1.035 . . . . 0.0 109.388 -173.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.64 179.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.702 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 2.6 m -69.02 165.22 2.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.673 0.749 . . . . 0.0 109.958 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.23 20.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 102' ' ' ASP . 16.6 t30 -73.35 157.57 36.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.793 0.806 . . . . 0.0 109.98 171.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.36 -19.06 23.32 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.74 0.7 . . . . 0.0 110.866 169.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' ASN . 0.8 OUTLIER -66.8 152.92 44.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD2' ' O ' ' A' ' 143' ' ' ILE . 0.4 OUTLIER -51.77 -46.3 64.07 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.935 -0.478 . . . . 0.0 110.572 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' A' ' 97' ' ' VAL . 26.8 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.799 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.5 t70 -141.07 143.11 34.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.623 0.725 . . . . 0.0 109.402 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.072 -163.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.66 48.04 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' A' ' 138' ' ' LEU . 23.0 t80 -133.55 155.08 50.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.355 0.662 . . . . 0.0 110.384 -163.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' A' ' 138' ' ' LEU . . . -173.46 170.57 43.72 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.999 170.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' HE22 ' A' ' 88' ' ' GLN . 5.1 m-85 -92.98 137.14 32.63 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.866 0.841 . . . . 0.0 111.195 -169.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.49 42.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.508 -1.224 . . . . 0.0 107.997 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' A' ' 83' ' ' TYR . 2.8 mp -71.06 111.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.539 ' HG3' ' HA ' ' A' ' 132' ' ' LEU . 18.9 mt-10 -91.04 -30.15 16.95 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.87 149.19 10.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.922 0.783 . . . . 0.0 109.067 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.529 ' HG3' HH11 ' A' ' 116' ' ' ARG . 1.4 tmm_? -121.13 138.9 53.98 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.518 ' HG2' HG22 ' F' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -177.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.458 . . . . 0.0 111.205 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.0 OUTLIER -102.2 125.81 49.01 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.638 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.4 22.15 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG23 ' CG2' ' F' ' 33' ' ' THR . 15.2 t -77.13 -55.91 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.518 -0.401 . . . . 0.0 111.122 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 169.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.567 ' HA2' ' HG ' ' L' ' 43' ' ' LEU . . . 90.35 153.54 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 166.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' F' ' 7' ' ' MET . . . -80.03 163.91 23.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.617 0.722 . . . . 0.0 110.731 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' O ' ' F' ' 7' ' ' MET . 18.6 m -55.14 146.22 4.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.063 -171.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 29.8 mp0 -127.15 129.71 48.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.109 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' A' ' 130' ' ' ILE . 26.5 mt -114.86 124.88 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.96 45.57 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.616 ' O ' HG13 ' A' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.76 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -106.59 130.05 54.42 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.665 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 114' ' ' GLU . 0.4 OUTLIER -142.81 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.137 -172.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.847 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.8 pt20 -121.07 163.25 18.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 167.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 110' ' ' PHE . 4.2 t -121.77 128.43 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.459 ' H ' HG12 ' A' ' 135' ' ' ILE . 6.9 pt -67.27 -51.39 53.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.338 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.449 ' H ' HG13 ' A' ' 135' ' ' ILE . . . -125.25 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.727 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.91 24.84 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.042 0.925 . . . . 0.0 110.653 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' A' ' 109' ' ' GLY . 2.4 mt -127.89 151.89 48.53 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.65 34.32 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.92 150.81 19.18 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.799 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.423 169.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' A' ' 94' ' ' VAL . 2.8 tp10 -111.16 143.44 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.578 ' O ' ' HD2' ' A' ' 103' ' ' LYS . 1.7 mp -104.69 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.771 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.91 20.83 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.002 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.771 HG21 HG21 ' A' ' 94' ' ' VAL . 12.8 p -109.55 31.45 5.78 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.389 175.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.4 56.55 17.5 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.445 1.898 . . . . 0.0 109.364 -173.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.83 21.94 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.217 1.278 . . . . 0.0 115.349 -159.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.32 -32.26 66.51 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.616 171.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 145' ' ' THR . 17.2 mt -71.73 -45.17 67.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 119.178 0.899 . . . . 0.0 111.287 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 2.4 t -79.01 -39.86 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.14 121.15 28.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.452 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.524 HG22 ' HD3' ' L' ' 49' ' ' LYS . 13.5 p -104.22 110.33 30.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.5 144.68 37.42 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HD3' ' CA ' ' G' ' 136' ' ' GLY . 6.8 mttt -74.63 -34.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.49 11.64 77.26 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.359 0.981 . . . . 0.0 113.057 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.72 4.79 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 -176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.19 24.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.282 1.033 . . . . 0.0 108.632 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -32.96 70.71 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.527 ' HA ' ' HH2' ' G' ' 92' ' ' TRP . 83.1 t80 -133.97 112.45 11.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 127.689 2.396 . . . . 0.0 109.176 167.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.583 ' HB3' ' HG3' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -141.71 45.05 1.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 154.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . 22.9 tt0 -58.18 -53.8 62.22 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -166.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 162' ' ' GLN . 22.2 Cg_exo -82.66 131.65 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.087 1.781 . . . . 0.0 113.861 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.5 99.76 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.583 ' HG3' ' HB3' ' A' ' 161' ' ' GLN . 1.3 tt0 -60.43 -42.45 96.07 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.857 1.329 . . . . 0.0 110.916 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.31 70.42 0.45 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.806 1.642 . . . . 0.0 111.908 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.769 ' HA ' HG22 ' A' ' 173' ' ' THR . 37.8 p -132.5 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.323 -167.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.03 -167.58 42.51 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.48 172.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -29.49 70.5 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.773 0.287 . . . . 0.0 111.472 -177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.14 60.33 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.526 0.73 . . . . 0.0 109.248 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.75 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.775 0 C-N-CA 121.286 1.324 . . . . 0.0 112.797 -156.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.769 HG22 ' HA ' ' A' ' 167' ' ' THR . 11.1 t -108.52 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.998 0.899 . . . . 0.0 109.877 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.49 157.2 86.51 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.392 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.68 61.34 Favored 'Trans proline' 0 C--N 1.348 0.536 0 CA-C-N 119.511 0.861 . . . . 0.0 111.73 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 125.47 1.508 . . . . 0.0 112.268 -171.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HE3' ' C' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 109.217 -1.109 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.94 22.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' C' ' 125' ' ' ALA . 0.0 OUTLIER -89.04 -177.94 5.57 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.86 0.838 . . . . 0.0 110.764 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.91 -31.62 78.67 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 114.513 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -18.43 62.12 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 117.783 0.791 . . . . 0.0 112.395 172.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' B' ' 96' ' ' THR . 4.8 t70 -66.21 -37.62 85.99 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.631 HG11 HH21 ' B' ' 93' ' ' ARG . 28.0 m -101.64 117.78 47.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' B' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.38 26.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.669 0.747 . . . . 0.0 110.496 176.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.16 98.66 7.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.799 -164.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.28 28.78 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 174.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.497 ' HB3' HD11 ' B' ' 89' ' ' ILE . 19.2 m-85 -126.04 137.67 53.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.432 0.635 . . . . 0.0 109.968 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' B' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.25 47.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.55 147.35 47.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.016 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.656 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 2.0 pt -64.47 -47.03 91.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.001 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' B' ' 18' ' ' ILE . 2.0 p30 -85.87 -11.81 52.32 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.54 82.6 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.441 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.94 40.08 20.15 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.246 1.418 . . . . 0.0 111.784 -173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 163.62 13.57 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.84 4.84 68.84 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 113.726 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.5 142.74 28.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.967 0.384 . . . . 0.0 111.775 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' B' ' 16' ' ' GLN . . . -100.08 122.56 50.05 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 127.028 2.131 . . . . 0.0 112.38 -174.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' B' ' 15' ' ' PHE . 27.7 Cg_exo -70.36 127.17 13.75 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.445 0.838 . . . . 0.0 112.495 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 150' ' ' ILE . 0.8 OUTLIER -106.51 126.97 52.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 168.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -90.36 140.51 27.03 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.841 -2.344 . . . . 0.0 110.548 -167.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.89 169.92 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.854 0.689 . . . . 0.0 112.422 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.55 12.88 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.372 1.469 . . . . 0.0 111.531 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.576 ' HB2' HG21 ' G' ' 48' ' ' THR . 2.9 m-85 -71.88 133.11 45.23 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.588 1.185 . . . . 0.0 111.071 173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.2 -111.12 0.13 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.521 HG22 HG23 ' C' ' 122' ' ' VAL . 18.2 p -121.32 174.25 6.84 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 122.763 1.268 . . . . 0.0 111.084 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.517 ' OD1' HG22 ' B' ' 65' ' ' VAL . 5.2 t0 -159.2 129.48 5.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.984 -164.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.64 7.58 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 170.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' C' ' 117' ' ' GLU . 57.4 t -107.22 126.13 63.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.812 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 6.0 p -130.91 80.47 1.95 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.54 4.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.25 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.401 ' H ' ' HA ' ' C' ' 115' ' ' SER . 0.1 OUTLIER -105.19 90.68 3.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' B' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.49 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.715 0.769 . . . . 0.0 110.144 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' B' ' 41' ' ' ARG . 0.0 OUTLIER -146.29 141.48 27.36 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -167.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.788 HD13 ' HA2' ' B' ' 57' ' ' GLY . 0.0 OUTLIER -73.43 166.01 24.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.518 -179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.466 ' HA ' HG12 ' B' ' 53' ' ' ILE . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.188 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.545 ' H ' HG21 ' B' ' 53' ' ' ILE . 26.4 t70 -110.62 100.08 8.93 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.22 64.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.3 26.58 5.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.592 1.557 . . . . 0.0 111.667 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.646 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.93 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.516 1.526 . . . . 0.0 111.54 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HG2' ' HG2' ' B' ' 52' ' ' ARG . 6.3 tptt -116.57 -92.22 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.444 -177.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.576 ' CG ' HG23 ' C' ' 59' ' ' VAL . 17.8 m-20 -152.31 33.97 0.52 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.56 ' H ' ' HB2' ' B' ' 46' ' ' GLU . . . 80.12 36.13 25.35 Favored Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.55 ' HG2' ' HG2' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -102.62 116.29 32.29 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.545 HG21 ' H ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -132.88 136.01 56.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.883 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.717 HD22 HD13 ' C' ' 135' ' ' ILE . 0.4 OUTLIER -109.08 25.14 12.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.706 0.614 . . . . 0.0 113.927 -170.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.497 ' O ' HD22 ' B' ' 43' ' ' LEU . 68.2 Cg_endo -80.12 160.1 23.6 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.803 0.655 . . . . 0.0 113.803 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . 0.788 ' HA2' HD13 ' B' ' 43' ' ' LEU . . . -124.88 -70.95 0.2 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.39 170.22 21.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.56 0.695 . . . . 0.0 110.506 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.435 HG23 ' CG ' ' A' ' 50' ' ' ASN . 2.3 t -114.99 110.6 32.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.76 104.53 14.05 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -171.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.861 ' HA ' ' HA ' ' B' ' 133' ' ' GLN . 92.4 p -142.75 163.43 32.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.953 0.901 . . . . 0.0 110.081 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . 0.453 ' O ' ' HG ' ' B' ' 132' ' ' LEU . . . -147.0 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.126 176.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.732 ' HG2' ' HA ' ' B' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.61 51.6 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' B' ' 34' ' ' ASP . 85.5 t -129.25 125.15 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.89 24.08 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -91.38 143.06 27.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.62 141.68 23.0 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 114.924 0.73 . . . . 0.0 114.924 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.594 ' H ' HE22 ' B' ' 76' ' ' GLN . 0.4 OUTLIER -123.1 151.05 42.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 174.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.13 70.01 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -172.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.24 -123.09 2.87 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.481 ' OD2' ' HD3' ' B' ' 70' ' ' LYS . 87.8 m-20 67.51 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.129 1.371 . . . . 0.0 111.046 169.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' B' ' 77' ' ' LYS . . . -85.29 -12.08 53.21 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -74.2 -47.0 19.12 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.832 168.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.615 ' HA ' ' HB ' ' B' ' 79' ' ' ILE . 7.0 tt0 -66.94 -37.1 83.68 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.15 -0.618 . . . . 0.0 111.883 171.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' B' ' 74' ' ' ALA . 1.6 mtmt -66.38 -38.59 87.87 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.844 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.82 79.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.92 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.615 ' HB ' ' HA ' ' B' ' 76' ' ' GLN . 4.4 mm -59.55 -48.61 86.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.071 0.462 . . . . 0.0 110.508 172.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.45 64.55 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.763 -0.586 . . . . 0.0 112.455 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.56 -46.18 87.42 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.584 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.75 86.09 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.541 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.746 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 5.3 t80 -62.25 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.936 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.64 35.81 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.471 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.038 172.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.73 30.06 75.68 Favored Glycine 0 N--CA 1.45 -0.427 0 O-C-N 122.372 -0.205 . . . . 0.0 112.84 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.471 ' HE2' ' OD1' ' B' ' 85' ' ' ASN . 15.1 mttm -70.7 143.0 51.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' B' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.23 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' B' ' 15' ' ' PHE . 7.7 tt -118.82 139.4 46.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.366 0.603 . . . . 0.0 109.837 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.656 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 4.9 mtmp? -85.69 131.16 34.39 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.93 42.17 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.551 1.14 . . . . 0.0 109.996 -166.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.24 115.15 20.59 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.183 0.993 . . . . 0.0 108.353 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.631 HH21 HG11 ' B' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.09 17.85 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.769 HG21 HG21 ' B' ' 145' ' ' THR . 2.5 m -122.38 152.39 26.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.251 1.024 . . . . 0.0 109.41 -173.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 11' ' ' VAL . 1.0 OUTLIER -87.19 162.81 17.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.627 179.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 10' ' ' ASP . 28.1 m -99.24 -25.04 14.64 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.626 -176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.495 ' O ' ' HD1' ' B' ' 104' ' ' TYR . 2.6 m -69.09 165.23 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.652 0.739 . . . . 0.0 109.944 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.003 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' B' ' 102' ' ' ASP . 16.6 t30 -73.27 157.6 36.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.81 0.814 . . . . 0.0 109.978 171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.09 23.31 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.21 -83.49 0.25 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.884 169.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' B' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 167.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' B' ' 143' ' ' ILE . 0.4 OUTLIER -51.78 -46.23 64.1 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.882 -0.511 . . . . 0.0 110.604 171.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' B' ' 97' ' ' VAL . 26.7 m-85 -138.18 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.786 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.5 t70 -141.0 143.14 34.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.644 0.735 . . . . 0.0 109.461 177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.69 43.89 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.049 -163.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.67 130.62 48.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 157.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 138' ' ' LEU . 23.1 t80 -133.53 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.409 0.684 . . . . 0.0 110.458 -163.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' B' ' 138' ' ' LEU . . . -173.46 170.58 43.72 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.968 170.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.648 ' HB3' HE22 ' B' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.11 32.7 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 167.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.55 159.93 38.97 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.918 0.866 . . . . 0.0 111.168 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.97 136.45 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.968 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' B' ' 83' ' ' TYR . 2.8 mp -71.07 111.22 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.534 ' HG3' ' HA ' ' B' ' 132' ' ' LEU . 18.9 mt-10 -91.03 -30.19 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.81 149.2 10.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.935 0.789 . . . . 0.0 109.063 174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.545 ' HG3' HH11 ' B' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.602 ' HG2' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.2 18.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.08 120.61 42.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.651 ' HB2' ' HB2' ' B' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.84 48.9 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.679 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.32 22.16 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 33' ' ' THR . 15.2 t -77.25 -55.88 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.522 -0.399 . . . . 0.0 111.072 176.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.33 159.54 14.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.626 ' HA2' ' HG ' ' G' ' 43' ' ' LEU . . . 90.43 153.55 28.95 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 7' ' ' MET . . . -80.04 163.95 23.8 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.717 . . . . 0.0 110.75 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.19 4.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.016 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' B' ' 119' ' ' SER . 29.7 mp0 -127.13 129.7 48.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.136 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' B' ' 130' ' ' ILE . 26.6 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.88 45.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.608 ' O ' HG13 ' B' ' 130' ' ' ILE . 12.7 pt -119.84 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.732 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.07 54.35 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.715 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.534 ' HA ' ' HG3' ' B' ' 114' ' ' GLU . 0.4 OUTLIER -142.92 163.19 33.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.066 -172.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.861 ' HA ' ' HA ' ' B' ' 62' ' ' SER . 1.8 pt20 -121.09 163.16 18.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 167.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' B' ' 110' ' ' PHE . 4.1 t -121.69 128.41 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.584 HD13 HD22 ' A' ' 54' ' ' LEU . 6.9 pt -67.28 -51.33 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.308 0.575 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' B' ' 135' ' ' ILE . . . -125.27 116.88 2.81 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.704 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 122.032 0.92 . . . . 0.0 110.672 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' B' ' 109' ' ' GLY . 2.4 mt -127.88 151.87 48.54 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.69 34.44 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.98 150.78 19.03 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.786 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -67.74 151.6 52.16 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.367 169.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' B' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' B' ' 103' ' ' LYS . 1.7 mp -104.7 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.773 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.88 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.005 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 0.769 HG21 HG21 ' B' ' 94' ' ' VAL . 12.7 p -109.49 31.45 5.77 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 118.704 -0.665 . . . . 0.0 112.354 175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.45 56.49 17.48 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.46 1.904 . . . . 0.0 109.362 -173.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.08 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.254 1.303 . . . . 0.0 115.307 -159.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.579 171.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.672 HD12 ' O ' ' B' ' 145' ' ' THR . 17.2 mt -71.7 -45.13 67.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.162 0.892 . . . . 0.0 111.339 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 2.4 t -78.99 -39.95 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.17 28.31 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.469 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.52 HG22 ' HD3' ' G' ' 49' ' ' LYS . 13.6 p -104.26 110.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 171.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.75 37.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -172.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.491 ' HD3' ' CA ' ' H' ' 136' ' ' GLY . 6.8 mttt -74.7 -34.01 62.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.52 11.66 77.15 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 119.397 0.999 . . . . 0.0 112.991 -176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.78 4.8 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.318 1.047 . . . . 0.0 108.631 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -33.01 70.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -158.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.555 ' HA ' ' HH2' ' H' ' 92' ' ' TRP . 83.2 t80 -133.92 112.44 11.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.711 2.405 . . . . 0.0 109.17 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.581 ' HB3' ' HG3' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.03 1.71 Allowed 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.591 ' HB3' ' HD3' ' B' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.72 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' B' ' 162' ' ' GLN . 22.3 Cg_exo -82.71 131.62 6.31 Favored 'Trans proline' 0 C--O 1.239 0.555 0 CA-C-N 122.055 1.77 . . . . 0.0 113.897 171.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.72 42.49 99.76 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 118.342 2.097 . . . . 0.0 118.342 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' B' ' 161' ' ' GLN . 1.3 tt0 -60.35 -42.51 95.89 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.89 1.345 . . . . 0.0 110.96 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.51 0.44 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.853 1.661 . . . . 0.0 111.873 175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' B' ' 173' ' ' THR . 37.5 p -132.55 147.58 52.36 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.294 -167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.07 -167.59 42.58 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.492 172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -29.51 70.54 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.78 0.29 . . . . 0.0 111.429 -177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.11 60.34 Favored Pre-proline 0 C--O 1.235 0.315 0 C-N-CA 123.53 0.732 . . . . 0.0 109.268 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.73 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.285 1.323 . . . . 0.0 112.77 -156.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.69 82.72 1.15 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' B' ' 167' ' ' THR . 11.2 t -108.48 153.43 23.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.012 0.906 . . . . 0.0 109.862 170.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.57 157.22 86.36 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.385 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.42 137.74 61.82 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.543 0.873 . . . . 0.0 111.71 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.411 1.484 . . . . 0.0 112.34 -171.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HE3' ' D' ' 70' ' ' LYS . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.48 127.88 21.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' D' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.99 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.937 0.875 . . . . 0.0 110.704 -177.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.76 -31.75 79.25 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.344 -0.844 . . . . 0.0 114.491 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.758 0.779 . . . . 0.0 112.376 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' C' ' 96' ' ' THR . 4.8 t70 -66.21 -37.65 86.07 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.636 HG11 HH21 ' C' ' 93' ' ' ARG . 28.0 m -101.61 117.77 47.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' C' ' 12' ' ' LYS . 0.0 OUTLIER -117.8 157.39 26.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.687 0.756 . . . . 0.0 110.502 176.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -114.18 98.61 7.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.76 -164.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.28 28.81 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' C' ' 89' ' ' ILE . 18.9 m-85 -126.06 137.61 53.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.418 0.628 . . . . 0.0 109.981 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.658 ' HG2' ' HA ' ' C' ' 25' ' ' ALA . 1.3 tm0? -131.89 136.28 47.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 147.3 47.87 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.564 0.697 . . . . 0.0 111.047 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.65 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 2.0 pt -64.41 -47.08 90.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.982 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . 0.469 ' N ' HG13 ' C' ' 18' ' ' ILE . 2.0 p30 -85.8 -11.89 52.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -171.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.94 -37.46 82.42 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.401 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.86 40.12 19.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.184 1.394 . . . . 0.0 111.799 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.08 163.58 13.59 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.86 68.79 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 116.307 -0.406 . . . . 0.0 113.673 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.75 28.4 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.994 0.397 . . . . 0.0 111.757 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' C' ' 16' ' ' GLN . . . -100.09 122.61 49.89 Favored Pre-proline 0 C--O 1.238 0.495 0 C-N-CA 126.997 2.119 . . . . 0.0 112.399 -174.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' C' ' 15' ' ' PHE . 27.8 Cg_exo -70.38 127.22 13.81 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.466 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.562 HD22 HG23 ' C' ' 150' ' ' ILE . 0.8 OUTLIER -106.5 126.93 52.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 168.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.37 140.52 27.02 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.814 -2.354 . . . . 0.0 110.555 -167.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.91 169.99 21.05 Favored 'Trans proline' 0 C--N 1.332 -0.308 0 CA-C-O 121.899 0.708 . . . . 0.0 112.409 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.55 13.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 111.587 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . 0.519 ' HB2' HG21 ' H' ' 48' ' ' THR . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.504 1.145 . . . . 0.0 111.028 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.28 -111.11 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.595 ' CG2' HG23 ' D' ' 122' ' ' VAL . 18.3 p -121.37 174.24 6.86 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.801 1.286 . . . . 0.0 111.079 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.511 ' OD1' HG22 ' C' ' 65' ' ' VAL . 5.2 t0 -159.09 129.56 5.9 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.99 -164.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.01 131.58 7.55 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.364 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 109.02 18.0 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.537 HG22 ' HG2' ' D' ' 117' ' ' GLU . 57.3 t -107.23 126.06 63.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.717 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 6.1 p -130.84 80.51 1.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.214 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' D' ' 115' ' ' SER . 0.1 OUTLIER -105.17 90.7 3.51 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.458 HH12 ' HG2' ' C' ' 42' ' ' GLU . 10.5 mmm180 -65.48 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.755 0.788 . . . . 0.0 110.136 -174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.458 ' HG2' HH12 ' C' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -167.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' C' ' 57' ' ' GLY . 0.0 OUTLIER -73.46 166.01 24.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.526 -179.12 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.476 ' HA ' HG12 ' C' ' 53' ' ' ILE . 5.4 t80 -108.85 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.239 171.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.548 ' H ' HG21 ' C' ' 53' ' ' ILE . 26.4 t70 -110.63 100.1 8.95 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.632 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.22 64.39 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.28 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.602 1.561 . . . . 0.0 111.664 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.632 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.97 21.51 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.514 1.526 . . . . 0.0 111.561 -164.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.532 ' HG2' ' HG2' ' C' ' 52' ' ' ARG . 6.4 tptt -116.62 -92.16 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.458 -177.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . 0.662 ' CG ' HG23 ' D' ' 59' ' ' VAL . 17.9 m-20 -152.32 33.94 0.52 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' C' ' 46' ' ' GLU . . . 80.15 36.1 25.35 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' C' ' 49' ' ' LYS . 0.1 OUTLIER -102.66 116.3 32.3 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.548 HG21 ' H ' ' C' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.03 56.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.915 178.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.695 HD22 HD13 ' D' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.18 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 121.634 0.574 . . . . 0.0 113.932 -170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' C' ' 43' ' ' LEU . 69.0 Cg_endo -80.11 160.1 23.63 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.832 0.666 . . . . 0.0 113.832 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' C' ' 43' ' ' LEU . . . -124.82 -70.94 0.21 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.18 21.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.554 0.693 . . . . 0.0 110.47 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.576 HG23 ' CG ' ' B' ' 50' ' ' ASN . 2.3 t -114.96 110.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.07 83.11 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.56 14.1 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . 0.884 ' HA ' ' HA ' ' C' ' 133' ' ' GLN . 92.3 p -142.81 163.32 33.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.969 0.908 . . . . 0.0 110.034 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' C' ' 132' ' ' LEU . . . -146.94 155.7 26.67 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.165 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.739 ' HG2' ' HA ' ' C' ' 131' ' ' SER . 0.0 OUTLIER -122.73 141.66 51.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.511 HG22 ' OD1' ' C' ' 34' ' ' ASP . 85.6 t -129.28 125.11 61.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.06 137.59 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.39 167.86 24.14 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.14 26.94 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.7 141.68 22.92 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.608 ' H ' HE22 ' C' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.09 42.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -37.15 70.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' C' ' 70' ' ' LYS . 87.9 m-20 67.62 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.168 1.387 . . . . 0.0 111.034 169.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' C' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 117.506 2.41 . . . . 0.0 117.506 -156.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.58 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -74.17 -46.97 19.47 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.201 -0.999 . . . . 0.0 112.876 168.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.616 ' HA ' ' HB ' ' C' ' 79' ' ' ILE . 7.0 tt0 -67.03 -37.03 83.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.869 171.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' C' ' 74' ' ' ALA . 1.6 mtmt -66.47 -38.56 87.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.772 171.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.87 79.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.912 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' C' ' 76' ' ' GLN . 4.4 mm -59.49 -48.71 86.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.5 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.43 64.78 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.75 -0.594 . . . . 0.0 112.482 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.6 -46.13 87.67 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.603 169.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.53 -45.65 86.25 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.554 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.812 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 5.3 t80 -62.31 -50.32 72.12 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.919 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.5 -25.58 35.87 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.475 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 18.4 m120 -95.04 -0.37 53.77 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.05 172.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.08 75.69 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 122.279 -0.263 . . . . 0.0 112.823 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.475 ' HE2' ' OD1' ' C' ' 85' ' ' ASN . 15.2 mttm -70.8 142.95 51.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.653 HE22 ' HB3' ' C' ' 110' ' ' PHE . 0.0 OUTLIER -73.52 142.17 46.72 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' C' ' 15' ' ' PHE . 7.7 tt -118.74 139.45 46.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.364 0.602 . . . . 0.0 109.835 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.65 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.15 34.37 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.03 122.93 42.23 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.491 1.116 . . . . 0.0 110.025 -166.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.636 HH21 HG11 ' C' ' 11' ' ' VAL . 20.2 ttt180 -104.41 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 172.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.759 HG21 HG21 ' C' ' 145' ' ' THR . 2.5 m -122.31 152.41 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-O 122.256 1.027 . . . . 0.0 109.421 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' C' ' 11' ' ' VAL . 1.0 OUTLIER -87.18 162.74 17.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.662 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.562 ' N ' ' O ' ' C' ' 10' ' ' ASP . 27.9 m -99.12 -25.05 14.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.708 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' C' ' 104' ' ' TYR . 2.5 m -69.13 165.21 2.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.686 0.755 . . . . 0.0 109.909 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.64 108.14 19.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.982 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' C' ' 102' ' ' ASP . 16.6 t30 -73.25 157.6 36.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.843 0.83 . . . . 0.0 109.991 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.34 -19.12 23.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.17 -83.48 0.25 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 118.737 0.699 . . . . 0.0 110.868 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' C' ' 99' ' ' ASN . 0.8 OUTLIER -66.83 152.92 44.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.572 ' HD2' ' O ' ' C' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.25 64.04 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.926 -0.484 . . . . 0.0 110.599 171.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' C' ' 97' ' ' VAL . 26.8 m-85 -138.21 -170.53 2.82 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.784 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.5 t70 -141.03 143.15 34.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.592 0.71 . . . . 0.0 109.421 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.033 -163.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.64 130.64 48.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 157.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' C' ' 138' ' ' LEU . 23.0 t80 -133.61 155.04 50.38 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.373 0.669 . . . . 0.0 110.419 -163.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' C' ' 138' ' ' LEU . . . -173.44 170.61 43.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 119.46 -1.353 . . . . 0.0 111.958 170.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.653 ' HB3' HE22 ' C' ' 88' ' ' GLN . 5.1 m-85 -92.97 137.22 32.56 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.67 159.87 39.23 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.905 0.86 . . . . 0.0 111.146 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.89 136.51 42.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.468 -1.242 . . . . 0.0 108.015 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' C' ' 83' ' ' TYR . 2.8 mp -71.1 111.18 4.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' C' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.1 16.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.401 ' HA ' ' H ' ' B' ' 40' ' ' GLU . 44.8 t -163.86 149.19 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.94 0.791 . . . . 0.0 109.125 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' C' ' 116' ' ' ARG . 1.4 tmm_? -121.16 138.87 54.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.576 ' HG2' HG22 ' B' ' 37' ' ' VAL . 0.2 OUTLIER -135.09 120.27 18.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.12 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.098 0.475 . . . . 0.0 111.155 176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' C' ' 127' ' ' GLU . 1.0 OUTLIER -102.1 125.8 48.89 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.665 177.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.47 114.89 21.32 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 167.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.97 -175.29 22.17 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 175.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . 0.521 HG23 HG22 ' B' ' 33' ' ' THR . 15.3 t -77.31 -55.9 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.493 -0.416 . . . . 0.0 111.069 176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.32 159.49 14.98 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 169.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . 0.714 ' HA2' ' HG ' ' H' ' 43' ' ' LEU . . . 90.47 153.56 29.0 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 166.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' B' ' 7' ' ' MET . . . -80.02 163.95 23.81 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.549 0.69 . . . . 0.0 110.781 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.2 146.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.002 -171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' C' ' 119' ' ' SER . 29.7 mp0 -127.13 129.72 48.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.078 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.459 HG22 HG23 ' C' ' 130' ' ' ILE . 26.6 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.18 121.84 45.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.598 HG13 ' O ' ' C' ' 130' ' ' ILE . 12.7 pt -119.79 122.49 68.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.739 ' HA ' ' HG2' ' C' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.06 54.38 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.717 -178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.532 ' HA ' ' HG3' ' C' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.149 -172.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.884 ' HA ' ' HA ' ' C' ' 62' ' ' SER . 1.8 pt20 -121.07 163.24 18.66 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.415 HG13 ' O ' ' C' ' 110' ' ' PHE . 4.1 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.717 HD13 HD22 ' B' ' 54' ' ' LEU . 6.9 pt -67.19 -51.39 53.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.364 -173.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.443 ' H ' HG13 ' C' ' 135' ' ' ILE . . . -125.29 116.9 2.81 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.728 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.57 123.91 24.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.997 0.904 . . . . 0.0 110.69 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' C' ' 109' ' ' GLY . 2.4 mt -127.89 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.72 34.43 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.0 150.81 19.03 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.784 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -67.81 151.57 52.11 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.431 169.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.419 ' HG2' HG11 ' C' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.39 41.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.572 ' O ' ' HD2' ' C' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.773 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.94 20.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.944 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 0.759 HG21 HG21 ' C' ' 94' ' ' VAL . 12.8 p -109.56 31.55 5.7 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.734 -0.65 . . . . 0.0 112.377 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.54 17.48 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.436 1.894 . . . . 0.0 109.372 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.6 Cg_exo -69.15 -7.84 21.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.212 1.275 . . . . 0.0 115.303 -159.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.25 66.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.575 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.64 1.59 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' C' ' 145' ' ' THR . 17.2 mt -71.69 -45.25 67.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.129 0.877 . . . . 0.0 111.273 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 2.4 t -78.92 -39.92 22.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.11 28.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.477 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.27 110.35 30.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.51 144.67 37.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.432 ' HD3' ' CA ' ' I' ' 136' ' ' GLY . 6.8 mttt -74.62 -34.0 62.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.61 77.37 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 119.335 0.97 . . . . 0.0 113.059 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.82 117.79 4.82 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -94.03 112.25 24.06 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.274 1.03 . . . . 0.0 108.569 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -32.9 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -158.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.505 ' HA ' ' HH2' ' I' ' 92' ' ' TRP . 83.2 t80 -134.01 112.46 11.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.71 2.404 . . . . 0.0 109.118 167.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 154.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' C' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.75 62.81 Favored Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -166.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' C' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.66 6.26 Favored 'Trans proline' 0 C--O 1.239 0.546 0 CA-C-N 122.046 1.766 . . . . 0.0 113.844 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' C' ' 161' ' ' GLN . 1.3 tt0 -60.39 -42.54 96.11 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.86 1.33 . . . . 0.0 110.881 175.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 111.915 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.793 ' HA ' HG22 ' C' ' 173' ' ' THR . 37.6 p -132.54 147.51 52.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.32 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.96 -167.61 42.5 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.541 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -29.58 70.54 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.806 0.303 . . . . 0.0 111.398 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.15 156.14 60.3 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.485 0.714 . . . . 0.0 109.29 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.298 1.332 . . . . 0.0 112.72 -156.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.62 82.78 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.179 1.631 . . . . 0.0 117.179 165.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.793 HG22 ' HA ' ' C' ' 167' ' ' THR . 11.2 t -108.47 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.002 0.901 . . . . 0.0 109.916 170.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.49 157.15 86.56 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.398 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.42 Favored 'Trans proline' 0 C--N 1.349 0.567 0 CA-C-N 119.515 0.863 . . . . 0.0 111.735 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.433 1.493 . . . . 0.0 112.311 -171.698 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HE3' ' E' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 109.15 -1.134 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.5 127.89 22.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' E' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.97 5.59 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.943 0.878 . . . . 0.0 110.743 -177.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' E' ' 125' ' ' ALA . . . -66.91 -31.61 78.63 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.47 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.81 -18.37 62.09 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 117.781 0.79 . . . . 0.0 112.397 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' D' ' 96' ' ' THR . 4.8 t70 -66.24 -37.6 85.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.626 HG11 HH21 ' D' ' 93' ' ' ARG . 28.1 m -101.66 117.77 47.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . 0.561 ' HE3' ' HA ' ' D' ' 12' ' ' LYS . 0.0 OUTLIER -117.74 157.43 26.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 110.56 176.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.15 98.62 7.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.747 -164.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.28 28.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.487 ' O ' ' HD2' ' D' ' 26' ' ' PRO . 18.8 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.486 0.66 . . . . 0.0 109.96 176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.645 ' HG2' ' HA ' ' D' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 147.32 47.82 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.997 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.628 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 2.0 pt -64.45 -47.05 91.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.994 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . 0.478 ' H ' HG13 ' D' ' 18' ' ' ILE . 2.0 p30 -85.77 -12.01 52.1 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.82 -37.53 82.33 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.474 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.99 40.04 20.22 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.79 -173.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.72 13.54 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.97 4.92 68.45 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.662 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.51 142.71 28.33 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.014 0.407 . . . . 0.0 111.833 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.645 ' HA ' ' HG2' ' D' ' 16' ' ' GLN . . . -100.14 122.62 49.73 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.95 2.1 . . . . 0.0 112.374 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' D' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.2 13.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 119.416 0.827 . . . . 0.0 112.475 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 150' ' ' ILE . 0.8 OUTLIER -106.55 127.0 52.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.39 140.51 26.98 Favored Pre-proline 0 C--N 1.317 -0.847 0 C-N-CA 115.793 -2.363 . . . . 0.0 110.541 -167.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.13 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.878 0.699 . . . . 0.0 112.45 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.56 13.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.343 1.457 . . . . 0.0 111.569 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' D' ' 27' ' ' LEU . 2.9 m-85 -71.82 133.08 45.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.528 1.156 . . . . 0.0 111.061 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.22 -111.01 0.13 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . 0.535 ' CG2' HG23 ' E' ' 122' ' ' VAL . 18.2 p -121.37 174.2 6.88 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 122.743 1.259 . . . . 0.0 111.117 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' D' ' 65' ' ' VAL . 5.2 t0 -159.13 129.57 5.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.981 -164.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.04 131.61 7.56 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.308 170.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 108.95 17.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.601 HG22 ' HG2' ' E' ' 117' ' ' GLU . 57.3 t -107.21 126.11 63.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . 0.772 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 6.0 p -130.91 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.54 4.77 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.213 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' D' ' 42' ' ' GLU . 10.5 mmm180 -65.49 -179.52 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.681 0.753 . . . . 0.0 110.145 -174.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' D' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.5 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.774 HD13 ' HA2' ' D' ' 57' ' ' GLY . 0.0 OUTLIER -73.46 165.98 24.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.503 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . 0.477 ' HA ' HG12 ' D' ' 53' ' ' ILE . 5.4 t80 -108.86 85.02 2.02 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.248 171.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.561 ' H ' HG21 ' D' ' 53' ' ' ILE . 26.4 t70 -110.63 100.09 8.94 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 155.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.641 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 10.2 pt-20 -68.75 -21.25 64.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.34 26.63 5.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.62 1.568 . . . . 0.0 111.64 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.641 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.9 21.6 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.513 1.525 . . . . 0.0 111.587 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.551 ' HG2' ' HG2' ' D' ' 52' ' ' ARG . 6.3 tptt -116.56 -92.21 0.52 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.465 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . 0.427 ' CG ' HG23 ' E' ' 59' ' ' VAL . 17.9 m-20 -152.24 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.561 ' H ' ' HB2' ' D' ' 46' ' ' GLU . . . 80.2 36.1 25.18 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' D' ' 49' ' ' LYS . 0.1 OUTLIER -102.64 116.31 32.33 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.561 HG21 ' H ' ' D' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.0 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.84 178.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.56 HD22 HD13 ' E' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.13 12.17 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.26 12.89 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 121.712 0.618 . . . . 0.0 113.934 -170.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . 0.495 ' O ' HD22 ' D' ' 43' ' ' LEU . 68.7 Cg_endo -80.07 160.13 23.74 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . 0.774 ' HA2' HD13 ' D' ' 43' ' ' LEU . . . -124.85 -71.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.38 170.2 21.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.552 0.691 . . . . 0.0 110.521 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.662 HG23 ' CG ' ' C' ' 50' ' ' ASN . 2.3 t -114.91 110.61 32.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.035 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.01 83.15 2.66 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.81 104.59 14.11 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -171.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' D' ' 133' ' ' GLN . 92.5 p -142.78 163.41 32.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 110.024 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' D' ' 132' ' ' LEU . . . -146.95 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.198 176.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.747 ' HG2' ' HA ' ' D' ' 131' ' ' SER . 0.0 OUTLIER -122.76 141.59 51.64 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' D' ' 34' ' ' ASP . 86.1 t -129.22 125.17 61.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.12 137.57 51.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.4 167.87 24.13 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.39 143.11 26.96 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.65 22.95 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.621 ' H ' HE22 ' D' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.07 42.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.476 0.655 . . . . 0.0 109.261 174.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.448 HH11 ' HB ' ' C' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.07 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.2 -123.1 2.88 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.478 ' OD2' ' HD3' ' D' ' 70' ' ' LYS . 87.8 m-20 67.61 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.12 1.368 . . . . 0.0 111.032 169.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' D' ' 77' ' ' LYS . . . -85.25 -12.08 53.32 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 -156.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -74.19 -47.0 19.19 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.831 168.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.621 HE22 ' H ' ' D' ' 70' ' ' LYS . 7.0 tt0 -66.99 -37.09 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.827 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' D' ' 74' ' ' ALA . 1.6 mtmt -66.42 -38.59 87.79 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.791 171.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.76 79.18 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.933 168.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' D' ' 76' ' ' GLN . 4.4 mm -59.61 -48.64 86.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-O 121.044 0.45 . . . . 0.0 110.447 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.753 -0.592 . . . . 0.0 112.458 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.25 87.3 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.6 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.69 86.44 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.602 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.717 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 5.3 t80 -62.29 -50.32 72.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 120.354 -0.538 . . . . 0.0 111.932 -174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.48 -25.62 35.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.473 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.43 53.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.063 172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.72 30.07 75.69 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 122.339 -0.226 . . . . 0.0 112.875 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' D' ' 85' ' ' ASN . 15.2 mttm -70.75 142.95 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.652 HE22 ' HB3' ' D' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.17 46.69 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB3' ' D' ' 15' ' ' PHE . 7.7 tt -118.77 139.45 46.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.386 0.612 . . . . 0.0 109.841 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.628 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.17 34.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.1 122.91 42.09 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.495 1.118 . . . . 0.0 109.941 -165.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -124.28 115.17 20.6 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.626 HH21 HG11 ' D' ' 11' ' ' VAL . 20.1 ttt180 -104.41 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.765 HG21 HG21 ' D' ' 145' ' ' THR . 2.5 m -122.38 152.37 26.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.242 1.02 . . . . 0.0 109.425 -173.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' D' ' 11' ' ' VAL . 1.0 OUTLIER -87.14 162.75 17.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.66 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' D' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.646 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . 0.498 ' O ' ' HD1' ' D' ' 104' ' ' TYR . 2.6 m -69.12 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.725 0.774 . . . . 0.0 109.87 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.18 20.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.95 -174.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' D' ' 102' ' ' ASP . 16.6 t30 -73.25 157.57 36.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.81 0.814 . . . . 0.0 109.955 171.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.01 23.35 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.2 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.774 0.715 . . . . 0.0 110.84 169.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' D' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.89 44.66 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' D' ' 143' ' ' ILE . 0.4 OUTLIER -51.72 -46.3 63.9 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.854 -0.529 . . . . 0.0 110.577 171.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' D' ' 97' ' ' VAL . 26.8 m-85 -138.22 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.5 t70 -141.07 143.12 34.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.659 0.743 . . . . 0.0 109.433 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.12 140.7 43.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.061 -163.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.63 130.65 48.01 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 157.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' D' ' 138' ' ' LEU . 23.1 t80 -133.55 155.01 50.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.4 0.68 . . . . 0.0 110.426 -163.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . 0.791 ' HA2' HD12 ' D' ' 138' ' ' LEU . . . -173.43 170.63 43.78 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.94 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.652 ' HB3' HE22 ' D' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.14 32.66 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 167.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.9 39.12 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 111.166 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.9 136.51 42.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.495 -1.23 . . . . 0.0 107.987 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' D' ' 83' ' ' TYR . 2.8 mp -71.14 111.2 4.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' D' ' 132' ' ' LEU . 18.8 mt-10 -91.02 -30.16 16.95 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' C' ' 40' ' ' GLU . 44.8 t -163.82 149.16 10.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.958 0.799 . . . . 0.0 109.118 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.537 ' HG3' HH11 ' D' ' 116' ' ' ARG . 1.3 tmm_? -121.06 138.93 53.94 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.537 ' HG2' HG22 ' C' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.26 18.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.09 120.64 42.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.094 0.473 . . . . 0.0 111.163 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.646 ' HB2' ' HB2' ' D' ' 127' ' ' GLU . 1.0 OUTLIER -102.13 125.9 48.95 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.681 177.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.57 114.92 21.3 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 167.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.34 22.14 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-O 121.694 0.608 . . . . 0.0 111.595 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' C' ' 33' ' ' THR . 15.2 t -77.16 -55.96 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.473 -0.428 . . . . 0.0 111.084 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.39 159.58 14.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 169.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . 0.481 ' HA2' ' HG ' ' I' ' 43' ' ' LEU . . . 90.39 153.56 28.92 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 166.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' C' ' 7' ' ' MET . . . -80.07 163.92 23.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.638 0.732 . . . . 0.0 110.706 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . . . . . . . . . 18.6 m -55.12 146.18 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.071 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.646 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 29.7 mp0 -127.16 129.77 48.49 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.131 -176.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . 0.462 HG22 HG23 ' D' ' 130' ' ' ILE . 26.4 mt -114.95 124.84 71.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.9 45.43 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.606 HG13 ' O ' ' D' ' 130' ' ' ILE . 12.8 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.747 ' HA ' ' HG2' ' D' ' 64' ' ' GLU . 0.8 OUTLIER -106.5 130.04 54.36 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.733 -178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.537 ' HA ' ' HG3' ' D' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.19 33.48 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.17 -172.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' D' ' 62' ' ' SER . 1.8 pt20 -121.06 163.23 18.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' D' ' 110' ' ' PHE . 4.2 t -121.75 128.45 75.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.695 HD13 HD22 ' C' ' 54' ' ' LEU . 6.8 pt -67.32 -51.31 54.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.283 0.563 . . . . 0.0 110.332 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.44 ' H ' HG13 ' D' ' 135' ' ' ILE . . . -125.31 116.88 2.8 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.671 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.91 24.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.027 0.917 . . . . 0.0 110.669 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.791 HD12 ' HA2' ' D' ' 109' ' ' GLY . 2.4 mt -127.86 151.88 48.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -174.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 130.73 34.47 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.06 150.77 18.88 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -67.82 151.63 52.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.401 169.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.417 ' HG2' HG11 ' D' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.4 41.93 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' D' ' 103' ' ' LYS . 1.7 mp -104.76 -64.24 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.752 -176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.289 -0.565 . . . . 0.0 110.994 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.765 HG21 HG21 ' D' ' 94' ' ' VAL . 12.8 p -109.47 31.51 5.72 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.709 -0.663 . . . . 0.0 112.383 175.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.33 56.59 17.5 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.441 1.896 . . . . 0.0 109.373 -173.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.14 -7.85 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.23 1.287 . . . . 0.0 115.347 -159.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.55 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.599 171.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.66 1.59 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.685 HD12 ' O ' ' D' ' 145' ' ' THR . 17.2 mt -71.72 -45.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 119.176 0.898 . . . . 0.0 111.314 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 2.4 t -78.97 -39.9 22.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.15 28.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.447 -176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' I' ' 49' ' ' LYS . 13.5 p -104.27 110.34 30.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.79 37.32 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -172.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.44 ' HD3' ' CA ' ' J' ' 136' ' ' GLY . 6.8 mttt -74.69 -34.08 62.57 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.57 11.62 77.1 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 119.36 0.982 . . . . 0.0 113.038 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.91 112.15 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.331 1.052 . . . . 0.0 108.615 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.94 70.71 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -158.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.484 ' HA ' ' CH2' ' J' ' 92' ' ' TRP . 83.1 t80 -133.99 112.43 11.21 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.701 2.4 . . . . 0.0 109.127 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.576 ' HB3' ' HG3' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 154.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.595 ' HB3' ' HD3' ' D' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.75 62.8 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' D' ' 162' ' ' GLN . 22.2 Cg_exo -82.68 131.7 6.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 CA-C-N 122.078 1.778 . . . . 0.0 113.89 171.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.47 99.76 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.386 2.115 . . . . 0.0 118.386 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.576 ' HG3' ' HB3' ' D' ' 161' ' ' GLN . 1.3 tt0 -60.38 -42.51 95.99 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.895 1.347 . . . . 0.0 110.879 175.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.24 70.5 0.44 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.816 1.646 . . . . 0.0 111.929 176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.783 ' HA ' HG22 ' D' ' 173' ' ' THR . 37.6 p -132.53 147.54 52.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.308 -167.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.65 42.61 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.498 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . 0.445 ' OE1' HD12 ' I' ' 54' ' ' LEU . 0.0 OUTLIER -62.31 -29.55 70.52 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.703 0.287 . . . . 0.0 111.48 -177.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.09 60.46 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.294 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.69 97.76 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.763 0 C-N-CA 121.304 1.336 . . . . 0.0 112.759 -156.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.71 1.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.783 HG22 ' HA ' ' D' ' 167' ' ' THR . 11.1 t -108.53 153.42 23.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 118.027 0.913 . . . . 0.0 109.891 170.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.241 0.619 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.414 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.49 137.7 61.26 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.543 0.873 . . . . 0.0 111.735 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 C-N-CA 125.466 1.506 . . . . 0.0 112.349 -171.657 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.534 ' HB3' ' HG3' ' F' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.17 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.46 127.89 21.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' F' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.96 5.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.858 0.837 . . . . 0.0 110.775 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.89 -31.68 78.86 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 114.47 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -18.46 62.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.824 0.812 . . . . 0.0 112.419 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' E' ' 96' ' ' THR . 4.8 t70 -66.23 -37.62 85.96 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -171.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' E' ' 93' ' ' ARG . 28.2 m -101.68 117.75 47.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' E' ' 12' ' ' LYS . 0.0 OUTLIER -117.73 157.41 26.57 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.671 0.748 . . . . 0.0 110.532 176.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.18 98.66 7.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.73 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' E' ' 25' ' ' ALA . 5.5 mp -87.0 141.29 28.78 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' E' ' 89' ' ' ILE . 19.1 m-85 -126.08 137.64 53.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.508 0.671 . . . . 0.0 109.969 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' E' ' 25' ' ' ALA . 1.3 tm0? -131.95 136.26 47.21 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 170.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.57 147.27 47.8 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.007 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.635 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 2.0 pt -64.39 -47.03 91.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.021 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.466 ' H ' HG13 ' E' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.91 52.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -37.54 82.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.43 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.9 40.11 20.06 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.249 1.42 . . . . 0.0 111.818 -173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.11 163.69 13.54 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.93 4.9 68.55 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.301 -0.408 . . . . 0.0 113.687 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.52 142.75 28.36 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.969 0.385 . . . . 0.0 111.798 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' E' ' 16' ' ' GLN . . . -100.12 122.63 49.76 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 126.937 2.095 . . . . 0.0 112.392 -174.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' E' ' 15' ' ' PHE . 27.8 Cg_exo -70.41 127.26 13.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 119.395 0.819 . . . . 0.0 112.446 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.576 HD22 HG23 ' E' ' 150' ' ' ILE . 0.8 OUTLIER -106.59 126.92 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 168.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -90.29 140.51 27.14 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.557 -167.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.93 169.96 21.1 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.009 0.682 . . . . 0.0 112.428 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.0 48.6 13.01 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.421 1.488 . . . . 0.0 111.543 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . 0.425 ' HE1' ' HG ' ' E' ' 27' ' ' LEU . 2.9 m-85 -71.78 133.14 45.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.539 1.161 . . . . 0.0 111.074 173.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.23 -111.1 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.37 174.17 6.9 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.776 1.274 . . . . 0.0 111.091 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.519 ' OD1' HG22 ' E' ' 65' ' ' VAL . 5.2 t0 -159.13 129.48 5.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.088 -1.415 . . . . 0.0 107.999 -164.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.66 7.59 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.344 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 109.0 17.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 173.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' F' ' 117' ' ' GLU . 57.7 t -107.22 126.12 63.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -173.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . 0.736 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 6.1 p -130.87 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -166.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.76 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.198 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' E' ' 42' ' ' GLU . 10.5 mmm180 -65.53 -179.47 0.65 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 110.172 -174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' E' ' 41' ' ' ARG . 0.0 OUTLIER -146.3 141.49 27.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.801 HD13 ' HA2' ' E' ' 57' ' ' GLY . 0.0 OUTLIER -73.44 165.98 24.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.521 -179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' E' ' 53' ' ' ILE . 5.3 t80 -108.83 84.99 2.02 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.264 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . 0.559 ' H ' HG21 ' E' ' 53' ' ' ILE . 26.4 t70 -110.61 100.05 8.91 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 155.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.634 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.19 64.37 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.57 5.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.6 1.56 . . . . 0.0 111.685 -172.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.634 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.89 21.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.527 1.531 . . . . 0.0 111.565 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' E' ' 52' ' ' ARG . 6.4 tptt -116.55 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.455 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . 0.638 ' CG ' HG23 ' F' ' 59' ' ' VAL . 17.9 m-20 -152.29 33.93 0.52 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . 0.556 ' H ' ' HB2' ' E' ' 46' ' ' GLU . . . 80.15 36.16 25.19 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' E' ' 49' ' ' LYS . 0.1 OUTLIER -102.7 116.32 32.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.559 HG21 ' H ' ' E' ' 45' ' ' ASP . 0.3 OUTLIER -132.84 136.01 56.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.898 178.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.652 HD22 HD13 ' F' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.11 12.19 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.29 12.88 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-O 121.681 0.601 . . . . 0.0 113.91 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' E' ' 43' ' ' LEU . 69.0 Cg_endo -80.06 160.06 23.78 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . 0.801 ' HA2' HD13 ' E' ' 43' ' ' LEU . . . -124.81 -70.93 0.21 Allowed Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.4 170.18 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.583 0.706 . . . . 0.0 110.505 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.427 HG23 ' CG ' ' D' ' 50' ' ' ASN . 2.3 t -114.95 110.7 32.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.12 83.13 2.63 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.59 14.13 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -171.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' E' ' 133' ' ' GLN . 92.3 p -142.8 163.4 32.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.935 0.894 . . . . 0.0 110.067 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' E' ' 132' ' ' LEU . . . -146.96 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.222 176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.755 ' HG2' ' HA ' ' E' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.62 51.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.519 HG22 ' OD1' ' E' ' 34' ' ' ASP . 86.5 t -129.28 125.13 61.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 33.7 p -113.05 137.59 51.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 174.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.42 167.83 24.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.64 141.71 23.01 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.937 0.735 . . . . 0.0 114.937 -175.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.615 ' H ' HE22 ' E' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.01 42.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.487 HH11 ' HB ' ' D' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.16 69.94 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -172.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.07 2.88 Favored Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' E' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.115 1.366 . . . . 0.0 111.014 169.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' E' ' 77' ' ' LYS . . . -85.3 -12.05 53.29 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -156.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -74.21 -47.07 18.87 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.818 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.615 HE22 ' H ' ' E' ' 70' ' ' LYS . 7.0 tt0 -66.95 -37.05 83.57 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.862 171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' E' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.57 87.68 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.959 -0.697 . . . . 0.0 111.803 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.8 79.27 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.912 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' E' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.477 172.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.87 -41.42 64.73 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.698 -0.627 . . . . 0.0 112.494 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.62 -46.16 87.66 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.562 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.73 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.076 -1.049 . . . . 0.0 111.571 174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.772 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 5.3 t80 -62.29 -50.3 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.9 -174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.49 -25.62 35.85 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 18.3 m120 -94.96 -0.37 53.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.059 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.02 75.6 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.318 -0.239 . . . . 0.0 112.863 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' E' ' 85' ' ' ASN . 15.2 mttm -70.67 142.94 51.53 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.649 HE22 ' HB3' ' E' ' 110' ' ' PHE . 0.0 OUTLIER -73.54 142.22 46.69 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' E' ' 15' ' ' PHE . 7.7 tt -118.76 139.4 46.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.32 0.581 . . . . 0.0 109.893 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 4.9 mtmp? -85.72 131.09 34.4 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.92 42.21 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.543 1.137 . . . . 0.0 109.986 -165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -124.26 115.15 20.58 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.212 1.005 . . . . 0.0 108.322 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' E' ' 11' ' ' VAL . 20.1 ttt180 -104.4 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.784 HG21 HG21 ' E' ' 145' ' ' THR . 2.5 m -122.29 152.41 26.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.194 0.997 . . . . 0.0 109.441 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' E' ' 11' ' ' VAL . 1.0 OUTLIER -87.27 162.75 17.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.628 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' E' ' 10' ' ' ASP . 28.2 m -99.17 -25.04 14.65 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.651 -176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . 0.499 ' O ' ' HD1' ' E' ' 104' ' ' TYR . 2.6 m -69.03 165.17 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.665 0.745 . . . . 0.0 109.925 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.17 19.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.979 -174.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' E' ' 102' ' ' ASP . 16.6 t30 -73.21 157.55 36.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.84 0.828 . . . . 0.0 109.945 171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.37 -19.06 23.32 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.13 -83.54 0.25 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.753 0.706 . . . . 0.0 110.899 169.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' E' ' 99' ' ' ASN . 0.8 OUTLIER -66.82 152.95 44.58 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 167.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.573 ' HD2' ' O ' ' E' ' 143' ' ' ILE . 0.4 OUTLIER -51.76 -46.3 64.06 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.872 -0.518 . . . . 0.0 110.565 171.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.499 ' HD1' ' O ' ' E' ' 97' ' ' VAL . 26.8 m-85 -138.16 -170.45 2.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.5 t70 -141.11 143.14 34.14 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.63 0.728 . . . . 0.0 109.41 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.74 44.03 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.057 -163.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.67 48.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' E' ' 138' ' ' LEU . 23.2 t80 -133.59 155.06 50.33 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.404 -163.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . 0.779 ' HA2' HD12 ' E' ' 138' ' ' LEU . . . -173.45 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.911 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.649 ' HB3' HE22 ' E' ' 88' ' ' GLN . 5.1 m-85 -93.0 137.14 32.62 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 167.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.58 159.83 39.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.975 0.893 . . . . 0.0 111.166 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.9 136.5 42.4 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.033 -174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.416 HG21 ' HD1' ' E' ' 83' ' ' TYR . 2.8 mp -71.08 111.22 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.541 ' HG3' ' HA ' ' E' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.16 16.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.85 149.16 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.949 0.795 . . . . 0.0 109.091 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.528 HH11 ' HG3' ' E' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.88 53.99 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.601 ' HG2' HG22 ' D' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -177.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.62 42.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.113 0.482 . . . . 0.0 111.196 176.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . 0.647 ' HB2' ' HB2' ' E' ' 127' ' ' GLU . 1.0 OUTLIER -102.15 125.82 48.95 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.693 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 167.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.95 -175.31 22.18 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-O 121.696 0.609 . . . . 0.0 111.611 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' D' ' 33' ' ' THR . 15.1 t -77.19 -56.0 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 O-C-N 122.507 -0.407 . . . . 0.0 111.097 176.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.56 14.95 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . 0.559 ' HA2' ' HG ' ' J' ' 43' ' ' LEU . . . 90.41 153.51 28.89 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 166.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' D' ' 7' ' ' MET . . . -79.99 163.9 23.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.582 0.706 . . . . 0.0 110.742 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . . . . . . . . . 18.7 m -55.14 146.24 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.057 -171.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' E' ' 119' ' ' SER . 29.7 mp0 -127.18 129.69 48.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.107 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' E' ' 130' ' ' ILE . 26.4 mt -114.87 124.87 71.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.2 121.88 45.42 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.614 HG13 ' O ' ' E' ' 130' ' ' ILE . 12.7 pt -119.87 122.51 68.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.755 ' HA ' ' HG2' ' E' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.705 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.541 ' HA ' ' HG3' ' E' ' 114' ' ' GLU . 0.4 OUTLIER -142.9 163.22 33.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.083 -172.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.882 ' HA ' ' HA ' ' E' ' 62' ' ' SER . 1.8 pt20 -121.11 163.18 18.81 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.4 -1.334 . . . . 0.0 107.4 167.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.416 HG13 ' O ' ' E' ' 110' ' ' PHE . 4.1 t -121.69 128.38 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.56 HD13 HD22 ' D' ' 54' ' ' LEU . 6.9 pt -67.27 -51.33 54.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 121.284 0.564 . . . . 0.0 110.35 -173.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.454 ' H ' HG13 ' E' ' 135' ' ' ILE . . . -125.28 116.84 2.8 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.743 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.9 24.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 122.057 0.932 . . . . 0.0 110.693 174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.779 HD12 ' HA2' ' E' ' 109' ' ' GLY . 2.4 mt -127.87 151.92 48.48 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 130.67 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.99 150.75 19.0 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -67.79 151.62 52.15 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.375 169.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.415 ' HG2' HG11 ' E' ' 94' ' ' VAL . 2.8 tp10 -111.12 143.42 41.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.573 ' O ' ' HD2' ' E' ' 103' ' ' LYS . 1.7 mp -104.71 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.76 -176.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.91 20.81 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.953 -176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.784 HG21 HG21 ' E' ' 94' ' ' VAL . 12.7 p -109.51 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.38 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.54 17.5 Favored Pre-proline 0 C--N 1.346 0.439 0 C-N-CA 126.441 1.896 . . . . 0.0 109.386 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -69.07 -7.88 22.07 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.185 1.257 . . . . 0.0 115.362 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.27 66.46 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.608 171.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.87 -45.65 1.58 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' E' ' 145' ' ' THR . 17.3 mt -71.74 -45.19 67.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.141 0.882 . . . . 0.0 111.253 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 2.4 t -78.98 -39.93 22.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.08 121.14 28.26 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' J' ' 49' ' ' LYS . 13.7 p -104.19 110.33 30.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.72 37.48 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -172.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.501 ' HD3' ' CA ' ' K' ' 136' ' ' GLY . 6.9 mttt -74.68 -34.02 62.59 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.47 11.64 77.31 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 119.389 0.995 . . . . 0.0 113.065 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.84 117.65 4.78 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.93 112.21 24.02 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.307 1.043 . . . . 0.0 108.622 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.93 70.68 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -158.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.595 ' HA ' ' HH2' ' K' ' 92' ' ' TRP . 83.2 t80 -133.97 112.46 11.25 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 127.704 2.402 . . . . 0.0 109.17 167.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.578 ' HB3' ' HG3' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -141.72 45.06 1.71 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.584 ' HB3' ' HD3' ' E' ' 163' ' ' PRO . 22.9 tt0 -58.17 -53.78 62.47 Favored Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -166.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' E' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.66 6.35 Favored 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.017 1.756 . . . . 0.0 113.873 171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.74 42.4 99.74 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 118.398 2.119 . . . . 0.0 118.398 -171.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' E' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.48 95.89 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 118.872 1.336 . . . . 0.0 110.931 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.44 0.45 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.822 1.649 . . . . 0.0 111.887 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.767 ' HA ' HG22 ' E' ' 173' ' ' THR . 37.6 p -132.5 147.52 52.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.341 -167.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.514 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.34 -29.54 70.53 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.838 0.319 . . . . 0.0 111.405 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.18 156.12 60.22 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.213 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -80.71 97.74 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.315 1.343 . . . . 0.0 112.745 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.67 82.74 1.15 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.767 HG22 ' HA ' ' E' ' 167' ' ' THR . 11.2 t -108.55 153.43 23.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.001 0.9 . . . . 0.0 109.888 170.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.53 157.22 86.43 Favored Pre-proline 0 C--O 1.241 0.615 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.387 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.47 137.72 61.53 Favored 'Trans proline' 0 C--N 1.349 0.602 0 CA-C-N 119.548 0.874 . . . . 0.0 111.758 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.228 0 C-N-CA 125.419 1.487 . . . . 0.0 112.367 -171.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.537 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 N-CA-C 109.189 -1.12 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 126' ' ' VAL . 6.0 pt -61.5 127.92 22.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.577 ' HA ' ' HA ' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -89.02 -177.95 5.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.9 0.857 . . . . 0.0 110.721 -177.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -66.89 -31.68 78.84 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.486 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.45 62.13 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.756 0.778 . . . . 0.0 112.347 172.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' F' ' 96' ' ' THR . 4.8 t70 -66.27 -37.56 85.75 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.645 HG11 HH21 ' F' ' 93' ' ' ARG . 28.3 m -101.69 117.83 47.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' F' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.45 26.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.662 0.744 . . . . 0.0 110.488 176.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.69 7.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.726 -164.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' F' ' 25' ' ' ALA . 5.5 mp -87.0 141.26 28.8 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' F' ' 89' ' ' ILE . 18.9 m-85 -126.1 137.65 53.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.526 0.679 . . . . 0.0 109.974 176.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.644 ' HG2' ' HA ' ' F' ' 25' ' ' ALA . 1.3 tm0? -131.91 136.21 47.22 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.49 147.32 47.89 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.571 0.7 . . . . 0.0 111.015 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.633 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 2.0 pt -64.44 -47.07 90.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.955 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . 0.465 ' H ' HG13 ' F' ' 18' ' ' ILE . 2.0 p30 -85.85 -11.91 52.13 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.49 82.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.445 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.97 40.03 20.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.253 1.421 . . . . 0.0 111.789 -173.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.65 13.57 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.72 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.48 142.76 28.42 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.978 0.389 . . . . 0.0 111.809 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' F' ' 16' ' ' GLN . . . -100.14 122.66 49.6 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 126.936 2.094 . . . . 0.0 112.377 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' F' ' 15' ' ' PHE . 27.7 Cg_exo -70.41 127.21 13.77 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.418 0.828 . . . . 0.0 112.49 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.581 HD22 HG23 ' F' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.97 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.38 140.5 26.99 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.821 -2.351 . . . . 0.0 110.532 -167.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.86 169.93 21.2 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 CA-C-N 119.007 0.681 . . . . 0.0 112.481 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.1 48.56 12.81 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.385 1.474 . . . . 0.0 111.49 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' K' ' 48' ' ' THR . 2.9 m-85 -71.87 133.12 45.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.518 1.152 . . . . 0.0 111.036 173.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . 0.472 ' CG2' HG23 ' A' ' 122' ' ' VAL . 18.4 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.784 1.278 . . . . 0.0 111.06 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' F' ' 65' ' ' VAL . 5.2 t0 -159.12 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.023 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.99 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.387 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.42 108.92 17.87 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 173.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.518 HG22 ' HG2' ' A' ' 117' ' ' GLU . 57.3 t -107.14 126.1 63.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -173.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . 0.719 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 6.1 p -130.93 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.74 118.51 4.76 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.237 -178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.71 3.52 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.461 HH12 ' HG2' ' F' ' 42' ' ' GLU . 10.5 mmm180 -65.52 -179.49 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.682 0.754 . . . . 0.0 110.166 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . 0.461 ' HG2' HH12 ' F' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.48 27.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -167.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' F' ' 57' ' ' GLY . 0.0 OUTLIER -73.52 165.98 24.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.468 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . 0.47 ' HA ' HG12 ' F' ' 53' ' ' ILE . 5.4 t80 -108.88 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.202 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . 0.559 ' H ' HG21 ' F' ' 53' ' ' ILE . 26.4 t70 -110.65 100.14 8.98 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.636 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 10.1 pt-20 -68.8 -21.16 64.34 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.59 5.35 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.623 1.569 . . . . 0.0 111.702 -172.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.636 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 0.0 OUTLIER 50.42 48.87 21.73 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.492 1.517 . . . . 0.0 111.569 -164.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' F' ' 52' ' ' ARG . 6.4 tptt -116.51 -92.23 0.52 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.486 -177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -152.3 33.91 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' F' ' 46' ' ' GLU . . . 80.16 36.11 25.29 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.556 ' HG2' ' HG2' ' F' ' 49' ' ' LYS . 0.1 OUTLIER -102.61 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.559 HG21 ' H ' ' F' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.0 56.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.849 178.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.05 25.13 12.16 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.38 161.26 12.88 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 121.641 0.578 . . . . 0.0 113.961 -170.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . 0.493 ' O ' HD22 ' F' ' 43' ' ' LEU . 68.2 Cg_endo -80.08 160.14 23.71 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 N-CA-C 113.801 0.654 . . . . 0.0 113.801 -175.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' F' ' 43' ' ' LEU . . . -124.93 -70.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.4 170.17 21.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.554 0.693 . . . . 0.0 110.477 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.638 HG23 ' CG ' ' E' ' 50' ' ' ASN . 2.3 t -114.96 110.64 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.1 2.65 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.54 14.07 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -171.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . 0.855 ' HA ' ' HA ' ' F' ' 133' ' ' GLN . 92.6 p -142.73 163.39 32.93 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.941 0.896 . . . . 0.0 110.067 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' F' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.183 176.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.763 ' HG2' ' HA ' ' F' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.59 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.506 HG22 ' OD1' ' F' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.06 137.6 51.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.41 143.13 26.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.63 141.66 22.97 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 114.927 0.731 . . . . 0.0 114.927 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.616 ' H ' HE22 ' F' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 151.04 42.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . 0.498 HH11 ' HB ' ' E' ' 97' ' ' VAL . 0.0 OUTLIER -56.53 -37.18 70.12 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . 0.479 ' OD2' ' HD3' ' F' ' 70' ' ' LYS . 87.9 m-20 67.63 126.83 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.124 1.369 . . . . 0.0 111.011 169.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' F' ' 77' ' ' LYS . . . -85.26 -12.03 53.42 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -156.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.576 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -74.19 -47.05 19.04 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.832 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.616 HE22 ' H ' ' F' ' 70' ' ' LYS . 7.0 tt0 -67.0 -37.05 83.51 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.149 -0.618 . . . . 0.0 111.831 171.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' F' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.54 87.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.84 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.73 79.09 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.928 168.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.601 ' HB ' ' HA ' ' F' ' 76' ' ' GLN . 4.4 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 0.0 110.447 172.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.85 -41.48 64.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.757 -0.589 . . . . 0.0 112.456 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.2 87.35 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.575 169.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.69 86.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.542 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 5.3 t80 -62.23 -50.36 72.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.941 -174.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.47 -25.64 35.9 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -167.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.474 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 18.4 m120 -95.0 -0.34 53.9 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.035 172.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.03 75.6 Favored Glycine 0 N--CA 1.449 -0.46 0 O-C-N 122.31 -0.244 . . . . 0.0 112.835 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.474 ' HE2' ' OD1' ' F' ' 85' ' ' ASN . 15.2 mttm -70.74 142.91 51.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.64 HE22 ' HB3' ' F' ' 110' ' ' PHE . 0.0 OUTLIER -73.5 142.23 46.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' F' ' 15' ' ' PHE . 7.7 tt -118.76 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 121.326 0.584 . . . . 0.0 109.838 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.633 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 4.9 mtmp? -85.8 131.13 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.93 42.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.495 1.118 . . . . 0.0 109.951 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -124.28 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.209 1.003 . . . . 0.0 108.34 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.645 HH21 HG11 ' F' ' 11' ' ' VAL . 20.1 ttt180 -104.39 107.08 17.83 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.776 HG21 HG21 ' F' ' 145' ' ' THR . 2.4 m -122.31 152.39 26.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-O 122.29 1.043 . . . . 0.0 109.418 -173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' F' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.78 17.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.607 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.574 ' N ' ' O ' ' F' ' 10' ' ' ASP . 28.1 m -99.21 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.854 -1.067 . . . . 0.0 112.669 -176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . 0.666 ' HB ' HH11 ' A' ' 71' ' ' ARG . 2.6 m -69.06 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-O 121.709 0.766 . . . . 0.0 109.922 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.17 19.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.945 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.519 ' HB3' ' O ' ' F' ' 102' ' ' ASP . 16.7 t30 -73.26 157.57 36.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.809 0.814 . . . . 0.0 109.935 171.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.38 -19.08 23.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.14 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.928 169.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' F' ' 99' ' ' ASN . 0.8 OUTLIER -66.89 152.92 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 167.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' F' ' 143' ' ' ILE . 0.4 OUTLIER -51.71 -46.33 63.88 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.913 -0.492 . . . . 0.0 110.576 171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.477 ' HD1' ' O ' ' F' ' 97' ' ' VAL . 26.6 m-85 -138.15 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.809 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.5 t70 -141.09 143.17 34.18 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.656 0.741 . . . . 0.0 109.372 177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.14 140.68 43.83 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.048 -163.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.62 130.63 47.99 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 157.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.495 ' CE2' HD13 ' F' ' 138' ' ' LEU . 23.1 t80 -133.57 155.03 50.36 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.414 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . 0.801 ' HA2' HD12 ' F' ' 138' ' ' LEU . . . -173.44 170.59 43.74 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 119.434 -1.365 . . . . 0.0 111.906 170.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.64 ' HB3' HE22 ' F' ' 88' ' ' GLN . 5.1 m-85 -93.04 137.12 32.68 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.53 159.9 39.06 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.939 0.876 . . . . 0.0 111.183 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -134.92 136.53 42.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.497 -1.229 . . . . 0.0 107.995 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.417 HG21 ' HD1' ' F' ' 83' ' ' TYR . 2.8 mp -71.11 111.21 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.54 ' HG3' ' HA ' ' F' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 44.7 t -163.85 149.21 10.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.91 0.777 . . . . 0.0 109.082 174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.547 HH11 ' HG3' ' F' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.93 53.97 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.575 ' HG2' HG22 ' E' ' 37' ' ' VAL . 0.2 OUTLIER -135.17 120.25 18.74 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -177.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.05 120.6 42.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 111.162 176.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . 0.623 ' HB2' ' HB2' ' F' ' 127' ' ' GLU . 1.0 OUTLIER -102.11 125.83 48.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.681 177.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.49 114.87 21.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 167.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.35 22.19 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.24 -55.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.469 -0.43 . . . . 0.0 111.113 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 169.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' K' ' 43' ' ' LEU . . . 90.38 153.53 28.87 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 166.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' E' ' 7' ' ' MET . . . -80.0 163.91 23.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.579 0.704 . . . . 0.0 110.711 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.18 146.21 4.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.074 -171.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' F' ' 119' ' ' SER . 29.8 mp0 -127.11 129.73 48.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.128 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' F' ' 130' ' ' ILE . 26.5 mt -114.91 124.91 72.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.91 45.47 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 168.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' F' ' 130' ' ' ILE . 12.7 pt -119.86 122.43 68.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.763 ' HA ' ' HG2' ' F' ' 64' ' ' GLU . 0.8 OUTLIER -106.46 130.04 54.33 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.36 0.664 . . . . 0.0 109.74 -178.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' HG3' ' F' ' 114' ' ' GLU . 0.4 OUTLIER -142.87 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.139 -172.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.855 ' HA ' ' HA ' ' F' ' 62' ' ' SER . 1.8 pt20 -121.13 163.22 18.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' F' ' 110' ' ' PHE . 4.1 t -121.77 128.38 75.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.652 HD13 HD22 ' E' ' 54' ' ' LEU . 6.9 pt -67.25 -51.33 54.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 121.375 0.607 . . . . 0.0 110.377 -173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.446 ' H ' HG13 ' F' ' 135' ' ' ILE . . . -125.28 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.738 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.97 25.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.049 0.928 . . . . 0.0 110.604 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.801 HD12 ' HA2' ' F' ' 109' ' ' GLY . 2.4 mt -127.94 151.88 48.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.78 130.69 34.46 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.99 150.77 19.01 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.809 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -67.78 151.63 52.16 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.335 169.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.42 ' HG2' HG11 ' F' ' 94' ' ' VAL . 2.8 tp10 -111.17 143.4 41.97 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -174.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.575 ' O ' ' HD2' ' F' ' 103' ' ' LYS . 1.7 mp -104.72 -64.27 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.78 -176.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.85 113.87 20.77 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.985 -176.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.776 HG21 HG21 ' F' ' 94' ' ' VAL . 12.9 p -109.47 31.47 5.75 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.413 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.41 56.51 17.48 Favored Pre-proline 0 C--N 1.346 0.434 0 C-N-CA 126.428 1.891 . . . . 0.0 109.422 -173.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.436 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.12 -7.77 21.77 Favored 'Trans proline' 0 C--N 1.351 0.694 0 N-CA-C 115.356 1.252 . . . . 0.0 115.356 -159.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.37 -32.29 66.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.561 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.683 HD12 ' O ' ' F' ' 145' ' ' THR . 17.3 mt -71.74 -45.26 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.131 0.878 . . . . 0.0 111.231 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 2.4 t -78.91 -39.92 22.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.04 121.14 28.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.46 -176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . 0.587 HG22 ' HD3' ' K' ' 49' ' ' LYS . 13.6 p -104.24 110.38 30.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . 0.411 ' C ' ' NZ ' ' K' ' 49' ' ' LYS . 5.4 p -109.54 144.72 37.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.467 ' HD3' ' HA2' ' L' ' 136' ' ' GLY . 6.8 mttt -74.64 -34.09 62.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 175.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.48 11.7 77.15 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 119.389 0.995 . . . . 0.0 113.001 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.658 ' HA3' HD21 ' L' ' 138' ' ' LEU . . . -77.86 117.77 4.81 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.14 23.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.59 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.75 ' HB3' ' HB3' ' L' ' 140' ' ' ASN . 0.2 OUTLIER -70.43 -32.95 70.75 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -158.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.884 ' CD2' ' OE1' ' L' ' 142' ' ' GLU . 83.3 t80 -133.96 112.49 11.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.661 2.384 . . . . 0.0 109.149 167.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.764 ' H ' ' HH2' ' L' ' 92' ' ' TRP . 0.0 OUTLIER -141.69 45.03 1.71 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 154.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.578 ' HA ' ' CZ2' ' L' ' 92' ' ' TRP . 22.9 tt0 -58.14 -53.76 62.6 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' F' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.65 6.31 Favored 'Trans proline' 0 C--O 1.239 0.554 0 CA-C-N 122.063 1.772 . . . . 0.0 113.918 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.421 ' H ' ' HA2' ' L' ' 23' ' ' GLY . . . 61.73 42.43 99.75 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 118.409 2.123 . . . . 0.0 118.409 -171.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.685 ' OE1' ' HZ2' ' L' ' 92' ' ' TRP . 1.3 tt0 -60.34 -42.52 95.86 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 118.886 1.343 . . . . 0.0 110.923 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.577 HG23 ' HB2' ' L' ' 21' ' ' ALA . 3.2 m 48.22 70.49 0.44 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.807 1.643 . . . . 0.0 111.938 176.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.781 ' HA ' HG22 ' F' ' 173' ' ' THR . 37.8 p -132.49 147.48 52.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.306 -167.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.02 -167.64 42.61 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.513 172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.653 ' OE1' ' HG3' ' L' ' 88' ' ' GLN . 0.0 OUTLIER -62.32 -29.51 70.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.776 0.288 . . . . 0.0 111.445 -177.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.13 156.15 60.33 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.527 0.731 . . . . 0.0 109.274 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.78 97.79 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 121.304 1.336 . . . . 0.0 112.672 -156.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.59 82.75 1.14 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 117.201 1.641 . . . . 0.0 117.201 165.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.781 HG22 ' HA ' ' F' ' 167' ' ' THR . 11.3 t -108.43 153.39 23.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.986 0.893 . . . . 0.0 109.891 170.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.52 157.18 86.49 Favored Pre-proline 0 C--O 1.241 0.61 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.387 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.5 137.73 61.37 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.503 0.858 . . . . 0.0 111.72 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.45 1.5 . . . . 0.0 112.294 -171.719 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 50.6 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 109.249 -1.096 . . . . 0.0 109.249 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.537 ' O ' HG22 ' H' ' 126' ' ' VAL . 6.0 pt -61.45 127.86 21.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' H' ' 125' ' ' ALA . 0.0 OUTLIER -88.99 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.952 0.882 . . . . 0.0 110.727 -177.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.92 -31.62 78.63 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.471 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.8 -18.4 62.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.82 0.81 . . . . 0.0 112.374 172.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' G' ' 96' ' ' THR . 4.8 t70 -66.22 -37.63 86.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.634 HG11 HH21 ' G' ' 93' ' ' ARG . 28.1 m -101.62 117.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' G' ' 12' ' ' LYS . 0.0 OUTLIER -117.82 157.46 26.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.696 0.76 . . . . 0.0 110.484 176.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.22 98.61 7.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.781 -164.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -86.96 141.27 28.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.5 ' HB3' HD11 ' G' ' 89' ' ' ILE . 19.0 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.463 0.649 . . . . 0.0 109.96 176.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' G' ' 25' ' ' ALA . 1.3 tm0? -131.94 136.27 47.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 147.29 47.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.039 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.652 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 2.0 pt -64.47 -46.99 91.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.989 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . 0.475 ' H ' HG13 ' G' ' 18' ' ' ILE . 2.0 p30 -85.88 -11.83 52.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -37.53 82.61 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.402 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.0 40.03 20.28 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.218 1.407 . . . . 0.0 111.772 -173.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.07 163.68 13.55 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.91 4.89 68.64 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.248 -0.433 . . . . 0.0 113.712 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.77 28.42 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.008 0.404 . . . . 0.0 111.802 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.638 ' HA ' ' HG2' ' G' ' 16' ' ' GLN . . . -100.13 122.64 49.71 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 126.965 2.106 . . . . 0.0 112.423 -174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' G' ' 15' ' ' PHE . 27.7 Cg_exo -70.43 127.21 13.75 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.421 0.829 . . . . 0.0 112.479 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.58 HD22 HG23 ' G' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.95 52.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 168.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.5 27.03 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 115.85 -2.34 . . . . 0.0 110.543 -167.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.93 169.94 21.15 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 CA-C-O 121.86 0.692 . . . . 0.0 112.423 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.09 48.54 12.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.371 1.468 . . . . 0.0 111.54 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . 0.42 ' HE1' ' HG ' ' G' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.13 45.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 122.532 1.158 . . . . 0.0 111.047 173.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.25 -111.04 0.13 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.39 174.23 6.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.8 1.286 . . . . 0.0 111.071 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' G' ' 65' ' ' VAL . 5.2 t0 -159.12 129.52 5.86 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.003 -164.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.02 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.331 170.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.47 108.96 17.91 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.597 HG22 ' HG2' ' H' ' 117' ' ' GLU . 57.6 t -107.2 126.05 63.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . 0.648 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 6.0 p -130.83 80.49 1.95 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.7 118.48 4.75 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.263 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.08 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.473 HH12 ' HG2' ' G' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.756 0.788 . . . . 0.0 110.13 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . 0.473 ' HG2' HH12 ' G' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.49 27.33 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.799 HD13 ' HA2' ' G' ' 57' ' ' GLY . 0.0 OUTLIER -73.45 165.94 24.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.502 -179.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . 0.472 ' HA ' HG12 ' G' ' 53' ' ' ILE . 5.4 t80 -108.83 85.01 2.02 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.265 171.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . 0.555 ' H ' HG21 ' G' ' 53' ' ' ILE . 26.4 t70 -110.62 100.06 8.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 155.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 10.2 pt-20 -68.68 -21.27 64.44 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.58 5.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.596 1.558 . . . . 0.0 111.667 -172.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.639 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 0.0 OUTLIER 50.38 48.91 21.62 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 111.611 -164.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . 0.562 ' HG2' ' HG2' ' G' ' 52' ' ' ARG . 6.4 tptt -116.55 -92.25 0.52 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.444 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.3 33.96 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' G' ' 46' ' ' GLU . . . 80.18 36.17 25.08 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' G' ' 49' ' ' LYS . 0.1 OUTLIER -102.71 116.3 32.31 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.555 HG21 ' H ' ' G' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 136.01 56.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.888 178.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.07 25.15 12.14 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.32 12.86 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-O 121.681 0.6 . . . . 0.0 113.93 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . 0.494 ' O ' HD22 ' G' ' 43' ' ' LEU . 68.6 Cg_endo -80.08 160.07 23.72 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . 0.799 ' HA2' HD13 ' G' ' 43' ' ' LEU . . . -124.85 -70.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.44 170.17 21.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 0.0 110.508 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.91 110.64 32.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.065 -177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.03 83.07 2.64 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.72 104.59 14.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . 0.854 ' HA ' ' HA ' ' G' ' 133' ' ' GLN . 92.3 p -142.78 163.35 33.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.98 0.912 . . . . 0.0 110.05 -178.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG ' ' G' ' 132' ' ' LEU . . . -146.96 155.73 26.68 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.175 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' G' ' 131' ' ' SER . 0.0 OUTLIER -122.72 141.58 51.63 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' G' ' 34' ' ' ASP . 85.9 t -129.25 125.19 61.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.67 51.09 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.45 167.85 24.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.33 143.15 26.93 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -80.7 141.71 22.95 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 114.884 0.714 . . . . 0.0 114.884 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.624 ' H ' HE22 ' G' ' 76' ' ' GLN . 0.4 OUTLIER -123.07 151.06 42.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.421 0.629 . . . . 0.0 109.323 174.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . 0.705 HH11 ' HB ' ' L' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.17 70.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -172.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.22 -123.12 2.88 Favored Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' G' ' 70' ' ' LYS . 87.8 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.129 1.371 . . . . 0.0 111.02 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' G' ' 77' ' ' LYS . . . -85.32 -12.12 53.05 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -156.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.578 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -74.16 -47.01 19.38 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.836 168.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.624 HE22 ' H ' ' G' ' 70' ' ' LYS . 7.0 tt0 -67.03 -37.07 83.47 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.121 -0.635 . . . . 0.0 111.798 171.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.528 ' HB2' ' HA ' ' G' ' 74' ' ' ALA . 1.6 mtmt -66.44 -38.55 87.64 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.789 171.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.12 -34.73 79.1 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.929 168.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.608 ' HB ' ' HA ' ' G' ' 76' ' ' GLN . 4.3 mm -59.59 -48.68 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.1 0.476 . . . . 0.0 110.456 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.9 -41.4 64.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.729 -0.607 . . . . 0.0 112.489 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.63 -46.18 87.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 119.954 -0.699 . . . . 0.0 111.55 169.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.43 -45.75 86.17 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.145 -1.022 . . . . 0.0 111.589 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 5.3 t80 -62.28 -50.3 72.22 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.978 -174.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.432 ' HG2' ' NZ ' ' L' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.07 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -167.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 18.5 m120 -94.97 -0.41 53.89 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.016 172.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.0 75.55 Favored Glycine 0 N--CA 1.448 -0.506 0 O-C-N 122.315 -0.241 . . . . 0.0 112.858 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' G' ' 85' ' ' ASN . 15.1 mttm -70.66 142.98 51.55 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.646 HE22 ' HB3' ' G' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.21 46.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.5 HD11 ' HB3' ' G' ' 15' ' ' PHE . 7.7 tt -118.77 139.44 46.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.342 0.591 . . . . 0.0 109.848 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 4.9 mtmp? -85.82 131.12 34.37 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.98 122.95 42.32 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.485 1.114 . . . . 0.0 109.984 -165.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.527 ' HH2' ' HA ' ' A' ' 160' ' ' PHE . 56.1 m95 -124.29 115.15 20.56 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.21 1.004 . . . . 0.0 108.304 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.634 HH21 HG11 ' G' ' 11' ' ' VAL . 20.1 ttt180 -104.43 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.774 HG21 HG21 ' G' ' 145' ' ' THR . 2.4 m -122.29 152.38 26.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.234 1.016 . . . . 0.0 109.408 -173.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' G' ' 11' ' ' VAL . 1.0 OUTLIER -87.2 162.77 17.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.635 179.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.578 ' N ' ' O ' ' G' ' 10' ' ' ASP . 28.0 m -99.18 -25.06 14.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.891 -1.049 . . . . 0.0 112.665 -176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . 0.649 ' HB ' HH11 ' H' ' 71' ' ' ARG . 2.6 m -69.04 165.25 2.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.708 0.766 . . . . 0.0 109.937 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.7 108.21 20.01 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.992 -174.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.521 ' HB3' ' O ' ' G' ' 102' ' ' ASP . 16.6 t30 -73.23 157.6 36.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.838 0.828 . . . . 0.0 109.962 171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.4 -19.08 23.27 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 114.079 1.141 . . . . 0.0 114.079 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -90.11 -83.5 0.25 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.767 0.712 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' G' ' 99' ' ' ASN . 0.8 OUTLIER -66.79 152.88 44.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 167.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' G' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.29 63.93 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.841 -0.537 . . . . 0.0 110.594 171.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.489 ' HD1' ' O ' ' G' ' 97' ' ' VAL . 26.5 m-85 -138.17 -170.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.802 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.5 t70 -141.03 143.12 34.22 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.606 0.717 . . . . 0.0 109.435 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.04 140.71 44.04 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.062 -163.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.73 130.71 48.19 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' G' ' 138' ' ' LEU . 23.1 t80 -133.57 155.05 50.33 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.367 0.667 . . . . 0.0 110.371 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . 0.784 ' HA2' HD12 ' G' ' 138' ' ' LEU . . . -173.47 170.59 43.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.509 -1.329 . . . . 0.0 111.96 170.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.646 ' HB3' HE22 ' G' ' 88' ' ' GLN . 5.1 m-85 -93.01 137.18 32.6 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.58 -1.266 . . . . 0.0 107.58 167.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.63 159.83 39.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.9 0.857 . . . . 0.0 111.159 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.87 136.49 42.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.021 -174.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' G' ' 83' ' ' TYR . 2.8 mp -71.09 111.21 4.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' G' ' 132' ' ' LEU . 18.9 mt-10 -91.06 -30.09 16.96 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 44.9 t -163.86 149.18 10.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.975 0.807 . . . . 0.0 109.077 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.54 ' HG3' HH11 ' G' ' 116' ' ' ARG . 1.4 tmm_? -121.11 138.91 53.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.596 ' HG2' HG22 ' L' ' 37' ' ' VAL . 0.2 OUTLIER -135.14 120.26 18.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.66 42.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.101 0.477 . . . . 0.0 111.215 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . 0.643 ' HB2' ' HB2' ' G' ' 127' ' ' GLU . 1.0 OUTLIER -102.18 125.84 48.99 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.676 177.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.9 21.31 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 167.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.34 22.16 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-O 121.718 0.621 . . . . 0.0 111.584 174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.16 -55.9 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 O-C-N 122.482 -0.422 . . . . 0.0 111.145 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.37 159.57 14.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.39 153.56 28.93 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.884 -1.687 . . . . 0.0 108.884 166.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' L' ' 7' ' ' MET . . . -79.99 163.97 23.83 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.599 0.714 . . . . 0.0 110.719 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.548 HG13 ' O ' ' L' ' 7' ' ' MET . 18.6 m -55.22 146.25 4.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.045 -171.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' G' ' 119' ' ' SER . 29.8 mp0 -127.2 129.68 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.087 -176.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . 0.473 HG22 HG23 ' G' ' 130' ' ' ILE . 26.7 mt -114.84 124.87 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.21 121.86 45.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.624 ' O ' HG13 ' G' ' 130' ' ' ILE . 12.7 pt -119.78 122.45 68.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' G' ' 64' ' ' GLU . 0.8 OUTLIER -106.48 130.05 54.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.756 -178.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' G' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.24 33.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.069 -172.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.854 ' HA ' ' HA ' ' G' ' 62' ' ' SER . 1.8 pt20 -121.13 163.17 18.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' G' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.456 HD13 HD22 ' L' ' 54' ' ' LEU . 6.9 pt -67.26 -51.35 54.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -173.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 155' ' ' LYS . . . -125.31 116.86 2.8 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.694 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.5 123.97 24.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.034 0.921 . . . . 0.0 110.684 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.784 HD12 ' HA2' ' G' ' 109' ' ' GLY . 2.4 mt -127.9 151.84 48.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 130.72 34.46 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -160.01 150.78 18.99 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -67.8 151.57 52.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.183 -1.008 . . . . 0.0 111.382 169.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' G' ' 94' ' ' VAL . 2.8 tp10 -111.13 143.49 41.79 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.576 ' O ' ' HD2' ' G' ' 103' ' ' LYS . 1.7 mp -104.74 -64.25 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.751 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.87 113.89 20.79 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.944 -176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.774 HG21 HG21 ' G' ' 94' ' ' VAL . 12.8 p -109.55 31.52 5.72 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.385 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.37 56.62 17.54 Favored Pre-proline 0 C--N 1.346 0.442 0 C-N-CA 126.471 1.908 . . . . 0.0 109.328 -173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.18 -7.84 21.99 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.225 1.283 . . . . 0.0 115.314 -159.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.29 -32.31 66.5 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.586 171.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.83 -45.68 1.59 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' G' ' 145' ' ' THR . 17.5 mt -71.79 -45.11 67.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.147 0.885 . . . . 0.0 111.278 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 2.4 t -78.98 -39.98 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.03 121.1 28.17 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.474 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 13.5 p -104.23 110.34 30.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 171.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.49 144.8 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.71 -34.09 62.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.54 11.68 77.03 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.386 0.994 . . . . 0.0 112.996 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.76 4.8 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.96 112.2 24.0 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.331 1.053 . . . . 0.0 108.638 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.94 70.66 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -134.01 112.41 11.18 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.687 2.395 . . . . 0.0 109.165 167.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.57 ' HB3' ' HG3' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -141.69 45.1 1.71 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . 0.572 ' HB3' ' HD3' ' G' ' 163' ' ' PRO . 22.9 tt0 -58.13 -53.83 61.95 Favored Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -166.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' G' ' 162' ' ' GLN . 22.3 Cg_exo -82.68 131.71 6.37 Favored 'Trans proline' 0 C--O 1.239 0.544 0 CA-C-N 122.079 1.778 . . . . 0.0 113.855 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.47 99.76 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 118.356 2.103 . . . . 0.0 118.356 -171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' G' ' 161' ' ' GLN . 1.3 tt0 -60.44 -42.45 96.15 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 118.861 1.33 . . . . 0.0 110.909 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.28 70.46 0.44 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 111.891 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.784 ' HA ' HG22 ' G' ' 173' ' ' THR . 37.6 p -132.55 147.52 52.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.285 -167.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.57 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.516 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.53 70.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.799 0.299 . . . . 0.0 111.437 -177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.505 0.722 . . . . 0.0 109.273 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.71 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.313 1.342 . . . . 0.0 112.739 -156.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.76 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 165.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.784 HG22 ' HA ' ' G' ' 167' ' ' THR . 11.2 t -108.51 153.4 23.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.985 0.892 . . . . 0.0 109.893 170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.5 157.17 86.53 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.414 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.45 137.69 61.46 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.502 0.858 . . . . 0.0 111.706 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.46 1.504 . . . . 0.0 112.309 -171.721 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.492 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.172 0 N-CA-C 109.21 -1.112 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.542 ' O ' HG22 ' I' ' 126' ' ' VAL . 6.0 pt -61.46 127.92 22.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.573 ' O ' HG13 ' I' ' 126' ' ' VAL . 0.0 OUTLIER -88.98 -177.95 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.915 0.864 . . . . 0.0 110.761 -177.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.68 78.84 Favored Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.514 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.75 -18.37 62.13 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 117.742 0.771 . . . . 0.0 112.425 172.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' H' ' 96' ' ' THR . 4.8 t70 -66.2 -37.64 86.06 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.643 HG11 HH21 ' H' ' 93' ' ' ARG . 28.1 m -101.63 117.79 47.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' H' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.39 26.65 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.669 0.747 . . . . 0.0 110.52 176.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -114.12 98.69 7.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.721 -164.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.04 141.3 28.76 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 174.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.494 ' HB3' HD11 ' H' ' 89' ' ' ILE . 19.0 m-85 -126.08 137.66 53.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.452 0.644 . . . . 0.0 109.967 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.651 ' HG2' ' HA ' ' H' ' 25' ' ' ALA . 1.3 tm0? -131.9 136.24 47.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.62 147.32 47.67 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.524 0.678 . . . . 0.0 110.996 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 2.0 pt -64.46 -47.02 91.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.989 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . 0.471 ' H ' HG13 ' H' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.86 52.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -172.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.46 82.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.413 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.93 40.05 20.05 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.229 1.412 . . . . 0.0 111.769 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.05 163.65 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.88 4.91 68.74 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.726 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.74 28.36 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.997 0.399 . . . . 0.0 111.761 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' H' ' 16' ' ' GLN . . . -100.13 122.59 49.89 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.956 2.102 . . . . 0.0 112.438 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' H' ' 15' ' ' PHE . 27.8 Cg_exo -70.42 127.23 13.79 Favored 'Trans proline' 0 C--N 1.349 0.566 0 CA-C-N 119.413 0.826 . . . . 0.0 112.45 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.572 HD22 HG23 ' H' ' 150' ' ' ILE . 0.8 OUTLIER -106.53 126.93 52.88 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.33 140.49 27.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 C-N-CA 115.829 -2.349 . . . . 0.0 110.553 -167.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.89 169.93 21.17 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 CA-C-O 121.883 0.701 . . . . 0.0 112.414 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.06 48.55 12.94 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.322 1.449 . . . . 0.0 111.566 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . 0.429 ' HE1' ' HG ' ' H' ' 27' ' ' LEU . 2.9 m-85 -71.84 133.07 45.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.538 1.161 . . . . 0.0 111.036 173.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.19 -111.15 0.13 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 18.3 p -121.33 174.19 6.88 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.791 1.281 . . . . 0.0 111.107 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.515 ' OD1' HG22 ' H' ' 65' ' ' VAL . 5.2 t0 -159.13 129.52 5.85 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.988 -164.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.03 131.62 7.56 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.323 170.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.44 108.98 17.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' I' ' 117' ' ' GLU . 57.9 t -107.25 126.1 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -173.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 6.1 p -130.81 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.77 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.232 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.11 90.67 3.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.471 HH12 ' HG2' ' H' ' 42' ' ' GLU . 10.5 mmm180 -65.47 -179.51 0.64 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.69 0.757 . . . . 0.0 110.165 -174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . 0.471 ' HG2' HH12 ' H' ' 41' ' ' ARG . 0.0 OUTLIER -146.35 141.47 27.27 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -167.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.81 HD13 ' HA2' ' H' ' 57' ' ' GLY . 0.0 OUTLIER -73.45 166.0 24.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.489 -179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' H' ' 53' ' ' ILE . 5.3 t80 -108.83 84.97 2.01 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.264 171.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . 0.549 ' H ' HG21 ' H' ' 53' ' ' ILE . 26.4 t70 -110.63 100.15 8.99 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 155.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.648 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 10.2 pt-20 -68.76 -21.21 64.38 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.21 26.6 5.4 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.64 1.576 . . . . 0.0 111.715 -172.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.648 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 0.0 OUTLIER 50.41 48.92 21.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.495 1.518 . . . . 0.0 111.561 -164.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' H' ' 52' ' ' ARG . 6.3 tptt -116.56 -92.23 0.52 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.467 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.27 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' H' ' 46' ' ' GLU . . . 80.16 36.1 25.33 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.546 ' HG2' ' HG2' ' H' ' 49' ' ' LYS . 0.1 OUTLIER -102.63 116.28 32.27 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.549 HG21 ' H ' ' H' ' 45' ' ' ASP . 0.3 OUTLIER -132.85 136.02 56.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.86 178.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.12 25.22 12.06 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.46 161.25 12.9 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-O 121.651 0.584 . . . . 0.0 113.953 -170.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' H' ' 43' ' ' LEU . 68.7 Cg_endo -80.08 160.05 23.73 Favored 'Trans proline' 0 CA--C 1.516 -0.415 0 N-CA-C 113.806 0.656 . . . . 0.0 113.806 -175.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . 0.81 ' HA2' HD13 ' H' ' 43' ' ' LEU . . . -124.79 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.44 170.18 21.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.544 0.687 . . . . 0.0 110.519 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.89 110.64 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.061 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 83.14 2.65 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.8 104.57 14.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -171.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' H' ' 133' ' ' GLN . 92.6 p -142.73 163.42 32.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.946 0.899 . . . . 0.0 110.093 -178.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HG ' ' H' ' 132' ' ' LEU . . . -147.04 155.66 26.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.166 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.756 ' HG2' ' HA ' ' H' ' 131' ' ' SER . 0.0 OUTLIER -122.67 141.69 51.48 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.515 HG22 ' OD1' ' H' ' 34' ' ' ASP . 86.5 t -129.32 125.11 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.02 137.59 51.17 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -148.43 167.86 24.18 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.35 143.11 26.97 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -80.68 141.65 22.92 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 114.933 0.733 . . . . 0.0 114.933 -175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.617 ' H ' HE22 ' H' ' 76' ' ' GLN . 0.4 OUTLIER -123.01 151.07 42.24 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.46 0.648 . . . . 0.0 109.29 174.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . 0.649 HH11 ' HB ' ' G' ' 97' ' ' VAL . 0.0 OUTLIER -56.51 -37.19 70.08 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.17 -123.05 2.87 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' H' ' 70' ' ' LYS . 87.7 m-20 67.51 126.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.092 1.357 . . . . 0.0 111.059 169.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' H' ' 77' ' ' LYS . . . -85.35 -12.02 53.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.577 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -74.22 -47.04 18.93 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.796 168.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.617 HE22 ' H ' ' H' ' 70' ' ' LYS . 7.0 tt0 -66.94 -37.06 83.61 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.123 -0.634 . . . . 0.0 111.884 171.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' H' ' 74' ' ' ALA . 1.6 mtmt -66.51 -38.49 87.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.761 171.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.81 79.27 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.892 168.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' H' ' 76' ' ' GLN . 4.4 mm -59.56 -48.66 86.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.048 0.452 . . . . 0.0 110.446 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.88 -41.43 64.7 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.738 -0.601 . . . . 0.0 112.423 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.63 -46.19 87.62 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.543 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.67 86.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.589 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.648 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 5.3 t80 -62.36 -50.3 72.15 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.9 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -25.61 36.02 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -167.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.466 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 18.4 m120 -95.01 -0.42 53.81 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.047 172.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.99 75.5 Favored Glycine 0 N--CA 1.449 -0.472 0 O-C-N 122.282 -0.261 . . . . 0.0 112.839 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.466 ' HE2' ' OD1' ' H' ' 85' ' ' ASN . 15.2 mttm -70.72 142.96 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.642 HE22 ' HB3' ' H' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.19 46.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' H' ' 15' ' ' PHE . 7.7 tt -118.75 139.47 45.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 121.367 0.603 . . . . 0.0 109.89 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 4.9 mtmp? -85.76 131.15 34.38 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.9 42.16 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.505 1.122 . . . . 0.0 110.03 -166.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.555 ' HH2' ' HA ' ' B' ' 160' ' ' PHE . 55.6 m95 -124.2 115.12 20.58 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.24 1.016 . . . . 0.0 108.347 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.643 HH21 HG11 ' H' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.13 17.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.762 HG21 HG21 ' H' ' 145' ' ' THR . 2.5 m -122.32 152.43 26.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 122.291 1.043 . . . . 0.0 109.414 -173.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' H' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.75 17.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.613 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.575 ' N ' ' O ' ' H' ' 10' ' ' ASP . 28.0 m -99.16 -25.04 14.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.679 -176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . 0.731 ' HB ' HH11 ' I' ' 71' ' ' ARG . 2.6 m -69.09 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.648 0.737 . . . . 0.0 109.965 176.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.68 108.22 20.04 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 -174.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' H' ' 102' ' ' ASP . 16.6 t30 -73.3 157.59 36.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.838 0.827 . . . . 0.0 109.958 171.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.33 -19.16 23.24 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.15 -83.52 0.25 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.751 0.705 . . . . 0.0 110.871 169.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' H' ' 99' ' ' ASN . 0.8 OUTLIER -66.77 152.95 44.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 167.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' H' ' 143' ' ' ILE . 0.4 OUTLIER -51.8 -46.27 64.19 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.894 -0.504 . . . . 0.0 110.577 171.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' H' ' 97' ' ' VAL . 26.5 m-85 -138.18 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.788 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.5 t70 -141.11 143.12 34.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.638 0.732 . . . . 0.0 109.408 177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.1 140.69 43.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.05 -163.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -101.68 130.66 48.09 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' H' ' 138' ' ' LEU . 23.1 t80 -133.54 155.04 50.31 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.449 0.7 . . . . 0.0 110.426 -163.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' H' ' 138' ' ' LEU . . . -173.5 170.58 43.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.495 -1.336 . . . . 0.0 111.954 170.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.642 ' HB3' HE22 ' H' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.18 32.59 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.65 159.89 39.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.937 0.875 . . . . 0.0 111.172 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.94 136.51 42.33 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.47 -1.241 . . . . 0.0 107.988 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.423 HG21 ' HD1' ' H' ' 83' ' ' TYR . 2.8 mp -71.1 111.2 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.542 ' HG3' ' HA ' ' H' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.14 16.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.84 149.15 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.92 0.782 . . . . 0.0 109.119 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.546 ' HG3' HH11 ' H' ' 116' ' ' ARG . 1.4 tmm_? -121.1 138.88 53.98 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' G' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.28 18.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -177.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.63 42.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 111.184 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . 0.641 ' HB2' ' HB2' ' H' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.87 48.97 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.693 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.5 114.88 21.29 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 167.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.99 -175.35 22.15 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.19 -55.91 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.462 -0.434 . . . . 0.0 111.113 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.34 159.53 14.96 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 169.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.53 28.92 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' G' ' 7' ' ' MET . . . -79.97 163.96 23.85 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.649 0.738 . . . . 0.0 110.727 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.575 HG13 ' O ' ' G' ' 7' ' ' MET . 18.6 m -55.19 146.22 4.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.055 -171.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' H' ' 119' ' ' SER . 29.7 mp0 -127.16 129.73 48.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.076 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . 0.468 HG22 HG23 ' H' ' 130' ' ' ILE . 26.5 mt -114.87 124.94 72.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.24 121.84 45.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 168.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.613 ' O ' HG13 ' H' ' 130' ' ' ILE . 12.7 pt -119.76 122.44 68.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.756 ' HA ' ' HG2' ' H' ' 64' ' ' GLU . 0.8 OUTLIER -106.52 130.01 54.37 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.35 0.66 . . . . 0.0 109.711 -178.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.542 ' HA ' ' HG3' ' H' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.13 -172.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.85 ' HA ' ' HA ' ' H' ' 62' ' ' SER . 1.8 pt20 -121.12 163.23 18.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 167.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.412 HG13 ' O ' ' H' ' 110' ' ' PHE . 4.1 t -121.73 128.39 75.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.442 HG13 ' H ' ' H' ' 136' ' ' GLY . 6.9 pt -67.26 -51.34 54.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -173.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.491 ' CA ' ' HD3' ' B' ' 155' ' ' LYS . . . -125.3 116.85 2.79 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.743 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.51 123.92 24.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.003 0.906 . . . . 0.0 110.672 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' H' ' 109' ' ' GLY . 2.4 mt -127.87 151.87 48.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.81 130.69 34.37 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -159.97 150.84 19.1 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.788 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -67.85 151.65 52.13 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.379 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' H' ' 94' ' ' VAL . 2.9 tp10 -111.2 143.42 41.98 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.579 ' O ' ' HD2' ' H' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.739 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.82 113.88 20.8 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.985 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.762 HG21 HG21 ' H' ' 94' ' ' VAL . 12.7 p -109.53 31.57 5.68 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.349 175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.461 1.904 . . . . 0.0 109.361 -173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.439 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.6 Cg_exo -69.12 -7.82 21.91 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.21 1.273 . . . . 0.0 115.372 -159.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -32.24 66.56 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.612 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.8 -45.68 1.59 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.676 HD12 ' O ' ' H' ' 145' ' ' THR . 17.3 mt -71.69 -45.26 67.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.151 0.887 . . . . 0.0 111.281 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 2.4 t -78.93 -39.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.07 121.16 28.28 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.479 -176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.27 110.39 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.58 144.72 37.5 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.7 -33.99 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.68 77.29 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 119.402 1.001 . . . . 0.0 113.041 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.74 4.79 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.16 23.97 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.34 1.056 . . . . 0.0 108.646 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.96 70.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -158.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.95 112.37 11.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.742 2.417 . . . . 0.0 109.19 167.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.588 ' HB3' ' HG3' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -141.65 44.98 1.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 154.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . 0.588 ' HB3' ' HD3' ' H' ' 163' ' ' PRO . 22.8 tt0 -58.12 -53.68 63.48 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' H' ' 162' ' ' GLN . 22.3 Cg_exo -82.77 131.64 6.25 Favored 'Trans proline' 0 C--O 1.239 0.55 0 CA-C-N 122.073 1.776 . . . . 0.0 113.878 171.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.69 42.54 99.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.367 2.107 . . . . 0.0 118.367 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.588 ' HG3' ' HB3' ' H' ' 161' ' ' GLN . 1.3 tt0 -60.42 -42.48 96.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.898 1.349 . . . . 0.0 110.94 175.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.27 70.47 0.44 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.841 1.656 . . . . 0.0 111.88 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.788 ' HA ' HG22 ' H' ' 173' ' ' THR . 37.7 p -132.47 147.51 52.37 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.29 -167.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.01 -167.63 42.58 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.487 172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -29.56 70.53 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.768 0.284 . . . . 0.0 111.421 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.14 156.16 60.3 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 123.436 0.694 . . . . 0.0 109.252 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.75 97.8 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.731 0 C-N-CA 121.316 1.344 . . . . 0.0 112.755 -156.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.58 82.8 1.14 Allowed Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.788 HG22 ' HA ' ' H' ' 167' ' ' THR . 11.2 t -108.56 153.43 23.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.965 0.883 . . . . 0.0 109.847 170.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.51 157.18 86.51 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.405 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.68 61.35 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.509 0.861 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.306 0 C-N-CA 125.412 1.485 . . . . 0.0 112.277 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.594 ' HB3' ' HE3' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.116 0 N-CA-C 109.156 -1.132 . . . . 0.0 109.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 pt -61.51 127.91 22.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.51 ' HA ' ' HA ' ' J' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.93 5.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.949 0.88 . . . . 0.0 110.716 -177.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' J' ' 125' ' ' ALA . . . -66.88 -31.66 78.82 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.356 -0.838 . . . . 0.0 114.501 175.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.43 62.15 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.738 0.769 . . . . 0.0 112.417 172.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' I' ' 96' ' ' THR . 4.8 t70 -66.17 -37.7 86.26 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 113.988 1.106 . . . . 0.0 113.988 -171.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.633 HG11 HH21 ' I' ' 93' ' ' ARG . 28.4 m -101.66 117.81 47.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' I' ' 12' ' ' LYS . 0.0 OUTLIER -117.78 157.46 26.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.634 0.731 . . . . 0.0 110.535 176.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -114.2 98.63 7.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.743 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.02 141.3 28.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' I' ' 89' ' ' ILE . 18.8 m-85 -126.06 137.64 53.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.47 0.652 . . . . 0.0 109.978 176.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' I' ' 25' ' ' ALA . 1.3 tm0? -131.96 136.23 47.17 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.52 147.3 47.87 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.028 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.643 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 2.0 pt -64.43 -47.04 91.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . 0.474 ' H ' HG13 ' I' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.89 52.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -171.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.53 82.48 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.04 19.84 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.181 1.392 . . . . 0.0 111.846 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 163.69 13.56 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.95 4.93 68.51 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.706 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.51 142.81 28.44 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 117.001 0.401 . . . . 0.0 111.781 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.659 ' HA ' ' HG2' ' I' ' 16' ' ' GLN . . . -100.15 122.59 49.82 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 126.964 2.106 . . . . 0.0 112.419 -174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' I' ' 15' ' ' PHE . 27.9 Cg_exo -70.39 127.24 13.82 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.424 0.83 . . . . 0.0 112.458 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.57 HD22 HG23 ' I' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.92 52.88 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 168.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.35 140.47 27.04 Favored Pre-proline 0 C--N 1.316 -0.878 0 C-N-CA 115.84 -2.344 . . . . 0.0 110.55 -167.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.88 169.96 21.11 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.829 0.679 . . . . 0.0 112.435 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.02 48.56 13.02 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.378 1.471 . . . . 0.0 111.528 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . 0.437 ' HE1' ' HG ' ' I' ' 27' ' ' LEU . 3.0 m-85 -71.81 133.09 45.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.55 1.167 . . . . 0.0 111.073 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.21 -111.08 0.13 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.423 ' CG2' HG23 ' J' ' 122' ' ' VAL . 18.2 p -121.33 174.24 6.84 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.762 1.268 . . . . 0.0 111.112 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' I' ' 65' ' ' VAL . 5.2 t0 -159.16 129.49 5.82 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.018 -1.446 . . . . 0.0 107.968 -164.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.95 131.6 7.57 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.374 170.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.45 109.06 18.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.681 HG22 ' HG2' ' J' ' 117' ' ' GLU . 57.4 t -107.27 126.06 63.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -173.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . 0.725 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 6.1 p -130.82 80.52 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -166.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.79 118.55 4.77 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.236 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.13 90.66 3.51 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' I' ' 42' ' ' GLU . 10.5 mmm180 -65.46 -179.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.732 0.777 . . . . 0.0 110.191 -174.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' I' ' 41' ' ' ARG . 0.0 OUTLIER -146.32 141.52 27.36 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.797 HD13 ' HA2' ' I' ' 57' ' ' GLY . 0.0 OUTLIER -73.51 166.0 24.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.493 -179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' I' ' 53' ' ' ILE . 5.3 t80 -108.85 85.02 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.247 171.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . 0.549 ' H ' HG21 ' I' ' 53' ' ' ILE . 26.4 t70 -110.62 100.07 8.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 155.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 10.2 pt-20 -68.74 -21.2 64.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.24 26.61 5.37 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.603 1.561 . . . . 0.0 111.688 -172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.646 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 0.0 OUTLIER 50.39 48.95 21.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.49 1.516 . . . . 0.0 111.554 -164.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . 0.539 ' HG2' ' HG2' ' I' ' 52' ' ' ARG . 6.3 tptt -116.58 -92.24 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.455 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' J' ' 59' ' ' VAL . 17.8 m-20 -152.3 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . 0.569 ' H ' ' HB2' ' I' ' 46' ' ' GLU . . . 80.18 36.06 25.35 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' I' ' 49' ' ' LYS . 0.1 OUTLIER -102.61 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.549 HG21 ' H ' ' I' ' 45' ' ' ASP . 0.3 OUTLIER -132.89 136.03 56.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.899 178.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.522 HD22 HD13 ' J' ' 135' ' ' ILE . 0.4 OUTLIER -109.13 25.2 12.08 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 176.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 161.24 12.9 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-O 121.647 0.582 . . . . 0.0 113.929 -170.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . 0.491 ' O ' HD13 ' I' ' 43' ' ' LEU . 68.5 Cg_endo -80.11 160.09 23.61 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.846 0.671 . . . . 0.0 113.846 -175.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . 0.797 ' HA2' HD13 ' I' ' 43' ' ' LEU . . . -124.8 -70.94 0.21 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.47 170.16 21.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 110.5 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.93 110.66 32.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.64 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.53 14.04 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' I' ' 133' ' ' GLN . 92.6 p -142.74 163.43 32.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.947 0.899 . . . . 0.0 110.078 -178.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' I' ' 132' ' ' LEU . . . -146.97 155.64 26.64 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.2 176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.742 ' HG2' ' HA ' ' I' ' 131' ' ' SER . 0.0 OUTLIER -122.64 141.7 51.45 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 174.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' I' ' 34' ' ' ASP . 85.9 t -129.33 125.13 61.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -113.09 137.57 51.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.36 167.86 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -91.31 143.13 26.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -80.67 141.71 22.98 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.931 0.733 . . . . 0.0 114.931 -175.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.625 ' H ' HE22 ' I' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.06 42.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.731 HH11 ' HB ' ' H' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.21 70.07 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.19 -123.06 2.87 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . 0.49 ' OD2' ' HD3' ' I' ' 70' ' ' LYS . 87.6 m-20 67.58 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.139 1.376 . . . . 0.0 110.992 169.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' I' ' 77' ' ' LYS . . . -85.32 -12.07 53.18 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.583 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -74.17 -46.97 19.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.866 168.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.625 HE22 ' H ' ' I' ' 70' ' ' LYS . 7.0 tt0 -66.99 -37.07 83.55 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.853 171.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' I' ' 74' ' ' ALA . 1.6 mtmt -66.45 -38.51 87.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.841 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.82 79.31 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.93 168.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' I' ' 76' ' ' GLN . 4.4 mm -59.49 -48.67 86.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.134 0.492 . . . . 0.0 110.551 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.91 -41.45 64.58 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.439 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.54 -46.18 87.36 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.634 169.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.44 -45.7 86.32 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.59 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 5.3 t80 -62.31 -50.34 72.05 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.896 -174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' I' ' 83' ' ' TYR . 0.9 OUTLIER -81.43 -25.65 35.98 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.078 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 18.3 m120 -94.97 -0.45 53.85 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.051 172.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.77 30.03 75.61 Favored Glycine 0 N--CA 1.448 -0.521 0 O-C-N 122.306 -0.246 . . . . 0.0 112.906 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' I' ' 85' ' ' ASN . 15.2 mttm -70.76 142.95 51.36 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.65 HE22 ' HB3' ' I' ' 110' ' ' PHE . 0.0 OUTLIER -73.49 142.2 46.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' I' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.327 0.584 . . . . 0.0 109.865 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.19 34.36 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.04 122.88 42.1 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.494 1.118 . . . . 0.0 110.011 -165.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.505 ' HH2' ' HA ' ' C' ' 160' ' ' PHE . 55.9 m95 -124.23 115.2 20.68 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.21 1.004 . . . . 0.0 108.311 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.633 HH21 HG11 ' I' ' 11' ' ' VAL . 20.1 ttt180 -104.42 107.07 17.82 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 172.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.763 HG21 HG21 ' I' ' 145' ' ' THR . 2.5 m -122.33 152.43 26.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.255 1.026 . . . . 0.0 109.377 -173.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' I' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.76 17.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.646 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.566 ' N ' ' O ' ' I' ' 10' ' ' ASP . 27.9 m -99.13 -25.08 14.65 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.691 -176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . 0.736 ' HB ' HH11 ' J' ' 71' ' ' ARG . 2.6 m -69.07 165.2 2.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.683 0.754 . . . . 0.0 109.906 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.66 108.2 20.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.968 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.522 ' HB3' ' O ' ' I' ' 102' ' ' ASP . 16.5 t30 -73.23 157.53 36.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.867 0.841 . . . . 0.0 109.981 171.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.29 -19.08 23.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.24 -83.44 0.25 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.871 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' I' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.9 44.68 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 167.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.574 ' HD2' ' O ' ' I' ' 143' ' ' ILE . 0.4 OUTLIER -51.74 -46.31 63.99 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.883 -0.511 . . . . 0.0 110.574 171.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' I' ' 97' ' ' VAL . 26.7 m-85 -138.17 -170.49 2.81 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.787 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.625 0.726 . . . . 0.0 109.477 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.07 140.69 43.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.089 -163.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.69 130.69 48.12 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 157.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.493 ' CE2' HD13 ' I' ' 138' ' ' LEU . 23.1 t80 -133.58 155.03 50.38 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.412 0.685 . . . . 0.0 110.397 -163.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . 0.782 ' HA2' HD12 ' I' ' 138' ' ' LEU . . . -173.47 170.6 43.75 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 119.541 -1.314 . . . . 0.0 111.974 170.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.65 ' HB3' HE22 ' I' ' 88' ' ' GLN . 5.1 m-85 -92.95 137.17 32.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 167.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.6 159.87 39.19 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.926 0.87 . . . . 0.0 111.204 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -134.94 136.55 42.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.482 -1.235 . . . . 0.0 107.97 -174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.42 HG21 ' HD1' ' I' ' 83' ' ' TYR . 2.8 mp -71.05 111.19 4.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.538 ' HG3' ' HA ' ' I' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.17 16.94 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 44.8 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.946 0.794 . . . . 0.0 109.092 174.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.533 ' HG3' HH11 ' I' ' 116' ' ' ARG . 1.3 tmm_? -121.08 138.92 53.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 176.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.535 ' HG2' HG22 ' H' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.21 18.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.04 120.68 42.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.066 0.46 . . . . 0.0 111.193 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . 0.638 ' HB2' ' HB2' ' I' ' 127' ' ' GLU . 1.0 OUTLIER -102.17 125.85 48.98 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.671 177.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.51 114.92 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.02 -175.37 22.14 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 15.2 t -77.17 -55.96 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 O-C-N 122.522 -0.399 . . . . 0.0 111.069 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.4 159.56 14.94 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.44 153.53 28.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' H' ' 7' ' ' MET . . . -80.06 163.94 23.78 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.625 0.726 . . . . 0.0 110.721 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.573 HG13 ' O ' ' H' ' 7' ' ' MET . 18.7 m -55.16 146.23 4.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.031 -171.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' I' ' 119' ' ' SER . 29.8 mp0 -127.17 129.7 48.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.135 -176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . 0.465 HG22 HG23 ' I' ' 130' ' ' ILE . 26.5 mt -114.84 124.83 71.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.16 121.87 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.602 HG13 ' O ' ' I' ' 130' ' ' ILE . 12.7 pt -119.83 122.47 68.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.742 ' HA ' ' HG2' ' I' ' 64' ' ' GLU . 0.8 OUTLIER -106.51 130.05 54.36 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.687 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.538 ' HA ' ' HG3' ' I' ' 114' ' ' GLU . 0.4 OUTLIER -142.89 163.2 33.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.14 -172.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.844 ' HA ' ' HA ' ' I' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 167.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.413 HG13 ' O ' ' I' ' 110' ' ' PHE . 4.1 t -121.75 128.4 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.451 HG13 ' H ' ' I' ' 136' ' ' GLY . 6.9 pt -67.22 -51.39 53.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.345 0.593 . . . . 0.0 110.355 -173.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.451 ' H ' HG13 ' I' ' 135' ' ' ILE . . . -125.24 116.91 2.82 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.733 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.54 123.9 24.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 122.01 0.909 . . . . 0.0 110.683 174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.782 HD12 ' HA2' ' I' ' 109' ' ' GLY . 2.4 mt -127.89 151.88 48.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -174.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.457 ' NZ ' ' HG2' ' J' ' 84' ' ' GLN . 0.0 OUTLIER -135.76 130.69 34.48 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.79 19.06 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.787 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -67.79 151.61 52.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.345 169.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.416 ' HG2' HG11 ' I' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -174.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.574 ' O ' ' HD2' ' I' ' 103' ' ' LYS . 1.7 mp -104.7 -64.26 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.817 -176.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.89 113.95 20.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.949 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 0.763 HG21 HG21 ' I' ' 94' ' ' VAL . 12.8 p -109.52 31.44 5.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.364 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.56 17.5 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.462 1.905 . . . . 0.0 109.38 -173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.438 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -69.1 -7.9 22.12 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.263 1.309 . . . . 0.0 115.348 -159.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -32.26 66.5 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.599 171.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.88 -45.66 1.58 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -173.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' I' ' 145' ' ' THR . 17.1 mt -71.68 -45.25 67.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.181 0.9 . . . . 0.0 111.327 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 2.4 t -78.88 -39.93 22.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.11 121.17 28.34 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.454 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.34 30.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.53 144.76 37.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -74.67 -34.09 62.61 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.67 77.13 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 119.367 0.985 . . . . 0.0 113.043 -176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.91 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.246 1.019 . . . . 0.0 108.633 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -32.97 70.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -158.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.93 112.4 11.23 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.714 2.406 . . . . 0.0 109.179 167.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -141.66 45.07 1.71 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . 0.594 ' HB3' ' HD3' ' I' ' 163' ' ' PRO . 22.9 tt0 -58.24 -53.69 63.41 Favored Pre-proline 0 C--O 1.241 0.624 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -166.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' I' ' 162' ' ' GLN . 22.3 Cg_exo -82.76 131.7 6.29 Favored 'Trans proline' 0 C--O 1.238 0.51 0 CA-C-N 122.106 1.788 . . . . 0.0 113.811 171.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.68 42.5 99.76 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.365 2.106 . . . . 0.0 118.365 -171.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' I' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.53 96.02 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.86 1.33 . . . . 0.0 110.901 175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.33 70.43 0.45 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.911 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.796 ' HA ' HG22 ' I' ' 173' ' ' THR . 37.6 p -132.53 147.51 52.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.305 -167.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.05 -167.65 42.65 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.456 172.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.29 -29.59 70.54 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.811 0.306 . . . . 0.0 111.414 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.18 60.38 Favored Pre-proline 0 C--O 1.235 0.337 0 C-N-CA 123.474 0.71 . . . . 0.0 109.278 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.75 97.75 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.325 1.35 . . . . 0.0 112.715 -156.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.64 82.79 1.15 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 117.144 1.618 . . . . 0.0 117.144 165.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.796 HG22 ' HA ' ' I' ' 167' ' ' THR . 11.2 t -108.48 153.39 23.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.028 0.914 . . . . 0.0 109.864 170.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.23 86.4 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.386 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.54 137.69 61.0 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.516 0.863 . . . . 0.0 111.723 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 C-N-CA 125.441 1.496 . . . . 0.0 112.335 -171.673 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.555 ' HB3' ' HE3' ' K' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.227 -1.105 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.441 ' O ' HG22 ' K' ' 126' ' ' VAL . 6.0 pt -61.47 127.9 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' K' ' 125' ' ' ALA . 0.0 OUTLIER -89.03 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.933 0.873 . . . . 0.0 110.72 -177.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.498 ' N ' ' HA ' ' K' ' 125' ' ' ALA . . . -66.85 -31.66 78.85 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.515 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 -18.48 62.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.762 0.781 . . . . 0.0 112.412 172.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' J' ' 96' ' ' THR . 4.8 t70 -66.12 -37.7 86.35 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' J' ' 93' ' ' ARG . 28.2 m -101.61 117.82 47.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . 0.553 ' HE3' ' HA ' ' J' ' 12' ' ' LYS . 0.0 OUTLIER -117.83 157.47 26.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.716 0.77 . . . . 0.0 110.463 176.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.22 98.68 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.744 -164.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -87.0 141.29 28.77 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' J' ' 89' ' ' ILE . 19.1 m-85 -126.12 137.66 53.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.456 0.646 . . . . 0.0 109.937 176.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' J' ' 25' ' ' ALA . 1.3 tm0? -131.97 136.25 47.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.58 147.32 47.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.557 0.694 . . . . 0.0 111.029 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.645 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 2.0 pt -64.44 -47.0 91.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.013 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' J' ' 18' ' ' ILE . 2.0 p30 -85.82 -11.93 52.17 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.49 82.41 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.422 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.85 40.11 19.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.184 1.393 . . . . 0.0 111.806 -173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.04 163.66 13.57 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.86 4.8 68.7 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 116.342 -0.39 . . . . 0.0 113.747 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.45 142.81 28.5 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.955 0.378 . . . . 0.0 111.761 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.652 ' HA ' ' HG2' ' J' ' 16' ' ' GLN . . . -100.18 122.56 49.87 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 126.928 2.091 . . . . 0.0 112.411 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' J' ' 15' ' ' PHE . 27.7 Cg_exo -70.32 127.25 13.89 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.43 0.832 . . . . 0.0 112.485 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.561 HD22 HG23 ' J' ' 150' ' ' ILE . 0.8 OUTLIER -106.58 127.02 53.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 168.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.41 140.47 26.95 Favored Pre-proline 0 C--N 1.316 -0.873 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.487 -167.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.89 169.92 21.19 Favored 'Trans proline' 0 C--N 1.331 -0.346 0 CA-C-O 121.857 0.691 . . . . 0.0 112.42 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.01 48.6 12.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.415 1.486 . . . . 0.0 111.553 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' J' ' 27' ' ' LEU . 2.9 m-85 -71.86 133.07 45.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.078 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.15 -111.08 0.13 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . 0.446 ' CG2' HG23 ' K' ' 122' ' ' VAL . 18.4 p -121.4 174.17 6.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.807 1.289 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' J' ' 65' ' ' VAL . 5.2 t0 -159.13 129.54 5.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.011 -164.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.98 131.59 7.56 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.362 170.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.48 108.98 17.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.635 HG22 ' HG2' ' K' ' 117' ' ' GLU . 57.3 t -107.17 126.1 63.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . 0.615 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 6.0 p -130.89 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -166.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.69 118.53 4.76 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.259 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.09 90.69 3.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' J' ' 42' ' ' GLU . 10.4 mmm180 -65.56 -179.5 0.66 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.691 0.758 . . . . 0.0 110.132 -174.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' J' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.51 27.37 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.785 HD13 ' HA2' ' J' ' 57' ' ' GLY . 0.0 OUTLIER -73.49 165.95 24.13 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.52 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . 0.475 ' HA ' HG12 ' J' ' 53' ' ' ILE . 5.4 t80 -108.84 84.98 2.02 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.228 171.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . 0.558 ' H ' HG21 ' J' ' 53' ' ' ILE . 26.4 t70 -110.58 100.06 8.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.635 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 10.2 pt-20 -68.73 -21.2 64.4 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.27 26.6 5.34 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.574 1.549 . . . . 0.0 111.693 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.635 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 0.0 OUTLIER 50.37 48.94 21.58 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.498 1.519 . . . . 0.0 111.553 -164.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . 0.538 ' HG2' ' HG2' ' J' ' 52' ' ' ARG . 6.4 tptt -116.61 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.434 -177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -152.27 33.88 0.52 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' J' ' 46' ' ' GLU . . . 80.18 36.15 25.12 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.538 ' HG2' ' HG2' ' J' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.3 32.32 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.558 HG21 ' H ' ' J' ' 45' ' ' ASP . 0.3 OUTLIER -132.86 135.95 56.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.854 178.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.441 HD22 HD13 ' K' ' 135' ' ' ILE . 0.4 OUTLIER -109.05 25.14 12.15 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.39 161.28 12.88 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 121.6 0.555 . . . . 0.0 113.989 -170.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . 0.491 ' O ' HD22 ' J' ' 43' ' ' LEU . 69.0 Cg_endo -80.09 160.06 23.69 Favored 'Trans proline' 0 CA--C 1.516 -0.42 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . 0.785 ' HA2' HD13 ' J' ' 43' ' ' LEU . . . -124.83 -70.93 0.2 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.43 170.21 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 110.46 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' I' ' 50' ' ' ASN . 2.3 t -114.97 110.62 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.13 83.18 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.77 104.6 14.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -171.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . 0.885 ' HA ' ' HA ' ' J' ' 133' ' ' GLN . 92.3 p -142.79 163.43 32.81 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.924 0.89 . . . . 0.0 110.03 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' J' ' 132' ' ' LEU . . . -146.99 155.69 26.66 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.159 176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' J' ' 131' ' ' SER . 0.0 OUTLIER -122.69 141.63 51.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' J' ' 34' ' ' ASP . 85.6 t -129.27 125.19 61.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.1 137.62 51.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -148.39 167.87 24.13 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -91.43 143.13 26.93 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.66 141.74 23.01 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 -175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.636 ' H ' HE22 ' J' ' 76' ' ' GLN . 0.4 OUTLIER -123.06 150.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 174.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . 0.736 HH11 ' HB ' ' I' ' 97' ' ' VAL . 0.0 OUTLIER -56.52 -37.12 70.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.21 -123.04 2.87 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' J' ' 70' ' ' LYS . 87.8 m-20 67.52 126.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.132 1.373 . . . . 0.0 111.051 169.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' J' ' 77' ' ' LYS . . . -85.29 -12.09 53.2 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 117.469 2.396 . . . . 0.0 117.469 -156.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.587 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -74.2 -47.04 19.06 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.795 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.636 HE22 ' H ' ' J' ' 70' ' ' LYS . 7.0 tt0 -66.98 -37.01 83.46 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.152 -0.616 . . . . 0.0 111.87 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' J' ' 74' ' ' ALA . 1.6 mtmt -66.48 -38.53 87.48 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.763 171.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.8 79.24 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.925 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' J' ' 76' ' ' GLN . 4.3 mm -59.51 -48.65 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.5 172.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.93 -41.48 64.48 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.72 -0.613 . . . . 0.0 112.393 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.55 -46.22 87.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.69 86.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.066 -1.054 . . . . 0.0 111.567 174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.725 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 5.3 t80 -62.25 -50.39 71.92 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.93 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.457 ' HG2' ' NZ ' ' I' ' 139' ' ' LYS . 0.9 OUTLIER -81.37 -25.73 36.06 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -167.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.479 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 18.4 m120 -94.95 -0.42 53.92 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.051 172.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.83 29.98 75.48 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.338 -0.226 . . . . 0.0 112.821 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.479 ' HE2' ' OD1' ' J' ' 85' ' ' ASN . 15.1 mttm -70.7 142.99 51.48 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' J' ' 110' ' ' PHE . 0.0 OUTLIER -73.59 142.22 46.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' J' ' 15' ' ' PHE . 7.7 tt -118.78 139.43 46.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.305 0.574 . . . . 0.0 109.897 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 4.9 mtmp? -85.77 131.11 34.38 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.01 122.91 42.2 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.532 1.133 . . . . 0.0 110.019 -165.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.484 ' CH2' ' HA ' ' D' ' 160' ' ' PHE . 55.7 m95 -124.23 115.17 20.62 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.21 1.004 . . . . 0.0 108.318 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' J' ' 11' ' ' VAL . 20.2 ttt180 -104.39 107.06 17.8 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.753 HG21 HG21 ' J' ' 145' ' ' THR . 2.5 m -122.32 152.42 26.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-O 122.248 1.023 . . . . 0.0 109.424 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' J' ' 11' ' ' VAL . 1.0 OUTLIER -87.21 162.72 17.31 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.648 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' J' ' 10' ' ' ASP . 28.0 m -99.15 -25.01 14.67 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.679 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . 0.682 ' HB ' HH11 ' K' ' 71' ' ' ARG . 2.5 m -69.11 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.715 0.769 . . . . 0.0 109.883 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.63 108.17 20.0 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.002 -174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' J' ' 102' ' ' ASP . 16.7 t30 -73.31 157.63 36.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.821 0.819 . . . . 0.0 109.938 171.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.35 -19.09 23.3 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -90.23 -83.46 0.25 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.728 0.695 . . . . 0.0 110.869 169.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' J' ' 99' ' ' ASN . 0.8 OUTLIER -66.81 152.93 44.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' J' ' 143' ' ' ILE . 0.4 OUTLIER -51.79 -46.27 64.13 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.871 -0.518 . . . . 0.0 110.551 171.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' J' ' 97' ' ' VAL . 26.6 m-85 -138.19 -170.45 2.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.798 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.5 t70 -141.12 143.1 34.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.637 0.732 . . . . 0.0 109.456 177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.11 140.72 43.93 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.033 -163.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.7 130.68 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 157.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.481 ' CE2' HD13 ' J' ' 138' ' ' LEU . 23.2 t80 -133.58 155.04 50.36 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.374 0.67 . . . . 0.0 110.384 -163.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . 0.798 ' HA2' HD12 ' J' ' 138' ' ' LEU . . . -173.46 170.65 43.8 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.494 -1.336 . . . . 0.0 111.937 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' J' ' 88' ' ' GLN . 5.1 m-85 -93.08 137.21 32.64 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.62 159.87 39.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.942 0.877 . . . . 0.0 111.188 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.92 136.47 42.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.025 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' J' ' 83' ' ' TYR . 2.8 mp -71.04 111.21 4.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' J' ' 132' ' ' LEU . 18.9 mt-10 -91.05 -30.12 16.96 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 45.1 t -163.89 149.19 10.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.041 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.542 ' HG3' HH11 ' J' ' 116' ' ' ARG . 1.4 tmm_? -121.14 138.91 53.98 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.681 ' HG2' HG22 ' I' ' 37' ' ' VAL . 0.2 OUTLIER -135.15 120.24 18.76 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.06 120.62 42.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.087 0.47 . . . . 0.0 111.216 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . 0.635 ' HB2' ' HB2' ' J' ' 127' ' ' GLU . 1.0 OUTLIER -102.21 125.85 49.03 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.643 177.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.48 114.85 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 167.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.94 -175.36 22.19 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-O 121.717 0.62 . . . . 0.0 111.568 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.423 HG23 ' CG2' ' I' ' 33' ' ' THR . 15.3 t -77.17 -56.01 9.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.441 -0.447 . . . . 0.0 111.073 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.26 159.51 14.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 169.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.41 153.49 28.86 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' I' ' 7' ' ' MET . . . -80.02 163.9 23.86 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.581 0.705 . . . . 0.0 110.769 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.503 HG13 ' O ' ' I' ' 7' ' ' MET . 18.6 m -55.16 146.23 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.058 -171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' J' ' 119' ' ' SER . 29.8 mp0 -127.16 129.69 48.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.112 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . 0.466 HG22 HG23 ' J' ' 130' ' ' ILE . 26.4 mt -114.87 124.92 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.26 121.92 45.52 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.611 HG13 ' O ' ' J' ' 130' ' ' ILE . 12.7 pt -119.86 122.47 68.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.735 ' HA ' ' HG2' ' J' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 130.04 54.37 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.691 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.528 ' HA ' ' HG3' ' J' ' 114' ' ' GLU . 0.4 OUTLIER -142.85 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.166 -172.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.885 ' HA ' ' HA ' ' J' ' 62' ' ' SER . 1.8 pt20 -121.06 163.22 18.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' J' ' 110' ' ' PHE . 4.1 t -121.71 128.42 75.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.522 HD13 HD22 ' I' ' 54' ' ' LEU . 6.9 pt -67.27 -51.34 54.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.364 0.602 . . . . 0.0 110.341 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.456 ' H ' HG13 ' J' ' 135' ' ' ILE . . . -125.31 116.85 2.79 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.703 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.53 123.93 24.9 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.068 0.937 . . . . 0.0 110.625 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.798 HD12 ' HA2' ' J' ' 109' ' ' GLY . 2.4 mt -127.9 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.439 ' NZ ' ' HG2' ' K' ' 84' ' ' GLN . 0.0 OUTLIER -135.83 130.69 34.34 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -160.02 150.75 18.95 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.798 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -67.77 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.378 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' D' ' 160' ' ' PHE . 2.8 tp10 -111.1 143.41 41.86 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' J' ' 103' ' ' LYS . 1.7 mp -104.7 -64.29 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.758 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 113.88 20.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.275 0.559 . . . . 0.0 110.976 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.753 HG21 HG21 ' J' ' 94' ' ' VAL . 12.8 p -109.5 31.49 5.74 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.755 -0.641 . . . . 0.0 112.383 175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.38 56.57 17.51 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.466 1.906 . . . . 0.0 109.378 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.13 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.25 1.3 . . . . 0.0 115.343 -159.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.33 -32.26 66.53 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.592 171.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.86 -45.69 1.58 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.675 HD12 ' O ' ' J' ' 145' ' ' THR . 17.2 mt -71.67 -45.28 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 119.172 0.896 . . . . 0.0 111.269 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 2.4 t -78.92 -39.89 22.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -176.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.12 121.15 28.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.454 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.2 110.37 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.56 144.76 37.42 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.65 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.45 11.69 77.24 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.37 0.986 . . . . 0.0 113.079 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.9 117.77 4.8 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.97 112.21 24.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.29 1.036 . . . . 0.0 108.635 177.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -32.94 70.69 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -158.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -133.96 112.47 11.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.71 2.404 . . . . 0.0 109.169 167.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.572 ' HB3' ' HG3' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -141.74 45.09 1.71 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' J' ' 163' ' ' PRO . 22.9 tt0 -58.21 -53.74 62.89 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -166.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' J' ' 162' ' ' GLN . 22.2 Cg_exo -82.69 131.63 6.33 Favored 'Trans proline' 0 C--O 1.239 0.548 0 CA-C-N 122.048 1.767 . . . . 0.0 113.901 171.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.77 42.46 99.75 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 118.326 2.09 . . . . 0.0 118.326 -171.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.572 ' HG3' ' HB3' ' J' ' 161' ' ' GLN . 1.3 tt0 -60.34 -42.59 96.0 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.921 1.361 . . . . 0.0 110.908 175.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.31 70.51 0.44 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.863 1.665 . . . . 0.0 111.866 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.798 ' HA ' HG22 ' J' ' 173' ' ' THR . 37.5 p -132.54 147.52 52.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.282 -167.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.04 -167.6 42.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -29.58 70.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.787 0.294 . . . . 0.0 111.456 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.09 156.15 60.44 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.474 0.71 . . . . 0.0 109.307 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.72 97.73 1.03 Allowed 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 121.319 1.346 . . . . 0.0 112.729 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.66 82.7 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 165.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.798 HG22 ' HA ' ' J' ' 167' ' ' THR . 11.2 t -108.51 153.42 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.996 0.898 . . . . 0.0 109.895 170.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.54 157.21 86.44 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.394 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.45 137.71 61.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 CA-C-N 119.501 0.858 . . . . 0.0 111.69 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 C-N-CA 125.397 1.479 . . . . 0.0 112.329 -171.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' HE3' ' L' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.466 -0.133 0 N-CA-C 109.195 -1.117 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.436 ' O ' ' HB1' ' L' ' 125' ' ' ALA . 6.0 pt -61.51 127.87 21.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.616 ' HA ' ' HA ' ' L' ' 125' ' ' ALA . 0.0 OUTLIER -89.0 -177.95 5.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.927 0.87 . . . . 0.0 110.72 -177.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' L' ' 125' ' ' ALA . . . -66.89 -31.66 78.81 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 0.0 114.521 175.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.74 -18.37 62.14 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 117.762 0.781 . . . . 0.0 112.441 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' K' ' 96' ' ' THR . 4.8 t70 -66.21 -37.69 86.17 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -172.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.64 HG11 HH21 ' K' ' 93' ' ' ARG . 28.2 m -101.63 117.82 47.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' K' ' 12' ' ' LYS . 0.0 OUTLIER -117.77 157.47 26.49 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.666 0.745 . . . . 0.0 110.505 176.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -114.25 98.62 7.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.742 -164.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' K' ' 25' ' ' ALA . 5.5 mp -87.0 141.24 28.82 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 174.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.479 ' O ' ' HD2' ' K' ' 26' ' ' PRO . 19.2 m-85 -126.06 137.67 53.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.518 0.675 . . . . 0.0 109.931 176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.643 ' HG2' ' HA ' ' K' ' 25' ' ' ALA . 1.3 tm0? -131.92 136.3 47.28 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.38 47.67 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.018 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.62 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 2.0 pt -64.51 -47.05 90.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.949 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . 0.476 ' H ' HG13 ' K' ' 18' ' ' ILE . 2.0 p30 -85.84 -11.83 52.36 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -171.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.89 -37.53 82.52 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.076 -0.649 . . . . 0.0 111.41 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . . . . . . . . . . . 49.89 40.1 20.0 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.231 1.412 . . . . 0.0 111.783 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.03 163.61 13.59 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.8 4.81 68.96 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 123.314 0.384 . . . . 0.0 113.739 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -146.49 142.74 28.39 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.984 0.392 . . . . 0.0 111.762 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.643 ' HA ' ' HG2' ' K' ' 16' ' ' GLN . . . -100.11 122.61 49.86 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.975 2.11 . . . . 0.0 112.431 -174.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' K' ' 15' ' ' PHE . 27.5 Cg_exo -70.39 127.17 13.74 Favored 'Trans proline' 0 C--N 1.349 0.591 0 CA-C-N 119.432 0.833 . . . . 0.0 112.506 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.587 HD22 HG23 ' K' ' 150' ' ' ILE . 0.8 OUTLIER -106.52 126.94 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 168.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -90.35 140.46 27.03 Favored Pre-proline 0 C--N 1.317 -0.827 0 C-N-CA 115.831 -2.347 . . . . 0.0 110.536 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.861 0.692 . . . . 0.0 112.409 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.05 48.55 12.97 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.324 1.45 . . . . 0.0 111.514 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . 0.427 ' HE1' ' HG ' ' K' ' 27' ' ' LEU . 3.0 m-85 -71.82 133.11 45.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.541 1.162 . . . . 0.0 111.075 173.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -95.24 -111.0 0.13 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . 0.494 HG22 HG23 ' L' ' 122' ' ' VAL . 18.3 p -121.4 174.2 6.89 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.806 1.289 . . . . 0.0 111.077 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.514 ' OD1' HG22 ' K' ' 65' ' ' VAL . 5.2 t0 -159.13 129.53 5.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.002 -164.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.63 7.58 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.35 170.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.49 108.99 17.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 173.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.608 HG22 ' HG2' ' L' ' 117' ' ' GLU . 57.5 t -107.18 126.1 63.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . 0.603 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 6.0 p -130.88 80.5 1.95 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.72 118.57 4.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.657 -0.782 . . . . 0.0 113.208 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.16 90.68 3.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' K' ' 42' ' ' GLU . 10.5 mmm180 -65.54 -179.5 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.123 -174.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' K' ' 41' ' ' ARG . 0.0 OUTLIER -146.31 141.5 27.35 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -167.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.803 HD13 ' HA2' ' K' ' 57' ' ' GLY . 0.0 OUTLIER -73.49 166.03 23.98 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.517 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . 0.478 ' HA ' HG12 ' K' ' 53' ' ' ILE . 5.4 t80 -108.87 84.96 2.01 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.259 171.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . 0.56 ' H ' HG21 ' K' ' 53' ' ' ILE . 26.4 t70 -110.59 100.12 8.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.639 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 10.2 pt-20 -68.79 -21.22 64.35 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.26 26.62 5.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.636 1.575 . . . . 0.0 111.677 -172.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.639 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 0.0 OUTLIER 50.34 48.96 21.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.501 1.52 . . . . 0.0 111.57 -164.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . 0.587 ' HD3' HG22 ' F' ' 153' ' ' VAL . 6.3 tptt -116.57 -92.2 0.52 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.469 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.476 ' CB ' HG23 ' L' ' 59' ' ' VAL . 17.8 m-20 -152.31 33.98 0.52 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . 0.572 ' H ' ' HB2' ' K' ' 46' ' ' GLU . . . 80.16 36.12 25.24 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' K' ' 49' ' ' LYS . 0.1 OUTLIER -102.67 116.25 32.22 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.56 HG21 ' H ' ' K' ' 45' ' ' ASP . 0.3 OUTLIER -132.83 135.99 56.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.9 178.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.613 HD22 HD13 ' L' ' 135' ' ' ILE . 0.4 OUTLIER -109.06 25.18 12.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 176.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.43 161.26 12.89 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.66 0.589 . . . . 0.0 113.978 -170.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . 0.496 ' O ' HD22 ' K' ' 43' ' ' LEU . 69.2 Cg_endo -80.09 160.09 23.67 Favored 'Trans proline' 0 CA--C 1.515 -0.445 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . 0.803 ' HA2' HD13 ' K' ' 43' ' ' LEU . . . -124.85 -70.96 0.2 Allowed Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 8.5 t -160.37 170.21 21.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.564 0.697 . . . . 0.0 110.5 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.96 110.63 32.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.13 2.65 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.75 104.5 14.02 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . 0.869 ' HA ' ' HA ' ' K' ' 133' ' ' GLN . 92.8 p -142.69 163.4 32.93 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.012 0.925 . . . . 0.0 110.12 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' K' ' 132' ' ' LEU . . . -147.01 155.67 26.65 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.173 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.743 ' HG2' ' HA ' ' K' ' 131' ' ' SER . 0.0 OUTLIER -122.7 141.65 51.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 174.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.514 HG22 ' OD1' ' K' ' 34' ' ' ASP . 85.7 t -129.3 125.16 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 33.6 p -113.03 137.59 51.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -148.44 167.88 24.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -91.35 143.16 26.92 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.65 141.63 22.92 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.64 ' H ' HE22 ' K' ' 76' ' ' GLN . 0.4 OUTLIER -123.05 151.04 42.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . 0.682 HH11 ' HB ' ' J' ' 97' ' ' VAL . 0.0 OUTLIER -56.47 -37.22 70.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -172.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.18 -123.11 2.88 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HD3' ' K' ' 70' ' ' LYS . 87.7 m-20 67.66 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.141 1.376 . . . . 0.0 110.969 169.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' K' ' 77' ' ' LYS . . . -85.29 -12.11 53.16 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 117.443 2.386 . . . . 0.0 117.443 -156.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -74.18 -47.0 19.24 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.844 168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.64 HE22 ' H ' ' K' ' 70' ' ' LYS . 7.0 tt0 -67.02 -37.03 83.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 122.141 -0.623 . . . . 0.0 111.853 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' K' ' 74' ' ' ALA . 1.6 mtmt -66.41 -38.58 87.78 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.795 171.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.13 -34.79 79.24 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.921 168.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.597 ' HB ' ' HA ' ' K' ' 76' ' ' GLN . 4.4 mm -59.58 -48.63 86.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.006 0.432 . . . . 0.0 110.482 172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.42 64.55 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.775 -0.578 . . . . 0.0 112.412 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.57 -46.19 87.43 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.59 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -45.62 86.28 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.586 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.615 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 5.4 t80 -62.21 -50.39 71.98 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.969 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.439 ' HG2' ' NZ ' ' J' ' 139' ' ' LYS . 0.9 OUTLIER -81.41 -25.67 36.02 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -167.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.476 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 18.4 m120 -94.97 -0.41 53.9 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.04 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.75 30.06 75.66 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.358 -0.214 . . . . 0.0 112.833 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.476 ' HE2' ' OD1' ' K' ' 85' ' ' ASN . 15.2 mttm -70.77 142.98 51.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.657 HE22 ' HB3' ' K' ' 110' ' ' PHE . 0.0 OUTLIER -73.56 142.24 46.64 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' K' ' 15' ' ' PHE . 7.7 tt -118.77 139.42 46.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.295 0.569 . . . . 0.0 109.881 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 4.9 mtmp? -85.73 131.16 34.38 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.06 122.9 42.12 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.517 1.127 . . . . 0.0 109.993 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.595 ' HH2' ' HA ' ' E' ' 160' ' ' PHE . 56.0 m95 -124.26 115.18 20.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 108.349 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.64 HH21 HG11 ' K' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.1 17.86 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.775 HG21 HG21 ' K' ' 145' ' ' THR . 2.5 m -122.34 152.38 26.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 122.254 1.026 . . . . 0.0 109.417 -173.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' K' ' 11' ' ' VAL . 1.0 OUTLIER -87.16 162.8 17.3 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.663 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.576 ' N ' ' O ' ' K' ' 10' ' ' ASP . 28.0 m -99.19 -25.01 14.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.656 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . 0.588 ' HB ' HH11 ' L' ' 71' ' ' ARG . 2.6 m -69.09 165.26 2.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.676 0.75 . . . . 0.0 109.929 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.72 108.2 20.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' K' ' 102' ' ' ASP . 16.7 t30 -73.3 157.55 36.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.779 0.8 . . . . 0.0 109.953 171.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.28 -19.2 23.24 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -90.17 -83.44 0.25 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.872 169.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' K' ' 99' ' ' ASN . 0.8 OUTLIER -66.87 152.89 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 167.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' K' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.27 63.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.815 -0.553 . . . . 0.0 110.614 171.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' K' ' 97' ' ' VAL . 26.9 m-85 -138.2 -170.48 2.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.807 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.5 t70 -141.1 143.1 34.12 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.62 0.724 . . . . 0.0 109.435 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.08 140.72 43.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.03 -163.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.66 130.59 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 157.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' K' ' 138' ' ' LEU . 23.1 t80 -133.52 155.1 50.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.402 0.681 . . . . 0.0 110.42 -163.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . 0.799 ' HA2' HD12 ' K' ' 138' ' ' LEU . . . -173.49 170.59 43.74 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 119.56 -1.305 . . . . 0.0 112.029 170.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.657 ' HB3' HE22 ' K' ' 88' ' ' GLN . 5.1 m-85 -93.05 137.15 32.66 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 167.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.57 159.88 39.12 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.883 0.849 . . . . 0.0 111.18 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -134.93 136.52 42.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.995 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.418 HG21 ' HD1' ' K' ' 83' ' ' TYR . 2.8 mp -71.12 111.2 4.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' K' ' 132' ' ' LEU . 18.9 mt-10 -91.02 -30.19 16.93 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.86 149.17 10.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.943 0.792 . . . . 0.0 109.094 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.546 HH11 ' HG3' ' K' ' 116' ' ' ARG . 1.4 tmm_? -121.06 138.92 53.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.635 ' HG2' HG22 ' J' ' 37' ' ' VAL . 0.2 OUTLIER -135.18 120.29 18.79 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.07 120.57 42.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.068 0.461 . . . . 0.0 111.191 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . 0.628 ' HB2' ' HB2' ' K' ' 127' ' ' GLU . 1.0 OUTLIER -102.12 125.86 48.93 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.687 177.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.55 114.92 21.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.01 -175.35 22.14 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' J' ' 33' ' ' THR . 15.2 t -77.2 -55.89 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.513 -0.404 . . . . 0.0 111.11 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.35 159.59 14.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 169.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.32 153.53 28.82 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 166.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' J' ' 7' ' ' MET . . . -80.06 163.92 23.8 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.586 0.708 . . . . 0.0 110.726 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.52 HG13 ' O ' ' J' ' 7' ' ' MET . 18.6 m -55.11 146.2 4.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.046 -171.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' K' ' 119' ' ' SER . 29.7 mp0 -127.15 129.77 48.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.11 -176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . 0.47 HG22 HG23 ' K' ' 130' ' ' ILE . 26.3 mt -114.92 124.89 72.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.17 121.88 45.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 168.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.604 HG13 ' O ' ' K' ' 130' ' ' ILE . 12.6 pt -119.83 122.45 68.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.743 ' HA ' ' HG2' ' K' ' 64' ' ' GLU . 0.8 OUTLIER -106.54 130.04 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.725 -178.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.524 ' HA ' ' HG3' ' K' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.26 33.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.087 -172.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.869 ' HA ' ' HA ' ' K' ' 62' ' ' SER . 1.8 pt20 -121.1 163.22 18.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 167.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.418 HG13 ' O ' ' K' ' 110' ' ' PHE . 4.1 t -121.73 128.35 75.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.455 HG13 ' H ' ' K' ' 136' ' ' GLY . 7.0 pt -67.21 -51.42 53.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.343 0.592 . . . . 0.0 110.322 -173.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.501 ' CA ' ' HD3' ' E' ' 155' ' ' LYS . . . -125.25 116.9 2.82 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.708 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.59 123.94 24.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.054 0.93 . . . . 0.0 110.67 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.799 HD12 ' HA2' ' K' ' 109' ' ' GLY . 2.4 mt -127.85 151.89 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' L' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.68 34.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -177.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -159.97 150.76 19.04 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -67.79 151.58 52.13 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.239 -0.981 . . . . 0.0 111.385 169.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.418 ' HG2' HG11 ' K' ' 94' ' ' VAL . 2.8 tp10 -111.14 143.41 41.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.567 ' O ' ' HD2' ' K' ' 103' ' ' LYS . 1.7 mp -104.67 -64.34 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.775 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.84 113.89 20.81 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.007 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.775 HG21 HG21 ' K' ' 94' ' ' VAL . 12.8 p -109.49 31.46 5.76 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.385 175.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.34 56.55 17.47 Favored Pre-proline 0 C--O 1.237 0.438 0 C-N-CA 126.435 1.894 . . . . 0.0 109.397 -173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.1 -7.86 22.01 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.224 1.283 . . . . 0.0 115.337 -159.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.28 -32.28 66.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.632 171.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.84 -45.6 1.59 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.682 HD12 ' O ' ' K' ' 145' ' ' THR . 17.4 mt -71.78 -45.16 66.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.175 0.898 . . . . 0.0 111.234 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 2.4 t -78.96 -39.97 22.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.02 121.13 28.2 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.471 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.22 110.37 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 171.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 5.4 p -109.59 144.71 37.52 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.65 -34.04 62.66 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.46 11.69 77.23 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 119.389 0.995 . . . . 0.0 113.002 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.89 117.75 4.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.94 112.19 23.99 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.299 1.039 . . . . 0.0 108.595 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.48 -32.92 70.64 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -158.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -133.98 112.44 11.23 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.707 2.403 . . . . 0.0 109.155 167.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.594 ' HB3' ' HG3' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.04 1.71 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 154.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . 0.59 ' HB3' ' HD3' ' K' ' 163' ' ' PRO . 22.8 tt0 -58.13 -53.77 62.49 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -166.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' K' ' 162' ' ' GLN . 22.2 Cg_exo -82.72 131.66 6.31 Favored 'Trans proline' 0 C--O 1.238 0.489 0 CA-C-N 122.05 1.768 . . . . 0.0 113.886 171.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.76 42.43 99.75 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' K' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.47 95.88 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.955 1.377 . . . . 0.0 110.926 175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 3.1 m 48.27 70.44 0.44 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.771 1.628 . . . . 0.0 111.908 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.791 ' HA ' HG22 ' K' ' 173' ' ' THR . 37.6 p -132.54 147.47 52.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.303 -167.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.99 -167.67 42.62 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.49 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -29.62 70.55 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.791 0.295 . . . . 0.0 111.395 -177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.1 156.16 60.41 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.471 0.708 . . . . 0.0 109.271 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.77 97.77 1.03 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.319 1.346 . . . . 0.0 112.74 -156.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.6 82.79 1.14 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.791 HG22 ' HA ' ' K' ' 167' ' ' THR . 11.1 t -108.53 153.45 23.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.947 0.874 . . . . 0.0 109.873 170.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . . . . . . . . . 4.3 m -74.55 157.16 86.46 Favored Pre-proline 0 C--O 1.24 0.594 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.399 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.37 137.67 61.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.508 0.86 . . . . 0.0 111.708 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.453 1.501 . . . . 0.0 112.298 -171.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.504 ' HB3' ' HE3' ' G' ' 70' ' ' LYS . 49.4 Cg_endo . . . . . 0 N--CA 1.466 -0.121 0 N-CA-C 109.168 -1.128 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.483 ' O ' HG22 ' G' ' 126' ' ' VAL . 6.0 pt -61.55 127.97 22.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.604 ' HA ' ' HA ' ' G' ' 125' ' ' ALA . 0.0 OUTLIER -89.08 -177.96 5.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.888 0.852 . . . . 0.0 110.75 -177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.448 ' N ' ' HA ' ' G' ' 125' ' ' ALA . . . -66.83 -31.65 78.87 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.346 -0.843 . . . . 0.0 114.547 175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.78 -18.33 62.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.754 0.777 . . . . 0.0 112.442 172.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.571 ' O ' ' N ' ' L' ' 96' ' ' THR . 4.8 t70 -66.24 -37.62 85.94 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -172.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.627 HG11 HH21 ' L' ' 93' ' ' ARG . 28.1 m -101.66 117.78 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . 0.559 ' HE3' ' HA ' ' L' ' 12' ' ' LYS . 0.0 OUTLIER -117.76 157.48 26.47 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.636 0.731 . . . . 0.0 110.533 176.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -114.19 98.65 7.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.742 -164.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.4 HD23 ' HB3' ' L' ' 25' ' ' ALA . 5.5 mp -87.03 141.26 28.79 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.493 ' HB3' HD11 ' L' ' 89' ' ' ILE . 19.1 m-85 -126.04 137.64 53.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.45 0.643 . . . . 0.0 109.947 176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.636 ' HG2' ' HA ' ' L' ' 25' ' ' ALA . 1.3 tm0? -131.93 136.28 47.25 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 147.31 47.73 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.008 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.642 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 2.0 pt -64.52 -46.96 91.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.959 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . 0.469 ' H ' HG13 ' L' ' 18' ' ' ILE . 2.0 p30 -85.86 -11.9 52.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -37.46 82.36 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.439 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.577 ' HB2' HG23 ' F' ' 166' ' ' THR . . . 49.87 40.12 19.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.228 1.411 . . . . 0.0 111.822 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.06 163.69 13.55 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.421 ' HA2' ' H ' ' F' ' 164' ' ' GLY . . . -94.9 4.86 68.65 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.743 -178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -146.46 142.72 28.41 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.988 0.394 . . . . 0.0 111.86 -177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' L' ' 16' ' ' GLN . . . -100.07 122.6 49.95 Favored Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.018 2.127 . . . . 0.0 112.41 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' L' ' 15' ' ' PHE . 27.7 Cg_exo -70.42 127.23 13.78 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.462 0.844 . . . . 0.0 112.455 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.591 HD22 HG23 ' L' ' 150' ' ' ILE . 0.8 OUTLIER -106.57 126.94 52.9 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 168.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -90.36 140.49 27.03 Favored Pre-proline 0 C--N 1.316 -0.858 0 C-N-CA 115.8 -2.36 . . . . 0.0 110.562 -167.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.9 169.96 21.11 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-N 118.996 0.677 . . . . 0.0 112.437 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.08 48.52 12.94 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.318 1.447 . . . . 0.0 111.577 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.431 ' HE1' ' HG ' ' L' ' 27' ' ' LEU . 2.9 m-85 -71.85 133.12 45.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 122.489 1.138 . . . . 0.0 111.074 173.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.24 -111.13 0.13 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 18.2 p -121.33 174.21 6.86 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.814 1.292 . . . . 0.0 111.091 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.518 ' OD1' HG22 ' L' ' 65' ' ' VAL . 5.2 t0 -159.12 129.51 5.86 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.004 -164.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.97 131.68 7.6 Favored Glycine 0 N--CA 1.441 -1.031 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.35 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.52 108.97 17.9 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.596 HG22 ' HG2' ' G' ' 117' ' ' GLU . 57.3 t -107.24 126.03 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -173.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . 0.636 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 6.0 p -130.82 80.53 1.95 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.73 118.52 4.76 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.249 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.12 90.73 3.53 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.475 HH12 ' HG2' ' L' ' 42' ' ' GLU . 10.5 mmm180 -65.57 -179.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.745 0.783 . . . . 0.0 110.147 -174.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . 0.475 ' HG2' HH12 ' L' ' 41' ' ' ARG . 0.0 OUTLIER -146.34 141.49 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -167.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.786 HD13 ' HA2' ' L' ' 57' ' ' GLY . 0.0 OUTLIER -73.48 166.05 23.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.501 -179.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . 0.471 ' HA ' HG12 ' L' ' 53' ' ' ILE . 5.4 t80 -108.88 84.99 2.02 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.207 171.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . 0.555 ' H ' HG21 ' L' ' 53' ' ' ILE . 26.4 t70 -110.58 100.1 8.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.638 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 10.1 pt-20 -68.76 -21.23 64.37 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 69.31 26.63 5.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.564 1.546 . . . . 0.0 111.641 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.638 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 0.0 OUTLIER 50.35 48.92 21.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.496 1.518 . . . . 0.0 111.59 -164.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' L' ' 52' ' ' ARG . 6.4 tptt -116.58 -92.21 0.52 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.457 -177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -152.3 33.85 0.52 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . 0.562 ' H ' ' HB2' ' L' ' 46' ' ' GLU . . . 80.24 36.15 24.93 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' L' ' 49' ' ' LYS . 0.1 OUTLIER -102.65 116.33 32.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.555 HG21 ' H ' ' L' ' 45' ' ' ASP . 0.3 OUTLIER -132.9 135.98 56.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.861 178.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.456 HD22 HD13 ' G' ' 135' ' ' ILE . 0.4 OUTLIER -109.03 25.14 12.16 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.42 161.27 12.88 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.64 0.578 . . . . 0.0 113.938 -170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . 0.498 ' O ' HD22 ' L' ' 43' ' ' LEU . 68.7 Cg_endo -80.06 160.11 23.76 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 N-CA-C 113.85 0.673 . . . . 0.0 113.85 -175.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . 0.786 ' HA2' HD13 ' L' ' 43' ' ' LEU . . . -124.88 -71.01 0.2 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 8.4 t -160.36 170.23 21.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.6 0.714 . . . . 0.0 110.52 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.476 HG23 ' CB ' ' K' ' 50' ' ' ASN . 2.3 t -114.99 110.62 32.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.06 83.14 2.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.82 104.52 14.03 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . 0.857 ' HA ' ' HA ' ' L' ' 133' ' ' GLN . 92.4 p -142.72 163.41 32.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.971 0.909 . . . . 0.0 110.089 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' L' ' 132' ' ' LEU . . . -146.95 155.68 26.66 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.174 176.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' L' ' 131' ' ' SER . 0.0 OUTLIER -122.71 141.59 51.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.518 HG22 ' OD1' ' L' ' 34' ' ' ASP . 86.0 t -129.25 125.17 61.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 33.8 p -113.06 137.61 51.16 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.4 167.85 24.17 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -91.42 143.17 26.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . . . . . . . . . . . -80.71 141.72 22.95 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.634 ' H ' HE22 ' L' ' 76' ' ' GLN . 0.4 OUTLIER -123.09 151.04 42.42 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 174.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.588 HH11 ' HB ' ' K' ' 97' ' ' VAL . 0.0 OUTLIER -56.49 -37.16 69.99 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -122.23 -123.13 2.88 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' L' ' 70' ' ' LYS . 87.8 m-20 67.6 126.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.125 1.37 . . . . 0.0 111.004 169.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . 0.532 ' HA ' ' HB2' ' L' ' 77' ' ' LYS . . . -85.23 -12.06 53.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.574 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -74.24 -46.99 18.99 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.819 168.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.634 HE22 ' H ' ' L' ' 70' ' ' LYS . 7.0 tt0 -67.0 -37.08 83.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.851 171.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' L' ' 74' ' ' ALA . 1.6 mtmt -66.43 -38.57 87.7 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.837 171.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.84 79.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.904 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.594 ' HB ' ' HA ' ' L' ' 76' ' ' GLN . 4.4 mm -59.51 -48.7 86.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 110.461 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -72.92 -41.35 64.65 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.745 -0.597 . . . . 0.0 112.459 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.66 -46.13 87.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.587 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -45.76 86.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.146 -1.022 . . . . 0.0 111.534 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 5.3 t80 -62.26 -50.31 72.22 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.936 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.512 ' HG2' ' NZ ' ' K' ' 139' ' ' LYS . 0.9 OUTLIER -81.5 -25.61 35.83 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -167.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.469 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 18.3 m120 -94.99 -0.41 53.86 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.986 172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 66.74 30.01 75.59 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 122.353 -0.217 . . . . 0.0 112.878 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.469 ' HE2' ' OD1' ' L' ' 85' ' ' ASN . 15.1 mttm -70.68 142.98 51.5 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.655 HE22 ' HB3' ' L' ' 110' ' ' PHE . 0.0 OUTLIER -73.62 142.21 46.53 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 168.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' L' ' 15' ' ' PHE . 7.7 tt -118.74 139.46 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.399 0.619 . . . . 0.0 109.843 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 4.9 mtmp? -85.81 131.18 34.36 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -120.08 122.85 41.99 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.545 1.138 . . . . 0.0 109.988 -165.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.764 ' HH2' ' H ' ' F' ' 161' ' ' GLN . 55.9 m95 -124.23 115.21 20.69 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.17 0.988 . . . . 0.0 108.363 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.627 HH21 HG11 ' L' ' 11' ' ' VAL . 20.1 ttt180 -104.44 107.11 17.88 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 172.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.787 HG21 HG21 ' L' ' 145' ' ' THR . 2.5 m -122.3 152.39 26.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.215 1.007 . . . . 0.0 109.429 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' L' ' 11' ' ' VAL . 1.0 OUTLIER -87.17 162.82 17.28 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.637 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.571 ' N ' ' O ' ' L' ' 10' ' ' ASP . 28.1 m -99.26 -25.01 14.64 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.637 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . 0.705 ' HB ' HH11 ' G' ' 71' ' ' ARG . 2.6 m -69.1 165.24 2.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.722 0.772 . . . . 0.0 109.906 176.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.69 108.16 19.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.938 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' L' ' 102' ' ' ASP . 16.6 t30 -73.27 157.54 36.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.786 0.803 . . . . 0.0 109.967 171.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.3 -19.14 23.29 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -90.12 -83.51 0.25 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.743 0.701 . . . . 0.0 110.922 169.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' L' ' 99' ' ' ASN . 0.8 OUTLIER -66.78 152.88 44.67 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.575 ' HD2' ' O ' ' L' ' 143' ' ' ILE . 0.4 OUTLIER -51.73 -46.25 63.92 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.871 -0.518 . . . . 0.0 110.617 171.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.491 ' HD1' ' O ' ' L' ' 97' ' ' VAL . 26.6 m-85 -138.21 -170.46 2.81 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.5 t70 -141.09 143.08 34.12 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.651 0.738 . . . . 0.0 109.402 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.06 140.72 44.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.081 -163.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -101.71 130.68 48.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 157.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.494 ' CE2' HD13 ' L' ' 138' ' ' LEU . 23.2 t80 -133.59 155.01 50.42 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.429 0.692 . . . . 0.0 110.437 -163.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . 0.794 ' HA2' HD12 ' L' ' 138' ' ' LEU . . . -173.45 170.6 43.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.959 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.655 ' HB3' HE22 ' L' ' 88' ' ' GLN . 5.1 m-85 -93.03 137.2 32.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 167.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -133.59 159.88 39.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 0.0 111.226 -169.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.96 136.45 42.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 107.985 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.422 HG21 ' HD1' ' L' ' 83' ' ' TYR . 2.8 mp -71.01 111.13 4.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' L' ' 132' ' ' LEU . 18.9 mt-10 -90.95 -30.22 16.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 45.0 t -163.79 149.19 10.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.94 0.791 . . . . 0.0 109.119 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.54 HH11 ' HG3' ' L' ' 116' ' ' ARG . 1.3 tmm_? -121.1 138.96 53.94 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.608 ' HG2' HG22 ' K' ' 37' ' ' VAL . 0.2 OUTLIER -135.22 120.31 18.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.11 120.6 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.065 0.459 . . . . 0.0 111.174 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . 0.642 ' HB2' ' HB2' ' L' ' 127' ' ' GLU . 1.0 OUTLIER -102.16 125.85 48.97 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.677 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -122.45 114.85 21.28 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.98 -175.33 22.16 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.494 HG23 HG22 ' K' ' 33' ' ' THR . 15.1 t -77.18 -55.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.501 -0.411 . . . . 0.0 111.122 176.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.3 159.52 14.97 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.42 153.51 28.88 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' K' ' 7' ' ' MET . . . -79.98 163.95 23.85 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.635 0.731 . . . . 0.0 110.767 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.449 HG13 ' O ' ' K' ' 7' ' ' MET . 18.6 m -55.14 146.2 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.013 -171.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' L' ' 119' ' ' SER . 29.8 mp0 -127.17 129.69 48.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.103 -176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . 0.474 HG22 HG23 ' L' ' 130' ' ' ILE . 26.4 mt -114.89 124.84 71.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.15 121.89 45.4 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 168.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.615 HG13 ' O ' ' L' ' 130' ' ' ILE . 12.7 pt -119.82 122.51 68.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.769 ' HA ' ' HG2' ' L' ' 64' ' ' GLU . 0.8 OUTLIER -106.53 129.98 54.38 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.752 -178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.529 ' HA ' ' HG3' ' L' ' 114' ' ' GLU . 0.4 OUTLIER -142.84 163.21 33.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.101 -172.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.857 ' HA ' ' HA ' ' L' ' 62' ' ' SER . 1.8 pt20 -121.07 163.22 18.69 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.417 HG13 ' O ' ' L' ' 110' ' ' PHE . 4.2 t -121.74 128.37 75.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.613 HD13 HD22 ' K' ' 54' ' ' LEU . 6.9 pt -67.24 -51.36 54.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 121.309 0.576 . . . . 0.0 110.35 -173.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.467 ' HA2' ' HD3' ' F' ' 155' ' ' LYS . . . -125.3 116.89 2.81 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.688 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.55 123.91 24.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.002 0.906 . . . . 0.0 110.685 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.794 HD12 ' HA2' ' L' ' 109' ' ' GLY . 2.4 mt -127.88 151.88 48.53 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.432 ' NZ ' ' HG2' ' G' ' 84' ' ' GLN . 0.0 OUTLIER -135.78 130.74 34.51 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.75 ' HB3' ' HB3' ' F' ' 159' ' ' ASP . 13.0 p-10 -160.0 150.75 18.98 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -67.82 151.61 52.13 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.413 169.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.884 ' OE1' ' CD2' ' F' ' 160' ' ' PHE . 2.8 tp10 -111.11 143.47 41.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' F' ' 160' ' ' PHE . 1.7 mp -104.77 -64.2 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -120.91 113.84 20.7 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.996 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.787 HG21 HG21 ' L' ' 94' ' ' VAL . 12.7 p -109.49 31.5 5.73 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 118.739 -0.648 . . . . 0.0 112.4 175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 mm? 47.42 56.52 17.48 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 126.449 1.9 . . . . 0.0 109.382 -173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.4 Cg_exo -69.07 -7.85 21.97 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.256 1.304 . . . . 0.0 115.389 -159.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 -32.31 66.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.537 171.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -126.82 -45.67 1.59 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.684 HD12 ' O ' ' L' ' 145' ' ' THR . 17.3 mt -71.76 -45.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.167 0.894 . . . . 0.0 111.292 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 2.4 t -79.02 -39.81 21.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -86.13 121.18 28.36 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.455 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.24 110.38 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -109.54 144.73 37.43 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -74.68 -33.99 62.57 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.44 11.72 77.2 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 119.37 0.986 . . . . 0.0 112.999 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -77.92 117.79 4.8 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -93.98 112.2 24.01 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.33 1.052 . . . . 0.0 108.613 177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -32.97 70.75 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -158.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -133.96 112.49 11.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.657 2.383 . . . . 0.0 109.154 167.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.593 ' HB3' ' HG3' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -141.7 45.09 1.71 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 154.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . 0.577 ' HB3' ' HD3' ' L' ' 163' ' ' PRO . 22.9 tt0 -58.22 -53.73 62.96 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -166.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' L' ' 162' ' ' GLN . 22.2 Cg_exo -82.71 131.63 6.31 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.035 1.762 . . . . 0.0 113.912 171.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 61.71 42.52 99.76 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' L' ' 161' ' ' GLN . 1.3 tt0 -60.37 -42.56 96.07 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.875 1.338 . . . . 0.0 110.903 175.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 3.2 m 48.34 70.41 0.45 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.79 1.636 . . . . 0.0 111.917 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.787 ' HA ' HG22 ' L' ' 173' ' ' THR . 37.6 p -132.54 147.53 52.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.307 -167.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -84.09 -167.57 42.57 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.471 172.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -29.59 70.53 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.779 0.29 . . . . 0.0 111.452 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -85.11 156.12 60.39 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.456 0.702 . . . . 0.0 109.265 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -80.71 97.77 1.04 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.296 1.331 . . . . 0.0 112.778 -156.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.65 82.69 1.15 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.207 1.643 . . . . 0.0 117.207 165.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.787 HG22 ' HA ' ' L' ' 167' ' ' THR . 11.1 t -108.49 153.38 23.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.999 0.899 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.43 157.16 86.67 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.447 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.4 137.68 61.61 Favored 'Trans proline' 0 C--N 1.348 0.543 0 CA-C-N 119.507 0.859 . . . . 0.0 111.75 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 C-N-CA 125.406 1.482 . . . . 0.0 112.302 -171.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.795 1.036 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' B' ' 126' ' ' VAL . 67.2 mt -131.19 154.89 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.894 0.854 . . . . 0.0 110.724 -177.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -67.42 -15.06 65.42 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.387 -0.824 . . . . 0.0 114.495 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.02 -6.59 26.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.791 0.796 . . . . 0.0 112.4 172.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 26.6 t0 -66.47 -51.61 54.96 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.74 121.0 35.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.36 50.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.683 0.754 . . . . 0.0 110.468 176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 34' ' ' ASP . 51.5 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.738 -164.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -93.55 130.52 39.39 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.2 115.2 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.419 0.628 . . . . 0.0 109.953 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 15.5 tt0 -113.66 127.28 55.99 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.39 146.38 36.66 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.524 0.678 . . . . 0.0 111.008 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.851 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.85 71.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.002 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.05 66.91 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.34 67.68 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.4 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.55 54.43 11.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.209 1.404 . . . . 0.0 111.805 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.28 6.47 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.337 -0.392 . . . . 0.0 113.732 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.24 -37.45 69.13 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.009 0.404 . . . . 0.0 111.834 -177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 49.48 77.08 0.48 Allowed Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.949 2.1 . . . . 0.0 112.379 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.85 46.76 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 119.452 0.84 . . . . 0.0 112.493 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -126.56 146.62 50.07 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' A' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.801 -2.359 . . . . 0.0 110.519 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.71 -178.67 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.313 0 CA-C-O 121.861 0.692 . . . . 0.0 112.407 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 60.49 39.26 18.47 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.363 1.465 . . . . 0.0 111.592 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.62 47.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.53 1.157 . . . . 0.0 111.05 173.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.98 170.48 13.91 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 122.766 1.27 . . . . 0.0 111.073 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' A' ' 65' ' ' VAL . 1.6 t0 -162.41 102.5 1.08 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.969 -164.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.81 140.4 15.07 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.366 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 19.1 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 173.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' B' ' 117' ' ' GLU . 31.1 m -127.71 145.91 34.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.28 123.87 24.93 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.44 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.246 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.46 123.56 44.84 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' A' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.77 57.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.726 0.774 . . . . 0.0 110.193 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.801 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.44 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -167.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.13 120.72 39.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.508 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 0.6 OUTLIER -130.65 88.44 2.62 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.22 171.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 1.6 t70 -107.8 168.91 8.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 1.9 mp0 -71.8 -47.18 55.11 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 176.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.15 35.57 26.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.595 1.558 . . . . 0.0 111.672 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.91 48.95 5.14 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.51 1.524 . . . . 0.0 111.56 -164.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.502 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.99 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' A' ' 44' ' ' PHE . . . 82.67 174.09 49.85 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HA ' HH11 ' A' ' 52' ' ' ARG . 0.0 OUTLIER -118.26 122.36 42.74 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.878 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.2 pp -128.69 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.822 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' B' ' 88' ' ' GLN . 0.8 OUTLIER -65.25 -23.8 67.15 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 176.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.674 0.596 . . . . 0.0 113.97 -170.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.34 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.839 0.669 . . . . 0.0 113.839 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 3.2 t -85.9 153.14 22.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.567 0.699 . . . . 0.0 110.538 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 12.5 p -104.62 132.02 52.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -106.66 110.85 23.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.13 16.15 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.47 31.78 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.945 0.898 . . . . 0.0 110.083 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.73 25.6 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.181 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.83 130.95 26.43 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' A' ' 34' ' ' ASP . 15.7 t -112.69 122.48 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -112.36 137.75 50.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -72.17 143.77 35.09 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 114.971 0.748 . . . . 0.0 114.971 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 8.8 tttp -113.57 151.68 31.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.445 0.641 . . . . 0.0 109.279 174.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.14 -51.62 17.59 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.49 -113.34 3.12 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' A' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.15 1.38 . . . . 0.0 111.031 169.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.53 -26.82 20.67 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.42 -53.08 44.62 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.848 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.61 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.818 171.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -38.3 85.6 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.839 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.63 98.32 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.904 168.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.119 0.485 . . . . 0.0 110.459 172.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 1.0 OUTLIER -67.64 -46.86 71.23 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.685 -0.635 . . . . 0.0 112.402 -178.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.1 -36.46 75.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.588 169.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.829 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.92 -50.19 74.97 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.582 174.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.668 ' HD1' HG22 ' A' ' 113' ' ' ILE . 57.3 t80 -74.06 -48.39 30.17 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.927 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.92 63.65 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 87' ' ' LYS . 35.2 m120 -83.38 -36.16 24.54 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.01 172.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.81 2.82 Favored Glycine 0 N--CA 1.448 -0.538 0 O-C-N 122.293 -0.254 . . . . 0.0 112.882 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 11.4 mptt -137.45 148.46 46.12 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -69.14 141.54 54.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 168.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 82' ' ' ALA . 13.1 mm -116.46 129.06 73.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.323 0.582 . . . . 0.0 109.86 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.72 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.96 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.541 1.136 . . . . 0.0 110.022 -165.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' A' ' 108' ' ' PHE . 6.5 m95 -123.51 121.54 35.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.204 1.001 . . . . 0.0 108.389 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.75 18.18 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.609 HG11 ' HG2' ' A' ' 142' ' ' GLU . 13.5 m -128.49 151.6 35.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 122.282 1.039 . . . . 0.0 109.388 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.01 157.53 16.05 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.625 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.52 -4.09 55.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.64 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.82 136.15 28.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.694 0.759 . . . . 0.0 109.903 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 12.7 tttp -66.88 126.04 27.84 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.964 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.1 168.13 12.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.848 0.833 . . . . 0.0 109.986 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.91 51.05 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.86 -42.15 1.13 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.761 0.71 . . . . 0.0 110.911 169.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.11 167.5 20.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.94 85.42 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.894 -0.504 . . . . 0.0 110.585 171.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' A' ' 151' ' ' VAL . 97.2 m-85 -148.07 176.41 10.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.78 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.51 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.674 0.75 . . . . 0.0 109.451 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -143.48 149.34 37.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.045 -163.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' A' ' 139' ' ' LYS . 63.3 mt-30 -120.61 131.17 54.5 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 157.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' A' ' 138' ' ' LEU . 85.3 t80 -123.6 148.79 46.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.376 0.67 . . . . 0.0 110.405 -163.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.89 31.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.534 -1.317 . . . . 0.0 111.966 170.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' VAL . 2.4 m-85 -86.59 123.89 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 167.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.9 145.9 51.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.907 0.86 . . . . 0.0 111.215 -169.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -123.87 125.21 44.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.534 -1.212 . . . . 0.0 107.968 -174.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.668 HG22 ' HD1' ' A' ' 83' ' ' TYR . 60.4 mt -78.65 102.37 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.98 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.65 45.11 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.954 0.797 . . . . 0.0 109.115 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.96 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.72 120.15 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 22.8 p90 -121.07 138.87 53.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.165 176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 25.9 t -109.8 140.34 43.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.697 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 167.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.38 28.23 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.31 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.511 -0.405 . . . . 0.0 111.096 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.51 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 169.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.11 149.67 50.22 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.862 HG23 HG21 ' F' ' 6' ' ' ILE . 45.5 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.045 -171.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.12 -176.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.45 111.9 31.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.4 t -114.94 125.86 54.12 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' A' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.35 139.76 43.9 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.375 0.67 . . . . 0.0 109.698 -178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.35 40.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.102 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.3 145.82 38.13 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 167.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.791 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.5 p -138.2 141.57 37.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.967 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -59.4 -49.03 85.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.327 -173.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -160.62 145.33 10.95 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.712 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.78 44.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.029 0.919 . . . . 0.0 110.662 174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -174.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' A' ' 107' ' ' GLN . 15.0 mtmt -86.32 134.29 33.75 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.09 0.94 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -119.77 154.26 16.51 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.434 169.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.94 24.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -174.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.71 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.751 -176.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.53 8.95 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.928 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' A' ' 150' ' ' ILE . 38.0 p -94.42 21.13 7.45 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.352 175.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.455 ' N ' ' HD3' ' A' ' 147' ' ' PRO . 1.0 OUTLIER 55.27 53.35 8.91 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.426 1.891 . . . . 0.0 109.392 -173.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.721 ' HB3' HG21 ' A' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.74 41.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.53 -51.25 49.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.528 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -173.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 145' ' ' THR . 1.0 OUTLIER -76.84 -41.26 32.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.186 0.903 . . . . 0.0 111.252 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 147' ' ' PRO . 24.3 t -73.33 -36.42 49.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.66 116.76 32.32 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.487 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.64 62.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.409 ' HA ' ' ND2' ' L' ' 50' ' ' ASN . 1.6 p -141.05 134.77 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -172.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 156' ' ' GLY . 0.2 OUTLIER -55.03 -44.53 74.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 175.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.551 ' O ' ' HD2' ' A' ' 155' ' ' LYS . . . 138.96 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 119.422 1.01 . . . . 0.0 113.073 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' CE2' ' HB2' ' A' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 108.616 177.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' G' ' 140' ' ' ASN . 2.2 m-20 -70.83 -44.97 65.39 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HB2' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -131.56 117.59 18.96 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.677 2.391 . . . . 0.0 109.143 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -122.64 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.541 ' HG2' ' O ' ' G' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.5 2.12 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 -166.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.544 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -84.98 -3.16 9.69 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.068 1.774 . . . . 0.0 113.842 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.74 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.567 0 N-CA-C 118.385 2.114 . . . . 0.0 118.385 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.522 ' O ' HG22 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.23 69.64 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 118.903 1.351 . . . . 0.0 110.863 175.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' G' ' 21' ' ' ALA . 1.8 p 47.08 51.72 12.69 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.788 1.635 . . . . 0.0 111.939 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.433 HG21 ' H ' ' A' ' 172' ' ' GLY . 85.6 m -124.38 156.16 37.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.328 -167.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 167' ' ' THR . . . -89.52 -152.23 26.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.463 172.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.88 99.64 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.797 0.299 . . . . 0.0 111.394 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.9 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.527 0.731 . . . . 0.0 109.27 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.679 ' HB2' ' CE2' ' A' ' 158' ' ' TYR . 85.3 Cg_endo -79.34 150.28 22.31 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.319 1.346 . . . . 0.0 112.755 -156.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.522 ' HA3' ' CE1' ' A' ' 158' ' ' TYR . . . 80.57 12.6 82.74 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 117.15 1.62 . . . . 0.0 117.15 165.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.8 38.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.007 0.904 . . . . 0.0 109.906 170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 165' ' ' GLN . 38.0 t -107.19 114.57 61.05 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.423 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 31.5 Cg_exo -70.25 165.51 31.27 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.511 0.861 . . . . 0.0 111.747 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 125.391 1.476 . . . . 0.0 112.301 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--O 1.231 0.156 0 N-CA-C 114.751 1.02 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.789 HG21 HG23 ' C' ' 126' ' ' VAL . 67.4 mt -131.14 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.818 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -117.81 159.18 23.48 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.924 0.869 . . . . 0.0 110.773 -177.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -67.37 -15.17 65.44 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.334 -0.848 . . . . 0.0 114.471 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.54 26.46 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.799 0.799 . . . . 0.0 112.405 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.818 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 26.6 t0 -66.5 -51.6 54.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -172.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.5 t -83.75 121.01 35.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.33 50.58 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.627 0.727 . . . . 0.0 110.506 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' B' ' 34' ' ' ASP . 50.8 m-85 -106.73 105.24 15.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.744 -164.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' B' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.56 39.36 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.28 115.2 21.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.497 0.665 . . . . 0.0 109.971 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.583 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 15.4 tt0 -113.66 127.26 55.98 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 170.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.37 146.38 36.69 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.037 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.873 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.0 OUTLIER -62.14 -35.9 71.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.001 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.28 -23.06 66.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -171.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.26 67.64 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.456 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.42 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.197 1.399 . . . . 0.0 111.827 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.33 6.44 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.8 27.37 7.18 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.708 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.26 -37.45 69.07 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.979 0.389 . . . . 0.0 111.798 -177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 49.41 77.09 0.48 Allowed Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.962 2.105 . . . . 0.0 112.436 -174.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.38 144.9 46.76 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.423 0.83 . . . . 0.0 112.464 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.7 tt -126.56 146.6 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 76' ' ' GLN . 62.3 t80 -102.7 133.08 20.65 Favored Pre-proline 0 C--N 1.316 -0.848 0 C-N-CA 115.79 -2.364 . . . . 0.0 110.516 -167.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.67 -178.66 3.9 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 CA-C-O 121.879 0.699 . . . . 0.0 112.421 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' G' ' 47' ' ' GLN . . . 60.54 39.24 18.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.355 1.462 . . . . 0.0 111.54 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' B' ' 28' ' ' PHE . 12.7 m-30 -71.25 135.6 47.55 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 122.499 1.142 . . . . 0.0 111.077 173.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.89 170.47 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.773 1.273 . . . . 0.0 111.07 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' B' ' 65' ' ' VAL . 1.6 t0 -162.37 102.44 1.08 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.017 -1.447 . . . . 0.0 107.981 -164.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.71 140.38 15.07 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.361 170.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.595 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 19.0 t -133.92 120.75 20.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 173.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.414 HG12 ' HB3' ' C' ' 117' ' ' GLU . 31.1 m -127.66 145.92 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.31 123.91 24.96 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.48 118.07 3.82 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.242 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.54 123.56 44.92 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.574 HH22 ' HB2' ' B' ' 60' ' ' ALA . 1.7 mtm-85 -61.16 135.77 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.757 . . . . 0.0 110.16 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.872 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -137.35 125.5 23.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.466 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.459 ' CE2' ' HA3' ' B' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.34 2.61 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.238 171.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' B' ' 51' ' ' GLY . 1.6 t70 -107.77 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 155.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.633 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.12 55.15 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.15 35.54 26.39 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.605 1.562 . . . . 0.0 111.691 -172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 33.4 p 42.89 48.97 5.12 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 111.551 -164.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.22 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.482 -177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.48 0.32 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' B' ' 45' ' ' ASP . . . 82.74 174.13 49.94 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.528 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.31 42.61 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.967 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.2 pp -128.66 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.877 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.781 HD23 ' HG3' ' C' ' 88' ' ' GLN . 0.8 OUTLIER -65.3 -23.75 67.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.649 0.583 . . . . 0.0 113.968 -170.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.31 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.412 0 N-CA-C 113.836 0.668 . . . . 0.0 113.836 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.87 29.29 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.516 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.591 0.71 . . . . 0.0 110.492 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 12.5 p -104.63 131.94 52.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.574 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -106.6 110.83 23.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' B' ' 134' ' ' VAL . 13.3 m-20 -98.77 104.11 16.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.965 0.906 . . . . 0.0 110.063 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.14 154.7 25.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.184 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.81 130.95 26.46 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' B' ' 34' ' ' ASP . 15.5 t -112.6 122.41 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.33 137.74 50.05 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -159.59 162.53 35.32 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.73 33.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.78 35.17 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.498 ' HG2' ' OD1' ' B' ' 73' ' ' ASP . 8.8 tttp -113.6 151.67 31.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.446 0.641 . . . . 0.0 109.289 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.451 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.61 17.62 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . 0.498 ' OD1' ' HG2' ' B' ' 70' ' ' LYS . 1.4 m-20 72.16 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.132 1.373 . . . . 0.0 111.029 169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.51 -26.78 20.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 -156.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -62.41 -53.08 44.61 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.84 168.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.494 ' HB3' ' CE1' ' B' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.822 171.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -38.25 85.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 119.924 -0.711 . . . . 0.0 111.798 171.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -43.62 98.33 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.878 168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.604 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -52.4 -47.89 46.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.082 0.468 . . . . 0.0 110.51 172.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.82 71.18 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.772 -0.58 . . . . 0.0 112.447 -178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.36 75.15 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.572 169.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.837 ' HB2' HD11 ' B' ' 89' ' ' ILE . . . -58.94 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.563 174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' B' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.22 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.944 -174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.98 63.55 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' B' ' 87' ' ' LYS . 35.2 m120 -83.36 -36.13 24.6 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.029 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.77 2.81 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.291 -0.256 . . . . 0.0 112.841 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.616 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 11.5 mptt -137.39 148.55 46.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.74 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -69.18 141.57 54.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' B' ' 82' ' ' ALA . 13.1 mm -116.43 129.0 73.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 121.364 0.602 . . . . 0.0 109.847 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.873 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 8.5 mtmt -82.94 111.28 18.66 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' B' ' 111' ' ' ALA . 39.0 t80 -105.96 124.63 49.88 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.52 1.128 . . . . 0.0 110.002 -165.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' B' ' 108' ' ' PHE . 6.5 m95 -123.51 121.53 35.9 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.253 1.021 . . . . 0.0 108.339 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.09 107.74 18.16 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 172.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.628 HG11 ' HG2' ' B' ' 142' ' ' GLU . 13.5 m -128.47 151.56 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.182 0.992 . . . . 0.0 109.452 -173.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.55 16.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.603 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.58 -4.06 55.75 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.663 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -96.85 136.19 28.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.693 0.758 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 12.7 tttp -66.88 126.06 27.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.982 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.2 12.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.839 0.828 . . . . 0.0 109.979 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.52 -5.83 50.97 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.89 -42.26 1.12 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.742 0.701 . . . . 0.0 110.827 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' B' ' 104' ' ' TYR . 0.3 OUTLIER -79.99 167.53 20.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 167.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -66.93 -37.95 85.29 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.901 -0.499 . . . . 0.0 110.521 171.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' B' ' 151' ' ' VAL . 97.3 m-85 -148.09 176.39 10.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.796 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.25 37.47 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.631 0.729 . . . . 0.0 109.447 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -143.46 149.33 37.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.069 -163.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.553 ' HG2' ' HG2' ' B' ' 139' ' ' LYS . 63.2 mt-30 -120.57 131.23 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' B' ' 138' ' ' LEU . 85.3 t80 -123.6 148.82 46.04 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.336 0.654 . . . . 0.0 110.401 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.83 31.21 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.968 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' B' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.97 32.31 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' B' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.926 0.87 . . . . 0.0 111.179 -169.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.0 t80 -123.77 125.16 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.044 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' B' ' 83' ' ' TYR . 60.6 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.801 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.03 20.96 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.65 45.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.912 0.778 . . . . 0.0 109.133 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.94 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.459 ' HB3' HG12 ' A' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.1 34.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 22.8 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.12 0.485 . . . . 0.0 111.179 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' B' ' 127' ' ' GLU . 25.9 t -109.8 140.32 43.85 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.683 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.42 31.82 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 167.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.63 -178.42 28.33 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.33 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.501 -0.411 . . . . 0.0 111.111 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.645 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 3.1 tp10 -129.98 142.53 50.62 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.65 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.16 149.65 50.21 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.603 0.716 . . . . 0.0 110.73 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 6' ' ' ILE . 45.1 t -52.96 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.026 -171.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.3 OUTLIER -76.16 102.24 5.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -176.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.47 111.94 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 65' ' ' VAL . 3.4 t -114.91 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.524 HG13 ' HB ' ' B' ' 65' ' ' VAL . 1.6 pp -118.08 130.02 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.77 43.9 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.712 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.43 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.138 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.83 38.16 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 167.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.878 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.5 p -138.24 141.65 37.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.822 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.02 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.365 0.603 . . . . 0.0 110.35 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -160.63 145.35 10.98 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.704 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.35 122.82 44.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.022 0.915 . . . . 0.0 110.685 174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.63 43.72 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -174.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.553 ' HG2' ' HG2' ' B' ' 107' ' ' GLN . 15.0 mtmt -86.35 134.32 33.74 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' B' ' 106' ' ' ALA . 1.1 p-10 -161.54 -163.08 0.94 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.796 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -119.84 154.35 16.48 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.214 -0.994 . . . . 0.0 111.365 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 21.7 tp10 -106.7 151.95 24.44 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.75 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.746 -176.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.995 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' B' ' 150' ' ' ILE . 37.7 p -94.42 21.09 7.49 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.753 -0.641 . . . . 0.0 112.361 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' B' ' 150' ' ' ILE . 1.1 mm? 55.35 53.37 8.82 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.468 1.907 . . . . 0.0 109.338 -173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.717 ' HB3' HG21 ' B' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.83 41.46 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.223 1.282 . . . . 0.0 115.334 -159.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.38 -51.28 47.36 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.626 171.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.56 6.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' B' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.14 0.882 . . . . 0.0 111.322 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' B' ' 147' ' ' PRO . 24.4 t -73.31 -36.39 49.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.71 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.449 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.88 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 171.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.06 134.74 30.19 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.548 ' HD2' ' O ' ' B' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.58 74.56 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 175.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' B' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.367 0.985 . . . . 0.0 113.053 -176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.17 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' B' ' 171' ' ' PRO . 0.0 OUTLIER -111.53 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.24 1.016 . . . . 0.0 108.591 177.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . 0.413 ' OD2' ' HB3' ' H' ' 140' ' ' ASN . 2.2 m-20 -70.86 -44.98 65.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.563 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.58 18.98 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 127.729 2.412 . . . . 0.0 109.164 167.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.402 ' HB3' ' HA ' ' B' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.57 1.75 Allowed 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 153.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' H' ' 144' ' ' ASP . 0.9 OUTLIER -70.78 -31.54 2.13 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.486 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.3 Cg_exo -85.01 -3.12 9.67 Favored 'Trans proline' 0 C--O 1.238 0.516 0 CA-C-N 122.001 1.75 . . . . 0.0 113.882 171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.7 68.6 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 118.37 2.108 . . . . 0.0 118.37 -171.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' B' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.21 69.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.907 1.353 . . . . 0.0 110.883 175.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' H' ' 21' ' ' ALA . 1.8 p 47.03 51.79 12.53 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.781 1.632 . . . . 0.0 111.885 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.426 HG21 ' H ' ' B' ' 172' ' ' GLY . 85.4 m -124.39 156.15 37.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.33 -167.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . 0.415 ' N ' HG22 ' B' ' 167' ' ' THR . . . -89.41 -152.2 25.84 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.484 172.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.03 -41.82 99.63 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.758 0.279 . . . . 0.0 111.4 -177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.05 51.77 Favored Pre-proline 0 C--O 1.235 0.325 0 C-N-CA 123.524 0.73 . . . . 0.0 109.24 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.678 ' HB2' ' CE2' ' B' ' 158' ' ' TYR . 85.4 Cg_endo -79.36 150.33 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.76 0 C-N-CA 121.308 1.339 . . . . 0.0 112.721 -156.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' B' ' 158' ' ' TYR . . . 80.52 12.57 82.82 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 165.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.8 38.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.994 0.897 . . . . 0.0 109.858 170.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' B' ' 165' ' ' GLN . 37.8 t -107.18 114.62 61.01 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.397 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' B' ' 176' ' ' ALA . 31.5 Cg_exo -70.37 165.48 31.51 Favored 'Trans proline' 0 C--N 1.348 0.552 0 CA-C-N 119.514 0.862 . . . . 0.0 111.712 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.239 0 C-N-CA 125.424 1.49 . . . . 0.0 112.327 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 N-CA-C 114.795 1.037 . . . . 0.0 114.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.743 HG21 HG23 ' D' ' 126' ' ' VAL . 67.4 mt -131.14 154.89 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.836 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -117.84 159.17 23.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.957 0.884 . . . . 0.0 110.699 -177.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -67.42 -15.09 65.45 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.302 -0.863 . . . . 0.0 114.477 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.95 -6.61 26.34 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 117.797 0.799 . . . . 0.0 112.384 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.836 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 26.7 t0 -66.49 -51.6 54.97 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.7 121.01 35.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.31 50.58 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.671 0.748 . . . . 0.0 110.49 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.562 ' OH ' ' HB3' ' C' ' 34' ' ' ASP . 51.0 m-85 -106.7 105.21 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.794 -164.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' C' ' 27' ' ' LEU . 1.0 OUTLIER -93.5 130.5 39.32 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 174.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.27 115.21 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.489 0.661 . . . . 0.0 109.962 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 15.4 tt0 -113.68 127.28 55.98 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.42 146.44 36.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.582 0.706 . . . . 0.0 111.015 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.76 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.009 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -22.96 66.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.08 -41.27 67.52 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.036 -0.665 . . . . 0.0 111.439 -175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.61 54.36 11.33 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.176 1.39 . . . . 0.0 111.78 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.4 6.4 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.88 27.31 7.17 Favored Glycine 0 N--CA 1.45 -0.404 0 O-C-N 123.374 0.421 . . . . 0.0 113.711 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.44 69.01 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.978 0.389 . . . . 0.0 111.814 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 49.46 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.447 0 C-N-CA 126.956 2.102 . . . . 0.0 112.409 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.42 144.87 46.47 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.42 0.829 . . . . 0.0 112.487 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -126.5 146.64 50.03 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' C' ' 76' ' ' GLN . 62.5 t80 -102.74 133.07 20.64 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.796 -2.361 . . . . 0.0 110.487 -167.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 CA-C-N 119.027 0.688 . . . . 0.0 112.436 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' H' ' 47' ' ' GLN . . . 60.58 39.24 18.17 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.32 1.448 . . . . 0.0 111.54 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' C' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.62 47.53 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 122.476 1.131 . . . . 0.0 111.089 173.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 9.8 mm-40 -106.27 -93.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.98 170.41 14.0 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 122.771 1.272 . . . . 0.0 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.722 ' OD1' HG13 ' C' ' 65' ' ' VAL . 1.6 t0 -162.38 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.088 -1.415 . . . . 0.0 108.007 -164.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.78 140.41 15.08 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.338 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 19.2 t -133.94 120.81 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.68 145.93 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.29 123.85 24.89 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.4 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.233 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.55 44.88 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' C' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.81 57.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.777 0.798 . . . . 0.0 110.185 -174.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.775 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.43 23.01 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -167.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.07 120.73 38.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.526 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' C' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.38 2.61 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.198 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.471 ' O ' ' HA2' ' C' ' 51' ' ' GLY . 1.6 t70 -107.78 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 155.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.608 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 1.9 mp0 -71.86 -47.16 54.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.12 35.64 26.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.627 1.571 . . . . 0.0 111.66 -172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.85 48.97 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.488 1.515 . . . . 0.0 111.581 -164.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.29 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.468 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.93 21.57 0.31 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' C' ' 45' ' ' ASP . . . 82.68 174.12 49.88 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.28 42.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.952 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.2 pp -128.64 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.879 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.704 HD23 ' HG3' ' D' ' 88' ' ' GLN . 0.8 OUTLIER -65.29 -23.78 67.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 176.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.26 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-O 121.693 0.607 . . . . 0.0 113.943 -170.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.27 176.55 9.81 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.49 -168.9 29.38 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.633 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 3.2 t -85.96 153.14 22.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.569 0.7 . . . . 0.0 110.533 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 12.6 p -104.63 131.94 52.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -106.58 110.82 23.12 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.557 ' HB2' ' O ' ' C' ' 134' ' ' VAL . 13.3 m-20 -98.75 104.12 16.14 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.94 143.54 31.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 110.033 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.18 154.74 25.62 Favored Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.134 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.85 130.97 26.41 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' C' ' 34' ' ' ASP . 15.6 t -112.67 122.41 66.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 24.4 p -112.35 137.76 50.04 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.49 35.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.49 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 19.4 m-30 -88.2 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 143.75 35.14 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' C' ' 73' ' ' ASP . 8.8 tttp -113.58 151.75 31.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . 0.41 HH21 ' HD3' ' C' ' 71' ' ' ARG . 10.1 ptp180 -47.24 -51.62 18.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -172.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.47 -113.4 3.13 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' C' ' 70' ' ' LYS . 1.4 m-20 72.19 121.36 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.14 1.376 . . . . 0.0 111.009 169.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.76 20.69 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.517 2.414 . . . . 0.0 117.517 -156.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.418 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.45 -53.01 45.0 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.891 168.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' C' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.29 92.48 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 122.161 -0.611 . . . . 0.0 111.853 171.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.27 85.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.801 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.65 98.25 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.878 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.601 HD12 HD11 ' C' ' 113' ' ' ILE . 5.7 mm -52.46 -47.83 46.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.063 0.458 . . . . 0.0 110.501 172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 1.0 OUTLIER -67.67 -46.87 71.11 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.75 -0.594 . . . . 0.0 112.439 -178.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.14 -36.4 75.17 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.006 -0.677 . . . . 0.0 111.594 169.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.826 ' HB2' HD11 ' C' ' 89' ' ' ILE . . . -58.93 -50.28 74.64 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.523 174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.672 ' HD1' HG22 ' C' ' 113' ' ' ILE . 57.1 t80 -73.97 -48.44 30.45 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.954 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.49 -51.88 63.7 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -167.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . 0.417 ' HB2' ' NZ ' ' C' ' 87' ' ' LYS . 35.2 m120 -83.39 -36.11 24.55 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.029 172.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.16 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.457 0 O-C-N 122.305 -0.247 . . . . 0.0 112.86 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 11.4 mptt -137.43 148.5 46.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.781 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.48 54.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.826 HD11 ' HB2' ' C' ' 82' ' ' ALA . 13.0 mm -116.41 129.07 73.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.348 0.594 . . . . 0.0 109.881 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 8.5 mtmt -82.93 111.28 18.65 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.404 ' HB2' ' HB3' ' C' ' 111' ' ' ALA . 39.0 t80 -105.95 124.65 49.91 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.486 1.114 . . . . 0.0 110.005 -165.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' C' ' 108' ' ' PHE . 6.5 m95 -123.56 121.51 35.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.211 1.004 . . . . 0.0 108.33 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.76 18.2 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 172.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.634 HG11 ' HG2' ' C' ' 142' ' ' GLU . 13.5 m -128.48 151.58 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 CA-C-O 122.273 1.035 . . . . 0.0 109.366 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.94 157.59 16.04 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.67 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 16.7 m -91.61 -4.03 55.74 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.842 -1.072 . . . . 0.0 112.636 -176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.88 136.14 28.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.733 0.777 . . . . 0.0 109.855 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 12.7 tttp -66.81 126.0 27.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.996 -174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.13 168.16 12.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.802 0.81 . . . . 0.0 109.984 171.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.42 -5.89 51.08 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.28 1.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 118.781 0.718 . . . . 0.0 110.83 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' C' ' 104' ' ' TYR . 0.3 OUTLIER -79.97 167.48 20.42 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -66.82 -37.99 85.57 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.871 -0.518 . . . . 0.0 110.605 171.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' C' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.38 10.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.804 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 4.1 p-10 -117.46 151.28 37.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.635 0.731 . . . . 0.0 109.433 177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.919 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -143.52 149.35 37.34 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.026 -163.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.563 ' HG2' ' HG2' ' C' ' 139' ' ' LYS . 63.4 mt-30 -120.61 131.16 54.49 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.669 ' HD2' HD11 ' C' ' 138' ' ' LEU . 85.2 t80 -123.55 148.83 45.95 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.389 0.676 . . . . 0.0 110.413 -163.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.86 31.24 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.517 -1.325 . . . . 0.0 111.966 170.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.701 ' O ' HG23 ' C' ' 134' ' ' VAL . 2.4 m-85 -86.52 123.92 32.26 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' C' ' 91' ' ' PHE . . . -129.99 145.9 51.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.941 0.877 . . . . 0.0 111.161 -169.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.685 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.0 t80 -123.83 125.18 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.017 -174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.672 HG22 ' HD1' ' C' ' 83' ' ' TYR . 60.4 mt -78.57 102.42 4.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.872 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.0 mt-10 -96.83 -16.13 20.92 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.63 141.66 45.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.871 0.759 . . . . 0.0 109.066 174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.31 106.95 4.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.414 ' HB3' HG12 ' B' ' 37' ' ' VAL . 6.2 mt-10 -120.68 120.12 34.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' B' ' 36' ' ' SER . 22.8 p90 -121.02 138.87 53.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.053 0.454 . . . . 0.0 111.198 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' C' ' 127' ' ' GLU . 25.9 t -109.8 140.29 43.89 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.716 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.44 31.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.71 -178.41 28.23 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.703 0.613 . . . . 0.0 111.57 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.27 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.489 -0.418 . . . . 0.0 111.14 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . 0.605 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.56 50.61 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 169.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.59 156.28 9.27 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 166.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.18 149.64 50.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.639 0.733 . . . . 0.0 110.695 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.789 HG23 HG21 ' B' ' 6' ' ' ILE . 45.3 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.075 -171.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.2 5.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.093 -176.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.96 31.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' C' ' 65' ' ' VAL . 3.4 t -114.92 125.8 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 168.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.52 HG13 ' HB ' ' C' ' 65' ' ' VAL . 1.6 pp -118.13 130.01 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.776 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.23 151.44 40.59 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.107 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.83 38.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 167.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.967 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.6 p -138.25 141.53 37.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.777 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -59.43 -48.91 85.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.296 0.57 . . . . 0.0 110.402 -173.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.617 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -160.67 145.31 10.91 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.761 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.37 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.042 0.925 . . . . 0.0 110.632 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.669 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.2 OUTLIER -97.18 131.72 43.65 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -174.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.563 ' HG2' ' HG2' ' C' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.34 33.73 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . 0.602 ' ND2' ' HB3' ' C' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.09 0.94 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.804 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -119.87 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.353 169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.919 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.97 24.37 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -174.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.52 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.83 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.733 -176.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.95 96.53 8.97 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.976 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 0.516 ' O ' HD12 ' C' ' 150' ' ' ILE . 38.1 p -94.35 21.03 7.47 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-O 118.736 -0.649 . . . . 0.0 112.398 175.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' C' ' 150' ' ' ILE . 1.1 mm? 55.28 53.43 8.96 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.468 1.907 . . . . 0.0 109.371 -173.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.706 ' HB3' HG21 ' C' ' 151' ' ' VAL . 31.5 Cg_exo -66.67 -13.81 41.39 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.219 1.279 . . . . 0.0 115.361 -159.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.42 -51.26 48.05 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.601 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.32 -32.54 6.7 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.516 HD12 ' O ' ' C' ' 145' ' ' THR . 1.0 OUTLIER -76.8 -41.26 32.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 119.148 0.885 . . . . 0.0 111.273 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' C' ' 147' ' ' PRO . 24.3 t -73.3 -36.45 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.64 116.78 32.38 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.9 119.59 62.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.27 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' C' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 175.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' C' ' 155' ' ' LYS . . . 138.95 137.02 3.47 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.368 0.985 . . . . 0.0 113.032 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.13 80.62 0.36 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' C' ' 171' ' ' PRO . 0.0 OUTLIER -111.59 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.298 1.039 . . . . 0.0 108.633 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.79 -44.99 65.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.471 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -131.55 117.56 18.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.713 2.405 . . . . 0.0 109.148 167.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' C' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.53 1.75 Allowed 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' I' ' 144' ' ' ASP . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.241 0.605 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -166.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.419 ' O ' ' HA3' ' I' ' 23' ' ' GLY . 22.3 Cg_exo -85.04 -3.08 9.65 Favored 'Trans proline' 0 C--O 1.239 0.539 0 CA-C-N 122.085 1.781 . . . . 0.0 113.84 171.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.76 68.56 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -171.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.525 ' O ' HG22 ' C' ' 174' ' ' VAL . 0.7 OUTLIER -71.47 -41.22 69.64 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.932 1.366 . . . . 0.0 110.862 175.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.427 HG22 ' HB1' ' I' ' 21' ' ' ALA . 1.8 p 47.03 51.77 12.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.811 1.644 . . . . 0.0 111.899 176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' C' ' 172' ' ' GLY . 86.1 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.306 -167.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . 0.413 ' N ' HG22 ' C' ' 167' ' ' THR . . . -89.43 -152.21 25.89 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.479 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.88 99.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.77 0.285 . . . . 0.0 111.43 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.89 129.03 51.9 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 123.505 0.722 . . . . 0.0 109.28 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.677 ' HB2' ' CE2' ' C' ' 158' ' ' TYR . 86.7 Cg_endo -79.25 150.32 22.56 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.326 1.351 . . . . 0.0 112.759 -156.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.534 ' HA3' ' CE1' ' C' ' 158' ' ' TYR . . . 80.52 12.57 82.83 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 117.195 1.638 . . . . 0.0 117.195 165.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.82 38.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.987 0.893 . . . . 0.0 109.849 170.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' C' ' 165' ' ' GLN . 37.9 t -107.19 114.59 61.03 Favored Pre-proline 0 C--O 1.241 0.629 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.451 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' C' ' 176' ' ' ALA . 31.5 Cg_exo -70.27 165.49 31.38 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.49 0.854 . . . . 0.0 111.715 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' C' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 125.429 1.492 . . . . 0.0 112.306 -171.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 N-CA-C 114.764 1.024 . . . . 0.0 114.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.8 HG21 HG23 ' E' ' 126' ' ' VAL . 67.4 mt -131.15 154.84 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.84 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -117.8 159.15 23.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.859 0.838 . . . . 0.0 110.774 -177.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -67.39 -15.09 65.38 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.512 175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.57 26.36 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.829 0.814 . . . . 0.0 112.417 172.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.84 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 26.7 t0 -66.55 -51.54 55.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.98 35.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.49 144.37 50.57 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.734 0.778 . . . . 0.0 110.471 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.57 ' OH ' ' HB3' ' D' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.22 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.793 -164.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' D' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.3 115.21 21.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.48 0.657 . . . . 0.0 109.917 176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 15.5 tt0 -113.62 127.23 55.98 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 170.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.34 146.41 36.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.593 0.711 . . . . 0.0 110.973 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.854 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.0 OUTLIER -62.25 -35.78 71.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.03 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -23.02 66.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.36 67.67 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.588 0.631 . . . . 0.0 111.406 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.54 54.48 11.09 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.194 1.397 . . . . 0.0 111.791 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.9 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.9 27.42 7.12 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.294 -0.412 . . . . 0.0 113.706 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.4 -37.42 68.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.976 0.388 . . . . 0.0 111.729 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.434 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 49.45 77.11 0.48 Allowed Pre-proline 0 C--O 1.237 0.426 0 C-N-CA 126.93 2.092 . . . . 0.0 112.398 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.35 144.86 46.79 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.407 0.824 . . . . 0.0 112.503 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -126.51 146.65 50.04 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' D' ' 76' ' ' GLN . 62.3 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.852 -2.339 . . . . 0.0 110.52 -167.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -73.65 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.925 0.719 . . . . 0.0 112.406 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' I' ' 47' ' ' GLN . . . 60.56 39.21 18.25 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.347 1.459 . . . . 0.0 111.581 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . 0.43 ' CE1' ' O ' ' D' ' 28' ' ' PHE . 12.6 m-30 -71.3 135.64 47.51 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.56 1.171 . . . . 0.0 111.048 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 25.8 p -129.95 170.43 13.95 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.8 1.286 . . . . 0.0 111.098 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.713 ' OD1' HG13 ' D' ' 65' ' ' VAL . 1.6 t0 -162.4 102.48 1.08 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.068 -1.424 . . . . 0.0 107.966 -164.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.4 15.07 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.362 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . 0.582 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 19.2 t -133.94 120.76 20.75 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 173.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' E' ' 117' ' ' GLU . 31.1 m -127.64 145.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.35 123.83 24.78 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -166.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.37 118.05 3.82 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.278 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.56 123.58 44.97 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.564 HH22 ' HB2' ' D' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.8 57.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.759 0.79 . . . . 0.0 110.154 -174.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.809 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -137.32 125.46 23.01 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -167.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.73 39.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.509 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . 0.463 ' CE2' ' HA3' ' D' ' 51' ' ' GLY . 0.7 OUTLIER -130.72 88.39 2.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.191 171.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.477 ' O ' ' HA2' ' D' ' 51' ' ' GLY . 1.6 t70 -107.78 168.88 8.96 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 155.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.474 ' OE2' ' HB3' ' E' ' 58' ' ' SER . 1.9 mp0 -71.79 -47.14 55.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.07 35.66 26.64 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.645 1.578 . . . . 0.0 111.663 -172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.8 49.02 5.02 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 111.578 -164.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.32 -165.12 2.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.469 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.56 0.32 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' D' ' 45' ' ' ASP . . . 82.67 174.1 49.85 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.33 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.87 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.2 pp -128.73 -33.28 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.841 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.681 HD23 ' HG3' ' E' ' 88' ' ' GLN . 0.8 OUTLIER -65.35 -23.72 67.06 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 176.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.24 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 121.664 0.591 . . . . 0.0 113.954 -170.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.51 9.85 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.4 -168.91 29.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . 0.608 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 3.2 t -85.88 153.09 22.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.525 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 12.5 p -104.6 132.0 52.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.564 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -106.66 110.83 23.12 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' D' ' 134' ' ' VAL . 13.3 m-20 -98.7 104.08 16.08 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -171.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.49 31.74 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.961 0.904 . . . . 0.0 110.056 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.8 25.64 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.139 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.97 26.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.713 HG13 ' OD1' ' D' ' 34' ' ' ASP . 15.6 t -112.68 122.44 66.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.4 137.77 50.1 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.55 35.27 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.475 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 19.4 m-30 -88.26 134.75 33.72 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.11 143.79 35.2 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.976 0.75 . . . . 0.0 114.976 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' D' ' 73' ' ' ASP . 8.8 tttp -113.6 151.73 31.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.425 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.1 ptp180 -47.14 -51.7 17.46 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.43 -113.35 3.13 Favored Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' D' ' 70' ' ' LYS . 1.4 m-20 72.19 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 111.028 169.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.84 20.72 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 -156.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.36 -53.1 44.58 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.879 168.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.493 ' HB3' ' CE1' ' D' ' 28' ' ' PHE . 0.0 OUTLIER -60.88 -40.26 92.35 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.859 171.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.26 85.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.794 171.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.69 -43.61 98.37 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.928 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.598 HG23 HD13 ' D' ' 113' ' ' ILE . 5.7 mm -52.51 -47.83 47.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.07 0.462 . . . . 0.0 110.471 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 1.0 OUTLIER -67.7 -46.82 71.18 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 121.72 -0.613 . . . . 0.0 112.415 -178.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.19 -36.41 75.3 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.556 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' D' ' 89' ' ' ILE . . . -58.92 -50.25 74.75 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.551 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.663 ' HD1' HG22 ' D' ' 113' ' ' ILE . 57.3 t80 -74.03 -48.4 30.37 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.922 -174.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.46 -51.94 63.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -167.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' D' ' 87' ' ' LYS . 35.3 m120 -83.38 -36.15 24.53 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.003 172.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.466 0 O-C-N 122.313 -0.242 . . . . 0.0 112.839 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 11.4 mptt -137.48 148.46 46.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.704 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -69.13 141.56 54.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 168.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' D' ' 82' ' ' ALA . 13.0 mm -116.41 129.06 73.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.351 0.596 . . . . 0.0 109.844 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.854 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 8.6 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.96 124.66 49.93 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.514 1.126 . . . . 0.0 109.969 -165.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' D' ' 108' ' ' PHE . 6.4 m95 -123.55 121.53 35.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.22 1.008 . . . . 0.0 108.333 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.08 107.7 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' D' ' 142' ' ' GLU . 13.5 m -128.46 151.63 35.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.247 1.022 . . . . 0.0 109.427 -173.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.02 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.613 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.51 -4.17 55.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.662 -176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -96.82 136.16 28.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-O 121.721 0.772 . . . . 0.0 109.911 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 12.7 tttp -66.88 125.98 27.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -174.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.03 168.15 12.5 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.77 0.795 . . . . 0.0 110.007 171.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.5 -5.87 50.92 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.84 -42.25 1.13 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.775 0.716 . . . . 0.0 110.896 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.5 20.39 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.86 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.91 -0.494 . . . . 0.0 110.623 171.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.546 ' OH ' HG21 ' D' ' 151' ' ' VAL . 97.4 m-85 -148.13 176.41 10.24 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.794 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 4.1 p-10 -117.5 151.23 37.53 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.634 0.731 . . . . 0.0 109.438 177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.891 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -143.45 149.34 37.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.061 -163.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.546 ' HG2' ' HG2' ' D' ' 139' ' ' LYS . 63.3 mt-30 -120.59 131.18 54.52 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 157.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' D' ' 138' ' ' LEU . 85.2 t80 -123.5 148.77 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.382 0.673 . . . . 0.0 110.445 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.84 158.91 31.33 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 119.481 -1.342 . . . . 0.0 111.908 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.709 ' O ' HG23 ' D' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.27 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 167.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.98 145.87 51.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.931 0.872 . . . . 0.0 111.155 -169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.0 t80 -123.82 125.17 44.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.511 -1.222 . . . . 0.0 107.973 -174.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.663 HG22 ' HD1' ' D' ' 83' ' ' TYR . 60.5 mt -78.62 102.43 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.775 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.0 mt-10 -96.85 -16.04 20.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.63 45.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.88 0.764 . . . . 0.0 109.072 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.32 106.89 4.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -120.68 120.09 34.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 22.7 p90 -121.02 138.77 54.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.045 0.45 . . . . 0.0 111.184 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' D' ' 127' ' ' GLU . 25.9 t -109.84 140.34 43.88 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.689 177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.26 117.45 31.9 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 167.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.39 -46.02 97.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.517 -0.402 . . . . 0.0 111.127 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . 0.521 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 3.1 tp10 -130.08 142.51 50.6 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.23 9.24 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.1 149.67 50.23 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 121.588 0.709 . . . . 0.0 110.745 -177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.743 HG23 HG21 ' C' ' 6' ' ' ILE . 45.2 t -53.08 119.99 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.016 -171.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.3 OUTLIER -76.04 102.21 5.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.119 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' D' ' 65' ' ' VAL . 3.3 t -114.93 125.81 54.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' D' ' 65' ' ' VAL . 1.6 pp -118.06 129.99 73.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.72 44.02 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.694 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.2 151.38 40.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.109 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.86 38.08 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.952 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.6 p -138.25 141.57 37.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 175.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.759 HG23 HG12 ' C' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.03 85.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.358 0.599 . . . . 0.0 110.355 -173.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -160.56 145.35 11.0 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.749 177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.4 122.81 44.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.02 0.914 . . . . 0.0 110.698 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.69 43.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.546 ' HG2' ' HG2' ' D' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' D' ' 106' ' ' ALA . 1.1 p-10 -161.58 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.794 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -119.83 154.3 16.5 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.371 169.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.891 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 21.7 tp10 -106.59 151.98 24.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.533 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.3 OUTLIER -109.83 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.774 -176.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.043 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.511 ' O ' HD12 ' D' ' 150' ' ' ILE . 38.0 p -94.33 21.02 7.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.409 175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' D' ' 147' ' ' PRO . 1.1 mm? 55.3 53.35 8.86 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 126.419 1.888 . . . . 0.0 109.431 -173.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' D' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.85 41.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.252 1.301 . . . . 0.0 115.314 -159.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.27 47.63 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.573 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.6 6.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.511 HD12 ' O ' ' D' ' 145' ' ' THR . 1.0 OUTLIER -76.76 -41.26 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 119.148 0.885 . . . . 0.0 111.281 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' D' ' 147' ' ' PRO . 24.3 t -73.34 -36.4 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . 0.461 HG21 ' O ' ' I' ' 48' ' ' THR . 32.8 m -116.9 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 171.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . 0.45 ' HA ' ' ND2' ' I' ' 50' ' ' ASN . 1.6 p -141.02 134.73 30.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' D' ' 156' ' ' GLY . 0.2 OUTLIER -55.01 -44.53 74.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . 0.554 ' O ' ' HD2' ' D' ' 155' ' ' LYS . . . 138.96 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 119.367 0.985 . . . . 0.0 113.03 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.666 ' CE2' ' HB2' ' D' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.332 1.053 . . . . 0.0 108.633 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . 0.507 ' OD2' ' HB3' ' J' ' 140' ' ' ASN . 2.2 m-20 -70.88 -44.98 65.22 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -158.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.58 18.98 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.707 2.403 . . . . 0.0 109.169 167.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.418 ' HB3' ' HA ' ' D' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 154.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.9 OUTLIER -70.77 -31.57 2.15 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.584 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.1 Cg_exo -85.01 -3.02 9.67 Favored 'Trans proline' 0 C--O 1.238 0.524 0 CA-C-N 122.083 1.78 . . . . 0.0 113.894 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.59 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.389 2.116 . . . . 0.0 118.389 -171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.526 ' O ' HG22 ' D' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.7 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.931 1.365 . . . . 0.0 110.89 175.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' J' ' 21' ' ' ALA . 1.8 p 47.04 51.79 12.55 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.811 1.644 . . . . 0.0 111.894 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.442 HG21 ' H ' ' D' ' 172' ' ' GLY . 87.1 m -124.42 156.18 37.59 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.295 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.407 ' N ' HG22 ' D' ' 167' ' ' THR . . . -89.39 -152.25 25.9 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.515 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.94 -41.83 99.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.755 0.277 . . . . 0.0 111.482 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.87 129.01 52.0 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.468 0.707 . . . . 0.0 109.34 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.666 ' HB2' ' CE2' ' D' ' 158' ' ' TYR . 86.0 Cg_endo -79.31 150.31 22.41 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.367 1.378 . . . . 0.0 112.75 -156.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' D' ' 158' ' ' TYR . . . 80.49 12.59 82.82 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 165.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.999 0.899 . . . . 0.0 109.85 170.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.526 HG22 ' O ' ' D' ' 165' ' ' GLN . 37.9 t -107.22 114.58 60.99 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.403 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' D' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.55 31.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.514 0.862 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' D' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.238 0 C-N-CA 125.407 1.483 . . . . 0.0 112.351 -171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' O ' ' F' ' 69' ' ' GLY . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.148 0 N-CA-C 114.779 1.03 . . . . 0.0 114.779 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.848 HG21 HG23 ' F' ' 126' ' ' VAL . 67.3 mt -131.12 154.88 41.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.829 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.15 23.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.857 0.836 . . . . 0.0 110.77 -177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.4 -15.15 65.49 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 115.389 -0.823 . . . . 0.0 114.491 175.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.59 26.39 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.791 0.795 . . . . 0.0 112.4 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.829 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 26.6 t0 -66.45 -51.65 54.62 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.67 120.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 144.37 50.55 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.712 0.767 . . . . 0.0 110.5 176.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.558 ' OH ' ' HB3' ' E' ' 34' ' ' ASP . 50.9 m-85 -106.75 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.714 -164.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' E' ' 27' ' ' LEU . 1.0 OUTLIER -93.58 130.5 39.45 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 174.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -122.21 115.23 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.51 0.671 . . . . 0.0 109.977 176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.28 55.97 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.42 146.39 36.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.56 0.695 . . . . 0.0 111.024 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.007 -179.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.06 -41.25 67.64 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.471 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.49 54.49 11.08 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.231 1.412 . . . . 0.0 111.793 -173.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.79 27.35 7.19 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.711 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.32 -37.37 68.93 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 117.0 0.4 . . . . 0.0 111.798 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 49.43 77.05 0.48 Allowed Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.927 2.091 . . . . 0.0 112.439 -174.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.38 144.94 46.84 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.452 0.84 . . . . 0.0 112.446 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -126.56 146.64 50.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' E' ' 76' ' ' GLN . 62.7 t80 -102.76 133.02 20.66 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.829 -2.348 . . . . 0.0 110.539 -167.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.65 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.326 0 CA-C-O 121.91 0.713 . . . . 0.0 112.391 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' J' ' 47' ' ' GLN . . . 60.61 39.21 18.09 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.346 1.459 . . . . 0.0 111.527 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' E' ' 28' ' ' PHE . 12.7 m-30 -71.23 135.57 47.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.544 1.164 . . . . 0.0 111.077 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.476 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 9.6 mm-40 -106.22 -93.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.91 170.44 13.92 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 122.791 1.282 . . . . 0.0 111.058 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.704 ' OD1' HG13 ' E' ' 65' ' ' VAL . 1.6 t0 -162.38 102.5 1.08 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.984 -164.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.4 15.07 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.342 170.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CZ ' ' F' ' 118' ' ' TYR . 19.1 t -133.94 120.84 20.84 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 173.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' F' ' 117' ' ' GLU . 31.0 m -127.7 145.89 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.26 123.9 25.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -166.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.43 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.223 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.57 44.9 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' E' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.76 57.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 -174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.737 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -137.29 125.48 23.1 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.17 120.72 39.07 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.518 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' E' ' 51' ' ' GLY . 0.7 OUTLIER -130.74 88.43 2.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.211 171.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . 0.463 ' O ' ' HA2' ' E' ' 51' ' ' GLY . 1.6 t70 -107.8 168.91 8.94 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 155.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.737 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 1.9 mp0 -71.91 -47.1 54.98 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.16 35.54 26.37 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.579 1.552 . . . . 0.0 111.629 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 33.5 p 42.9 48.98 5.13 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.519 1.527 . . . . 0.0 111.528 -164.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.06 2.15 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.457 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -78.06 21.62 0.32 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' E' ' 44' ' ' PHE . . . 82.69 174.09 49.86 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.488 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.32 42.63 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 1.006 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.2 pp -128.66 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.878 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.542 HD23 ' HG3' ' F' ' 88' ' ' GLN . 0.8 OUTLIER -65.34 -23.72 67.07 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 176.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.53 2.17 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 121.687 0.604 . . . . 0.0 113.927 -170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.36 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.407 0 N-CA-C 113.837 0.668 . . . . 0.0 113.837 -175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.91 29.37 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . 0.474 ' HB3' ' OE2' ' D' ' 46' ' ' GLU . 3.2 t -85.96 153.15 22.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 0.0 110.494 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 12.4 p -104.69 131.96 52.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -106.62 110.83 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' E' ' 134' ' ' VAL . 13.3 m-20 -98.74 104.12 16.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -171.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.89 143.42 31.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.019 0.927 . . . . 0.0 110.116 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.75 25.6 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.226 -0.897 . . . . 0.0 112.186 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.96 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.704 HG13 ' OD1' ' E' ' 34' ' ' ASP . 15.6 t -112.67 122.45 66.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.38 137.8 50.03 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.63 162.53 35.22 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.471 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.76 33.71 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.13 143.74 35.1 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 114.98 0.752 . . . . 0.0 114.98 -175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' E' ' 73' ' ' ASP . 8.8 tttp -113.56 151.66 31.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.43 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.1 ptp180 -47.16 -51.62 17.77 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.48 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' E' ' 70' ' ' LYS . 1.4 m-20 72.23 121.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.1 1.36 . . . . 0.0 111.023 169.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.5 -26.85 20.69 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -156.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.37 -53.07 44.75 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.236 -0.983 . . . . 0.0 112.846 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' E' ' 28' ' ' PHE . 0.0 OUTLIER -60.95 -40.24 92.57 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.167 -0.608 . . . . 0.0 111.826 171.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -38.33 85.75 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.822 171.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.56 98.47 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.894 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.609 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -52.49 -47.88 47.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.063 0.458 . . . . 0.0 110.506 172.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.81 71.32 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.763 -0.586 . . . . 0.0 112.446 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.13 -36.43 75.2 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.597 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' E' ' 89' ' ' ILE . . . -58.89 -50.24 74.75 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.542 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.677 ' HD1' HG22 ' E' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.37 30.11 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.902 -174.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.9 63.7 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -167.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' E' ' 87' ' ' LYS . 35.3 m120 -83.44 -36.06 24.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.035 172.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.7 2.81 Favored Glycine 0 N--CA 1.448 -0.52 0 O-C-N 122.293 -0.254 . . . . 0.0 112.889 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.638 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 11.4 mptt -137.36 148.52 46.32 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.681 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -69.1 141.56 54.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.822 HD11 ' HB2' ' E' ' 82' ' ' ALA . 13.0 mm -116.43 129.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.349 0.595 . . . . 0.0 109.834 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 8.5 mtmt -82.9 111.26 18.62 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -105.91 124.65 49.91 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.5 1.12 . . . . 0.0 110.042 -166.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' E' ' 108' ' ' PHE . 6.6 m95 -123.57 121.54 35.88 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.72 18.16 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 172.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' E' ' 142' ' ' GLU . 13.5 m -128.5 151.65 35.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 122.296 1.045 . . . . 0.0 109.352 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.52 16.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.606 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.53 -4.12 55.78 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.65 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.675 0.75 . . . . 0.0 109.894 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 12.7 tttp -66.85 126.07 27.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.975 -174.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.2 168.18 12.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.819 0.818 . . . . 0.0 109.947 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.48 -5.86 51.0 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.9 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.883 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' E' ' 104' ' ' TYR . 0.3 OUTLIER -80.04 167.5 20.35 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 167.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.91 85.26 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.825 -0.547 . . . . 0.0 110.546 171.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' E' ' 151' ' ' VAL . 97.4 m-85 -148.11 176.39 10.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.779 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 4.1 p-10 -117.47 151.31 37.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.629 0.728 . . . . 0.0 109.421 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.912 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -143.49 149.35 37.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.082 -163.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' E' ' 139' ' ' LYS . 63.1 mt-30 -120.58 131.19 54.53 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 157.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.662 ' HD2' HD11 ' E' ' 138' ' ' LEU . 85.2 t80 -123.57 148.79 46.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.409 0.684 . . . . 0.0 110.439 -163.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.84 31.23 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.502 -1.332 . . . . 0.0 111.931 170.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' E' ' 134' ' ' VAL . 2.4 m-85 -86.54 123.92 32.28 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.915 0.864 . . . . 0.0 111.195 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.668 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -123.82 125.22 44.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.467 -1.242 . . . . 0.0 107.974 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.677 HG22 ' HD1' ' E' ' 83' ' ' TYR . 60.3 mt -78.58 102.38 4.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.809 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.0 mt-10 -96.78 -16.06 21.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.64 45.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.941 0.791 . . . . 0.0 109.089 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.33 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.45 ' HB3' HG12 ' D' ' 37' ' ' VAL . 6.2 mt-10 -120.7 120.14 34.83 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' D' ' 36' ' ' SER . 22.9 p90 -121.03 138.87 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.07 0.462 . . . . 0.0 111.182 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . 0.454 ' HB3' ' HB2' ' E' ' 127' ' ' GLU . 25.9 t -109.85 140.33 43.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.676 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.29 117.46 31.88 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 167.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.59 -178.39 28.39 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.39 -46.07 97.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.525 -0.397 . . . . 0.0 111.1 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . 0.611 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 3.1 tp10 -130.0 142.52 50.62 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.26 9.26 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 166.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.13 149.69 50.18 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.615 0.721 . . . . 0.0 110.753 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.8 HG23 HG21 ' D' ' 6' ' ' ILE . 45.3 t -53.02 120.0 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.031 -171.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.25 5.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.136 -176.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.92 31.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' E' ' 65' ' ' VAL . 3.4 t -114.94 125.85 54.1 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.511 HG13 ' HB ' ' E' ' 65' ' ' VAL . 1.6 pp -118.09 130.04 73.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 139.75 43.99 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.35 0.66 . . . . 0.0 109.715 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.4 40.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.124 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.34 145.86 38.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 167.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.87 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.5 p -138.24 141.61 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.825 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -59.42 -49.05 85.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.365 0.602 . . . . 0.0 110.336 -173.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.613 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -160.59 145.4 11.06 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.747 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.43 122.8 44.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.071 0.939 . . . . 0.0 110.634 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.662 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.68 43.67 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 -174.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' E' ' 107' ' ' GLN . 14.9 mtmt -86.36 134.33 33.73 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' E' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.779 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -119.86 154.29 16.5 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.363 169.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.99 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.535 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.3 OUTLIER -109.8 -82.78 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.786 -176.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.98 96.52 8.95 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.982 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.51 ' O ' HD12 ' E' ' 150' ' ' ILE . 38.1 p -94.36 21.09 7.43 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.7 -0.666 . . . . 0.0 112.387 175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . 0.462 ' N ' ' HD3' ' E' ' 147' ' ' PRO . 1.0 OUTLIER 55.23 53.36 8.97 Favored Pre-proline 0 C--O 1.237 0.411 0 C-N-CA 126.399 1.88 . . . . 0.0 109.433 -173.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.722 ' HB3' HG21 ' E' ' 151' ' ' VAL . 31.5 Cg_exo -66.59 -13.89 41.76 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.224 1.283 . . . . 0.0 115.362 -159.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.39 -51.26 47.79 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.574 171.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.55 6.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.51 HD12 ' O ' ' E' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.24 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 119.181 0.9 . . . . 0.0 111.335 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.722 HG21 ' HB3' ' E' ' 147' ' ' PRO . 24.3 t -73.37 -36.37 48.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.464 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . 0.43 HG21 ' O ' ' J' ' 48' ' ' THR . 32.8 m -116.92 119.62 62.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . 0.4 ' HA ' ' ND2' ' J' ' 50' ' ' ASN . 1.6 p -140.99 134.75 30.33 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -172.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.58 ' HE3' HG12 ' K' ' 135' ' ' ILE . 0.2 OUTLIER -55.0 -44.56 74.61 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 175.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' E' ' 155' ' ' LYS . . . 139.02 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 119.382 0.992 . . . . 0.0 113.048 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.67 ' CE2' ' HB2' ' E' ' 171' ' ' PRO . 0.0 OUTLIER -111.55 91.64 3.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.33 1.052 . . . . 0.0 108.575 177.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.88 -44.95 65.25 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -158.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.473 ' HB2' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -131.52 117.62 19.02 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.693 2.397 . . . . 0.0 109.135 167.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' E' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.55 1.75 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 154.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' K' ' 144' ' ' ASP . 0.9 OUTLIER -70.83 -31.51 2.1 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -166.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.552 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.2 Cg_exo -85.0 -3.06 9.68 Favored 'Trans proline' 0 C--O 1.238 0.525 0 CA-C-N 122.092 1.783 . . . . 0.0 113.895 171.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.8 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.514 ' O ' HG22 ' E' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.91 1.355 . . . . 0.0 110.914 175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' K' ' 21' ' ' ALA . 1.8 p 47.01 51.76 12.53 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.82 1.648 . . . . 0.0 111.913 176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' E' ' 172' ' ' GLY . 86.7 m -124.38 156.18 37.52 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.337 -167.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . 0.411 ' N ' HG22 ' E' ' 167' ' ' THR . . . -89.44 -152.2 25.87 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.513 172.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.93 -41.83 99.61 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.782 0.291 . . . . 0.0 111.482 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.98 129.06 51.59 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.501 0.721 . . . . 0.0 109.252 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.67 ' HB2' ' CE2' ' E' ' 158' ' ' TYR . 85.2 Cg_endo -79.4 150.28 22.14 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.317 1.345 . . . . 0.0 112.714 -156.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' E' ' 158' ' ' TYR . . . 80.57 12.59 82.76 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 165.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.04 120.82 38.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.988 0.894 . . . . 0.0 109.847 170.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.514 HG22 ' O ' ' E' ' 165' ' ' GLN . 38.0 t -107.18 114.58 61.06 Favored Pre-proline 0 C--O 1.24 0.605 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.433 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' E' ' 176' ' ' ALA . 31.4 Cg_exo -70.26 165.53 31.22 Favored 'Trans proline' 0 C--N 1.348 0.551 0 CA-C-N 119.513 0.862 . . . . 0.0 111.738 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' E' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 125.451 1.501 . . . . 0.0 112.3 -171.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.862 HG21 HG23 ' A' ' 126' ' ' VAL . 67.5 mt -131.17 154.88 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.802 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -117.88 159.17 23.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.959 0.885 . . . . 0.0 110.71 -177.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -67.42 -15.11 65.47 Favored Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.32 -0.855 . . . . 0.0 114.513 175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.96 -6.51 26.49 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 117.798 0.799 . . . . 0.0 112.418 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.802 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 26.7 t0 -66.57 -51.56 55.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -171.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.72 121.01 35.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.967 -1.124 . . . . 0.0 107.967 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.37 50.55 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 110.532 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' F' ' 34' ' ' ASP . 51.1 m-85 -106.67 105.21 15.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.788 -164.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.603 ' HG ' HD12 ' F' ' 27' ' ' LEU . 1.0 OUTLIER -93.54 130.57 39.36 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 174.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.27 115.21 21.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 0.0 109.946 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.567 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.22 55.97 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.43 146.4 36.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.042 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.0 OUTLIER -62.17 -35.88 71.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.981 -179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.29 -23.1 66.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -171.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.99 -41.32 67.78 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.098 -0.641 . . . . 0.0 111.472 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 50.53 54.46 11.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.265 1.426 . . . . 0.0 111.781 -173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.36 6.42 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -118.86 27.38 7.15 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 113.731 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.48 68.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.982 0.391 . . . . 0.0 111.724 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 49.44 77.09 0.48 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 126.98 2.112 . . . . 0.0 112.446 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -71.4 144.89 46.63 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.384 0.816 . . . . 0.0 112.525 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.603 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -126.56 146.57 50.09 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 168.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.5 ' CE1' ' HB3' ' F' ' 76' ' ' GLN . 62.5 t80 -102.67 133.07 20.67 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 115.844 -2.342 . . . . 0.0 110.573 -167.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.7 -178.7 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 CA-C-O 121.876 0.698 . . . . 0.0 112.385 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 60.53 39.21 18.38 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.35 1.46 . . . . 0.0 111.592 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' F' ' 28' ' ' PHE . 12.6 m-30 -71.22 135.64 47.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 122.484 1.135 . . . . 0.0 111.051 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.492 ' HA ' ' OE1' ' F' ' 32' ' ' GLN . 9.6 mm-40 -106.3 -93.69 0.38 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.45 13.92 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.744 1.259 . . . . 0.0 111.085 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' F' ' 65' ' ' VAL . 1.6 t0 -162.39 102.5 1.08 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.001 -164.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.84 140.38 15.06 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.335 170.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 19.3 t -133.94 120.83 20.83 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.71 145.99 34.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.91 24.93 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -166.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.44 118.01 3.81 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.268 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.47 123.58 44.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' F' ' 60' ' ' ALA . 1.7 mtm-85 -61.29 135.81 57.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.761 0.791 . . . . 0.0 110.126 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -137.3 125.45 23.03 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.16 120.73 39.07 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.498 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' F' ' 51' ' ' GLY . 0.6 OUTLIER -130.65 88.36 2.61 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.246 171.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . 0.458 ' O ' ' HA2' ' F' ' 51' ' ' GLY . 1.6 t70 -107.74 168.91 8.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 155.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.09 55.3 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 57.14 35.59 26.47 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 111.67 -172.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.88 48.97 5.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.454 1.501 . . . . 0.0 111.557 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.11 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.477 -177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.95 21.51 0.32 Allowed 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' F' ' 44' ' ' PHE . . . 82.79 174.09 49.94 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.527 ' HA ' ' HD3' ' F' ' 52' ' ' ARG . 0.0 OUTLIER -118.27 122.31 42.62 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.967 HG12 HG23 ' A' ' 135' ' ' ILE . 1.2 pp -128.67 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.878 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.451 HD12 ' H ' ' F' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.76 67.07 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 176.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.28 109.54 2.18 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.713 0.618 . . . . 0.0 113.924 -170.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.3 176.51 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.404 0 N-CA-C 113.871 0.681 . . . . 0.0 113.871 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 -168.87 29.26 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . 0.737 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 3.2 t -85.93 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.506 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 12.4 p -104.69 132.0 52.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -106.66 110.81 23.1 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' F' ' 134' ' ' VAL . 13.3 m-20 -98.65 104.08 16.09 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -171.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.92 143.5 31.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.916 0.886 . . . . 0.0 110.063 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.8 25.65 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.151 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.87 130.97 26.39 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.716 HG13 ' OD1' ' F' ' 34' ' ' ASP . 15.7 t -112.67 122.47 66.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.39 137.77 50.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.59 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 19.4 m-30 -88.27 134.77 33.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -72.15 143.75 35.1 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.959 0.743 . . . . 0.0 114.959 -175.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' F' ' 73' ' ' ASP . 8.8 tttp -113.55 151.69 31.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . 0.445 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.1 ptp180 -47.12 -51.64 17.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.36 3.12 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' F' ' 70' ' ' LYS . 1.4 m-20 72.18 121.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.147 1.379 . . . . 0.0 111.057 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.47 -26.85 20.72 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.424 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -62.37 -53.03 45.05 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.888 168.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.5 ' HB3' ' CE1' ' F' ' 28' ' ' PHE . 0.0 OUTLIER -60.97 -40.19 92.46 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.889 171.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.25 85.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.77 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.61 98.35 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.906 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' F' ' 113' ' ' ILE . 5.8 mm -52.45 -47.89 46.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 121.066 0.46 . . . . 0.0 110.443 172.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -46.83 71.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.726 -0.609 . . . . 0.0 112.412 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.21 -36.35 75.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.549 169.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' F' ' 89' ' ' ILE . . . -58.94 -50.23 74.82 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.595 174.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.653 ' HD1' HG22 ' F' ' 113' ' ' ILE . 57.2 t80 -74.01 -48.44 30.17 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.922 -174.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -52.0 63.44 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -167.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' F' ' 87' ' ' LYS . 35.2 m120 -83.35 -36.15 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.036 172.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.2 102.78 2.81 Favored Glycine 0 N--CA 1.449 -0.489 0 O-C-N 122.291 -0.256 . . . . 0.0 112.87 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.64 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 11.4 mptt -137.4 148.47 46.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' F' ' 112' ' ' TYR . 1.6 tm0? -69.13 141.51 54.63 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' F' ' 82' ' ' ALA . 13.1 mm -116.39 129.03 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 121.374 0.607 . . . . 0.0 109.885 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 8.6 mtmt -82.95 111.35 18.73 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -106.0 124.64 49.9 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.509 1.124 . . . . 0.0 110.01 -165.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' F' ' 108' ' ' PHE . 6.5 m95 -123.54 121.57 35.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.181 0.992 . . . . 0.0 108.371 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.07 107.74 18.18 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.613 HG11 ' HG2' ' F' ' 142' ' ' GLU . 13.4 m -128.46 151.61 35.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-O 122.226 1.012 . . . . 0.0 109.411 -173.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.56 16.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.639 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.57 -4.06 55.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.675 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.11 28.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.659 0.742 . . . . 0.0 109.932 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 12.7 tttp -66.88 126.02 27.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.978 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.08 168.13 12.65 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.765 0.793 . . . . 0.0 109.995 171.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.86 51.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.18 1.12 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.75 0.704 . . . . 0.0 110.863 169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' F' ' 104' ' ' TYR . 0.3 OUTLIER -80.01 167.47 20.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -66.83 -37.99 85.55 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.835 -0.541 . . . . 0.0 110.597 171.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.543 ' OH ' HG21 ' F' ' 151' ' ' VAL . 97.2 m-85 -148.06 176.37 10.25 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.768 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.31 37.36 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.621 0.724 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.906 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -143.47 149.29 37.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.072 -163.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.561 ' HG2' ' HG2' ' F' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.21 54.57 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 157.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.677 ' HD2' HD11 ' F' ' 138' ' ' LEU . 85.2 t80 -123.59 148.75 46.09 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.396 0.678 . . . . 0.0 110.418 -163.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.82 158.86 31.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.959 170.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.705 ' O ' HG23 ' F' ' 134' ' ' VAL . 2.4 m-85 -86.45 123.91 32.19 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.86 51.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.91 0.862 . . . . 0.0 111.122 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.0 t80 -123.78 125.23 44.35 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.013 -174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.653 HG22 ' HD1' ' F' ' 83' ' ' TYR . 60.5 mt -78.64 102.41 4.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.737 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.0 mt-10 -96.86 -16.0 20.96 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.66 141.62 45.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.956 0.798 . . . . 0.0 109.087 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' F' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.97 4.84 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.416 ' HB3' HG12 ' E' ' 37' ' ' VAL . 6.2 mt-10 -120.69 120.14 34.84 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 22.7 p90 -120.99 138.87 53.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 0.0 111.174 176.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' F' ' 127' ' ' GLU . 25.9 t -109.89 140.35 43.94 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.624 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 117.48 31.96 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.68 -178.37 28.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 81.6 t -61.33 -46.1 97.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.512 -0.405 . . . . 0.0 111.099 176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.05 142.5 50.61 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 169.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.24 9.25 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 166.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.12 149.6 50.3 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.565 0.697 . . . . 0.0 110.746 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.848 HG23 HG21 ' E' ' 6' ' ' ILE . 45.2 t -52.95 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.054 -171.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.3 OUTLIER -76.14 102.22 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.084 -176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.87 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' F' ' 65' ' ' VAL . 3.4 t -114.89 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' F' ' 65' ' ' VAL . 1.6 pp -118.07 130.03 73.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.4 139.75 43.98 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.753 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.25 151.39 40.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.32 145.84 38.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 167.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 1.006 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.6 p -138.24 141.52 37.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.893 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -59.41 -48.97 85.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.297 0.57 . . . . 0.0 110.339 -173.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -160.61 145.34 10.96 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.696 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.79 44.38 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.078 0.942 . . . . 0.0 110.646 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.677 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.72 43.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -174.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.561 ' HG2' ' HG2' ' F' ' 107' ' ' GLN . 15.0 mtmt -86.39 134.31 33.72 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' F' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.1 0.94 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.768 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -119.86 154.36 16.47 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.327 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.906 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.94 24.42 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.53 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.3 OUTLIER -109.84 -82.8 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.762 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.91 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.988 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.518 ' O ' HD12 ' F' ' 150' ' ' ILE . 38.1 p -94.32 21.02 7.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.4 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' F' ' 150' ' ' ILE . 1.1 mm? 55.29 53.38 8.9 Favored Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.474 1.91 . . . . 0.0 109.372 -173.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.716 ' HB3' HG21 ' F' ' 151' ' ' VAL . 31.5 Cg_exo -66.66 -13.86 41.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.257 1.305 . . . . 0.0 115.321 -159.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.39 -51.27 47.61 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.614 171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.518 HD12 ' O ' ' F' ' 145' ' ' THR . 1.0 OUTLIER -76.85 -41.21 32.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.133 0.879 . . . . 0.0 111.26 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' F' ' 147' ' ' PRO . 24.4 t -73.29 -36.44 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.77 32.33 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.471 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . 0.472 HG21 ' O ' ' K' ' 48' ' ' THR . 32.8 m -116.85 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 171.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . 0.573 ' HA ' ' ND2' ' K' ' 50' ' ' ASN . 1.6 p -141.04 134.7 30.19 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -172.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.534 ' HD2' ' O ' ' F' ' 156' ' ' GLY . 0.2 OUTLIER -54.95 -44.55 74.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' F' ' 155' ' ' LYS . . . 138.93 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 119.376 0.989 . . . . 0.0 113.061 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.26 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.675 ' CE2' ' HB2' ' F' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.318 1.047 . . . . 0.0 108.636 177.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.799 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 2.2 m-20 -70.8 -45.06 65.34 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -158.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -131.5 117.63 19.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.681 2.392 . . . . 0.0 109.183 167.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.504 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 0.1 OUTLIER -122.62 48.48 1.76 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.836 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.9 OUTLIER -70.75 -31.61 2.18 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -166.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.835 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -84.91 -3.16 9.74 Favored 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.045 1.766 . . . . 0.0 113.88 171.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' F' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.2 69.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.899 1.349 . . . . 0.0 110.934 175.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 1.8 p 47.03 51.78 12.53 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.821 1.649 . . . . 0.0 111.885 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.812 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 85.2 m -124.37 156.16 37.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.311 -167.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.562 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -89.45 -152.24 25.94 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.495 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.529 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 1.1 tt0 -62.91 -41.86 99.59 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.763 0.281 . . . . 0.0 111.456 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.9 129.06 51.77 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.52 0.728 . . . . 0.0 109.233 -178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.675 ' HB2' ' CE2' ' F' ' 158' ' ' TYR . 85.2 Cg_endo -79.36 150.33 22.3 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 121.265 1.31 . . . . 0.0 112.699 -156.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' F' ' 158' ' ' TYR . . . 80.58 12.53 82.83 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.01 120.79 38.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.007 0.904 . . . . 0.0 109.875 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 165' ' ' GLN . 38.0 t -107.12 114.51 61.23 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.454 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' F' ' 176' ' ' ALA . 31.5 Cg_exo -70.24 165.48 31.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.521 0.865 . . . . 0.0 111.741 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' F' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.245 0 C-N-CA 125.478 1.511 . . . . 0.0 112.266 -171.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 N-CA-C 114.721 1.008 . . . . 0.0 114.721 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.995 HG21 HG23 ' H' ' 126' ' ' VAL . 67.3 mt -131.12 154.87 41.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.795 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.914 0.864 . . . . 0.0 110.753 -177.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' H' ' 123' ' ' GLU . . . -67.38 -15.12 65.41 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.491 175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.61 26.36 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.791 0.795 . . . . 0.0 112.396 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.795 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 26.6 t0 -66.48 -51.59 55.18 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.68 120.99 35.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.35 50.57 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.677 0.751 . . . . 0.0 110.477 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' G' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.19 15.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.797 -164.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.597 ' HG ' HD12 ' G' ' 27' ' ' LEU . 1.0 OUTLIER -93.48 130.46 39.31 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.507 0.67 . . . . 0.0 109.947 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.569 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 15.4 tt0 -113.7 127.27 55.97 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.41 146.42 36.6 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.009 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.867 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.993 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.02 66.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.32 67.56 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.39 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' THR . . . 50.6 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.245 1.418 . . . . 0.0 111.79 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.84 179.34 6.43 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -118.84 27.37 7.16 Favored Glycine 0 N--CA 1.45 -0.389 0 O-C-N 123.367 0.417 . . . . 0.0 113.738 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.39 69.02 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.95 0.375 . . . . 0.0 111.804 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 49.36 77.12 0.48 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 126.947 2.099 . . . . 0.0 112.428 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -71.34 144.87 46.87 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.394 0.819 . . . . 0.0 112.502 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.597 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.8 tt -126.53 146.65 50.05 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' G' ' 76' ' ' GLN . 62.6 t80 -102.73 133.04 20.66 Favored Pre-proline 0 C--N 1.316 -0.859 0 C-N-CA 115.83 -2.348 . . . . 0.0 110.546 -167.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.67 -178.69 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.293 0 CA-C-O 121.863 0.693 . . . . 0.0 112.392 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' G' ' 68' ' ' TYR . . . 60.49 39.27 18.46 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 111.584 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' O ' ' G' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.63 47.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.526 1.155 . . . . 0.0 111.096 173.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' G' ' 32' ' ' GLN . 9.7 mm-40 -106.26 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 26.1 p -129.92 170.46 13.9 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.786 1.279 . . . . 0.0 111.101 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.71 ' OD1' HG13 ' G' ' 65' ' ' VAL . 1.6 t0 -162.39 102.48 1.08 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 108.002 -164.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.36 15.05 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.325 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 19.1 t -133.89 120.8 20.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 173.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.526 ' HB ' ' OE1' ' H' ' 117' ' ' GLU . 30.9 m -127.69 145.92 34.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 11.1 m -134.31 123.89 24.92 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -166.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.241 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.51 44.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.573 HH22 ' HB2' ' G' ' 60' ' ' ALA . 1.7 mtm-85 -61.15 135.8 57.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.713 0.768 . . . . 0.0 110.165 -174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.47 23.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.534 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.5 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' G' ' 51' ' ' GLY . 0.6 OUTLIER -130.71 88.41 2.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.203 171.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . 0.468 ' O ' ' HA2' ' G' ' 51' ' ' GLY . 1.6 t70 -107.83 168.9 8.94 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 155.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.86 -47.15 54.97 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 1.5 mt-30 57.17 35.58 26.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.631 1.573 . . . . 0.0 111.637 -172.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.86 48.96 5.08 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.477 1.511 . . . . 0.0 111.584 -164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.26 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.459 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.95 21.48 0.32 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' G' ' 45' ' ' ASP . . . 82.77 174.09 49.93 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.541 ' HD3' ' HA ' ' G' ' 52' ' ' ARG . 0.0 OUTLIER -118.28 122.38 42.76 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 1.034 HG12 HG23 ' H' ' 135' ' ' ILE . 1.2 pp -128.7 -33.33 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.877 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.453 HD12 ' H ' ' G' ' 54' ' ' LEU . 0.8 OUTLIER -65.26 -23.8 67.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.27 109.53 2.17 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.679 0.6 . . . . 0.0 113.914 -170.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.29 176.57 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.877 0.684 . . . . 0.0 113.877 -175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.9 29.31 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 3.2 t -85.94 153.19 22.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.574 0.702 . . . . 0.0 110.476 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 12.5 p -104.71 131.96 52.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . 0.573 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -106.58 110.79 23.09 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' G' ' 134' ' ' VAL . 13.3 m-20 -98.76 104.16 16.18 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -171.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.97 143.46 31.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.979 0.911 . . . . 0.0 110.042 -178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.08 154.76 25.61 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.164 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.91 26.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.71 HG13 ' OD1' ' G' ' 34' ' ' ASP . 15.7 t -112.63 122.45 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.41 137.75 50.13 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.54 162.57 35.46 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 19.4 m-30 -88.23 134.83 33.69 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -72.2 143.75 35.03 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -175.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.497 ' HG2' ' OD1' ' G' ' 73' ' ' ASP . 8.8 tttp -113.58 151.69 31.32 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . 0.431 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.1 ptp180 -47.1 -51.7 17.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.34 3.13 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HG2' ' G' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.156 1.382 . . . . 0.0 111.006 169.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.52 -26.82 20.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -156.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.425 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -62.39 -53.08 44.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.848 168.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CE1' ' G' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.24 92.49 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 122.148 -0.619 . . . . 0.0 111.813 171.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.33 85.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.774 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.62 98.34 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.882 168.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.629 HD12 HD11 ' G' ' 113' ' ' ILE . 5.7 mm -52.44 -47.93 46.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 110.449 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.81 71.23 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.777 -0.577 . . . . 0.0 112.422 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.13 -36.39 75.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.541 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.98 -50.21 74.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.548 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.673 ' HD1' HG22 ' G' ' 113' ' ' ILE . 57.3 t80 -74.04 -48.44 29.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.905 -174.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.96 63.69 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -167.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . 0.407 ' HB2' ' NZ ' ' G' ' 87' ' ' LYS . 35.3 m120 -83.4 -36.06 24.58 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.069 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.13 102.83 2.82 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.337 -0.227 . . . . 0.0 112.851 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.636 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 11.4 mptt -137.43 148.51 46.19 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.681 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -69.2 141.52 54.49 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' G' ' 82' ' ' ALA . 13.1 mm -116.4 129.11 73.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.36 0.6 . . . . 0.0 109.831 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.867 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 8.5 mtmt -82.97 111.31 18.71 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -105.95 124.59 49.82 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.538 1.135 . . . . 0.0 110.044 -166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' G' ' 108' ' ' PHE . 6.4 m95 -123.49 121.48 35.79 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.219 1.008 . . . . 0.0 108.384 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.04 107.73 18.18 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' G' ' 142' ' ' GLU . 13.5 m -128.46 151.62 35.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.282 1.039 . . . . 0.0 109.397 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.58 16.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.621 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.61 -4.09 55.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.627 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.85 136.2 28.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.687 0.756 . . . . 0.0 109.89 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 12.7 tttp -66.89 126.0 27.69 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.975 -174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.05 168.17 12.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.796 0.808 . . . . 0.0 110.023 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.56 -5.77 50.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.89 -42.22 1.12 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.787 0.721 . . . . 0.0 110.851 169.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.0 167.53 20.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 167.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -66.9 -37.9 85.24 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.905 -0.497 . . . . 0.0 110.579 171.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.542 ' OH ' HG21 ' G' ' 151' ' ' VAL . 97.4 m-85 -148.16 176.32 10.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.762 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 4.1 p-10 -117.44 151.28 37.39 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.618 0.723 . . . . 0.0 109.445 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.884 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -143.52 149.36 37.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.041 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.557 ' HG2' ' HG2' ' G' ' 139' ' ' LYS . 63.4 mt-30 -120.58 131.14 54.51 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 157.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.685 ' HD2' HD11 ' G' ' 138' ' ' LEU . 85.2 t80 -123.54 148.83 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.417 0.687 . . . . 0.0 110.436 -163.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.87 158.89 31.29 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.527 -1.321 . . . . 0.0 111.962 170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.712 ' O ' HG23 ' G' ' 134' ' ' VAL . 2.4 m-85 -86.55 123.91 32.27 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 167.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.8 51.65 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.918 0.866 . . . . 0.0 111.165 -169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.681 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.0 t80 -123.76 125.24 44.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.988 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.673 HG22 ' HD1' ' G' ' 83' ' ' TYR . 60.6 mt -78.67 102.41 4.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.51 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.09 20.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.67 141.61 45.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 118.943 0.792 . . . . 0.0 109.07 174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' G' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.94 4.85 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.508 ' OE1' ' HB ' ' L' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.15 34.87 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.552 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 22.7 p90 -121.01 138.85 53.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.08 0.467 . . . . 0.0 111.169 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' G' ' 127' ' ' GLU . 25.9 t -109.83 140.34 43.87 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.679 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.34 117.49 31.94 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 167.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.62 -178.38 28.35 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-O 121.706 0.615 . . . . 0.0 111.568 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 82.5 t -61.38 -46.11 97.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 122.443 -0.446 . . . . 0.0 111.077 176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . 0.507 ' HA ' ' HA3' ' L' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.53 50.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.6 156.21 9.24 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 166.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.1 149.64 50.27 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.638 0.733 . . . . 0.0 110.746 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.93 HG23 HG21 ' L' ' 6' ' ' ILE . 45.2 t -52.99 120.01 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.085 -0.962 . . . . 0.0 110.038 -171.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.23 5.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.134 -176.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.43 111.92 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' G' ' 65' ' ' VAL . 3.4 t -114.94 125.83 54.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 168.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.522 HG13 ' HB ' ' G' ' 65' ' ' VAL . 1.5 pp -118.15 130.01 73.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.71 43.98 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.758 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.28 151.38 40.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.117 -172.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.92 38.01 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.972 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.5 p -138.31 141.58 37.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 1.028 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -59.45 -48.98 85.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.317 0.58 . . . . 0.0 110.352 -173.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.61 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -160.59 145.33 10.96 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.738 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.39 122.81 44.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 122.059 0.933 . . . . 0.0 110.666 174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.685 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.14 131.72 43.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.557 ' HG2' ' HG2' ' G' ' 107' ' ' GLN . 15.0 mtmt -86.43 134.3 33.71 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . 0.599 ' ND2' ' HB3' ' G' ' 106' ' ' ALA . 1.1 p-10 -161.55 -163.12 0.94 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.762 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -119.8 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.18 -1.01 . . . . 0.0 111.405 169.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.884 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 21.7 tp10 -106.63 151.95 24.39 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 160' ' ' PHE . 0.3 OUTLIER -109.83 -82.79 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.792 -176.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.5 8.95 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.997 -176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.512 ' O ' HD12 ' G' ' 150' ' ' ILE . 38.0 p -94.39 21.1 7.44 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.379 175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' G' ' 150' ' ' ILE . 1.1 mm? 55.19 53.46 9.11 Favored Pre-proline 0 C--N 1.346 0.437 0 C-N-CA 126.507 1.923 . . . . 0.0 109.371 -173.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' G' ' 151' ' ' VAL . 31.5 Cg_exo -66.68 -13.81 41.42 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.21 1.273 . . . . 0.0 115.36 -159.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.4 -51.26 47.83 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.626 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.26 -32.59 6.7 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.512 HD12 ' O ' ' G' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.19 32.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 119.146 0.885 . . . . 0.0 111.32 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' G' ' 147' ' ' PRO . 24.3 t -73.38 -36.34 48.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.74 32.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.465 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.87 119.68 62.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 171.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.04 134.73 30.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' G' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.55 74.52 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 175.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . 0.553 ' O ' ' HD2' ' G' ' 155' ' ' LYS . . . 138.98 137.02 3.47 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 119.383 0.992 . . . . 0.0 113.043 -176.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.19 80.56 0.36 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 -177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . 0.668 ' CE2' ' HB2' ' G' ' 171' ' ' PRO . 0.0 OUTLIER -111.48 91.65 3.74 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.315 1.046 . . . . 0.0 108.645 177.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.94 65.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -158.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.55 117.61 18.99 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.709 2.404 . . . . 0.0 109.161 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' G' ' 165' ' ' GLN . 0.1 OUTLIER -122.65 48.57 1.75 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 154.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.8 -31.5 2.11 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -85.02 -3.11 9.67 Favored 'Trans proline' 0 C--O 1.239 0.543 0 CA-C-N 122.039 1.764 . . . . 0.0 113.876 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.65 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 118.36 2.104 . . . . 0.0 118.36 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.519 ' O ' HG22 ' G' ' 174' ' ' VAL . 0.7 OUTLIER -71.48 -41.22 69.63 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.897 1.348 . . . . 0.0 110.87 175.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.06 51.73 12.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.839 1.655 . . . . 0.0 111.899 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.428 HG21 ' H ' ' G' ' 172' ' ' GLY . 87.2 m -124.39 156.18 37.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.26 -167.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . 0.421 ' N ' HG22 ' G' ' 167' ' ' THR . . . -89.48 -152.22 25.95 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.517 172.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.836 0.318 . . . . 0.0 111.433 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.99 129.04 51.66 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 123.483 0.713 . . . . 0.0 109.264 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . 0.668 ' HB2' ' CE2' ' G' ' 158' ' ' TYR . 85.4 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.281 1.32 . . . . 0.0 112.751 -156.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . 0.525 ' HA3' ' CE1' ' G' ' 158' ' ' TYR . . . 80.51 12.59 82.81 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 117.208 1.643 . . . . 0.0 117.208 165.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.05 120.84 38.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.998 0.899 . . . . 0.0 109.829 170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' G' ' 165' ' ' GLN . 37.9 t -107.14 114.55 61.15 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.405 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' G' ' 176' ' ' ALA . 31.4 Cg_exo -70.25 165.53 31.2 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.542 0.872 . . . . 0.0 111.729 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' G' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.213 0 C-N-CA 125.429 1.492 . . . . 0.0 112.31 -171.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.625 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 N-CA-C 114.742 1.016 . . . . 0.0 114.742 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.994 HG21 HG23 ' I' ' 126' ' ' VAL . 67.4 mt -131.13 154.88 41.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.811 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -117.87 159.18 23.53 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.909 0.861 . . . . 0.0 110.741 -177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' I' ' 123' ' ' GLU . . . -67.36 -15.15 65.4 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.353 -0.839 . . . . 0.0 114.502 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -100.0 -6.52 26.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.786 0.793 . . . . 0.0 112.397 172.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 26.6 t0 -66.49 -51.64 54.52 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -83.71 120.99 35.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 144.33 50.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.619 0.724 . . . . 0.0 110.556 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.571 ' OH ' ' HB3' ' H' ' 34' ' ' ASP . 51.7 m-85 -106.74 105.2 15.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.738 -164.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.615 ' HG ' HD12 ' H' ' 27' ' ' LEU . 1.0 OUTLIER -93.52 130.53 39.34 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.25 22.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.491 0.663 . . . . 0.0 109.939 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.579 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 15.4 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.35 36.66 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.048 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.855 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.76 70.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.99 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.07 66.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -172.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.35 67.57 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.386 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' B' ' 166' ' ' THR . . . 50.57 54.45 11.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.255 1.422 . . . . 0.0 111.788 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 179.34 6.44 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' B' ' 163' ' ' PRO . . . -118.84 27.46 7.12 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.73 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.38 -37.38 68.76 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.978 0.389 . . . . 0.0 111.762 -177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 49.4 77.11 0.48 Allowed Pre-proline 0 C--O 1.238 0.455 0 C-N-CA 127.022 2.129 . . . . 0.0 112.406 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -71.4 144.87 46.62 Favored 'Trans proline' 0 C--N 1.349 0.598 0 CA-C-N 119.409 0.825 . . . . 0.0 112.472 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' H' ' 76' ' ' GLN . 62.6 t80 -102.77 133.05 20.64 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.773 -2.371 . . . . 0.0 110.487 -167.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.66 -178.72 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 CA-C-O 121.873 0.697 . . . . 0.0 112.41 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' H' ' 68' ' ' TYR . . . 60.5 39.29 18.39 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.346 1.458 . . . . 0.0 111.572 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' H' ' 28' ' ' PHE . 12.6 m-30 -71.25 135.59 47.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.509 1.147 . . . . 0.0 111.075 173.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 9.8 mm-40 -106.24 -93.6 0.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 26.0 p -129.96 170.48 13.9 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.786 1.279 . . . . 0.0 111.095 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.718 ' OD1' HG13 ' H' ' 65' ' ' VAL . 1.6 t0 -162.43 102.45 1.07 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.988 -164.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.365 170.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 19.2 t -133.92 120.8 20.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' OE1' ' I' ' 117' ' ' GLU . 31.0 m -127.65 145.95 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.3 123.88 24.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -166.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.46 118.02 3.81 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.256 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.52 123.59 44.93 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.571 HH22 ' HB2' ' H' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.81 57.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.748 0.785 . . . . 0.0 110.082 -174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.46 23.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -167.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.19 120.74 39.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.504 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . 0.468 ' CE2' ' HA3' ' H' ' 51' ' ' GLY . 0.6 OUTLIER -130.69 88.36 2.61 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.222 171.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . 0.461 ' O ' ' HA2' ' H' ' 51' ' ' GLY . 1.6 t70 -107.8 168.92 8.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 155.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.84 -47.14 55.16 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . 0.511 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 1.5 mt-30 57.15 35.56 26.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.642 1.577 . . . . 0.0 111.62 -172.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 33.7 p 42.94 48.91 5.16 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.501 1.52 . . . . 0.0 111.578 -164.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.24 -165.1 2.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.482 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -77.98 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . 0.468 ' HA3' ' CE2' ' H' ' 44' ' ' PHE . . . 82.73 174.11 49.91 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.458 ' HA ' HH11 ' H' ' 52' ' ' ARG . 0.0 OUTLIER -118.26 122.34 42.69 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 1.023 HG12 HG23 ' I' ' 135' ' ' ILE . 1.2 pp -128.68 -33.29 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.894 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.443 HD12 ' H ' ' H' ' 54' ' ' LEU . 0.8 OUTLIER -65.36 -23.75 67.06 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.19 109.51 2.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-O 121.633 0.574 . . . . 0.0 113.944 -170.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.37 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.517 -0.372 0 N-CA-C 113.814 0.659 . . . . 0.0 113.814 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.48 -168.86 29.3 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 3.2 t -85.97 153.13 22.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.478 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 12.5 p -104.65 132.01 52.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . 0.571 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -106.64 110.83 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 174.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' H' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -171.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.93 143.49 31.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.93 0.892 . . . . 0.0 110.055 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.12 154.73 25.6 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.185 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.88 130.91 26.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.718 HG13 ' OD1' ' H' ' 34' ' ' ASP . 15.6 t -112.62 122.45 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.36 137.78 50.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 174.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.53 35.3 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.494 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 19.4 m-30 -88.18 134.79 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -72.18 143.75 35.05 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' H' ' 73' ' ' ASP . 8.8 tttp -113.52 151.69 31.2 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.2 -51.62 18.04 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.46 -113.38 3.13 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' H' ' 70' ' ' LYS . 1.4 m-20 72.15 121.39 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.115 1.366 . . . . 0.0 111.04 169.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.6 -26.72 20.65 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.481 2.4 . . . . 0.0 117.481 -156.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.429 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -62.45 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.832 168.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' H' ' 28' ' ' PHE . 0.0 OUTLIER -60.9 -40.24 92.34 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.139 -0.624 . . . . 0.0 111.886 171.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -38.31 85.76 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.755 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.57 98.46 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.94 168.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.617 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -52.48 -47.9 47.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.459 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 1.0 OUTLIER -67.65 -46.8 71.39 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.781 -0.575 . . . . 0.0 112.474 -178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.12 -36.42 75.17 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.564 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.83 ' HB2' HD11 ' H' ' 89' ' ' ILE . . . -58.89 -50.3 74.53 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.551 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.67 ' HD1' HG22 ' H' ' 113' ' ' ILE . 57.3 t80 -73.99 -48.4 30.56 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.951 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.96 63.37 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -167.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . 0.416 ' HB2' ' NZ ' ' H' ' 87' ' ' LYS . 35.2 m120 -83.34 -36.13 24.63 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.063 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.88 2.82 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 122.3 -0.25 . . . . 0.0 112.841 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 11.4 mptt -137.47 148.49 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.68 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -69.1 141.49 54.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 168.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.83 HD11 ' HB2' ' H' ' 82' ' ' ALA . 13.1 mm -116.38 129.02 73.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.322 0.582 . . . . 0.0 109.884 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 8.6 mtmt -82.92 111.27 18.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' H' ' 111' ' ' ALA . 39.2 t80 -105.98 124.66 49.92 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.495 1.118 . . . . 0.0 110.01 -165.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.57 ' CE2' ' HE1' ' H' ' 108' ' ' PHE . 6.5 m95 -123.54 121.55 35.94 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.211 1.005 . . . . 0.0 108.335 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.12 107.72 18.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.618 HG11 ' HG2' ' H' ' 142' ' ' GLU . 13.5 m -128.48 151.59 35.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.264 1.03 . . . . 0.0 109.414 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.601 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . . . . . . . . . 16.1 m -91.56 -4.1 55.74 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.871 -1.058 . . . . 0.0 112.684 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.695 0.76 . . . . 0.0 109.882 176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.924 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.12 168.15 12.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.805 0.812 . . . . 0.0 110.004 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.82 51.1 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.93 -42.18 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 118.729 0.695 . . . . 0.0 110.877 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 167.45 20.42 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 167.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -66.88 -37.86 85.21 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.888 -0.507 . . . . 0.0 110.568 171.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' H' ' 151' ' ' VAL . 97.5 m-85 -148.16 176.36 10.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.777 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 4.1 p-10 -117.49 151.3 37.39 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.632 0.73 . . . . 0.0 109.411 177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.915 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -143.46 149.37 37.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.111 -163.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' H' ' 139' ' ' LYS . 63.1 mt-30 -120.63 131.19 54.48 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 157.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.69 ' HD2' HD11 ' H' ' 138' ' ' LEU . 85.3 t80 -123.59 148.74 46.1 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.391 0.676 . . . . 0.0 110.445 -163.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.81 158.88 31.3 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.948 170.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.717 ' O ' HG23 ' H' ' 134' ' ' VAL . 2.4 m-85 -86.53 123.86 32.2 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' H' ' 91' ' ' PHE . . . -129.9 145.88 51.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.926 0.869 . . . . 0.0 111.174 -169.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -123.84 125.25 44.35 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.926 -174.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.67 HG22 ' HD1' ' H' ' 83' ' ' TYR . 60.4 mt -78.61 102.41 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.0 mt-10 -96.89 -15.99 20.93 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.62 141.64 45.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.927 0.785 . . . . 0.0 109.1 174.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' H' ' 116' ' ' ARG . 2.0 ttt180 -142.36 106.98 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.526 ' OE1' ' HB ' ' G' ' 37' ' ' VAL . 6.2 mt-10 -120.79 120.15 34.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 22.4 p90 -121.03 138.79 54.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.052 0.453 . . . . 0.0 111.202 176.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . 0.46 ' HB3' ' HB2' ' H' ' 127' ' ' GLU . 26.0 t -109.77 140.37 43.76 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.672 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.31 117.46 31.87 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.32 28.3 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 121.737 0.631 . . . . 0.0 111.555 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.41 -46.08 97.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.464 -0.433 . . . . 0.0 111.074 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . 0.475 ' HA ' ' HA3' ' G' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 169.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.14 149.64 50.23 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.598 0.713 . . . . 0.0 110.735 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.995 HG23 HG21 ' G' ' 6' ' ' ILE . 45.3 t -53.05 120.03 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.045 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.3 OUTLIER -76.09 102.22 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.114 -176.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.92 31.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' H' ' 65' ' ' VAL . 3.4 t -114.88 125.79 54.05 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.521 HG13 ' HB ' ' H' ' 65' ' ' VAL . 1.6 pp -118.07 130.04 73.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.45 139.76 44.03 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.675 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.27 151.37 40.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.101 -172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.33 145.89 38.04 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.9 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.5 p -138.28 141.62 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 1.034 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -59.48 -49.03 85.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.406 0.622 . . . . 0.0 110.305 -173.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.615 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -160.56 145.41 11.08 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.711 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.47 122.84 44.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.033 0.92 . . . . 0.0 110.653 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.69 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.2 OUTLIER -97.14 131.67 43.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -174.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' H' ' 107' ' ' GLN . 15.0 mtmt -86.36 134.3 33.73 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' H' ' 106' ' ' ALA . 1.1 p-10 -161.53 -163.11 0.95 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.777 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -119.81 154.31 16.49 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.389 169.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 21.7 tp10 -106.68 151.95 24.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' B' ' 160' ' ' PHE . 0.3 OUTLIER -109.78 -82.74 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.807 -176.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' B' ' 162' ' ' GLN . 7.0 p-10 -95.99 96.58 8.98 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.959 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.521 ' O ' HD12 ' H' ' 150' ' ' ILE . 38.1 p -94.42 21.11 7.46 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.399 175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . 0.466 ' HB2' HG13 ' H' ' 150' ' ' ILE . 1.0 OUTLIER 55.25 53.36 8.94 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.401 1.88 . . . . 0.0 109.424 -173.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.719 ' HB3' HG21 ' H' ' 151' ' ' VAL . 31.4 Cg_exo -66.64 -13.88 41.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.259 1.306 . . . . 0.0 115.351 -159.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.33 -51.3 46.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.605 171.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.28 -32.57 6.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.521 HD12 ' O ' ' H' ' 145' ' ' THR . 1.0 OUTLIER -76.81 -41.28 32.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 119.15 0.886 . . . . 0.0 111.265 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' H' ' 147' ' ' PRO . 24.3 t -73.3 -36.43 49.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.79 32.37 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.431 -176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.66 62.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.08 134.73 30.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' H' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' H' ' 155' ' ' LYS . . . 138.98 137.04 3.47 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 119.378 0.99 . . . . 0.0 113.039 -176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.2 80.61 0.36 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' H' ' 171' ' ' PRO . 0.0 OUTLIER -111.54 91.59 3.72 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.32 1.048 . . . . 0.0 108.636 177.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.87 -44.92 65.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -158.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.57 117.65 19.03 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.67 2.388 . . . . 0.0 109.088 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.408 ' HB3' ' HA ' ' H' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.51 1.76 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 153.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -31.53 2.14 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.96 -3.1 9.7 Favored 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.042 1.765 . . . . 0.0 113.891 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.62 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 118.369 2.108 . . . . 0.0 118.369 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' H' ' 174' ' ' VAL . 0.7 OUTLIER -71.44 -41.22 69.74 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 118.886 1.343 . . . . 0.0 110.875 175.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.03 51.74 12.58 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.801 1.64 . . . . 0.0 111.941 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.427 HG21 ' H ' ' H' ' 172' ' ' GLY . 87.0 m -124.38 156.16 37.55 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.295 -167.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . 0.419 ' N ' HG22 ' H' ' 167' ' ' THR . . . -89.44 -152.24 25.94 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.48 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.97 -41.79 99.65 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.808 0.304 . . . . 0.0 111.449 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.92 129.06 51.71 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 123.505 0.722 . . . . 0.0 109.251 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . 0.676 ' HB2' ' CE2' ' H' ' 158' ' ' TYR . 85.7 Cg_endo -79.3 150.31 22.43 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 121.332 1.355 . . . . 0.0 112.75 -156.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . 0.517 ' HA3' ' CE1' ' H' ' 158' ' ' TYR . . . 80.51 12.58 82.82 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.81 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.986 0.893 . . . . 0.0 109.871 170.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' H' ' 165' ' ' GLN . 38.0 t -107.19 114.6 61.01 Favored Pre-proline 0 C--O 1.241 0.624 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.379 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' H' ' 176' ' ' ALA . 31.5 Cg_exo -70.31 165.52 31.32 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.52 0.864 . . . . 0.0 111.749 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' H' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 125.421 1.488 . . . . 0.0 112.334 -171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.46 ' HB2' ' O ' ' J' ' 69' ' ' GLY . 49.6 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 114.758 1.022 . . . . 0.0 114.758 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.867 HG21 HG23 ' J' ' 126' ' ' VAL . 67.3 mt -131.17 154.91 41.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.804 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -117.91 159.17 23.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.959 0.885 . . . . 0.0 110.713 -177.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' J' ' 123' ' ' GLU . . . -67.37 -15.13 65.38 Favored Glycine 0 C--N 1.335 0.476 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.54 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.98 -6.56 26.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.757 0.778 . . . . 0.0 112.393 172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 26.7 t0 -66.52 -51.54 55.48 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.79 121.01 35.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.48 144.34 50.58 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.743 0.782 . . . . 0.0 110.445 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.555 ' OH ' ' HB3' ' I' ' 34' ' ' ASP . 51.1 m-85 -106.71 105.19 15.11 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.807 -164.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.605 ' HG ' HD12 ' I' ' 27' ' ' LEU . 1.0 OUTLIER -93.47 130.52 39.28 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.23 115.22 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.466 0.65 . . . . 0.0 109.933 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 15.5 tt0 -113.67 127.27 55.98 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -77.43 146.42 36.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.979 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.866 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.0 OUTLIER -62.29 -35.79 71.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.981 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.35 -22.99 66.87 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -172.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.04 -41.27 67.67 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.476 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.427 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 50.55 54.45 11.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.18 1.392 . . . . 0.0 111.785 -173.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.31 6.45 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 163' ' ' PRO . . . -118.82 27.34 7.18 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 123.338 0.399 . . . . 0.0 113.738 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.29 -37.43 69.0 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.987 0.393 . . . . 0.0 111.799 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 49.54 77.04 0.48 Allowed Pre-proline 0 C--O 1.238 0.479 0 C-N-CA 126.942 2.097 . . . . 0.0 112.401 -174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.89 46.6 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.448 0.839 . . . . 0.0 112.503 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.605 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -126.53 146.61 50.06 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 168.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' I' ' 76' ' ' GLN . 62.5 t80 -102.68 133.03 20.69 Favored Pre-proline 0 C--N 1.317 -0.82 0 C-N-CA 115.837 -2.345 . . . . 0.0 110.545 -167.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.63 -178.73 3.93 Favored 'Trans proline' 0 C--N 1.332 -0.311 0 CA-C-N 118.988 0.674 . . . . 0.0 112.467 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' I' ' 68' ' ' TYR . . . 60.59 39.25 18.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.427 1.491 . . . . 0.0 111.519 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' I' ' 28' ' ' PHE . 12.6 m-30 -71.27 135.6 47.53 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.495 1.14 . . . . 0.0 111.036 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 9.6 mm-40 -106.24 -93.62 0.38 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.95 170.46 13.92 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.792 1.282 . . . . 0.0 111.08 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' I' ' 65' ' ' VAL . 1.6 t0 -162.41 102.43 1.08 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.014 -164.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.77 140.37 15.06 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.368 170.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' J' ' 118' ' ' TYR . 19.2 t -133.89 120.83 20.89 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 173.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' J' ' 117' ' ' GLU . 31.1 m -127.71 145.97 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.33 123.92 24.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -166.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . 0.654 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.46 118.06 3.82 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.229 -178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.49 123.56 44.87 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' I' ' 60' ' ' ALA . 1.7 mtm-85 -61.2 135.79 57.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.762 0.791 . . . . 0.0 110.157 -174.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.624 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -137.31 125.42 22.98 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.71 39.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.516 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . 0.461 ' CE2' ' HA3' ' I' ' 51' ' ' GLY . 0.6 OUTLIER -130.62 88.31 2.61 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.249 171.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HA2' ' I' ' 51' ' ' GLY . 1.6 t70 -107.75 168.85 8.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 155.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' J' ' 58' ' ' SER . 1.9 mp0 -71.82 -47.16 55.2 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 1.5 mt-30 57.18 35.61 26.43 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.623 1.569 . . . . 0.0 111.644 -172.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.461 ' O ' HG21 ' D' ' 153' ' ' VAL . 33.8 p 42.86 48.97 5.09 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.439 1.496 . . . . 0.0 111.609 -164.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.3 -165.08 2.16 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.485 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' D' ' 154' ' ' SER . 6.1 m-80 -77.99 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' I' ' 45' ' ' ASP . . . 82.78 174.07 49.92 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.54 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -118.27 122.33 42.66 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 1.025 HG12 HG23 ' J' ' 135' ' ' ILE . 1.2 pp -128.65 -33.37 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.875 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.449 ' H ' HD12 ' I' ' 54' ' ' LEU . 0.8 OUTLIER -65.32 -23.72 67.08 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.22 109.52 2.16 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.658 0.588 . . . . 0.0 113.982 -170.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -78.37 176.56 9.78 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.829 0.665 . . . . 0.0 113.829 -175.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.41 -168.86 29.23 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . 0.464 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 3.2 t -85.97 153.09 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.562 0.696 . . . . 0.0 110.496 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 12.6 p -104.6 131.95 52.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -106.61 110.89 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 174.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' I' ' 134' ' ' VAL . 13.3 m-20 -98.78 104.13 16.14 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -171.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.96 143.5 31.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.946 0.899 . . . . 0.0 110.017 -178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.15 154.71 25.59 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.175 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.84 130.97 26.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' I' ' 34' ' ' ASP . 15.7 t -112.68 122.49 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 24.5 p -112.38 137.72 50.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.6 162.54 35.31 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.79 33.69 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -72.15 143.78 35.14 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 -175.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' I' ' 73' ' ' ASP . 8.7 tttp -113.6 151.72 31.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.421 ' HD3' HH21 ' I' ' 71' ' ' ARG . 10.1 ptp180 -47.2 -51.63 17.98 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -172.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.51 -113.4 3.12 Favored Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' I' ' 70' ' ' LYS . 1.4 m-20 72.19 121.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.094 1.358 . . . . 0.0 111.019 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.43 -26.9 20.74 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 -156.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.416 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.32 -53.12 44.51 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.857 168.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' I' ' 28' ' ' PHE . 0.0 OUTLIER -60.91 -40.22 92.32 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.866 171.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -38.27 85.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.8 171.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.66 98.24 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.894 168.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.608 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -52.41 -47.93 46.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.053 0.454 . . . . 0.0 110.485 172.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 1.0 OUTLIER -67.62 -46.85 71.34 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.729 -0.607 . . . . 0.0 112.428 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.18 -36.36 75.17 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.577 169.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' I' ' 89' ' ' ILE . . . -58.96 -50.24 74.84 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.531 174.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.658 ' HD1' HG22 ' I' ' 113' ' ' ILE . 57.2 t80 -73.98 -48.48 30.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.939 -174.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.42 -51.92 63.73 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -167.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . 0.406 ' HB2' ' NZ ' ' I' ' 87' ' ' LYS . 35.3 m120 -83.36 -36.11 24.61 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.08 172.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.23 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.504 0 O-C-N 122.32 -0.238 . . . . 0.0 112.877 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.618 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 11.4 mptt -137.44 148.49 46.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.673 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -69.17 141.56 54.54 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' I' ' 82' ' ' ALA . 13.1 mm -116.44 129.09 73.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.35 0.595 . . . . 0.0 109.857 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 8.5 mtmt -82.96 111.33 18.72 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' I' ' 111' ' ' ALA . 39.1 t80 -106.0 124.62 49.87 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.532 1.133 . . . . 0.0 110.012 -165.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.571 ' CE2' ' HE1' ' I' ' 108' ' ' PHE . 6.5 m95 -123.54 121.47 35.72 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.235 1.014 . . . . 0.0 108.392 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.74 18.19 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.63 HG11 ' HG2' ' I' ' 142' ' ' GLU . 13.4 m -128.48 151.55 35.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 CA-C-O 122.216 1.008 . . . . 0.0 109.429 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.98 157.57 16.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.56 -4.04 55.8 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.691 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 28.7 m -96.87 136.14 28.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.72 0.771 . . . . 0.0 109.902 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.953 -174.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -68.15 168.2 12.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.805 0.812 . . . . 0.0 109.975 171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.49 -5.89 50.91 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.87 -42.2 1.13 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.785 0.72 . . . . 0.0 110.901 169.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' I' ' 104' ' ' TYR . 0.3 OUTLIER -80.09 167.49 20.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 167.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -66.84 -37.91 85.39 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.86 -0.525 . . . . 0.0 110.593 171.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.552 ' OH ' HG21 ' I' ' 151' ' ' VAL . 97.4 m-85 -148.12 176.41 10.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.77 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.26 37.49 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.63 0.729 . . . . 0.0 109.415 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.911 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -143.51 149.3 37.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.091 -163.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.554 ' HG2' ' HG2' ' I' ' 139' ' ' LYS . 63.2 mt-30 -120.55 131.19 54.56 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 157.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.683 ' HD2' HD11 ' I' ' 138' ' ' LEU . 85.2 t80 -123.55 148.79 45.99 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.448 0.699 . . . . 0.0 110.405 -163.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.88 158.84 31.21 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.518 -1.325 . . . . 0.0 111.951 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.708 ' O ' HG23 ' I' ' 134' ' ' VAL . 2.4 m-85 -86.49 123.93 32.25 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 167.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' I' ' 91' ' ' PHE . . . -129.97 145.84 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.903 0.858 . . . . 0.0 111.172 -169.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.673 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.996 -174.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' I' ' 83' ' ' TYR . 60.4 mt -78.64 102.4 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.07 20.98 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.62 45.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.947 0.794 . . . . 0.0 109.082 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' I' ' 116' ' ' ARG . 2.0 ttt180 -142.27 106.98 4.85 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' H' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.12 34.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 22.5 p90 -121.01 138.87 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.057 0.456 . . . . 0.0 111.204 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . 0.467 ' HB3' ' HB2' ' I' ' 127' ' ' GLU . 25.8 t -109.87 140.33 43.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.634 177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.25 117.47 31.94 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 167.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.38 28.28 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 82.8 t -61.4 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.473 -0.428 . . . . 0.0 111.083 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . 0.449 ' HA ' ' HA3' ' H' ' 8' ' ' GLY . 3.1 tp10 -130.03 142.52 50.61 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.64 156.25 9.25 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.1 149.61 50.31 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.536 0.684 . . . . 0.0 110.78 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.994 HG23 HG21 ' H' ' 6' ' ' ILE . 45.3 t -52.99 120.04 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.991 -171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.3 OUTLIER -76.15 102.28 5.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.074 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.95 31.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' I' ' 65' ' ' VAL . 3.4 t -114.97 125.82 54.06 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 168.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' I' ' 65' ' ' VAL . 1.5 pp -118.11 129.99 73.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.76 43.93 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.341 0.656 . . . . 0.0 109.679 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.42 40.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.104 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.35 145.82 38.2 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.955 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.5 p -138.22 141.63 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 1.023 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -59.46 -49.0 85.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.365 0.602 . . . . 0.0 110.325 -173.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -160.65 145.35 10.97 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.693 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.38 122.8 44.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 122.038 0.923 . . . . 0.0 110.665 174.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.2 OUTLIER -97.11 131.67 43.66 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -174.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.554 ' HG2' ' HG2' ' I' ' 107' ' ' GLN . 14.9 mtmt -86.39 134.35 33.72 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' I' ' 106' ' ' ALA . 1.1 p-10 -161.51 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.77 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -119.81 154.33 16.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.395 169.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.911 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.97 24.38 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.527 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.77 -176.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' C' ' 162' ' ' GLN . 7.0 p-10 -95.93 96.46 8.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.988 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 0.513 ' O ' HD12 ' I' ' 150' ' ' ILE . 38.0 p -94.39 21.14 7.4 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.365 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' I' ' 147' ' ' PRO . 1.1 mm? 55.23 53.41 9.01 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.509 1.923 . . . . 0.0 109.421 -173.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.714 ' HB3' HG21 ' I' ' 151' ' ' VAL . 31.6 Cg_exo -66.69 -13.87 41.62 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.225 1.283 . . . . 0.0 115.289 -159.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.43 -51.2 48.76 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.607 171.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.66 6.67 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.513 HD12 ' O ' ' I' ' 145' ' ' THR . 1.0 OUTLIER -76.77 -41.29 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 119.189 0.904 . . . . 0.0 111.294 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.714 HG21 ' HB3' ' I' ' 147' ' ' PRO . 24.3 t -73.27 -36.44 49.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.68 116.8 32.38 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.445 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.93 119.66 62.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.76 30.25 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' I' ' 156' ' ' GLY . 0.2 OUTLIER -55.0 -44.54 74.62 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' I' ' 155' ' ' LYS . . . 138.98 137.01 3.47 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 119.331 0.969 . . . . 0.0 113.046 -176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.21 80.6 0.36 Allowed Glycine 0 CA--C 1.521 0.423 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . 0.672 ' CE2' ' HB2' ' I' ' 171' ' ' PRO . 0.0 OUTLIER -111.52 91.61 3.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.329 1.052 . . . . 0.0 108.636 177.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.78 -45.05 65.41 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -158.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.45 117.65 19.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.682 2.393 . . . . 0.0 109.171 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HA ' ' I' ' 165' ' ' GLN . 0.1 OUTLIER -122.62 48.5 1.76 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 154.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.54 2.15 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -166.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.03 -3.07 9.65 Favored 'Trans proline' 0 C--O 1.238 0.507 0 CA-C-N 122.035 1.763 . . . . 0.0 113.89 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.77 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 118.358 2.103 . . . . 0.0 118.358 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.53 ' O ' HG22 ' I' ' 174' ' ' VAL . 0.7 OUTLIER -71.45 -41.22 69.73 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.863 1.332 . . . . 0.0 110.923 175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.09 51.74 12.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.794 1.638 . . . . 0.0 111.909 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.43 HG21 ' H ' ' I' ' 172' ' ' GLY . 87.0 m -124.43 156.15 37.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.303 -167.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . 0.418 ' N ' HG22 ' I' ' 167' ' ' THR . . . -89.49 -152.22 25.96 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.436 172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.82 99.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.759 0.279 . . . . 0.0 111.414 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.93 129.09 51.61 Favored Pre-proline 0 C--O 1.235 0.324 0 C-N-CA 123.473 0.709 . . . . 0.0 109.256 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . 0.672 ' HB2' ' CE2' ' I' ' 158' ' ' TYR . 85.3 Cg_endo -79.35 150.29 22.28 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.31 1.34 . . . . 0.0 112.778 -156.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' I' ' 158' ' ' TYR . . . 80.56 12.6 82.75 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 117.166 1.626 . . . . 0.0 117.166 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.06 120.8 38.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.005 0.903 . . . . 0.0 109.867 170.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.53 HG22 ' O ' ' I' ' 165' ' ' GLN . 37.9 t -107.15 114.6 61.09 Favored Pre-proline 0 C--O 1.241 0.625 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.397 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' I' ' 176' ' ' ALA . 31.4 Cg_exo -70.28 165.52 31.29 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 119.526 0.866 . . . . 0.0 111.769 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' I' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.209 0 C-N-CA 125.442 1.497 . . . . 0.0 112.354 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.515 ' HB2' ' O ' ' K' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.129 0 N-CA-C 114.752 1.02 . . . . 0.0 114.752 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.914 HG21 HG23 ' K' ' 126' ' ' VAL . 67.5 mt -131.11 154.89 41.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.816 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -117.89 159.19 23.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.974 0.892 . . . . 0.0 110.717 -177.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -67.38 -15.15 65.43 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.31 -0.859 . . . . 0.0 114.478 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.93 -6.61 26.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.791 0.795 . . . . 0.0 112.428 172.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.816 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 26.6 t0 -66.47 -51.57 55.38 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -172.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.73 121.03 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.45 144.38 50.56 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.663 0.744 . . . . 0.0 110.473 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.567 ' OH ' ' HB3' ' J' ' 34' ' ' ASP . 51.4 m-85 -106.76 105.23 15.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.75 -164.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' J' ' 27' ' ' LEU . 1.0 OUTLIER -93.49 130.49 39.32 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.25 115.26 22.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.491 0.663 . . . . 0.0 109.952 176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 15.4 tt0 -113.69 127.26 55.97 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 33.0 p -77.4 146.44 36.6 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.02 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.874 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.0 OUTLIER -62.24 -35.81 71.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.985 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.41 -23.02 66.85 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.31 67.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.451 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' D' ' 166' ' ' THR . . . 50.64 54.41 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.204 1.401 . . . . 0.0 111.761 -173.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.37 6.42 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.584 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -118.89 27.38 7.14 Favored Glycine 0 N--CA 1.45 -0.379 0 O-C-N 123.363 0.414 . . . . 0.0 113.683 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.27 -37.41 69.06 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.976 0.388 . . . . 0.0 111.829 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 126.954 2.101 . . . . 0.0 112.425 -174.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.44 144.89 46.44 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.407 0.824 . . . . 0.0 112.491 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -126.5 146.6 50.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 168.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' J' ' 76' ' ' GLN . 62.3 t80 -102.71 133.06 20.66 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 115.846 -2.342 . . . . 0.0 110.537 -167.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.68 -178.69 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-N 118.972 0.669 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' J' ' 68' ' ' TYR . . . 60.53 39.26 18.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.372 1.469 . . . . 0.0 111.56 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' J' ' 28' ' ' PHE . 12.6 m-30 -71.26 135.59 47.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 122.486 1.136 . . . . 0.0 111.074 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.483 ' HA ' ' OE1' ' J' ' 32' ' ' GLN . 9.7 mm-40 -106.24 -93.58 0.38 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 26.3 p -129.94 170.42 13.96 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 122.773 1.273 . . . . 0.0 111.064 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.711 ' OD1' HG13 ' J' ' 65' ' ' VAL . 1.6 t0 -162.32 102.44 1.09 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.064 -1.426 . . . . 0.0 107.994 -164.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.4 15.08 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.325 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . 0.408 ' HB3' ' CZ ' ' K' ' 118' ' ' TYR . 19.0 t -133.95 120.8 20.79 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.537 HG12 ' HB3' ' K' ' 117' ' ' GLU . 31.3 m -127.67 145.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 11.0 m -134.34 123.88 24.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.47 118.04 3.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.175 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.51 123.56 44.88 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.561 HH22 ' HB2' ' J' ' 60' ' ' ALA . 1.7 mtm-85 -61.23 135.78 57.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.714 0.769 . . . . 0.0 110.156 -174.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.45 22.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.491 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . 0.463 ' CE2' ' HA3' ' J' ' 51' ' ' GLY . 0.6 OUTLIER -130.71 88.38 2.61 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.222 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . 0.472 ' O ' ' HA2' ' J' ' 51' ' ' GLY . 1.6 t70 -107.79 168.93 8.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 155.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.401 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 1.9 mp0 -71.86 -47.12 55.17 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 176.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . 0.519 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 1.5 mt-30 57.17 35.56 26.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 111.653 -172.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.43 ' O ' HG21 ' E' ' 153' ' ' VAL . 33.6 p 42.84 49.0 5.06 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.538 1.535 . . . . 0.0 111.553 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.28 -165.08 2.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' E' ' 154' ' ' SER . 6.1 m-80 -77.96 21.56 0.32 Allowed 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' J' ' 45' ' ' ASP . . . 82.75 174.11 49.93 Favored Glycine 0 N--CA 1.452 -0.27 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.532 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -118.32 122.33 42.62 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 1.067 HG12 HG23 ' K' ' 135' ' ' ILE . 1.2 pp -128.67 -33.34 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.852 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.438 HD12 ' H ' ' J' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.73 67.07 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 176.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.21 109.55 2.18 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-O 121.695 0.608 . . . . 0.0 113.938 -170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.39 176.59 9.75 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 N-CA-C 113.86 0.677 . . . . 0.0 113.86 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.46 -168.88 29.31 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . 0.476 ' HB3' ' OE2' ' I' ' 46' ' ' GLU . 3.2 t -85.9 153.13 22.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.539 0.685 . . . . 0.0 110.523 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 12.5 p -104.61 131.93 52.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . 0.561 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -106.62 110.87 23.19 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' J' ' 134' ' ' VAL . 13.2 m-20 -98.76 104.14 16.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 -171.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.48 31.77 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.945 0.898 . . . . 0.0 110.075 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.13 154.74 25.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.173 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.82 130.92 26.39 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.711 HG13 ' OD1' ' J' ' 34' ' ' ASP . 15.6 t -112.6 122.39 66.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -177.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . . . . . . . . . 24.7 p -112.36 137.81 50.0 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.52 35.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 19.4 m-30 -88.24 134.79 33.7 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -72.15 143.73 35.07 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 -175.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' J' ' 73' ' ' ASP . 8.8 tttp -113.56 151.69 31.27 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.16 -51.58 17.9 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.5 -113.33 3.12 Favored Glycine 0 N--CA 1.452 -0.26 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . 0.504 ' OD1' ' HG2' ' J' ' 70' ' ' LYS . 1.4 m-20 72.17 121.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.116 1.366 . . . . 0.0 111.055 169.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.78 20.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -156.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.42 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.39 -53.07 44.73 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.853 168.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' J' ' 28' ' ' PHE . 0.0 OUTLIER -60.96 -40.2 92.44 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.149 -0.618 . . . . 0.0 111.838 171.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -38.34 85.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.758 171.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.74 -43.54 98.53 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.914 168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.614 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -52.48 -47.89 47.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.074 0.464 . . . . 0.0 110.459 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' J' ' 84' ' ' GLN . 1.0 OUTLIER -67.69 -46.8 71.26 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.733 -0.605 . . . . 0.0 112.442 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.11 -36.45 75.2 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.601 169.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.82 ' HB2' HD11 ' J' ' 89' ' ' ILE . . . -58.89 -50.21 74.88 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.589 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' J' ' 113' ' ' ILE . 57.3 t80 -74.05 -48.46 29.8 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.865 -174.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.98 63.64 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -167.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . 0.414 ' HB2' ' NZ ' ' J' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.11 24.6 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.074 172.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.17 102.78 2.81 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.304 -0.248 . . . . 0.0 112.853 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 11.5 mptt -137.41 148.51 46.23 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.688 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -69.18 141.52 54.52 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' J' ' 82' ' ' ALA . 13.1 mm -116.39 129.07 73.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.354 0.597 . . . . 0.0 109.871 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 8.5 mtmt -82.91 111.34 18.7 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -105.99 124.6 49.84 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.518 1.127 . . . . 0.0 110.025 -165.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.557 ' CE2' ' HE1' ' J' ' 108' ' ' PHE . 6.4 m95 -123.5 121.54 35.93 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.75 18.21 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.627 HG11 ' HG2' ' J' ' 142' ' ' GLU . 13.3 m -128.49 151.56 35.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 122.247 1.022 . . . . 0.0 109.406 -173.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.99 157.61 16.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.646 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.6 -4.1 55.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.645 -176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 m -96.83 136.16 28.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-O 121.66 0.743 . . . . 0.0 109.926 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 12.7 tttp -66.91 126.05 27.86 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.982 -174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.14 168.18 12.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.769 0.795 . . . . 0.0 109.961 171.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -5.9 50.94 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.85 -42.26 1.13 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.739 0.7 . . . . 0.0 110.867 169.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.99 167.47 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -66.86 -37.84 85.19 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.835 -0.541 . . . . 0.0 110.633 171.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' J' ' 151' ' ' VAL . 97.3 m-85 -148.19 176.33 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 4.1 p-10 -117.43 151.27 37.41 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.652 0.739 . . . . 0.0 109.447 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.907 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -143.54 149.32 37.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.068 -163.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' J' ' 139' ' ' LYS . 63.2 mt-30 -120.59 131.15 54.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' J' ' 138' ' ' LEU . 85.2 t80 -123.56 148.79 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.448 0.699 . . . . 0.0 110.416 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.89 158.87 31.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.48 -1.343 . . . . 0.0 111.903 170.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.7 ' O ' HG23 ' J' ' 134' ' ' VAL . 2.4 m-85 -86.51 123.94 32.28 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 167.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -130.02 145.85 51.67 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.949 0.881 . . . . 0.0 111.14 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.688 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.0 t80 -123.76 125.19 44.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.005 -174.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' J' ' 83' ' ' TYR . 60.3 mt -78.6 102.43 4.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.0 mt-10 -96.88 -16.06 20.91 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.6 141.65 45.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.922 0.783 . . . . 0.0 109.096 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' J' ' 116' ' ' ARG . 2.0 ttt180 -142.35 106.97 4.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' I' ' 37' ' ' VAL . 6.2 mt-10 -120.75 120.13 34.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.547 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 22.7 p90 -120.98 138.83 53.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.009 0.433 . . . . 0.0 111.217 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' J' ' 127' ' ' GLU . 26.0 t -109.83 140.26 43.96 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.673 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.22 117.46 31.94 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 167.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.66 -178.38 28.29 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-O 121.672 0.596 . . . . 0.0 111.618 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 83.1 t -61.43 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 O-C-N 122.503 -0.41 . . . . 0.0 111.093 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . 0.487 ' HA ' ' HA3' ' I' ' 8' ' ' GLY . 3.1 tp10 -130.01 142.49 50.62 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.61 156.23 9.25 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.08 149.62 50.31 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.578 0.704 . . . . 0.0 110.742 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.867 HG23 HG21 ' I' ' 6' ' ' ILE . 45.4 t -52.98 120.0 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.005 -171.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.3 OUTLIER -76.12 102.24 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.065 -176.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.48 111.95 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' J' ' 65' ' ' VAL . 3.4 t -114.95 125.8 54.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.51 HG13 ' HB ' ' J' ' 65' ' ' VAL . 1.6 pp -118.11 130.01 73.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.36 139.79 43.88 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.698 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.29 151.43 40.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.089 -172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.38 145.9 38.09 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.948 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.5 p -138.31 141.65 37.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 1.025 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.99 85.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 110.348 -173.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.619 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -160.54 145.38 11.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.715 177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.41 122.83 44.46 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.026 0.917 . . . . 0.0 110.643 174.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.2 OUTLIER -97.16 131.66 43.69 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' J' ' 107' ' ' GLN . 14.9 mtmt -86.37 134.32 33.73 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' J' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.13 0.95 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -119.79 154.32 16.49 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.411 169.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.907 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 21.7 tp10 -106.66 151.92 24.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -174.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' D' ' 160' ' ' PHE . 0.3 OUTLIER -109.77 -82.77 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.783 -176.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 7.0 p-10 -95.95 96.47 8.92 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.979 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.515 ' O ' HD12 ' J' ' 150' ' ' ILE . 37.7 p -94.4 21.15 7.4 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 118.711 -0.662 . . . . 0.0 112.334 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . 0.467 ' N ' ' HD3' ' J' ' 147' ' ' PRO . 1.1 mm? 55.2 53.44 9.08 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.474 1.91 . . . . 0.0 109.377 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.713 ' HB3' HG21 ' J' ' 151' ' ' VAL . 31.6 Cg_exo -66.67 -13.86 41.6 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.245 1.297 . . . . 0.0 115.336 -159.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.45 -51.23 48.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.553 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.29 -32.63 6.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.515 HD12 ' O ' ' J' ' 145' ' ' THR . 1.0 OUTLIER -76.75 -41.23 33.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.145 0.884 . . . . 0.0 111.305 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.713 HG21 ' HB3' ' J' ' 147' ' ' PRO . 24.3 t -73.39 -36.33 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.7 116.75 32.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.463 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.91 119.65 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 171.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.01 134.72 30.26 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . 0.545 ' HD2' ' O ' ' J' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.55 74.56 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 175.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . 0.545 ' O ' ' HD2' ' J' ' 155' ' ' LYS . . . 138.98 137.05 3.47 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 119.407 1.003 . . . . 0.0 113.038 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.22 80.63 0.36 Allowed Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . 0.661 ' CE2' ' HB2' ' J' ' 171' ' ' PRO . 0.0 OUTLIER -111.56 91.65 3.74 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.298 1.039 . . . . 0.0 108.618 177.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.85 -44.99 65.29 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -158.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.53 117.68 19.11 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.669 2.387 . . . . 0.0 109.135 167.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' J' ' 165' ' ' GLN . 0.1 OUTLIER -122.66 48.51 1.76 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 154.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.74 -31.57 2.16 Favored Pre-proline 0 C--O 1.241 0.61 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -166.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -84.98 -3.07 9.7 Favored 'Trans proline' 0 C--O 1.239 0.535 0 CA-C-N 122.099 1.785 . . . . 0.0 113.855 171.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.83 68.61 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -171.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.524 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.29 69.76 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 118.889 1.345 . . . . 0.0 110.909 175.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.74 12.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.807 1.643 . . . . 0.0 111.893 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.439 HG21 ' H ' ' J' ' 172' ' ' GLY . 85.8 m -124.39 156.11 37.66 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.337 -167.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . 0.416 ' N ' HG22 ' J' ' 167' ' ' THR . . . -89.41 -152.2 25.83 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.482 172.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.98 -41.85 99.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.413 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.88 129.01 51.96 Favored Pre-proline 0 C--O 1.235 0.339 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . 0.661 ' HB2' ' CE2' ' J' ' 158' ' ' TYR . 85.6 Cg_endo -79.39 150.31 22.2 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.31 1.34 . . . . 0.0 112.757 -156.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' J' ' 158' ' ' TYR . . . 80.5 12.62 82.78 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.02 120.72 37.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.977 0.888 . . . . 0.0 109.914 170.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.524 HG22 ' O ' ' J' ' 165' ' ' GLN . 38.0 t -107.12 114.56 61.18 Favored Pre-proline 0 C--O 1.241 0.622 0 CA-C-N 114.755 -1.112 . . . . 0.0 108.385 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.401 ' O ' ' HB3' ' J' ' 176' ' ' ALA . 31.4 Cg_exo -70.27 165.54 31.2 Favored 'Trans proline' 0 C--N 1.35 0.608 0 CA-C-N 119.515 0.863 . . . . 0.0 111.785 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' J' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.279 0 C-N-CA 125.412 1.485 . . . . 0.0 112.327 -171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.434 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.161 0 N-CA-C 114.798 1.038 . . . . 0.0 114.798 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.945 HG21 HG23 ' L' ' 126' ' ' VAL . 67.4 mt -131.16 154.85 41.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.82 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.18 23.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.878 0.847 . . . . 0.0 110.751 -177.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.646 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -67.41 -15.13 65.48 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.37 -0.832 . . . . 0.0 114.475 175.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.97 -6.53 26.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 117.799 0.799 . . . . 0.0 112.429 172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 26.6 t0 -66.53 -51.56 55.27 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -172.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . . . . . . . . . 97.3 t -83.76 121.02 35.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.627 0.727 . . . . 0.0 110.54 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' K' ' 34' ' ' ASP . 51.2 m-85 -106.74 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.724 -164.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.608 ' HG ' HD12 ' K' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.49 39.34 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 174.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.24 115.26 22.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.536 0.684 . . . . 0.0 109.958 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 15.5 tt0 -113.68 127.22 55.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 170.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 32.9 p -77.32 146.38 36.81 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.064 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.871 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.0 OUTLIER -62.19 -35.85 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.997 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.34 -23.02 66.89 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.03 -41.35 67.62 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.419 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' E' ' 166' ' ' THR . . . 50.56 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.235 1.414 . . . . 0.0 111.771 -173.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 179.35 6.42 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.371 0.42 . . . . 0.0 113.751 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.33 -37.39 68.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 117.001 0.401 . . . . 0.0 111.777 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 49.37 77.14 0.48 Allowed Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 126.984 2.114 . . . . 0.0 112.417 -174.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.4 144.84 46.5 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.429 0.832 . . . . 0.0 112.482 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.608 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.8 tt -126.5 146.65 50.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' K' ' 76' ' ' GLN . 62.5 t80 -102.75 133.07 20.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 C-N-CA 115.807 -2.357 . . . . 0.0 110.512 -167.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.68 -178.67 3.91 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.86 0.692 . . . . 0.0 112.398 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' K' ' 68' ' ' TYR . . . 60.48 39.27 18.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.393 1.477 . . . . 0.0 111.564 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . 0.425 ' CE1' ' O ' ' K' ' 28' ' ' PHE . 12.6 m-30 -71.24 135.67 47.6 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.547 1.165 . . . . 0.0 111.075 173.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.484 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 9.7 mm-40 -106.28 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 26.2 p -129.97 170.42 13.98 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 122.756 1.265 . . . . 0.0 111.068 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.707 ' OD1' HG13 ' K' ' 65' ' ' VAL . 1.6 t0 -162.4 102.49 1.08 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.981 -164.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.75 140.34 15.05 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.359 170.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 19.1 t -133.93 120.82 20.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.483 HG12 ' HB3' ' L' ' 117' ' ' GLU . 31.2 m -127.72 145.94 34.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -173.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 10.9 m -134.34 123.85 24.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -166.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.38 118.07 3.83 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.263 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.5 123.57 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.56 HH22 ' HB2' ' K' ' 60' ' ' ALA . 1.7 mtm-85 -61.25 135.76 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.693 0.758 . . . . 0.0 110.179 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . 0.58 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -137.28 125.46 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.18 120.73 39.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.525 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' K' ' 51' ' ' GLY . 0.6 OUTLIER -130.64 88.44 2.62 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.222 171.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . 0.475 ' O ' ' HA2' ' K' ' 51' ' ' GLY . 1.6 t70 -107.82 168.9 8.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 1.9 mp0 -71.83 -47.16 55.04 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.5 mt-30 57.1 35.64 26.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.635 1.574 . . . . 0.0 111.655 -172.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.472 ' O ' HG21 ' F' ' 153' ' ' VAL . 33.5 p 42.86 48.98 5.08 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.507 1.523 . . . . 0.0 111.541 -164.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.25 -165.1 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.463 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' F' ' 154' ' ' SER . 6.1 m-80 -77.91 21.51 0.31 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' K' ' 45' ' ' ASP . . . 82.73 174.16 49.96 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.531 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -118.34 122.28 42.48 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 1.095 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.2 pp -128.62 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.912 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.448 HD12 ' H ' ' K' ' 54' ' ' LEU . 0.8 OUTLIER -65.33 -23.75 67.08 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.2 109.51 2.15 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-O 121.68 0.6 . . . . 0.0 113.974 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.32 176.58 9.77 Favored 'Trans proline' 0 CA--C 1.515 -0.432 0 N-CA-C 113.843 0.67 . . . . 0.0 113.843 -175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.88 29.32 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . 0.465 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 3.2 t -85.94 153.15 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.537 0.684 . . . . 0.0 110.504 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 12.6 p -104.6 131.94 52.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . 0.56 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -106.62 110.86 23.17 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' K' ' 134' ' ' VAL . 13.3 m-20 -98.69 104.1 16.11 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -171.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.95 143.51 31.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.927 0.891 . . . . 0.0 110.039 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.78 25.62 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.156 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.89 130.86 26.21 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.707 HG13 ' OD1' ' K' ' 34' ' ' ASP . 15.6 t -112.59 122.47 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 24.8 p -112.45 137.77 50.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -159.58 162.54 35.34 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 19.4 m-30 -88.19 134.82 33.69 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -72.15 143.81 35.18 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.986 0.754 . . . . 0.0 114.986 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.5 ' HG2' ' OD1' ' K' ' 73' ' ' ASP . 8.7 tttp -113.59 151.69 31.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -47.22 -51.6 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.42 -113.35 3.13 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . 0.5 ' OD1' ' HG2' ' K' ' 70' ' ' LYS . 1.4 m-20 72.14 121.4 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.167 1.387 . . . . 0.0 111.016 169.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.54 -26.8 20.67 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.428 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.43 -53.06 44.67 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.837 168.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.501 ' HB3' ' CE1' ' K' ' 28' ' ' PHE . 0.0 OUTLIER -60.89 -40.26 92.4 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.163 -0.61 . . . . 0.0 111.879 171.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -38.28 85.82 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.746 171.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.54 98.54 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.961 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.626 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -52.51 -47.87 47.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.037 0.446 . . . . 0.0 110.473 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 1.0 OUTLIER -67.68 -46.76 71.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.787 -0.57 . . . . 0.0 112.453 -178.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.16 -36.43 75.26 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.579 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.843 ' HB2' HD11 ' K' ' 89' ' ' ILE . . . -58.97 -50.16 75.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.056 -1.058 . . . . 0.0 111.596 174.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.665 ' HD1' HG22 ' K' ' 113' ' ' ILE . 57.3 t80 -74.09 -48.35 30.26 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.925 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.9 63.62 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . 0.413 ' HB2' ' NZ ' ' K' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.12 24.59 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.059 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.74 2.81 Favored Glycine 0 N--CA 1.448 -0.501 0 O-C-N 122.345 -0.222 . . . . 0.0 112.846 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.645 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 11.4 mptt -137.4 148.52 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.678 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -69.09 141.51 54.7 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' K' ' 82' ' ' ALA . 13.1 mm -116.45 129.03 73.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.388 0.613 . . . . 0.0 109.872 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.871 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 8.6 mtmt -82.93 111.3 18.68 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.99 124.67 49.95 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.499 1.12 . . . . 0.0 109.971 -165.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.569 ' CE2' ' HE1' ' K' ' 108' ' ' PHE . 6.5 m95 -123.58 121.53 35.84 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.198 0.999 . . . . 0.0 108.328 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.03 107.69 18.13 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 172.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.607 HG11 ' HG2' ' K' ' 142' ' ' GLU . 13.4 m -128.48 151.59 35.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.393 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.02 157.57 16.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.655 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . . . . . . . . . 16.4 m -91.53 -4.09 55.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.644 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.84 136.13 28.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.684 0.754 . . . . 0.0 109.908 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 12.7 tttp -66.83 126.06 27.87 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.959 -174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -68.11 168.08 12.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.825 0.822 . . . . 0.0 109.987 171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.41 -5.87 51.15 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.94 -42.17 1.12 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.859 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' K' ' 104' ' ' TYR . 0.3 OUTLIER -80.02 167.54 20.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 167.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -66.95 -37.92 85.18 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.89 -0.506 . . . . 0.0 110.552 171.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.55 ' OH ' HG21 ' K' ' 151' ' ' VAL . 97.5 m-85 -148.08 176.41 10.22 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.767 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 4.1 p-10 -117.53 151.31 37.39 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.679 0.752 . . . . 0.0 109.421 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.917 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -143.52 149.36 37.36 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.054 -163.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' K' ' 139' ' ' LYS . 63.0 mt-30 -120.63 131.14 54.46 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 157.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.671 ' HD2' HD11 ' K' ' 138' ' ' LEU . 85.2 t80 -123.52 148.76 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.447 0.699 . . . . 0.0 110.431 -163.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.86 31.26 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.523 -1.322 . . . . 0.0 112.005 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.71 ' O ' HG23 ' K' ' 134' ' ' VAL . 2.4 m-85 -86.5 123.87 32.19 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 167.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.97 145.88 51.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.97 0.89 . . . . 0.0 111.167 -169.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.678 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -123.84 125.16 44.18 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.455 -1.248 . . . . 0.0 107.97 -174.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.665 HG22 ' HD1' ' K' ' 83' ' ' TYR . 60.5 mt -78.61 102.43 4.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.532 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.0 mt-10 -96.81 -16.15 20.94 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.58 141.67 45.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.934 0.788 . . . . 0.0 109.055 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' K' ' 116' ' ' ARG . 2.0 ttt180 -142.3 106.92 4.83 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.537 ' HB3' HG12 ' J' ' 37' ' ' VAL . 6.2 mt-10 -120.67 120.17 34.93 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 22.7 p90 -121.06 138.79 54.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.473 . . . . 0.0 111.149 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . 0.47 ' HB3' ' HB2' ' K' ' 127' ' ' GLU . 26.0 t -109.74 140.34 43.75 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.725 177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.24 117.43 31.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 167.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.64 -178.39 28.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 121.713 0.618 . . . . 0.0 111.577 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.35 -46.09 97.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 O-C-N 122.486 -0.42 . . . . 0.0 111.151 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . 0.539 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 3.1 tp10 -129.99 142.53 50.62 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 169.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.62 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 166.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.09 149.67 50.23 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.627 0.727 . . . . 0.0 110.717 -177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.914 HG23 HG21 ' J' ' 6' ' ' ILE . 45.3 t -53.03 119.99 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.051 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.3 OUTLIER -76.08 102.18 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.11 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.46 111.97 31.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' K' ' 65' ' ' VAL . 3.4 t -114.93 125.84 54.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 168.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' K' ' 65' ' ' VAL . 1.5 pp -118.11 130.0 73.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.39 139.71 44.01 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.363 0.665 . . . . 0.0 109.737 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.22 151.42 40.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.11 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.37 145.84 38.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.962 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.6 p -138.22 141.64 37.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 1.067 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -59.52 -48.97 85.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 -173.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.616 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -160.62 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.714 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.83 44.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 122.001 0.905 . . . . 0.0 110.66 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.671 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.2 OUTLIER -97.2 131.73 43.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.544 ' HG2' ' HG2' ' K' ' 107' ' ' GLN . 15.0 mtmt -86.4 134.33 33.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' K' ' 106' ' ' ALA . 1.1 p-10 -161.56 -163.08 0.94 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -119.83 154.31 16.49 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.245 -0.978 . . . . 0.0 111.363 169.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.917 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 21.7 tp10 -106.61 151.94 24.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.522 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.3 OUTLIER -109.85 -82.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.736 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' E' ' 162' ' ' GLN . 7.0 p-10 -95.87 96.44 8.94 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.005 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.497 ' O ' HD12 ' K' ' 150' ' ' ILE . 37.9 p -94.39 21.13 7.42 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.428 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' K' ' 150' ' ' ILE . 1.1 mm? 55.29 53.39 8.91 Favored Pre-proline 0 C--N 1.346 0.446 0 C-N-CA 126.429 1.892 . . . . 0.0 109.386 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.718 ' HB3' HG21 ' K' ' 151' ' ' VAL . 31.5 Cg_exo -66.71 -13.78 41.26 Favored 'Trans proline' 0 C--N 1.351 0.659 0 N-CA-C 115.338 1.245 . . . . 0.0 115.338 -159.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.46 -51.22 48.89 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.595 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.497 HD12 ' O ' ' K' ' 145' ' ' THR . 1.0 OUTLIER -76.79 -41.31 32.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 119.109 0.868 . . . . 0.0 111.259 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.718 HG21 ' HB3' ' K' ' 147' ' ' PRO . 24.3 t -73.31 -36.39 49.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -109.68 116.78 32.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.442 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 32.8 m -116.89 119.67 62.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.05 134.72 30.19 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -172.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . 0.552 ' HD2' ' O ' ' K' ' 156' ' ' GLY . 0.2 OUTLIER -54.98 -44.53 74.53 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 175.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . 0.552 ' O ' ' HD2' ' K' ' 155' ' ' LYS . . . 138.97 137.09 3.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.394 0.997 . . . . 0.0 112.995 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.28 80.64 0.36 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . 0.667 ' CE2' ' HB2' ' K' ' 171' ' ' PRO . 0.0 OUTLIER -111.51 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.319 1.048 . . . . 0.0 108.648 177.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.86 -44.92 65.37 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -158.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.59 117.58 18.92 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.688 2.395 . . . . 0.0 109.166 167.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' K' ' 165' ' ' GLN . 0.1 OUTLIER -122.61 48.59 1.74 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 154.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -31.53 2.13 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -166.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -85.0 -3.09 9.68 Favored 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.051 1.768 . . . . 0.0 113.895 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.58 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.517 ' O ' HG22 ' K' ' 174' ' ' VAL . 0.7 OUTLIER -71.41 -41.25 69.8 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.882 1.341 . . . . 0.0 110.951 175.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.11 51.72 12.74 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.831 1.653 . . . . 0.0 111.885 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.443 HG21 ' H ' ' K' ' 172' ' ' GLY . 85.3 m -124.34 156.14 37.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.312 -167.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . 0.408 ' N ' HG22 ' K' ' 167' ' ' THR . . . -89.4 -152.2 25.83 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.499 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.99 -41.84 99.68 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.793 0.296 . . . . 0.0 111.462 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.91 129.02 51.87 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 123.47 0.708 . . . . 0.0 109.284 -178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . 0.667 ' HB2' ' CE2' ' K' ' 158' ' ' TYR . 85.8 Cg_endo -79.32 150.28 22.36 Favored 'Trans proline' 0 C--N 1.324 -0.735 0 C-N-CA 121.295 1.33 . . . . 0.0 112.786 -156.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . 0.529 ' HA3' ' CE1' ' K' ' 158' ' ' TYR . . . 80.53 12.62 82.75 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 117.215 1.646 . . . . 0.0 117.215 165.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.03 120.81 38.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.967 0.884 . . . . 0.0 109.925 170.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' K' ' 165' ' ' GLN . 37.9 t -107.19 114.62 60.99 Favored Pre-proline 0 C--O 1.24 0.597 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.365 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' K' ' 176' ' ' ALA . 31.5 Cg_exo -70.33 165.53 31.33 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 119.465 0.845 . . . . 0.0 111.703 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' K' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.465 0.276 0 C-N-CA 125.389 1.475 . . . . 0.0 112.3 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.559 ' HB2' ' O ' ' G' ' 69' ' ' GLY . 50.0 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 N-CA-C 114.765 1.025 . . . . 0.0 114.765 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.93 HG21 HG23 ' G' ' 126' ' ' VAL . 67.3 mt -131.17 154.86 41.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.821 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -117.85 159.17 23.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.88 0.848 . . . . 0.0 110.77 -177.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' G' ' 123' ' ' GLU . . . -67.42 -15.13 65.5 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.347 -0.842 . . . . 0.0 114.488 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -99.94 -6.55 26.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.81 0.805 . . . . 0.0 112.402 172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.821 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 26.6 t0 -66.49 -51.6 55.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.7 120.98 35.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.44 144.34 50.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.695 0.76 . . . . 0.0 110.474 176.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' L' ' 34' ' ' ASP . 51.5 m-85 -106.72 105.26 15.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.79 -164.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.593 ' HG ' HD12 ' L' ' 27' ' ' LEU . 1.0 OUTLIER -93.51 130.56 39.32 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -122.32 115.24 21.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.512 0.672 . . . . 0.0 109.935 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 15.5 tt0 -113.64 127.24 55.98 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 170.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 32.8 p -77.44 146.4 36.55 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.03 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.844 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.0 OUTLIER -62.22 -35.84 71.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.965 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.32 -23.04 66.91 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 -41.27 67.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.441 -175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 50.58 54.45 11.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.212 1.405 . . . . 0.0 111.763 -173.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.87 179.36 6.42 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -118.83 27.38 7.16 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 123.361 0.413 . . . . 0.0 113.724 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -72.36 -37.37 68.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.026 0.413 . . . . 0.0 111.776 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.459 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 49.42 77.13 0.48 Allowed Pre-proline 0 C--O 1.238 0.462 0 C-N-CA 126.926 2.09 . . . . 0.0 112.406 -174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -71.41 144.87 46.57 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.444 0.837 . . . . 0.0 112.461 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.593 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -126.54 146.69 50.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 168.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' L' ' 76' ' ' GLN . 62.6 t80 -102.73 133.0 20.69 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.536 -167.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.63 -178.71 3.92 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.067 0.702 . . . . 0.0 112.44 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' L' ' 68' ' ' TYR . . . 60.59 39.17 18.2 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.342 1.457 . . . . 0.0 111.571 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' L' ' 28' ' ' PHE . 12.6 m-30 -71.23 135.61 47.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.506 1.146 . . . . 0.0 111.06 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.48 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 9.6 mm-40 -106.29 -93.61 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 25.9 p -129.92 170.45 13.91 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 122.777 1.275 . . . . 0.0 111.072 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.72 ' OD1' HG13 ' L' ' 65' ' ' VAL . 1.6 t0 -162.44 102.47 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.037 -1.438 . . . . 0.0 107.959 -164.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.79 140.32 15.03 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.367 170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . 0.41 ' HB3' ' CE1' ' G' ' 118' ' ' TYR . 19.0 t -133.87 120.82 20.89 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.508 ' HB ' ' OE1' ' G' ' 117' ' ' GLU . 31.0 m -127.7 145.93 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -173.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 10.8 m -134.33 123.91 24.94 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -166.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . 0.641 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.49 118.08 3.82 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.208 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -100.53 123.57 44.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' L' ' 60' ' ' ALA . 1.7 mtm-85 -61.21 135.77 57.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.709 0.766 . . . . 0.0 110.108 -174.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -137.33 125.5 23.05 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 120.78 39.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.518 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . 0.466 ' CE2' ' HA3' ' L' ' 51' ' ' GLY . 0.7 OUTLIER -130.76 88.41 2.62 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.212 171.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . 0.46 ' O ' ' HA2' ' L' ' 51' ' ' GLY . 1.6 t70 -107.76 168.92 8.93 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 155.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.87 -47.19 54.6 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.5 mt-30 57.17 35.51 26.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.602 1.561 . . . . 0.0 111.716 -172.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 33.6 p 42.94 48.94 5.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.491 1.516 . . . . 0.0 111.569 -164.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -147.27 -165.09 2.16 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.475 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . 0.409 ' ND2' ' HA ' ' A' ' 154' ' ' SER . 6.1 m-80 -77.96 21.58 0.32 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' L' ' 44' ' ' PHE . . . 82.7 174.13 49.9 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -118.3 122.33 42.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 1.028 HG12 HG23 ' G' ' 135' ' ' ILE . 1.2 pp -128.65 -33.31 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.901 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.45 HD12 ' H ' ' L' ' 54' ' ' LEU . 0.8 OUTLIER -65.35 -23.74 67.07 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 176.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 109.48 2.14 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-O 121.682 0.601 . . . . 0.0 113.926 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.32 176.56 9.79 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 N-CA-C 113.845 0.671 . . . . 0.0 113.845 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.43 -168.89 29.3 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . 0.459 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 3.2 t -85.96 153.17 22.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.548 0.69 . . . . 0.0 110.517 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 12.5 p -104.6 131.99 52.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . 0.572 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -106.6 110.81 23.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' L' ' 134' ' ' VAL . 13.3 m-20 -98.72 104.12 16.13 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.87 143.46 31.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.994 0.918 . . . . 0.0 110.073 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.11 154.84 25.67 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.161 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -139.92 130.87 26.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.72 HG13 ' OD1' ' L' ' 34' ' ' ASP . 15.7 t -112.6 122.46 66.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 24.6 p -112.39 137.79 50.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -159.61 162.54 35.28 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 19.4 m-30 -88.22 134.79 33.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -72.16 143.75 35.09 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 114.974 0.749 . . . . 0.0 114.974 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.486 ' HG2' ' OD1' ' L' ' 73' ' ' ASP . 8.8 tttp -113.56 151.72 31.23 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.406 ' HD3' HH21 ' L' ' 71' ' ' ARG . 10.1 ptp180 -47.19 -51.63 17.96 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -113.45 -113.37 3.13 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . 0.486 ' OD1' ' HG2' ' L' ' 70' ' ' LYS . 1.4 m-20 72.19 121.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.128 1.371 . . . . 0.0 111.002 169.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.55 -26.78 20.67 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -156.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.422 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -62.43 -53.05 44.77 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.82 168.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.499 ' HB3' ' CE1' ' L' ' 28' ' ' PHE . 0.0 OUTLIER -60.94 -40.26 92.56 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.148 -0.619 . . . . 0.0 111.835 171.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.04 -38.32 85.76 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.746 171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.58 98.44 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.882 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.633 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -52.47 -47.9 47.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 110.457 172.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 1.0 OUTLIER -67.63 -46.84 71.3 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.701 -0.625 . . . . 0.0 112.452 -178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.2 -36.34 75.21 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.594 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.818 ' HB2' HD11 ' L' ' 89' ' ' ILE . . . -58.93 -50.24 74.79 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.57 174.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.671 ' HD1' HG22 ' L' ' 113' ' ' ILE . 57.2 t80 -74.0 -48.46 30.04 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.943 -174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.43 -51.9 63.76 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -167.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . 0.409 ' HB2' ' NZ ' ' L' ' 87' ' ' LYS . 35.2 m120 -83.37 -36.15 24.57 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.037 172.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.22 102.79 2.81 Favored Glycine 0 N--CA 1.449 -0.464 0 O-C-N 122.352 -0.218 . . . . 0.0 112.844 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.628 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 11.4 mptt -137.38 148.51 46.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.684 ' HG2' ' HD1' ' L' ' 112' ' ' TYR . 1.6 tm0? -69.12 141.54 54.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 168.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' L' ' 82' ' ' ALA . 13.0 mm -116.45 129.03 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.356 0.598 . . . . 0.0 109.867 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.844 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 8.5 mtmt -82.89 111.31 18.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -105.98 124.62 49.86 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.521 1.128 . . . . 0.0 109.989 -165.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.572 ' CE2' ' HE1' ' L' ' 108' ' ' PHE . 6.4 m95 -123.52 121.49 35.79 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.194 0.997 . . . . 0.0 108.319 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -109.05 107.75 18.2 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.617 HG11 ' HG2' ' L' ' 142' ' ' GLU . 13.6 m -128.5 151.61 35.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 CA-C-O 122.288 1.042 . . . . 0.0 109.409 -173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.0 157.55 16.05 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.639 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . . . . . . . . . 16.5 m -91.59 -4.04 55.76 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.682 -176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -96.89 136.21 28.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.7 0.762 . . . . 0.0 109.877 176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 12.7 tttp -66.9 126.04 27.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.006 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.15 168.17 12.69 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.784 0.802 . . . . 0.0 109.982 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.43 -5.92 51.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -130.88 -42.22 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.838 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' L' ' 104' ' ' TYR . 0.3 OUTLIER -80.0 167.47 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 167.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -66.91 -37.88 85.19 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.921 -0.487 . . . . 0.0 110.602 171.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.536 ' OH ' HG21 ' L' ' 151' ' ' VAL . 97.3 m-85 -148.1 176.41 10.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.778 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 4.1 p-10 -117.48 151.25 37.48 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.611 0.719 . . . . 0.0 109.464 177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.887 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -143.47 149.38 37.46 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.07 -163.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.559 ' HG2' ' HG2' ' L' ' 139' ' ' LYS . 63.2 mt-30 -120.63 131.18 54.48 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 157.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.674 ' HD2' HD11 ' L' ' 138' ' ' LEU . 85.2 t80 -123.6 148.76 46.1 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.419 0.688 . . . . 0.0 110.396 -163.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.83 158.85 31.24 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.493 -1.336 . . . . 0.0 111.934 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.704 ' O ' HG23 ' L' ' 134' ' ' VAL . 2.4 m-85 -86.47 123.87 32.16 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.94 145.92 51.63 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.91 0.862 . . . . 0.0 111.19 -169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.684 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -123.83 125.19 44.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.949 -174.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.671 HG22 ' HD1' ' L' ' 83' ' ' TYR . 60.3 mt -78.58 102.37 4.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.0 mt-10 -96.82 -16.06 20.97 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -135.61 141.67 45.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.924 0.783 . . . . 0.0 109.092 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' L' ' 116' ' ' ARG . 2.0 ttt180 -142.34 106.93 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.483 ' HB3' HG12 ' K' ' 37' ' ' VAL . 6.2 mt-10 -120.71 120.09 34.67 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 22.5 p90 -120.98 138.85 53.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.069 0.462 . . . . 0.0 111.202 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' L' ' 127' ' ' GLU . 26.0 t -109.81 140.32 43.87 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.699 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.3 117.42 31.78 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.67 -178.35 28.29 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.36 -46.13 97.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 O-C-N 122.475 -0.427 . . . . 0.0 111.073 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 3.1 tp10 -129.97 142.55 50.62 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 125.57 156.23 9.25 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.07 149.63 50.31 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.604 0.716 . . . . 0.0 110.732 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.945 HG23 HG21 ' K' ' 6' ' ' ILE . 45.3 t -53.0 120.05 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.007 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.3 OUTLIER -76.18 102.24 5.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.092 -176.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.49 111.9 31.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' L' ' 65' ' ' VAL . 3.4 t -114.9 125.8 54.07 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.512 HG13 ' HB ' ' L' ' 65' ' ' VAL . 1.5 pp -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.38 139.75 43.94 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.738 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 pp -143.26 151.44 40.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.098 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.36 145.82 38.21 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 167.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 1.095 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.5 p -138.25 141.6 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.949 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -59.5 -48.96 85.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 121.317 0.579 . . . . 0.0 110.314 -173.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.614 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -160.61 145.36 11.0 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.696 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -101.36 122.8 44.38 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.674 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.2 131.65 43.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' L' ' 107' ' ' GLN . 14.9 mtmt -86.34 134.3 33.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.799 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 1.1 p-10 -161.51 -163.06 0.94 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.778 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -119.83 154.33 16.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.349 169.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.887 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 21.7 tp10 -106.67 151.94 24.44 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' F' ' 160' ' ' PHE . 0.3 OUTLIER -109.76 -82.85 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.771 -176.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.835 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 7.0 p-10 -95.91 96.48 8.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.963 -176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.514 ' O ' HD12 ' L' ' 150' ' ' ILE . 37.9 p -94.35 21.14 7.37 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 118.767 -0.635 . . . . 0.0 112.395 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' L' ' 25' ' ' ALA . 1.1 mm? 55.16 53.47 9.15 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.491 1.916 . . . . 0.0 109.4 -173.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.72 ' HB3' HG21 ' L' ' 151' ' ' VAL . 31.5 Cg_exo -66.7 -13.79 41.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.215 1.277 . . . . 0.0 115.328 -159.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.44 -51.25 48.38 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.596 171.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -111.27 -32.59 6.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -173.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.514 HD12 ' O ' ' L' ' 145' ' ' THR . 1.0 OUTLIER -76.78 -41.25 32.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.154 0.888 . . . . 0.0 111.321 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.72 HG21 ' HB3' ' L' ' 147' ' ' PRO . 24.3 t -73.31 -36.42 49.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -109.68 116.79 32.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.431 -176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 32.9 m -116.89 119.63 62.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.6 p -141.03 134.76 30.29 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' L' ' 156' ' ' GLY . 0.2 OUTLIER -54.97 -44.58 74.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 175.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' L' ' 155' ' ' LYS . . . 139.0 137.09 3.48 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 119.334 0.97 . . . . 0.0 112.994 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -127.23 80.59 0.36 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' L' ' 171' ' ' PRO . 0.0 OUTLIER -111.5 91.62 3.73 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.304 1.042 . . . . 0.0 108.66 177.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.82 -45.02 65.31 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.5 117.55 18.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 127.723 2.409 . . . . 0.0 109.206 167.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.406 ' HB3' ' HA ' ' L' ' 165' ' ' GLN . 0.1 OUTLIER -122.6 48.54 1.75 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 154.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -31.62 2.19 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -166.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -84.96 -3.07 9.71 Favored 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.067 1.774 . . . . 0.0 113.881 171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.82 68.61 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 118.331 2.092 . . . . 0.0 118.331 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.521 ' O ' HG22 ' L' ' 174' ' ' VAL . 0.7 OUTLIER -71.46 -41.19 69.71 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.91 1.355 . . . . 0.0 110.924 175.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 1.8 p 47.0 51.8 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.83 1.652 . . . . 0.0 111.871 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.438 HG21 ' H ' ' L' ' 172' ' ' GLY . 86.7 m -124.41 156.18 37.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.29 -167.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . 0.414 ' N ' HG22 ' L' ' 167' ' ' THR . . . -89.46 -152.24 25.97 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.466 172.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.96 -41.88 99.65 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.785 0.292 . . . . 0.0 111.429 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -87.84 129.02 52.03 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 123.54 0.736 . . . . 0.0 109.284 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . 0.665 ' HB2' ' CE2' ' L' ' 158' ' ' TYR . 86.4 Cg_endo -79.29 150.3 22.45 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.323 1.349 . . . . 0.0 112.766 -156.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' L' ' 158' ' ' TYR . . . 80.52 12.62 82.77 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.07 120.8 38.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.007 0.903 . . . . 0.0 109.863 170.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.521 HG22 ' O ' ' L' ' 165' ' ' GLN . 37.9 t -107.16 114.58 61.09 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.42 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' L' ' 176' ' ' ALA . 31.4 Cg_exo -70.24 165.45 31.47 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.52 0.864 . . . . 0.0 111.771 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' L' ' 175' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.439 1.496 . . . . 0.0 112.298 -171.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 N-CA-C 103.604 -3.268 . . . . 0.0 103.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.526 ' O ' ' HB1' ' B' ' 125' ' ' ALA . 6.3 mt -87.13 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.1 14.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.89 0.852 . . . . 0.0 110.759 -177.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.7 68.15 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.358 -0.837 . . . . 0.0 114.474 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.32 -31.08 43.08 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 117.759 0.779 . . . . 0.0 112.394 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.26 69.35 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -171.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.459 HG22 ' OD1' ' A' ' 95' ' ' ASP . 32.3 t -89.06 115.25 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.51 49.09 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.71 0.767 . . . . 0.0 110.473 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.52 125.18 53.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.769 -164.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.44 40.6 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 174.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 91' ' ' PHE . 2.2 m-85 -125.25 149.41 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.476 0.655 . . . . 0.0 109.962 176.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 4.3 tt0 -131.27 131.95 44.23 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.61 137.56 42.37 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.548 0.69 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -61.57 -34.18 60.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.99 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 18' ' ' ILE . 29.3 m-20 -84.38 -16.4 42.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.81 42.06 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.455 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.97 6.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.177 1.391 . . . . 0.0 111.776 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.33 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.45 -0.423 0 O-C-N 123.371 0.42 . . . . 0.0 113.714 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.938 0.369 . . . . 0.0 111.757 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . . . -98.53 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 126.972 2.109 . . . . 0.0 112.418 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.04 150.1 47.8 Favored 'Trans proline' 0 C--N 1.349 0.579 0 CA-C-N 119.401 0.822 . . . . 0.0 112.477 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.55 44.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 168.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' A' ' 29' ' ' PRO . 32.6 t80 -100.56 143.55 26.77 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.867 -2.333 . . . . 0.0 110.566 -167.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' A' ' 28' ' ' PHE . 50.0 Cg_endo -79.11 175.14 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.306 0 CA-C-O 121.849 0.687 . . . . 0.0 112.444 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.87 1.94 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.367 1.467 . . . . 0.0 111.557 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.68 146.68 40.02 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.514 1.149 . . . . 0.0 111.086 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.87 -64.4 1.16 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 122.769 1.271 . . . . 0.0 111.08 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.81 10.69 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.963 -164.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.327 170.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.37 121.65 44.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' B' ' 117' ' ' GLU . 2.4 t -121.76 132.44 70.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -173.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' OH ' ' B' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -166.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 124.6 8.01 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.234 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.35 41.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.764 0.793 . . . . 0.0 110.136 -174.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -130.24 174.0 10.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -167.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.84 HD23 ' HA3' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.0 34.94 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.229 171.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.82 110.03 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' A' ' 48' ' ' THR . 2.9 tt0 -67.43 -35.2 78.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 0.0 OUTLIER 71.33 20.23 5.05 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.576 1.55 . . . . 0.0 111.657 -172.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HA ' ' OE1' ' A' ' 46' ' ' GLU . 5.8 m 42.35 55.38 4.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.468 1.507 . . . . 0.0 111.599 -164.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 8.8 mmtp -107.74 -133.47 0.33 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.5 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.56 15.96 27.24 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 43' ' ' LEU . 4.1 mmp_? -109.74 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.839 HG13 HG22 ' B' ' 135' ' ' ILE . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.878 178.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 176.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.84 ' HA3' HD23 ' A' ' 43' ' ' LEU . . . -104.35 158.19 16.71 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-O 121.642 0.579 . . . . 0.0 113.937 -170.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.44 138.73 15.81 Favored 'Trans proline' 0 CA--C 1.516 -0.411 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 -175.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.09 17.52 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.96 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 0.0 110.482 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 40' ' ' GLU . 16.5 t -117.43 129.78 73.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.4 44.61 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.15 11.97 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -171.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.29 148.28 42.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.998 0.919 . . . . 0.0 110.116 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.38 152.04 22.64 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.187 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 143.9 51.06 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.451 HG12 ' HD1' ' A' ' 67' ' ' TYR . 59.1 t -129.88 122.74 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.21 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' HD1' HG12 ' A' ' 65' ' ' VAL . 24.2 p90 -168.8 167.95 10.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 48.5 m-85 -98.91 118.08 34.88 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 128' ' ' ILE . . . -71.45 135.9 24.22 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -175.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.691 ' H ' ' HZ ' ' A' ' 28' ' ' PHE . 9.4 mttm -92.87 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.59 62.47 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.43 158.9 43.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.083 1.353 . . . . 0.0 111.019 169.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.57 -37.62 56.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -64.18 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.813 168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' OE1' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.91 66.36 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.138 -0.624 . . . . 0.0 111.839 171.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 6.2 mtmp? -62.5 -27.09 68.9 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.813 171.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.09 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.903 168.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 75' ' ' GLY . 2.3 mm -64.92 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.1 0.476 . . . . 0.0 110.511 172.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.672 ' HG3' ' OE1' ' A' ' 76' ' ' GLN . 10.6 mm-40 -63.64 -44.42 93.91 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.711 -0.618 . . . . 0.0 112.421 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.36 -37.6 80.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.576 169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.873 ' HA ' ' HG3' ' A' ' 87' ' ' LYS . . . -52.46 -52.79 52.45 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.535 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.499 ' OH ' ' HB2' ' F' ' 38' ' ' SER . 25.4 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.909 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.666 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 3.5 mt-30 -74.42 -43.16 57.52 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.71 -28.67 58.68 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.04 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.556 0 O-C-N 122.315 -0.241 . . . . 0.0 112.869 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.873 ' HG3' ' HA ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -137.4 152.03 49.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -82.73 142.31 31.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 168.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 1.3 mm -117.27 152.09 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.339 0.59 . . . . 0.0 109.882 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.25 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' A' ' 132' ' ' LEU . 1.6 t80 -121.38 123.33 41.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.558 1.143 . . . . 0.0 110.028 -166.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.06 52.8 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.215 1.006 . . . . 0.0 108.326 -179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.629 ' HD3' ' OE1' ' A' ' 107' ' ' GLN . 12.6 ptm180 -130.55 119.11 22.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 172.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.44 HG12 ' CB ' ' A' ' 106' ' ' ALA . 1.6 m -134.83 159.3 41.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.234 1.016 . . . . 0.0 109.398 -173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.52 ' HB2' ' OD1' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.05 23.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.639 179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 10' ' ' ASP . 47.7 p -79.21 -25.96 42.61 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.63 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.61 143.45 14.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.631 0.729 . . . . 0.0 109.928 176.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 131.72 43.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.96 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 105' ' ' ASP . 1.4 t30 -78.23 136.28 37.75 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.776 0.798 . . . . 0.0 110.001 171.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.29 50.57 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.19 3.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.752 0.706 . . . . 0.0 110.853 169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.54 1.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.647 ' HD2' ' HA ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.68 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 121.842 -0.536 . . . . 0.0 110.55 171.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' A' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.86 4.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' A' ' 99' ' ' ASN . 3.2 p30 -122.03 140.43 52.5 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.618 0.723 . . . . 0.0 109.464 177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . . . -140.0 156.18 46.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.037 -163.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' A' ' 137' ' ' GLU . 29.0 tt0 -127.95 139.64 52.46 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 91' ' ' PHE . 14.2 t80 -131.25 150.55 52.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.357 0.663 . . . . 0.0 110.411 -163.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.38 37.77 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.938 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.56 35.71 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.46 31.07 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.916 0.865 . . . . 0.0 111.129 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.695 ' HD1' HD13 ' F' ' 54' ' ' LEU . 1.2 t80 -132.87 164.58 26.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.0 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -96.63 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' A' ' 133' ' ' GLN . 3.6 tt0 -76.35 -43.05 42.69 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.16 38.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.981 0.81 . . . . 0.0 109.127 174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.46 25.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 176.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.78 123.02 26.76 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.82 56.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.086 0.47 . . . . 0.0 111.164 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.96 39.28 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.649 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.41 53.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.59 158.47 20.66 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.464 HG11 ' O ' ' F' ' 31' ' ' TYR . 25.4 m -69.89 -27.74 34.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.541 -0.388 . . . . 0.0 111.13 176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 149.39 21.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.3 -143.59 30.8 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' F' ' 6' ' ' ILE . . . -141.38 155.78 45.88 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.57 0.7 . . . . 0.0 110.764 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.575 ' CG2' ' HB ' ' F' ' 6' ' ' ILE . 33.7 m -53.19 147.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.033 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CE2' ' A' ' 68' ' ' TYR . 3.3 tm-20 -128.62 131.25 48.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.101 -176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.608 ' CD1' ' HA3' ' A' ' 69' ' ' GLY . 25.5 mt -112.62 126.5 70.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.57 50.45 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 168.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' A' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.95 31.98 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.713 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' A' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.77 26.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.129 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -93.37 158.03 15.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.662 HG11 ' HG3' ' A' ' 137' ' ' GLU . 81.0 t -141.55 159.8 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.428 HG22 HG13 ' F' ' 53' ' ' ILE . 6.6 pt -109.7 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.312 0.577 . . . . 0.0 110.326 -173.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.31 1.45 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.687 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.663 ' HB3' HE21 ' A' ' 107' ' ' GLN . 10.0 mt-10 -81.17 139.04 35.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 122.014 0.911 . . . . 0.0 110.683 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.24 148.56 43.53 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 107' ' ' GLN . 1.7 mptt -94.53 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.52 0.99 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -109.19 147.12 16.81 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.222 -0.989 . . . . 0.0 111.399 169.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 3.7 tp10 -85.56 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -174.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.647 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 1.2 mp -96.37 -49.8 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.734 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.99 107.55 9.41 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.011 -176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.35 -43.05 96.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 118.758 -0.639 . . . . 0.0 112.385 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.8 61.76 12.04 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 126.502 1.921 . . . . 0.0 109.39 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -70.57 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.244 1.296 . . . . 0.0 115.35 -159.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.01 -43.95 66.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.595 171.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' H ' ' A' ' 150' ' ' ILE . 3.3 mp -61.79 -47.04 95.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 119.151 0.887 . . . . 0.0 111.25 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 147' ' ' PRO . 77.7 t -74.36 -43.81 49.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.71 114.89 28.62 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.51 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.0 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.54 162.79 15.75 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.06 57.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.26 3.73 61.45 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 119.367 0.985 . . . . 0.0 113.044 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.25 136.39 28.39 Favored Glycine 0 CA--C 1.521 0.422 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.33 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.323 1.049 . . . . 0.0 108.618 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.68 77.68 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -158.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.722 2.409 . . . . 0.0 109.167 167.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.31 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.751 ' HD2' HE22 ' A' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.5 1.7 Allowed 'Trans proline' 0 C--O 1.239 0.558 0 CA-C-N 122.082 1.779 . . . . 0.0 113.862 171.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 118.354 2.102 . . . . 0.0 118.354 -171.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.751 HE22 ' HD2' ' A' ' 163' ' ' PRO . 5.8 mp0 -106.74 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.914 1.357 . . . . 0.0 110.926 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.812 ' HA ' ' HB2' ' G' ' 21' ' ' ALA . 26.3 m 31.05 73.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.842 1.657 . . . . 0.0 111.876 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.841 ' HA ' ' HB ' ' A' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.8 8.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.343 -167.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.445 ' C ' HD13 ' G' ' 18' ' ' ILE . . . -148.94 -158.88 8.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.499 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.14 67.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.808 0.304 . . . . 0.0 111.417 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.36 153.52 74.03 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.505 0.722 . . . . 0.0 109.24 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' G' ' 110' ' ' PHE . 85.7 Cg_endo -80.29 -12.34 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 121.28 1.32 . . . . 0.0 112.686 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.24 96.05 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 117.189 1.636 . . . . 0.0 117.189 165.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.841 ' HB ' ' HA ' ' A' ' 167' ' ' THR . 0.2 OUTLIER -105.82 148.06 27.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.986 0.893 . . . . 0.0 109.862 170.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.427 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 166' ' ' THR . 31.5 Cg_exo -72.9 123.84 9.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 CA-C-N 119.509 0.86 . . . . 0.0 111.776 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.247 0 C-N-CA 125.473 1.509 . . . . 0.0 112.34 -171.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 103.611 -3.265 . . . . 0.0 103.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' C' ' 126' ' ' VAL . 6.3 mt -87.13 132.63 32.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.05 14.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.89 0.852 . . . . 0.0 110.721 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.71 68.2 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.331 -0.85 . . . . 0.0 114.484 175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.28 -31.13 43.26 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 117.761 0.78 . . . . 0.0 112.4 172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' B' ' 96' ' ' THR . 0.4 OUTLIER -53.48 -44.36 68.94 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' B' ' 95' ' ' ASP . 32.8 t -89.05 115.24 28.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.627 0.727 . . . . 0.0 110.518 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.763 -164.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.539 ' HA ' ' HB3' ' B' ' 27' ' ' LEU . 0.1 OUTLIER -120.14 150.42 40.65 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' B' ' 91' ' ' PHE . 2.2 m-85 -125.24 149.39 48.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.524 0.678 . . . . 0.0 109.937 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' B' ' 90' ' ' LYS . 4.2 tt0 -131.24 131.95 44.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 80.7 p -74.56 137.55 42.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.068 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.15 60.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.995 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.495 ' OD1' HD12 ' B' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.46 42.94 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -172.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.06 -51.83 42.14 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.425 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.09 51.99 6.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.249 1.42 . . . . 0.0 111.78 -173.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.37 168.97 8.75 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' SER . . . -93.04 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 113.706 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' B' ' 23' ' ' GLY . 3.5 p 176.02 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.024 0.412 . . . . 0.0 111.793 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.425 ' HA ' ' HG3' ' B' ' 16' ' ' GLN . . . -98.52 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.434 0 C-N-CA 126.929 2.092 . . . . 0.0 112.418 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.11 150.07 47.39 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 119.423 0.83 . . . . 0.0 112.463 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' B' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.6 44.25 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 168.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.7 ' HZ ' ' H ' ' B' ' 70' ' ' LYS . 32.6 t80 -100.54 143.64 26.93 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.843 -2.343 . . . . 0.0 110.556 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' B' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.307 0 CA-C-O 121.859 0.691 . . . . 0.0 112.397 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.54 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.34 1.456 . . . . 0.0 111.572 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.65 146.67 40.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.578 1.18 . . . . 0.0 111.053 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.41 159.58 3.74 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 122.783 1.278 . . . . 0.0 111.154 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.86 10.73 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.997 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.51 4.11 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.332 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.33 121.71 44.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' C' ' 117' ' ' GLU . 2.4 t -121.78 132.48 70.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . 0.449 ' HB2' ' OH ' ' C' ' 83' ' ' TYR . 51.3 p -136.72 107.43 6.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -166.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.235 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.534 ' CD ' HD13 ' C' ' 113' ' ' ILE . 5.3 tt0 -104.62 98.12 7.92 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 151.31 41.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.743 0.782 . . . . 0.0 110.166 -174.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.21 173.93 10.3 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -167.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' B' ' 55' ' ' GLY . 0.1 OUTLIER -69.4 136.47 51.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.573 -179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.54 135.98 34.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.243 171.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.86 110.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 155.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' B' ' 48' ' ' THR . 2.9 tt0 -67.51 -35.16 78.57 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.427 ' HB2' ' HG2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER 71.28 20.29 5.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.586 1.554 . . . . 0.0 111.637 -172.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.558 ' HA ' ' OE1' ' B' ' 46' ' ' GLU . 5.8 m 42.26 55.42 3.98 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.511 1.525 . . . . 0.0 111.589 -164.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' HB2' ' B' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.464 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.1 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.32 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' B' ' 43' ' ' LEU . 4.0 mmp_? -109.72 25.32 11.92 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.922 HG13 HG22 ' C' ' 135' ' ' ILE . 0.7 OUTLIER -123.57 1.65 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.873 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.72 HD22 ' HB2' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -104.55 36.3 2.46 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 176.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' B' ' 43' ' ' LEU . . . -104.28 158.22 16.75 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-O 121.612 0.562 . . . . 0.0 113.957 -170.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.54 138.72 15.62 Favored 'Trans proline' 0 CA--C 1.516 -0.394 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.09 17.52 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 167.04 20.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.522 0.677 . . . . 0.0 110.545 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' GLU . 16.3 t -117.49 129.75 73.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.33 129.32 44.62 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.54 111.16 12.0 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -171.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.37 148.27 42.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.95 0.9 . . . . 0.0 110.052 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.34 152.09 22.65 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.188 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.454 HG12 ' HD1' ' B' ' 67' ' ' TYR . 59.1 t -129.89 122.72 55.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.16 146.88 32.08 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' B' ' 79' ' ' ILE . 24.1 p90 -168.8 167.91 10.82 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' B' ' 127' ' ' GLU . 48.1 m-85 -98.87 118.11 34.88 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' B' ' 128' ' ' ILE . . . -71.58 135.94 24.08 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . 0.7 ' H ' ' HZ ' ' B' ' 28' ' ' PHE . 9.4 mttm -92.88 153.9 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.452 0.644 . . . . 0.0 109.299 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.409 HH21 ' HD2' ' B' ' 71' ' ' ARG . 0.0 OUTLIER -54.14 -35.58 62.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.48 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.112 1.365 . . . . 0.0 111.002 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' B' ' 78' ' ' ALA . . . -76.61 -37.5 56.32 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 117.514 2.413 . . . . 0.0 117.514 -156.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.499 ' O ' HG12 ' B' ' 79' ' ' ILE . . . -64.17 -39.2 96.91 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.853 168.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' B' ' 80' ' ' GLU . 0.8 OUTLIER -61.78 -51.89 66.48 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 122.159 -0.612 . . . . 0.0 111.847 171.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' B' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.08 68.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.786 171.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 74' ' ' ALA . . . -64.15 -41.62 97.11 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.903 168.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 75' ' ' GLY . 2.3 mm -64.98 -40.5 89.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.102 0.477 . . . . 0.0 110.529 172.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.67 ' HG3' ' OE1' ' B' ' 76' ' ' GLN . 10.7 mm-40 -63.65 -44.43 93.85 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.749 -0.595 . . . . 0.0 112.399 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.59 80.53 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.532 169.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.872 ' HA ' ' HG3' ' B' ' 87' ' ' LYS . . . -52.44 -52.79 52.22 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.558 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 38' ' ' SER . 25.4 t80 -83.92 -51.36 7.23 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.91 -174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 3.5 mt-30 -74.36 -43.24 57.38 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -167.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.7 -28.55 58.67 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.056 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.5 1.11 Allowed Glycine 0 N--CA 1.448 -0.512 0 O-C-N 122.3 -0.25 . . . . 0.0 112.899 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.872 ' HG3' ' HA ' ' B' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.0 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' B' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.33 31.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.538 ' CD1' ' HD2' ' B' ' 87' ' ' LYS . 1.3 mm -117.31 152.06 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.338 0.589 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.23 33.31 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.573 ' HE1' HD21 ' B' ' 132' ' ' LEU . 1.6 t80 -121.32 123.35 41.95 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.544 1.138 . . . . 0.0 110.022 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.97 134.05 52.77 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.236 1.014 . . . . 0.0 108.306 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.635 ' HD3' ' OE1' ' B' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.03 21.97 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' B' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 122.231 1.015 . . . . 0.0 109.435 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.523 ' HB2' ' OD1' ' B' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.06 23.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.617 179.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' B' ' 10' ' ' ASP . 47.6 p -79.17 -25.95 42.76 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.706 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.65 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.715 0.769 . . . . 0.0 109.909 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.68 43.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.977 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.543 ' OD1' ' HB3' ' B' ' 105' ' ' ASP . 1.4 t30 -78.26 136.2 37.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.827 0.822 . . . . 0.0 109.983 171.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.61 -22.34 50.94 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.91 39.23 3.93 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.763 0.71 . . . . 0.0 110.854 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.25 -178.62 1.77 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 167.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' B' ' 143' ' ' ILE . 0.0 OUTLIER -62.6 -69.4 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.857 -0.527 . . . . 0.0 110.611 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.5 ' OH ' HG22 ' B' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.84 4.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.543 ' HB3' ' OD1' ' B' ' 99' ' ' ASN . 3.2 p30 -122.02 140.38 52.55 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.591 0.71 . . . . 0.0 109.434 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' B' ' 142' ' ' GLU . . . -139.93 156.2 46.79 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.091 -163.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.656 HE21 ' HB3' ' B' ' 137' ' ' GLU . 29.1 tt0 -127.92 139.63 52.48 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.416 ' HD1' ' O ' ' B' ' 91' ' ' PHE . 14.2 t80 -131.29 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.382 0.673 . . . . 0.0 110.407 -163.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.34 37.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 119.508 -1.33 . . . . 0.0 111.965 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.567 ' O ' HG13 ' B' ' 134' ' ' VAL . 3.3 m-85 -89.12 129.6 35.7 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.41 31.2 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.858 0.837 . . . . 0.0 111.208 -169.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' A' ' 54' ' ' LEU . 1.2 t80 -132.84 164.68 26.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.965 -174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -96.68 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.486 ' CD ' ' HG3' ' B' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.08 42.37 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.19 38.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 118.996 0.816 . . . . 0.0 109.074 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.854 ' HG2' HG22 ' B' ' 130' ' ' ILE . 0.0 OUTLIER -144.34 135.46 25.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.93 26.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.95 39.22 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.694 177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -108.16 127.35 53.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.46 20.59 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.83 -27.86 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.524 -0.398 . . . . 0.0 111.111 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.06 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 169.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.65 30.93 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.526 ' HB1' ' O ' ' A' ' 6' ' ' ILE . . . -141.33 155.83 45.91 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.641 0.734 . . . . 0.0 110.707 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.517 ' CG2' ' HB ' ' A' ' 6' ' ' ILE . 33.7 m -53.25 147.54 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.055 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' B' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.22 47.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.109 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.615 ' CD1' ' HA3' ' B' ' 69' ' ' GLY . 25.5 mt -112.53 126.52 69.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.27 123.51 50.34 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 168.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . 0.854 HG22 ' HG2' ' B' ' 116' ' ' ARG . 5.8 pt -122.42 126.54 74.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.2 146.96 32.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.686 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.573 HD21 ' HE1' ' B' ' 91' ' ' PHE . 0.4 OUTLIER -145.13 138.74 26.81 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.151 -172.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . 0.486 ' HG3' ' CD ' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.05 15.94 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' B' ' 137' ' ' GLU . 80.3 t -141.58 159.86 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.839 HG22 HG13 ' A' ' 53' ' ' ILE . 6.6 pt -109.72 29.84 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.361 0.601 . . . . 0.0 110.358 -173.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.9 92.26 1.45 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.714 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' B' ' 134' ' ' VAL . 10.0 mt-10 -81.16 139.07 35.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 122.038 0.923 . . . . 0.0 110.676 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.62 43.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' B' ' 107' ' ' GLN . 1.7 mptt -94.55 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -160.51 0.99 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -109.17 147.17 16.81 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.364 169.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 3.7 tp10 -85.58 131.1 34.42 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' B' ' 103' ' ' LYS . 1.2 mp -96.43 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.72 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.6 9.47 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.923 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.48 -42.95 97.34 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.388 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.81 11.93 Favored Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 126.457 1.903 . . . . 0.0 109.414 -173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.579 ' HA ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -70.67 9.97 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.188 1.258 . . . . 0.0 115.312 -159.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.0 -44.0 66.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.571 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.83 2.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.484 HD12 ' H ' ' B' ' 150' ' ' ILE . 3.4 mp -61.85 -46.98 95.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 119.12 0.873 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.579 ' HB ' ' HA ' ' B' ' 147' ' ' PRO . 77.4 t -74.39 -43.82 49.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.91 28.64 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.447 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.41 104.06 9.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.79 15.76 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.52 -5.07 57.61 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.22 3.77 61.48 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 119.395 0.998 . . . . 0.0 113.103 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' H' ' 138' ' ' LEU . . . -69.3 136.4 28.32 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.26 145.4 47.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.286 1.034 . . . . 0.0 108.603 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.83 -46.72 77.51 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -158.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.57 158.41 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.681 2.392 . . . . 0.0 109.178 167.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.53 81.86 1.79 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 154.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . 0.439 ' CD ' ' HB2' ' H' ' 144' ' ' ASP . 8.0 tt0 -108.48 -29.23 0.17 Allowed Pre-proline 0 C--O 1.242 0.666 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 -166.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.752 ' HD2' HE22 ' B' ' 165' ' ' GLN . 22.3 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.13 1.796 . . . . 0.0 113.85 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.83 88.05 0.47 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 118.339 2.096 . . . . 0.0 118.339 -171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.752 HE22 ' HD2' ' B' ' 163' ' ' PRO . 5.8 mp0 -106.66 58.95 0.64 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.891 1.345 . . . . 0.0 110.934 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.798 ' HA ' ' HB2' ' H' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.803 1.641 . . . . 0.0 111.928 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.842 ' HA ' ' HB ' ' B' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.315 -167.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.98 -158.93 8.29 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.5 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.13 67.78 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.773 0.287 . . . . 0.0 111.445 -177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.51 74.23 Favored Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 123.486 0.714 . . . . 0.0 109.251 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' H' ' 110' ' ' PHE . 85.6 Cg_endo -80.3 -12.3 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.27 1.314 . . . . 0.0 112.754 -156.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 96.06 0.18 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.842 ' HB ' ' HA ' ' B' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.05 28.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.98 0.89 . . . . 0.0 109.856 170.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' B' ' 165' ' ' GLN . 32.6 m -122.53 168.67 11.26 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.409 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . 0.576 ' HA ' ' HB ' ' B' ' 166' ' ' THR . 31.5 Cg_exo -72.96 123.85 9.2 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.535 0.87 . . . . 0.0 111.702 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.232 0 C-N-CA 125.403 1.481 . . . . 0.0 112.327 -171.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . 0.479 ' HA ' ' HE ' ' D' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 N-CA-C 103.617 -3.263 . . . . 0.0 103.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.428 ' HB ' ' CG2' ' D' ' 126' ' ' VAL . 6.3 mt -87.15 132.67 31.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -91.14 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.939 0.875 . . . . 0.0 110.702 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.71 -33.62 68.13 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.481 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.38 -31.11 42.76 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.785 0.793 . . . . 0.0 112.36 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' C' ' 96' ' ' THR . 0.4 OUTLIER -53.51 -44.32 69.02 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -172.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.481 HG22 ' OD1' ' C' ' 95' ' ' ASP . 32.4 t -89.06 115.19 28.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.661 0.743 . . . . 0.0 110.5 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -113.64 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.741 -164.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' C' ' 27' ' ' LEU . 0.1 OUTLIER -120.16 150.39 40.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 174.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' C' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.41 47.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.517 0.675 . . . . 0.0 109.941 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' C' ' 90' ' ' LYS . 4.2 tt0 -131.25 131.96 44.27 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.58 42.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.007 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.96 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 0.7 OUTLIER -61.62 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.003 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . 0.497 ' OD1' HD12 ' C' ' 18' ' ' ILE . 29.6 m-20 -84.35 -16.43 42.91 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -171.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.13 -51.84 41.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.41 -175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.08 51.96 6.65 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.206 1.402 . . . . 0.0 111.825 -173.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.29 168.98 8.75 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' C' ' 24' ' ' SER . . . -93.05 36.47 3.7 Favored Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.344 0.403 . . . . 0.0 113.73 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' C' ' 23' ' ' GLY . 3.5 p 175.99 140.26 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.983 0.391 . . . . 0.0 111.798 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' C' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.06 150.08 47.65 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 119.402 0.822 . . . . 0.0 112.482 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' C' ' 14' ' ' LEU . 0.7 OUTLIER -130.12 156.59 44.3 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 168.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' HD2' ' C' ' 29' ' ' PRO . 32.7 t80 -100.61 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.849 -2.34 . . . . 0.0 110.541 -167.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.692 ' HD2' ' CD1' ' C' ' 28' ' ' PHE . 50.1 Cg_endo -79.15 175.07 11.26 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-N 119.049 0.696 . . . . 0.0 112.396 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.6 63.89 1.92 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.299 1.44 . . . . 0.0 111.543 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -75.73 146.69 39.91 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.517 1.151 . . . . 0.0 111.087 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.488 ' O ' HG13 ' D' ' 122' ' ' VAL . 2.7 tm0? -105.95 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 111.108 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.84 10.71 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.0 -164.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.54 4.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.346 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.34 121.7 44.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.47 70.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . 0.404 ' HB2' ' OH ' ' D' ' 83' ' ' TYR . 51.4 p -136.68 107.45 6.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.57 8.0 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.249 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' C' ' 59' ' ' VAL . 5.4 tt0 -104.63 98.06 7.87 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.35 41.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 110.182 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' D' ' 133' ' ' GLN . 23.3 mt-10 -130.24 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.846 HD23 ' HA3' ' C' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.48 51.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.5 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.97 34.96 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.263 171.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t0 72.84 110.06 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 155.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.553 ' OE1' ' HA ' ' C' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.14 78.58 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.428 ' HB2' ' HG2' ' C' ' 49' ' ' LYS . 0.0 OUTLIER 71.22 20.31 5.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.601 1.56 . . . . 0.0 111.666 -172.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.553 ' HA ' ' OE1' ' C' ' 46' ' ' GLU . 5.9 m 42.31 55.38 4.03 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.487 1.515 . . . . 0.0 111.537 -164.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' C' ' 47' ' ' GLN . 8.8 mmtp -107.69 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.48 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.59 16.01 27.09 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.37 1.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.081 -0.807 . . . . 0.0 111.081 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' C' ' 43' ' ' LEU . 4.0 mmp_? -109.73 25.24 12.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.798 HG13 HG22 ' D' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.81 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.919 178.315 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.709 HD22 ' HB2' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -104.67 36.37 2.45 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . 0.846 ' HA3' HD23 ' C' ' 43' ' ' LEU . . . -104.34 158.22 16.7 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.695 0.608 . . . . 0.0 113.921 -170.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.51 138.72 15.68 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 N-CA-C 113.855 0.675 . . . . 0.0 113.855 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.05 17.48 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.98 20.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.518 0.675 . . . . 0.0 110.522 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' C' ' 40' ' ' GLU . 16.2 t -117.49 129.73 73.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.41 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.63 111.15 11.95 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -171.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.34 148.33 42.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.95 0.9 . . . . 0.0 110.084 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.42 152.02 22.65 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.137 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.6 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 174.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.447 HG12 ' HD1' ' C' ' 67' ' ' TYR . 59.0 t -129.88 122.77 55.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.19 146.85 32.16 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.46 ' OH ' HG13 ' C' ' 79' ' ' ILE . 24.2 p90 -168.77 167.87 10.9 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' C' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.09 34.85 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' C' ' 128' ' ' ILE . . . -71.55 135.98 24.17 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' C' ' 28' ' ' PHE . 9.4 mttm -92.88 153.88 18.55 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . 0.417 ' HA ' HD11 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -54.09 -35.66 62.34 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.64 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.89 43.28 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.166 1.387 . . . . 0.0 111.058 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' C' ' 78' ' ' ALA . . . -76.57 -37.58 56.31 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 -156.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.49 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -64.26 -39.08 96.73 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.847 168.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . 0.671 ' OE1' ' HG3' ' C' ' 80' ' ' GLU . 0.8 OUTLIER -61.8 -51.9 66.39 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 122.178 -0.601 . . . . 0.0 111.862 171.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' C' ' 80' ' ' GLU . 6.2 mtmp? -62.56 -27.06 68.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.755 171.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' C' ' 74' ' ' ALA . . . -64.15 -41.64 97.1 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.887 168.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.503 HD13 ' N ' ' C' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.056 0.455 . . . . 0.0 110.441 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.671 ' HG3' ' OE1' ' C' ' 76' ' ' GLN . 10.7 mm-40 -63.62 -44.46 93.88 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.701 -0.624 . . . . 0.0 112.421 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.43 -37.5 80.32 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.6 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' C' ' 87' ' ' LYS . . . -52.46 -52.79 52.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.554 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.449 ' OH ' ' HB2' ' B' ' 38' ' ' SER . 25.5 t80 -83.94 -51.36 7.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.863 -174.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.664 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 3.5 mt-30 -74.41 -43.1 57.82 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -167.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.83 -28.53 58.3 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.013 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.14 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.345 -0.222 . . . . 0.0 112.867 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' C' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.04 49.19 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.584 ' HB3' ' CE1' ' C' ' 112' ' ' TYR . 0.0 OUTLIER -82.67 142.28 31.81 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 168.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.532 ' CD1' ' HD2' ' C' ' 87' ' ' LYS . 1.3 mm -117.32 152.09 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.345 0.593 . . . . 0.0 109.834 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.579 ' HE1' HD21 ' C' ' 132' ' ' LEU . 1.6 t80 -121.39 123.35 41.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.554 1.142 . . . . 0.0 109.975 -165.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.99 134.03 52.76 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.236 1.015 . . . . 0.0 108.371 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' C' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.09 22.08 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' C' ' 106' ' ' ALA . 1.6 m -134.79 159.31 41.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.268 1.032 . . . . 0.0 109.375 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' C' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.62 179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' C' ' 10' ' ' ASP . 48.2 p -79.16 -26.0 42.78 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.714 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.6 143.46 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.661 0.743 . . . . 0.0 109.958 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 131.71 43.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.953 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' C' ' 105' ' ' ASP . 1.4 t30 -78.26 136.3 37.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.805 0.812 . . . . 0.0 109.967 171.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.32 50.61 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.86 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.792 0.724 . . . . 0.0 110.887 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.16 -178.55 1.78 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.638 ' HD2' ' HA ' ' C' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 121.892 -0.505 . . . . 0.0 110.597 171.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.491 ' OH ' HG22 ' C' ' 151' ' ' VAL . 7.4 m-85 -136.65 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' C' ' 99' ' ' ASN . 3.2 p30 -121.97 140.39 52.52 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.574 0.702 . . . . 0.0 109.455 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.811 ' HB2' ' HB2' ' C' ' 142' ' ' GLU . . . -139.93 156.24 46.77 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.061 -163.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.657 HE21 ' HB3' ' C' ' 137' ' ' GLU . 29.0 tt0 -127.98 139.61 52.47 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.415 ' HD1' ' O ' ' C' ' 91' ' ' PHE . 14.1 t80 -131.23 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 110.439 -163.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.32 165.32 37.74 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.57 -1.3 . . . . 0.0 111.98 170.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.555 ' O ' HG13 ' C' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.59 35.72 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 167.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.41 31.24 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.923 0.868 . . . . 0.0 111.168 -169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.72 ' HB2' HD22 ' B' ' 54' ' ' LEU . 1.2 t80 -132.81 164.59 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.484 -1.234 . . . . 0.0 107.971 -174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' B' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.18 4.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.487 ' CD ' ' HG3' ' C' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.14 42.02 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.79 163.17 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.933 0.788 . . . . 0.0 109.143 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . 0.845 ' HG2' HG22 ' C' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' B' ' 37' ' ' VAL . 4.7 tm-20 -131.77 122.98 26.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.09 128.77 56.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.089 0.471 . . . . 0.0 111.204 176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.14 120.97 39.33 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.667 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.21 127.45 53.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.44 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-O 121.727 0.626 . . . . 0.0 111.548 175.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 25.0 m -69.84 -27.82 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 O-C-N 122.484 -0.421 . . . . 0.0 111.131 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.32 21.73 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.61 30.89 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' B' ' 6' ' ' ILE . . . -141.33 155.84 45.91 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.596 0.712 . . . . 0.0 110.743 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.483 ' CG2' ' HB ' ' B' ' 6' ' ' ILE . 33.7 m -53.27 147.57 2.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.0 -171.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CE2' ' C' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.094 -176.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' C' ' 69' ' ' GLY . 25.3 mt -112.56 126.46 69.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.56 50.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . 0.845 HG22 ' HG2' ' C' ' 116' ' ' ARG . 5.9 pt -122.47 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.14 146.92 32.0 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.365 0.666 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.579 HD21 ' HE1' ' C' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.78 26.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.114 -172.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . 0.487 ' HG3' ' CD ' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.06 15.93 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.666 HG11 ' HG3' ' C' ' 137' ' ' GLU . 80.3 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.922 HG22 HG13 ' B' ' 53' ' ' ILE . 6.6 pt -109.69 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.377 0.608 . . . . 0.0 110.358 -173.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.82 92.28 1.46 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.708 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . 0.666 ' HG3' HG11 ' C' ' 134' ' ' VAL . 10.0 mt-10 -81.17 139.06 35.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 122.008 0.908 . . . . 0.0 110.656 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.28 148.66 43.42 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' C' ' 107' ' ' GLN . 1.7 mptt -94.51 141.24 28.81 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.51 0.99 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -109.22 147.13 16.83 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.357 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.811 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.06 34.43 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.638 ' HA ' ' HD2' ' C' ' 103' ' ' LYS . 1.2 mp -96.37 -49.73 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.78 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.07 107.58 9.53 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.967 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.41 -43.0 97.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 118.791 -0.623 . . . . 0.0 112.405 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.75 61.76 12.0 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 126.463 1.905 . . . . 0.0 109.403 -173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.58 ' HA ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.92 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 121.231 1.287 . . . . 0.0 115.36 -159.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.97 66.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.58 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.491 ' H ' HD12 ' C' ' 150' ' ' ILE . 3.3 mp -61.78 -47.03 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 119.144 0.884 . . . . 0.0 111.259 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' C' ' 147' ' ' PRO . 77.4 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.65 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.477 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.45 104.02 9.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.49 162.75 15.77 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.05 57.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.27 3.75 61.41 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 119.389 0.995 . . . . 0.0 113.063 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.26 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.16 145.4 47.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.327 1.051 . . . . 0.0 108.633 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.63 77.78 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -158.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.65 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.707 2.403 . . . . 0.0 109.18 167.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.51 81.87 1.79 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.51 -29.19 0.17 Allowed Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -166.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . 0.752 ' HD2' HE22 ' C' ' 165' ' ' GLN . 22.2 Cg_exo -75.07 10.43 1.74 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 122.081 1.779 . . . . 0.0 113.882 171.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.03 0.47 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 118.346 2.098 . . . . 0.0 118.346 -171.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.752 HE22 ' HD2' ' C' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.943 1.371 . . . . 0.0 110.924 175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.768 ' HA ' ' HB2' ' I' ' 21' ' ' ALA . 26.1 m 31.13 73.34 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.779 1.631 . . . . 0.0 111.92 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.853 ' HA ' ' HB ' ' C' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.84 8.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.319 -167.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.92 8.27 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.45 172.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.14 67.78 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.756 0.278 . . . . 0.0 111.426 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.35 153.55 74.07 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.441 0.696 . . . . 0.0 109.212 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' I' ' 110' ' ' PHE . 85.6 Cg_endo -80.32 -12.3 12.88 Favored 'Trans proline' 0 C--N 1.324 -0.759 0 C-N-CA 121.309 1.339 . . . . 0.0 112.734 -156.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.27 95.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.853 ' HB ' ' HA ' ' C' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.0 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 118.0 0.9 . . . . 0.0 109.882 170.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' C' ' 165' ' ' GLN . 32.5 m -122.49 168.65 11.29 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.442 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' C' ' 166' ' ' THR . 31.5 Cg_exo -72.91 123.81 9.2 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.53 0.868 . . . . 0.0 111.71 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.249 0 C-N-CA 125.392 1.477 . . . . 0.0 112.286 -171.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 N-CA-C 103.636 -3.256 . . . . 0.0 103.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.496 ' O ' ' HB1' ' E' ' 125' ' ' ALA . 6.3 mt -87.12 132.69 31.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.874 0.845 . . . . 0.0 110.736 -177.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.74 -33.64 68.33 Favored Glycine 0 C--N 1.334 0.419 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.467 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.32 -31.06 43.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.81 0.805 . . . . 0.0 112.427 172.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 0.54 ' HA ' ' OG1' ' D' ' 96' ' ' THR . 0.4 OUTLIER -53.63 -44.2 69.36 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -172.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' D' ' 95' ' ' ASP . 32.1 t -89.06 115.18 28.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.24 147.52 49.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.647 0.737 . . . . 0.0 110.532 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -113.55 125.14 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.779 -164.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' D' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.43 40.66 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.413 ' HE2' ' CE1' ' D' ' 91' ' ' PHE . 2.3 m-85 -125.18 149.4 47.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.457 0.646 . . . . 0.0 109.962 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' D' ' 90' ' ' LYS . 4.2 tt0 -131.29 131.95 44.2 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.59 137.6 42.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.931 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.13 60.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.991 -179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' D' ' 18' ' ' ILE . 29.5 m-20 -84.37 -16.46 42.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.04 -51.89 41.75 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.414 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.16 51.95 6.57 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 111.797 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.3 168.98 8.75 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' D' ' 24' ' ' SER . . . -93.08 36.43 3.72 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 123.364 0.415 . . . . 0.0 113.667 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' D' ' 23' ' ' GLY . 3.5 p 175.98 140.23 0.06 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 117.001 0.401 . . . . 0.0 111.783 -177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' D' ' 16' ' ' GLN . . . -98.55 115.56 65.73 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 126.953 2.101 . . . . 0.0 112.412 -174.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.04 150.08 47.81 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.378 0.814 . . . . 0.0 112.481 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' D' ' 14' ' ' LEU . 0.7 OUTLIER -130.14 156.51 44.44 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 168.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . 0.699 ' CD1' ' HD2' ' D' ' 29' ' ' PRO . 32.6 t80 -100.52 143.6 26.86 Favored Pre-proline 0 C--N 1.317 -0.846 0 C-N-CA 115.819 -2.353 . . . . 0.0 110.562 -167.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.699 ' HD2' ' CD1' ' D' ' 28' ' ' PHE . 49.7 Cg_endo -79.1 175.06 11.3 Favored 'Trans proline' 0 C--N 1.331 -0.368 0 CA-C-O 121.888 0.703 . . . . 0.0 112.397 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.9 1.92 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.419 1.488 . . . . 0.0 111.516 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.6 146.65 40.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 122.524 1.154 . . . . 0.0 111.08 173.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.42 ' O ' HG13 ' E' ' 122' ' ' VAL . 2.7 tm0? -105.93 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.6 3.73 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 122.793 1.283 . . . . 0.0 111.117 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.2 115.81 10.66 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.046 -1.434 . . . . 0.0 107.974 -164.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.14 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.384 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . . . . . . . . . 25.1 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.431 HG22 ' HG2' ' E' ' 117' ' ' GLU . 2.4 t -121.73 132.45 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -173.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . 0.442 ' HB2' ' OH ' ' E' ' 83' ' ' TYR . 51.2 p -136.68 107.49 6.63 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.58 8.0 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.194 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . 0.502 ' HA ' HG22 ' D' ' 59' ' ' VAL . 5.4 tt0 -104.65 98.06 7.87 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.29 41.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.746 0.784 . . . . 0.0 110.142 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 174.01 10.22 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -167.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' D' ' 55' ' ' GLY . 0.1 OUTLIER -69.5 136.55 51.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.511 -179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.59 136.0 34.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.232 171.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.81 110.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 155.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' D' ' 48' ' ' THR . 2.9 tt0 -67.53 -35.09 78.4 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' D' ' 49' ' ' LYS . 0.0 OUTLIER 71.22 20.26 5.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.602 1.561 . . . . 0.0 111.7 -172.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.559 ' HA ' ' OE1' ' D' ' 46' ' ' GLU . 5.8 m 42.35 55.37 4.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.48 1.512 . . . . 0.0 111.592 -164.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' D' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.44 0.33 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.56 15.95 27.25 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.81 81.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' D' ' 43' ' ' LEU . 4.1 mmp_? -109.84 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.813 HG13 HG22 ' E' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.66 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.854 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.701 HD22 ' HB2' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -104.56 36.31 2.45 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' D' ' 43' ' ' LEU . . . -104.27 158.15 16.78 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 121.652 0.585 . . . . 0.0 113.922 -170.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.47 138.71 15.76 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 N-CA-C 113.848 0.672 . . . . 0.0 113.848 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.06 17.51 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.79 166.97 20.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 0.0 110.47 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' D' ' 40' ' ' GLU . 16.4 t -117.42 129.73 73.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.04 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.39 44.62 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.19 12.01 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.29 42.68 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.901 0.88 . . . . 0.0 110.059 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.36 152.09 22.66 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.16 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.84 51.1 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.461 HG12 ' HD1' ' D' ' 67' ' ' TYR . 59.1 t -129.83 122.82 55.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' D' ' 32' ' ' GLN . 30.0 p -108.21 146.87 32.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' D' ' 65' ' ' VAL . 24.2 p90 -168.78 167.92 10.85 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' D' ' 127' ' ' GLU . 48.0 m-85 -98.83 118.12 34.87 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.619 ' HA3' ' CD1' ' D' ' 128' ' ' ILE . . . -71.6 135.97 24.09 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . 0.68 ' H ' ' HZ ' ' D' ' 28' ' ' PHE . 9.4 mttm -92.85 153.91 18.56 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.479 ' HE ' ' HA ' ' C' ' 5' ' ' PRO . 0.0 OUTLIER -54.1 -35.64 62.36 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -172.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.7 0.13 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -141.44 158.9 43.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.086 1.354 . . . . 0.0 111.004 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.54 -37.59 56.4 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.516 2.414 . . . . 0.0 117.516 -156.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.502 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -64.16 -39.22 96.93 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.829 168.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . 0.67 ' OE1' ' HG3' ' D' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.83 66.67 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.867 171.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' D' ' 80' ' ' GLU . 6.2 mtmp? -62.58 -27.12 68.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.773 171.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.62 97.2 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.935 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.502 HG12 ' O ' ' D' ' 75' ' ' GLY . 2.3 mm -64.94 -40.55 89.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.088 0.47 . . . . 0.0 110.501 172.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 10.6 mm-40 -63.58 -44.47 93.95 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.713 -0.617 . . . . 0.0 112.432 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.39 -37.58 80.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.549 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.895 ' HA ' ' HG3' ' D' ' 87' ' ' LYS . . . -52.49 -52.74 52.87 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.556 174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.404 ' OH ' ' HB2' ' C' ' 38' ' ' SER . 25.6 t80 -83.92 -51.35 7.23 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 120.339 -0.545 . . . . 0.0 111.939 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.53 58.47 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.031 172.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.05 78.58 1.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 O-C-N 122.345 -0.222 . . . . 0.0 112.864 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.895 ' HG3' ' HA ' ' D' ' 82' ' ' ALA . 0.1 OUTLIER -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' D' ' 112' ' ' TYR . 0.0 OUTLIER -82.75 142.3 31.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 168.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.529 HD11 ' HD2' ' D' ' 87' ' ' LYS . 1.3 mm -117.32 152.13 19.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.326 0.584 . . . . 0.0 109.859 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.931 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.28 33.29 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' D' ' 132' ' ' LEU . 1.6 t80 -121.42 123.35 41.88 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.496 1.118 . . . . 0.0 109.998 -165.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.405 ' HB2' ' HG ' ' D' ' 14' ' ' LEU . 4.3 m95 -124.93 134.07 52.8 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.242 1.017 . . . . 0.0 108.369 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.631 ' HD3' ' OE1' ' D' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 172.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' D' ' 106' ' ' ALA . 1.6 m -134.81 159.3 41.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 122.317 1.056 . . . . 0.0 109.357 -173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.517 ' HB2' ' OD1' ' D' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.11 23.31 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.655 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.54 ' OG1' ' HA ' ' D' ' 10' ' ' ASP . 48.3 p -79.16 -26.05 42.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.677 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.58 143.48 14.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 121.733 0.778 . . . . 0.0 109.895 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.955 -174.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' D' ' 105' ' ' ASP . 1.4 t30 -78.25 136.26 37.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.795 0.807 . . . . 0.0 109.994 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -22.27 50.6 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.88 39.15 3.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.785 0.72 . . . . 0.0 110.894 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.24 -178.59 1.76 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 167.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.666 ' HD2' ' HA ' ' D' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.34 0.27 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.863 -0.523 . . . . 0.0 110.631 171.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.496 ' OH ' HG22 ' D' ' 151' ' ' VAL . 7.5 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' D' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.48 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.636 0.731 . . . . 0.0 109.415 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.814 ' HB2' ' HB2' ' D' ' 142' ' ' GLU . . . -139.97 156.21 46.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.064 -163.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.64 HE21 ' HB3' ' D' ' 137' ' ' GLU . 29.0 tt0 -127.92 139.68 52.45 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.408 ' HD1' ' O ' ' D' ' 91' ' ' PHE . 14.1 t80 -131.26 150.55 52.1 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.411 0.684 . . . . 0.0 110.454 -163.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.34 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.953 170.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.564 ' O ' HG13 ' D' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.55 35.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.46 31.05 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.907 0.86 . . . . 0.0 111.155 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.709 ' HB2' HD22 ' C' ' 54' ' ' LEU . 1.2 t80 -132.86 164.62 26.48 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.982 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' C' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.11 4.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' D' ' 133' ' ' GLN . 3.6 tt0 -76.37 -43.05 42.5 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.19 38.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.932 0.787 . . . . 0.0 109.041 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.85 ' HG2' HG22 ' D' ' 130' ' ' ILE . 0.0 OUTLIER -144.28 135.46 25.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.82 123.0 26.67 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.05 128.8 56.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.079 0.466 . . . . 0.0 111.211 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.19 120.93 39.2 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.695 177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.37 53.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 167.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.53 158.48 20.63 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.488 HG13 ' O ' ' C' ' 32' ' ' GLN . 25.4 m -69.88 -27.78 34.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.461 -0.435 . . . . 0.0 111.081 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 169.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.65 30.9 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 108.846 -1.702 . . . . 0.0 108.846 166.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.34 155.79 45.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.626 0.727 . . . . 0.0 110.739 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' C' ' 6' ' ' ILE . 33.7 m -53.24 147.55 2.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.021 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.478 ' HG2' ' CE2' ' D' ' 68' ' ' TYR . 3.3 tm-20 -128.68 131.24 47.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.078 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . 0.619 ' CD1' ' HA3' ' D' ' 69' ' ' GLY . 25.3 mt -112.51 126.49 69.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.25 123.61 50.57 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . 0.85 HG22 ' HG2' ' D' ' 116' ' ' ARG . 5.8 pt -122.5 126.57 74.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.92 32.11 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.354 0.661 . . . . 0.0 109.735 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' D' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.8 26.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.107 -172.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -93.34 158.1 15.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 167.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' D' ' 137' ' ' GLU . 80.8 t -141.65 159.79 21.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.798 HG22 HG13 ' C' ' 53' ' ' ILE . 6.6 pt -109.71 29.9 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.314 0.578 . . . . 0.0 110.312 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.84 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.716 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . 0.68 ' HG3' HG11 ' D' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.01 35.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.029 0.918 . . . . 0.0 110.652 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.2 148.65 43.4 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' D' ' 107' ' ' GLN . 1.7 mptt -94.57 141.25 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.48 0.99 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -109.21 147.11 16.82 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.38 169.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.814 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.666 ' HA ' ' HD2' ' D' ' 103' ' ' LYS . 1.2 mp -96.39 -49.68 12.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.794 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.09 107.62 9.58 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.96 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.42 -42.98 97.14 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.369 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.73 61.8 11.93 Favored Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 126.483 1.913 . . . . 0.0 109.416 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -70.59 9.89 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.209 1.272 . . . . 0.0 115.338 -159.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -43.98 66.93 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.608 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.2 -58.9 2.09 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.493 HD12 ' H ' ' D' ' 150' ' ' ILE . 3.4 mp -61.83 -46.94 95.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.195 0.907 . . . . 0.0 111.275 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' D' ' 147' ' ' PRO . 77.6 t -74.43 -43.85 48.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.64 114.95 28.74 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.455 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.49 104.08 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.57 162.72 15.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.453 ' HD3' ' OE2' ' I' ' 46' ' ' GLU . 4.7 mmtt -81.48 -5.04 57.54 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.23 3.79 61.46 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.357 0.98 . . . . 0.0 113.052 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . 0.415 ' CA ' HD11 ' J' ' 138' ' ' LEU . . . -69.35 136.39 28.22 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.25 145.29 47.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.352 1.061 . . . . 0.0 108.642 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.75 -46.71 77.82 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -158.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.59 158.42 44.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.682 2.393 . . . . 0.0 109.186 167.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.55 81.74 1.79 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.406 ' CD ' ' HB2' ' J' ' 144' ' ' ASP . 8.1 tt0 -108.41 -29.25 0.17 Allowed Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.75 ' HD2' HE22 ' D' ' 165' ' ' GLN . 22.3 Cg_exo -75.03 10.48 1.71 Allowed 'Trans proline' 0 C--O 1.238 0.523 0 CA-C-N 122.069 1.775 . . . . 0.0 113.856 171.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' J' ' 22' ' ' THR . . . 78.73 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.75 HE22 ' HD2' ' D' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.63 Allowed 'General case' 0 C--O 1.238 0.468 0 CA-C-N 118.852 1.326 . . . . 0.0 110.924 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.886 ' HA ' ' HB2' ' J' ' 21' ' ' ALA . 26.1 m 31.18 73.36 0.06 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.815 1.646 . . . . 0.0 111.893 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.864 ' HA ' ' HB ' ' D' ' 173' ' ' THR . 0.6 OUTLIER -92.84 172.88 8.05 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.313 -167.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . 0.432 ' C ' HD13 ' J' ' 18' ' ' ILE . . . -148.99 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.2 67.8 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.819 0.31 . . . . 0.0 111.431 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.21 153.5 74.41 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 123.488 0.715 . . . . 0.0 109.289 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . 0.622 ' HA ' ' CE1' ' J' ' 110' ' ' PHE . 85.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.314 1.343 . . . . 0.0 112.736 -156.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.172 1.629 . . . . 0.0 117.172 165.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . 0.864 ' HB ' ' HA ' ' D' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.04 28.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.956 0.878 . . . . 0.0 109.88 170.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' D' ' 165' ' ' GLN . 32.6 m -122.54 168.65 11.31 Favored Pre-proline 0 C--O 1.24 0.579 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.421 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' D' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.84 9.21 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.494 0.855 . . . . 0.0 111.712 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.478 1.511 . . . . 0.0 112.303 -171.714 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.557 ' HA ' ' HE ' ' F' ' 71' ' ' ARG . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 N-CA-C 103.635 -3.256 . . . . 0.0 103.635 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CG2' ' F' ' 126' ' ' VAL . 6.3 mt -87.1 132.71 31.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.05 14.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.902 0.858 . . . . 0.0 110.76 -177.277 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.66 68.13 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.488 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.3 -31.08 43.17 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.801 0.8 . . . . 0.0 112.424 172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' E' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.25 69.4 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -171.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' E' ' 95' ' ' ASP . 32.5 t -89.04 115.18 28.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.27 147.51 49.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.661 0.743 . . . . 0.0 110.504 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.54 125.11 53.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.782 -164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.546 ' HA ' ' HB3' ' E' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.43 40.61 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.411 ' HE2' ' CE1' ' E' ' 91' ' ' PHE . 2.3 m-85 -125.22 149.34 48.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.474 0.654 . . . . 0.0 109.948 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' E' ' 90' ' ' LYS . 4.2 tt0 -131.2 131.96 44.35 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.6 42.39 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.579 0.704 . . . . 0.0 111.022 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.92 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.13 60.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.02 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' E' ' 18' ' ' ILE . 29.3 m-20 -84.31 -16.53 42.67 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -51.81 42.36 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.421 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.12 51.92 6.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.226 1.41 . . . . 0.0 111.796 -173.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.29 168.93 8.78 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' E' ' 24' ' ' SER . . . -92.97 36.39 3.72 Favored Glycine 0 N--CA 1.45 -0.41 0 O-C-N 123.34 0.4 . . . . 0.0 113.718 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' E' ' 23' ' ' GLY . 3.5 p 176.02 140.24 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.975 0.388 . . . . 0.0 111.785 -177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' E' ' 16' ' ' GLN . . . -98.56 115.57 65.72 Favored Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 126.944 2.097 . . . . 0.0 112.395 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -73.09 150.08 47.53 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.384 0.816 . . . . 0.0 112.483 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' E' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.62 44.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' E' ' 29' ' ' PRO . 32.5 t80 -100.65 143.62 26.91 Favored Pre-proline 0 C--N 1.316 -0.849 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.524 -167.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' E' ' 28' ' ' PHE . 50.0 Cg_endo -79.14 175.13 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.852 0.688 . . . . 0.0 112.421 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.53 63.9 1.93 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.367 1.467 . . . . 0.0 111.541 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.561 1.172 . . . . 0.0 111.023 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.93 -64.27 1.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.5 159.59 3.68 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 122.799 1.285 . . . . 0.0 111.074 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.12 115.84 10.73 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.994 -164.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.13 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.388 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . . . . . . . . . 26.0 m -106.33 121.71 44.77 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.51 70.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . 0.612 ' HB2' ' OH ' ' F' ' 83' ' ' TYR . 51.4 p -136.73 107.55 6.63 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -166.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.21 124.5 7.97 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.276 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . 0.526 ' HB3' ' O ' ' F' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.07 7.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.51 151.31 41.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.743 0.782 . . . . 0.0 110.131 -174.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.2 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.819 HD23 ' HA3' ' E' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.57 135.98 34.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.245 171.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.85 110.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.562 ' OE1' ' HA ' ' E' ' 48' ' ' THR . 2.9 tt0 -67.48 -35.18 78.65 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' HG2' ' E' ' 49' ' ' LYS . 0.0 OUTLIER 71.21 20.28 5.14 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.588 1.555 . . . . 0.0 111.701 -172.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.562 ' HA ' ' OE1' ' E' ' 46' ' ' GLU . 5.8 m 42.26 55.47 3.96 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.539 1.536 . . . . 0.0 111.578 -164.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' E' ' 47' ' ' GLN . 8.8 mmtp -107.75 -133.46 0.33 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.463 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.55 15.91 27.4 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.86 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' E' ' 43' ' ' LEU . 4.1 mmp_? -109.78 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.851 HG13 HG22 ' F' ' 135' ' ' ILE . 0.7 OUTLIER -123.6 1.8 5.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.873 178.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.636 ' HG ' HG12 ' F' ' 135' ' ' ILE . 0.0 OUTLIER -104.55 36.22 2.48 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 176.159 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . 0.819 ' HA3' HD23 ' E' ' 43' ' ' LEU . . . -104.3 158.22 16.73 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.705 0.614 . . . . 0.0 113.94 -170.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.52 138.73 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.418 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.13 17.57 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.78 167.0 20.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.573 0.701 . . . . 0.0 110.498 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' E' ' 40' ' ' GLU . 16.5 t -117.42 129.72 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.6 111.12 11.93 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.97 0.908 . . . . 0.0 110.079 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.07 22.65 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.173 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.61 143.87 51.08 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.449 HG12 ' HD1' ' E' ' 67' ' ' TYR . 59.1 t -129.87 122.76 55.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.86 32.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 174.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.449 ' HD1' HG12 ' E' ' 65' ' ' VAL . 24.2 p90 -168.76 167.91 10.89 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' E' ' 127' ' ' GLU . 47.8 m-85 -98.83 118.1 34.83 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' E' ' 128' ' ' ILE . . . -71.55 135.87 24.06 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.936 0.734 . . . . 0.0 114.936 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . 0.69 ' H ' ' HZ ' ' E' ' 28' ' ' PHE . 9.4 mttm -92.87 153.91 18.54 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.446 HH21 ' HD2' ' E' ' 71' ' ' ARG . 0.0 OUTLIER -54.13 -35.58 62.35 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -172.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.76 95.61 0.13 Allowed Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.93 43.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.123 1.369 . . . . 0.0 110.998 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.63 -37.55 56.14 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 -156.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -64.23 -39.18 96.84 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.807 168.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' E' ' 80' ' ' GLU . 0.8 OUTLIER -61.74 -51.88 66.52 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.859 171.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' E' ' 80' ' ' GLU . 6.2 mtmp? -62.59 -27.01 68.89 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.798 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.7 97.07 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.893 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.496 HD13 ' N ' ' E' ' 79' ' ' ILE . 2.3 mm -64.95 -40.54 89.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-O 121.087 0.47 . . . . 0.0 110.47 172.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' E' ' 76' ' ' GLN . 10.6 mm-40 -63.59 -44.45 93.97 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.733 -0.605 . . . . 0.0 112.441 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.33 -37.62 80.72 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.557 169.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.885 ' HA ' ' HG3' ' E' ' 87' ' ' LYS . . . -52.47 -52.79 52.49 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.544 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' D' ' 38' ' ' SER . 25.5 t80 -83.88 -51.34 7.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.351 -0.54 . . . . 0.0 111.916 -174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.668 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 3.5 mt-30 -74.46 -43.14 57.46 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -167.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.68 -28.63 58.76 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.03 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.488 0 O-C-N 122.315 -0.241 . . . . 0.0 112.888 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.885 ' HG3' ' HA ' ' E' ' 82' ' ' ALA . 0.1 OUTLIER -137.33 152.03 49.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.596 ' HB3' ' CE1' ' E' ' 112' ' ' TYR . 0.0 OUTLIER -82.7 142.32 31.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' E' ' 87' ' ' LYS . 1.3 mm -117.31 152.09 19.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.312 0.577 . . . . 0.0 109.886 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.92 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 11.8 mtmt -86.12 136.25 33.29 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.58 ' HE1' HD21 ' E' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.524 1.129 . . . . 0.0 109.997 -165.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.403 ' HB2' ' HG ' ' E' ' 14' ' ' LEU . 4.3 m95 -124.88 134.06 52.84 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.203 1.001 . . . . 0.0 108.318 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.638 ' HD3' ' OE1' ' E' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.11 22.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' E' ' 106' ' ' ALA . 1.6 m -134.82 159.26 41.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.274 1.035 . . . . 0.0 109.369 -173.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' E' ' 105' ' ' ASP . 0.1 OUTLIER -93.58 147.08 23.32 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.642 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' E' ' 10' ' ' ASP . 47.5 p -79.17 -25.99 42.76 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.869 -1.06 . . . . 0.0 112.639 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.64 0.733 . . . . 0.0 109.906 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.76 43.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.936 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' E' ' 105' ' ' ASP . 1.4 t30 -78.26 136.29 37.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.807 0.813 . . . . 0.0 109.971 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.75 -22.21 50.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.9 39.13 3.95 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.789 0.722 . . . . 0.0 110.895 169.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.22 -178.58 1.77 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' E' ' 143' ' ' ILE . 0.0 OUTLIER -62.63 -69.35 0.26 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.844 -0.535 . . . . 0.0 110.593 171.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' E' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.89 4.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' E' ' 99' ' ' ASN . 3.2 p30 -122.0 140.43 52.48 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 109.477 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' E' ' 142' ' ' GLU . . . -139.97 156.2 46.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.03 -163.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.652 HE21 ' HB3' ' E' ' 137' ' ' GLU . 29.1 tt0 -127.93 139.71 52.43 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' E' ' 91' ' ' PHE . 14.2 t80 -131.26 150.57 52.09 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.367 0.667 . . . . 0.0 110.417 -163.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 119.523 -1.322 . . . . 0.0 111.957 170.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.561 ' O ' HG13 ' E' ' 134' ' ' VAL . 3.3 m-85 -89.14 129.54 35.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 167.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.944 0.878 . . . . 0.0 111.181 -169.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.701 ' HB2' HD22 ' D' ' 54' ' ' LEU . 1.2 t80 -132.84 164.67 26.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.44 -1.254 . . . . 0.0 107.957 -174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' D' ' 40' ' ' GLU . 0.3 OUTLIER -96.7 95.09 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.495 ' CD ' ' HG3' ' E' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.1 42.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.84 163.17 38.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.934 0.788 . . . . 0.0 109.134 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.859 ' HG2' HG22 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -144.29 135.47 25.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.431 ' HG2' HG22 ' D' ' 37' ' ' VAL . 4.7 tm-20 -131.79 123.05 26.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.043 0.449 . . . . 0.0 111.151 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.22 120.96 39.25 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.632 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.24 127.42 53.82 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.54 158.41 20.61 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-O 121.721 0.623 . . . . 0.0 111.561 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . 0.42 HG13 ' O ' ' D' ' 32' ' ' GLN . 25.3 m -69.79 -27.81 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 122.486 -0.42 . . . . 0.0 111.114 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.12 149.4 21.66 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.25 -143.59 30.86 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 166.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' D' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.542 0.687 . . . . 0.0 110.745 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.48 ' CG2' ' HB ' ' D' ' 6' ' ' ILE . 33.7 m -53.19 147.54 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.091 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.472 ' HG2' ' CD2' ' E' ' 68' ' ' TYR . 3.3 tm-20 -128.72 131.28 47.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.068 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . 0.61 ' CD1' ' HA3' ' E' ' 69' ' ' GLY . 25.3 mt -112.58 126.49 69.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.59 50.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 168.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.859 HG22 ' HG2' ' E' ' 116' ' ' ARG . 5.8 pt -122.51 126.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.757 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.58 HD21 ' HE1' ' E' ' 91' ' ' PHE . 0.4 OUTLIER -145.05 138.77 26.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.137 -172.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . 0.495 ' HG3' ' CD ' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.04 15.94 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.685 HG11 ' HG3' ' E' ' 137' ' ' GLU . 80.4 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.813 HG22 HG13 ' D' ' 53' ' ' ILE . 6.6 pt -109.67 29.84 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.345 0.593 . . . . 0.0 110.395 -173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.87 92.36 1.46 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.69 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.685 ' HG3' HG11 ' E' ' 134' ' ' VAL . 10.0 mt-10 -81.25 139.05 35.69 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.033 0.921 . . . . 0.0 110.631 174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.29 148.61 43.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -174.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.602 ' HB2' ' OE1' ' F' ' 84' ' ' GLN . 1.7 mptt -94.53 141.34 28.71 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.66 -160.51 0.98 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -109.19 147.18 16.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.195 -1.003 . . . . 0.0 111.399 169.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.668 ' HA ' ' HD2' ' E' ' 103' ' ' LYS . 1.2 mp -96.45 -49.73 11.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.755 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.04 107.54 9.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.989 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . . . . . . . . . 73.8 p -60.35 -43.0 96.91 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.396 175.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.72 61.75 12.0 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.475 1.91 . . . . 0.0 109.434 -173.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' E' ' 151' ' ' VAL . 31.5 Cg_exo -70.56 9.87 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.225 1.283 . . . . 0.0 115.344 -159.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.97 -43.98 66.97 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.566 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.25 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.486 HD12 ' H ' ' E' ' 150' ' ' ILE . 3.3 mp -61.76 -47.01 95.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 119.144 0.883 . . . . 0.0 111.303 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' E' ' 147' ' ' PRO . 77.8 t -74.37 -43.88 49.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.61 114.88 28.62 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.507 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.38 104.09 9.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.59 162.77 15.8 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.458 ' HD3' ' OE2' ' J' ' 46' ' ' GLU . 4.7 mmtt -81.49 -5.1 57.62 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.74 61.41 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 119.339 0.972 . . . . 0.0 113.048 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.34 28.36 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.24 145.36 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.333 1.053 . . . . 0.0 108.614 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.64 77.83 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -158.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.674 2.39 . . . . 0.0 109.182 167.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.53 81.81 1.79 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 154.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.38 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.626 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -166.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' E' ' 165' ' ' GLN . 22.2 Cg_exo -75.02 10.43 1.72 Allowed 'Trans proline' 0 C--O 1.238 0.497 0 CA-C-N 122.051 1.768 . . . . 0.0 113.872 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.87 88.03 0.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' E' ' 163' ' ' PRO . 5.8 mp0 -106.73 59.02 0.63 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.952 1.376 . . . . 0.0 110.928 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.826 ' HA ' ' HB2' ' K' ' 21' ' ' ALA . 26.3 m 31.08 73.39 0.06 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.803 1.641 . . . . 0.0 111.896 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.876 ' HA ' ' HB ' ' E' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.09 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.316 -167.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . 0.462 ' C ' HD13 ' K' ' 18' ' ' ILE . . . -148.91 -158.86 8.24 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.509 172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -24.12 67.76 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.771 0.286 . . . . 0.0 111.401 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.3 153.52 74.17 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 123.476 0.711 . . . . 0.0 109.278 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . 0.574 ' HA ' ' CE1' ' K' ' 110' ' ' PHE . 86.4 Cg_endo -80.21 -12.38 12.99 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.316 1.344 . . . . 0.0 112.735 -156.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.3 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 117.146 1.618 . . . . 0.0 117.146 165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . 0.876 ' HB ' ' HA ' ' E' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.08 27.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.943 0.871 . . . . 0.0 109.873 170.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.566 ' HA ' ' HB3' ' E' ' 165' ' ' GLN . 32.7 m -122.59 168.69 11.25 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.361 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' E' ' 166' ' ' THR . 31.4 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 119.457 0.842 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.227 0 C-N-CA 125.409 1.484 . . . . 0.0 112.349 -171.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.556 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 49.1 Cg_endo . . . . . 0 N--CA 1.465 -0.151 0 N-CA-C 103.612 -3.265 . . . . 0.0 103.612 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.575 ' HB ' ' CG2' ' A' ' 126' ' ' VAL . 6.4 mt -87.14 132.7 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 0.479 ' H ' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -91.12 164.1 14.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.924 0.869 . . . . 0.0 110.731 -177.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 125' ' ' ALA . . . -57.78 -33.57 68.33 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.337 -0.847 . . . . 0.0 114.496 175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -79.36 -31.09 42.88 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 117.769 0.784 . . . . 0.0 112.408 172.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' F' ' 96' ' ' THR . 0.4 OUTLIER -53.52 -44.31 69.04 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' F' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.56 49.05 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.52 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -113.63 125.13 53.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.722 -164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.555 ' HA ' ' HB3' ' F' ' 27' ' ' LEU . 0.1 OUTLIER -120.1 150.47 40.54 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' F' ' 91' ' ' PHE . 2.3 m-85 -125.28 149.34 48.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.523 0.678 . . . . 0.0 109.941 176.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' F' ' 90' ' ' LYS . 4.3 tt0 -131.23 131.97 44.31 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.58 137.52 42.4 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.036 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.97 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.1 60.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.978 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . 0.488 ' OD1' HD12 ' F' ' 18' ' ' ILE . 29.3 m-20 -84.28 -16.55 42.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -172.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.81 42.45 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.414 -175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 59.13 51.92 6.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.168 1.387 . . . . 0.0 111.825 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.33 168.98 8.74 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' F' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.699 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' F' ' 23' ' ' GLY . 3.5 p 176.01 140.25 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.986 0.393 . . . . 0.0 111.816 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' F' ' 16' ' ' GLN . . . -98.48 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 126.971 2.108 . . . . 0.0 112.464 -174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.09 47.79 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 119.426 0.831 . . . . 0.0 112.473 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.555 ' HB3' ' HA ' ' F' ' 14' ' ' LEU . 0.7 OUTLIER -130.13 156.54 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 168.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' F' ' 29' ' ' PRO . 32.5 t80 -100.51 143.6 26.86 Favored Pre-proline 0 C--N 1.316 -0.854 0 C-N-CA 115.824 -2.35 . . . . 0.0 110.569 -167.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' F' ' 28' ' ' PHE . 50.0 Cg_endo -79.16 175.08 11.25 Favored 'Trans proline' 0 C--N 1.331 -0.351 0 CA-C-N 119.04 0.693 . . . . 0.0 112.448 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.408 ' H ' ' HD2' ' K' ' 49' ' ' LYS . . . 55.58 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.38 1.472 . . . . 0.0 111.572 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . 0.464 ' O ' HG11 ' A' ' 122' ' ' VAL . 10.6 m-85 -75.69 146.69 40.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 122.529 1.157 . . . . 0.0 111.048 173.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.428 ' O ' HG13 ' A' ' 122' ' ' VAL . 2.7 tm0? -105.94 -64.33 1.17 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.45 159.56 3.71 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 122.734 1.254 . . . . 0.0 111.105 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.14 115.84 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.063 -1.426 . . . . 0.0 107.948 -164.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.48 4.11 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . . . . . . . . . 25.7 m -106.29 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.79 132.52 70.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -173.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . 0.499 ' HB2' ' OH ' ' A' ' 83' ' ' TYR . 51.3 p -136.71 107.43 6.59 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.12 124.52 7.99 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.27 -178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . 0.489 ' HA ' HG22 ' F' ' 59' ' ' VAL . 5.4 tt0 -104.58 98.06 7.88 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.55 151.38 41.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.732 0.777 . . . . 0.0 110.124 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.26 173.94 10.3 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' F' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.56 51.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.473 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.65 135.98 34.89 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.24 171.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.88 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 155.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . 0.55 ' OE1' ' HA ' ' F' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.19 78.65 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' F' ' 49' ' ' LYS . 0.0 OUTLIER 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.62 1.568 . . . . 0.0 111.666 -172.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.55 ' HA ' ' OE1' ' F' ' 46' ' ' GLU . 5.9 m 42.33 55.43 4.02 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 111.56 -164.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' F' ' 47' ' ' GLN . 8.8 mmtp -107.75 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.457 -177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.51 15.93 27.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' F' ' 43' ' ' LEU . 4.1 mmp_? -109.78 25.32 11.93 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.428 HG13 HG22 ' A' ' 135' ' ' ILE . 0.7 OUTLIER -123.59 1.78 5.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.885 178.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.695 HD13 ' HD1' ' A' ' 112' ' ' TYR . 0.0 OUTLIER -104.64 36.29 2.47 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 176.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' F' ' 43' ' ' LEU . . . -104.27 158.16 16.78 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-O 121.657 0.587 . . . . 0.0 113.945 -170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -78.5 138.77 15.74 Favored 'Trans proline' 0 CA--C 1.516 -0.414 0 N-CA-C 113.865 0.679 . . . . 0.0 113.865 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.07 17.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.8 166.98 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.605 0.716 . . . . 0.0 110.502 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' F' ' 40' ' ' GLU . 16.2 t -117.45 129.78 73.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.43 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.17 11.98 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.96 0.904 . . . . 0.0 110.041 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.09 22.66 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.173 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.64 143.86 51.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' F' ' 67' ' ' TYR . 59.1 t -129.82 122.79 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.23 146.85 32.22 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.461 ' OH ' HG13 ' F' ' 79' ' ' ILE . 24.1 p90 -168.8 167.92 10.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.475 ' CD2' ' HG2' ' F' ' 127' ' ' GLU . 48.0 m-85 -98.84 118.15 34.94 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' F' ' 128' ' ' ILE . . . -71.64 135.91 23.95 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' F' ' 28' ' ' PHE . 9.4 mttm -92.83 153.91 18.57 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 109.278 174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . 0.557 ' HE ' ' HA ' ' E' ' 5' ' ' PRO . 0.0 OUTLIER -54.13 -35.65 62.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.68 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.4 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.127 1.371 . . . . 0.0 111.001 169.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.61 -37.6 56.15 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' F' ' 79' ' ' ILE . . . -64.14 -39.16 96.89 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.846 168.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . 0.681 ' OE1' ' HG3' ' F' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.82 66.66 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 122.177 -0.602 . . . . 0.0 111.84 171.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . 0.477 ' HA ' ' HB2' ' F' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -27.04 68.92 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.818 171.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.65 97.08 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.885 168.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.501 HG12 ' O ' ' F' ' 75' ' ' GLY . 2.3 mm -64.91 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.083 0.468 . . . . 0.0 110.501 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . 0.681 ' HG3' ' OE1' ' F' ' 76' ' ' GLN . 10.6 mm-40 -63.66 -44.37 93.97 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.76 -0.588 . . . . 0.0 112.413 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -68.43 -37.61 80.44 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.522 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' F' ' 87' ' ' LYS . . . -52.44 -52.8 52.15 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.096 -1.041 . . . . 0.0 111.544 174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' E' ' 38' ' ' SER . 25.5 t80 -83.93 -51.29 7.27 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.911 -174.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.674 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.16 57.67 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -167.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.77 -28.59 58.5 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.012 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.16 78.52 1.11 Allowed Glycine 0 N--CA 1.449 -0.473 0 O-C-N 122.349 -0.22 . . . . 0.0 112.854 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' F' ' 82' ' ' ALA . 0.1 OUTLIER -137.39 151.98 49.15 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.591 ' HB3' ' CE1' ' F' ' 112' ' ' TYR . 0.0 OUTLIER -82.66 142.26 31.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 168.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' F' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.358 0.599 . . . . 0.0 109.843 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.97 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 11.8 mtmt -86.07 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.567 ' HE1' HD21 ' F' ' 132' ' ' LEU . 1.6 t80 -121.34 123.36 41.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.52 1.128 . . . . 0.0 110.051 -166.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.93 134.08 52.79 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.2 1.0 . . . . 0.0 108.365 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' F' ' 107' ' ' GLN . 12.6 ptm180 -130.5 119.1 22.1 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 172.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' F' ' 106' ' ' ALA . 1.5 m -134.85 159.28 41.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 122.265 1.031 . . . . 0.0 109.42 -173.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . 0.512 ' HB2' ' OD1' ' F' ' 105' ' ' ASP . 0.1 OUTLIER -93.61 147.09 23.32 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.638 179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.534 ' OG1' ' HA ' ' F' ' 10' ' ' ASP . 48.1 p -79.2 -25.94 42.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.703 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.51 14.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 131.72 43.56 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.94 -174.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.548 ' OD1' ' HB3' ' F' ' 105' ' ' ASP . 1.4 t30 -78.24 136.28 37.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.809 0.814 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.31 50.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.87 39.14 3.94 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.902 169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -173.2 -178.58 1.77 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.652 ' HD2' ' HA ' ' F' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.44 0.26 Allowed 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.882 -0.511 . . . . 0.0 110.576 171.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.501 ' OH ' HG22 ' F' ' 151' ' ' VAL . 7.5 m-85 -136.63 -176.85 4.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.548 ' HB3' ' OD1' ' F' ' 99' ' ' ASN . 3.2 p30 -122.01 140.42 52.5 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.623 0.725 . . . . 0.0 109.426 177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' F' ' 142' ' ' GLU . . . -139.91 156.23 46.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.086 -163.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.663 HE21 ' HB3' ' F' ' 137' ' ' GLU . 29.1 tt0 -127.98 139.63 52.46 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 157.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' F' ' 91' ' ' PHE . 14.1 t80 -131.24 150.56 52.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.417 0.687 . . . . 0.0 110.427 -163.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.35 37.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.462 -1.352 . . . . 0.0 111.95 170.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.566 ' O ' HG13 ' F' ' 134' ' ' VAL . 3.3 m-85 -89.11 129.59 35.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.943 0.878 . . . . 0.0 111.119 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' F' ' 88' ' ' GLN . 1.2 t80 -132.86 164.64 26.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.939 -174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.526 ' O ' ' HB3' ' E' ' 40' ' ' GLU . 0.3 OUTLIER -96.67 95.11 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.489 ' CD ' ' HG3' ' F' ' 133' ' ' GLN . 3.6 tt0 -76.34 -43.13 42.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.86 163.17 38.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.947 0.794 . . . . 0.0 109.094 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . 0.871 ' HG2' HG22 ' F' ' 130' ' ' ILE . 0.0 OUTLIER -144.27 135.48 25.45 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.96 26.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.01 128.79 56.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.062 0.458 . . . . 0.0 111.197 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.94 39.25 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.45 53.84 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.58 158.41 20.64 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.82 -27.76 34.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.493 -0.416 . . . . 0.0 111.11 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.15 149.38 21.69 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 169.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.28 -143.6 30.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 166.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.37 155.8 45.88 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.589 0.709 . . . . 0.0 110.717 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' E' ' 6' ' ' ILE . 33.7 m -53.2 147.56 2.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.032 -171.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' F' ' 68' ' ' TYR . 3.3 tm-20 -128.71 131.23 47.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.067 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . 0.601 ' CD1' ' HA3' ' F' ' 69' ' ' GLY . 25.3 mt -112.55 126.49 69.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.57 50.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 168.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.871 HG22 ' HG2' ' F' ' 116' ' ' ARG . 5.9 pt -122.49 126.47 74.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.13 146.91 32.0 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.739 -178.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.567 HD21 ' HE1' ' F' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.78 26.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.105 -172.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . 0.489 ' HG3' ' CD ' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.09 15.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.672 HG11 ' HG3' ' F' ' 137' ' ' GLU . 81.0 t -141.58 159.79 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.851 HG22 HG13 ' E' ' 53' ' ' ILE . 6.6 pt -109.72 29.96 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.388 0.613 . . . . 0.0 110.343 -173.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.8 92.29 1.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.727 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.672 ' HG3' HG11 ' F' ' 134' ' ' VAL . 10.0 mt-10 -81.24 139.06 35.7 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.088 0.947 . . . . 0.0 110.62 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.25 148.64 43.44 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.493 ' HB2' ' OE1' ' A' ' 84' ' ' GLN . 1.7 mptt -94.55 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.51 0.99 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -109.2 147.11 16.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.372 169.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.652 ' HA ' ' HD2' ' F' ' 103' ' ' LYS . 1.2 mp -96.37 -49.77 11.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.783 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.996 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.39 -43.0 97.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.375 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.71 61.8 11.91 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 126.463 1.905 . . . . 0.0 109.4 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.557 ' HA ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.95 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.201 1.267 . . . . 0.0 115.359 -159.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.02 -43.99 66.79 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.559 171.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.93 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.472 HD12 ' H ' ' F' ' 150' ' ' ILE . 3.4 mp -61.75 -47.02 95.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 119.151 0.887 . . . . 0.0 111.273 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' F' ' 147' ' ' PRO . 77.5 t -74.39 -43.85 48.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -176.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.69 114.96 28.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.44 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.41 104.05 9.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.56 162.75 15.81 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -172.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.54 -5.06 57.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.77 61.39 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 119.438 1.017 . . . . 0.0 113.047 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . 0.585 ' CA ' HD11 ' L' ' 138' ' ' LEU . . . -69.3 136.39 28.3 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.493 ' N ' HD11 ' L' ' 138' ' ' LEU . 46.5 m-85 -135.2 145.36 47.61 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.342 1.057 . . . . 0.0 108.602 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.601 ' OD2' ' HB3' ' L' ' 140' ' ' ASN . 13.6 t70 -65.86 -46.64 77.72 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -158.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.538 ' CD2' HD13 ' L' ' 143' ' ' ILE . 4.2 p90 -148.66 158.39 44.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.69 2.396 . . . . 0.0 109.174 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.717 ' C ' ' HH2' ' L' ' 92' ' ' TRP . 14.9 mt-30 -141.55 81.82 1.79 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 154.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.731 ' OE1' ' OE2' ' L' ' 142' ' ' GLU . 8.0 tt0 -108.44 -29.29 0.17 Allowed Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -166.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.738 ' HD2' HE22 ' F' ' 165' ' ' GLN . 22.2 Cg_exo -74.98 10.38 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.561 0 CA-C-N 122.052 1.769 . . . . 0.0 113.856 171.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . 0.677 ' HA3' ' O ' ' L' ' 22' ' ' THR . . . 78.81 88.09 0.46 Allowed Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.738 HE22 ' HD2' ' F' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.02 0.63 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.872 1.336 . . . . 0.0 110.896 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.863 ' HA ' ' HB2' ' L' ' 21' ' ' ALA . 26.2 m 31.13 73.37 0.06 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.836 1.654 . . . . 0.0 111.89 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.857 ' HA ' ' HB ' ' F' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.83 8.09 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.322 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . 0.725 ' O ' HG21 ' L' ' 18' ' ' ILE . . . -148.92 -158.85 8.24 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.529 172.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.747 ' HA ' ' HG2' ' L' ' 88' ' ' GLN . 0.1 OUTLIER -63.05 -24.16 67.78 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.792 0.296 . . . . 0.0 111.398 -177.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . 0.435 ' O ' ' HE1' ' L' ' 110' ' ' PHE . . . -80.27 153.54 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.505 0.722 . . . . 0.0 109.266 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . 0.649 ' HA ' ' CD1' ' L' ' 110' ' ' PHE . 86.0 Cg_endo -80.3 -12.29 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 121.251 1.3 . . . . 0.0 112.791 -156.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.97 0.18 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 165.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . 0.857 ' HB ' ' HA ' ' F' ' 167' ' ' THR . 0.2 OUTLIER -105.81 148.02 28.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.039 0.92 . . . . 0.0 109.893 170.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.555 ' HA ' ' HB3' ' F' ' 165' ' ' GLN . 32.6 m -122.49 168.72 11.11 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.411 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' F' ' 166' ' ' THR . 31.5 Cg_exo -72.92 123.82 9.19 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 119.542 0.872 . . . . 0.0 111.707 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 C-N-CA 125.437 1.495 . . . . 0.0 112.313 -171.75 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.573 ' HB3' ' HG2' ' H' ' 70' ' ' LYS . 50.3 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.605 -3.267 . . . . 0.0 103.605 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' H' ' 126' ' ' VAL . 6.4 mt -87.18 132.73 31.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 0.474 ' H ' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -91.13 164.1 14.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.879 0.847 . . . . 0.0 110.74 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.73 -33.65 68.32 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.335 -0.848 . . . . 0.0 114.497 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.34 -31.04 42.98 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.758 0.779 . . . . 0.0 112.405 172.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 0.545 ' HA ' ' OG1' ' G' ' 96' ' ' THR . 0.4 OUTLIER -53.62 -44.29 69.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -172.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.469 HG22 ' OD1' ' G' ' 95' ' ' ASP . 32.5 t -89.02 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.25 147.51 49.06 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.641 0.734 . . . . 0.0 110.503 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -113.52 125.13 53.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.776 -164.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.548 ' HA ' ' HB3' ' G' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.4 40.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -125.23 149.38 48.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 109.942 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' G' ' 90' ' ' LYS . 4.2 tt0 -131.27 131.96 44.23 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 170.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.62 137.62 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.989 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.978 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 0.7 OUTLIER -61.63 -34.17 60.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.971 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . 0.49 ' OD1' HD12 ' G' ' 18' ' ' ILE . 29.5 m-20 -84.38 -16.36 43.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.89 41.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.382 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.812 ' HB2' ' HA ' ' A' ' 166' ' ' THR . . . 59.14 51.96 6.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.262 1.425 . . . . 0.0 111.755 -173.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.27 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' G' ' 24' ' ' SER . . . -93.05 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.388 0 O-C-N 123.326 0.391 . . . . 0.0 113.709 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . 0.475 ' HB3' ' O ' ' G' ' 23' ' ' GLY . 3.5 p 176.03 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.985 0.392 . . . . 0.0 111.791 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' G' ' 16' ' ' GLN . . . -98.57 115.54 65.73 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.96 2.104 . . . . 0.0 112.399 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.07 150.06 47.59 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.422 0.829 . . . . 0.0 112.456 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HA ' ' G' ' 14' ' ' LEU . 0.7 OUTLIER -130.07 156.56 44.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . 0.693 ' CD1' ' HD2' ' G' ' 29' ' ' PRO . 32.8 t80 -100.63 143.63 26.93 Favored Pre-proline 0 C--N 1.316 -0.851 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.493 -167.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' CD1' ' G' ' 28' ' ' PHE . 50.3 Cg_endo -79.14 175.09 11.25 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 CA-C-O 121.851 0.688 . . . . 0.0 112.439 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.58 63.86 1.93 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.351 1.46 . . . . 0.0 111.571 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.65 146.72 40.05 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 122.592 1.187 . . . . 0.0 111.047 173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.99 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.59 3.71 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.094 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.85 10.71 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.963 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.16 116.51 4.12 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.345 170.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' H' ' 118' ' ' TYR . 25.6 m -106.34 121.72 44.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 173.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.82 132.42 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . 0.677 ' HB2' ' OH ' ' H' ' 83' ' ' TYR . 51.7 p -136.66 107.41 6.6 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -166.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.15 124.55 7.99 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.239 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . 0.491 ' HA ' HG22 ' G' ' 59' ' ' VAL . 5.3 tt0 -104.64 98.1 7.9 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.53 151.34 41.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.715 0.769 . . . . 0.0 110.125 -174.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . 0.841 HD23 ' HA3' ' G' ' 55' ' ' GLY . 0.1 OUTLIER -69.46 136.53 51.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.542 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.56 135.99 34.95 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.244 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . . . . . . . . . 33.6 t0 72.8 110.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 155.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' G' ' 48' ' ' THR . 2.9 tt0 -67.44 -35.17 78.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' G' ' 49' ' ' LYS . 0.0 OUTLIER 71.23 20.31 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.617 1.567 . . . . 0.0 111.647 -172.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . 0.551 ' HA ' ' OE1' ' G' ' 46' ' ' GLU . 5.8 m 42.25 55.44 3.97 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.49 1.516 . . . . 0.0 111.609 -164.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' G' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.505 -177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.57 16.05 26.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.82 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' G' ' 43' ' ' LEU . 4.0 mmp_? -109.69 25.2 12.06 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.582 HG13 HG22 ' H' ' 135' ' ' ILE . 0.7 OUTLIER -123.54 1.75 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.863 178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.528 HD13 ' HD1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -104.57 36.26 2.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 176.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . 0.841 ' HA3' HD23 ' G' ' 43' ' ' LEU . . . -104.26 158.2 16.77 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.626 0.57 . . . . 0.0 113.949 -170.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.52 138.72 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 N-CA-C 113.864 0.679 . . . . 0.0 113.864 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.07 17.49 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 166.89 21.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.594 0.711 . . . . 0.0 110.48 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' G' ' 40' ' ' GLU . 16.2 t -117.37 129.78 73.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.36 44.61 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.58 111.14 11.96 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -171.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.35 148.28 42.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.939 0.896 . . . . 0.0 110.07 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.06 22.64 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.192 176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 143.8 51.11 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.45 HG12 ' HD1' ' G' ' 67' ' ' TYR . 59.0 t -129.78 122.77 55.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.17 146.85 32.14 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.454 ' OH ' HG13 ' G' ' 79' ' ' ILE . 24.1 p90 -168.74 167.96 10.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.476 ' CE2' ' HG2' ' G' ' 127' ' ' GLU . 48.4 m-85 -98.9 118.06 34.81 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.611 ' HA3' ' CD1' ' G' ' 128' ' ' ILE . . . -71.48 135.9 24.19 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -175.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' G' ' 28' ' ' PHE . 9.4 mttm -92.81 153.87 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . 0.444 HH21 ' HD2' ' G' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.6 62.45 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.41 158.9 43.27 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.126 1.37 . . . . 0.0 111.031 169.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' G' ' 78' ' ' ALA . . . -76.58 -37.55 56.33 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 117.515 2.413 . . . . 0.0 117.515 -156.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' G' ' 79' ' ' ILE . . . -64.2 -39.15 96.83 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.828 168.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . 0.674 ' OE1' ' HG3' ' G' ' 80' ' ' GLU . 0.8 OUTLIER -61.84 -51.84 66.58 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.858 171.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' G' ' 80' ' ' GLU . 6.2 mtmp? -62.6 -26.99 68.89 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.772 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' G' ' 74' ' ' ALA . . . -64.17 -41.64 97.05 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.872 168.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.502 HD13 ' N ' ' G' ' 79' ' ' ILE . 2.3 mm -65.0 -40.49 89.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.096 0.474 . . . . 0.0 110.496 172.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.674 ' HG3' ' OE1' ' G' ' 76' ' ' GLN . 10.6 mm-40 -63.62 -44.42 93.95 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 121.734 -0.604 . . . . 0.0 112.424 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.42 -37.51 80.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.005 -0.678 . . . . 0.0 111.583 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.886 ' HA ' ' HG3' ' G' ' 87' ' ' LYS . . . -52.51 -52.74 53.1 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.564 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' L' ' 38' ' ' SER . 25.5 t80 -83.93 -51.36 7.22 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.902 -174.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.676 ' OE1' ' HB2' ' L' ' 139' ' ' LYS . 3.5 mt-30 -74.35 -43.19 57.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -167.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.56 58.57 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.073 172.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.09 78.51 1.11 Allowed Glycine 0 N--CA 1.449 -0.481 0 O-C-N 122.345 -0.222 . . . . 0.0 112.854 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.886 ' HG3' ' HA ' ' G' ' 82' ' ' ALA . 0.1 OUTLIER -137.34 152.06 49.3 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.595 ' HB3' ' CE1' ' G' ' 112' ' ' TYR . 0.0 OUTLIER -82.77 142.33 31.68 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 168.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.539 ' CD1' ' HD2' ' G' ' 87' ' ' LYS . 1.3 mm -117.31 152.08 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-O 121.365 0.602 . . . . 0.0 109.923 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 11.8 mtmt -86.05 136.24 33.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.577 ' HE1' HD21 ' G' ' 132' ' ' LEU . 1.6 t80 -121.35 123.31 41.84 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.544 1.138 . . . . 0.0 109.986 -165.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.04 52.82 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.206 1.003 . . . . 0.0 108.362 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.637 ' HD3' ' OE1' ' G' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.06 22.01 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' G' ' 106' ' ' ALA . 1.6 m -134.8 159.28 41.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.283 1.039 . . . . 0.0 109.38 -173.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . 0.522 ' HB2' ' OD1' ' G' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.1 23.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.607 179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.545 ' OG1' ' HA ' ' G' ' 10' ' ' ASP . 47.5 p -79.19 -26.01 42.68 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.614 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.66 143.44 14.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-O 121.691 0.758 . . . . 0.0 109.906 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 131.72 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.957 -174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' G' ' 105' ' ' ASP . 1.4 t30 -78.24 136.29 37.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.793 0.806 . . . . 0.0 109.953 171.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.33 50.47 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.84 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.749 0.704 . . . . 0.0 110.949 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.19 -178.55 1.77 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 167.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.659 ' HD2' ' HA ' ' G' ' 143' ' ' ILE . 0.0 OUTLIER -62.71 -69.34 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.886 -0.509 . . . . 0.0 110.585 171.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' G' ' 151' ' ' VAL . 7.4 m-85 -136.68 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.541 ' HB3' ' OD1' ' G' ' 99' ' ' ASN . 3.2 p30 -121.97 140.42 52.48 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.604 0.716 . . . . 0.0 109.448 177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' HB2' ' G' ' 142' ' ' GLU . . . -139.97 156.21 46.75 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.06 -163.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' G' ' 137' ' ' GLU . 29.1 tt0 -127.96 139.65 52.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' G' ' 91' ' ' PHE . 14.2 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 123.377 0.671 . . . . 0.0 110.355 -163.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.39 165.4 37.81 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.97 170.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 171' ' ' PRO . 3.3 m-85 -89.15 129.53 35.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 167.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.02 160.48 30.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.923 0.868 . . . . 0.0 111.187 -169.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' G' ' 88' ' ' GLN . 1.2 t80 -132.86 164.59 26.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.984 -174.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.448 ' O ' ' HB3' ' L' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.09 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' G' ' 133' ' ' GLN . 3.6 tt0 -76.33 -43.06 42.81 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.85 163.21 38.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.968 0.803 . . . . 0.0 109.071 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.867 ' HG2' HG22 ' G' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.46 25.35 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.77 123.03 26.8 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.429 ' HD2' ' HB2' ' L' ' 36' ' ' SER . 0.0 OUTLIER -112.13 128.78 56.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.075 0.464 . . . . 0.0 111.226 176.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.11 120.97 39.36 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.669 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.18 127.39 53.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.57 158.44 20.64 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-O 121.739 0.633 . . . . 0.0 111.56 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 122.474 -0.427 . . . . 0.0 111.152 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.34 21.72 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.26 -143.59 30.85 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 166.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' L' ' 6' ' ' ILE . . . -141.35 155.77 45.9 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.618 0.723 . . . . 0.0 110.719 -177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' L' ' 6' ' ' ILE . 33.6 m -53.2 147.52 2.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.056 -171.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.476 ' HG2' ' CE2' ' G' ' 68' ' ' TYR . 3.4 tm-20 -128.7 131.23 47.94 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.103 -176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . 0.611 ' CD1' ' HA3' ' G' ' 69' ' ' GLY . 25.3 mt -112.51 126.51 69.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.26 123.56 50.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . 0.867 HG22 ' HG2' ' G' ' 116' ' ' ARG . 5.8 pt -122.48 126.51 74.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.91 32.06 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.351 0.661 . . . . 0.0 109.713 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.577 HD21 ' HE1' ' G' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.079 -172.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.06 15.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 167.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.663 HG11 ' HG3' ' G' ' 137' ' ' GLU . 81.1 t -141.57 159.86 21.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.546 HG22 HG13 ' L' ' 53' ' ' ILE . 6.6 pt -109.71 29.82 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.283 0.563 . . . . 0.0 110.304 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.34 1.46 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.667 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . 0.663 ' HG3' HG11 ' G' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.07 35.71 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.021 0.915 . . . . 0.0 110.622 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 148.69 43.38 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -174.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.691 ' HB2' ' OE1' ' H' ' 84' ' ' GLN . 1.7 mptt -94.6 141.29 28.78 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -177.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.5 0.99 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -109.2 147.17 16.82 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.326 169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.818 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 3.7 tp10 -85.52 131.04 34.44 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.659 ' HA ' ' HD2' ' G' ' 103' ' ' LYS . 1.2 mp -96.39 -49.77 11.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.76 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.01 107.56 9.45 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.96 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . . . . . . . . . 73.5 p -60.42 -42.98 97.16 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.371 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.73 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 126.464 1.906 . . . . 0.0 109.438 -173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.89 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.208 1.272 . . . . 0.0 115.335 -159.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.04 -43.92 66.88 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.579 171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.22 -58.86 2.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.481 HD12 ' H ' ' G' ' 150' ' ' ILE . 3.3 mp -61.82 -47.03 95.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.101 0.864 . . . . 0.0 111.297 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' G' ' 147' ' ' PRO . 78.2 t -74.31 -43.89 49.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.63 114.93 28.7 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.459 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.45 104.03 9.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.74 15.82 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.45 -5.1 57.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.32 3.72 61.36 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.343 0.974 . . . . 0.0 113.019 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.27 136.36 28.32 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.22 145.35 47.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 108.62 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.83 -46.65 77.78 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -158.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.41 44.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 127.678 2.391 . . . . 0.0 109.169 167.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.83 1.79 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 154.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.22 0.17 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -166.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . 0.735 ' HD2' HE22 ' G' ' 165' ' ' GLN . 22.3 Cg_exo -75.13 10.52 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.542 0 CA-C-N 122.043 1.765 . . . . 0.0 113.839 171.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.78 88.07 0.46 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.381 2.112 . . . . 0.0 118.381 -171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.735 HE22 ' HD2' ' G' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.879 1.34 . . . . 0.0 110.922 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' G' ' 175' ' ' PRO . 26.2 m 31.1 73.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.838 1.655 . . . . 0.0 111.908 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.87 ' HA ' ' HB ' ' G' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.83 8.09 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.287 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.92 -158.93 8.28 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.48 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -24.2 67.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.803 0.301 . . . . 0.0 111.444 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.26 153.5 74.27 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.46 0.704 . . . . 0.0 109.296 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.324 -0.745 0 C-N-CA 121.308 1.339 . . . . 0.0 112.705 -156.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.28 96.08 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 117.168 1.627 . . . . 0.0 117.168 165.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . 0.87 ' HB ' ' HA ' ' G' ' 167' ' ' THR . 0.2 OUTLIER -105.83 148.02 28.01 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.941 0.871 . . . . 0.0 109.91 170.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.557 ' HA ' ' HB3' ' G' ' 165' ' ' GLN . 32.6 m -122.5 168.66 11.26 Favored Pre-proline 0 C--O 1.241 0.606 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.397 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' G' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.84 9.2 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.501 0.858 . . . . 0.0 111.718 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 C-N-CA 125.423 1.489 . . . . 0.0 112.315 -171.712 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.584 ' HB3' ' HG2' ' I' ' 70' ' ' LYS . 50.1 Cg_endo . . . . . 0 N--CA 1.465 -0.176 0 N-CA-C 103.656 -3.248 . . . . 0.0 103.656 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' I' ' 126' ' ' VAL . 6.3 mt -87.17 132.65 32.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 0.48 ' H ' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -91.07 164.08 14.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.918 0.866 . . . . 0.0 110.768 -177.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.69 -33.6 67.94 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.371 -0.831 . . . . 0.0 114.551 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.4 -31.05 42.67 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.742 0.771 . . . . 0.0 112.369 172.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 0.544 ' HA ' ' OG1' ' H' ' 96' ' ' THR . 0.4 OUTLIER -53.64 -44.28 69.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -171.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.471 HG22 ' OD1' ' H' ' 95' ' ' ASP . 32.1 t -89.03 115.19 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.53 49.03 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.64 0.733 . . . . 0.0 110.535 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.55 125.15 53.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.753 -164.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' H' ' 27' ' ' LEU . 0.1 OUTLIER -120.12 150.43 40.63 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 174.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.404 ' HE2' ' CE1' ' H' ' 91' ' ' PHE . 2.2 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.454 0.645 . . . . 0.0 109.965 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' H' ' 90' ' ' LYS . 4.2 tt0 -131.28 131.95 44.21 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.59 137.55 42.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.562 0.696 . . . . 0.0 110.997 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.974 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.16 60.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.99 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' H' ' 18' ' ' ILE . 29.4 m-20 -84.32 -16.47 42.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.1 -51.79 42.39 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.447 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.798 ' HB2' ' HA ' ' B' ' 166' ' ' THR . . . 59.06 52.0 6.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.218 1.407 . . . . 0.0 111.816 -173.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.32 168.94 8.77 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' H' ' 24' ' ' SER . . . -93.0 36.38 3.73 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.714 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' H' ' 23' ' ' GLY . 3.5 p 176.04 140.29 0.06 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 117.001 0.4 . . . . 0.0 111.757 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.438 ' HA ' ' HG3' ' H' ' 16' ' ' GLN . . . -98.56 115.58 65.72 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 127.008 2.123 . . . . 0.0 112.402 -174.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -73.12 150.04 47.32 Favored 'Trans proline' 0 C--N 1.349 0.583 0 CA-C-N 119.398 0.821 . . . . 0.0 112.48 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' H' ' 14' ' ' LEU . 0.7 OUTLIER -130.09 156.56 44.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 168.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . 0.692 ' HZ ' ' H ' ' H' ' 70' ' ' LYS . 32.7 t80 -100.6 143.59 26.84 Favored Pre-proline 0 C--N 1.316 -0.861 0 C-N-CA 115.788 -2.365 . . . . 0.0 110.572 -167.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . 0.688 ' HD2' ' CD1' ' H' ' 28' ' ' PHE . 50.2 Cg_endo -79.1 175.07 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.301 0 CA-C-N 119.028 0.688 . . . . 0.0 112.464 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.57 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.375 1.47 . . . . 0.0 111.578 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -75.7 146.68 39.97 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 122.513 1.149 . . . . 0.0 111.037 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.94 -64.32 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.46 159.57 3.7 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 122.8 1.286 . . . . 0.0 111.089 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 115.88 10.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.15 116.48 4.11 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.365 170.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 25.3 m -106.31 121.69 44.73 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.78 132.46 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . 0.652 ' HB2' ' OH ' ' I' ' 83' ' ' TYR . 51.5 p -136.69 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -166.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.17 124.52 7.98 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.238 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . 0.504 ' HA ' HG22 ' H' ' 59' ' ' VAL . 5.4 tt0 -104.59 98.0 7.82 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.47 151.41 41.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.717 0.77 . . . . 0.0 110.148 -174.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.27 173.97 10.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -167.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . 0.85 HD23 ' HA3' ' H' ' 55' ' ' GLY . 0.1 OUTLIER -69.54 136.55 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.477 -179.081 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.6 135.95 34.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.85 110.13 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 155.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' H' ' 48' ' ' THR . 2.9 tt0 -67.5 -35.15 78.57 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 176.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . 0.421 ' HB2' ' HG2' ' H' ' 49' ' ' LYS . 0.0 OUTLIER 71.24 20.34 5.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.642 1.577 . . . . 0.0 111.627 -172.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . 0.554 ' HA ' ' OE1' ' H' ' 46' ' ' GLU . 5.9 m 42.28 55.46 3.98 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.519 1.527 . . . . 0.0 111.533 -164.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' HB2' ' H' ' 47' ' ' GLN . 8.8 mmtp -107.78 -133.48 0.33 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.489 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.51 15.9 27.39 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.84 81.44 1.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.461 ' O ' ' HB3' ' H' ' 43' ' ' LEU . 4.1 mmp_? -109.75 25.28 11.97 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.481 HG13 HG22 ' I' ' 135' ' ' ILE . 0.7 OUTLIER -123.58 1.75 5.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.902 178.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -104.58 36.27 2.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . 0.85 ' HA3' HD23 ' H' ' 43' ' ' LEU . . . -104.29 158.16 16.76 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 121.677 0.598 . . . . 0.0 113.931 -170.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.54 138.77 15.67 Favored 'Trans proline' 0 CA--C 1.516 -0.422 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.07 -179.13 17.57 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.73 166.94 20.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.508 0.671 . . . . 0.0 110.535 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' H' ' 40' ' ' GLU . 16.4 t -117.45 129.75 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.4 44.62 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.59 111.18 11.99 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.4 148.3 42.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.934 0.894 . . . . 0.0 110.029 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.07 22.67 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.191 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.85 51.09 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.453 HG12 ' HD1' ' H' ' 67' ' ' TYR . 59.3 t -129.85 122.77 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.24 146.86 32.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.453 ' HD1' HG12 ' H' ' 65' ' ' VAL . 24.2 p90 -168.75 167.92 10.91 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' H' ' 127' ' ' GLU . 48.3 m-85 -98.85 118.09 34.83 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' H' ' 128' ' ' ILE . . . -71.53 135.89 24.09 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 -175.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.692 ' H ' ' HZ ' ' H' ' 28' ' ' PHE . 9.4 mttm -92.81 153.85 18.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.436 0.636 . . . . 0.0 109.29 174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . 0.419 HH21 ' HD2' ' H' ' 71' ' ' ARG . 0.0 OUTLIER -54.15 -35.56 62.37 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -172.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.72 95.67 0.13 Allowed Glycine 0 N--CA 1.452 -0.242 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.86 43.31 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.185 1.394 . . . . 0.0 111.068 169.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' H' ' 78' ' ' ALA . . . -76.59 -37.55 56.31 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 -156.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . 0.498 ' O ' HG12 ' H' ' 79' ' ' ILE . . . -64.19 -39.11 96.81 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.843 168.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' H' ' 80' ' ' GLU . 0.8 OUTLIER -61.83 -51.9 66.35 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 122.13 -0.63 . . . . 0.0 111.819 171.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . 0.482 ' HA ' ' HB2' ' H' ' 80' ' ' GLU . 6.2 mtmp? -62.52 -27.11 68.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.784 171.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' H' ' 74' ' ' ALA . . . -64.14 -41.65 97.11 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.902 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.498 HG12 ' O ' ' H' ' 75' ' ' GLY . 2.3 mm -64.95 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.024 0.44 . . . . 0.0 110.465 172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.676 ' HG3' ' OE1' ' H' ' 76' ' ' GLN . 10.7 mm-40 -63.57 -44.45 94.08 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 121.741 -0.599 . . . . 0.0 112.48 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -68.45 -37.53 80.3 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.524 169.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.876 ' HA ' ' HG3' ' H' ' 87' ' ' LYS . . . -52.45 -52.81 52.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.091 -1.043 . . . . 0.0 111.573 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.677 ' OH ' ' HB2' ' G' ' 38' ' ' SER . 25.7 t80 -83.92 -51.31 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.898 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.691 ' OE1' ' HB2' ' G' ' 139' ' ' LYS . 3.5 mt-30 -74.38 -43.17 57.62 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -167.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.73 -28.59 58.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.018 172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 O-C-N 122.334 -0.229 . . . . 0.0 112.888 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.876 ' HG3' ' HA ' ' H' ' 82' ' ' ALA . 0.1 OUTLIER -137.35 152.04 49.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' H' ' 112' ' ' TYR . 0.0 OUTLIER -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.54 ' CD1' ' HD2' ' H' ' 87' ' ' LYS . 1.3 mm -117.29 152.11 19.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 121.395 0.617 . . . . 0.0 109.823 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.974 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.28 33.29 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.574 ' HE1' HD21 ' H' ' 132' ' ' LEU . 1.6 t80 -121.45 123.31 41.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.528 1.131 . . . . 0.0 109.966 -165.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.203 1.001 . . . . 0.0 108.37 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' H' ' 107' ' ' GLN . 12.6 ptm180 -130.59 119.09 21.98 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' H' ' 106' ' ' ALA . 1.5 m -134.77 159.29 41.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 122.229 1.014 . . . . 0.0 109.394 -173.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . 0.513 ' HB2' ' OD1' ' H' ' 105' ' ' ASP . 0.1 OUTLIER -93.64 147.06 23.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.627 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' H' ' 10' ' ' ASP . 48.1 p -79.13 -26.03 42.88 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.682 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.62 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.697 0.761 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 131.69 43.52 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.936 -174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.544 ' OD1' ' HB3' ' H' ' 105' ' ' ASP . 1.4 t30 -78.25 136.33 37.75 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.831 0.824 . . . . 0.0 109.936 171.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 -22.32 50.48 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.2 3.93 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.852 169.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -173.21 -178.57 1.77 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.63 ' HD2' ' HA ' ' H' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.36 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.893 -0.504 . . . . 0.0 110.605 171.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.503 ' OH ' HG22 ' H' ' 151' ' ' VAL . 7.4 m-85 -136.67 -176.85 4.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.544 ' HB3' ' OD1' ' H' ' 99' ' ' ASN . 3.2 p30 -122.01 140.44 52.47 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.623 0.725 . . . . 0.0 109.386 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.82 ' HB2' ' HB2' ' H' ' 142' ' ' GLU . . . -139.98 156.22 46.74 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.074 -163.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.646 HE21 ' HB3' ' H' ' 137' ' ' GLU . 29.1 tt0 -128.01 139.61 52.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 157.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.419 ' HD1' ' O ' ' H' ' 91' ' ' PHE . 14.1 t80 -131.22 150.56 52.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.421 0.688 . . . . 0.0 110.415 -163.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.34 37.76 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.524 -1.322 . . . . 0.0 111.983 170.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' B' ' 171' ' ' PRO . 3.3 m-85 -89.1 129.6 35.69 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.06 160.44 31.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.969 0.89 . . . . 0.0 111.127 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' H' ' 88' ' ' GLN . 1.2 t80 -132.87 164.62 26.49 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.473 -1.24 . . . . 0.0 107.983 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.438 HD12 ' H ' ' H' ' 113' ' ' ILE . 0.3 OUTLIER -96.69 95.11 4.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' H' ' 133' ' ' GLN . 3.6 tt0 -76.31 -43.17 42.54 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.77 163.22 38.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.942 0.792 . . . . 0.0 109.115 174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . 0.853 ' HG2' HG22 ' H' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.49 25.34 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 176.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.83 122.99 26.65 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' HB2' ' G' ' 36' ' ' SER . 0.0 OUTLIER -112.1 128.76 56.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.192 176.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.13 120.94 39.24 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.699 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.19 127.44 53.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.47 20.64 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-O 121.743 0.635 . . . . 0.0 111.535 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 25.2 m -69.81 -27.89 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 122.454 -0.439 . . . . 0.0 111.1 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.08 149.38 21.67 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.62 30.91 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 166.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' G' ' 6' ' ' ILE . . . -141.33 155.8 45.91 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.585 0.707 . . . . 0.0 110.766 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.637 ' CG2' ' HB ' ' G' ' 6' ' ' ILE . 33.7 m -53.19 147.55 2.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.064 -171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' H' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.161 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . 0.604 ' CD1' ' HA3' ' H' ' 69' ' ' GLY . 25.4 mt -112.52 126.47 69.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.3 123.61 50.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . 0.853 HG22 ' HG2' ' H' ' 116' ' ' ARG . 5.8 pt -122.49 126.53 74.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.23 146.9 32.15 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.731 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.574 HD21 ' HE1' ' H' ' 91' ' ' PHE . 0.4 OUTLIER -145.1 138.79 26.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.129 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -93.32 158.07 15.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.668 HG11 ' HG3' ' H' ' 137' ' ' GLU . 80.7 t -141.58 159.83 21.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 175.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.582 HG22 HG13 ' G' ' 53' ' ' ILE . 6.5 pt -109.69 29.87 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.35 0.595 . . . . 0.0 110.367 -173.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.85 92.32 1.46 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.715 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . 0.668 ' HG3' HG11 ' H' ' 134' ' ' VAL . 10.0 mt-10 -81.2 139.1 35.73 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.034 0.921 . . . . 0.0 110.632 174.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.41 HD11 ' HA3' ' B' ' 157' ' ' GLY . 0.1 OUTLIER -120.29 148.59 43.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -174.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.699 ' HB2' ' OE1' ' I' ' 84' ' ' GLN . 1.7 mptt -94.48 141.28 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.65 -160.53 0.99 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -109.22 147.16 16.83 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.351 169.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.82 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 3.7 tp10 -85.53 131.06 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.63 ' HA ' ' HD2' ' H' ' 103' ' ' LYS . 1.2 mp -96.42 -49.74 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.773 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' B' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.57 9.51 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.962 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.37 -43.04 96.95 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.375 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.82 61.69 12.17 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 126.422 1.889 . . . . 0.0 109.418 -173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -70.55 9.86 0.67 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.27 1.313 . . . . 0.0 115.301 -159.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 -44.01 66.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.545 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.18 -58.84 2.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.49 HD12 ' H ' ' H' ' 150' ' ' ILE . 3.3 mp -61.8 -47.0 95.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 119.144 0.884 . . . . 0.0 111.253 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HA ' ' H' ' 147' ' ' PRO . 77.7 t -74.36 -43.84 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.98 28.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.437 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.56 162.81 15.73 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.53 -5.07 57.63 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.28 3.78 61.39 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 119.405 1.002 . . . . 0.0 113.034 -176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.34 136.35 28.2 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.35 47.67 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.352 1.061 . . . . 0.0 108.66 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.85 -46.6 77.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -158.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.38 44.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.686 2.395 . . . . 0.0 109.149 167.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -141.54 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 154.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.48 -29.18 0.17 Allowed Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -166.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . 0.755 ' HD2' HE22 ' H' ' 165' ' ' GLN . 22.2 Cg_exo -75.05 10.38 1.75 Allowed 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.024 1.759 . . . . 0.0 113.873 171.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.89 88.02 0.47 Allowed Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 118.355 2.102 . . . . 0.0 118.355 -171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.755 HE22 ' HD2' ' H' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.879 1.34 . . . . 0.0 110.909 175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' H' ' 175' ' ' PRO . 26.2 m 31.09 73.36 0.06 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.791 1.637 . . . . 0.0 111.911 176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' H' ' 173' ' ' THR . 0.6 OUTLIER -92.77 172.83 8.1 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.312 -167.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.89 8.27 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.449 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -24.15 67.76 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.788 0.294 . . . . 0.0 111.423 -177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.34 153.49 74.06 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 123.488 0.715 . . . . 0.0 109.282 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.2 -12.37 13.01 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.318 1.345 . . . . 0.0 112.74 -156.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 117.187 1.635 . . . . 0.0 117.187 165.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' H' ' 167' ' ' THR . 0.2 OUTLIER -105.84 148.03 28.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.016 0.908 . . . . 0.0 109.866 170.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' H' ' 165' ' ' GLN . 32.3 m -122.52 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.627 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.438 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' H' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.83 9.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.517 0.863 . . . . 0.0 111.71 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 C-N-CA 125.392 1.477 . . . . 0.0 112.319 -171.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.547 ' HB3' ' HG2' ' J' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 N-CA-C 103.614 -3.264 . . . . 0.0 103.614 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' J' ' 126' ' ' VAL . 6.3 mt -87.12 132.69 31.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 0.486 ' H ' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -91.1 164.06 14.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.94 0.876 . . . . 0.0 110.774 -177.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.67 -33.64 67.98 Favored Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.489 175.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.35 -31.08 42.92 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.797 0.798 . . . . 0.0 112.393 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 0.548 ' HA ' ' OG1' ' I' ' 96' ' ' THR . 0.4 OUTLIER -53.56 -44.26 69.14 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.016 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' I' ' 95' ' ' ASP . 32.5 t -89.09 115.2 28.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.29 147.55 49.07 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.58 125.15 53.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.749 -164.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' I' ' 27' ' ' LEU . 0.1 OUTLIER -120.07 150.44 40.58 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.412 ' HE2' ' CE1' ' I' ' 91' ' ' PHE . 2.2 m-85 -125.26 149.41 48.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.47 0.653 . . . . 0.0 109.939 176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' I' ' 90' ' ' LYS . 4.3 tt0 -131.3 131.97 44.2 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 170.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.6 137.56 42.4 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.037 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.947 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.15 60.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.959 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . 0.494 ' OD1' HD12 ' I' ' 18' ' ' ILE . 29.4 m-20 -84.33 -16.45 42.89 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -171.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.86 41.76 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.421 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.768 ' HB2' ' HA ' ' C' ' 166' ' ' THR . . . 59.11 51.94 6.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.186 1.394 . . . . 0.0 111.855 -173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -104.34 168.96 8.76 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' I' ' 24' ' ' SER . . . -92.97 36.33 3.75 Favored Glycine 0 N--CA 1.45 -0.401 0 O-C-N 123.37 0.419 . . . . 0.0 113.74 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' I' ' 23' ' ' GLY . 3.5 p 176.04 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.002 0.401 . . . . 0.0 111.763 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' I' ' 16' ' ' GLN . . . -98.55 115.6 65.71 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.921 2.088 . . . . 0.0 112.354 -174.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.11 150.13 47.5 Favored 'Trans proline' 0 C--N 1.349 0.6 0 CA-C-N 119.378 0.813 . . . . 0.0 112.451 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' I' ' 14' ' ' LEU . 0.7 OUTLIER -130.11 156.51 44.41 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 168.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . 0.694 ' CD1' ' HD2' ' I' ' 29' ' ' PRO . 32.6 t80 -100.57 143.61 26.89 Favored Pre-proline 0 C--N 1.316 -0.86 0 C-N-CA 115.863 -2.335 . . . . 0.0 110.537 -167.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . 0.694 ' HD2' ' CD1' ' I' ' 28' ' ' PHE . 50.1 Cg_endo -79.13 175.05 11.3 Favored 'Trans proline' 0 C--N 1.332 -0.332 0 CA-C-N 119.011 0.683 . . . . 0.0 112.446 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.61 63.91 1.92 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.356 1.462 . . . . 0.0 111.495 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . 0.458 ' O ' HG11 ' J' ' 122' ' ' VAL . 10.5 m-85 -75.75 146.7 39.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 122.545 1.164 . . . . 0.0 111.055 173.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.4 ' O ' HG13 ' J' ' 122' ' ' VAL . 2.7 tm0? -105.9 -64.38 1.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.4 159.6 3.75 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 122.756 1.265 . . . . 0.0 111.079 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.17 115.88 10.73 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.002 -164.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.22 116.5 4.11 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.315 170.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' J' ' 118' ' ' TYR . 25.4 m -106.37 121.67 44.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 173.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.466 HG22 ' HG2' ' J' ' 117' ' ' GLU . 2.4 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -173.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . 0.634 ' HB2' ' OH ' ' J' ' 83' ' ' TYR . 51.5 p -136.68 107.47 6.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.22 124.56 7.98 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.236 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' J' ' 113' ' ' ILE . 5.4 tt0 -104.57 98.05 7.87 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.61 151.35 41.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.736 0.779 . . . . 0.0 110.113 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.18 173.96 10.27 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -167.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . 0.852 HD23 ' HA3' ' I' ' 55' ' ' GLY . 0.1 OUTLIER -69.45 136.53 51.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.521 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.6 136.05 34.91 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.219 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.78 110.09 0.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 155.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' I' ' 48' ' ' THR . 2.9 tt0 -67.46 -35.12 78.58 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . 0.431 ' HB2' ' HG2' ' I' ' 49' ' ' LYS . 0.0 OUTLIER 71.18 20.35 5.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.659 1.583 . . . . 0.0 111.678 -172.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.552 ' HA ' ' OE1' ' I' ' 46' ' ' GLU . 5.8 m 42.29 55.46 3.99 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.474 1.509 . . . . 0.0 111.573 -164.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' I' ' 47' ' ' GLN . 8.8 mmtp -107.77 -133.52 0.33 Allowed 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.47 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.52 15.95 27.23 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.85 81.38 1.3 Allowed Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' I' ' 43' ' ' LEU . 4.0 mmp_? -109.69 25.29 11.96 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.708 HG13 HG22 ' J' ' 135' ' ' ILE . 0.7 OUTLIER -123.53 1.62 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 178.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' J' ' 135' ' ' ILE . 0.0 OUTLIER -104.49 36.23 2.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 176.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . 0.852 ' HA3' HD23 ' I' ' 43' ' ' LEU . . . -104.28 158.2 16.76 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-O 121.7 0.611 . . . . 0.0 113.932 -170.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.51 138.71 15.67 Favored 'Trans proline' 0 CA--C 1.515 -0.433 0 N-CA-C 113.819 0.661 . . . . 0.0 113.819 -175.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.05 -179.05 17.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.77 166.98 20.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.551 0.691 . . . . 0.0 110.551 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.504 HG22 ' HA ' ' I' ' 40' ' ' GLU . 16.2 t -117.47 129.77 73.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.33 44.62 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.55 111.16 11.99 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.36 148.27 42.65 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.944 0.897 . . . . 0.0 110.044 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.32 152.06 22.63 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.153 -0.931 . . . . 0.0 112.165 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.62 143.88 51.08 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 174.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.455 HG12 ' HD1' ' I' ' 67' ' ' TYR . 58.9 t -129.89 122.76 55.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . . . . . . . . . 30.1 p -108.23 146.89 32.15 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.455 ' HD1' HG12 ' I' ' 65' ' ' VAL . 24.2 p90 -168.78 167.87 10.88 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' I' ' 127' ' ' GLU . 48.0 m-85 -98.82 118.12 34.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.618 ' HA3' ' CD1' ' I' ' 128' ' ' ILE . . . -71.52 135.9 24.12 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 114.955 0.742 . . . . 0.0 114.955 -175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.694 ' H ' ' HZ ' ' I' ' 28' ' ' PHE . 9.4 mttm -92.82 153.89 18.59 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.404 ' HD2' HH21 ' I' ' 71' ' ' ARG . 0.0 OUTLIER -54.16 -35.61 62.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -172.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.74 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.42 158.87 43.3 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.005 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -37.6 56.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 117.495 2.405 . . . . 0.0 117.495 -156.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -64.25 -39.14 96.79 Favored Glycine 0 C--N 1.338 0.656 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.784 168.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . 0.667 ' OE1' ' HG3' ' I' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.84 66.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.904 171.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' I' ' 80' ' ' GLU . 6.2 mtmp? -62.54 -27.09 68.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.784 171.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.6 97.07 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.906 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.5 HD13 ' N ' ' I' ' 79' ' ' ILE . 2.3 mm -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 110.464 172.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.667 ' HG3' ' OE1' ' I' ' 76' ' ' GLN . 10.7 mm-40 -63.67 -44.39 93.92 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.772 -0.58 . . . . 0.0 112.427 -178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.37 -37.58 80.57 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.598 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' I' ' 87' ' ' LYS . . . -52.43 -52.82 51.95 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.582 174.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.652 ' OH ' ' HB2' ' H' ' 38' ' ' SER . 25.5 t80 -83.93 -51.27 7.29 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.314 -0.555 . . . . 0.0 111.923 -174.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' H' ' 139' ' ' LYS . 3.5 mt-30 -74.41 -43.17 57.5 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.021 172.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.08 78.58 1.11 Allowed Glycine 0 N--CA 1.448 -0.523 0 O-C-N 122.349 -0.22 . . . . 0.0 112.855 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' I' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' I' ' 112' ' ' TYR . 0.0 OUTLIER -82.69 142.29 31.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 168.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' I' ' 87' ' ' LYS . 1.3 mm -117.33 152.14 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 109.845 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 11.8 mtmt -86.06 136.23 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HE1' HD21 ' I' ' 132' ' ' LEU . 1.6 t80 -121.41 123.31 41.79 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.508 1.123 . . . . 0.0 109.977 -165.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.09 52.8 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.219 1.008 . . . . 0.0 108.36 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.632 ' HD3' ' OE1' ' I' ' 107' ' ' GLN . 12.6 ptm180 -130.52 119.07 22.03 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' I' ' 106' ' ' ALA . 1.6 m -134.81 159.32 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-O 122.267 1.032 . . . . 0.0 109.407 -173.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' I' ' 105' ' ' ASP . 0.1 OUTLIER -93.67 147.08 23.35 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.632 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.548 ' OG1' ' HA ' ' I' ' 10' ' ' ASP . 48.5 p -79.14 -25.98 42.87 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.704 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.666 0.746 . . . . 0.0 109.946 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.74 43.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.966 -174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.54 ' OD1' ' HB3' ' I' ' 105' ' ' ASP . 1.4 t30 -78.28 136.25 37.71 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.795 0.807 . . . . 0.0 109.981 171.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.71 -22.26 50.7 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.86 39.11 3.95 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.792 0.723 . . . . 0.0 110.912 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.22 -178.61 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' I' ' 143' ' ' ILE . 0.0 OUTLIER -62.59 -69.4 0.26 Allowed 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.813 -0.554 . . . . 0.0 110.587 171.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.502 ' OH ' HG22 ' I' ' 151' ' ' VAL . 7.4 m-85 -136.7 -176.92 4.51 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.54 ' HB3' ' OD1' ' I' ' 99' ' ' ASN . 3.2 p30 -121.94 140.42 52.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.584 0.707 . . . . 0.0 109.478 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' I' ' 142' ' ' GLU . . . -139.98 156.19 46.75 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.039 -163.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.635 HE21 ' HB3' ' I' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.65 52.46 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 157.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' I' ' 91' ' ' PHE . 14.1 t80 -131.26 150.6 52.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 110.43 -163.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.38 165.3 37.76 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.925 170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' C' ' 171' ' ' PRO . 3.3 m-85 -89.12 129.55 35.71 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.47 31.02 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.922 0.868 . . . . 0.0 111.173 -169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.598 ' CE1' ' HB3' ' I' ' 88' ' ' GLN . 1.2 t80 -132.83 164.59 26.52 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.02 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.422 HD12 ' H ' ' I' ' 113' ' ' ILE . 0.3 OUTLIER -96.65 95.08 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.494 ' CD ' ' HG3' ' I' ' 133' ' ' GLN . 3.6 tt0 -76.25 -43.12 43.39 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.87 163.18 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.923 0.783 . . . . 0.0 109.06 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.843 ' HG2' HG22 ' I' ' 130' ' ' ILE . 0.0 OUTLIER -144.35 135.45 25.3 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 176.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.81 122.98 26.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 128.81 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 111.2 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.15 120.99 39.4 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.693 177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.24 127.39 53.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 25.1 m -69.81 -27.81 34.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 122.533 -0.392 . . . . 0.0 111.133 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.1 149.39 21.66 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.24 -143.57 30.86 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.35 155.79 45.9 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.561 0.696 . . . . 0.0 110.767 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' H' ' 6' ' ' ILE . 33.7 m -53.24 147.53 2.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.044 -171.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' I' ' 68' ' ' TYR . 3.3 tm-20 -128.67 131.23 48.01 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.126 -176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . 0.618 ' CD1' ' HA3' ' I' ' 69' ' ' GLY . 25.5 mt -112.55 126.48 69.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.22 123.6 50.57 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . 0.843 HG22 ' HG2' ' I' ' 116' ' ' ARG . 5.9 pt -122.48 126.5 74.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.18 146.87 32.12 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.375 0.67 . . . . 0.0 109.724 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.562 HD21 ' HE1' ' I' ' 91' ' ' PHE . 0.4 OUTLIER -145.08 138.81 26.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.085 -172.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . 0.494 ' HG3' ' CD ' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -93.33 158.03 15.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 167.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.657 HG11 ' HG3' ' I' ' 137' ' ' GLU . 81.1 t -141.58 159.81 21.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.481 HG22 HG13 ' H' ' 53' ' ' ILE . 6.6 pt -109.71 29.92 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.374 0.607 . . . . 0.0 110.348 -173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 92.23 1.46 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.772 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . 0.657 ' HG3' HG11 ' I' ' 134' ' ' VAL . 10.0 mt-10 -81.13 139.09 35.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.057 0.932 . . . . 0.0 110.647 174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.31 148.65 43.45 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -174.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.632 ' HB2' ' OE1' ' J' ' 84' ' ' GLN . 1.7 mptt -94.51 141.27 28.79 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 -160.54 0.99 Allowed 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -109.17 147.11 16.8 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.383 169.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.816 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 3.7 tp10 -85.45 131.05 34.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.649 ' HA ' ' HD2' ' I' ' 103' ' ' LYS . 1.2 mp -96.41 -49.79 11.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.722 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.03 107.64 9.52 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.948 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . . . . . . . . . 73.7 p -60.41 -43.05 97.09 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.359 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.79 61.82 11.95 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 126.508 1.923 . . . . 0.0 109.335 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' I' ' 151' ' ' VAL . 31.5 Cg_exo -70.66 9.92 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.227 1.285 . . . . 0.0 115.33 -159.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.05 -43.84 67.0 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.609 171.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.28 -58.87 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.489 HD12 ' H ' ' I' ' 150' ' ' ILE . 3.4 mp -61.81 -47.02 95.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 119.135 0.88 . . . . 0.0 111.257 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' I' ' 147' ' ' PRO . 77.6 t -74.34 -43.84 49.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.7 114.94 28.7 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.463 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.5 104.03 9.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.55 162.78 15.76 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.55 -5.01 57.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.3 3.66 61.42 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 119.388 0.994 . . . . 0.0 113.054 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.22 136.38 28.44 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.23 145.35 47.55 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.297 1.039 . . . . 0.0 108.57 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.85 -46.61 77.86 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -158.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.63 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.724 2.409 . . . . 0.0 109.163 167.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.54 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 153.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.19 0.17 Allowed Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -166.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . 0.749 ' HD2' HE22 ' I' ' 165' ' ' GLN . 22.3 Cg_exo -75.09 10.49 1.73 Allowed 'Trans proline' 0 C--O 1.238 0.514 0 CA-C-N 122.052 1.769 . . . . 0.0 113.922 171.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.11 0.46 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 118.344 2.098 . . . . 0.0 118.344 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.749 HE22 ' HD2' ' I' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.01 0.63 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.859 1.329 . . . . 0.0 110.944 175.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' I' ' 175' ' ' PRO . 26.4 m 31.07 73.44 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.836 1.654 . . . . 0.0 111.857 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.844 ' HA ' ' HB ' ' I' ' 173' ' ' THR . 0.6 OUTLIER -92.79 172.87 8.07 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.35 -167.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.97 -158.88 8.26 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.522 172.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -24.18 67.79 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.851 0.326 . . . . 0.0 111.466 -177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.28 153.53 74.24 Favored Pre-proline 0 C--O 1.235 0.334 0 C-N-CA 123.466 0.707 . . . . 0.0 109.264 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.29 -12.36 12.89 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 121.295 1.33 . . . . 0.0 112.716 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 117.203 1.641 . . . . 0.0 117.203 165.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . 0.844 ' HB ' ' HA ' ' I' ' 167' ' ' THR . 0.2 OUTLIER -105.79 148.0 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.025 0.913 . . . . 0.0 109.92 170.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' I' ' 165' ' ' GLN . 32.6 m -122.49 168.68 11.19 Favored Pre-proline 0 C--O 1.241 0.628 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.397 178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . 0.583 ' HA ' ' HB ' ' I' ' 166' ' ' THR . 31.6 Cg_exo -72.93 123.88 9.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 119.52 0.864 . . . . 0.0 111.692 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 125.416 1.486 . . . . 0.0 112.332 -171.713 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.586 ' HB3' ' HG2' ' K' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.113 0 N-CA-C 103.594 -3.271 . . . . 0.0 103.594 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.601 ' HB ' ' CG2' ' K' ' 126' ' ' VAL . 6.3 mt -87.1 132.69 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 0.481 ' H ' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -91.09 164.09 14.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.938 0.875 . . . . 0.0 110.721 -177.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.68 -33.69 68.17 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.53 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.31 -31.05 43.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.738 0.769 . . . . 0.0 112.432 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 0.542 ' HA ' ' OG1' ' J' ' 96' ' ' THR . 0.4 OUTLIER -53.59 -44.3 69.28 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -172.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.474 HG22 ' OD1' ' J' ' 95' ' ' ASP . 32.8 t -89.06 115.24 28.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.3 147.53 49.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.704 0.764 . . . . 0.0 110.494 176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -113.59 125.12 53.82 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.887 -1.052 . . . . 0.0 108.747 -164.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' J' ' 27' ' ' LEU . 0.1 OUTLIER -120.11 150.42 40.63 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.414 ' HE2' ' CE1' ' J' ' 91' ' ' PHE . 2.3 m-85 -125.23 149.41 48.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.467 0.651 . . . . 0.0 109.938 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.499 ' O ' ' HB2' ' J' ' 90' ' ' LYS . 4.2 tt0 -131.27 131.97 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.63 137.6 42.36 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.949 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 0.7 OUTLIER -61.64 -34.14 60.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.042 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' J' ' 18' ' ' ILE . 29.5 m-20 -84.27 -16.53 42.79 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.05 -51.88 41.72 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.382 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . 0.886 ' HB2' ' HA ' ' D' ' 166' ' ' THR . . . 59.14 51.99 6.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.227 1.411 . . . . 0.0 111.8 -173.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' D' ' 164' ' ' GLY . 1.1 t -104.35 168.93 8.77 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' J' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 O-C-N 123.354 0.408 . . . . 0.0 113.698 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' J' ' 23' ' ' GLY . 3.5 p 176.05 140.28 0.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.0 0.4 . . . . 0.0 111.809 -177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' J' ' 16' ' ' GLN . . . -98.54 115.5 65.75 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 126.972 2.109 . . . . 0.0 112.413 -174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -73.09 150.09 47.56 Favored 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 119.415 0.827 . . . . 0.0 112.452 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.545 ' HB3' ' HA ' ' J' ' 14' ' ' LEU . 0.7 OUTLIER -130.15 156.52 44.43 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 168.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . 0.701 ' CD1' ' HD2' ' J' ' 29' ' ' PRO . 32.6 t80 -100.53 143.59 26.83 Favored Pre-proline 0 C--N 1.317 -0.832 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.565 -167.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . 0.701 ' HD2' ' CD1' ' J' ' 28' ' ' PHE . 50.5 Cg_endo -79.07 175.07 11.31 Favored 'Trans proline' 0 C--N 1.331 -0.345 0 CA-C-N 119.053 0.698 . . . . 0.0 112.436 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.56 63.89 1.93 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.326 1.45 . . . . 0.0 111.542 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . 0.492 ' O ' HG11 ' K' ' 122' ' ' VAL . 10.6 m-85 -75.66 146.67 40.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 122.489 1.138 . . . . 0.0 111.055 173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.4 ' HB3' ' OG1' ' J' ' 66' ' ' THR . 2.7 tm0? -105.93 -64.31 1.17 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.44 159.57 3.72 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.82 1.295 . . . . 0.0 111.107 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 115.79 10.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.017 -164.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.17 116.55 4.13 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.339 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' K' ' 118' ' ' TYR . 25.2 m -106.36 121.64 44.65 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 173.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' K' ' 117' ' ' GLU . 2.3 t -121.71 132.44 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -173.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . 0.573 ' HB2' ' OH ' ' K' ' 83' ' ' TYR . 51.6 p -136.7 107.5 6.62 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -166.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.59 7.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.231 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . 0.503 ' HA ' HG22 ' J' ' 59' ' ' VAL . 5.4 tt0 -104.66 98.07 7.88 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 151.33 41.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.717 0.77 . . . . 0.0 110.183 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.25 173.96 10.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -167.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . 0.839 HD23 ' HA3' ' J' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.63 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.521 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.58 136.01 34.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.267 171.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.83 110.07 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 155.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.559 ' OE1' ' HA ' ' J' ' 48' ' ' THR . 2.9 tt0 -67.49 -35.14 78.57 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . 0.428 ' HB2' ' HG2' ' J' ' 49' ' ' LYS . 0.0 OUTLIER 71.23 20.28 5.12 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.564 1.546 . . . . 0.0 111.667 -172.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.559 ' HA ' ' OE1' ' J' ' 46' ' ' GLU . 5.8 m 42.31 55.41 4.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.477 1.511 . . . . 0.0 111.569 -164.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' J' ' 47' ' ' GLN . 8.8 mmtp -107.78 -133.43 0.33 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.503 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -101.59 15.98 27.18 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.36 1.3 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' J' ' 43' ' ' LEU . 4.0 mmp_? -109.7 25.21 12.05 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.566 HG13 HG22 ' K' ' 135' ' ' ILE . 0.7 OUTLIER -123.51 1.7 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.901 178.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.539 HD13 ' HD1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -104.61 36.33 2.45 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 176.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . 0.839 ' HA3' HD23 ' J' ' 43' ' ' LEU . . . -104.31 158.15 16.74 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.745 0.636 . . . . 0.0 113.915 -170.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.49 138.79 15.77 Favored 'Trans proline' 0 CA--C 1.516 -0.391 0 N-CA-C 113.813 0.659 . . . . 0.0 113.813 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.06 -179.07 17.51 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.81 167.0 20.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 0.0 110.484 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' J' ' 40' ' ' GLU . 16.4 t -117.46 129.77 73.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.34 129.42 44.61 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.62 111.13 11.93 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -171.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.33 148.31 42.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.949 0.899 . . . . 0.0 110.055 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.35 152.1 22.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.135 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.67 143.84 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 174.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' J' ' 67' ' ' TYR . 59.1 t -129.85 122.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' J' ' 32' ' ' GLN . 29.9 p -108.22 146.83 32.23 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 174.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' J' ' 65' ' ' VAL . 24.1 p90 -168.76 167.92 10.9 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.481 ' CE2' ' HG2' ' J' ' 127' ' ' GLU . 48.4 m-85 -98.88 118.11 34.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' J' ' 128' ' ' ILE . . . -71.52 135.89 24.12 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.679 ' H ' ' HZ ' ' J' ' 28' ' ' PHE . 9.4 mttm -92.89 153.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 174.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -35.6 62.31 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.71 95.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.282 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.43 158.91 43.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.121 1.368 . . . . 0.0 111.043 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -37.56 56.24 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 117.479 2.4 . . . . 0.0 117.479 -156.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.501 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -64.21 -39.12 96.8 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.825 168.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . 0.678 ' OE1' ' HG3' ' J' ' 80' ' ' GLU . 0.8 OUTLIER -61.85 -51.85 66.55 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 122.143 -0.622 . . . . 0.0 111.821 171.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . 0.485 ' HA ' ' HB2' ' J' ' 80' ' ' GLU . 6.2 mtmp? -62.55 -27.09 68.93 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.796 171.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.63 97.16 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.939 168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.505 HD13 ' N ' ' J' ' 79' ' ' ILE . 2.3 mm -64.97 -40.51 89.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.042 0.448 . . . . 0.0 110.49 172.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.678 ' HG3' ' OE1' ' J' ' 76' ' ' GLN . 10.7 mm-40 -63.69 -44.37 93.91 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.757 -0.589 . . . . 0.0 112.424 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.4 -37.53 80.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.626 169.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.887 ' HA ' ' HG3' ' J' ' 87' ' ' LYS . . . -52.51 -52.76 53.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.064 -1.055 . . . . 0.0 111.594 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' I' ' 38' ' ' SER . 25.6 t80 -83.89 -51.33 7.26 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.927 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.665 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.16 57.6 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -167.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.72 -28.6 58.63 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.055 172.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.1 78.56 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 O-C-N 122.303 -0.248 . . . . 0.0 112.882 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.887 ' HG3' ' HA ' ' J' ' 82' ' ' ALA . 0.1 OUTLIER -137.38 152.02 49.2 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.594 ' HB3' ' CE1' ' J' ' 112' ' ' TYR . 0.0 OUTLIER -82.72 142.32 31.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' J' ' 87' ' ' LYS . 1.3 mm -117.34 152.08 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-O 121.316 0.579 . . . . 0.0 109.872 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.949 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 11.8 mtmt -86.08 136.26 33.3 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.578 ' HE1' HD21 ' J' ' 132' ' ' LEU . 1.6 t80 -121.38 123.31 41.8 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.52 1.128 . . . . 0.0 110.009 -166.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.91 134.12 52.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.206 1.002 . . . . 0.0 108.328 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.634 ' HD3' ' OE1' ' J' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.04 21.93 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 172.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.443 HG12 ' CB ' ' J' ' 106' ' ' ALA . 1.6 m -134.77 159.31 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 122.285 1.041 . . . . 0.0 109.399 -173.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' OD1' ' J' ' 105' ' ' ASP . 0.1 OUTLIER -93.63 147.1 23.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.64 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' J' ' 10' ' ' ASP . 47.6 p -79.24 -25.93 42.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.664 -176.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.67 143.53 14.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 CA-C-O 121.674 0.75 . . . . 0.0 109.887 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.66 131.7 43.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.957 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' J' ' 105' ' ' ASP . 1.4 t30 -78.22 136.25 37.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.831 0.824 . . . . 0.0 109.974 171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.69 -22.23 50.83 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.94 39.17 3.94 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.76 0.709 . . . . 0.0 110.858 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.58 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 167.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.658 ' HD2' ' HA ' ' J' ' 143' ' ' ILE . 0.0 OUTLIER -62.57 -69.45 0.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.884 -0.51 . . . . 0.0 110.582 171.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' J' ' 151' ' ' VAL . 7.5 m-85 -136.67 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.547 ' HB3' ' OD1' ' J' ' 99' ' ' ASN . 3.2 p30 -122.03 140.42 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.66 0.743 . . . . 0.0 109.422 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.812 ' HB2' ' HB2' ' J' ' 142' ' ' GLU . . . -139.93 156.26 46.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.044 -163.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.658 HE21 ' HB3' ' J' ' 137' ' ' GLU . 29.0 tt0 -128.01 139.6 52.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 157.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' J' ' 91' ' ' PHE . 14.1 t80 -131.2 150.6 52.08 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 123.394 0.678 . . . . 0.0 110.437 -163.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.33 165.35 37.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 119.554 -1.307 . . . . 0.0 111.975 170.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' D' ' 171' ' ' PRO . 3.3 m-85 -89.18 129.58 35.75 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 167.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.03 160.49 30.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.957 0.884 . . . . 0.0 111.171 -169.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.594 ' CE1' ' HB3' ' J' ' 88' ' ' GLN . 1.2 t80 -132.85 164.61 26.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.002 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' I' ' 40' ' ' GLU . 0.3 OUTLIER -96.62 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.491 ' CD ' ' HG3' ' J' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.01 42.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.9 163.17 38.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.954 0.797 . . . . 0.0 109.063 174.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . 0.841 ' HG2' HG22 ' J' ' 130' ' ' ILE . 0.0 OUTLIER -144.32 135.41 25.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 176.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.466 ' HG2' HG22 ' I' ' 37' ' ' VAL . 4.7 tm-20 -131.73 122.98 26.77 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.492 ' HD2' ' HB2' ' I' ' 36' ' ' SER . 0.0 OUTLIER -112.03 128.82 56.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.071 0.462 . . . . 0.0 111.163 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.23 120.95 39.22 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.647 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.23 127.42 53.83 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.56 158.45 20.64 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . 0.458 HG11 ' O ' ' I' ' 31' ' ' TYR . 25.0 m -69.79 -27.86 34.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 O-C-N 122.519 -0.4 . . . . 0.0 111.14 176.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.07 149.35 21.7 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.29 -143.63 30.88 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' I' ' 6' ' ' ILE . . . -141.3 155.83 45.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.61 0.719 . . . . 0.0 110.713 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' I' ' 6' ' ' ILE . 33.7 m -53.25 147.56 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.011 -171.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.481 ' HG2' ' CE2' ' J' ' 68' ' ' TYR . 3.3 tm-20 -128.7 131.22 47.94 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.139 -176.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . 0.616 ' CD1' ' HA3' ' J' ' 69' ' ' GLY . 25.3 mt -112.51 126.5 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.29 123.55 50.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . 0.841 HG22 ' HG2' ' J' ' 116' ' ' ARG . 5.9 pt -122.48 126.52 74.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.15 146.92 32.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.712 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.578 HD21 ' HE1' ' J' ' 91' ' ' PHE . 0.4 OUTLIER -145.11 138.77 26.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.113 -172.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . 0.491 ' HG3' ' CD ' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -93.3 158.11 15.91 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' J' ' 137' ' ' GLU . 81.0 t -141.61 159.79 21.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.708 HG22 HG13 ' I' ' 53' ' ' ILE . 6.6 pt -109.71 29.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.342 0.591 . . . . 0.0 110.317 -173.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.29 1.45 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.691 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' J' ' 134' ' ' VAL . 10.0 mt-10 -81.19 139.04 35.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.069 0.938 . . . . 0.0 110.636 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.415 HD11 ' CA ' ' D' ' 157' ' ' GLY . 0.1 OUTLIER -120.28 148.64 43.45 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.627 ' HB2' ' OE1' ' K' ' 84' ' ' GLN . 1.7 mptt -94.58 141.26 28.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -160.56 0.99 Allowed 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -109.16 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.409 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.812 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.02 34.44 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.658 ' HA ' ' HD2' ' J' ' 103' ' ' LYS . 1.2 mp -96.37 -49.75 11.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.789 -176.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.406 ' HB2' ' CD ' ' D' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.985 -176.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . . . . . . . . . 73.3 p -60.45 -43.01 97.29 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 118.709 -0.662 . . . . 0.0 112.35 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.76 61.79 11.97 Favored Pre-proline 0 C--N 1.346 0.433 0 C-N-CA 126.478 1.911 . . . . 0.0 109.398 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.572 ' HA ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -70.58 9.85 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 121.22 1.28 . . . . 0.0 115.344 -159.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.95 -43.99 67.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.562 171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.21 -58.87 2.09 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.476 ' H ' HD12 ' J' ' 150' ' ' ILE . 3.3 mp -61.78 -47.01 95.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 119.151 0.887 . . . . 0.0 111.299 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' J' ' 147' ' ' PRO . 77.6 t -74.4 -43.8 48.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -176.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.72 114.92 28.67 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.39 104.03 9.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 8.9 t -113.57 162.79 15.77 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.08 57.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 175.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.24 3.74 61.47 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.365 0.984 . . . . 0.0 113.045 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.24 136.3 28.34 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.584 -0.606 . . . . 0.0 111.584 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.18 145.35 47.64 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 108.67 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.82 -46.65 77.81 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -158.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.37 44.09 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.672 2.389 . . . . 0.0 109.161 167.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.46 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 154.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.43 -29.23 0.17 Allowed Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -166.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' J' ' 165' ' ' GLN . 22.3 Cg_exo -75.07 10.46 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.541 0 CA-C-N 122.04 1.764 . . . . 0.0 113.888 171.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.05 0.46 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 118.401 2.12 . . . . 0.0 118.401 -171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' J' ' 163' ' ' PRO . 5.8 mp0 -106.72 59.05 0.63 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.884 1.342 . . . . 0.0 110.906 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . 0.566 ' HB ' ' HA ' ' J' ' 175' ' ' PRO . 26.1 m 31.12 73.37 0.06 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.795 1.638 . . . . 0.0 111.911 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.852 ' HA ' ' HB ' ' J' ' 173' ' ' THR . 0.6 OUTLIER -92.81 172.85 8.08 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.306 -167.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.96 -158.9 8.27 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.459 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -24.15 67.78 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.793 0.297 . . . . 0.0 111.439 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.31 153.5 74.15 Favored Pre-proline 0 C--O 1.236 0.345 0 C-N-CA 123.487 0.715 . . . . 0.0 109.3 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.26 -12.32 12.94 Favored 'Trans proline' 0 C--N 1.323 -0.773 0 C-N-CA 121.273 1.315 . . . . 0.0 112.731 -156.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.26 96.0 0.18 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 117.199 1.64 . . . . 0.0 117.199 165.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' J' ' 167' ' ' THR . 0.2 OUTLIER -105.85 148.03 28.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.986 0.893 . . . . 0.0 109.896 170.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' J' ' 165' ' ' GLN . 32.6 m -122.56 168.61 11.4 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.413 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' J' ' 166' ' ' THR . 31.5 Cg_exo -72.89 123.85 9.23 Favored 'Trans proline' 0 C--N 1.349 0.582 0 CA-C-N 119.514 0.862 . . . . 0.0 111.69 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.226 0 C-N-CA 125.482 1.513 . . . . 0.0 112.299 -171.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.442 ' HB3' ' HG2' ' L' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 N-CA-C 103.592 -3.272 . . . . 0.0 103.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.629 ' HB ' ' CG2' ' L' ' 126' ' ' VAL . 6.3 mt -87.15 132.73 31.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 0.483 ' H ' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -91.11 164.08 14.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.919 0.866 . . . . 0.0 110.736 -177.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.55 68.3 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.481 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -79.39 -31.1 42.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 117.775 0.788 . . . . 0.0 112.377 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 0.546 ' HA ' ' OG1' ' K' ' 96' ' ' THR . 0.4 OUTLIER -53.53 -44.33 69.09 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.511 ' CG2' HG11 ' L' ' 126' ' ' VAL . 32.7 t -89.07 115.19 28.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.26 147.53 49.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 110.462 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -113.52 125.16 53.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.75 -164.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' K' ' 27' ' ' LEU . 0.1 OUTLIER -120.17 150.42 40.67 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.406 ' HE2' ' CE1' ' K' ' 91' ' ' PHE . 2.2 m-85 -125.19 149.35 48.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.455 0.645 . . . . 0.0 109.994 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' K' ' 90' ' ' LYS . 4.2 tt0 -131.19 131.92 44.34 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 170.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 80.5 p -74.53 137.61 42.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.578 0.704 . . . . 0.0 111.03 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.939 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 0.7 OUTLIER -61.66 -34.15 60.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.936 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . 0.492 ' OD1' HD12 ' K' ' 18' ' ' ILE . 29.6 m-20 -84.4 -16.43 42.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -171.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.14 -51.75 42.49 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.429 -175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' E' ' 166' ' ' THR . . . 59.08 51.96 6.66 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.223 1.409 . . . . 0.0 111.814 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -104.35 168.99 8.74 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' K' ' 24' ' ' SER . . . -93.01 36.36 3.74 Favored Glycine 0 N--CA 1.449 -0.446 0 O-C-N 123.326 0.391 . . . . 0.0 113.712 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' K' ' 23' ' ' GLY . 3.5 p 176.02 140.28 0.06 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 117.001 0.4 . . . . 0.0 111.8 -177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' K' ' 16' ' ' GLN . . . -98.52 115.49 65.75 Favored Pre-proline 0 C--O 1.238 0.461 0 C-N-CA 126.952 2.101 . . . . 0.0 112.449 -174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.08 150.09 47.59 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.415 0.827 . . . . 0.0 112.524 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' K' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.56 44.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 168.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . 0.703 ' CD1' ' HD2' ' K' ' 29' ' ' PRO . 32.4 t80 -100.54 143.6 26.87 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 115.827 -2.349 . . . . 0.0 110.607 -167.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . 0.703 ' HD2' ' CD1' ' K' ' 28' ' ' PHE . 50.0 Cg_endo -79.15 175.06 11.27 Favored 'Trans proline' 0 C--N 1.332 -0.31 0 CA-C-O 121.88 0.7 . . . . 0.0 112.394 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.67 63.85 1.93 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.347 1.459 . . . . 0.0 111.544 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . 0.426 ' O ' HG11 ' L' ' 122' ' ' VAL . 10.6 m-85 -75.72 146.74 39.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.574 1.178 . . . . 0.0 111.033 173.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.96 -64.31 1.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.58 3.73 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 122.759 1.266 . . . . 0.0 111.1 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.16 115.86 10.72 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.02 -164.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.19 116.49 4.11 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.357 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -106.31 121.7 44.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.44 70.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . 0.527 ' HB2' ' OH ' ' L' ' 83' ' ' TYR . 52.1 p -136.66 107.52 6.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.25 124.58 7.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.225 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . 0.492 ' HA ' HG22 ' K' ' 59' ' ' VAL . 5.4 tt0 -104.6 98.01 7.83 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.54 151.39 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.762 0.792 . . . . 0.0 110.121 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -130.28 173.92 10.33 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . 0.826 HD23 ' HA3' ' K' ' 55' ' ' GLY . 0.1 OUTLIER -69.44 136.49 51.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.515 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.55 136.0 34.95 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.245 171.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.82 110.15 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 155.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' K' ' 48' ' ' THR . 2.9 tt0 -67.52 -35.14 78.53 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' K' ' 49' ' ' LYS . 0.0 OUTLIER 71.24 20.26 5.13 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.618 1.567 . . . . 0.0 111.629 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.564 ' HA ' ' OE1' ' K' ' 46' ' ' GLU . 5.9 m 42.31 55.47 4.0 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.519 1.527 . . . . 0.0 111.534 -164.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' K' ' 47' ' ' GLN . 8.8 mmtp -107.72 -133.46 0.33 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.522 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.57 15.91 27.4 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 81.39 1.3 Allowed Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' K' ' 43' ' ' LEU . 4.0 mmp_? -109.74 25.34 11.9 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.602 HG13 HG22 ' L' ' 135' ' ' ILE . 0.7 OUTLIER -123.64 1.76 5.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.858 178.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.558 ' HG ' HG12 ' L' ' 135' ' ' ILE . 0.0 OUTLIER -104.62 36.29 2.46 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . 0.826 ' HA3' HD23 ' K' ' 43' ' ' LEU . . . -104.36 158.2 16.7 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.653 0.585 . . . . 0.0 113.908 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -78.48 138.69 15.71 Favored 'Trans proline' 0 CA--C 1.516 -0.408 0 N-CA-C 113.878 0.684 . . . . 0.0 113.878 -175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.04 -179.12 17.55 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.95 20.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.606 0.717 . . . . 0.0 110.526 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' K' ' 40' ' ' GLU . 16.5 t -117.4 129.71 73.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.32 129.39 44.6 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.61 111.2 12.0 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -171.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 82.8 p -139.37 148.28 42.65 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.921 0.888 . . . . 0.0 110.046 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.4 152.08 22.68 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.127 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.82 51.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.452 HG12 ' HD1' ' K' ' 67' ' ' TYR . 58.9 t -129.81 122.78 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . . . . . . . . . 29.9 p -108.14 146.85 32.1 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' K' ' 79' ' ' ILE . 24.2 p90 -168.75 167.93 10.9 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.48 ' CE2' ' HG2' ' K' ' 127' ' ' GLU . 48.3 m-85 -98.91 118.12 34.95 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.603 ' HA3' ' CD1' ' K' ' 128' ' ' ILE . . . -71.52 135.95 24.18 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 114.925 0.73 . . . . 0.0 114.925 -175.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.673 ' H ' ' HZ ' ' K' ' 28' ' ' PHE . 9.4 mttm -92.84 153.89 18.57 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 109.274 174.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . 0.443 HH21 ' HD2' ' K' ' 71' ' ' ARG . 0.0 OUTLIER -54.17 -35.66 62.52 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.66 95.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.39 158.9 43.26 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.136 1.374 . . . . 0.0 111.011 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.59 -37.53 56.33 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 117.495 2.406 . . . . 0.0 117.495 -156.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.492 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -64.22 -39.15 96.82 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.822 168.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . 0.676 ' OE1' ' HG3' ' K' ' 80' ' ' GLU . 0.8 OUTLIER -61.79 -51.92 66.32 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.85 171.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' K' ' 80' ' ' GLU . 6.2 mtmp? -62.57 -27.05 68.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.784 171.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.11 -41.64 97.18 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.901 168.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.499 HD13 ' N ' ' K' ' 79' ' ' ILE . 2.3 mm -65.0 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.464 172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 10.7 mm-40 -63.61 -44.42 93.99 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.784 -0.572 . . . . 0.0 112.432 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -68.42 -37.53 80.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.603 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.88 ' HA ' ' HG3' ' K' ' 87' ' ' LYS . . . -52.47 -52.8 52.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.564 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.573 ' OH ' ' HB2' ' J' ' 38' ' ' SER . 25.6 t80 -83.85 -51.32 7.29 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.954 -174.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 3.5 mt-30 -74.38 -43.22 57.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -167.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -75.76 -28.55 58.5 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.041 172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.12 78.53 1.11 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 122.322 -0.236 . . . . 0.0 112.834 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.88 ' HG3' ' HA ' ' K' ' 82' ' ' ALA . 0.1 OUTLIER -137.36 152.05 49.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.588 ' HB3' ' CE1' ' K' ' 112' ' ' TYR . 0.0 OUTLIER -82.68 142.26 31.82 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.536 HD11 ' HD2' ' K' ' 87' ' ' LYS . 1.3 mm -117.31 152.07 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.369 0.604 . . . . 0.0 109.856 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.939 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 11.8 mtmt -86.1 136.18 33.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.569 ' HE1' HD21 ' K' ' 132' ' ' LEU . 1.6 t80 -121.32 123.37 41.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.491 1.116 . . . . 0.0 109.985 -165.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -124.9 134.1 52.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.221 1.008 . . . . 0.0 108.346 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.641 ' HD3' ' OE1' ' K' ' 107' ' ' GLN . 12.6 ptm180 -130.6 119.09 21.97 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' K' ' 106' ' ' ALA . 1.6 m -134.77 159.3 41.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 CA-C-O 122.249 1.023 . . . . 0.0 109.394 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . 0.514 ' HB2' ' OD1' ' K' ' 105' ' ' ASP . 0.1 OUTLIER -93.66 147.07 23.36 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.611 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.546 ' OG1' ' HA ' ' K' ' 10' ' ' ASP . 47.7 p -79.14 -25.99 42.83 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.668 -176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.67 143.49 14.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.68 0.752 . . . . 0.0 109.869 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 131.7 43.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.997 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' K' ' 105' ' ' ASP . 1.4 t30 -78.29 136.3 37.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.83 0.824 . . . . 0.0 109.916 171.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.68 -22.31 50.74 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -121.91 39.23 3.92 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.57 1.76 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' K' ' 143' ' ' ILE . 0.0 OUTLIER -62.66 -69.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.928 -0.483 . . . . 0.0 110.637 171.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.489 ' OH ' HG22 ' K' ' 151' ' ' VAL . 7.4 m-85 -136.66 -176.88 4.5 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' K' ' 99' ' ' ASN . 3.2 p30 -121.94 140.44 52.44 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.584 0.707 . . . . 0.0 109.461 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.815 ' HB2' ' HB2' ' K' ' 142' ' ' GLU . . . -139.99 156.25 46.73 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.036 -163.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.641 ' OE1' ' HD3' ' K' ' 93' ' ' ARG . 29.1 tt0 -127.96 139.6 52.48 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 157.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.418 ' HD1' ' O ' ' K' ' 91' ' ' PHE . 14.1 t80 -131.22 150.61 52.07 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.369 0.668 . . . . 0.0 110.425 -163.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.4 165.29 37.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.952 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' E' ' 171' ' ' PRO . 3.3 m-85 -89.07 129.58 35.67 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 167.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.04 160.41 31.2 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.922 0.868 . . . . 0.0 111.162 -169.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.588 ' CE1' ' HB3' ' K' ' 88' ' ' GLN . 1.2 t80 -132.8 164.59 26.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.479 -1.237 . . . . 0.0 107.993 -174.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' J' ' 40' ' ' GLU . 0.3 OUTLIER -96.63 95.14 4.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.497 ' CD ' ' HG3' ' K' ' 133' ' ' GLN . 3.6 tt0 -76.41 -43.08 41.97 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.82 163.14 38.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.945 0.793 . . . . 0.0 109.087 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . 0.851 ' HG2' HG22 ' K' ' 130' ' ' ILE . 0.0 OUTLIER -144.26 135.47 25.45 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.419 ' HG2' HG22 ' J' ' 37' ' ' VAL . 4.7 tm-20 -131.76 122.97 26.7 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.428 ' HD2' ' HB2' ' J' ' 36' ' ' SER . 0.0 OUTLIER -112.06 128.8 56.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.081 0.467 . . . . 0.0 111.183 176.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.97 39.31 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.694 177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -108.22 127.38 53.78 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.49 158.48 20.59 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . 0.492 HG11 ' O ' ' J' ' 31' ' ' TYR . 25.2 m -69.84 -27.84 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 122.499 -0.412 . . . . 0.0 111.137 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.09 149.37 21.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 169.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.27 -143.6 30.86 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 166.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' J' ' 6' ' ' ILE . . . -141.33 155.78 45.91 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.749 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.601 ' CG2' ' HB ' ' J' ' 6' ' ' ILE . 33.7 m -53.21 147.55 2.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.021 -171.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.48 ' HG2' ' CE2' ' K' ' 68' ' ' TYR . 3.4 tm-20 -128.71 131.22 47.91 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.083 -176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . 0.603 ' CD1' ' HA3' ' K' ' 69' ' ' GLY . 25.5 mt -112.54 126.53 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . . . . . . . . . 11.7 t -113.27 123.55 50.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . 0.851 HG22 ' HG2' ' K' ' 116' ' ' ARG . 5.8 pt -122.48 126.52 74.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.16 146.96 31.96 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.741 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.569 HD21 ' HE1' ' K' ' 91' ' ' PHE . 0.4 OUTLIER -145.12 138.75 26.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.152 -172.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . 0.497 ' HG3' ' CD ' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -93.38 158.08 15.91 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' K' ' 137' ' ' GLU . 81.2 t -141.56 159.81 21.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.566 HG22 HG13 ' J' ' 53' ' ' ILE . 6.6 pt -109.71 29.9 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.371 0.605 . . . . 0.0 110.396 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.3 1.45 Allowed Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.694 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . 0.682 ' HG3' HG11 ' K' ' 134' ' ' VAL . 10.0 mt-10 -81.23 139.04 35.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.054 0.93 . . . . 0.0 110.641 174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.23 148.59 43.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.555 ' HB2' ' OE1' ' L' ' 84' ' ' GLN . 1.7 mptt -94.56 141.3 28.76 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.59 -160.55 0.99 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -109.15 147.12 16.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.431 169.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.815 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 3.7 tp10 -85.49 131.02 34.45 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -174.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.648 ' HA ' ' HD2' ' K' ' 103' ' ' LYS . 1.2 mp -96.33 -49.82 11.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.804 -176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -77.0 107.56 9.44 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.006 -176.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.32 -43.13 96.65 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.381 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . . . . . . . . . 4.7 mt 45.84 61.76 12.09 Favored Pre-proline 0 C--N 1.346 0.423 0 C-N-CA 126.431 1.893 . . . . 0.0 109.38 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.584 ' HA ' ' HB ' ' K' ' 151' ' ' VAL . 31.5 Cg_exo -70.6 9.9 0.68 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.214 1.276 . . . . 0.0 115.286 -159.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -43.98 66.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.586 171.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.24 -58.92 2.09 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.469 HD12 ' H ' ' K' ' 150' ' ' ILE . 3.4 mp -61.76 -47.03 95.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 119.132 0.878 . . . . 0.0 111.294 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' K' ' 147' ' ' PRO . 78.2 t -74.31 -43.84 49.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.75 114.93 28.67 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.428 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 12.8 p -130.43 104.03 9.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 171.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.58 162.73 15.84 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.51 -5.1 57.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.75 61.37 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 119.393 0.997 . . . . 0.0 113.04 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.28 136.31 28.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -135.17 145.39 47.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.307 1.043 . . . . 0.0 108.613 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.87 -46.64 77.69 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.64 158.36 44.08 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.661 2.384 . . . . 0.0 109.144 167.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -141.51 81.79 1.79 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 154.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.44 -29.2 0.17 Allowed Pre-proline 0 C--O 1.241 0.619 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . 0.742 ' HD2' HE22 ' K' ' 165' ' ' GLN . 22.3 Cg_exo -75.04 10.43 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 122.095 1.784 . . . . 0.0 113.91 171.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.82 88.05 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.363 2.105 . . . . 0.0 118.363 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.742 HE22 ' HD2' ' K' ' 163' ' ' PRO . 5.8 mp0 -106.71 59.04 0.63 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-N 118.886 1.343 . . . . 0.0 110.935 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' K' ' 175' ' ' PRO . 26.2 m 31.12 73.33 0.06 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.829 1.652 . . . . 0.0 111.913 175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.873 ' HA ' ' HB ' ' K' ' 173' ' ' THR . 0.6 OUTLIER -92.78 172.79 8.12 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.308 -167.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.9 -158.89 8.26 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.519 172.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -24.18 67.8 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.817 0.309 . . . . 0.0 111.42 -177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.25 153.51 74.31 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.471 0.708 . . . . 0.0 109.279 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.24 -12.39 12.95 Favored 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.319 1.346 . . . . 0.0 112.751 -156.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.22 95.99 0.18 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 117.185 1.634 . . . . 0.0 117.185 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . 0.873 ' HB ' ' HA ' ' K' ' 167' ' ' THR . 0.2 OUTLIER -105.78 148.06 27.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.003 0.902 . . . . 0.0 109.903 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' K' ' 165' ' ' GLN . 32.7 m -122.58 168.69 11.24 Favored Pre-proline 0 C--O 1.24 0.57 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.369 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . 0.563 ' HA ' ' HB ' ' K' ' 166' ' ' THR . 31.5 Cg_exo -72.88 123.86 9.24 Favored 'Trans proline' 0 C--N 1.349 0.57 0 CA-C-N 119.47 0.847 . . . . 0.0 111.719 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.393 1.477 . . . . 0.0 112.345 -171.721 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' HG2' ' G' ' 70' ' ' LYS . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.127 0 N-CA-C 103.585 -3.275 . . . . 0.0 103.585 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.637 ' HB ' ' CG2' ' G' ' 126' ' ' VAL . 6.3 mt -87.15 132.69 31.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 0.488 ' H ' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -91.06 164.1 14.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.925 0.869 . . . . 0.0 110.725 -177.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.78 -33.59 68.42 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.343 -0.844 . . . . 0.0 114.513 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -79.39 -31.0 42.72 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 117.785 0.793 . . . . 0.0 112.385 172.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 0.529 ' HA ' ' OG1' ' L' ' 96' ' ' THR . 0.4 OUTLIER -53.67 -44.26 69.54 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -171.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' L' ' 95' ' ' ASP . 31.8 t -89.01 115.16 28.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -125.22 147.56 49.02 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.678 0.752 . . . . 0.0 110.471 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -113.65 125.18 53.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.727 -164.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' L' ' 27' ' ' LEU . 0.1 OUTLIER -120.15 150.38 40.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.402 ' HE2' ' CE1' ' L' ' 91' ' ' PHE . 2.3 m-85 -125.21 149.4 48.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.429 0.633 . . . . 0.0 109.953 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' L' ' 90' ' ' LYS . 4.3 tt0 -131.25 131.97 44.27 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 80.6 p -74.61 137.55 42.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.026 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.928 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 0.7 OUTLIER -61.61 -34.13 60.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.985 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . 0.499 ' OD1' HD12 ' L' ' 18' ' ' ILE . 29.4 m-20 -84.34 -16.47 42.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -51.8 42.19 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.397 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' HA ' ' F' ' 166' ' ' THR . . . 59.1 51.99 6.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.223 1.409 . . . . 0.0 111.762 -173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . 0.677 ' O ' ' HA3' ' F' ' 164' ' ' GLY . 1.1 t -104.37 168.95 8.76 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' F' ' 163' ' ' PRO . . . -93.02 36.39 3.73 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 113.713 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' L' ' 23' ' ' GLY . 3.5 p 176.01 140.3 0.06 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.963 0.381 . . . . 0.0 111.789 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' L' ' 16' ' ' GLN . . . -98.55 115.51 65.75 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 126.999 2.12 . . . . 0.0 112.383 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -73.04 150.06 47.74 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 119.405 0.823 . . . . 0.0 112.492 178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' L' ' 14' ' ' LEU . 0.7 OUTLIER -130.1 156.58 44.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 168.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . 0.698 ' CD1' ' HD2' ' L' ' 29' ' ' PRO . 32.7 t80 -100.6 143.64 26.94 Favored Pre-proline 0 C--N 1.317 -0.844 0 C-N-CA 115.845 -2.342 . . . . 0.0 110.524 -167.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . 0.698 ' HD2' ' CD1' ' L' ' 28' ' ' PHE . 49.2 Cg_endo -79.19 175.1 11.21 Favored 'Trans proline' 0 C--N 1.332 -0.318 0 CA-C-O 121.834 0.681 . . . . 0.0 112.415 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.59 63.87 1.93 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.347 1.459 . . . . 0.0 111.54 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -75.69 146.67 40.01 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 122.579 1.181 . . . . 0.0 111.058 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -105.92 -64.34 1.16 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -173.42 159.65 3.74 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.817 1.294 . . . . 0.0 111.08 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.21 115.79 10.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.959 -164.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.12 116.5 4.12 Favored Glycine 0 N--CA 1.441 -1.016 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.371 170.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' G' ' 118' ' ' TYR . 25.3 m -106.33 121.69 44.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -121.75 132.5 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -173.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . 0.637 ' HB2' ' OH ' ' G' ' 83' ' ' TYR . 51.8 p -136.71 107.45 6.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -166.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.16 124.54 7.99 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.288 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' L' ' 59' ' ' VAL . 5.4 tt0 -104.61 98.09 7.9 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 151.31 41.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.682 0.753 . . . . 0.0 110.179 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -130.22 173.99 10.25 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -167.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . 0.829 HD23 ' HA3' ' L' ' 55' ' ' GLY . 0.1 OUTLIER -69.52 136.47 51.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.535 -179.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.49 135.99 34.99 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.25 171.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t0 72.8 110.11 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 155.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.558 ' OE1' ' HA ' ' L' ' 48' ' ' THR . 2.9 tt0 -67.54 -35.11 78.43 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 176.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' HG2' ' L' ' 49' ' ' LYS . 0.0 OUTLIER 71.21 20.38 5.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.642 1.577 . . . . 0.0 111.615 -172.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . 0.558 ' HA ' ' OE1' ' L' ' 46' ' ' GLU . 5.8 m 42.31 55.39 4.02 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 111.583 -164.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' L' ' 47' ' ' GLN . 8.8 mmtp -107.76 -133.51 0.33 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.428 -177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.54 16.03 27.01 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.8 81.31 1.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' L' ' 43' ' ' LEU . 4.1 mmp_? -109.7 25.32 11.93 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.546 HG13 HG22 ' G' ' 135' ' ' ILE . 0.7 OUTLIER -123.57 1.69 5.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.831 178.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.529 ' HG ' HG12 ' G' ' 135' ' ' ILE . 0.0 OUTLIER -104.55 36.27 2.46 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . 0.829 ' HA3' HD23 ' L' ' 43' ' ' LEU . . . -104.25 158.19 16.78 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.656 0.586 . . . . 0.0 113.983 -170.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.48 138.72 15.73 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 -175.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -140.09 -179.1 17.55 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.72 166.99 20.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.586 0.708 . . . . 0.0 110.492 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' L' ' 40' ' ' GLU . 16.2 t -117.51 129.77 73.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.35 129.37 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.56 111.19 12.02 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 82.9 p -139.38 148.32 42.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.903 0.881 . . . . 0.0 110.032 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 152.07 22.67 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.125 176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.63 143.88 51.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.458 HG12 ' HD1' ' L' ' 67' ' ' TYR . 59.1 t -129.89 122.75 55.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . . . . . . . . . 30.0 p -108.18 146.87 32.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.458 ' HD1' HG12 ' L' ' 65' ' ' VAL . 24.1 p90 -168.79 167.91 10.83 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.477 ' CE2' ' HG2' ' L' ' 127' ' ' GLU . 48.0 m-85 -98.8 118.11 34.8 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' L' ' 128' ' ' ILE . . . -71.57 135.93 24.08 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . 0.678 ' H ' ' HZ ' ' L' ' 28' ' ' PHE . 9.4 mttm -92.86 153.88 18.57 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.442 HH21 ' HD2' ' L' ' 71' ' ' ARG . 0.0 OUTLIER -54.1 -35.67 62.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -172.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.7 95.66 0.13 Allowed Glycine 0 N--CA 1.453 -0.219 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -141.36 158.92 43.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.15 1.38 . . . . 0.0 111.069 169.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.67 -37.54 56.05 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 117.483 2.401 . . . . 0.0 117.483 -156.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . 0.496 ' O ' HG12 ' L' ' 79' ' ' ILE . . . -64.2 -39.15 96.84 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.88 168.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . 0.663 ' OE1' ' HG3' ' L' ' 80' ' ' GLU . 0.8 OUTLIER -61.77 -51.92 66.35 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 122.149 -0.619 . . . . 0.0 111.849 171.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' L' ' 80' ' ' GLU . 6.2 mtmp? -62.53 -27.09 68.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.766 171.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.64 97.06 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.857 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.502 ' N ' HD13 ' L' ' 79' ' ' ILE . 2.3 mm -64.91 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.109 0.48 . . . . 0.0 110.48 172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' L' ' 84' ' ' GLN . 10.7 mm-40 -63.62 -44.34 94.2 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.712 -0.617 . . . . 0.0 112.481 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -68.41 -37.56 80.44 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.964 -0.695 . . . . 0.0 111.611 169.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.87 ' HA ' ' HG3' ' L' ' 87' ' ' LYS . . . -52.46 -52.75 52.63 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.6 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.527 ' OH ' ' HB2' ' K' ' 38' ' ' SER . 25.5 t80 -83.91 -51.34 7.25 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.927 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 3.5 mt-30 -74.4 -43.14 57.64 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -75.75 -28.58 58.54 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.01 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.13 78.44 1.11 Allowed Glycine 0 N--CA 1.448 -0.502 0 O-C-N 122.343 -0.223 . . . . 0.0 112.879 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.87 ' HG3' ' HA ' ' L' ' 82' ' ' ALA . 0.1 OUTLIER -137.28 152.05 49.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.747 ' HG2' ' HA ' ' F' ' 169' ' ' GLU . 0.0 OUTLIER -82.75 142.29 31.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 168.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.537 ' CD1' ' HD2' ' L' ' 87' ' ' LYS . 1.3 mm -117.34 152.09 19.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.366 0.603 . . . . 0.0 109.804 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.928 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 11.8 mtmt -86.03 136.2 33.34 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.575 ' HE1' HD21 ' L' ' 132' ' ' LEU . 1.6 t80 -121.4 123.32 41.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.54 1.136 . . . . 0.0 110.012 -166.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.717 ' HH2' ' C ' ' F' ' 161' ' ' GLN . 4.3 m95 -124.86 134.09 52.84 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.21 1.004 . . . . 0.0 108.361 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.628 ' HD3' ' OE1' ' L' ' 107' ' ' GLN . 12.6 ptm180 -130.56 119.07 21.98 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' L' ' 106' ' ' ALA . 1.6 m -134.77 159.32 41.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 122.26 1.029 . . . . 0.0 109.36 -173.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . 0.524 ' HB2' ' OD1' ' L' ' 105' ' ' ASP . 0.1 OUTLIER -93.65 147.09 23.33 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.654 179.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' L' ' 10' ' ' ASP . 48.4 p -79.18 -26.0 42.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.666 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.63 143.47 14.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-O 121.698 0.761 . . . . 0.0 109.9 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.65 131.7 43.55 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.0 -174.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.545 ' OD1' ' HB3' ' L' ' 105' ' ' ASP . 1.4 t30 -78.21 136.26 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.798 0.809 . . . . 0.0 109.981 171.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.72 -22.25 50.65 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -121.92 39.19 3.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.766 0.712 . . . . 0.0 110.857 169.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -173.23 -178.54 1.76 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 167.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' L' ' 143' ' ' ILE . 0.0 OUTLIER -62.7 -69.37 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.923 -0.485 . . . . 0.0 110.544 172.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.495 ' OH ' HG22 ' L' ' 151' ' ' VAL . 7.4 m-85 -136.71 -176.87 4.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.545 ' HB3' ' OD1' ' L' ' 99' ' ' ASN . 3.2 p30 -122.02 140.46 52.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.611 0.719 . . . . 0.0 109.438 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.817 ' HB2' ' HB2' ' L' ' 142' ' ' GLU . . . -140.0 156.19 46.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.007 -163.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.643 HE21 ' HB3' ' L' ' 137' ' ' GLU . 29.1 tt0 -127.95 139.61 52.48 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 157.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' L' ' 91' ' ' PHE . 14.2 t80 -131.23 150.58 52.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.371 0.668 . . . . 0.0 110.414 -163.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.35 165.33 37.76 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.966 170.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.649 ' CD1' ' HA ' ' F' ' 171' ' ' PRO . 3.3 m-85 -89.13 129.61 35.7 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . . . . . . . . . . . -127.05 160.43 31.16 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.917 0.865 . . . . 0.0 111.175 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' L' ' 88' ' ' GLN . 1.2 t80 -132.84 164.59 26.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.496 -1.229 . . . . 0.0 107.988 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' K' ' 40' ' ' GLU . 0.3 OUTLIER -96.64 95.1 4.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.493 ' CD ' ' HG3' ' L' ' 133' ' ' GLN . 3.6 tt0 -76.28 -43.12 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . . . . . . . . . 9.5 t -157.83 163.18 38.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.907 0.776 . . . . 0.0 109.072 174.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.866 ' HG2' HG22 ' L' ' 130' ' ' ILE . 0.0 OUTLIER -144.3 135.42 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 176.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -131.76 123.05 26.86 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.15 128.81 56.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.076 0.465 . . . . 0.0 111.168 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.16 120.94 39.23 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.647 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -108.22 127.44 53.83 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -126.55 158.45 20.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . 0.426 HG11 ' O ' ' K' ' 31' ' ' TYR . 25.4 m -69.9 -27.79 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 122.48 -0.423 . . . . 0.0 111.091 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.13 149.37 21.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.32 -143.61 30.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 166.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' K' ' 6' ' ' ILE . . . -141.3 155.82 45.93 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.565 0.698 . . . . 0.0 110.747 -177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' K' ' 6' ' ' ILE . 33.7 m -53.23 147.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.054 -171.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.477 ' HG2' ' CE2' ' L' ' 68' ' ' TYR . 3.4 tm-20 -128.68 131.22 47.98 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.105 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . 0.607 ' CD1' ' HA3' ' L' ' 69' ' ' GLY . 25.5 mt -112.54 126.5 69.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . . . . . . . . . 11.8 t -113.28 123.62 50.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . 0.866 HG22 ' HG2' ' L' ' 116' ' ' ARG . 5.8 pt -122.45 126.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m -108.19 146.88 32.13 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.379 0.671 . . . . 0.0 109.764 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.575 HD21 ' HE1' ' L' ' 91' ' ' PHE . 0.4 OUTLIER -145.09 138.79 26.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 -172.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . 0.493 ' HG3' ' CD ' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -93.31 158.1 15.91 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 167.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' L' ' 137' ' ' GLU . 80.0 t -141.64 159.8 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.602 HG22 HG13 ' K' ' 53' ' ' ILE . 6.6 pt -109.67 29.88 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.37 -173.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.86 92.23 1.45 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.697 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' L' ' 134' ' ' VAL . 10.1 mt-10 -81.17 139.05 35.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.061 0.934 . . . . 0.0 110.686 174.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.585 HD11 ' CA ' ' F' ' 157' ' ' GLY . 0.1 OUTLIER -120.28 148.63 43.47 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.676 ' HB2' ' OE1' ' G' ' 84' ' ' GLN . 1.7 mptt -94.53 141.27 28.78 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.601 ' HB3' ' OD2' ' F' ' 159' ' ' ASP . 0.3 OUTLIER -156.64 -160.6 1.0 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -109.15 147.16 16.8 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.161 -1.018 . . . . 0.0 111.416 169.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.817 ' HB2' ' HB2' ' L' ' 106' ' ' ALA . 3.7 tp10 -85.54 131.08 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.657 ' HA ' ' HD2' ' L' ' 103' ' ' LYS . 1.2 mp -96.44 -49.75 11.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.744 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.501 ' HB2' ' HG2' ' F' ' 162' ' ' GLN . 4.5 m-20 -77.06 107.61 9.54 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.969 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -60.36 -43.05 96.9 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 118.744 -0.646 . . . . 0.0 112.398 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . . . . . . . . . 4.8 mt 45.75 61.78 11.97 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 126.515 1.926 . . . . 0.0 109.379 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.581 ' HA ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -70.62 9.96 0.67 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 121.197 1.265 . . . . 0.0 115.304 -159.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -43.92 66.8 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.563 171.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.19 -58.88 2.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.473 HD12 ' H ' ' L' ' 150' ' ' ILE . 3.4 mp -61.8 -46.97 95.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 119.133 0.879 . . . . 0.0 111.315 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' L' ' 147' ' ' PRO . 78.0 t -74.4 -43.85 48.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -110.66 114.91 28.66 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.425 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.4 104.07 9.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 8.8 t -113.52 162.75 15.79 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -172.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -81.5 -5.12 57.64 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.31 3.79 61.34 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 119.393 0.997 . . . . 0.0 113.038 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.33 136.35 28.22 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.17 145.38 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.325 1.05 . . . . 0.0 108.652 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.88 -46.59 77.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -158.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -148.67 158.37 44.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.666 2.386 . . . . 0.0 109.145 167.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -141.5 81.77 1.79 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 154.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -108.46 -29.21 0.17 Allowed Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . 0.744 ' HD2' HE22 ' L' ' 165' ' ' GLN . 22.4 Cg_exo -75.13 10.54 1.73 Allowed 'Trans proline' 0 C--O 1.239 0.534 0 CA-C-N 122.054 1.769 . . . . 0.0 113.84 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.79 88.04 0.46 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 118.391 2.116 . . . . 0.0 118.391 -171.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.744 HE22 ' HD2' ' L' ' 163' ' ' PRO . 5.8 mp0 -106.7 59.0 0.64 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.944 1.372 . . . . 0.0 110.902 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' L' ' 175' ' ' PRO . 26.0 m 31.13 73.3 0.06 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.957 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.88 ' HA ' ' HB ' ' L' ' 173' ' ' THR . 0.6 OUTLIER -92.76 172.82 8.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.358 -167.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -148.93 -158.86 8.25 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.488 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -24.06 67.74 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.811 0.305 . . . . 0.0 111.452 -177.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.51 73.97 Favored Pre-proline 0 C--O 1.236 0.366 0 C-N-CA 123.521 0.728 . . . . 0.0 109.27 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.29 -12.33 12.91 Favored 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 121.276 1.317 . . . . 0.0 112.763 -156.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . . . . . . . . . . . -145.25 96.07 0.18 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.224 1.65 . . . . 0.0 117.224 165.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . 0.88 ' HB ' ' HA ' ' L' ' 167' ' ' THR . 0.2 OUTLIER -105.87 148.05 28.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.98 0.89 . . . . 0.0 109.858 170.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' L' ' 165' ' ' GLN . 32.5 m -122.52 168.66 11.26 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.413 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' L' ' 166' ' ' THR . 31.5 Cg_exo -72.95 123.82 9.18 Favored 'Trans proline' 0 C--N 1.35 0.606 0 CA-C-N 119.499 0.857 . . . . 0.0 111.727 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 125.486 1.514 . . . . 0.0 112.28 -171.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 119.883 -0.132 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.812 HG21 HG23 ' B' ' 126' ' ' VAL . 26.2 mt -127.89 161.72 35.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 1.056 ' HG2' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -121.9 154.81 36.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.874 0.845 . . . . 0.0 110.774 -177.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' B' ' 123' ' ' GLU . . . -62.77 -17.94 58.69 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.478 175.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.31 25.6 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 117.768 0.784 . . . . 0.0 112.429 172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.056 ' HB2' ' HG2' ' A' ' 7' ' ' MET . 28.8 t0 -66.9 -50.84 61.16 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -171.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG22 ' OD2' ' A' ' 95' ' ' ASP . 78.7 t -84.0 121.77 36.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HG2' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -125.12 147.57 48.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.749 . . . . 0.0 110.539 176.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HD1' ' CE1' ' A' ' 91' ' ' PHE . 40.1 m-85 -111.2 105.48 14.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.706 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' TRP . 1.8 mp -90.26 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' A' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.48 0.657 . . . . 0.0 109.964 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 90' ' ' LYS . 14.6 tt0 -114.22 137.71 51.42 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 170.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.8 p -82.69 148.09 28.11 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.825 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 1.1 pp -62.47 -39.81 85.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.007 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.4 63.52 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.84 84.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.404 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.19 1.396 . . . . 0.0 111.843 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' A' ' 22' ' ' THR . . . -125.14 23.69 6.09 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 123.401 0.438 . . . . 0.0 113.755 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.81 -30.4 65.47 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.965 0.383 . . . . 0.0 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 146' ' ' LEU . . . 46.33 76.4 0.55 Allowed Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.957 2.103 . . . . 0.0 112.404 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.75 147.48 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.415 0.827 . . . . 0.0 112.424 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD12 ' HG ' ' A' ' 14' ' ' LEU . 8.8 tt -130.45 150.32 51.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 168.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.56 133.43 20.62 Favored Pre-proline 0 C--N 1.317 -0.813 0 C-N-CA 115.805 -2.358 . . . . 0.0 110.497 -167.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.76 -175.63 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.3 0 CA-C-O 121.825 0.677 . . . . 0.0 112.465 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.752 ' HA ' ' HB3' ' L' ' 47' ' ' GLN . . . 59.31 37.27 23.56 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.378 1.471 . . . . 0.0 111.558 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.05 135.35 46.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 122.473 1.13 . . . . 0.0 111.078 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 7.2 mm-40 -103.97 -91.6 0.36 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.7 170.17 16.23 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.839 1.304 . . . . 0.0 111.067 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' OD1' HG22 ' A' ' 65' ' ' VAL . 3.0 t0 -158.94 102.36 1.64 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.007 -1.451 . . . . 0.0 107.991 -164.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.3 170.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.502 ' HB3' ' CZ ' ' B' ' 118' ' ' TYR . 48.1 t -133.33 119.39 19.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 173.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' B' ' 117' ' ' GLU . 19.0 m -130.91 144.95 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.5 128.11 38.69 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -166.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -119.46 114.9 2.88 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.24 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.31 125.89 40.25 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.825 HH22 ' HB2' ' A' ' 60' ' ' ALA . 2.1 mtm-85 -68.75 132.29 46.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.717 0.77 . . . . 0.0 110.136 -174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HB3' ' HG2' ' B' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.36 32.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.548 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.601 ' CE2' ' HA3' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.77 3.12 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.228 171.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.527 ' O ' ' HA2' ' A' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 155.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' B' ' 58' ' ' SER . 2.7 mp0 -71.25 -48.08 53.24 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' NE2' ' HB2' ' A' ' 52' ' ' ARG . 1.4 mt-30 57.83 38.58 27.24 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.574 1.55 . . . . 0.0 111.658 -172.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.25 3.29 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 111.542 -164.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.88 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.446 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.89 16.79 1.08 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.601 ' HA3' ' CE2' ' A' ' 44' ' ' PHE . . . 87.03 167.51 43.83 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -112.19 122.32 47.4 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.816 HD13 ' HA ' ' B' ' 134' ' ' VAL . 1.5 pp -127.16 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.923 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.872 HD23 ' HG3' ' B' ' 88' ' ' GLN . 1.3 mp -61.74 -16.91 53.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.62 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 121.662 0.59 . . . . 0.0 113.944 -170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 54' ' ' LEU . 68.7 Cg_endo -76.83 178.83 7.12 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 N-CA-C 113.869 0.681 . . . . 0.0 113.869 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.96 -163.77 24.56 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . 1.7 t -87.4 153.88 21.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.534 0.683 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 14.4 p -103.85 130.96 53.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.825 ' HB2' HH22 ' A' ' 41' ' ' ARG . . . -107.58 111.04 23.09 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' OD1' ' HA2' ' A' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.46 18.56 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.77 27.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.932 0.893 . . . . 0.0 110.019 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.18 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.72 25.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 129' ' ' SER . 40.7 t -116.25 123.66 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' A' ' 129' ' ' SER . 62.9 p -114.2 140.42 48.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 174.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.717 ' HE2' HD12 ' A' ' 128' ' ' ILE . 5.6 p90 -161.26 162.48 31.1 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HB3' ' HB3' ' A' ' 125' ' ' ALA . 22.0 m-30 -83.46 136.77 34.17 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' F' ' 5' ' ' PRO . . . -74.94 142.28 29.42 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 114.984 0.753 . . . . 0.0 114.984 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' F' ' 5' ' ' PRO . 16.3 tttp -111.57 154.28 25.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.97 -54.28 41.11 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -172.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.95 -117.4 3.6 Favored Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.122 1.369 . . . . 0.0 111.012 169.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.67 27.09 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 117.46 2.392 . . . . 0.0 117.46 -156.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -62.73 -49.9 68.91 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.23 -0.986 . . . . 0.0 112.888 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.67 84.86 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 122.144 -0.621 . . . . 0.0 111.881 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -37.31 87.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.766 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.69 -45.75 92.67 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.952 168.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 113' ' ' ILE . 5.7 mm -54.05 -42.37 54.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.044 0.45 . . . . 0.0 110.464 172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' GLN . 0.7 OUTLIER -69.54 -48.11 61.51 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.719 -0.613 . . . . 0.0 112.447 -178.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 87' ' ' LYS . 29.2 t70 -60.95 -34.87 75.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 119.999 -0.68 . . . . 0.0 111.572 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.737 ' HB2' HD11 ' A' ' 89' ' ' ILE . . . -58.58 -53.77 54.56 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.574 174.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.545 ' HD1' HG22 ' A' ' 113' ' ' ILE . 64.6 t80 -74.69 -48.33 26.66 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.915 -174.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -63.48 -51.6 64.89 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -167.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.86 18.42 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 0.0 110.997 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.58 102.52 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.28 -0.263 . . . . 0.0 112.854 178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 82' ' ' ALA . 9.5 mptt -139.3 145.49 39.17 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.671 ' HG2' ' HD1' ' A' ' 112' ' ' TYR . 1.6 tm0? -67.33 142.91 56.65 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' A' ' 82' ' ' ALA . 5.5 mm -118.81 129.1 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.352 0.596 . . . . 0.0 109.902 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.825 ' HE2' ' HA ' ' A' ' 18' ' ' ILE . 6.5 mtmt -84.3 112.93 20.75 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' A' ' 15' ' ' PHE . 24.6 t80 -108.63 123.43 48.94 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.553 1.141 . . . . 0.0 109.977 -165.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.762 ' HB2' ' HB2' ' A' ' 14' ' ' LEU . 6.6 m95 -116.34 121.99 43.56 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.249 1.02 . . . . 0.0 108.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.515 ' HD2' ' HB2' ' A' ' 107' ' ' GLN . 2.4 tmt_? -108.92 102.6 11.59 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.752 HG12 ' HB2' ' A' ' 106' ' ' ALA . 20.7 m -125.33 153.11 32.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 122.261 1.029 . . . . 0.0 109.424 -173.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD2' HG22 ' A' ' 11' ' ' VAL . 5.6 m-20 -96.11 157.0 16.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.618 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ASP . 25.8 m -87.13 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.05 137.79 27.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 121.69 0.757 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.38 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.015 -174.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 102' ' ' ASP . 20.6 t30 -64.69 163.57 13.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.83 0.824 . . . . 0.0 109.919 171.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.81 57.71 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.57 -36.78 0.95 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.811 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.564 ' HB2' HD22 ' A' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.02 13.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 167.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.95 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.884 -0.51 . . . . 0.0 110.581 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 142' ' ' GLU . 93.9 m-85 -147.82 172.47 14.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.81 ' HA ' ' HA2' ' A' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.68 33.41 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.65 0.738 . . . . 0.0 109.433 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.752 ' HB2' HG12 ' A' ' 94' ' ' VAL . . . -147.43 155.42 41.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.05 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.515 ' HB2' ' HD2' ' A' ' 93' ' ' ARG . 53.3 mt-30 -123.92 135.31 53.61 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 157.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.821 ' HD2' HD11 ' A' ' 138' ' ' LEU . 66.3 t80 -128.48 154.61 45.92 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.406 0.682 . . . . 0.0 110.404 -163.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.4 156.61 25.6 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.954 170.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' A' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.6 23.54 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' A' ' 132' ' ' LEU . . . -126.21 144.75 50.66 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.913 0.863 . . . . 0.0 111.193 -169.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.671 ' HD1' ' HG2' ' A' ' 88' ' ' GLN . 3.1 t80 -122.27 117.39 26.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.506 -1.225 . . . . 0.0 107.969 -174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.545 HG22 ' HD1' ' A' ' 83' ' ' TYR . 55.1 mt -68.52 101.83 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' F' ' 42' ' ' GLU . 4.4 mt-10 -94.92 -13.52 25.33 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 131' ' ' SER . 1.9 m -138.17 137.42 37.61 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.932 0.787 . . . . 0.0 109.093 174.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -135.68 102.36 5.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 176.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -119.32 118.89 32.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 12.4 p90 -122.63 137.96 54.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.058 0.456 . . . . 0.0 111.169 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.09 139.63 45.02 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.67 177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.31 31.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 167.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.65 -45.32 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 122.518 -0.401 . . . . 0.0 111.094 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.437 ' HA ' ' HA3' ' F' ' 8' ' ' GLY . 2.7 tp10 -125.99 142.34 51.56 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.45 157.46 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 68' ' ' TYR . . . -67.29 156.66 35.83 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.605 0.717 . . . . 0.0 110.716 -177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.831 HG23 HG21 ' F' ' 6' ' ' ILE . 86.5 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.006 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.67 10.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.131 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.717 HD12 ' HE2' ' A' ' 67' ' ' TYR . 3.1 mt -108.39 113.19 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' A' ' 66' ' ' THR . 4.7 t -119.07 123.62 44.91 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 168.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.84 65.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.4 OUTLIER -110.76 141.32 44.23 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.706 -178.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' A' ' 111' ' ' ALA . 2.0 pp -148.03 150.72 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.088 -172.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.14 146.03 39.92 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.692 ' HA ' HD13 ' F' ' 53' ' ' ILE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.851 HG23 HG12 ' F' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.56 48.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.384 0.612 . . . . 0.0 110.342 -173.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 135' ' ' ILE . . . -155.51 148.64 19.14 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.712 177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.87 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.089 0.947 . . . . 0.0 110.663 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.821 HD11 ' HD2' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.61 44.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.48 ' HD3' ' HG2' ' B' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.96 34.34 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.32 1.93 Allowed 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.81 ' HA2' ' HA ' ' A' ' 105' ' ' ASP . . . -121.27 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.406 169.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . 16.0 tp10 -101.32 156.45 17.44 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.856 ' H ' HD12 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.38 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.736 -176.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.982 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.667 ' O ' HD12 ' A' ' 150' ' ' ILE . 53.3 p -95.12 22.64 6.45 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.387 175.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 52.18 56.8 15.74 Favored Pre-proline 0 C--N 1.345 0.403 0 C-N-CA 126.454 1.902 . . . . 0.0 109.452 -173.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.64 33.75 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.226 1.284 . . . . 0.0 115.347 -159.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.97 44.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.577 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.12 8.35 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 145' ' ' THR . 5.2 mt -78.56 -50.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 119.172 0.897 . . . . 0.0 111.305 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 147' ' ' PRO . 21.7 t -65.41 -40.69 89.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.59 115.58 30.77 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.44 -176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.6 123.04 69.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 171.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.553 ' HA ' HD21 ' L' ' 50' ' ' ASN . 1.0 OUTLIER -141.73 137.76 31.88 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -172.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HE3' HG12 ' G' ' 135' ' ' ILE . 0.1 OUTLIER -57.36 -41.25 79.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 175.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 158' ' ' TYR . . . 137.06 141.21 4.21 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 119.393 0.997 . . . . 0.0 113.062 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.26 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.561 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -108.81 89.32 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.353 1.061 . . . . 0.0 108.634 177.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.65 67.2 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -158.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' CB ' HD11 ' G' ' 143' ' ' ILE . 0.3 OUTLIER -132.11 121.73 24.25 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 127.696 2.399 . . . . 0.0 109.142 167.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.516 ' HB3' ' CA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.74 1.89 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 154.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -32.91 4.27 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -166.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.488 ' O ' ' HA3' ' G' ' 23' ' ' GLY . 22.3 Cg_exo -82.78 -0.81 10.26 Favored 'Trans proline' 0 C--O 1.238 0.518 0 CA-C-N 122.101 1.786 . . . . 0.0 113.888 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.17 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 118.357 2.103 . . . . 0.0 118.357 -171.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.516 ' CA ' ' HB3' ' A' ' 161' ' ' GLN . 0.8 OUTLIER -71.73 -43.71 65.37 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.913 1.356 . . . . 0.0 110.883 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.778 HG22 ' HB1' ' G' ' 21' ' ' ALA . 6.9 p 52.56 49.16 21.01 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.785 1.634 . . . . 0.0 111.919 176.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.557 HG21 ' H ' ' A' ' 172' ' ' GLY . 26.8 m -126.28 157.38 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.329 -167.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.42 -152.16 20.24 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.523 172.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' G' ' 88' ' ' GLN . 0.9 OUTLIER -61.53 -43.34 99.04 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.847 0.323 . . . . 0.0 111.435 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.48 65.17 Favored Pre-proline 0 C--O 1.236 0.344 0 C-N-CA 123.493 0.717 . . . . 0.0 109.276 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.326 1.351 . . . . 0.0 112.769 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' H ' HG21 ' A' ' 167' ' ' THR . . . 88.41 8.24 71.34 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.18 37.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.962 0.881 . . . . 0.0 109.895 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 165' ' ' GLN . 24.4 t -106.63 117.45 56.88 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.41 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.74 163.24 36.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 119.516 0.863 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.28 0 C-N-CA 125.424 1.49 . . . . 0.0 112.293 -171.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.157 0 CA-C-O 119.892 -0.128 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.739 HG21 HG23 ' C' ' 126' ' ' VAL . 26.2 mt -127.91 161.73 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' MET . . . . . 1.073 ' HG2' ' HB2' ' B' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.81 36.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 110.731 -177.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' C' ' 123' ' ' GLU . . . -62.8 -17.85 58.64 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.338 -0.846 . . . . 0.0 114.474 175.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.53 -4.31 25.49 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 117.774 0.787 . . . . 0.0 112.386 172.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . 1.073 ' HB2' ' HG2' ' B' ' 7' ' ' MET . 28.8 t0 -66.87 -50.86 61.16 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -172.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' B' ' 95' ' ' ASP . 79.1 t -83.96 121.79 36.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.564 ' HG2' HD11 ' B' ' 27' ' ' LEU . 0.0 OUTLIER -125.18 147.54 49.0 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.687 0.756 . . . . 0.0 110.5 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' TYR . . . . . 0.457 ' HD1' ' CE1' ' B' ' 91' ' ' PHE . 39.8 m-85 -111.18 105.45 14.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.734 -164.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' B' ' 92' ' ' TRP . 1.8 mp -90.2 136.55 32.98 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' B' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.47 0.653 . . . . 0.0 109.99 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' B' ' 90' ' ' LYS . 14.6 tt0 -114.16 137.67 51.45 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.75 148.14 28.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.546 0.689 . . . . 0.0 111.012 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.841 ' HA ' ' HE2' ' B' ' 90' ' ' LYS . 1.1 pp -62.53 -39.82 85.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.936 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -19.47 63.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.88 84.35 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.445 -175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.2 57.64 5.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.218 1.407 . . . . 0.0 111.796 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.442 ' H ' HG22 ' B' ' 22' ' ' THR . . . -125.19 23.72 6.07 Favored Glycine 0 N--CA 1.451 -0.334 0 O-C-N 123.345 0.403 . . . . 0.0 113.741 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.82 -30.39 65.44 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.983 0.392 . . . . 0.0 111.793 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' B' ' 146' ' ' LEU . . . 46.36 76.41 0.55 Allowed Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.944 2.097 . . . . 0.0 112.43 -174.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.78 147.48 69.19 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.438 0.835 . . . . 0.0 112.449 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' B' ' 14' ' ' LEU . 8.8 tt -130.42 150.34 51.68 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 168.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.54 133.41 20.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 115.817 -2.353 . . . . 0.0 110.558 -167.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.8 -175.57 2.39 Favored 'Trans proline' 0 C--N 1.332 -0.328 0 CA-C-O 121.901 0.709 . . . . 0.0 112.39 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . 0.707 ' HA ' ' HB3' ' G' ' 47' ' ' GLN . . . 59.21 37.33 23.88 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.395 1.478 . . . . 0.0 111.599 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.08 135.41 46.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.516 1.15 . . . . 0.0 111.049 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' B' ' 32' ' ' GLN . 7.3 mm-40 -104.07 -91.66 0.37 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.65 170.19 16.18 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.767 1.27 . . . . 0.0 111.118 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' B' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.067 -1.424 . . . . 0.0 107.989 -164.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.1 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.357 170.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.564 ' HB3' ' CZ ' ' C' ' 118' ' ' TYR . 48.1 t -133.36 119.34 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 173.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' C' ' 117' ' ' GLU . 18.8 m -130.84 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.46 128.11 38.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -166.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' B' ' 59' ' ' VAL . . . -119.47 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.265 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.27 125.87 40.2 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' B' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 -174.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HG2' ' C' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.39 32.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -167.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 121.6 42.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.506 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PHE . . . . . 0.593 ' CE2' ' HA3' ' B' ' 51' ' ' GLY . 0.3 OUTLIER -128.48 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.235 171.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.53 ' O ' ' HA2' ' B' ' 51' ' ' GLY . 3.2 t70 -111.78 170.22 8.29 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 155.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLU . . . . . 0.617 ' OE2' ' HB3' ' C' ' 58' ' ' SER . 2.7 mp0 -71.27 -48.16 52.56 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' B' ' 52' ' ' ARG . 1.4 mt-30 57.91 38.6 27.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.618 1.567 . . . . 0.0 111.633 -172.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.92 45.26 3.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 111.607 -164.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.73 1.69 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.86 16.72 1.09 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' B' ' 44' ' ' PHE . . . 87.1 167.56 43.85 Favored Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.54 ' HA ' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -112.22 122.36 47.52 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' C' ' 134' ' ' VAL . 1.5 pp -127.22 -39.14 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.839 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.886 HD23 ' HG3' ' C' ' 88' ' ' GLN . 1.4 mp -61.83 -16.91 53.96 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.95 1.13 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.643 0.579 . . . . 0.0 113.931 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' PRO . . . . . 0.532 ' HB3' ' OH ' ' C' ' 112' ' ' TYR . 68.5 Cg_endo -76.9 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 N-CA-C 113.879 0.684 . . . . 0.0 113.879 -175.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.76 24.59 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 41' ' ' ARG . 1.7 t -87.49 153.85 21.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.593 0.711 . . . . 0.0 110.515 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' B' ' 39' ' ' GLY . 14.3 p -103.76 130.9 53.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.037 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' B' ' 41' ' ' ARG . . . -107.56 111.06 23.12 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 174.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' B' ' 136' ' ' GLY . 15.3 m-20 -102.15 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -171.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.14 144.76 27.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.951 0.9 . . . . 0.0 110.062 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.93 145.99 17.26 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.175 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.72 25.71 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' B' ' 129' ' ' SER . 40.6 t -116.24 123.67 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' B' ' 129' ' ' SER . 63.6 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' TYR . . . . . 0.714 ' HE2' HD12 ' B' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' TYR . . . . . 0.656 ' HB3' ' HB3' ' B' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.75 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.35 29.5 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.24 25.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ARG . . . . . 0.441 HH21 ' HD3' ' B' ' 71' ' ' ARG . 10.5 ptp180 -53.88 -54.29 40.67 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -172.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.05 120.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.084 1.353 . . . . 0.0 110.984 169.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.4 -21.68 27.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 -156.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -49.93 68.55 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.202 -0.999 . . . . 0.0 112.868 168.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.63 84.72 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.841 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.19 86.76 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.787 171.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.74 -45.79 92.42 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.915 168.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 113' ' ' ILE . 5.7 mm -53.99 -42.41 54.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 110.507 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' B' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.775 -0.578 . . . . 0.0 112.431 -178.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.412 ' OD1' ' HE2' ' B' ' 87' ' ' LYS . 29.1 t70 -60.98 -34.86 75.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.578 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.748 ' HA ' ' HB2' ' B' ' 87' ' ' LYS . . . -58.63 -53.73 55.08 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.609 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' TYR . . . . . 0.553 ' HD1' HG22 ' B' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.42 26.34 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.897 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' B' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.66 64.95 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -167.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.63 -40.86 18.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.062 172.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.62 102.46 2.59 Favored Glycine 0 N--CA 1.449 -0.47 0 O-C-N 122.328 -0.233 . . . . 0.0 112.854 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.748 ' HB2' ' HA ' ' B' ' 82' ' ' ALA . 9.5 mptt -139.23 145.57 39.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLN . . . . . 0.872 ' HG3' HD23 ' A' ' 54' ' ' LEU . 1.6 tm0? -67.39 142.95 56.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 168.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' B' ' 82' ' ' ALA . 5.5 mm -118.85 129.12 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 121.357 0.599 . . . . 0.0 109.831 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' B' ' 18' ' ' ILE . 6.4 mtmt -84.34 112.91 20.75 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' B' ' 15' ' ' PHE . 24.9 t80 -108.66 123.43 48.95 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.521 1.129 . . . . 0.0 109.986 -165.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' B' ' 14' ' ' LEU . 6.6 m95 -116.34 122.01 43.64 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.188 0.995 . . . . 0.0 108.356 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.507 ' HD2' ' HB2' ' B' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.52 11.53 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 172.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.746 HG12 ' HB2' ' B' ' 106' ' ' ALA . 20.8 m -125.24 153.16 32.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 122.28 1.038 . . . . 0.0 109.375 -173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' B' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.92 16.13 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.633 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.406 ' N ' ' O ' ' B' ' 10' ' ' ASP . 25.8 m -87.05 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.68 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.97 137.78 27.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.668 0.747 . . . . 0.0 109.946 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' B' ' 103' ' ' LYS . 9.9 tttp -68.64 129.29 39.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.945 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASN . . . . . 0.577 HD22 ' HB2' ' B' ' 102' ' ' ASP . 20.5 t30 -64.73 163.63 13.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.798 0.809 . . . . 0.0 109.956 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -8.79 57.65 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.59 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 118.747 0.703 . . . . 0.0 110.858 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . 0.577 ' HB2' HD22 ' B' ' 99' ' ' ASN . 0.2 OUTLIER -79.59 173.04 12.99 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 167.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' B' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.05 67.93 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 171.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' B' ' 142' ' ' GLU . 93.9 m-85 -147.85 172.43 14.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' B' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.43 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.619 0.723 . . . . 0.0 109.44 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ALA . . . . . 0.746 ' HB2' HG12 ' B' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.052 -163.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLN . . . . . 0.507 ' HB2' ' HD2' ' B' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.27 53.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 157.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' B' ' 138' ' ' LEU . 66.4 t80 -128.4 154.69 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.373 0.669 . . . . 0.0 110.422 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.47 156.62 25.54 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.962 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' B' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.69 23.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.571 ' HB1' HD13 ' B' ' 132' ' ' LEU . . . -126.28 144.7 50.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.918 0.866 . . . . 0.0 111.177 -169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' TYR . . . . . 0.663 ' HD1' ' HG2' ' B' ' 88' ' ' GLN . 3.1 t80 -122.2 117.45 26.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.489 -1.232 . . . . 0.0 107.96 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.553 HG22 ' HD1' ' B' ' 83' ' ' TYR . 55.4 mt -68.61 101.86 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . 0.789 ' HG2' ' HB3' ' A' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.45 25.33 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 131' ' ' SER . 1.9 m -138.13 137.35 37.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.915 0.78 . . . . 0.0 109.154 174.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' B' ' 116' ' ' ARG . 0.2 OUTLIER -135.65 102.34 5.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 176.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.82 32.25 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' B' ' 127' ' ' GLU . 12.3 p90 -122.6 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.093 0.473 . . . . 0.0 111.175 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.1 139.62 45.05 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.701 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.58 116.33 31.74 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 167.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.2 26.86 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.68 -45.34 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.503 -0.41 . . . . 0.0 111.113 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.563 ' HA ' ' HA3' ' A' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 169.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 166.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' B' ' 68' ' ' TYR . . . -67.23 156.65 35.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.605 0.717 . . . . 0.0 110.734 -177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' VAL . . . . . 0.812 HG23 HG21 ' A' ' 6' ' ' ILE . 86.6 t -56.85 122.18 5.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.018 -171.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' B' ' 118' ' ' TYR . 0.5 OUTLIER -75.88 110.67 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.153 -176.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.714 HD12 ' HE2' ' B' ' 67' ' ' TYR . 3.1 mt -108.4 113.17 43.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' B' ' 66' ' ' THR . 4.7 t -119.06 123.66 45.03 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.3 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' B' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.32 44.11 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.74 -178.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LEU . . . . . 0.571 HD13 ' HB1' ' B' ' 111' ' ' ALA . 2.0 pp -148.01 150.69 34.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.107 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.06 39.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 167.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' VAL . . . . . 0.816 ' HA ' HD13 ' A' ' 53' ' ' ILE . 2.0 p -135.06 144.16 35.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 175.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.758 HG23 HG12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -56.07 -52.48 49.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.314 0.578 . . . . 0.0 110.341 -173.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.663 ' H ' HG12 ' B' ' 135' ' ' ILE . . . -155.55 148.64 19.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.688 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.82 119.89 37.24 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.053 0.93 . . . . 0.0 110.677 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' B' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.61 44.37 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' LYS . . . . . 0.507 ' HD3' ' HG2' ' C' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.92 34.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.59 -168.24 1.93 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' B' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.385 169.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' B' ' 106' ' ' ALA . 15.9 tp10 -101.31 156.46 17.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.87 HD12 ' H ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -110.21 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.749 -176.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.62 95.47 6.46 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.95 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' THR . . . . . 0.671 ' O ' HD12 ' B' ' 150' ' ' ILE . 52.8 p -95.14 22.7 6.4 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 118.718 -0.658 . . . . 0.0 112.361 175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' B' ' 25' ' ' ALA . 0.9 OUTLIER 52.22 56.75 15.67 Favored Pre-proline 0 C--O 1.238 0.485 0 C-N-CA 126.44 1.896 . . . . 0.0 109.419 -173.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' B' ' 151' ' ' VAL . 31.5 Cg_exo -69.54 -12.66 33.79 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.307 1.338 . . . . 0.0 115.311 -159.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.87 45.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.636 171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.3 -31.1 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.671 HD12 ' O ' ' B' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 119.17 0.896 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' B' ' 147' ' ' PRO . 21.7 t -65.44 -40.64 88.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.87 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.43 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.62 123.05 69.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . 0.516 ' HA ' HD21 ' G' ' 50' ' ' ASN . 1.0 OUTLIER -141.77 137.73 31.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -172.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.31 79.59 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . 0.559 ' HA3' ' CE2' ' B' ' 158' ' ' TYR . . . 137.04 141.32 4.23 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 119.434 1.015 . . . . 0.0 113.043 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.522 0.469 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.559 ' CE2' ' HA3' ' B' ' 156' ' ' GLY . 0.0 OUTLIER -108.88 89.3 2.95 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.304 1.042 . . . . 0.0 108.587 177.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.65 67.1 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' PHE . . . . . 0.567 ' CB ' HD11 ' H' ' 143' ' ' ILE . 0.3 OUTLIER -132.06 121.69 24.23 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.754 2.422 . . . . 0.0 109.191 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' B' ' 165' ' ' GLN . 0.0 OUTLIER -117.65 45.78 1.87 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 154.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -32.87 4.16 Favored Pre-proline 0 C--O 1.241 0.647 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -166.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.429 ' O ' ' HA3' ' H' ' 23' ' ' GLY . 22.1 Cg_exo -82.75 -0.88 10.3 Favored 'Trans proline' 0 C--O 1.239 0.57 0 CA-C-N 122.124 1.794 . . . . 0.0 113.876 171.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.18 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 -171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' B' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.66 65.36 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 118.938 1.369 . . . . 0.0 110.912 175.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . 0.735 HG22 ' HB1' ' H' ' 21' ' ' ALA . 6.7 p 52.52 49.19 20.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.815 1.646 . . . . 0.0 111.885 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' B' ' 172' ' ' GLY . 26.9 m -126.33 157.32 38.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.313 -167.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.33 -152.13 19.95 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.502 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.765 0.282 . . . . 0.0 111.44 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.5 65.1 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 123.494 0.718 . . . . 0.0 109.271 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.66 146.04 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.757 0 C-N-CA 121.301 1.334 . . . . 0.0 112.781 -156.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' B' ' 167' ' ' THR . . . 88.44 8.25 71.2 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 165.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.14 36.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 118.007 0.904 . . . . 0.0 109.911 170.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 165' ' ' GLN . 24.4 t -106.58 117.36 57.16 Favored Pre-proline 0 C--O 1.241 0.637 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.436 178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.68 163.23 35.97 Favored 'Trans proline' 0 C--N 1.348 0.549 0 CA-C-N 119.528 0.867 . . . . 0.0 111.689 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 125.437 1.495 . . . . 0.0 112.316 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.466 -0.118 0 CA-C-O 119.902 -0.124 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.715 HG21 HG23 ' D' ' 126' ' ' VAL . 25.9 mt -127.88 161.77 35.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' MET . . . . . 1.07 ' HG2' ' HB2' ' C' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.76 36.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.931 0.872 . . . . 0.0 110.764 -177.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' D' ' 123' ' ' GLU . . . -62.8 -17.8 58.57 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.518 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.55 -4.32 25.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.772 0.786 . . . . 0.0 112.357 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ASP . . . . . 1.07 ' HB2' ' HG2' ' C' ' 7' ' ' MET . 28.8 t0 -66.91 -50.83 61.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' C' ' 95' ' ' ASP . 78.7 t -83.99 121.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' LYS . . . . . 0.574 ' HG2' HD11 ' C' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.616 0.722 . . . . 0.0 110.538 176.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' TYR . . . . . 0.465 ' HD1' ' CE1' ' C' ' 91' ' ' PHE . 40.1 m-85 -111.12 105.51 14.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.749 -164.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' LEU . . . . . 0.754 ' HB2' ' HB2' ' C' ' 92' ' ' TRP . 1.8 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' PHE . . . . . 0.563 ' CE1' ' HD1' ' C' ' 91' ' ' PHE . 23.0 m-85 -125.88 115.35 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 0.0 109.925 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' C' ' 90' ' ' LYS . 14.6 tt0 -114.26 137.76 51.37 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 170.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.8 148.16 27.95 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.568 0.699 . . . . 0.0 111.021 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ILE . . . . . 0.857 ' HA ' ' HE2' ' C' ' 90' ' ' LYS . 1.1 pp -62.48 -39.79 85.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -19.47 63.54 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -171.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.86 84.08 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.414 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.19 57.69 5.89 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.244 1.417 . . . . 0.0 111.802 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . 0.439 HG22 ' H ' ' C' ' 23' ' ' GLY . 0.2 OUTLIER -137.89 -179.64 5.89 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . 0.439 ' H ' HG22 ' C' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 116.297 -0.411 . . . . 0.0 113.734 -178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.78 -30.38 65.49 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.971 0.386 . . . . 0.0 111.805 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' C' ' 146' ' ' LEU . . . 46.34 76.29 0.56 Allowed Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 126.92 2.088 . . . . 0.0 112.461 -174.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.66 147.43 69.82 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.451 0.84 . . . . 0.0 112.51 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . 0.614 HD12 ' HG ' ' C' ' 14' ' ' LEU . 8.8 tt -130.46 150.36 51.71 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 168.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.49 133.4 20.61 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 115.826 -2.35 . . . . 0.0 110.527 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.74 -175.61 2.4 Favored 'Trans proline' 0 C--N 1.332 -0.33 0 CA-C-N 119.035 0.691 . . . . 0.0 112.486 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' H' ' 47' ' ' GLN . . . 59.31 37.28 23.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.337 1.455 . . . . 0.0 111.534 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.37 46.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.537 1.161 . . . . 0.0 111.084 173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' C' ' 32' ' ' GLN . 7.2 mm-40 -103.93 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' THR . . . . . 0.444 HG22 HG23 ' D' ' 122' ' ' VAL . 16.7 p -134.75 170.13 16.31 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 122.808 1.29 . . . . 0.0 111.067 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' C' ' 65' ' ' VAL . 3.0 t0 -158.91 102.31 1.65 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.999 -164.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.09 136.23 13.36 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.379 170.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' SER . . . . . 0.533 ' HB3' ' CZ ' ' D' ' 118' ' ' TYR . 48.0 t -133.44 119.38 19.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' D' ' 117' ' ' GLU . 18.9 m -130.87 144.88 36.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.44 128.17 38.93 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' C' ' 59' ' ' VAL . . . -119.46 114.87 2.87 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.253 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.34 125.92 40.3 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' ARG . . . . . 0.798 HH22 ' HB2' ' C' ' 60' ' ' ALA . 2.1 mtm-85 -68.76 132.34 46.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.695 0.76 . . . . 0.0 110.126 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' GLU . . . . . 0.828 ' HB3' ' HG2' ' D' ' 114' ' ' GLU . 0.0 OUTLIER -138.76 133.38 32.1 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -167.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.507 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PHE . . . . . 0.589 ' CE2' ' HA3' ' C' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.255 171.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.541 ' O ' ' HA2' ' C' ' 51' ' ' GLY . 3.2 t70 -111.82 170.16 8.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 155.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' GLU . . . . . 0.593 ' OE2' ' HB3' ' D' ' 58' ' ' SER . 2.7 mp0 -71.15 -48.12 53.76 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' HB2' ' C' ' 52' ' ' ARG . 1.4 mt-30 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.561 1.544 . . . . 0.0 111.649 -172.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.92 45.33 3.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.541 1.537 . . . . 0.0 111.521 -164.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.89 -163.76 1.69 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.496 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.93 16.79 1.09 Allowed 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.589 ' HA3' ' CE2' ' C' ' 44' ' ' PHE . . . 87.1 167.5 43.8 Favored Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.503 ' HA ' ' HD3' ' C' ' 52' ' ' ARG . 0.0 OUTLIER -112.2 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.892 HD13 ' HA ' ' D' ' 134' ' ' VAL . 1.5 pp -127.21 -39.18 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.836 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' LEU . . . . . 0.847 HD23 ' HG3' ' D' ' 88' ' ' GLN . 1.3 mp -61.75 -16.93 53.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.59 105.93 1.12 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.625 0.569 . . . . 0.0 113.961 -170.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' C' ' 54' ' ' LEU . 68.7 Cg_endo -76.86 178.88 7.07 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.01 -163.78 24.61 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.617 ' HB3' ' OE2' ' B' ' 46' ' ' GLU . 1.7 t -87.47 153.88 21.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 39' ' ' GLY . 14.3 p -103.83 130.92 53.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ALA . . . . . 0.798 ' HB2' HH22 ' C' ' 41' ' ' ARG . . . -107.6 110.98 23.0 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' C' ' 136' ' ' GLY . 15.4 m-20 -102.1 107.45 18.56 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.8 27.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.01 17.27 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.16 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' C' ' 64' ' ' GLU . 2.5 pt-20 -138.49 128.73 25.78 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 129' ' ' SER . 40.9 t -116.34 123.64 71.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.777 HG22 ' HB2' ' C' ' 129' ' ' SER . 63.3 p -114.16 140.43 48.53 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' TYR . . . . . 0.718 ' HE2' HD12 ' C' ' 128' ' ' ILE . 5.6 p90 -161.29 162.44 30.99 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' C' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.79 34.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.04 142.29 29.32 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 114.907 0.723 . . . . 0.0 114.907 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.59 154.28 25.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.44 0.638 . . . . 0.0 109.293 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.32 40.35 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.02 -117.42 3.59 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.92 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.15 1.38 . . . . 0.0 111.07 169.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.65 27.18 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 117.488 2.403 . . . . 0.0 117.488 -156.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' C' ' 79' ' ' ILE . . . -62.75 -49.96 68.24 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.826 168.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -36.66 84.83 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 122.143 -0.622 . . . . 0.0 111.86 171.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -37.15 86.62 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.798 171.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.73 92.6 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.914 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' C' ' 113' ' ' ILE . 5.6 mm -54.0 -42.44 54.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.46 172.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' C' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.11 61.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.707 -0.621 . . . . 0.0 112.49 -178.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' C' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.88 75.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.575 169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' ALA . . . . . 0.749 ' HA ' ' HB2' ' C' ' 87' ' ' LYS . . . -58.64 -53.78 54.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.089 -1.045 . . . . 0.0 111.562 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' TYR . . . . . 0.552 ' CD1' HG22 ' C' ' 113' ' ' ILE . 64.5 t80 -74.6 -48.43 26.59 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.901 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' C' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.62 64.9 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -167.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.65 -40.81 18.49 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.065 172.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.465 0 O-C-N 122.29 -0.256 . . . . 0.0 112.856 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' C' ' 82' ' ' ALA . 9.5 mptt -139.26 145.55 39.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLN . . . . . 0.886 ' HG3' HD23 ' B' ' 54' ' ' LEU . 1.6 tm0? -67.38 142.97 56.57 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 168.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' C' ' 82' ' ' ALA . 5.5 mm -118.83 129.1 75.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.355 0.597 . . . . 0.0 109.831 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' C' ' 18' ' ' ILE . 6.4 mtmt -84.31 112.94 20.77 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' PHE . . . . . 0.563 ' HD1' ' CE1' ' C' ' 15' ' ' PHE . 24.7 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.539 1.136 . . . . 0.0 109.998 -165.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' TRP . . . . . 0.754 ' HB2' ' HB2' ' C' ' 14' ' ' LEU . 6.6 m95 -116.33 122.0 43.62 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.22 1.008 . . . . 0.0 108.364 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' ARG . . . . . 0.501 ' HD2' ' HB2' ' C' ' 107' ' ' GLN . 2.4 tmt_? -108.93 102.6 11.59 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.748 HG12 ' HB2' ' C' ' 106' ' ' ALA . 20.7 m -125.33 153.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 122.295 1.045 . . . . 0.0 109.395 -173.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' C' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.91 16.13 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.648 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.423 ' N ' ' O ' ' C' ' 10' ' ' ASP . 25.8 m -87.03 -3.1 59.06 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.695 -176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.99 137.82 27.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.668 0.746 . . . . 0.0 109.898 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' C' ' 103' ' ' LYS . 9.9 tttp -68.64 129.3 39.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.996 -174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' C' ' 102' ' ' ASP . 20.5 t30 -64.65 163.57 13.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.819 0.818 . . . . 0.0 109.939 171.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.79 57.68 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.69 0.96 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.762 0.71 . . . . 0.0 110.874 169.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ASP . . . . . 0.581 ' HB2' HD22 ' C' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.02 13.01 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 167.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' C' ' 98' ' ' LYS . 0.1 OUTLIER -71.29 -42.99 68.0 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.861 -0.524 . . . . 0.0 110.608 171.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' C' ' 142' ' ' GLU . 93.6 m-85 -147.81 172.48 14.06 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.825 ' HA ' ' HA2' ' C' ' 141' ' ' GLY . 1.7 p-10 -116.39 152.67 33.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.603 0.716 . . . . 0.0 109.447 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ALA . . . . . 0.748 ' HB2' HG12 ' C' ' 94' ' ' VAL . . . -147.42 155.42 41.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.056 -163.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' GLN . . . . . 0.501 ' HB2' ' HD2' ' C' ' 93' ' ' ARG . 53.2 mt-30 -123.93 135.32 53.6 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 157.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PHE . . . . . 0.834 ' HD2' HD11 ' C' ' 138' ' ' LEU . 66.5 t80 -128.47 154.64 45.87 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.406 -163.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.62 25.6 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.515 -1.326 . . . . 0.0 111.976 170.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' PHE . . . . . 0.673 ' O ' HG23 ' C' ' 134' ' ' VAL . 1.5 m-85 -82.83 118.66 23.57 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ALA . . . . . 0.581 ' HB1' HD13 ' C' ' 132' ' ' LEU . . . -126.3 144.74 50.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.906 0.86 . . . . 0.0 111.175 -169.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' TYR . . . . . 0.661 ' HD1' ' HG2' ' C' ' 88' ' ' GLN . 3.1 t80 -122.19 117.42 26.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.449 -1.251 . . . . 0.0 107.998 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' C' ' 83' ' ' TYR . 55.2 mt -68.55 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' B' ' 42' ' ' GLU . 4.4 mt-10 -95.01 -13.41 25.27 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 131' ' ' SER . 1.9 m -138.13 137.39 37.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.922 0.783 . . . . 0.0 109.143 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.71 102.32 5.05 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.856 -2.275 . . . . 0.0 104.856 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.92 32.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' C' ' 127' ' ' GLU . 12.5 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.032 0.444 . . . . 0.0 111.167 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.15 139.62 45.11 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.641 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.6 116.3 31.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 167.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.29 175.25 26.9 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-O 121.747 0.637 . . . . 0.0 111.54 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.72 -45.31 99.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 122.504 -0.409 . . . . 0.0 111.111 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' B' ' 8' ' ' GLY . 2.7 tp10 -125.97 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.37 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 166.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' C' ' 68' ' ' TYR . . . -67.31 156.71 35.74 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.58 0.705 . . . . 0.0 110.713 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' VAL . . . . . 0.739 HG23 HG21 ' B' ' 6' ' ' ILE . 86.4 t -56.88 122.2 5.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.032 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' C' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.67 10.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.139 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' ILE . . . . . 0.718 HD12 ' HE2' ' C' ' 67' ' ' TYR . 3.1 mt -108.39 113.2 43.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' SER . . . . . 0.777 ' HB2' HG22 ' C' ' 66' ' ' THR . 4.7 t -119.07 123.65 44.99 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.84 65.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' C' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.39 44.01 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.366 0.666 . . . . 0.0 109.725 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' LEU . . . . . 0.581 HD13 ' HB1' ' C' ' 111' ' ' ALA . 1.9 pp -148.12 150.6 34.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.101 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.07 39.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' B' ' 53' ' ' ILE . 2.0 p -135.0 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ILE . . . . . 0.728 HG23 HG12 ' B' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.53 48.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.35 0.595 . . . . 0.0 110.389 -173.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' GLY . . . . . 0.67 ' H ' HG12 ' C' ' 135' ' ' ILE . . . -155.55 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.662 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.88 119.85 37.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.101 0.953 . . . . 0.0 110.695 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' LEU . . . . . 0.834 HD11 ' HD2' ' C' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -174.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' LYS . . . . . 0.457 ' HD3' ' HG2' ' D' ' 80' ' ' GLU . 16.4 mtmt -86.34 130.94 34.34 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.66 -168.29 1.93 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.825 ' HA2' ' HA ' ' C' ' 105' ' ' ASP . . . -121.27 150.9 17.09 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.405 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' C' ' 106' ' ' ALA . 16.0 tp10 -101.29 156.5 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . 0.867 HD12 ' H ' ' C' ' 143' ' ' ILE . 0.1 OUTLIER -110.27 -76.36 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.761 -176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.52 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.969 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' C' ' 150' ' ' ILE . 52.9 p -95.2 22.65 6.51 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.377 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' C' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.78 15.65 Favored Pre-proline 0 C--N 1.346 0.444 0 C-N-CA 126.499 1.92 . . . . 0.0 109.409 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' C' ' 151' ' ' VAL . 31.5 Cg_exo -69.55 -12.64 33.73 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 121.26 1.306 . . . . 0.0 115.343 -159.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.63 -53.93 44.87 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.6 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.16 8.35 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' C' ' 145' ' ' THR . 5.2 mt -78.56 -50.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 119.13 0.877 . . . . 0.0 111.273 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' C' ' 147' ' ' PRO . 21.6 t -65.45 -40.62 88.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.417 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' VAL . . . . . . . . . . . . . 35.3 m -114.64 123.07 69.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.72 137.72 31.87 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -172.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.414 ' HE3' HG12 ' I' ' 135' ' ' ILE . 0.1 OUTLIER -57.28 -41.35 79.59 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 175.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' C' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 119.353 0.979 . . . . 0.0 113.059 -176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.23 0.48 Allowed Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' C' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.303 1.041 . . . . 0.0 108.641 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.27 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -158.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' PHE . . . . . 0.502 ' CB ' HD11 ' I' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.76 24.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.707 2.403 . . . . 0.0 109.139 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' GLN . . . . . 0.506 ' HB3' ' CA ' ' C' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.75 1.88 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 154.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.89 4.22 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -166.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.84 10.27 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.077 1.778 . . . . 0.0 113.861 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.74 73.22 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.397 2.119 . . . . 0.0 118.397 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' GLN . . . . . 0.506 ' CA ' ' HB3' ' C' ' 161' ' ' GLN . 0.8 OUTLIER -71.75 -43.76 65.24 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 118.934 1.367 . . . . 0.0 110.886 175.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' THR . . . . . 0.721 HG22 ' HB1' ' I' ' 21' ' ' ALA . 6.8 p 52.52 49.2 20.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.793 1.637 . . . . 0.0 111.907 176.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' THR . . . . . 0.553 HG21 ' H ' ' C' ' 172' ' ' GLY . 26.7 m -126.32 157.35 38.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.323 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.31 -152.14 19.9 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.512 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.59 -43.32 99.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.778 0.289 . . . . 0.0 111.442 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.06 126.46 65.27 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 123.497 0.719 . . . . 0.0 109.291 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.67 146.1 14.85 Favored 'Trans proline' 0 C--N 1.324 -0.73 0 C-N-CA 121.271 1.314 . . . . 0.0 112.754 -156.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.553 ' H ' HG21 ' C' ' 167' ' ' THR . . . 88.34 8.37 71.4 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.66 122.16 36.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 118.019 0.909 . . . . 0.0 109.911 170.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' C' ' 165' ' ' GLN . 24.4 t -106.61 117.4 57.02 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.424 178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.64 163.18 36.1 Favored 'Trans proline' 0 C--N 1.349 0.578 0 CA-C-N 119.517 0.863 . . . . 0.0 111.718 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 125.405 1.482 . . . . 0.0 112.332 -171.733 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 N--CA 1.466 -0.14 0 CA-C-O 119.854 -0.144 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.776 HG21 HG23 ' E' ' 126' ' ' VAL . 26.0 mt -127.96 161.73 35.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' D' ' 10' ' ' ASP . 0.0 OUTLIER -121.96 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.875 0.845 . . . . 0.0 110.775 -177.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' E' ' 123' ' ' GLU . . . -62.82 -17.83 58.66 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.498 175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.798 0.799 . . . . 0.0 112.396 172.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' D' ' 7' ' ' MET . 28.8 t0 -66.88 -50.76 61.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' VAL . . . . . 0.431 HG22 ' OD2' ' D' ' 95' ' ' ASP . 78.9 t -84.04 121.86 37.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' LYS . . . . . 0.571 ' HG2' HD11 ' D' ' 27' ' ' LEU . 0.0 OUTLIER -125.22 147.58 49.01 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.72 0.772 . . . . 0.0 110.47 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' TYR . . . . . 0.464 ' HD1' ' CE1' ' D' ' 91' ' ' PHE . 40.1 m-85 -111.23 105.49 14.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.761 -164.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' LEU . . . . . 0.75 ' HB2' ' HB2' ' D' ' 92' ' ' TRP . 1.9 mp -90.19 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' PHE . . . . . 0.554 ' CE1' ' HD1' ' D' ' 91' ' ' PHE . 22.9 m-85 -125.87 115.3 19.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.944 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' D' ' 90' ' ' LYS . 14.6 tt0 -114.25 137.7 51.44 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.76 148.15 28.0 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.56 0.695 . . . . 0.0 110.995 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' ILE . . . . . 0.853 ' HA ' ' HE2' ' D' ' 90' ' ' LYS . 1.1 pp -62.49 -39.82 85.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.018 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.45 63.54 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.88 84.25 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.424 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.23 57.59 6.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.184 1.394 . . . . 0.0 111.81 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' D' ' 23' ' ' GLY . 0.2 OUTLIER -137.83 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.444 ' H ' HG22 ' D' ' 22' ' ' THR . . . -125.19 23.7 6.07 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.772 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.86 -30.35 65.34 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.92 0.36 . . . . 0.0 111.75 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.477 ' HB3' HD21 ' D' ' 146' ' ' LEU . . . 46.31 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 126.983 2.113 . . . . 0.0 112.415 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.441 0.836 . . . . 0.0 112.494 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . 0.62 HD12 ' HG ' ' D' ' 14' ' ' LEU . 8.8 tt -130.39 150.35 51.65 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 168.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.62 133.44 20.63 Favored Pre-proline 0 C--N 1.317 -0.821 0 C-N-CA 115.794 -2.363 . . . . 0.0 110.499 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.74 -175.64 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 CA-C-O 121.862 0.693 . . . . 0.0 112.449 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' I' ' 47' ' ' GLN . . . 59.28 37.31 23.64 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.341 1.456 . . . . 0.0 111.53 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.15 135.39 46.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 122.556 1.169 . . . . 0.0 111.046 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' D' ' 32' ' ' GLN . 7.2 mm-40 -103.98 -91.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.73 170.13 16.29 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.788 1.28 . . . . 0.0 111.091 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' ASP . . . . . 0.437 ' OD1' HG22 ' D' ' 65' ' ' VAL . 3.0 t0 -158.92 102.26 1.65 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.994 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.12 136.15 13.31 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.337 170.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' SER . . . . . 0.556 ' HB3' ' CZ ' ' E' ' 118' ' ' TYR . 48.0 t -133.34 119.36 19.62 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 173.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' E' ' 117' ' ' GLU . 18.9 m -130.84 144.9 36.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.47 128.1 38.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' D' ' 59' ' ' VAL . . . -119.42 114.91 2.89 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.256 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.33 125.9 40.27 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' ARG . . . . . 0.793 HH22 ' HB2' ' D' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.3 46.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.723 0.773 . . . . 0.0 110.134 -174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HG2' ' E' ' 114' ' ' GLU . 0.0 OUTLIER -138.7 133.43 32.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -167.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.59 42.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.492 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' PHE . . . . . 0.597 ' CE2' ' HA3' ' D' ' 51' ' ' GLY . 0.3 OUTLIER -128.46 90.83 3.13 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.205 171.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.544 ' O ' ' HA2' ' D' ' 51' ' ' GLY . 3.2 t70 -111.82 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 155.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' GLU . . . . . 0.457 ' OE2' ' HB3' ' E' ' 58' ' ' SER . 2.7 mp0 -71.21 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' HB2' ' D' ' 52' ' ' ARG . 1.4 mt-30 57.84 38.59 27.21 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.622 1.569 . . . . 0.0 111.673 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 30.7 p 42.01 45.26 3.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.466 1.506 . . . . 0.0 111.577 -164.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.75 1.69 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.483 -177.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.92 16.83 1.07 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' D' ' 44' ' ' PHE . . . 87.06 167.56 43.88 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HD3' ' D' ' 52' ' ' ARG . 0.0 OUTLIER -112.23 122.35 47.47 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.83 HD13 ' HA ' ' E' ' 134' ' ' VAL . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.87 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' LEU . . . . . 0.814 HD23 ' HG3' ' E' ' 88' ' ' GLN . 1.3 mp -61.8 -16.87 53.44 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.61 105.92 1.12 Allowed Glycine 0 N--CA 1.443 -0.866 0 CA-C-O 121.648 0.582 . . . . 0.0 113.928 -170.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' D' ' 54' ' ' LEU . 68.7 Cg_endo -76.84 178.92 7.02 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 N-CA-C 113.867 0.68 . . . . 0.0 113.867 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.04 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' SER . . . . . 0.593 ' HB3' ' OE2' ' C' ' 46' ' ' GLU . 1.7 t -87.49 153.87 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.592 0.71 . . . . 0.0 110.485 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' D' ' 39' ' ' GLY . 14.4 p -103.8 130.94 53.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.001 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ALA . . . . . 0.793 ' HB2' HH22 ' D' ' 41' ' ' ARG . . . -107.6 111.02 23.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' D' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.48 18.59 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -171.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.78 27.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.931 0.892 . . . . 0.0 110.011 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.95 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.155 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' D' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' D' ' 129' ' ' SER . 40.8 t -116.34 123.66 71.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . 0.79 HG22 ' HB2' ' D' ' 129' ' ' SER . 62.9 p -114.14 140.45 48.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' TYR . . . . . 0.71 ' HE2' HD12 ' D' ' 128' ' ' ILE . 5.6 p90 -161.27 162.49 31.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' D' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.77 34.2 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.0 142.31 29.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 114.944 0.737 . . . . 0.0 114.944 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.6 154.25 25.13 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' ARG . . . . . 0.417 HH21 ' HD3' ' D' ' 71' ' ' ARG . 10.5 ptp180 -53.86 -54.34 39.9 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.05 -117.4 3.58 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.97 120.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.148 1.379 . . . . 0.0 111.067 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.3 -21.65 27.2 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -156.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.4 ' O ' HG12 ' D' ' 79' ' ' ILE . . . -62.8 -49.91 68.57 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.839 168.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 122.114 -0.639 . . . . 0.0 111.885 171.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.23 86.89 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.772 171.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.81 92.4 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.896 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . 0.526 HD12 HD11 ' D' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.046 0.45 . . . . 0.0 110.455 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' D' ' 84' ' ' GLN . 0.7 OUTLIER -69.55 -48.11 61.43 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.758 -0.589 . . . . 0.0 112.462 -178.043 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' ASP . . . . . 0.413 ' OD1' ' HE2' ' D' ' 87' ' ' LYS . 29.1 t70 -60.91 -34.86 75.33 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.633 169.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' ALA . . . . . 0.732 ' HA ' ' HB2' ' D' ' 87' ' ' LYS . . . -58.61 -53.79 54.33 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.548 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' TYR . . . . . 0.55 ' HD1' HG22 ' D' ' 113' ' ' ILE . 64.5 t80 -74.64 -48.38 26.63 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.894 -174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' D' ' 80' ' ' GLU . 0.0 OUTLIER -63.45 -51.62 64.92 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -167.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.66 -40.79 18.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.019 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.54 102.5 2.6 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 122.325 -0.234 . . . . 0.0 112.843 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' LYS . . . . . 0.732 ' HB2' ' HA ' ' D' ' 82' ' ' ALA . 9.5 mptt -139.29 145.5 39.21 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.138 -1.431 . . . . 0.0 107.138 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLN . . . . . 0.847 ' HG3' HD23 ' C' ' 54' ' ' LEU . 1.6 tm0? -67.29 142.97 56.67 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' D' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.363 0.601 . . . . 0.0 109.846 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' D' ' 18' ' ' ILE . 6.4 mtmt -84.32 112.94 20.77 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' PHE . . . . . 0.554 ' HD1' ' CE1' ' D' ' 15' ' ' PHE . 24.9 t80 -108.64 123.49 49.04 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.506 1.122 . . . . 0.0 110.009 -166.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' TRP . . . . . 0.75 ' HB2' ' HB2' ' D' ' 14' ' ' LEU . 6.6 m95 -116.36 122.06 43.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.192 0.997 . . . . 0.0 108.317 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' D' ' 107' ' ' GLN . 2.4 tmt_? -108.96 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 172.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.774 HG12 ' HB2' ' D' ' 106' ' ' ALA . 20.8 m -125.27 153.15 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 122.257 1.027 . . . . 0.0 109.377 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ASP . . . . . 0.431 ' OD2' HG22 ' D' ' 11' ' ' VAL . 5.6 m-20 -96.18 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.64 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' D' ' 10' ' ' ASP . 25.8 m -87.07 -3.1 59.05 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.615 -176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.02 137.79 27.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.682 0.753 . . . . 0.0 109.894 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' D' ' 103' ' ' LYS . 9.9 tttp -68.59 129.27 39.44 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.956 -174.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' ASN . . . . . 0.578 HD22 ' HB2' ' D' ' 102' ' ' ASP . 20.6 t30 -64.7 163.65 13.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.869 0.842 . . . . 0.0 109.913 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -8.83 57.6 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.71 0.96 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.759 0.709 . . . . 0.0 110.885 169.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' ASP . . . . . 0.578 ' HB2' HD22 ' D' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 167.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' D' ' 98' ' ' LYS . 0.1 OUTLIER -71.25 -43.04 68.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.869 -0.519 . . . . 0.0 110.627 171.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' TYR . . . . . 0.468 ' O ' ' N ' ' D' ' 142' ' ' GLU . 93.9 m-85 -147.87 172.51 14.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.833 ' HA ' ' HA2' ' D' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.69 33.46 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.58 0.705 . . . . 0.0 109.419 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' ALA . . . . . 0.774 ' HB2' HG12 ' D' ' 94' ' ' VAL . . . -147.45 155.44 41.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.047 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' GLN . . . . . 0.505 ' HB2' ' HD2' ' D' ' 93' ' ' ARG . 53.2 mt-30 -123.96 135.29 53.56 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 157.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PHE . . . . . 0.805 ' HD2' HD11 ' D' ' 138' ' ' LEU . 66.2 t80 -128.46 154.6 45.91 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.39 0.676 . . . . 0.0 110.386 -163.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.6 25.52 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 119.505 -1.331 . . . . 0.0 111.972 170.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' PHE . . . . . 0.671 ' O ' HG23 ' D' ' 134' ' ' VAL . 1.5 m-85 -82.75 118.65 23.53 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' D' ' 132' ' ' LEU . . . -126.27 144.76 50.68 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.891 0.853 . . . . 0.0 111.134 -169.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' TYR . . . . . 0.672 ' HD1' ' HG2' ' D' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.942 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . 0.55 HG22 ' HD1' ' D' ' 83' ' ' TYR . 55.4 mt -68.54 101.84 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' GLU . . . . . 0.828 ' HG2' ' HB3' ' C' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.45 25.26 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 131' ' ' SER . 1.9 m -138.14 137.36 37.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.943 0.792 . . . . 0.0 109.132 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' ARG . . . . . 0.404 ' HD3' HH11 ' D' ' 116' ' ' ARG . 0.2 OUTLIER -135.63 102.37 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' C' ' 37' ' ' VAL . 5.6 mt-10 -119.32 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' D' ' 127' ' ' GLU . 12.3 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.062 0.458 . . . . 0.0 111.204 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.08 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.663 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.59 116.32 31.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 167.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.22 26.85 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 175.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' VAL . . . . . 0.444 HG23 HG22 ' C' ' 33' ' ' THR . 75.9 t -62.75 -45.27 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 O-C-N 122.516 -0.403 . . . . 0.0 111.111 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' GLU . . . . . 0.446 ' HA ' ' HA3' ' C' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 169.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.44 10.19 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 166.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' D' ' 68' ' ' TYR . . . -67.28 156.64 35.87 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.605 0.717 . . . . 0.0 110.738 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' VAL . . . . . 0.715 HG23 HG21 ' C' ' 6' ' ' ILE . 86.7 t -56.85 122.22 5.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.036 -171.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' D' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.73 10.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.074 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' ILE . . . . . 0.71 HD12 ' HE2' ' D' ' 67' ' ' TYR . 3.1 mt -108.45 113.23 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' SER . . . . . 0.79 ' HB2' HG22 ' D' ' 66' ' ' THR . 4.7 t -119.09 123.69 45.06 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 168.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.83 65.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' D' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.03 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.712 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' D' ' 111' ' ' ALA . 1.9 pp -148.11 150.64 34.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.131 -172.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.01 39.95 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 167.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' VAL . . . . . 0.892 ' HA ' HD13 ' C' ' 53' ' ' ILE . 2.0 p -134.98 144.15 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ILE . . . . . 0.691 ' H ' HD13 ' D' ' 135' ' ' ILE . 0.0 OUTLIER -56.03 -52.57 48.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.344 0.592 . . . . 0.0 110.296 -173.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' D' ' 135' ' ' ILE . . . -155.51 148.65 19.15 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.704 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.91 119.9 37.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.093 0.949 . . . . 0.0 110.637 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' D' ' 108' ' ' PHE . 0.1 OUTLIER -97.4 128.61 44.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' E' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.96 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.26 1.92 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.833 ' HA2' ' HA ' ' D' ' 105' ' ' ASP . . . -121.29 150.89 17.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.402 169.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.52 17.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -174.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' D' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.752 -176.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.58 95.47 6.48 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.991 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' THR . . . . . 0.666 ' O ' HD12 ' D' ' 150' ' ' ILE . 53.0 p -95.15 22.71 6.4 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.361 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' D' ' 25' ' ' ALA . 0.9 OUTLIER 52.19 56.81 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.448 1.899 . . . . 0.0 109.381 -173.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' PRO . . . . . 0.568 ' O ' ' HB ' ' D' ' 151' ' ' VAL . 31.5 Cg_exo -69.62 -12.5 33.29 Favored 'Trans proline' 0 C--N 1.351 0.69 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -159.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.93 45.11 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.575 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.25 -31.14 8.34 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' ILE . . . . . 0.666 HD12 ' O ' ' D' ' 145' ' ' THR . 5.2 mt -78.61 -50.46 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 119.148 0.886 . . . . 0.0 111.251 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' D' ' 147' ' ' PRO . 21.9 t -65.44 -40.66 89.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.59 30.8 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.456 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' VAL . . . . . 0.427 HG21 ' O ' ' I' ' 48' ' ' THR . 35.3 m -114.58 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' SER . . . . . 0.639 ' HA ' HD21 ' I' ' 50' ' ' ASN . 1.0 OUTLIER -141.79 137.76 31.78 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' J' ' 135' ' ' ILE . 0.1 OUTLIER -57.26 -41.31 79.43 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 175.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' D' ' 158' ' ' TYR . . . 137.07 141.28 4.22 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 119.339 0.972 . . . . 0.0 113.09 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' D' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.28 2.95 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.308 1.043 . . . . 0.0 108.595 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.03 -46.67 67.34 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -158.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 160' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' J' ' 143' ' ' ILE . 0.3 OUTLIER -132.14 121.69 24.15 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.693 2.397 . . . . 0.0 109.145 167.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' D' ' 165' ' ' GLN . 0.0 OUTLIER -117.69 45.73 1.88 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 154.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 162' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' J' ' 144' ' ' ASP . 0.4 OUTLIER -68.29 -32.86 4.21 Favored Pre-proline 0 C--O 1.241 0.64 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -166.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 163' ' ' PRO . . . . . 0.535 ' O ' ' HA3' ' J' ' 23' ' ' GLY . 22.3 Cg_exo -82.79 -0.81 10.25 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.096 1.784 . . . . 0.0 113.858 171.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.73 73.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 118.411 2.124 . . . . 0.0 118.411 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' D' ' 161' ' ' GLN . 0.8 OUTLIER -71.77 -43.67 65.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 118.881 1.34 . . . . 0.0 110.941 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 166' ' ' THR . . . . . 0.684 HG22 ' HB1' ' J' ' 21' ' ' ALA . 6.9 p 52.5 49.17 21.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.736 1.614 . . . . 0.0 111.94 176.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 167' ' ' THR . . . . . 0.569 HG21 ' H ' ' D' ' 172' ' ' GLY . 26.9 m -126.33 157.35 38.65 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.275 -167.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.35 -152.11 19.94 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.49 172.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' J' ' 88' ' ' GLN . 0.9 OUTLIER -61.68 -43.22 99.27 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.748 0.274 . . . . 0.0 111.411 -177.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.47 65.01 Favored Pre-proline 0 C--O 1.235 0.295 0 C-N-CA 123.498 0.719 . . . . 0.0 109.23 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 171' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.66 146.05 14.84 Favored 'Trans proline' 0 C--N 1.324 -0.719 0 C-N-CA 121.33 1.354 . . . . 0.0 112.718 -156.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . 0.569 ' H ' HG21 ' D' ' 167' ' ' THR . . . 88.39 8.33 71.26 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 165.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.15 36.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.995 0.897 . . . . 0.0 109.897 170.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 165' ' ' GLN . 24.5 t -106.6 117.42 56.99 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.405 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.69 163.28 35.78 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 119.47 0.846 . . . . 0.0 111.749 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.253 0 C-N-CA 125.435 1.494 . . . . 0.0 112.347 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' F' ' 70' ' ' LYS . 49.9 Cg_endo . . . . . 0 N--CA 1.466 -0.139 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.823 HG21 HG23 ' F' ' 126' ' ' VAL . 26.1 mt -127.9 161.77 35.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' MET . . . . . 1.025 ' HG2' ' HB2' ' E' ' 10' ' ' ASP . 0.0 OUTLIER -122.0 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.884 0.849 . . . . 0.0 110.741 -177.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.74 -17.9 58.53 Favored Glycine 0 C--N 1.333 0.415 0 CA-C-N 115.388 -0.823 . . . . 0.0 114.52 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.49 -4.25 25.66 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.783 0.792 . . . . 0.0 112.428 172.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ASP . . . . . 1.025 ' HB2' ' HG2' ' E' ' 7' ' ' MET . 28.7 t0 -66.94 -50.82 61.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' VAL . . . . . 0.435 HG22 ' OD2' ' E' ' 95' ' ' ASP . 78.8 t -84.01 121.8 36.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' E' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.01 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.655 0.741 . . . . 0.0 110.505 176.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' TYR . . . . . 0.456 ' HD1' ' CE1' ' E' ' 91' ' ' PHE . 39.6 m-85 -111.11 105.52 14.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.743 -164.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' LEU . . . . . 0.747 ' HB2' ' HB2' ' E' ' 92' ' ' TRP . 1.9 mp -90.26 136.52 33.0 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' PHE . . . . . 0.559 ' CE1' ' HD1' ' E' ' 91' ' ' PHE . 22.8 m-85 -125.82 115.27 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.406 0.622 . . . . 0.0 109.959 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' E' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.73 51.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.74 148.14 28.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ILE . . . . . 0.84 ' HA ' ' HE2' ' E' ' 90' ' ' LYS . 1.1 pp -62.47 -39.85 85.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.988 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.43 63.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.84 84.22 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.438 -175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.18 57.63 5.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.217 1.407 . . . . 0.0 111.792 -173.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' E' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.64 5.88 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' E' ' 22' ' ' THR . . . -125.22 23.69 6.07 Favored Glycine 0 N--CA 1.45 -0.409 0 O-C-N 123.332 0.395 . . . . 0.0 113.718 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.76 -30.44 65.58 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.972 0.386 . . . . 0.0 111.784 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' E' ' 146' ' ' LEU . . . 46.34 76.36 0.56 Allowed Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.949 2.1 . . . . 0.0 112.398 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.73 147.44 69.45 Favored 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 119.416 0.827 . . . . 0.0 112.494 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . 0.635 HD12 ' HG ' ' E' ' 14' ' ' LEU . 8.8 tt -130.41 150.32 51.69 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.55 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.518 -167.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.83 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.321 0 CA-C-O 121.879 0.7 . . . . 0.0 112.399 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' ALA . . . . . 0.628 ' HA ' ' HB3' ' J' ' 47' ' ' GLN . . . 59.32 37.31 23.53 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.378 1.471 . . . . 0.0 111.529 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.14 135.41 46.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 122.543 1.163 . . . . 0.0 111.082 173.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' GLN . . . . . 0.414 ' OE1' ' HA ' ' E' ' 32' ' ' GLN . 7.2 mm-40 -104.0 -91.63 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.68 170.19 16.2 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.765 1.269 . . . . 0.0 111.119 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' E' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.98 -164.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.13 136.21 13.34 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.336 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' SER . . . . . 0.415 ' HB3' ' CE1' ' F' ' 118' ' ' TYR . 48.0 t -133.4 119.41 19.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' F' ' 117' ' ' GLU . 18.9 m -130.9 144.88 36.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -173.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -166.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' E' ' 59' ' ' VAL . . . -119.46 114.85 2.87 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.204 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.29 125.83 40.19 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' ARG . . . . . 0.813 HH22 ' HB2' ' E' ' 60' ' ' ALA . 2.1 mtm-85 -68.69 132.3 46.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.777 0.799 . . . . 0.0 110.152 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' GLU . . . . . 0.771 ' HB3' ' HG2' ' F' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.41 32.21 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -167.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.51 121.59 42.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.516 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' PHE . . . . . 0.603 ' CE2' ' HA3' ' E' ' 51' ' ' GLY . 0.3 OUTLIER -128.41 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.251 171.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' ASP . . . . . 0.534 ' O ' ' HA2' ' E' ' 51' ' ' GLY . 3.2 t70 -111.75 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' GLU . . . . . 0.721 ' OE2' ' HB3' ' F' ' 58' ' ' SER . 2.7 mp0 -71.2 -48.14 53.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' E' ' 52' ' ' ARG . 1.4 mt-30 57.88 38.55 27.09 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.623 1.569 . . . . 0.0 111.663 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 41.98 45.28 3.27 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.482 1.513 . . . . 0.0 111.534 -164.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.88 -163.81 1.71 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.474 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.83 16.77 1.07 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' GLY . . . . . 0.603 ' HA3' ' CE2' ' E' ' 44' ' ' PHE . . . 87.05 167.55 43.87 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' ARG . . . . . 0.493 ' HA ' ' HD3' ' E' ' 52' ' ' ARG . 0.0 OUTLIER -112.22 122.37 47.55 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.914 HD13 ' HA ' ' F' ' 134' ' ' VAL . 1.5 pp -127.21 -39.19 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.868 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' LEU . . . . . 0.697 HD23 ' HG3' ' F' ' 88' ' ' GLN . 1.3 mp -61.78 -16.87 53.34 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.94 1.13 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-O 121.668 0.593 . . . . 0.0 113.951 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' E' ' 54' ' ' LEU . 68.4 Cg_endo -76.88 178.85 7.11 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 N-CA-C 113.797 0.653 . . . . 0.0 113.797 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.8 24.64 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' SER . . . . . 0.516 ' HB3' ' HE ' ' E' ' 41' ' ' ARG . 1.7 t -87.43 153.87 21.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.565 0.697 . . . . 0.0 110.515 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' E' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' ALA . . . . . 0.813 ' HB2' HH22 ' E' ' 41' ' ' ARG . . . -107.61 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' E' ' 136' ' ' GLY . 15.3 m-20 -102.06 107.43 18.54 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.12 144.7 27.97 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 110.105 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 145.99 17.25 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.185 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' E' ' 64' ' ' GLU . 2.5 pt-20 -138.45 128.77 25.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' E' ' 129' ' ' SER . 40.6 t -116.28 123.65 71.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' THR . . . . . 0.775 HG22 ' HB2' ' E' ' 129' ' ' SER . 63.1 p -114.18 140.43 48.55 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' TYR . . . . . 0.719 ' HE2' HD12 ' E' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' TYR . . . . . 0.629 ' HB3' ' HB3' ' E' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.79 34.2 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.96 142.34 29.48 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.66 154.26 25.2 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 174.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' ARG . . . . . 0.427 HH21 ' HD3' ' E' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.31 40.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.41 3.59 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 176.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.95 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.139 1.376 . . . . 0.0 111.038 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.72 27.09 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -156.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' E' ' 79' ' ' ILE . . . -62.76 -49.91 68.65 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.822 168.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -36.69 84.91 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.884 171.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -37.23 86.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.775 171.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.76 92.57 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.937 168.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . 0.54 HD12 HD11 ' E' ' 113' ' ' ILE . 5.7 mm -54.07 -42.31 54.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.029 0.443 . . . . 0.0 110.466 172.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' E' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.16 61.17 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.761 -0.587 . . . . 0.0 112.416 -178.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' E' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.82 75.3 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.601 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 82' ' ' ALA . . . . . 0.735 ' HA ' ' HB2' ' E' ' 87' ' ' LYS . . . -58.67 -53.77 54.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.575 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 83' ' ' TYR . . . . . 0.554 ' CD1' HG22 ' E' ' 113' ' ' ILE . 64.5 t80 -74.63 -48.34 26.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.934 -174.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 84' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' E' ' 80' ' ' GLU . 0.0 OUTLIER -63.4 -51.64 64.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -167.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -83.68 -40.83 18.43 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.008 172.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.59 102.44 2.59 Favored Glycine 0 N--CA 1.449 -0.435 0 O-C-N 122.324 -0.235 . . . . 0.0 112.865 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 87' ' ' LYS . . . . . 0.735 ' HB2' ' HA ' ' E' ' 82' ' ' ALA . 9.5 mptt -139.21 145.57 39.43 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 88' ' ' GLN . . . . . 0.814 ' HG3' HD23 ' D' ' 54' ' ' LEU . 1.6 tm0? -67.36 142.98 56.59 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 168.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 89' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' E' ' 82' ' ' ALA . 5.5 mm -118.86 129.13 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 90' ' ' LYS . . . . . 0.84 ' HE2' ' HA ' ' E' ' 18' ' ' ILE . 6.5 mtmt -84.39 112.99 20.84 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 91' ' ' PHE . . . . . 0.559 ' HD1' ' CE1' ' E' ' 15' ' ' PHE . 24.9 t80 -108.62 123.43 48.93 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.518 1.127 . . . . 0.0 110.019 -165.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 92' ' ' TRP . . . . . 0.747 ' HB2' ' HB2' ' E' ' 14' ' ' LEU . 6.6 m95 -116.35 122.03 43.69 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.219 1.007 . . . . 0.0 108.348 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 93' ' ' ARG . . . . . 0.511 ' HD2' ' HB2' ' E' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.56 11.56 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 94' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' E' ' 106' ' ' ALA . 20.7 m -125.31 153.14 32.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.269 1.033 . . . . 0.0 109.402 -173.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 95' ' ' ASP . . . . . 0.435 ' OD2' HG22 ' E' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.67 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 96' ' ' THR . . . . . 0.424 ' N ' ' O ' ' E' ' 10' ' ' ASP . 25.9 m -87.12 -3.03 59.04 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.622 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.98 137.8 27.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 121.689 0.757 . . . . 0.0 109.89 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 98' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' E' ' 103' ' ' LYS . 9.9 tttp -68.65 129.28 39.47 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.991 -174.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 99' ' ' ASN . . . . . 0.568 HD22 ' HB2' ' E' ' 102' ' ' ASP . 20.5 t30 -64.7 163.58 13.68 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.837 0.827 . . . . 0.0 109.97 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -8.83 57.69 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.52 -36.78 0.96 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.748 0.704 . . . . 0.0 110.87 169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 102' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' E' ' 99' ' ' ASN . 0.2 OUTLIER -79.55 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 167.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 103' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' E' ' 98' ' ' LYS . 0.1 OUTLIER -71.32 -42.93 67.96 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.858 -0.526 . . . . 0.0 110.608 171.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 104' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' E' ' 142' ' ' GLU . 93.7 m-85 -147.89 172.47 14.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.815 ' HA ' ' HA2' ' E' ' 141' ' ' GLY . 1.7 p-10 -116.36 152.72 33.36 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.664 0.745 . . . . 0.0 109.442 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 106' ' ' ALA . . . . . 0.761 ' HB2' HG12 ' E' ' 94' ' ' VAL . . . -147.46 155.41 41.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.065 -163.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 107' ' ' GLN . . . . . 0.511 ' HB2' ' HD2' ' E' ' 93' ' ' ARG . 53.4 mt-30 -123.87 135.25 53.61 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 157.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 108' ' ' PHE . . . . . 0.828 ' HD2' HD11 ' E' ' 138' ' ' LEU . 66.2 t80 -128.43 154.63 45.85 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.406 0.682 . . . . 0.0 110.464 -163.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.59 25.55 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.474 -1.346 . . . . 0.0 111.969 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 110' ' ' PHE . . . . . 0.684 ' O ' HG23 ' E' ' 134' ' ' VAL . 1.5 m-85 -82.89 118.67 23.61 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 111' ' ' ALA . . . . . 0.57 ' HB1' HD13 ' E' ' 132' ' ' LEU . . . -126.23 144.71 50.68 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.871 0.843 . . . . 0.0 111.196 -169.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 112' ' ' TYR . . . . . 0.68 ' HD1' ' HG2' ' E' ' 88' ' ' GLN . 3.1 t80 -122.22 117.47 26.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.488 -1.233 . . . . 0.0 107.977 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . 0.554 HG22 ' CD1' ' E' ' 83' ' ' TYR . 55.1 mt -68.53 101.85 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 114' ' ' GLU . . . . . 0.784 ' HG2' ' HB3' ' D' ' 42' ' ' GLU . 4.4 mt-10 -95.03 -13.44 25.21 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 115' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 131' ' ' SER . 1.9 m -138.18 137.35 37.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.964 0.802 . . . . 0.0 109.108 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 116' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' E' ' 116' ' ' ARG . 0.2 OUTLIER -135.62 102.38 5.09 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 117' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' D' ' 37' ' ' VAL . 5.6 mt-10 -119.29 118.87 32.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 118' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' E' ' 127' ' ' GLU . 12.4 p90 -122.65 137.98 54.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 111.131 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 12.3 t -110.08 139.59 45.05 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.699 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.36 31.8 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 167.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.66 -45.33 99.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 122.52 -0.4 . . . . 0.0 111.12 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 123' ' ' GLU . . . . . 0.503 ' HA ' ' HA3' ' D' ' 8' ' ' GLY . 2.7 tp10 -125.96 142.4 51.54 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 169.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.39 157.5 10.21 Favored Glycine 0 C--O 1.243 0.684 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 166.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' E' ' 68' ' ' TYR . . . -67.28 156.6 35.97 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.559 0.695 . . . . 0.0 110.752 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 126' ' ' VAL . . . . . 0.776 HG23 HG21 ' D' ' 6' ' ' ILE . 86.2 t -56.8 122.15 5.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.017 -171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 127' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' E' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.72 10.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.082 -176.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 128' ' ' ILE . . . . . 0.719 HD12 ' HE2' ' E' ' 67' ' ' TYR . 3.1 mt -108.43 113.14 43.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 129' ' ' SER . . . . . 0.775 ' HB2' HG22 ' E' ' 66' ' ' THR . 4.7 t -119.02 123.65 45.04 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.86 65.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 131' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' E' ' 115' ' ' SER . 0.4 OUTLIER -110.78 141.39 44.17 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.689 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 132' ' ' LEU . . . . . 0.57 HD13 ' HB1' ' E' ' 111' ' ' ALA . 2.0 pp -148.09 150.61 34.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.154 -172.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.07 146.0 39.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 167.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 134' ' ' VAL . . . . . 0.83 ' HA ' HD13 ' D' ' 53' ' ' ILE . 2.0 p -135.01 144.18 35.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 135' ' ' ILE . . . . . 0.789 HG23 HG12 ' D' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.57 48.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.339 0.59 . . . . 0.0 110.322 -173.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 136' ' ' GLY . . . . . 0.677 ' H ' HG12 ' E' ' 135' ' ' ILE . . . -155.46 148.66 19.2 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.75 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.9 119.89 37.33 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 122.053 0.93 . . . . 0.0 110.657 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 138' ' ' LEU . . . . . 0.828 HD11 ' HD2' ' E' ' 108' ' ' PHE . 0.1 OUTLIER -97.37 128.59 44.32 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 139' ' ' LYS . . . . . 0.422 ' HD3' HE21 ' F' ' 84' ' ' GLN . 16.4 mtmt -86.31 130.94 34.34 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.21 1.91 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.815 ' HA2' ' HA ' ' E' ' 105' ' ' ASP . . . -121.31 150.94 17.08 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.383 169.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 142' ' ' GLU . . . . . 0.643 ' HB2' ' HB2' ' E' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . 0.844 HD12 ' H ' ' E' ' 143' ' ' ILE . 0.1 OUTLIER -110.23 -76.31 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.747 -176.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.67 95.52 6.49 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.965 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 145' ' ' THR . . . . . 0.652 ' O ' HD12 ' E' ' 150' ' ' ILE . 52.5 p -95.16 22.63 6.49 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.332 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' E' ' 25' ' ' ALA . 0.9 OUTLIER 52.28 56.73 15.57 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.443 1.897 . . . . 0.0 109.389 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 147' ' ' PRO . . . . . 0.57 ' O ' ' HB ' ' E' ' 151' ' ' VAL . 31.4 Cg_exo -69.55 -12.59 33.62 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.271 1.314 . . . . 0.0 115.359 -159.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.68 -53.88 45.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.593 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.27 -31.13 8.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 150' ' ' ILE . . . . . 0.652 HD12 ' O ' ' E' ' 145' ' ' THR . 5.2 mt -78.66 -50.42 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 119.125 0.875 . . . . 0.0 111.271 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 151' ' ' VAL . . . . . 0.57 ' HB ' ' O ' ' E' ' 147' ' ' PRO . 21.8 t -65.45 -40.62 88.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.63 30.86 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.413 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 153' ' ' VAL . . . . . 0.402 HG21 ' O ' ' J' ' 48' ' ' THR . 35.3 m -114.62 123.07 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 154' ' ' SER . . . . . 0.56 ' HA ' HD21 ' J' ' 50' ' ' ASN . 1.0 OUTLIER -141.75 137.74 31.83 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.517 ' HE3' HG12 ' K' ' 135' ' ' ILE . 0.1 OUTLIER -57.26 -41.32 79.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 156' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' E' ' 158' ' ' TYR . . . 137.06 141.31 4.23 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 119.392 0.996 . . . . 0.0 113.047 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.34 71.28 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.525 -0.63 . . . . 0.0 111.525 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' E' ' 156' ' ' GLY . 0.0 OUTLIER -108.91 89.29 2.95 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.288 1.035 . . . . 0.0 108.651 177.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.08 -46.64 67.3 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -158.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 160' ' ' PHE . . . . . 0.461 ' CB ' HD11 ' K' ' 143' ' ' ILE . 0.3 OUTLIER -132.08 121.71 24.26 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 127.694 2.398 . . . . 0.0 109.197 167.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 161' ' ' GLN . . . . . 0.512 ' HB3' ' CA ' ' E' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.81 1.86 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 154.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.91 4.2 Favored Pre-proline 0 C--O 1.241 0.633 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -166.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 163' ' ' PRO . . . . . 0.476 ' O ' ' HA3' ' K' ' 23' ' ' GLY . 22.3 Cg_exo -82.72 -0.88 10.31 Favored 'Trans proline' 0 C--O 1.239 0.532 0 CA-C-N 122.072 1.776 . . . . 0.0 113.907 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.16 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 118.371 2.108 . . . . 0.0 118.371 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 165' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' E' ' 161' ' ' GLN . 0.8 OUTLIER -71.79 -43.63 65.34 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 118.915 1.358 . . . . 0.0 110.927 175.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 166' ' ' THR . . . . . 0.853 HG22 ' HB1' ' K' ' 21' ' ' ALA . 6.8 p 52.48 49.21 20.94 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 111.878 176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 167' ' ' THR . . . . . 0.554 HG21 ' H ' ' E' ' 172' ' ' GLY . 26.9 m -126.33 157.39 38.54 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.313 -167.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.13 20.16 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.474 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.772 0.286 . . . . 0.0 111.442 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.15 126.42 65.16 Favored Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 123.504 0.722 . . . . 0.0 109.259 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 171' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.63 146.11 14.92 Favored 'Trans proline' 0 C--N 1.324 -0.724 0 C-N-CA 121.271 1.314 . . . . 0.0 112.766 -156.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . 0.554 ' H ' HG21 ' E' ' 167' ' ' THR . . . 88.35 8.29 71.47 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 165.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.63 122.14 36.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.965 0.882 . . . . 0.0 109.93 170.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' E' ' 165' ' ' GLN . 24.5 t -106.57 117.41 57.04 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.429 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.67 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.412 1.485 . . . . 0.0 112.302 -171.716 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 49.8 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 119.936 -0.11 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.831 HG21 HG23 ' A' ' 126' ' ' VAL . 26.0 mt -127.88 161.74 35.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' MET . . . . . 1.033 ' HG2' ' HB2' ' F' ' 10' ' ' ASP . 0.0 OUTLIER -121.97 154.79 36.73 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.906 0.86 . . . . 0.0 110.759 -177.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 123' ' ' GLU . . . -62.76 -17.87 58.53 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.38 -0.827 . . . . 0.0 114.485 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.48 -4.38 25.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 117.826 0.813 . . . . 0.0 112.406 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' ASP . . . . . 1.033 ' HB2' ' HG2' ' F' ' 7' ' ' MET . 28.7 t0 -66.89 -50.84 61.18 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -171.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' F' ' 95' ' ' ASP . 78.8 t -83.99 121.79 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' F' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.58 48.97 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.701 0.762 . . . . 0.0 110.497 176.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' TYR . . . . . 0.47 ' HD1' ' CE1' ' F' ' 91' ' ' PHE . 39.6 m-85 -111.15 105.47 14.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.753 -164.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' LEU . . . . . 0.767 ' HB2' ' HB2' ' F' ' 92' ' ' TRP . 1.8 mp -90.23 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' PHE . . . . . 0.56 ' CE1' ' HD1' ' F' ' 91' ' ' PHE . 22.8 m-85 -125.84 115.28 19.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 0.0 109.967 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' F' ' 90' ' ' LYS . 14.6 tt0 -114.21 137.67 51.47 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.7 148.18 28.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.015 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' ILE . . . . . 0.816 ' HA ' ' HE2' ' F' ' 90' ' ' LYS . 1.1 pp -62.5 -39.86 86.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.97 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.67 -19.47 63.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -171.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.426 -175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' ALA . . . . . . . . . . . . . . . 48.17 57.65 5.92 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.174 1.39 . . . . 0.0 111.801 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' F' ' 23' ' ' GLY . 0.2 OUTLIER -137.87 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' F' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.45 -0.4 0 O-C-N 123.318 0.386 . . . . 0.0 113.686 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.8 -30.38 65.46 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.976 0.388 . . . . 0.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.484 ' HB3' HD21 ' F' ' 146' ' ' LEU . . . 46.34 76.38 0.55 Allowed Pre-proline 0 C--O 1.238 0.474 0 C-N-CA 126.928 2.091 . . . . 0.0 112.433 -174.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.37 69.41 Favored 'Trans proline' 0 C--N 1.349 0.553 0 CA-C-N 119.437 0.835 . . . . 0.0 112.488 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . 0.633 HD12 ' HG ' ' F' ' 14' ' ' LEU . 8.8 tt -130.41 150.38 51.65 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -108.58 133.47 20.61 Favored Pre-proline 0 C--N 1.316 -0.853 0 C-N-CA 115.82 -2.352 . . . . 0.0 110.506 -167.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 CA-C-N 118.988 0.674 . . . . 0.0 112.448 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' ALA . . . . . 0.824 ' HA ' ' HB3' ' K' ' 47' ' ' GLN . . . 59.29 37.26 23.62 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.327 1.451 . . . . 0.0 111.551 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.1 135.35 46.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.541 1.162 . . . . 0.0 111.066 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 32' ' ' GLN . 7.2 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.67 170.18 16.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.794 1.283 . . . . 0.0 111.07 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 34' ' ' ASP . . . . . 0.43 ' OD1' HG22 ' F' ' 65' ' ' VAL . 3.0 t0 -158.95 102.3 1.64 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.02 -164.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.11 136.17 13.32 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.372 170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 36' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 118' ' ' TYR . 48.1 t -133.33 119.4 19.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 173.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.88 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.43 128.11 38.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -166.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' F' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.229 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.28 125.89 40.22 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 41' ' ' ARG . . . . . 0.823 HH22 ' HB2' ' F' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.3 46.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.676 0.751 . . . . 0.0 110.172 -174.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 42' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -138.73 133.39 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -167.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.56 121.57 42.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.537 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 44' ' ' PHE . . . . . 0.599 ' CE2' ' HA3' ' F' ' 51' ' ' GLY . 0.3 OUTLIER -128.43 90.8 3.13 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.231 171.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 45' ' ' ASP . . . . . 0.527 ' O ' ' HA2' ' F' ' 51' ' ' GLY . 3.2 t70 -111.78 170.18 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 155.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.19 -48.19 53.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 47' ' ' GLN . . . . . 0.435 HE22 ' HB2' ' F' ' 52' ' ' ARG . 1.4 mt-30 57.86 38.61 27.17 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.605 1.562 . . . . 0.0 111.642 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 30.9 p 41.97 45.27 3.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.442 1.497 . . . . 0.0 111.602 -164.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 49' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -142.92 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.461 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.87 16.77 1.08 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 51' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' F' ' 44' ' ' PHE . . . 87.13 167.5 43.79 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 52' ' ' ARG . . . . . 0.471 ' HA ' HH11 ' F' ' 52' ' ' ARG . 0.0 OUTLIER -112.21 122.33 47.44 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.851 HG12 HG23 ' A' ' 135' ' ' ILE . 1.5 pp -127.14 -39.22 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.896 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 54' ' ' LEU . . . . . 0.558 HD12 ' H ' ' F' ' 54' ' ' LEU . 1.3 mp -61.76 -16.92 53.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 176.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 121.673 0.596 . . . . 0.0 113.966 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 56' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' F' ' 54' ' ' LEU . 68.9 Cg_endo -76.8 178.86 7.08 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 N-CA-C 113.859 0.677 . . . . 0.0 113.859 -175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.79 24.64 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 58' ' ' SER . . . . . 0.721 ' HB3' ' OE2' ' E' ' 46' ' ' GLU . 1.7 t -87.48 153.89 21.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 0.0 110.486 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' F' ' 39' ' ' GLY . 14.3 p -103.81 130.92 53.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 60' ' ' ALA . . . . . 0.823 ' HB2' HH22 ' F' ' 41' ' ' ARG . . . -107.61 110.98 22.99 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 174.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' F' ' 136' ' ' GLY . 15.3 m-20 -102.07 107.4 18.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -171.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.11 144.76 27.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.988 0.915 . . . . 0.0 110.025 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.97 146.06 17.34 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.156 176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' F' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.77 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' F' ' 129' ' ' SER . 40.9 t -116.36 123.68 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 66' ' ' THR . . . . . 0.778 HG22 ' HB2' ' F' ' 129' ' ' SER . 62.8 p -114.18 140.42 48.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 67' ' ' TYR . . . . . 0.723 ' HE2' HD12 ' F' ' 128' ' ' ILE . 5.7 p90 -161.26 162.47 31.08 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 68' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' F' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.76 34.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 69' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' E' ' 5' ' ' PRO . . . -75.0 142.29 29.37 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 114.948 0.739 . . . . 0.0 114.948 -175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 70' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' E' ' 5' ' ' PRO . 16.3 tttp -111.57 154.27 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 71' ' ' ARG . . . . . 0.426 HH21 ' HD3' ' F' ' 71' ' ' ARG . 10.5 ptp180 -53.97 -54.3 40.83 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -172.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' F' ' 71' ' ' ARG . . . -112.0 -117.4 3.59 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.96 120.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.119 1.368 . . . . 0.0 111.017 169.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.37 -21.6 27.11 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -156.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.94 68.3 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.83 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -36.62 84.7 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.822 171.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.3 87.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 120.009 -0.677 . . . . 0.0 111.767 171.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.85 92.26 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.889 168.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' F' ' 113' ' ' ILE . 5.7 mm -54.0 -42.33 53.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.04 0.448 . . . . 0.0 110.495 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' F' ' 84' ' ' GLN . 0.7 OUTLIER -69.62 -48.05 61.32 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.745 -0.597 . . . . 0.0 112.439 -178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' F' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.587 169.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 82' ' ' ALA . . . . . 0.736 ' HA ' ' HB2' ' F' ' 87' ' ' LYS . . . -58.61 -53.75 54.83 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.056 -1.057 . . . . 0.0 111.551 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 83' ' ' TYR . . . . . 0.556 ' HD1' HG22 ' F' ' 113' ' ' ILE . 64.5 t80 -74.65 -48.39 26.55 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.914 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 84' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' F' ' 80' ' ' GLU . 0.0 OUTLIER -63.37 -51.69 64.85 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -167.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.6 -40.83 18.56 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.087 172.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.6 102.49 2.59 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.376 -0.202 . . . . 0.0 112.854 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 87' ' ' LYS . . . . . 0.736 ' HB2' ' HA ' ' F' ' 82' ' ' ALA . 9.5 mptt -139.27 145.53 39.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 88' ' ' GLN . . . . . 0.697 ' HG3' HD23 ' E' ' 54' ' ' LEU . 1.6 tm0? -67.42 142.97 56.51 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 168.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 89' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' F' ' 82' ' ' ALA . 5.5 mm -118.83 129.15 75.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 121.342 0.591 . . . . 0.0 109.825 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 90' ' ' LYS . . . . . 0.816 ' HE2' ' HA ' ' F' ' 18' ' ' ILE . 6.5 mtmt -84.37 112.94 20.8 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 91' ' ' PHE . . . . . 0.56 ' HD1' ' CE1' ' F' ' 15' ' ' PHE . 25.0 t80 -108.66 123.47 49.02 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.519 1.128 . . . . 0.0 109.966 -165.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 92' ' ' TRP . . . . . 0.767 ' HB2' ' HB2' ' F' ' 14' ' ' LEU . 6.6 m95 -116.4 122.05 43.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 93' ' ' ARG . . . . . 0.518 ' HD2' ' HB2' ' F' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.57 11.56 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 172.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 94' ' ' VAL . . . . . 0.758 HG12 ' HB2' ' F' ' 106' ' ' ALA . 20.4 m -125.29 153.13 32.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 122.27 1.033 . . . . 0.0 109.44 -173.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' F' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.95 16.12 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.602 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 96' ' ' THR . . . . . 0.428 ' N ' ' O ' ' F' ' 10' ' ' ASP . 25.9 m -87.12 -3.14 59.05 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.622 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.85 27.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.7 0.762 . . . . 0.0 109.898 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 98' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' F' ' 103' ' ' LYS . 9.9 tttp -68.68 129.29 39.49 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.946 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 99' ' ' ASN . . . . . 0.561 HD22 ' HB2' ' F' ' 102' ' ' ASP . 20.5 t30 -64.72 163.59 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.848 0.833 . . . . 0.0 109.916 171.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.01 -8.83 57.68 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.739 0.7 . . . . 0.0 110.885 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 102' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' F' ' 99' ' ' ASN . 0.2 OUTLIER -79.58 173.02 13.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 103' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' F' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -43.03 67.94 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.902 -0.499 . . . . 0.0 110.548 171.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' F' ' 142' ' ' GLU . 93.6 m-85 -147.84 172.5 14.04 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.828 ' HA ' ' HA2' ' F' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.63 33.56 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.605 0.717 . . . . 0.0 109.499 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 106' ' ' ALA . . . . . 0.758 ' HB2' HG12 ' F' ' 94' ' ' VAL . . . -147.37 155.47 42.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.053 -163.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 107' ' ' GLN . . . . . 0.518 ' HB2' ' HD2' ' F' ' 93' ' ' ARG . 53.2 mt-30 -124.02 135.26 53.49 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 157.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' F' ' 138' ' ' LEU . 66.3 t80 -128.43 154.62 45.86 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.381 0.672 . . . . 0.0 110.426 -163.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.6 25.54 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.562 -1.304 . . . . 0.0 111.985 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 110' ' ' PHE . . . . . 0.678 ' O ' HG23 ' F' ' 134' ' ' VAL . 1.5 m-85 -82.84 118.68 23.59 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 111' ' ' ALA . . . . . 0.576 ' HB1' HD13 ' F' ' 132' ' ' LEU . . . -126.25 144.78 50.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.96 0.886 . . . . 0.0 111.197 -169.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 112' ' ' TYR . . . . . 0.677 ' HD1' ' HG2' ' F' ' 88' ' ' GLN . 3.1 t80 -122.27 117.43 26.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.491 -1.231 . . . . 0.0 107.938 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . 0.556 HG22 ' HD1' ' F' ' 83' ' ' TYR . 55.1 mt -68.53 101.82 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 114' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' E' ' 42' ' ' GLU . 4.4 mt-10 -94.89 -13.48 25.4 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 115' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 131' ' ' SER . 1.9 m -138.13 137.38 37.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 118.948 0.795 . . . . 0.0 109.105 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.68 102.33 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 117' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' E' ' 37' ' ' VAL . 5.6 mt-10 -119.3 118.9 32.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 118' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' F' ' 127' ' ' GLU . 12.3 p90 -122.66 137.95 54.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.089 0.471 . . . . 0.0 111.181 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.64 45.03 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.678 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.35 31.78 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 167.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.34 175.21 26.8 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 122' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.67 -45.39 98.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.493 -0.416 . . . . 0.0 111.063 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.46 51.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 169.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.47 10.2 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 166.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' F' ' 68' ' ' TYR . . . -67.32 156.65 35.9 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.607 0.718 . . . . 0.0 110.723 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 126' ' ' VAL . . . . . 0.823 HG23 HG21 ' E' ' 6' ' ' ILE . 86.3 t -56.84 122.18 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.991 -171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 127' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' F' ' 118' ' ' TYR . 0.5 OUTLIER -75.89 110.69 10.55 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.129 -176.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 128' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' F' ' 67' ' ' TYR . 3.1 mt -108.42 113.2 43.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 129' ' ' SER . . . . . 0.778 ' HB2' HG22 ' F' ' 66' ' ' THR . 4.6 t -119.15 123.67 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.81 65.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 131' ' ' SER . . . . . 0.579 ' HB2' ' HB2' ' F' ' 115' ' ' SER . 0.3 OUTLIER -110.68 141.36 44.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.772 -178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 132' ' ' LEU . . . . . 0.576 HD13 ' HB1' ' F' ' 111' ' ' ALA . 1.9 pp -148.1 150.63 34.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.104 -172.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.11 146.0 39.95 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 167.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 134' ' ' VAL . . . . . 0.914 ' HA ' HD13 ' E' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 135' ' ' ILE . . . . . 0.837 HG23 HG12 ' E' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.52 49.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.356 0.598 . . . . 0.0 110.326 -173.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' F' ' 135' ' ' ILE . . . -155.52 148.65 19.17 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.751 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.92 37.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.037 0.922 . . . . 0.0 110.657 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' F' ' 108' ' ' PHE . 0.1 OUTLIER -97.51 128.62 44.41 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 139' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 80' ' ' GLU . 16.5 mtmt -86.35 130.99 34.32 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -177.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.67 -168.25 1.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.828 ' HA2' ' HA ' ' F' ' 105' ' ' ASP . . . -121.31 150.92 17.08 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.166 -1.016 . . . . 0.0 111.386 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 142' ' ' GLU . . . . . 0.632 ' HB2' ' HB2' ' F' ' 106' ' ' ALA . 15.9 tp10 -101.34 156.46 17.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . 0.869 HD12 ' H ' ' F' ' 143' ' ' ILE . 0.1 OUTLIER -110.19 -76.4 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.754 -176.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.48 6.48 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.989 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 145' ' ' THR . . . . . 0.673 ' O ' HD12 ' F' ' 150' ' ' ILE . 52.8 p -95.13 22.65 6.45 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 118.692 -0.671 . . . . 0.0 112.352 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 146' ' ' LEU . . . . . 0.484 HD21 ' HB3' ' F' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.77 15.68 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.465 1.906 . . . . 0.0 109.427 -173.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 147' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' F' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.59 33.58 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.231 1.287 . . . . 0.0 115.324 -159.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.87 46.07 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.574 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.21 -31.16 8.35 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 150' ' ' ILE . . . . . 0.673 HD12 ' O ' ' F' ' 145' ' ' THR . 5.2 mt -78.55 -50.52 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 119.112 0.869 . . . . 0.0 111.295 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 151' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' F' ' 147' ' ' PRO . 21.5 t -65.37 -40.68 89.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.58 115.59 30.79 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.471 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 153' ' ' VAL . . . . . 0.434 HG21 ' O ' ' K' ' 48' ' ' THR . 35.2 m -114.57 123.05 69.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 154' ' ' SER . . . . . 0.738 ' HA ' HD21 ' K' ' 50' ' ' ASN . 1.0 OUTLIER -141.72 137.71 31.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -172.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.522 ' HE2' HD23 ' L' ' 138' ' ' LEU . 0.1 OUTLIER -57.3 -41.25 79.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 175.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' F' ' 158' ' ' TYR . . . 137.03 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 119.393 0.997 . . . . 0.0 113.089 -176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.33 71.21 0.48 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' F' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.31 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.324 1.05 . . . . 0.0 108.613 177.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 159' ' ' ASP . . . . . 0.73 ' HB3' ' CB ' ' L' ' 140' ' ' ASN . 1.6 m-20 -69.07 -46.63 67.33 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -158.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 160' ' ' PHE . . . . . 0.606 ' HB2' HD11 ' L' ' 143' ' ' ILE . 0.3 OUTLIER -132.12 121.73 24.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.696 2.398 . . . . 0.0 109.162 167.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' F' ' 165' ' ' GLN . 0.0 OUTLIER -117.74 45.76 1.88 Allowed 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 154.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 162' ' ' GLN . . . . . 0.95 ' HB2' ' OE2' ' L' ' 142' ' ' GLU . 0.4 OUTLIER -68.29 -32.89 4.23 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -166.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 163' ' ' PRO . . . . . 0.903 ' HG3' ' OD1' ' L' ' 144' ' ' ASP . 22.2 Cg_exo -82.73 -0.91 10.32 Favored 'Trans proline' 0 C--O 1.238 0.517 0 CA-C-N 122.046 1.766 . . . . 0.0 113.893 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.78 73.25 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 -171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' F' ' 161' ' ' GLN . 0.8 OUTLIER -71.81 -43.67 65.25 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.932 1.366 . . . . 0.0 110.881 175.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 166' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' L' ' 21' ' ' ALA . 6.8 p 52.49 49.2 20.96 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 167' ' ' THR . . . . . 0.61 ' H ' ' NZ ' ' L' ' 90' ' ' LYS . 26.9 m -126.33 157.38 38.56 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.31 -167.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.16 20.11 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.507 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . 0.815 ' HG3' ' HG3' ' L' ' 88' ' ' GLN . 0.9 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.754 0.277 . . . . 0.0 111.438 -177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.11 126.44 65.22 Favored Pre-proline 0 C--O 1.235 0.297 0 C-N-CA 123.465 0.706 . . . . 0.0 109.277 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.6 146.1 14.96 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.31 1.34 . . . . 0.0 112.746 -156.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . 0.561 ' H ' HG21 ' F' ' 167' ' ' THR . . . 88.3 8.35 71.55 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 117.22 1.648 . . . . 0.0 117.22 165.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.15 36.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.996 0.898 . . . . 0.0 109.903 170.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 174' ' ' VAL . . . . . 0.494 HG22 ' O ' ' F' ' 165' ' ' GLN . 24.4 t -106.64 117.43 56.94 Favored Pre-proline 0 C--O 1.241 0.607 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.384 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 175' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -67.67 163.24 35.91 Favored 'Trans proline' 0 C--N 1.349 0.562 0 CA-C-N 119.526 0.866 . . . . 0.0 111.681 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.222 0 C-N-CA 125.453 1.501 . . . . 0.0 112.37 -171.709 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 5' ' ' PRO . . . . . 0.566 ' HB2' ' O ' ' H' ' 69' ' ' GLY . 49.5 Cg_endo . . . . . 0 N--CA 1.466 -0.142 0 CA-C-O 119.896 -0.127 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 6' ' ' ILE . . . . . 0.985 HG21 HG23 ' H' ' 126' ' ' VAL . 25.9 mt -127.9 161.74 35.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 7' ' ' MET . . . . . 1.055 ' HG2' ' HB2' ' G' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.78 36.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.934 0.873 . . . . 0.0 110.753 -177.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.81 -17.9 58.75 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.444 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.31 25.59 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.823 0.812 . . . . 0.0 112.376 172.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 10' ' ' ASP . . . . . 1.055 ' HB2' ' HG2' ' G' ' 7' ' ' MET . 28.7 t0 -66.93 -50.76 61.37 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -172.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 11' ' ' VAL . . . . . 0.447 HG22 ' OD2' ' G' ' 95' ' ' ASP . 78.8 t -83.96 121.82 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 12' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' G' ' 27' ' ' LEU . 0.0 OUTLIER -125.23 147.52 49.04 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.685 0.755 . . . . 0.0 110.52 176.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 13' ' ' TYR . . . . . 0.468 ' HD1' ' CE1' ' G' ' 91' ' ' PHE . 40.0 m-85 -111.17 105.51 14.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.704 -164.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 14' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' G' ' 92' ' ' TRP . 1.8 mp -90.27 136.58 32.96 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 15' ' ' PHE . . . . . 0.556 ' CE1' ' HD1' ' G' ' 91' ' ' PHE . 22.7 m-85 -125.89 115.26 19.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 176.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 16' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' G' ' 90' ' ' LYS . 14.6 tt0 -114.19 137.68 51.45 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 170.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -82.73 148.15 28.03 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.047 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 18' ' ' ILE . . . . . 0.83 ' HA ' ' HE2' ' G' ' 90' ' ' LYS . 1.1 pp -62.51 -39.83 85.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.951 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -19.44 63.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -171.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.86 84.18 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.424 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 21' ' ' ALA . . . . . 0.778 ' HB1' HG22 ' A' ' 166' ' ' THR . . . 48.2 57.59 5.99 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.2 1.4 . . . . 0.0 111.816 -173.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 22' ' ' THR . . . . . 0.444 HG22 ' H ' ' G' ' 23' ' ' GLY . 0.2 OUTLIER -137.84 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 163' ' ' PRO . . . -125.17 23.72 6.08 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.32 -0.4 . . . . 0.0 113.715 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.83 -30.38 65.42 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 117.018 0.409 . . . . 0.0 111.769 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 25' ' ' ALA . . . . . 0.485 ' HB3' HD21 ' G' ' 146' ' ' LEU . . . 46.32 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.922 2.089 . . . . 0.0 112.436 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.44 69.22 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.423 0.83 . . . . 0.0 112.501 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . 0.632 HD12 ' HG ' ' G' ' 14' ' ' LEU . 8.7 tt -130.43 150.36 51.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.48 20.6 Favored Pre-proline 0 C--N 1.317 -0.841 0 C-N-CA 115.832 -2.347 . . . . 0.0 110.516 -167.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 29' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.82 -175.6 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.309 0 CA-C-O 121.884 0.702 . . . . 0.0 112.412 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 30' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' G' ' 67' ' ' TYR . . . 59.29 37.3 23.61 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.37 1.468 . . . . 0.0 111.564 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.16 135.39 46.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.527 1.156 . . . . 0.0 111.07 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 32' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' G' ' 32' ' ' GLN . 7.2 mm-40 -104.05 -91.6 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.25 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.747 1.261 . . . . 0.0 111.103 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 34' ' ' ASP . . . . . 0.425 ' OD1' HG22 ' G' ' 65' ' ' VAL . 3.0 t0 -158.94 102.35 1.65 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.026 -1.443 . . . . 0.0 107.962 -164.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.21 13.33 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.338 170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.37 119.33 19.54 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 37' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' H' ' 117' ' ' GLU . 18.8 m -130.83 144.94 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.78 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -166.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 39' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' G' ' 59' ' ' VAL . . . -119.45 114.86 2.87 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.245 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.32 125.88 40.25 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 41' ' ' ARG . . . . . 0.806 HH22 ' HB2' ' G' ' 60' ' ' ALA . 2.1 mtm-85 -68.65 132.28 46.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.684 0.754 . . . . 0.0 110.161 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 42' ' ' GLU . . . . . 0.517 ' HB3' ' HG2' ' H' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.39 32.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -167.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.5 121.62 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.498 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 44' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' G' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.83 3.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.224 171.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 45' ' ' ASP . . . . . 0.539 ' O ' ' HA2' ' G' ' 51' ' ' GLY . 3.2 t70 -111.81 170.14 8.35 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 155.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -71.12 -48.14 53.91 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 47' ' ' GLN . . . . . 0.707 ' HB3' ' HA ' ' B' ' 30' ' ' ALA . 1.4 mt-30 57.86 38.6 27.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.611 1.564 . . . . 0.0 111.638 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 48' ' ' THR . . . . . . . . . . . . . 30.5 p 41.95 45.3 3.24 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.478 1.511 . . . . 0.0 111.581 -164.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.475 -177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 50' ' ' ASN . . . . . 0.516 HD21 ' HA ' ' B' ' 154' ' ' SER . 7.7 m-80 -79.94 16.83 1.08 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 51' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' G' ' 44' ' ' PHE . . . 87.06 167.55 43.86 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 52' ' ' ARG . . . . . 0.478 ' HA ' HH11 ' G' ' 52' ' ' ARG . 0.0 OUTLIER -112.21 122.38 47.57 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.264 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.99 HG12 HG23 ' H' ' 135' ' ' ILE . 1.5 pp -127.22 -39.23 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.844 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 54' ' ' LEU . . . . . 0.561 HD12 ' H ' ' G' ' 54' ' ' LEU . 1.3 mp -61.73 -16.93 53.51 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.63 105.96 1.14 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.705 0.614 . . . . 0.0 113.952 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 56' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' G' ' 54' ' ' LEU . 68.8 Cg_endo -76.84 178.89 7.06 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 N-CA-C 113.886 0.687 . . . . 0.0 113.886 -175.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.02 -163.74 24.56 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 58' ' ' SER . . . . . 0.521 ' HB3' ' HE ' ' G' ' 41' ' ' ARG . 1.7 t -87.51 153.84 21.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 110.498 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' G' ' 39' ' ' GLY . 14.3 p -103.81 130.95 53.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 60' ' ' ALA . . . . . 0.806 ' HB2' HH22 ' G' ' 41' ' ' ARG . . . -107.59 111.01 23.04 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 61' ' ' ASP . . . . . 0.407 ' OD1' ' HA2' ' G' ' 136' ' ' GLY . 15.4 m-20 -102.09 107.44 18.54 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.16 144.81 27.87 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.901 0.88 . . . . 0.0 110.041 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.98 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.152 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 64' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' G' ' 64' ' ' GLU . 2.5 pt-20 -138.53 128.76 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 65' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' G' ' 129' ' ' SER . 40.7 t -116.31 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 66' ' ' THR . . . . . 0.767 HG22 ' HB2' ' G' ' 129' ' ' SER . 63.1 p -114.16 140.44 48.53 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 67' ' ' TYR . . . . . 0.709 ' HE2' HD12 ' G' ' 128' ' ' ILE . 5.6 p90 -161.28 162.43 31.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 68' ' ' TYR . . . . . 0.653 ' HB3' ' HB3' ' G' ' 125' ' ' ALA . 22.0 m-30 -83.38 136.78 34.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' L' ' 5' ' ' PRO . . . -74.96 142.31 29.43 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 114.93 0.732 . . . . 0.0 114.93 -175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 70' ' ' LYS . . . . . 0.529 ' HG3' ' HA ' ' L' ' 5' ' ' PRO . 16.3 tttp -111.67 154.22 25.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' G' ' 71' ' ' ARG . 10.5 ptp180 -53.84 -54.32 40.14 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.97 -117.45 3.6 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.04 120.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.15 1.38 . . . . 0.0 111.011 169.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.41 -21.63 27.02 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -156.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.79 -49.87 69.0 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.863 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -36.64 84.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.852 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.19 86.75 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.802 171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.76 92.51 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.9 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . 0.541 HD12 HD11 ' G' ' 113' ' ' ILE . 5.6 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.09 0.471 . . . . 0.0 110.491 172.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' G' ' 84' ' ' GLN . 0.7 OUTLIER -69.57 -48.03 61.62 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' G' ' 87' ' ' LYS . 29.2 t70 -61.01 -34.83 75.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.544 169.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 82' ' ' ALA . . . . . 0.729 ' HB2' HD11 ' G' ' 89' ' ' ILE . . . -58.64 -53.79 54.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.566 174.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 83' ' ' TYR . . . . . 0.554 ' HD1' HG22 ' G' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.39 26.82 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.944 -174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' G' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.69 64.79 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -167.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.67 -40.76 18.52 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.033 172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.51 102.53 2.6 Favored Glycine 0 N--CA 1.448 -0.511 0 O-C-N 122.313 -0.242 . . . . 0.0 112.862 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 87' ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' G' ' 82' ' ' ALA . 9.5 mptt -139.27 145.5 39.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 88' ' ' GLN . . . . . 0.658 ' HG2' ' HD1' ' G' ' 112' ' ' TYR . 1.6 tm0? -67.34 142.94 56.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 89' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' G' ' 82' ' ' ALA . 5.5 mm -118.84 129.14 75.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.331 0.586 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 90' ' ' LYS . . . . . 0.83 ' HE2' ' HA ' ' G' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.92 20.76 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 91' ' ' PHE . . . . . 0.556 ' HD1' ' CE1' ' G' ' 15' ' ' PHE . 25.0 t80 -108.64 123.44 48.96 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.548 1.139 . . . . 0.0 109.983 -165.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 92' ' ' TRP . . . . . 0.746 ' HB2' ' HB2' ' G' ' 14' ' ' LEU . 6.6 m95 -116.32 122.0 43.63 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.181 0.993 . . . . 0.0 108.355 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 93' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' G' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.57 11.57 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 94' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' G' ' 106' ' ' ALA . 20.7 m -125.28 153.12 32.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.223 1.011 . . . . 0.0 109.416 -173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 95' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' G' ' 11' ' ' VAL . 5.6 m-20 -96.08 156.94 16.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.657 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 96' ' ' THR . . . . . 0.432 ' N ' ' O ' ' G' ' 10' ' ' ASP . 25.6 m -87.1 -3.06 59.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.647 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.711 0.767 . . . . 0.0 109.909 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' G' ' 103' ' ' LYS . 9.9 tttp -68.6 129.25 39.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.964 -174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 99' ' ' ASN . . . . . 0.563 HD22 ' HB2' ' G' ' 102' ' ' ASP . 20.6 t30 -64.67 163.58 13.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.817 0.817 . . . . 0.0 110.001 171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.83 57.65 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -133.54 -36.75 0.96 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.866 169.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 102' ' ' ASP . . . . . 0.563 ' HB2' HD22 ' G' ' 99' ' ' ASN . 0.2 OUTLIER -79.57 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 167.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' G' ' 98' ' ' LYS . 0.1 OUTLIER -71.31 -43.0 67.91 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.936 -0.478 . . . . 0.0 110.548 171.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 104' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' G' ' 142' ' ' GLU . 93.8 m-85 -147.86 172.46 14.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 105' ' ' ASP . . . . . 0.829 ' HA ' ' HA2' ' G' ' 141' ' ' GLY . 1.7 p-10 -116.4 152.68 33.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.601 0.715 . . . . 0.0 109.445 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 106' ' ' ALA . . . . . 0.749 ' HB2' HG12 ' G' ' 94' ' ' VAL . . . -147.41 155.39 41.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.094 -163.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 107' ' ' GLN . . . . . 0.519 ' HB2' ' HD2' ' G' ' 93' ' ' ARG . 53.2 mt-30 -123.92 135.2 53.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 157.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 108' ' ' PHE . . . . . 0.838 ' HD2' HD11 ' G' ' 138' ' ' LEU . 66.2 t80 -128.35 154.61 45.78 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.435 0.694 . . . . 0.0 110.473 -163.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.43 156.65 25.65 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.503 -1.332 . . . . 0.0 111.964 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 110' ' ' PHE . . . . . 0.682 ' O ' HG23 ' G' ' 134' ' ' VAL . 1.5 m-85 -82.91 118.64 23.6 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 111' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' G' ' 132' ' ' LEU . . . -126.25 144.73 50.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.897 0.856 . . . . 0.0 111.212 -169.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 112' ' ' TYR . . . . . 0.658 ' HD1' ' HG2' ' G' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.958 -174.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . 0.554 HG22 ' HD1' ' G' ' 83' ' ' TYR . 54.9 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 114' ' ' GLU . . . . . 0.545 ' HG2' ' HB3' ' L' ' 42' ' ' GLU . 4.4 mt-10 -94.97 -13.47 25.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 115' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 131' ' ' SER . 1.9 m -138.15 137.44 37.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 118.909 0.777 . . . . 0.0 109.096 174.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 116' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' G' ' 116' ' ' ARG . 0.2 OUTLIER -135.69 102.26 5.04 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.897 -2.261 . . . . 0.0 104.897 176.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 117' ' ' GLU . . . . . 0.477 ' HB3' HG12 ' L' ' 37' ' ' VAL . 5.6 mt-10 -119.27 118.91 32.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 118' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' G' ' 127' ' ' GLU . 12.2 p90 -122.6 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.061 0.457 . . . . 0.0 111.191 176.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.61 45.06 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.673 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.54 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.33 175.18 26.8 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 122' ' ' VAL . . . . . . . . . . . . . 76.3 t -62.68 -45.35 99.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.494 -0.416 . . . . 0.0 111.097 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.94 142.45 51.51 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 169.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.38 157.47 10.2 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 125' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' G' ' 68' ' ' TYR . . . -67.27 156.68 35.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.582 0.706 . . . . 0.0 110.766 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 126' ' ' VAL . . . . . 0.917 HG23 HG21 ' L' ' 6' ' ' ILE . 86.7 t -56.84 122.16 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.072 -171.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 127' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' G' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.68 10.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.089 -176.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 128' ' ' ILE . . . . . 0.709 HD12 ' HE2' ' G' ' 67' ' ' TYR . 3.1 mt -108.39 113.17 43.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 129' ' ' SER . . . . . 0.767 ' HB2' HG22 ' G' ' 66' ' ' THR . 4.7 t -119.09 123.7 45.09 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 168.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.29 132.83 65.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 131' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' G' ' 115' ' ' SER . 0.3 OUTLIER -110.71 141.39 44.06 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.359 0.664 . . . . 0.0 109.744 -178.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 132' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' G' ' 111' ' ' ALA . 2.0 pp -148.09 150.66 34.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.097 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.05 39.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 134' ' ' VAL . . . . . 0.871 ' HA ' HD13 ' L' ' 53' ' ' ILE . 2.0 p -135.01 144.14 35.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 135' ' ' ILE . . . . . 0.957 HG23 HG12 ' L' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.55 48.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-O 121.313 0.578 . . . . 0.0 110.362 -173.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 136' ' ' GLY . . . . . 0.672 ' H ' HG12 ' G' ' 135' ' ' ILE . . . -155.5 148.68 19.24 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.695 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.87 37.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.994 0.902 . . . . 0.0 110.709 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 138' ' ' LEU . . . . . 0.838 HD11 ' HD2' ' G' ' 108' ' ' PHE . 0.1 OUTLIER -97.43 128.54 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -174.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 139' ' ' LYS . . . . . 0.55 ' HD3' HE21 ' H' ' 84' ' ' GLN . 16.5 mtmt -86.28 130.95 34.34 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.25 1.92 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 141' ' ' GLY . . . . . 0.829 ' HA2' ' HA ' ' G' ' 105' ' ' ASP . . . -121.29 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.366 169.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 142' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' G' ' 106' ' ' ALA . 16.0 tp10 -101.39 156.47 17.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -174.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . 0.861 ' H ' HD12 ' G' ' 143' ' ' ILE . 0.1 OUTLIER -110.2 -76.39 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.743 -176.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.63 95.54 6.51 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.993 -176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' G' ' 150' ' ' ILE . 53.1 p -95.17 22.69 6.44 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 118.751 -0.643 . . . . 0.0 112.391 175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 146' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' G' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.83 15.8 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.461 1.905 . . . . 0.0 109.428 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 147' ' ' PRO . . . . . 0.563 ' O ' ' HB ' ' G' ' 151' ' ' VAL . 31.5 Cg_exo -69.59 -12.58 33.53 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.249 1.3 . . . . 0.0 115.305 -159.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.72 -53.9 45.59 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.613 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.17 -31.18 8.36 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' G' ' 145' ' ' THR . 5.2 mt -78.64 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 119.145 0.884 . . . . 0.0 111.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' G' ' 147' ' ' PRO . 22.0 t -65.42 -40.64 88.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.6 115.64 30.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.451 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.59 123.09 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 171.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.8 137.77 31.76 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -41.27 79.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 156' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' G' ' 158' ' ' TYR . . . 137.05 141.27 4.22 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 119.373 0.988 . . . . 0.0 113.085 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.31 71.26 0.47 Allowed Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 158' ' ' TYR . . . . . 0.565 ' CE2' ' HA3' ' G' ' 156' ' ' GLY . 0.0 OUTLIER -108.84 89.28 2.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.366 1.066 . . . . 0.0 108.604 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.12 -46.61 67.23 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.14 121.76 24.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.669 2.388 . . . . 0.0 109.135 167.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 161' ' ' GLN . . . . . 0.505 ' HB3' ' CA ' ' G' ' 165' ' ' GLN . 0.0 OUTLIER -117.67 45.78 1.87 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -32.85 4.16 Favored Pre-proline 0 C--O 1.241 0.62 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.82 -0.82 10.25 Favored 'Trans proline' 0 C--O 1.238 0.495 0 CA-C-N 122.048 1.767 . . . . 0.0 113.862 171.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.2 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 118.403 2.121 . . . . 0.0 118.403 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 165' ' ' GLN . . . . . 0.505 ' CA ' ' HB3' ' G' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.61 65.32 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 118.937 1.368 . . . . 0.0 110.932 175.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.5 49.17 21.02 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.806 1.642 . . . . 0.0 111.913 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 167' ' ' THR . . . . . 0.543 HG21 ' H ' ' G' ' 172' ' ' GLY . 26.8 m -126.31 157.4 38.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.298 -167.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.41 -152.09 20.06 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.482 172.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.3 99.11 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.782 0.291 . . . . 0.0 111.469 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.44 65.35 Favored Pre-proline 0 C--O 1.235 0.313 0 C-N-CA 123.488 0.715 . . . . 0.0 109.328 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.67 146.09 14.85 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 121.316 1.344 . . . . 0.0 112.711 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . 0.543 ' H ' HG21 ' G' ' 167' ' ' THR . . . 88.37 8.3 71.38 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 165.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.67 122.13 36.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.94 0.87 . . . . 0.0 109.897 170.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' G' ' 165' ' ' GLN . 24.4 t -106.6 117.47 56.87 Favored Pre-proline 0 C--O 1.241 0.618 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.406 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.73 163.24 36.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 CA-C-N 119.509 0.86 . . . . 0.0 111.725 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.427 1.491 . . . . 0.0 112.33 -171.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 5' ' ' PRO . . . . . 0.582 ' HB2' ' O ' ' I' ' 69' ' ' GLY . 49.2 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.87 -0.137 . . . . 0.0 112.286 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 6' ' ' ILE . . . . . 0.938 HG21 HG23 ' I' ' 126' ' ' VAL . 26.1 mt -127.87 161.76 35.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 7' ' ' MET . . . . . 1.068 ' HG2' ' HB2' ' H' ' 10' ' ' ASP . 0.0 OUTLIER -122.02 154.73 36.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.924 0.869 . . . . 0.0 110.706 -177.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.7 -17.92 58.42 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.537 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.45 -4.31 25.62 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 117.717 0.758 . . . . 0.0 112.409 172.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 10' ' ' ASP . . . . . 1.068 ' HB2' ' HG2' ' H' ' 7' ' ' MET . 28.7 t0 -66.92 -50.8 61.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -172.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 11' ' ' VAL . . . . . 0.441 HG22 ' OD2' ' H' ' 95' ' ' ASP . 78.8 t -84.02 121.78 36.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 12' ' ' LYS . . . . . 0.553 ' HG2' HD11 ' H' ' 27' ' ' LEU . 0.0 OUTLIER -125.14 147.53 48.99 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.725 0.774 . . . . 0.0 110.522 176.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 13' ' ' TYR . . . . . 0.462 ' HD1' ' CE1' ' H' ' 91' ' ' PHE . 39.6 m-85 -111.16 105.5 14.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.75 -164.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 14' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' H' ' 92' ' ' TRP . 1.8 mp -90.22 136.47 33.03 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 174.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 15' ' ' PHE . . . . . 0.555 ' CE1' ' HD1' ' H' ' 91' ' ' PHE . 22.8 m-85 -125.86 115.38 19.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.508 0.671 . . . . 0.0 109.946 176.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 16' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' H' ' 90' ' ' LYS . 14.6 tt0 -114.29 137.74 51.4 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.78 148.14 27.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.02 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 18' ' ' ILE . . . . . 0.827 ' HA ' ' HE2' ' H' ' 90' ' ' LYS . 1.1 pp -62.43 -39.84 85.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.021 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -19.4 63.54 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -171.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.87 84.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.057 -0.657 . . . . 0.0 111.442 -175.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 21' ' ' ALA . . . . . 0.735 ' HB1' HG22 ' B' ' 166' ' ' THR . . . 48.29 57.6 6.02 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.24 1.416 . . . . 0.0 111.732 -173.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 22' ' ' THR . . . . . 0.447 HG22 ' H ' ' H' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.63 5.88 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.447 ' H ' HG22 ' H' ' 22' ' ' THR . . . -125.17 23.69 6.08 Favored Glycine 0 N--CA 1.449 -0.44 0 O-C-N 123.335 0.397 . . . . 0.0 113.724 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.89 -30.35 65.3 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.048 0.424 . . . . 0.0 111.752 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 25' ' ' ALA . . . . . 0.488 ' HB3' HD21 ' H' ' 146' ' ' LEU . . . 46.32 76.31 0.56 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.934 2.094 . . . . 0.0 112.457 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.67 147.41 69.71 Favored 'Trans proline' 0 C--N 1.349 0.561 0 CA-C-N 119.411 0.825 . . . . 0.0 112.533 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . 0.624 HD12 ' HG ' ' H' ' 14' ' ' LEU . 8.7 tt -130.38 150.33 51.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 168.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 28' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -108.51 133.46 20.6 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 115.892 -2.323 . . . . 0.0 110.569 -167.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 29' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.84 -175.63 2.43 Favored 'Trans proline' 0 C--N 1.332 -0.333 0 CA-C-O 121.865 0.694 . . . . 0.0 112.415 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 30' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' H' ' 67' ' ' TYR . . . 59.27 37.33 23.67 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.366 1.466 . . . . 0.0 111.567 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.1 135.4 46.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 122.506 1.146 . . . . 0.0 111.08 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' H' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.62 0.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.66 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 122.798 1.285 . . . . 0.0 111.088 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 34' ' ' ASP . . . . . 0.428 ' OD1' HG22 ' H' ' 65' ' ' VAL . 3.0 t0 -158.98 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.005 -164.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.33 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.306 170.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.35 119.42 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 37' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' I' ' 117' ' ' GLU . 18.8 m -130.92 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -173.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 38' ' ' SER . . . . . . . . . . . . . 8.9 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -166.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' H' ' 59' ' ' VAL . . . -119.43 114.84 2.87 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.247 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.88 40.22 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 41' ' ' ARG . . . . . 0.802 HH22 ' HB2' ' H' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.29 46.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.656 0.741 . . . . 0.0 110.189 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 42' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' I' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.42 32.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -167.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.57 121.66 42.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.497 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 44' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' H' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.81 3.12 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.179 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 45' ' ' ASP . . . . . 0.532 ' O ' ' HA2' ' H' ' 51' ' ' GLY . 3.2 t70 -111.85 170.18 8.33 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 155.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 46' ' ' GLU . . . . . 0.405 ' OE2' ' NE ' ' I' ' 41' ' ' ARG . 2.7 mp0 -71.19 -48.13 53.45 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 47' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 30' ' ' ALA . 1.4 mt-30 57.89 38.56 27.09 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.583 1.553 . . . . 0.0 111.615 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p 42.02 45.23 3.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.495 1.518 . . . . 0.0 111.581 -164.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.74 1.69 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.442 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 50' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -79.87 16.78 1.07 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 51' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' H' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 52' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' H' ' 52' ' ' ARG . 0.0 OUTLIER -112.24 122.32 47.39 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.946 HG12 HG23 ' I' ' 135' ' ' ILE . 1.5 pp -127.17 -39.18 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.844 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 54' ' ' LEU . . . . . 0.559 HD12 ' H ' ' H' ' 54' ' ' LEU . 1.4 mp -61.75 -16.93 53.63 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.54 105.88 1.11 Allowed Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 121.65 0.583 . . . . 0.0 113.954 -170.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 56' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 54' ' ' LEU . 68.9 Cg_endo -76.83 178.91 7.03 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 N-CA-C 113.858 0.676 . . . . 0.0 113.858 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.06 -163.8 24.7 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' H' ' 41' ' ' ARG . 1.7 t -87.45 153.83 21.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.572 0.701 . . . . 0.0 110.518 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' H' ' 39' ' ' GLY . 14.4 p -103.83 130.98 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 60' ' ' ALA . . . . . 0.802 ' HB2' HH22 ' H' ' 41' ' ' ARG . . . -107.63 110.95 22.95 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 174.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 61' ' ' ASP . . . . . 0.408 ' OD1' ' HA2' ' H' ' 136' ' ' GLY . 15.3 m-20 -102.08 107.41 18.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.75 27.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.959 0.903 . . . . 0.0 110.047 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.177 -0.919 . . . . 0.0 112.201 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 64' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' H' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.77 25.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 65' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' H' ' 129' ' ' SER . 40.8 t -116.32 123.67 71.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 66' ' ' THR . . . . . 0.759 HG22 ' HB2' ' H' ' 129' ' ' SER . 62.5 p -114.22 140.47 48.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 67' ' ' TYR . . . . . 0.713 ' HE2' HD12 ' H' ' 128' ' ' ILE . 5.6 p90 -161.31 162.44 30.92 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' H' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.76 34.21 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' G' ' 5' ' ' PRO . . . -74.99 142.33 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.952 0.741 . . . . 0.0 114.952 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 70' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' G' ' 5' ' ' PRO . 16.4 tttp -111.62 154.24 25.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 109.281 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.87 -54.35 39.82 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.99 -117.43 3.59 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 69.98 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.14 1.376 . . . . 0.0 111.046 169.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.31 -21.68 27.17 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 117.464 2.394 . . . . 0.0 117.464 -156.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.8 -49.9 68.65 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.85 168.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.6 84.65 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.875 171.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -37.25 86.98 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.784 171.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.8 92.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.906 168.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . 0.529 HD12 HD11 ' H' ' 113' ' ' ILE . 5.7 mm -53.99 -42.46 54.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.089 0.471 . . . . 0.0 110.457 172.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' H' ' 84' ' ' GLN . 0.7 OUTLIER -69.48 -48.15 61.63 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.715 -0.616 . . . . 0.0 112.439 -178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 81' ' ' ASP . . . . . 0.406 ' OD1' ' HE2' ' H' ' 87' ' ' LYS . 29.2 t70 -60.96 -34.88 75.44 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.552 169.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 82' ' ' ALA . . . . . 0.738 ' HA ' ' HB2' ' H' ' 87' ' ' LYS . . . -58.56 -53.79 54.31 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.129 -1.029 . . . . 0.0 111.558 174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 83' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' H' ' 113' ' ' ILE . 64.5 t80 -74.66 -48.4 26.42 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.877 -174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 84' ' ' GLN . . . . . 0.553 ' HB2' ' O ' ' H' ' 80' ' ' GLU . 0.0 OUTLIER -63.41 -51.64 64.92 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -167.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.71 -40.81 18.41 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.995 172.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.46 2.6 Favored Glycine 0 N--CA 1.449 -0.471 0 O-C-N 122.308 -0.245 . . . . 0.0 112.872 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 87' ' ' LYS . . . . . 0.738 ' HB2' ' HA ' ' H' ' 82' ' ' ALA . 9.5 mptt -139.25 145.54 39.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 88' ' ' GLN . . . . . 0.648 ' HG2' ' HD1' ' H' ' 112' ' ' TYR . 1.6 tm0? -67.39 142.95 56.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB2' ' H' ' 82' ' ' ALA . 5.5 mm -118.83 129.13 75.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 121.364 0.602 . . . . 0.0 109.829 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 90' ' ' LYS . . . . . 0.827 ' HE2' ' HA ' ' H' ' 18' ' ' ILE . 6.4 mtmt -84.37 112.96 20.81 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 91' ' ' PHE . . . . . 0.555 ' HD1' ' CE1' ' H' ' 15' ' ' PHE . 25.0 t80 -108.69 123.44 48.99 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 109.986 -166.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 92' ' ' TRP . . . . . 0.761 ' HB2' ' HB2' ' H' ' 14' ' ' LEU . 6.6 m95 -116.3 122.05 43.78 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.168 0.987 . . . . 0.0 108.349 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' H' ' 107' ' ' GLN . 2.4 tmt_? -108.97 102.61 11.59 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' H' ' 106' ' ' ALA . 20.6 m -125.29 153.09 32.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 122.258 1.027 . . . . 0.0 109.424 -173.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 95' ' ' ASP . . . . . 0.441 ' OD2' HG22 ' H' ' 11' ' ' VAL . 5.6 m-20 -96.12 156.96 16.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.617 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 96' ' ' THR . . . . . 0.409 ' N ' ' O ' ' H' ' 10' ' ' ASP . 26.0 m -87.13 -3.05 59.04 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.658 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -100.99 137.81 27.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-O 121.696 0.76 . . . . 0.0 109.92 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 98' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' H' ' 103' ' ' LYS . 9.9 tttp -68.61 129.25 39.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 99' ' ' ASN . . . . . 0.555 HD22 ' HB2' ' H' ' 102' ' ' ASP . 20.6 t30 -64.68 163.56 13.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.812 0.815 . . . . 0.0 109.96 171.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.04 -8.75 57.71 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.74 0.96 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.851 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 102' ' ' ASP . . . . . 0.555 ' HB2' HD22 ' H' ' 99' ' ' ASN . 0.2 OUTLIER -79.63 173.04 12.99 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 167.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' H' ' 98' ' ' LYS . 0.1 OUTLIER -71.22 -43.08 68.05 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.85 -0.531 . . . . 0.0 110.584 171.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 104' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' H' ' 142' ' ' GLU . 93.7 m-85 -147.81 172.48 14.07 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 105' ' ' ASP . . . . . 0.847 ' HA ' ' HA2' ' H' ' 141' ' ' GLY . 1.7 p-10 -116.38 152.69 33.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.664 0.745 . . . . 0.0 109.457 177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' H' ' 94' ' ' VAL . . . -147.44 155.43 41.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.074 -163.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' H' ' 93' ' ' ARG . 53.2 mt-30 -123.91 135.23 53.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 108' ' ' PHE . . . . . 0.835 ' HD2' HD11 ' H' ' 138' ' ' LEU . 66.3 t80 -128.45 154.62 45.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.416 0.686 . . . . 0.0 110.422 -163.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.41 156.6 25.57 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.948 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 110' ' ' PHE . . . . . 0.683 ' O ' HG23 ' H' ' 134' ' ' VAL . 1.5 m-85 -82.85 118.71 23.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 167.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 111' ' ' ALA . . . . . 0.582 ' HB1' HD13 ' H' ' 132' ' ' LEU . . . -126.26 144.73 50.68 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.903 0.858 . . . . 0.0 111.173 -169.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 112' ' ' TYR . . . . . 0.648 ' HD1' ' HG2' ' H' ' 88' ' ' GLN . 3.1 t80 -122.23 117.45 26.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.502 -1.226 . . . . 0.0 108.008 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . 0.549 HG22 ' CD1' ' H' ' 83' ' ' TYR . 55.2 mt -68.57 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 114' ' ' GLU . . . . . 0.517 ' HG2' ' HB3' ' G' ' 42' ' ' GLU . 4.3 mt-10 -94.97 -13.48 25.27 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 115' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 131' ' ' SER . 1.9 m -138.13 137.41 37.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 118.965 0.802 . . . . 0.0 109.093 174.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.66 102.32 5.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 117' ' ' GLU . . . . . 0.469 ' HB3' HG12 ' G' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.87 32.38 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 118' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' H' ' 127' ' ' GLU . 12.2 p90 -122.59 138.02 54.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.088 0.47 . . . . 0.0 111.198 176.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.14 139.62 45.09 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.661 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 120' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' G' ' 11' ' ' VAL . 0.3 OUTLIER -106.57 116.33 31.74 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 167.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.17 26.82 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-O 121.737 0.631 . . . . 0.0 111.532 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 122' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.63 -45.33 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.484 -0.421 . . . . 0.0 111.152 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.0 142.44 51.52 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.46 10.2 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 166.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' H' ' 68' ' ' TYR . . . -67.31 156.65 35.88 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.577 0.703 . . . . 0.0 110.733 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 126' ' ' VAL . . . . . 0.985 HG23 HG21 ' G' ' 6' ' ' ILE . 86.5 t -56.79 122.14 5.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.039 -171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 127' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' H' ' 118' ' ' TYR . 0.5 OUTLIER -75.9 110.67 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.101 -176.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 128' ' ' ILE . . . . . 0.713 HD12 ' HE2' ' H' ' 67' ' ' TYR . 3.2 mt -108.44 113.23 43.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . 0.759 ' HB2' HG22 ' H' ' 66' ' ' THR . 4.7 t -119.04 123.66 45.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.31 132.85 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 131' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' H' ' 115' ' ' SER . 0.3 OUTLIER -110.73 141.35 44.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.744 -178.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 132' ' ' LEU . . . . . 0.582 HD13 ' HB1' ' H' ' 111' ' ' ALA . 2.0 pp -148.06 150.65 34.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.102 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 167.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 134' ' ' VAL . . . . . 0.807 ' HA ' HD13 ' G' ' 53' ' ' ILE . 2.0 p -135.02 144.08 35.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 135' ' ' ILE . . . . . 0.99 HG23 HG12 ' G' ' 53' ' ' ILE . 0.0 OUTLIER -55.97 -52.51 48.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.377 0.608 . . . . 0.0 110.362 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 136' ' ' GLY . . . . . 0.66 ' H ' HG12 ' H' ' 135' ' ' ILE . . . -155.56 148.66 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.722 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.83 119.85 37.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.054 0.93 . . . . 0.0 110.674 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 138' ' ' LEU . . . . . 0.835 HD11 ' HD2' ' H' ' 108' ' ' PHE . 0.1 OUTLIER -97.42 128.62 44.36 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -174.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 139' ' ' LYS . . . . . 0.534 ' HD3' HE21 ' I' ' 84' ' ' GLN . 16.4 mtmt -86.35 130.93 34.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.65 -168.23 1.92 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 141' ' ' GLY . . . . . 0.847 ' HA2' ' HA ' ' H' ' 105' ' ' ASP . . . -121.28 150.95 17.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.422 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 142' ' ' GLU . . . . . 0.625 ' HB2' ' HB2' ' H' ' 106' ' ' ALA . 16.0 tp10 -101.38 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -174.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . 0.859 ' H ' HD12 ' H' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.43 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.79 -176.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.6 95.5 6.49 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.007 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 145' ' ' THR . . . . . 0.669 ' O ' HD12 ' H' ' 150' ' ' ILE . 52.6 p -95.17 22.73 6.39 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 118.726 -0.654 . . . . 0.0 112.385 175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 146' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' H' ' 25' ' ' ALA . 0.9 OUTLIER 52.15 56.86 15.81 Favored Pre-proline 0 C--N 1.346 0.45 0 C-N-CA 126.512 1.925 . . . . 0.0 109.394 -173.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' H' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.56 33.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.233 1.289 . . . . 0.0 115.31 -159.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' H' ' 149' ' ' GLU . 1.5 tt0 -53.76 -53.84 46.58 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.607 171.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' H' ' 148' ' ' GLU . 1.5 pm0 -107.23 -31.17 8.34 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 150' ' ' ILE . . . . . 0.669 HD12 ' O ' ' H' ' 145' ' ' THR . 5.2 mt -78.61 -50.41 19.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.155 0.889 . . . . 0.0 111.298 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' H' ' 147' ' ' PRO . 22.0 t -65.39 -40.66 89.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -176.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.62 30.84 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.459 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.06 69.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.72 31.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -172.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.34 79.57 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 175.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 156' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' H' ' 158' ' ' TYR . . . 137.08 141.25 4.22 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 119.379 0.99 . . . . 0.0 113.034 -176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.3 71.3 0.47 Allowed Glycine 0 CA--C 1.521 0.431 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 158' ' ' TYR . . . . . 0.563 ' CE2' ' HA3' ' H' ' 156' ' ' GLY . 0.0 OUTLIER -108.89 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.277 1.031 . . . . 0.0 108.614 177.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.13 -46.62 67.21 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -158.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.76 24.3 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.675 2.39 . . . . 0.0 109.155 167.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 161' ' ' GLN . . . . . 0.51 ' HB3' ' CA ' ' H' ' 165' ' ' GLN . 0.0 OUTLIER -117.7 45.79 1.87 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 154.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.35 -32.86 4.16 Favored Pre-proline 0 C--O 1.241 0.612 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -166.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.9 10.3 Favored 'Trans proline' 0 C--O 1.239 0.528 0 CA-C-N 122.046 1.766 . . . . 0.0 113.859 171.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.79 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 118.387 2.115 . . . . 0.0 118.387 -171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 165' ' ' GLN . . . . . 0.51 ' CA ' ' HB3' ' H' ' 161' ' ' GLN . 0.8 OUTLIER -71.78 -43.67 65.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.894 1.347 . . . . 0.0 110.923 175.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.57 49.11 21.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.758 1.623 . . . . 0.0 111.946 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 167' ' ' THR . . . . . 0.551 HG21 ' H ' ' H' ' 172' ' ' GLY . 26.9 m -126.34 157.36 38.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.283 -167.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.15 20.13 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.472 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.54 -43.37 98.98 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.794 0.297 . . . . 0.0 111.419 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.305 0 C-N-CA 123.463 0.705 . . . . 0.0 109.302 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 171' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 121.254 1.303 . . . . 0.0 112.757 -156.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . 0.551 ' H ' HG21 ' H' ' 167' ' ' THR . . . 88.36 8.29 71.44 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 117.181 1.632 . . . . 0.0 117.181 165.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.69 122.17 37.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.972 0.886 . . . . 0.0 109.888 170.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 174' ' ' VAL . . . . . 0.499 HG22 ' O ' ' H' ' 165' ' ' GLN . 24.4 t -106.58 117.42 57.01 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.416 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 175' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -67.69 163.18 36.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.55 0.875 . . . . 0.0 111.751 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 125.423 1.489 . . . . 0.0 112.326 -171.699 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' I' I ' 5' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' J' ' 70' ' ' LYS . 49.7 Cg_endo . . . . . 0 N--CA 1.465 -0.162 0 CA-C-O 119.915 -0.119 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 6' ' ' ILE . . . . . 0.839 HG21 HG23 ' J' ' 126' ' ' VAL . 26.1 mt -127.84 161.75 35.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 7' ' ' MET . . . . . 1.078 ' HG2' ' HB2' ' I' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.79 36.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.885 0.85 . . . . 0.0 110.757 -177.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.8 -17.85 58.63 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 115.375 -0.83 . . . . 0.0 114.502 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.47 -4.36 25.52 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 117.81 0.805 . . . . 0.0 112.415 172.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 10' ' ' ASP . . . . . 1.078 ' HB2' ' HG2' ' I' ' 7' ' ' MET . 28.7 t0 -66.89 -50.77 61.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 11' ' ' VAL . . . . . 0.439 HG22 ' OD2' ' I' ' 95' ' ' ASP . 78.9 t -84.01 121.81 36.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 12' ' ' LYS . . . . . 0.545 ' HG2' HD11 ' I' ' 27' ' ' LEU . 0.0 OUTLIER -125.15 147.52 48.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.659 0.742 . . . . 0.0 110.496 176.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' CE1' ' I' ' 91' ' ' PHE . 40.0 m-85 -111.2 105.45 14.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.71 -164.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 14' ' ' LEU . . . . . 0.764 ' HB2' ' HB2' ' I' ' 92' ' ' TRP . 1.8 mp -90.18 136.48 33.02 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 15' ' ' PHE . . . . . 0.562 ' CE1' ' HD1' ' I' ' 91' ' ' PHE . 22.7 m-85 -125.84 115.3 19.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.488 0.661 . . . . 0.0 109.964 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 16' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' I' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 170.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -82.73 148.14 28.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.055 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 18' ' ' ILE . . . . . 0.849 ' HA ' ' HE2' ' I' ' 90' ' ' LYS . 1.1 pp -62.48 -39.81 85.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.959 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -171.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.88 84.05 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.385 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 21' ' ' ALA . . . . . 0.721 ' HB1' HG22 ' C' ' 166' ' ' THR . . . 48.21 57.66 5.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.24 1.416 . . . . 0.0 111.756 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 22' ' ' THR . . . . . 0.445 HG22 ' H ' ' I' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.67 5.9 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . 0.445 ' H ' HG22 ' I' ' 22' ' ' THR . . . -125.25 23.76 6.04 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.702 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.29 65.3 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.987 0.394 . . . . 0.0 111.802 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 25' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' I' ' 146' ' ' LEU . . . 46.18 76.48 0.54 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 126.978 2.111 . . . . 0.0 112.411 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.83 147.41 68.74 Favored 'Trans proline' 0 C--N 1.35 0.612 0 CA-C-N 119.376 0.813 . . . . 0.0 112.506 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . 0.609 HD12 ' HG ' ' I' ' 14' ' ' LEU . 8.8 tt -130.35 150.29 51.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 168.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 28' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -108.52 133.49 20.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.55 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 29' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -175.65 2.43 Favored 'Trans proline' 0 C--N 1.331 -0.343 0 CA-C-O 121.847 0.686 . . . . 0.0 112.424 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 30' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' I' ' 67' ' ' TYR . . . 59.29 37.32 23.62 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.324 1.45 . . . . 0.0 111.591 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 31' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -72.14 135.35 46.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 122.543 1.163 . . . . 0.0 111.057 173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 32' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' I' ' 32' ' ' GLN . 7.1 mm-40 -103.95 -91.6 0.36 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 33' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' J' ' 120' ' ' ASP . 16.6 p -134.7 170.16 16.24 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 122.798 1.285 . . . . 0.0 111.114 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 34' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' I' ' 65' ' ' VAL . 3.0 t0 -158.93 102.32 1.65 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.966 -164.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.24 13.35 Favored Glycine 0 N--CA 1.44 -1.072 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.311 170.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 36' ' ' SER . . . . . 0.487 ' HB3' ' CE1' ' J' ' 118' ' ' TYR . 48.2 t -133.4 119.36 19.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 37' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' J' ' 117' ' ' GLU . 18.9 m -130.91 144.9 36.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.41 128.15 38.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -166.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 39' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' I' ' 59' ' ' VAL . . . -119.48 114.82 2.86 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.231 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.23 125.85 40.15 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 41' ' ' ARG . . . . . 0.804 HH22 ' HB2' ' I' ' 60' ' ' ALA . 2.1 mtm-85 -68.71 132.29 46.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.713 0.768 . . . . 0.0 110.175 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 42' ' ' GLU . . . . . 0.662 ' HB3' ' HG2' ' J' ' 114' ' ' GLU . 0.0 OUTLIER -138.67 133.42 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -167.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.58 121.58 42.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.545 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 44' ' ' PHE . . . . . 0.594 ' CE2' ' HA3' ' I' ' 51' ' ' GLY . 0.3 OUTLIER -128.39 90.78 3.13 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.249 171.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 45' ' ' ASP . . . . . 0.524 ' O ' ' HA2' ' I' ' 51' ' ' GLY . 3.3 t70 -111.8 170.19 8.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 155.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 46' ' ' GLU . . . . . 0.461 ' OE2' ' HB3' ' J' ' 58' ' ' SER . 2.7 mp0 -71.16 -48.17 53.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 47' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' D' ' 30' ' ' ALA . 1.4 mt-30 57.87 38.6 27.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.6 1.56 . . . . 0.0 111.64 -172.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 48' ' ' THR . . . . . 0.427 ' O ' HG21 ' D' ' 153' ' ' VAL . 30.6 p 42.0 45.28 3.29 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.501 1.521 . . . . 0.0 111.547 -164.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.77 1.7 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.442 -177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 50' ' ' ASN . . . . . 0.639 HD21 ' HA ' ' D' ' 154' ' ' SER . 7.6 m-80 -79.89 16.81 1.07 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 51' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' I' ' 44' ' ' PHE . . . 87.09 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' HD3' ' I' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.33 47.43 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.948 HG12 HG23 ' J' ' 135' ' ' ILE . 1.5 pp -127.17 -39.19 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.907 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 54' ' ' LEU . . . . . 0.565 ' H ' HD12 ' I' ' 54' ' ' LEU . 1.4 mp -61.79 -16.86 53.31 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.65 105.9 1.12 Allowed Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 121.709 0.616 . . . . 0.0 113.965 -170.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' I' ' 54' ' ' LEU . 69.0 Cg_endo -76.79 178.85 7.09 Favored 'Trans proline' 0 CA--C 1.515 -0.429 0 N-CA-C 113.885 0.686 . . . . 0.0 113.885 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.0 -163.79 24.63 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 58' ' ' SER . . . . . 0.52 ' HB3' ' HE ' ' I' ' 41' ' ' ARG . 1.7 t -87.45 153.86 21.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.617 0.723 . . . . 0.0 110.529 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' I' ' 39' ' ' GLY . 14.3 p -103.82 130.96 53.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 60' ' ' ALA . . . . . 0.804 ' HB2' HH22 ' I' ' 41' ' ' ARG . . . -107.65 111.02 23.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 61' ' ' ASP . . . . . 0.406 ' OD1' ' HA2' ' I' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.43 18.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -171.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.17 144.76 27.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.956 0.902 . . . . 0.0 110.044 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.94 145.98 17.24 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.151 176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 64' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' I' ' 64' ' ' GLU . 2.5 pt-20 -138.52 128.76 25.78 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 174.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 65' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' I' ' 129' ' ' SER . 40.6 t -116.32 123.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 66' ' ' THR . . . . . 0.764 HG22 ' HB2' ' I' ' 129' ' ' SER . 63.3 p -114.14 140.4 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 67' ' ' TYR . . . . . 0.72 ' HE2' HD12 ' I' ' 128' ' ' ILE . 5.6 p90 -161.24 162.43 31.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 68' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' I' ' 125' ' ' ALA . 22.0 m-30 -83.43 136.78 34.19 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HB2' ' H' ' 5' ' ' PRO . . . -75.03 142.38 29.45 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 114.897 0.719 . . . . 0.0 114.897 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 70' ' ' LYS . . . . . 0.575 ' HG3' ' HA ' ' H' ' 5' ' ' PRO . 16.3 tttp -111.63 154.25 25.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 174.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 71' ' ' ARG . . . . . 0.408 HH21 ' HD3' ' I' ' 71' ' ' ARG . 10.5 ptp180 -53.91 -54.3 40.65 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 72' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' I' ' 71' ' ' ARG . . . -112.03 -117.38 3.58 Favored Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.02 120.81 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.071 1.348 . . . . 0.0 111.037 169.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.68 27.11 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 75' ' ' GLY . . . . . 0.402 ' O ' HG12 ' I' ' 79' ' ' ILE . . . -62.76 -49.94 68.45 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 120.228 -0.987 . . . . 0.0 112.831 168.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -36.65 84.82 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.849 171.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.815 171.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.8 92.4 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.902 168.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . 0.53 HD12 HD11 ' I' ' 113' ' ' ILE . 5.7 mm -53.99 -42.4 54.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 110.468 172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' I' ' 84' ' ' GLN . 0.7 OUTLIER -69.58 -48.1 61.33 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 112.39 -177.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 81' ' ' ASP . . . . . 0.401 ' OD1' ' HE2' ' I' ' 87' ' ' LYS . 29.1 t70 -60.96 -34.88 75.43 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.547 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 82' ' ' ALA . . . . . 0.747 ' HA ' ' HB2' ' I' ' 87' ' ' LYS . . . -58.6 -53.79 54.33 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.579 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 83' ' ' TYR . . . . . 0.555 ' HD1' HG22 ' I' ' 113' ' ' ILE . 64.4 t80 -74.55 -48.47 26.69 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.919 -174.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 84' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' I' ' 80' ' ' GLU . 0.0 OUTLIER -63.44 -51.61 64.99 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -167.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 85' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -83.64 -40.85 18.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.884 -0.727 . . . . 0.0 111.032 172.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.48 2.6 Favored Glycine 0 N--CA 1.449 -0.482 0 O-C-N 122.292 -0.255 . . . . 0.0 112.857 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 87' ' ' LYS . . . . . 0.747 ' HB2' ' HA ' ' I' ' 82' ' ' ALA . 9.5 mptt -139.24 145.54 39.34 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 88' ' ' GLN . . . . . 0.662 ' HG2' ' HD1' ' I' ' 112' ' ' TYR . 1.6 tm0? -67.43 142.94 56.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 168.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 89' ' ' ILE . . . . . 0.737 HD11 ' HB2' ' I' ' 82' ' ' ALA . 5.5 mm -118.85 129.08 75.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.377 0.608 . . . . 0.0 109.856 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 90' ' ' LYS . . . . . 0.849 ' HE2' ' HA ' ' I' ' 18' ' ' ILE . 6.4 mtmt -84.29 112.97 20.79 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 91' ' ' PHE . . . . . 0.562 ' HD1' ' CE1' ' I' ' 15' ' ' PHE . 25.0 t80 -108.67 123.42 48.94 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.531 1.132 . . . . 0.0 110.0 -165.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 92' ' ' TRP . . . . . 0.764 ' HB2' ' HB2' ' I' ' 14' ' ' LEU . 6.5 m95 -116.32 121.99 43.59 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.23 1.012 . . . . 0.0 108.359 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 93' ' ' ARG . . . . . 0.508 ' HD2' ' HB2' ' I' ' 107' ' ' GLN . 2.4 tmt_? -108.91 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 172.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 94' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' I' ' 106' ' ' ALA . 20.6 m -125.22 153.1 32.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 122.228 1.013 . . . . 0.0 109.414 -173.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 95' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' I' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.9 16.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.668 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' I' ' 10' ' ' ASP . 25.7 m -87.04 -3.07 59.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.709 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -101.03 137.78 27.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.705 0.764 . . . . 0.0 109.901 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 98' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' I' ' 103' ' ' LYS . 9.9 tttp -68.59 129.24 39.36 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.999 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 99' ' ' ASN . . . . . 0.579 HD22 ' HB2' ' I' ' 102' ' ' ASP . 20.6 t30 -64.64 163.56 13.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.776 0.798 . . . . 0.0 109.992 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.06 -8.8 57.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.55 -36.68 0.96 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.858 169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 102' ' ' ASP . . . . . 0.579 ' HB2' HD22 ' I' ' 99' ' ' ASN . 0.2 OUTLIER -79.6 173.0 13.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 103' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' I' ' 98' ' ' LYS . 0.1 OUTLIER -71.27 -43.0 68.06 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.828 -0.545 . . . . 0.0 110.584 171.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 104' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' I' ' 142' ' ' GLU . 93.7 m-85 -147.83 172.54 13.97 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 105' ' ' ASP . . . . . 0.857 ' HA ' ' HA2' ' I' ' 141' ' ' GLY . 1.7 p-10 -116.46 152.69 33.51 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.631 0.729 . . . . 0.0 109.421 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 106' ' ' ALA . . . . . 0.744 ' HB2' HG12 ' I' ' 94' ' ' VAL . . . -147.44 155.4 41.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.013 -163.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 107' ' ' GLN . . . . . 0.508 ' HB2' ' HD2' ' I' ' 93' ' ' ARG . 53.2 mt-30 -123.94 135.27 53.56 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 157.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 108' ' ' PHE . . . . . 0.831 ' HD2' HD11 ' I' ' 138' ' ' LEU . 66.1 t80 -128.47 154.61 45.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.392 0.677 . . . . 0.0 110.413 -163.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.46 156.58 25.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.967 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' I' ' 134' ' ' VAL . 1.5 m-85 -82.77 118.63 23.52 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 167.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 111' ' ' ALA . . . . . 0.583 ' HB1' HD13 ' I' ' 132' ' ' LEU . . . -126.29 144.78 50.67 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.915 0.864 . . . . 0.0 111.148 -169.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 112' ' ' TYR . . . . . 0.662 ' HD1' ' HG2' ' I' ' 88' ' ' GLN . 3.1 t80 -122.22 117.44 26.19 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.983 -174.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . 0.555 HG22 ' HD1' ' I' ' 83' ' ' TYR . 55.4 mt -68.59 101.88 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 114' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' H' ' 42' ' ' GLU . 4.4 mt-10 -94.99 -13.48 25.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 131' ' ' SER . 1.9 m -138.11 137.39 37.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.913 0.779 . . . . 0.0 109.079 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 116' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' I' ' 116' ' ' ARG . 0.2 OUTLIER -135.67 102.36 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 176.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 117' ' ' GLU . . . . . 0.406 ' HB3' HG12 ' H' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.82 32.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 118' ' ' TYR . . . . . 0.575 ' HA ' ' O ' ' I' ' 127' ' ' GLU . 12.3 p90 -122.57 137.99 54.72 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 121.043 0.449 . . . . 0.0 111.213 176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.11 139.6 45.08 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.679 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.57 116.35 31.77 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 167.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.31 175.18 26.82 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-O 121.696 0.609 . . . . 0.0 111.602 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 122' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.69 -45.36 99.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 O-C-N 122.452 -0.44 . . . . 0.0 111.058 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.93 142.41 51.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.43 157.48 10.19 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 166.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 125' ' ' ALA . . . . . 0.649 ' HB3' ' HB3' ' I' ' 68' ' ' TYR . . . -67.26 156.63 35.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.588 0.709 . . . . 0.0 110.766 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 126' ' ' VAL . . . . . 0.938 HG23 HG21 ' H' ' 6' ' ' ILE . 87.0 t -56.85 122.15 5.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.081 -171.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 127' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' I' ' 118' ' ' TYR . 0.5 OUTLIER -75.86 110.63 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 -176.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 128' ' ' ILE . . . . . 0.72 HD12 ' HE2' ' I' ' 67' ' ' TYR . 3.1 mt -108.37 113.21 43.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 129' ' ' SER . . . . . 0.764 ' HB2' HG22 ' I' ' 66' ' ' THR . 4.7 t -119.08 123.61 44.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.83 65.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' I' ' 115' ' ' SER . 0.3 OUTLIER -110.69 141.35 44.08 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.734 -178.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 132' ' ' LEU . . . . . 0.583 HD13 ' HB1' ' I' ' 111' ' ' ALA . 2.0 pp -148.07 150.67 34.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.133 -172.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 146.0 39.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 167.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 134' ' ' VAL . . . . . 0.857 ' HA ' HD13 ' H' ' 53' ' ' ILE . 2.0 p -135.0 144.15 35.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 135' ' ' ILE . . . . . 0.946 HG23 HG12 ' H' ' 53' ' ' ILE . 0.0 OUTLIER -55.99 -52.54 48.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.344 0.593 . . . . 0.0 110.369 -173.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' I' ' 135' ' ' ILE . . . -155.54 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.706 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.84 119.91 37.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.038 0.923 . . . . 0.0 110.653 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 138' ' ' LEU . . . . . 0.831 HD11 ' HD2' ' I' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.56 44.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -174.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 139' ' ' LYS . . . . . 0.572 ' HD3' ' HG2' ' J' ' 80' ' ' GLU . 16.4 mtmt -86.33 130.97 34.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.69 -168.28 1.92 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 141' ' ' GLY . . . . . 0.857 ' HA2' ' HA ' ' I' ' 105' ' ' ASP . . . -121.24 150.94 17.09 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.216 -0.993 . . . . 0.0 111.369 169.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 142' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' I' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.48 17.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . 0.871 HD12 ' H ' ' I' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.34 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.781 -176.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.64 95.56 6.52 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.917 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 145' ' ' THR . . . . . 0.665 ' O ' HD12 ' I' ' 150' ' ' ILE . 53.0 p -95.21 22.62 6.55 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.342 175.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 146' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' I' ' 25' ' ' ALA . 0.9 OUTLIER 52.24 56.81 15.66 Favored Pre-proline 0 C--O 1.237 0.42 0 C-N-CA 126.489 1.916 . . . . 0.0 109.394 -173.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 147' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' I' ' 151' ' ' VAL . 31.6 Cg_exo -69.61 -12.56 33.46 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.215 1.277 . . . . 0.0 115.34 -159.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.75 -53.85 46.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.579 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -107.22 -31.17 8.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -173.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 150' ' ' ILE . . . . . 0.665 HD12 ' O ' ' I' ' 145' ' ' THR . 5.2 mt -78.6 -50.44 18.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.146 0.884 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' I' ' 147' ' ' PRO . 21.6 t -65.45 -40.65 88.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 152' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -103.62 115.61 30.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.467 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.57 123.11 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.82 137.75 31.7 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -41.26 79.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 156' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' I' ' 158' ' ' TYR . . . 137.04 141.28 4.22 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 119.353 0.979 . . . . 0.0 113.097 -176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.28 71.19 0.48 Allowed Glycine 0 CA--C 1.521 0.442 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 158' ' ' TYR . . . . . 0.544 ' CE2' ' HA3' ' I' ' 156' ' ' GLY . 0.0 OUTLIER -108.86 89.33 2.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.311 1.044 . . . . 0.0 108.629 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.11 -46.63 67.22 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -158.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.11 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.685 2.394 . . . . 0.0 109.159 167.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' I' ' 165' ' ' GLN . 0.0 OUTLIER -117.73 45.8 1.87 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 154.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.3 -32.87 4.21 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -166.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.73 -0.9 10.32 Favored 'Trans proline' 0 C--O 1.239 0.533 0 CA-C-N 122.079 1.778 . . . . 0.0 113.871 171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.19 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 118.378 2.111 . . . . 0.0 118.378 -171.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' I' ' 161' ' ' GLN . 0.8 OUTLIER -71.76 -43.67 65.38 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.923 1.361 . . . . 0.0 110.921 175.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' I' I ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.49 49.21 20.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.804 1.642 . . . . 0.0 111.916 176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 167' ' ' THR . . . . . 0.558 HG21 ' H ' ' I' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.293 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.38 -152.14 20.09 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.503 172.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.6 -43.33 99.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.833 0.316 . . . . 0.0 111.4 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.08 126.46 65.21 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 123.518 0.727 . . . . 0.0 109.273 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.64 146.07 14.89 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.348 1.365 . . . . 0.0 112.74 -156.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . 0.558 ' H ' HG21 ' I' ' 167' ' ' THR . . . 88.31 8.31 71.57 Favored Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 117.19 1.636 . . . . 0.0 117.19 165.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.64 122.17 36.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 118.012 0.906 . . . . 0.0 109.858 170.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 174' ' ' VAL . . . . . 0.501 HG22 ' O ' ' I' ' 165' ' ' GLN . 24.5 t -106.62 117.48 56.83 Favored Pre-proline 0 C--O 1.24 0.585 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.4 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' I' I ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.72 163.25 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.501 0.858 . . . . 0.0 111.729 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' I' I ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 C-N-CA 125.413 1.485 . . . . 0.0 112.308 -171.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' J' J ' 5' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' K' ' 70' ' ' LYS . 50.5 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 119.849 -0.146 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' K' ' 126' ' ' VAL . 26.0 mt -127.94 161.73 35.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 7' ' ' MET . . . . . 1.059 ' HG2' ' HB2' ' J' ' 10' ' ' ASP . 0.0 OUTLIER -121.99 154.77 36.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 0.0 110.769 -177.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' K' ' 123' ' ' GLU . . . -62.77 -17.84 58.54 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.362 -0.836 . . . . 0.0 114.519 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.51 -4.3 25.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 117.772 0.786 . . . . 0.0 112.413 172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 10' ' ' ASP . . . . . 1.059 ' HB2' ' HG2' ' J' ' 7' ' ' MET . 28.7 t0 -66.94 -50.8 61.22 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 11' ' ' VAL . . . . . 0.444 HG22 ' OD2' ' J' ' 95' ' ' ASP . 79.1 t -83.98 121.82 36.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' J' ' 27' ' ' LEU . 0.0 OUTLIER -125.21 147.52 49.03 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.742 0.782 . . . . 0.0 110.464 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 13' ' ' TYR . . . . . 0.454 ' HD1' ' CE1' ' J' ' 91' ' ' PHE . 39.6 m-85 -111.13 105.44 14.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.789 -164.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 14' ' ' LEU . . . . . 0.731 ' HB2' ' HB2' ' J' ' 92' ' ' TRP . 1.8 mp -90.17 136.53 32.99 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 15' ' ' PHE . . . . . 0.549 ' CE1' ' HD1' ' J' ' 91' ' ' PHE . 23.0 m-85 -125.86 115.29 19.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.648 . . . . 0.0 109.925 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 16' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' J' ' 90' ' ' LYS . 14.6 tt0 -114.24 137.7 51.44 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 170.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.72 148.15 28.05 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.551 0.691 . . . . 0.0 111.026 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 18' ' ' ILE . . . . . 0.858 ' HA ' ' HE2' ' J' ' 90' ' ' LYS . 1.1 pp -62.48 -39.83 85.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.005 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.75 -19.41 63.53 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -171.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.88 84.31 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.433 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 21' ' ' ALA . . . . . 0.684 ' HB1' HG22 ' D' ' 166' ' ' THR . . . 48.14 57.67 5.89 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.253 1.421 . . . . 0.0 111.796 -173.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 22' ' ' THR . . . . . 0.436 HG22 ' H ' ' J' ' 23' ' ' GLY . 0.2 OUTLIER -137.85 -179.69 5.91 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' D' ' 163' ' ' PRO . . . -125.16 23.69 6.08 Favored Glycine 0 N--CA 1.451 -0.366 0 O-C-N 123.365 0.416 . . . . 0.0 113.695 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 -30.38 65.41 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 117.021 0.41 . . . . 0.0 111.79 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' J' ' 146' ' ' LEU . . . 46.39 76.36 0.56 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 126.938 2.095 . . . . 0.0 112.391 -174.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -68.76 147.43 69.19 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.45 0.839 . . . . 0.0 112.461 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . 0.626 HD12 ' HG ' ' J' ' 14' ' ' LEU . 8.8 tt -130.42 150.33 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 168.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.53 133.47 20.6 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.818 -2.353 . . . . 0.0 110.509 -167.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 29' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -74.8 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.314 0 CA-C-O 121.895 0.706 . . . . 0.0 112.398 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 30' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' J' ' 67' ' ' TYR . . . 59.24 37.27 23.8 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.354 1.462 . . . . 0.0 111.631 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.04 135.35 46.3 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 122.535 1.16 . . . . 0.0 111.077 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 32' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' J' ' 32' ' ' GLN . 7.1 mm-40 -104.0 -91.67 0.36 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.65 170.17 16.21 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 122.8 1.286 . . . . 0.0 111.08 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 34' ' ' ASP . . . . . 0.431 ' OD1' HG22 ' J' ' 65' ' ' VAL . 3.0 t0 -158.96 102.28 1.64 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.065 -1.425 . . . . 0.0 107.987 -164.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.19 13.32 Favored Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.384 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 36' ' ' SER . . . . . . . . . . . . . 48.1 t -133.34 119.35 19.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 37' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' K' ' 117' ' ' GLU . 18.9 m -130.88 144.87 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 38' ' ' SER . . . . . . . . . . . . . 9.1 m -131.48 128.14 38.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -166.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 39' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' J' ' 59' ' ' VAL . . . -119.5 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.219 -178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 40' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -95.24 125.88 40.18 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 41' ' ' ARG . . . . . 0.794 HH22 ' HB2' ' J' ' 60' ' ' ALA . 2.1 mtm-85 -68.74 132.31 46.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.707 0.765 . . . . 0.0 110.133 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 42' ' ' GLU . . . . . 0.568 ' HB3' ' HG2' ' K' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -167.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.61 121.59 42.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.506 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 44' ' ' PHE . . . . . 0.6 ' CE2' ' HA3' ' J' ' 51' ' ' GLY . 0.3 OUTLIER -128.4 90.77 3.12 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.287 171.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 45' ' ' ASP . . . . . 0.544 ' O ' ' HA2' ' J' ' 51' ' ' GLY . 3.2 t70 -111.81 170.19 8.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 155.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 46' ' ' GLU . . . . . 0.446 ' OE2' ' NE ' ' K' ' 41' ' ' ARG . 2.7 mp0 -71.2 -48.14 53.24 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 47' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' E' ' 30' ' ' ALA . 1.4 mt-30 57.86 38.56 27.17 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.675 1.59 . . . . 0.0 111.656 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 48' ' ' THR . . . . . 0.402 ' O ' HG21 ' E' ' 153' ' ' VAL . 30.4 p 42.01 45.24 3.28 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.51 1.524 . . . . 0.0 111.586 -164.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.89 -163.71 1.68 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.48 -177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 50' ' ' ASN . . . . . 0.56 HD21 ' HA ' ' E' ' 154' ' ' SER . 7.6 m-80 -79.88 16.74 1.09 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 51' ' ' GLY . . . . . 0.6 ' HA3' ' CE2' ' J' ' 44' ' ' PHE . . . 87.07 167.52 43.83 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 52' ' ' ARG . . . . . 0.534 ' HA ' ' HD3' ' J' ' 52' ' ' ARG . 0.0 OUTLIER -112.19 122.41 47.66 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.92 HG12 HG23 ' K' ' 135' ' ' ILE . 1.5 pp -127.24 -39.2 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.862 178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 54' ' ' LEU . . . . . 0.571 HD12 ' H ' ' J' ' 54' ' ' LEU . 1.3 mp -61.75 -16.9 53.42 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.9 1.11 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 121.601 0.556 . . . . 0.0 113.926 -170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 56' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' J' ' 54' ' ' LEU . 69.0 Cg_endo -76.81 178.85 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.402 0 N-CA-C 113.852 0.674 . . . . 0.0 113.852 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.98 -163.75 24.54 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 58' ' ' SER . . . . . 0.525 ' HB3' ' HE ' ' J' ' 41' ' ' ARG . 1.7 t -87.45 153.84 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.59 0.71 . . . . 0.0 110.493 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' J' ' 39' ' ' GLY . 14.3 p -103.8 130.96 53.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 60' ' ' ALA . . . . . 0.794 ' HB2' HH22 ' J' ' 41' ' ' ARG . . . -107.58 111.0 23.04 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' J' ' 136' ' ' GLY . 15.4 m-20 -102.07 107.45 18.57 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.18 144.72 27.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.972 0.909 . . . . 0.0 110.051 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.02 17.29 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.184 -0.917 . . . . 0.0 112.146 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' J' ' 64' ' ' GLU . 2.5 pt-20 -138.51 128.8 25.86 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 65' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' J' ' 129' ' ' SER . 40.7 t -116.34 123.61 71.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 66' ' ' THR . . . . . 0.77 HG22 ' HB2' ' J' ' 129' ' ' SER . 62.5 p -114.17 140.43 48.54 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 67' ' ' TYR . . . . . 0.722 ' HE2' HD12 ' J' ' 128' ' ' ILE . 5.6 p90 -161.26 162.47 31.09 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 68' ' ' TYR . . . . . 0.642 ' HB3' ' HB3' ' J' ' 125' ' ' ALA . 22.0 m-30 -83.4 136.74 34.22 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' I' ' 5' ' ' PRO . . . -75.01 142.34 29.43 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 114.911 0.724 . . . . 0.0 114.911 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 70' ' ' LYS . . . . . 0.542 ' HG3' ' HA ' ' I' ' 5' ' ' PRO . 16.3 tttp -111.6 154.26 25.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 71' ' ' ARG . . . . . 0.448 HH21 ' HD3' ' J' ' 71' ' ' ARG . 10.5 ptp180 -53.9 -54.35 39.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -172.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.0 -117.38 3.59 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.03 120.82 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.09 1.356 . . . . 0.0 110.977 169.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.35 -21.63 27.12 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -156.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 75' ' ' GLY . . . . . 0.404 ' O ' HG12 ' J' ' 79' ' ' ILE . . . -62.85 -49.83 69.13 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.858 168.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -36.66 84.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.189 -0.604 . . . . 0.0 111.81 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -37.22 86.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.846 171.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.75 -45.79 92.4 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.859 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . 0.535 HD12 HD11 ' J' ' 113' ' ' ILE . 5.7 mm -54.01 -42.4 54.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 121.062 0.458 . . . . 0.0 110.456 172.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . 0.572 ' HG2' ' HD3' ' I' ' 139' ' ' LYS . 0.7 OUTLIER -69.59 -48.09 61.31 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.767 -0.583 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 81' ' ' ASP . . . . . 0.41 ' OD1' ' HE2' ' J' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.85 75.36 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.586 169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 82' ' ' ALA . . . . . 0.739 ' HA ' ' HB2' ' J' ' 87' ' ' LYS . . . -58.61 -53.82 54.07 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.08 -1.048 . . . . 0.0 111.563 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 83' ' ' TYR . . . . . 0.553 ' CD1' HG22 ' J' ' 113' ' ' ILE . 64.4 t80 -74.6 -48.35 27.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.941 -174.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' J' ' 80' ' ' GLU . 0.0 OUTLIER -63.51 -51.62 64.71 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -167.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.64 -40.81 18.52 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.039 172.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.56 102.51 2.6 Favored Glycine 0 N--CA 1.449 -0.467 0 O-C-N 122.358 -0.214 . . . . 0.0 112.849 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 87' ' ' LYS . . . . . 0.739 ' HB2' ' HA ' ' J' ' 82' ' ' ALA . 9.5 mptt -139.28 145.53 39.27 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 88' ' ' GLN . . . . . 0.651 ' HG2' ' HD1' ' J' ' 112' ' ' TYR . 1.6 tm0? -67.37 142.94 56.59 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 168.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 89' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' J' ' 82' ' ' ALA . 5.5 mm -118.85 129.14 75.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.364 0.602 . . . . 0.0 109.795 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 90' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' J' ' 18' ' ' ILE . 6.5 mtmt -84.42 112.94 20.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 91' ' ' PHE . . . . . 0.549 ' HD1' ' CE1' ' J' ' 15' ' ' PHE . 24.9 t80 -108.63 123.5 49.05 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.515 1.126 . . . . 0.0 109.98 -165.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 92' ' ' TRP . . . . . 0.731 ' HB2' ' HB2' ' J' ' 14' ' ' LEU . 6.6 m95 -116.38 122.06 43.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.189 0.996 . . . . 0.0 108.318 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 93' ' ' ARG . . . . . 0.509 ' HD2' ' HB2' ' J' ' 107' ' ' GLN . 2.4 tmt_? -108.98 102.55 11.54 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 94' ' ' VAL . . . . . 0.757 HG12 ' HB2' ' J' ' 106' ' ' ALA . 20.5 m -125.28 153.09 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 122.254 1.026 . . . . 0.0 109.43 -173.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 95' ' ' ASP . . . . . 0.444 ' OD2' HG22 ' J' ' 11' ' ' VAL . 5.6 m-20 -96.11 156.89 16.14 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.627 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 96' ' ' THR . . . . . 0.429 ' N ' ' O ' ' J' ' 10' ' ' ASP . 25.7 m -87.03 -3.11 59.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.665 -176.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.95 137.84 27.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.684 0.754 . . . . 0.0 109.882 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 98' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' J' ' 103' ' ' LYS . 9.9 tttp -68.67 129.19 39.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.958 -174.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 99' ' ' ASN . . . . . 0.58 HD22 ' HB2' ' J' ' 102' ' ' ASP . 20.6 t30 -64.63 163.55 13.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.844 0.831 . . . . 0.0 109.983 171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.98 -8.86 57.69 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.79 0.96 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.753 0.706 . . . . 0.0 110.893 169.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 102' ' ' ASP . . . . . 0.58 ' HB2' HD22 ' J' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 172.99 13.04 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' J' ' 98' ' ' LYS . 0.1 OUTLIER -71.24 -43.02 68.09 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.839 -0.538 . . . . 0.0 110.586 171.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 104' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' J' ' 142' ' ' GLU . 93.8 m-85 -147.82 172.46 14.1 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 105' ' ' ASP . . . . . 0.848 ' HA ' ' HA2' ' J' ' 141' ' ' GLY . 1.7 p-10 -116.34 152.72 33.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.61 0.719 . . . . 0.0 109.488 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 106' ' ' ALA . . . . . 0.757 ' HB2' HG12 ' J' ' 94' ' ' VAL . . . -147.46 155.42 41.9 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.0 -163.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 107' ' ' GLN . . . . . 0.509 ' HB2' ' HD2' ' J' ' 93' ' ' ARG . 53.1 mt-30 -123.92 135.28 53.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 108' ' ' PHE . . . . . 0.827 ' HD2' HD11 ' J' ' 138' ' ' LEU . 66.4 t80 -128.46 154.61 45.89 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.43 0.692 . . . . 0.0 110.456 -163.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.42 156.62 25.6 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 119.535 -1.316 . . . . 0.0 111.997 170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 110' ' ' PHE . . . . . 0.675 ' O ' HG23 ' J' ' 134' ' ' VAL . 1.5 m-85 -82.87 118.69 23.61 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 167.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 111' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' J' ' 132' ' ' LEU . . . -126.31 144.72 50.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.892 0.853 . . . . 0.0 111.182 -169.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 112' ' ' TYR . . . . . 0.651 ' HD1' ' HG2' ' J' ' 88' ' ' GLN . 3.1 t80 -122.18 117.46 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.48 -1.237 . . . . 0.0 107.991 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . 0.553 HG22 ' CD1' ' J' ' 83' ' ' TYR . 55.2 mt -68.58 101.9 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 114' ' ' GLU . . . . . 0.662 ' HG2' ' HB3' ' I' ' 42' ' ' GLU . 4.4 mt-10 -95.02 -13.43 25.24 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 115' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 131' ' ' SER . 1.9 m -138.18 137.34 37.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.958 0.799 . . . . 0.0 109.12 174.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.36 5.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 117' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' I' ' 37' ' ' VAL . 5.6 mt-10 -119.33 118.84 32.3 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 118' ' ' TYR . . . . . 0.578 ' HA ' ' O ' ' J' ' 127' ' ' GLU . 12.4 p90 -122.62 138.04 54.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.125 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.19 139.63 45.14 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.665 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 120' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' I' ' 33' ' ' THR . 0.3 OUTLIER -106.54 116.29 31.67 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 167.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.28 175.21 26.88 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-O 121.702 0.612 . . . . 0.0 111.573 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 122' ' ' VAL . . . . . . . . . . . . . 75.8 t -62.7 -45.34 99.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 122.499 -0.412 . . . . 0.0 111.105 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 123' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -125.95 142.38 51.54 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 169.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.41 157.45 10.19 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 125' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' J' ' 68' ' ' TYR . . . -67.25 156.66 35.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.588 0.709 . . . . 0.0 110.767 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 126' ' ' VAL . . . . . 0.839 HG23 HG21 ' I' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.982 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 127' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' J' ' 118' ' ' TYR . 0.5 OUTLIER -75.97 110.71 10.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.1 -176.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 128' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' J' ' 67' ' ' TYR . 3.1 mt -108.45 113.18 43.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 129' ' ' SER . . . . . 0.77 ' HB2' HG22 ' J' ' 66' ' ' THR . 4.7 t -119.07 123.68 45.07 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.28 132.84 65.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 131' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' J' ' 115' ' ' SER . 0.3 OUTLIER -110.66 141.38 43.99 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.745 -178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 132' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' J' ' 111' ' ' ALA . 2.0 pp -148.16 150.66 34.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.105 -172.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.07 39.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 167.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 134' ' ' VAL . . . . . 0.921 ' HA ' HD13 ' I' ' 53' ' ' ILE . 2.0 p -135.03 144.12 35.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 135' ' ' ILE . . . . . 0.948 HG23 HG12 ' I' ' 53' ' ' ILE . 0.0 OUTLIER -56.03 -52.49 49.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.315 0.578 . . . . 0.0 110.381 -173.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 136' ' ' GLY . . . . . 0.674 ' H ' HG12 ' J' ' 135' ' ' ILE . . . -155.51 148.69 19.25 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.694 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.93 119.94 37.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.11 0.957 . . . . 0.0 110.623 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 138' ' ' LEU . . . . . 0.827 HD11 ' HD2' ' J' ' 108' ' ' PHE . 0.1 OUTLIER -97.48 128.6 44.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 139' ' ' LYS . . . . . 0.527 ' HD3' ' HG2' ' K' ' 80' ' ' GLU . 16.4 mtmt -86.32 130.98 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.68 -168.23 1.91 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 141' ' ' GLY . . . . . 0.848 ' HA2' ' HA ' ' J' ' 105' ' ' ASP . . . -121.28 150.91 17.09 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.356 169.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 142' ' ' GLU . . . . . 0.641 ' HB2' ' HB2' ' J' ' 106' ' ' ALA . 16.0 tp10 -101.33 156.5 17.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -174.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . 0.868 HD12 ' H ' ' J' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.37 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.786 -176.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 144' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' D' ' 162' ' ' GLN . 9.0 p-10 -101.57 95.45 6.46 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.984 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' J' ' 150' ' ' ILE . 53.0 p -95.16 22.71 6.41 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 118.721 -0.657 . . . . 0.0 112.391 175.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' J' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.84 15.72 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.492 1.917 . . . . 0.0 109.351 -173.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' J' ' 151' ' ' VAL . 31.5 Cg_exo -69.63 -12.54 33.37 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.207 1.272 . . . . 0.0 115.343 -159.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.66 -53.97 44.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.594 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -107.2 -31.14 8.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' J' ' 145' ' ' THR . 5.2 mt -78.6 -50.41 19.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 119.123 0.874 . . . . 0.0 111.286 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' J' ' 147' ' ' PRO . 21.6 t -65.49 -40.63 88.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.61 115.62 30.85 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.439 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.61 123.04 69.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.7 137.75 31.93 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.34 79.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 175.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 156' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' J' ' 158' ' ' TYR . . . 137.07 141.29 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 119.365 0.984 . . . . 0.0 113.011 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 158' ' ' TYR . . . . . 0.553 ' CE2' ' HA3' ' J' ' 156' ' ' GLY . 0.0 OUTLIER -108.85 89.33 2.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.332 1.053 . . . . 0.0 108.63 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.14 -46.63 67.12 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 115.427 1.639 . . . . 0.0 115.427 -158.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.1 121.76 24.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.661 2.385 . . . . 0.0 109.125 167.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 161' ' ' GLN . . . . . 0.501 ' HB3' ' CA ' ' J' ' 165' ' ' GLN . 0.0 OUTLIER -117.72 45.81 1.87 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 153.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.29 -32.92 4.25 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -166.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.77 -0.91 10.31 Favored 'Trans proline' 0 C--O 1.239 0.538 0 CA-C-N 122.081 1.779 . . . . 0.0 113.888 171.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.8 73.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 118.364 2.106 . . . . 0.0 118.364 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 165' ' ' GLN . . . . . 0.503 ' O ' HG22 ' J' ' 174' ' ' VAL . 0.8 OUTLIER -71.7 -43.72 65.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.909 1.354 . . . . 0.0 110.91 175.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' J' J ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.57 49.18 20.96 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.805 1.642 . . . . 0.0 111.88 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 167' ' ' THR . . . . . 0.546 HG21 ' H ' ' J' ' 172' ' ' GLY . 27.0 m -126.29 157.42 38.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.269 -167.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.11 20.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.456 172.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.65 -43.29 99.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.811 0.306 . . . . 0.0 111.38 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.05 126.43 65.36 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 123.53 0.732 . . . . 0.0 109.255 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 171' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -81.66 146.11 14.87 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.32 1.347 . . . . 0.0 112.737 -156.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . 0.546 ' H ' HG21 ' J' ' 167' ' ' THR . . . 88.37 8.23 71.49 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 165.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.68 122.17 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.954 0.877 . . . . 0.0 109.874 170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 174' ' ' VAL . . . . . 0.503 HG22 ' O ' ' J' ' 165' ' ' GLN . 24.4 t -106.58 117.46 56.92 Favored Pre-proline 0 C--O 1.241 0.605 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.396 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' J' J ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.68 163.16 36.25 Favored 'Trans proline' 0 C--N 1.349 0.564 0 CA-C-N 119.503 0.858 . . . . 0.0 111.709 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' J' J ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 125.48 1.512 . . . . 0.0 112.33 -171.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' K' K ' 5' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' L' ' 69' ' ' GLY . 49.3 Cg_endo . . . . . 0 N--CA 1.466 -0.143 0 CA-C-O 119.83 -0.154 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 6' ' ' ILE . . . . . 0.896 HG21 HG23 ' L' ' 126' ' ' VAL . 25.9 mt -127.95 161.73 35.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 7' ' ' MET . . . . . 1.035 ' HG2' ' HB2' ' K' ' 10' ' ' ASP . 0.0 OUTLIER -121.98 154.72 36.84 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.876 0.846 . . . . 0.0 110.747 -177.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 8' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' L' ' 123' ' ' GLU . . . -62.74 -17.88 58.49 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.379 -0.828 . . . . 0.0 114.507 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.43 -4.39 25.51 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.746 0.773 . . . . 0.0 112.4 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 10' ' ' ASP . . . . . 1.035 ' HB2' ' HG2' ' K' ' 7' ' ' MET . 28.7 t0 -66.94 -50.75 61.37 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 11' ' ' VAL . . . . . 0.433 HG22 ' OD2' ' K' ' 95' ' ' ASP . 78.9 t -84.01 121.79 36.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 12' ' ' LYS . . . . . 0.561 ' HG2' HD11 ' K' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.53 49.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.668 0.747 . . . . 0.0 110.53 176.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 13' ' ' TYR . . . . . 0.452 ' HD1' ' CE1' ' K' ' 91' ' ' PHE . 39.6 m-85 -111.14 105.48 14.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.766 -164.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 14' ' ' LEU . . . . . 0.76 ' HB2' ' HB2' ' K' ' 92' ' ' TRP . 1.8 mp -90.22 136.5 33.01 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 174.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 15' ' ' PHE . . . . . 0.558 ' CE1' ' HD1' ' K' ' 91' ' ' PHE . 22.6 m-85 -125.82 115.26 19.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.449 0.643 . . . . 0.0 109.991 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 16' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' K' ' 90' ' ' LYS . 14.6 tt0 -114.13 137.69 51.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 170.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 17' ' ' SER . . . . . . . . . . . . . 60.6 p -82.77 148.13 28.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.551 0.691 . . . . 0.0 111.002 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 18' ' ' ILE . . . . . 0.848 ' HA ' ' HE2' ' K' ' 90' ' ' LYS . 1.1 pp -62.44 -39.84 85.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.003 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -19.53 63.58 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.83 84.31 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.431 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 21' ' ' ALA . . . . . 0.853 ' HB1' HG22 ' E' ' 166' ' ' THR . . . 48.13 57.68 5.88 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.259 1.424 . . . . 0.0 111.77 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 22' ' ' THR . . . . . 0.431 HG22 ' H ' ' K' ' 23' ' ' GLY . 0.2 OUTLIER -137.9 -179.71 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' E' ' 163' ' ' PRO . . . -125.19 23.74 6.06 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.743 -178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.79 -30.35 65.44 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.949 0.374 . . . . 0.0 111.832 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 25' ' ' ALA . . . . . 0.476 ' HB3' HD21 ' K' ' 146' ' ' LEU . . . 46.26 76.37 0.55 Allowed Pre-proline 0 C--O 1.237 0.439 0 C-N-CA 126.953 2.101 . . . . 0.0 112.456 -174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 26' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.69 147.39 69.55 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 119.411 0.825 . . . . 0.0 112.506 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . 0.621 HD12 ' HG ' ' K' ' 14' ' ' LEU . 8.7 tt -130.37 150.36 51.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 28' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -108.56 133.38 20.64 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.515 -167.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 29' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -74.79 -175.61 2.41 Favored 'Trans proline' 0 C--N 1.332 -0.295 0 CA-C-N 118.998 0.678 . . . . 0.0 112.464 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 30' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' K' ' 67' ' ' TYR . . . 59.34 37.27 23.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.339 1.456 . . . . 0.0 111.574 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.13 135.38 46.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.54 1.162 . . . . 0.0 111.095 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 32' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' K' ' 32' ' ' GLN . 7.1 mm-40 -104.04 -91.63 0.37 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 33' ' ' THR . . . . . . . . . . . . . 16.6 p -134.67 170.15 16.24 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-O 122.814 1.292 . . . . 0.0 111.096 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 34' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' K' ' 65' ' ' VAL . 3.0 t0 -158.91 102.29 1.65 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.99 -164.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.15 136.17 13.31 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.313 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 36' ' ' SER . . . . . 0.402 ' HB3' ' CZ ' ' L' ' 118' ' ' TYR . 48.0 t -133.33 119.39 19.67 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 173.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 37' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' L' ' 117' ' ' GLU . 19.1 m -130.9 144.94 36.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -131.44 128.11 38.81 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -166.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 39' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' K' ' 59' ' ' VAL . . . -119.44 114.9 2.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.239 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.29 125.86 40.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 41' ' ' ARG . . . . . 0.818 HH22 ' HB2' ' K' ' 60' ' ' ALA . 2.1 mtm-85 -68.72 132.32 46.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.761 0.791 . . . . 0.0 110.148 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 42' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' L' ' 114' ' ' GLU . 0.0 OUTLIER -138.72 133.43 32.22 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -167.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.6 121.71 42.94 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.479 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 44' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' K' ' 51' ' ' GLY . 0.3 OUTLIER -128.5 90.76 3.12 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.189 171.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 45' ' ' ASP . . . . . 0.541 ' O ' ' HA2' ' K' ' 51' ' ' GLY . 3.3 t70 -111.87 170.16 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 155.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 46' ' ' GLU . . . . . 0.542 ' OE2' ' NE ' ' L' ' 41' ' ' ARG . 2.7 mp0 -71.21 -48.13 53.28 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 47' ' ' GLN . . . . . 0.824 ' HB3' ' HA ' ' F' ' 30' ' ' ALA . 1.4 mt-30 57.81 38.58 27.31 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.609 1.563 . . . . 0.0 111.714 -172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 48' ' ' THR . . . . . 0.434 ' O ' HG21 ' F' ' 153' ' ' VAL . 30.5 p 41.98 45.31 3.27 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.505 1.522 . . . . 0.0 111.559 -164.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.87 -163.76 1.7 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.5 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 50' ' ' ASN . . . . . 0.738 HD21 ' HA ' ' F' ' 154' ' ' SER . 7.7 m-80 -79.9 16.8 1.08 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 51' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' K' ' 44' ' ' PHE . . . 87.04 167.47 43.78 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 52' ' ' ARG . . . . . 0.532 ' HA ' ' HD3' ' K' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.36 47.53 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.973 HD13 ' HA ' ' L' ' 134' ' ' VAL . 1.5 pp -127.19 -39.17 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.87 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 54' ' ' LEU . . . . . 0.581 HD23 ' HG3' ' L' ' 88' ' ' GLN . 1.4 mp -61.77 -16.93 53.71 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.56 105.96 1.13 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-O 121.625 0.569 . . . . 0.0 113.951 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' K' ' 54' ' ' LEU . 68.1 Cg_endo -76.91 178.87 7.1 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 N-CA-C 113.816 0.66 . . . . 0.0 113.816 -175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.03 -163.78 24.65 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 58' ' ' SER . . . . . 0.509 ' HB3' ' HE ' ' K' ' 41' ' ' ARG . 1.7 t -87.49 153.82 21.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.542 0.687 . . . . 0.0 110.498 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' K' ' 39' ' ' GLY . 14.3 p -103.72 130.98 53.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 60' ' ' ALA . . . . . 0.818 ' HB2' HH22 ' K' ' 41' ' ' ARG . . . -107.62 111.01 23.03 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 61' ' ' ASP . . . . . 0.404 ' OD1' ' HA2' ' K' ' 136' ' ' GLY . 15.3 m-20 -102.13 107.42 18.5 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.08 144.77 27.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.94 0.896 . . . . 0.0 110.077 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.99 146.03 17.3 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.15 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 64' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' K' ' 64' ' ' GLU . 2.5 pt-20 -138.56 128.76 25.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 65' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' K' ' 129' ' ' SER . 40.7 t -116.24 123.58 71.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 66' ' ' THR . . . . . 0.793 HG22 ' HB2' ' K' ' 129' ' ' SER . 63.3 p -114.12 140.46 48.48 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 67' ' ' TYR . . . . . 0.715 ' HE2' HD12 ' K' ' 128' ' ' ILE . 5.6 p90 -161.32 162.44 30.89 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 68' ' ' TYR . . . . . 0.643 ' HB3' ' HB3' ' K' ' 125' ' ' ALA . 22.0 m-30 -83.41 136.73 34.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 69' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' J' ' 5' ' ' PRO . . . -74.99 142.37 29.49 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 114.949 0.74 . . . . 0.0 114.949 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 70' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' J' ' 5' ' ' PRO . 16.3 tttp -111.64 154.29 25.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 71' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -53.91 -54.34 40.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.04 -117.42 3.59 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.83 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.118 1.367 . . . . 0.0 111.036 169.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.33 -21.68 27.13 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -156.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 75' ' ' GLY . . . . . 0.405 ' O ' HG12 ' K' ' 79' ' ' ILE . . . -62.8 -49.91 68.62 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.822 168.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.3 -36.64 84.77 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 122.173 -0.604 . . . . 0.0 111.832 171.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -37.26 87.0 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.738 171.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.79 92.49 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.945 168.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . 0.548 HD12 HD11 ' K' ' 113' ' ' ILE . 5.7 mm -54.02 -42.38 54.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.029 0.442 . . . . 0.0 110.466 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . 0.542 ' O ' ' HB2' ' K' ' 84' ' ' GLN . 0.7 OUTLIER -69.52 -48.2 61.31 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.786 -0.571 . . . . 0.0 112.446 -178.051 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 81' ' ' ASP . . . . . 0.404 ' OD1' ' HE2' ' K' ' 87' ' ' LYS . 29.2 t70 -60.88 -34.89 75.33 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.554 169.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 82' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' K' ' 87' ' ' LYS . . . -58.58 -53.81 54.13 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.565 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 83' ' ' TYR . . . . . 0.551 ' HD1' HG22 ' K' ' 113' ' ' ILE . 64.4 t80 -74.59 -48.45 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.924 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 84' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' K' ' 80' ' ' GLU . 0.0 OUTLIER -63.39 -51.63 65.01 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -167.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 85' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -83.64 -40.87 18.43 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.026 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.55 102.5 2.6 Favored Glycine 0 N--CA 1.449 -0.454 0 O-C-N 122.356 -0.215 . . . . 0.0 112.879 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 87' ' ' LYS . . . . . 0.726 ' HB2' ' HA ' ' K' ' 82' ' ' ALA . 9.5 mptt -139.23 145.53 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 88' ' ' GLN . . . . . 0.666 ' HG2' ' HD1' ' K' ' 112' ' ' TYR . 1.6 tm0? -67.42 142.95 56.51 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 89' ' ' ILE . . . . . 0.719 HD11 ' HB2' ' K' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 CA-C-O 121.36 0.6 . . . . 0.0 109.846 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 90' ' ' LYS . . . . . 0.848 ' HE2' ' HA ' ' K' ' 18' ' ' ILE . 6.4 mtmt -84.37 113.0 20.84 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 91' ' ' PHE . . . . . 0.558 ' HD1' ' CE1' ' K' ' 15' ' ' PHE . 24.8 t80 -108.69 123.44 48.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.497 1.119 . . . . 0.0 109.981 -165.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 92' ' ' TRP . . . . . 0.76 ' HB2' ' HB2' ' K' ' 14' ' ' LEU . 6.6 m95 -116.35 122.08 43.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 93' ' ' ARG . . . . . 0.514 ' HD2' ' HB2' ' K' ' 107' ' ' GLN . 2.4 tmt_? -108.94 102.54 11.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 94' ' ' VAL . . . . . 0.775 HG12 ' HB2' ' K' ' 106' ' ' ALA . 20.7 m -125.28 153.11 32.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.286 1.041 . . . . 0.0 109.378 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 95' ' ' ASP . . . . . 0.433 ' OD2' HG22 ' K' ' 11' ' ' VAL . 5.6 m-20 -96.1 156.87 16.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.657 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 96' ' ' THR . . . . . 0.422 ' N ' ' O ' ' K' ' 10' ' ' ASP . 25.5 m -87.0 -3.11 59.06 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.703 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 97' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.96 137.8 27.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.657 0.741 . . . . 0.0 109.92 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 98' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' K' ' 103' ' ' LYS . 9.9 tttp -68.62 129.29 39.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.96 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' K' ' 102' ' ' ASP . 20.6 t30 -64.72 163.6 13.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.839 0.828 . . . . 0.0 109.924 171.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.78 57.69 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.58 -36.71 0.96 Allowed 'General case' 0 C--O 1.235 0.302 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.855 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' K' ' 99' ' ' ASN . 0.2 OUTLIER -79.56 173.05 12.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 103' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' K' ' 98' ' ' LYS . 0.1 OUTLIER -71.3 -43.01 67.94 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 110.588 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 104' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' K' ' 142' ' ' GLU . 93.8 m-85 -147.87 172.45 14.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 105' ' ' ASP . . . . . 0.827 ' HA ' ' HA2' ' K' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.73 33.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.649 0.738 . . . . 0.0 109.408 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 106' ' ' ALA . . . . . 0.775 ' HB2' HG12 ' K' ' 94' ' ' VAL . . . -147.49 155.41 41.87 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.065 -163.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 107' ' ' GLN . . . . . 0.514 ' HB2' ' HD2' ' K' ' 93' ' ' ARG . 53.2 mt-30 -123.95 135.25 53.55 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 157.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 108' ' ' PHE . . . . . 0.825 ' HD2' HD11 ' K' ' 138' ' ' LEU . 66.5 t80 -128.43 154.63 45.84 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.382 0.673 . . . . 0.0 110.392 -163.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.44 156.61 25.56 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.512 -1.328 . . . . 0.0 111.935 170.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 110' ' ' PHE . . . . . 0.681 ' O ' HG23 ' K' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 111' ' ' ALA . . . . . 0.586 ' HB1' HD13 ' K' ' 132' ' ' LEU . . . -126.32 144.73 50.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.962 0.887 . . . . 0.0 111.158 -169.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 112' ' ' TYR . . . . . 0.666 ' HD1' ' HG2' ' K' ' 88' ' ' GLN . 3.1 t80 -122.21 117.43 26.16 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.008 -174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . 0.551 HG22 ' HD1' ' K' ' 83' ' ' TYR . 55.5 mt -68.62 101.87 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 114' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' J' ' 42' ' ' GLU . 4.4 mt-10 -94.95 -13.49 25.3 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 115' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 131' ' ' SER . 1.9 m -138.14 137.38 37.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.93 0.787 . . . . 0.0 109.111 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.62 102.33 5.07 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 117' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' J' ' 37' ' ' VAL . 5.6 mt-10 -119.31 118.85 32.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' K' ' 127' ' ' GLU . 12.3 p90 -122.61 137.98 54.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 111.177 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.07 139.58 45.04 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.706 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.34 31.76 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 167.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.32 175.19 26.81 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-O 121.738 0.632 . . . . 0.0 111.553 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 122' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.69 -45.32 99.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.495 -0.415 . . . . 0.0 111.131 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' HA3' ' J' ' 8' ' ' GLY . 2.7 tp10 -125.98 142.42 51.53 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 169.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.4 157.46 10.19 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 166.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 125' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' K' ' 68' ' ' TYR . . . -67.28 156.67 35.79 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.553 0.692 . . . . 0.0 110.76 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' J' ' 6' ' ' ILE . 86.8 t -56.85 122.17 5.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.061 -171.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' K' ' 118' ' ' TYR . 0.5 OUTLIER -75.93 110.68 10.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.113 -176.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 128' ' ' ILE . . . . . 0.715 HD12 ' HE2' ' K' ' 67' ' ' TYR . 3.1 mt -108.42 113.19 43.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 129' ' ' SER . . . . . 0.793 ' HB2' HG22 ' K' ' 66' ' ' THR . 4.7 t -119.02 123.67 45.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 168.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.26 132.8 65.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 131' ' ' SER . . . . . 0.587 ' HB2' ' HB2' ' K' ' 115' ' ' SER . 0.3 OUTLIER -110.7 141.39 44.05 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.353 0.661 . . . . 0.0 109.701 -178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 132' ' ' LEU . . . . . 0.586 HD13 ' HB1' ' K' ' 111' ' ' ALA . 2.0 pp -148.08 150.63 34.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.104 -172.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.12 146.03 39.91 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 167.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 134' ' ' VAL . . . . . 0.857 ' HA ' HD13 ' J' ' 53' ' ' ILE . 2.0 p -135.02 144.09 35.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 135' ' ' ILE . . . . . 0.92 HG23 HG12 ' J' ' 53' ' ' ILE . 0.0 OUTLIER -56.01 -52.51 49.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 121.376 0.608 . . . . 0.0 110.347 -173.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 136' ' ' GLY . . . . . 0.676 ' H ' HG12 ' K' ' 135' ' ' ILE . . . -155.53 148.64 19.13 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.725 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -97.86 119.96 37.39 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 122.043 0.925 . . . . 0.0 110.623 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 138' ' ' LEU . . . . . 0.825 HD11 ' HD2' ' K' ' 108' ' ' PHE . 0.1 OUTLIER -97.5 128.59 44.38 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 139' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' L' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.92 34.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 140' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.62 -168.18 1.91 Allowed 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 141' ' ' GLY . . . . . 0.827 ' HA2' ' HA ' ' K' ' 105' ' ' ASP . . . -121.31 150.93 17.08 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.399 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 142' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' K' ' 106' ' ' ALA . 16.0 tp10 -101.37 156.46 17.44 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . 0.855 HD12 ' H ' ' K' ' 143' ' ' ILE . 0.1 OUTLIER -110.16 -76.47 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.737 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 144' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.57 95.51 6.5 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.969 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 145' ' ' THR . . . . . 0.649 ' O ' HD12 ' K' ' 150' ' ' ILE . 52.4 p -95.18 22.68 6.46 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.382 175.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 146' ' ' LEU . . . . . 0.476 HD21 ' HB3' ' K' ' 25' ' ' ALA . 0.9 OUTLIER 52.21 56.86 15.74 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 126.502 1.921 . . . . 0.0 109.352 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 147' ' ' PRO . . . . . 0.569 ' O ' ' HB ' ' K' ' 151' ' ' VAL . 31.6 Cg_exo -69.64 -12.58 33.42 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.237 1.292 . . . . 0.0 115.308 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 148' ' ' GLU . . . . . 0.403 ' HB3' ' OE1' ' K' ' 149' ' ' GLU . 1.5 tt0 -53.7 -53.88 45.8 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.602 171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' K' ' 148' ' ' GLU . 1.5 pm0 -107.2 -31.21 8.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 150' ' ' ILE . . . . . 0.649 HD12 ' O ' ' K' ' 145' ' ' THR . 5.2 mt -78.62 -50.45 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 119.167 0.894 . . . . 0.0 111.266 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' K' ' 147' ' ' PRO . 21.9 t -65.39 -40.63 88.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.63 115.62 30.84 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.45 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.62 123.06 69.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.75 137.68 31.78 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -172.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.22 79.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE2' ' K' ' 158' ' ' TYR . . . 137.03 141.3 4.23 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 119.395 0.998 . . . . 0.0 113.03 -176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.29 71.24 0.47 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HA3' ' K' ' 156' ' ' GLY . 0.0 OUTLIER -108.82 89.26 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.347 1.059 . . . . 0.0 108.616 177.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.05 -46.64 67.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 -158.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.75 24.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.666 2.386 . . . . 0.0 109.125 167.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 161' ' ' GLN . . . . . 0.508 ' HB3' ' CA ' ' K' ' 165' ' ' GLN . 0.0 OUTLIER -117.71 45.71 1.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 154.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.31 -32.89 4.22 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -166.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 163' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -82.77 -0.83 10.27 Favored 'Trans proline' 0 C--O 1.239 0.536 0 CA-C-N 122.073 1.776 . . . . 0.0 113.881 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.75 73.21 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 118.393 2.117 . . . . 0.0 118.393 -171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 165' ' ' GLN . . . . . 0.508 ' CA ' ' HB3' ' K' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.64 65.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 118.882 1.341 . . . . 0.0 110.895 175.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' K' K ' 166' ' ' THR . . . . . . . . . . . . . 6.9 p 52.48 49.18 20.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.832 1.653 . . . . 0.0 111.95 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 167' ' ' THR . . . . . 0.566 HG21 ' H ' ' K' ' 172' ' ' GLY . 26.8 m -126.32 157.37 38.59 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.291 -167.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.4 -152.16 20.19 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.497 172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -43.31 99.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.783 0.291 . . . . 0.0 111.445 -177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.09 126.43 65.29 Favored Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 123.498 0.719 . . . . 0.0 109.267 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 171' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.62 146.12 14.94 Favored 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.275 1.317 . . . . 0.0 112.748 -156.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . 0.566 ' H ' HG21 ' K' ' 167' ' ' THR . . . 88.33 8.35 71.43 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 117.233 1.653 . . . . 0.0 117.233 165.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.71 122.1 36.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.948 0.874 . . . . 0.0 109.886 170.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 174' ' ' VAL . . . . . 0.49 HG22 ' O ' ' K' ' 165' ' ' GLN . 24.5 t -106.52 117.4 57.12 Favored Pre-proline 0 C--O 1.241 0.617 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.458 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' K' K ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.25 35.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 CA-C-N 119.548 0.874 . . . . 0.0 111.717 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' K' K ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.267 0 C-N-CA 125.397 1.479 . . . . 0.0 112.337 -171.685 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' L' L ' 5' ' ' PRO . . . . . 0.529 ' HA ' ' HG3' ' G' ' 70' ' ' LYS . 50.0 Cg_endo . . . . . 0 N--CA 1.466 -0.146 0 CA-C-O 119.907 -0.122 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 6' ' ' ILE . . . . . 0.917 HG21 HG23 ' G' ' 126' ' ' VAL . 26.2 mt -127.94 161.71 35.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 7' ' ' MET . . . . . 1.042 ' HG2' ' HB2' ' L' ' 10' ' ' ASP . 0.0 OUTLIER -121.94 154.76 36.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.866 0.841 . . . . 0.0 110.75 -177.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -17.93 58.6 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.487 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 9' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -102.46 -4.33 25.57 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.789 0.795 . . . . 0.0 112.393 172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 10' ' ' ASP . . . . . 1.042 ' HB2' ' HG2' ' L' ' 7' ' ' MET . 28.7 t0 -66.88 -50.81 61.29 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 11' ' ' VAL . . . . . 0.438 HG22 ' OD2' ' L' ' 95' ' ' ASP . 78.8 t -84.0 121.83 37.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 12' ' ' LYS . . . . . 0.544 ' HG2' HD11 ' L' ' 27' ' ' LEU . 0.0 OUTLIER -125.16 147.48 49.02 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.631 0.729 . . . . 0.0 110.522 176.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 13' ' ' TYR . . . . . 0.469 ' HD1' ' CE1' ' L' ' 91' ' ' PHE . 39.4 m-85 -111.09 105.44 14.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.816 -164.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 14' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' L' ' 92' ' ' TRP . 1.8 mp -90.23 136.56 32.97 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 15' ' ' PHE . . . . . 0.557 ' CE1' ' HD1' ' L' ' 91' ' ' PHE . 23.1 m-85 -125.92 115.27 19.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.453 0.644 . . . . 0.0 109.958 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 16' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' L' ' 90' ' ' LYS . 14.6 tt0 -114.2 137.71 51.41 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 170.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 17' ' ' SER . . . . . . . . . . . . . 60.4 p -82.75 148.2 27.98 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.999 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 18' ' ' ILE . . . . . 0.833 ' HA ' ' HE2' ' L' ' 90' ' ' LYS . 1.1 pp -62.56 -39.76 85.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.008 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.76 -19.43 63.52 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.74 -40.85 84.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.439 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 21' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' F' ' 166' ' ' THR . . . 48.18 57.66 5.92 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.266 1.426 . . . . 0.0 111.759 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 22' ' ' THR . . . . . 0.442 HG22 ' H ' ' L' ' 23' ' ' GLY . 0.2 OUTLIER -137.82 -179.64 5.88 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.646 ' HA3' ' O ' ' F' ' 163' ' ' PRO . . . -125.24 23.79 6.04 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.698 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 24' ' ' SER . . . . . . . . . . . . . 1.5 p -71.88 -30.34 65.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.02 0.41 . . . . 0.0 111.773 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' L' ' 146' ' ' LEU . . . 46.27 76.37 0.55 Allowed Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 126.979 2.112 . . . . 0.0 112.428 -174.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.71 147.44 69.53 Favored 'Trans proline' 0 C--N 1.349 0.571 0 CA-C-N 119.43 0.832 . . . . 0.0 112.488 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . 0.625 HD12 ' HG ' ' L' ' 14' ' ' LEU . 8.8 tt -130.41 150.31 51.69 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 28' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -108.54 133.45 20.61 Favored Pre-proline 0 C--N 1.317 -0.835 0 C-N-CA 115.839 -2.344 . . . . 0.0 110.554 -167.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 29' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -74.8 -175.62 2.42 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.853 0.689 . . . . 0.0 112.412 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 30' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' L' ' 67' ' ' TYR . . . 59.31 37.25 23.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.399 1.48 . . . . 0.0 111.54 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -72.07 135.34 46.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.52 1.152 . . . . 0.0 111.114 173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 32' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' L' ' 32' ' ' GLN . 7.1 mm-40 -103.99 -91.62 0.36 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 33' ' ' THR . . . . . . . . . . . . . 16.7 p -134.69 170.16 16.24 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 122.793 1.282 . . . . 0.0 111.081 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . 0.429 ' OD1' HG22 ' L' ' 65' ' ' VAL . 3.0 t0 -158.94 102.31 1.64 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.946 -164.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 35' ' ' GLY . . . . . . . . . . . . . . . -90.16 136.21 13.34 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.367 170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 36' ' ' SER . . . . . . . . . . . . . 48.0 t -133.36 119.41 19.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 37' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' G' ' 117' ' ' GLU . 19.1 m -130.91 144.92 36.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 38' ' ' SER . . . . . . . . . . . . . 9.0 m -131.43 128.14 38.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -166.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 39' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' L' ' 59' ' ' VAL . . . -119.47 114.83 2.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.251 -178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -95.25 125.85 40.17 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 41' ' ' ARG . . . . . 0.816 HH22 ' HB2' ' L' ' 60' ' ' ALA . 2.1 mtm-85 -68.68 132.23 46.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.681 0.753 . . . . 0.0 110.179 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 42' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' G' ' 114' ' ' GLU . 0.0 OUTLIER -138.68 133.45 32.34 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -167.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.59 121.63 42.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 44' ' ' PHE . . . . . 0.594 ' CE2' ' HA3' ' L' ' 51' ' ' GLY . 0.3 OUTLIER -128.51 90.77 3.12 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.212 171.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 45' ' ' ASP . . . . . 0.528 ' O ' ' HA2' ' L' ' 51' ' ' GLY . 3.2 t70 -111.86 170.2 8.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 155.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 46' ' ' GLU . . . . . 0.432 ' OE2' ' NE ' ' G' ' 41' ' ' ARG . 2.7 mp0 -71.23 -48.13 53.12 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 47' ' ' GLN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 1.4 mt-30 57.9 38.55 27.06 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.595 1.558 . . . . 0.0 111.665 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 48' ' ' THR . . . . . . . . . . . . . 30.4 p 41.94 45.32 3.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.479 1.512 . . . . 0.0 111.593 -164.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -142.9 -163.76 1.7 Allowed 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.453 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 50' ' ' ASN . . . . . 0.553 HD21 ' HA ' ' A' ' 154' ' ' SER . 7.7 m-80 -79.88 16.8 1.07 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 51' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' L' ' 44' ' ' PHE . . . 87.07 167.49 43.8 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' HD3' ' L' ' 52' ' ' ARG . 0.0 OUTLIER -112.18 122.28 47.29 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.957 HG12 HG23 ' G' ' 135' ' ' ILE . 1.5 pp -127.18 -39.12 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.882 178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 54' ' ' LEU . . . . . 0.569 HD12 ' H ' ' L' ' 54' ' ' LEU . 1.4 mp -61.77 -16.92 53.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.6 105.91 1.12 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-O 121.675 0.597 . . . . 0.0 113.966 -170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 56' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' L' ' 54' ' ' LEU . 68.8 Cg_endo -76.78 178.91 7.02 Favored 'Trans proline' 0 CA--C 1.516 -0.409 0 N-CA-C 113.881 0.685 . . . . 0.0 113.881 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.07 -163.82 24.74 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 58' ' ' SER . . . . . 0.513 ' HB3' ' HE ' ' L' ' 41' ' ' ARG . 1.7 t -87.5 153.84 21.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.579 0.704 . . . . 0.0 110.5 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' L' ' 39' ' ' GLY . 14.3 p -103.78 130.93 53.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 60' ' ' ALA . . . . . 0.816 ' HB2' HH22 ' L' ' 41' ' ' ARG . . . -107.66 111.05 23.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 174.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 61' ' ' ASP . . . . . 0.409 ' OD1' ' HA2' ' L' ' 136' ' ' GLY . 15.3 m-20 -102.14 107.4 18.47 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -171.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.07 144.76 27.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.939 0.895 . . . . 0.0 110.051 -178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.96 146.0 17.25 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.183 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 64' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' L' ' 64' ' ' GLU . 2.5 pt-20 -138.5 128.8 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 65' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' L' ' 129' ' ' SER . 40.6 t -116.29 123.61 71.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 66' ' ' THR . . . . . 0.768 HG22 ' HB2' ' L' ' 129' ' ' SER . 63.0 p -114.17 140.4 48.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 174.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 67' ' ' TYR . . . . . 0.702 ' HE2' HD12 ' L' ' 128' ' ' ILE . 5.6 p90 -161.23 162.53 31.18 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 68' ' ' TYR . . . . . 0.625 ' HB3' ' HB3' ' L' ' 125' ' ' ALA . 22.0 m-30 -83.48 136.78 34.16 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 69' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' K' ' 5' ' ' PRO . . . -74.94 142.32 29.47 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 114.954 0.741 . . . . 0.0 114.954 -175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -111.63 154.27 25.13 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 71' ' ' ARG . . . . . 0.44 HH21 ' HD3' ' L' ' 71' ' ' ARG . 10.5 ptp180 -53.92 -54.3 40.71 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -172.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 72' ' ' GLY . . . . . . . . . . . . . . . -112.01 -117.45 3.59 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.0 120.84 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.115 1.366 . . . . 0.0 111.004 169.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.6 27.08 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 -156.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.78 -49.91 68.67 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.848 168.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -36.67 84.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 122.152 -0.616 . . . . 0.0 111.835 171.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -37.2 86.78 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.797 171.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.77 92.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.933 168.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . 0.55 HD12 HD11 ' L' ' 113' ' ' ILE . 5.7 mm -54.01 -42.37 54.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.124 0.488 . . . . 0.0 110.49 172.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' K' ' 139' ' ' LYS . 0.7 OUTLIER -69.57 -48.11 61.35 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.71 -0.619 . . . . 0.0 112.423 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 81' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' L' ' 87' ' ' LYS . 29.2 t70 -60.94 -34.9 75.44 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.521 169.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 82' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' L' ' 87' ' ' LYS . . . -58.59 -53.78 54.5 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.562 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 83' ' ' TYR . . . . . 0.547 ' HD1' HG22 ' L' ' 113' ' ' ILE . 64.4 t80 -74.61 -48.42 26.63 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.926 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 84' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' L' ' 80' ' ' GLU . 0.0 OUTLIER -63.38 -51.65 64.96 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -167.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 85' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -83.63 -40.88 18.44 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.031 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.65 102.47 2.59 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 122.342 -0.224 . . . . 0.0 112.836 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 87' ' ' LYS . . . . . 0.742 ' HB2' ' HA ' ' L' ' 82' ' ' ALA . 9.5 mptt -139.26 145.47 39.23 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 88' ' ' GLN . . . . . 0.815 ' HG3' ' HG3' ' F' ' 169' ' ' GLU . 1.6 tm0? -67.31 142.9 56.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 168.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 89' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' L' ' 82' ' ' ALA . 5.5 mm -118.83 129.11 75.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.364 0.602 . . . . 0.0 109.88 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 90' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' L' ' 18' ' ' ILE . 6.4 mtmt -84.33 112.9 20.74 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 91' ' ' PHE . . . . . 0.557 ' HD1' ' CE1' ' L' ' 15' ' ' PHE . 24.9 t80 -108.62 123.41 48.91 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.516 1.126 . . . . 0.0 110.027 -165.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 92' ' ' TRP . . . . . 0.756 ' HB2' ' HB2' ' L' ' 14' ' ' LEU . 6.6 m95 -116.29 122.06 43.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.167 0.987 . . . . 0.0 108.353 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 93' ' ' ARG . . . . . 0.52 ' HD2' ' HB2' ' L' ' 107' ' ' GLN . 2.4 tmt_? -108.95 102.53 11.53 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 94' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' L' ' 106' ' ' ALA . 20.8 m -125.23 153.15 32.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-O 122.278 1.037 . . . . 0.0 109.385 -173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 95' ' ' ASP . . . . . 0.438 ' OD2' HG22 ' L' ' 11' ' ' VAL . 5.6 m-20 -96.16 156.95 16.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.643 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 96' ' ' THR . . . . . 0.43 ' N ' ' O ' ' L' ' 10' ' ' ASP . 25.8 m -87.1 -3.05 59.05 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.63 -176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -101.04 137.86 27.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-O 121.741 0.781 . . . . 0.0 109.877 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 98' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' L' ' 103' ' ' LYS . 9.9 tttp -68.64 129.24 39.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.962 -174.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 99' ' ' ASN . . . . . 0.559 HD22 ' HB2' ' L' ' 102' ' ' ASP . 20.5 t30 -64.63 163.57 13.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.802 0.81 . . . . 0.0 110.011 171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.03 -8.84 57.65 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -133.5 -36.76 0.96 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.788 0.722 . . . . 0.0 110.875 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 102' ' ' ASP . . . . . 0.559 ' HB2' HD22 ' L' ' 99' ' ' ASN . 0.2 OUTLIER -79.54 173.01 13.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 167.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 103' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' L' ' 98' ' ' LYS . 0.1 OUTLIER -71.28 -42.99 68.04 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.874 -0.516 . . . . 0.0 110.582 171.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 104' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' L' ' 142' ' ' GLU . 93.6 m-85 -147.87 172.49 14.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 105' ' ' ASP . . . . . 0.819 ' HA ' ' HA2' ' L' ' 141' ' ' GLY . 1.7 p-10 -116.41 152.64 33.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.581 0.705 . . . . 0.0 109.445 177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 106' ' ' ALA . . . . . 0.753 ' HB2' HG12 ' L' ' 94' ' ' VAL . . . -147.42 155.42 41.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.034 -163.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 107' ' ' GLN . . . . . 0.52 ' HB2' ' HD2' ' L' ' 93' ' ' ARG . 53.4 mt-30 -123.88 135.3 53.64 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 157.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 108' ' ' PHE . . . . . 0.837 ' HD2' HD11 ' L' ' 138' ' ' LEU . 66.1 t80 -128.51 154.6 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.443 0.697 . . . . 0.0 110.403 -163.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.45 156.58 25.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 119.478 -1.344 . . . . 0.0 111.954 170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 110' ' ' PHE . . . . . 0.674 ' O ' HG23 ' L' ' 134' ' ' VAL . 1.5 m-85 -82.82 118.69 23.59 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 167.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 111' ' ' ALA . . . . . 0.573 ' HB1' HD13 ' L' ' 132' ' ' LEU . . . -126.31 144.7 50.71 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.941 0.877 . . . . 0.0 111.138 -169.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 112' ' ' TYR . . . . . 0.655 ' HD1' ' HG2' ' L' ' 88' ' ' GLN . 3.0 t80 -122.2 117.39 26.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.48 -1.236 . . . . 0.0 107.983 -174.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . 0.55 HD11 HD12 ' L' ' 79' ' ' ILE . 55.4 mt -68.51 101.84 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 114' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' K' ' 42' ' ' GLU . 4.3 mt-10 -94.96 -13.52 25.26 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 115' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 131' ' ' SER . 1.9 m -138.1 137.42 37.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.881 0.764 . . . . 0.0 109.095 174.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 116' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' L' ' 116' ' ' ARG . 0.2 OUTLIER -135.7 102.39 5.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 176.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 117' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' K' ' 37' ' ' VAL . 5.6 mt-10 -119.34 118.89 32.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 118' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' L' ' 127' ' ' GLU . 12.4 p90 -122.61 137.97 54.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 0.0 111.174 176.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 12.2 t -110.12 139.61 45.07 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.726 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.55 116.32 31.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.16 26.86 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-O 121.724 0.624 . . . . 0.0 111.587 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 122' ' ' VAL . . . . . . . . . . . . . 76.2 t -62.68 -45.34 99.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 122.478 -0.425 . . . . 0.0 111.148 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 123' ' ' GLU . . . . . 0.53 ' HA ' ' HA3' ' K' ' 8' ' ' GLY . 2.7 tp10 -125.92 142.43 51.52 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 169.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 124' ' ' GLY . . . . . . . . . . . . . . . 120.36 157.43 10.19 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 166.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 125' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' L' ' 68' ' ' TYR . . . -67.21 156.62 35.81 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.611 0.719 . . . . 0.0 110.738 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 126' ' ' VAL . . . . . 0.896 HG23 HG21 ' K' ' 6' ' ' ILE . 86.4 t -56.85 122.2 5.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.997 -171.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' L' ' 118' ' ' TYR . 0.5 OUTLIER -75.95 110.72 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.075 -176.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 128' ' ' ILE . . . . . 0.702 HD12 ' HE2' ' L' ' 67' ' ' TYR . 3.1 mt -108.44 113.2 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 129' ' ' SER . . . . . 0.768 ' HB2' HG22 ' L' ' 66' ' ' THR . 4.7 t -119.05 123.67 45.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.25 132.8 65.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 131' ' ' SER . . . . . 0.593 ' HB2' ' HB2' ' L' ' 115' ' ' SER . 0.4 OUTLIER -110.69 141.4 44.02 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.736 -178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 132' ' ' LEU . . . . . 0.573 HD13 ' HB1' ' L' ' 111' ' ' ALA . 2.0 pp -148.07 150.65 34.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.13 -172.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.1 146.01 39.92 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 167.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 134' ' ' VAL . . . . . 0.973 ' HA ' HD13 ' K' ' 53' ' ' ILE . 2.0 p -135.01 144.15 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 135' ' ' ILE . . . . . 0.873 HG23 HG12 ' K' ' 53' ' ' ILE . 0.0 OUTLIER -56.02 -52.56 48.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.355 0.597 . . . . 0.0 110.321 -173.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 136' ' ' GLY . . . . . 0.675 ' H ' HG12 ' L' ' 135' ' ' ILE . . . -155.53 148.65 19.15 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.717 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -97.88 119.91 37.33 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.093 0.949 . . . . 0.0 110.672 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 138' ' ' LEU . . . . . 0.837 HD11 ' HD2' ' L' ' 108' ' ' PHE . 0.1 OUTLIER -97.44 128.54 44.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -174.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 139' ' ' LYS . . . . . 0.528 ' HD3' ' HG2' ' G' ' 80' ' ' GLU . 16.4 mtmt -86.3 130.94 34.35 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 140' ' ' ASN . . . . . 0.73 ' CB ' ' HB3' ' F' ' 159' ' ' ASP . 0.9 OUTLIER -161.64 -168.2 1.91 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 141' ' ' GLY . . . . . 0.819 ' HA2' ' HA ' ' L' ' 105' ' ' ASP . . . -121.35 150.93 17.07 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.374 169.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 142' ' ' GLU . . . . . 0.95 ' OE2' ' HB2' ' F' ' 162' ' ' GLN . 16.0 tp10 -101.35 156.47 17.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . 0.864 HD12 ' H ' ' L' ' 143' ' ' ILE . 0.1 OUTLIER -110.22 -76.42 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.734 -176.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 144' ' ' ASP . . . . . 0.903 ' OD1' ' HG3' ' F' ' 163' ' ' PRO . 9.0 p-10 -101.58 95.52 6.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.976 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 145' ' ' THR . . . . . 0.67 ' O ' HD12 ' L' ' 150' ' ' ILE . 52.6 p -95.16 22.63 6.5 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 118.732 -0.652 . . . . 0.0 112.372 175.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 146' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' L' ' 25' ' ' ALA . 0.9 OUTLIER 52.26 56.76 15.62 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 126.439 1.896 . . . . 0.0 109.412 -173.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 147' ' ' PRO . . . . . 0.556 ' O ' ' HB ' ' L' ' 151' ' ' VAL . 31.5 Cg_exo -69.57 -12.63 33.67 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.294 1.33 . . . . 0.0 115.319 -159.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 148' ' ' GLU . . . . . 0.402 ' HB3' ' OE1' ' L' ' 149' ' ' GLU . 1.5 tt0 -53.71 -53.88 45.81 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.585 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' L' ' 148' ' ' GLU . 1.5 pm0 -107.24 -31.12 8.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 150' ' ' ILE . . . . . 0.67 HD12 ' O ' ' L' ' 145' ' ' THR . 5.2 mt -78.63 -50.45 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 119.132 0.878 . . . . 0.0 111.247 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 151' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' L' ' 147' ' ' PRO . 21.5 t -65.52 -40.59 88.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 152' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -103.62 115.57 30.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.45 -176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 153' ' ' VAL . . . . . . . . . . . . . 35.2 m -114.56 123.13 69.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 171.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 154' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.76 137.76 31.83 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.37 -41.22 79.76 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 156' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' L' ' 158' ' ' TYR . . . 137.05 141.25 4.22 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 119.425 1.012 . . . . 0.0 113.055 -176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 157' ' ' GLY . . . . . . . . . . . . . . . -126.32 71.27 0.47 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 158' ' ' TYR . . . . . 0.558 ' CE2' ' HA3' ' L' ' 156' ' ' GLY . 0.0 OUTLIER -108.87 89.32 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.344 1.057 . . . . 0.0 108.603 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 159' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.1 -46.68 67.13 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -158.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 160' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.12 121.69 24.18 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 127.65 2.38 . . . . 0.0 109.161 167.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 161' ' ' GLN . . . . . 0.514 ' HB3' ' CA ' ' L' ' 165' ' ' GLN . 0.0 OUTLIER -117.64 45.72 1.88 Allowed 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 154.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.27 -32.9 4.25 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -166.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 163' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -82.78 -0.88 10.29 Favored 'Trans proline' 0 C--O 1.239 0.537 0 CA-C-N 122.01 1.754 . . . . 0.0 113.864 171.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 164' ' ' GLY . . . . . . . . . . . . . . . 171.77 73.24 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 118.374 2.11 . . . . 0.0 118.374 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 165' ' ' GLN . . . . . 0.514 ' CA ' ' HB3' ' L' ' 161' ' ' GLN . 0.8 OUTLIER -71.82 -43.65 65.24 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.878 1.339 . . . . 0.0 110.871 175.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' L' L ' 166' ' ' THR . . . . . . . . . . . . . 6.8 p 52.52 49.23 20.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.835 1.654 . . . . 0.0 111.867 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 167' ' ' THR . . . . . 0.559 HG21 ' H ' ' L' ' 172' ' ' GLY . 26.8 m -126.33 157.34 38.68 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 119.891 -0.723 . . . . 0.0 109.284 -167.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 168' ' ' GLY . . . . . . . . . . . . . . . -86.37 -152.1 19.98 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.514 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -43.21 99.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.782 0.291 . . . . 0.0 111.461 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.14 126.46 65.08 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 123.497 0.719 . . . . 0.0 109.275 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 171' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.66 146.09 14.86 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.347 1.365 . . . . 0.0 112.743 -156.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . 0.559 ' H ' HG21 ' L' ' 167' ' ' THR . . . 88.34 8.31 71.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 165.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 173' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 122.15 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.991 0.895 . . . . 0.0 109.868 170.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 174' ' ' VAL . . . . . 0.486 HG22 ' O ' ' L' ' 165' ' ' GLN . 24.5 t -106.59 117.39 57.08 Favored Pre-proline 0 C--O 1.24 0.567 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.457 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' L' L ' 175' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -67.66 163.22 35.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 CA-C-N 119.473 0.848 . . . . 0.0 111.77 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' L' L ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 C-N-CA 125.451 1.5 . . . . 0.0 112.304 -171.708 . . . . . . . . 0 0 . 1 stop_ save_